Website is intended for physicians
Search:
Всего найдено: 996

authors: 

Abstract:

Article describes a rare case of iatrogenic arterial priapism, which was the result of inadequate surgical tactics in treatment of recurrent venous priapism.

Aim: was to formulate an algorithm of examination and treatment of patients with various forms of priapism.

Materials and methods: treatment of patient with iatrogenic arterial priapism, which developed as a result of inadequate surgical tactics in treatment of venous priapism, was analyzed step by step.

Results: reasons for development of arterial priapism in surgical treatment of venous priapism were identified. Achieved success in arresting arterial priapism by selective embolization a. pudenda interna.

Conclusion: angiography and subsequent selective embolization is a highly effective and safe method of arresting arterial priapism.

 

Abstract:

Two clinical cases of treatment of spontaneous hematomas in elderly patients with COVID-19 using endovascular diagnostic and treatment methods are presented.

Aim: was to show the effectiveness of endovascular hemostasis and, in some cases, there is no alternative to the use of other techniques.

Material and methods: we presented two clinical cases and analyzed the work of domestic and foreign authors on the prevention of venous thrombosis in patients with COVID-19 and endovascular treatment of spontaneous hematomas in patients with COVID-19.

Results: article describes two case reports of catheter embolization in patients with spontaneous hematoma during treatment of severe COVID-19. Elderly patients underwent prevention of thromboembolic complications with low-molecular-weight anticoagulants in prophylactic dosages; during therapy, soft tissue hematomas were revealed in one case in abdominal wall, in the other in chest. In both cases, conservative treatment was ineffective; bleeding required transfusion of blood components. In both cases, embolization was effective, and patients' condition stabilized. In one case, the progression of respiratory failure led to death, the second patient was discharged for out-patient treatment.

Conclusion: catheter embolization for arterial bleeding can be used as monotherapy or as a stage of stabilizing the patient before open surgical treatment.

 

Abstract:

Introduction: intramural hematoma of the aortic wall is a component of acute aortic syndrome, and is also considered a precursor of aortic dissection. Due to peculiarities of the natural course, there are significant disagreements in choosing the optimal strategy for the treatment of intramural hematoma.

Aim: was to evaluate the possibility of a differential tactical approach to the treatment of acute intramural aortic hematoma in various situations.

Material and methods: two clinical cases demonstrate different approaches to the treatment of intramural aortic hematoma.

Results: in given clinical examples, a conservative tactics of managing patients with intramural hematoma of the aorta "watch and wait" was applied. However, in the first case, an emergency surgical intervention was required, due to the complicated course of the disease, according to dynamic studies. The second case demonstrated the acceptability of a conservative approach with long-term monitoring of the condition of the aortic wall.

Conclusions: the balance between risks of surgery and the safety of conservative therapy is the cornerstone in deciding on the optimal tactics for treating this pathology.

 

Abstract:

Article presents a review of the scientific literature containing data on the role of ultrasound examination of joints in the diagnosis of rheumatoid arthritis, ultrasound signs of damage of main elements of joints and periarticular tissues, modern semi-quantitative scales for assessing the severity of main pathological changes detected by ultrasound examination of joints and tendons in patients with rheumatoid arthritis.

Aim: was to analyze scientific publications in domestic and world literature on ultrasound examination of joints in rheumatoid arthritis.

Materials and methods: 38 scientific sources of leading domestic and foreign journals were analyzed.

Results: currently, radiography is the gold standard in the diagnosis of rheumatoid arthritis and is widely used to monitor the progression of rheumatoid arthritis. However, it is not sensitive enough to detect changes at early stage of rheumatoid arthritis, since it only allows assessing bone structures that are involved in the pathological process 6-12 months after the onset of first signs of the disease. Ultrasound examination provides new possibilities for early detection of rheumatoid arthritis, since it allows to detect changes at early pre-radiological stage and to prevent the development of significant structural changes leading to early disability of patients.

Conclusion: the use of ultrasound examination of joints in the diagnosis of rheumatoid arthritis accelerates the diagnosis, is used to dynamically assess the course of the disease, evaluate the effectiveness of therapy, and also to predict outcomes. The diagnostic effectiveness of ultrasound examination of joints in rheumatoid arthritis involves the identification of synovitis, tenosynovitis, structural changes in the articular cartilage and bone (erosion), and an assessment of the severity of the inflammatory reaction.

 

Abstract:

Background: mortality in polytrauma with pelvic injuries and intrapelvic bleeding remains high and can be reduced through a multidisciplinary approach to hemostasis.

Aim: was to determine possibilities and tactics of using endovascular interventions to stop intrapelvic bleeding in polytrauma with pelvic injuries.

Material and methods: a search was made for scientific articles in the PubMed database and the Scientific Electronic Library (eLIBRARY.ru), published from 2017 to 2021. Transcatheter embolization of pelvic arteries is an effective method for stopping intrapelvic bleeding and is indicated for detecting extravasation of contrast in computed tomography and angiography. In patients with unstable hemodynamics, embolization can be used if it is possible to perform it no later than 30-60 minutes after the detection of intrapelvic bleeding. Resuscitation endovascular balloon occlusion of the aorta can serve as an important component of the damage control strategy and a bridge to the application of methods for the final control of abdominal and intrapelvic bleeding in patients with unstable hemodynamics and systolic blood pressure less than 70 mm hg.

Conclusion: methods of endovascular surgery do not oppose and do not exclude the use of extraperitoneal pelvic packing and/or external fixation of the pelvis to stop intrapelvic bleeding in case of polytrauma. The choice of methods of hemostasis and the algorithm for their application are determined by the degree of hemodynamic disturbances, the presence of combined injuries, the data of radiation diagnostics, and the technical and logistical resources of the trauma center.

 

Abstract:

Introduction: prevalence of atrial fibrillation (AF) in the population continues to rise steadily due to the rapid aging of the population [1]. The search for the morphological substrate of AF has been going on for more than half a century. Left atrial remodeling has become such an important aspect in the pathogenesis of AF that some authors advocate the definition of atrial cardiomyopathies [3].

Aim: was to examine the impact of various imaging techniques on the detection of atrial fibrosis and their key role in the treatment of atrial fibrillation.

Conclusions: currently, radiological imaging techniques are available for clinical practice and provide additional possibilities in the assessment of left anterior segment function in AF. Morpho-functional changes in the left atrium can have a great impact on the global hemodynamic function of the left atrium, and as a consequence, these changes can be a significant predictor of the risk of AF progression and stroke development. Morpho-functional changes in the left atrium can have a great impact on the global hemodynamic function of the left atrium, and as a consequence, these changes can be a significant predictor of the risk of AF progression and stroke development.

 

Abstract:

Aim: was to compare results of using of direct stenting and coronary artery stenting after pre-dilation (CSaPD) in STEMI patients with occlusive coronary artery thrombosis in terms of frequency of no-reflow syndrome and adverse cardiovascular events (MACE) during in-hospital period.

Material and methods: study included 620 patients with acute myocardial infarction with elevation of the ST segment of the electrocardiogram and occlusive thrombosis of the infarct-dependent coronary artery, who successfully underwent endovascular revascularization by stenting. The CSaPD group included 297 patients who underwent stenting after a preliminary balloon angioplasty. The direct stenting group consisted of 323 patients who underwent stenting without prior dilation. The primary endpoint of the study was the occurrence of no-reflow syndrome, secondary endpoints were cardiac death, certain stent thrombosis, recurrence of myocardial infarction, as well as the combined MACE point. Patients of both groups were monitored during in-hospital period.

Results: there were no significant differences between the groups of CSaPD and direct stenting in main clinical-demographic and clinical-angiographic indicators, with the exception of the average length of hospitalization (11 [8;12] vs 8 [7;9], respectively, p = 0,04). Endpoint analysis revealed differences in the incidence of no-reflow syndrome (34 (11,45%) vs 9 (2,79%) in the CSaPD and direct stenting groups, respectively, p = 0,03), cardiac death (31 (10,44%) vs 7 (2,17%) in the CSaPD and direct stenting groups, respectively, p = 0,04), as well as the combined MACE point (37 (12,46%) vs 8 (2,48%) in the CSaPD and direct stenting groups, respectively, p = 0,02).

Conclusion: in STEMI patients with occlusive coronary artery thrombosis, direct stenting of the infarct-dependent artery during the restoration of coronary blood flow to TIMI I after passage of coronary guide-wire, significantly reduces the incidence of no-reflow syndrome (34 (11,45%) vs 9 (2,79%) in the CSaPD and direct stenting, respectively, p = 0,03) and cardiac death (31 (10,44%) vs 7 (2,17%) in the CSaPD and direct stenting groups, respectively, p = 0,04).

 

Abstract:

Aim: was to study the mutual influence of new coronavirus infection COVID-19 and acute coronary syndrome and to evaluate the effectiveness of percutaneous coronary interventions in these conditions.

Material and methods: for the period from March 21, 2020 to October 31, 2021, 5093 patients were treated for COVID-19. Including 208 patients with acute coronary syndrome with concurrent COVID-19 disease. All patients underwent following diagnostic procedures: computed tomography of the chest, electrocardiography, echocardiography, coronary angiography and, if necessary, percutaneous coronary intervention.

Results: we present data on the distribution of patients with COVID-19 according to the presence or absence of ST segment elevation on the electrocardiogram and the degree of lung tissue damage, as well as information on the nature of coronary interventions and mortality in these groups. A high frequency of massive thrombosis of infarct-related coronary arteries was demonstrated in the group of patients with STEMI. Possible mechanisms of left ventricular dysfunction that persist after percutaneous coronary intervention are described. A positive effect of endovascular myocardial revascularization on the degree of hypoxia in patients with COVID-19 was shown.

Conclusions: development of acute coronary syndrome with concurrent coronavirus infection significantly worsens the prognosis of the disease. Despite of the success of endovascular treatment, worsening COVID-19 infection can be accompanied by a sharp deterioration in the condition of patients, leading to death.

 

Abstract:

Background: coronavirus disease is characterized by hypercoagulation and requires treatment with anticoagulants. At the background of anticoagulant therapy, life-threatening soft tissue bleeding may occur.

Aim: was to evaluate the efficacy of transcatheter arterial embolization in patients with severe COVID-19 complicated by soft tissue bleeding.

Materials and methods: within the period from January 30, 2021 to February 18, 2022, transcatheter arterial embolization of soft tissue bleeding was performed in 25 patients with COVID-19-associated pneumonia.

Results: transcatheter arterial embolization was performed in 19 of 25 patients (76%). Postoperative mortality was 42%, and overall mortality was 40%. Fifteen patients (60%) were discharged in satisfactory condition.

Conclusions: severe soft tissue bleeding may occur in patients with coronavirus disease while treated with anticoagulants. The method of choice for treatment of these hemorrhages is transcatheter arterial embolization.

 

Abstract:

Introduction: one of directions in development of intravascular diagnostic methods is creation of stations or development of methods that allow combining or uniting possibilities of different modalities. This approach makes it possible to overcome limitations inherent in each method of invasive vascular diagnostics, including angiography. This work is devoted to the analysis of possibilities and first results of using the SyncVision station (Philips Volcano), which allows, in various combinations, to carry out joint registration of angiography data, intravascular ultrasound (IVUS) and instantaneous blood flow reserve (iFR) in various combinations - a non-hyperemic version of fractional flow reserve study.

Aim: was to describe possibilities provided by the use of joint recording of data from angiography, IVUS and real-time instantaneous blood flow reserve, the technique for performing these procedures, as well as to analyze the application of these methods in a department with a large volume of intravascular studies.

Material and methods: the first experience in Russian Federation of the clinical use of the SyncVision station, which is an addition to the s5i intravascular ultrasound system (Philips Volcano), is presented. The station allows you to implement five options that expand the operator's ability to analyze study data and develop a treatment strategy directly at the operating table: co-registration of angiography and intravascular ultrasound (IVUS) data; co-registration of angiography data and instantaneous flow reserve (iFR); triple co-registration - angiography, IVUS and iFR; modification of the program for the quantitative calculation of coronary artery stenosis (QCA); real-time image enhancement software for interventional devices.

Results: studies using co-registration with angiography accounted for 21% of all IVUS procedures and 62,4% of iFR procedures. In 67,3% of all studies with angio-IVUS co-registration, the indication for this diagnostic variant was an extended lesion of artery, which required clarification of length of stenotic area, localization of reference segments, and diameter of artery at different levels. In 30 of these patients, triple co-registration was performed. To clarify the hemodynamic significance of lesion with an angiographically indeterminate or borderline picture, co-registration was performed in 13,2% of all cases, to study a bifurcation lesion with a significant difference in the reference segments and angiographically difficult to determine the entry of lateral branch - in 7,3%.

Based on results of triple co-registration, the decision to perform surgical treatment was made in 30 out of 42 patients (71,4%).

Conclusion: joint registration of IVUS data, coronary angiography, and instantaneous flow reserve (iFR) in real time, forms a new diagnostic modality that significantly expands possibilities of intraoperative examination and affects the planning or analysis of intervention results.

 

Abstract:

Introduction: in recanalization of chronic total occlusions (CTO), contralateral injection is the most important stage, significantly increasing chance of technical success and reducing the incidence of complications.

Materials and methods: 60-year old male patients, with angina pectoris, 3 functional class. After the examination, decision was made to conduct coronary angiography. According to coronarography, occlusion of proximal third of right coronary artery (RCA) was revealed, with collateral filling from the left coronary artery (LCA) R2 and the development of collaterals CC0. According to the scintigraphy data, a «viable myocardium» was detected behind the occlusion zone. Patient underwent mechanical recanalization of RCA with contralateral contrast-agent injection, balloon angioplasty, drug-eluting stents (DES) 3,5?38 mm and 3,5?24 mm were sequentially implanted with a good angiographic result.

Result: contralateral contrast-agent injection during this recanalization helped to avoid complications associated with perforation of lateral branches and greatly facilitated the positioning of guidewire into true lumen of artery. Patient continued military service under the contract.

Conclusion: in case of proper examination, management, and selection of patients, recanalization of chronic occlusion can significantly improve patient's quality of life. It is worth noting that for many patients, social indications are also important, such as the possibility to continue military service or work in a specialty. However, medical indications should be considered first, since unjustified recanalization of chronic occlusion will not improve patient's condition, and a number of serious complications may occur during the operation.

 

Abstract:

Introduction: coronavirus (COVID) pandemic has caused temporary changes in work algorithms of different hospitals, that have not previously provided care for infectious patients. However, the consequences of COVID go beyond infectious pathology. Widespread use of therapeutic doses of anticoagulants as a necessary treatment option and resistant to treatment, cough as a typical symptom, led to an increase in spontaneous ruptures of epigastric arteries with hematomas of abdominal wall, which was an undesirable complication of the main disease.

Aim: was to demonstrate possibilities of endovascular methods in treatment of patients with spontaneous rupture of epigastric arteries on the background of COVID-19 and anticoagulant therapy.

Material and methods: at joinant infectious hospital, inpatient care was provided to 421 patients with coronavirus infection. At the same time, during treatment 9 patients had hematomas of abdominal wall and two of them had spontaneous rupture of rectus abdominis muscle and branches of inferior epigastric artery were damaged. In this article, we present both observations demonstrating the potential of endovascular surgery in treatment of such lesions in patients with COVID-19. Both patients, on the 6 and 10th day of inpatient treatment (severity of lung involvement was Grade 1 and Grade 2) during intense coughing, noted pain and swelling of anterior abdominal wall, accompanied by clinical and laboratory signs of blood loss. Computed tomography angiography (CT-A) revealed extravasation from small branches of inferior epigastric artery with an extensive hematoma that spread into the retroperitoneal space. In a hybrid operating room, a selective embolization of inferior (in one case, due to the high localization of the hematoma, inferior and superior) epigastric artery with an adhesive composition (N-butyl cyanoacrylate with iodolipol) was performed with successful angiographic and clinical results. Patients were discharged without complications on the 7th and 9th days of the postoperative period.

Conclusion: timely CT-diagnostic of severe bleeding, even in cases with atypical localization, and its management by selective embolization of damaged artery is the basis in treatment of spontaneous (cough-associated) ruptures of rectus abdominis muscle in patients with new coronavirus infection.

 

Abstract:

Introduction: dextrocardia - is a congenital heart disease, in which the heart is located in right half of chest. Incidence of ischemic heart disease in patients with dextrocardia is unknown, but some authors write that it is the same as in the general population. Guiding principles of endovascular treatment of chronic total occlusion (CTO) of coronary arteries, consider dualcatheter angiography to be an obligatory option for successful recanalization.

Aim: was to estimate possibilities of DRON-access and various radial accesses in treatment of multivessel disease in a patient with dextrocardia, severe comorbidity, and single vascular access.

Material and methods: we present case report of a 63-year-old female patient, who previously had ischemic stroke with tleft-sided hemiplegia; she was examined before surgery for instability of the prosthesis of right hip joint. Coronary angiography through traditional radial access revealed multivessel lesions of coronary arteries: chronic total occlusion (CTO) of right coronary artery, stenosis of the left anterior descending artery (LAD) in proximal and distal third; eccentric circumflex artery (Cx) stenosis. Further examination revealed: severe spastic paralysis of left hand, occlusion of left common femoral artery, chronic osteomyelitis of right leg with suppuration.

Medical consilium decided to perform staged endovascular revascularization of the myocardium.

For this purpose, to provide access for double-catheter recanalization of CTO and subsequent interventions, DRON-access (Distal radial and Radial One-handed accesses for interventions iN chronic occlusions of coronary arteries) and various radial accesses were used.

Results: at the first stage, using DRON-access, we performed double-catheter angiography and CTO recanalization of right coronary artery (RCA) with stenting. At the second stage, through traditional radial access, we performed angioplasty and stenting of LAD at two levels. After 3 months, control coronary angiography was performed through distal radial access: implanted stents had no signs of restenosis, there was no progression of atherosclerotic process. Patient was discharged to prepare for correction of instability of right hip joint prosthesis.

Conclusions: patients with severe and variable comorbidities require not only a multidisciplinary approach, but also, in various of clinical situations, need personalized approach. The use of DRON-access may allow operators to perform endovascular intervention using double-catheter angiography even in patients with single vascular access, which meets modern criteria for providing care for chronic coronary artery occlusions.

 

Abstract:

Introduction: although great progress has been made in the diagnosis and treatment of oncological diseases, malignant tumors still remain among the leading death causes globally. Thus, improving diagnostic methods, as well as predicting response to cancer treatment is a relevant clinical medicine problem.

Aim: was to study the role of radiomics and radiogenomics in the diagnosis, clinical prognosis and treatment response assessment in oncological diseases on the basis of available scientific information sources.

Material and methods: analysis of 55 domestic and foreign literature sources. Images obtained by the methods of diagnostic radiology (CT, MRI, PET) represent the phenotypic manifestation substrate of malignant tumors and can be correlated with the expression profiles of certain genes.

Malignant tumors radiomics and radiogenomics involves the search for correlations of visualization quantitative signs with a genomic signature using computer algorithms for data analysis. The ultimate goal of this process is to establish a link between imaging features, tumor molecular genetic characteristics and treatment response assessment.

Conclusion: numerous studies illustrate the possibility of involving radiomics and radiogenomics in all stages of oncological care, from diagnosis to therapeutic response evaluation and relapse risk assessment in a particular patient, which contributes to a personalized approach in oncology and clinical decision-making system implementation.

 

Abstract:

Aim: was to identify and analyze key factors affecting the outcome of subarachnoid hemorrhage (SAH) in patients with ruptured cerebral aneurysms and endovascular embolization.

Materials and methods: as a material for this study, results of endovascular treatment of 150 patients with ruptured cerebral aneurysms operated in the acute period of subarachnoid hemorrhage were analyzed.

Results: statistically significant factors influencing the target indicator «Unfavorable outcome» on the Rankin scale (mRs 3-5) and the indicator «Fatal outcome» in patients with SAH who underwent endovascular method were identified. Among factors contributing to an unfavorable outcome are: severity of neurological status, prevalence of SAH according to computed tomography (CT), timing of surgical treatment from the moment of onset of SAH symptoms.

Conclusion: factors of severity of the condition on the Hunt-Hess scale (HH), severity of subarachnoid hemorrhage on the Fischer scale (F) and timing of the operation have the greatest influence on the outcome of subarachnoid hemorrhage of aneurysmal genesis.

 

Abstract:

Aim: was to study the impact of angiographic projection on patient and operator radiation dose during endovascular interventions aimed at diagnosing and treating cerebrovascular diseases.

Materials and methods: in experiment, radiation dose rate of phantom model (cGy?cm2/s) and equivalent dose rate from scattered radiation (mSv/h) measured in the area of conditional location of operator were studied when the angle of the X-ray tube was changed in modes of digital subtraction angiography (DSA) and fluoroscopy. Radiation dose rate of endovascular surgeon (mSv/h) was assessed during 12 cerebral angiography procedures and 15 neuro-interventions in general angiographic projections. Values of the kerma-area product (Gy?cm2), fluoroscopy time (min), operator exposure dose (µSv) during 87 procedures of endovascular occlusion of aneurysm of cavernous and supraclinoid sections of internal carotid arteries (ICA) were retrospectively analyzed to indirectly assess the effect of angiographic projection on patient and surgeon occupational dose. Interventions were divided into 2 groups depending on the location of detected aneurysm. The 1st group included 35 operations in the right ICA, the 2nd group included 53 operations in the left ICA.

Results: in experimental study, highest values of radiation dose rate of the phantom model were found in frontal projection with cranial angulation, lowest - in lateral and oblique projections; The highest average dose rates from scattered radiation in operator's area were found in left lateral projections whereas the smallest in right lateral projection in DSA mode and also in frontal and right lateral projections in fluoroscopy mode.

When studying doses of scattered radiation during neuro-interventional procedures, it was found that when the position of the X-ray tube changes from 0° in the direction of left lateral projection, an increase in the average dose rate of the operator in the DSA mode is up to 2,6 times, with fluoroscopy - up to 2,4 times. The equivalent dose rate in left lateral projection is up to 1.5 times higher than in right lateral projection. In left oblique projection, there is an increase in dose rate up to 2,3 times compared to right oblique projection.When comparing radiation exposure indicators during aneurysm embolization procedures, a significant increase in operator exposure doses is observed in group of interventions in the left ICA.

Conclusion: when performing neuro-interventional procedures, it is possible to achieve a significant reduction in radiation exposure to patient and operator without a significant loss in image quality along with maintaining optimal visualization of pathological changes by choosing angiographic projections with lower radiation doses.

 

Abstract:

Aim: was to evaluate the safety and efficacy of delayed endovascular treatment without stent implantation in ST-elevation myocardial infarction (STEMI) caused by massive thrombotic load and ectasia of infarct-related coronary artery.

Material and methods: out of 4263 primary percutaneous coronary interventions (PCI) performed for STEMI for the period from January 2016 to September 2021, retrospective analysis included data of 21 patients with ectasia of infarct-related coronary artery and massive thrombotic load (TTG ? 3).

Results: method of delayed endovascular treatment, without stent implantation, in STEMI caused by massive thrombotic load and ectasia of infarct-related coronary artery, allowed to significantly improve parameters of epicardial coronary blood flow according to  TIMI and CFTC scales in 71% and 67% of examined patients (p <0,001, p=0,001); increase myocardial perfusion according to MBG in 62% of patients (p=0,001); reduce the severity of thrombotic load according to TTG scale in 71% of the subjects (p=0,001).

Conclusion: in patients with ST-elevation myocardial infarction caused by massive thrombotic load and ectasia of infarct-related coronary artery, the strategy of delayed endovascular treatment with-out stent implantation is safe and effective at the hospital stage.

 

Abstract:

Introduction: the importance of intravascular diagnostic methods and the frequency of their use in clinical practice is steadily increasing. However, in the Russian Federation, studies on the analysis of possibilities of intravascular imaging or physiology are sporadic, and statistical data are presented only in very generalized form. This makes it relevant to create a specialized register dedicated to these diagnostic methods.

Aim: was to present the structure, tasks and possibilities of the Russian registry for the use of intravascular imaging and physiology based on results of the first year of its operation.

Material and methods: In total, in 2021, forms were filled out for 2632 studies in 1356 patients.

Studies included all types of intravascular imaging and physiology - intravascular ultrasound, optical coherence tomography, measurement of fractional flow reserve and non-hyperemic indices.

The registry's web-based data platform includes 14 sections and 184 parameters to describe all possible scenarios for applying these methodologies. Data entry is possible both from a stationary computer and from mobile devices, and takes no more than one minute per study. Received material is converted into Excel format for further statistical processing.

Results: 13 departments participated in the register, while the share of the eight most active ones accounted for 97,5% of all entered forms. On average, 1.9 studies per patient were performed, with fluctuations between clinics from 1,6 to 2,9. Studies of the fractional flow reserve accounted for 40% of total data array, intravascular ultrasound - 37%, optical coherence tomography - 23%. Of all studies, 80% were performed on coronary arteries for chronic coronary artery disease, 18% - for acute coronary syndrome, 2% were studies for non-coronary pathology. In 41% of cases, studies were performed at the diagnostic stage, without subsequent surgery. In 89,6% of cases, this was due to the detection of hemodynamically insignificant lesions, mainly by means of physiological assessment. In 72% of cases, the use of intravascular imaging or physiology methods directly influenced the tactics or treatment strategy - from deciding whether to perform surgery or not to choose the optimal size of instruments or additional manipulations to optimize the outcome of the intervention. In the clinics participating in the register, the equipment of all major manufacturers represented on the Russian market was used.

Conclusions: the design of the online registry database is convenient for data entry. Participation in the registry of most departments that actively and systematically use methods of intravascular imaging and physiology ensured the representativeness of obtained data for analysis in interests of both practical medicine and industry, as well as for scientific research in the field of intravascular imaging and physiology. The register has great potential for both quantitative and qualitative improvement.

 

Abstract:

Aim: was to study the efficacy and functionality of the Yukon Chrome PC stent in clinical practice.

Materials and methods: in 2021, a prospective, observational study of the safety, effectiveness of the Yukon Chrome PC stent, as well as its functionality during implantation in clinical practice, was launched on the basis of 25 domestic clinics. The study included 364 patients who underwent implantation of 495 Yukon Chrome PC stents. Mean age of patients was 62,8 years (from 33 to 89 years). Men were 263 (72,3%). The vast majority (82,4%) of patients were diagnosed with acute coronary syndrome (ACS): without ST segment elevation - 180 (49,45%) patients; with ST segment elevation - 120 (32,9%) patients. Unstable angina was verified in 22 (6%) patients. There were 42 (11,5%) patients with stable angina class 2-3.

Moderate tortuosity of vessels occurred in 27,7% of cases, while severe tortuosity of vessels occurred in 3,57% of cases. Moderate calcification was noted in 115 (31,5%) patients, severe/massive - in 23 (6,3%) cases. A complex lesion combining severe/moderate calcification and severe/moderate tortuosity of the target artery occurred in 79 (21,7%) patients.

Results: technical success of the procedure was achieved in 97,5% of cases. In one patient with severe calcification, the Yukon Chrome PC stent could not be inserted into the affected area. Attempts to implant another stent were also unsuccessful.

Depending on the number of implanted stents, the patients were distributed as follows: 3 stents were inplanted in 31 (8,5%) patients; 2 stents - 102 (28%) patients, 1 stent - 231 (63,5%) patients.

Bifurcation stenting using a two-stent technique was performed in 69 (19%) patients. Stenting of the left main was performed in 11 (3%) cases. Predilation was performed in 245 (67%) patients; postdilation - in 179 (49%) patients.

Conclusion: analysis of hospital results of implantation of Yukon Chrome PC stents indicates good flexibility and deliverability of stents even in patients with moderate and severe sheath calcification.

The overall assessment of the functional characteristics of the stent among endovascular surgeons who performed stenting is quite high.

 

 

Abstract:

Introduction: pathological tortuosity of internal carotid arteries (ICA) is widespread; its frequency in population varies within 18-34%. Currently, there are several approaches for the determination of indications for surgical intervention in pathological ICA tortuosity. The main criteria are hemodynamic changes in the arterial flow and the presence of neurological symptoms, so an informative preoperative examination is an integral part in treatment strategy determination in patients' subsequent treatment.

Aim: was to estimate the condition of carotid arteries and substance of the brain in isolated pathological tortuosity and in combination with stenotic lesions, based on results of CT angiography.

Materials and methods: we analyzed results of examination and treatment of 70 patients. Ultrasound and CT angiography of brachiocephalic arteries were performed on a Philips iCT 256-slice multislice computed tomograph. During CT angiography, a non-contrast study, arterial and venous phases of contrast enhancement were performed with an intravenous bolus injection of 50.0 ml of isoosmolar iodinated contrast-agent at 4-5 ml/sec.

Patients were divided into two groups: patients with isolated pathological carotid tortuosity (28 pts) and patients with a combination of carotid tortuosity and stenotic lesions (42 pts). We assessed the effect of carotid tortuosity on the severity of the brain tissue alterations using statistical analysis.

Results: a lesser severity of changes in the substance of the brain was noted in patients in the group with isolated pathological tortuosity of ICA. In 9 cases, we did not detect focal lesions; in 15 cases, small foci of microangiopathy and individual cerebrospinal fluid cysts were noted, in 4 patients, we noted areas and zones of cystic-glial changes. S- and C-shaped deformation became the most frequent variants of tortuosity; the formation of 3 saccular aneurysms (two true and one false) was revealed.

Manifestations of ischemic damage of the brain substance in the group of patients with a combination of ICA tortuosity and stenotic lesion were more pronounced. Thus, in 11 cases, zones and areas of cystic-glial changes were determined within the framework of past cerebrovascular accidents; in 20 patients, foci of microangiopathy expressed in varying degrees, as well as individual cerebrospinal fluid cysts, were noted. In 11 cases, no focal lesions were detected in the brain.

Statistical processing showed a correlation between the condition of carotid arteries and the presence of focal brain damage - in the group with combination of pathological tortuosity and stenosis of ICA, more pronounced chronic ischemic brain damage was detected (p=0,012).

Conclusion: CT-angiography was noted to be highly informative in assessment of condition of carotid arteries and brain substance in patients with isolated pathological tortuosity, as well as in combination with a stenotic lesion of internal carotid arteries. With a combination of pathological tortuosity and a stenosis in internal carotid arteries, data were obtained on a more pronounced damage of the brain substance. According to computed tomography, clinical manifestations of chronic cerebrovascular insufficiency were generally more pronounced compared to changes in the brain substance. However, there was a correlation between the increase in the degree of chronic cerebrovascular insufficiency and the aggravation of the state of the brain substance.

authors: 

 

Article exists only in Russian.

 

Abstract:

Introduction: pseudo-aneurysm of subclavian artery is a rare pathology and most often develops due to trauma or iatrogenic causes. Despite the rarity of this pathology, it can be accompanied by the risk of lethal rupture or distal embolism. Article presents a case report of endovascular treatment of post-traumatic pseudo-aneurysm of right subclavian artery with a stent-graft.

Aim: was to demonstrate advantages of endovascular treatment of pseudo-aneurysms, based on case report of patient with post-traumatic pseudo-aneurysm of right subclavian artery.

Material and methods: a case report of a patient with post-traumatic pseudo-aneurysm of right subclavian artery, polytrauma and pulmonary embolism is presented.

Results: successful endovascular treatment of pseudo-aneurysm of right subclavian artery with the implantation of stent-graft was performed. Postoperative period was uneventful, and the patient was discharged with improved health.

Conclusions: endovascular treatment is the preferred method, due to its less invasiveness and lower complication frequency in comparison with open surgery.

 

Abstract:

Introduction: treatment of patients with bilobar metastatic liver disease remains an unsolved problem. Among methods of regional chemotherapy, the least studied is isolated liver chemoperfusion, which is an unpopular technique due to its high trauma and difficult reproducibility.

Aim: was to demonstrate the method of endovascular isolated liver chemoperfusion (EILHP) developed by us.

Case report: EILCP was performed using a heart-lung machine (HLM) in a patient with cancer of the rectum, stage 2 (pT3N0M0), after combined treatment (radiation therapy (SOD 60 Gy) + anterior resection of the rectum in 2007). Disease progression. Isolated metastatic liver disease (01.2021). Isolated chemoperfusion was performed endovascularly using 2-balloon catheters, which provided vascular isolation of the liver and its isolated perfusion during the procedure. Posi- tioning of balloon catheters was performed in an open way through femoral artery and vein. Perfusion was carried out for 30 minutes with chemotherapy drugs (CtD) oxaliplatin 42,5 mg/m2 and irinotecan 82,5 mg/m2 injected directly into the circuit.

Results: the duration of intervention was 160 minutes, intraoperative blood loss was 50 ml. During insertion and positioning of aortic balloon, a limited dissection of the aorta developed in area of left common iliac artery deviation, which did not require any intervention in postoperative period. Duration of intensive care unit stay was 1 day. There were no complications associated with aortic dissection during 3-month follow-up. Level of ALT and AST remained within reference values during entire postoperative period. No hematological toxicity was observed. Patient was discharged on the 7th day after operation in satisfactory condition.

Patient underwent control CT scan of abdominal organs, 30 days after endovascular isolated chemoperfusion of the liver. According to the RECIST scale, stabilization of tumor process was noted.

Conclusions: proposed technique of endovascular isolated liver chemoperfusion is technically feasible and safe. The use of this method may be appropriate in treatment of patients with isolated liver metastases who require dose reduction of chemotherapeutic agents due to their severe toxicity or high patient comorbidity.

 

Abstract:

Introduction: currently, chemoradiation therapy is widely used as the main method of specific treatment for locally advanced head and neck cancer. Previously it was believed that radiation damage of carotid arteries occurs only several years after treatment.

Material and methods: article presents two case reports of internal carotid artery stenosis which arose directly during the course of chemoradiation of head and neck malignant tumors. In the first case, patient K., 54 years old, had laryngeal cancer (stage III: T3N1M0), in the second case, patient M., 40 years old, had tongue cancer (stage I: T1N0M0).

Conlusion: article presents angiographically confirmed carotid artery stenosis arisen directly during chemoradiation and in early stages after its completion. The discussion presents data on the incidence of stenosing lesions of carotid arteries, cerebrovascular events among patients undergoing radiation therapy. It is necessary to draw attention of specialists to the problem of early stenosis of carotid arteries during radiation and chemoradiation therapy of head and neck tumors.

 

Abstract:

Aim: was to evaluate the effectiveness of the complex use of MRI and high-resolution ultrasound for the diagnostics of fillers.

Material and methods: in presented case report, the study was carried out using a SOMATOM Aera SIMENS 1.5 Т tomograph in T1, T1 Dixon, T1 Fs, T2, T2 STIR modes, the slice thickness was 3 mm. Ultrasound was performed with a MyLab Alpha, Esaote device, linear sensors with a frequency of 6 - 18 MHz and 10 - 22 MHz were used in B-mode, Color Doppler Imaging mode.

Results: case report demonstrates possibilities of complex use of ultrasound and MRI in patients with atypical ultrasound pattern for hyaluronic acid-based fillers. When choosing treatment tactics, data obtained during the examination, indicating the presence of a filler in soft tissues of the chin that does not correspond to the ultrasound and MRI signs of hyaluronic acid, were taken into account.

Conclusions: complex diagnostics of dermal fillers using high-resolution ultrasound and MRI is indicated for patients with complications of contouring, for differential diagnostics of hyaluronic acid with fillers of non-hyaluronic nature.

 

Abstract:

Introduction: about 200 million people in the world suffer from ischemia of lower limbs. This pathology occupies a large part in the structure of all lesions of the vascular bed. Most patients with lesions of lower limb arteries have critical lower limb ischemia (CLLI), which is characterized by pain at rest and/or trophic lesions of foot. CLLI is the final stage of lower limb vascular bed lesion and is always accompanied by a deterioration in the quality of life, high morbidity and mortality. The only effective way to treat this pathology is revascularization, however, the current lack of clinical data does not allow us to determine the optimal strategy in treatment of this pathology.

Aim: was to determine advantages and disadvantages of using various methods of lower limb revascularization.

Material and methods: literature data from information aggregators Cyberleninka, Pubmed and MEDLINE on this topic, published in Russian and English for the period from 2010 to 2021, were selected for analysis. Articles written in German and French were included in the study in case of available translation to English. Termins as an inclusion criteria: critical limb ischaemia, ischaemic pain, tissue loss, gangrene, hybrid intervention, open surgical recanalization, endovascular revascularization, claudication, stenosis.

Results: it is determined that revascularization by open surgery showed better long-term results, however, it cannot be recommended for patients with severe comorbid diseases and defeat of lower limb and foot arteries, while endovascular revascularization techniques allow the procedure to be performed in almost all patients, regardless of the severity of their somatic status, however, extended multilevel lesions are poorly amenable to this method of treatment, and also have a relatively lower patency in the long-term period. Hybrid interventions combine advantages of both methods, however, they have high requirements for the equipment of the medical institution and the qualifications of the staff. In addition, hybrid methods are also more dangerous for the patient in comparison with revascularization by endovascular methods.

 

Abstract:

Patients with suspected peripheral artery disease (PAD) with critical limb ischemia (CLI) require intervention for limb salvage. Successful revascularization depends on quality and accurate visualization of vascular bed of lower limbs. Recent advances in imaging technology have significantly impacted the preoperative assessment of patients with PAD. The following is a description of main invasive techniques of obtaining high-quality images of arteries of lower limbs.

Aim: was to summarize data of modern literature sources, on the effectiveness of modern instrumental diagnostic methods for early and effective invasive assessment of blood flow and perfusion of lower limbs for planning revascularization interventions and assessing its effectiveness.

Material and methods: we analyzed sources of Russian and foreign literature over the past 5 years on the issue of modern possibilities of invasive diagnosis of critical lower limb ischemia. When choosing sources, we relied on the information content of described methods, the relevance of research, results of which are being applied today, and outlined prospects for their application in the future.

Conclusions: over the years, digital subtraction angiography has been traditionally the «gold standard» for intravascular imaging of lower limbs. Over time, this method has been improved because technological advances have created high-quality alternatives for preoperative (computed tomography [CT] angiography and magnetic resonance angiography [MRA]) and intraoperative imaging (Vascular Flow Reserve [VFR], intravascular ultrasound [IVUS], optical coherence tomography [OCT] and angiography CO2).

 

Abstract:

Introduction: percutaneous coronary intervention plays an important role in treatment of acute myocardial infarction with ST-segment elevation. However, the benefit of performing delayed PCI is controversial (>12h after onset of symptoms typical for STEMI).

Aim: was to compare results of PCI and medical therapy (MT) in patients, who had been admitted to the hospital with verified STEMI, diagnosed 12 hours after the onset of symptoms, and to estimate their effect on clinical outcomes.

Material and methods: data of 100 patients was analyzed, PCI was performed in 62 patients and 38 patients underwent medical therapy. The task was to compare clinical outcomes, which included mortality and major adverse cardiac events (MACE).

Results: all-cause mortality in groups of delayed PCI and MT was 4 (6,45%) and 9 (23,6%) respectively (p <0,05). It was also recorded that minor cases of cardiac death occurred in the group of delayed PCI in comparison with the MT group, 1 (1,6%) and 6 (15,7%) respectively (p <0,05).

Conclusion: delayed PCI (12 hours after the onset of the myocardial infarction in STEMI patients) leads to improvement in all-cause mortality and cardiac death rates compared with conservative treatment.

 

 

Abstract:

Article presents a retrospective analysis of using the modified way experience in removing the occlusive substrate from cerebral vessels in the ischemic stroke acute phase after failed standard thrombectomy.

Aim: to study the efficacy and advantages of thrombectomy technique from intracranial arteries in patients with acute ischemic stroke combining a stent-retriever with reperfusion catheter in comparison with the standard stent retriever thromboextraction.

Methods: we analyzed 54 hospital charts of patients who had underwent endovascular recanalization of intracranial large vessel occlusion in acute ischemic stroke. Patients were divided into two equal groups, depending on thrombus removal method. Standard stent-retriever thrombectomy with a balloon guide-catheter was performed as the first stage in both groups. In 27 cases (1st group), after standard stent-retriever technique failed, we carried out combination of retriever extraction with distal aspiration and a guiding balloon-catheter. If we couldn’t safely insert stent-retriever into catheter of distal approach (during thrombectomy), we switched to vacuum aspiration from guiding balloon-catheter (vacuum-blocked) and removed stent-retriever, microcatheter and distal approach catheter simultaneously without reducing tension. In 27 patients (2nd group) after standard thrombectomy failed we repeated this technique several times.

Results: embolic complications relative risk was 2,249, 95% CI (1,126 - 4,492) and reperfusion mTICI 3 100% versus 74,07% rate was higher in the first group, in comparison with the second group. Other complications and hospital outcomes of disease did not differ between groups.

Conclusion: a stent retriever combined with distal aspiration and a simultaneous transition to vacuum-blocked extraction using after an unsuccessful standard thrombectomy increases the efficiency of complete reperfusion by 25%. Its use is 1,8 times safer than standard thrombectomy in terms of embolic complications.

 

Abstract:

Article describes cases of detection of viral pneumonia in patients who underwent additional examination before planned hospitalization for surgical treatment in the presence of negative test results for the SARS-CoV-2 virus.

Aim: was to detect early computed tomography (CT) signs of COVID-19 during admission to hospital, in case of presence of normal clinical and laboratory data and negative results of PCR test.

Material and methods: image analysis of CT examinations of chest organs in patients admitted for surgical treatment for various osteoarticular pathologies, for the period of 3 months, was carried out in radiology department.

Results: during CT examination of chest organs, in 9,1% patients, signs of viral pneumonia were revealed, including those caused by SARS-CoV-2, in condition of negative results of PCR tests, immunoserological tests for the presence of immunoglobulins M and G to SARS-CoV-2.

Conclusion: computed tomography of lungs can be considered the «gold standard» of diagnostics, which makes it possible to detect early subclinical inflammatory changes in lungs, in particular, in pneumonia associated with COVID-19, which is the main task during a pandemic.

 

 

Abstract:

Introduction: a case report of successful treatment of an extremely rare pathology (0,27-0,34%) - acute occlusion of both internal carotid arteries (ICA) is presented.

Aim: was to show possibilities of endovascular surgery in the diagnosis and treatment of acute ischemic stroke (AIS) in patients with bilateral acute ICA occlusion.

Materials and methods: a 38-year-old patient was hospitalized by ambulance with the diagnosis of AIS. Multispiral computed tomography (MSCT) revealed left ICA occlusion in the C2-C5 segment. Selective angiography of ICA was performed: right ICA - non-occlusive thrombosis C2-C3 segments; left ICA - thrombotic occlusion in C1 segment.

Results: thrombaspiration was performed from the left ICA and right ICA; full recovery of antegrade cerebral blood flow was achieved in both ICA, according to the modified treatment in cerebral infarction score (mTICI) - 3. Patient was discharged after 28 days. At the time of discharge, the modified Rankin Scale (mRS) score was 3. 6 months after discharge mRS was 1.

Conclusions: Selective angiography of both ICA in a patient with AIS enabled to detect right ICA thrombosis not detected by MCT, which in its turn changed the treatment tactics of the patient. Aspiration thromebctomy from both internal carotid arteries allowed to achiev full recovery of antergrade cerebral blood flow of both internal carotid arteries.

 

References

1.     The top ten cuases of death, WHO fact sheets 2020.

https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causes-of-death

2.     Shapoval IN, Nikitina SYu, Ageeva LI, et al. Zdravoochranenie v Rossii. 2019 [In Russ].

https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2019.pdf

3.     Aigner A, Grittner U, Rolfs A, et al. Contribution of established stroke risk factors to the burden of stroke in young adults. Stroke. 2017; 48: 1744-1751.

https://doi.org/10.1161/STROKEAHA.117.016599

4.     Gafarova AV, Gromova EA, Panov DО, et al. Social support and stroke risk: an epidemiological study of a population aged 25-64 years in Russia/Siberia (the WHO MONICA-psychosocial program). Neurology, Neuropsychiatry, Psychosomatics. 2019; 11(1): 12-20 [In Russ].

https://doi.org/10.14412/2074-2711-2019-1-12-20

5.     Putaala J. Ischemic Stroke in Young Adults. Continuum. 2020; 26(2): 386-414.

https://doi.org/10.1212/CON.0000000000000833

6.     Si Y, Xiang S, Zhang Y. et al. Clinical profile of etiological and risk factors of young adults with ischemic stroke in West China. Clinical Neurology and Neurosurgery. 2020; 193.

https://doi.org/10.1016/j.clineuro.2020.105753

7.     Ekker MS, Boot EM, Singhal AB, et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults. The Lancet Neurology. 2018; 17(9): 790-801.

https://doi.org/10.1016/s1474-4422(18)30233-3

8.     Chi X, Zhao R, Pei H, et al. Diffusion-weighted imaging-documented bilateral small embolic stroke involving multiple vascular territories may indicate occult cancer: A retrospective case series and a brief review of the literature. Aging Med. 2020; 3(1): 53-59.

https://doi.org/10.1002/agm2.12105

9.     Dietrich U, Graf T, Sch?bitzb WR. Sudden coma from acute bilateral M1 occlusion: successful treatment with mechanical thrombectomy. Case Rep Neurol. 2014; 6: 144-148.

https://doi.org/10.1159/000362160

10.   Pop R, Manisor M, Wolff V. Endovascular treatment in two cases of bilateral ischemic stroke. Cardiovasc Intervent Radiol. 2014; 37: 829-834.

https://doi.org/10.1007/s00270-013-0746-4

11.   Larrew T, Hubbard Z, Almallouhi E.et al. Simultaneous bilateral carotid thrombectomies: a technical note. Oper Neurosurg. 2019; 5(18): 143-148.

https://doi.org/10.1093/ons/opz230

12.   Storey C, Lebovitz J, Sweid A, et al. Bilateral mechanical thrombectomies for simultaneous MCA occlusions. World Neurosurg. 2019; 132: 165-168.

https://doi.org/10.1016/j.wneu.2019.08.236

13.   Braksick SA, Robinson CP, Wijdicks EFM. Bilateral middle cerebral artery occlusion in rapid succession during thrombolysis. Neurohospitalist. 2018; 8: 102-103.

https://doi.org/10.1177/1941874417712159

14.   Jeromel M, Milosevic Z, Oblak J. Mechanical recanalization for acute bilateral cerebral artery occlusion - literature overview with a case. Radiology and Oncology. 2020; 54(2): 144-148.

https://doi.org/10.2478/raon-2020-0017

 

Abstract:

Introduction: aneurysms of splenic arteries have a fairly high prevalence in relation to the total number of all visceral aneurysms. According to modern clinical guidelines, both symptomatic and asymptomatic aneurysms are subject to treatment. Recently, the priority direction in treatment of visceral aneurysms is endovascular surgery, which is characterized by minimal invasiveness and high efficiency, which makes it possible to consider transcatheter endovascular embolization of splenic artery aneurysms as the preferred method of treatment.

Aim: was to estimate the role and possibilities of endovascular methods of treatment in a patient with a false aneurysm of splenic artery (ASA) formed after pancreatic necrosis and complicated by gastrointestinal bleeding.

Materials and methods: a case report of transcatheter embolization of splenic artery aneurysm using the «front-to-back-door» technique using coils and telescopic system, is presented.

Results: patient was discharged on the 3rd day after embolization. The postoperative period proceeded calmly, there was no abdominal pain, indicators of clinical and biochemical blood tests were within acceptable limits.

Conclusions: studies devoted to treatment of giant aneurysms of splenic artery are not described in the modern literature, there are only few reports. Treatment of this type of ASA can lead to an increase in the cost of procedure, but minimal invasiveness, technical success, almost no deaths and early activation of patients make it possible to consider transcatheter endovascular embolization as the only possible method of treatment.

 

References

1.     Chaer RA, Abularrage CJ, Coleman DM, et al. The Society for Vascular Surgery clinical practice guidelines on the management of visceral aneurysms. J Vasc Surg. 2020; 72: 3-39.

https://doi.org/10.1016/j.jvs.2020.01.039

2.     Wang W, Chang H, Liu B, et al. Long-term outcomes of elective transcatheter dense coil embolization for splenic artery aneurysms: a two-center experience. J Int Med Res. 2020; 48: 300060519873256.

https://doi.org/10.1177/0300060519873256

3.     Musselwhite CC, Mitta M, Sternberg M. Splenic Artery Pseudoaneurysm. J Emerg Med. 2020; 58: 231-232.

https://doi.org/10.1016/j.jemermed.2020.02.014

4.     Rhusheet P, Mark G. Splenic artery pseudoaneurysm with hemosuccus pancreaticus requiring multimodal treatment. J. Vasc. Surg. 2019; 69: 592-595.

https://doi.org/10.1016/j.jvs.2018.06.198

5.     Venturini M, Piacentino F, Coppola A, et al. Visceral Artery Aneurysms Embolization and Other Interventional Options: State of the Art and New Perspectives. J Clin Med. 2021; 10: 2520.

https://doi.org/10.3390/jcm10112520

6.     Hemp JH, Sabri SS. Endovascular management of visceral arterial aneurysms. Tech. Vasc. Interv. Radiol. 2015; 18: 14-23.

https://doi.org/10.1053/j.tvir.2014.12.003

7.     Regus S, Lang W. Management of true visceral artery aneurysms in 31 cases. J. Visc. Surg. 2016; 153: 347-352.

https://doi.org/10.1016/j.jviscsurg.2016.03.008

8.     Kok HK, Asadi H, Sheehan M, et al. Systematic review and single center experience for endovascular management of visceral and renal artery aneurysms. J. Vasc. Interv. Radiol. 2016; 27: 1630-1641.

https://doi.org/10.1016/j.jvir.2016.07.030

9.     Gorsi U, Agarwal V, Nair V, et al. Endovascular and percutaneous transabdominal embolisation of pseudoaneurysms in pancreatitis: An experience from a tertiary-care referral centre. Clin. Radiol. 2021; 76(314): 17-23.

https://doi.org/10.1016/j.crad.2020.12.016

10.   Barrionuevo P, Malas MB, Nejim B, et al. A systematic review and meta-analysis of the management of visceral artery aneurysms. J. Vasc. Surg. 2020; 72: 40-45.

https://doi.org/10.1016/j.jvs.2020.05.018

11.   Vemireddy LP, Majlesi D, Prasad S, et al. Early Thrombosis of Splenic Artery Stent Graft. Cureus. 2021; 13: 16285.

https://doi.org/10.7759/cureus.16285

12.   Kapranov MS, Kulikovskiy VF, Karpachev AA, et al. A Case Report of Successful Endovascular Treatment of «Sentinel Bleeding» in Patient with Adverse Anatomy. EJMCM. 2020; 7(2): 146-150.

https://doi.org/10.31838/ejmcm.07.02.24

13.   Саховский С.А., Абугов С.А., Вартанян Э.Л. и др. Эндоваскулярная коррекция структурной патологии клапанов и аорты у реципиентов сердца. Эндоваскулярная хирургия. 2021; 8(1): 53-9.

Sakhovskii SA, Abugov SA, Vartanyan EL, et al. Transcatheter correction of structural valve and aortic diseases in heart recipients. Endovaskulyarnaya khirurgiya. 2021; 8(1): 53-9 [In Russ].

https://doi.org/10.24183/2409-4080-2021-8-1-53-59

14.   Tipaldi MA, Krokidis M, Orgera G, et al. Endovascular management of giant visceral artery aneurysms. Sci Rep. 2021; 11: 700.

https://doi.org/10.1038/s41598-020-80150-2

 

Abstract:

Introduction: half-year data on results of using new domestic NanoMed devices for closing atrial septal defects (ASD) were obtained. The occluder is a nitinol self-expanding and self-centering double disc device with a polyester membrane.

Aim: was to evaluate the safety and efficacy of a new domestic occluder for closing of atrial septal defect in a small group of patients over a 6-month follow-up period.

Material and methods: four pediatric patients underwent closure of atrial septal defects with domestic NanoMed occluders. Clinical examination and transthoracic echocardiography were performed at 24 hours, 1, 3, and 6 months. Endpoints included technical success of intervention, efficacy and safety of the procedure at follow-up instrumentation and physical examination.

Results: the average age of patients was 5,2 years (range 4 to 7 years). Mean ASD diameters and device waist sizes were 11,9 ± 1,2 mm and 13,7 ± 1,2 mm and 13,7 ± 1,2 mm, respectively. Technical and procedural success achieved in 100% of cases. During the six-month follow-up, no adverse events and residual flows were identified.

Conclusion: initial half-year data on the absence of adverse events and residual flows indicate the safety and effectiveness of the use of NanoMed occluders.


References

1.     Stout K, Daniels C, Aboulhosn J, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019; 73(12): 1494-1563.

https://doi.org/10.1016/j.jacc.2018.08.1028

2.     Pettersen MD, Du W, Skeens ME, Humes RA. Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. Journal of the American Society of Echocardiography. 2008; 21(8): 922-934.

https://doi.org/10.1016/j.echo.2008.02.006

3.     Gillespie MJ, Javois AJ, Moore P, et al. Use of the GORE CARDIOFORM septal occluder for percutaneous closure of secundum atrial septal defects: results of the multicenter U.S. IDE trial. Catheterization and Cardiovascular Interventions. 2020; 95(7): 1296-1304.

https://doi.org/10.1002/ccd.28814

4.     Sharifi M, Burks J. Efficacy of clopidogrel in the treatment of post-ASD closure migraines. Catheter Cardiovasc Interv. 2004; 63: 255.

https://doi.org/10.1002/ccd.20144

authors: 

 

Abstract: 

Aim: was to present the experience of using blockers of IIb/IIIa glycoprotein receptors in treatment of thromboembolic complications of endovascular treatment of cerebral aneurysms.

Materials and methods: from December 2007 to June 2021, 695 patients underwent embolization of cerebral aneurysms. Thromboembolic complications were observed in 45 patients (6,5%), blockers of IIb/IIIa glycoprotein receptors were used in 32 patients (4,6%).

Results: blockers of IIb/IIIa glycoprotein receptors were used in 10,1% of patients with embolization of aneurysms and stent implantation, in 9,2% of cases with implantation of flow-diverters, and in 1% of patients with embolization of aneurysms using only coils. Effective restoration of blood flow was observed in 90,6% of patients. Intracranial hemorrhagic complications were not observed. The incidence of bleeding from the gastrointestinal tract was 6,3%, the incidence of puncture hematomas was 12,5%.

Conclusion: blockers of glycoprotein IIb/IIIa receptors can be effectively and safely used in treatment of thromboembolic complications of endovascular treatment of cerebral aneurysms.

 

References

1.     Kandyba DV. Rol' assistiruyushchih metodov pri vnutrisosudistoj okklyuzii anevrizm golovnogo mozga. Avtoreferat. Diss. kand. med. nauk. SPb. 2018; 160 [In Russ].

2.     Kiselev VS, Gafurov RR, Sosnov AO, Perfil’ev AM. Using of low-profile stents in the endovascular treatment of complex aneurysms of the brain. Neyrokhirurgiya. 2018; 20(1): 49-55 [In Russ].

https://doi.org/10.17650/1683-3295-2018-20-1-49-55

3.     Dornbos D, Katz JS, Youssef P, et al. Glycoprotein IIb/IIIa Inhibitors in Prevention andиRescue Treatment of Thromboembolic Complications During Endovascular Embolization of Intracranial Aneurysms. Neurosurgery. 2017; 0: 1-10.

https://doi.org/10.1093/neuros/nyx170J

4.     Kansagra AP, McEachern JD, Madaelil ThP, et al. Intra-arterial versus intravenous abciximab therapy for thromboembolic complications of neuroendovascular procedures: case review and meta-analysis. NeuroIntervent Surg. 2017; 9: 131-136.

https://doi.org/10.1136/neurintsurg-2016-012587

5.     Brinjikji W, Morales-Valero SF, Murad MH, et al. Rescue treatment of thromboembolic complications during endovascular treatment of cerebral aneurysms: a meta-analysis. Am J Neuroradiol. 2015; 36: 121-5.

https://doi.org/10.3174/ajnr.A4066

6.     Lin L-M, Jiang B, Campos JK, et al. Coon Strategy for the Management of Acute Intraprocedural Thromboembolic Complications during Pipeline Flow Diversion Treatment of Intracranial Aneurysms. Intervent Neurol. 2018; 7: 218-232.

https://doi.org/10.1159/000486458

7.     Cheung NK, Carr MW, Ray U, et al. Platelet Function Testing in Neurovascular Procedures: Tool or Gimmick? Intervent Neurol 2019; 8: 123-134.

https://doi.org/0.1159/000496702

8.     Zelenskaya EM, Slepuhina AA, Koch NV, et al. Genetic, pathophysiological and clinical aspects of antiplatelet therapy (review). Pharmacogenetics and Pharmacogenomics. 2015; 1:12-19 [In Russ].

 

Abstract:

Aim: was to develop a score scale for the prediction of complete tumor necrosis to assess the potential effectiveness of radiofrequency ablation of colorectal cancer focals in liver, on the base of results of the use of radiological diagnostic methods.

Materials and methods: a comparative analysis of results of radiological diagnosis of solitary colorectal cancer metastases in liver was carried out in 51 patients, depending on their characteristics before and at different times after radiofrequency ablation (RFA).

The survey and interventions were carried out between 2014 and 2020 in accordance with standards of treatment approved in Belarus. Ultrasound and CT with bolus contrast enhancement were used as radiation diagnostic methods.

The initial morphological parameters of tumor focals were evaluated according to results of ultrasound examination. CT with bolus contrast was used to control the effectiveness of RFA (determining the frequency of complete tumor necrosis): on the day of discharge of patients from the hospital, after 1 month, and then - once every 3 months (quarterly) during the year.

Results: the dependence of the effectiveness of RFA (frequency of complete tumor necrosis) on initial characteristics of solitary focals of colorectal cancer in liver was revealed and confirmed by results of a comparative statistical analysis. On the basis of obtained data, a score scale for predicting the effectiveness of RFA was developed and validated. The sensitivity of the new technique was 80,0%; specificity - 82,9%.

Conclusion: for the first time, a scale for the prediction of complete tumor necrosis was developed to assess the potential effectiveness of radiofrequency ablation of solitary colorectal cancer focals in liver.

ROC-analysis of the scale validation results showed that the sensitivity and specificity of the model are sufficient for its application in practice: 80,0% and 82,93%, respectively.

 

References

1.     Hideo T, Eren B. Role of thermal ablation in the management of colorectal liver metastasis. Hepatobiliary Surg. Nutr. 2020; 9(1): 49-58.

https://doi.org/10.21037/hbsn.2019.06.08

2.     Machi J, Oishi AJ, Nancy LF, Robert HO. Sonographically guided radio frequency thermal ablation for unresectable recurrent tumors in the retroperitoneum and the pelvis. J. Ultrasound. Med. 2003; 22(5): 507-13.

https://doi.org/10.7863/jum.2003.22.5.507

3.     Furrukh J, Cameron S, Iswanto S. The use of thermal ablation in the treatment of colorectal liver metastasis-proper selection and application of technology. Hepatobiliary Surg. Nutr. 2021; 10(2): 279-280.

https://doi.org/10.21037/hbsn-21-54

4.     Vasiniotis KN, Kaye EA, Sofocleous CT. Image-Guided Thermal Ablation for Colorectal Liver Metastases. Tech. Vasc. Interv. Radiol. 2020; 23(2): 100672.

https://doi.org/10.1016/j.tvir.2020.100672

5.     Rafael D-N, Stephen F, Hassan M, Graeme P. Defining the Optimal Use of Ablation for Metastatic Colorectal Cancer to the Liver Without High-Level Evidence. Curr. Treat. Options. Oncol. 2017; 18(2): 8.

https://doi.org/10.1007/s11864-017-0452-6

6.     Мурашко К.Л., Сорокин В.Г., Громов Д.Г. Методы локального воздействия на очаговые образования печени, применяемые в онкорадиологии. Диагностическая и интервенционная радиология. 2020;14: 60-66.

Murashko KL, Sorokin VG, Gromov DG. Metody lokal'nogo vozdejstviya na ochagovye obrazovaniya pecheni, primenyaemye v onkoradiologii. Diagnosticheskaya i intervencionnaya radiologiya. 2020; 14: 60-66 [In Russ].

https://doi.org/10.25512/DIR.2020.14.2.07

7.     Binbin J, Hongjie L, Kun Y, Zhongyi Z. Ten-Year Outcomes of Percutaneous Radiofrequency Ablation for Colorectal Cancer Liver Metastases in Perivascular vs. Non-Perivascular Locations: A Propensity-Score Matched Study. Front. Oncol. 2020; 16(10): 553556.

https://doi.org/10.3389/fonc.2020.553556

8.     Lu DSK, Steven SR, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J. Vasc. Interv. Radiol. 2003; 14(10): 1267-74.

https://doi.org/10.1097/01.rvi.0000092666.72261.6b

9.     Lu DS, et al. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: Assessment of the “heat sink” effect. Am. J. Roentgenol. 2002; 178: 47-51.

https://doi.org/10.2214/ajr.178.1.1780047

10.   You L, Hui H, Ziwei W, et al. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules. Biosci. Rep. 2020; 28; 40(2): BSR20193875.

https://doi.org/10.1042/BSR20193875

11.   Wang QQ, Yu SC, Qi X, et al. Overview of logistic regression model analysis and application. Zhonghua Yu. Fang. Yi. Xue. Za. Zhi. 2019; 6; 53(9): 955-960.

https://doi.org/10.3760/cma.j.issn.0253-9624.2019.09.018

12.   Adina NK, Trevor C, Ruwanthi K-D. Time-dependent ROC curve analysis in medical research: current methods and applications. BMC Med. Res. Methodol. 2017; 17(1): 53.

https://doi.org/10.1186/s12874-017-0332-6

13.   Nakas CT, Reiser B. Editorial for the special issue of “Statistical Methods in Medical Research” on “Advanced ROC analysis”. Statistical Methods in Medical Research. 2018; 27(3): 649-650.

https://doi.org/10.1177/0962280217742536

14.   Xieling C, Haoran X, Fu L, et al. A bibliometric analysis of natural language processing in medical research. BMC Med. Inform. Decis. Mak. 2018; 18(1): 14.

https://doi.org/10.1186/s12911-018-0594-x

15.   Young C, Soung WJ, Jae YJ, Yong JK. Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma. Int. J. Mol. Sci. 2020; 31; 21(21): 8165.

https://doi.org/10.3390/ijms21218165

16.   Riccardo L. Loco-regional treatment of hepatocellular carcinoma. Hepatology. 2010; 52(2): 762-73.

https://doi.org/10.1002/hep.23725

17.   Hinshaw JL, Lubner MG, Ziemlewicz TJ, et al. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation - what should you use and why? Radiographics. 2014; 34(5): 1344-62.

https://doi.org/10.1148/rg.345140054

18.   Pierre A, Roberto LC, Guillaume K, et al. Percutaneous tumor ablation. Presse. Med. 2019; 48(10): 1146-1155.

https://doi.org/10.1016/j.lpm.2019.10.011

19.   Fan Z, Hongying S, Xiangjun H, et al. Tumor Thermal Ablation Enhancement by Micromaterials. Curr. Drug. Deliv. 2017; 14(3): 323-333.

https://doi.org/10.2174/1567201813666160108114208

20.   Mehta A, Oklu R, Sheth RA. Thermal Ablative Therapies and Immune Checkpoint Modulation: Can Locoregional Approaches Effect a Systemic Response? Gastroenterol. Res. Pract. 2016; 9251375.

https://doi.org/10.1155/2016/9251375

 

Abstract:

Aim: was to assess the frequency, predominant localization and severity of atherosclerotic plaques in coronary arteries according to multidetector computed tomography (MDCT) in patients with suspicion on coronary heart disease (CHD).

Materials and methods: analysis of results of CT of coronary arteries (CT-CA) was carried out in 1590 patients. The average age was 53,9 ± 10,7 years. The number of men was 1133 (71,3%). Studies were carried out on 64- and 256-slice CT scanners.

Results: in patients with suspicion on coronary artery disease, atherosclerotic lesions of coronary arteries (CA) were not detected in 582 (36,6%) cases. Minimal and initial CA stenoses were observed in 80 (5%) and 416 (26,2%) patients, respectively. Moderate CA stenoses were found in 236 (14,8%) patients. Severe coronary artery stenoses were detected in 183 patients (11,5%). CA occlusions were observed in 84 (5,3%) cases. Most often, the stenotic process was detected in proximal segments of coronary arteries, in particular, in the left anterior descending artery.

Conclusions: MDCT makes it possible to determine in detail the severity and nature of atherosclerotic coronary lesions, as well as to assess the predominant location of plaques.

 

References

1.     Барбараш Л.С. Двадцатипятилетний итог развития кардиологии Кузбасса. Актуал. пробл. кардиол. и серд-сосуд. хир. 2016; 1: 6-13.

Barbash LS. The twenty-five-year result of the development of cardiology in Kuzbass. Actual problems of cardiology and cardiovascular surgery. 2016; 1: 6-13 [In Russ].

2.     Benjamin EJ, Muntner P, Flonso F, еt al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019; 139: 526-528.

3.     Островский Ю.П. и др. Сердечная недостаточность. Минск: Белорусcкая наука. 2016; 503.

Ostrovskiy YuP et al. Heart failure. Minsk: Belarusian science. 2016; 503 [In Russ].

4.     Paech DC, Weston AR. A systematic review of the clinical effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronaryangiography in the investigation of suspected coronary artery disease. BMC Cardiovasc. Disord. 2011; 11: 32.

5.     Hell MM, Bittner D, Schuhbaeck A, et al. Prospectively ECG-triggered high-pitch coronary angiography with third-generation dual-source CT at 70 kVp tube voltage: feasibility, image quality, radiation dose, and effect of iterative reconstruction. J. Cardiovasc. Comput. Tomogr. 2014; 8(2); 418-425.

6.     Korean Guidelines for the Appropriate Use of Cardiac CT. Korean J. Radiol. 2015; 16(2): 251-285.

7.     Liang J, Wang H, Hu L, et al. Diagnostic performance of 256-row detector coronary CT angiography in patients with high heart rates within a single cardiac cycle: a preliminary study. Clinikal Radiology. 2017; 72(8): 694.e7-694.e14.

8.     Терновой С.К., Веселова Т.Н. Выявление нестабильных бляшек в коронарных артериях с помощью мультиспиральной компьютерной томографии. Russ. Electr. J. Radiol. 2014; 4(1): 7-13.

Ternovoy SK, Veselova TN. MDCT in detection of unstable coronary plaques. Russ. Electr. J. Radiol. 2014; 4(1): 7-13 [In Russ].

9.     Foldyna B, Szilveszter B, Scholtz JE, et al. CAD-RADS-A New Clinical Decision Support Tool for Coronary Computed Tomography Angiography. Eur Radiol. 2018; 28(4): 1365-1372.

10.   Maroules CD, Goerne H, Abbara S, Cury RC. Improving quality and communication in cardiac imaging: the coronary artery disease reporting and data system (CAD-RADS™). Curr Cardiovasc Imaging Rep. 2017; 10: 20.

11.   Ramanathan S, Al Heidous M, Alkuwari M. Coronary artery disease-reporting and data system (CAD-RADS): strengths and limitations. Clin Radiol. 2019; 74: 411-417.

12.   Basha MA, Aly SA, Ismail AA, et al. The validity and applicability of CAD-RADS in the management of patients with coronary artery disease. Insights Imaging. 2019; 10: 117.

13.   Manzke R, Grass M, Nielsen T, et al. Adaptive temporal resolution optimization in helical cardiac cone beam CT reconstruction. Med. Phys. 2003; 30: 3072-80.

14.   Lee JW, Kim JY, Han K, et al. Coronary CT Angiography CAD-RADS versus Coronary Artery Calcium Score in Patients with Acute Chest Pain. Radiology. 2021.

15.   Koulaouzidis G, Powell A, McArthur T, et al. Computed tomography coronary angiography as initial work-up for unstable angina pectoris. Eur J Gen Med. 2012; 9(2): 111-117.

16.   Groothuis JG, Beek AM, Brinckman SL, et al. Low to Intermediate Probability of Coronary Artery Disease: Comparison of Coronary CT Angiography with First-Pass MR Myocardial Perfusion Imaging. Radiology. 2010; 254(2): 384-392.

17.   Sultan OM, Hamed Al-obaidic LS, Abdulla DB, et al. Estimation of frequency and pretest probability of CAD in patients presenting with recent onset chest pain by multi-detector CT angiography. Egypt. J. Radiol. and Nucl Med. 2016; 47(1): 111-117.

18.   Wasilewski J, Niedziela J, Osadnik T, et al. Predominant location of coronary artery atherosclerosis in the left anterior descending artery. The impact of septal perforators and the myocardial bridging effect. Kardiochirurgia i Torakochirurgia Polska. 2015; 12(4): 376-385.

 

Abstract:

Introduction: development of intravascular diagnostic methods has significantly increased the amount of information in the study of various vessels in comparison with standard angiography. Technological and software improvement of optical coherence tomography (OCT) allows expanding diagnostic capabilities and providing greater convenience for analyzing of results of this method of intravascular examination, which leads to an increase in its importance both for daily clinical practice and in scientific research.

Aim: was to describe the methodology of performing a new modification of OCT and to analyze accumulated experience, advantages and possibilities provided by this method.

Material and methods: the modern version of the complex for optical coherence tomography OPTIS allows to implement such new features as automatic indication of malapposition of stents, easy-to-perceive three-dimensional image of examination data in various versions, joint presentation (co-registration) of angiography and OCT data in real time. The first experience of clinical use of this system in the Russian Federation is presented, with an analysis of priority indications for the use of new possibilities. Using the angio-OCT-co-registration function, 309 studies of 205 arteries in 178 patients were performed, which accounted for 63,3% of all OCT procedures performed in our department. 

Results: priority indications for the use of the method were identified, which primarily include: cases of extended stenoses with an uncertainty in the hemodynamic significance of individual sections or the entire lesion as a whole; difficulties in constructing an optimal projection of the angiogram (without overlapping branches and significant shortening of the target area); bifurcation lesions; diagnostics of thrombus, dissections, plaque ruptures, severe calcification, including in acute coronary syndrome; selection of the optimal size of biodegradable scaffold and preparation of the artery for its implantation; intermediate or final control of results of coronary artery stenting. The use of co-registration of angiography and OCT contributes to a more accurate determination of the area of interest during repeated studies, which is especially important for the dynamic assessment of the patient's condition and for scientific research.

Conclusions: the development and modernization of optical coherence tomography causes an increase in its importance both in daily clinical practice and in scientific research. The possibility of spatial co-registration of OCT data with angiographic images, as well as new options for automatic processing of resulting images, including stent apposition assessment, significantly increase the operator's ability to quickly and accurately analyze examination data directly at the operating table.

 

References

1.     Demin VV. Clinical guide to intravascular ultrasound. Orenburg. Yuzhnyj Ural. 2005: 400 [In Russ].

2.     Raber L, Mintz GS, Koskinas KC, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. EuroIntervention. 2018; 14: 656-677.

https://doi.org/10.4244/EIJY18M06_011

3.     Johnson TW, Raber L, di Mario C, et al. Clinical use of intracoronary imaging. Part 2: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. EuroIntervention. 2019; 15: 434-451.

https://doi.org/10.4244/EIJY19M06_02

4.     Van der Sijde JN, Guagliumi G, Sirbu V, et al. The OPTIS Integrated System: real-time, co-registration of angiography and optical coherence tomography. EuroIntervention. 2016; 12: 855-860.

https://doi.org/10.4244/EIJV12I7A140

5.     Karanasos A, Van der Sijde JN, Ligthart J, et al. Utility of Optical Coherence Tomography Imaging with Angiographic Co-registration for the Guidance of Percutaneous Coronary Intervention. Radcliffe Cardiology.com. 2015. [Internet source]

6.     Demin VV, Demin DV, Seroshtanov EV, et al. Clinical issues of optical coherence tomography for coronary diagnosis. International Journal of Interventional Cardioangilogy. 2016; 44: 34-48 [In Russ].

7.     Ermolaev PA, Khramykh TP, Vyaltsin AS. Use of optical coherence tomography for intermediate coronary artery lesions. Circulation Pathology and Cardiac Surgery. 2019; 23(3): 47-56 [In Russ].

https://doi.org/10.21688/1681-3472-2019-3-47-56

8.     Onuma Y, Okamura T, Muramatsu T, et al. New implication of three-dimensional optical coherence tomography in optimising bifurcation PCI. EuroIntervention. 2015; 11: 71-74.

https://doi.org/10.4244/EIJV11SVA15

9.     Alegr?a-Barrero E, Foin N, Chan PH, et al. Optical coherence tomography for guidance of distal cell recrossing in bifurcation stenting: choosing the right cell matters. EuroIntervention. 2012; 8: 205-213.

https://doi.org/10.4244/EIJV8I2A34

10.   Tyczynski P, Ferrante G, Kukreja N, et al. Optical coherence tomography assessment of a new dedicated bifurcation stent. EuroIntervention. 2009; 5: 544-551.

https://doi.org/10.4244/EIJV5I5A89

11.   Souteyrand G, Amabile N, Combaret N, et al. Invasive management without stents in selected acute coronary syndrome patients with a large thrombus burden: a prospective study of optical coherence tomography guided treatment decisions. EuroIntervention. 2015; 11: 895-904.

https://doi.org/10.4244/EIJY14M07_18

12.   Souteyrand G, Arbustini E, Motreff P, et al. Serial optical coherence tomography imaging of ACS-causing culprit plaques. EuroIntervention. 2015; 11: 319-324.

https://doi.org/10.4244/EIJV11I3A59

13.   Mustafina IA, Pavlov VN, Ishmetov VSh, et al. Identification of plaque morphology in acute coronary syndrome by optical coherence tomography. Bashkortostan Medical Journal. 2017; 12; 4(70): 27-32 [In Russ].

14.   Allahwala UK, Cockburn JA, Shaw E, et al. Clinical utility of optical coherence tomography (OCT) in the optimisation of Absorb bioresorbable vascular scaffold deployment during percutaneous coronary intervention. EuroIntervention. 2015; 10: 1154-1159.

https://doi.org/10.4244/EIJV10I10A190

15.   Shugushev ZK, Maksimkin DA, Vorob'eva YuS, et al. Results of biodegradable vascular endoprotheses implantation in ischemic heart disease patients with type 2 diabetes. Russian Journal of Cardiology. 2016; 9(137): 19-24 [In Russ].

https://doi.org/10.15829/1560-4071-2016-9-19-24

16.   R?ber L, Radu MD. Optimising cardiovascular outcomes using optical coherence tomography-guided percutaneous coronary interventions. EuroIntervention. 2012; 8: 765-771.

https://doi.org/10.4244/EIJV8I7A118

17.   Tanigawa J, Barlis P, Dimopoulos K, et al. Optical coherence tomography to assess malapposition in overlapping drug-eluting stents. EuroIntervention. 2008; 3(5): 580-583.

https://doi.org/10.4244/EIJV3I5A104

18.   Radu M, J?rgensen E, Kelb?k H, et al. Optical coherence tomography at follow-up after percutaneous coronary intervention: relationship between procedural dissections, stent strut malapposition and stent healing. EuroIntervention. 2011; 7: 353-361.

https://doi.org/10.4244/EIJV7I3A60

19.   Trusov IS, Nifontov EM, Biryukov AV, et al. The use of optical coherence tomography imaging of the vascular wall of the coronary arteries before and after stenting. Regional blood circulation and microcirculation. 2019; 18(1): 77-85 [In Russ].

https://doi.org/10.24884/1682-6655-2019-18-1-77-85

20.   Demin VV, Galin PYu, Demin DV, et al. The comparison of intravascular ultrasound guided and angiography guided implantation of drug-eluting stents: The randomized trial ORENBURG. Part 1: Study design, direct clinical results. Diagnostic & Interventional Radiology. 2015; 9(3): 31-43 [In Russ].

21.   Demin VV, Murzajkina MM, Galin PYu, et al. Comparison between implantation of drug-eluting stents under control of intravascular ultrasound and angiography: The randomized trial ORENBURG. Part 2: The data of angiography and intravascular methods of visualization. Diagnostic & Interventional Radiology. 2016; 10(2): 31-47 [In Russ].

22.   Demin VV, Gusev SD, Murzaykina MM, et al. Immediate and early results of a clinical trial comparing different strategies of drug-eluting stents implantation under IVUS and angiographic guidance. International Journal of Interventional Cardioangilogy. 2016; 44: 49-59 [In Russ].

23.   Demin VV, Demin AV, Demin DV, et al. The drug-eluting balloons for coronary arterial restenosis: 7-year experience. International Journal of Interventional Cardioangilogy. 2016; 44: 59-71 [In Russ].

 

Abstract:

Introduction: it is well known that magnetic resonance imaging (MRI) has superiority above computed tomography (CT) in identification of epileptogenic substrates due to higher resolution of images and the best differentiation between white and gray matter. But in some peculiar cases, CT can be the method of choice.

Aim: was to illustrate the role of CT in presurgical examination in children with drug-resistant focal epilepsy.

Materials and methods: results of CT of 65 patients with focal epilepsy had been analyzed. All patients underwent multimodal presurgical examination with followed antiepileptic surgical operation and morphological analysis.  CT was performed on GE Lightspeed and Philips Ingenity Elite scanners.

Results: in presurgical period, native CT was performed in 11 (16,9%) patients and in 6 patients, structural brain changes responsible for epilepsy were identified. In 13 patients (20%) we’ve used CT angiography for estimation of angio-architectonic environment in the area of potential surgical intervention and in case of suspicion on arteriovenous malformation (AVM). CT on the 1st day of post-operative period was made in 48 (73,8%) of patients, and in 2 cases CT revealed structural changes that influenced further treatment tactics. At the background of exacerbation in 3 patients, repeated CT revealed sings of acute disorders of cerebrospinal fluid cirdulation.

Conclusion: computed tomography can be an effective diagnostic method in examination of patients with epilepsy, especially when verifying bone and vascular (CT-angiography) changes, is used for neuronavigation to control the position of invasive electrodes and exclude post-implantation hemorrhages, and also helps to identify early postoperative complications, thus influencing tactics and outcomes of surgical treatment of epilepsy. In children with focal epilepsy undergoing surgical treatment, computed tomography and magnetic resonance imaging are complementary studies that provide adequate neuroradiological support.

 

References

1.     Fitsiori A, Hiremath SB, Boto J, et al. Morphological and Advanced Imaging of Epilepsy: Beyond the Basics. Children. 2019; 6(3): 43.

https://doi.org/10.3390/children6030043

2.     Baumgartner C, Koren JP, Britto-Arias M, et al. Presurgical epilepsy evaluation and epilepsy surgery. F1000Research. 2019; 8.

https://doi.org/10.12688/f1000research.17714.1

3.     Skjei KL, Dlugos DJ. The evaluation of treatment-resistant epilepsy. Semin Pediatr Neurol. 2011; 18: 150-170.

https://doi.org/10.1016/j.spen.2011.06.002

4.     Middlebrooks EH, Ver Hoef L, Szaflarski JP. Neuroimaging in Epilepsy. Curr Neurol Neurosci Rep. 2017; 17(4): 32.

https://doi.org/10.1007/s11910-017-0746-x

5.     Takanashi J. MRI and CT in the diagnosis of epilepsy. Nihon Rinsho. 2014; 72(5): 819-26.

6.     Полянская М.В., Демушкина А.А., Костылев Ф.А. и др. Возможности режима SWI в магнитно-резонансной нейровизуализации у детей с фокальной эпилепсией. Эпилепсия и пароксизмальные состояния. 2020; 12(2): 105-116.

Polyanskaya MV, Demushkina AA, Kostylev FA, et al. The role of susceptibility-weighted imaging (SWI) in neuroimaging in children with focal epilepsy. Epilepsy and paroxysmal conditions. 2020; 12(2): 105-116 [In Russ].

https://doi.org/10.17749/2077-8333/epi.par.con.2020.025

7.     Cendes F, Theodore WH, Brinkmann BH, et al. Neuroimaging of epilepsy. Handbook of Clin. Neurol. 2016; 136: 985-1014.

https://doi.org/10.1016/B978-0-444-53486-6.00051-X

8.     Roy T, Pandit A. Neuroimaging in epilepsy. Annals of Indian Academy of Neurology. 2011; 14(2): 78.

https://doi.org/10.4103/0972-2327.82787

9.     Lapalme-Remis S, Cascino GD. Imaging for Adults With Seizures and Epilepsy. Continuum. 2016; 22(5): 1451-1479.

https://doi.org/10.1212/CON.0000000000000370

10.   Duncan JS. Brain imaging in epilepsy. Practical Neurology. 2018: 002180.

https://doi.org/10.1136/practneurol-2018-002180

11.   Tranvinh E, Lanzman B, Provenzale J, Wintermark M. Imaging Evaluation of the Adult Presenting With New-Onset Seizure. Am J Roentgenol. 2019; 212(1): 15-25.

https://doi.org/10.2214/AJR.18.20202

12.   Lompo DL, Diallo O, Dao BA, et al. Etiologies of non-genetic epilepsies of child and adolescent, newly diagnosed in Ouagadougou, Burkina Faso. Pan African Medical Journal. 2019; 31.

https://doi.org/10.11604/pamj.2018.31.175.170

13.   Goel D, Dhanai JS, Agarwal A, et al. Neurocysticercosis and its impact on crude prevalence rate of epilepsy in an Indian community. Neurol India. 2011; 59(1): 37-40.

https://doi.org/10.4103/0028-3886.76855

14.   Mengistu G, Ewunetu BD, Johnston JC, Metaferia GZ. Neuroimaging of Ethiopian patients with epilepsy: a retrospective review. Ethiop Med J. 2014; 52(2): 57-66.

15.   Patel N, Jain A, Iyer V, et al. Clinico - diagnostic and therapeutic relevance of computed tomography scan of brain in children with partial seizures. Annals of Indian Academy of Neurology. 2013; 16(3): 352.

https://doi.org/10.4103/0972-2327.116928

16.   Cherian A, Syam UK, Sreevidya D, et al. Low seroprevalence of systemic cysticercosis among patients with epilepsy in Kerala, South India. J Infect Public Health. 2014; 7(4): 271-6.

https://doi.org/10.1016/j.jiph.2013.08.005

17.   Panov F, Li Y, Chang EF, et al. Epilepsy with temporal encephalocele: Characteristics of electrocorticography and surgical outcome. Epilepsia. 2015; 57(2): 33-38.

https://doi.org/10.1111/epi.13271

18.   Van Rooijen BD, Backes WH, Schijns OEMG, et al. Brain Imaging in Chronic Epilepsy Patients After Depth Electrode (Stereoelectroencephalography) Implantation. Neurosurgery. 2013; 73(3): 543-549.

https://doi.org/10.1227/01.neu.0000431478.79536.68

19.   Lee DJ, Zwienenberg-Lee M, Seyal M, Shahlaie K. Intraoperative computed tomography for intracranial electrode implantation surgery in medically refractory epilepsy. Journal of Neurosurgery. 2015; 122(3): 526-531.

https://doi.org/10.3171/2014.9.jns13919

20.   Schmidt RF, Lang MJ, Hoelscher CM, et al. Flat-Detector Computed Tomography for Evaluation of Intracerebral Vasculature for Planning of Stereoelectroencephalography Electrode Implantation. World Neurosurg. 2018; 110: 585-592.

https://doi.org/10.1016/j.wneu.2017.11.063

21.   Freyschlag CF, Gruber R, Bauer M, et al. Routine postoperative CT is not helpful after elective craniotomy. World Neurosurgery. 2018.

https://doi.org/10.1016/j.wneu.2018.11.079

22.   Fontes RB, Smith AP, Munoz LF, et al. Relevance of early head CT scans following neurosurgical procedures: an analysis of 892 intracranial procedures at Rush University Medical Center. J Neurosurg. 2014; 121: 307-312.

23.   Almohiy H. Paediatric computed tomography radiation dose: A review of the global dilemma. World J. Radiol. 2014; 6: 1-6.

https://doi.org/10.4329/wjr.v6.i1.1

authors: 

 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.

 

Abstract:

In interventional radiology department of clinical hospital № 27 (Moscow) since 2002 till 2009 TIPS was performed in 62 patients for hepatic cirrhosis with portal hypertension. One of the patients underwent orthotopic liver transplantation in Germany.
Material and methods. Mean age in the group was 5f ,6 y. o., 17 women, 45 men. Three types of stents were used: matrix stents, self-expanding and stent-grapfts. Patients were divided in 2 groups. In Group 1 (17 pts) we performed TIPS with stent-grafts (Gore Viatorr TIPS Endoprosthesis); in Group 2 (47 pts) bare metal stents were used (matrix stents Perico, Genesis, JoMed and self-expanding stents Za-stent, Zilver, Wallstent, sinus-SuperFlex Visual-Stent, SMART-control).
Results. During 18 months follow-up there were no thrombosis, significant stenosis in patients of Group 1, and primary patency rate was 100%. In Group 2 primary and secondary patency rates were 69,3% and 85,6% correspondingly. Freedom from recurr­ ent esophageal varices hemorrhage was 82,8% in Group 1 and 69,3% in Group 2, ascitis and hydrothorax regression - 93,9% and 80,0%, absence of hepatic cerebropathy progression - 93,9% and 80,0%, overall survival - 87,8% и 76,0% correspondingly.
Conclusions. Therefore use of stent-graft in TIPS procedure improve patency of intrahepatic shunt (p < 0,01), significantly reduce risk of recurrent variceal hemorrhage (0,1 < p < 0,5), and reduce volume of ascitis (0,1 < p < 0,5). It worth saying that cerebropathy progression was caused by non-compliance to diet, and was corrected with medicamental treatment. In long-term follow-up stent­ graft «Viatorr» deployment improves survival of patients (0,1 < p < 0,5). Introduction of stent-grafts marked a new stage of TIPS pro­ cedure improvement.


authors: 

 

Article exists only in Russian.

 

Abstract:

Chemodectomas are rare, in most cases, benign neoplasms. They originate from the chemoreceptor cells of the carotid glomus in the bifurcation of the carotid artery. Chemodectoma treatment is surgical. Classical removal of the tumor carries a high risk of damage of arteries and nerves. We present a case report of high localization (C1) carotid chemodectoma removal in a hybrid operating room. Tumor was successfully removed after selective embolization of chemodectoma with protection of distal flow of the internal carotid artery. This approach helped to minimize intraoperative blood loss, as well as to shorten time of intervention.

 

References

1.     De Franciscis S, Grande R, Butrico L, et al. Resection of Carotid Body Tumors reduces arterial blood pressure. An underestimated neuroendocrine syndrome. International Journal of Surgery. 2014; 12: 63-67.

https://doi.org/10.1016/j.ijsu.2014.05.052

2.     Serra R, Grande R, Gallelli L, et al. Carotid body paragangliomas and matrix metalloproteinases. Annals of Vascular Surgery. 2014, 28(7): 1665-1670

https://doi.org/10.1016/j.avsg.2014.03.022

3.     Luo T, Zhang C, Ning YC, et al. Surgical treatment of carotid body tumor: Case report and literature review. J. Geriatr. Cardiol. 2013; 10: 116-118.

https://doi.org/10.3969/j. issn.1671-5411.2013.01.018

4.     Sajid MS, Hamilton G, Baker DM. A multicenter review of carotid body tumor management. Eur. J. Vasc. Endovasc. Surg. 2007: 34(2): 127-130.

https://doi.org/10.1016/j.ejvs.2007.01.015

5.     Knight TTJr., Gonzalez JA, Ray JM, Rush DS. Current concepts for the surgical management of carotid body tumor. Am. J. Surg. 2006; 191: 104-110.

https://doi.org/10.1016/j.amjsurg.2005.10.010

6.     Scudder CL. Tumor of the inter carotid body. A report of one case, together with one case in the literature. Am J Med Sci. 1903; 126: 384-9.

7.     Dickinson PH, Griffin SM, Guy AG, McNeill IF. Carotid body tumor: 30 years experience. Dr J Surg. 1986; 73: 14-6.

https://doi.org/10.1002/bjs.1800730107

8.     Amato B, Serra R, Fappiano F, et al. Surgical complications of carotid body tumors surgery: a review. Int Angiol. 2015; 34(6.1): 15-22.

9.     Lim JY, Kim J, Kim SH, et al. Surgical treatment of carotid body paragangliomas: outcomes and complications according to the Shamlin classification. Clin Exp Otorhinolaryngol. 2010; 3(2): 91-5.

https://doi.org/10.3342/ceo.2010.3.2.91

10.   Amato B, Bianco T, Compagna R, et al. Surgical resection of carotid body paragangliomas: 10 years of experience. American Journal of Surgery. 2014; 207(2): 293-298.

https://doi.org/10.1016/j.amjsurg.2013.06.002

11.   Sahin MA, Jahollari A, Guler A, et al. Results of combined preoperative direct percutaneous embolization and surgical excision in treatment of carotid body tumors. Vasa. 2011; 40(6): 461-6.

https://doi.org/10.1024/0301-1526/a000149

12.   Thakkar R, Qazi U, Kim Y, et al. Technique and role of embolization using ethylene vinylalcohol copolymer before carotid body tumor resection. Clin. Pract. 2014; 4(3).

https://doi.org/10.4081/ср.2014.661

13.   Carroll W, Stenson K, Stringer S. Malignant carotid body tumor. Head Neck. 2004; 26(3): 301-306.

https://doi.org/10.1002/hed.20017

14.   Shamblin WR, Remine WH, Sheps SG, Harrison EG. Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. Am J Surg. 1971; 122(6): 732-739.

https://doi.org/10.1016/0002-9610(71)90436-3

15.   Arya S, Rao V, Juvekar S, Dcruz AK. Carotid body tumors: objective criteria to predict the Shamblin group on MR imaging. AJNR Am J Neuroradiol 2008; 29(7): 1349-54.

16.   Wu J, Liu S, Feng L, et al. Clinical analysis of 24 cases of carotid body tumor. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015: 50(1): 25-27.

https://doi.org/10.3174/ajnr.A1092

17.   Базылев В.В., Шматков М.Г., Морозов З.А. Стентирование сонных артерий как этап в лечении пациентов с билатеральным поражением каротидного бассейна и сопутствующим поражением коронарного русла. Кардиология и сердечно-сосудистая хирургия. 2012; 5(5): 39-48.

Bazilev VV, Shmatkov MG, Morozov ZA. Carotid artery stenting as a stage in treatment of patients with bilateral carotid lesions and concomitant coronary affection. Kardiologiya i serdechno-sosudistaya khirurgiya. 2012; 5(5): 39-48 [In Russ].

18.   Базылев В.В., Шматков М.Г., Морозов З.А. и др. Сравнение показателей качества жизни пациентов, перенесших каротидную эндартерэктомию и стентирование сонных артерий. Диагностическая и интервиционная радиология. 2017; 11(11): 54-58.

Bazylev VV, Shmatkov MG, Morozov ZA, et al. Comparison of Indicators of quality of life in patients undergoing carotid endarterectomy and carotid stenting. Diagnosticheskaya i Interventsionnaya radiologiya. 2017; 11(11): 54-58 [In Russ].

 

Abstract:

This case describes successful combined treatment of patient with large hepatocellular carcinoma BCLC «B», occupying the entire right lobe of the liver, extending to the fourth segment and occupying the right lateral flank till small pelvis. As the first stage, selective tumor chemoembolization, mechanical chemoembolization of right portal vein branches with the aim of vicarious hypertrophy of remaining liver segments were performed. One and half months after performed procedure, the volume of remnant parenchyma was 31% of the total volume. According to the test with indocyanine green, the plasma elimination rate (ICG-PDR) was 12,2%/min, and the residual concentration at 15 minutes was 16%. Subsequently, was performed surgical intervention: Starzl laparotomy, revision of abdominal organs, cholecystectomy, right-sided hemihepatectomy + SI, drainage of the common bile duct according to Vishnevsky, lymphadenectomy of the hepatoduodenal ligament, drainage of abdominal cavity. Postoperative period was complicated by formation of an external biliary fistula and hepatic failure, regarded as class «B» according to criteria of the International Research Group for Liver Surgery (ISGLS), which required medical correction of patient's condition without use of extracorporeal detoxification methods. Later, patient was diagnosed with foci of recurrence of disease in the remaining parenchyma of the liver, for which endovascular treatment was carried out. Currently, patient is alive (6 years after surgery) and is receiving systemic treatment for the extrahepatic spread of the underlying disease.

 

References

1.     Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394-424.

https://doi.org/10.3322/caac.21492

2.     Llovet JM, Br? C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Seminars in liver disease. 1999; 19(3): 329-338.

3.     Vishnevsky VA, Ayvazyan KA, Ikramov RZ, et al. Sovremennye printsipy lecheniya gepatotsellyulyarnogo raka. Annaly khirurgicheskoy gepatologii 2020; 25(2): 15-26 [In Russ].

https://doi.org/10.16931/1995-5464.2020215-26

4.     Mizuguchi T, Kawamoto M, Meguro M, et al. Preoperative liver function assessments to estimate the prognosis and safety of liver resections. Surg Today. 2014; 44(1): 1-10.

https://doi.org/10.1007/s00595-013-0534-4

5.     European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018; 69(1): 182-236.

https://doi.org/10.1016/j.jhep.2018.03.019

6.     Kamiyama T, Orimo T, Wakayama K, et al. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification. World J Surg Oncol. 2017; 15(1): 156.

https://doi.org/10.1186/s12957-017-1229-x

7.     Kim H, Ahn SW, Hong SK, et al. Korean Liver Cancer Association. Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma. Br J Surg. 2017; 104(8): 1045-1052.

https://doi.org/10.1002/bjs.10541

8.     Samuel M, Chow PK, Chan Shih-Yen E, et al. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev. 2009; 1: CD001199.

https://doi.org/10.1002/14651858.CD001199.pub2

9.     Tremosini S, Reig M, de Lope CR, et al. Treatment of early hepatocellular carcinoma: Towards personalized therapy. Dig Liver Dis. 2010; 42(3): 242-8.

https://doi.org/10.1016/S1590-8658(10)60512-9

10.   Bolondi L, Burroughs A, Dufour JF, et al Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis. 2012; 32(4): 348-59.

https://doi.org/10.1055/s-0032-1329906

11.   Kudo M, Arizumi T, Ueshima K, et al. Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria). Dig Dis. 2015; 33(6): 751-8.

https://doi.org/10.1159/000439290

12.   Wada H, Eguchi H, Noda T, et al. Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma. Surgery. 2016; 160(5): 1227-1235.

https://doi.org/10.1016/j.surg.2016.05.023

13.   Wang W, Yang LY, Huang GW, et al. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. Br J Cancer. 2004; 90(12): 2349-55.

https://doi.org/10.1038/sj.bjc.6601749

14.   Yang LY, Wang W, Peng JX, et al. Differentially expressed genes between solitary large hepatocellular carcinoma and nodular hepatocellular carcinoma. World J Gastroenterol. 2004; 10(24): 3569-73.

https://doi.org/10.3748/wjg.v10.i24.3569

15.   Chen J, Lai L, Lin Q, et al. Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study. Oncotarget. 2017; 8(1): 408-417.

https://doi.org/10.18632/oncotarget.13427

16.   Pirtskhalava TL, Granov DA, Maystrenko DN. Kombinirovannaya rezektsiya pecheni i nizhnei poloi veny pri gepatotsellyulyarnom rake. Annaly khirurgicheskoy gepatologii. 2016; 21(2): 52-55 [In Russ].

https://doi.org/10.16931/1995-5464.2016252-55

17.   Granov AM, Tarazov PG, Granov DA, et al. Uspeshnoe kombinirovannoe lechenie patsienta s retsidiviruyushchei gepatotsellyulyarnoi kartsinomoi. Vestnik khirurgii imeni II Grekova. 2015; 174(2): 98-100 [In Russ].

18.   Granov DA, Polehin AS, Tarazov PG, et al. Khimioehmbolizatsiya pechenochnykh arterii u bol'nykh gepatotsellyulyarnym rakom na fone tsirroza pered transplantatsiei pecheni: prognosticheskoe znachenie kontsentratsii al'fafetoproteina. Russian Journal of Transplantology and Artificial Organs. 2020; 22(4): 52-57 [In Russ].

https://doi.org/10.15825/1995-1191-2020-4-52-57

 

Abstract:

This review is devoted to critical upper limb ischemia in patients with hemodialysis vascular access. Possible etiological causes of critical ischemia and diagnostic aspects of this pathology are considered. Contemporary approaches of treatment of critical ischemia in this group of patients are demonstrated; indications and contraindications for methods of treatment are discussed. Particular attention has been paid to endovascular method of revascularization of hand, which can become the method of choice in treatment of patients with critical ischemia of the upper limb caused by occlusive lesions of arteries in patients with hemodialysis vascular access.

 

References

1.     Vennesland JB, S?reide K, Kval?y JT, et al. A Population-Based Study of Incidence, Presentation, Management and Outcome of Primary Thromboembolic Ischemia in the Upper Extremity. World J Surg. 2019; 43(9): 2320-2327.

https://doi.org/10.1007/s00268-019-05023-w

2.     Thibaudeau S, Serebrakian AT, Gerety PA, Levin LS. An algorithmic approach to the surgical treatment of chronic ischemia of the hand: а systematic review of the literature. Plast Reconstr Surg. 2016; 137: 818-828.

3.     Huber TS, Larive B, Imrey PB, et al. Access-related hand ischemia and the Hemodialysis Fistula Maturation Study. J Vasc Surg. 2016; 64(4): 1050-1058.

https://doi.org/10.1016/j.jvs.2016.03.449

4.     Horst VD, Nelson PR, Mallios A, et al. Avoiding hemodialysis access-induced distal ischemia. The Journal of Vascular Access. 2020. https://doi.org/10.1177/1129729820943464

5.     Mohamed AS, Peden EK. Dialysis-associated steal syndrome (DASS). The Journal of Vascular Access. 2017; 18(1): 68-73.

https://doi.org/10.5301/jva.5000684

6.     Stolic RV, Trajkovic GZ, Miric DJ, et al. Arteriovenous fistulas and digital hypoperfusion ischemic syndrome in patients on hemodialysis. World J Nephrol. 2013; 2(2): 26-30.

https://doi.org/10.5527/wjn.v2.i2.26

7.     Cheun TJ, Jayakumar L, Sideman MJ, et al. Upper extremity arterial endovascular interventions for symptomatic vascular access-induced steal syndrome. J Vasc Surg. 2019; 70 (2): 1896-1903.

8.     Sedov VM, Karpov SA, Alfyorov SV, Grinyov KM. Phenomenon of ischemic steal syndrome in patients with different arteriovenous fistulas for hemodialysis and its surgical correction. Grekov's Bulletin of Surgery. 2013;172(6): 051-055 [In Russ].

9.     Vaes RHD, Wouda R, Teijink JAW, Scheltinga MR. Venous side branch ligation as a first step treatment for haemodialysis access induced hand ischemia: effects on access flow volume and digital perfusion. Eur J Vasc Endovasc Surg. 2015; 50: 810-814.

10.   Tordoir JHM, Dammers R, van der Sande FM.мUpper extremity ischemia and hemodialysis vascular access. Eur J Vasc Endovasc Surg. 2004; 27: 1-5.

11.   Gurkov A, Lobov G, Gurevich K. Blood flow in the large vessels of the forearm and in the microvessels of the hand in patients on programmed hemodialysis. The Doctor. 2012; 6: 64-67 [In Russ].

12.   Cheun TJ, Jayakumar L, Sheehan MK et al. Outcomes of upper extremity interventions for chronic critical ischemia. J Vasc Surg. 2018; 69 (1): 20-128.

13.   Tursunov BZ, Usmanov HH, Temirov SN. Balloon angioplasty of the radial artery in critical hand ischemia. Angiology and Vascular Surgery. 2018; 24: 64-69 [In Russ].

14.   Guerra A, Raynaud A, Beyssen B, et al. Arterial percutaneous angioplasty in upper limbs with vascular access devices for haemodialysis. Nephrol Dial Transplant. 2002; 17: 843-851.

15.   Oprea A, Molnar A, Scridon T, Mircea PA. Digital pressure in haemodialysis patients with brachial arteriovenous fistula. Indian J Med Res. 2019; 149(3): 376-383.

16.   Tolba M, Maresch M, Kamal D. Distal radial artery ligation for treatment of steal syndrome associated with radiocephalic arteriovenous fistula. J Surg Case Rep. 2020; 2020(9): rjaa314.

https://doi.org/10.1093/jscr/rjaa314

17.   Alie-Cusson FS, Bhat K, Ramchandani J, et al. Distal Revascularization and Interval Ligation for the Management of Dialysis Access Steal Syndrome. Ann Vasc Surg. 2021; 74: 29-35.

https://doi.org/10.1016/j.avsg.2021.01.102

18.   Scali ST, Chang CK, Raghinaru D, et al. Prediction of graft patency and mortality after distal revascularization and interval ligation for hemodialysis access-related hand ischemia. Eur J Vasc Endovasc Surg. 2013; 45:195.

19.   De Caprio JD, Valentine RJ, Kakish HB, et al. Steal syndrome complicating hemodialysis access. Cardiovasc Surg. 1997; 5: 648-653.

20.   Sheaffer WW, Hangge PT, Chau AH, et al. Minimally Invasive Limited Ligation Endoluminal-Assisted Revision (MILLER): A Review of the Available Literature and Brief Overview of Alternate Therapies in Dialysis Associated Steal Syndrome. J Clin Med. 2018; 7(6): 128.

21.   Kordzadeh A, Garzon LAN, Parsa AD. Revision Using Distal Inflow for the Treatment of Dialysis Access Steal Syndrome: A Systematic Review. Ann Vasc Dis. 2018; 11(4): 473-478.

22.   Vaes RHD, van Loon M, Selma MM, et al. One-year efficacy of the RUDI technique for flow reduction in high-flow autologous brachial artery-based hemodialysis vascular access. J Vasc Access. 2015; 16(9): 96-101.

23.   Shaikh FA, Siddiqui N, Shahzad N, et al. Operative Techniques to Prevent Dialysis Access-associated Steal Syndrome in High-risk Patients Undergoing Surgery for Hemodialysis Access: A Systematic Review. Cureus. 2019; 11(11): 6086.

24.   Schaffer D. A prospective, randomized trial of 6-mm versus 4-7-mm PTFE grafts for hemodialysis access in diabetic patients. In: Vascular Access for Hemodialysis, 5th. ed., edited by Henry ML, Ferguson RM, Tucson, WL. Gore and Associates, Inc., and Precept Press, 1997; 91-94.

25.   Scholz H. Arteriovenous Access Surgery. New-York: Springer-Verlag Berlin Heidelberg. 2015.

26.   Patel MS, Davies MG, Nassar GM, Naoum JJ. Open repair and venous inflow plication of the arteriovenous fistula is effective in treating vascular steal syndrome. Ann Vasc Surg. 2015; 29(5): 927-933.

https://doi.org/10.1016/j.avsg.2014.12.042

27.   Zamani P, Kaufman J, Kinlay S. Ischemic steal syndrome following arm arteriovenous fistula for hemodialysis. Vascular Medicine. 2009; 14: 371-376.

28.   Leake AE, Winger DG, Leers SA, et al. Management and outcomes of dialysis access-associated steal syndrome. J Vasc Surg. 2015; 61(3): 754-760.

29.   Misskey J, Yang C, MacDonald S, et al. A comparison of revision using distal inflow and distal revascularization-interval ligation for the management of severe access-related hand ischemia. J Vasc Surg. 2016; 63(6): 1574-1581.

30.   Shakarchi JA, Stolba J, Houston JG, et al. Surgical techniques for haemodialysis access-induced distal ischaemia. J Vasc Access. 2016; 17(1): 40-46.

31.   Spinelli F, Benedetto F, Passari G, et al. Bypass Surgery for the Treatment of Upper Limb Chronic Ischaemia. Eur J Vasc Endovasc Surg. 2010; 39: 165-170.

32.   Pederson WC. Revascularization Options for Terminal Distal Ischemia. Hand Clin. 2015; 31: 75-83.

33.   Cornejo A, Neaman KC, Srinivasan RC, et al. In situ venous bypass for chronic hand ischemia. Ann plast surg. 2016; 76(4): 275-279.

34.   Masden LD, Seruya M, Higgins JP. A systematic review of the outcomes of distal upper extremity bypass surgery with arterial and venous conduits. Hand Surg. 2012; 37(A): 2362-2367.

35.   Hoexum F, Coveliers HM, Lu JJ, et al. Thoracic sympathectomy for upper extremity ischemia. Minerva Cardioangiologica. 2016; 64(6): 676-685.

36.   Zeng W, Hammert WC. Arterialization of the Venous System for Treatment of Chronic Ischemia in the Hand. Plast Reconstr Surg. 2016; 137(4): 1213-1220.

37.   Zatevahin II, Cipciashvili MSh, Gorbenko UF. Тransplantation of omentum major in the treatment of distal lesions of the tibial arteries. Clinical angiology: Manual/Ed. by A.V. Pokrovsky. - Moscow: Medicine Publishers, 2004; 2: 316-325 [In Russ].

38.   Shukla PA, Contractor S, Huang JT, Curi MA. Coil embolization as a treatment alternative for dialysis-associated steal syndrome. Vasc Endovascular Surg. 2012; 46(7): 546-9.

https://doi.org/10.1177/1538574412456435

39.   Davies MG. Management of Arteriovenous Fistula Side Branches: Ligation or Coil Embolization. Journal of Vascular Surgery. 2019: 70(2): 34.

https://doi.org/doi:10.1016/j.jvs.2019.06.041

40.   Kasirajan K. Coil Embolization of Tributaries of Brachiocephalic Fistula is Effective in the Management of Vascular Steal. Ann Vasc Surg. 2021; 72: 307-314.

https://doi.org/10.1016/j.avsg.2020.08.150

41.   Tomoi Y, Soga Y, Fujihara M, et al. Outcomes of Endovascular Therapy for Upper Extremity Peripheral Artery Disease With Critical Hand Ischemia. J Endovasc Ther. 2016; 23(5): 717-22.

https://doi.org/10.1177/1526602816659279

42.   Law Y, Chan YC, Cheng SW. Angioplasty of forearm arteries as a finger salvage procedure for patient with end-stage renal failure. Int J Nephrol Renovasc Dis. 2016; 9: 105-109.

https://doi.org/10.2147/IJNRD.S102257

43.   Gandini R, Angelopoulos G, Da Ros V, et al. Percutaneous transluminal angioplasty for treatment of critical hand ischemia with a novel endovascular approach: the radial to ulnar artery loop technique. J Vasc Surg. 2010; 52: 760-762.

44.   Singh A, Kumar N, Jain AP, et al. Endovascular management of critical hand ischemia by 'palmar arch loop' technique. Vascular. 2021; 29(4): 597-605.

https://doi.org/10.1177/1708538120966939

45.   Bahro A, Igyarto Z, Martinsen B. Critical hand ischemia treatment via orbital atherectomy - A single center observational retrospective analysis. Cardiovascular Revascularization Medicine. 2017; 18: 91-94.

46.   Gandini R, Fabiano S, Morosetti D, et al. Endovascular treatment of below-the-elbow arteries in critical hand ischemia. Minerva Cardioangiol. 2016; 64(6): 662-71.

47.   Yeager RA, Moneta GL, Edwards JM, et al. Relationship of hemodialysis access to finger gangrene in patients with end-stage renal disease. J Vasc Surg. 2002; 36(2): 245-249.

 

Abstract:

Introduction: the main methods for diagnosing cardiac neoplasms, allowing to determine the localization, size, involvement of heart structures, to suggest the nature of the pathological process and to plan treatment tactics, are: echocardiography (EchoCG), contrast multispiral computed coronary angiography (MSCT CAG), magnetic resonance imaging (MRI) and positron emission computed tomography (PET CT). At the same time, any additional information about the pathological process can improve the quality of diagnosis and treatment. So, for example, selective coronary angiography (CAG), which in this case can be performed to clarify the coronary anatomy and exclude concomitant coronary atherosclerosis, in hands of attentive and experienced specialist of endovascular diagnostic and treatment methods can make a significant contribution to understanding the nature of blood supply of heart neoplasm, thereby bringing closer the formulation of the correct diagnosis and, ultimately, improving results of surgical treatment.

Aim: was to study the nature of blood supply of heart myxoma based on results of a detailed analysis of data of selective coronary angiography in patients with this pathology.

Material and methods: since 2005, 20 patients underwent surgery to remove heart myxoma. The average age of patients was 56,6 + 8,0 (43-74) years. According to data of ultrasound examination, sizes of myxomas ranged from 10 to 46 mm in width and from 15 to 71 mm in length (average size ? 25,6 ? 39,1 mm). In 2/3 of all cases (15 out of 20,75%), the fibrous part of the inter-atrial septum (fossa oval region) was the base of myxomas. In 8 of 20 (40%) cases, tumor prolapse into the left ventricle through structures of the mitral valve was noted in varying degrees. In order to exclude coronary pathology, CAG was performed in 14 cases, in the rest - MSCT CAG.

Results: of 14 patients with myxoma who underwent selective coronary angiography, 12 (85,7%) patients had distinct angiographic signs of vascularization. In all 12 cases, the sinus branch participated in the blood supply of myxoma, begins from the right coronary artery (RCA) in 10 cases: in 7 case it begins from proximal segment of the RCA and, in 3 cases, from the posterior-lateral branch (PLB) of the RCA. In one case, the source of blood supply of neoplasm was the sinus branch extending from PLB of dominant (left type) circumflex artery of the left coronary artery (PLB CxA LCA). In one case, the blood supply to the neoplasm involved branches both from the RCA and CxA, mainly from the left atrial branch of CxA. Moreover, in all 12 cases, sinus branch formed two branches: branch of sinus node itself and left atrial branch. It was the left atrial branch that was the source of blood supply of myxoma. Analysis of angiograms in patients with myxoma of LA showed that left atrial branch in terminal section formed a pathological vascularization in the LA projection, accumulating contrast-agent in the capillary phase (MBG 3-4). In addition to newly formed vascularization, lacunae of irregular shape were distinguished, the size of which varied from 2 to 8 mm along the long axis. In 8 cases, hypervascular areas with areas of lacunar accumulation of contrast-agent showed signs of paradoxical mobility and accelerated onset of venous phase. In two cases, there were distinct angiographic signs of arteriovenous shunt. In 2 cases (when the size of the myxoma did not exceed 15-20 mm according to EchoCG and CT), angiographic signs allowing to determine the presence of LA myxoma were not so convincing: there was no lacunar accumulation of contrast-agent; small (up to 10 mm) hypervascular areas were noticed, the capillary network of which stood out against the general background of uniform contrasting impregnation and corresponded to MBG grade 1-2.

Conclusion: according to our data, angiographic signs of vascularization of myxomas are detected in most cases with this pathology (85,7%). The source of blood supply, in the overwhelming majority of cases, is branch of coronary artery, which normally supplies the structure of the heart, on which the basement of the pathological neoplasm is located. The aforementioned angiographic signs characteristic of myxomas deserve the attention of specialists in the field of endovascular diagnosis and treatment and should be described in details in protocols of invasive coronary angiography.

 

References

1.     Петровский Б.В., Константинов Б.А., Нечаенко М.А. Первичные опухоли сердца. М.: Медицина, 1997; 152.

Petrovskiy BV, Konstantinov BA, Nechaenko MA. Primary heart tumors. M.: Medicina, 1997 [In Russ].

2.     Balci AY, Sargin M, Akansel S, et al. The importance of mass diameter in decision-making for preoperative coronary angiography in myxoma patients. Interact Cardiovasc Thorac Surg. 2019; 28(1): 52-57.

https://doi.org/10.1093/icvts/ivy217

3.     Omar HR. The value of coronary angiography in the work-up of atrial myxomas. Herz. 2015; 40(3): 442-446.

4.     Gupta PN, Sagar N, Ramachandran R, Rajeshekharan VR. How does knowledge of the blood supply to an intracardiac tumour help? BMJ Case Rep. 2019; 12(2): 225900.

https://doi.org/10.1136/bcr-2018-225900

5.     Marshall WHJr., Steiner RM, Wexler L. Tumor vascularity in left atrial myxoma demonstrated by selective coronary arteriography. Radiology. 1969; 93(4): 815-816.

6.     Lee SY, Lee SH, Jung SM, et al. Value of Coronary Angiography in the Cardiac Myxoma. Clin Anat. 2020; 33(6): 833-838.

https://doi.org/10.1002/ca.23527

 

Abstract:

Currently, endovascular correction has become the method of choice in most cases of secondary atrial septal defects.

The obvious superiority lies in low trauma, a decrease in the incidence of early complications, atrial flutter and fibrillation, systemic thromboembolism, ischemic stroke, and all-cause mortality.

We present the initial experience of using new occluders for ASD closure.

 

References

1.     Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American heart association task force on practice guidelines (Writing committee to develop guidelines on the management of adults with congenital heart disease). Developed in collaboration with the American society of echocardiography, heart rhythm society, international society for adult congenital heart disease, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol. 2008; 52: 143-263.

2.     King TD, Thompson SL, Steiner C, et al. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA. 1976; 235: 2506-2509.

3.     Alexi-Meskishvili VV, Konstantinov IE. Surgery for atrial septal defect: from the first experiments to clinical practice. Ann Thorac Surg. 2003; 76: 322-327.

4.     Nassif М, Abdelghani М, Bouma J, et al. Historical developments of atrial septal defect closure devices: what we learn from the past. Expert Review of Medical Devices. 2016; 13(6).

5.     Регистрационное удостоверение на медицинское изделие от 30 марта 2020 года № РЗН 2020/9850: «Окклюдер кардиологический «NanoMed» по НАЕФ.942511.015 ТУ.

Registration certificate for medical device, March 30, 2020 No. RZN 2020/9850: «NanoMed cardiological occluder» ac. to NAEF.942511.015 [In Russ].

6.     Базылев В.В., Шматков М.Г., Пьянзин А.И., Морозов З.А. «Отдаленные результаты применения отечественных коронарных стентов с биоинертным углеродным покрытием «Наномед». Журнал Диагностическая и интервенционная радиология. 2020; 14(1); 47-54.

Bazylev VV, Shmatkov MG, Pianzin AI, Morozov ZA. Long-term results of using domestic coronary stents with bioinert carbon coating, «Nanomed». Journal Diagnostic & interventional radiology. 2020; 14(1); 47-54 [In Russ].

https://doi.org/10.25512/DIR.2020.14.1.05

7.     Базылев В.В., Шматков М.Г., Морозов З.А. «Сравнительные результаты использования коронарных стентов с лекарственным покрытием «НаноМед» и Orsiro. Журнал Диагностическая и интервенционная радиология. 2019; 13(4); 21-26.

Bazylev VV, Shmatkov MG, Morozov ZA. Comparison of results of the use of coronary stents with drug eluting, «Nanomed» and Orsiro. Journal Diagnostic & interventional radiology. 2019; 13(4); 21-26 [In Russ].

https://doi.org/10.25512/DIR.2019.13.4.02

8.     Majunke N, Sievert H. ASD/PFO devices: what is in the pipeline? J Interv Cardiol. 2007; 20: 517-523.

9.     Aytemir K, Oto A, Ozkutlu S, et al. Early-midterm follow-up results of percutaneous closure of the interatrial septal defects with occlutech figulla devices: a single center experience. J Interv Cardiol. 2012; 25: 375-381.

10.   Haas NA, Happel CM, Soetemann DB, et al. Optimal septum alignment of the Figulla(R) Flex occluder to the atrial septum in patients with secundum atrial septal defects. EuroIntervention. 2016: 11(10):1153-60.

https://doi.org/10.4244/EIJY14M12_09

11.   Roymanee S, Promphan W, Tonklang N, et al. Comparison of the Occlutech (R) Figulla (R) septal occluder and Amplatzer (R) septal occluder for atrial septal defect device closure. Pediatr Cardiol. 2015; 36: 935-941.

12.   Sharifi M, Burks J. Efficacy of clopidogrel in the treatment of post-ASD closure migraines. Catheter Cardiovasc Interv. 2004; 63: 255.

 

Abstract:

Introduction: surgical treatment of an area of accumulation of breast microcalcifications requires the surgeon to choose the optimal method of surgery. For a long time, the gold standard of surgery was the placement of a wire needle under X-ray control and subsequent removal. In our study, we want to demonstrate one of new methods, which is based on the placement of ultrasound marks in the area of accumulation of calcifications at the preoperative stage and further removal under the control of ultrasound device.

Aim: was to make comparative analysis and estimate the effectiveness of preoperative marking with ultrasound-positive (US-positive) marks in patients with non-palpable breast neoplasms.

Material and methods: the study included 165 patients (age 32 - 71 years). Patients were divided into three groups depending on the preoperative marking. The first group: installed ultrasound-positive Gel Mark UltraCor Bard marks in the region of microcalcifications at the outpatient stage.

The second group: marking with a wire needle «DuaLok» Bard immediately before the operation.

The third group: according to results of a repeated preoperative examination, which included: unilateral mammography in two projections with marker, a skin mark was established in the projection of a non-palpable formation.

Results: study showed that when choosing a surgical treatment using ultrasound-positive marks, the risk of detecting tumor cells at edges of the resection decreases, the time of surgery is shortened, and the volume of resection of healthy breast tissue is minimized.

Study proved that marking using ultrasound-positive marks has an advantage over other methods of preoperative marking and can be implemented in medical organizations that are not equipped with x-ray equipment for marking non-palpable breast formations immediately before surgery.

 

References

1.     Kaprin AD, Starinsky VV, Petrova GV. The status of cancer care for the population of Russia in 2018. MNII P.A. Herzen - branch of the Federal State Budgetary Institution Scientific Research Center for Radiology of the Ministry of Health of Russia, 2019: 236 [In Russ].

2.     World Health Organization. World health statistics 2019.

https://www.who.int/gho/publications/world_health_statistics/2019/EN_WHS_2019_Main.pdf?ua=1

3.     Kaprin AD, Starinsky VV, Petrova GV. Malignant neoplasms in Russia in 2018 (morbidity and mortality). - M.: MNII them. P.A. Herzen - branch of the Federal State Budgetary Institution Scientific Research Center for Radiology of the Ministry of Health of Russia, 2019; 250 [In Russ].

4.     Manuylova OO, Pavlova TV, Didenko VV, et al. Guidelines for the use of the BI-RADS system for mammography examination. Moscow. 2017; 23 [In Russ].

5.     American College of Radiology, ACR BI-RADS Atlas 5th Edition, 2013.

6.     Bonfiglio R, Scimeca M, Urbano N, et al. Breast microcalcifications: biological and diagnostic perspectives. Future Oncol. 2018; 14(30): 3097-3099.

7.     Tardioli S, Ballesio L, Gigli S, et al. Wire-guided Localization in Non-palpable Breast Cancer: Results from Monocentric Experience. Anticancer Res. 2016; 36(5): 2423-2427.

 

Abstract:

Introduction: all over the world, the number of patients with peripheral arterial lesions is growing, the progression of the disease leads to the chronic limb-threatening ischemia (CLTI) with an increasement in mortality. To carry out revascularization, it is required to accurately determine the degree and length of lesions of arteries of limbs, with the creation of a «road map» of lesions and the choice of the least affected artery ? the target arterial pathway.

Aim: was to determine the effectiveness of CT angiography in diagnosing lesions of shin arteries in patients with critical lower limb ischemia (CLI) by calculating its sensitivity and specificity in comparison with digital subtraction angiography.

Materials and methods: the study included 26 patients (15 men and 11 women, average age of patients 69,3 ± 10,8 years) with critical lower limb ischemia, against the background of lesions of the femoro-popliteal segment of arteries, class D TASC II. All patients underwent CT angiography on a 64-spiral computed tomography scanner. Obtained data was compared with results of catheter angiography (digital subtraction angiography), used as a reference method.

Results: the sensitivity of CT angiography in determining the degree of lesion (stenosis or occlusion) of leg arteries was 100% and 94%, the specificity was 83% and 96%, respectively. The overall accuracy of CT angiography in the tibial segment was 87% for stenoses and 94% for occlusions. According to results of CTA, massive calcification was detected in 13% of cases from the total number of analyzed arteries. When evaluating these arteries according to DSA data, most of arteries (11 of 12) were occluded, and the length of occlusions in 8 cases was maximum according to the GLASS classification (the length was more than 1/3 of the artery length). The presence of strong correlations between CT angiography and digital angiography on the presence of occlusions, stenoses> 50% and their length was determined.

Conclusions: CT angiography is a highly informative method for diagnosing the degree and length of lesions of shin arteries in patients with critical lower limb ischemia.

 

References

1.     GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159): 1789-1858.

https://doi.org/10.1016/S0140-6736(18)32279-7

2.     Reinecke H, Unrath, M, Freisinger E, et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. European heart journal. 2015; 36(15), 932-938.

https://doi.org/10.1093/eurheartj/ehv006

3.     National guidelines for the diagnosis and treatment of lower limb arterial diseases. Expert group for the preparation of recommendations: chairmen of the expert group Academician of the Russian Academy of Sciences Bokeria LA, Academician of the Russian Academy of Sciences Pokrovsky AV. Moscow, 2019 [In Russ].

http://www.angiolsurgery.org/library/recommendations/2019/recommendations_LLA_2019.pdf

4.     Aboyans V, Ricco JB, Bartelink M, et al. ESC Scientific Document Group (2018). 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). European heart journal. 2018; 39(9): 763-816.

https://doi.org/10.1093/eurheartj/ehx095

5.     Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007; 33 (1): 1-75.

https://doi.org/doi:10.1016/j.ejvs.2006.09.024

6.     Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019; 69(6S): 3-125.

https://doi.org/doi:10.1016/j.jvs.2019.02.016

7.     Pokrovsky AV, Yakhontov DI. The value of assessing the outflow tract in femoral-tibial reconstructions. Rossijskij Mediko-biologicheskij vestnik im. akademika I.P. Pavlova. 2013; 4: 104-112 [In Russ].

8.     Hamburg NM, Creager MA. Pathophysiology of Intermittent Claudication in Peripheral Artery Disease. Circulation journal: official journal of the Japanese Circulation Society. 2017; 81(3): 281-289.

https://doi.org/10.1253/circj.CJ-16-1286

9.     Bollinger A, Breddin K, Hess H, et al. Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images. Atherosclerosis. 1981; 38(3-4): 339-346.

https://doi.org/doi:10.1016/0021-9150(81)90050-2

10.   Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997; 26(3): 517-538.

https://doi.org/doi:10.1016/s0741-5214(97)70045-4

11.   Graziani L, Silvestro A, Bertone V, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg. 2007; 33(4): 453-460.

https://doi.org/doi:10.1016/j.ejvs.2006.11.022

12.   Radiation diagnostics of diseases of the heart and blood vessels. National leadership. (Ed. by LS Kokov; SK Ternovoj.) Moscow, GEOTAR-Media, 2011; 688 [In Russ].

13.   ?urovi? Sarajli? V, Toti? D, Bi?o Osmanagi? A, et al. Is 64-Row Multi-Detector Computed Tomography Angiography Equal to Digital Subtraction Angiography in Treatment Planning in Critical Limb Ischemia? Psychiatr Danub. 2019; 31(5): 814-820.

14.   Al-Rudaini HEA, Han P, Liang H. Comparison Between Computed Tomography Angiography and Digital Subtraction Angiography in Critical Lower Limb Ischemia. Curr Med Imaging Rev. 2019; 15(5): 496-503.

https://doi.org/doi:10.2174/1573405614666181026112532

15.   Lim JC, Ranatunga D, Owen A, et al. Multidetector (64+) Computed Tomography Angiography of the Lower Limb in Symptomatic Peripheral Arterial Disease: Assessment of Image Quality and Accuracy in a Tertiary Care Setting. J Comput Assist Tomogr. 2017; 41(2): 327-333.

https://doi.org/doi:10.1097/RCT.0000000000000494

16.   Mohler ER, Jaff MR Peripheral Artery Disease 2nd Edition. Wiley-Blackwell. 2017; 208.

17.   Ayubova NL, Bondarenko ON, Galstyan GR, et al. Peculiarities of lesions of the arteries of the lower extremities and clinical outcomes of endovascular interventions in patients with diabetes mellitus with critical ischemia of the lower extremities and chronic kidney disease. Saharnyj diabet. 2013; (4): 85-94 [In Russ].

18.   Molitvoslovova NA, Manchenko OV, Jaroslavceva MV, et al. The relationship of calcification of the arteries of the lower extremities with the severity of distal neuropathy in patients with diabetes mellitus. Problemy jendokrinologii. 2013; 59(2): 7-11 [In Russ].

https://doi.org/10.14341/probl20135927-11

19.   Konijn LCD, Takx RAP, de Jong PA, et al. Arterial calcification and long-term outcome in chronic limb-threatening ischemia patients. Eur J Radiol. 2020; 132: 109305.

https://doi.org/doi:10.1016/j.ejrad.2020.109305

 

Abstract:

Introduction: incidence of aortic valve stenosis is 3rd in the group of cardio-vascular diseases. Most important questions of aortic valve replacement (AVR) are: prosthesis effective orifice area (EOA) sufficiency for certain patient and need of posterior aortoplasty (PA). Each prosthesis of certain number has technical data and size. Reasonable frequency of posterior aortoplasty is a discussed question.

Aim: was to analyze echocardiographic data in two groups: isolated AVR and AVR + PA in order to study the reasonable frequency of posterior aortoplasty application while using stented bioprosthesis NeoCor-21 «UniLine».

Materials and methods: 99 patients with bioprosthesis NeoCor-21 «UniLine» implantation were enrolled in study for investigation of problem of aortoplasty need. According to application/absence of posterior aortoplasty patients were divided in two groups. In postoperative period groups were compared in echocardiographic data calculations: left ventricle end-diastolic volume (LV EDV), ejection fraction (LV EF), stroke volume (LV SV), peak and mean valve gradients. Indexes were calculated and compared: stroke volume index (SVI) and prosthesis effective orifice area index (EOAI).

Results: the group of AVR + PA consisted of 14 (14,14%) patients. Immediate postoperative echocardiographic calculations revealed no statistic difference between two groups: in left ventricle end diastolic volume (LV EDV), ejection fraction (LV EF), stroke volume (LV SV), peak and mean valve gradients, stroke volume index (SVI) and valve effective orifice area index (EOAI). Group without posterior aortoplasty had slightly higher end diastolic volume (LV EDV), stroke volume (LV SV), peak and mean valve gradients. Opposite patients with posterior aortoplasty had slightly higher ejection fraction (LV EF), stroke volume index (SVI), slightly less peak and mean valve gradients. Left ventricle function was more optimal in the posterior aortoplasty group.

Conclusion: in our practice, incidence of posterior aortoplasty in using stented bioprosthesis NeoCor-21 «UniLine» was 14,14%. Echocardiographic calculations of postoperative data demonstrated that this frequency was reasonable. Probably posterior aortoplasty is to be applied more frequently.

Conflict of interest: the authors declare no conflict of interest.

 

References

1.     Bokeriya LA, Belaya G. Methods of echocardiographic assessment of aortic valve hemodynamics after prosthetics: methods and precautions. Kreativnaya kardiologiya-Creative cardiology. 2012; 6(1): 73-79 [In Russ].

2.     Iqbal A, Panicker VT, Karunakaran J. Patient prosthesis mismatch and its impact on left ventricular regression following aortic valve replacement in aortic stenosis patients. Indian J Thorac Cardiovasc Surg. 2019; 35: 6-14.

https://doi.org/10.1007/s12055-018-0706-3

3.     Malhotra A. Prosthesis patient mismatch: myth or reality? Indian J Thorac Cardiovasc Surg. 2019; 35: 3-5.

https://doi.org/10.1007/s12055-018-0708-1

4.     Rashimtoola SH. The problem of valve prosthesis-patient mismatch. Circulation. 1978; 58: 20-24.

5.    Sazonenkov MA, Ismatov KhH, Prisyazhnyuk EI, et al. Comparison of the manufacturers technical specification with postoperative results in four types of stented bioprostheses in the aortic position. Actualnye problemy mediciny. 2020; 43(1): 113-123 [In Russ].

6.     Klyshnikov KYu, Ovcharenko EA, Shcheglova NA, Barbarash L.S. Functional characteristics of Uniline bioprostheses. Kompleksnye problemy serdechno-sosudistykh zabolevaniy. 2017; 3: 6-12 [In Russ].

https://doi.org/10.17802/2306-1278-2017-6-3-6-12

7.     Manufacturers information. ZAO «NeoCor» 1978-2020 [In Russ].

https://neocor.ru/aortalnyyklapan-3

8.     Nicks R, Cartmill T, Bernstein L. Hypoplasia of the aortic root. The problem of aortic valve replacement. Thorax. 1970; 25(3): 339-346.

9.     Rittenhouse EA, Sauvage LR, Stamm SJ, et al. Radical enlargement of the aortic root and outflow tract to allow valve replacement. Ann Thorac Surg. 1979; 27(4): 367-73.

10.   Clinical guidelines: Aortic stenosis. Association of Cardiovascular Surgeons of Russia. Moscow 2020 [In Russ].

11.   Manouguian S, Seybold-Epting W. Patch enlargement of the aortic valve ring by extending the aortic incision into the anterior mitral leaflet. New operative technique. J Thorac Cardiovasc Surg. 1979; 78(3): 402-412.

12.   Belov YuV, Charchyan ER, Katkov AI, et al. Influence of the discrepancy between the diameter of the prosthesis and the patient's body surface area on the long-term results of aortic valve replacement. Kardiologiya i serdechno-sosudistaya khirurgiya. 2016; 9 (2): 46-51 [In Russ].

https://doi.org/10.17116/kardio20169246-51

13.   Pibarot P, Magne J, Leipsic J, et al. Imaging for Predicting and Assessing Prosthesis-Patient Mismatch After Aortic Valve Replacement. JACC Cardiovasc Imaging. 2019; 12(1): 149-162.

https://doi.org/10.1016/j.jcmg.2018.10.020

14.   Tam DY, Dharma C, Rocha RV, et al. Early and late outcomes of aortic root enlargement: a multicenter propensity score-matched cohort analysis. J Thorac Cardiovasc Surg. 2020; 160: 908-19.

https://doi.org/10.1016/j.jtcvs.2019.09.062

15.   Concistr? G, Dell'aquila A, Pansini S, et al. Aortic valve replacement with smaller prostheses in elderly patients: does patient prosthetic mismatch affect outcomes? J Card Surg. 2013; 28(4): 341-7.

16.   Dumani S, Likaj E, Dibra L, et al. Aortic Annular Enlargement during Aortic Valve Replacement. Open Access Maced J Med Sci. 2016; 15; 4(3): 455-457.

https://doi.org/10.3889/oamjms.2016.098

17.   S? MP, Zhigalov K, Cavalcanti LRP, et al. Impact of aortic annulus enlargement on the outcomes of aortic valve replacement: a meta-analysis. Semin Thorac Cardiovasc Surg. 2021; 33(2): 316-325.

18.   Yu W, Tam DY, Rocha RV, et al. Aortic Root Enlargement Is Safe and Reduces the Incidence of Patient-Prosthesis Mismatch: A Meta-analysis of Early and Late Outcomes. Can J Cardiol. 2019; 35(6): 782-790.

authors: 


Article exists only in Russian.

authors: 


Article exists only in Russian.

authors: 

 

Article exists only in Russian.

authors: 

 

Article exists only in Russian.

authors: 

 

Abstract:

Introduction: the problem of the shortage of donor organs can be partially solved by expanding the donor selection criteria. The consequence of this is an increase in the risk of transmission of atherosclerotic lesions of the coronary arteries from the donor to the recipient. According to current publications, endovascular correction is the preferred treatment. Assessment of the hemodynamic significance of borderline stenosis of the coronary arteries in recipients, detected at the first coronary angiography in the early postoperative period, remains a topical issue.

Case report: article presents case report of results of endovascular correction of donor-associated lesion of coronary arteries in recipient under control of iFr.

Conclusion: due to the severity of patient's condition, the use of non-invasive methods for verifying myocardial ischemia is sharply limited, which determines the high importance of endovascular technologies for the physiological assessment of stenosis.

 

References

1.     Lee HY, Oh BH. Heart Transplantation in Asia. Circulation Journal. 2017; 81(5): 617-621.

https://doi.org/10.1253/circj.CJ-17-0162

2.     Yusen RD, Christie JD, Edwards LB, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report. Focus Theme: Age. J Heart Lung Transplant. 2013; 32(10): 965-978.

3.     Sakhovsky SA, Izotov DA, Koloskova NN, et al. Angiograficheskaya otsenka ateroskleroticheskogo porazheniya koronarnikh arterii serdechnogo transplantata. Vestnik transplantologii i iskusstvennih organov. 2018; 20(4): 22-29 [In Russ].

https://doi.org/10.15825/1995-1191-2018-4-22-29

4.     Chestukhin VV, Ostroumov EN, Tyunyaeva IYu, et al. Bolezn’ koronarnikh arterii peresazhennogo serdtsa. Vozmozhnosti diagnostiki i lecheniya. Ocherki klinicheskoi transplantologii pod redakciei Got’e SV. M. 2009; 88-93 [In Russ].

5.     Darenskii DI, Gramovich VV, Zharova EA, et al. Diagnosticheskaya tsennost izmereniya momental’nogo rezerva krovotoka po sravneniyu s neinvazivnimi metodami viyavleniya ishemii miokarda pri otsenke funktsionalnoi znachimosti pogranichnikh stenozov koronarnikh arterii. Terapevticheskii arkhiv. 2017; 4: 15-21 [In Russ].

6.     Gramovich VV, Zharova EA, Mitroshkin MG, et al. Opredelenie porogovikh znachenii momental’nogo rezerva krovotoka pri otsenke funktsionalnoi znachimosti stenozov koronarnish arterii pogranichnoi stepeni tyazhesti s ispolzovaniem neinvazivnikh metodov verifikatsii ishemii miokarda v kachestve standarta. Evraziiskii kardiologicheskii zhurnal. 2016; 4: 34-41 [In Russ].

7.     Tonino PAL, De Bruyne B, Pijls NHJ, et al. Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention. The New England Journal of Medicine. 2009; 360: 213-224.

https://doi.org/10.1056/NEJMoa0807611

8.     De Bruyne B, Pijls NH, Kalesan B, et al. FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012; 367(11): 991-1001.

https://doi.org/10.1056/NEJMoa1205361

9.     Xaplanteris P, Fournier S, Pijls NHJ, et al. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. The New England Journal of Medicine. 2018; 379: 250-259.

https://doi.org/10.1056/NEJMoa1803538

10.   Barbato E, Toth GG, Johnson NP, et al. Prospective natural history study of coronary atherosclerosis using fractional flow reserve. Journal of the American College of Cardiology. 2016; 68(21): 2247-2255.

https://doi.org/10.1016/j.jacc.2016.08.055

11.   G?tberg M, Christiansen EH, Gudmundsdottir IJ, et al. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PC. The New England Journal of Medicine. 2017; 376: 1813-23.

https://doi.org/10.1056/NEJMoa1616540

12.   Andell P, Berntorp K, Christiansen EH, et al. Reclassification of Treatment Strategy With Instantaneous Wave-Free Ratio and В Fractional Flow Reserve: A Substudy From the iFR-SWEDEHEART Trial. JACC: Cardiovascular Interventions. 2018; 11(20): 2084-2094.

https://doi.org/10.1016/j.jcin.2018.07.035

13.   Davies JE, Sen S, Dehbi HM, et al. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. The New England Journal of Medicine. 2017; 376: 1824-1834.

https://doi.org/10.1056/NEJMoa1700445

14.   Neumann FJ, Sousa-Uva M, Ahlsson A, et al. ESC Scientific Document Group; 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019; 40(2): 87-165.

https://doi.org/10.1093/eurheartj/ehy394

 

Abstract:

Introduction: the review is devoted to clinical results of the use of radiological and endovascular interventionsin intrahepatic cholangiocarcinoma: chemoinfusion, chemo- and radioembolization of the hepatic artery, preoperative embolization of right branch of portal vein.

Aim: was to evaluate and compare the effectiveness of methods of intravascular therapy for intrahepatic cholangiocarcinoma.

Materials and methods: article presents an analysis of 50 scientific literature sources in leading domestic and foreign scientific journals.

Results: it was found that intra-arterial treatment methods have approximately the same clinical efficacy. Chemoinfusion is a technically simple and effective method of treatment, prospects of which are associated with the creation of new chemotherapy drugs and therapeutic regimens. Chemoembolization is most effective for hypervascular cholangiocarcinoma. The question of its use in a neoadjuvant mode requires study, even in resectable cases, it helps to reduce the biological activity of the tumor. Radioembolization (RE) effectively slows down the growth of cholangiocarcinoma and is well tolerated by patients, but long-term results are little bit worse to those of infusion and embolization. The procedure seems to be technically difficult and requires expensive logistics. When solving these problems, ER can become one of the most important methods of treating cholangiocarcinoma, especially when the tumor is resistant to other methods of therapy.

Preoperative portal vein embolization is routinely used in clinical practice. However, operations performed after this procedure account for only 3-6% of all liver resections. The wider application of this technically simple and safe technique seems logical.

Conclusions: in the treatment of cholangiocarcinoma, a combined approach should be used with the use of surgical, X-ray endovascular and other methods of anticancer therapy: this makes it possible to expand possibilities of treating patients and achieve improved long-term results.

 

References

1.     Datta J, Narayan RR, Kemeny NE, D’Angelica MI. Role of hepatic artery infusion chemotherapy in treatment of initially unresectable colorectal liver metastases (review). JAMA Surg. 2019; 154(8): 768-776.

https://doi.org/10.1001/jamasurg.2019.1694

2.     Rutkin IO, Granov DA, Polysalov VN, et al. Combination of cytoreductive surgery and implantation of intra-arterial infusion systems in the treatment of unresectable liver tumors. Voprosy Onkologii. 2007; 53(2): 206-209 [In Russ].

3.     Generalov MI, Balakhnin PV, Tsurkan VA, et al. Diagnosis and treatment of toxic complications of regional chemotherapy through percutaneously implanted systems. Diagnosticheskaja i Intervencionnaya Radiologiya. 2007; 1(3): 46-51 [In Russ].

4.     Imamine R, Shibata T, Shinozuka K, Togashi K. Complications in hepatic arterial infusion chemotherapy: retrospective comparison of catheter tip placement in the right/left hepatic artery vs. the gastroduodenal artery. Surg. Today. 2017; 47(7): 851-858.

5.     Kozlov AV, Tarazov PG, Polikarpov AA, Polysalov VN. Possibility of regional chemotherapy in patients with cancer of the liver and biliary ducts complicated by obstructive jaundice. Rossijskij Onkologicheskij Zhurnal. 2004; 1: 11-15 [In Russ].

6.     Konstantinidis IT, Do RKG, Gultekin GH, et al. Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potentional role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials. Ann. Surg. Oncol. 2014; 21(8): 2675-2683.

https://doi.org/10.1245/s10434-014-3649-y

7.     Konstantinidis IT, Koerkamp BG, Do RKG, et al. Unresectable intrahepatic cholangiocarcinoma: systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone. Cancer. 2016; 122(5): 758-765.

https://doi.org/10.1002/cncr.29824

8.     Sinn M, Nicolaou A, Gebauer B, et al. Hepatic arterial infusion with oxaliplatin and 5-FU/folinic acid for advanced biliary tract cancer: a phase II study. Dig. Dis. Sci. 2013; 58(8): 2399-2405.

https://doi.org/10.1007/s10620-013-2624-y

9.     Wang X, Hu J, Caj G, et al. Phase II study of hepatic arterial infusion chemotherapy with oxaliplatin and 5-fluorouracil for advanced perihilar cholangiocarcinoma. Radiology. 2017; 283(2): 580-589.

https://doi.org/10.1148/radiol.2016160572

10.   Thiels CA, D’Angelica MI. Hepatic artery infusion pumps (review). J. Surg. Oncol. 2020; 122(1): 70-77.

https://doi.org/10.1002/jso.25913

11.   Savic LJ, Chapiro J, Geschwind J-FH. Intra-arterial embolotherapy for intrahepatic cholangiocarcinoma: update and future prospects (review). Hepatobiliary Surg. Nutr. 2017; 6(1): 7-21.

https://doi.org/10.21037/hbsn.2016.11.02

12.   Lewis AL, Hall B. Toward a better understanding of the mechanism of action for intra-arterial delivery of irinotecan from DC Bead (DEBIRI). Future Oncology. 2019; 15(17): 2053-2068.

https://doi.org/10.2217/fon-2019-0071

13.   Faramazzalian A, Armitage KB, Kapoor B, Kalva SP. Medical management of tumor lysis syndrome, postprocedural pain, and venous thromboembolism following interventional radiology procedures. Semin. Intervent. Radiol. 2015; 32(2): 209-216.

https://doi.org/10.1055/s-0035-1549379

14.   Matsui Y, Figi A, Horikawa M, et al. Arteriopathy after transarterial chemo-lipiodolization for hepatocellular carcinoma. Diagn. Interv. Imag. 2017; 98(12): 827-835.

https://doi.org/10.3748/wjg.v25.i31.4360

15.   Newgard BJ, Getrajdman GI, Erinjeri JP, et al. Incidence and consequence of nontarget embolization following bland hepatic arterial embolization. Cardiovasc. Intervent. Radiol. 2019; 42(8): 1135-1141.

https://doi.org/10.1007/s00270-019-02229-2

16.   Dolgushin BI, Virshke ER, Kosyrev VJ, et al. Transarterial chemoembolization in the treatment of inoperable patients with nodular cholangiocarcinoma. Annaly Khirurgicheskoy Gepatologii. 2015; 20(3): 24-30 [In Russ].

https://doi.org/10.16931/1995-5464.2015324-30

17.   Park S-Y, Kim JH, Yoon H-J, et al. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma. Clin. Radiol. 2011; 66(4): 322-328.

https://doi.org/10.1016/j.crad.2010.11.002

18.   Gusani NJ, Balaa FK, Steel JL, et al. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. J. Gastrointest. Surg. 2008; 12(1): 129-137.

https://doi.org/10.1007/s11605-007-0312-y

19.   Burger I, Hong K, Schulik R, et al. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J. Vasc. Interv. Radiol. 2005; 16(3): 353-361.

https://doi.org/10.1097/01.RVI.0000143768.60751.7

20.   Kiefer MV, Albert M, McNally M, et al. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. Cancer. 2011; 117(7): 1498-1505.

https://doi.org/10.1002/cncr.25625

21.   Vogl TJ, Naguib NN, Nour-Eldin NE, et al. Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: results and prognostic factors governing treatment success. Int. J. Cancer. 2012; 31(3): 733-740.

https://doi.org/10.1002/ijc.26407

22.   Popov VV, Polikarpov AA, Alentiev SA, et al. Possibilities of regional chemotherapy in the treatment of unresectable cholangiocarcinoma. Klinicheskaja Patofisiologija. 2016; 3-1(22): 21-24 [In Russ].

https://doi.org/10.1111/liv.12364

23.   Li J, Wang Q, Lei Z, et al. Adjuvant transarterial chemoembolization following liver resection for intrahepatic cholangiocarcinoma based on survival risk stratification. Oncologist. 2015; 26(6): 640-647.

https://doi.org/10.1634/theoncologist.2014-0470

24.   Lu Z, Liu S, Yi Y, et al. Serum gamma-glutamyl transferase levels affect the prognosis in patients with intrahepatic cholangiocarcinoma who receive postoperative adjuvant transcatheter arterial chemoembolization: a propensity score matching study. Int. J. Surg. 2017; 37: 24-28.

https://doi.org/10.1016/j.ijsu.2016.10.015

25.   Wu ZF, Zhang HB, Yang N, et al. Postoperative adjuvant transcatheter arterial chemoembolization improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series. Eur. J. Surg. Oncol. 2012; 38(7): 602-610.

https://doi.org/10.1016/j.ejso.2012.02.185

26.   Park HM, Yun SP, Lee EC, et al. Outcomes for patients with recurrent intrahepatic cholangiocarcinoma after surgery. Ann. Surg. Oncol. 2016; 23(13): 4392-4400.

https://doi.org/10.1245/s10434-016-5454-2

27.   Ge Y, Jeong S, Luo G-J, et al. Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: development of a prognostic nomogram. Hepatobiliary Pancreat. Dis. Int. 2020; 19(2): 138-146.

https://doi.org/10.1016/j.hbpd.2020.02.005

28.   Aliberti C, Benea G, Tilli M, Fiorentini G. Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results. Cardiovasc. Intervent. Radiol. 2008; 31(5): 883-888.

https://doi.org/10.1007/s00270-008-9336-2

29.   Aliberti C, Carandina R, Sarti D, et al. Chemoembolization with drug-eluting microspheres loaded with doxorubicin for the treatment of cholangiocarcinoma. Anticancer Res. 2017; 37(4): 1859-1863.

https://doi.org/10.21873/anticanres.11522

30.   Kuhlman JB, Euringer W, Spangenberg HC, et al. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy. Eur. J. Gastroenterol. Hepatol. 2012; 24(4): 437-443.

https://doi.org/10.1097/MEG.0b013e3283502241

31.   Schiffman SC, Metzger T, Dubel G, et al. Precision hepatic arterial irinotecan therapy in the treatment of unresectable cholangiocellular carcinoma: optimal tolerance and prolonged overall survival. Ann. Surg. Oncol. 2011; 18(2): 431-438.

https://doi.org/10.1245/s10434-010-1333-4

32.   Ray CE, Edwards A, Smith MT, et al. Meta-analysis of survival, complications, and imaging response following chemotherapy-based transarterial therapy in patients with unresectable intrahepatic cholangiocarcinoma. J. Vasc. Interv. Radiol. 2013; 24(8): 1218-1226.

https://doi.org/10.1016/j.jvir.2013.03.019

33.   Radosa CG, Radosa JC, Grosche-Schlee S, et al. Holmium-166 radioembolization in hepatocellular carcinoma: feasibility and safety of a new treatment option in clinical practice. Cardiovasc. Intervent. Radiol. 2019; 42(3): 405-412.

https://doi.org/10.1007/s00270-018-2133-7

34.   Gangi A, Shah J, Hatfield N, et al. Intrahepatic cholangiocarcinoma treated with transarterial yttrium-90 glass microsphere radioembolization: Results of a single institution retrospective study. J. Vasc. Interv. Radiol. 2018; 29(8): 1101-1108.

https://doi.org/10.1016/j.jvir.2018.04.001

35.   Reimer P, Virarkar MK, Binnenhei M, et al. Prognostic factors in overall survival of patients with unresectable intrahepatic cholangiocarcinoma treated by means of yttrium-90 radioembolization: results in therapy-na?ve patients. Cardiovasc. Intervent. Radiol. 2018; 41(5): 744-752.

https://doi.org/10.1007/s00270-017-1871-2

36.   Al-Adra DP, Gill RS, Axford SJ, et al. Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis. Eur. J. Surg. Oncol. 2015; 41(1): 120-127.

https://doi.org/10.1016/j.ejso.2014.09.007

37.   Zhen Y, Liu B, Chang Z, et al. A pooled analysis of transarterial radioembolization with ittrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma. Onco Targets Ther. 2019; 12: 4489-4498.

https://doi.org/10.2147/OTT.S.202875

38.   Rayar M, Sulpice L, Edeline J, et al. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment. Ann. Surg. Oncol. 2015; 22(9): 3102-3108.

https://doi.org/10.1245/s10434-014-4365-3

39.   Bargellini I, Mosconi C, Pizzi G, et al. Yttrium-90 radioembolization in unresectable intrahepatic cholangiocarcinoma: Results of a multicenter retrospective study. Cardiovasc. Intervent. Radiol. 2020; 43(9): 1305-1314.

https://doi.org/10.1007/s00270-020-02569-4

40.   Edeline J, Touchefeu Y, Guiu B, et al. Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: A phase 2 clinical trial. JAMA Oncol. 2019; 6(1): 51-59.

https://doi.org/10.1001/jamaoncol.2019.3702

41.   White J, Carolan-Rees G, Dale M, et al. Yttrium-90 transarterial radioembolization for chemotherapy-refractory intrahepatic cholangiocarcinoma: a prospective, observational study. J. Vasc. Interv. Radiol. 2019; 30(8): 1185-1192.

https://doi.org/10.1016/j.jvir.2019.03.018

42.   Buettner S, Braat AJAT, Margonis GA, et al. Yttrium-90 radioembolization in intrahepatic cholangiocarcinoma: a multicenter retrospective analysis. J. Vasc. Interv. Radiol. 2020; 31(7): 1035-1043.

https://doi.org/10.1016/j.jvir.2020.02.008

43.   Akinwande O, Shah V, Mills A, et al. Chemoembolization versus radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma in a single institution: image-based efficacy and comparative toxicity. Hepatic Oncology. 2017; 4(3): 75-81.

https://doi.org/10.2217/hep-2017-0005

44.   Currie BM, Soulen MC. Decision making: intra-arterial therapies for cholangiocarcinoma – TACE and TARE. Semin. Intervent. Radiol. 2017; 34(2): 92-100.

https://doi.org/10.1055/s-0037-1602591

45.   Hyder O, Marsh JW, Salem R, et al. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis. Ann. Surg. Oncol. 2013; 20(12): 3779-3786.

https://doi.org/10.1245/s10434-013-3127-y

46.   Boehm LM, Jayakrishnan TT, Miura JT, et al. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma. J. Surg. Oncol. 2015; 111(2): 213-220.

https://doi.org/10.1002/jso.23781

47.   Yang L, Shan J, Shan L, et al. Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic review. J. Gastrointest. Oncol. 2015; 6(5): 570-588.

https://doi.org/10.3978/j.issn.2078-6891.2015.055

48.   Wright GP, Perkins S, Jones H, et al. Surgical resection does not improve survival in multifocal intrahepatic cholangiocarcinoma: a comparison of surgical resection with intra-arterial therapies. Ann. Surg. Oncol. 2018; 25(1): 83-90.

https://doi.org/10.1245/s10434-017-6110-1

49.   Ebata T, Yokoyama Y, Igami T, et al. Portal vein embolization before extended hepatectomy for biliary cancer: current technique and review of 494 consecutive embolizations. Dig. Surg. 2012; 29(1): 23-29.

https://doi.org/10.1159/000335718

50.   Higuchi R, Yamamoto M. Indications for portal vein embolization in perihilar cholangiocarcinoma. J. Hep. Bil. Pancr.Sci. 2014; 21(86): 542-549.

https://doi.org/10.1002/jhbp.77

 

Abstract:

Introduction: article provides a literature review on the role of various imaging methods used in the diagnosis and control of effectiveness of therapy for rheumatoid arthritis.

Aim: to analyze domestic and foreign literature sources reflecting the state of the problem and aspects of radiological diagnosis of rheumatoid arthritis.

Materials and methods: 52 scientific sources of leading domestic and foreign journals were analyzed.

Results: conventional radiography today is the most widely used imaging technique for diagnosing and monitoring of progression of rheumatoid arthritis. However, it is not sensitive enough to detect changes in the early stage of rheumatoid arthritis, since it only allows assessment of bone structures. Establishing the diagnosis of rheumatoid arthritis at the stage of detecting structural abnormalities in joints indicates the presence of functional impairment and disability of patients. At the same time, early diagnosis of rheumatoid arthritis, at the stage of pre-radiological changes, leads to an improved prognosis of the disease and contributes to preservation of working capacity. In this regard, it becomes necessary to introduce into clinical practice sensitive advanced imaging methods aimed at identifying changes that precede the development of structural changes in bone.

Conclusion: the diagnostic effectiveness of radiation research methods in rheumatoid arthritis implies the identification of synovitis, tenosynovitis, early inflammatory changes in the bone, structural changes in the articular cartilage and bone (erosion), assessment of the severity of the inflammatory response.

 

References

1.     Muravyev YuV. Extraarticular manifestations of rheumatoid arthritis. Nauchno-prakticheskaya revmatologiya. 2018; 56(3): 356-362 [In Russ].

https://doi.org/10.14412/1995-4484-2018-356-362

2.     Nasonov EL, Olyunin YuA, Lila AM. Rheumatoid arthritis: the problems of remission and therapy resistance. Nauchno-prakticheskaya revmatologiya. 2018; 56(3): 263-271 [In Russ].

https://doi.org/10.14412/1995-4484-2018-263-271

3.     Turan A, ?eltik?i P, Tufan A, ?zt?rk MA. Basic radiological assessment of synovial diseases: a pictorial essay. Eur J Rheumatol. 2017; 4(2): 166-174.

https://doi.org/10.5152/eurjrheum.2015.0032

4.     Galushko EA, Nasonov EL. Prevalence of rheumatic diseases in Russia. Al'manah klinicheskoj mediciny. 2018; 46(1): 32-39 [In Russ].

https://doi.org/10.18786/2072-0505-2018-46-1-32-39

5.     Nasonov EL, Lila AM. The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence. Nauchno-prakticheskaya revmatologiya. 2019; 57(5): 564-577 [In Russ].

https://doi.org/10.14412/1995-4484-2019-564-57

6.     Lila AM, Dreval RО, Shipitsyn VV. Assessment of organization of medical care and drug provision for patients with rheumatic diseases, and the socioeconomic burden of these diseases in the Russian Federation. Sovremennaya revmatologiya. 2018; 12(3): 112-119 [In Russ]. https://doi.org/10.14412/1996-7012-2018-3-112-119

7.     Guo Q, Wang Y, Xu D, et al. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018; 6: 15.

https://doi.org/10.1038/s41413-018-0016-9

8.     Sharif K, Sharif A, Jumah F, et al. Rheumatoid arthritis in review: Clinical, anatomical, cellular and molecular points of view. Clin Anat. 2018; 31(2): 216-223.

https://doi.org/10.1002/ca.22980

9.     Sapundzhieva T, Karalilova R, Batalov A. Hand ultrasound patterns in rheumatoid and psoriatic arthritis: the role of ultrasound in the differential diagnosis. Rheumatol Int. 2020; 40(6): 837-848.

https://doi.org/10.1007/s00296-020-04559-8

10.   Bollow M. Rheumatoid arthritis of the hand: Part 2: Imaging. Radiologe. 2021; 61(4): 362-374.

https://doi.org/10.1007/s00117-021-00833-3

11.   Mikhaylova AS, Lesnyak OM. Pannus growth regulators as potential targets for biological therapy in rheumatoid arthritis. Sovremennaya revmatologiya. 2018; 12(1): 55-59 [In Russ].

https://doi.org/10.14412/1996-7012-2018-1-55-59

12.   Avdeeva AS, Artyukhov AS, Dashinimaeva EB, et al. Changes of cytokine profile measures during the treatment of rheumatoid arthritis with rituximab biosimilar (Acellbia, BIOCAD) and the original drug (MabThera, F. Hoffmann-La Roche Ltd., Switzerland). Nauchno-prakticheskaya revmatologiya. 2019; 57(1): 46-55 [In Russ].

https://doi.org/10.14412/1995-4484-2019-46-55

13.   Korolev MA, Ubshaeva YuB, Banshchikova NY, et al. The results of investigating the efficacy and safety of non-medical switching from the original rituximab to its biosimilar in rheumatoid arthritis patients (AMBIRA study). Nauchno-prakticheskaya revmatologiya. 2020; 58(6): 663-672 [In Russ].

https://doi.org/10.47360/1995-4484-2020-663-672

14.   Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31(3): 315-24.

https://doi.org/10.1002/art.1780310302

15.   Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010; 69(9): 1580-8.

https://doi.org/10.1136/ard.2010.138461

16.   Emery P, Breedveld FC, Dougados M, et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis. 2002; 61(4): 290-297.

https://doi.org/10.1136/ard.61.4.290

17.   Sudo?-Szopi?ska I, Jurik AG, Eshed I, et al. Recommendations of the ESSR Arthritis Subcommittee for the Use of Magnetic Resonance Imaging in Musculoskeletal Rheumatic Diseases. Semin Musculoskelet Radiol. 2015; 19(4): 396-411.

https://doi.org/10.1055/s-0035-1564696

18.   Toyama S, Tokunaga D, Tsuchida S, et al. Comprehensive assessment of alterations in hand deformities over 11 years in patients with rheumatoid arthritis using cluster analysis and analysis of covariance. Arthritis Res Ther. 2021; 23(1): 66.

https://doi.org/10.1186/s13075-021-02448-4

19.   Shiraishi M, Fukuda T, Igarashi T, et al. Differentiating Rheumatoid and Psoriatic Arthritis of the Hand: Multimodality Imaging Characteristics. Radiographics. 2020; 40(5): 1339-1354.

https://doi.org/10.1148/rg.2020200029

20.   Kgoebane K, Ally MMTM, Duim-Beytell MC, Suleman F.E. The role of imaging in rheumatoid arthritis. South African Journal of Radiology. 2018; 22(1).

https://doi.org/10.4102/sajr.v22i1.1316

21. Drosos AA, Pelechas E, Voulgari PV. Conventional radiography of the hands and wrists in rheumatoid arthritis. What a rheumatologist should know and how to interpret the radiological fndings. Rheumatology International. 2019; 39: 1331-1341.

https://doi.org/10.1007/s00296-019-04326-4

22. Salaffi F, Carotti M, Beci G, et al. Radiographic scoring methods in rheumatoid arthritis and psoriatic arthritis. Radiol Med. 2019; 124(11): 1071-1086.

https://doi.org/10.1007/s11547-019-01001-3

23. Vyas S, Bhalla AS, Ranjan P, et al. Rheumatoid Arthritis Revisited – Advanced Imaging Review. Pol J Radiol. 2016; 81: 629-635.

https://doi.org/10.12659/PJR.899317

24.   Llopis E, Kroon HM, Acosta J, Bloem JL. Conventional Radiology in Rheumatoid Arthritis. Radiol Clin N Am. 2017; 55: 917-941.

http://doi.org/10.1016/j.rcl.2017.04.002

25.   Forslind K, Eberhardt K, Svensson B. Repair of Erosions in Patients with Rheumatoid Arthritis. The Journal of Rheumatology. 2019; 46 (7) 670-675. https://doi.org/10.3899/jrheum.180557

26.   Smirnov AV. Atlas of X-ray diagnostics of rheumatoid arthritis. M.: IMA-PRESS, 2009 [In Russ].

27.   Van der Heijde DM. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol. 1999; 26 (3): 743-5.

28.   Van der Heijde DM, Dankert T, Nieman F, et al. Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis. Rheumatology (Oxford). 1999; 38(10): 941-7.

https://doi.org/10.1093/rheumatology/38.10.941

29.   Mathew AJ, Danda D, Conaghan PG. MRI and ultrasound in rheumatoid arthritis. Curr Opin Rheumatol. 2016; 28(3): 323-9.

https://doi.org/10.1097/BOR.0000000000000282

30.   Wang MY, Wang XB, Sun XH, et al. Diagnostic value of high-frequency ultrasound and magnetic resonance imaging in early rheumatoid arthritis. Exp Ther Med. 2016; 12(5): 3035-3040.

https://doi.org/10.3892/etm.2016.3695

31. Waleed MH, Sherin MSh, Gehan AG. Role of magnetic resonance imaging and ultrasonography in diagnosis and followup rheumatoid arthritis in hand and wrist joints. The Egyptian Journal of Radiology and Nuclear Medicine. 2018; 49(4): 1043.

https://doi.org/10.1016/j.ejrnm.2018.05.013

32.   Sapundzhieva T, Karalilova R, Batalov A. Musculoskeletal ultrasound as a biomarker of remission - results from a one-year prospective study in patients with rheumatoid arthritis. Med Ultrason. 2018; 20(4): 453-460.

https://doi.org/10.11152/mu-1609

33.   Tan YK, Li H, Allen JC Jr, Thumboo J. Ultrasound power Doppler and gray scale joint inflammation: What they reveal in rheumatoid arthritis. Int J Rheum Dis. 2019; 22(9): 1719-1723.

https://doi.org/10.1111/1756-185X.13653

34.   Sun X, Deng X, Xie W, et al. The agreement between ultrasound-determined joint inflammation and clinical signs in patients with rheumatoid arthritis. Arthritis Res Ther. 2019; 21(1): 100.

https://doi.org/10.1186/s13075-019-1892-0

35.   Lee KA, Min SH, Kim TH, et al. Magnetic resonance imaging-assessed synovial and bone changes in hand and wrist joints of rheumatoid arthritis patients. Korean J Intern Med. 2019; 34(3): 651-659.

https://doi.org/10.3904/kjim.2016.271

36.   Seifeldein GS, Moussa DK, Galal MAA, et al. Grading of Ultrasonography in Rheumatoid Arthritis of Wrist and Hand Joints. Acad Radiol. 2020; 27(7): 937-943.

https://doi.org/10.1016/j.acra.2019.09.033

37.   Kaeley GS, Bakewell C, Deodhar A. The impor- tance of ultrasound in identifying and differentiating patients with early inflammatory arthritis: a narrative review. Arthritis Res Ther. 2020; 22: 1.

https://doi.org/10.1186/s13075-019-2050-4

38.   do Prado AD, Staub HL, Bisi MC, et al. Ultrasound and its clinical use in rheumatoid arthritis: where do we stand? Adv Rheumatol. 2018; 58(1): 19.

https://doi.org/10.1186/s42358-018-0023-y

39.   Filippucci E, Cipolletta E, Mashadi Mirza R, et al. Ultrasound imaging in rheumatoid arthritis. Radiol Med. 2019; 124(11): 1087-1100.

https://doi.org/10.1007/s11547-019-01002-2

40.   Henniger M, Rehart S. Tendinopathy in rheumatic diseases. Unfallchirurg. 2017; 120(3): 214-219.

https://doi.org/10.1007/s00113-016-0291-0

41.   Nishino A, Kawashiri SY, Shimizu T, et al. Assessment of both articular synovitis and tenosynovitis by ultra-sound is useful for evaluations of hand dysfunction in early rheumatoid arthritis patients. Mod Rheumatol. 2017; 27(4): 605-608.

https://doi.org/10.1080/14397595.2016.1253813

42.   Alekseeva OG. Joint ultrasonography in rheumatoid arthritis: pathogenetic rationale, possible use in diagnosis, therapy efficiency evaluation, and outcome prediction. Nauchno-prakticheskaya revmatologiya. 2018; 56(1): 82-92 [In Russ].

https://doi.org/10.14412/1995-4484-2018-82-92

43.   Szkudlarek M, Terslev L, Wakefield RJ, et al. Summary findings of a systematic literature review of the ultra-sound assessment of bone erosions in rheumatoid arthritis. J Rheumatol. 2016; 43(1): 12-21.

https://doi.org/10.3899/jrheum.141416

44.   Hassan R, Hussain S, Bacha R, et al. Reliability of Ultrasound for the Detection of Rheumatoid Arthritis. J Med Ultrasound. 2019; 27(1): 3-12.

https://doi.org/10.4103/JMU.JMU_112_18

45.   Xu H, Zhang Y, Zhang H, et al. Comparison of the clinical effectiveness of US grading scoring system vs MRI in the diagnosis of early rheumatoid arthritis (RA). J Orthop Surg Res. 2017; 12(1): 152.

https://doi.org/10.1186/s13018-017-0653-5

46.   El-Gohary RM, Mahmoud AAMA., Khalil A, et al. Validity of 7-Joint Versus Simplified 12-Joint Ultrasonography Scoring Systems in Assessment of Rheumatoid Arthritis Activity. J Clin Rheumatol. 2019; 25(6): 264-271.

https://doi.org/10.1097/RHU.0000000000000847

47.   Zou X, Zou J, Guo D, et al. Role of 7-Joint Ultrasonic Score in Predicting the Prognosis of Rheumatoid Arthritis. Iran J Radiol. 2020; 17(4): e102875.

https://doi.org/10.5812/iranjradiol.102875

48.   M?ller I, Loza E, Uson J, et al. Recommendations for the use of ultrasound and magnetic resonance in patients with rheumatoid arthritis. Reumatol Clin. 2018; 14(1): 9-19.

https://doi.org/10.1016/j.reuma.2016.08.010

49.   Rubin DA. MRI and ultrasound of the hands and wrists in rheumatoid arthritis. I. Imaging findings. Skeletal Radiol. 2019; 48(5): 677-695.

https://doi.org/10.1007/s00256-019-03179-z

50.   Cikutovic P, Contreras O, Burdiles ?, et al. Magnetic resonance of the hands for the diagnosis and follow-up of rheumatoid arthritis. Rev Med Chil. 2020; 148(9): 1315-1327.

https://doi.org/10.4067/S0034-98872020000901315

51.   ?stergaard M, Peterfy C, Conaghan P, et al. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol. 2003; 30(6): 1385-6.

52.   Smirnov A.V. Golimumab therapy-induced indicators of X-ray inflammation progression and magnitude according to magnetic resonance imaging evidence in patients with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis. Sovremennaya revmatologiya. 2013; 7(2): 75-82 [In Russ].

https://doi.org/10.14412/1996-7012-2013-2387

  

Abstract:

Aim: was to evaluate the effectiveness of endovascular interventions in patients with critical limb ischemia (CLI) with multilevel extended lesions of lower limb arteries of types C and D according to TASC II.

Materials and methods: a retrospective analysis of results of surgical treatment of patients with critical limb ischemia, who underwent 127 endovascular interventions on arteries of the femoral- popliteal-tibial segment for the period from 2007 to 2020, was carried out. 15 patients had ischemic limb pain at rest (11,8%) and 112 patients had trophic lesions (88,2%). Our study included patients with arterial lesions of type C (18 patients, 14,2%) and type D (109 patients, 85,8%) according to TASC II.

Results: technical success of performed endovascular interventions was 95,3%. Within a 30-day period, 2 patients (1,6%) had myocardial infarction, 3 patients (2,4%) underwent early «high» amputation. Perioperative mortality was 0,8% (1 patient). Primary patency of endovascular interventions was 87%, 58% and 36% after 1, 3 and 5 years, respectively, while secondary patency was 91%, 81% and 58% after 1, 3 and 5 years, respectively. Limb salvage rate was 93%, 89% and 79% after 1, 3 and 5 years, respectively. Patient survival rate was 95%, 84% and 78% after 1, 3 and 5 years, respectively.

Conclusions: endovascular interventions on femoral-popliteal-tibial arterial lesions of types C and D according to TASC II in patients with critical limb ischemia are effective, and modern method of treatment with good immediate and long-term results.

 

References

1.     Conte MC, Bradbury AW, Kolh Ph, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Journal of Vascular Surgery. 2019; 69(6): 123-125.

https://doi.org/10.1016/j.jvs.2019.02.016

2.     Pokrovskij AV, Ivandeev AS. Sostojanie sosudistoj hirurgii v Rossii v 2016 godu. M.: Obshhestvo angiologov i sosudistyh hirurgov. Moskva. 2017; 76 [In Russ].

3.     Barriocanal АM, L?pez A, Monreal M, Montan? E. Quality assessment of peripheral artery disease clinical guidelines. J Vascular Surgery. 2016; 63(4): 1091-1097.

https://doi.org/10.1016/j.jvs.2015.12.040

4.     Farber A, Eberhardt RT. The Current State of Critical Limb Ischemia. A Systematic Review. JAMA Surg. 2016; 151(11): 1070-1077.

https://doi.org/10.1001/jamasurg.2016.2018

5.     Agarwal S, Sud K, Shishehbor MH. Nationwide trends of hospital admission and outcomes among critical limb ischemia patients: from 2003-2011. J Am Coll Cardiol. 2016; 67(16): 1901-1913.

https://doi.org/10.1016/j.jacc.2016.02.040

6.     Duff S, Mafilio MS, Bhounsul P, Hasegawa JT. The burden of critical limb ischemia: a review of recent literature. Vascular Health and Risk Management. 2019; 15: 187-208.

https://doi.org/10.2147/VHRM.S209241

7.     Darling JD, McCallum JC, Soden PA, et al. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia. J Vasc Surg. 2017; 66(2): 466-475.

https://doi.org/10.1016/j.jvs.2017.01.024

8.     Antoniou GA, Georgiadis GS, Antoniou SA, et al. Bypass surgery for chronic lower limb ischemia (Review). Cochrane Database of Systematic Reviews. 2017; 3(4): CD002000.

https://doi.org/10.1002/14651858.CD002000.pub3

9.     Uccioli L, Meloni M, Izzo V, et al. Critical limb ischemia: current challenges and future prospects. Vascular Health and Risk Management. 2018; 14: 63-74.

https://doi.org/10.2147/VHRM.S125065

10.   Norgren L, Patel MR, Hiatt WR, et al. Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial. Eur J Vasc Endovasc Surg. 2018; 55: 109-117.

https://doi.org/10.1016/j.ejvs.2017.11.006

11.   Spillerov? К, et al. Angiosome Targeted PTA is More Important in Endovascular Revascularisation than in Surgical Revascularisation: Analysis of 545 Patients with Ischaemic Tissue Lesions. Eur J Vasc Endovasc Surg. 2017; 3: 1-9.

https://doi.org/10.1016/j.ejvs.2017.01.008

12.   Pokrovskij AV, Kazakov YuI, Lukin IB. Kriticheskaja ishemija nizhnih konechnostej. Ifraingvinal'noe porazhenie. M.: Tver': Tver. Gos. Un-e. 2018; 225 [In Russ].

13.   Aboyans V, Ricco JB, Bartelink ME, et al. Editor’s choiced 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018; 55: 305-368.

https://doi.org/10.1093/eurheartj/ehx095

14.   Brouillet J, Deloose K, Goueffic Y, et al. Primary stenting for TASC C and D femoropopliteal lesions: one-year results from a multicentric trial on 203 patients. The Journal of Cardiovascular Surgery. 2018; 59(3): 392-404.

https://doi.org/10.23736/S0021-9509.16.09282-X

15.   Schreuder SM, Hendrix Y, Reekers JA, Bipat S. Predictive Parameters for Clinical Outcome in Patients with Critical Limb Ischemia Who Underwent Percutaneous Transluminal Angioplasty (PTA): A Systematic Review. Cardiovasc Intervent Radiol. 2018; 41(1): 1-20.

https://doi.org/10.1007/s00270-017-1796-9

16.   Norgren L, Patel MR, Hiatt WR, et al. Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial. Eur J Vasc Endovasc Surg. 2018; 55: 109-117.

https://doi.org/10.1016/j.ejvs.2017.11.006

17.   Papojan SA, Shhegolev AA, Radchenko AN, et al. Otdalennye rezul'taty jendovaskuljarnogo lechenija porazhenij poverhnostnoj bedrennoj arterii tipov S i D po klassifikacii TASC II. Angiologija i sosudistaja hirurgija. 2018; 24(1): 73-78 [In Russ].

18.   Biagioni RB, Biagioni LC, Nasser F, et al. Infrapopliteal Angioplasty of One or More than One Artery for Critical Limb Ischaemia: A Randomised Clinical Trial. Eur J Vasc Endovasc Surg. 2018; 55: 518-527.

https://doi.org/10.1016/j.ejvs.2017.12.022

19.   Schneider PA, Laird JR, Tepe G, et al. Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial. Circ Cardiovasc Interv. 2018; 11 (1): 885-891.

https://doi.org/10.1161/CIRCINTERVENTIONS.117.005891

20.   Reijnen MJ. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study. J Endovasc Ther. 2019; 26: 305-315.

https://doi.org/10.1177/1526602819839044

authors: 

 

Abstract:

Introduction: research is dedicated to use of intracerebral laser photobiomodulation therapy (PBMT) in treatment of ischemic stroke after-effects in comparison with conservative therapy methods.

Aim: was to evaluate effectiveness of intracerebral transcatheter laser PBMT in patients with previous ischemic stroke.

Materials and methods: 836 patients were included in study, within the period from 6 months to 6 years after ischemic strokes of various severity, aged 29-81 (mean age 74,9): 593 men (70,93%), 243 women (29,07%). Test Group - 511 (61,12%) patients with distal lesions of intracerebral arteries who underwent transcatheter intracerebral laser PBMT; control Group - 325 (38,88%) patients with similar distal lesions of intracerebral arteries who received conservative treatment.

Results: Test Group: good clinical results were obtained in 259 (87,21%) cases after small focal strokes; in 94 (60,26%) after midfocal strokes; in 12 (20,69%) after macrofocal strokes. Satisfactory clinical results were obtained in 33 (11.11%) cases after small focal strokes; 39 (25,00%) after midfocal strokes; 22 (37,93%) after macrofocal strokes.

Control Group: 51 (21,07%) patients after small focal strokes showed good clinical results; patients after midfocal strokes and macrofocal strokes did not have good results; 60 (24,79%) patients after small focal strokes and 8 (19,05%) patients after midfocal strokes showed satisfactory clinical results; patients after macrofocal strokes did not have satisfactory results.

Conclusions: transcatheter intracerebral laser photobiomodulation therapy is an effective, pathogenetically substantiated method of treatment in patients with ischemic stroke after-effects, leading to restoration of activities of daily living, of cognitive and mental functions and returning patients to fully active life.

 

References

1.     Ahmad FB, Anderson RA. The Leading Causes of Death in the US for 2020. JAMA. 2021.

2.     Maksimovich IV. Transcatheter Treatment of Atherosclerotic Lesions of the Brain Complicated by Vascular Dementia. Diagnostic and Interventional Radiology. 2013; 7(2): 65-75 [In Russ].

3.     Maksimovich IV. Transcatheter intracerebral photobiomodulation in ischemic brain disorders: clinical studies (Part 2). Photobiomodulation in the Brain. 2019; 529-544.

4.     Caplan LR. The Effect of Small Artery Disease on the Occurrence and Management of Large Artery Disease. JAMA Neurol. 2016; 73(1): 19-20.

5.     Zhulev NM, Pustozertsev VG, Zhulev SN. Cerebrovascular Diseases. 2002; Moscow, BINOM [In Russ].

6.     Maksimovich IV. Application of transcatheter laser technologies in treatment of atherosclerotic lesions of the brain. Diagnostic and Interventional Radiology. 2016; 10(3): 57-67 [In Russ].

7.     Hamblin MR. Photobiomodulation for Traumatic Brain Injury and Stroke. J Neurosci Res. 2018; 96(4): 731-743.

8.     Maksimovich IV. Results of brain transcatheter laser revascularization in the treatment of the consequences of ischemic stroke. J Vas Dis Treat. 2017; 1(1): 2-5.

9.     Pasi M, Cordonnier Ch. Clinical Relevance of Cerebral Small Vessel Diseases. Stroke. 2020; 51(1): 47-53.

10.   Regenhardt RW, Das AS, Lo EH, et al. Advances in Understanding the Pathophysiology of Lacunar Stroke: A Review. JAMA Neurol. 2018; 75(10): 1273-1281.

11.   Pendlebury ST, Rothwell PM. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol. 2019; 18(3): 248-258.

12.   Akioka N, Takaiwa A, Kashiwazaki D, et al. Clinical significance of hemodynamic cerebral ischemia on cognitive function in carotid artery stenosis: a prospective study before and after revascularization. J Nucl Med Mol Imaging. 2017; 61(3): 323-330.

13.   Haupert G, Ammi M, Hersant J, et al. Treatment of carotid restenoses after endarterectomy: A retrospective monocentric study. Ann Vasc Surg. 2020; 64: 43-53.

14.   Featherstone RL, Dobson J, Ederle J, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): a randomised controlled trial with cost-effectiveness analysis. Health Technol Assess. 2016; 20(20): 81-94.

15.   Lamanna A, Maingard J, Barras CD, et al. Carotid artery stenting: Current state of evidence and future directions. Acta Neurol Scand. 2019; 139(4): 318-333.

16.   Kim NY, Choi JW, Whang K, et al. Neurologic complications in patients with carotid artery stenting. J Cerebrovasc Endovasc Neurosurg. 2019; 21(2): 86-93.

17.   Yoo J, Choi JW, Lee SJ, et al. Ischemic Diffusion Lesion Reversal After Endovascular Treatment. Stroke. 2019; 50(6): 1504-1509.

18.   Gramegna LL, Cardozo A, Folleco E, Tomasello A. Flow-diverter reconstruction of an intracranial internal carotid artery dissection during thrombectomy for acute ischaemic stroke. BMJ Case Rep. 2020; 13(1).

19.   Snyder T, Agarwal S, Huang J, et al. Stroke Treatment Delay Limits Outcome After Mechanical Thrombectomy: Stratification by Arrival Time and ASPECTS. J Neuroimaging. 2020; 30(5): 625-630.

20.   Chu YT, Lee KP, Chen CH, et al. Contrast-Induced Encephalopathy After Endovascular Thrombectomy for Acute Ischemic Stroke. Stroke. 2020; 51(12): 3756-3759.

21.   Maksimovich IV. Laser Technologies as a New Direction in Transcatheter Interventions. Photobiomodul Photomed and Laser Surg. 2019; 37(8): 455-456.

22.   Maksimovich IV. Transluminal laser angioplasty in treatment of ischemic lesions of a brain. Ph.D. Dissertation, Russian University of Friendship of the People 2004; Moscow [In Russ].

23.   Hamblin MR. Photobiomodulation, Photomedicine, and Laser Surgery: A New Leap Forward Into the Light for the 21st Century. Photobiomodul Photomed Laser Surg. 2018; 36(8): 395-396.

24.   Salehpour F, Gholipour-Khalili S, Farajdokht F, et al. Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: a narrative review. Reviews in the Neurosciences. 2020; 31(3): 269-286.

25.   Saltmarche AE, Margaret A, Naeser MA, et al. Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report. Photomedicine and Laser Surgery. 2017; 35(8): 432-441.

26.   Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol. 2018; 94(2):199-212.

27.   Huang YY, Hamblin MR. Photobiomodulation on cultured cortical neurons. Photobiomodulation in the Brain. 2019: 35-46.

28.   Hamblin MR. Mechanisms of photobiomodulation in the brain Photobiomodulation in the Brain. 2019: 97-110.

29.   Lapchak PA. The challenge of effectively translating transcranial near-infrared laser therapy to treat acute ischemic stroke. Photobiomodulation in the Brain. 2019: 289-298.

30.   Taboada LD, Hamblin MR. Transcranial photobiomodulation for stroke in animal models. Photobiomodulation in the Brain. 2019: 111-124.

31.   Maksimovich IV. Intracerebral Transcatheter Laser PBMT in the Treatment of Binswanger's Disease and Vascular Parkinsonism: Research and Clinical Experience. Photobiomodul Photomed and Laser Surg. 2019; 37(10): 606-614.

32.   Mahoney FI, Barthel DM. Functional evaluation: The barthel index. Maryland State Medical Journal. 1965; 14: 61-65.

33.   Morris JC. The Clinical Dementia Rating (CDR): Current Version and Scoring Rules. Neurology. 1993; 11(43): 2412-2414.

34.   Folstein MF, Folstein SE, McHugh PR. «Mini-mental state». A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3): 189-198.

 

Abstract:

Introduction: the problem of restenosis prevention and its early detection is very important in patients who underwent coronary intervention with bare-metal stent (BMS) implantation in acute coronary syndrome (ACS). But when is it necessary to perform elective coronary angiography in order not to miss possible restenosis development? This question needs to be answered.

Aim: was to define the correct period to perform elective coronary angiography after bare-metal stent implantation in acute coronary syndrome.

Material and methods: the study included 124 patients who underwent coronary intervention with BMS implantation in ACS, in period of 1-14 months before current admission. All patients included in this study had indications for repeating coronary angiography and were diagnosed hemodynamically relevant in-stent restenosis. No risk factors of restenosis were revealed at these patients.

Results: average time of restenosis detection was 7,9±1,99 months. Average percent of restenosis among all included patients was 68,6±13,1%. We also revealed direct correlation of percent of restenosis with time of restenosis detection (r=0,5785, p <0,05). Correlation between time and percentage of restenosis and stent type or TIMI grade, was also estimated in this study.

Conclusion: according to results of our study, there are good reasons to repeat coronary angiography in 7-9 month after BMS implantation in ACS, even if patients have no risk factors of restenosis.

 

References

1.     Bokerija LA, Alekjan BG, Anri M. Rukovodstvo po rentgenojendovaskuljarnoj hirurgii serdca i sosudov. 3-e izd. Tom. 3. Rentgenojendovaskuljarnaja hirurgija ishemicheskoj bolezni serdca [Guide on endovascular surgery of heart and vessels. 3rd ed. Vol. 3. Endovascular surgery of ischemic heart disease]. Moscow: Bakulev Scientific Center of Cardiovascular Surgery. 2008. 648 pages [In Russ].

2.     Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016; 8(10): 1150-1162.

3.     Ibanez B, James S, Agewall S, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2017; 39(2): 119-177.

4.     Cortese B, Berti S, Biondi-Zoccai G, et al. Italian Society of Interventional Cardiology. Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology. Catheter Cardiovasc Interv. 2014; 83(3): 427-35.

5.     Alfonso F, Byrne RA, Rivero F, Kastrati A. Current treatment of in-stent restenosis. J Am Coll Cardiol. 2014; 63(24): 2659-73.

6.     Agostoni P, Valgimigli M, Biondi-Zoccai GG, et al. Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: insights from a systematic overview of randomized trials in light of the drug-eluting stent era. Am Heart J. 2006; 151(3): 682-9.

7.     Goncharov AI, Kokov LS, Likharev AYu. Otsenka effektivnosti stentirovaniya koronarnyh arterij razlichnymi tipami stentov u bol'nyh IBS. Mezhdunarodnyj zhurnal intervencionnoj kardioangiologii. 2009; 19: 23-24 [In Russ].

 

Abstract:

Background: pulmonary embolism (PE), is one of the most common cardiopulmonary pathologies in the world, has a high risk of developing after major operations on the osteoarticular system. Mortality from PE remains high, ranking third after myocardial infarction and stroke.

Aim: was to identify tomographic signs of PE in patients with osteoarticular pathology in the postoperative period.

Materials and methods: we analyzed results of computed angiopulmonography of 11 patients with suspicion on pulmonary embolism who were operated on osteoarticular pathology at the Federal Center for Traumatology, Orthopedics and Endoprosthetics of the Ministry of Health of the Russian Federation (Cheboksary). Patients showed such indirect signs of PE as discshaped atelectasis of lung tissues, expansion of diameter of pulmonary trunk and right pulmonary artery, signs of congestion in pulmonary circulation and pulmonary hypertension. Direct radiological signs included occlusion of a branch of pulmonary artery by thrombus.

Results: in 91% of examined patients, occlusion of branch of pulmonary artery by thrombus was detected, in 82% of cases - the defeat of branches of right pulmonary artery. Embolism at the level of lobar arteries was detected in 30%, segmental branches - in 60% of patients; signs of pulmonary embolism of one of subsegmental branches of right pulmonary artery - in one patient (10%). Bilateral thrombosis was observed in two patients, including massive bilateral PE in one case. One patient had discoid atelectasis of lung tissues. Expansion of diameter of pulmonary trunk and right pulmonary artery was observed in 78% of patients with PE, signs of congestion in pulmonary circulation - in 27% of cases, pulmonary hypertension - in 73% of cases.

Conclusion: visualization of direct and indirect signs of pulmonary embolism during computed pulmonary angiography confirmed the diagnosis in all examined patients. The detection of blood clots in pulmonary arteries themselves is the main criterion in making the final diagnosis.

 

 

References

 

1.     Nikolaev NS, Trofimov NA, Kachaeva ZA, et al. Prevention and treatment of pulmonary thromboembolism in traumatology and orthopedics. Tutorial. Cheboksary: Publishing house of the Chuvash University, 2020; 108 [In Russ].

2.     Krivosheeva EN, Komarov AL, Shakhnovich RM, et al. Clinical analysis of a patient with antiphospholipid syndrome and submassive pulmonary embolism. Aterotromboz. 2018; (1): 76-87 [In Russ].

https://doi.org/10.21518/2307-1109-2018-1-76-87

3.     Hepburn-Brown M, Darvall J, Hammerschlag G. Acute pulmonary embolism: a concise review of diagnosis and management. Internal Medicine Journal. 2019; 49(1): 15-27.

https://doi.org/10.1111/imj.14145

4.     Ostapenko EN, Novikova NP. Pulmonary embolism: modern approaches to diagnosis and treatment. Ekstrennaya meditsina. 2013; 1(5): 84-110 [In Russ].

5.     Sinyukova AS, Kiseleva LP, Kupaeva VA. A clinical case of recurrent pulmonary embolism and the complexity of the diagnostic search. Sovremennaya meditsina: aktual'nye voprosy. 2015; (42-43): 24-31 [In Russ].

6.     Bagrova IV, Kukharchik GA, Serebryakova VI, et al. Modern approaches to the diagnosis of pulmonary embolism. Flebologiya. 2012; 6(4): 35-42 [In Russ].

7.     Kuznetsov AB, Boyarinov GA. Early diagnosis of pulmonary embolism (review). Sovremennye tekhnologii v meditsine. 2016; 8(4): 330-336 [In Russ].

8.     Bershteyn LL. Pulmonary embolism: clinical manifestations and diagnosis in the light of the new recommendations of the European Society of Cardiology. Kardiologiya. 2015; 55(4): 111-119 [In Russ].

https://doi.org/10.18565/cardio.2015.4.111-119

9.     Sakharyuk AP, Shimko VV, Tarasyuk ES, et al. Pulmonary embolism in clinical practice. Byulleten' fiziologii i patologii dykhaniya. 2015; (55): 48-53 [In Russ].

10.   M Al-hinnawi A-R. Computer-Aided Detection, Pulmonary Embolism, Computerized Tomography Pulmonary Angiography: Current Status. Intech Open. 2019; 19.

http://doi.org/10.5772/intechopen.79339

11.   Gilyarov MYu, Konstantinova EV. How do new approaches to the treatment of pulmonary embolism affect disease outcome? Meditsinskiy sovet. 2017; (7): 48-55 [In Russ].

https://doi.org/10.21518/2079-701X-2017-7-48-55

12.   Konstantinides S. Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur. Heart J. 2014; (35): 3033-3080.

13.   Tagalakis V, Patenaude V, Kahn SR, Suissa S. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med. 2013; 126(832): 13-21.

https://doi.org/10.1016/j.amjmed.2013.02.024

 

Abstract:

Introduction: treatment of splenic artery aneurysms is a complex and urgent task of modern surgery. With the development of endovascular techniques, it became possible to use fundamentally new minimally invasive methods for correction of this pathology, the essence of which is to exclude the aneurysm from the blood flow by embolization.

Case report: the article presents a case report of a young female patient without previous anamnesis, during regular examination, in which ultrasound examination, subsequent CT examination and angiography revealed saccular aneurysm of the proximal third of the splenic artery sized 22?24 mm.

Patient underwent successful endovascular embolization of aneurysm with microcoils and Onyx adhesive composition using balloon assistance performed through the transradial vascular access.

Conclusion: world experience and presented case report indicate high efficiency and relative safety of endovascular embolization of splenic artery aneurysms even under the condition of pathological vessel tortuosity, which significantly complicates the intervention, and also demonstrate the advantages of using transradial access in such anatomically difficult situations.

 

References

1.     Pitton MB, Dappa E, Jungmann F, et al. Visceral artery aneurysms: Incidence, management, and outcome analysis in a tertiary care center over one decade. Eur. Radiol. 2015; 25: 2004-2014.

2.     Kassem MM, Gonzalez L. Splenic Artery Aneurysm. StatPearls Publishing. 2021. Available from:

https://www.ncbi.nlm.nih.gov/books/NBK430849/

3.     Mesbahi M, Zouaghi A, Zaafouri H, et al. Surgical management of splenic artery aneurysm. Ann Med Surg (Lond). 2021; 69: 102712.

4.     Lakin RO, Bena JF, Sarac TP, et al. The contemporary management of splenic artery aneurysms. Journal of Vascular Surgery. 2011; 53: 958-965.

5.     Veluppillai C, Perreve S, de Kerviler B, Ducarme G. Splenic arterial aneurysm and pregnancy: A review. Presse Med. 2015; 44(10): 991-4.

6.     T?treau R, Beji H, Henry L, et al. Arterial splanchnic aneurysms: Presentation, treatment and outcome in 112 patients. Diagn. Interv. Imaging. 2016; 97: 81-90.

7.     Patel A, Weintraub JL, Nowakowski FS, et al. Single-center experience with elective transcatheter coil embolization of splenic artery aneurysms: technique and midterm follow-up. J. Vasc. Interv. Radiol. 2012; 23: 893-899.

8.     Hogendoorn W, Lavida A, Hunink MG, et al. Open repair, endovascular repair, and conservative management of true splenic artery aneurysms. J. Vasc. Surg. 2014; 60: 1667-1676.

9.     Reed NR, Oderich GS, Manunga J, et al. Feasibility of endovascular repair of splenic artery aneurysms using stent grafts. J Vasc Surg. 2015; 62(6): 1504-10.

10.   Posham R, Biederman DM, Patel RS, et al. Transradial approach for noncoronary interventions: a single-center review of safety and feasibility in the first 1,500 cases. J. Vasc. Interv. Radiol. 2015; 27(2): 159-166.

 

Abstract:

Introduction: сarotid chemodectoma is a benign, slowly growing, vascularized tumor that is one of the most common paragangliomas of head and neck. It is localized in the area of anterior surface of neck - in the area of carotid artery bifurcation. Despite the relative knowledge of the disease, surgical treatment of patients with these newgroth is difficult due to development of intraoperative hemorrhagic complications.

Aim: was to assess possibilities of primary embolization in the complex treatment of patients with chemodectoma.

Materials and methods: 70-year-old female patient was examined and treated. She was admitted with complaints on painless, pulsating, gradually progressive newgrowth of neck. After examination, carotid chemodectoma was diagnosed. The first stage was selective embolization of branches of the external carotid artery (ECA) feeding the tumor. Open chemodectomectomy was performed three days after embolization.

Results: analysis of literature sources and our case report showed that the volume of blood loss during an open operation for removal of chemodectoma using previous embolization is insignificant. This aspect also leads to a reduction of time of the intervention.

Conclusions: preoperative chemodectoma embolization significantly reduces the volume of blood loss and reduces the risk of developing other complications.

 

 

References

1.     Qaqish N, Gaillard F. Carotid body tumor. 2020.

https://radiopaedia.org/articles/carotid-body-tumour

2.     Martins R, Bugalho MJ. Paragangliomas/Pheochromocytomas: clinically oriented genetic testing. Int J Endocrinol. 2014; 2014: 794187.

3.     Shamsi ZA, Shaikh FA, Wasif M. Hypoglossal Nerve Paraganglioma Depicting as Glomus Tumor of Neck. Iranian Journal of Otorhinolaryngology. 2021; 33(115): 113-117.

4.     Lv H, Chen X, Zhou Sh, et al. Imaging findings of malignant bilateral carotid body tumors: A case report and review of the literature. Oncol Lett. 2016; 11(4): 2457-2462.

5.     Hoang VT, Trinh CT, Lai AKh, et al. Carotid body tumor: a case report and literature review. J Radiol Case Rep. 2019; 13(8): 19-30.

6.     Wieneke JA, Wieneke AS. Paraganglioma: Carotid Body Tumor. Head Neck Pathol. 2009; 3(4): 303-306.

7.     Cobb AN, Barkat A, Daungjaiboon W, et al. Carotid Body Tumor Resection: Just as Safe without Preoperative Embolization. Ann Vasc Surg. 2018; 46: 54-59.

8.     Jackson RS, Myhill JA, Padhya TA, et al. The Effects of Preoperative Embolization on Carotid Body Paraganglioma Surgery: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2015; 153(6): 943-50.

 

Abstract:

Introduction: renal arteriovenous malformation (AVM) is a pathological communication between renal arteries and veins, both acquired and congenital. Congenital AVMs of kidneys, on average, remain asymptomatic for up to 30-40 years, occurring mainly in women, may manifest with hematuria and pain. Nephrectomy is known to be historical method of treating AVM of the kidney, however, with the development of angiographic instrumentation, endovascular methods of treatment began to be introduced into practice more often.

Case report: a 30-year-old female patient with ongoing recurrent bleeding from the urogenital tract. Performed preoperative examination: laboratory tests, cystoscopy, ultrasound, multispiral computed tomography. Patient underwent angiography followed by embolization of kidney AVM with Squid.

Results: intraoperatively, it was noted that AVM embolization is partial. During the first day of the observation period, the presence of postembolization syndrome in the form of hyperthermia, pain and dysuric syndromes, a phenomenon of systemic reaction according to laboratory tests were noted. After 1,5 months, patient was hospitalized for second stage of embolizaion, but during angiography it appeared, that AVM is totally embolized.

Conclusions: renal artery embolization in patients with renal arteriovenous malformations is a minimally invasive, effective method of treatment.

1. The process of selective embolization is controlled and can be used as an independent method of treatment.

2. Due to selective catheterization of arteries and the infusion of agent directly into the affected area, segmental infarction occurs, as a result of which there is minimal destruction of the healthy part of the kidney parenchyma, the function of the kidney will not suffer.

 

References

1.     Kenny DPN, Egizi T, Camp R. Cirsoid renal arteriovenous malformation. Applied Radiology. 2016; 45: 35-37.

2.     Mukendi AM, Rauf A, Doherty S, et al. Renal arteriovenous malformation: An unusual pathology. SA Journal of Radiolog. 2019: 23(1).

3.     Rosen RJ, Ryles TS: Arterial venous malformations. In Vascular disease. Surgical and Interventional Therapy Volume 2. Edited by: Strandness DE, Van Breda A. New York, Churchill Livingstone; 1994:1121-37.

4.     Neeraj V, Cinosh M, Kim JM, et al. Massive hematuria due to congenital renal arteriovenous malformation successfully treated by renal artery embolization. J Assoc Phys India. 2018; 66: 78-80.

5.     Sorokin NI. Superselective renal artery occlusion. Diss. doct. med. sciences. M., 2015; 346 [In Russ].

 

Abstract:

Introduction: more than 10 million ischemic strokes are recorded in the world every year - a disease, the mechanism of development of which is associated with impaired blood flow to the brain tissues, mainly due to embolism in intracranial arteries. One of treatment methods of ischemic stroke within the «therapeutic window», in the absence of contraindications, is systemic thrombolytic therapy. Thrombolytic therapy has a number of limitations and contraindications, including ongoing or occurring bleeding of various localization within a period of up to 6 months.

Aim: was to evaluate the possibility of performing and the effectiveness of «off-label» simultaneous selective thrombolytic therapy and uterine arteries embolization in a patient with acute ischemic stroke with multiple distal lesions of middle cerebral artery branches against the background of ongoing uterine bleeding.

Case report: patient S., 42 years old, was hospitalized to the pulmonary department for bronchial asthma treatment with the aim of preoperative preparation before extirpation of the uterus, against the background of menometrorrhagia. At one of days of hospitalization, patient suffered from acute dysarthria, right-sided hemiparesis. When performing multislice computed tomography and angiography, multiple occlusions were revealed in the distal segments (M3-M4) of the left middle cerebral artery. The patient underwent simultaneous selective thrombolytic therapy of the left middle cerebral artery and uterine artery embolization.

Results: in the next few hours of the postoperative period, the patient experienced regression of neurological deficit: symptoms of dysarthria were arrested, almost complete restoration of motor activity in the right extremities, residual slight asymmetry of the face; bleeding from uterine stopped.

The patient was discharged on the 16th day with a slight neurological deficit. The follow-up period is 18 months. Neurological status with minor deficits: slight asymmetry of facial muscles; the strength of muscles of right limbs is reduced to 4-4,5 points. Ultrasound: a significant decrease in the size of the uterus and myomatous nodes. Menstrual cycle is restored.

Conclusions: a wide range of angiographic instruments and skills of endovascular surgeons made it possible to perform «off-label» simultaneous intervention in a patient with ischemic stroke and multiple distal lesions of branches of the middle cerebral artery against the background of ongoing uterine bleeding and giant myoma. The use of methods of endovascular hemostasis makes it possible to stop bleeding by overcoming contraindications to thrombolytic therapy. The use of thrombolytic therapy within the «therapeutic window» allows regression of neurological deficits in patients with multiple distal cerebral artery lesions.

  

References 

1.     GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18(5): 439-458.

https://doi.org/10.1016/S1474-4422(19)30034-1

2.     Клинические рекомендации по ведению больных с ишемическим инсультом и транзиторными ишемическими атаками. Москва; 2017: 92.

Clinical guidelines for the management of patients with ischemic stroke and transient ischemic attacks. Moscow; 2017: 92 [In Russ].

3.     Клинические рекомендации по проведению тромболитической терапии при ишемическом инсульте. Москва; 2015: 34.

Clinical guidelines for thrombolytic therapy in ischemic stroke. Moscow; 2015: 34 [In Russ].

4.     Chiasakul T, Bauer KA. Thrombolytic therapy in acute venous thromboembolism. Hematology Am Soc Hematol Educ Program. 2020; 1: 612-618.

5.     Yuan K, Zhang JL, Yan JY, et al. Uterine Artery Embolization with Small-Sized Particles for the Treatment of Symptomatic Adenomyosis: A 42-Month Clinical Follow-Up. Int J Gen Med. 2021; 14: 3575-3581.

6.     Клинические рекомендации: миома матки. Москва; 2020: 48.

Clinical guidelines: uterine fibroids. Moscow; 2020: 48 [In Russ].

 

Abstract:

Introduction: the main indicator that determines the prognosis of cancer is the degree of prevalence of tumor process at the time of detection. In terms of the growth of primary morbidity among urological cancers, bladder cancer ranks third, and prostate cancer is second. Treatment of patients in advanced stages is palliative and aimed at improving the quality of life and increasing its duration.

Bleeding from the bladder or prostate in such cases is a life-threatening complication and one of the most common causes of death in advanced cancer.

Aim: was to evaluate the effectiveness of embolization of arteries of the bladder and prostate in cancer patients with bleeding from the lower urinary tract as a preparatory stage for the subsequent specialized therapy of the oncological process.

Materials and methods: from 2019 to August 2021, 38 embolizing interventions were performed in 36 patients with recurrent bleeding from the bladder with ineffective conservative hemostatic therapy. Of these, there were 30 men and 6 women. The average age was 63 ± 2,6 years. All patients at the prehospital stage were diagnosed with pelvic cancer with invasion of the bladder wall without the possibility of radical treatment. Particles with a size of 300-500 µm, embolization coils and fragmentated hemostatic sponge were used for embolization.

Results: immediate angiographic success in the form of stagnation of blood flow through the target arteries was achieved in 100% of operations. In most cases, the relief of macrohematuria was achieved at day 4 (average values of erythrocytes in urine are 3,66 in p/sp). 2 patients (5,6%) underwent a second endovascular intervention during hospitalization due to the many small afferents suppluying the bladder tumor from the a. pudenta interna. Bleeding stopped in these patients by the 8th day of hospital stay. The early postoperative period in 100% of patients was accompanied by mild postembolization syndrome, which was stopped by symptomatic therapy within 24 hours.

Conclusions: endovascular embolization in patients with oncopathology using the superselective technique has shown efficacy in stopping urological oncological bleeding, allows to achieve stable hemostasis in a short time and to continue specific treatment of cancer in patients of the 2nd clinical group.

  

References

1.     Kaprin AD, Starinskiy VV, Shakhzadova AO. The state of cancer care for the population of Russia in 2019. - M.: MNIOI them. P.A. Herzen - branch of the Federal State Budgetary Institution "National Medical Research Center of Radiology" of the Ministry of Health of Russia. 2020. - ill. – 239 [In Russ].

2.     Schuhrke TD, Barr JW. Intractable bladder hemorrhage: therapeutic angiographic embolization of the hypogastric arteries. J Urol. 1976; 116(4): 523-525.

https://doi.org/10.1016/s0022-5347(17)58892-8

3.     Granov AM, Karelin MI, Tarazov PG. X-ray endovascular surgery in oncourology. Bulletin of roentgenology and radiology. 1996; 1: 35-37 [In Russ].

4.     Taha DE, Shokeir AA, Aboumarzouk OA. Selective embolisation for intractable bladder haemorrhages: A systematic review of the literature. Arab J Urol. 2018; 16(2): 197-205.

https://doi.org/10.1016/j.aju.2018.01.004

5.     Mohan S, Kumar S, Dubey D, et al. Superselective vesical artery embolization in the management of intractable hematuria secondary to hemorrhagic cystitis. World J Urol. 2019; 37(10): 2175 - 2182.

https://doi.org/10.1007/s00345-018-2604-0

6.     Tibilov AM, Baymatov MS, Kulchiev AA, et al. Arterial embolization in the treatment of inoperable bladder tumors complicated by bleeding. Materials of the V Russian Congress of Interventional Cardioangiologists. 2013; 35: 79 [In Russ].

7.     Bilhim T, Pisco JM, Tinto HR, et al. Prostatic arterial supply: anatomic and imaging findings relevant for selective arterial embolization. J. Vasc. Interv. Radiol. 2012; 23 (11): 1403-1415.

https://doi.org/10.1016/j.jvir.2012.07.028

8.     Bilhim T, Pereira JA, Tinto HR, et al. Middle rectal artery: myth or reality? Retrospective study with CT angiography and digital subtraction angiography. Surg Radiol Anat. 2013; 35(6): 517-522.

https://doi.org/10.1007/s00276-012-1068-y

9.     Korkmaz M, Sanal B, Aras B, et al. The short- and long-term effectiveness of transcatheter arterial embolization in patients with intractable hematuria. Diagn Interv Imaging. 2016; 97: 197-201.

https://doi.org/10.1016/j.diii.2015.06.020

10.   Liguori G, Amodeo A, Mucelli FP, et al. Intractable haematuria: long-term results after selective embolization of the internal iliac arteries. BJU Int. 2010; 106: 500-503.

https://doi.org/10.1111/j.1464-410X.2009.09192.x

 

11.   Karpov VK, Kapranov SA, Shaparov BM, Kamalov AA. Superselective embolization of urinary bladder arteries in the treatment of recurrent gross hematuria in bladder tumors. Urology. 2020; 5: 133-138 [In Russ].

https://doi.org/10.18565/urology.2020.5.133-138

 

Abstract:

Currently, the results of diagnostics and treatment of gastric cancer (GC) are still not satisfactory. With the advent of modern catheters and angiographic devices, regional intra-arterial chemotherapy in patients with gastric cancer has become more often used in clinical practice.

Aim: was to improve results of treatment of patients with gastric cancer using regional intra-arterial chemotherapy (RIACT).

Material and methods: the immediate and long-term results of complex treatment of 110 patients with stomach cancer for the period 2005-2020 were analyzed. The average age of patients was 59,2 + 4,3 years. The prevalence of the tumor process according to the TNM classification was as follows: T3N0M0 - 37(33,63%) patients, T3N1M0 - 41 (37,27%) patients, and T3N2M0 - 32 (29,1%) patients. Histologically, all patients showed various forms of adenocarcinoma. At the first stage, all patients underwent neoadjuvant RIACT according to the DPF scheme (Docetaxel 75mg/m2 + Cisplatin 75mg/m2 + Fluorouracil 1000mg/m2 on the 1st day) for 2 courses with an interval of 28 days, then surgery.

Results: the immediate results of RIACT showed the effectiveness of treatment after 2 courses of neoadjuvant intra-arterial regional chemotherapy in 93 (84,5%) patients, partial regression was noted, in 17(15,5%) patients, stabilization of the process was noted. These patients underwent a radical operation with the second stage of complex treatment - extended gastrectomy with D2 lymphadenectomy. The drug pathomorphosis of the 1-2 degree was noted in 34 (30,9%) patients, the third degree was noted in 38 (34,5%), the pathomorphosis of the fourth degree in 9 (8,1%) patients. With dynamic follow-up of patients 9(8,1%) patients lived 6 months, 63 (57,2%) patients lived 12 months, 59 (53,3%) patients lived 18 months, 57(51,8%) patients lived 24 months, 47 (42,7%) patients lived 36 months, 41 (37,2%) patients lived 48 months and 35 (31,8%) patients 60 lived months and still are alive. The median survival rate was 51,8 + 1,5 months.

Conclusions: results of neoadjuvant intra-arterial chemotherapy in the treatment of gastric cancer patients proved to be effective in 84,5% of patients. In 42,6% of patients, grade 3-4 therapeutic pathomorphosis was noted. The 3- and 5-year survival rates were 42,7% and 31,8%, respectively. The median survival rate was 51,8 + 1,5 months.

Preoperative intra-arterial chemotherapy may be the method of choice for improving the survival and quality of life of patients with gastric cancer.

 

References

1.     Kaidarova DR. Indicators of the Oncological Service of the Republic of Kazakhstan for 2019 (statistical and analytical materials). Almaty. - 2020. -137 [In Russ].

2.     Kaprin AD, Starinskiy VV, Petrova GV. Malignant neoplasms in Russia in 2016 (morbidity and mortality). - M.: FGBU «MNIOI after named P.A. Herzen» of the Ministry of Health of Russia. - 2018. - 250 [In Russ].

3.     https://gco.iarc.fr/today/data/factsheets/cancers/7-Stomach-fact-sheet.pdf

4.     Abdollah MH, Farhad TB, Reza M. Lack of Any Relationship of Stomach Cancer Incidence and Mortality with Development in Asia. Asian Pacific Journal of Cancer Prevention. 2016, 17(8): 3775-3781.

https://doi.org/10.14456/apjcp.2016.169

5.     Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020; 396(10251): 635-648.

https://doi.org/10.1016/S0140-6736(20)31288-5

6.     Zyryanov BN, Makarkin NA, Tikhonov VI, Tuzikov SA. Combined treatment with intra-arterial regional chemotherapy for locally advanced gastric cancer. Russian Journal of Oncology. 1997; 1: 17-20 [In Russ].

7.     Barone C, Cassano A, Pozzo C, et al. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer. Oncology. 2004; 67(1): 48-53.

https://doi.org/10.1159/000080285

8.     Wang J, Shi H, Yang G, et al. Combined intra-arterial and intravenous chemotherapy for unresectable, advanced gastric cancer has an improved curative effect compared with intravenous chemotherapy only. Oncology Letters. 2018; 15(4).

https://doi.org/10.3892/ol.2018.8068

9.     Song Z, Wu Y, Yang J, et al. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017; 39(7): 1010428317714626.

https://doi.org/10.1177/1010428317714626

10.   Choi AH, Kim J, Chao J. Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond. World J Gastroenterol. 2015; 21(24): 7343-8.

https://doi.org/10.3748/wjg.v21.i24.7343

11.   Johnston FM, Beckman M. Updates on Management of Gastric Cancer. Curr Oncol Rep. 2019;21(8): 67.

https://doi.org/10.1007/s11912-019-0820-4

12.   Ikegame K, Terashima M. Perioperative Chemotherapy for Gastric Cancer. Gan to Kagaku Ryoho. 2020; 47(4): 569-573.

 

 

 

Abstract:

Introduction: treatment of gastric cancer (GC) remains an urgent problem in oncology. One of the unsolved problems in treatment of gastric cancer remains the treatment of patients with liver metastases. With the development of interventional radiology, it became possible to treat gastric cancer patients with liver metastases.

Aim: was to improve results of treatment of gastric cancer patients with liver metastases by using of trans-arterial chemoembolization (TACE).

Material and methods: we analyzed results of 60 patients for the period 2008-2020, who suffered for metastatic liver disease, previously they received combined treatment for stomach cancer at various times. The average age of patients was 58,1 ± 5,8 years. When planning TACE, all patients had a general condition above 80% according to Karnovsky, according to ECOG 1-2. All TACE patients with liver metastatic foci were treated with Lipiodol 6-8ml + Doxorubicin 25mg/m2. The interval between TACE cycles was 1,5-2 months. Each patient received 5-6 TACE courses.

Results: immediate results showed the effectiveness of treatment after 2 courses of TACE in 49 (81,7%) patients: partial regression was noted in 36 (60%) patients, and significant regression of the process was noted in 13 (21,6%) patients, stabilization of the process was noted in 11(18,3%) patients. With dynamic follow-up 37 (61,7%) patients lived 6 months, 24 (40%) patients lived 12 months, 11 (18,3%) patients lived 18 months, 8 (13,3%) patients lived 24 months, only 3 (5,0%) patients lived 36 months. The median survival rate was 15,5 ± 1,2 months.

Conclusions: immediate and long-term results of the study, carrying out TACE in patients with metastases of gastric cancer to the liver was effective in 50% of patients. Currently, to improve the survival rate and quality of life of patients with metastases of gastric cancer, the technique of trans-arterial chemoembolization can be considered as an effective, low-toxic method of treatment and it can be the method of choice.

 


References

1.     Mastoraki A, Benetou C, Mastoraki S, et al. The role of surgery in the therapeutic approach of gastric cancer liver metastases. Indian J. Gastroenterol. 2016; 35(5): 331-336.

https://doi.org/10.1007/s12664-016-0683-7

2.     Kaidarova DR. Indicators of the Oncological Service of the Republic of Kazakhstan for 2019 (statistical and analytical materials), Almaty, 2020, -137 [In Russ].

3.     Kaprin AD, Starinskiy VV, Petrova GV. Malignant neoplasms in Russia in 2016 (morbidity and mortality). - M.: FGBU «MNIOI after named P.A. Herzen» of the Ministry of Health of Russia, 2018. - 250 [In Russ].

4.     Zhang K, Chen L. Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases. Ther Adv Med Oncol. 2020; 12: 1758835920904803.

https://doi.org/10.1177/1758835920904803.

5.     Granov AM, et al. Interventional radiology in oncology (ways of development and technology) - SPb.: - Foliant. - 2007. - 88-97 [In Russ].

6.     Gantsev ShKh, Arybzhanov DT, Kulakeev OK. A method of chemotherapy for gastric cancer metastases in the liver. Patent of the Russian Federation No. 2364397 dated 20.08.2009. Bul. 23 [In Russ].

7.     Chen H, Gao S, Yang XZ, et al. Comparison of Safety and Efficacy of Different Models of Target Vessel Regional Chemotherapy for Gastric Cancer with Liver Metastases. Chemotherapy. 2016; 61(2): 99-107.

https://doi.org/10.1159/000440945

8.     Chen H, Zhang J, Cao G, et al. Target hepatic artery regional chemotherapy and bevacizumab perfusion in liver metastatic colorectal cancer after failure of first-line or second-line systemic chemotherapy. Anticancer Drugs. 2016; 27(2): 118-26.

https://doi.org/10.1097/CAD.0000000000000290

9.     Sawatsubashi T, Nakatsuka H, Nihei K, Takano T. A Case of Metachronous Multiple Liver Metastases of AFP and PIVKA-Producing Gastric Cancer, Responding to Transcatheter Arterial Chemoembolization. Gan To Kagaku Ryoho. 2020; 47(2): 319-321.

10.   Liu SF, Lu CR, Cheng HD, et al. Comparison of Therapeutic Efficacy between Gastrectomy with Transarterial Chemoembolization Plus Systemic Chemotherapy and Systemic Chemotherapy Alone in Gastric Cancer with Synchronous Liver Metastasis. Chin Med J. 2015; 128(16): 2194-201.

https://doi.org/10.4103/0366-6999.162497

11.   Xu H, Min X, Ren Y, et al. Comparative Study of Drug-eluting Beads versus Conventional Transarterial Chemoembolization for Treating Peculiar Anatomical Sites of Gastric Cancer Liver Metastasis. Med Sci Monit. 2020; 26: 922988.

https://doi.org/10.12659/MSM.922988

 

Abstract:

Background: atrial septal defect (ASD) is characterized by a progressive increase in pulmonary vascular resistance and, accordingly, pressure in small circulation circle. It is noteworthy that these hemodynamic changes go in parallel with morphofunctional changes in small vessels of pulmonary artery system. At the same time, changes in hemodynamics of small circulatory circulation after endovascular closure in this category of patients and reversibility of pulmonary hypertension are not fully studied.

Aim: was to assess clinical course, indicators of cardiac chamber geometry and hemodynamics of small circulation circle after transcatheter closure of secondary ASD in adult patients with moderate and significant pulmonary hypertension in immediate and long-term periods.

Material and methods: from 2009 to 2020, 103 patients (mean age 48,3 ± 15,3 years) with secondary ASD underwent endovascular transcatheter closure of the defect. 60 (58,3%) patients had pulmonary hypertension. Depending on systolic pulmonary arterial pressure (SPAP), patients were divided into 3 groups: the first group consisted of 41 (68,3%) patients with mild PH (from 40 to 49 mm Hg); the second group included 10 (16,6%) patients with moderate PH (50 to 59 Hg); and the third group consisted of 9 (15%) patients with high SPAP (? 60 mm Hg). Average pulmonary artery systolic pressure in groups was: 43,6 ± 2,9 mm Hg; 52,1 ± 2,5 mm Hg; 64,4 ± 5,2 mm Hg, respectively. Average sizes of ASD (according to Pre-TEE data) were 18,7 + 6,1 mm; 22,1 ± 7,5 mm and 21,3 ± 5,3 mm, respectively. In all cases, echocardiographic signs of the right heart volume overload were detected. Follow-up was performed on an outpatient basis with an assessment of the clinical status and TTE in the long-term period.

Results: technical success of endovascular defect closure was 100%. Average size of the occluder was 26,3 + 6,96 (from 12 to 40) mm. Immediately after implantation of device, complete closure of ASD was observed in 55 (91,7%) cases. Residual flow (<3 mm) was observed in 5 cases (2 cases in the first group, 1 case in second group, and 2 cases in third group, (p >0,05)). In the vast majority of cases - 54 (90%) hospital period proceeded smoothly. All patients were examined in the long-term period (on average 12,5 + 6,5 months). The survival rate in groups was 100%. In the long- term follow-up remodeling of the right heart was observed in all patients. In the first group the size of RA decreased from 6,0 ± 0,5 cm to 3,3 ± 0,4 cm, RV size decreased from 4,7 ± 0,5 to 3,1 ± 0,4 cm; in the second group RA from 5,7 ± 0,7 cm to 3,8 ± 0,5 cm, RV - from 4,7 ± 0,9 to 3,8 ± 0,6 cm; in the third group RA - from 5,5 ± 0,6 cm and 4,2 ± 0,5 cm, the size of RV decreased from 4,5 ± 0,6 4,0 ± 0,5 cm, respectively. In all patients, significant decrease in SPAP was observed, in some cases up to normalization. In the first group, SPAP decreased from 43,7 ± 2,9 to 32,1 ± 2,6 mmHg, in the second group - from 52,1 ± 2,5 to 34,3 ± 2,6 mmHg; in the third group - from 64,4 ± 5,2 to 50,3 ± 4,8 mmHg. The most expressed decrease of pressure occurred in the second group of patients. At the same time, in the third group, dynamics of pressure reduction was significantly less expressed in comparison with the other two groups. At the same time in two patients of third group high PH remained in the long-term period, despite the successful closure of the defect.

Conclusion: results show that in case of left-right shunt in the absence of hypoxemia, transcatheter closure of ASD in adult patients with moderate and significant pulmonary hypertension is a pathophysiologically and clinically justified, is a highly effective treatment method that allows achieving significant improvement of both clinical manifestations and intracardiac and systemic hemodynamics. In patients with a significant degree of pulmonary hypertension and a high probability of the latter, the following tactical approaches may be considered:

1. primary closure of defect with further drug therapy;

2. primary drug therapy aimed on regulating of the anatomic-functional state of the arterial bed of the small circulation and hence reducing pulmonary vascular resistance followed by endovascular ASD-closure;

3. closure of the defect with a fenestrated occluder (in case of a negative test for temporary balloon occlusion), followed by drug therapy. This assumption can be considered in future research.

 

References

1.     Jain S, Dalvi B. Atrial septal defect with pulmonary hypertension: when/how can we consider closure? J Thorac Dis. 2018; 10(24): 2890-2898.

2.     Fraisse, et al. Atrial Septal Defect Closure: Indications and Contra-Indications. J Thorac Dis. 2018; 10(24): 2874-2881.

3.     Akagi T. Current concept of transcatheter closure of atrial septal defect in adults. J Cardiol. 2015; 65(1): 17-25.

4.     Kefer J. Percutaneous Transcatheter Closure of Interatrial Septal Defect in Adults: Procedural Outcome and Long-Term Results. Catheter Cardiovasc Interv. 2012; 79(2): 322-30.

5.     Gruner C, Akkaya E, Kretschmar O, et al. Pharmacologic preconditioning therapy prior to atrial septal defect closure in patients at high risk for acute pulmonary edema. J Interv Cardiol. 2012; 25: 505-12.

6.     Abaci A, Unlu S, Alsancak Y, et al. Short- and long-term complications of device closure of atrial septal defect and patent foramen ovale: metaanalysis of 28,142 patients from 203 studies. Catheter Cardiovasc Interv. 2013; 82(7): 1123-1138.

7.     Humenberger M, Rosenhek R, Gabriel H, et al. Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J. 2011; 32: 553-560.

8.     Ioseliani DG, Kovalchuk IA, Rafaeli TR, et al. Simultaneous Percutaneous Coronary Intervention and Endovascular Closure of Atrial Septal Defect in Adults. Kardiologia. 2019; 59(2): 56-60 [In Russ].

9.     Correction to: 2018 AHA/ACC Guideline for the Management of Adults with Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 139(14): 833-834.

10.   Gali? N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016; 37(1): 67-119.

11.   Haas NA, Soetemann DB, Ates I, et al. Closure of secundum atrial septal defects by using the occlutech occluder devices in more than 1300 patients: the IRFACODE project: a retrospective case series. Catheter Cardiovasc Interv. 2016; 88: 71-81.

12.   Nakahawa K, Akagi T, Taniguchi M, et al. Transcatheter closure of atrial septal defect in a geriatric population. Catheter Cardiovasc Interv. 2012.

13.   Marwick TH, Gillebert TC, Aurigemma G, et al. Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr. 2015; 28(7): 727-754.

14.   Galderisi M, Cosyns B, Edvardsen T, et al. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2017; 18(12): 1301-1310.

15.   Bossone E, D'Andrea A, D'Alto M, et al. Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr. 2013; 26(1): 1-14.

16.   Miranda WR, Hagler DJ, Reeder GS, et al. Temporary balloon occlusion of atrial septal defects in suspected or documented left ventricular diastolic dysfunction: Hemodynamic and clinical findings. Catheter Cardiovasc Interv. 2019; 93(6): 1069-1075.

17.   Shin C, Kim J, Kim J-Y, et al. Determinants of serial left ventricular diastolic functional change after device closure of atrial septal defect. JACC. 2020; 75(11).

18.   Martin-Garcia AC, Dimopoulos K, Boutsikou M, et al. Tricuspid regurgitation severity after atrial septal defect closure or pulmonic valve replacement. Heart. 2020; 106(6): 455-461.

19.   Zwijnenburg RD, Baggen VJM, Witsenburg M, et al. Risk Factors for Pulmonary Hypertension in Adults After Atrial Septal Defect Closure. Am J Cardiol. 2019; 123(8): 1336-1342.

authors: 

 

Article exists only in Russian.

 

Abstract:

Introduction: treatment of patients with primary malignant neoplasms (PMN) of head and neck remains an unsolved problem. About 70% of neoplasms are unresectable, and one-year mortality rate reaches 90%.

Aim: was to demonstrate possibilities of using the technique of isolated chemoperfusion of head and neck (ICPHN) developed by us in the experiment.

Material and methods: ICPHN was performed using the method of extracorporeal membrane oxygenation (ECMO) on two non-human primates (hamadryas baboons), 20 kg males, 12–14 years old. The open version of intervention involved performing sternotomy, cannulation of brachiocephalic arteries (BCA) and superior vena cava (SVC) with their subsequent clamping after starting parallel ECMO. The endovascular version was made by overlapping the BCA and SVC with transfemorally inserted balloon catheters. Cannulation for ECMO was performed percutaneously through the axillary artery and vein. Perfusion was carried out for 30 minutes with a chemotherapy (CP) drug carboplatin at a dose of 150 mg injected immediately into the circuit.

Results: both procedures were carried out successfully with good immediate and long-term (30 days of follow-up) results. After 10, 20 and 30 minutes from the moment of CP injection into the isolated circuit, its content in the circuit was 7-10 times, 3-3,5 times and 4-4,5 times exceeding the concentration in the systemic circulation, respectively. During the perioperative period, vital functions and laboratory parameters were within normal limits. No complications associated with both procedures were observed. All animals quickly recovered from anesthesia without signs of neurological disorders.

Conclusions: the use of isolated chemoperfusion of head and neck with carboplatin in the experiment is feasible and safe. In the head and neck contour, the concentration of CP is observed, 3-5 times higher than in the systemic circulation, and that allows a more pronounced targeted effect on tumor. Taking into account the minimally invasiveness and repeatability of the procedure, the use of endovascular isolated chemoperfusion of head and neck is more promising.

 

 

References

 

1.     Vleeschouwer SD. Glioblastoma. Brisbane. Codon Publications. 2017; 678.

2.     Maghami E. Multidisciplinary Care of the head and neck cancer patient. Springer International Publishing. 2018; 282.

3.     Srinivasan VM, Lang FF, Chen SR, et al. Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors. J Neurointerv Surg. 2020; 12(2): 197-203.

4.     Newton HB. Intra-arterial chemotherapy of primary brain tumors. Curr Treat Options Oncol. 2005; 6(6): 519-530.

5.     Klopp CT, Alford TG, Bateman J, et al. Fractionated intra-arterial chemotherapy with methyl bis amine hydrochloride; a preliminary report. Ann Surg. 1950; 4: 811-832.

6.     Creech O, Krementz ET, Ryan RF, et al. Chemotherapy of сancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg. 1958; 4: 616-632.

7.     Woodhall B, Hall K, Mahaley S, et. al. Chemotherapy of brain cancer: experimental and clinical studies in localized hypothermic perfusion. Ann Surg. 1959; 4: 640-651.

8.     Feind CR, Herter F, Markowitz A. Improvements in isolation head perfusion. Am J Surg. 1963; 5: 777-782.

 

Abstract:

Aim: was to demonstrate possibilities of timely radiological diagnosis and treatment of spinal tuberculosis in a patient with a single lung after pleuropneumonectomy for fibrocavernous pulmonary tuberculosis.

Materials and methods: patient, 26 y.o. female, country inhabitant, grocery store clerk. She was hospitalized to the National Medical Research Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation with a diagnosis: “Tuberculosis spondylitis Th12-L2, focal tuberculosis S2 of the single right lung in the infiltration phase. M.Tb(-). Pleuropneumonectomy for fibrocavernous tuberculosis of left lung (December 18, 2018)”. To clarify etiology and lesion volume and to determine surgical treatment tactics, multispiral computed tomography (MSCT) of lungs and thoracolumbar spine and subsequent percutaneous trephine biopsy of the L1 vertebra were performed.

Results: according to MSCT data, destruction of Th12-L1-2 vertebral bodies was revealed; in single right lung, medium-intensity focal lesion with a diameter of 5 mm in C1, a small calcinate in C2, and a subpleural focal lesion in C4 were visualized. Small-focal dissemination was observed throughout the entire length of single lung. Bacteriological study of biological material taken during trephine biopsy revealed the growth of Mycobacterium tuberculosis, confirmed by diagnostics of polymerase chain reaction (PCR). Taking into account the pulmonary pathology, operation was performed in the volume of resection of Th12-L1-2 bodies and antero-lateral spinal fusion with a Mesh body replacement implant with bone autoplasty from left-side access, transpedicular fixation (TPF) of Th11-L3 with a four-screw structure under intraoperative radiation control. As a result of treatment, patient was discharged in a satisfactory condition.

Conclusions: presented case report demonstrates the importance of timely radiological diagnosis in patients with combined infectious lesions of lungs and spine for obtaining of complete information about the state of respiratory and bone systems, using MSCT and interventional radiology methods and for determination of pathological process etiology. It made it possible to perform timely diagnosis and complex surgical intervention with the most sparing and light surgical access to affected vertebrae in tuberculosis spondylitis from the side of previous pleuropneumonectomy.

  

 

References

 

1.     Giller DB, Martel’ II, Imagozhev YG, et al. An experience of single lung resection and pneumonectomy after contralateral lung resection in treatment of tuberculosis. Khirurgiya (Mosk). 2021; (1): 15-21 [In Russ].

https://doi.org/10.17116/hirurgia2015935-42

2.     Giller DB, Giller GV, Imagozhev YG. Surgical collapse in the treatment of single lung tuberculosis. Khirurgiia. 2021; (1): 15-21 [In Russ].

https://doi.org/10.17116/hirurgia202101115

3.     Mushkin AYu, Vishnevskiy AA, Peretsmanas EO, et al. Infectious Lesions of the Spine: Draft National Clinical Guidelines. Khirurgiya pozvonochnika. 2019; 16(4): 63-76 [In Russ].

https://doi.org/10.14531/ss2019.4.63-76

4.     Sovetova NA, Vasileva GYu, Soloveva NS. Tuberculous spondylitis in adults (clinical and radiographic manifestation). Tuberkulez I bolezni legkikh. 2014; (10): 33-37 [In Russ].

5.     Dunn RN, Ben Husien M. Spinal tuberculosis: review of current management. Bone Joint J. 2018; 1(100-B(4)): 425-431.

https://doi.org/10.1302/0301-620X.100B4.BJJ-2017- 1040.R1

 

Abstract:

Introduction: basilar artery thrombosis (BAT) is the cause of about 1% of ischemic strokes (IS). About 27% of strokes in posterior circulation are associated with BAT. Mortality in BAT without recanalization reaches 85-95%. In 80.7% of patients with BAT at the onset of disease a decrease in level of consciousness is observed, in 34% of them – coma.

Aim: was to show the possibility of performing thrombectomy (TE) in patients with BAT and reduced level of consciousness as the only effective way to prevent death in this pathology.

Materials and methods: two case reports of successful TE from basilar artery in patients with IS and decrease in level of wakefulness to coma, are presented.

Results: article describes two successful cases of TE in patients with angiographically confirmed BAT and decrease in the level of consciousness to moderate coma at the onset of disease. In two presented patients, TE made a complete restoration of BA blood flow. Good clinical outcomes were noted in both patients by 90th day of disease (modified Rankin scale 0-2 points). The Rivermead mobility index at discharge from hospital was 14 points, and the Bartel index by 90th day – complete independence from others in everyday life (from 90 to 100 points), and that once again indicates that TE in BAT is not only a life-saving procedure, but significantly improves functional and clinical outcomes of disease.

Conclusions: basilar artery thrombosis is a life-threatening condition that requires urgent reperfusion therapy as the only effective method of treatment. Endovascular treatment for basilar artery thrombosis should be considered in all patients, regardless the decrease in the level of consciousness at the onset of disease, because thrombectomy is a life-saving procedure.

  

 

References 

1.     Reinemeyer NE, Tadi P, Lui F. Basilar Artery Thrombosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; January 31, 2021. Available at:

https://www.ncbi.nlm.nih.gov/books/NBK532241/

2.     Ekker MS, Boot EM, Singhal AB, et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol. 2018; 17(9): 790-801.

https://doi.org/10.1016/S1474-4422(18)30233-3

3.     Ikram A, Zafar A. Basilar Artery Infarct. In: StatPearls. Treasure Island (FL): StatPearls Publishing; August 10, 2020. Available at:

https://www.ncbi.nlm.nih.gov/books/NBK551854/

4.     Gory B, Mazighi M, Labreuche J, et al. Predictors for Mortality after Mechanical Thrombectomy of Acute Basilar Artery Occlusion. Cerebrovasc Dis. 2018; 45(1-2): 61-67.

https://doi.org/10.1159/000486690

5.     Writing Group for the BASILAR Group, Zi W, Qiu Z, et al. Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective Registry. JAMA Neurol. 2020; 77(5): 561-573.

https://doi.org/10.1001/jamaneurol.2020.0156

6.     Bracard S, Ducrocq X, Mas JL, et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016; 15(11): 1138-1147.

https://doi.org/10.1016/S1474-4422(16)30177-6

7.     Liu Z, Liebeskind DS. Basilar Artery Occlusion and Emerging Treatments. Semin Neurol. 2021; 41(1): 39-45.

https://doi.org/10.1055/s-0040-1722638

8.     Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019; 50(12): 344-418.

https://doi.org/10.1161/STR.0000000000000211

9.     Baik SH, Park HJ, Kim JH, et al. Mechanical Thrombectomy in Subtypes of Basilar Artery Occlusion: Relationship to Recanalization Rate and Clinical Outcome. Radiology. 2019; 291(3): 730-737.

https://doi.org/10.1148/radiol.2019181924

10.   Weber R, Minnerup J, Nordmeyer H, et al. Thrombectomy in posterior circulation stroke: differences in procedures and outcome compared to anterior circulation stroke in the prospective multicentre REVASK registry. Eur J Neurol. 2019; 26(2): 299-305.

https://doi.org/10.1111/ene.13809

11.   Kang DH, Jung C, Yoon W, et al. Endovascular Thrombectomy for Acute Basilar Artery Occlusion: A Multicenter Retrospective Observational Study. J Am Heart Assoc. 2018; 7(14): 009419.

https://doi.org/10.1161/JAHA.118.009419

12.   Liu X, Dai Q, Ye R, et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurol. 2020; 19(2): 115-122.

https://doi.org/10.1016/S1474-4422(19)30395-3

13.   Potter JK, Clemente JD, Asimos AW. Hyperdense basilar artery identified on unenhanced head CT in three cases of pediatric basilar artery occlusion. Am J Emerg Med. 2021; 42: 221-224.

https://doi.org/10.1016/j.ajem.2020.11.055

 

Abstract:

Introduction: congenital portosystemic venous shunts (CPVS) are rare vascular abnormalities that occur secondary to abnormal development or involution of fetal vasculature. They allow intestinal blood to enter the systemic circulation, bypassing the liver, which in the long term leads to various symptoms and complications. Today, thanks to advanced imaging techniques, the number of reported cases of CPVS is increasing, although for the most part these are single clinical cases or reports summarizing small series of cases. The overall incidence of CPVS is estimated at 1:30 000 births and 1:50 000 for those persisting beyond early childhood.

Material and methods: article consists of 44 foreign literature sources, that  highlight pathogenesis, classification, clinical picture, diagnosis and treatment of CPVS.

Conclusion: early diagnosis and correction of this anomaly using any (endovascular or surgical) occlusion regresses symptoms and prevents long-term complications. At present, given the rarity of this pathology, there is no large statistical analysis and no standards, developed for the management of this category of patients. However, further collection of material, an emphasis on the pathophysiology and anatomy of these lesions, will help to provide more effective care for patients with congenital portosystemic venous shunts.

  

 

References

 

1.     Kim MJ, Ko JS, Seo JK, et al. Clinical features of congenital portosystemic shunt in children. Eur J Pediatr. 2012; 171(2): 395-400.

2.     Florio F, Nardella M, Balzano S, et al. Congenital intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol. 1998; 21(5): 421-424.

3.     Baiges A, Turon F, Simуn-Talero M, et al. Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study. Hepatology. 2020; 71(2): 658-669.

https://doi.org/10.1002/hep.30817

4.     Ольхова Е.Б., Туманян Г.T., Венгерская Г.В. и др. Мальформация Абернети у новорожденных. Эхографическая диагностика. Радиология-практика. 2015; 5(54): 46-58.

Olkhova EB, Tumanyan GT, Hungarian GV, et al. Abernathy malformation in newborns. Echographic diagnostics. Radiology-practice. 2015; 5 (54): 46-58 [In Russ].

5.     Малышева Е.Б., Захарова Е.М., Рыхтик П.И., Жулина Н.И. Мальформация Абернетти - редкая причина гемодинамического цирроза печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. Приложение. 2017; 27(1) S49; 48.

Malysheva EB, Zakharova EM, Rykhtik PI, Zhulina NI. Abernetty's malformation is a rare cause of hemodynamic cirrhosis of the liver. Russian journal of gastroenterology, hepatology, coloproctology. Application. 2017; 27(1) S49; 48 [In Russ].

6.     Abernethy J. Account of two instances of uncommon formation in the viscera of the human body. Philos Trans R Soc Lond B Biol Sci. 1793; 83: 59-66.

7.     Sokollik C, Bandsma RH, Gana JC, et al. Congenital portosystemic shunt: characterization of a multisystem disease. J. Pediatr. Gastroenterol. Nutr. 2013; 56(6): 675-681.

8.     Gu?rin F, Blanc T, Gauthier F, et al. Congenital portosystemic vascular malformations. Semin. Pediatr. Surg. 2012; 21(3): 233-244.

9.     Bernard O, Franchi-Abella S, Branchereau S, et al. Congenital portosystemic shunts in children: recognition, evaluation, and management. Semin Liver Dis. 2012; 32(4): 273-287.

10.   Lin ZY, Chen SC, Hsieh MY, et al. Incidence and clinical significance of spontaneous intrahepatic portosystemic venous shunts detected by sonography in adults without potential cause. J Clin Ultrasound. 2006; 34(1): 22-26.

11.   Gitzelmann R, Forster I, Willi UV. Hypergalactosaemia in a newborn: self-limiting intrahepatic portosystemic venous shunt. Eur J Pediatr. 1997; 156: 719-722.

12.   Ponziani FR, Faccia M, Zocco MA, et al. Congenital extrahepatic portosystemic shunt: description of four cases and review of the literature. J Ultrasound. 2019; 22(3): 349-358.

https://doi.org/10.1007/s40477-018-0329-y

13.   De Paula Oliveira GJ, Ferreira S, Barbosa A. Abernethy Malformation – Congenital Extra-hepatic Portosystemic Shunt Associated with Multiple Liver Adenomatosis: Case Report. Universal Journal of Public Health. 2019; 7(3): 129-137.

14.   Nagata H, Yamamura K, Ikeda K. Balloon-occluded retrograde transvenous obliteration for congenital portosystemic venous shunt: report of two cases. Pediatr Int. 2012; 54(3): 419-421.

https://doi.org/10.1111/j.1442-200X.2011.03459.x

15.   Passalacqua M, Lie KT, Yarmohammadi H. Congenital extrahepatic portosystemic shunt (Abernethy malformation) treated endovascularly with vascular plug shunt closure. Pediatr Surg Int. 2012; 28(1): 79-83.

https://doi.org/10.1007/s00383-011-2944-y

16.   Raghuram KA, Bijulal S, Krishnamoorthy KM, Tharakan JA. Regression of pulmonary vascular disease after therapy of Abernethy malformation in visceral heterotaxy. Pediatr Cardiol. 2013; 34(8):1882-5.

https://doi.org/10.1007/s00246-012-0428-z

17.   DiPaola F, Trout AT, Walther AE, et al. Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes. Dig Dis Sci. 2020; 65(4): 1239-1251.

https://doi.org/10.1007/s10620-019-05834-w

18.   Ogul H, Bayraktutan U, Yalcin A, et al. Congenital absence of the portal vein in a patient with multiple vascular anomalies. Surg Radiol Anat. 2013; 35(6): 529-534.

https://doi.org/10.1007/s00276-012-1059-z

19.   Morgan G, Superina R. Congenital absence of the portal vein: two cases and a proposed classification system forportasystemic vascular anomalies. J Pediatr Surg. 1994; 29(9):1239-1241.

20.   Glonnegger H, Schulze M, Kathemann S, et al. Case Report: Hepatic Adenoma in a Child With a Congenital Extrahepatic Portosystemic Shunt. Front Pediatr. 2020; 8: 501.

https://doi.org/10.3389/fped.2020.00501

21.   Raskin NH, Price JB, Fishman RA. Portal-systemic encephalopathy due to congenital intrahepatic shunts. The New England Journal of Medicine. 1964; 270: 225-229.

22.   Park JH, Cha SH, Han JK, Han MC. Intrahepatic portosystemic venous shunt. Am J Roentgenol. 1990; 155: 527-528.

23.   Senocak E, O?uz B, Edgьer T, Cila A. Congenital intrahepatic portosystemic shunt with variant inferior right hepatic vein. Diagn Interv Radiol. 2008; 14: 97-99.

24.   Niwa T, Aida N, Tachibana K, et al. Congenital absence of the portal vein: clinical and radiologic findings. J Comput Assist Tomogr. 2002; 26(5): 681-6.

https://doi.org/10.1097/00004728-200209000-00003

25.   Kobayashi N, Niwa T, Kirikoshi H, et al. Clinical classification of congenital extrahepatic portosystemic shunts. Hepatol Res. 2010; 40(6): 585-93.

https://doi.org/10.1111/j.1872-034X.2010.00667.x

26.   Benedict M, Rodriguez-Davalos M, Emre S, et al. Congenital Extrahepatic Portosystemic Shunt (Abernethy Malformation Type Ib) With Associated Hepatocellular Carcinoma: Case Report and Literature Review. Pediatr Dev Pathol. 2017; 20(4): 354-362.

https://doi.org/10.1177/1093526616686458

27.   Kroencke T, Murnauer M, Jordan FA, et al. Radioembolization for Hepatocellular Carcinoma Arising in the Setting of a Congenital Extrahepatic Portosystemic Shunt (Abernethy Malformation). Cardiovasc Intervent Radiol. 2018; 41(8): 1285-1290.

https://doi.org/10.1007/s00270-018-1965-5

28.   Alonso-Gamarra E, Parr?n M, P?rez A, et al. Clinical and radiologic manifestations of congenital extrahepatic portosystemic shunts: a comprehensive review. Radiographics. 2011; 31(3): 707-722.

https://doi.org/10.1148/rg.313105070

29.   Brasoveanu V, Ionescu MI, Grigorie R, et al. Living Donor Liver Transplantation for Unresectable Liver Adenomatosis Associated with Congenital Absence of Portal Vein: A Case Report and Literature Review. Am J Case Rep. 2015; 16: 637-644.

https://doi.org/10.12659/AJCR.895235

30.   Duprey J, Gouin B, Benazet MF, le Gal J. Glucose intolerance and post-stimulative hypoglycaemia secondary to congenital intra-hepatic porto-caval anastomosis. Annales de Medecine Interne. 1985; 136(8): 655-658.

31.   Watanabe A. Portal-systemic encephalopathy in non-chirrotic patients: classification of clinical types, diagnosis and treatment. Journal of Gastroenterology and Hepatology. 2000; 15(9): 969-979.

32.   Murray CP, Yoo SJ, Babyn PS. Congenital extrahepatic portosystemic shunts. Pediatric Radiology. 2003; 33(9): 614-620.

33.   Nishimura Y, Tajima G, Dwi Bahagia A, et al. Differential diagnosis of neonatal mild hypergalactosaemia detected by mass screening: clinical significance of portal vein imaging. Journal of Inherited Metabolic Disease. 2004; 27(1): 11-18.

34.   Eroglu Y, Donaldson J, Sorensen LG, et al. Improved neurocognitive function after radiologic closure of congenital portosystemic shunts. Journal of Pediatric Gastroenterology and Nutrition. 2004; 39(4): 410-417.

35.   Emre S, Amon R, Cohen E, et al. Resolution of hepatopulmonary syndrome after auxiliary partial orthotopic liver transplantation in Abernethy malformation. A case report. Liver Transplantation. 2007; 13(12): 1662-1668.

36.   Kim MJ, Ko JS, Seo JK, et al. Clinical features of congenital portosystemic shunt in children. European Journal of Pediatrics. 2012; 171(2): 395-400.

37.   Timpanaro T, Passanisi S, Sauna A, et al. Congenital portosystemic shunt: our experience. Case Rep Pediatr. 2015; 691618.

https://doi.org/10.1155/2015/691618

38.   Chocarro G, Amesty MV, Encinas JL, et al. Congenital Portosystemic Shunts: Clinic Heterogeneity Requires an Individual Management of the Patient. Eur J Pediatr Surg. 2016; 26(1): 74-80.

https://doi.org/10.1055/s-0035-1566097

39.   Achiron R, Kivilevitch Z. Fetal umbilical-portal-systemic venous shunt: in utero classification and clinical significance. Ultrasound Obstet Gynecol. 2016; 47: 739-747.

https://doi.org/10.1002/uog.14906

40.   Franchi-Abella S, Gonzales E, Ackermann O, et al. Congenital portosystemic shunts: diagnosis and treatment. Abdom Radiol (NY). 2018; 43(8): 2023-2036.

https://doi.org/10.1007/s00261-018-1619-8

41.   Musa J, Madani K, Saliaj K, et al. Asymptomatic presentation of a congenital malformation of the portal vein with portosystemic shunt. Radiol Case Rep. 2020; 15(10): 2009-2014.

https://doi.org/10.1016/j.radcr.2020.07.076

42.   Back SJ, Maya CL, Khwaja A. Ultrasound of congenital and inherited disorders of the pediatric hepatobiliary system, pancreas and spleen. Pediatr Radiol. 2017; 47: 1069-1078.

https://doi.org/10.1007/s00247-017-3869-y

43.   Nam HD. Living-donor liver transplantation for Abernethy malformation - case report and review of literature. Ann Hepatobiliary Pancreat Surg. 2020; 24(2): 203-208.

https://doi.org/10.14701/ahbps.2020.24.2.203

44.   Papamichail M, Pizanias M, Heaton N. Congenital portosystemic venous shunt. Eur J Pediatr. 2018; 177(3): 285-294.

https://doi.org/10.1007/s00431-017-3058-x

 

Abstract:

Introduction: improving the technique of radiofrequency denervation of renal arteries seems to be extremely important for optimizing the effectiveness of lowering blood pressure in patients with resistant arterial hypertension. Our study presents an assessment of the comparison of long-term results of renal artery denervation (RAD) using various techniques and instruments.

Aim: was to compare the use of various techniques for renal artery denervation and to evaluate longterm results in patients with resistant arterial hypertension using various radio frequency catheters.

Materials and methods: in a prospective study, three groups of patients (n = 58) aged 18-85 years with resistant systolic-diastolic arterial hypertension of 1-2 stages were studied: patients underwent denervation of renal arteries by various methods, against background of standardized antihypertensive therapy. In group I (n = 21), denervation was performed only in the proximal segment of the renal artery (before the first bifurcation). In group II (n = 19), ablation was performed both in proximal segment and in branches of the second and third order, as well as in the accessory renal arteries with a diameter of more than 3 mm. The third control group included 18 patients who received only standardized drug antihypertensive therapy.

Results: technical success of the operation was achieved in 100% of cases. According to the 24-hours ambulatory blood pressure monitoring (ABPM) data, the decrease in blood pressure (BP) in group I by the second year of observation was 6,7 mm Hg, p <0,05 for systolic BP (SBP) and ? 2,7 mm Hg, p> 0,05 for diastolic BP (DBP). In the second group, a greater decrease in mean SBP and DBP was recorded: ? 9,2 mm Hg, p <0,05 and ? 4,3 mm Hg, p <0,05, respectively. In the control group of drug treatment, the weakest antihypertensive effect of treatment was revealed. The average indicators of SBP and DBP decreased by - 4,9/1,9 mm Hg, p> 0,05.

Conclusion: results of the use of prolonged radiofrequency denervation of the main, segmental and accessory renal arteries with a large number of ablation points demonstrate a similar safety and greater efficacy in treatment of patients with resistant arterial hypertension, in comparison with denervation of only main trunk of renal artery.

  

 

References 

1.     Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129: 49-73.

https://doi.org/10.1161/01.cir.0000437741.48606.98

2.     Group SR, Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373: 2103-2116.

https://doi.org/10.1056/NEJMoa1511939

3.     Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013; 34: 2940-2948.

https://doi.org/10.1093/eurheartj/eht295

4.     Fengler K, Ewen S, Hцllriegel R, et al. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients with Resistant Hypertension. J Am Heart Assoc. 2017; 6(8): 006196.

https://doi.org/10.1161/JAHA.117.006196

5.     Reshetnik A, Gohlisch C, Scheurig-M?nkler C, et al. Predictors for success in renal denervation-a single centre retrospective analysis. Sci Rep. 2018; 8(1): 15505.

https://doi.org/10.1038/s41598-018-33783-3

6.     Wang A. 2019 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Renal Denervation for the Management of Arterial Hypertension. Acta Cardiologica Sinica. 2019; 35(3): 199-230.

https://doi.org/10.6515/ACS.201905_35(3).20190415A

7.     Steigerwald K, Titova A, Malle C, et al. Morphological assessment of renal arteries after radiofrequency catheter-based sympathetic denervation in a porcine model J Hypertens. 2012; 30(11).

https://doi.org/10.1097/HJH.0b013e32835821e5

8.     Пекарский С.Е., Баев А.Е., Фальковская А.Ю. и др. Анатомически оптимизированная дистальная ренальная денервация — стойкий гипотензивный эффект в течение 3 лет после вмешательства. Патология кровообращения и кардиохирургия. 2020; 24(3S): 98-107.

Pekarskij SE, Baev AE, Fal'kovskaya AYU, et al. Anatomically optimized distal renal denervation – permanent hypotensive effect for 3 years after intervention. Patologiya krovoobrashcheniya i kardiohirurgiya, 2020; 24(3S): 98-107 [In Russ].

http://dx.doi.org/10.21688/1681-3472-2020-3S-98-107

9.     Mahfoud F, Tunev S, Ewen S,et al. Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation. Journal of the American College of Cardiology. 2015; 66: 1766-1775.

https://doi.org/10.1016/j.jacc.2015.08.018

10.   Bertog S, Fischel T, Vega F, et al. Randomised, blinded and controlled comparative study of chemical and radiofrequency-based renal denervation in a porcine model. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2017; 12: 1898-1906.

https://doi.org/10.4244/EIJ-D-16-00206

11.   Mahfoud F, Pipenhagen C, Moon L, et al. Comparison of branch and distally focused main renal artery denervation using two different radio-frequency systems in a porcine model. International journal of cardiology. 2017; 241: 373-378.

https://doi.org/10.1016/j.ijcard.2017.04.057

12.   Vink E, Goldschmeding R, Vink A, et al. Limited destruction of renal nerves after catheter-based renal denervation: results of a human case study. Nephrology, dialysis, transplantation - European Renal Association. 2014; 29: 1608-1610.

https://doi.org/10.1093/ndt/gfu192

13.   Агаева Р.А., Данилов Н.М., Щелкова Г.В. и др. Радиочастотная денервация почечных артерий моно-электродным и мультиэлектродным устройствами у пациентов с неконтролируемой артериальной гипертонией: результаты 6-месячного наблюдения. Системные гипертензии. 2020; 17(1): 46-50.

Agaeva RA, Danilov NM, Shchcelkova GV, et al. Radiofrequency renal denervation with mono-electrode and multielectrode device for treatment in patient with uncontrolled hypertension: results of a 6-month follow-up. Sistemnye gipertenzii. 2020; 17(1): 46-50 [In Russ].

https://doi.org/10.26442/2075082X.2020.1.200077

14.   Mahfoud F, Tunev S, Ewen S, et al. Impact of lesion placement on efficacy and safety of catheter-based radiofrequency renal denervation. J Am Coll Cardiol. 2015; 66: 1766-1775.

https://doi.org/10.1016/j.jacc.2015.08.018

15.   Henegar JR, Zhang Y, Hata C, et al. Catheter-based radiofrequency renal denervation: location effects on renal norepinephrine. Am J Hypertens. 2015; 28: 909-914.

https://doi.org/10.1093/ajh/hpu258

16.   Konstantinos PT, Lida F, Kyriakos D. Safety and performance of diagnostic electrical mapping of renal nerves in hypertensive patients. EuroIntervention. 2018; 14: 1334-1342.

https://doi.org/10.4244/EIJ-D-18-00536

 

Abstract:

Aim: was to determine the influence of blood plasma fibrinogen level on results of the left main coronary artery stenting.

Material and methods: clinical, laboratory and angiographic parameters of 819 patients after elective stenting of the unprotected left main coronary artery were used. The end-point was target lesion failure (TLF), including adverse events as repeated revascularization of the target lesion (TLR), myocardial infarction (MI) and death from cardiac causes.

Results: in 5 years follow-up period, end-point was achieved in 158 cases (19,3%). Independent predictors of TLF were: SyntaxScore > 32 (HR 1,089 95% CI 1,029-1,153, p = 0,003), creatinine level (HR 1,009 95% CI 1,004-1,013, p=0,001) and fibrinogen level (HR 1,4 95% CI 1,169-1698, p=0001). According to results of the Kaplan-Meier analysis, the cumulative probability of the TLF was higher in patients with fibrinogen values greater than 3,48 g/L (log-rank 0,001).

Conclusion: blood plasma fibrinogen level was an independent predictor of the TLF after left main coronary artery stenting. Increase in the level of blood fibrinogen for each 1 g/L led to an increase in the risk of TLF by 1,4 times per month.

   

References 

1.     G?n?reux P, Stone GW, Harrington RA, et al. Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention). J Am Coll Cardiol. 2014; 63: 619.

2.     Kurtul A, Yarlioglues M, Murat SN, et al.The associationof plasmafibrinogen with the extent andcomplexity of coronary lesions in patients with acute coronary syndrome. Kardiol Pol. 2016; 74: 338-345.

3.     Jiang P, Gao Z, Zhao W, et al. Relationship between fibrinogen levels and cardiovascular events in patients receiving percutaneous coronary intervention: a large single-center study. Chinese Medical Journal. 2019; 132(8).

4.     Ang L, Behnamfar O, Palakodeti S, et al. Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention. JAHA. 2017; 117.

5.     Gershlick A, Kandzar D, Banning A, et al. Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site. Results From the EXCEL Trial. JACC. 2018; 11(13).

6.     Castell JV, Gomez-Lechon MJ, David M, et al. Acutephase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990; 12: 1179-1186.

7.     Rahel BM, Visseren FLJ, Suttorp M, et al. Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention. Cardiovasc Res. 2003; 60: 136-140.

8.     Ou Baiqing, Yang Yulian, Chen Zhimin, et al. The Effect of Lumbrokinase on the Fibrinogen Increase Following Percutaneous Coronary Intervention. Chinese Journal of new Drugs. 2004; 13(12): 1158-60.

9.     Shi Y, Wu Y, Bian C, et al. Predictive value of plasma fibrinogen levels in patients admitted for acute coronary syndrome. Tex Heart Inst J. 2010; 37: 178-183.

10.   Corrado E, Novo S. Role of inflammation and infection in vascular disease. Acta Chir Belg. 2005; 105: 567-579.

11.   Ehtisham M, Mattheus R, Enright K, et al. Effect of Serum Fibrinogen, Total Stent Length, and Type of Acute Coronary Syndrome on 6-Month Major Adverse Cardiovascular Events and Bleeding Following Percutaneous Coronary Intervention. The American Journal of Cardiology. 2016; 117(10): 1575-1581.

12.   Otsuka M, Hayashi Y, Ueda H, et al. Predictive value of preprocedural fibrinogen concerning coronary stenting. Atherosclerosis. 2002; 164: 371-378.

13.   Kavitha S, Sridhar M, Satheesh S. Periprocedural plasma fibrinogen levels and coronary stent outcome. Indian heart journal. 2015; 67: 440-443.

 

Abstract:

Introduction: pulmonary arterial hypertension (PAH) is a pathophysiological syndrome that can occur in a variety of clinical conditions. Percutaneous balloon dilatation and stent implantation are methods for creating or expanding atrial communication in a variety of conditions to improve cardiac output. It should be kept in mind that creation of an inadequate size of the shunt leads to an excess of right-left shunt, worsening of pulmonary blood flow, severe hypoxemia, and acute left ventricular failure. Possibility of a calculated determination of required size of shunt in the interatrial septum will increase the effectiveness and safety of atrioseptostomy, which is especially important in this severe category of patients.

Aim: to substantiate a method of determining of optimal diameter of the atrial communication during atrioseptostomy in patients with PAH for increase of exercise tolerance, prevention of syncope and reducing the risk of sudden death.

Materials and methods: the choice of the diameter of the interatrial communication during atrioseptostomy operation in patients with PAH is as follows: before the operation, patient undergoes an invasive measurement of pressure in right and left atrium and determination of stroke volume of left ventricle. Then calculation the diameter of the interatrial communication according to the formula is performed. We performed calculation according to presented formula in 4 patients with PAH. In 2 patients, a fenestrated occluder was implanted, in 1 patient atrial septum stenting was performed, and 1 patient underwent open atrioseptostomy.

Results: in all patients after atrioseptostomy, an improvement in quality of life was observed: decreased dyspnea, increased exercise tolerance, decreased edema of lower limbs, and the absence of syncopal conditions. Thus, after the operation, there was a positive dynamics in clinical status of patients, indicators of test with a six-minute walk, as well as changes in echocardiographic indicators: a decrease in the size of the right ventricle and square area of right atrium, an increase in the end-diastolic size of the left ventricle, which indicates an improvement in function of both ventricles.

Conclusion: a mathematical model based on principles of intracardiac hemodynamics, demonstrates the importance of choosing of size of foramen to create a certain Qp/Qs. Size of foramen, depending on the pressure in atrium, in conditions of high pulmonary hypertension has a small range of values (from 6 to 8 mm). Therefore, the use of the 7 mm size, previously obtained empirically by other authors, is physically justified. Our first experience testifies to applicability of the developed model, but due to the small number of observations associated with the rarity of the pathology, it requires further research.

  

Referenses 

1.     Micheletti A, Hislop AA, Lammers A, et al. Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension. Heart. 2006; 92: 969-72.

http://doi.org/10.1136/hrt.2005.077669

2.     Baglini R, Scardulla C., Reduction of a previous atrial septostomy in a patient with end-stage pulmonary hypertension by a manually fenestrated device. Cardiovasc Revasc Med. 2010; 11(4).

http://doi.org/10.1016/j.carrev.2009.11.005

3.     St?mper O, Gewillig M, Vettukattil J, et al. Modified technique of stent fenestration of the atrial septum. Heart. 2003; 89: 1227-30.

http://doi.org/10.1136/heart.89.10.1227

4.     Sivaprakasam M, Kiesewetter C, Veldtman GR, et al. New technique for fenestration of the interatrial septum. J Interv Cardiol. 2006; 19: 334-6.

5.     Alekyan BG, Pursanov MG. Atrial septal stenting. Textbook of endovascular surgery for cardiovascular diseases. AN Bakulev National Medical Research Center of Cardiovascular Surgery. 2008; 2: 57-65 [In Russ].

6.     Gorbachevsky SV, Belkina MV, Pursanov MG, et al. Atrial septostomy as a long bridge to lung transplantation in patients with idiopathic pulmonary arterial hypertension. J. Cardiovasc. Surg. 2012; 53(2): 11 [In Russ].

7.     Alekyan BG, Gorbachevskiy SV, Pursanov MG, et al. Atrial septal stenting with idiopathic pulmonary hypertension. AN Bakulev National Medical Research Center of Cardiovascular Surgery. Thoracic and Cardiovascular Surgery. 2016; 58(5): 258-314 [In Russ].

8.     Pardaev DB, Alekyan BG, Gorbachevskiy SV, et al. Atrioseptostomy with atrial septum stenting in patients with idiopathic pulmonary hypertension. AN Bakulev National Medical Research Center of Cardiovascular Surgery. 2017 [In Russ].

9.     Weimar T, Watanabe Y, Kazui T, et al. Impact of differential right-to-left shunting on systemic perfusion in pulmonary arterial hypertension. Cathet. Cardiovasc. Interv. 2013; 81(5): 888-95.

http://doi.org/10.1002/ccd.24458

10.   Sandoval J, Arroyo JG, Gaspar J, et al. Interventional and surgical therapeutic strategies for pulmonary arterial hypertension: Beyond palliative treatments. J. Cardiol. 2015; 66: 304-4.

http://doi.org/10.1016/j.jjcc.2015.02.001

11.   Lammers AE, Derrick G, Haworth SG, et al. Efficacy and long-term patency of fenestrated Amplatzer devices in children. Cathet. Cardiovasc. Interv. 2007; 70(4): 578-84.

http://doi.org/10.1002/ccd.21216

12.   Shmaltc АА, Nishonov NА. Atrioseptostomy in patients with pulmonary hypertension. Thorax and Cardiovascular Surgery. 2015; 57(5): 18-25 [In Russ].

13.   Chiu JS, Zuckerman WA, Turner ME, et al. Balloon atrial septostomy in pulmonary arterial hypertension: effect on survival and associated outcomes. J Heart Lung Transplant. 2015; 34(3): 376-380.

http://doi.org/10.1016/j.healun.2015.01.004

14.   Hirsch R, Bagby MC, Zussman ME. Fenestrated ASD closure in a child with idiopathic pulmonary hypertension and exercise desaturation. Congenit Heart Dis. 2011; 6(2): 162-166.

http://doi.org/10.1111/j.1747-0803.2010.00472.x

15.   Kurzyna M, Dabrowski M, Bielecki D, et al. Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest. 2007; 131(4): 977-983.

http://doi.org/10.1378/chest.06-1227

16.   Patel MB, Samuel BP, Girgis RE, et al. Implantable atrial flow regulator for severe, irreversible pulmonary arterial hypertension. EuroIntervention. 2015; 11(6): 706-709.

http://doi.org/10.4244/EIJY15M07_08

17.   Kapoor A, Khanna R, Batra A, et al. Inoue balloon atrial septostomy in severe persistent pulmonary hypertension following surgical ASD closure. J Cardiol Cases. 2012; 6(1): 1-3.

http://doi.org/10.1016/j.jccase.2012.02.002

18.   Rajeshkumar R, Pavithran S, Sivakumar K, et al. Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension. Catheter Cardiovasc Interv. 2017; 90(7): 1145-1153.

http://doi.org/10.1002/ccd.27233

19.   Baglini R, Scardulla C. Reduction of a previous atrial septostomy in a patient with end-stage pulmonary hypertension by a manually fenestrated device. Cardiovasc Revasc Med. 2010; 11(4).

http://doi.org/10.1016/j.carrev.2009.11.005

20.   Alekyan BG, Gorbachevsky SV, Pursanov MG, et al. Stenting of the interatrial septum for the treatment of idiopathic pulmonary arterial hypertension. J. Invasive Cardiol. 2015 [In Russ].

21.   Koval PV. Hydraulics and hydraulic lines of mining machines: Textbook for universities in the specialty «Mining machines and complexes». Engineering. 1979.

 

Abstract:

Aim: was to systematize and clarify possible puncture approaches in percutaneous CT-guided mini-invasive procedures in patients with tumor lesions of pelvic bones.

Methods and materials: 63 CT-guided interventions were performed on pelvic bones (53 trephine biopsy and 10 cryoablations) in 52 patients. Manipulations were performed using the Philips Ingenuity CT scanner, Maxio Perfint robotic system and «Medical Cryotherapeutic System».

Results: during interventional procedures, three topographic regions were identified - zones of the pelvic ring: upper zone (at the level of the ilium), middle zone (level of the articular space of the hip joint), and lower zone (at the level of the ramus of the ischial and pubic bones). In each zone, within certain safety sectors, puncture approaches are highlighted, associated with five optimal positions of the patient in the gantry aperture. Clinical examples of puncture procedures with various localization of the pathological process are given, demonstrating the safety of approaches and the validity of proposed recommendations. There were no complications after interventions.

Conclusion: the choice of the optimal puncture approach and standard patient’ positions in miniinvasive CT-guided operations in patients with pelvic bone lesions can improve the efficiency and safety of surgical procedures.

  

 

References 

1.     Garnon J, Koch G, Caudrelier J, et al. Expanding the borders: Image-guided procedures for the treatment of musculoskeletal tumors. Diagnostic and Interventional Imaging. 2017; 98(9): 635-644.

2.     Sun G, Jin P, Liu XW, et al. Cementoplasty for managing painful bone metastases outside the spine. European Radiology. 2014; 24(3): 731-737.

3.     Burovik IA, Prokhorov GG, Lushina PA, et al. CT-guided robotic-assisted percutaneous interventions: first experience. Medical Visualization. 2019; (2): 27-35 [In Russ].

4.     Lin YC, Wu JS, Kung JW. Image guided biopsy of musculoskeletal lesions with low diagnostic yield. Current Medical Imaging Reviews. 2017; 13(3): 260-267.

5.     Miranda OM, Moser TP. A practical guide for planning pelvic bone percutaneous interventions (biopsy, tumour ablation and cementoplasty). Insights into Imaging. 2018; 9: 275-285.

6.     Coleman RE, Croucher PI, Padhani AR, et al. Bone metastases. Nature Reviews Disease Primers. 2020; 6: 83.

7.     Filippiadis DK, Charalampopoulos G, Mazioti A, et al. Bone and Soft-Tissue Biopsies: What You Need to Know. Seminars in Interventional Radiology. 2018; 35(4): 215-220.

8.     Veltri A, Bargellini I, Giorgi L, et al. CIRSE guidelines on percutaneous needle biopsy (PNB). CardioVascular and Interventional Radiology. 2017; 40(10): 1501-1513.

9.     Meagan C, Keegan BA, Darcy AK. Fine-needle aspiration biopsy for the diagnosis of bone and soft tissue lesions: a systematic review and meta-analysis. Journal of the American Society of Cytopathology. 2020; 9(5): 429-441.

10.   Barrientos-Ruiz I, Ortiz-Cruz EJ, Serrano-Montilla J, et al. Are Biopsy Tracts a Concern for Seeding and Local Recurrence in Sarcomas? Clinical Orthopaedics and Related Research. 2017; 475(2): 511-518.

11.   Burovik IA, Prokhorov GG. Computed tomography as a method of control of percutaneous tumor cryoablation. Diagnostic radiology and radiotherapy. 2019; (4): 57-65 [In Russ].

 

Abstract:

Introduction: every year in the world, more than 13 millions strokes are recorded, most often (up to 80%) - acute cerebrovascular accidents of ischemic type, in which the cause of cerebral infarction is acute embolic occlusion of intracranial artery. Restoration of cerebral perfusion as early as possible from the onset of the disease can lead to a decrease of infarction zone and an improvement in clinical outcomes of the disease.

Case report: a 78-year-old patient was admitted with a clinical picture of acute stroke 90 minutes after onset; after computed tomography was performed, according to generally accepted method, systemic thrombolytic therapy was started. Angiography (occlusion of left middle cerebral artery (MCA) in the M1 segment followed by aspiration and then mechanical thrombectomy showed an «early» bifurcation of middle cerebral artery with a large lateral branch. Occluding thrombus was localized precisely in the area of MCA bifurcation, in branches of equal diameter. After unsuccessful attempts at thrombus extraction using the standard thrombus extraction and aspiration technique, patient underwent thrombus extraction using the original method (we called R-Culotte): simultaneous use of two retrievers positioned in the Culotte style (Culotte - «pants», French, R -retriever, English) in lumen of the bifurcation of middle cerebral artery. Blood flow in MCA was restored to mTICI-3 without complications. After the intervention, there was a rapid positive trend. Patient was discharged on 12th day with minimal neurological deficit.

Conclusions: this technique allowed to remove the thrombus and restore antegrade blood flow without complications after a series of unsuccessful attempts using the standard approach. Endovascular treatment of ischemic stroke has opened a new era in the treatment of this formidable disease. The search for new techniques for using existing devices contributes to the development of this promising technique.

 

References

1.     Ciccone A, del Zoppo GJ. Evolving Role of Endovascular Treatment of Acute Ischemic Stroke. Curr Neurol Neurosci Rep. 2014 Jan; 14(1): 416.

2.     Sardar P, Chatterjee S, Giri J, et al. Endovascular therapy for acute ischaemic stroke: a systematic review and meta-analysis of randomized trials. Eur Heart J. 2015; 36 (35): 2373-2380.

3.     Novakovic RL, Toth G, Narayanan S, Zaidat OO. Retrievable stents, «stentrievers», for endovascular acute ischemic stroke therapy. Neurology. 2012; 79 (13 Suppl 1): 148–157.

4.     Arnaout OM, Rahme RJ, El Ahmadieh TY, et al. Past, present, and future perspectives on the endovascular treatment of acute ischemic stroke. Tech Vasc Interv Radiol. 2012; 15: 87-92.

5.     Koh JS, Lee SJ, Ryu CW, Kim HS. Safety and efficacy of mechanical thrombectomy with solitaire stent retrieval for acute ischemic stroke: A systematic review. J Neurointervention. 2012; 7: 1-9.

6.     Singh P, Kaur R, Kaur A. Endovascular treatment of acute ischemic stroke. J Neurosci Rural Pract. 2013 Jul-Sep; 4(3): 298-303.

7.     Goyal M, Yu AY, Menon BK, et al. Endovascular Therapy in Acute Ischemic Stroke. J Stroke. 2016; 47: 548-553.

8.     GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18(5): 439-458.

https://doi.org/10.1016/S1474-4422(19)30034-1

 

Abstract:

Introduction: osteoarthritis (OA) is the most common disease of the musculoskeletal system, the main cause of pain development, loss of joint function and, as a consequence, one of leading factors of population disability. Treatment strategy for patients with gonarthrosis is not fully defined, especially in patients with grade 1-2. In this cohort of patients, conservative treatment is indicated, but it does not always lead to a decrease in the severity of pain, significantly reducing the quality of life. One of treatment options for such patients is transcatheter embolization of the hypervascular area of popliteal arteries.

Aim: was to present a case report of the successful use of transcatheter arterial embolization of branches of the popliteal artery in gonarthrosis.

Materials and methods: patient B., 72 years old, consulted a rheumatologist in November 2019 with complaints on pain in knee joints, aggravated by movements, going up and down stairs, as well as pain in the area of small joints of the feet, ankle, and shoulder joints. In view of the ineffectiveness of conservative therapy, patient was offered transcatheter embolization of branches of the hypervascular area of the popliteal artery. Selective embolization of the artery of the hypervascular vasculature of right knee joint was performed under local anesthesia.

Results: 1 month after the procedure, patient noticed a significant decrease in the intensity of pain in right knee joint, increased range of motion. The result of filling out the WOMAC questionnaire 1 month after embolization of popliteal artery branches was 26 points (satisfactory result). At the visit 3 months after the manipulation, patient noted the persistence of effect of procedure. The result of the WOMAC questionnaire is 22 points.

Conclusions: transcatheter arterial embolization of the hypervascular area in osteoarthritis of various origins and localization can be successfully used as an alternative treatment if conservative therapy is ineffective and if there are contraindications to surgical treatment.

 

 

References

1.     Bannuru RR, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis and cartilage. 2019; 27(11): 1578-1589.

2.     Spitaels D, et al. Epidemiology of knee osteoarthritis in general practice: a registry-based study. BMJ open. 2020; 10(1).

3.     Litwic A, et al. Epidemiology and burden of osteoarthritis. British medical bulletin. 2013; 105(1): 185-199.

4.     Kabalyk MA. Prevalence of osteoarthritis in Russia: regional aspects of trends in statistical parameters during 2011-2016. Rheumatology Science and Practice. 2018; 56(4): 416.

5.     Vitaloni M, et al. Global management of patients with knee osteoarthritis begins with quality of life assessment: a systematic review. BMC musculoskeletal disorders. 2019; 20(1): 493.

6.     Gr?ssel S, Muschter D. Peripheral nerve fibers and their neurotransmitters in osteoarthritis pathology. International Journal of Molecular Sciences. 2017; 18(5): 931.

7.     Okuno Y, et al. Transcatheter arterial embolization as a treatment for medial knee pain in patients with mild to moderate osteoarthritis. CardioVascular and Interventional Radiology. 2015; 38(2): 336-343.

8.     Landers S, et al. Protocol for a single-centre, parallel-arm, randomised controlled superiority trial evaluating the effects of transcatheter arterial embolisation of abnormal knee neovasculature on pain, function and quality of life in people with knee osteoarthritis. BMJ open. 2017; 7(5).

9.     Palazzo C, et al. Risk factors and burden of osteoarthritis. Annals of physical and rehabilitation medicine. 2016; 59(3): 134-138.

10.   McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage. 2014; 22(3): 363-388.

11.   Dieppe P, Lim K, Lohmander S. Who should have knee joint replacement surgery for osteoarthritis? International Journal of Rheumatic Diseases. 2011; 14(2): 175-80.

12.   Kim JR, Yoo JJ, Kim HA. Therapeutics in osteoarthritis based on an understanding of its molecular pathogenesis. International journal of molecular sciences. 2018; 19(3): 674.

13.   William HR, Christin ML, Qian W, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nature Reviews Rheumatology. 2016; 12(10): 580-592.

14.   Yiyun W, Jiajia X, Xudong Z, et al. TNF-?-induced LRG1 promotes angiogenesis and mesenchymal stem cell migration in the subchondral bone during osteoarthritis. Cell Death and Disease. 2017; 8(3): 2715-2715.

15.   Turovskaya EF, Alekseeva LI, Filatova EG. Current ideas about the pathogenetic mechanisms of pain in osteoarthrosis. Scientific and practical rheumatology. 2014; 52 (4): 438-444 [In Russ].

16.   Mapp PI, Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. National Reviews Rheumatalogy. 2012; 8(7): 390.

17.   Ashraf S, Mapp PI, Walsh DA. Contributions of angiogenesis to inflammation, joint damage, and pain in a rat model of osteoarthritis. Arthritis & Rheumatology. 2011; 63(9): 2700-2710.

 

Abstract:

Introduction: arterial complications after orthotopic liver transplantation are common cause of graft loss (10-40%).

Aim: was to estimate efficiency of endovascular interventions in correction of revealed arterial complications in patients after OLT.

Material and methods: for the period of 2015-2020, arterial complications after 104 OLT were revealed in 24(23%) pts and were divided into 4 groups: «steal»-syndrome (n=8), hepatic artery thrombosis (n=7), combination of hepatic artery stenosis and «steal» syndrome (n=6), hepatic artery stenosis (n=3). Endovascular interventios such as splenic artery embolization, direct thrombolysis, stenting and balloon plastic were performed for correction of these complications.

Results: using of endovascular treatment, we successfully identified and correct complications with saving of the graft in 14 pts (58%), 10 pts died because of biliary necrosis, sepsis and graft loss.

Conclusion: early detection and elimination of emerging arterial complications after OLT play a keyrole in saving of organs and patients’ life.

  

 

References

1.     Gautier SV, Khomyakov SM. Organ donation and transplantation in the Russian Federation in 2018 году. 11th report from the registry of the Russian Transplant Society. Russian journal of transplantology and artificial organs. 2019; 21(3): 7-32 [In Russ].

2.     Buck DG, Zajko AB. Biliary complications after orthotopic liver transplantation. Tech Vasc Interv Radiol. 2008; 11(01): 51-59.

3.     Seehofer D, Eurich D, Veltzke-Shlieker W, et al. Biliary complications after liver transplantation: old problems and new challenges. Am J Transplant. 2013; 13(02): 253-265.

4.     Ingraham C, Montenovo M. Ishemic complications after liver transplantation. Dig Dis Interv. 2018; 2: 244-248.

5.     Goldsmith LE, Wiebke K, Seal J, et al. Complications after endovascular treatment of hepatic artery stenosis after liver transplantation. J Vasc Surg. 2017; 66(5): 1488-1496.

6.     Prieto M, Gastaca M, Valdivieso A, et al. Does low hepatic artery flow increase rate of biliary strictures in deceased donor liver transplantation? Transplantation. 2017; 101(9): 311.

7.     Chen J, Weinstein J, Black S, et al. Surgical and endovascular treatment of hepatic arterial complications following liver transplant. Clin Transplant. 2014; 28(12): 1305-1312.

8.     Kim PT, Fernandez H, Gupta A, et al. Low measured hepatic artery flow increases rate of biliary strictures in deceased donor liver transplantation: an age-dependent phenomenon. Transplantation. 2017; 101(2): 332-340.

9.     Galperin EI, Kunichan MD. Manometric and debitometric study in bile ducts. Surgery. 1969; 8: 74-78 [In Russ].

10.   Polikarpov АА, Tarazov PG, Polekhin AS, et al. Biliary manometric test (BMT) to assess the effectiveness balloon plasty of strictures of the bile ducts after orthotopic liver transplantation (OLT). Modern technologies in medicine. 2017; 9(4): 60-65 [In Russ].

11.   Buis CI, Verdonk RC, Van der Jagt EJ, et al. Nonanastomotic biliary strictures after liver transplantation, part 1: Radiological features and risk factors for early vs late presentation. Liver Transpl. 2007; 13: 708-718.

12.   Moiseenko AV, Polikarpov АA, Tarazov PG, et al. Method for invasive graft perfusion determination. Russian patent № 270496: 23.10.2019 2019. № 30 [In Russ].

13.   Pinto S, Reddy SN, Horrow MM, et al. Splenic artery syndrome after orthotopic liver transplantation: a review. Int J Surg. 2014; 12(11): 1228-34.

14.   Mogl N, N?ssler N, Presser S, et al. Evolving experience with prevention and treatment of splenic artery syndrome after orthotopic liver transplantation. Transpl. Int. 2010; 23(8): 831-841.

15.   Dokmak S, Aussilhou B, Belghiti J. Liver transplantation and splenic artery steal syndrome: the diagnosis should be established preoperatively. Liver Transpl. 2013; 19(6): 667-668.

16.   Grieser С, Denecke T, Steffen I, et al. Computed tomography for preoperative assessment of hepatic vasculature and prediction of splenic artery steal syndrome in patients with liver cirrhosis before transplantation. Eur. Radiol. 2010; 20(1): 108-117.

17.   Li H, Gao K, Huang Q, et al. Successful management of splenic artery steal syndrome with hepatic artery stenosis in an orthotopic liver transplant recipient. Ann. Transplant. Q. Pol. Transplant. 2014; 145-148.

18.   Strain D, Brady P, Matalon T, et al. Splenic artery embolization as treatment for splenic artery steal syndrome after liver transplantation. J. Vasc. Intervent. Radiol. 2013; 24(4): 159-160.

19.   G?m?n G, Gelley F, Doros A, et al. Biliary complications after orthotopic liver transplantation: The Hungarian Experience. Transplantation Proceedings. 2013; 45: 3695-3697.

20.   Lee IJ, Kim SH, Lee SD, et al. Feasibility and midterm results of endovascular treatment of hepatic artery occlusion within 24 hours after living-donor liver transplantation. J Vasc Interv Radiol. 2017; 28(2): 269-275.

21.   Fujiki M, Hashimoto K, Palaios E, et al. Probability, management, and long-term outcomes of biliary complications after hepatic artery thrombosis in liver transplant recipients. Surgery. 2017; 162(5): 1101-1111.

 

Abstract:

Aim: was to estimate results of endovascular treatment of subclavian arteries lesions.

Materials and methods: study analyzes results of endovascular treatment of patients with occlusive-stenotic lesions of subclavian arteries. For the period 2014-2018, 87 endovascular interventions were performed on subclavian arteries. Indication for surgery was occlusion of subclavian artery or stenosis of more than 70% with the development of steal-syndrome. Before surgery, all patients underwent duplex scanning of brachiocephalic vessels and CT angiography of branches of the aortic arch with cerebral phase. There was no difference in severity of symptoms and comorbidity between patients with stenosis or occlusions (р>0,05). In case of stenosis, direct stenting of subclavian artery was performed. For occlusions, mechanical recanalization was performed using hydrophilic wires, balloon angioplasty followed by stenting. In all cases, we used a balloon-expandable stent.

Results: technical success was achieved in 98,8% of interventions. There were no lethal outcomes, myocardial infarction, or stroke. In one patient, brachial artery thrombosis occurred in early postoperative period; thrombectomy from the brachial artery was performed with restoration of blood flow. Patency of subclavian artery after 1 and 3 years was 100% and 94%, respectively.

Conclusions: endovascular interventions for occlusive-stenotic lesions of subclavian arteries is an effective and safe method of treatment of vertebrobasilar insufficiency.

 

 

 

References

1.     Piradov MA, Maksimova MYu, Tanashyan MM. Stroke: guidelines. M: GEOTAR-Media. 2019; 288 [In Russ].

2.     Woo EY, Fairman RM, Velazquez OC, et al. Endovascular therapy of symptomatic innominate-subclavian arterial occlusive lesions. Vasc. Endovasc.Surg. 2006; 40(1): 27-33.

3.     Tan TY, Schminke U, Lien LM, et al. Subclavian steal syndrome: can the blood pressure difference between arms predict the severity of steal?. J. Neuroimaging. 2002; 12: 131-35.

4.     Hennerici M, Klemm C, Rautenberg W. The subclavian steal phenomenon: a common vascular disorder with rare neurologic deficits. Neurology. 1988; 38: 669-73.

5.     Perren F. Vertebral artery hypoplasia: a predisposing factor for posterior circulation stroke. Neurology. 2007; 2: 6

6.     Sigala F, Galyfos G, Coutelle AG, et al. Open reconstructions for symptomatic atheroscherotic lesions of the supra-aortic vessels: thirty years results from two university hospitals. Ann Vasc Surg. 2015 (29): 404.

7.     Towne JB, Hollier LH. Complications in vascular surgery. New York, Marcel. Dekken. 2005; 457-466.

8.     Bachman DM, Kim RM, Bachman DM, et al. Transluminal dilatation for subclavian steal syndrome. Am J Roentgenol. 1980; 135: 995-996.

9.     Eisenhauer AC. Subclavian and innominate revascularization: surgical therapy versus catheter-based intervention. Curr. Interv. Cardiol. 2000; 2: 101-110.

10.   Mousa AY, Abu Rahma AF, Bozzay J, et al. Anatomic and clinical predictors of reintervention after subclavian artery stenting. J. Vasc. Surg. 2015; 15.

11.   Tomoi Y, Soga Y, Fujihara M, et al. Outcomes of endovascular therapy for upper extremity peripheral artery disease with critical hand ischemia. J Endovasc Ther. 2016; 23: 717-22

12.   Endovascular surgery. National guideline: In 4 books. Vol.3. (ed.by acad. BG Alekyan). М: Litterra, 2017 [In Russ].

13.   National guidelines by treatment of patients whith brachiocephalic arteries deseases. Angiology and vascular surgery (Suppl.). 2013; 19(2) [In Russ].

14.   Usai MV, Bosiers M, Bisdas T, et al. Surgical versus endovascular revascularization of subclavian artery arteriosclerotic disease. The Journal of Cardiovascular Surgery. 2018.

15.   Aboyans V, Ricco J-B, Bartelink M-L, et al. 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018; 55: 305-368.

16.   Benhammamia M, Mazzaccaro D, Ben Mrad M, et al. Endovascular And Surgical Management Of Subclavian Artery Occlusive Disease: Early And Long Term Outcomes. Annals of Vascular Surgery. 2020.

17.   Alekyan BG, Zakaryan NV, Shumilina MV, et al. Low term and long term outcomes of stenting by subclavian artery deseases. Thoracic and cardiovascular surgery. 2011; 1: 24-31 [In Russ].

18.   De Vries JP, Jager LC, van den Berg JC. Durability of Percutaneous trans- luminal angioplasty for obstructive lesions of proximal subclavian artery: long term results. J. Vasc. Surg. 2005; 41: 19-23.

19.   Linni K, Ugurluoglu A, Mader N, et al. Endovascular management versus surgery for proximal subclavian artery lesions. Ann. Vasc. Surg. 2008; 22(6): 769-67.

 

Abstract:

Aim: was to study in-hospital results of high-risk percutaneous coronary intervention (PCI) with extracorporeal circulatory support.

Material and methods: a single center, retrospective study was performed in 49 adult patients undergoing high-risk PCI with mechanical circulatory support (cardiopulmonary bypass - CPB and еxtracorporeal membrane oxygenation – ECMO) performed in high-risk patients with acute coronary syndrome, multiple coronary lesions and impaired ejection fraction between 2011 to 2019. Mean age was 64,4±6,7 years. Previous myocardial infarction had 38(77%) patients, 18(37%) patients had a history of previous cardiac surgery. In 18(37%) patients, ejection fraction (Simpson) was less than 30%. Mean value of the left main (LM) artery stenosis was 74,6±8,9%, while combined with occlusion or subocclusion right coronary artery (RCA) in 38(77%) patients. Multivessel coronary lesion had 42(86%) patients (average SYNTAX Score was 42,1±11,5 points)

Results: 17 patients (35%) underwent high-risk PCI under preventional mechanical circulatory support with CPB. Myocardial infarction, strokes, stent thrombosis, limb ischemia, lethal outcomes were not observed in these patients. 7(14%) patients were admitted to the Cath Lab with myocardial infarction complicated by cardiogenic shock, in 3 patients – with pulmonary edema. 12(24%) patients after previous heart surgery were admitted to the Cath Lab after cardiopulmonary resuscitation on extracorporeal circulatory support, four of them (8%) with ongoing chest compressions. In 6(12%) patients, during CAG/PCI, critical hemodynamic instability was observed, induced by incurable cardiac arrhythmias required an emergency extracorporeal support. Average time of extracorporeal circulatory support was 128,62±92,4 min. Complications associated with CPB and ECMO were not observed. Two patients (4%) had stroke in the postoperative period. Hospital mortality was 17(34,7%) patients.

Conclusion: extracorporeal circulatory supports provide good life maintenance for high-risk PCI and an possibility for emergency PCI in extreme clinical situations.

  

 

References

1.     Phillips S, Zeff R, Kongtahworn C, et al. Percutaneous cardiopulmonary bypass: application and indication for use. Ann Thorac Surg. 1989; 47: 121-123.

https://doi.org/10.1016/0003-4975(89)90252-x

2.     Taub J, L'Hommedieu B, Raithel S, et al. Extracorporeal membrane oxygenation for percutaneous coronary angioplasty in high risk patients. ASAIO. Trans. 1989. 35(3): 664-6.

https://doi.org/10.1097/00002480-198907000-00161

3.     Rihal C, Naidu S, et al. Society for Cardiovascular Angiography and Interventions (SCAI); Heart Failure Society of America (HFSA); Society of Thoracic Surgeons (STS);American Heart Association (AHA) and American College of Cardiology (ACC). 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologied 'intervention. J Am Coll.Cardiol. 2015; 65(19): 7-26.

https://doi.org/10.1016/j.jacc.2015.03.036

4.     Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2010; 31: 2501-2555.

https://doi.org/10.1093/eurheartj/ehq277

5.     Thiele H, Zeymer U, Neumann F, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomized, open-label trial. Lancet. 2013; 382: 1638-1645.

https://doi.org/10.1016/S0140-6736(13)61783-3

6.     O’Gara P, Kushner F, Ascheim D, et al. 2013 ACCF/AHA guideline for management of ST-elevation myocardial infarction. J Am Coll Cardiol. 2013; 61: 78-140.

https://doi.org/10.1016/j.jacc.2012.11.019

7.     Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014; 35: 2541-2619.

https://doi.org/10.1093/eurheartj/ehu278

8.     De Waha S, Desch S, Eitel I, et al. Reprint of «intraaortic balloon countrpulsation – basic principles and clinical evidence». Vascul Pharmacol. 2014; 61: 30-34.

https://doi.org/10.1016/j.vph.2014.03.002

9.     Aggarwal B, Aman W, Jeroudi O, Kleiman N. Mechanical Circulatory Support in High-Risk Percutaneous Coronary Intervention. Methodist Debakey Cardiovasc J. 2018; 14(1): 23-31.

https://doi.org/10.14797/mdcj-14-1-23

10.   Jones H, Kalisetti D, Gaba M, et al. Left ventricular assist for high-risk percutaneous coronary intervention. J Invasive Cardiol. 2012; 24(10): 544-50.

11.   Zeymer U, Vogt A. Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI). Eur Heart J. 2004; 25: 322-328.

https://doi.org/10.1016/j.ehj.2003.12.008

12.   Nichol G, Karmy-Jones R, Salerno C, et al. Systematic review of percutaneous cardiopulmonary bypass for cardiac arrest or cardiogenic shock states. Resuscitation. 2006; 70: 381-394.

https://doi.org/10.1016/j.resuscitation.2006.01.018

13.   Takayama H, Truby L, Koekort M, et al. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. J Heart Lung Transplant. 2013; 32: 106-111.

https://doi.org/10.1016/j.healun.2012.10.005

14.   Ternus B, Jentzer J, Bohman K, et al. Initiation of Extracorporeal Membrane Oxygenation in the Cardiac Catheterization Laboratory: The Mayo Clinic Experience. J Invasive Cardiol. 2020; 32(2): 64-69.

15.   O'Neill W, Schreiber T, Wohns D, et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol. 2014; 27(1): 1-11.

https://doi.org/10.1111/joic.12080

16.   Atkinson T, Ohman E, O'Neill W, et al. Interventional Scientific Council of the American College of Cardiology. A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective. JACC Cardiovasc Interv. 2016; 9(9): 871-83.

https://doi.org/10.1016/j.jcin.2016.02.046

17.   Ganyukov VI, Popov VA, Shukevich DL. Hospital outcomes of percutaneous coronary intervention with biventricular circulatory support in combination with extracorporeal membrane oxygenation. Kardiologiya i serdechno-sosudistaya hirurgiya. 2014; 1: 15-20 [In Russ].

18.   Bazylev VV, Evdokimov ME, Pantyuhina MA, Morozov ZA. Cardiopulmonary bypass for high-risk percutaneous coronary interventions. Angiologiya i sosudistaya hirurgiya. 2016; 22: 112-118 [In Russ].

 

Abstract:

Introduction: the role of intracerebral stenosis of brain arteries in the development of postoperative strokes in patients with extensive atherosclerosis remains unresolved, and in clinical practice, magnetic resonance angiography (MRA) of cerebral arteries is not carried out routinely to predict the risk of postoperative cerebrovascular disorders.

Aim: was to identify factors of MRA of intracerebral arteries essential for prognosis of ischemic strokes in postoperative period of angiosurgical interventions and in acute period of myocardial infarction (AMI), from the quantitative processing of brain MRA recruited from the MRI — MRA register.

Materials and methods: results of brain MRA of 195 patients with extensive atherosclerosis carried out before cardio- or angiosurgical interventions were analyzed. Of these, three had an ischemic stroke after carotid endarterectomy, three — after CABG operations, and five — after surgical treatment of thoracic aortic aneurysms, on 2-5 day after surgery. We also studied results of brain MRA in five patients who developed an episode of ischemic brain stroke in the acute period of acute myocardial infarction. In all cases of circulatory disorders were localized in the region of middle cerebral artery (MCA). Everyone was given a time-of-flight MRA with reconstruction of three-dimensional anatomical picture of cerebral arteries. The index of gradient of narrowing of arterial lumen (GNL) of artery was calculated as the ratio of the difference in the area of artery at stenosis and at nearest proximal non-stenosed level, to the distance between them, along the course of the vessel: GNL={(Snorm–Sstenosis)/Dnorm–stenosis}, mm2/mm.

Results: analyzing the visual picture of brain MRA in patients, the sign of critical narrowing of MCA for >50% was observed in all five patients with acute ischemic stroke concomitant with acute myocardial infarction. In all 11 patients who developed postoperative stroke, the visual picture of MCA stenosis was bilateral, more pronounced on the side of the ischemic disorder after the operation. When using the GNL index, it was obvious that ischemic stroke developed only when the stenosis was more sharp than GSP >1,05 mm2/mm. Of five patients who showed signs of MCA stenosis but did not have postoperative stroke, four took doses of 250 mg/day or more of ethylmethylhydroxypyridine succinate (mexidol) for more than a month at the outpatient stage. The sensitivity of MRA preoperative sign of MCA stenosis in relation to postoperative ischemic stroke was 100% in all groups, the specificity and diagnostic accuracy was 97,5%, the predictability of a positive conclusion was 62,5-75%, and the predictability of a negative conclusion was 97-99%.

Conclusion: technology for evaluating the gradient of narrowing of arterial lumen in the area of atherosclerotic stenosis of intracerebral arteries in patients with extensive atherosclerosis allows predicting the risk of postoperative stroke. Gradient of narrowing of arterial lumen index for atherosclerotic middle cerebral artery over 1,05 mm2/mm in patients with extensive atherosclerosis predicts increased risk of strokes in postoperative period, or as a complication of acute myocardial infarction. Long-term preoperative injection of mexidol probably reduces the risk of postoperative stroke in extensive atherosclerosis.

  

 

References

1.     Louyenko VB, Doudarev VYe, Sorokina YeA. Diagnosis of ishemic stroke reasons early after the surgery in patients with occlusive atherosclerosis of brachiocephalic arteries. Siberian medical journal (Tomsk). 2009; 24(4-2): 62-64 [In Russ].

2.     Filimonova PA, Volkova LI, Alasheev AM, Grichuk EA. In hospital stroke in patients after cardiovascular surgery. Annals of clinical and experimental neurology. 2017; 11(1): 28-33 [In Russ].

3.     Kamenskaya OV, Loginova IYu, Klinkova AS, et al. Predictors of neurological complications during surgical treatment of the ascending aorta and aortic arch chronic dissection. S.S.Korsakov Journal of neurology and psychiatry. 2018. 118(7): 12-17 [In Russ].

https://doi.org/10.17116/jnevro20181187112

4.     Bilalova RR, Ibragimova GZ, Zaytseva AR, et al. Combined acute cerebrovascular disease and myocardial infarction treatment experience. Bulletin of Current Clinical Medicine. 2018; 11(5): 16-22 [In Russ].

https://doi.org/10.20969/VSKM.2018.11(5).16-22

5.     Berns SA, Zykova DS, Zykov MV, et al. The Role of Multifocal Atherosclerosis in Realization of New Cardiovascular Complications During One Year After Non ST-Elevation Acute Coronary Syndrome. Cardiologia. 2013; 53(8): 15-23 [In Russ].

6.     Garganeeva AA, Tukish OV, Kuzheleva EA, et al. Portrait of the patient with myocardial infarction over a 30-year period. Clinical medicine. 2018; 96(7): 641-647 [In Russ].

https://doi.org/10.18821/0023-2149-2018-96-7-641-647

7.     Echahidi N, Pibarot P, O'hara G, Mathieu P. Pathogenesis, Prophylaxis and treatment of atrial fibrillation after cardiac surgery interventions. Pathology of circulation and cardiac surgery. 2014; 18(3): 87-96 [In Russ].

8.     Karetnikova VN, Kalaeva VV, Evseeva MV, et al. Chronic renal disease in evaluation of course of postinfarction period. Clinical medicine. 2017; 95(6): 563-570 [In Russ].

https://doi.org/10.18821/0023-2149-2017-95-563-570

9.     Arous EJ, Simons JP, Flahive JM, et al. National variation in preoperative imaging, carotid duplex ultrasound criteria, and threshold for surgery for asymptomatic carotid artery stenosis. J.Vasc.Surg. 2015; 62(4): 937-944.

https://doi.org/10.1016/j.jvs.2015.04.438

10.   Belichenko OI, Dadvani SA, Abramova NN, Ternovoi SK. Magnetic resonance tomography in diagnosis of cerebrovascular diseases. Moscow. Vidar Publ.Co. 1998. 112P [In Russ].

11.   Fox AJ. Carotid endartectomy trials. Neuroimaging Clin N Am. 1996; 6(4): 931-938.

12.   Pokrovsky AV, Beloyartsev DF, Talybly OL. Analysis of remote results of eversion carotid endarterectomy. Angiology and vascular surgery. 2014; 20(4): 100-108 [In Russ].

13.   Bobrikova EE, Maksimova AS, Plotnikov MP, et al. Simultaneous cerebral MRI and MR-angiographic study of carotid arteries as screening technique for high-risk carotid atherosclerosis. Siberian medical journal (Tomsk). 2015; 30(4): 49-56 [In Russ].

14.   Purinya BA, Kasyanov VA. Biomechanics of large blood vessels of man. Riga: Zinatne Publ., 1980. 260P [In Russ].

15.   Pedly T. Haemodynamic of large blood vessels. Moscow. Mir Publ., 1983. 400P. [In Russ].

16.   Ussov WYu, Maksimova AS, Sinitsyn VE, et al. Gradient of luminal narrowing of internal carotid artery on atherosclerotic plaque as risk factor for cerebral ischemic damage. Russian Journal of Cardiology. 2019; 24(12): 62-69 [In Russ].

https://doi.org/10.15829/1560-4071-2019-12-62-69

17.   Ragino YuI, Volkov AM, Chernyavskyi AM. Stages of atherosclerotic plaque development and unstable plaque types: pathophysiologic and histologic characteristics. Russ. J.Cardiol. 2013; 5 (103): 88-95 [In Russ].

18.   Medixant. RadiAnt DICOM Viewer [Software]. Version 2020.1. Mar 9, 2020.

URL: https://www.radiantviewer.com

19.   Lomivorotov VV, Efremov SM, Pokushalov EA, Boboshko VA. Atrial fibrillation after cardiac surgery operations: pathiphysiology and methods of prophylaxis. Bulletin of anesthesiology and reanimatology. 2017; 14(1): 58-66 [In Russ].

20.   Chernyavskiy AM, Kalybekova AT. Comparative characteristics of biatrial and left atrial ablation in surgical treatment of long-standing persistant atrial fibrillation in patients with concomitant disease. Annals of arrhythmology. 2019; 16(4): 194-03 [In Russ].

21.   Gorokhov AS, Kozlov BN, Kuznetsov MS, Shipulin VM. Concomitant atherosclerosis of carotid and coronary arteries: choice of surgical tctics based on functional reserves of brain. Complex problems of cardiovascular diseases. 2013; (3): 50-56 [In Russ].

22.   Bukhovets IL, Maksimova AS, Plotnikov MP, et al. Ultrasonographic control of cerebral blood flow in patients with stenosis of brachiocephalic arteries before and after carotid endarterectomy. Angiology and vascular surgery. 2018; 24(1): 66-71 [In Russ].

23.   Kokov LS. Rentgeno-surgical methods of diagnosis and treatment of cardiovascular diseases. Urgent medical service. N.V. Sklifosovsky journal. 2013; (1): 23-27 [In Russ].

24.   Prokhorova ES, Kizimenko NN, Prokhorov SI. Magnetic resonance angiography in diagnosis of intracranial aneuisms. Medical Visualisation. 2005; (5): 105-108 [In Russ].

25.   Cho YD, Kim KM, Lee WJ, et al. Time-of-flight magnetic resonance angiography for follow-up of coil embolization with enterprise stent for intracranial aneurysm: usefulness of source images. Korean J Radiol. 2014; 15(1): 161-8.

https://doi.org/10.3348/kjr.2014.15.1.161

26.   Sato K, Yamada M, Kuroda H, et al. Time-of-Flight MR Angiography for Detection of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Moyamoya Disease. Am J Neuroradiol. 2016; 37(7): 1244-8.

https://doi.org/10.3174/ajnr.A4715

27.   Ballotta E, Angelini A, Mazzalai F, et al. Carotid endarterectomy for symptomatic low-grade carotid stenosis. J Vasc Surg 2014; 59: 25-31.

28.   Maximova AS, Bobrikova EE, Bukhovets IL, et al. The structure of atherosclerotic plaque as a defining factor of cerebrovascular reactivity in patients with carotid atherosclerosis. Siberian medical Journal (Tomsk). 2016; 31(2): 38-43 [In Russ].

29.   Baradaran H, Patel P, Gialdini G, et al Quantifying Intracranial Internal Carotid Artery Stenosis on MR Angiography. Am J Neuroradiol. 2017; 38(5): 986-990.

https://doi.org/10.3174/ajnr.A5113

30.   Lishchuk VA, Gazizova DSh, Frolov SV. Mathematical model of vessel bifurcation addressed to cardiovascular clinic. Problems of current sience and praxis. V.I.Vernadski University. 2009; 12(26): 127-131 [In Russ].

31.   Ussov WYu, Plotnikov MP, Del' OA, et al Contrastenhanced MRI of the aortic wall in the efficiency evaluation of ethyl methylhydroxypiridine succinate (mexidol) longterm use to prevent aorticprohression of aortic atherosclerosis. Bulletin of new medical technologies. 2018; 25(1): 125-132 [In Russ].

https://doi.org/10.24411/1609-2163-2018-15973

32.   Khazanov VA. Pharmacological regulation of energy metabolism. Experimental and clinical pharmacology. 2009; 72(4): 61-64 [In Russ].

 

 

Abstract:

Introduction: left atrial (LA) volumes measured during different phases of the cardiac cycle can be used for the evaluation of the LA functional properties before and after catheter ablation (CA). Increase of LA ejection fraction (EF) supposed to be early and more sensitive marker of LA reverse remodeling process, than LA volume and can be important for assessing the effectiveness of CA.

Aim: was to estimate volumetric parameters and function of LV before and after cryo- and radiofrequency catheter ablation of pulmonary veins in patients with paroxysmal atrial fibrillation.

Materials and methods: 21 patients with paroxysmal atrial fibrillation (AF) were included in study. All patients underwent multidetector computed tomography (MDCT) of pulmonary veins (PV) and LA before CA and 12±2 months after CA. 3-dimensional images at phases 0%, 40%, 75% of the cardiac cycle were used to assess LA functional properties.

Results: LA maximal volume before CA was increased insignificantly in patients with AF recurrence (124,52±38,22 ml vs. 117,89±23,94 ml, p>0,05). In patients without recurrence after CA, LA volumes decreased slightly (LA max 115,31±20,13 ml, p>0,05, LA min 73,43±14,91 ml, p>0,05), while in patients with recurrence increased (LA max 130,88±25,20 ml, p<0,05, LA min to 94,92±31,75 ml, p<0,05). Global LA ejection fraction was less in patients without recurrence before CA (22,37%±4,69 vs. 31,31%±9,89, p=0,013), but increased significantly after CA, while in patients with recurrence global LA EF was without relevant changes (36,54%±3,27 vs. 28,89%±9,41, p=0,011).

Conclusion: improved left atrial mechanical function was demonstrated in patients without any recurrence after ablation. The anatomic and functional reverse remodeling was not significant in patients with atrial fibrillation recurrence.

  

 

References

1.     Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021; 16(2): 217-221.

https://doi.org/10.1177/1747493019897870

2.     Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021; 42(5): 373-498.

https://doi.org/10.1093/eurheartj/ehaa612

3.     Hindricks G, Sepehri Shamloo A, Lenarczyk R, et al. Catheter ablation of atrial fibrillation: current status, techniques, outcomes and challenges. Kardiol Pol. 2018; 76(12): 1680-1686.

https://doi.org/10.5603/KP.a2018.0216

4.     Artjuhina EA, Revishvili ASh. New technologies in the treatment of cardiac arrhythmias. Vysokotehnologichnaja medicina. 2017; 1: 7-15 [In Russ].

5.     Darby AE. Recurrent Atrial Fibrillation After Catheter Ablation: Considerations For Repeat Ablation And Strategies To Optimize Success. J Atr Fibrillation. 2016; 9(1): 1427.

https://doi.org/10.4022/jafib.1427

6.     Murray MI, Arnold A, Younis M, et al. Cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation: a meta-analysis of randomized controlled trials. Clin Res Cardiol. 2018; 107(8): 658-669.

https://doi.org/10.1007/s00392-018-1232-4

7.     Kuck KH, Brugada J, F?rnkranz A, et al. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med. 2016; 374(23): 2235-2245.

https://doi.org/10.1056/NEJMoa1602014

8.     Mathew ST, Patel J, Joseph S, et al. Atrial fibrillation: mechanistic insights and treatment options. Eur J Intern Med. 2009; 20(7): 672-81.

https://doi.org/10.1016/j.ejim.2009.07.011

9.     Vasamreddy CR, Lickfett L, Jayam VK, et al. Predictors of recurrence following catheter ablation of atrial fibrillation using an irrigated-tip ablation catheter. J Cardiovasc Electrophysiol. 2004; 15(6): 692-697.

https://doi.org/10.1046/j.1540-8167.2004.03538.x

10.   Tops LF, Bax JJ, Zeppenfeld K, et al. Effect of radiofrequency catheter ablation for atrial fibrillation on left atrial cavity size. Am J Cardiol. 2006; 97(8): 1220-1222.

https://doi.org/10.1016/j.amjcard.2005.11.043

11.   Tsao HM, Hu WC, Wu MH, et al. The impact of catheter ablation on the dynamic function of the left atrium in patients with atrial fibrillation: insights from four-dimensional computed tomographic images. J Cardiovasc Electrophysiol. 2010; 21(3): 270-277.

https://doi.org/10.1111/j.1540-8167.2009.01618.x

12.   Abhayaratna WP, Seward JB, Appleton CP, et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol. 2006; 47(12): 2357-2363.

https://doi.org/10.1016/j.jacc.2006.02.048

13.   Hoit BD. Left atrial size and function: role in prognosis. J Am Coll Cardiol. 2014; 63(6): 493-505.

https://doi.org/10.1016/j.jacc.2013.10.055

14.   Costa FM, Ferreira AM, Oliveira S, et al. Left atrial volume is more important than the type of atrial fibrillation in predicting the long-term success of catheter ablation. Int J Cardiol. 2015; 184: 56-61.

https://doi.org/10.1016/j.ijcard.2015.01.060

15.   Avelar E, Durst R, Rosito GA, et al. Comparison of the accuracy of multidetector computed tomography versus two-dimensional echocardiography to measureleft atrial volume. Am J Cardiol. 2010; 106(1): 104-109.

https://doi.org/10.1016/j.amjcard.2010.02.021

16.   K?hl JT, L?nborg J, Fuchs A, et al. Assessment of left atrial volume and function: a comparative study between echocardiography, magnetic resonance imaging and multi slice computed tomography. Int J Cardiovasc Imaging. 2012; 28(5): 1061-1071.

https://doi.org/10.1007/s10554-011-9930-2

17.   Hof I, Chilukuri K, Arbab-Zadeh A, et al. Does left atrial volume and pulmonary venous anatomy predict the outcome of catheter ablation of atrial fibrillation? J Cardiovasc Electrophysiol. 2009; 20(9): 1005-1010.

https://doi.org/10.1111/j.1540-8167.2009.01504.x

18.   Abecasis J, Dourado R, Ferreira A, et al. Left atrial volume calculated by multi-detector computed tomography may predict successful pulmonary vein isolation in catheter ablation of atrial fibrillation. Europace. 2009; 11(10): 1289-1294.

https://doi.org/10.1093/europace/eup198

19.   Amin V, Finkel J, Halpern E, et al. Impact of left atrial volume on outcomes of pulmonary vein isolation in patients with non-paroxysmal (persistent) and paroxysmal atrial fibrillation. Am J Cardiol. 2013; 112(7): 966-970.

https://doi.org/10.1016/j.amjcard.2013.05.034

20.   Lemola K, Sneider M, Desjardins B, et al. Effects of left atrial ablation of atrial fibrillation on size of the left atrium and pulmonary veins. Heart Rhythm. 2004; 1(5): 576-581.

https://doi.org/10.1016/j.hrthm.2004.07.020

21.   Park MJ, Jung JI, Oh YS, et al. Assessment of the structural remodeling of the left atrium by 64-multislice cardiac CT: comparative studies in controls and patients with atrial fibrillation. Int J Cardiol. 2012; 159(3): 181-186.

https://doi.org/10.1016/j.ijcard.2011.02.053

22.   Lemola K, Desjardins B, Sneider M, et al. Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function. Heart Rhythm. 2005; 2(9): 923-928.

https://doi.org/10.1016/j.hrthm.2005.06.026

23.   Perea RJ, Tamborero D, Mont L, et al. Left atrial contractility is preserved after successful circumferential pulmonary vein ablation in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2008; 19(4): 374-379.

https://doi.org/10.1111/j.1540-8167.2007.01086.x 

authors: 

 

Abstract:

Background: prolonged vasospasm of coronary arteries (CA) is quite often cause of myocardial infarction (MI) in young patients. As a rule, it is associated to drug-using, as an example, cocaine that among other things has systemic vasoconstrictive effect.

Material and methods: article describes the development of acute large myocardial infarction with ST elevation in a 50-year-old patient with no risk factors for cardiovascular complications (RF CVC), except for obesity 1 grade. Previously, she was observed with mild bronchial asthma and chronic allergic rhinitis, for which she used a nasal spray with xylometazoline at doses many times higher than the therapeutic ones for a long time. These conditions we consider to be a cause of her persistent coronary spasm, which led to acute coronary insufficiency and myocardial infarction.

Results: coronary angiography revealed multiple subtotal lesions in the basin of left coronary artery (LCA) and acute occlusion of right coronary artery (RCA), which was the source of MI. Patient underwent recanalization of occlusion and balloon angioplasty with partial restoration of blood flow. Intracoronary injection of isosorbide dinitrate led to recovery of arterial lumen in all segment except distal third where stenosis was ment to be atherosclerotic plaque and the the initial trigger of complete RCA obstruction. After stent implantation in the zone of stenosis and several intra-arterial injections of isosorbide dinitrate, RCA lumen was fully restored. During control angiography of left coronary artery basin, spasm was totally treated with full recovery of lumen of all previously defeated arteries.

During hospitalization period, pain did not recur; prolongedrelease oral nitrates (isosorbide mononitr 40 mg) were prescribed to prevent vasospasm. However, less than a 1,5 month, acute coronary syndrome recurred: the cause was a pronounced spasm of circumflex artery (Cx), that was treated by intracoronary injection of nitrates. Subsequently, therapy was changed: instead of nitrates, calcium channels blocking agents were recommended (CCB - felodipine 5 mg per day). During 9 months of observation, the pain did not recur.

Conclusion: this is the first case report of developed myocardial infarction due to an overdose of xylometazoline, described in the literature. It should be kept in mind, that in case of spastic lesions detected with coronary angiography, especially in young patients without risk factors for cardiovascular diseases, carefully obtaining of anamnesis  should be done, and nobody should neglect the intracoronary injection of low doses of nitrates even if blood pressure is low.

 

References

1.     Beijk MA, Vlastra WV, Delewi R, van de Hoef TP, Boekholdt SM, Sjauw KD, Piek JJ. Myocardial infarction with non-obstructive coronary arteries: a focus on vasospastic angina. Neth Heart J 2019; 27:237-45.

https://doi.org/10.1007/s12471-019-1232-7

2.     Beltrame JF, Crea F, Kaski JC, et al. International standardization of diagnostic criteria for vasospastic angina. Eur Heart J 2017; 38:2565-68.

https://doi.org/10.1093/eurheartj/ehv351

3.     Miyata K, Shimokawa H, Yamawaki T, et al. Endothelial vasodilator function is preserved at the spastic/inflammatory coronary lesions in pigs. Circulation 1999; 100:1432-1437.

4.     Hung MJ, Cherng WJ, Cheng CW, Li LF. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease. Am J Cardiol 2006; 97: 1429-1434.

5.     Ohyama K, Matsumoto Y, Takanami K, et al. Coronary adventitial and perivascular adipose tissue inflammation in patients with vasospastic angina. J Am Coll Cardiol 2018; 71: 414-425.

6.     Satake K, Lee JD, Shimizu H, Ueda T, Nakamura T. Relation between severity of magnesium deficiency and frequency of anginal attacks in men with variant angina. J Am Coll Cardiol 1996; 28: 897-902.

7.     Yasue H, Touyama M, Shimamoto M, Kato H, Tanaka S. Role of autonomic nervous system in the pathogenesis of Prinzmetal’s variant form of angina. Circulation 1974; 50: 534-539.

8.     Miyamoto S, Kawano H, Sakamoto T, et al. Increased plasma levels of thioredoxin in patients with coronary spastic angina. Antioxid Redox Signal 2004; 6: 75-80.

9.     Glueck CJ, Valdes A, Bowe D, Munsif S, Wang P. The endothelial nitric oxide synthase T-786c mutation, a treatable etiology of Prinzmetal’s angina. Transl Res 2013; 162: 64-66.

10.   Yoo SY, Kim J, Cheong S, et al. Rho-associated kinase 2 polymorphism in patients with vasospastic angina. Korean Circ J 2012; 42: 406-413.

11.   Shimokawa H, Sunamura S, Satoh K. RhoA/Rho-Kinase in the Cardiovascular System. Circ Res 2016; 118: 352-366.

12.   Kandabashi T, Shimokawa H, Miyata K, et al. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation 2000; 101: 1319-1323.

13.   Daniela L, Katja E. Wartenberg, MD, PhD. Xylometazoline Abuse Induced Ischemic Stroke in a Young Adult. The Neurologist 2011; 17: 41-43.

 

Abstract:

Introduction: pulmonary arterial hypertension (PAH) is a disease characterized by a progressive increase in pulmonary vascular resistance that leads to the development of right ventricular heart failure and premature death of patients. Today, there are several ways to create an atrial communication: balloon dilatation, Park procedure, balloon knife atrial septostomy, atrial septum stenting and implantation of fenestrated occluder.

The main problem with positioning of the device is that the atrial septum is not visible on fluoroscopy, where the stent is visible throughout. And the stent is not visible throughout on echocardiography, where the septum is visible. Exactly for this operation, the combination of echo- and fluoroscopic image in real time is very useful in order to accurately place in the middle at the level of stent in the septum and to avoid its dislocation with embolization of right or left heart chambers, or vessels of pulmonary and systemic circuit.

Material and methods: we present a case report of atrial septostomy with stent implantation into the atrial septum using the EchoNavigator® hybrid imaging system in a patient with pulmonary arterial hypertension.Surgical intervention was performed on a patient with PAH: atrial septostomy with intubation anesthesia under the control of fluoroscopy and transesophageal echocardiography (TEE) using the EchoNavigator® system. The procedure was performed using a Palmaz stent, that was implanted without additional fixation.

Results: patient with pulmonary hypertension underwent an atrial septostomy using the EchoNavigator® hybrid imaging system, which was used for positioning and implantation of stent into the atrial septum as quickly and accurately as possible. This surgical intervention significantly improved patient's clinical condition, cardiac hemodynamics and, accordingly, increased the quality of life.

Conclusion: atrial septostomy is a surgical method for patients with severe pulmonary arterial hypertension. Carrying out this operation under the control of the EchoNavigator® system with the function of hybrid imaging in real time greatly facilitated the procedure for positioning and implanting of stent, facilitated the safe implementation.

 

References

1.     Gali? N, Rubin L. Pulmonary arterial hypertension. Epidemiology, pathobiology, assessment and therapy. Journal of the American College of Cardiology. 2004; 43:1–90.

2.     Badesch DB, Abman SH, Simonneau G, et al. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest. 2007; 131:1918–28.

http://doi.org/10.1378/chest.06-2674

3.     Reichenberger F, Pepke-Zaba J, McNeil K, et al. Atrial seprostomy in the treatment of severe pulmonary arterial hypertension. Thorax. 2003; 58:797–800.

http://doi.org/10.1136/thorax.58.9.797

4.     Law M, Grifka RG, Mullins CE, et al. Atrial septostomy improves survival in select patients with pulmonary hypertension. Am Heart J. 2007; 153:779–84.

http://doi.org/10.1016/j.ahj.2007.02.019

5.     Kurzyna M, Dabrowski M, Bielecki D, et al. Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest. 2007; 131:977–83.

http://doi.org/10.1378/chest.06-1227

6.     Gorbachevsky SV, Belkina MV, Pursanov MG, et al. Atrial septostomy as a long bridge to lung transplantation in patients with idiopathic pulmonary arterial hypertension. J. Cardiovasc. Surg. 2012; 53:11.

7.     Alekyan BG, Gorbachevsky SV, Pursanov MG, et al. Atrial septal stenting in idiopathic pulmonary hypertension. Journal of thoracic and cardiovascular surgery. 2016; 58(5): 258-314 [In Russ].

8.     Schmaltz АА, Nishonov NА. Atrioseptostomy in patients with pulmonary hypertension. Journal of thoracic and cardiovascular surgery. 2015; 57(5): 18-25 [In Russ].

9.     Sandoval J, Gaspar J, Pena H, et al. Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension. Eur. Respir. J. 2011; 38: 1343–8.

http://doi.org/10.1183/09031936.00072210

10.   Chiu S, Zuckerman WA, Turner ME, et al. Balloon atrial septostomy in pulmonary arterial hypertension: Effect on survival and associated outcomes. J. Heart Transplant. 2015;34(3):376-80.

http://doi.org/10.1016/j.healun.2015.01.004

11.   Fraisse A, Chetaille P, Amin Z, et al. Use of Amplatzer fenestrated atrial septal defect device in a child with familial pulmonary hypertension. Pediatr. Cardiol. 2006; 27: 759–62.

12.   O’loughlin AJ, Keogh A, Muller DW. Insertion of a fenestrated Amplatzer atrial septostomy device for severe pulmonary hypertension. Heart Lung Circ. 2006; 15: 275–7.

http://doi.org/10.1016/j.hlc.2006.02.002

13.   Prieto LR, Latson LA, Jennings C. Atrial septostomy using a butterfly stent in a patient with severe pulmonary arterial hypertension. Cathet. Cardiovasc. Interv. 2006; 68: 642–7.

http://doi.org/10.1002/ccd.20745

14.   Althoff TF, Knebel F, Panda A, et al. Longterm follow-up of a fenestrated Amplatzer atrial septal occlude in pulmonary arterial hypertension. Chest. 2008; 133; 283–5.

http://doi.org/10.1378/chest.07-1222

15.   Troost E, Delcroix M, Gewillig M, et al. A modified technique of stent fenestration of the interatrial septum improves patients with pulmonary hypertension. Cathet. Cardiovasc. Interv. 2008; 73: 173–9.

https://doi.org/10.1002/ccd.21760

16.   Roy AK, Gaine SP, Walsh KP. Percutaneous atrial septostomy with modified butterfly stent and intracardiac echocardiographic guidance in a patient with syncope and refractory pulmonary arterial hypertension. Heart Lung Circ. 2013; 22(8):668–71.

https://doi.org/10.1016/j.hlc.2013.01.005

17.   Alekyan BG, Pursanov MG. Atrial septal stenting. Guide to endovascular surgery of the heart and blood vessels. 2008; 2:57–65 [In Russ].

18.   Sager JS, Ahya VN. Surgical therapies for pulmonary arterial hypertension. Clin. Chest Med. 2007; 28: 187–202.

https://doi.org/10.1016/j.ccm.2006.11.003

19.   Unger P, Stoupel E, Vachiery JL, et al. Atrial septostomy under transesophageal guidance in a patient with primary pulmonary hypertension and absent right superior vena cava. Intensive Care Med. 1996; 22:1410–11.

https://doi.org/10.1007/BF01709560

20.   Bidoggia H, Maciel JP, Alvarez JA. Transseptal left heart catheterization: usefulness of the intracavitary electrocardiogram in the localization of the fossa ovalis. Cathet. Cardiovasc. Diagn. 1991; 24:221–5.

https://doi.org/10.1002/ccd.1810240318

21.   Moscucci M, Dairywala IT, Chetcuti S, et al. Balloon atrial septostomy in end-stage pulmonary hypertension guided by a novel intracardiac echocardiographic transducer. Cathet. Cardiovasc. Interv. 2001; 52:530–4.

https://doi.org/10.1002/ccd.1116

22.   Sorajja P, Cabalka AK, Hagler DJ, et al. Long-term follow-up of percutaneous repair of paravalvular prosthetic regurgitation. J Am Coll Cardiol. 2011; 58:2218–2224.

https://doi.org/10.1016/j.jacc.2011.07.041

23.   Zorinas A, Janusauskas V, Davidavicius G, et al. Fusion of real-time 3D transesophageal echocardiography and cardiac fluoroscopy imaging in transapical catheter-based mitral paravalvular leak closure. Advances in Interventional Cardiology. 2017; 13(3):263-268.

https://doi.org/10.5114/aic.2017.70200

24.   Corti R, Biaggi P, Gaemperli O, et al. Integrated x-ray and echocardiography imaging for structural heart interventions. EuroIntervention. 2013; 9:863-869.

https://doi.org/10.4244/EIJV9I7A140

25.   S?ndermann SH, Biaggi P, Gr?nenfelder J, et al. Safety and feasibility of novel technology fusing echocardiography and fluoroscopy images during MitraClip interventions. EuroIntervention. 2014; 9:1210-1216.

https://doi.org/10.4244/EIJV9I10A203

 

Abstract:

Introduction: carboxyangiography does not come into extensive use nowadays, due to two fundamental reasons: the impossibility of getting an equitable to Iodinated Contrast Agents (ICA) quality of angiographic image without special angiography system software. Besides, labour intensity, continuance, and potential risks of the methodology of «hand-operated» injection of carbon dioxide. Carboxyangiography made by automatic injector CO2 appears a fundamentally new technique, free from pointed limitations.

Aim: was to inform possibilities and safety of carboxyangiography with automatic injector in different vascular basins.

Materials and methods: article presents data on possibilities and safety of performing carboxyangiography of various vascular basins, based on the analysis of world literature data. Data on indications and contraindications, on  features of this technique are presented. Article also provides clinical examples of such interventions as: revascularization of various peripheral basins (renal arteries, arteries of lower limbs, veins of upper limbs), primary and secondary interventions for abdominal aortic aneurysms (EVAR, diagnostics of endoleaks), formation and disconnection of various fistulas and shunts (TIPS, correction of fistulas and AVMs), interventions for gastrointestinal bleedings, implantation of cava filters, as well as a number of diagnostic procedures.

Conclusions: carboxyangiography with the use of the automatic injector can be performed for diagnostic and treatment endovascular interventions, as well in high operation risk patients with contrast-induced nephropathy (CIN) or/and ICA allergy. In case of use of automatic injector and special angiographic software, image quality is highly competitive with ICA contrast-enhanced imaging.

 

References

1.     Carelli HH, Sordelli E. A new procedure for examining the kidney. Rev Asoc Med Argent. 1921;34:18-24.

2.     Colle G. Sugli effetti della introduzione di gas in circulo. Arch. Ital. di chir. 1924;9:419-453.

3.     Moor RM, Braselton Jr CW. Injections of air and of carbon dioxide into a pulmonare vein. Annals of Surgery. 1940;112(2):212-218.

https://doi.org/10.1097/00000658-194008000-00004

4.     Hodiev JeM. Contrasting of heart cavities with carbon dioxide. Vestnik rentgenologii i radiologii. 1965;5:8-11 [In Russ].

5.     Hodiev JeM, Mazaev VP. Coronary angiography with carbon dioxide injected into the heart cavity. Jeksperimental'naja hirurgija i anesteziologija. 1967;2:22-25 [In Russ].

6.     Tihonov KB. Possibility and prospects of studying the cardiovascular system using a gas environment. Voprosy rentgenologii i onkologii. 1958;3:61-66 [In Russ].

7.     Antonov OS, Mezencev GD, Blau JuI, Konovalov ED. Carbon dioxide angiocardiography for the diagnosis of congenital and acquired heart defects. Materialy pervoj oblastnoj konferencii rentgenologov i radiologov. 1964;5-8 [In Russ].

8.     Shipovskij VN, Kurbanov RV, Saakjan AM, Marov KB. Carboxyangiography is a new type of contrast enhancement in angiographic practice. First clinical experience. Angiologija i sosudistaja hirurgija. 2010;16:73-82 [In Russ].

9.     Shipovskij VN, Zolkin VN, Kurbanov RV et al. Using carbon dioxide as a contrast agent in aortoarteriography. Vestnik RGMU. 2011;6:16–20 [In Russ].

10.   Derkach VV. Using of an automatic CO2 injector in patients with critical lower limb ischemia. Angiologija i sosudistaja hirurgija. 2018;24:133-135 [In Russ].

11.   Derkach VV. A case report of superficial femoral artery stenting in a patient with critical limb ischemia and chronic kidney disease under the control of carboxyangiography. Angiologija i sosudistaja hirurgija. 2018;24:133 [In Russ].

12.   Maksimov AV, Makarimov JeSh, Glinkin VV et al. Experience in the use of carbon dioxide in angiography. Prakticheskaja med icina. 2015;1(89):97-100 [In Russ].

13.   Zatevahin II, Kokov LS, Shipovskij VN et al. Diagnostics and endovascular treatment of arterial insufficiency of lower limbs. M.: RAN. 2019;244 [In Russ].

14.   Back MR, Caridi JG, Hawkins IF Jr, Seeger JM. Angiography with carbon dioxide (CO2). Surgical Clinics of North America. 1998;78(4):575-591.

https://doi.org/10.1016/S0039-6109(05)70335-2

15.   Ehrman KO, Taber TE, Gaylord GM, Brown PB. et al. Comparison of diagnostic accuracy with carbon dioxide versus iodinated contrast material in the imaging of hemodialysis access fistulas. Journal of Vascular and Interventional Radiology. 1994;5(5):771-775.

https://doi.org/10.1016/S1051-0443(94)71599-2

16.   Cronin P, Patel JV, Kessel DO, Robertson I, McPherson SJ. Carbon dioxide angiography: a simple and safe system of delivery. Clinical Radiology. 2005;60(1): 123-125.

https://doi.org/10.1016/j.crad.2004.05.005

17.   Mascoli C, Faggioli G, Gallitto E. et al. Standardization of a Carbon Dioxide Automated System for Endovascular Aortic Aneuryzm Repair. Annals of Vascular Surgery. 2018;51:160-169.

18.   Caridi JG, Cho KJ, Fauria C, Eghbalieh N. Carbon dioxide digital subtraction angiography (CO2 DSA): a comprehensive user guide for all perators. Vascular Disease Management. 2014;11(10):221-256.

 

Abstract:

Aim: was to evaluate the feasibility and effectiveness of using transperineal access for sanitation of «deep» exudative pelvic lesions in patients after gynecological operations.

Materials and methods: results of percutaneous drainage with perineal access of «deep» – perirectal postoperative exudative pelvic lesions in 18 patients after extirpation of the uterus in oncological pathology were subjected to retrospective analysis. Exudative formations in the pelvis were detected during continuous postoperative ultrasound screening of operated patients starting from 3rd day of the postoperative period, taking into account clinical data.

Perineal access was used in patients with verification of the nature of the pathological contents and subsequent drainage of the pathological exudation zone by 8fr drains with form memory using Seldinger method.

Results: manipulation was successful in all 18 patients. In 5 cases, a lyzed pelvic hematoma was drained, and in 13 cases, an abscess was drained. In three cases, the connection of the abscess cavity with the lumen of the rectum was revealed. There were no complications due to manipulation. The drainage period was 6-7 days for hematoma and 10-16 days for abscess without internal fistula. If there is a connection with the lumen of the rectum, the drainage period was 21 days, the drainage was removed with x-ray confirmed closure of the internal fistula.

Conclusion: our first positive experience of using transperineal access for the rehabilitation of intrapelvic exudative complications of the postoperative period in oncogynecological patients inspires cautious optimism, expands the arsenal of mini-invasive methods of treatment of intra-pelvic postoperative exudative complications, but undoubtedly requires further research for optimal integration of the technique into the practice of oncogynecology and x-ray surgery departments.

 

References

1.     Lorenz JM, Al-Refaie WB, Cash BD, et al. ACR appropriateness criteria radiologic management of infected fluid collections. J Am Coll Radiol 2015; 12: 791–799.

2.     Hynes D, Aghajafari P, Janne d'Othee B. Role of Interventional Radiology in the Management of Infection. Semin Ultrasound CT MR. 2020 Feb; 41(1):20-32.

3.     Kadrev AV. Punctures under the control of echography in the diagnosis and treatment of pelvic fluid in women. Cand. of med. sci. diss. Мoscow. 2007: 159 [In Russ].

4.     Albuquerque A, Pereira E. Current applications of transperineal ultrasound in gastroenterology. World J Radiol. 2016; 8(4): 370-377.

5.     Sperling DC, Needleman L, Eschelman DJ, Hovsepian DM, Lev-Toaff AS. Deep pelvic abscesses: transperineal US-guided drainage. Radiology. 1998; 208(1):111-5.

6.     Golferi R, Cappelli A. Computed tomography-guided percutaneous abscess drainage in coloproctology: review of the literature. Tech Coloproctol. 2007; 11: 197–208.

7.     Khurrum Baig M, Hua Zhao R, Batista O, et al. Percutaneous postoperative intra-abdominal abscess drainage after elective colorectal surgery. Tech Coloproctol. 2002; 6: 159–164.

8.     De Kok BM, Marinelli A.W.K.S., Puylaert J.B.C.M., et. al. Image-guided posterior transperineal drainage for presacral abscess: An analysis of 21 patients. Diagn Interv Imaging. 2019; 100(2): 77-83.

 

Abstract:

Introduction: up to the present day, there were no published multicenter randomized researches, that could compare combined concept of thrombectomy, including different methods of stent-retrievers traction with elements of aspiration and thrombolysis. There is no data on the effect of embolic complications after extraction of thrombus from cerebral arteries on outcomes of treatment.

Aim: was to increase the effectiveness of treatment of patients with ischemic stroke basing on a comparison of results of various methods of endovascular thrombectomy from cerebral vessels and intravenous thrombolysis, and on the base of assessment of effect of distal embolism on treatment outcomes in acute period of ischemic stroke.

Materials and methods: we carried out statistical analysis of results of different methods of thrombectomy in 75 patients and intravenous thrombolysis in 75 patients in acute phase of ischemic stroke. Effect of embolic complications after thrombectomy on outcomes of treatment of ischemic stroke was determined.

Results: groups of patients were comparable in age, neurological deficit, sex, localization and stroke subtype. The first group is burdened by the proportion of documented cerebral artery occlusion, diabetes mellitus and ischemic stroke in anamnesis. Differences in deaths and disability rates were not reliable. Thrombectomy demonstrated neurological deficit regression at all evaluation intervals, as well as the superiority of 2 times at achievement of functionally independent outcome in comparison with intravenous thrombolysis group.

Conclusions: a concept to thrombectomy, that supposes different methods of use of stent-retrievers and aspiration demonstrates better functional outcomes in treatment of ischemic stroke in the acute phase compared with intravenous thrombolysis. Embolic complications of reperfusion treatment adversely affect ischemic stroke outcomes and should be considered as a factor requiring minimization.

 

References

1.     Domashenko MA, Maksimova MY, Gafarova ME et al. The personification of reperfusion therapy approaches for ischemic stroke. Annals of Clinical and Experimental Neurology. 2017;11(1):7-13 [In Russ].

2.     Powers W, Rabinstein A, Ackerson T et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018; 49(3):e46-e99.

https://doi.org/10.1161/STR.0000000000000158

3.     Sandercock P, Wardlaw JM, Lindley RI et al.; IST-3 collaborative group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. The Lancet. 2012;379(9834):2352-2363.

https://doi.org/10.1016/S0140-6736(12)60768-5

4.     Riedel C, Zimmermann P, Jensen-Kondering U et al. The Importance of Size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke. 2011;42(6):1775-1777.

https://doi.org/10.1161/STROKEAHA.110.609693

5.     Kharitonova T, Ahmed N, Thoren M et al. Hyperdense Middle Cerebral Artery Sign on Admission CT Scan – Prognostic Significance for Ischaemic Stroke Patients Treated with Intravenous Thrombolysis in the Safe Implementation of Thrombolysis in Stroke International Stroke Thrombolysis Register. Cerebrovascular Diseases. 2008;27(1): 51-59.

https://doi.org/10.1159/000172634

6.     Thomalla G, Kruetzelmann A, Siemonsen S et al. Clinical and Tissue Response to Intravenous Thrombolysis in Tandem Internal Carotid Artery/Middle Cerebral Artery Occlusion. Stroke. 2008;39(5):1616-1618.

https://doi.org/10.1161/STROKEAHA.107.504951

7.     Turc G, Bhogal P, Fischer U et al. European Stroke Organisation (ESO) – European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke. Journal of NeuroInterventional Surgery. 2019;11(6):535-538.

https://doi.org/10.1136/neurintsurg-2018-014568

8.     Fransen P, Berkhemer O, Lingsma H et al. Time to Reperfusion and Treatment Effect for Acute Ischemic Stroke: A Randomized Clinical Trial. JAMA Neurology. 2016;73(2):190-196.

https://doi.org/10.1001/jamaneurol.2015.3886

9.     Goyal M, Demchuk A, Menon B et al. Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke. New England Journal of Medicine. 2015;372(11): 1019-1030.

https://doi.org/10.1056/NEJMoa1414905

10.   Campbell B, Mitchell P, Kleinig T et al. Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection. New England Journal of Medicine. 2015;372(11): 1009-1018.

https://doi.org/10.1056/NEJMoa1414792

11.   Bracard S, Ducrocq X, Mas J et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. The Lancet Neurology. 2016;15(11):1138-1147.

https://doi.org/10.1016/S1474-4422(16)30177-6

12.   Jovin T, Chamorro A, Cobo E et al. Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke. New England Journal of Medicine. 2015;372(24):2296-2306.

https://doi.org/10.1056/NEJMoa1503780

13.   Muir K, Ford G, Messow C et al. Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial. Journal of Neurology, Neurosurgery & Psychiatry. 2016;88(1):38-44.

https://doi.org/10.1136/jnnp-2016-314117

14.   Saver J, Goyal M, Bonafe A et al. Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke. New England Journal of Medicine. 2015;372(24):2285-2295.

https://doi.org/10.1056/NEJMoa1415061

15.   McCarthy D, Diaz A, Sheinberg D et al. Long-Term Outcomes of Mechanical Thrombectomy for Stroke: A Meta-Analysis. The Scientific World Journal. 2019; 2019:1-9.

https://doi.org/10.1155/2019/7403104

16.   Logvinenko RL, Domashenko MA, Frantsevich AM et al. Choice of reperfusion strategy in acute period of ischemic stroke. Journal Diagnostic & interventional radiology. 2018;12(2):77-84 [In Russ].

17.   Semitko SP, Analeev AI, Azarov AV et al. Results of primary endovascular treatment of patients with acute ischemic stroke and high risk or contraindication for thrombolytic therapy. Journal Diagnostic & interventional radiology. 2018;12(4):52-58. [In Russ]

18.   Kang D, Kim B, Heo J et al. Effect of balloon guide catheter utilization on contact aspiration thrombectomy. Journal of Neurosurgery. 2018;1-7.

https://doi.org/10.3171/2018.6.JNS181045

19.   Maegerlein C, Monch S, Boeckh-Behrens T et al. PROTECT: PRoximal balloon Occlusion TogEther with direCt Thrombus aspiration during stent retriever thrombectomy – evaluation of a double embolic protection approach in endovascular stroke treatment. Journal of NeuroInterventional Surgery. 2017;10(8):751-755.

https://doi.org/10.1136/neurintsurg-2017-013558

20.   Goto S, Ohshima T, Ishikawa K et al. A Stent-Retrieving into an Aspiration Catheter with Proximal Balloon (ASAP) Technique: A Technique of Mechanical Thrombectomy. World Neurosurgery. 2018;109:e468-e475.

https://doi.org/10.1016/j.wneu.2017.10.004

21.   Lee D, Sung J, Kim S et al. Effective use of balloon guide catheters in reducing incidence of mechanical thrombectomy related distal embolization. Acta Neurochirurgica. 2017;159(9):1671-1677.

https://doi.org/10.1007/s00701-017-3256-3

22.   Stampfl S, Pfaff J, Herweh C et al. Combined proximal balloon occlusion and distal aspiration: a new approach to prevent distal embolization during neurothrombectomy. Journal of NeuroInterventional Surgery. 2016;9(4):346-351.

https://doi.org/10.1136/neurintsurg-2015-012208

23.   Maus V, Behme D, Kabbasch C et al. Maximizing First-Pass Complete Reperfusion with SAVE. Clinical Neu-roradiology. 2017;28(3):327-338.

https://doi.org/10.1007/s00062-017-0566-z

24.   Jadhav A, Aghaebrahim A, Horev A et al. Stent Retriever-Mediated Manual Aspiration Thrombectomy for Acute Ischemic Stroke. Interventional Neurology. 2016;6(1-2):16-24.

https://doi.org/10.1159/000449321

25.   Patent RUS №2670193/ 18.10.18. Byul. №29. Logvinenko RL, Arablinskiy AV, Domashenko MA et al. The method of endovascular combined thrombectomy from cerebral arteries. [In Russ.] Available at (23.09.2019):

http://www1.fips.ru/registers-doc-view/fips_servlet?DB=RUPAT&rn=1407&DocNum-ber=2670193&TypeFile=html

26.   Hwang Y, Kang D, Kim Y, Kim Y, Park S, Suh C. Outcome of forced-suction thrombectomy in acute intracranial internal carotid occlusion. J Neurointervent Surg. 2012;5(suppl 1):i81-i84.

https://doi.org/10.1136/neurintsurg-2012-010277

27.   Turk A, Spiotta A, Frei D, Mocco J, Baxter B, Siddiqui A et al. O-002 Initial Clinical Experience with the ADAPT technique: A Direct Aspiration first Pass Technique for Stroke Thrombectomy. J Neurointervent Surg. 2013;5(Suppl 2):A1.2-A1.

https://doi.org/10.1136/neurintsurg-2013-010870.2

28.   Volodukhin M.U. Roentengen-endovascular method of cerebral flow restoration in acute tandem occlusion of the internal carotid artery with embolism development in middle cerebral artery. Kazan medical journal. 2016;97(3): 457-460 [In Russ].

https://doi.org/10.17750/KMJ2016-457

29.   Geroulakos G, Ramaswami G, Nicolaides A et al. Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. British Journal of Surgery. 1993;80(10): 1274-1277.

https://doi.org/10.1002/bjs.1800801016

30.   Adams H, Bendixen B, Kappelle L et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41.

https://doi.org/10.1161/01.str.24.1.35

31.   Logvinenko RL, Kokov LS, Shabunin AV, Arablinskiy AlV, Tsurkan VA. Analysis of a modified method for combined removal of throbus from blood vessels of the brain in the treatment of acute ischemic stroke. REJR. 2020; 10 (1):159-177 [In Russ].

https://doi.org/10.21569/2222-7415-2020-10-1-159-177

32.   Chen C, Parsons M, Levi C, Spratt N, Miteff F, Lin L et al. Exploring the relationship between ischemic core volume and clinical outcomes after thrombectomy or thrombolysis. Neurology. 2019;93(3):e283-e292.

https://doi.org/10.1212/WNL.0000000000007768

33.   Southerland A, Johnston K. Considering hyperglycemia and thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial. Annals of the New York Academy of Sciences. 2012;1268(1):72-78.

https://doi.org/10.1111/j.1749-6632.2012.06731.x

34.   Lansberg M, Thijs V, Bammer R, Kemp S, Wijman C, Marks M et al. Risk Factors of Symptomatic Intracerebral Hemorrhage After tPA Therapy for Acute Stroke. Stroke. 2007;38(8):2275-2278.

https://doi.org/10.1161/STROKEAHA.106.480475

authors: 

 

Abstract:

Aim: was to develop a pharmacokinetic model and simulate the kinetics of radiopharmaceuticals in the human body for the functional study of the hepatobiliary system using the dynamic scintigraphy method.

Materials and methods: the paper uses the method of compartmental modeling of drug pharmacokinetics (pharmacokinetic modeling) and results of dynamic scintigraphy of the hepatobiliary system of a patient with choledocholithiasis before and after endoscopic papillosphincterotomy to identify model parameters.

Results: various methods of model parameters identification based on quantitative data of hepatobiliscintigraphy are proposed. Results of pharmacokinetic modeling for dynamic scintigraphy of the hepatobiliary system in cases of non-visualizing gallbladder (four-compartment model) and visualizing gallbladder with stimulation of its emptying (five-compartment model) are presented and analyzed.

Conclusion: results of pharmacokinetic modeling presented in the article (calculated quantitative parameters and time activity curves) are in good agreement with the clinical data of dynamic scintigraphy of the hepatobiliary system in normal and pathological conditions. From the comparative analysis of model time activity curves for different zones of interest, the time of stimulation of gallbladder emptying is justified, which normally should be 35-40 min from the beginning of the study.

 

References

1.     National guide on radionuclide diagnostics. In 2 volumes. Vol. 2. (Ed. by Yu.B. Lishmanov, V.I. Chernov). Tomsk: STT, 2010; 418 [In Russ].

2.     Rassam F, Zhang T, Cieslak KP et al. Comparison between dynamic gadoxetate-enhanced MRI and 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function. European Radiology. 2019; 29: 5063-5072.

3.     Lambie H, Cook AM, Scarsbrook AF et al. Tc99m-hepatobiliary iminodiacetic acid (HIDA) scintigraphy in clinical practice. Clinical Radiology. 2011; 66: 1094-1105.

4.     Gupta M, Choudhury PS, Singh S, Hazarika D. Liver functional volumetry by Tc99m mebrofenin hepatobiliary scintigraphy before major liver resection: A game changer. Indian Journal of Nuclear Medicine. 2018; 33: 277-283.

5.     Sergienko VI, Dzhelliff R, Bondareva IB. Applied pharmacokinetics: main provisions and clinical application. М.: Izd-vo RAMN, 2003; 208 [In Russ].

6.     Bellman R. Mathematical methods in medicine. (Ed. by L.N. Belykh). M.: Mir, 1987; 200 [In Russ].

7.     Kotina ED. Program complex «Diagnostics» for processing radionuclide research. Vestnik of Saint Petersburg University. 2010; 2: 100-113 [In Russ].

8.     Matveev AV, Korneeva MYu. Features of modeling of kinetics of radiopharmaceuticals in functional research of the gepatobiliarny system. Herald of Omsk University. 2015; 3: 42-51 [In Russ].

9.     Yusupova AF, Valiullina NM, Odincova AH. Dynamic scintigraphy of the hepatobiliary system in the diagnosis of postcholecystectomy syndrome. Kazan Medical Journal. 2007; 88 (1): 44-46 [In Russ].

10.   Hazanov AI. Functional diagnostics of liver diseases, 2nd ed. М.: Medicina, 1988; 304 [In Russ].

11.   Matveev AV, Noskovec DYu. Pharmacokinetic modeling and dosimetric planning of radioiodine therapy of thyrotoxicosis. Herald of Omsk University. 2014; 4: 57-64 [In Russ].

12.   Huk R, Dzhivs TA. Direct search for solutions to numerical and statistical problems. М.: Mir, 1961; 219 [In Russ].

13.   Kudryashova NE. Radionuclide diagnostics in emergency conditions. Dr. med. sci. diss.. Moscow. 2009; 325 [In Russ].

14.   Kudryashova NE, Ermolov AS, Ivanov PA et al. Hepatobiliscintigraphy in the diagnosis of mechanical jaundice. Vestnik rentgenologii i radiologii. 2007; 3: 39-45 [In Russ].

15.   Rogal' ML, Novikov SV, Magomedbekov MM et al. Choice of surgical treatment tactics for patients with acute cholecystitis complicated by choledocholithiasis. Khirurgiya. Zhurnal imeni N.I. Pirogova. 2018; 4: 41-45 [In Russ].

16.   Hubutiya MSh, Kudryashova NE, Sinyakova OG et al. Use of radionuclide studies in the preparation of patients for liver transplantation and in the postoperative period. Transplantologiya. 2010; 1: 5-10 [In Russ].

 

Abstract:

Aim: was to make preclinical and imaging tests of the trans-1,2-diaminocyclohexane-N,N,N',N'-tetraacetic acid (DCTA) complex as a universal contrast agent for MRI and single-photon emission imaging, with Mn (Cyclomang) and 99mTc- (Cyclotech), respectively.

Material and Methods: the complex of trans-1,2-diaminocyclohexane-N,N,N',N'-tetraacetic acid (DCTA) was synthesized at the department of organic chemistry of National Research Tomsk Polytechnic university, using the original technology in the nanopowder phase using manganese (II) carbonate, or generator eluate 99mTc, and NaH2DCTA, resulting in a 0.5 M solution of Мn-DCTA or 99mTc-DCTA. LD50 values were determined in experiments on laboratory mice. A visualization study was performed in 4 cats and 3 dogs with malignant neoplasms of chest organs and in one dog with a tumor of the left pontocerebellar angle. All of them underwent consecutively MRI with contrast enhancement with Mn-DCTA and SPECT - with 99mTc-DCTA.

Results: for Cyclotech LD50 >18/ml/kg, for 0.5 M Mn-DCTA (Cyclomang) solution, the LD50 index significantly exceeds 16.9 ml/kg BW. Changes in the content of manganese in the blood plasma of rats when they were administered Mn-DCTA, did not occur. LD50 values allow us to assign the drug in accordance with Russian regulation GOST 12.1.007-76. to group 4 (low-hazard substances). In both cases, in the range of physiological pH, the thermodynamic stability constant is >19.3. In studies in animals with MRI, the enhancement index of T1-weighted spin-echo image of the tumor in all cases exceeded 1.7 (mean 1.82±0.10). When calculating the «tumor/back-ground» index for 99mTc-DCTA, it was 2.6-7.3 (mean 4.12±1.05).

Conclusion: DCTA complexes with manganese (II) - for enhancement in MRI and with 99mTc- for SPECT- have very close pharmacokinetic properties, are non-toxic, do not dissociate in physiological environments and can be further used for contrast enhancement in multimodal MRI-SPECT studies. Chelate agents of the 99mTc with thermodynamic stability constants over 16 may be employed in the nearest future as important source for the development of paramagnetic contrast agents binding Mn.

 

References

1.     Panov VO, Shimanovskiy NL. The diagnostic efficacy and safety of macrocyclic gadolinium-based magnetic resonance contrast agents. Russian J Radiol. 2017; 98(3): 159-166 [In Russ].

http://doi.org/10.20862/0042-4676-2017-98-3-159-166

2.     Shimanovskiy NL, Epinetov MA, Melnikov MYa. Molecular and nanopharmacology. Moscow, 2009; 624 [In Russ].

3.     National guidebook on nuclear medicine. Vol.1. Ed. by Lishmanov YuB, Chernov VI. Tomsk. STT Publ. 2010; 432 [In Russ].

4.     Litvinenko IV. The possibility of SPECT-CT in the diagnosis of coronary artery stenoses. Medical Visualization. 2015; (2): 53-66 [In Russ].

5.     Narkevich BYa, Ryzhkov AD, Komanovskaya DA et al. Estimation of radiation risks in SPECT/CT of skeletal bones. Medical Physics. 2019; 3 (83): 66-74 [In Russ].

6.     Madru R, Kjellman P, Olsson F et al. 99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes. J Nucl Med. 2012; 53(3): 459-463.

http://doi.org/10.2967/jnumed.111.092437

7.     Onoprienko AV, Kostenikov NA, Velichko OB, et al. Use of Fused Images Combining Contrast-Enhanced MRI and 99mTc-MIBI SPECT in Diagnosis of Recidive Gliomas. Medical Visualization. 2004; (5): 38-46 [In Russ].

8.     Onoprienko A.V., Velichko O.B., Minin S.M. et al. Imaging of a Successful Medical Treatment of a Multiforme Glioblastoma by Means of Combination of Contrast-enhanced MRI and SPECT with 99mTc-Technetril. Medical Visualization. 2006; (2); 99-103 [In Russ].

9.     Ussov WYu, Belyanin ML, Bezlepkin Al et al. Magnetic Resonance Imaging of Brain Involvement in Dogs Using Paramagnetic Contrast Enhancement with Mn(II)-DCTA. Bull.Exp.Biol.Med. 2016; 161: 715-718.

http://doi.org/10.1007/s10517-016-3492-1

10.   Belyanin ML, Fedoushchak TA, Filimonov VD et al. Solid-nanophase synthesis and evaluation of manganese (II) complex with diethylentriaminpentaacetic acid as contrast agent for magnetic resonance imaging. Siberian medical journal (Tomsk). 2008; 23(2): 33-36 [In Russ].

11.   Zevatskiy YuE, Samoilov DV. Empiric method of quantification of influence of dissolvent on dissociation constants of carbonic acids. Zhurnal organicheskoi chimii. 2008; 44(1): 59-68 [In Russ].

12.   Kaviani S, Shahab S, Sheikhi M, Ahmadianarog M. DFT study on the selective complexation of meso-2,3-dimercaptosuccinic acid with toxic metal ions (Cd2+, Hg2+ and Pb2+) for pharmaceutical and biological applications. Journal o f Molecular Structure. 2019; (1176): 901-907.

13.   Mironov AN. Guidelines for conducting preclinical research of drugs. M. Grit and К Publ.house. 2012; 944 [In Russ].

14.   Rossotti F, Rossotti X. Determination of stability constants and other equilibrium constants in solutions. M. Mir Publ.house. 1965; 564 [In Russ].

15.   Medixant. RadiAnt DICOM Viewer [Software]. Version 2020.1. Mar 9, 2020.

URL: https://www.radiantviewer.com

16.   Ehman EC, Johnson GB, Villanueva-Meyer JE et al. PET/MRI: Where might it replace PET/CT? J Magn Reson Imaging. 2017; 46(5): 1247-1262.

http://doi.org/10.1002/jmri.25711

17.   Hochhegger B, Alves GR, Irion KL et al. PET/CT imaging in lung cancer: indications and findings. J.Bras.Pneumol. 2015; 41 (3): 264-274.

http://doi.org/10.1590/S1806-37132015000004479

18.   Ansheles AA., Sergienko VB. Interpretation of myocardial perfusion SPECT with attenuation correction. Russian Journal of Radiology. 2020; 101(1): 6-18 [In Russ].

http://doi.org/10.20862/0042-4676-2020-101-1-6-18

19.   Ussov WYu., Sinitsyn VE., Obradovich V. et al. Patterns of cerebral blood flow reactivity in adenosine stress­test in patients with carotid stenosis, evaluated with MRI and 99mTc-HMPAO SPECT brain study. Russian Journal of Radiology.2000; 81 (6): 4-9 [In Russ].

20.   Berry DJ, Torres Martin de Rosales R, Charoenphun P, Blower PJ. Dithiocarbamate complexes as radiopharmaceuticals for medical imaging. Mini Rev Med Chem. 2012; 12(12): 1174-1183.

http://doi.org/10.2174/138955712802762112

21.   Burilova EA, Ziyatdinova AB, Zyavkina Yul, Amirov RR. Influence of waterso;uble polymers on the formation of Manganese(II) complexomated in solutions. I Complexes with EDTA. Research proceedings of the Kazan University. Natural Sceinces. 2013; 155(2); 10-25 [In Russ].

22.   Belyanin ML, Prvulovich M, Karpova GV et al. Synthesis and evaluation of mangapentetate as paramagnetic contrast agent for magnetic resonance imaging. Diagnostic and Interventional Radiology. 2008; 2(1): 75-86 [In Russ].

23.   Meerovich IG, Gulyaev MV, Meerovich GA et al. Study of contrast agents based on phthalocyanin derivatives for magnetic resonance imaging. Russian chemical journal. 2013. 57(2): 110-114 [In Russ].

24.   Ussov WYu, Belyanin ML, Kodina GE et al. Magnetic resonance imaging of myocardium with paramagnetic contrast enhancement with Mn-methoxyisobutylisonitrile (Mn-MIBI) in an experiment. Medical visualization. 2016; (1): 31-38 [In Russ].

25.   Ussov VYu, Bezlepkin Al, Kovalenko AYu et al. Preclinical study of paramagnetic contrast enhancement with Mn(II)-dimercaptosuccinate complex in magnetic resonance imaging of primary tumor and metastatic spread of breast cancer. Diagnostic Radiology and Radiation Therapy. 2020; (1 (11)): 70-77 [In Russ].

http://doi.org/10.22328/2079-5343-2020-11-1-70-77

26.   Ussov VYu, Belyanin ML, Filimonov VD et al. Theoretical basis and experimental study of the Mn(II) complex with hexamethylpropylenaminoxim as a paramagnetic contrast agent for visualization of malignant tumors. Diagnostic Radiology and Radiation Therapy. 2019; (2 (10)): 42-49 [In Russ].

http://doi.org/10.22328/2079-5343-2019-10-2-42-49

27.   Serebrennikov W. Chemistry of rare earth elements (scandium, yttrium, lanthanides). Tomsk. TSU Publ. House. 1959; 531 [In Russ].

28.   Batyreva VA, Kozik W, Serebrennikov W, Yakunina GM. Synthesis of compounds of rare earth elements. Tomsk. TSU Publ. House. 1983; 144 [In Russ].

29.   Ussov VYu, Belyanin ML, Bezlepkin Al etal. Evaluation of Manganese-trans-1,2-Diaminocyclohexane-N,N,N’,N’-tetraacetate Complex (Cyclomang) as Paramagnetic Contrast Agent for Magnetic Resonance Imaging. Eksperimentalnaya i klinicheskaya farmakologiya. 2013; 76(10): 32-38 [In Russ].

 

Abstract:

Diagnostic criteria for extranodal lymphoma (non-Hodgkin's lymphoma) are well known and described in the literature. However, primary extranodal lymphomas are rare and pose problems for differential diagnosis with primary or secondary lesions.

In the presented clinical case of a woman, 58 years old, with primary extranodal lymphoma of the stomach and spleen, an incorrect preoperative diagnosis was made: a tumor of the stomach and spleen abscess. It was mainly due to the presence of pain in the epigastric region and hospitalization for "severe acute biliary pancreatitis" in anamnesisd. Similar complaints and a "blurry" picture of manifestations of lymphoma did not allow her to be suspected preoperatively. The tumor nature of the focal lesion of the stomach was not in doubt, while the underestimation of MRI data, combined with the anamnesis, led to the erroneous diagnosis o f" spleen abscess". Patient underwent surgical operation: extended combined gastrectomy, distal resection of pancreas, splenectomy “en-bloc”, lymphadenectomy, cholecystectomy, “Roux-Y" reconstruction.

The clinical picture of extranodal lymphoma depends on its primary localization and the degree of its spread. Clinical manifestations of primary lymphoma of the stomach and spleen are often non­specific, therefore, against the background of previously transferred diseases of the hepatopancreatobiliary zone and their residual manifestations, an erroneous assessment of the situation is possible. In the presence of focal lesions, it is advisable to be more attentive to results of radiology examination, which can provide comprehensive information about their nature.

 

 

References

1.     WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., Thiele J. (Eds). Revised 4th edition. Lyon: IARC Press, 2017; 585.

2.     Manzella A, Borba-Filho P, D'Ippolito G, Farias M. Abdominal manifestations of lymphoma: spectrum of imaging features. ISRN Radiol. 2013; 2013: 483069.

http://doi.org/10.5402/2013/483069

3.     Lee W-K, Lau EWF, Duddalwar VA, et al. Abdominal manifestations of extranodal lymphoma: spectrum of imaging findings. American Journal of Roentgenology. 2008; 191(1): 198-206.

http://doi.org/10.2214/AJR.07.3146

4.     FSBI «National Medical Research Center of Oncology named after N.N. Blokhin »of the Ministry of Health of Russia Diagnostics and treatment. Types of diseases. Lymphomas, (date of access 08.07.20) [In Russ.].

https://www.ronc.ru/grown/treatment/diseases/limfomy/

5.     Psyrri A, Papageorgiou S, Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Annals of Oncology. 2008; 19(12): 1992-1999.

http://doi.org/10.1093/annonc/mdn525

6.     Ghai S, Pattison J, Ghai S et al. Primary gastrointestinal lymphoma: spectrum of imaging findings with pathologic correlation. Radiographics. 2007; 27(5): 1371-1388.

http://doi.org/10.1148/rg.275065151

7.     Juarez-Salcedo LM, Sokol L, Chavez JC, Dalia S. Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment. Cancer Control. 2018; 25(1): 1073274818778256.

http://doi.org/10.1177/1073274818778256

8.     NORD: National Organization for Rare Disorders. Rare Disease Database. Primary Gastric Lymphoma. Luh JY Nabavizadeh N, Thomas CR. Jr., (date of access 20.07.2020).

https://rarediseases.org/rare-diseases/primary-qastric-lymphoma

9.     De Jong PA, Van Ufford HMQ, Baarslag H-J et al. CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma. American Journal of Roentgenology. 2009; 192(3): 745-753.

http://doi.org/10.2214/AJR.08.1160

10.   Ingle SB, Hinge CR. Primary splenic lymphoma: Current diagnostic trends. World J Clin Cases. 2016 December 16; 4(12): 385-389.

http://doi.org/10.12998/wjcc.v4.i12.385

11.   Dobrovolskiene L, Balukeviciute J, Maksimaitiene J. Virskinimo trakto limfomu radiologine diagnostika [Radiographic diagnosis of gastrointestinal lymphoma]. Medicina(Kaunas). 2002; 38(2):165-171.

12.   Chien SH, Liu CJ, Hu YW, et al. Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies: A nationwide population-based study. Int J Cancer. 2015 Aug 1; 137(3): 658-665.

http://doi.org/10.1002/ijc.29433

13.   Chernobai TN, Golovko TS. Radiation diagnosis of extranodal lymphomas. Clinical oncology. 2017; 4(28): 73-76 (date of access 8.07.2020) [In Ukr.].

https://www.clinicaloncology.com.ua/article/19925/luchevaya-diagnostika-ekstranodalnyx-limfom

14.   Frampas E. Lymphomas: Basic points that radiologists should know. Diagnostic and Interventional Imaging. February 2013; 94(2): 131-144.

http://doi.org/10.1016/j.diii.2012.11.006

 

Abstract:

In recent years, with the growth of number of patients with multifocal atherosclerosis, revascularization of the brain and myocardium through hybrid intervention is gaining popularity. Although, in the world literature there are practically no results of significant randomized researches concerning percutaneous coronary intervention and carotid endarterectomy in hybrid mode, this technique is becoming more and more preferable and promising in comparison with other methods of treatment.

Aim: was to demonstrate results of revascularization of the brain and myocardium with staged and hybrid strategies, on the base of evaluation of advantages and disadvantages of these strategies on the example of case reports.

Materialsand methods: article presents two case reports, demonstrating different approaches to surgical treatment in patients with combined lesions of arteries of the brain and myocardium. Both patients were over 65 years age, at the time of treatment, had a history of acute cerebral circulation disorders, coronary heart disease and arterial hypertension. At the outpatient stage, they received antiplatelet, hypotensive, and hypolipidemic therapy. During further examination, both patients were found to have unilateral hemodynamically significant stenoses of internal carotid arteries and isolated stenoses of coronary arteries. In first case, patient was selected for hybrid surgical tactics in the volume of carotid endarterectomy and stenting of coronary artery, which was performed with a further favorable prognosis. In the second case, tactics was determined in favor of a staged procedure: first performing carotid endarterectomy, then stenting the affected coronary artery. However, taking into account subjective and objective factors, none of planned interventions were performed.

Results: hybrid revascularization allows to perform correction in two arterial of different regions in a short period of time using surgical and endovascular techniques. An important advantage of this method is the one-time performance, that means correction of MFA manifestations for one hospitalization, or even one anesthesia, with increasing in the availability of revascularization. In the first case report, the successful implementation of a hybrid approach in the treatment of combined vascular pathology in an elderly patient with a burdened anamnesis and significant comorbidities was demonstrated. Within one day, we managed to complete the planned volume of myocardial and brain revascularization and avoid the development of adverse events both in the early postoperative and long-term follow-up periods. The second clinical example clearly shows disadvantages of staged strategy, when the patient is at risk of developing adverse cardiovascular events while waiting for staged interventions, or for subjective reasons may refuse to be hospitalized in a clinic for performimg a particular operation, that as a result, led to negative dynamics and fatal outcome due to acute stroke.

Conclusions: thus, demonstrated case reports show significant potential and effectiveness of hybrid myocardial and brain revascularization using percutaneous coronary intervention and carotid endarteectomy in treatment of patients with combined lesions of two vascular regions. This method of treatment is especially promising in patients with burdened anamnesis and additional risk factors. It not only prevents adverse cardiovascular events in brain and myocardium, but also has greatest availability and implementation of the planned volume of treatment, completely excluding the influence of subjective factors (change of tactics, failure of patient to attend the next stage of treatment, etc.).

 

References

1.     Bajkov VYu. Combined atherosclerotic lesion of coronary and brachiocephalic arteries - choice of surgical tactics. Bulletin o f Pirogov National Medical & Surgical Center. 2013; 8 (4): 108-111 [In Russ].

2.     Shevchenko YuL, Popov LV, Batrashev VA, Bajkov VYu. Results of surgical treatment of patients with combined atherosclerotic lesions of coronary and brachiocephalic arteries. Bulletin o f Pirogov National Medical & Surgical Center. 2014; 9 (1): 14-17 [In Russ].

3.     Tarasov RS, Kazantsev AN, Ivanov SV et al. Personalized choice of the optimal revascularization strategy in patients with combined lesions of coronary and brachiocephalic arteries: results of testing an automated decision support system in clinical practice. Russian Cardiology Bulletin. 2018; 13 (1): 30-39 [In Russ].

4.     Kazanchyan PO, Sotnikov PG, Kozorin MG, Lar'kov RN. Surgical treatment of multifocal lesions in impaired blood circulation of several arterial territories. Russian Journal of Thoracic and Cardiovascular Surgery. 2013; (4): 31-38 [In Russ].

5.     Zaharov PI, Tobohov AV. Tactics of surgical treatment of generalized atherosclerosis with combined hemodynamically significant defeat of coronary and carotid arteries. Yakut medical journal. 2013; 2 (42): 52-55 [In Russ].

6.     Charchyan ER, Stepanenko AB, BelovYuV, et al. One-Stage Carotid and Coronary Artery Surgeries in Treatment of Multifocal Atherosclerosis. Cardiology. 2014; 54 (9): 46-51 [In Russ].

7.     2018 ESC/EACTS guidelines on myocardial revascularization. Russian Journal o f Cardiology. 2019; 24 (8): 151-226 [In Russ].

8.     ESC/ESVS Recommendations for the diagnosis and treatment of peripheral arterial disease 2017. Rossijskij kardiologicheskij zhurnal 2018; 23 (8), 218-221 [In Russ].

9.     Tarasov RS, Kazantsev AN, Ivanov SV, et al. Surgical treatment of multifocal atherosclerosis: coronary and brachiocephalic pathology and predictors of early adverse events development. Cardiovascular Therapy and Prevention. 2017; 16 (4): 37-44 [In Russ].

10.   Tarasov RS, Ivanov SV, Kazantsev AN etal. Hospital results of different strategies of surgical treatment of patients with concomitant coronary disease and internal carotid arteries stenoses. Complex Issues o f Cardiovascular Diseases. 2016; 5 (4): 15-24 [In Russ].

11.   Shilov AA, Kochergin NA, Ganyukov VI. Hybrid myocardial revascularization in multivessel coronary disease. Current state of the issue. Interventional cardiology. 2015; (41): 22-29 [In Russ].

12.   Alekyan BG, Karapetyan NG. Hybrid surgery in treatment of coronary heart disease. Russian journal of Endovascular surgery. 2017; 4 (1): 5-17 [In Russ].

13. Khubulava GG, Kozlov KL, Sedova EV et al. Importance and role of endovascular techniques in the diagnosis and treatment of generalized atherosclerosis in patients of elderly and senile age. Clinical gerontology. 2014; 20 (5-6): 35-40 [In Russ].

14.   Tarasov RS, Kazantsev AN, Ivanov SV et al. Choosing a strategy for brain and myocardial revascularization in patients with atherosclerosis of internal carotid and coronary arteries: a place for personified medicine. Russian journal of Endovascular surgery. 2018; 5 (2): 241-249 [In Russ].

15.   Frota dos Reis PF, Linhares PV, Pitta FG, Lima EG. Approach to concurrent coronary and carotid artery disease: Epidemiology, screening and treatment. Rev Assoc Med Bras. 2017; 63(11): 1012-1016.

16.   Tomai F, Pesarini G, Castriota F et al. Early and Long-Term Outcomes After Combined Percutaneous Revascularization in Patients With Carotid and Coronary Artery Stenoses. Cardiovascular interventios. 2011: 560-8.

17.   Zhang J, Dong Z, Liu P et al. Different Strategies in Simultaneous Coronary and Carotid Artery Revascularization - A Single Center Experience. Arch Iran Med. 2019; 22 (3): 132-136.

18.   Drakopoulou M, Oikonomou G, Soulaidopoulos S et al. Management of patients with concomitant coronary and carotid artery disease. Expert Review o f Cardiovascular Therapy. 2019: 1-32.

 

Abstract:

Article presents a case report of a 38-year-old patient who was admitted to our hospital with symptoms of acute appendicitis, she was examined and then urgently operated.

Postoperative period was complicated by clinical picture of colonic bleeding. During 1 st day of postoperative period, patient underwent a diagnostic search of bleeding source, conservative hemostatic therapy, transfusion of blood components, however, taking into consideration negative dynamics of patient's condition, laboratory test indicators, the next day, she was urgently operated: lower midline laparotomy, suturing of cecum hematoma, drainage of the abdominal cavity. Eight hours after repeated surgical treatment, against the background of transfusion of blood components, further negative dynamics of patient's condition, laboratory test indicators also worsened, medical concilium decided to perform angiography, followed by a decision on the amount of treatment intraoperatively. Selective angiography of branches of the mesenteric artery was performed, the source of bleeding was diagnosed, and a successful temporary pharmacologic endovascular hemostasis of the branch of the superior mesenteric artery was performed. Post-hemorrhagic anemia in the patient was corrected on the 3rd day after endovascular intervention, 10 days after, patient was discharged in a satisfactory condition.

The choice of the method of endovascular intervention was carried out taking into consideration the ineffective of reoperation, patient's condition, as well as peculiarities of the blood supply to the area of the alleged source of bleeding.

The study also discusses indications and methods of endovascular treatment of colonic bleeding.

 

 

References

1.     Avdos'ev JuV, Belozerov IV, Kudrevich AN. Endovascular methods for the diagnosis and treatment of acute bleeding into the lumen of the gastrointestinal tract. Novostihirurgii. 2018; 26 (2): 169-178 [In Russ].

2.     Soh B, Chan S. The use of super-selective mesenteric embolisation as a first-line management of acute lower gastrointestinal bleeding. Annals of Medicine and Sur­gery. 2017; 17: 27-32.

3.     Avdos'ev JuV, Bojko W. Angiography and endovascular abdominal bleeding. Ukraina: Savchuk. 2011; 648. [In Russ].

4.     Tan К К, Wong D, Sim R. Superselective Embolization for Lower Gastrointestinal Hemorrhage: An Institutional Review Over 7 Years. World J Surg. 2008; 32:2707-2715.

http://doi.org/10.1007/s00268-008-9759-6

5.     Annamalai G, Masson N, Robertson I. Acute gastrointestinal haemorrhage: investigation and treatment. Imaging. 2009; 21(2): 142-151.

6.     Urbano J, Manuel Cabrera J, Franco A, Alonso-Burgos A. Selective arterial embolization with ethylenevinyl alcohol copolymer for control of massive lower gastrointestinal bleeding: feasibility and initial experience. J Vase I nterv Radiol. 2014; 25: 839-846.

7.     Walker TG, Salazar GM, Waltman AC. Angiographic evaluation and management of acute gastrointestinal hemorrhage. World J Gastroenterol. 2012;18 (11): 1191-1201.

http://doi.org/10.3748/wjg.v18.i11.1191

8.     Jang Bl. Lower gastrointestinal bleeding: is urgent colonoscopy necessary for all hematochezia? Clinical Endosc. 2013; 46: 476-479.

9.     Green ВТ, Rockey DC, Portwood G et al. Urgent colonoscopy for evaluation and management of acute lower gastrointestinal hemorrhage: a randomized controlled trial. Am J Gastroenterol. 2005; 100: 2395-2402.

10.   Loffroy R, Falvo N, Nakai M et al. When all else fails - radiological management of severe gastrointestinal bleeding. Best Practice & Research Clinical Gastroenterology. 2019; 1-9.

http://doi.org/10.1016/j.bpg.2019.04.005

11.   Shi Z X, Yang J, Liang H W et al. Emergency transcatheter arterial embolization for massive gastrointestinal arterial hemorrhage. Medicine. 2017; 96(52): 9437.

http://doi.org/10.1097/md.0000000000009437

12.   Nanavati S M. What if endoscopic hemostasis fails? Alternative treatment strategies: interventional radiology. Gastroenterol Clin North Am. 2014;43(4): 739-752.

http://doi.org/10.1016/i.gtc.2014.08.013

 

Abstract:

Background and aim: in Russian Federation, more than 10 million people suffer from peripheral artery disease (PAD), and from chronic limb-threatening ischemia (CLTI) as one of it’s complications. According to Russian guidelines on treatment of patients with CLTI, the initial diagnosis should include measurement of ankle-brachial and finger-brachial indices (ABI, ТВ I), as well as ultrasound duplex scanning (USDS) - however, the sensitivity and diagnostic accuracy of these methods are often insufficient. In this review, we have summarized the entire range of modern instrumental methods for early and effective diagnosis of critical lower limb-threatening ischemia and for the evaluation of limb perfusion.

Materials and methods: 31 sources of domestic and foreign literature published in last 5 years on the issue of modern possibilities for early precision diagnosis of critical limb-threatening ischemia were examined.

Results and conclusions: AHA Experts recommend some experimental technologies for evaluating lower limb perfusion, including angiography with indigocarmine, perfusion computed tomography (CT perfusion), magnetic resonance imaging (MRI), contrast echography, and hyperspectral imaging. Among other things, implantable bio-sensors can be identified: for example, oxygen-platform LuMee, which works in real time and provides continuous monitoring of oxygen levels in tissues. New technologies allow us to improve the accuracy of diagnosis and quality of treatment of patients with CLTI. It is worth considering switching from traditional methods to more modern ones, which can significantly reduce the frequency of amputations and the risk of disability and improve the quality of life of our patients.

 

References

1.     Lobachev АА. Comparative evaluation and long-term results of various methods of surgical revascularization of shin arteries in patients with obliterating atherosclerosis of lower limb arteries. Diss.kand.med.nauk - M., 2019; 110 [In Russ].

2.     Aboyans V, Ricco JB, Bartelink MEL et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). ESC Guidelines. 2017; 39:763-821.

3.     Misra S, Shishehbor MH, Takahashi EA et al. Perfusion Assessment in Critical Limb Ischemia: Principles for Understanding and the Development of Evidence and Evaluation of Devices: A Scientific Statement From the American Heart Association published. Circulation. 2019; 140: 657-672.

4.     «National guidelines for the management of patients with diseases of lower limb arteries»- M.: 2013 [In Russ].

http://www.angiolsurgery.org/recommendations/2013/recommendations_LLA.pdf

5.     Zyyatdinov KSH, Sharafeev AZ, Cibul'kin NA et al. Diagnostics and treatment of clinical manifestations of atherosclerosis. Monografiya. Kazan': Medicina. 2014; 197 [In Russ].

6.     Aboyans V, Criqui MH, Abraham P et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012; 126 (24): 2890-909.

7.     Maksimov AV, Gajsina EA, Plotnikov MV. Vascular and endovascular surgery in figures and diagrams. Uchebnoe posobie. 2018; 152 [In Russ].

8.     Cornell M, Gabriel PO. Non-invasive imaging techniques in lower extremity artery disease. E-Journal of Cardiology Practice. 2018; 16(5) - 21 Mar 2018.

9.     Gerhard-Herman MD, Gornik HL, Barrett C et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary. Circulation. 2017; 135 (12):e686-e725.

10.   Schiro GR, Sessa S, Piccioli A, Maccauro G. Primary amputation vs limb salvage in mangled extremity: a systematic review of the current scoring system. BMC Musculoskeletal Disorders. 2015; 16: 372.

11.   Terskov DV, SHnajder NA. Transcutaneous oximetry as a technique for identifying of threatening critical ischemia in patients with diabetic foot syndrome and occlusive lesions of arteries of lower limbs. Vestnik Klinicheskojbol'nicy №51. 2010; 3(8): 56-61 [In Russ].

12.   Rother U, Lang W. Noninvasive measurements of tissue perfusion in critical limb ischemia. Gefasschirurgie. 2018; 23(Suppl 1): 8-12.

13.   Mahe G, Liedl DA, McCarter C et al. Digital obstructive arterial disease can be detected by laser Doppler measurements with high sensitivity and specificity. Journal of vascular surgery. 2014 Apr;59(4): 1051-1057.e1.

14.   Gurmikova NL. Optimization of methods for diagnosing peripheral arterial diseases in patients with diabetes mellitus. Dissertaciya. 2014; 143-146 [In Russ].

15.   Sitdikova DI. Perioperative control of the efficiency of reconstructive operations in patients with critical lower limb ischemia. Angiologiya i sosudistaya hirurgiya. 2016; 22(2); 320-321 [In Russ].

16.   Lopez D, Pollak AW, Meyer CH et al. Arterial spin labeling perfusion cardiovascular magnetic resonance of the calf in peripheral arterial disease: cuff occlusion hyperemia vs exercise. J Cardiovasc Magn. Reson. 2015; 17(1): 23.

17.   Kikuchi S, Miyake K, Tada Y et al. Laser speckle flowgraphy can also be used to show dynamic changes in the blood flow of the skin of the foot after surgical revascularization. Vascular. 2019; 27(3) 242-251.

18.   Krupatkin Al, Sidorova W. Laser Doppler flowmetry of blood microcirculation. Monografiya. 2005; 119-122 [In Russ].

19.   Aleksandrov DA, Timoshina PA, Tuchin W et al. Dynamics of indicators of laser speckle-visualization of blood flow and morphological changes in tissues with complete temporary local ischemia of the pancreas. Saratovskij nauchno-medicinskij zhurnal. 2014; 10 (4): 596-600 [In Russ].

20.   Jennifer Garcia. Laser Associated Sciences Receives 510(k) FDA Clearance for FlowMet-R. 2019.

http://innovation.uci.edu/2019/04/laser-associated-sciences-receives-510k-fda-clearance-for-flowmet-r/

21.   Met R, Bipat S, Legemate DA et al. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA. 2009; 301 (4):415-24.

22.   Jens S, Koelemay MJ, Reekers JA, Bipat S. Diagnostic performance of computed tomography angiography and contrast-enhanced magnetic resonance angiography in patients with critical limb ischemia and intermittent claudication: systematic review and meta-analysis. Eur Radiol. 2013; 23(11):3104-14.

23.   Jens S, Marquering HA, Koelemay MJ, Reekers JA. Perfusion angiography of the foot in patients with critical limb ischemia: description of the technique. Cardiovasc Intervent Radiol. 2015; 38:201-205.

24.   Marco Manzi, Jos C. van den Berg. 2D Perfusion Angiography: A Useful Tool for CLI Treatment. Endovascular. 2015; 76-79.

25.   Pollak AW, Meyer CH, Epstein FH et al. Arterial spin labeling MR imaging reproducibly measures peak-exercise calf muscle perfusion: a study in patients with peripheral arterial disease and healthy volunteers. JACC Cardiovasc Imaging. 2012 Dec; 5(12): 1224-30.

26.   Aschwanden M, Partovi S, Jacobi В et al. Assessing the end-organ in peripheral arterial occlusive disease-from contrast-enhanced ultrasound to blood-oxygen-level-dependent MR imaging. Cardiovascular Diagnosis and Therapy. 2014; 4(2), 165-172.

27.   Muller MD, Luck JC, Gao Z et al. Muscle oxygenation during dynamic plantar flexion exercise: combining BOLD MRI with traditional physiological measurements. 2016; 4 (20): e13004.

28.   Maslennikova NS. Possibilities of the method of magnetic resonance imaging in assessing the effectiveness of conservative therapy for chronic ischemia of lower limbs. Dissertaciya. 2017; 94-96 [In Russ].

29.   Higashimori A, Takahara M, Utsunomiya M. Utility of indigo carmine angiography in patients with critical limb ischemia: Prospective multi-center intervention study (DIESEL-study). Catheter Cardiovasc Interv. 2019 Jan 1;93(1):108-112.

30.   Brodmann M. Assessing the clinical utility of real­time tissue oxygen monitoring for endovascular revascularization procedures. Presentation on LINK-2020.

31.   ESC I ESVS Recommendations for the diagnosis and treatment of peripheral arterial disease 2017. Rossijskij kardiologicheskij zhurnal 2018; 23 (8), 218-221 [In Russ].

 

Abstract:

Cervical cancer (CC) is one of the most common oncological disease in the world. There are lots of methods to treat it. Often we use radiation therapy (RT), chemotherapy (CT), surgical treatment. However, when on one hand we have successes, on the other hand we have a number of unsolved problems. To solve them, we study the method of chemoembolization of uterine arteries (CUA). This treatment option is being studied as one of promising methods in the complex or combined radiation treatment of primary and recurrent cervical cancer. This allows, with minimal trauma and relapse rate, to stop bleeding and reduce the size of the tumor. In this article a number of literature sources about using embolization or chemoembolization and results of treatment with CUA has been analyzed.

 

References

1.     Kaprin AD, Starinskij W, Petrova GV. The state of cancer care for the population of Russia in 2018. - M.: MNIOI im. P.A. Gertsena - filial FGBU «NMITS radiologii» Minzdrava Rossii, 2019; 236 [In Russ].

2.     Lindsey AT, Ahmedin J, Rebecca L. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018; (68): 394-424.

3.     Ashrafyan LA, Antonova IB, Aleshikova Ol et al. Surgical stage as one of the main components in the complex treatment of cervical cancer stage IIb-IIIb. Russian journal o f oncology. 2007; (3): 21-25 [In Russ].

4.     Benedetti-Panici P, Greggy S, Colombo A et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locallyadvanced squamous cell cervical cancer: results from the Italian multicenter randomizedstudy. J Clin Oncol. 2002; (20): 179-188.

5.     Benedetti-Panici PL, Zullo MA, Muzii Let. al. The role of neoadjuvant chemotherapy followed by radical surgery in the treatment of locally advanced cervical cancer. EurJ Gynecol Oncol. 2003; 24 (6): 467-470.

6.     Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A et al. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carbo-platin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol. 2003; 14 (8): 1278-1284.

7.     Sananes C, Giaroli A, Soderini A et al. Neoadjuvant chemotherapy followed by radical hysterectomy and post­operative adjuvant chemotherapy in the treatment of carcinoma of the cervix uteri: long-term follow-up of a pilot study. Eur J Gynaecol Oncol. 1998; 19 (40): 368-373.

8.     Pavlov AS, Kostromina KN. Cervical cancer (radiation therapy). Meditsina. 1983; 160 [In Russ].

9.     Suvorova JuV. The role of angiography and arterial embolization in malignant tumors of the uterus and bladder complicated by bleeding. Avtoref. dis. kand. med. nauk. 1998; 24 [In Russ].

10.   Oliver J Jr, Lance J. Selective embolization to control massive hemorrhage following pelvic surgery. Am J Obstet Gyn. 1979; (135): 431-432.

11.   Ravina JH, Merland JJ, Herbreteau D. et al. Preoperative embolization of uterine fibroma. Pres Med. 1994; (23): 1540.

12.   Chen C, Wang W, Zhou H et al. Pharmacokinetic comparison between systemic and local chemotherapy by carboplatin in dogs. Department of Obstetrics and Gynecology, Nanfang Hospital, Guangdong Province, PR China. Reprod Sci. 2009; Nov.

13.   Kosenko IA, Matylevich OP, Dudarev VS et al. The effectiveness of complex treatment of locally advanced cervical cancer using uterine artery chemoembolization. Oncological journal named P.A. Gertsena. 2012; (10): 15-19 [In Russ].

14.   Sabekiya IM, Stolyarova IV, Vinokurov VM. Role of endovascular interventions in combined treatment of patients with locally advanced cervical cancer. Oncology issues. 2004; (5): 590-594 [In Russ].

15.   Kobayashi K, Furukawa A, Takahashi M, Murata K. Neoadjuvant intra-arterial chemotherapy for locally advanced uterine cervical cancer: clinical efficacy and fac­tors influencing response. Cardiovasc Intervent Radiol. 2003; 26 (3): 234-241.

16.   Komov DV, Roshhin EM, Kuchinskij GA et al. Results of the first phase of clinical studies of the doxorubicin-estrone complex in patients with malignant neoplasms of the liver during chemoembolization with lipiodol. Bulletin of the ONTs AMS of Russia. 1997; (4): 34-37 [In Russ].

17.   Huang K, Zhou Q, Wang R et al. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma. J Gastroenterol Hepatol. 2014; 29 (5): 920-925.

18.   Lichinitser MR, Gutorov SL. A new approach to chemotherapeutic treatment of cancer. Jornal Oncology.ru (internetsource). 2011; 13 [In Russ].

https://rosoncoweb.ru/librarv/chemotherapy/001.pdf

19.   Dmitriev VN, Golivets TP, Sukhoterin IV et al. Chemotherapy of tumors of the female reproductive system: definitions and methodological aspects. Scientific statements of BSU, Medicine Pharmacy. 2011; 22(177): 234-244 [In Russ].

20.   Thigpen J, Blessing H, Homesley et al. Phase III trial of doxorubicin +/- cisplatin in advanced or recurrent endometrial carcinoma: a Gynaecologic Oncology group study. Proceedings of ASCO. 1993; 12: 261.

21.   Arybzhanov DT, Bajnazarova AA, Kulakeev OK. Embolization of uterine arteries in the treatment of patients with cervical cancer. Medical Bulletin of Bashkortostan. 2009; (2): 39-41 [In Russ].

22.   Suvorova JuV, Tarazov PG, Zharinov GM. Arterial embolization in chronic bleeding in patients with uterine cancer. Oncology issues. 1996; 42 (4): 59-61 [In Russ].

23.   Suvorova JuV, Tarazov PG. Arterial embolization in uterine and bladder tumors complicated by bleeding. Palliative medicine and rehabilitation. 199; (2): 79-80 [In Russ].

24.   Tarazov PG, Suvorova JuV, Neklasova NY Arterial embolization in malignant tumors of the uterus complicated by bleeding. Obstetrics and gynecology. 1996; (3): 39 [In Russ].

25.   Kedrova AG, Lebedev DP, Shablovskij OR et al. Modern chemoembolization of the pelvic vessels as a stage in the treatment of malignant tumors of the body and cervix. Clinical practice. 2016; (2) [In Russ].

26.   Shakhov EB, Kanishheva NV, Ermolaeva AM et al. The first experience of using selective chemoembolization of the uterine arteries in patients with cervical cancer. Oncology. Medical Almanac Journal. 2016; (2): 124-126 [In Russ].

27.   Nalgieva FK, Shanazarov NA. The problem of treatment of complicated cervical cancer at the present stage. Basic research. 2011; 1 (11): 221 -226 [In Russ].

28.   Bajnazarova AA, Yakubova MB, Kulakeev OK et al. Embolization of uterine arteries in the treatment of patients with cervical cancer. Oncology. Medical Bulletin of Bashkortostan. 2009. (2): 39-41 [In Russ].

29.   Bajnazarova AA, Yakubova MB, Kulakeev OK et al. Embolization of uterine arteries in the treatment of patients with cervical cancer. Oncology. Tyumen Medical Journal. 2010; (3-4): 37-39 [In Russ].

30.   Kosenko IA, ZHavrid EA, Matylevich OP et al. Immediate results of surgical intervention after neoadjuvant polychemotherapy with selective chemoembolization. Tumors of the female reproductive system. 2009; (3-4): 121-124 [In Russ].

31.   Bokhman YV. Oncology guide. 2002; 544 [In Russ].

32.   Stolyarova IV, Vinokurov VL. Modern possibilities of chemoradiation therapy in the treatment of advanced uterine cancer. VII Ross, onkol. kongress 25-27 noyabrya 2003: Congress materials. 2003; 198 [In Russ].

33.   Tian ZZ, Li S, Wang Y et al. Investigation of uterine arterial chemoembolization and uterine arterial infusion chemotherapy for advanced cervical cancer before radical radiotherapy: a long-term follow-up study. Arch Gynecol Obstet. 2014; 290 (1): 155-162.

34.   Yu L, Tan GS, Xiang XH et al. Comparison of uterine artery chemoembolization and internal iliac arterial infusion chemotherapy for the combining treatment for women with locally advanced cervical cancer. Ai Zheng. 2009; 28 (4): 402-407.

35.   Song J, Chen W, Zhu X et al. Short-term efficacy, safety, and cost-effectiveness of transarterial chemoembolization with drug-eluting beads versus synchronous radiochemotherapy for cervical cancer. Int J Gynaecol Obstet. 2019; 147 (1): 29-35.

36.   Babaeva NA, Antonova IB, Aleshikova Ol et al. The role of selective chemoembolization of the uterine arteries in the complex treatment of locally advanced cervical cancer. Doctor.Ru. 2018. 146 (2): 20-25 [In Russ].

 

Abstract:

Aim: was to elucidate factors of poor prognosis for chronic brain ischemia in «asymptomatic» patients with atherosclerotic stenosis of vertebral arteries, who regularly take optimal medical therapy.

Methods: in 1st group (n = 44), secondary prevention of cerebrovascular accidents was carried out in a combined strategy - stenting of vertebral arteries in combination with medication therapy, and in 2nd group (n = 56) - only medication therapy. Long-term follow-up was planned after 12, 24 and 36 months. Inclusion criteria: «asymptomatic» patients with stenosis of vertebral arteries 50-95%; diameter of vertebral arteries is not less than 3.0 and not more than 5 mm; presence of cerebral and focal symptoms corresponding to the initial (asymptomatic) stage of chronic brain ischemia (according to E.V. Schmidt). Primary endpoint: total frequency of cardiovascular complications (death, transient ischemic attack or stroke, myocardial infarction).

Results: the total frequency of major cerebral complications over 36 months of follow-up was 4.5% in group 1 and 37.5% in group II (? 2=15.101; p<0.0001). The frequency of cardiac events was 9.1 and 19.6%, respectively, to 1st and 2nd groups (? 2=14.784; p<0.0001). These indicators were obtained against the background of high patient adherence to treatment and high rates of achieving tough target lipid values. Restenosis of stents was observed in general, in 38.67% of patients from group I. Moreover, restenosis alone did not affect the incidence of major cerebral complications in the long-term period (? 2=0.1643; p=0.735). Most significant poor prognosis factors of chronic brain ischemia in «asymptomatic» patients with vertebral artery stenosis, who regularly take optimal medical therapy are: arrhythmia, total cholesterol more than 6.0 mmol/l, incomplete circle of Willis, arterial hypertension, bilateral defeat of vertebral arteries, (low-density lipoprotein) LDL levels of more than 3.5 mmol/I, combined lesion of vertebral and carotid arteries, calcification of vertebral arteries, coronary heart disease in anamnesis.

Conclusion: endovascular intervention in combination with medical therapy could help to avoid the development of major brain complications arising from the instability of atherosclerotic plaque in «asymptomatic» patients with vertebral artery stenosis, and in the presence of poor prognosis factors identified can be regarded as a method of secondary prevention of cerebral circulatory disorders.

 

References 

1.     Britov AN, Pozdnyakov YuM, Volkova EG, et al. National guidelines on cardiovascular prevention. Kardio-vaskulyarnaya terapiya i profilaktika. 2011;10(6)2: 1-64 [In Russ].

2.     Suslina ZA, Guglevskaja TS, Maksimova MJu, Morgunov VA. Cerebrovascular accidents: diagnosis, treatment, prevention. Moscow: MEDpress-inform, 2016, 440 [In Russ].

3.     Shchukin IA, Lebedeva AV, Burd GS, et al. Chronic cerebral ischemia: syndromological approaches to thera­py. Nevrologiya irevmatologiya. 2015;1:17-24 [In Russ].

4.     Zakharov W, Voznesenskaya TG. Neuropsychiatric Disorders: Diagnostic Tests; podobshch. red. N.N.Yakhno. M.: MEDpress-inform, 2015: 320 [In Russ].

5.     Chechetkin AO, Skrylev SI, Koshheev AJu, et al. Clinical and instrumental assessment of the effectiveness of stenting of the vertebral arteries in the near and remote postoperative periods. Annaly klinicheskoj i jeksperimental'noj nevrologii. 2018;12(3): 13-22 [In Russ].

http://doi.org/10.25692/ACEN.2018.3.2

6.     Sermagambetova ZhN, Maksimova MJu, Skrylev SI, et al. Interventional technologies for the prevention of stroke in the vertebral-basilar system. Consilium Medicum. 2017;19(2): 96-103 [In Russ].

7.     Migunova SG. Clinical and epidemiological study of cerebrovascular diseases and a comparative analysis of the effectiveness of treatment of patients with cerebral atherosclerosis: Diss. kand. med. Ekaterinburg, 2018: 145 [In Russ].

8.     Aboyans V, Ricco JB, Bartelink MEL et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Soci­ety for Vascular Surgery (ESVS). Eur J Vase Endovasc Surg. 2017 Aug 26.

http://doi.org/10.1093/eurhearti/ehx095

9.     Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardio­vascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). European Heart Journal. 2020;41:255-323.

http://doi.org/10.1093/eurhearti/ehz486

10.   Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European Heart Journal. 2020;41: 111-188.

http://doi.org/10.1093/eurhearti/ehz455

11.   Kamchatnov PR, Umarova HJa, Kabanov AA, Abieva NA. The problem of diagnosis and treatment of patients with vertebrobasilar insufficiency. Lechebnoedelo. 2017;3: 68-75 [In Russ].

12.   Kocak B, Korkmazer B, Islak C, et al. Endovascular treatment of extracranial vertebral artery stenosis. World J. 2012;4:391-400.

http://doi.org/10.4329/wir.v4.i9.391

13.   Markus HS, Larsson SC, Kuker W, et al. VIST Investigators. Stenting for symptomatic vertebral artery stenosis: The Vertebral Artery Ischemia Stenting Trial. Neurology. 2017;89(12):1229-1236.

http://doi.org/10.1212/WNL.00000000000Q4385

14.   Babayan GB, Zorin RA, Pshennikov AS, et al. Predictors of neurological deficiency in hemodynamically significant stenoses of the carotid and vertebral arteries. Nauka molodykh (Eruditio Juvenium). 2019;7(4): 533-540 [In Russ].

http://doi.org/10.23888/HMJ201974533-540

15.   Rakhmonov RA, Todzhiddinov ТВ, Isoeva MB, Zuurbekova DP. Total Cardiovascular Risk - A New Approach to Stroke Prediction. Vestnik Avitsenny. 2017;19(4): 471-475. [In Russ].

http://doi.org/10.25005/2074-0581-2017-19-4-471-475

16.   Shao JX, Ling YA, Du HP, et al. Comparison of hemodynamic changes and prognosis between stenting and standardized medical treatment in patients with symptomatic moderate to severe vertebral artery origin stenosis. M edicine(Baltimore). 2019;98( 13): e14899.

http://doi.org/10.1097/md.0000000000014899

 

Abstract:

Aim: was to estimate efficacy of methods of permanent or temporary blocking of blood flow through the gastroduodenal artery (GDA) during arterial chemoinfusion/chemoembolization of hepatic and pancreatic malignancies.

Materials and methods: for the period of 5 years (2015-2019), GDA embolization with coils was performed in 90 patients. Of them, 39 patients with liver tumors underwent occlusion of proximal GDA. GDA embolization distally to pancreatic branches (commonly on the level of gastroepiploic artery) was done in 51 patients with pancreatic head adenocarcinoma. Alternatively, in 12 patients with liver and 23 patients with pancreatic cancer, hand compression of GDA was used.

Results: technical success was 98% (88/90 patients). During embolization, coil migration into the hepatic artery developed in two patients with liver tumors: in one case stenting of the common hepatic artery was performed, the other case was asymptomatic and the presence of coil did not complicate the following arterial therapy. There were no other complications. Patients received multiple repeated courses of arterial chemotherapy.

Conclusion: methods of blocking of GDA blood flow are relatively safe, effective, simple and inexpensive. Both, embolization and hand compression, help to prevent non-target chemoinfusion and embolization.

  

References

1.     Generalov Ml, Balakhnin PV, Tsurkan VA, et al. Percutaneously implanted «port-catheter» systems for long-lasting regional chemotherapy in patients with metastatic liver disease. Diagnosticheskaja i Intervenzionnaya Radiologiya. 2007; 1(4): 51-59 [In Russ].

2.     Arybzhanov DT, Gantsev SH, Kulakeev OK, et al. Results of endovascular methods of treatment in liver tumors in South Kazakhstan. Diagnosticheskaya i Intervenzionnaya Radiologiya. 2009; 3(1): 15-19 [In Russ].

3.     Popov AA, Skupchenko AV, Polarush NF. Colorectal liver metastases after chemoembolization with microspheres: comparison of the different criteria for tumor response assessment. Diagnosticheskaya i Intervenzionnaya Radiologiya. 2014; 8(1): 37-46 [In Russ].

4.     Dolgushin Bl, Virshke ER, KosyrevVJ. Interventional radiological technologies in treatment of intermediate stage HCC (BCLC B). Onkologicheskiy Zhurnal. 2018. 1(1): 60-62 [In Russ].

5.     Kozlov AV, Granov DA, Tarazov PG et al. Intra-arterial chemotherapy in patients with unresectable pancreatic cancer. Annaly Khirurgicheskoy Gepatologii. 2019; 24(3): 73-86 [In Russ].

6.     Pavlovskij AV, Stacenko AA, Popov SA et al. The first experience of selective intra-arterial injection of albuminbound paclitaxel (Abraxane) in patients with pancreatic adenocarcinoma. Diagnosticheskaya i Intervenionnaya Radiologiya. 2019; 13(1): 59-64 [In Russ].

7.     Bagdasarov W, Bagdasarova EA, Chernookov Al et al. Endovascular arterial embolization in duodenal bleeding - alternative to surgical treatment. Khirurgiya. 2016; (2): 45-50 [In Russ].

8.     Musinov IM, Chikin AE, Ganin AS, Kachesov EYu. Transcatheter arterial embolization in treatment of gastroduodenal ulcers with bleeding. Vestnik Khirugii. 2018; 177(6): 27-30 [In Russ].

9.     Tibilov AM, BaymatovMS. Endovascular intervention in the treatment of recurrent gastroduodenal hemorrhage. Diagnosticheskaya i Intervenzionnaya Radiologiya. 2009; 3(3): 45-48 [In Russ].

10.   Tarazov PG, Granov DA, Polikarpov AA et al. Endovascular control of arterial bleeding after major surgery in pancreatic cancer. Vestnik Khirugii. 2012; 171(1): 24-30 [In Russ].

11.   Chuang VP, Wallace S, Stroehlen J et al. Hepatic artery infusion chemotherapy: gastroduodenal complications. American Journal o f Roentgenology. 1981; 137(2): 347-350.

12.   Granmayeh M, Wallace S, Schwarten D. Transcatheter occlusion of the gastroduodenal artery. Radiology. 1979; 131(1): 59-62.

13.   Kuribayashi S, Phillips D, Harrington DP et al. Therapeutic embolization of the gastroduodenal artery in hepatic artery infusion chemotherapy. American Journal of Roentgenology. 1981; 137(6): 1169-1172.

14.   Kuyumcu G, Latich I, Hardman RLet al. Gastroduodenal embolization: indications, technical pearls, and outcomes. Journal o f Clinical Medicine. 2018; 7(5): pii E101.

http://doi.org/10.3390/icm7050101

15.   Desai GS, Pande PM. Gastroduodenal artery: Singe key for many locks (review). Journal of Hepatobiliary and Pancreatic Surgery. 2019; 26(7): 281-291.

16.   Tarazov PG, Polikarpov AA, Ivanova AA. Arterial radioembilzation of liver malignancies with glass yttrium-90 microspheres: first experience. Diagnosticheskaya i Intervenzionnaya Radiologiya. 2014; 8(4): 59-66 [In Russ].

17.   Tarazov PG, Ryzhkov VK. Gastroduodenal artery embolization during endovascular interventions in cirrhosis and tumors of the liver. Vestnik Khirugii. 1988; 140(1): 83- 85 [In Russ].

18.   Lopez-Benitez R, Hallscheidt P, Kratochwil C et al. Protective embolization of the gastroduodenal artery with a one HydroCoil technique in radioembolization procedures. Cardiovascular and Interventional Radiology. 2013; 36(1): 105-110.

19.   Enriquez J, Javadi S, Murthy R et al. Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepatoenteric flow: incidence and predisposing technical factors in 142 patients. Acta Radiologica. 2013; 54(7): 790-794.

20.   Kubota H, Nimura X Hayakawa N, Shionoya S. Hepatic transcatheter arterial embolization with gastroduodenal artery blocking by finger compression. Radiology. 1989; 170(2): 562-563.

21.   Tarazov PG, Pavlovskij AV, Granov DA. Oily chemoembolization of pancreatic head adenocarcinoma. Cardiovascular Interventional Radiology. 2001; 24(6): 424-426.

22.   Karimov Shi, Borovskiy SP, Khakimov MSh, Adylkhodzhaev AA. Regional chemotherapy in the treatment of unresectable pancreatic tumors. Annaly Khirurgicheskoy Gepatologii. 2010; 15(3): 105-109 [In Russ].

23.   Khayrutdinov ER, Tsurkan VA, Arablinskiy AV, Gromov DG. First experience in using transradial arterial approach in selective chemoembolization of malignant pancreatic tumor. Diagnosticheskaya i Intervenzionnaya Radiologiya. 2017; 11(4): 81-85 [In Russ].

 

Abstract:

Aim: was to assess the possibility of x-ray surgical recovering of the integrity of the upper urinary tract in the absence of dilatation of kidney collecting system.

Material and methods: for the period of 2018-2020, under our supervision there were 9 patients with an unexpanded kidney collecting system against the background of the existing external or internal urinary fistula. In 6 patients after cystoprostatectomy and ureteroenterocutaneostomy (Bricker surgery), a migration of urethral drainage occurred. In 3 cases, after gynecological operations, patients were diagnosed with iatrogenic complete transverse ureter damage with the formation of retroperitoneal (intrapelvic) uroma. At the first stage in all 9 patients we performed percutaneous nephrostomy on unexpanded kidneys’ collecting system under ultrasound guidance using special techniques.

To restore patency of the damaged ureter, a combined ante-retrograde approach was used. The antegrade flexible guidewire was moved through damaged (cut off) ureter, and retrograde through the entrance of damaged ureter or enterostomy with a capturing device, under x-ray control, the guidewire was brought out. Then, pyeloureteral drainage was placed in an adequate position of the enterocutaneostomy retrograde or antegrade, splinting the ureter damage zone.

Results: in 6 patients, after Bricker surgery, the lost ureteral drainage was adequately restored. In patients with a cut off ureter, it was possible to restore the course of the damaged ureter on the external-internal pyelo-urethral drainage by closing the internal urinary fistula and eliminating retroperitoneal urine by percutaneous drainage under radiation control. There were no complications associated with the technique of x-ray surgery.

Conclusion: percutaneous nephrostomy on an unexpanded kidney collecting system using special techniques for the verification of kidney collecting system is a potentially replicable safe technique that allows to perform in stages adequate external derivation of urine. Percutaneous nephrostomy can be used as a «bridge» technique for subsequent x-ray surgical interventions on the ureter, including with its complete iatrogenic damage.

 

 

References

1.     Patel U, Hussain FF. Percutaneous nephrostomy of non-dilated renal collecting systems with fluoroscopic guidance: technique and results. Radiology. 2004 Oct; 233(1 ):226-233.

https://doi.org/10.1148/radiol. 2331031342

2.     Liu BX, Huang GL, Xie XH et al. Contrast-enhanced US-assisted Percutaneous Nephrostomy: A Technique to Increase Success Rate for Patients with Nondilated Renal Collecting System. Radiology. 2017 Oct; 285(1):293-301.

https://doi.org/10.1148/radiol.2017161604

3.     Usawachintachit M, Tzou DT, Mongan J et al. Feasibility of Retrograde Ureteral Contrast Injection to Guide Ultrasonographic Percutaneous Renal Access in the Nondilated Collecting System. J Endourol. 2017 Feb; 31 (2): 129-134.

https://doi.org/10.1089/end.2016.0693

4.     Dagli M, Ramchandani P. Percutaneous nephrostomy: technical aspects and indications. Semin Intervent Radiol. 2011 Dec; 28(4):424-37.

https://doi.org/10.1055/S-0031-1296085

5.     Brandes S, Coburn M, Armenakas N, McAninch J. Diagnosis and management of ureteric injury: an evidencebased analysis. BJU Int. 2004 Aug; 94(3):277-89.

https://doi.org/10.1111 /j.1464-410X.2004.04978.X

6.     Ray CE Jr, Brown AC, Smith MT, Rochon PJ. Percutaneous access of nondilated renal collecting systems. Semin Intervent Radiol. 2014 Mar; 31 (1):98-100.

https://doi.org/10.1055/S-0033-1363849

7.     American College of Radiology (ACR) and the Standarts of Practice Committee of the Society of Interventional Radiology (SIR) and the Society for Pediatric Radiology (SPR) practice guideline for the performance of percutaneous nephrostomy. Revised 2011 (resolution 42). Accessed March 9, 2013.

http://www.arc.org/~/media/ACR/Documents/PGTS/guidelines/Percutaneous_Nephrostomv.pdf

8.     Clark TW, Abraham RJ, Flemming BK. Is routine micropuncture access necessary for percutaneous nephrostomy? A randomized trial. Can Assoc Radiol J. 2002 Apr; 53(2):87-91.

 

Abstract:

Background: pulmonary hypertension not only aggravates the course of myocardial infarction, but also significantly worsens the prognosis, increasing disability and mortality due to the steadily progressing course. The need to predict the development of pulmonary hypertension in patients with myocardial infarction is not in doubt, since a clear clinical picture manifests itself only in the late stages of the disease, when the effectiveness of the treatment reduces and its cost increases.

Aim: was to define most significant factors, influencing the development of pulmonary hypertension in the subacute period of myocardial infarction to elaborate a model for predicting this pathological condition.

Material and methods: study included 451 men aged 18-60 y.o. with a verified diagnosis of myocardial infarction. All patients underwent a standard diagnostic algorithm, including a comprehensive echocardiographic examination - in first 48 hours and at the end of the third week of the disease. The study group included 84 patients with pulmonary hypertension, which had occurred at the end of the third week of the disease at an initially normal level of mean pressure in the pulmonary artery. Control group consisted of 367 patients with a normal level of mean pulmonary artery pressure in both phases of the study or normalization of this indicator at the end of the subacute period of the disease. Using multivariate analysis of variance from the analytical base, we selected parameters associated with levels of mean pulmonary artery pressure, the proportion of patients with first­time pulmonary hypertension at the end of the subacute Ml. Then, with step-by-step and binary logistic regressions, most sensitive of them were selected for the prognostic model.

Results: study established a number of significant for the development of pulmonary hypertension in the subacute period of myocardial infarction clinical and anamnestic (heart rate, diastolic blood pressure, the presence of pulmonary edema and chronic lung diseases), laboratory (concentrations of the sodium, potassium, chloride; glucose, some parameters of lipid concentration in the blood plasma) and instrumental (the value of left atrium, end-diastolic size of the right ventricle, values of indices of end-systolic and end-diastolic left ventricular volumes, cardiac index, total pulmonary resistance, the presence of regurgitation at the aortic valve) parameters. Final prognostic model included mean pulmonary artery pressure, heart rate and the presence of aortic valve regurgitation of the second degree and higher in first 48 hours of myocardial infarction. Characteristics of the resulting model allow us to recommend it for practical use.

Conclusions: using a combination of these predictors, as well as prognostic modeling, makes it possible to distinguish among men under 60 years, a high-risk group for the development of pulmonary hypertension in the subacute period of the disease in order to conduct timely additional diagnostic and therapeutic measures.

 

References

1.     Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology and the European Respiratory Society: Endorsed by: Association for European Pediatric and Congenital Cardiology, International Society for Heart and Lung Transplantation. Eur Heart J. 2016;37(1): 67-119. PMID:26320113.

https://doi.org/10.1093/eurhearti/ehv317

2.     Haeck ML, Hoogslag GE, Boden H, et al. Prognostic Implications of Elevated Pulmonary Artery Pressure After ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2016; 118(3): 326-31. PMID: 27265675.

https://doi.orq/10.1016/i.amicard.2016.05.008

3.     Thygesen K, Alpert JS, Jaffe AS, et al. Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72(18):2231-2264. PMID: 30153967.

https://doi.org/10.1016/i.iacc.2O18.08.1038

4.     Lang RM, Badano LP, Mor-AviV, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015; 16(3): 233-70. PMID: 25712077.

https://doi.org/10.1093/ehici/iev014

5.     Erlikh AD. Novel score for mortality risk prediction 6 months after acute coronary syndrome. Russian Journal of Cardiology. 2020;25(2):3416 [In Russ].

https://doi.org/10.15829/1560-4071 -2020-2-3416

6.     Sotnikov AV, Epifanov SYu, Kudinova AN etal. Predictors of recurrent ischemic damages in men under 60 years of age with myocardial infarction. Science of the young (Eruditio Juvenium) 2019; 7(4): 565-574 [In Russ].

http://doi.org/10.23888/HMJ201974565-574

7.     Panev Nl, FilimonovSN, Korotenko OYu et al. System for predicting the probability of developing respiratory failure in chronic mechanic bronchitis. Medicine in Kuzbass. 2017;16(3): 52-56 [In Russ].

8.     Bax JJ, Di Carli M, Narula J, Delgado V. Multimodality imaging in ischaemic heart failure. Lancet. 2019;393(10175):1056-1070. PMID: 30860031.

https://doi.org/10.1016/S0140-6736(18)33207-0

9.     Sheludko EG, Naumov DE, Prikhodko AG, Kolosov VP. Clinical and functional peculiarities of comorbid obstructive sleep apnea syndrome and asthma. Bulletin Physiology and Pathology o f Respiration. 2019; (71): 23-30 [In Russ].

http://doi.org/10.12737/article_5c88b5e86b9c18.75963991

10.   Chistyakova MV, Govorin AV, Radaeva EV. Opportunities for prediction of pulmonary hypertension development in patients with viral liver cirrhosis. Russian Journal of Cardiology. 2017;(4):70-74 [In Russ].

https://doi.org/10.15829/1560-4071-2017-4-70-74

11.   Agapitov LI. Diagnostics and treatment of childish pulmonary arterial hypertension. Diagnostics and treatment of childish pulmonary arterial hypertension. Lechaschi Vrach Journal. 2014; 4: 50 [In Russ].

12.   Laletin DA, Bautin AE, Rubinchik VE, Mikhailov AP. Right ventricle contractility during early postoperative period after coronary artery bypass grafting with cardiopulmonary bypass. Circulation Pathology and Cardiac Surgery. 2014; 18(3): 34-38 [In Russ].

13.   Kirillova W. Early ultrasound detection of venous congestion in pulmonary circulation in patients with chronic heart failure. Russian Heart Failure Journal. 2017; 18(3):208-212 [In Russ].

http://doi.org/10.18087/RHFJ.2017.3.2315

 

Abstract:

Introduction: among patients with ischemic stroke (IS), more than 17% has atrial fibrillation (AF). The active application of aspiration thrombectomy (AT), in addition to thrombolytic therapy (TLT), can significantly improve functional outcome, prognosis and survival of patients with IS. The main method of preventing of IS in patients with nonvalvular AF today is still an anticoagulant therapy, but percutaneous transcatheter occlusion of the left atrium appendage (LAA) can be an alternative method, especially if anticoagulant therapy is contraindicated or ineffective.

Aim: was to demonstrate results of a complex staged treatment of an age-related patient with nonvalvular atrial fibrillation, complicated by the development of cardioembolic ischemic stroke while taking anticoagulants.

Material and methods: a clinical observation of a 81-year-old patient delivered to the hospital with a clinical manifestation of ischemic stroke in the “therapeutic window”, with a history of persistent AF and taking anticoagulants, is presented. After conservative therapy - a regression of neurological symptoms was achieved. Three days after - negative dynamics in the clinical picture with development of aphasia and right-sided hemiplegia. Multispiral computed tomography with contrast (MSCT-A): occlusion of M2 segment of the left middle cerebral artery (MCA). Patient underwent aspiration thrombectomy with complete restoration of blood flow and regression of neurological symptoms. After 2 months from the episode of IS, patient underwent implantation of occlude in the left atrial appendage as a prophylaxis of re-embolism, followed by the abolition of warfarin.

Results: a senile patient returned to normal life and self-care (assessed using the modified Rankin scale 1). During next 13 months patient had no major adverse cardiac events (MACE) or significant bleeding and all that shows that occlusion of LAA is effective.

Conclusions: in the early period of ischemic stroke, isolated aspiration thrombectomy is the operation of choice in patients with atrial fibrillation and contraindication for thrombolytic therapy, and endovascular occlusion of the left atrial appendage can be the method of choice for secondary prevention of ischemic stroke. Further studies are required to assess applicability and reproducibility of the approach we have described in routine clinical practice.

  

References

1.     Hankey G.J. Stroke. The Lancet. 2017; 389 (10069): 641-654.

https://doi.org/10.1016/S0140-6736(16)30962-X

2.     Feigin V.L., Krishnamurthi R.V., Parmar P., et al; GBD Writing Group; GBD 2013 Stroke Panel Experts Group. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study. Neuroepidemiology. 2015; 45 (3):161-76.

https://doi.org/10.1159/000441085

3.     Savello AV, Voznjuk IA, Svistov DV, Babichev KN, Kandyba DV, Shenderov SV, Vlasenko SV, Shlojdo EA, Kachesov JeJu, Esipovich ID, Haritonova TV. Results of treatment of ischemic stroke using intravascular thromboembolectomy in conditions of regional vascular centers in a metropolis (St. Petersburg). Zhurnal nevrologii i psihiatrii im. C.C. Korsakova. 2018; 118 (12-2): 54-63.

https://doi.org/10.17116/jnevro201811812254

4.     Savello AV, Svistov DV, Sorokoumov VA. Endovascular treatments for ischemic stroke: Present status and prospects. Nevrologia, nejropsihiatria, psihosomatika. 2015; 7 (4): 42-49.

https://doi.org/10.14412/2074-2711-2015-4-42-49

5.     Saposnik G., Gladstone D., Raptis R., et al. Investigators of the Registry of the Canadian Stroke Network (RCSN) and the Stroke Outcomes Research Canada (SORCan) Working Group. Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes. Stroke. 2013; 44 (1): 99-104.

https://doi.org/10.1161/STROKEAHA.112.676551

6.     Lin H.J., Wolf P.A., Kelly-Hayes M., et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke. 1996; 27 (10): 1760-1764.

https://doi.org/10.1161/01.str.27.10.1760

7.     Pistoia F., Sacco S., Tiseo C., et al. The Epidemiology of Atrial Fibrillation and Stroke. Cardiol Clin. 2016; 34 (2): 255-268.

https://doi.org/10.1016/j.ccl.2015.12.002

8.     Aguilar M.I., Hart R., Pearce L.A. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev. 2007; 18 (3): CD006186.

https://doi.org/10.1002/14651858.CD006186.pub2

9.     Kamel H., Healey J.S. Cardioembolic Stroke. Circ Res. 2017; 120 (3): 514-526.

https://doi.org/10.1161/CIRCRESAHA.116.308407

10.   Go A.S., Hylek E.M, Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285 (18): 2370-2375.

https://doi.org/10.1001/jama.285.18.2370

11.   Demaerschalk B.M., Kleindorfer D.O., Adeoye O.M., et al. American Heart Association Stroke Council and Council on Epidemiology and Prevention. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/ American Stroke Association. Stroke. 2016; 47 (2): 581-641.

https://doi.org/10.1161/STR.0000000000000086

12.   Powers W.J., Rabinstein A.A., Ackerson T., et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019; 50 (12): 344-418

https://doi.org/10.1161/STR.0000000000000211

13.   Bajwa R.J., Kovell L., Resar J.R., et al. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Clin Cardiol. 2017; 40 (10): 825-831.

https://doi.org/10.1002/clc.22764

14.   Kirchhof P., Benussi S., Kotecha D., et al. 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS. 2017; 70 (1): 50.

https://doi.org/10.1016/j.rec.2016.11.033 

 

Abstract:

Introduction: the diagnosis of osteomyelitis in children and adolescents in early stages is the key to successful treatment of this formidable disease. Timely treatment will avoid a deterioration in the quality of life of patients, which is extremely important for adolescent patients. In recent decades, there has been an increase in the percentage of patients with osteomyelitis in childhood and adolescence.

Non-specific clinical manifestations of the disease and the absence of manifestations on radiographs for a long time lead to an incorrect interpretation of clinical and radiological data.

Aim: was to demonstrate possibilities of magnetic resonance imaging (MRI) and ultrasound (ultrasound) in diagnosis of osteomyelitis in case of adverse anatomical localization.

Material and methods: we present a case report of complex radiation diagnosis of inflammatory lesions of the musculoskeletal system of adverse anatomical localization in a teenager. Clinically patient suffered from severe pain in left hip joint with pain radiation to the left thigh, limitation of movements in the joint concerned, swelling of soft tissues of the left thigh and gluteal region against the background of hyperthermia.

Results: according to data of digital radiography, the patient did not reveal signs of the destructive process of bone tissue. Changes in the form of psoit and coxitis were detected by ultrasound. Examination was supplemented by MRI, according to which on T2 FatSat in coronal and axial projections the left-sided synovitis was confirmed, without inflammatory changes in the bone tissue. 10 days after, MRI revealed inflammatory changes in the bone marrow of the head of left femur, left pubic and iliac bones, adjacent soft tissues and left-sided synovitis, regarded as a manifestation of acute hematogenous osteomyelitis. Patient underwent surgical and symptomatic treatment with a positive result.

Conclusions:

1. Absence of pathological changes according to x-ray examinations in children and adolescents (radiography and MSCT) does not exclude the presence of osteomyelitis, due to the absence of manifestations on radiographs for a long time.

2. At early stages of disease, especially in young children, as well as at stages of conservative and surgical treatment, the most appropriate use of ultrasound and MRI.

3. Conducting MSCT is advisable after obtaining ultrasound and MRI data on the presence of bonedestructive changes.

  

References

1.     Bruchanov AV, Vasiliev AYu. Magnetic resonance imaging in osteology. Publishing house «Medicine», 2006; 200. [In Russ].

2.     Trufanov GE, Fokin VA. Features of the application of radiation diagnostic methods in pediatric practice. Vestnik sovremennoj klinicheskoj mediciny.2013; 6(6): 48–52 [In Russ].

3.     Peltola H, Paakkonen M. Acute Osteomyelitis in Children. N Engl J Med 2014; 370: 352-360.

4.     Basu S, Chryssikos T, Moghadem-Kia S, Zhuang H, Torigian DA, Alavi A. Positron emisson tomography as a diagnostic tool in infection: present role and future possibilities. Semin. Nucl. Med. 2009; 39 (1): 36-51

5.     Vasiliev AYu, Olkhova EB. Fundamentals of ultrasound diagnostics in pediatrics and pediatric surgery. M. 2019: 171-190 [In Russ].

 

Abstract:

Aim: was to analyze domestic and foreign literature sources, reflecting the possibility of applying local ablation methods of focal liver tumors.

Material and methods: article presents an analysis of domestic and foreign 37 publications containing information on the use of methods of local ablation of nodular pathology of liver, deposited in resources of PubMed and information portal eLIBRARY.RU.

Results: most important aspects of performing of methods of chemical, cryo-, microwave, and radiofrequency ablations, used in treatment of local liver tumors were presented.

Conclusion: analysis of various publications on methods of local destruction of tumors does not give a clear answer to the question of which method is preferred, however, article describes each of ablation methods, highlighting positive and negative aspects of their effect on lesions of the liver. The question of the inclusion of minimally invasive methods in schemes of combined and complex antitumor therapy for focal liver lesions also remains open.

Modern approaches and improving techniques of treatment of liver malignancies, expand indications for the use of minimally invasive techniques. Competent selection of patients, selection of the optimal method of local ablation of tumor and subsequent dynamic monitoring of patients reduce the number of relapses, increase the percentage of overall survival of patients and improve their quality of life.

  

References

1.     Truty MJ, Vauthey J-N. Surgical resection of highrisk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique. Ann. Surg. Oncol. 2010; 17: 1219-1225.

2.     Gillams AR. Radiofrequency ablation in the management of liver tumors. Eur. J. Surg. Oncol. 2003; 29(1): 9-16.

3.     Patjutko JuI, Chuchuev ES, Podluzhnyj DV, et al. Surgical tactics in treatment of colorectal cancer patients with synchronous liver metastases. Onkologicheskaja koloproktologija. 2011; 2: 13-19. [In Russ].

4.     Liu LX, Zhang WH, Jiang HC. Current treatment for liver metastases from colorectal cancer. World J. Gastroenterol. 2003; 9: 193-200.

5.     Patjutko JuI, Sagajdak IV. Indications and contraindications for liver resections in case of metastases of colorectal cancer. The value of prognostic factors and their classification. Ann. Hir. Gepatol. 2003; 8(1): 110-118 [In Russ].

6.     Granov DA, Tarazov PG. Endovascular interventions in treatment of malignant tumors of the liver. SPb. Foliant. 2002; 287 [In Russ].

7.     Verjasova NN. Treatment of malignant tumors of the liver with the use of local injection therapy with ethanol. CNIIRI. SPb. Avtoreferat. 2002; 6-8 [In Russ].

8.     Sugiura Y, Nakamura S, Iida S, et. al. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: A cooperative study of the Keio Bile Duct Cancer Study Group. Surgery. 1994; 15(4): 445-451.

9.     Elgindy N, Lindholm H, Gunvйn P. High dose percutaneous ethanol injection therapy of liver tumors: patient acceptance and complications. Acta Radiologica. 2000; (5): 458-463.

10.   Shaposhnikov AV, Bordshkov JuN, Nepomnjashhaja EM, at al. Local therapy of unresectable liver tumors. Ann. Hir. Gepatol. 2004; 9(1): 89-94 [In Russ].

11.   Siperstein AE, Berber E. Cryoablation, Percutaneous Alcohol Injection, and Radiofrequency Ablation for Treatment of Neuroendocrine Liver Metastases. World. J. Surg. 2001; (25): 693-696.

12.   Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat. Rev. Cancer. 2014; 3: 199-208.

13.   Adam R, Akpinar E, Johann M, et al. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg. 1997; 225: 239–250.

14.   Mala T. Cryoablation of colorectal liver metastases: minimally invasive tumor control. Scand. J. Gastroenter. 2004; 39: 571-578.

15.   Samojlov VA, Saljukov JuL, Gladenko AA, et al. Experience in the use of cryodestruction in treatment of metastatic liver cancer. Ann. Hir. Gepatol. 1998; 3: 326 [In Russ].

16.   Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J.R. Coll. Surg. Edinb. 1998; 43: 141-154.

17.   Erinjeri JP, Clark TW. Cryoablation: mechanism of action and devices. J Vasc Interv Radiol. 2010; 21: 187-191.

18.   Ahmed M, Brace CL, Lee FT, at al. Principles of and advances in percutaneous ablation. Radiology. 2011; 258(2): 351-369.

19.   Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat. Rev. Cancer. 2014; 14(3): 199-208.

20.   Starkov JuG, Shishin KV. Cryosurgery of focal liver lesions. Hirurgija. 2000; 7: 53-59 [In Russ].

21.   Hinshaw JL, Lubner MG, Ziemlewicz TJ, et al. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation – what should you use and why? Radiographics. 2014; 34(5): 1344-1362.

22.   Ravikumar TS, Kane R, Cady B, et al. A 5-year study of cryosurgeryin the treatment of liver tumors. Arc. Hir. Surg. 1991; 125: 1520-1524.

23.   Crews KA, Kuhn JA, McCarty TM, et al. Cryosurgical ablation of hepatic tumors. Am. J. Surg. 1997; 174: 614-617.

24.   Lubner MG, Brace CL, Hinshaw JL et al. Microwave tumor ablation: mechanism of action, clinical results, and devices. J. Vasc. Interv. Radiol. 2010; 21: 192-203.

25.   Lencioni R, de Baere T, Martin RC, at al. Imageguided ablation of malignant liver tumors: recommendations for clinical validation of novel thermal and non-thermal technologies - a western perspective. Liver Cancer. 2015; (4): 208–214.

26.   Mayo SC, Pawlik TM. Thermal ablative therapies for secondary hepatic malignancies. Cancer J. 2010; 16 (2): 111-117.

27.   Scudamore CH, Patterson EJ, Shapiro AM, et al. Liver tumor ablation techniques. J. Invest. Surg. 1997; 4: 157-64.

28.   Brace C. Thermal tumor ablation in clinical use. IEEE Pulse. 2011; (5):28-38.

29.   Iannitti DA, Martin RC, Simon CJ, et al. Hepatic tumor ablation with clustered microwave antennae. The US Phase II trial. HPB (Oxford). 2007; 9(2): 120.

30.   Rossi S, Carbagnati P, Rosa L, et al. Laparoscopic radio frequency thermal ablation for treatment of hepatocelluar carcinoma. Int. J. Clin. Oncol. 2002; 225-235.

31.   Zivin SP, Gaba RC. Technical and practical considerations for device selection in locoregional ablative therapy. Semin. Intervent. Radiol. 2014: 31(2): 212-24.

32.   Mehta A, Oklu R, Sheth RA. Thermal ablative therapies and immune checkpoint modulation: can locoregional approaches effect a systemic response? Gastroenterology Research and Practice. 2016; 9251375: 11.

33.   Sidana A. Cancer immunotherapy using tumor cryoablation. Immunotherapy. 2014; 6(1): 85-93.

34.   Dolgushin BI, Patjutko JuI, Sholohov VN, et al. Radiofrequency thermal ablation of liver tumors. Edited by MI Davydov. Prakticheskaja medicina. 2007; 192 [In Russ].

35.   Fedorov VD, Vishnevskij VA, Kornjak BS, at al. Radiofrequency ablation of malignant tumors of the liver (literature review). Hirurgija. 2003; 10: 77-80 [In Russ].

36.   Machi J, Oishi AJ, Mossing AJ, Furumoto NL, Oishi RH. Hand-assisted laparoscopic ultrasound-guided radiofrequency thermal ablation of liver tumors: a technical report. Surg Laparosc Endosc Percutan Tech. 2002; 12:160–164.

37.   Gilliams AR, Lees WR. CT mapping of the distribution of saline during radiofrequency ablation with perfusion electrodes. Cardiovasc Intervent Radiol. 2005; 476-480.

 

ABSTRACT:

Article presents a literature review on the role of magnetic resonance imaging (MRI) of sacroiliac joints in the diagnosis of ankylosing spondylitis.

Aim: was to analyze domestic and foreign literature sources that reflect the state of the problem and aspects of radiodiagnostics of sacroiliac joints in patients with ankylosing spondylitis.

Materials and methods: article contains analysis of 29 literature sources of leading domestic and foreign scientific journals.

Results: for a reliable diagnosis of ankylosing spondylitis, the presence of x-ray confirmed sacroiliitis is a prerequisite. However, difficulties in confirming or absence of sings of sacroiliitis on radiography at the beginning of the disease leads to a delay in the diagnosis of ankylosing spondylitis, which is established for 5-10 years after first clinical signs of the disease. Magnetic resonance imaging allows us to evaluate changes in sacroiliac joints in early stages of the disease and prevent the development of significant structural changes that lead to early disability of patients. MR-symptoms of active inflammation of sacroiliac joints in ankylosing spondylitis include: edema of the bone marrow (ostitis) in subchondral parts of iliac bones and sacrum, edema of the capsule (capsulitis) and periarticular ligaments (enteritis) joint, as well as synovitis, accompanied by synovial effusion into the joint cavity. MR-symptoms of structural changes in sacroiliac joints in ankylosing spondylitis include: bone erosion, sclerosis, fat deposits of the bone marrow, bone bridges, ankyloses.

Conclusion: magnetic resonance imaging currently occupies a leading position in the early diagnosis of ankylosing spondylitis, which allows us to identify active inflammatory and structural changes in sacroiliac joints.

  

References

1.     Jerdes ShF, Rebrov AP, Dubinina TV et al. Spondylarthritis: modern terminology and definitions. Terapevticheskij arhiv. 2019; 5: 84–88 [In Russ].

2.     Russian clinical guidelines. Rheumatology. (Ed. E.L. Nasonov.) Moscow: GEOTAR-Media, 2019; 464 [In Russ].

3.     Cherencova IA, Otteva EN, Ostrovskij AB. A new look at ankylosing spondylitis. Zdravoohranenie Dal'nego Vostoka. 2016; 2: 93–101 [In Russ].

4.     Van der Linden S, Valkenburg H, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum. 1984; 27: 361–368.

5.     Kellgren JH, Jeffrey MR. Spondylitis ankylopoetica: een Famile en Bevolkingsonderzoek en toetsing van diagnostische Criteria (thesis). Leiden University (The Netherlands). 1982; 16–70.

6.     Bennett P, Burch T. Population studies of the rheumatic diseases. Amsterdam: The Netherland. Excerpta Medica Foundation. 1968; 456–7.

7.     Smirnov AV, Erdes ShF. Optimization of radiodiagnostics of ankylosing spondylitis in clinical practice – the importance of a survey radiography of the pelvis. Nauchno-prakticheskaya revmatologiya. 2015; 53(2): 175–181 [In Russ].

8.     Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum. 2005; 52 (4): 1000–1008.

9.     Rudwaleit M, van der Heijde D, Khan MA et al. How to diagnose axial spondyloarthritis early. Ann Rheum Dis. 2004; 63: 535–43.

10.   Mau W, Zeidler H, Mau R et al. Outcome of possible ankylosing spondylitis in a 10 years' follow-up study. Clin Rheumatol. 1987; 6 (Suppl. 2): 60–6.

11.   Bashkova IB, Madyanov IV. Ankylosing spondylitis: diagnostic aspects and the importance of non-steroidal anti-inflammatory drugs in its treatment (to help a general practitioner). Russkij medicinskij zhurnal. 2016; 24 (2): 101–108 [In Russ].

12.   Rudwaleit M, Landewe R, van der Heijde D et al. SpondyloArthritis international Society (ASAS) classification criteria for axial spondyloarthritis (Part I): Classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009; 68: 770–776.

13.   Rudwaleit M, Jurik AG, Hermann KG et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS / OMERACT MRI group. Ann. Rheum. Dis. 2009; 10: 1520–1527.

14.   Levshakova AV. Differential diagnosis of sacroiliitis. Radiologiya – praktika. 2012; 2: 39–44 [In Russ].

15.   Erdes ShF, Bochkova AG, Dubinina TV et al. Early diagnosis of ankylosing spondylitis. Nauchno-prakticheskaya revmatologiya. 2013; 51 (4): 365–367 [In Russ].

16.   Rumyanceva DG, Dubinina TV, Demina AB et al. Ankylosing spondylitis and radiologically non-confirmed axial spondylitis: two stages of the same disease? Terapevticheskij arhiv. 2017; 5: 33–37 [In Russ].

17.   Bochkova AG, Levshakova AV. Criteria for a reliable diagnosis of sacroiliitis according to magnetic resonance imaging (ASAS / OMERACT recommendations and own data). Sovremennaya revmatologiya. 2010; 1: 12–17 [In Russ].

18.   Sieper J, van der Heijde D, Landewe R et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis International Society (ASAS). Ann. Rheum. Dis. 2009; 68: 784–788.

19.   Dubinina TV, Erdes Sh. Inflammatory pain in the lower back in the early diagnosis of spondyloartritis. Nauchno-prakticheskaya revmatologiya. 2014; 4: 55–73 [In Russ].

20.   Levshakova AV. Radiodiagnostics of sacroiliitis. Radiologiya – praktika. 2011; 3: 33–41 [In Russ].

21.   Sudo?-Szopi?ska I, Jurik AG, Eshed I et al. Recommendations of the ESSR Arthritis Subcommittee for the Use of Magnetic Resonance Imaging in Musculoskeletal Rheumatic Diseases. Semin Musculoskelet Radiol. 2015; 19 (4): 396–411.

22.   Oostveen J, Prevo R, den Boer J et al. Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography: a prospective, longitudinal study. J Rheumatol. 1999; 26: 1953–1958.

23.   Smirnov AV, Erdes ShF. Diagnosis of inflammatory changes in the axial skeleton in ankylosing spondylitis according to data of magnetic resonance imaging. Nauchno-prakticheskaya revmatologiya. 2016; 54 (1): 53–59[In Russ].

24.   Tyuhova EYu. Magnetic resonance imaging of the spine and sacroiliac joints in patients with spondyloartritis.Nauchno-prakticheskaya revmatologiya. 2012; 51 (2): 106–111 [In Russ].

25.   Levshakova AV, Bochkova AG, Bunchuk NV. Magnetic resonance imaging in the diagnosis of sacroiliitis in patients with ankylosing spondylitis. Medicinskaya vizualizaciya. 2008; 2: 97–103 [In Russ].

26.   Rudwaleit M, Jurik AG, Hermann KG et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis. 2009; 68 (10):1520–1527.

27.   Rudwaleit M, Landewe R, van der Heijde D et al. SpondyloArthritis international Society (ASAS) classification criteria for axial spondyloarthritis (Part II): Validation and final selection. Ann Rheum Dis. 2009; 68: 777–83.

28.   Sieper J, Rudwaleit M, Baraliakos X. The Assessment of Spondyloarthritis International Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009; 68 (2): 1–44.

29.   Levshakova AV, Bunchuk NV, Bochkova AG. Structural changes in sacroiliac joints in patients with ankylosing spondylitis according to magnetic resonance imaging. Kubanskij nauchnyj medicinskij vestnik. 2010; 6 (120): 70–74 [In Russ].

 

Abstract:

Introduction: vascular closure devices (VCD) for over 20 years have been used as an alternative to manual compression to achieve hemostasis. Despite the fact that clinical efficacy and safety of occlusive type VCD have been confirmed in a number of studies, their use remains controversial due to the formation of complications at the access site when using these devices.

Aim: was to estimate possible advantages and limitations of vascular closure devices of occlusive type (Angio-Seal) in patients, who had underwent percutaneous coronary interventions (PCI) via femoral access in comparison with traditional manual hemostasis.

Material and methods: data of 231 adult patients who underwent therapeutic endovascular procedures in the City Hospital named after M.P. Konchalovsky, Research and Development Center for Preventive Medicine were selected for retrospective research. The main group, with hemostasis after PCI with Angio-Seal (Terumo) obturating device, consisted of 113 patients, control group - included 118 patients with manual hemostasis. Subjective sensations (pain, numbness, etc.), complication rate, hemostasis time, immobilization and hospitalization duration were evaluated.

Results: success of using VCD was 98.23%, complication rate in the main group was 4.37%, in the control group - 6.78% (however, it was not reliable). The time of hemostasis (2.1 min versus 22.25 min), immobilization (3.5 hours versus 20.6 hours) and hospitalization (4 days versus 8 days) significantly decreased, and the patient comfort level was significantly higher in the main group.

Conclusions: the use of Angio-Seal VCD in patients after percutaneous transfemoral therapeutic endovascular procedures is an effective way to reduce hemostasis time in comparison with using of manual compression; allows to reduce patient's immobilization period, significantly increases patient comfort, and reduces patient's hospital stay.

Along with this procedure, it should be considered as an independent surgical intervention and surgeon should follow all necessary rules and stages of its implementation, should control result of hemostasis.

 

References

1.     Bockeria LA, Alekyan BG. State of endovascular diagnosis and treatment of cardiac and vascular diseases in the Russian Federation (2014). Russian Journal of Endovascular Surgery 2015; 2(1-2):5-20 [In Russ].

2.     Byrne RA, Cassese S, Linhardt M, Kastrati A. Vascular access and closure in coronary angiography and percutaneous intervention. Nat Rev Cardiol. 2013; 10(1):27-40.

3.     Semitko SP, Gubenko IM, Analeev AI, Azarov AV, Maiskov VV, Karpun NA, Iosseliani DG. Vascular complications of percutaneous coronary interventions and clinical results of the use of various devices providing hemostasis. Consilium medicum 2012; 14(10): 51-57 [In Russ].

4.     Dauerman HL, Applegate RJ, Cohen DJ. Vascular closure devices: the second decade. J Am Coll Cardiol. 2007; 50(17):1617-1626.

5.     Biancari F, D’Andrea V, Di Marco C, Savino G, Tiozzo V, Catania A. Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty. Am Heart J. 2010; 159(4): 518-531.

6.     Ndrepepa G, Berger PB, Mehilli J et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol 2008; 51:690.

7.     Rao SV, Kedev S. Approaching the post-femoral era for coronary angiography and intervention. JACC Cardiovasc. Interv. 2015; 8: 524–526.

8.     Lo TS et al. Radial artery anomaly and its influence on transradial coronary procedural outcome. Heart 2009; 95(5): 410–415.

9.     Sciahbasi A et al. Transradial approach (left versus right) and procedural times during percutaneous coronary procedures: TALENT study. Am. Heart J. 2011; 161: 172–179.

 

Abstract:

Article presents our experience of endovascular occlusion of gonadal veins in patients with pelvic congestion syndrome (PCS). Interventional treatment of patients with this pathology requires further research.

Aim: was to study aspects of endovascular occlusion of gonadal veins in patients with pelvic congestion syndrome.

Materials and methods: 22 patients with a primary form of pelvic congestion syndrome were included in a prospective, single-center study. The diagnosis was based on screening ultrasound duplex angioscanning. The criterion for inclusion in the study was the presence of varicose expansion of ovarian veins (OV) of more than 5 mm in combination with its valve failure. Exclusion criteria were: presence of secondary PCS against the background of obstructive syndromes, multivessel anatomy type of OV, pregnancy at any gestation age.

To assess the dynamics of manifestations of pelvic venous congestion, we used the PVVQ questionnaire (Pelvic Varicose Veins Questionnaire) and the PCS clinical severity scale - PVCSS (Pelvic Venous Clinical Severity Score), as well as the visual-analogue scale (VAS) of main symptoms of the disease.

Instrumental research methods included: ultrasound duplex transvaginal and transabdominal angioscanning (UDAS), multispiral computer phlebography (MSCT-phlebography), digital phlebography with invasive direct phlebomanometry.

Results: technical success of endovascular occlusion of ovarian veins was 100%. In two cases, immediately after the operation, a second intervention was performed: in one case - resection of the ovarian vein, in the second - re-positioning of the microspiral. In the long-term follow-up period, in one of the women due to relapse, the ovarian vein occlusion procedure was repeated.

Conclusions: estimation of results of clinical research methods, showed a decrease in the intensity of manifestations of pelvic congestion syndrome basing on severity scale and a visual-analogue scale, as well as an improvement in the quality of life of patients.

 

References

1.     Russian clinical recommendtaions on diagnostics and treatment of chronic diseases of veins. Flebologiya. 2018; 3(12): 146–240 [In Russ].

https://doi.org/10.17116/flebo20187031146 

2.     Howard FM. Chronic pelvic pain. Obstetrics Gynecology. 2003; 101: 594–611.

https://doi.org/10.1016/S0029-7844(02)02723-0

3.     Ganeshan A, Upponi S, Lye-Quen H. et al. Chronic pelvic pain due to pelvic congestion syndrome: The role of diagnostic and interventional radiology. Cardiovasc Intervent Radiol. 2007; 30: 1105–1111.

4.     Durham JD, Machan L. Pelvic Congestion Syndrome. Semin Intervent Radiol. 2013; 30: 372–380.

5.     Ahmed O, Ng J, Patel M et al. Endovascular Stent Placement for May-Thurner Syndrome in the Absence of Acute Deep Vein Thrombosis. J Vasc Interv Radiol. 2016; 27(2): 167–173.

https://doi.org/10.1016/j.jvir.2015.10.028

6.     Drazic BO, Z?rate BC, Vald?s EF et al. Embolization of insufficient pelvic veins for pelvic congestion syndrome. Analysis of 17 cases. [Article in Spanish]. Rev Med Chil. 2019; 147(1): 41–46.

https://doi.org/10.4067/S0034-98872019000100041

7.     Mahmoud O, Vikatmaa P, Aho P et al. Efficacy of endovascular treatment for pelvic congestion syndrome. J Vasc Surg Venous Lymphat Disord. 2016; 4(3): 355–370.

https://doi.org/10.1016/j.jvsv.2016.01.002

8.     Champaneria R, Shah L, Moss J et al. The relationship between pelvic vein incompetence and chronic pelvic pain in women: systematic reviews of diagnosis and treatment effectiveness. Health Technology Assessment. 2016; 20(5): 1–108.

9.     Sharma K, Bora M.K, Varghes J et al. Role of Trans Vaginal Ultrasound and Doppler in Diagnosis of Pelvic Congestion Syndrome. J. Clinic. And Diagnos. Research. 2014; 8(7): OD05 – OD07.

https://doi.org/10.7860/JCDR/2014/8106.4570

10.   Ahmetzianov RV, Bredihin RA, Fomina EE. Estimation of quality of life in patients with pelvic varicose veins. Flebologiya. 2019; 13(2): 133–139 [In Russ].

https://doi.org/10.17116/flebo201913021133

11.   Ahmetzianov RV, Bredihin RA, Fomina EE, Ignatiev I.M. Method of determining disease severity in women with pelvic varicose veins. Angiologiya i sosudistaya hirurgiya.2019; 25(3): 79–86 [In Russ].

12.   Meissner M, Gibson K. Clinical outcome after treatment of pelvic congestion syndrome: sense and nonsense. Phlebology. 2015; 30(1 Suppl): 73–80.

13.   Hartung O, Grisoli D, Boufi M et al. Endovascular stenting in the treatment of pelvic vein congestion caused by nutcracker syndrome: lessons learned from the first five cases. J Vasc Surg. 2005; 42(2): 275–280.

14.   Strahov SN, Pryadko SI, Bondar ZM et al. Variants of archytectonics, hemodynamics of left renal and ovarian veins and choice of pathogenetically reasonable method of surgical treatment of left-sided varicocele. Annaly hirurgii. 2014; 3: 32–40 [In Russ].

15.   Zhukov OB, Verzin AV, Pen'kov PL. Regional renal venous hypertension and left-sided varicocele. Andrologiya i genital'naya hirurgiya. 2013; 3: 29–37 [In Russ].

16.   Scultetus AH, Villavicencio JL, Gillespie DL. The nutcracker syndrome: its role in the pelvic venous disorders. J Vasc Surg. 2001; 34(5): 812–819.

https://doi.org/10.1067/mva.2001.118802

17.   Pokrovskij AB, Dan VN, Troickij AV et al. Resection and reimplantation of renal vein in its stenosis in aortomesenteric «weezers». Angiologiya i sosudistaya hirurgiya. 1998; 2: 131–138 [In Russ]. 

 

Abstract:

Aim: was to estimate long-term results of vertebral artery (VA) stenting in patients with vertebrobasilar insufficiency (VBI).

Material and methods: study included 194 patients with VBI caused by lesion of V1 segment of VA. All patients received the best course of drug therapy before admission to the clinic. In all these patients, atherosclerotic stenosis of 70% or more of VA was revealed in V1 sergment. All patients underwent surgical correction of V1 segment of VA. Open surgery was performed in «A» group – with a tortuosity of VA – 129(66,5%), in group «B» – without tortuosity of a VA – 65(33,5%) performed stenting of V1 segment of PA.

Bare-metal stents were implanted in 44 patients, drug-eluted stents - 14, renal stents – 7. Distal protection was used in 14 patients. In remaining patients, stenting was performed without embolic protection devices.

Main criteria for evaluating of results were: patency of the reconstruction zone and clinical improvement in the patient after surgery. Statistical processing of results was carried out by calculating ?2, the exact Fisher test (EFT) and constructing of Kaplan-Meier survival curves.

Results: it was determined that in «hopeless» patients, from the point of view of drug treatment, it is possible to achieve a significant clinical effect by surgical methods. Of 194 patients, clinical improvement in the early postoperative period was achieved in 189(97,4%) patients, after 1 year in 177 (91,2%) patients, and after 3 years in 156(80.2%) patients.

In case of stenting of V1 segment of VA – we received excellent immediate results – 100% of technical and clinical success. However, in the long term, results of open operations were better than results of stenting. 3 years after operation, a higher clinical efficacy of open methods was determined – 79,8%, in contrast to stenting – 73,8%. Although, differences were not statistically significant (p> 0,05). 3 years after operation, in case of open operations, a significantly smaller number of restenosis of the reconstruction zone was 1.6%, than with stenting – 15,4% (p <0.05). However, in patients with open operations, more thrombosis of the reconstruction zone were revealed – 5,5% than in patients with stenting – 1.5% (p>0,05). When performing open operations on V1 segment of VA, strokes were fewer – 2.3%, than in group of V1 stenting segment of VA – 3.1% (p> 0.05). When comparing Kaplan-Meyer curves, the median during open surgeries on VA is not achieved after 18 years, and in group of stenting of VA, it occurs after 7 years.

Conclusion: stenting of V1 segment of vertebral arteries in patients with VBI is not the operation of choice in terms of long-term results. However, this operation can be considered as the first stage of brain revascularization in the presence of significant stenosis of V1 segment of vertebral artery and low brain tolerance to ischemia in patients with multiple lesions of brachiocephalic arteries.

 

References

1.     Savitz SI, Caplan LR: Vertebrobasilar disease. N Engl J Med. 2005; 352:2618-2626.

2.     Caplan LR, Wityk RJ, Glass TA, Tapia J, Pazdera L, Chang HM, Teal P, Dashe JF, Chaves CJ, Breen JC, Vemmos K, Amarenco P, Tettenborn B, Leary M, Estol C, Dewitt LD, Pessin MS: New England Medical Center Posterior Circulation registry. Ann Neurol. 2004; 56:389-398.

3.     Vereschagin NV. Pathology of vertebrobasilar system and cerebrovascular accidents. M. 1980; 312. [In Russ].

4.     Puzin MN, Zinoveva GA, МеtelkinaLP. Aspects of medical treatment of patients with vertebrobasilar insufficiency. Klinicheskaya farmakologiya i terapia, 2006; 2: 23-26. [In Russ].

5.     Berguer R, Morasch M, Kline R. A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease. J Vasc Surg. 1998; 27 (5): 852-859.

6.     Pokrovskii AV, Belojarcev DF. Long-term results of operations subclavian-carotid transposition. Angiologiya i sosudistaya khirurgiya 2002; 8 (2): 84 - 91. [In Russ].

7.     He Y, Bai W, Li T et al. Perioperative complications of recanalization and stenting for symptomatic nonacute vertebrobasilar arteryocclusion. Ann Vasc Surg. 2014 Feb; 28 (2):386-393.

8.     2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018 Mar 1; 39(9): 763-816.

9.     National guidelines on the management of patients with brachiocephalic artery disease. Angiologiya i sosudistaya khirurgiya. 2013; 19 (2), appendix: 70 [In Russ].

10.   Schonewille WJ, Algra A, Serena J, Molina CA, Kappelle LJ. Outcome in patients with basilar artery occlusiontreated conventionally. J Neurol Neurosurg Psychiatry. 2005; 76:1238-1241.

11.   Coward LJ, McCabe DJ, Ederle J, Featherstone RL, Clifton A, Brown MM: Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Stroke. 2007; 38:1526-1530.

12.   Compter A, van der Worp HB, Schonewille WJ, Vos JA, Algra A, Lo TH, Mali WPThM, Moll FL and Kappelle LJ. VAST: Vertebral Artery Stenting Trial. Protocol for a randomized safety and feasibility trial. Trials 2008; 9: 65.

13.   Clifton A, Markus H, Kuker W, Rothwell P.E-050. The Rationale for the Vertebral artery Ischaemia Stenting trial (VIST): NeuroIntervent Surg 2013; 5. Suppl 2 A56.

14.   Compter A et al. VAST investigators. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial. Lancet Neurol. 2015 Jun; 14(6): 606-614.

15.   VIST (Vertebral artery Ischaemia Stenting Trial) ISRCT N 95212240.

16.   Markus HS, Harshfield EL, Compter A. et al. Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis. Lancet Neurol. 2019 Jul; 18(7): 666-673.

https://doi.org/10.1016/S1474-4422(19)30149-8

17.   Markus HS, Larsson SC, Dennis J et al. Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT. Health Technol Assess. 2019 Aug; 23(41): 1-30.

 

Abstract:

Aim: was to analyze the risk of malignancy incidence as a result of exposure of small doses of diagnostic radiation when examining patients on computed tomography (CT).

Material and methods: a retrospective study was conducted on the base of analysis of information from archival protocols for examinations of patients living in Ozersk city and examined in computed tomography department of the Chelyabinsk Regional Clinical Hospital for the period 1993-2004. Study includes generalized material containing data from several population registers of the Laboratory of Radiation Epidemiology of the South Ural Institute of Biophysics.

Results: study revealed the presence of a statistically insignificant excess of the risk of incidence of malignancy among patients who underwent a CT study from the beginning of the appearance of this type of study in hospitals in the Chelyabinsk region until the end of the first stage of epidemiological surveillance - December 31, 2004.

Conclusion: obtained results are interesting for various categories of specialists: radiologists, radiation epidemiologists, radiobiologists and radiation hygiene specialists. Further research is needed with an extension of the retrospective observation period.

 

References

1.     Collection of legislation of the Russian Federation. Federal Law 21.11.2011 No. 323-FZ «On Principles of the Protection of Citizens' Health in the Russian Federation». Part 4, article 34 [In Russ].

https://www.rosminzdrav.ru/documents/7025 

1.     Narkevich BYa, Dolgushin BI. Radiation safety assurance in computed tomography and interventional radiology. REJR. 2013; 2 (3): 7–19.

2.     Brenner DJ, Hall EJ. Computed tomography – an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277-2284.

3.     Order of the Ministry of Health of the Russian Federation No. 298 of July 31, 2000, dated January 9, 1996, No. 3-FZ (Federal Law) «On Approval of the Regulation on the Unified State System of Control and Accounting for iIndividual Exposures of Citizens» [In Russ].

http://legalacts.ru/doc/prikaz-minzdrava-rf-ot-31072000-n-298/ 

4.     Decree of the Government of the Russian Federation dated 16.06.97 No. 718 «On the procedure for creating a unified state system for monitoring and recording individual doses to citizens» [In Russ].

http://legalacts.ru/doc/postanovlenie-pravitelstva-rf-ot-16061997-n-718/ 

5.     Koshurnikova NA, Kabirova NR, Bolotnikova MG, et al. Description of the register of persons, had lived in childhood near the Mayak Production Association. Medical Radiology and Radiation Safety. 2003; 2: 27-34 [In Russ].

6.     Koshurnikova NA, Shilnikova NS, Okatenko PV, et al. Characteristics of cohort of workers of «Mayak» PO. Medical radiology and radiation safety. 1998; 43 (6): 43–57 [In Russ].

7.     United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation: United Nations Scientific Committee on the Effects of Atomic Radiation: UNSCEAR 2012 report to the General Assembly. Scientific Annexes. New York. United Nations; 2015.

8.     Abramson, JH. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiologic Perspectives & Innovations. 2011; 8:1

10.   Preston DL. Epicure User’s Guide. USA: 330.

11.   Howe GR. Lung Cancer Mortality between 1950 and 1987 after Exposure to Fractionated Moderate-Dose-Rate Ionizing Radiation in the Canadian Fluoroscopy Cohort Study and the Comparison with Lung Cancer Mortality in the Atomic Bomb Survivors Study. Radiation Research. 1995; 142: 295-304.

12.   Ivanov VK, Kashcheev VV, Menyaylo SYu, et al. Radiation risk of medical exposure. Radiation and risk. 2012; 21 (4): 7-23 [In Russ].

13.   Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumors: a retrospective cohort study. The Lancet. 2012; 380.

14.   Shilnikova NS, Preston DL, Ron E, et al. Cancer Mortality Risk among Workers at the Mayak Nuclear Complex. Radiation Research. 2003; 159: 787–798.

15.   Lebedev NI, Osipov MV, Babintseva NA, et al. Register of patients undergoing CT scan - examinations in the department of radiation diagnostics of the Central Medical Center-71, Ozersk. REJR. 2017; 7 (2): 110-116 [In Russ].

https://doi.org/10.21569/2222-7415-2017-7-2-110-116

16.   Finashov LV, Kuznetsova IS, Sokolnikov ME. Prostate cancer incidence among workers with work-related exposure of radiation at the Mayak Production Association. Radiation and Risk, 2019; 28 (4): 54–64 [In Russ].

https://doi.org/10.21870/0131-3878-2019-28-4-54-64

17.   Fomin EP, Osipov MV. Pooled database of Ozyorsk population exposed to computed tomography. REJR 2019; 9 (2):234-239.

https://doi.org/10.21569/2222-7415-2019-9-2-234-239

 

Abstract:

Introduction: development of software and hardware capabilities of modern computing systems has enabled three-dimensional (3D) modeling and 3D printing technology (medical prototyping) to become available for a wide range of healthcare specialists. Commercial software used for this purpose remains unavailable to private physicians and small institutions due to the high cost. However, there are freeware applications and affordable 3D printers that can also be used to create medical prototypes.

Aim: was to describe stages of creating of physical 3D models based on medical imaging data and to highlight main features of specialized software and to make an overview of main types of 3D printing used in medicine.

Material and methods: article describes process of creation of medical prototype, that can be divided on three main stages: 1) acquisition of medical imaging, obtained by ‘volumetric’ scanning methods (computed tomography (CT), magnetic-resonance imaging (MRI), 3D ultrasound (3D US)); 2) virtual 3D model making (on the basis of visualisation data) by segmentation, polygonal mesh extraction and correction; 3) 3D printing of virtual model by the chosen method of additive manufacturing, with or without post-processing.

Conclusion: medical prototypes with sufficient precision and physical properties are necessary for understanding of anatomical structure and surgical crew training and can be made with use of freely available software and inexpensive 3D printers.

 

References

1.     Luo H, Meyer-Szary О, Wang Z, Sabiniewicz R, Liu Y. Three-dimensional printing in cardiology: current applications and future challenges. Cardiol. J. 2017; 24 (4): 436–444.

2.     Vukicevic M, Mosadegh B, Min J K, Little S H. Cardiac 3D printing and its future directions. JACC Cardiovasc. Imaging. 2017; 10 (2): 171–184.

3.     Meier LM, Meineri ·M, Hiansen JQ, Horlick EM. Structural and congenital heart disease interventions: the role of three-dimensional printing. Neth Heart J. 2017; 25 (2): 65–75.

4.     Witschey WR, Pouch AM, McGarvey JR, Ikeuchi K, Contijoch F, Levack MM, Yushkevick PA, Sehgal CM, Jackson BM, Gorman RC, Gorman JH. Three-dimensional ultrasound-derived physical mitral valve modeling. Ann. Thorac. Surg. 2014; 98 (2): 691–694.

5.     Vukicevic M, Puperi DS, Grande-Allen KJ, Little SH. 3D Printed Modeling of the Mitral Valve for Catheter-Based Structural Interventions. Ann. Biomed. Eng. 2017; 45 (2): 508–519.

6.     Parimi M, Buelter J, Thanugundla V, Condoor S, Parkar N, Danon S, King W. Feasibility and Validity of Printing 3D Heart Models from Rotational Angiography. Pediatr. Cardiol. 2018; 39 (4): 653–658.

7.     Abudayyeh I, Gordon B, Ansari MM, Jutzy K, Stoletniy L, Hilliard A. A practical guide to cardiovascular 3D printing in clinical practice: Overview and examples. J. Interv. Cardiol. 2018; 31 (3): 375–383.

8.     Ripley B, Levin D, Kelil T, Hermsen JL, Kim S, Maki JH, Wilson GJ. 3D printing from MRI Data: Harnessing strengths and minimizing weaknesses. J.of Magnetic Resonance Imaging. 2016; 45 (3): 1–11.

9.     Wang J, Coles-Black J, Matalanis G, Chuen J. Innovations in cardiac surgery: techniques and applications of 3D printing. J. 3D Print. Med. 2018; 2 (4): 179–186.

10.   Nagibovich OA, Svistov DV, Peleshok SA, Korovin AE, Gorodkov EV. Appliance of 3D printing technology in medicine. Klin. patofiz. 2017; 23 (3): 14–22 [In Russ].

11.   Bagaturiya GO. Prospects for the use of 3D printing in planning of surgical operations. Med.: teorija i praktika. 2016; 1 (1): 26–35 [In Russ].

12.   Kim GB, Lee S, Kim H, Yang DH, Kim Y-H, Kyung YS, Kim C-S, Choi SH, Kim BJ, Ha H, Kwon SU, Kim N. Three-Dimensional Printing: Basic Principles and Applications in Medicine and Radiology. Korean J. of Radiol. 2016; 17): 182.

13.   Shi D, Liu K, Zhang X, Liao H, Chen X. Applications of three-dimensional printing technology in the cardiovascular field. Inter. and Emergency Med. 2015; 10: 769–780.

14.   Byrne N, Forte MV, Tandon A, Tandon A, Valverde I, Hussain T. A systematic review of image segmentation methodology, used in the additive manufacture of patient specific 3D printed models of the cardiovascular system. JRSM Cardiovasc. Disease. 2016; 5 (0): 1–9.

15.   Valverde I. Three-dimensional printed cardiac models: applications in the field of medical education, cardiovascular surgery, and structural heart interventions. Revista Espaсola de Cardiologнa (English Edition). 2017; 70 (4): 282–291.

16.   Karyakin NN, Shubnyakov II, Denisov AO, Kachko A V, Alyev RV, Gorbatov RO. Regulatory concerns about medical device manufacturing using 3D printing: current state of the issue. Travmatol. i ortop. Ross. 2018; 24 (4): 129–136 [In Russ].

 

Abstract

Aim: was to evaluate the effectiveness of carotid arterial revascularization by stenting of internal carotid arteries (ICA) in patients with a previous ischemic stroke.

Materials and methods: in FSBI «Treatment and rehabilitation center» of the Ministry of Health of Russia,104 patients on treatment and rehabilitation after previous ischemic stroke, underwent stenting of symptomatic atherosclerotic stenosis of the ICA. The average time since stroke was 67 days (from 28 to 273 days). ICA stenting was performed according to generally accepted standards with the mandatory use of intravascular protective devices against cerebral embolism. In most patients we used a filter protection system (77 observations), and for stenosis of more than 95% and in the presence of an unstable atherosclerotic plaque, a proximal defense system was used (27 patients). In some cases, if the situation required it, a combination of protective devices was used (5 observations). A few days before upcoming operation, all patients were evaluated for microcirculation and perfusion in brain tissue using single photon emission computed tomography (SPECT), followed by analysis of results and comparison with SPECT data in the postoperative period.

Results: when analyzing 30 days after stenting, there were no fatal outcomes. In one case (0.96%) after stenting of the subtotal stenosis of the ICA, a hemorrhagic stroke on the ipsilateral side developed on the fifth day. In another case, intraoperative embolism of the ophthalmic artery occurred on the side of the operation with partial loss of vision field.

In the long-term period (4 years and 7 months), the number of undesirable events was 2%. In one case (0.96%), the patient died of ischemic stroke on the ipsilateral side after 3 years and 2 months after stenting. In another case, patient after 1 year and 2 months had an ischemic stroke on the side of the operation. Thus, the total number of complications associated with ICA stenting (30-day period + long-term period) was 3.8%.

When evaluating results of stenting by the SPECT method, the state of cerebral perfusion was assessed using perfusion maps in two modes and by axial perfusion sections.

In all observations after stenting, improvement of cerebral perfusion was noticed, regardless of the side and severity of ICA stenosis and the presence of focal postischemic changes. Visually, perfusion sections show a general increase in cerebral blood perfusion (CBP), a decrease in one-sided focal deficiency of CBP . Same results were obtained for relative cortex perfusion (relCP) in four regions and in vascular basins.

Comparing results, obtained by the number of undesirable events (strokes, restenosis and death) with the four-year data of the analysis of the international CREST study, the complication rate in our group is significantly lower (3.8% versus 8.6% in the CREST stenting group and 8.4% in carotid endarterectomy group CREST).

Conclusion: carotid stenting is an effective method of treatment of atherosclerotic lesions of main cerebral arteries in patients with previous stroke. The effectiveness of this type of treatment is confirmed by a positive clinical result and with the help of modern diagnostic methods, in particular SPECT.

 

References

1.     Damulin IV, Parfenov VA, Skoromets AA, Yah NN. Circulatory disorders in the brain and spinal cord. In the book: «Diseases of the nervous system. A guide for doctors». Yakhno N.N., Shtulman D.R. (ed.). 2003; 231302 [In Russ].

2.     Thom T, Haase N, Rosamond W et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85-151.

3.     Kleindorfer D, Panagos P, Pancioli A et al. Incidence and short term prognosis of transient ischemic attack in a population-based study. Stroke. 2005;36: 720-723.

4.     Gusev EI, Skvortsova VI, Stakhovskaya LV. The problem of stroke in the Russian Federation: a time of active joint action. Zhurn. nevrol. and a psychiatrist. 2007; 8: 4-10 [In Russ].

5.     Gusev EI, Skvortsova VI, Stakhovskaya LV. Epidemiology of stroke in the Russian Federation. appendix of the Journal. nevrol. and a psychiatrist. them. SS Korsakova. 2003; 8: 4-9 [In Russ].

6.     Pinchuk EA. «Epidemiology and secondary prevention of ischemic stroke in a large industrial and cultural center» Diss. Cand. med. sciences. Ekaterinburg, 2004;136-137 [In Russ].

7.     Kadykov AS. Prevention of repeated ischemic stroke. AS Kadykov, NV Shakhparonova. Consilium medicum. 2006; 2: 96-99 [In Russ].

8.     Pokrovsky AV, KiyashkoVA. Ischemic stroke can be prevented. Rus. med. Journal. 2003; 11 (12): 691-695 [In Russ].

9.     Parfenov VA, Gurak SV. Repeated ischemic stroke and its prevention in patients with arterial hypertension. Zhurn. nevrol. and psychiatrist. them. SS Korsakova. Stroke. 2005; 14: 3-7 [In Russ].

10.   Sacco RL, Adams R, Albers G et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke. 2006; 37: 577 - 617.

11.   Touze E, Varenne O, Chatellier G et al. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke. 2005; 36:2748-2755.

12.   Kjellstrom T, Norrving B, Shatchkute A. Helsingborg Declaration 2006 on European Stroke Strategies. Helsingborg Declaration 2006 On European Stroke Strategies; pp. 9-12. Cerebrovasc Dis. 2007; 23(2-3): 231-41.

13.   European Carotid Surgery Triallists Collaborative Group: NRC European Carotid Surgery Trial; Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet. 1991; 337:1235-1243.

14.   North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effects of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med. 1991; 325:445-453.

15.   Asymptomatic Carotid Atherosclerosis Study. Clinical advisory: Carotid endarterectomy for patients with asymptomatic internal carotid artery stenosis. Stroke. 1994; 25:2523-2524.

16.   Brott TG, Hobson RW 2nd, Howard G, Roubin FS, et al. "CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010 Jul 1;363(1):11-23.

17.   Brown MM, Mas JL, Ringleb PA, Hacke W. Carotid artery stenting versus surgery: adequate comparisons? Lancet Neurol. 2010 , 9:341-342.

18.   Volzhenin VE, Dolinina EG, Dontsov AE et al. The state of cerebral blood flow according to SPECT, MRI and MPA. Thes. doc. 2nd Congress of the Russian Society of Nuclear Medicine. Modern problems of nuclear medicine and pharmaceuticals. Obninsk, 2000; 174-175 [In Russ].

Abstract

Article provides a literature review on problems of diagnosing of intracranial aneurysms (IA) rupture and its complications.

Aim: was to study relevant data on the use of computed tomography (CT), as well as other imaging methods, in patients with ruptured aneurysms in the acute period.

Materials and methods: a search was conducted for publications on this topic, dating up to December 2019, using main Internet resources: PubMed databases, scientific electronic library (Elibrary), Scopus, ScienceDirect, Google Scholar.

Results: we analyzed 45 literature sources, covering the period from 1993 to 2019, which include 3 meta-analyzes, 5 descriptions of studies evaluating the effectiveness of various visualization methods for ruptured IA. Both foreign and Russian publications were involved.

Conclusion: native CT is the leading visualization method to detect hemorrhages in nearest hours after the rupture of IA. CT angiography in combination with digital subtraction angiography (DSA), according to the vast majority of authors, allows to make thorough preoperative planning in the shortest time, as well as to identify unruptured aneurysms. Based on the obtained data, it is advisable to conduct a study to assess the role of CT in the acute period of IA rupture, as well as in the diagnosis of complications in the early postoperative period.

 

References

1.     Kornienko VN, Pronin IN. Diagnostic Neuroradiology. vol. 1. M.: Medlit, 2008; 339-382 [In Russ].

2.     Hughes JD, Bond KM, Mekary RA, et al. Estimating the global incidence of aneurysmal subarachnoid hemorrhage: a systematic review for central nervous system vascular lesions and meta-analysis of ruptured aneurysms. World Neurosurg. 2018; 115: 430-447.

3.     Krylov VV, Dash'yan VG, Shetova IM, et al. Neurosurgical care in patients with vascular diseases of the brain in the Russian Federation. Nejrohirurgiya. 2017; 4: 11-20 [In Russ].

4.     Passier PE, Visser-Meily JM, Rinkel GJ, et al. Life satisfaction and return to work after aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc. Dis. 2011; 20(4): 324-329.

5.     Lovelock CE, Rinkel GJE, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: populationbased study and systematic review. Neurology. 2010; 74(19): 1494-1501.

6.     Krylov VV, Prirodov AV Risk factors for surgical treatment of middle cerebral artery aneurysms in acute hemorrhage. Nejrohirurgiya. 2011; 1: 31-41 [In Russ].

7.     Korja M, Kivisaari R, Rezai Jahromi B, Lehto H. Natural history of ruptured but untreated intracranial aneurysms. Stroke. 2017; 48(4): 1081-1084.

8.     Krivoshapkin AL, Byval'cev VA, Sorokovikov VA. Natural course and risk of rupture of cerebral aneurysms. Klinicheskaya nevrologiya. 2010; 1: 32-35 [In Russ].

9.     Lasheras JC. The biomechanics of arterial aneurysms. Annu. Rev. Fluid Mech. 2007; 39: 293-319.

10.   Etminan N, Buchholz BA, Dreier R, et al. Cerebral aneurysms: formation, progression, and developmental chronology. Transl Stroke Res. 2014; 5(2): 167-173.

11.   Nasr DM, Fugate J, Brown RD. The Genetics of Cerebral Aneurysms and Other Vascular Malformations. In: Sharma P, Meschia J (ed.) Stroke Genetics. Springer, Cham. 2017; 53-78.

12.   Broderick JP, Brown Jr RD, Sauerbeck L, et al. Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms. Stroke. 2009;40(6): 1952-1957.

13.   Thompson BG, Brown Jr RD, Amin-Hanjani S, et al. Guidelines for the management of patients with unruptured intracranial aneurysms: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(8): 2368-2400.

14.   Krylov VV, Dash'yan VG, Shatohin TA, et al. Surgical treatment of intracranial aneurysms in Russian Federation. Zhurnal Voprosy nejrohirurgii imeni NN Burdenko. 2018; 82(6): 5-14 [In Russ].

15.   Ishmuhametov AI, Abakumov MM, Sharifullin DA, Mufazalov FF. X-ray computed tomography for trauma and acute disease. Ufa: OOO MDM-ARK, 2001; 111-119 [In Russ].

16.   Ujiie H, Tamano Y, Sasaki K, et al. Is the aspect ratio a reliable index for predicting the rupture of a saccular aneurysm? Neurosurgery. 2001; 48(3): 495-502.

17.   Cebral JR, Castro MA, Burgess JE, et al. Characterization of cerebral aneurysms for assessing risk of rupture by using patient-specific computational hemodynamics models. AJNR Am J Neuroradiol. 2005; 26(10): 2550-2559.

18.   Yang ZL, Ni QQ, Schoepf UJ, et al. Small intracranial aneurysms: diagnostic accuracy of CT angiography. Radiology. 2017; 285(3): 941-952.

19.   Kleinloog R, De Mul N, Verweij BH, et al. Risk factors for intracranial aneurysm rupture: a systematic review. Neurosurg. 2018; 82(4): 431-440.

20.   Marcolini E, Hine J. Approach to the Diagnosis and Management of Subarachnoid Hemorrhage. West J Emerg Med. 2019; 20(2): 203-211.

21.   Troshin VD, Pogodina TG. Emergency Neurology: a guide. M.: Medicinskoe informacionnoe agentstvo, 2016; 322-325 [In Russ].

22.   Danilov VI. Intracranial non-traumatic hemorrhage: diagnosis and indications for surgical treatment. Nevrologicheskij vestnik. 2005; 37(1-2): 77-84 [In Russ].

23.   Krylov VV, Prirodov AV, Kuznecova TK. Surgical methods for the prevention and treatment of vascular spasm in patients after rupture of cerebral aneurysms. Nejrohirurgiya. 2014; (1): 104-115 [In Russ].

24.   Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980; 6(1): 1-9.

25.   Johnston SC, Dowd CF, Higashida RT, et al. Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) study. Stroke. 2008; 39(1): 120-125.

26.   Krylov VV, Dash'yan VG, Grigor'ev IV, et al. Results of surgical treatment of patients with ruptured aneurysms of pericallous artery. Nejrohirurgiya. 2018; 2:17-26 [In Russ].

27.   Konovalov AN, Krylov VV, Filatov YuM, et al. Recommendatory management protocol for patients with subarachnoid hemorrhage due to rupture of cerebral aneurysms. Voprosy nejrohirurgii im. NN Burdenko. 2006; (3): 3-10 [In Russ].

28.   Lebedev VV, Ishmuhametov AI, Krylov VV, et al. The role of computed tomography of the brain in the acute rupture of arterial aneurysms. Med. radiologiya. 1993; 5: 9-12 [In Russ].

29.   Dubosh NM, Bellolio MF, Rabinstein AA Edlow JA. Sensitivity of early brain computed tomography to exclude aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Stroke. 2016; 47(3): 750-755.

30.   Kidwell CS, Wintermark M. Imaging of intracranial haemorrhage. Lancet Neurol. 2008; 7(3): 256-267.

31.   Verma RK, Kottke R, Andereggen L, et al. Detecting subarachnoid hemorrhage: comparison of combined FLAIR/SWI versus CT. Eur J Radiol. 2013; 82(9): 1539-1545.

32.   Martin SC, Teo MK, Young AM, et al. Defending a traditional practice in the modern era: the use of lumbar puncture in the investigation of subarachnoid haemorrhage. Br J Neurosurg. 2015; 29(6): 799-803.

33.   Meurer WJ, Walsh B, Vilke GM, Coyne CJ. Clinical guidelines for the emergency department evaluation of subarachnoid hemorrhage. J Emerg Med. 2016; 50(4): 696-701.

34.   Epanova AA. Clinic and comparative evaluation of various methods of radiation diagnostics in the detection of cerebral aneurysms. Sibirskij medicinskij zhurnal (Tomsk). 2007; 22(S2):103-107 [In Russ].

35.   Menke J, Larsen J, Kallenberg K. Diagnosing cerebral aneurysms by computed tomographic angiography: meta-analysis. Ann Neurol. 2011; 69(4): 646-654.

36.   Agid R, Lee SK, Willinsky RA, et al. Acute subarachnoid hemorrhage: using 64-slice multidetector CT angiography to «triage» patients’ treatment. Neuroradiology. 2006; 48(11):787-794.

37.   McCormack RF, Hutson A. Can computed tomography angiography of the brain replace lumbar puncture in the evaluation of acute-onset headache after a negative noncontrast cranial computed tomography scan? Acad Emerg Med. 2010;17(4):444-451.

38.   Epanova AA. Complex radiation diagnostics of aneurysms and vascular malformations of the brain: Cand. med. sci. diss. Moscow, 2010; 124 [In Russ].

39.   Grigor'eva EV, Polunina NA, Luk'yanchikov VA, et al. Features of CT angiography and the construction of 2D and 3D reconstructions of preoperative planning in patients with intracranial aneurysms. Nejrohirurgiya. 2017; (3): 88-95 [In Russ].

40.   Klimov AB, Ryabuhin VE, Kokov LS, Matveev PD. The use of stent-grafts in treatment of cerebral aneurysms. Diagnosticheskaya i intervencionnaya radiologiya. 2016; 10(3): 51-56 [In Russ].

41.   Krylov VV, Grigor'eva EV, Hamidova LT, et al. Comparative analysis of computed tomography and intracranial Doppler ultrasonography data in patients with cerebral angiospasm. Nevrologicheskij zhurnal. 2016; 21(6):344-352 [In Russ].

42.   Saribekyan AS, Balickaya NV, Rumyancev YuI, et al. The significance of the study of cerebral blood flow by CT perfusion in assessing the risk of developing cerebral ischemia in patients with ruptured intracranial arterial aneurysms. Voprosy nejrohirurgii im. NN Burdenko. 2019; 83(3): 17-28 [In Russ].

43.   Greenberg ED, Gobin YP, Riina H, et al. Role of CT perfusion imaging in the diagnosis and treatment of vasospasm. Imaging Med. 2011; 3(3): 287-297.

44.   Krylov VV, Dash'yan VG, Shatohin TA, et al. Choice of terms for open surgical treatment of patients with rupture of cerebral aneurysms complicated by massive basal subarachnoid hemorrhage (Fisher 3). Nejrohirurgiya. 2015; 3: 11-17 [In Russ].

45.   Kokov LS. Diagnostic and interventional radiology: today and tomorrow. Zhurnal im. NV Sklifosovskogo Neotlozhnaya medicinskaya pomoshch'. 2019; 8(2): 120-123 [In Russ].

Abstract

Background: advantages of endobiliary photodynamic therapy (PDT) described in the first part of review, namely: the safety of the intervention, the predictability and reproducibility of the effect, the absence of rough scarring of bile ducts, the possibility of repeating of procedures, affordability financially and economically - make this technology preferred among others locoregional effects in patients with hilus cholangiocarcinoma.

Aim: was to get a clinical specialist' view of endobiliary PDT as the perspective method: to describe dynamics of photosensitizer (PS) accumulation by tumor in vivo, to describe tools for delivering light into the lumen of bile ducts and intervention technique, to describe characteristics of light dosimetry, and to analyze immediate and long-term results of intra-duct photo exposure.

Material and methods: 66 domestic and foreign literary sources were analyzed.

Conclusion: endobiliary photodynamic therapy is a safe and effective method of locoregional treatment of patients with hilar cholangiocarcinoma, which significantly increases the duration and improves the quality of life of previously considered incurable patients.

 

References 

1.     Akopov AL, Rusanov AA, Papayan GV, Kazakov NV, Gerasin AV, Urtenova MA. Endobronchial photodynamic therapy under fluorescence control: Photodynamic theranostics. Photodiagnosis Photodyn Ther. 2017 Sep; 19: 7377.

2.     Goryainov SA. et al. Intraoperative fluorescence diagnostics and laser spectroscopy with repeated operations for brain gliomas. Questions of Neurosurgery named after NN Burdenko. 2014; 78 (2): 22-31 [In Russ].

3.     Yaroslavtseva-Isaeva EV, Kaplan MA, Kapinus VN, Spichenkova IS, Sokol N.I. Fluorescent diagnosis of malignant tumors of the skin with photosensitizers of chlorine series. Biomedical Photonics. 2018; 7(1): 13-20 [In Russ].

4.     Chissov VI, Sokolov VV, Bulgakova NN, Filonenko EV. Fluorescent endoscopy, dermatoscopy, spectrophotometry in the diagnosis of malignant tumors of main localizations. Russian Biotherapeutic Journal. 2003; 5(4): 42-56 [In Russ].

5.     Likhvantseva VG, Osipova EA, Loschenov VB, Kuzmin SG, Vorozhtsov GN. The method of differential diagnosis of eyelid skin. Patent RF № RU 2350262 C2. 2009. [In Russ].

6.     Rusakov IG, Teplov AA, Ulyanov RV, Filonenko EV. Fluorescent cystoscopy in patients with non-muscularinvasive bladder cancer. Biomedical photonics. 2015; 3: 29-35 [In Russ].

7.     Zykov AE. Laser fluorescence diagnostics and photodynamic therapy for cervical disease. Abstract of dissertation for the degree of candidate of medical sciences , Moscow 2011; 21 [In Russ].

8.     Denisova ED, Apolikhina IA, Bulgakova NN. Fluorescence diagnostics and photodynamic therapy of genital warts. Obstetrics and Gynecology. 2011; 8: 112-116 [In Russ].

9.     Silvia Affo, Le-Xing Yu, Robert F Schwabe. The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer. Ann Rev Pathol. 2017 Jan 24; 12: 153-186.

10.   Namikawa T, Yatabe T, Inoue K, Shuin T, Hanazaki K. Clinical applications of 5-aminolevulinic acid-mediated fluorescence for gastric cancer. World J Gastroenterol. 2015 Aug 7; 21(29): 8769-8775.

11.   Kishi K, Fujiwara Y Yano M, Motoori M, Sugimura K, Takahashi H, Ohue M, Sakon M (2016) Usefulness of diagnostic laparoscopy with 5-aminolevulinic acid (ALA)-mediated photodynamic diagnosis for the detection of peritoneal micrometastasis in advanced gastric cancer after chemotherapy. Surg Today. 2016 Dec;46 (12): 1427-1434.

12.   Shiryayev AA, Musaev GKh, Loschenov MV, Borodkin AV, Levkin VV, Okhotnikova NL, Volkov VV, Makarov VI, Loschenov VB. Fluorescent diagnosis and photodynamic therapy in combined treatment of cholangiocellular cancer. Biomedical Photonics. 2016; 5(4): 15-24 [In Russ].

13.   Goldman L. The biomedical laser: technology and clinical application. N.Y: Springer-Verlag, 1981; 342.

14.   Ivanov AV. Fiber optics. M .: Cyrus Company Systems, 1999; 342 [In Russ].

15.   Isaev SK Physics of fiber-optic devices. M .: MSU, 1986; 219 [In Russ].

16.   Gower J. Optical Communication Systems: Trans from English. M .: Radio and communication, 1989; 504.

17.   Thielen Patrick Woodtli Alain Light diffusing device for photodynamic treatment of organs United States Patent 6315775 Medlight S.A. (Ecublens, CH) 11/13/2001.

18.   Korobeynikov AG, Gatchin YuA, Dukelsky KV, Ter-Nersesyants E.V. Technological methods for reducing the level of optical losses in microstructured optical fibers. Scientific and Technical Journal of Information Technologies, Mechanics and Optics Scientific and Technical Journal of Information Technologies, Mechanics and Optics 2014; 1 (89) [In Russ].

19.   Lee Tae Yoon , Cheon Young Koog, Shim Chan Sup. Photodynamic Therapy in Patients with Advanced Hilar Cholangiocarcinoma: Percutaneous Cholangioscopic Versus Peroral Transpapillary Approach. Photomed Laser Surg. 2016 Apr;34(4):150-6.

20.   Frantsev DYu, Shorikov MA, Lapteva MG. Methodical aspects of percutaneous endobiliary photodynamic therapy in hilar cholangiocarcinoma inoperable patients. Actual problems of hepatopancreobiliary surgery. Materials of the XXIV International Congress of the Association of Hepa

Abstract

Aim: was to assess feasibility and effectiveness of using special methods for preventing of port-biliary fistula formation, at all stages of percutaneous transhepatic cholangiostomy (PTC).

Material and methods: we analyzed results of 3786 cholangiostomies with Seldinger technique, performed during the period from 1995 to 2019. Primary puncture of target bile duct was performed with a 17,5-18G needle for Amplaz guidewire 0,035’’ with a safe J-tip. With benign lesion of the biliary tree, 2066 cholangiostomies (54.6%) were performed, with tumor – 1720 (45,4%).

Results: significant hemobilia was registered in 21 patients (0.55%) from the analyzed group (3786 PTC), while in 3 cases arteriobiliary fistula was diagnosed, in 16-portbiliary fistula, 2 - biliary-venous fistula. The frequency of portоbiliary fistulas was 0,42%. The presence of blood impurities during aspiration from bile ducts was considered as obvious sign of portоbiliary fistula. Prevention of the formation of port-biliary fistula was realized by using well-guided puncture needles of large diameter (17,5-18G), including use of the «open needle» technique and timely changing the puncture trajectory during puncture of the vessel before penetration of the bile duct. Discredited access was used only for cholangiography with simultaneous puncture of bile ducts with a second needle along a different path and control of the severity of hemobilia according to the established second conflict-free cholangiostoma. All portоbiliary fistulas were closed conservatively.

Conclusion: the use of special methods of prophylaxis, determined a low frequency of portоbiliary fistulas - 4.2 port-biliary fistulas per 1000 percutaneous transhepatic cholangiostomy (0,42%), as well as their relatively benign nature (marginal wound of lateral portal vein branches), which did not require the use of embolization techniques.

  

References

1.     Shiau EL, Liang HL, Lin YH. (et al.). The Complication of Hepatic Artery Injuries of 1,304 Percutaneous Transhepatic Biliary Drainage in a Single Institute. J Vasc Interv Radiol. 2017 Jul;28(7):1025-1032. doi: 10.1016/j.jvir. 2017.03.016.

2.     Dolgushin BI, Virshke ER, Cherkasov VA, Kukushkin VA, Mkrtchjan GS. Selective Embolization of Hepatic Arteries in Bleeding Complications of Percutaneous Transhepatic Biliary Dranage. Annaly khirurgicheskoy gepatologii. Annals of HPB surgery. 2007; 12(4): 63-68 [In Russ].

3.     Aung TH, Too CW, Kumar N (et al.). Severe Bleeding after Percutaneous Transhepatic Drainage of the Biliary System. Radiology. 2016 Mar; 278(3):957-8. doi: 10.1148/ radiol.2016151954.

4.     Saad WE, Wallace MJ, Wojak JC (et al.). Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J Vasc Interv Radiol. 2010 Jun; 21(6): 789-95. doi: 10.1016/j.jvir.2010.01.012.

5.     Dietrich CF, Lorentzen T, Appelbaum L (et al.). EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part III-abdominal treatment procedures (Long Version). Ultraschall Med. 2016 Feb;37(1):E1-E32. doi: 10.1055/s-0035-1553917.

6.     Mortimer AM, Wallis A, Planner A. Multiphase multidetector CT in the diagnosis of haemobilia: a potentially catastrophic ruptured hepatic artery aneurysm complicating the treatment of a patient with locally advanced rectal cancer. Br J Radiol. 2011, May; 84(1001):e95-8. doi: 10.1259/bjr/20779582.

7.     Quencer KB, Tadros AS, Marashi KB (et al.). Bleeding after Percutaneous Transhepatic Biliary Drainage: Incidence, Causes and Treatments. J Clin Med. 2018 May 1;7(5). pii: E94. Doi 10.3390/jcm7050094.

8.     Chanyaputhipong J, Lo RH, Tan BS, Chow PK Portobiliary fistula: successful transcatheter treatment with embolisation coils. Singapore Med J. 2014 Mar; 55(3):e34-6.

9.     Madhusudhan KS, Dash NR, Afsan A (et al.). Delayed Severe Hemobilia Due to Bilio-venous Fistula After Percutaneous Transhepatic Biliary Drainage: Treatment With Covered Stent Placement. J Clin Exp Hepatol. 2016 Sep; 6(3):241-243.

 

Abstract

Introduction: article presents the first experience and long-term results of using domestic coronary balloon-expandable stents with a bioinert carbon coating, «Nanomed».

Aim: was to evaluate long-term results of using domestic coronary balloon-expandable stents with bioinert linear chain carbon coating (BLCCC), «Nanomed».

Materials and methods: the study included 387 patients, suffering from coronary heart disease, who underwent endovascular myocardial revascularization from 2016 to 2018, with implantation of coronary balloon-expandable stents with BLCCC by the Nanomed company, Penza. The control group included 320 patients who underwent endovascular myocardial revascularization with implantation of coronary balloon-expandable cobalt-chromium stents «MSure Cr» of the company «Multimedics», during the same period. A comparative estimation of long-term results was carried out on the basis of a study of the overall frequency of repeated myocardial revascularization; repeated interventions on the target vessel; the frequency of interventions on other coronary arteries with the progression of atherosclerosis; long-term survival rates.

Results: in the long-term period, the overall probability of absence of repeated revascularization in 47 months after PCI was 78,3 ± 2.1% and 72,1 ± 2.4% in the «Nanomed» BLCCC and «MSure Cr» groups, respectively. There was no statistically significant difference between groups (Log. Rank=0,77). However, the incidence of restenosis in the stent was statistically significantly higher in the «MSureCr» group. (p = 0,027). The overall probability of survival in 47 months after surgery was 98,2±2,4% and 98,1±2.6% in groups 1 and 2, respectively. No statistically significant difference between groups was found (Log. Rank=0,4).

Conclusions: 1. The use of a coronary balloon-expandable stent with a BLCCC, Nanomed for endovascular myocardial revascularization is an effective treatment in patients with coronary heart disease.

2. Long-term results of using bioinert carbon-coated stents, Nanomed and MSureCr stents were comparable in terms of absence of myocardial re-revascularization procedures due to relapse of the angina pectoris and survival time of up to 47 months. However, the incidence of restenosis in a stent with a bioinert carbon coating, Nanomed was statistically significantly lower.

 

References

1.     Allender S, Scarborough P, O’Flaherty M, Capewell S. Patterns of coronary heart disease mortality over the 20th century in England and Wales: Possible plateaus in the rate of decline. BMC Public Health 2008, 8, 148.

2.     De Scheerder I, Wang K, Wilczek K et al. Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents. Circulation. 1997; 95: 1549-1553.

3.     Morice M, Urban P, Greene S, Schuler G, Chevalier B. Why are we still using Coronary Bare-Metal Stents? JACC 2013;61;1122-3.

4.     De Mel A, Cousins BG, Seifalian AM. Surface modification of biomaterials: A quest for blood compatibility. Int. J. Biomater. 2012;  707863:1-707863:8.

5.     Kochkina K, Protopopov A. Comparative results of the use of stents with drug and carbon coatings in treatment of patients with all forms of acute coronary syndrome in the long-term follow-up. Kompleksnye problemy serdechno-sosudistyh zabolevanij. 2014; 1:52-58 [In Russ].

6.     Carrie D, Lefevre T, Cherradi R, et al. Does Carbofilm coating affect in-stent intimal proliferation? A randomized trial comparing Rx multi-link penta and TecnicCarbostent Stents: SIROCCO Trial. J Interv Cardiol. 2007; 20(5):3818.

7.     De Mel A, Jell G, Stevens MM, Seifalian AM. Biofunctionalization of biomaterials for accelerated in situ endothelialization: A review. Biomacromolecules. 2008; 9: 2969-2979.

8.     Hofma SH, Whelan DM, van Beusekom HM, Verdouw PD, van der Giessen WJ. Increasing arterial wall injury after long-term implantation of two types of stent in a porcine coronary model. Eur. Heart J. 1998; 19: 601-609.

9.     Wu KK, Thiagarajan, P. Role of endothelium in thrombosis and hemostasis. Annu. Rev. Med. 1996, 47, 315-331.

10.   Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J. Am. Coll. Cardiol. 2006; 193-202.

11.   Farb A, et al., Pathology of acute and chronic coronary stenting in humans. Circulation. 1999; 99(1): 44-52.

12.   Sarno G, et al., Lower risk of stent thrombosis and restenosis with unrestricted use of 'newgeneration' drug-eluting stents: a report from the nation wide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J. 2012;  33(5): 606-13.

13.   Palmerini T, et al., Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet. 2012;  379(9824): 1393-402.

14.   Antoniucci D, Bartorelli A, Vaenti R, et al. Clinical and angiographic outcome after coronary artery stenting with the Carbostent. Am J Cardiol. 2000; 85: 821-825.

15.   Antoniucci D, Valenti R, Migliorini A, et al. Clinical and angiographic outcomes following elective implantation of the Carbostent in patients at high risk of restenosis and target vessel failure. CathetCardiovasc Interv. 2001; 54: 420-426.

16.   Gian B Danzi, Cinzia Capuano, Marco Sesana et al. Six-Month Clinical and Angiographic Outcomes of the Technic Carbostent(TM) Coronary System: The Phantom IV Study. J Invasive Cardiol. 2004; 16(11): 641-4.

17.   Wiemer M, Butz T, Schmidt W, Schmitz KP, Horstkotte D, Langer C. Scanning electron microscopic analysis of different drug eluting stents after failed implantation: From nearly undamaged to major damaged polymers. Catheter. Cardiovasc. Interv. Off. J. Soc. Cardiac. Angiogr. Interv. 2010; 75: 905-911.

18.   Pendyala L, Jabara R, Robinson K, Chronos N. Passive and active polymer coatings for intracoronary stents: Novel devices to promote arterial healing. J. Interv. Cardiol. 2009; 22: 37-48.

19.   Kesavan S, Strange J, Johnson T et al. First-in-man evaluation of the MOMO cobalt-chromium carbon-coated stent. EuroIntervention 2013; 8:1012-1018.

20.   Jung JH, Min PK, Kin JY, Park S, Choi EY, Ko YG, Choi D, Jang Y, Shim WH and Cho SY: Does a carbon ion-implanted surface reduce the restenosis rate of coronary stents? Cardiology. 2005; 104 (2): 72-75,

21.   Kim Y, Whan Lee C, Hong M et al. Randomized comparison of carbon ion-implanted stent versus bare metal stent in coronary artery disease: The Asian Pacific Multicenter Arthos Stent Study (PASS) trial. American Heart Journal. 2005; 149 (2).

22.   George Cesar Ximenes Meireles, Luciano Mauricio de Abreu, Antonio Artur da Cruz Forte et al . Randomized comparative study of diamond-like carbon coated stainless steel stent versus uncoated stent implantation in patients with coronary artery disease. Cardiol. Sro Paulo Apr. 2007; 88 (4).

23.   Ben-Dor I, Waksman R, Pichard A.et al. The Current Role of Bare-Metal Stents. Cardiac interv. 2011; 1:40-45.

24.   Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Jukema JW, Huisman MV. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and metaanalysis. Am Heart J. 2007; 154:221-31.

25.   Bartorelli A, Trabattoni D, Montorsi P Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study. Catheter Cardiovasc Interv. 2002 Feb; 55(2):150-6.

26.   Goods C, Al-Shaibi, Liu M et al. Comparison of aspirin alone versus aspirin plus ticlopidin after coronary artery stenting. Am J Cardiol. 1996; 78:1042-1044.

27.   Leon M, Baim D,Popma J et al. A clinical trial comparing three anthitrombotic drug regimens after coronary artery stentings. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998; 339:1665-1671.

28.   Braun P et al. Prospective randomized study of the restenotic process in small coronary arteries using a Carbofilm coated stent in comparison with plain old balloon angioplasty: a multicenter study. Catheter Cardiovasc Interv. 2007 Dec 1; 70(7):920-7.

29.   Taema K, Moharram A. Long Term Clinical Follow-up of Carbon Coated Stents: Comparative Study with Bare-Metal Stents Med. J. Cairo Univ. 1-8, March: 18, 2014; 82 (2). 

Abstract

Background: in patients with congestive heart failure (CHF), there is a change in indicators of heart mechanics against the background of myocardium remodeling. Currently, magnetic resonance imaging (MRI) and speckle tracking echocardiography provide additional options for assessing changes in heart mechanics. Evaluation of mechanics of the myocardium rotational movement according to coronarography (CAG) has not been found in available literature. In this regard, there is a need to develop a methodology that allows to obtain a mathematical description of rotation processes and heartbeat during the CAG.

Material and methods: study included 90 patients aged 30-71 to assess indicators of heart rotation mechanics. Subjects were divided into groups: with dilated cardiomyopathy (DCMP, n=30), left ventricular aneurysm (LVA, n=30) and patients with autonomic nervous system disorder (ANSD, n=30) without heart failure (control group). Mechanics of heart rotation was studied using the CAG technique, modified by us, based on mathematical calculations of the rotation angle in motion of points on the heart surface, determined on the coronary angiogram in two projections.

Results: study found out, that in patients with DCMP and LVA with chronic heart failure, the angle of rotation of the heart was significantly lower than in patients with ANSD who do not have heart disease (p <0,05). The link between impaired myocardial contractile function in patients with DCMP and LVA with chronic heart failure and a decrease in the heart rotation angle was confirmed (DCMP: ?2=9,774; df=1; P <0,05), (LVA: ?2=9,600; df=1; P <0,05).

Conclusion: coronarography technique that we modified, makes it possible to quantify changes in parameters of the heart mechanics in examined patients. This makes it possible to determine the presence or absence of heart failure, depending on results.

  

References 

1.     Fomin IV. Chronic heart failure in the Russian Federation: what we know today and what we should do. Russian Journal of Cardiology. 2016, 8(136): 7-13 [In Russ].

2.     Belenkov YuN, Mareev VYu. Principles of rational treatment of heart failure.M. 2000. 266 [In Russ].

3.     Popescu BA, Beladan CC, Calin A, et al. Left ventricular remodelling and torsional dynamics in dilated cardiomyopathy: reversed apical rotation as a marker of disease severity. EurJHeartFail. 2009;11(10): 945-51.

4.     Pavlyukova EN, Kuzhel' DA, Matyushin GV, Savchenko EA, Filippova SA. Rotation, twisting and spinning of the left ventricle: physiological role and significance in clinical practice. Regional pharmacotherapy in cardiology. 2015; 11(1): 68-78 [In Russ].

5.     Mondillo S, Galderisi M, Mele D, et al.; Echocardiography Study Group Of The Italian Society Of Cardiology (Rome, Italy). Speckle-tracking echocardiography: a new technique for assessing myocardial function. J Ultrasound Med. 2011;30(1):71-83.

6.     Sergio Mondillo, MD, Maurizio Galderis, et al. Speckle-tracking echocardiography - a technique for assessing myocardial function. June 2, 2016. The international online community of specialists in ultrasound diagnostics [In Russ].

7.     Leitman M, Lysyansky P, Sidenko S et al. Two-dimensionalstrain - a novel software for real-time quantitative echocardiographic assessment of myocardial function. J. Am. Soc. Echocardiogr. 2004; 17(10): 1021-1029.

8.     Amundsen BH, Helle-Valle T, Edvardsen T et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J. Am. Coll. Cardiol. 2006; 47(4): 789-793.

9.     Buckberg G.D., Weisfeldt M.L., Ballester M. [et al.] Left ventricular form and function: scientific priorities and strategic planning for development of new views of disease. Circulation. 2004; 110: 333-336.

10.   Mirsky I., Parmley W.W. Assessment of passive elastic stiffness for isolated heart muscle and the intact heart. Circ. Res. 1973; 33: 233-243.

11.   Pouleur A., Knappe D., Shah A. [et al.] Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial. Eur. Heart J. 2011; 32:1720-29.

12.   Vermes E., Tardif J.C., Bourassa M.G. [et al.] Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies of Left Ventricular Dysfunction (SOLVD) trials. Circulation. 2003; 931: 2926-2.

13.   Victor Mor-Avi et al. The consensus decision of the American Echocardiographic Society and the European Association of Echocardiography on the methodology and indications, approved by the Japanese Society of Echocardiography. Articles. 07/07/2015 [In Russ].

14.   Roberto M Lang, Michelle Bierig [et al.] Roberto M Lang, Michelle Bierig [et al.]Recommendations for quantifying the structure and chambers of the heart.. Russian Journal of Cardiology 2012; 3(95). This edition of guidelines is published in Eur J Echocardiography 2006; 7: 79-108 [In Russ].

Abstract

Aim: was to determine the role of radiation and interventional methods of diagnosis and treatment of traumatic pelvic bleeding.

Material and methods: for the period 2016 -2019, we analyzed results of diagnosis and treatment of 37 patients with pelvic injuries, complicated by intra-pelvic bleeding. CT scanning of retroperitoneal pelvic hematoma (RPH) was performed in all cases, results of calculations were compared with the surgical classification of I.Z. Kozlova (1988) on the spread of retroperitoneal hemorrhage and volume of blood loss in pelvic fractures. MSCT-A was performed in 16 (45%) injured. Digital subtraction angiography (DSA) was performed in 10 (27%) cases, of which after MSCT-A – in 4 cases, and as the primary method for the diagnosis of arterial bleeding – in 6 cases.

Results: according to MSCT, the frequency of minor hemorrhages was 18 (50%), medium 16 (43%), large 3 (8%). CT calculation of the volume of small hemorrhages ranged from 92 to 541 cm3, medium – 477-1147 cm3, large –1534 cm3 and more. MSCT-A revealed signs of damage of arteries of the pelvic cavity: extravasation of contrast medium – in 4, cliff and «stop-contrast» – in 1, post-traumatic false aneurysm – in 1, displacement and compression of the vascular bundle – in 4 observations. DSA revealed signs of damage of vessels of the pelvis: extravasation of contrast medium – 3, angiospasm – 2 and occlusion – 2 observations. According to results of angiography, embolization of damaged arteries was performed in 5 observations.

Conclusion: MSCT is a highly sensitive method in assessing the distribution and calculation of RPH volume. The presence of a hematoma volume of more than 50-100 cm3, regardless of the type of pelvic damage, was an indication for MSCT. In patients with stable hemodynamics, DSA was used as a clarifying diagnostic method; in patients with unstable hemodynamics, it was used as the main method for diagnosis and treatment of injuries of pelvic vessels. Damage of pelvic vessels detected by angiography was observed predominantly in unstable pelvic fractures, accompanied by medium and large retroperitoneal pelvic hemorrhages.

  

References 

1.     Butovskij DI. The role of retroperitoneal hematomas in thanatogenesis in pelvic injuries. Sudmedekspert. 2003; 4: 14-16 [In Russ].

2.     Smolyar AN. Retroperitoneal hemorrhage in pelvic fractures. Hirurgiya. 2009; 8: 48-51 [In Russ].

3.     Fengbiao Wang, Fang Wang. The diagnosis and treatment of traumatic retroperitoneal hematoma. Pakistan Journal of Medical Sciences. 2013 Apr; 29(2): 573-576.

4.     Dorovskih GN. Radiation diagnosis of pelvic fractures, complicated by damage of pelvic organs. Radiologiya-praktika. 2013; 2: 4-15 [In Russ].

5.     Vasil'ev AV, Balickaya NV. Radiation diagnosis of pelvic injuries resulting traffic accidents. Medicinskaya vizualizaciya. 2012; 3: 135-138 [In Russ].

6.     Mahmoud Hussami, Silke Grabherr, Reto A Meuli, Sabine Schmidt. Severe pelvic injury: vascular lesions detected by ante- and post-mortem contrast mediumenhanced CT and associations with pelvic fractures. International Journal of Legal Medicine. 2017; 131: 731-738.

 

Abstract

Aim: was to study features of the clinical course, instrumental and biochemical parameters of patients with atherosclerotic aneurysmal expansion of the abdominal aorta on the base of retrospective analysis and prospective observation to determine indications for timely surgical correction.

Materials and methods: patients with the maximum diameter of the infra-renal abdominal aorta from 26 to 50mm (n=60) without primary indications for surgical treatment (endovascular abdominal aortic aneurysm repair) were selected for the prospective follow-up group. For the period of 2 years, all patients from prospective group underwent duplex scanning of the abdominal aorta every 6 months and multislice computed tomography (MSCT) of the aorta – once a year. The retrospective analysis included results of preoperative clinical-instrumental and laboratory examination of patients (n=55) who underwent endovascular aneurysm repair (EVAR) of the abdominal aorta with a maximum diameter of the infra-renal abdominal aorta more than 50mm.

Results: when comparing clinical, instrumental and biochemical parameters in patients with abdominal aortic aneurysm (AAA) before surgery and atherosclerotic aneurysmal abdominal aortic expansion of different degrees, not requiring surgical correction at the time of inclusion, it was shown that patients with AAA, statistically significantly differed from patients with AAA in clinical symptoms (pulsation and abdominal pain), burdened heredity, the number of smokers. There were no statistically significant differences in the severity of coronary and peripheral atherosclerosis. When comparing results of ultrasound duplex scanning and MSCT to estimate linear dimensions of the abdominal aorta in the group of patients with aneurysmal dilation and in the group of patients with abdominal aortic aneurysm, the comparability of results has been revealed. Prospective observation of patients with abdominal aortic aneurysmal dilation revealed predictors of disease progression: age less than 65 years, diameter of the upper third of the abdominal aorta more than 23mm, maximum diameter of the abdominal aorta more than 43mm, length of aneurismal dilation more than 52mm.

Conclusion: obtained results allowed to determine most informative indicators and criteria for the progression of atherosclerotic aneurysm expansion of the abdominal aorta, to determine further tactics of treatment, including the need for surgical correction of this pathology.

 

References

1.     Braithwaite B, J Cheshire N, M Greenhalgh R, Grieve R. IMPROVE Trial Investigators. Endovascular strategy or open repair for ruptured abdominal aortic aneurysm: oneyear outcomes from the IMPROVE randomized trial. Eur Heart J. 2015; 36(31): 2061-2069.

2.     Bown MJ. Meta-Analysis of 50 Years of Ruptured Abdominal Aortic Aneurysm the growth rate of small abdominal aortic aneurysms: A randomized placebocontrolled trial (AARDVARK). Eur Heart J. 2016; 37(42):3213-21.

3.     Kabardieva MR, Komlev AE, Kuchin IV, Kolmakova TE, Sharia MA, Imaev TE, Naumov VG, Akchurin RS. Abdominal aortic aneurysm: the view of a cardiologist and cardiovascular surgeon. Atherosclerosis and dyslipidemia. 2018; 33(4):17-24 [In Russ].

4.     Toghill BJ, Saratzis A, Liyanage LS, Sidloff D, Bown MJ. Genetics of Aortic Aneurysmal Disease. eLS: John Wiley & Sons, Ltd. Circulation. 2016; 133(24): 2516-2528.

5.     Kazanchian PO. Ruptures of abdominal aortic aneurysms. PO Kazanchian, VA Popov, PG Sotnikov. M.: Publisher MEI, 2006: 254 [In Russ].

6.     Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwoger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, Allmen RS, Vrints J; ESC Committee for Practice Guidelines. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014: 35(41): 2873-2926.

7.     Moll FL, Powell JT, Fraedrich G, Verzini F, Haulon S, Waltham M, van Herwaarden JA, Holt PJ, van Keulen JW, Rantner B, Schlosser FJ, Setacci F, Ricco JB; European Society for Vascular Surgery. Management of abdominal aortic aneurysms clinical practice guidelines of the European Society for Vascular Surgery. Eur J Vasc Endovasc Surg. 2011; 4: 1-58.

8.     Akchurin RS, Imaev TE. Vascular diseases. Aortic aneurysms. RS Akchurin, TE Imaev. Cardiology guidelines, edited by EI Chazov; 4: 548 [In Russ].

9.     National recomendations on management of patient with abdominal aorta aneurysms. Angiology and vascular surgery. 2013; 19(2) (appendix) [In Russ].

10.   Polyakov RS, Abugov SA, Charchian ER, Pyreckiy MV, Saakyan YM. Selection of patients for endovascular prosthetics of abdominal aorta. Medical alphabet. 2016; 1 (11) (274): 33-37 [In Russ].

11.   Kuchin IV, Imaev TE, Lepilin PM, Kolegaev AS, Komlev AE, Ternovoy SK, Akchurin RS. Recent state of a problem in endovascular treatment of infrarenal abdominal aortic aneurysm. Angiology and vascular surgery. 2018; 24 (3): 60-66 [In Russ].

12.   Lindholt JS, Bjorck M, Michel JB. Anti-platelet treatment of middle-sized abdominal aortic aneurysms. Curr Vasc Pharmacol. 2013; 11(3): 305-13.

13.   Chaikof EL. The Care of Patients with an Abdominal Aortic Aneurysm: The Society for Vascular Surgery Practice Guidelines. EL Chaikof, DC Brewster, RL Dalman [et al.] J. Vasc. Surg. 2009; 50(4): Suppl. 2-49.

14.   Hirsch AT, Haskal ZJ, Hertzer NR [et al.] Practice Guidelines for the Management of Patients with Peripheral Arterial Disease. Circ. 2006; 113: 463-654.

15.   Johnston KW, Rutherford RB, Tilson MD. Suggested Standards for Reporting on Arterial Aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J. Vasc. Surg. 1991; 13 (3): 452-458.

16.   Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, et al., Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet. 2002;360(9345):1531-9. doi: http://dx.doi.org/10.1016/S0140-6736(02)11522-4. PubMed.

17.   Johansson M, Zahl PH, Volkert Siersma V, Jorgensen KJ, Marklund B, Brodersen J. Benefits and harms of screening men for abdominal aortic aneurysm in Sweden: a registry-based cohort study. Lancet. 2018; 391(10138): 2441-2447.

18.   Anjum A, Powell JT Is the incidence of abdominal aortic aneurysm declining in the 21st century? Mortality and hospital admissions for England & Wales and Scotland. Eur J Vasc Endovasc Surg. 2012; 43: 161-166.

Abstract

Aim: was to identify possibilities of MRI with contrast enhancement in assessment of differentiation

grade of liver metastases of neuroendocrine tumors (NET).

Materials and methods: 103 patents with morphologically confirmed liver metastases of NET were enrolled in the study. All patients underwent abdominal contrast-enhanced MRI. A total of 241 lesions were assessed. In the region of interest, which corresponded to the rounded locus in solid port-contrast T1-weighted images. Obtained data were compared in groups of different grade of tumor tissues differentiation; the correlation of MRI parameters with Ki67 was also evaluated.

Results: study demonstrated that Grade (G) 1 of NET metastases are characterized by a more active accumulation of MR contrast agent (MRCA) and a higher SI in arterial (p=0,0002, p=0,0003, respectively) and venous (p=0,0003, p=0,0001, respectively) phases of contrast enhancement compared with G2 and G3. Also, well-differentiated NETs had higher SI in the delayed phase of contrast enhancement (p = 0,0038) and the more rapid wash-out of MRCA (p=0,0314). The Ki67 index inversely correlated with the degree of MRCA accumulation in arterial and venous phases of MRI with contrast enhancement. Revealed consistency may be useful for guided tissue sampling in biopsy and identification of the grade "migration" phenomenon, which will allow competently and timely choose/change treatment modality.

 

References

1.     Yao JC, Hassan M, Phan A et. al. One hundred years after ‘carcinoid’: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J. Clin. Oncol. 2008; 26(18): 3063-3072.

2.     Basuroy R, Srirajaskanthan R, Ramage JK. A multimodal approach to the management of neuroendocrine tumour liver metastases. Int. J. Hepatol. 2012; 81(9):80-93.

3.     Orel NF, Gorbunova VA, Delektorskaya VV et. al. Practical recommendations for treatment of neuroendocrine tumors of gastrointestinal tract and pancreas. Prakticheskie rekomendatsii RUSSCO. 2018; 12 (1): 430-456 [In Russ].

4.     Bosman FT, Carneiro F, Hruban RH. WHO Classification of Tumours of the Digestive System 4th ed. Lyon. IARC.2010.

5.     Rindi G, Falconi M, Klersy C et. al. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst. 2012; 104 (4): 764-777.

6.     Lloyd RV, Osamura RY Kloppel G. WHO Classification of Tumours of Endocrine Organs 4th ed. Lyon. IARC, 2017.

7.      Basturk O, Tang L, Hruban RH et. al. Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases. Am J Surg Pathol. 2014; (6): 437-447.

8.     Tang LH, Basturk O, Sue JJ. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas. Am J Surg Pathol. 2016; 40: 1192-1202.

9.     Iwazawa J, Onue S. Transarterial chemoembolization with miriplatinlipiodol emulsion for neuroendocrine metastases of the liver. World J. Radiol. 2010; 12: 468-471.

10.   Basturk O, Yang Z, Tang LH et. al. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms. Am J Surg Pathol. 2015; 39: 683-690.

11.   Khan MS, Luong TV, Watkins J et. al. A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms. Br J Cancer. 2013; 108: 1838-45.

12.   Ueda Y, Toyama H, Fukumoto T et. al. Prognosis of Patients with Neuroendocrine Neoplasms of the Pancreas According to the World Health Organization 2017 Classification. J. pancreas. 2017; 12: 216-220.

13.   Pavel RM, Baudin E, Couvelard A et. al. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 2012; 95 (2): 157-176.

14.   Cuneo KC, Chenevert TL, Ben-Josef E et. al. A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. Transl. Oncol. 2014; 7 (5): 644-649.

15.   Oberg K. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches. Curr Opin Oncol. 2012; 24 (4): 433-440.

16.   Kulke MH, Shah MH, Benson AB, Neuroendocrine tumors, version 1.2015. J Natl Compr Canc Netw. 2015; 13 (1): 78-108.

17.   Belousova EL (Amosova EL), Karmazanovskiy GG, Kubyshkin VA et. al. CT signs, allowing to determine the optimal treatment tactics for neuroendocrine pancreatic tumors. Meditsinskaya vizualizatsiya. 2015; 5: 73-82 [In Russ].

18.   Besa C, Ward S, Cui Y et. al. Neuroendocrine Liver Metastases: Value of Apparent Diffusion Coefficient and Enhancement Ratios for Characterization of Histopathologic Grade. J Magn Reson Imaging. 2016; 44 (6): 1432-1441.

19.   Guo CG, Ren S, Chen X et. al. Pancreatic neuroendocrine tumor: prediction of the tumor grade using magnetic resonance imaging findings and texture analysis with 3-T magnetic resonance. Cancer Manag Res. 2019; 11:1933-1944.

20.   Hussain SM, Liver MRI. Correlation with other imaging modalities and histopathology. 2007.

 

Abstract

The clinical case that is presented, demonstrates the need to sub-specialize radiologists in the field of mammology for a qualitative examination of the breast and timely diagnosis, including breast cancer. During last 8 years, the patient regularly (once every two years) underwent mammography in general-specialization medical facilities. According to findings of surveys conducted, nodal pathology of the breast was not identified. During the physical examination in the upper inner quadrant of the left mammary gland, a movable mass that was soldered to the skin up to 2.0 cm. When conducting a survey mammography in two standard projections in the lower inner quadrant of the left mammary gland, the nodal formation of the BIRADS 5 category was visualized. In a retrospective analysis of past mammograms, described above, nodal formation was noted on all presented mammographic images, the growth and changes in semiotic signs of the pathological focus were also observed. After additional diagnostic manipulations, a highly differentiated breast cancer with low mitotic activity was verified. 

 

References

1.     Kaprin A.D., Rozhkova N.I. National guidelines. Mammalogy. 2nd ed. M.: GEOTAR-Media. 2016; 496 [In Russ].

2.     Frantsuzova I.S. Analysis of risk factors for breast cancer. Mezhdunarodnyy nauchno-issledovatel'skiy zhurnal. 2019. -3 (81): 68-74 [In Russ].

3.     Chernaya A.V. Comparative analysis of informative value of digital mammography and mammoscintigraphy in breast cancer diagnostics. Dis. kand. med. nauk. SPb. 2018; 112. [In Russ].

4.     Vasil’ev A.Yu., Мanuylova О.О. Stereoscopic mammography. An alternative method for the breast cancer early diagnosis. Radiologiya-praktika. 2017.- 1(61): 6-14 [In Russ].

5.     Pavlova T.V., Vasil'ev A.Yu., Manuylova O.O. Method of сone-beam breast computed tomography (literature review). Radiologiya-praktika. 2019.-1(73): 21-27 [In Russ].

6.     Rozhkova N.I., Burdina I.I., Zapirova S.B., Kaprin A.D., Labazanova P.G., Mazo M.L., Mikushin S.Yu., Prokopenko S.P., Yakobs O.E. Areas of preventive work with the female population against breast cancer. Akademicheskiy zhurnal Zapadnoy Sibiri. 2019. Vol. 15.-2(79): 6-8 [In Russ].

7.     Visscher D.W. Sclerosingadenosis and risk of breast cancer / D. W. Visscher, A. Nassar, A. C. Degnim. Breast Cancer Res Treat. 2014. 144: 205-212.

8.     Pavlova T.V., Vasil'ev A.Yu., Manuylova O.O., Volobueva E.A. The impact of compliance with the rules of mammography laying on the timely diagnosis of breast cancer (the clinical example). Diagnosticheskaya i interventsionnaya radiologiya. 2019. -2 (13): 60-65 [In Russ].

9.     Shumakova T.A., Solntseva I.A., Safronova O.B., Savello V.E., Serebryakova S.V. The practical application of the international classification of Bi-RADS in mammology practice. Rukovodstvo dlya vrachey - SPb NII skoroy pomoshchi im. I.I.  Dzhanelidze. SPb. 2018; 217 [In Russ].

 

Abstract

The phenomenon of unrecovered coronary blood flow, or the «no-reflow» phenomenon, is the most formidable and insufficiently studied example of clinical failures after percutaneous coronary intervention (PCI) and is manifested as the absence of filling of distal coronary arteries. As a result, endovascular treatment may be completely unsuccessful or may be complicated by delayed recovery, the development of systolic dysfunction, the formation of heart aneurysm and other serious problems. Many experimental and clinical studies have been devoted to «no-reflow», but the evidence for this or that way of influencing the appearance of this phenomenon is very ambiguous. This article presents modern aspects related to risk factors, pathophysiology and methods for diagnosing this complication, as well as an analysis of methods for the prevention and correction of the developed «no-reflow» phenomenon.

 

References

1.     Alekyan B.G. Endovascular diagnosis and treatment of heart and vascular diseases in the Russian Federation - 2017. Endovaskulyarnaya hirurgiya. 2018. T.5, №2. S.93- 240 [In Russ]. 

2.     Van de Werf F. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST- Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Van de Werf F., [et al.] Eur Heart J. 2008. Vol. 29, P. 2909-2945.

3.     Bazanov I.S. Endovascular interventions on venous bypass (literature review). Vestnik RUDN. Seriya: Medicina. 2017. T.21, №2. S.171-183. [In Russ].

4.     Interventional Cardiology. Coronary angiography and stenting: a guideline. M.: GEOTAR-Media, 2010. S.410. [In Russ].

5.     Kaul, S. The «no reflow» phenomenon following acute myocardial infarction: Mechanisms and treatment options. Kaul, S. Journal of Cardiology. 2014. Vol. 64, No.2, P. 77-85.

6.     Kloner R.A. The «no-reflow» phenomenon after temporary coronary occlusion in the dog. Kloner R.A., Ganote C.E., Jennings R.B. J Clin Invest. 1974, Vol. 54, P. 14961508. 

7.     Czarnowska E. Ultrastructural demonstration of endothelial glycocalyx disruption in the reperfused rat heart. Involvement of oxygen free radicals. Czarnowska E, Karwatowska-Prokopczuk E. Basic Res Cardiol. - 1995, Vol. 90, No. 5, P. 3573-64

8.     Kloner R.A. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Kloner R.A., Rude R.E., Carlson N., [et al.] Circulation. 1980, Vol. 62, P. 945-952.

9.     Kleinbongard P. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. Kleinbongard P., Bose D., Baars T., [et al.] Circ Res. 2011, Vol. 108, P 344352

10.   Galagudza M.M., Sonin D.L., Pochkaeva E.I. Postischemic non-restoration of blood flow: mechanisms and therapeutic targets. Regionarnoe krovoobrashchenie i mikrocirkulyaciya. 2018. T. 17, №1. S.5-12. [In Russ].

11.   Higginson L.A. Determinants of myocardial hemorrhage after coronary reperfusion in the anesthetized dog. Higginson L.A., White F., Heggtveit H.A., Sanders T.M., Bloor C.M., Covell J.W. Circulation. 1982, Vol.65, P 62-69. 

12.   Kaul S. Microvasculature in acute myocardial ischemia: part II: evolving concepts in pathophysiology, diagnosis, and treatment. Kaul S., Ito H. Circulation. 2004, Vol. 109, P 310-315.

13.   Theilmeier G. Hypercholesterolemia in minipigs impairs left ventricular response to stress: association with decreased coronary flow reserve and reduced capillary density. Theilmeier G., VerhammeP, DymarkowskiM., [et al.] Circulation. — 2002; Vol. 106, P 1140-1146.

14.   Dogan N.B. Simple clinical risk score for no-reflow prediction in patients undergoing primary percutaneous coronary intervention with acute STEMI. Dogan N.B., Ozpelit E., Akdeniz S., Bilgin M., Baris N. Pak J Med Sci. - 2015, Vol. 31, No. 3. P 576-581.

15.   Plechev V.V., Risberg R.YU., Buzaev I.V. [et al.] Predictors of the development of intraoperative and early complications with planned stenting of coronary arteries. Permskij medicinskij zhurnal. 2017. T.34, №5. S.5-12. [In Russ].

16.   Kundin V.YU. Quantification of viable myocardium by radionuclide method. Serdechnaya nedostatochnost’. - 2010. №1. S.20-25. [In Russ].

17.   Strauss H.W. Procedure guideline for myocardial perfusion imaging 3.3. Strauss H. W., Miller, D. D., Wittry M.D., [et al.]. Journal of Nuclear Medicine Technology. 2008, Vol. 36, No. 3, P 155-161.

18.   Lockie T. Use of cardiovascular magnetic resonance imaging in acute coronary syndromes. Lockie T., Nagel E., Redwood S., Plein S. Circulation. 2009, Vol. 119, P 1671-1681

19.   Hayat S.A. Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time? Hayat S.A., Senior R. Eur Heart J. 2008, Vol. 29, P 299214. 

20.   Granfeldt A. Protective ischemia in patients: preconditioning and postconditioning. Granfeldt A., Lefer D.J., Vinten-Johansen J. Cardiovasc. Res. 2009, Vol. 83, No. 2, P. 234-246.

21.   M. R. Schmidt. Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic preconditioning. M. R. Schmidt [et al.] Am. J. Physiol. Heart Circ. Physiol. 2007, Vol. 292, No. 4, P 1883-1890.

22.   Heusch G. Remote ischemic conditioning. Heusch G., Botker H.E., Przyklenk K., [et al.] J Am Coll Cardiol. 2015, Vol. 65, P 177-195.

23.   Vinten-Johansen J. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions. Vinten-Johansen J., Shi W. J. Cardiovasc. Pharmacol. Ther. 2011, Vol. 16, No. 34, P 260-266.

24.   Mojbenko A. A., Dosenko V.E., Parhomenko. A.N Endogenous mechanisms of cardioprotection as a basis for pathogenetic therapy of heart diseases. Kiev, Naukova dumka, 2008. C. 520. [In Russ]. 

25.   Lishmanov YU.B., Maslov L.N. Ischemic postconditioning of the heart. Receptor mechanisms and clinical applications. Kardiologiya. 2010. №6. S.68-74.

26.   Zhao Z.Q. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Zhao Z.Q., Corvera J.S., HalkosM.E. , [et al.] Am. J. Physiol. Heart Circ. Physiol. 2003, Vol. 285, No. 2, P 579-588.

27.   Jivraj N. Ischaemic postconditioning: cardiac protection after the event. Jivraj N., Liew F, Marber M. Anaesthesia. 2015, Vol. 70, P 598-612.

28.   Limalanathan S. Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial. Limalanathan S., Andersen G.lll., Klaw N.E., Abdelnoor M., Hoffmann P, Eritsland J. J. Am. Heart Assoc. 2014, Vol. 3, No. 2, e000679.

29.   Cung T.T. Cyclosporine before PCI in patients with acute myocardial infarction. Cung T.T., Morel O., Cayla G., Rioufol G., Garcia-Dorado D., Angoulvant D., [et al.] New Engl. J. Med.-2015, Vol. 373, P 1021-1031.

30.   Tissier R. The small chill: Mild hypothermia for car- dioprotection? Tissier R., Chenoune M., Ghaleh B., Cohen M.V., Downey J.M., Berdeaux A. Cardiovasc Res. 2010, Vol. 88, P 406-414.

31.   O'Neill W. COOL-MI: Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients with Acute Myocardial Infarction. O'Neill W. Paper presented at: 15th Annual Transcatheter Cardiovascular Therapeutics Washington DC 2003.

32.   Erlinge D. Rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction (The CHILL-MI trial). Erlinge D., Gutberg M., LangI., [et al.] J Am Coll Cardiol. 2014, Vol. 63, No. 18, P. 1857-1865

33.   Marzilli M. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Marzilli M., Orsini E., Marraccini P., [et al.] Circulation. - 2000, Vol. 101, P. 2154-2159.

34.   Liu G.S. Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Liu G.S., Richards S.C., Olsson R.A., Mullane K., Walsh R.S., Downey J.M. Cardiovasc Res. 1994, Vol. 28, P. 1057-1061.

35.   Liu G.S. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Liu G.S., Thornton J., Van Winkle D.M., Stanley A.W., Olsson R.A., Downey J.M. Circulation. 1991, Vol. 84, P. 350-356.

36.   Niu X. Effect of intracoronary agents on the noreflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis. Niu X., Zhang J., Bai M., Peng Y, Sun S., Zhang Z. BMC Cardiovascular Disorders. 2018, Vol.18, P. 3.

37.   Pan W. Intracoronary nitroprusside in the prevention of the no-reflow phenomenon in acute myocardial infarction. Pan W., Wang L.F., [et al.] Chin Med J (Engl). 2009, Vol. 122, No. 22, P. 2718-2723

38.   Zhao S. Effect of intracoronary nitroprusside in preventing no reflow phenomenon during primary percutaneous coronary intervention: a meta-analysis. Zhao S., Qi G., Tian W., Chen L., Sun Y J Interv Cardiol. 2014, Vol. 27, No. 4, P. 356-364.

39.   Haeck J.D. Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study. Haeck J.D., Kuijt W.J., Koch K.T., et al. Heart. 2010, Vol. 96, P. 190-195.

40.   Haeck J.D. Proximal embolic protection in patients undergoing primary angioplasty for acute myocardial infarction (PREPARE): core lab adjudicated angiographic outcomes of a randomised controlled trial. Haeck J.D., Koch K.T., Gu YL., [et al.] Netherlands Heart Journal. - 2010, Vol. 18, No. 11, P. 531-536.

41.   Gurvitch R. Protection Devices and Thrombectomy for Native Coronary Artery ST Elevation Myocardial Infarction. Gurvitch R., Ajani A., Yan B., [et al.] J. Invasive Cardiol. 2008, Vol. 20, No. 4, P. 190-195.

42.   Stone G. Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST Segment Elevation Myocardial Infarction. Stone G., Webb J., Cox D., [et al.] J. Am. Heart Assoc. - 2005, Vol. 293, No. 9, P. 10631072.

43.   De Luca G.. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction: a metaanalysis of randomized trials. De Luca G., Dudek D., Sardella G., [et al.] Eur. Heart J. - 2008, Vol. 29, P. 3002-3010.

44.   Jolly S.S. Thrombus Aspiration in ST-Segment- Elevation Myocardial Infarction: An Individual Patient MetaAnalysis: Thrombectomy Trialists Collaboration. Jolly S.S., James S., Dhavнk V., [et al.] Circulation. 2017, Vol. 135, P. 143-152.

45.   Ibanez B.. Acute Myocardial Infarction in patients presenting with ST-segment elevation (Management of) ESC Clinical Practice Guidelines 2017. Ibanez B., James S.,    Ag S., [et al.] Eur. Heart J. 2017, P. 1-66

46.   Schroder R. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. Schroder R., Dissmann R., Bruggemann T., [et al.] J. Am. Coll. Cardiol. 1994, Vol. 24, P. 384-391.

47.   Taghizadeh B. AngioJet trombectomy and stenting for reperfusion in acute MI complicated with cardiogenic shock. Taghizadeh B., Chiu J.A., Papaleo R., [et al.] Cathet. Cardiovasc.Invervent. - 2002, Vol. 57, P. 79-84. 

 

Abstract

Background: hilar cholangiocarcinoma (Klatskin tumor) is a rare and severe hepatobiliary malignancy of proximal bile ducts with dismal prognosis, slow periductal growth, late metastatic spread and is mostly fatal due to local complications. Surgical resection is considered to be the only curative method to the date, but its results aren't satisfactory as the majority of patients (70-80%) aren't suitable surgical candidates due to a large tumor extent in local hilar area. Moreover, local recurrence rate reaches 80% over 7 years. Thus endobiliary loco-regional technologies have been proposed, one of which is a photodynamic therapy (PDT).

Aim: was to provide provide a preclinical rationale of PDT in Klatskin tumor patients: to describe principles and mechanisms of the method and summary experimental studies data; this can prepare the reader for the second part of the review, which is based on the analysis of clinical studies and can give practical orientation.

Material and methods: 63 domestic and foreign literature sources were analyzed.

Conclusion: endobiliary photodynamic therapy showed its safety and efficacy in many experimental studies and can successfully be applied in clinical practice. 

 

 

References

1.     Uzdenskii AB. Cellular-molecular mechanisms of photodynamic therapy 2010, St. Petersburg «Science» p.3-4, 13-14, 327. [In Russ].

2.     Tsyb AF, et al. Photodynamic therapy, «Medical Information Agency» 192 p., 2009, Moscow [In Russ].

3.     Reshetnikov AV. Photosensitizers in modern clinical practice (review). Materials of the scientific and practical conference of otorhinolaryngologists of the Central Federal District of the Russian Federation «Laser technologies in otorhinolaryngology» ed. V.G. Zenger and A.N. Nasedkina, Tula September 26-28, 2007 [In Russ].

4.     Davies MJ. Singlet oxygen-mediated damage to proteins and its consequences. Biochem Biophys Res Commun. 2003 Jun 6; 305(3): 761-770.

5.     Girotti AW. Photodynamic lipid peroxidation in biological systems. Photochem Photobiol. 1990 Apr; 51(4): 497-509.

6.     Hsieh YJ, Wu CC, Chang CJ, Yu JS. Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets. J Cell Physiol. 2003 Mar;194(3): 363-375.

7.     Berg K, Moan J. Lysosomes as photochemical targets. Int J Cancer. 1994 Dec 15; 59 (6): 814-822.

8.     Berg K, Moan J. Lysosomes and microtubules as targets for photochemotherapy of cancer. Photochem Photobiol. 1997 Mar; 65(3): 403-409.

9.     Chernyak BV, Izyumov DS, Lyamzaev KG, et al. Production of reactive oxygen species in mitochondria of HeLa cells under oxidative stress. Biochim Biophys Acta. 2006 May- Jun;1757 (5-6): 525-534. Epub 2006 Apr 7.

10.   Zhang LJ, O'Shea D, Zhang CY, et al. Evaluation of a bacteriochlorin-based photosensitizer's anti-tumor effect in vitro and in vivo. J Cancer Res Clin Oncol. 2015 Nov; 141(11): 1921-1930.

11.   Zhang LJ, Yan YJ, Liao PY, et al. Synthesis and antitumor activity evaluation of a novel porphyrin derivative for photodynamic therapy in vitro and in vivo. Tumour Biol. 2016 May; 37(5): 6923-6933.

12.   Shi R, Li C, Jiang Z, et al. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models. Molecules. 2017 Jan 11; 22(1). PII: E112.

13.   Korbelik M, Krosl G, Olive PL, Chaplin DJ. Distribution of Photofrin between tumour cells and tumour associated macrophages. Br. J. Cancer (I991), 64, 508512.

14.   Korbelik M, Krosl G. Photofrin accumulation in malignant and host cell populations of various tumours. British Journal of Cancer (1996) 73, 506-513.

15.   Sharma S, Jajoo A, Dube A. 5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines. J Photochem Photobiol B. 2007 Sep 25; 88(2-3): 156-162. Epub 2007 Aug 2.

16.   Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011 Jul-Aug;61(4): 250-281. doi: 10.3322/caac.20114. Epub 2011 May 26.

17.   Moan J, Peng Q, Sorensen R, et al. The biophysical foundations of photodynamic therapy. Endoscopy. 1998 May; 30 (4): 387-391.

18.   Profio AE, Doiron DR. Transport of light in tissue in photodynamic therapy. Photochem Photobiol 1987; 46: 591-599.

19.   Shackley DC, Whitehurst C, Moore JV, et al. Light penetration in bladder tissue: implication for the intravescical photodynamic therapy of bladder tumours. BJU Int 2000 l86: 638-643.

20.   Melo CA, Lima AL, Brasil IR, et al. Characterization of light penetration in rat tissues. J Clin Laser Med Surg. 2001 Aug; 19 (4): 175-179.

21.   Silvia Affo, Le-Xing Yu, Robert F Schwabe. The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer. Annu Rev Pathol. 2017 Jan 24; 12: 153-186.

22.   Parsa P, Jacques SL, Nishioka NS. Optical properties of rat liver between 350 and 2200 nm. Appl Opt. 1989 Jun 15; 28(12): 2325-30.

23.   Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci. 2002; 17: 173-186.

24.   Stranadko EF, Armichev AV, Geynits AV. Light sources for photodynamic therapy. Laser medicine, - 2011. - Vol. 15, no. 3: 63-69. [In Russ].

25.   Heiskanen V, Hamblin MR. Photobiomodulation: lasers vs. light emitting diodes? Photochem Photobiol Sci. 2018 Aug 8; 17(8): 1003-1017.

26.   Lima AC, et al. Low-Level Laser and Light-Emitting Diode Therapy for Pain Control in Hyperglycemic and Normoglycemic Patients Who Underwent Coronary Bypass Surgery with Internal Mammary Artery Grafts: A Randomized, Double-Blind Study with Follow-Up, Pho- tomed. Laser Surg., 2016, 34(6), 244-251. doi: 10.1089/pho.2015.4049

27.   Lima AC, et al. Photobiomodulation (Laser and LED) on Sternotomy Healing in Hyperglycemic and Normoglycemic Patients Who Underwent Coronary Bypass Surgery with Internal Mammary Artery Grafts: A Randomized, Double-Blind Study with Follow-Up, Photomed. Laser Surg., 2017, 35(1), 24-31. doi: 10.1089/pho.2016.4143

28.   Ammar TA. Monochromatic Infrared Photo Energy versus Low Level Laser Therapy in Patients with Knee Osteoarthritis, J. Lasers Med. Sci., 2014, 5(4), 176-182.

29.   Freitas AC, et al. Chemotherapy-induced oral mucositis: effect of LED and laser phototherapy treatment protocols, Photomed. Laser Surg., 2014, 32(2), 81-87.

30.   Reeds KB, Ridgway TD, Higbee RG, Lucroy MD. Non-coherent light for photodynamic therapy of superficial tumours in animals. Vet Comp Oncol. 2004 Sep;2(3):157- 63. doi: 10.1111/j.1476-5810.2004.00052.x.

31.   Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem. Photobiol. 1992; 55 (1): 145-157

32.   Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J. Natl. Cancer Inst. 1998; 90(12): 889-905.

33.   Dougherty TJ. An update on photodynamic therapy applications. J Clin Laser Med Surg. 2002 Feb; 20(1): 3-7.

34.   Chen B, Pogue BW, Goodwin IA. Blood flow dynamics after photodynamic therapy with verteporfin in the RIF-1 tumor. Radiat. Res.- 2003.- №160.- Р452-459.

35.   Gollnick SO, Owczarczak B, Maier P. Photodynamic therapy and anti-tumor immunity. Lasers Surg Med. 2006 Jun; 38(5): 509-515.

36.   Gollnick SO, Brackett CM. Enhancement of antitumor immunity by photodynamic therapy. Immunol Res. 2010 Mar; 46(1-3): 216-226.

37.   Pizova K, Tomankova K, Daskova A, et al. Photodynamic therapy for enhancing antitumour immunity. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012 Jun; 156(2): 93-102.

38.   Siddiqui SH, Awan KH, Javed F. Bactericidal efficacy of photodynamic therapy against Enterococcus faecalis in infected root canals: a systematic literature review. Photodiagnosis Photodyn Ther. 2013 Dec; 10(4): 632-643.

39.   Diniz IM, Teixeira KI, Araujo PV, et al. Evaluation of antibacterial photodynamic therapy effects on human dental pulp cell cultures. Photodiagnosis Photodyn Ther. 2014 Sep; 11(3): 300-306.

40.   Javed F, Samaranayake LP, Romanos GE. Treatment of oral fungal infections using antimicrobial photodynamic therapy: a systematic review of currently available evidence. Photochem Photobiol Sci. 2014 May; 13(5): 726-734.

41.   Fumes AC, da Silva Telles PD, Corona SAM, Borsatto MC. Effect of aPDT on Streptococcus mutans and Candida albicans present in the dental biofilm: Systematic review. Photodiagnosis Photodyn Ther. 2018 Mar; 21: 363366.

42.   Gintovt OI. The use of intraductal photoradiation in the complex treatment of patients with cholangitis of benign etiology: author. dis.cand. Med. Sciences O.I. Gintovt. St. Petersburg, 2008.- p. 18. [In Russ].

43.   Panteleev VS. Photodynamic effects in combination with laser antibiotic therapy in patients with purulent-septic complications. Author. Dis.doctor Med. Sciences V.S. Panteleyev. - Ufa, 2012. - P24-35 [In Russ].

44.   Vasilyev NE, Ogirenko AP. Antimicrobial photodynamic therapy. Laser medicine. - 2002. - V. 6. - №1. - p. 32-38. [In Russ].

45.   Efimova EG, Cheida AA, Garasko EV, et al. Antimicrobial effects of photodynamic therapy. Rus. bioter. journals 2007. No. 1. P. 15 [In Russ].

46.   Deshuk AN. Photodynamic therapy of experimental acute cholecystitis A.N. Deshuk, P.V. Garelik. Surgery News .- 2012.- Vol. 20, No. 5.- P. 3-10. [In Russ].

47.   Kiesslich T, Berlanda J, Plaetzer K, et al. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines. Photochem Photobiol Sci. 2007 Jun; 6 (6): 619-627.

48.   Cao LQ, Xue P, Lu HW, et al. Hematoporphyrin derivative-mediated photodynamic therapy inhibits tumor growth in human cholangiocarcinoma in vitro and in vivo. Hepatol Res. 2009 Dec; 39(12): 1190-1197.

49.   Wang JB, Liu LX, Pan SH, et al. Therapeutic effect of photodynamic therapy using hemato-porphyrin monomethyl ether (HMME) on human cholangiocarcinoma cell line QBC939. Neoplasma. 2010; 57(1): 79-85.

50.   Kim CH, Chung CW, Choi KH, et al. Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells. Int J Nanomedicine. 2011; 6: 1357-1363.

51.   Chung CW, Kim CH, Lee HM, et al. Aminolevulinic acid derivatives-based photodynamic therapy in human intra- and extrahepatic cholangiocarcinoma cells. Eur J Pharm Biopharm. 2013 Nov; 85(3 Pt A): 503-510.

52.   Chen YJ, Jiang HT, Cao JY. Influence of Photodynamic Therapy on Apoptosis and Invasion of Human Cholangiocarcinoma QBC939 Cell Line. Chin Med Sci J. 2015 Dec; 30(4): 252-259.

53.   Sirica AE, Zhang Z, Lai GH, et al. A novel «patient-like» model of cholangiocarcinoma progression based on bile duct inoculationof tumorigenic rat cholangiocyte cell lines. Hepatology. 2008 Apr;47(4):1178-1190.

54.   Wong K, Song LM, Wang KK, Zinsmeist AR. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model. Cancer. 1998; 82: 421-427

55.   Cadamuro M, Brivio S, Stecca T, et al. Animal models of cholangiocarcinoma: What they teach us about the human disease. Clin Res Hepatol Gastroenterol. 2018 Oct; 42(5): 403-415.

56.   Loeuillard E, Fischbach SR, Gores GJ, Rizvi S. Animal models of cholangiocarcinoma. Biochim Biophys Acta Mol Basis Dis. 2018 Apr 5. PII: S0925- 4439(18)30124-8.

57.   Tzerkovsky DA. Multiple-field interstitial photodynamic therapy of subcutaneously transplanted cholangiocellular carcinoma RS-1 in rats. Exp Oncol. 2017 Jul;39(2):117-120.

58.   van Hillegersberg R, Marijnissen JP, Kort WJ, et al. Interstitial photodynamic therapy in a rat liver metastasis model. Br J Cancer 1992; 66: 1005-14.

59.   Rovers JP, Saarnak AE, Molina A, et al. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra (hydroxyphenyl) chlorine (mTHPC), in a rat model. Br J Cancer 1999; 81: 600-608.

60.   Douillard S, Olivier D, Patrice T. In vitro and in vivo evaluation of Radachlorin(R) sensitizer for photodynamic therapy. Photochem Photobiol Sci. 2009 Mar; 8(3): 405413.

61.   Wang X, Li J, Li L, Li X. Photodynamic Therapy-Induced Apoptosis of Keloid Fibroblasts is Mediated by Radical Oxygen Species In Vitro. Clin Lab. 2015; 61(9): 1257-1266.

62.   Zhang C, Wang J, Chou A, et al. Photodynamic therapy induces antifibrotic alterations in primary human vocal fold fibroblasts. Laryngoscope. 2018 Sep; 128(9): E323-E331.

63.   Mendoza-Garcia J, Sebastian A, Alonso-Rasgado T, Bayat A. Ex vivo evaluation of the effect of photodynamic therapy on skin scars and striae distensae. Photodermatol photoimmunol photomed. 2015; 31: 239-251.

 

Abstract

Aim: was to explore clinical efficacy and safety of two distal radial approach (DRA) types in primary percutaneous coronary interventions (PCI) in acute coronary syndrome (ACS) patients.

Materials and methods: 113 ACS patients with endovascular procedure that had been performed through DRA - met entry criteria. Standard DRA was performed within anatomic snuffbox in 82 patients (72,6%) and modified - on the dorsal surface of the palm (dorsopalmar type) in 31 patients (27,4%). Approach conversion was performed in 7 patients (6,2%). PCI on syndrome- related artery was performed in 94 patients (83,2%). On completion of PCI and final approach angiography, hemostasis was performed with bandage application for 6 hours. Hemostasis comfort was determined by 10 point verbal descriptor Gaston-Johansson scale. On the 5th-7th day after PCI, all patients underwent visual check, palpation and ultrasound duplex scan (UDS).

Results: procedure and fluoroscopy time, X-ray load, hemostasis comfort - didn't depend on DRA type. Examination, palpation, UDS performed on the 5th-7th day after PCI didn't reveal cases of forearm radial artery occlusion (RAO). Subcutaneous forearm hematoma (EASY III - IV) was registered in 3 cases (2,7%). RAO was registered in standard DRA group only in 4 cases (3,5%). There were no cases of access side RAO in dorsopalmar DRA group.

Conclusion: DRA modifications for PCI in ACS patients are valuable addition to classic radial approach. Dorsopalmar DRA can be considered as basic approach.

 

References

1.     Campeau L. Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc Diagn. 1989; 16:3-7.

2.     Kiemeneij F, Laarmann Gj, de Melker E. Transradial coronary artery angioplasty (Abstr). Circulation. 1993; 88: I-251.

3.     Ibanez B, James S, Agewall S. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 2018; 39 (2): 119-77.

4.     Neumann F.J., Sousa-Uva M., Ahlsson A. et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2018; Aug. 25.

5.     Valgimigli M, Gagnor A, Calabro P. et al. MATRIX Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: A randomised multicentre trial. Lancet. 2015; 385:2465-2476.

6.     Bazemore E, Tift Man J, Problems and Complications of the Transradial Approach for Coronary Interventions: A Review Issue Number J Invasive Cardiol. 2005 Mar;17(3):156-9.

7.     Stawin J, Kubler P, Szczepanski A. et al. (2013). Radial artery occlusion after percutaneous coronary interventions - an underestimated issue. Postepy Kardiol Interwencyjnej. 2013 18; 9(4):353-61. Epub 2013 Nov 18.

8.     Avdikos G, Karatasakis A, Tsoumeleas A. et al. Radial artery occlusion after transradial coronary catheterization. Cardiovasc Diagn Ther. 2017; 7(3):305-316.

9.     Kotowycz MA, DГlavнk V. Radial artery patency after transradial catheterization. Circ Cardiovasc Interv. 2012; 5:127-33.

10.   Karpov YA, Samko AN, Buza VV. Coronary angioplasty and stenting. Moscow, 2010; 235 [In Russ].

11.   Babunashvili A, Dundua D. Recanalization and reuse of early occluded radial artery within 6 days after previous transradial diagnostic procedure. Catheter. Cardiovasc. Interv. 2011; 77 (4): 530-6.

12.   Kaledin AL, Kochanov IN, Seletskiy SS. et al. Peculiarities of arterial access in endovascular surgery in elderly patients. Uspekhi Gerontologii. 2014; 27 (1): 115-9 [In Russ].

13.   Kiemeneij F. Left distal transradial access in the anatomical snuffbox for coronary angiography (ldTRA) and interventions (ldTRI). EuroIntervention. 2017; 13 (7): 851-7.

14.   Al-Azizi KM, Lotfi AS. The distal left radial artery access for coronary angiography and intervention: a new era. Cardiovasc. Revasc. Med. 2018; Dec 26; 19(8S): 35-40.

15.   Valsecchi O, Vassileva A, Cereda AF. et al. Early clinical experience with right and left distal transradial access in the anatomical snuffbox in 52 consecutive patients. J. Invasive Cardiol. 2018; 30(6): 218-23.

16.   Soydan E, Akin M. Coronary angiography using the left distal radial approach - an alternative site to conventional radial coronary angiography. Anatol. J. Cardiol. 2018; 19: 243-248. Mar. 21.

17.   Manchurov VN, Orlov OS, Anisimov KV. et al. Distal transradial access for percutaneous coronary interventions in patients with acute coronary syndrome and ischemic heart disease. Endovasculyarnaya. khirurgiya. 2018; 5 (4): 438-44 [In Russ].

18.   Kaledin AL, Kochanov IN, Podmetin PS., et al. Distal part of the radial artery for endovascular interventions. Endоskulyarnaya khirurgiya. 2017; 4(2): 125-133 [In Russ].

19.   Amsterdam EA, Wenger NK, Brindis et al. (23 September 2014). "2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. 130 (25): e344-e426.

20.   Gaston-Johansson F, Albert M, Fagan et al. Similarities in pain descriptions of four different ethnic-culture groups. J Pain Symptom Manage. 1990; 5: 94-100.

21.   Bertrand OF. Acute forearm muscle swelling post transradial catheterization and compartment syndrome: prevention is better than treatment! Catheter Cardio Interv. 2010; 75:366-8.

22.   Radial access for percutaneous coronary procedure: relationship between operator expertise and complications. Clin Exp Emerg Med. 2018 Jun; 5(2): 95-99.

23.   Rafael J Ruiz-Salmeryna, Ramyn Moraa, Manuel Velez-Gimyna et al. Radial Artery Spasm in Transradial Cardiac Catheterization. Assessment of Factors Related to Its Occurrence, and of Its Consequences During Follow-Up. Revista Espanola de cardiologia. 2005; 58(5): 465610.

 

Abstract

Background: ongoing abdominal and pelvic bleeding is one of main causes of deaths among patients with penetrating and blunt trauma. Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a method for temporary patient's stabilization and reducing blood loss.

Aim: was to present result of work of 1st-level trauma-center: to describe experience of application of methodics of REBOA in center, to estimate its efficacy on the base of retrospective analysis of hospital charts of injured and heavy damaged patients.

Materials and methods: during the period between April 2013 and November 2017, 14 REBOA procedures to patients with abdominal (thoracic aorta occlusion) and pelvic (occlusion of the aortic bifurcation) bleeding were performed at the War Surgery Department of the «KirovMilitaryMedicalAcademy». A decision to do REBOA was made upon admission according to significant hypotension (systolic blood pressure [sBP] less than 70 mm Hg.) or cardiac arrest, abdominal free fluid and/or mechanically unstable pelvic fractures.

Results: mean time from admission to REBOA was 27,5 [10,0-52,5] minutes. The procedure took 10 [5-13] minutes. Average BP elevation after balloon inflation was 43±16 mm Hg. Survival in acute phase of trauma (first 12 hours) was 57.1%, while total survival rate was only 14.3% (2/14 patients). One REBOA-associated major complication was registered - development of irreversible ischemia due to long sheath dwell time in the femoral artery.

Conclusion: REBOA is effective for temporary hemodynamic stabilization and internal hemorrhage control, it allows increasing early survival in severe trauma. Factors to improve short- and long-term outcome, total survival warrant to be additionally investigated, especially in terms of intensive care improvement.

 

References

1.     Stannard A., Eliason J.L., Rasmussen T.E. Resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct for hemorrhagic shock. J. Trauma. 2011; 71(6): 1869-1872.

2.     Barnard E.B.G., Morrison J.J., Madureira R.M. et al. Resuscitative endovascular balloon occlusion of the aorta (REBOA): a population based gap analysis of trauma patients in England and Wales. Emerg. Med. J. 2015; 32 (12): 926-932.

3.     Brenner M.L., Moore L.J., DuBose J.J. et al. A clinical series of resuscitative endovascular balloon occlusion of the aorta for hemorrhage control and resuscitation. J. Trauma Acute Care Surg. 2013; 75 (3): 506-511.

4.     Moore L.J., Brenner M., Kozar R.A. et al. Implementation of resuscitative endovascular balloon occlusion of the aorta as an alternative to resuscitative thoracotomy for resuscitative balloon occlusion of the aorta (REBOA). J. Trauma Acute Care Surg. 2016; 81 (3): 409-419.

5.     Zavrazhnov A.A. Damage of large vessels of the abdomen: ways to improve diagnosis and treatment: Diss. kand. med. Nauk. St.Petersburg. 1996; 201 [In Russ].

6.     Sadeghi M., Nilsson K.F., Larzon T. et al. The use of aortic balloon occlusion in traumatic shock: first report from the ABO trauma registry. Eur. J. Trauma Emerg. Surg. 2018; 44 (4): 491-501.

7.     Hughes C.W. Use of an intra-aortic balloon catheter tamponade for controlling intra-abdominal hemorrhage in man. Surgery. 1954; 36 (1): 65-68.

8.     DuBose J.J., Scalea T.M., Brenner M. et al. The AAST prospective Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery (AORTA) registry: Data on contemporary utilization and outcomes of aortic occlusion and resuscitative balloon occlusion of the aorta (REBOA). J. Trauma Acute Care Surg. 2016; 81 (3): 409-419.

9.     Martinelli T., Thoni F., Declety P. et al. Intra-aortic balloon occlusion to salvage patients with life-threatening hemorrhagic shocks from pelvic fractures. J. Trauma. 2010; 68 (4): 942-948.

10.   Brenner M., Hoehn M., Pasley J. et al. Basic endovascular skills for trauma course: bridging the gap between endovascular techniques and the acute care surgeon. J. Trauma Acute Care Surg. 2014; 77 (2): 286-291.

11.   DuBose J., Fabian T., Bee T. et al. Contemporary utilization of resuscitative thoracotomy: results from the AAST aortic occlusion for resuscitation in trauma and acute care surgery (AORTA) multicenter registry. Shock. 2018; 50 (4): 414-420.

12.   Gumanenko E.K. An objective assessment of the severity of injuries. Voenno-medicinskij zhurnal. 1996; 317 (10): 25-34 [In Russ].

13.   Samokhvalov I.M., Reva V.A., Pronchenko A.A., Agliulin V.F. Comparison of the effectiveness of emergency thoracotomy in wounded and injured. Zdorov'e. Medicinskaja jekologija. Nauka. 2012; 1-2 (47-48): 43 [In Russ].

14.   White J.M., Cannon J.W., Stannard A. et al. Endovascular balloon occlusion of the aorta is superior to resuscitative thoracotomy with aortic clamping in a porcine model of hemorrhagic shock. Surgery. 2011; 150 (3): 400-409.

15.     Ogura T., Lefor A.T., Nakano M. et al. Nonoperative management of hemodynamically unstable abdominal trauma patients with angioembolization and resuscitative endovascular balloon occlusion of the aorta. J. Trauma Acute Care Surg. 2015; 78 (1): 132-135

 

Abstract

Aim: was to compare annual results of the use of stents with drug eluting - «NanoMed» and Orsiro.

Material and methods: in a randomized prospective study, an analysis of clinical and angiographic data of 1040 patients after stenting of coronary arteries with the observation period of 12 months was performed. The study and control groups randomly included 520 patients with implanted stents «NanoMed» and Orsiro.

Results: main initial clinical demographic and angiographic indicators did not statistically significantly differ. The primary endpoint (TLF - target lesion failure) was achieved in 6.5 and 5.9% in «NanoMed» and Orsiro groups, respectively (p = 0.7). Target lesion revascularization (TLR) was performed in study and control groups, respectively, in 1.7 versus 1.2% of cases (p = 0.4).

Conclusion: thus, in a comparative analysis of the use of stents «NanoMed» and Orsiro for a period of 12 months - no statistically significant difference was revealed.

 

References

1.     El-Hayek G, Bangalore S, Casso Dominguez A, et al. Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents. JACC Cardiovasc. Interv. 2017; 10(5): 462-473.

2.     Joner M, Finn A, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J. Am. Coll. Cardiol. 2006; 48: 193-202.

3.     Sarno G, Lagerqvist B, Fmbert O, et al. Lower risk of stent thrombosis and restenosis with unrestricted use of 'newgeneration' drug-eluting stents: a report from the nation wide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur. Heart J. 2012; 33(5): 606-613.

4.     ittelbach M, Diener T Orsiro - the first hybrid drug-eluting stent, opening up a new class of drug-eluting stents for superior patient outcomes. Interv. Cardiol. 2011; 6(2):142-144.

5.     Kandzari D, Mauri L, Koolen J, et al. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularization (BIOFLOW V): a randomised trial. Lancet. 2017; 390: 1843-1852.

6.     Cutlip D, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials. A Case for Standardized Definitions. Research Consortium. Circulation. 2007; 115(17): 2344-2351.

7.     Thygesen K, Alpert J, Jaffe A, et al. Third Universal Definition of Myocardial Infarction. ESC/ACCF/AHA/WHF Expert consensus document. Circulation. 2012; 126: 2020-2035.

8.     Silber S, Windecker S, Vranckx P, Serruys PW. Unrestricted randomiseduse of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers Trial. Lancet. 2011; 377: 1241-1247.

9.     Bazylev VV, SHmatkov MG, Morozov ZA. Comparative evaluation of endothelialization of stents with permanent and biodegradable coatings at an early stage with help of optical coherence tomography. Diagnosticheskaya i intervencionnaya radiologiya. 2017: 11(4): 11-15. [In Russ]

10.   Bazylev VV, SHmatkov MG, Morozov ZA. Comparative results of the use of coronary stents with drug coating «Nanomed» and Orsiro. Angiologiya i sosudistaya hirurgiya. 2019 ; 25(2): 57-62. [In Russ]

11.   Prohorihin AA, Bajstrukov VI, Grazhdankin IO, et al. Simple, blind, prospective, randomized, multicenter study of the efficacy and safety of the KalIpso sirolimus-eluting coronary stent and the XiencePrime everolimus-eluting coronary stent: PATRIOT study results. Patologiya krovoobrashcheniya i kardiohirurgiya. 2017; 21(3): 76-85. [In Russ]

 

Abstract

Aim: was to estimate condition of aorta branches in case of aortic dissection, using multislice computed tomography (MSCT): we estimated frequency and type of changes of main branches of the aorta involved in the dissection.

Material and methods: a retrospective analysis of 104 patients with aortic dissection (AD) was performed. All patients were admitted to Scientific-Research Institute of Emergency Medicine named after N.V Sklifosovsky All studies were carried out on a multispiral (80x0.5) tomograph in early stages of the disease.

Results: MSCT method allowed to obtain data of the high frequency of transition of aortic dissection to main branches (63.5%), mainly to iliac arteries (81% and 77% of aortic dissection type A and B respectively), both in isolation and in combination with other branches. However, the frequency of occurrence of hemodynamically significant stenosis, both static and dynamic, was significantly higher in groups of visceral branches and brachiocephalic arteries (82% and 71%, respectively).

Conclusion: the CT method allows to evaluate in detail the lumen of the aorta and branches of aorta, and to determine type and degree of stenosis of aortic branches involved in the dissection. Revealed patterns of combining of involvement in different groups of aortic branches in the pathological process, allow to procced more optimized diagnostic search for complications of dissection, including MSCT.

 

References

1.     Hirst Ae Jr, Johns Vj Jr, Kime Sw Jr. Dissecting aneurysm of the aorta: A Review of 505 cases. Medicine (Baltimore). 1958;37(3):217-279. PMID: 13577293        https://doi.org/10.1097/00005792- 195809000-00003 

2.     Litmanovich D, Bankier AA, Cantin L, Raptopoulos V. Boiselle PM. CT and MRI in Diseases of the Aorta. Am J Roentgenol. 2009;193(4):928-940. PMID:19770313 https://doi.org/10.2214/ajr.08.2166

3.     Wheat MW Jr. Acute dissecting aneurysms of the aorta: diagnosis and treatment-1979. Am Heart. 1980; 99(3):373-387. PMID:7355699 https://doi.org/10.1016/ 0002-8703(80)90353-1

4.     Borst HG, Heinemann MK, Stone CD. Surgical treatment of aortic dissection. Churchill Livingstone International; 1996.

5.     Ternovor SK, Sinitsyn VE. Spiral and electron beam angiography. Moscow: Vidar; 1998. [In Russ]. 

6.     Gamzaev AB ogly, Pichugin VV, Dobrotin SS. Diagnosis, surgical treatment tactics and methods for ensuring operations for aortic dissection. In: Medvedev AP, Pichugin VV. Emergency heart surgery: current and unresolved issues. Nizhny Novgorod; 2015.p.237-281. [In Russ]. 

7.     Belov YuV, Komarov RN, Stepanenko AB, Gens AP Savichev DD. Common sense in determining indications for surgical treatment of thoracoabdominal aortic aneurysms. Pirogov Russian Journal of Surgery. 2010;(6):16-20. [In Russ].

8.     Braverman AC. Acute Aortic Dissection. Clinician Update. Circulation. 2010; 122(2): 184-188. PMID: 20625143https://doi.org/10.1161/circulationaha.110.958975

9.     Barmina TG, Zabavskaya OA, Sharifullin FA, Abakumov MM. Possibilities of spiral computed tomography in the diagnosis of damage to the thoracic aorta. Medical Visualization; 2010;(6):84-88. [In Russ].

10.   Strayer RJ, Shearer PL, Hermann LK. Evaluation, and early management of acute aortic dissection in the ED. Curr Cardiol Rev. 2012;8(2): 152-157. PMID:22708909 https://doi.org/10.2174/157340312801784970

11.   Vu KN, Kaitoukov Y Morin-Roy F, Kauffmann C, Giroux MF, Therasse E, et al. Rupture signs on computed tomography, treatment, and outcome of abdominal aortic aneurysms. Insights Imaging. 2014;5(3):281-293. PM ID: 24789068 https://d0i.0rg/10.1007/s13244-014-0327-3

12.   Chiu KW, Lakshminarayan R, Ettles DF. Acute aortic syndrome: CT findings. Clin Radiol.2013;68(7):741-748. PMID:23582433 https://doi.org/10.1016/j.crad.2013.03. 001

13.   Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo R, Eggebrecht H, et al. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases. Europ Heart J. 2014 35(Is 41 ):2873-2926. PMID:25173340 https://doi.org/10.1093/eurheartj/ehu281

14.   Lansman SL, Saunders PC, Malekan R, Spielvogel D. Acute aortic syndrome. J Thorac Cardiovasc Surg. 2010; 140 (6Suppl): S92-97. PMID:21092805 https://doi.org/10.1016Zj.jtcvs.2010.07.062

15.   Bonaca MP, O'Gara PT. Diagnosis and management of acute aortic syndromes: dissection, intramural hematoma, and penetrating aortic ulcer. Curr Cardiol Rep. 2014;16(10):536. PMID:25156302 https://doi.org/ 10.1007/s11886-014-0536-x

16.   Tsai TT, Nienaber C, Eagle KA. Acute Aortic Syndromes. Circulation. 2005; 112(24): 3802-3813. PMID: 16344407 https://doi.org/10.1161/circulationaha.105.534198

17.   Strayer RJ, Shearer PL, Hermann LK. Screening. evaluation, and early management of acute aortic dissection in the ED. Curr Cardiol Rev. 2012;8(2): 152-157. PMID: 22708909 https://doi.org/10.2174/ 157340312801784970

18.   Husainy MA, Sayyed F, Puppala S. Acute aortic syndromepitfalls on gated and nongated CT scan. Emerg Radiol. 2016;23(4):397-403. PMID:27220654 https://doi.org/10.1007/s10140-016-1409-y

19.   Olsson C, Hillebrant CG, Liska J, Lockowandt U, Eriksson P, Franco-Cereceda A. Mortality in acute type A aortic dissection: validation of the Penn classification. Ann Thorac Surg. 2011 ;92(4):1376-1382. PMID:21855849 https://doi.org/10.1016/j.athoracsur.2011.05.011

20.   Kruger T, Conzelmann LO, Bonser RS, Borger MA, Czerny M, Wildhirt S, et al. Acute aortic dissection type A. Br J Surg. 2012;99( 10): 1331-1344. PMID:22961510 https://doi.org/10.1002/bjs.8840

21.   Toda R, Moriyama Y Masuda H, Iguro Y Yamaoka A, Taira A. Organ malperfusion in acute aortic dissection. Jpn J Thorac Cardiovasc Surg. 2000;48(9):545-550.PMID: 11030124 https://doi.org/10.1007/bf03218198

22.   Hallinan J, Anil G. Multi-detector computed tomography in the diagnosis and management of acute aortic syndromes. World J Radiol. 2014;6(6):355-365. PMID: 24976936 https://doi.org/10.4329/wjr.v6.i6.355

23.   Erbel R, Aboyans V, Boileau C, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Kardiol Pol. 2014;72(12):1169-252. PMID:25524604 https://doi.org/10.5603/kp.2014.0225

24.   Rubin GD. Helical CT angiography of the thoracic aorta. J Thorac Imaging. 1997;12(2): 128-149. PMID:9179826 https://doi.org/10.1097/00005382- 199704000-00011 

 

Abstract

Background: pancreatic cancer (PC) - oncologic disease with nonsignificant clinics on early stages and tendention of spreadind in population, as a result - late diagnosis and low rate of radical treatment (10-25%). Carried radical treatment, such as pancreaticoduodenectomy (PDE) - has a high risk of postoperative complications (30-70%) due to its difficulty Most often and dangerous complications are: bleeding, anastomotic leakage, postoperative pancreatitis, purulent complications. Bleeding occurs in 5-10% of cases, mortality varries between 30,7% and 58,5% according to moderd literature. "Sentinel bleeding" - term that meand non-fatal bleeding through drainage or gastrointestinal bleeding (GIB) that follows PDE, and is a predictor of further massive fatal bleeding. Material and methods: article presents data of patient (male, 64y) who underwent gastropancreaticoduodenectomy (GPDE) through bilateral hypochondriacal access as treatment of moderate differentiated (MD) ductal adenocarcinoma of pancreatic head. On 21st day after surgery - massive GIB with source of bleeding as pseudoaneurysm of right hepatic artery Taking into consideration "adverse anatomy", impossibility of stent-graft implantation and failure of primary embolization with "front-to-back-door" technique - against the background of reccurent bleeding, patient undewent coiling of pseudoaneurysm and subseqent coil implantation into right hepatic artery anc common hepatic artery Against the background of second reccurency of GIB - patient underwent successful "front-to-back-door" embolization with combinaton of coils and Onyx.

Results: technique of «front-to-back-door» embolization led to stable hemostasis and patient's discharge in satisfactory condition without recurrence of bleeding.

Conclusions: surgical hospital, carrying on resections of pancreas as a routine, should have a CathLab unit, equipped with wide specter of angiografic instruments and 24/7 surgical team with experience of hemostatic interventions. Bleeding after PDE should be considered as «sentinel bleeding». In case of side-injury of large vessels - stent-graft implantation is preferable, if it is impossible - "front-to-back-door" embolization should be used. 

 

References

1.      Barannikov AYU, Sahno VD. Actual problems of the surgical treatment of diseases of organs of the biliopancreatoduodenal region. Kubanskij nauchnyj medicinskij vestnik. 2018; 25(1): 143-154. DOI: 10.25207/1608-62282018-25-1-143-154. [In Russ.]

2.      Kubyshkin VA, Vishnevskij VA. Pancreatic cancer. M.: ID Medpraktika-M; 2003. 386 s. [In Russ.]

3.      Egorov VI. Treatment of pancreatic cancer. V kn.: Gal'perin E.I., Dyuzheva T.G., redaktory. Lekcii po gepatopankreatobiliarnoj hirurgii. M.: Vidar-M; 2011. 449478. [In Russ.]

4.      Putov NV, Artem'eva NN, Kohanenko NYU. Pancreatic cancer.SPb.: Piter; 2005, 416 s. [In Russ.]

5.      Rasulov RI, Hamatov RK, Songolov GI, Zemko MV. Complex treatment of patients with locally spread cancer of pancreatic head. Annaly hirurgicheskoj gepatologii. 2013; 18(2): 75-89. [In Russ.]

6.      Malignant neoplasms in Russia in 2013 (incidence and mortality) pod red. A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoj M., 2015. p. 36. [In Russ.]

7.      Malignant neoplasms in Russia in 2014 (incidence and mortality) pod red. A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoj M., 2016. p. 36. [In Russ.]

8.      Malignant neoplasms in Russia in 2015 (incidence and mortality) pod red. A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoj M., 2017. p. 36. [In Russ.]

9.      Malignant neoplasms in Russia in 2016 (incidence and mortality) pod red. A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoj M., 2018. p. 36. [In Russ.]

10.    Malignant neoplasms in Russia in 2017 (incidence and mortality) pod red. A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoj M., 2018. p. 36. [In Russ.]

11.    Onopriev VI, Korot'ko GF, Rogal' ML, Voskanyan SE. Pancreatoduodenal resection. Aspects of surgical technique, functional implications. Krasnodar: OOO «Kachestvo»; 2005. 135 s. [In Russ.]

12.    Patyutko YUI, Kotel'nikov AG. Surgery for cancer of organs of biliopancreatoduodenal zone. M.: Medicina; 2007. 448 c. [In Russ.]

13.    Patyutko YUI, Kudashkin NE, Kotel'nikov AG. Various types of pancreatodigestive anastomoses in pancreatoduodenal resection. Annaly hirurgicheskoj gepatologii. 2013; 18 (3): 9-14. [In Russ.]

14.    Propp AR. Diagnosis and surgical treatment of chronic pancreatitis with damage to the head of the pancreas. Annaly hirurgicheskoj gepatologii. 2013; 18(1): 103-151.

15.    Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J. Gastrointest. Surg. 2006; 10(9): 1199-1210. DOI: 10.1016/j.gassur. 2006.08.018.

16.    Veligockij NN, Veligockij AN, Arutyunov SE. Experience of 200 pancreatoduodenectomy - assessment of various options for anastomoses. Annaly hirurgicheskoj gepatologii. 2015; 20(1): 100-105. [In Russ.]

17.    Egorov VI, Vishnevskij VA, Kozlov IA, et al Results of standard and expanded pancreatoduodenal resection with ductal adenocarcinoma of the pancreas. Annaly hirurgicheskoj gepatologii. 2008; 13(4): 19-32. [In Russ.]

18.    Rogal' ML, YArcev PA, Vodyasov AV. Distal loop pancreatoenteroanastomosis in pancreatoduodenal resection.2014; 19(2): 14-18. [In Russ.]

19.    Lai ECH, Lau SHY, Lau WY. Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review. Arch. Surg. 2009; 144(11): 1074-1080. DOI: 10.1001/archsurg.2009.193. 70.

20.    McEvoy SH, Lavelle LP, Hoare SM, et al. Pancreaticoduodenectomy: expected post-operative anatomy and complications. Br. J. Radiol. 2014. Vol. 87. P. 1-8.

21.    Kabanov MYU, Semencov KV, YAkovleva DM, Alekseev VV. The state of the development of pancreatic fistula in patients who underwent pancreatoduodenal resection. VestnikNMHC im. Pirogova N.I. 2017 T. 12 № 2. S. 112-116. [In Russ.]

22.    Darnis B, Lebeau R, Chopin-Laly X, Adham M. Postpancreatectomy hemorrhage (PPH): predictors and management from a prospective database. Langenbecks Arch. Surg. 2013. Vol. 398. P. 441-448.

23.    Kabanov MYU, Semencov KV, YAkovleva DM, Alekseev VV. Bleeding after pancreatoduodenal resections. Vestnik Nacional'nogo mediko-hirurgicheskogo Centra im. N.I. Pirogova 2018, t. 13, № 2. C138-140. [In Russ.]

24.    Rogal' ML, Ivanov PA, YArcev PA, et al. Results of pancreatoduodenal resection in a specialized department of a multidisciplinary hospital. Zhurnal im. N.V. Sklifosovskogo Neotlozhnaya medicinskaya pomoshch'. 2016. №1. S. 54-58. [In Russ.]

25.    Wente, M.N., Veit, J.A., Bassi, C . et al. Postpancreatectomy hemorrhage (PPH)-An International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007. Vol. 142. P. 20-25.

26.    Ramacciato, G., Mercantini, P., N. Petrucciani, G.R., Nigri, A., Kazemi, M., Muroni, M., Del Gaudio, A,. Balesh, M., Cescon, A., Cucchetti, and M. Ravaioli (2011). Risk factors of pancreatic fistula after pancreaticoduodenectomy: a collective review. The American surgeon 77, 257-69.

27.    Brodsky JT, Turnbull AD. Arterial hemorrhage after pancreatoduodenectomy. The ‘sentinel bleed’. Arch Surg 1991;126 (8):1037-1040.

28.    Treckmann J1, Paul A, Sotiropoulos GC, et al. Sentinel bleeding after pancreaticoduodenectomy: a disregarded sign. J Gastrointest Surg. 2008 Feb;12(2):313-8. Epub 2007 Oct 20.

29.    Kriger AG, Kubyshkin VA, Karmazanovskij GG, et al. Postoperative pancreatitis during surgical interventions on the pancreas. Hirurgiya 2012; 4: 14-19.2. [In Russ.]

30.    Kubyshkin VA, Kriger AG, Vishnevskij VA, et al. Pancreatectomy for pancreatic tumors. Hirurgiya. 2013. №3.   S. 11-16. [In Russ.]

31.    Lai EC, Lau SH, Lau WY Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review. Arch Surg 2009; 144: 11: 1074-1180.

32.    de Castro S, Kuhlmann KFD, Busch ORC, et al. (2005) Delayed massive hemorrhage after pancreatic and biliary surgery: embolization or surgery? Ann Surg 241: 85-91.

33.    Iatrogenic and non-iatrogenic trauma. Casebased discussion. Marie Cerna. Cirse 2015.

 

Abstract

Recently, there has been a steady tendency to expand indications for organpreserving operations for kidney tumors.The success of the operation depends on many factors and, first of all, on the completeness of tumor removal and reliability of hemostasis without damage to the blood supply of the entire organ with a minimum time of thermal or cold ischemia. Particularly difficult for surgeon are tumors with intrarenal arrangement. This is due to difficulties of intraoperative determination of tumor localization, as well as technical aspects of removal of big newgrowth with the implementation of adequate hemostasis in the bed of the removed tumor. If resection of kidney poles with a tumor is a fairly simple operation, the enucleation of the latter in the depth of the parenchyma at the location in the middle segments of the kidney and in direct contact with large vessels, is of great technical complexity As a rule, central location of intrarenal tumor requires the "exposure" of kidney parenchyma by a separate incision, up to the sectional. The surgeon's task is to minimize such transparenchymal access, which creates difficulties with hemostasis in a limited space and time limit of thermal ischemia. Hemostatic insufficiency, in turn, can lead to postoperative bleeding, and formation of arteriovenous fistulas. Superselective embolization of branches of the renal artery supplying the intrarenal tumor ensures the subsequent optimal revision of the bed of the removed tumor, minimizes blood loss and allows to refuses blood flow arrest of entire organ.

Case report: article presents data of a young 33-year-old patient with a congenital anomaly in the blood supply of left kidney in the form of a multiple renal artery and kidney tumor T1AN0M0. Ultrasound, CT and MRI revealed an intraparenchymal tumor of the left kidney measuring 2,3x2,5x2,2 cm, with blood supply by 4 arteries extending from the aorta. As the first stage, superselective embolization of tumor's blood supplying artery with PVA 355-500 microns was performed. The second stage was the enucleation of a tumor of left kidney under the control of intraoperative ultrasound without thermal kidney ischemia. Intraoperative blood loss less than 150 ml. The patient was discharged on the 7th day

Conclusion: performing selective embolization of the renal artery feeding the tumor makes it possible to perform the operation without thermal ischemia of the kidney with minimal blood loss.

  

References

1.      Alyaev YU.G., Glybochko P.V., Grigoryan Z.G., Gazimiev M.A. Organ-preserving surgery for kidney tumors. M.:GEOTAR-Media,2009; S. 55-64. [In Russ.]

2.      3-D - technology for operations on the kidney: from virtual to real surgery. Pod red. Glybochko P.V., Alyaeva YU.G. M.: GEOTAR-Media, 2014; S.91-92. [In Russ.]

3.      MacLeman S, Imamura M., Lapitan M.C. Systematic review of perioperative end quality-of-life outcomes following surgical management of localized renal cancer. Eur Urol, 2012; 62:1097.

4.      May M., Brookman-Amissah S, Pflanz S., Roigas J., Hoschke B., Kendel F. Pre-operative renal arterial embolisation does not provide survival benefit in patients with radical nephrectomy for renal cell carcinoma. Br J Radiol, 2009; 82:724.

5.      Maxwell N.J., Saleem Amer N, Rogers E. Kiely D, Sweeney P, Brady AP, Renal artery embolisation in the palliative treatment of renal carcinoma. Br J Radiol, 2007; 80:96.

6.      Vishnyakova M.V., Vashchenko A.V., Demidov I.N., Gegenava B.B., Denisova L.B. Endovascular treatment of vascular pathology using three-dimensional navigation. First experience. Rossijskij elektronnyj zhurnal luchevoj diagnostiki. 2011; T1. №3. S.44-53. [In Russ.]

7.      Gegenava B.B., Vishnyakova M.V., Kiselev A.M., Vashchenko A.V., Demidov I.N., Vishnyakova M.V. (ml.) Endovascular treatment of arteriovenous malformations of cerebral vessels using three-dimensional guidance technology. Al'manah klinicheskoj mediciny. 2013g., №29 str.3-7. [In Russ.]

8.      Kokov L.S., Storozhev R.V., Bocharov S.M., Anisimov YU.A., Belozerov G.E., Pinchuk A.V., Experience in embolization of the artery of a renal allograft before nephrotransplantectomy at a long time after surgery. Transplantologiya. 2012; № 1-2. S. 70-73. [In Russ.]

9.      Bazaev V.V., Gegenava B.B., Stashuk G.A., Bychkova N.V., Kazanceva I.A. Successful resection of the kidney in a patient with rupture of angiomyolipoma with preliminary superselective embolization of renal vessels. Annaly hirurgii, 2018; T.23 №4. S239-246. [In Russ.]

 

Abstract

This study presents an overview of modern methods of surgical and endovascular treatment of atherosclerotic lesions of the superficial femoral artery

Aim: was to analyze the state of surgical and endovascular treatment of atherosclerotic lesions of the superficial femoral artery according to the modern literature in the field of vascular surgery

Results: this review analyzes more than 30 relevant publications presented in both domestic anc foreign press over the past 20 years, taking into account a variety of meta-analyses.

Conclusions: this topic is very relevant today, as the increase in the number of surgical and endovascular interventions in lesions of the superficial femoral artery dictates new research to develop optimal tactics of treatment of this category of patients.

  

References 

1.     Pokrovskij A.V. The state of vascular surgery in 2017. Moskva 2018. [In Russ.]

2.     Pokrovskij A.V. Clinical angiology. Guide-book for physicians. M.: Medicina. 2004; 2: 184 [In Russ.]

3.     Diamantopoulos A, Katsanos K. Treating femoropopliteal disease: established and emerging technologies. Semin Intervent Radiol. 2014 Dec; 31(4):345-52.

4.     Dominguez A, Bahadorani J, Reeves R, et al. Endovascular therapy for critical limb ischemia. Expert Rev Cardiovasc Ther. 2015 Apr; 13(4): 429-44.

5.     Bokeriya L.A., Temrezov M.B., Kovalenko V.I., i dr. Actual problems of surgical treatment of patients with critical ischemia of lower limbs - solutions (state of the problem). Annalyhirurgii. 2011; 1: 5-9. [In Russ.]

6.     Norgen L, Hiatt WR, Dormandy JA. et al. Inter-Society Consensus for the management of Peripheral Arterial Disease (TASC II). Eur. J. Vasc. Endovasc. Surg. 2007; 3(1): 1-75.

7.     Cotroneo AR, Iezzi R, Marano G. Hybryd therapy in patients with complex peripheral ultifocal steno-obstructive vascular disease: two-year results. Cardiovasc. Intervent. Radiol. 2007; 30: 355-361.

8.     Bokeriya L.A. Endovascular surgery of diseases of great vessels. M.:NCSSKH im. A.N. Bakuleva RAMN, 2008;291-310. [In Russ.]

9.     Gavrilenko A.V., Kotov A.E., Murav'eva YA.YU. The effect of tactical errors on results of surgical treatment in patients with critical lower limb ischemia. Angiologiya i sosudistaya hirurgiya. 2010; 16(1):138-143. [In Russ.]

10.   Marston WA, Davies SW, Armstrong В, Farber MA, Mendes RC, Fulton JJ, Keagy BA. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vase Surg. 2006 Jul; 44(1): 108-114.

11.   Kazakov YU. I., Lukin I. B., Kazakov A. YU. The choice of vascular reconstruction method for critical lower limb ischemia. Angiologiya i sosudistaya hirurgiya. 2015;21(2):152-8.

12.   Bied Dzh. D. Amputation or reconstruction for critical lower limb ischemia. Angiologiya i sosudistaya hirurgiya. 1998;4(1): 72-78. [In Russ.]

13.   Pokrovskij A.V. Russian consensus. Diagnosis and treatment of patients with critical lower limb ischemia. M., Shwarz Pharma, 2002; 40 s. [In Russ.]

14.   Linkert P. et al. Saphenous Vein Versus PTFE for Above-Knee Femoropopliteal Bypass. A Review of the Literature. Eur. J. Vasc. Endovasc. Surg. Elsevier BV. 2004; 27(4): 357-362.

15.   Abramov S.I., Majtesyan D.A., Lazaryan T.A. Longterm results with a semi-closed endarterectomy loop from the superficial femoral artery and femoral-popliteal bypass grafting. Angiologiya i sosudistaya hirurgiya. 2014; 20(4): 147-151 [In Russ.]

16.   Beard JD: which revascularization is best for critical limb ischemia: endovascular or open surgery? J Vasc Surg. 2008, 48: 112-116S. 10.1016 / j.jvs.2008.01.065.

17.   Blevins WA, Schneider PA: Endovascular treatment of critical limb ischemia. Eur J Vasc Endovasc Surg. 2010; 39 (6): 756-761. 10.1016 / j.ejvs.2010.02.008.

18.   Adam DJ, Beard JD, Cleveland T, et al: BASIL trial participants. Shunting and angioplasty in severe ischemia of the foot (basil): a multicenter, randomized controlled trial. Lancet. 2005, 366 (9501): 1925-1934.

19.   Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial: An intention-to-treat analisys of amputation-free and overall survival in patients randomized to a bypass surgery-first or a ballon angioplasty-first revascularization strategy. J. Vasc. Surg. 2010; 51: 5-17.

20.   Lindgren H, Qvarfordt P, Ekesson M, et al Primary Stenting of the Superficial Femoral Artery in Intermittent Claudication Improves Health Related Quality of Life, ABI and Walking Distance: 12 Month Results of a Controlled Randomised Multicentre Trial. Eur J Vasc Endovasc Surg. 2017        May; 53(5):686-694.

21.   Grimme FA., Goverde PA., Van Oostayen JA., et al. Covered stents for aortoiliac reconstruction of chronic occlusive lesions. J. Cardiovasc. Surg. (Torino). 2012; 53 (3):279-89.

22.   Gandini R, Fabiano S, Chiocchi M, et al. Percutaneous treatment in iliac artery occlusion: long-term results. Cardiovasc. Intervent. Radiol. 2008; 31 (6): 1069-76.

23.   Yokoi Y How should recent endovascular trials for femoropopliteal artery disease be interpreted. Cardiovasc Interv Ther. 2017 Apr; 32(2):106-113.

24.   Deloose K, Callaert J. Less is more: the "As Less As Reasonably Achievable Stenting" (ALARAS) strategy in the femoropopliteal area. J Cardiovasc Surg (Torino). 2018 Aug; 59(4):495-503.

25.   Chalmers n Walker PT, Belly AM et al. A randomized study of a smart stent versus balloon angioplasty for long superficial lesions of the femoral artery: a super-study. Cardiovascular and Interventional Radiology. 2013; 36 (2): 353-361

26.   Dake MD. et al. Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal ArteryCLINICAL PERSPECTIVE. Circulation. Ovid Technologies (Wolters Kluwer Health), 2016;133(15): 1472-1483.

27.   Muradin GSR, Bosch Denpasar, Stainen T, Hunink MGM. Balloon dilatation and stent implantation for the treatment of arterial disease of the femur: Meta-analysis. Radiology. 2001; 221 (1): 137-145.

28.   Acin F, de Haro J, Bleda S,et al Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials. J Endovasc Ther. 2012 Oct;19(5):585-95. doi: 10.1583/JEVT-12-3898R.1.

29.   Zatevahin         I.I., SHipovskij V.N., Tursunov S.B. i dr. Longterm results of angioplasty using drug-coated balloons for lesions of the femoral-popliteal segment. Angiologiya i sosudistaya hirurgiya. 2014; 20(4): 64-68. [In Russ.]

30.   Katsanos to Karnabatidis D. Kitrou P Spiliopoulos with Christeas H Siablis D. Paclitaxel-coated balloon angioplasty and a conventional dilatation balloon for treatment of non-dialysis access: 6-month interim results from a prospective randomized controlled trial. Journal of Endovascular Therapy. 2012; 19 (2): 263-272.

31.   Werk M, Albrecht T, Dirk-Roelfs Meyer D-R, et al. Paklitaxel-Coated Balloons Reduse Restenosis After Femoropopliteal Angioplasty. Circ. Cardivasc. Interv. 2012; 5:831-840.

32.   Fanelli F, Cannavale A, Boatta E, et al. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. J Endovasc Ther. 2012; 19: 571-580.

33.   Diamantopoulos A, Gupta Y, Zayed H. et al Paclitaxel-coated balloons and aneurysm formation in peripheral vessels. J Vasc Surg 2014; epub ahead of print.

34.   Pastromas G, Katsanos K, Krokidis M, et al Emerging stent and balloon technologies in the femoropopliteal arteries. Scientific World Journal. 2014; 2014:695402.

35.   Schmidt A, Piorkowski M, Werner M, et al: First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol. 2011; 58 (11): 1105-1109. 10.1016/j.jacc. 2011.05.034.

36.   Fanelli F, Cannavale A, Boatta E, et al: Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. J Endovasc Ther. 2012; 19 (5): 571-580. 10.1583/JEVT-12-3926MR.1.

37.   Liistro F, Porto I, Angioli P, et al: Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation. 2013.

38.   Bays S. The use of scoring balloons in the superficial femoral artery. J Cardiovasc Surg (Torino). 2018 Aug; 59(4):504-511.

39.   Saxon rubles. Heparin bonded stent grafts in SFA: VIPER annual results. The report is presented at the International Symposium on Endovascular Therapy; January 18, 2012; Miami, Fla, USA.

40.   Ansel G. 3-year vivid results. The document is available at: Vascular InterVentional Advances; October 2011; Las Vegas, Nev, USA.

41.   Vermassen F. Bouckenooghe I, Morel N Goverde P. Schroe N. The role of biodegradable stents in the superficial femoral artery. Journal of Cardiovascular Surgery. 2013; 54 (2): 225-234.

 

Abstract

We performed an analysis of literature data about angiosome concept in treatment of patients wih critical lower limb ishemia. We presented data on the appearance and development of this concept. Possibilities of using this tactic in various situations are considered, advantages and disadvantages of this concept are shown. Factors, limiting the effectiveness of this method, and alternative methods when it is impossible to restore blood flow according to the angiosome concept - the degree of lesion of arteries and the development of collateral blood flow to restore perfusion of soft tissues are given. It has been shown that the correct assessment of collateral arteries in critical lower limb ischemia plays a central role in any type of lower limb revascularization, and this statement also applies to a strategy based on the angiosome concept.

  

Refereneces

1.      Diabetes: Newsletter. No. 312 [Electronic resource]. Vsemirnaya Organizaciya Zdravoohraneniya. ZHeneva,2011. Rezhim dostupa: www.who.int/mediacentre/ factsheets/fs312/ru/index.html. Data dostupa: 31.03.11. [In Russ.]

2.      Wild S et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004. Vol. 27. P. 1047-1053.

3.      Sachek M.G., Bulavkin V.P., Eroshkin S.N. Possibilities of direct limb revascularization in treatment of patients with diabetic foot syndrome. Novosti hirurgii tom 19. №4.2011. [In Russ.]

4.      Ancyferov M. B. i dr. Prophylaxis system of lower limb' amputations in patients with diabetes mellitus and prospects for its implementation in Moscow. Problemy endokrinologii. 2007. T. 53, № 5. S. 8-12. [In Russ.]

5.      Norgren L, Hiatt WR, Dormandy JA, et al: Inter-society consensus for the management of peripheral arterial disease [TASC II]. Eur J Vasc Endovasc Surg. 2007; 33Suppl 1:S32-55 S.

6.      Mitchell ME: lower extremity major amputations. In: Diabetic foot, lower extremity arterial disease and limb salvage. Philadelphia, lippincott Williams & Wilkins, 2006:341-350.

7.      Eroshkin S.N.. Long-term results of treatment of patients with purulent-necrotic forms of diabetic foot syndrome, depending on used methods of revascularization. Novosti hirurgii tom 21. № 4. 2013. [In Russ.]

8.      Ikonen T.S., Sund R., Venermo M., Winell K.: Fewer major amputations among individuals with diabetes in Finland in 1997-2007: a population-based study. Diabetes Care 2010;33:2598-2603.

9.      Graziani l., Silvestro A., Bertone V., et al: Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 2007;33:453-460.

10.    Lepantalo M., Apelqvist J., Setacci C., et al: Chapter v: Diabetic foot. Eur J Vasc Endovasc Surg. 2011;42 Suppl 2: S60-74.

11.    Alexandrescu V., Sцderstrцm M., Venermo M. Angiosome theory: fact or fiction? Scandinavian Journal of Surgery 101: 125-131, 2012.

12.    Lepantalo M., Biancari F, Tukiainen E.: never amputate without consultation of a vascular surgeon. Diabetes Metab Res Rev2000;[16]: Suppl 1: S27-32

13.    Beard J.D. Which is the best revascularization for critical limb ischemia:endovascular or open surgery? J Vasc Surg. 2008; 48(6 Suppl): 11S-6S. doi: 10.1016/j.jvs.2008.08.036.

14.    Romiti M, Albers M, Brochado-Neto FC, et al. Metaanalysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008;47(5):975-981. doi: 10.1016/j.jvs.2008.01.005.

15.    Bondarenko O.N., Galstyan G.R., Ayubova N.L., i dr. Outcomes of endovascular interventions in patients with diabetes mellitus and critical lower limb ischemia. Sbornik tezisov. VI Vserossijskij diabetolgicheskij kongress. M.:2013.         S 170. [In Russ.]

16.    Soderstrom M, Arvela E, Alback A, Aho PS, lepantalo M: Healing of ischaemic tissue lesions after infrainguinal bypass surgery for critical leg ischaemia. Eur J Vasc Endovasc Surg 2008;36:90-9515.

17.    CheshireN.J.. Wolfe J.H.N. Does distal revascularization for limb salvage work? It Trials and tribulations of vascular surgery. R.M. Grcenhaugh. F.G.R. Fowkcs. eds. Philadelphia: Saunders. 1996. P 353-363.

18.    Berceli S.A.. Chan A.K.. Pomposelli F.B. ct al. Efficacy of dorsal pedal artery bypass in limb salvage for ischemic heel ulcers. J. Vase. Surg. 1999. Vol. 30. X» 3. P 499-508.

19.    Taylor GI, Palmer JH: The vascular territories [angiosomes] of the body: experimental studies and clinical applications. Br J Plast Surg 1987;40:113-141.

20.    Taylor GI, Pan WR: Angiosomes of the leg: anatomic study and clinical implications. Plast Reconstr Surg 1997;4:183-198.

21.    Attinger CE, Evans KK, Bulan E, Blume P, Cooper P Angiosomes of the Foot and Ankle and Clinical Implications for Limb Salvage: Reconstruction, Incisions, and Revascularization Plast. Reconstr. Surg. 117 (Suppl.): 261S, 2006.

22.    Neville RF, Attinger CE, Bulan EJ, et al: Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vasc Surg 2009;23[3]: 367-7320.

23.    Varela C, Acin nF, Haro JD, et al: The role of foot collateral vessels on ulcer healing and limb salvage after successful endovascular and surgical distal procedures according to an angiosome model. Vasc Endovasc Surg 2010;44:654-660.

24.    Iida o, nanto S, Uematsu M, et al: Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia. Catheter Cardiovasc Interv 2010;75:830-836.

25.    Iida О, Soga Y Hirano K, et al: long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. J Vasc Surg 2012;55:363-370.

26.    Soderstrom, M., Alback, A., Biancari, F., Lappalainen, K., Lepantalo, M., and Venermo, M. Angiosome-targeted infrapopliteal endovascular revascularization for treatment of diabetic foot ulcers. J Vasc Surg. 2013; 57: 427-435.

27.    Biancari F , Juvonen T. Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis. European journal of vascular and endovascular surgery volume 47. Issue 5 p. 517e522 2014.

28.    Huang Tzu-Yen, Huang Ting-Shuo, MD, PhD, et al, Direct revascularization with the angiosome concept for lower limb ischemia. A Systematic Review and Meta-Analysis.Medicine 94(34):e1427.

29.    Bosanquet D.C., Glasbey J.C.D., Williams I.M., Twine C.P. Systematic Review and Meta-analysis of Direct Versus Indirect Angiosomal Revascularisation of Infrapopliteal Arteries European Journal of Vascular and Endovascular Surgery Volume 48 Issue 1 p. 88e97 July/2014.

30.    Azuma N, Uchida H, Kokubo T, Koya A, Akasaka n, Sasajima T: Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery? Eur J Vasc Endovasc Surg 2012;43: 322-328.

31.    Iram Naz, Kaitlyn M. Dunphy, BS, et al . The Impact on Wound Healing and Major Amputation-free Survival in Patients With Isolated Below-the-Knee Arterial Disease After Angiosome-Directed Endovascular Revascularization Journal of Vascular Surgery August 2018, Volume 68, Issue 2, Page e24.

32.    Elbadawy A, Ali H, Saleh M, Hasaballah. A Prospective Study to Evaluate Complete Wound Healing and Limb Salvage Rates After Angiosome Targeted Infrapopliteal Balloon Angioplasty in Patients with Critical Limb Ischaemia A. Eur J Vasc Endovasc Surg 2018;55:391-6.

33.    Doherty TM, Fitzpatrick LA, Inoue D, et al. Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocr Rev. 2004;25(4):629-672. doi: 10.1210/ er.2003-0015.

34.    Dedov I.I., Anciferov M.B., Galstyan G.R., i dr. Diabetic foot syndrome. M.: «Universum Pablishing»; 1998. [In Russ.]

35.    Shanahan CM1, Cary NR, Salisbury JR, et al. Medial localization of mineralization-regulating proteins in association with Monckeberg’s sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation. 1999; 100(21 ):2168-2176. doi: 10.1161/01.CIR.100. 21.2168.

36.    Ayubova N.L., Bondarenko O.N., Galstyan G.R. i dr. Features of lesions of lower limb’ arteries and clinical outcomes of endovascular interventions in patients with diabetes mellitus with critical ischemia of lower limbs and chronic kidney disease. Saharnyj diabet. 2013. T. 16. №4 S.85-94. [In Russ.]

37.    Bondarenko O.N., Galstyan G.R., Dedov I.I. Clinical features of critical lower limb ischemia and the role of endovascular revascularization in patients with diabetes mellitus. 2015;18(3):57-69. [In Russ.]

38.    O’neal lW: Surgical pathology of the foot and clinicopathologic correlations. In: levin and o’neal’s The Diabetic Foot. Philadelphia, Mosby Elsevier 2008:367-401.

39.    Simons JP, Goodney PP, nolan BW, et al: Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia. J Vasc Surg 2010;51[6]: 1419-1424.

40.    Khan MU, lall P, Harris lM, et al: Predictors of limb loss despite a patent endovascular-treated arterial segment. J Vasc Surg 2009;49[6]:1445-1446.

41.    Platonov S. A., Kaputin M. YU., Ovcharenko D. V.. CHistyakov S. P., Voronkov A. A., Zavackij V. V., Dudonov I. P. The role of collateral blood supply to the foot in the healing of trophic defects and preservation of the limb in patients with critical lower limb ischemia. Med. akad. zhurn. 2011.T 11. № Z.S. 105-111. [In Russ.]

 

Abstract

Aim: was to determine characteristic signs of instability and threatening rupture of abdominal aortic aneurysms, detected by computed tomography (CT) according to analysis of modern literature.

Materials: international clinical recommendations and studies of 36 domestic and foreign authors on the diagnosis of abdominal aortic aneurysms (AAA) using computed tomography (CT) were studied. We studied publications that describe the pathogenetic mechanisms of AAA rupture, structural changes in the aortic wall and surrounding tissues, which can be regarded as signs of the formation of aneurysm rupture.

Conclusion: according to literature, specific CT signs of aortic wall instability and data on the high diagnostic value of some of them are presented. Methodological aspects of the analysis of CT data are described for large aneurysms and complex configurations.

  

References

1.      Pokrovskij A.V. (red.). Clinical Angiology: practical guide in in 2 vol. M.: Medicina. 2004. [In Russ]

2.      Davis C.A. Computed tomography for the diagnosis and management of abdominal aortic aneurysms. Surg. Clin. North Am. 2011; 91(1): 185-193.

3.      National guidelines for the management of patients with abdominal aortic aneurysms. Angiologiya i serdechno-sosudistaya hirurgiya. 2013; 19 (2, Pril.): 72. [In Russ]

4.      Prokop M., Galanski M. (red.). Spiral and multilayer computed tomography: in 2 vol. 3-e izd. M.: MEDpress- info. 2011. [ [In Russ]

5.      Pleumeekers H.J., Hoes A.W., van der Does E., et al. Aneurysms of the abdominal aorta in older Aneurysms of the abdominal aorta in older adults. The Rotterdam Study. Am. J. Epidemiol. 1995; 142 (12): 1291-1299.

6.      Singh K., Bonaa K.H., Jacobsen B.K., et al. Prevalence and risk factors for abdominal aortic aneurysms in a ence and risk factors for abdominal aortic aneurysms in a population-based study: the Tromsu Study. Am. J. Epidemiol. 2001; 154 (3): 236-244.

7.      Ahmed M.Z., Ling L., Ettles D.F. Common and uncommon CT findings in rupture and impending rupture of abdominal aortic aneurysms. Clin. Radiol. 2013; 68(9): 962-971.

8.      Genovese E.A., Fonio P, Floridi C. et al. Abdominal vascular emergencies: US and CT assessment. Crit. Ultrasound J. 2013; 5(Suppl 1): S10.

9.      Wadgaonkar A.D., Black J.H. 3rd, Weihe E.K. et al. Abdominal aortic aneurysms revisited: MDCT with multi-planar meconstructions for identifying indicators of instability in the pre- and postoperative patient. Radiographics. 2015; 35 (1): 254-268.

10.    Vorp D. Biomechanics of abdominal aortic aneurysm. J. Biomech. 2007; 40(9): 1887-1902.

11.    Fillinger M.F., Racusin J., Baker R.K. et al. Anatomic characteristics of ruptured abdominal aortic aneurysm on conventional CT scans: Implications for rupture risk. J. Vasc. Surg. 2004; 39 (6): 1243-1252.

12.    Hinchliffe R.J, Alric P, Rose D. et al. Comparison of morphologic features of intact and ruptured aneurysms of infrarenal abdominal aorta. J. Vasc. Surg. 2003; 38(1): 88-92.

13.    Johnson P.T., Fishman E.K. IV contrast selection for MDCT: current thoughts and practice. AJR Am. J. Roentgenol. 2006; 186 (2): 406-415.

14.    Brewster D.C., Cronenwett J.L., Hallett J.W. Jr et al. Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J. Vasc. Surg. 2003; 37(5): 1106-1117.

15.    Vu K.N., Kaitoukov Y, Morin-Roy F. et al. Rupture signs on computed tomography, treatment, and outcome of abdominal aortic aneurysms. Insights Imaging. 2014; 5 (3): 281-293.

16.    Halliday K.E., al-Kutoubi A. Draped aorta: CT sign of contained leak of aortic aneurysms. Radiology. 1996; 199(1): 41-43.

17.    Yuksekkaya R., Koner A.E., Celikyay F. et al. Multidetector computed tomography angiography findings of chronic-contained thoracoabdominal aortic aneurysm rupture with severe thoracal vertebral body erosion. Case Rep. Radiol. 2013; 2013: 596517.

18.    Schwartz S.A., Taljanovic M.S., Smyth S. et al. CT findings of rupture, impending rupture, and contained rupture of abdominal aortic aneurysms. AJR Am. J. Roentgenol. 2007; 188 (1): W57-62.

19.    Mehard W.B., Heiken J.P., Sicard G.A. High-attenuating crescent in abdominal aortic aneurysm wall at CT: a sign of acute or impending rupture. Radiology. 1994; 192(2): 359-362.

20.    Radiological diagnosis of diseases of the heart and blood vessels: a national guide. (edited by L.S. Kokova). M.: GEHOTAR-Media. 2011; 256. [ [In Russ]

21.    Erbel R., Aboyans V., Boileau C. et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur. Heart J. 2014; 35 (41): 28732926.

22.    Vorp D.A., Raghavan M.L., Webster M.W. Mechanical wall stress in abdominal aortic aneurysm: Influence of diameter and asymmetry. J. Vasc. Surg. 1998; 27(4): 632639.

23.    Fillinger M.F., Raghavan M.L., Marra S.P. et al. In vivo analysis of mechanical wall stress and abdominal aortic aneurysm rupture risk. J. Vasc. Surg. 2002; 36(3): 589-597.

24.    Kontopodis N., Metaxa E., Papaharilaou Y et al. Advancements in identifying biomechanical determinants for abdominal aortic aneurysm rupture. Vascular. 2015; 23(1): 65-77.

25.    Doyle B.J., Callanan A., Burke P.E. et al. Vessel asymmetry as an additional diagnostic tool in the assessment of abdominal aortic aneurysms. J. Vasc. Surg. 2009; 49(2): 443-454.

26.    Giannoglou G., Giannakoulas G., Soulis J. et al. Predicting the risk of rupture of abdominal aortic aneurysms by utilizing various geometrical parameters: Revisiting the diameter criterion. Angiology. 2006; 57(4): 487-494.

27.    Georgakarakos E., Ioannou C.V., Kamarianakis Y et al. The role of geometric parameters in the prediction of abdominal aortic aneurysm wall stress. Eur. J. Vasc. Surg. 2010; 39(1): 42-48.

28.    Moxon J.V., Adam Parr, Emeto T.I. et al. Diagnosis and monitoring of abdominal aortic aneurysm: Current status and future prospects. J. Curr. Probl. Cardiol. 2010; 35: 512-548.

29.    Polzer S., Gasser T.C., Swedenborg J., Bursa J. The impact of intraluminal thrombus failure on the mechanical stress in the wall of abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 2011; 41 (4):467-473.

30.    Hunter G.C., LeongS.C., Yu G.S. Aortic blebs: Possible site of aneurysm rupture. J. Vasc. Surg. 1989; 10(1): 93-99.

31.    Rakita D., Newatia A., Hines J.J. et al. Spectrum of CT findings in rupture and impending rupture of abdominal aortic aneurysms. RadioGraphics. 2007; 27(2): 497-507.

32.    Oldenburg W.A., Almerey T. Erosion of lumbar vertebral bodies from a chronic contained rupture of an abdominal aortic pseudoaneurysm. J. Vasc. Surg. Cas. Innovat. Techn. 2016; 2(4): 197-199.

33.    Endovascular aneurysm repair vs. open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomized control trial. Lancet. 2005; 365: 2179-2186.

34.    Zarins C.K., White R.A., Fogarty T.J. Aneurysm rupture after endovascular repair using the aneurx stent graft. J. Vasc. Surg. 2000; 31(5): 960-970.

35.    Zarins C.K., White R.A., Hodgson K.J. et al. Endoleak as a predictor of outcome after endovascular aneurysm repair: AneuRx multicenter clinical trial. J. Vasc. Surg. 2000; 32(1): 90-107.

36.    Bernhard V.M., Mitchell R.S., Matsumura J.S. et al. Ruptured abdominal aortic aneurysm after endovascular repair. J. Vasc. Surg. 2002; 35(6): 1155-1162.

 

Abstract

Heart transplantation (HTx) leads to a marked increase in the duration and quality of life of patients with terminal chronic heart failure. However, in the long-term period, recipients are faced with the problem of cardiac allograft vasculopathy (CAV), which significantly limits the survival of the heart transplant.

Aim: was to assess main approaches to the diagnosis and treatment of cardiac allograft vasculopathy, basing on analysis of literature data on the diagnostic value of invasive methods for assessing the condition of the coronary flow in CAV.

Materials and methods: 43 scientific sources of leading domestic and foreign journals were analyzed.

Results: the review provides data on modern imaging methods in assessing of intimal hyperplasia and neovascularization in patients with a transplanted heart. Possibilities of therapy and prevention of CAV are considered. Information on the role of myocardial revascularization by endovascular and surgical methods in treatment of CAV in various variants of coronary disease is analyzed.

Conclusion: CAV is the main cause of death of recipients in the long term after HTx. A prevention strategy should be based on early diagnosis to identify initial signs of the disease. Endovascular imaging methods are better than others to identify the development of CAV in early stages. Development of methods for the early diagnosis, prevention and treatment of transplant coronary artery disease is one of main tasks of modern transplantology.

  

References 

1.     Gao SZ, Alderman EL, Schroeder JS, Silverman JF. Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 1988; 12:334-40.

2.     Kazakov Je.N., Kormer A.Ja., Chestuhin V.V., Golubickij V.V. Pathology of coronary arteries of the transplanted heart according to coronary angiography. Transplantologija i iskusstvennye organy, 1996. 4: 74-77 [In Russ].

3.     Tjunjaeva I.Ju. Evaluation of ischemic injury and myocardial revascularization in coronary artery disease of the transplanted heart, Avt. dis. kand. med. nauk. M. 2005; 105 s [In Russ].

4.     Lund LH, Khush KK, Cherikh WS, Goldfarb S, Kuch- eryavaya AY, Levvey BJ, Meiser B, Rossano JW, Chambers DC, Yusen RD, Stehlik J; International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult heart transplantation report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant. 2017; 36:1037-1046.

5.     Chestukhin V.V., Ostroumov E.N., Tyunyaeva I.Yu., Zakharevich V.M. i dr. Coronary artery disease of the transplanted heart. Diagnostic and treatment options. Ocherki klinicheskoy transplantologii. Pod red. S.V. Gautier. M., 2009.   [In Russ]

6.     M.R. Mehra, M.G. Crespo-Leiro, A. Dipchand, S.M. Ensminger, NE Hiemann, JA Kobashigawa, J Madsen, J Parameshwar, RC Starling, PA Uber. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant 29, 717-727 (2010).

7.     AI Dipchand, LB Edwards, AY Kucheryavaya, C Benden, F Dobbels, BJ Levvey, LH Lund, B Meiser, RD Yusen, J Stehlik. The registry of the International Society for Heart and Lung Transplantation: seventeenth official pediatric heart transplantation report — 2014; focus theme: retransplantation. J Heart Lung Transplant 33, 985-995 (2014).

8.     Chestuhin V.V., Mironkov A.B., Tjunjaeva I.Ju., Rjadovoj I.G., Zaharevich V.M., Mironkov B.L. Assessment of diastolic dysfunction of the left ventricle of the heart transplant in the development of its vasculopathy. Vestnik transplantologii i iskusstvennyh organov. 2013; 1: 6-11 [In Russ].

9.     Bader FM, Islam N., Mehta N.A., Worthen N. Noninvasive Diagnosis of Cardiac Allograft Rejection Using Echocardiography Indices of Systolic and diastolic Function. J Transplantation Proceedings. 2011; 43: 3877-3881.

10.   Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010; 29:914-56.

11.   Bacal F, Moreira L, Souza G, Rodrigues AC, Fiorelli A, Stolf N et al. Dobutamine stress echocardiography predicts cardiac events or death in asymptomatic patients long-term after heart transplantation: 4-year prospective evaluation. J Heart Lung Transplant 2004; 23:1238-44.

12.   Rodrigues AC, Bacal F, Medeiros CC, Bocchi E, Sbano J, Morhy SS et al. Noninvasive detection of coronary allograft vasculopathy by myocardial contrast echocardiography. J Am Soc Echocardiogr 2005; 18:116-21.

13.   Sade LE , Eroglu S, Yьce D, Bircan A, Pirat B, Sezgin A, Aydi nalp A, Mьderr isoglu H. Follow-up of heart transplant recipients with serial echocardiographic coronary flow reserve and dobutamine stress echocardiography to detect cardiac allograft vasculopathy. J Am Soc Echocardiogr 2014; 27: 531- 539.

14.   Kobashigawa J. Coronary computed tomography angiography: is it time to replace the conventional coronary angiogram in heart transplant patients? J Am Coll Cardiol 2014; 63: 2005-2006.

15.   Wever-Pinzon O, Romero J, Kelesidis I, Wever-Pinzon J, Manrique C, Budge D et al. Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials. J Am Coll Cardiol 2014;63: 1992-2004.

16.   von Ziegler F, Leber AW, Becker A, Kaczmarek I, Schonermarck U, Raps C et al. Detection of significant coronary artery stenosis with 64-slice computed tomography in heart transplant recipients: a comparative study with conventional coronary angiography. Int J Cardiovasc Imaging 2009;25: 91-100.

17.   Pichler P, Loewe C, Roedler S, Syeda B, Stadler A, Aliabadi A et al. Detection of high-grade stenoses with multislice computed tomography in heart transplant patients. J Heart Lung Transplant 2008; 27:310-6.

18.   Rohnean A, Houyel L, Sigal-Cinqualbre A, To NT, Elfassy E, Paul JF. Heart transplant patient outcomes: 5-year mean follow-up by coronary computed tomography angiography. Transplantation 2011; 91: 583-8.

19.   Barthelemy O, Toledano D, Varnous S, Fernandez F Boutekadjirt R, Ricci F et al. Multislice computed tomography to rule out coronary allograft vasculopathy in heart transplant patients. J Heart Lung Transplant 2012; 31: 1262-8.

20.   Costanzo MR, Naftel DC, Pritzker MR, et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant 1998; 17: 744-53.

21.   Tsutsui H, Ziada KM, Schoenhagen P, et al. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study. Circulation 2001; 104: 653-7.

22.   Nissen S. Coronary angiography and intravascular ultrasound. Am J Cardiol 2001; 87:15A-20A.

23.   Mehra MR, Ventura HO, Stapleton DD, Smart FW. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift. J Heart Lung Transplant 1995;14(6 Pt 2): S207-11.

24.   Tuzcu EM, Kapadia SR, Sachar R, Ziada KM, Crowe TD, Feng J et al. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol 2005;45: 1538-42.

25.   Kobashigawa JA, Tobis JM, Starling RC, Tuzcu EM, Smith AL, Valantine HA et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol 2005;45: 1532-7.

26.   Stengel SM, Allemann Y, Zimmerli M, Lipp E, Kucher N, Mohacsi P et al. Doppler tissue imaging for assessing left ventricular diastolic dysfunction in heart transplant rejection. Heart 2001;86: 432-7.

27.   Demin V.V., Demin D.V., Seroshtanov E.V., Dolgov S.A., Grigoriev A.V., Demin A.V., Zheludkov A.N., Klochkov M.D., Lomakina E. V. Clinical aspects of the use of optical coherence tomography for the diagnosis of coronary arteries. Mezhdunarodnyj zhurnal intervencionnoj kardioangiologii. 2016. №44 С. 42-58. [In Russ]

28.   Francesco Prati, Evelyn Regar, Gary S. Mintz, Eloisa Arbustini, Carlo Di Mario, Ik-Kyung Jang, Takashi Akasaka, Marco Costa, Giulio Guagliumi, Eberhard Grube, Yukio Ozaki, Fausto Pinto, Patrick W.J. Serruys, for the Expert's OCT Review Document; Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis, European Heart Journal, Volume 31, Issue 4, 1 February 2010, Pages 401-415.

29.   Teruhiko Imamura, Koichiro Kinugawa, et al. Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness. International Heart Journal, 2014, Volume 55, Issue 2, Pages 178-180.

30.   Yasuhiro Ichibori, Tomohito Ohtani, Daisaku Nakatani, Kouichi Tachibana, Osamu Yamaguchi, Koichi Toda, Takashi Akasaka, Norihide Fukushima, Yoshiki Sawa, Issei Komuro, Junichi Kotani, Yasushi Sakata; Optical coherence tomography and intravascular ultrasound evaluation of cardiac allograft vasculopathy with and without intimal neovascularization, European Heart Journal - Cardiovascular Imaging, Volume 17, Issue 1, 1 January 2016, Pages 51-58.

31.   Kevin C. Harris, Anas Manouzi, Anthony Y Fung, Astrid De Souza, Hiram G. Bezerra, James E. Potts , and Martin C.K. Hosking Feasibility of Optical Coherence Tomography in Children With Kawasaki Disease and Pediatric Heart Transplant Recipients / Originally published - 29 May 2014 - Circulation: Cardiovascular Imaging. 2014;7: 671-678.

32.   S.A. Sahovskij, N.N. Koloskova, A.Ju. Goncharova, B.L. Mironkov. Intravascular Imaging Techniques in Assessing Transplanted Heart Vasculopathy. Vestnik transplantologii i iskusstvennyh organov. 2019; 1: 165-168. [In Russ].

33.   Muehling OM, Wilke NM, Panse P, Jerosch-Herold M, Wilson BV , Wilson RF, Miller LW . Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging. J Am Coll Cardiol 2003; 42: 10541060.

34.   Braggion-Santos MF, Lossnitzer D, Buss S, Lehrke S, Doesch A, Giannitsis E, Korosoglou G, Katus HA , Steen

H.    Late gadolinium enhancement assessed by cardiac magnetic resonance imaging in heart transplant recipients with different stages of cardiac allograft vasculopathy. Eur Heart J Cardiovasc Imaging 2015; 15: 1125-1132.

35.   Johnson MR, Aaronson KD, Canter CE, et al. Heart retransplantation. Am J Transplant 2007; 7: 2075-81.

36.   Klauss V, Spes CH, Rieber J, Siebert U,Werner F Stempfle HU et al. Predictors of reduced coronary flow reserve in heart transplant recipients without angiographically significant coronary artery disease. Transplantation 1999;68: 1477-81.

37.   Raichlin E, Prasad A, Kremers WK, et al. Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients. Eur Heart J 2009; 30:1356-63.

38.   Arora S, Ueland T, Wennerblom B, et al. Effect of everolimus introduction on cardiac allograft vasculopathy-results of a randomized, multicenter trial. Transplantation 2011;92: 235-43.

39.   Arora S, Andreassen AK, Andersson B, et al., SCHEDULE (SCandinavian HEart transplant everolimus De novo stUdy with earLy calcineurin inhibitors avoidanc E) Investigators. The effect of everolimus initiation and calcineurin inhibitor elimination on cardiac allograft vasculopathy in de novo recipients: one-year results of a Scandinavian randomized trial. Am J Transplant 2015; 15: 1967-75.

40.   Richard Cheng, Evan Kransdorf, David Chang, Jig- nesh Patel, Jon Kobashigawa and Babak Azarbal TCT-401 A Strategy of Percutaneous Coronary Intervention with Drug-Eluting Stents for the Treatment of Cardiac Allograft Vasculopathy May Normalize Survival (2018).

41.   Lee MS, Cheng RK, Kandzari DE, et al. Longterm outcomes of heart transplantation recipients with transplant coronary artery disease who develop in-stent restenosis after percutaneous coronary intervention. Am J Cardiol 2012; 109: 1729-32.

42.   Jay K. Bhama, Duc Q. Nguyen, Sun Scolieri, Jeffrey J. Teuteberg, Yoshiya Toyoda, Robert L. Kormos, Kenneth R. McCurry, Dennis McNamara, Christian A. Bermudez, Surgical revascularization for cardiac allograft vasculopathy: Is it still an option? The Journal of Thoracic and Cardiovascular Surgery, Volume 137, Issue 6, 2009, Pages 14881492.

43.   Ilke Sipahi, Randall C. Starling Cardiac Allograft Vasculopathy: An Update Heart Failure Clinics Volume 3, 2007; 1: 87-95.

authors: 

 

Abstract

The research is devoted to the clinical study of disorders in cerebral blood flow and microcirculatior in the development of Alzhelmer's disease in comparison with other neurodegenerative and ischemic diseases.

Materials and methods: 1117 patients with various types and stages of neurodegenerative ancischemic diseases were examined. 93 (8.33%) of them had various stages of Alzhelmer's disease - Test Group. Other 1024 (91.67%) had different types and stages of other cerebral neurodegenerative and ischemic lesions - Control Group. Control Group patients were divided: 23 (2.25%) suffered from Binswanger disease; 55 (5.37%) suffered from vascular Parkinsonism; 27 (2.64%) had initial signs of chronic cerebrovascular insufficiency of atherosclerotic origin; 577 (56.35%) had marked signs of chronic cerebrovascular insufficiency of atherosclerotic origin; 342 (33.40%) had a severe form of chronic cerebrovascular insufficiency accompanied by small-focal single or multiple strokes. Examination included: laboratory diagnostics, assessment of scales «The Clinical Dementia Rating scale» (CDR), «Mini-Mental State Examination» (MMSE), IB, cerebral scintiography (SG), rheoencephalography (REG), cerebral CT, MRI, MR angiography, digital angiography (DA).

Results: all patients with Alzheimer's disease, regardless of the stage of the disease, had a specific cerebral small vessel disease (CSVD) in temporal and frontoparietal regions, which manifests itself with dyscirculatory angiopathy of Alzheimer's type (DAAT), which is not found in control group patients.

Conclusions: DAAT is a specific to Alzheimer's disease lesion of cerebral angioarchitectonics and microvessels, which changes hemodynamics, causes cerebral hypoxia and contributes to disorders in beta-amyloid metabolism. The combination of deposition of amyloid beta in the cerebral tissue and the vascular wall, as well as specific microcirculation disorders, cause together neurodegeneration and the development of Alzheimer's disease. In patients with other neurodegenerative and ischemic diseases, CSVDs are of a different nature, with no DAAT phenomena observed.

  

References

1.     2019 Alzheimer's disease facts and figures. J Alzheimer’s & Dementia 2019; 13(4): 325-373.

2.     Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010; 9 (7): 689-701.

3.     Cai Z., Wang C., He W. et al. Cerebral small vessel disease and Alzheimer's disease. Clin Interv Aging. 2015; 23 (10):1695-1704.

4.     Grammas P,  Martinez  J., Sanchez, A. et al. A new paradigm for the treatment of Alzheimer's disease: targeting vascular activation. J Alzheimers Dis. 2014; 40(3):619-630.

5.     Gjulev, N.M., Pustozertsev, V.G., Gjulev, S.N. Cerebrovascular Diseases. The Neva Dialect 2002.[In Russ.] 

6.     Mormino E.C., Papp K.V., Rentz D.M., et al. Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid-p. J Alzheimer's & Dementia. 2017;13 (9): 10041012.

7.     Jack C.R., Petersen R.C, Xu YC., et al. Prediction of AD with MRI-based Hippocampal Volume in Mild Cognitive Impairment. Neurology. 1999; 52 (7): 1397-1403.

8.     Waldemar G., Dubois B., Emre M., et al. Recommendations for the diagnosis and management of Alzheimer’s disease and other disorders associated with dementia: EFNS guideline. European Journal of Neurology. 2007; 14, (1): e1-26.

9.     Burton E.J., Barber R., Mukaetova-Ladinska E.B., et al. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain. 2009; 132 (Pt1): 195-203.

10.   Trojanowski J.Q., Vandeerstichele H., Korecka M., et al. Update on the biomarker core of the Alzheimer’s Disease Neuroimaging Initiative subjects. J Alzheimer’s & Dementia. 2010; 6 (3): 230-238.

11.   Adriaase A., Sanz-Arigita E., Binnewijzend M., et al. Molecular markers of Alzheimer's Disease pathology and their relationship with default mode network integrity. J Alzheimer's & Dementia. 2011; 7 (4) S2-S3.

12.   Meyer PT., Hellwig S., Amtage F., et al. Dualbiomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B J Nucl Med. 2011; 52 (3): 393-400.

13.   Weiner W.W., Veitch D.P, Aisen PS., et al. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Journal of Alzheimer’s & Dementi. 2015; 11(6) e1-e120.

14.   Chiang G.C., Insel Ph.S., Tosun D., et al. Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes. Radiology. 2011; 259 (3): 844-851.

15.   De la Torre J.C. Hemodynamic consequences of deformed microvessels in the brain in Alzheimer’s disease. Annals of New York Acadmy Sciences. 1997; 26: 75-91. 

16.   Kalaria R. Small vessel disease and Alzheimer’s dementia: Pathological considerations. Cerebrovascular Diseases. 2002:13: 48-52.

17.   Maksimovich I.V. Dyscirculatory Angiopathy of Alzheimer’s Type. Journal of Behavioral and Brain Science. 2011 1 (2): 57-68.

18.   Zlokovic B.V. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nature Reviews. Neuroscience. 2011; 3: 723-738.

19.   Maksimovich I.V. Vascular factors in Alzheimer’s disease. Health. 2012; 4 (9A): 735-742.

20.   Baloiannis S.J., Baloiannis I.S. The vascular factor in Alzheimer’s disease: A study in Golgi technique and electron microscopy. Journal of the Neurological Sciences. 2012; 322: 117-121.

21.   Baloyannis S.J. (2015) Brain capillaries in Alzheimer's disease. Hell J Nucl Med.2015; 1 (Suppl 1): 152.

22.   Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 2004; 5, (5): 347-360.

23.   Maksimovich I.V., Gotman L.N. Method of complex radiation diagnostics at preclinical and clinical stages of Alzheimer’s disease. Patent RF №. 2315559. 2006. [In Russ.]

24.   Maksimovich I.V., Gotmanm L.N., Masyuk S.M. Method of Determining Dimensions of Temporal Brain Lobes in Patients Suffering from Alzheimer’s Disease. Patent RF № 2306102. 2006. [In Russ.]

25.   Bell R.D., Zlokovic B.V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer’s disease. Acta Neuropathologica. 2009; 118: 103-113.

26.   Koike M.A., Green K.N., Blurton-Jones M. Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. Am J Pathol. 2010; 177: 300-310.

27.   Nelson A.R., Sweeney M.D., Sagare A.P, Zlokovic A. V. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. Biochim Biophys Acta. 2016; 1862, (5): 887-900.

28.   Kimbrough I.F., Robel S., Roberson E.D., Son- theimer H. (2015) Vascular amyloidosis impairs the glio- vascular unit in a mouse model of Alzheimer's disease. Brain, 2015; 138, (Pt 12): 3716-3733.

29.   Maksimovich I.V. Radiodiagnostics of Alzheimer’s disease. Diagnostics and Intervention Radiology. 2008; 4: 27-38. [In Russ.]

30.   Morris J.C. The Clinical Dementia Rating (CDR): Current Version and Scoring Rules. Neurology. 1993; 11 (43): 2412-2414.

31.   Folstein M.F., Folstein S.E., McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12 (3): 189-198.

32.   Maksimovich I.V. The tomography dementia rating scale (TDR) - The rating scale of Alzheimer’s disease stages. Health. 2012; 4 (9A): 712-719.

33.   De Lin M., Jackson E.F. Applications of Imaging Technology in Radiation Research. Radiat Res. 2012; 177 (4): 387-397. 

34.   Brown W.R., Thore C.R. Review: cerebral microvas- cular pathology in ageing and neurodegeneration. Neu- ropatholApplNeurobiol. 2011; 37 (1): 56-74.

35.   Henry-Feugeas M.C. Alzheimer’s disease in late- life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction. Med Hypotheses. 2008; 70 (3): 866-875.

36.   Maksimovich I.V. Certain new aspects of etiology and pathogenesis of Alzheimer’s disease. Advances in Alzheimer’s Disease. 2012; 1 (3): 68-76.

37.   Maksimovich I.V. Disorders of cerebrovascular angioarchitectonics and microcirculation in the etiology and pathogenesis of Alzheimer’s disease Advances in Alzheimer’s Disease. 2013; 2, (4): 171-181.

38.   Zlokovic B.V. Neurodegeneration and the neurovascular unit. Nat Med. 2010; 16 (12): 1370-1371.

39.   Iadecola C. The overlap between neurodegenera- tive and vascular factors in the pathogenesis of dementia. Acta Neuropathol.2010 120 (3): 287-396.

40.   De la Torre J.C. A turning point for Alzheimer's disease? Bio Factors. 2012; 38 (2): 78-83.

41.   De la Torre J.C. Cerebral Perfusion Enhancing Interventions: A New Strategy for the Prevention of Alzheimer Dementia. Brain Pathology. 2016; 26 (5): 618-631.

42.   Love S., Miners J.S. Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's Disease Brain Pathology. 2016; 26 (5): 607-617.

43.   Nielsen R.B., Egefjord L., Angleys H., et al. Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease. J Alzheimer's & Dementia. 2017; 13 (10): 1143-1153. 4 4 . Bosco P., Redolfi A., Bocchetta M., et al. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study. J Alzheimer's & Dementia. 2017; 13 (9): 10131023.

45.   Iadecola C. Dangerous leaks: blood-brain barrier woes in the aging hippocampus. Neuron. 2015; 85 (2): 231-233.

46.   Montagne A., Barnes S.R., Sweeney M.D. et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015; 85 (2): 296-302.

47.   Maksimovich I.V. Morphometric Definition of Alzheimer's Disease Stages by Means of The Tomography Dementia Rating Scale (TDR). Brain Disord Ther. 2017; 6, (2): 1-4.

48.   Schmidtke K., Hull M. Cerebral small vessel disease: how does it progress? J Neurol Sci. 2005; 229-230: 13-20.

49.   Qureshi A.I., Caplan L.R. Intracranial atherosclerosis. Lancet. 2014; 15, 383 (9921), 984-998.

50.   Caplan L.R. The Effect of Small Artery Disease on the Occurrence and Management of Large Artery Disease. JAMA Neurol. 2016; 73 (1): 19-20.

51.   Ramos-Estebanez C., Moral-ArceI., Gonzalez- Mandly A. et al. Vascular cognitive impairment in small vessel disease: Clinical and neuropsychological features of lacunar state and Binswanger's disease. Age Ageing. 2011; 40 (2): 175-180. 

52.   AkiguchiI., Budka H., Shirakashi Y, et al. MRI features of Binswanger's disease predict prognosis and associated pathology. Ann Clin Transl Neurol. 2014; 1 (10): 813-821. 

53.   Maksimovich I.V. Possibilities of Application of Transcatheter Treatment of Vascular Dementia with Bin- swanger’s Disease. Global Journal of Health Science. 2017; 9 (6): 13-21.

 

Abstract

Scientific and technical progress of modern surgical treatment of foot pathology poses new diagnostic tasks for radiologists. Opening of the functional MSCT (fMSCT) of the foot with weight-bearing significantly changed the treatment protocol of patients with acquired foot deformities.

Purpose: to conduct a comparative analysis of the angular parameters on x-ray images anc weight-bearing fMSCT images of the foot in patients with acquired adult flat feet.

Materials and methods: 45 patients (88 feet) were examined, who underwent x-ray examination of the foot with weight-bearing and weight-bearing fMSCT of the foot. On the received images were examined angular indicators of a foot and was carried out statistical comparison of the received results.

Results: after processing the measurement data of fMSCT and x-ray examination it was found that statistically significant differences in the standard definition of the angular parameters of the foot is not determined. To compare the values obtained by radiographic method and fMSCT was used paired Student's t-test. To determine the presence or absence of dependence of the difference of measurements obtained by the two methods from the average values of these measurements were constructed graphs of Bland-Altman. Evaluation of the longitudinal arch angle of the foot showed that all measurements are within the 95% predictive interval. The index of the calcaneal inclination angle, the individual values of the difference were outside the borders of the 95% predictive interval, but do not depend on the measurements.

Conclusion: comparative analysis showed the statistical insignificance of differences in the average values of individual angular indicators measured in the two groups (radiography and fMSCT) The data obtained in the course of the study allow us to assert the possibility of using the fMSCT of the foot with the load as a modern reliable method for assessing the angular parameters of the foot in order to determine the degree of flat deformation.

  

References

1.     Orthopaedia: national guide. (Under S.P. Mironov, G. P. Kotelnikov). М.: GEOTAR-Media, 2008; 642-646 [In Russ].

2.     Bock P. et al. The inter- and intraobserver reliability for the radiological parameters of flatfoot, before and after surgery. Bone Joint J. 2018; 100: 596-602.

3.     Neri T, Barthelemy R, Tourne Y Radiologic analysis of hindfoot alignment: comparison of Meary, long axial and hindfoot alignment views. Orthop Traumatol Surg Res. 2016.     http://dx.doi.org/10.1016Zj.otsr.2017.08.014.

4.     Saltzman CL, El-Khoury GY The hindfoot alignment view. Foot Ankle Int. 1995; 16 (9): 572-576. DOI: 10.1177/107110079501600911.

5.     Serova NS., Belyaev AS, Bobrov DS, Ternovoy KS. Modern X-ray diagnosis of adult acquired flatfoot deformity. Vestnik Rentgenologii i Radiologii (Russian Journal of Radiology). 2017; 98 (5): 275-80. DOI: 10.20862/00424676-2017-98-5-275-280 [In Russ].

6.     Cheung ZB. et al. Weightbearing CT scan assessment of foot alignment in patients with hallux rigidus. Foot Ankle Int. 2018; 39 (1): 67-74. doi: 10.1177/ 1071100717732549.

7.     Ternovoy SK, Serova NS, Belyaev AS, Bobrov D S, Ternovoy KS. Methodology of functional multispiral computed tomography in the diagnosis of adult flatfoot. REJR. 2017; 7 (1):94-100. DOI:10.21569/2222-7415-2017-7-1- 94-100 [In Russ].

8.     Godoy-Santos AL, Cesar Netto C. Weight-bearing Computed Tomography International Study Group. Weight-bearing computed tomography of the foot and ankle: an update and future directions. Acta Ortop Bras. 2018; 26 (2): 135-9.

9.     Haleem AM. et al. Comparison of deformity with respect to the talus in patients with posterior tibial tendon dysfunction and controls using multiplanar weight-bearing imaging or conventional radiography. J Bone Joint Surg Am. 2014; 96 (8): 63. doi: 10.2106/JBJS.L.01205.

10.   Burssens A. et al. Reliability and correlation analysis of computed methods to convert conventional 2D radiological hindfoot measurements to a 3D setting using weight-bearing CT. Int J Comput Assist Radiol Surg. 2018; 13 (12): 1999-2008. doi: 10.1007/s11548-018-1727-5.

11.   Ternovoy SK, Serova NS, Abramov AS, Ternovoy KS. Functional multislise computed tomography in the diagnosis of cervical spine vertebral-motor segment instability. REJR. 2016; 6 (4):38-43. DOI:10.21569/2222-7415- 2016-6-4-38-43. [In Russ]

12.   Lychagin AV, Rukin YA, Zakharov GG, Serova N.S., Bahvalova V.D, Dhillon H.S. Functional computed tomography for diagnostics of the knee endoprothesis loosening. REJR 2018; 8(4):134-142. DOI: 10.21569/2222-74152018-8-4-134-142 [In Russ].

13.   Tuominen EK. et al. Weight-bearing CT imaging of the lower extremity. AJR Am J Roentgenol. 2013; 200 (1): 146-8. doi: 10.2214/AJR.12.8481.

14.   De Cesar Netto C. et al. Flexible adult acquired flat-foot deformity: comparison between weight-bearing and non-weight-bearing measurements using cone-beam computed tomography. J Bone Joint Surg Am. 2017; 99 (18): 98. doi: 10.2106/JBJS.16.01366.

15.   Ferri M. et al. Weight-bearing CT scan of severe flexible pes planus deformities. Foot Ankle Int. 2008; 29 (2) : 199-204. doi: 10.3113/FAI.2008.0199.

16.   Bobrov DS. et al. Pain syndrome reasons in patients with acquired flatfoot. Kafedra travmatologii I ortopedii. 2015; 2 (14): 8-11 [In Russ].

 

Abstract:

Aim: was to develop a compleх ultrasound assessment of atherosclerotic plaque instability in correlation with morphological evaluation.

Material and methods: research included 121 patients with stenosis of left/right internal carotic artery (ICA) of 50% and more (due to NASCET scale): 80 men and 41 women, mean age 56,0 years. All patients underwent standart and contrast-enhanced ultrasonic scanning (CEUS), bilateral duplex monitoring of cerebral blood flow with registration of microembolic signals (MES). All patients in period up to 3 days after hospitalization - underwent carotid endarterectomy with histological examination of atheroscleroitc plaque.

Results: analysis of relationship between ultrasound and histological characteristics showed a moderate association between the intensity of contrast agent accumulation and the degree of plaque vascularization (Cramer's V 0,529; p<<0,000;) number of lipofages (Cramer's V 0,569; p<<0,001). There were no significant differences between the degree of plaque vascularization and the degree of plaque stenosis (p<0,05). We revealed significant differences between the number of MES and the intensity of atherosclerotic plaque blood supply (<<0,001).

Discussions: intensive accumulation of contrast agent in a plaque is associated with the process of angiogenesis and inflammation, and contrast-enhanced ultrasound examination of the plaque is promising for assessing its instability and the possible risk of developing cerebral vascular complications. Neovascularization intensity detected by contrast-enhanced ultrasound is associated with the number of detected microparticles in the cerebral blood flow, and does not depend on the degree of stenosis.

Conclusions: method of comprehensive assessment using CEUS and Doppler detection of microembolic particles can be effective in stratifying the risk of possible ischemic stroke in asymptomatic patients, for optimizing indications for surgical treatment of atherosclerotic plaque, and evaluating the effectiveness of lipid-lowering and statin therapy.

  

References

1.     Liapis CD, Bell PR., Mikhailidis D., Sivenius J.et al. ESVS Guidelines Collaborators. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg. 2009 Apr; 37(4 Suppl):1-19.

2.     Nicolaides AN, Kakkos SK, Kyriacou E, Griffin M, et al. Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification.Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. J Vasc Surg. 2010 Dec; 52(6):1486-1496.e1-5.

3.     Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease ACCF/AHA Pocket Guideline Based on the 2011ASA/ACCF/AHA/AANN/AANS/ACR/CNS/SAIP/SCAI/ SIR/SNIS/SVM/SVS. P 22-23.

4.     Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis.Circulation. 2002 Mar 5; 105(9):1135-43.

5.     Redgrave JN, Lovett JK, Rothwell PM. Histological features of symptomatic carotid plaques in relation to age and smoking: the oxford plaque study. Stroke. 2010; 41:2288-94.

6.     Gray-Weale AC, Graham JC, Burnett JR, Byrne K, Lusby RJ. Carotid artery atheroma: comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology. J Cardiovasc Surg. 1988;29:676-681.

7.     Kwon HM, Sangiorgi GU, Ritman EL, et al.Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest 1998; 101: 15511556.

8.     Cosgrove D. Angiogenesis imaging-ultrasound. Br J Radiol 2003; 76:S43-9.

9.     Kumamoto M, Nakashima Y, Sueishi K. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol 1995; 26:450-6.

10.   Balahonova T.V., Pogorelova O.A., Tripoten' M.I., Gerasimova V.V., Safiulina A.A., Rogoza A.N. Contrast enhancement during ultrasound examination of blood vessels: atherosclerosis, nonspecific aortoarteritis. Ul'trazvukovaya i funkcional'naya diagnostika 2015; 4: 33-45. [In Russ].

11.   Coli S, Magnoni M, Sangiorgi G, Marrocco-Trischitta M. et al.Contrast-Enhanced Ultrasound imaging of intraplaque neovascularisatopn in carotid arteries. J of the American College of Cardioilogy 2008; 52(3): 345-2.

12.   Vicenzini E. Giannoni MF, Puccinelli F. et al. Detection of carotid adventitial vasa vasorum and plaque vascularisation with ultrasound cadence contrast pulsr sequencing technique and echo-contrast agents. Stroke 2007; 38:2841-3.

13.   Shah F, Balah P, Weinber M, et al. Contrast-enhanced ultrasound imaging of atherosclerotic plaque neovascularization: a new surrogate marker of atherosclerosis? Vasc Med 2007; 12:291-7.

14.   CHechetkin AO, Druina L.D., Possibilities of contrast ultrasound in angioneurology. Annaly klinicheskoj I eksperimental'noj nevrologii 2015; 9(2): 33-40. [In Russ].

15.   Silvestre-Roig C, de Winther MP Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies. Weber C, Daemen MJ, Lutgens E, Soehnlein O. Circ Res. 2014 Jan 3; 114(1):214-26.

16.   Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999; 138:S419-20. doi: 10.1016/S0002-8703(99)70266-8.

17.   Casadei M, Floreani R, Catalini C, Serra AP, Assanti and P Concif Sonographic characteristics of carotid artery plaques: Implications for follow-up planning? J Ultrasound. 2012 Sep; 15(3): 151-157.

18.   Carmeliet P Angiogenesis in health and disease. Nat Med 2003;9;653-52.

19.   Moulton K.,Vakili K., Zurakovski D., et al. Inhibition of plaque neovascularizatopn reduces macrophage accumulation and progression of anvanced atherosclerosis. Proc Natl Acad Sci U S A 2003; 100: 4736-41.

20.   Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation. 2003;108:1772-8. doi: 10.1161/01.CIR.0000087481.55887.C9.

21.   Gutstein DE, Fuster V. Pathophysiology and clinical significance of atherosclerotic plaque rupture. Cardiovasc Res. 1999; 41:323-33. doi: 10.1016/S0008-6363(98) 00322-8.

22.   Petrikov SS, Hamidova LT. About the conference «Emergency care for patients with acute cerebrovascular accident» ZHurnal im. N.V. Sklifosovskogo «Neotlozhnaya medicinskaya pomoshch'». 2015; 1:11-18. [In Russ].

23.   Krylov VV., Dash'yan VG., Lemenyov VL., Dalibaldyan VA., i dr. Surgical treatment of patients with bilateral occlusion-stenotic lesions of brachiocephalic arteries. Nejrohirurgiya.2014; 16-25. [In Russ].

24.   Novikov N.E. Contrast-enhanced ultrasound examinations. History of development and modern possibilities. Russian Electr. J. Radiol. (REJR). 2012; 2 (1): 20-28. [In Russ].

 

Abstract

Aim: was to evaluate possibilities of puncture biopsy under ultrasound guidance of parasternal lymph nodes in patients with breast cancer.

Material and methods: study included 34 patients with breast cancer. Criteria for inclusion in the study were: primary breast cancer with a central or medial tumor localization, and patients under observation after previously undergoing surgical treatment. All patients underwent an ultrasound examination of the breast and regional zones, including the parasternal lymphatic collector. All patients underwent biopsy.

Results: in total, 39 parasternal lymph nodes suspicious on secondary lesion were detected, of which 17 (43,5%) lymph nodes had a specific lesion, 22 (56,5%) lymph nodes showed cystological signs of hyperplasia according to results of cytological examination. Parasternal lymph nodes metastases were detected in 16 (47,1%) of 34 patients included in our study. In all cases of specific lesion, lymph nodes were rounded, there was a violation of differentiation of anatomical structures, the absence of a central echo complex, a violation of differentiation and thickening of the cortical layer. In the group of primary patients, 3 (27,3%) patients with metastases in parasternal lymph nodes had distant metastases, remaining 8 (72,7%) patients, due to the lesion of the parasternal lymphatic collector, the stage of the disease were adjusted upwards (stage IIIA).

Conclusion: fine-needle aspiration biopsy under ultrasound-guidance in case of suspected secondary lesion of parasternal lymph nodes, can be successfully used to obtain morphological material with minimal traumatic impact, without the use of anesthesia, which will more adequately assess the state of parasternal lymph nodes at the preoperative stage, correctly set the stage of the disease and prescribe the appropriate treatment.

  

References

1.       Хоперия В.Г. Тонкоигольная аспирационная пункционная биопсия узлов щитовидной железы: показания, техника, клиническое применение. Украинский научно-практический центр эндокринной хирургии и трансплантации эндокринных органов и тканей МЗ Украины. Номер: 1 (35), 2011 г. С. 57-67.

2.       Федотов Ю.Н., Воробьев С.Л., Черников РА. Тонкоигольная аспирационная биопсия в диагностике заболеваний щитовидной железы. Корреляция между заключением цитолога и гистолога, технические аспекты. Клиническая и экспериментальная тиреоидология. 2009. Т. 5. № 4. С. 28-32.

3.       Бурдюков М.С., Нечипай А.М. Тонкоигольная пункция под контролем эндоскопической ультрасонографии: осложнения и альтернативы. Российский электронный журнал лучевой диагностики. 2013. Т. 3. № 2. С. 26-37.

4.       Марченко М.Г., Трофимов Е.И., Виноградов В.В. Современные методы выявления метастазов рака гортани и гортаноглотки в лимфатические узлы шеи. Российская оториноларингология. 2011. № 1 (50). С. 114-117.

5.       TNM Classification of Malignant Tumours, 7th ed. Sobin L.H., Gospodarowicz M.K., Wittekind Ch., eds. New York: Wiley-Blackwell; 2009.

6.       V. L. Kovalenko, M. F. Musafirov, R. V. Experience of video-assisted thoracoscopic parasternal lymph node dissection in breast cancer. Dal'nevostochnyj medicinskij zhural 2014 g. [In Russ.]

7.       Ujmanov V.A., Nechushkin M.I., Trigolosov A.V.. Petrovskij A.V., Vishnevskaya YA.V., Zajceva A.A. Surgical techniques for morphological assessment of the state of the parasternal lymphatic collector as part of organ-preserving treatment in patients with breast cancer. Vestnik RONTS im. N.N. Blochina RAMN. Tom 23: 3(89), 2012: 29 34. [In Russ.]

8.       McDonald E, Haagensen C.D. In: Diseases of the breast. 2nd ed. Philadelphia: W. B. Saunders; 1971.

9.       Letyagin V.P., Laktionov K.P, Vysockaya I.V., Kotov V.A. Breast cancer. - M., 1996. - 150 s. [In Russ.]

10.     Sinyakov A.G. Videothoracoscopic parasternal lymphadenectomy in the treatment of breast cancer. Mezhdunarodnyj zhurnal prikladnyh i fundamental’nyh issledovanij. №10, 2014. [In Russ.]

 

Abstract

Aim: was to define possibilities of multispiral computed tomography (MSCT) in assessment of condition of aorta and it's branches, during preparation for reconstructive surgery in patients with horseshoe kidney.

Material and methods: for the period 2015-2018, 415 patients were examined during preparation for aortic reconstructive surgery. Patient underwent target ultrasonic diagnostics, followed by computed tomography made on 256-slice Philips iCT, before and after injection of contrast agent. We used a special program for comparing various phases of the study ("Fusion") for better visualization of arterial vessels of kidney, aorta and renal excretory system. In 5 cases, a combination of aortic pathology with abnormal horseshoe kidney was revealed.

Results: in all cases we revealed branched type of blood supply of abnormal kidney A total of 5 patients had 25 renal arteries. In 4 cases we revealed branched type of renal veins, its total ammount was 20. Duplication of upper urinary tract was found in 1 case. From the surveyed group, 3 patients out of 5 were operated. Intraoperatively all data detected by CT scan regarding the condition of the aorta, the position of the kidney, the number of renal vessels were confirmed.

Conclusion: MSCT allows detailly assessment of anatomical features of abnormal horseshoe kidney and facilitates subsequent surgical intervention in patients with a rare combination of aortic pathology and a horseshoe kidney.

  

References

1.       Kirkpatrick J.J., Leslie S.W. Horseshoe Kidney. In: StatPearls [Internet], 2018.

2.       Gianfagna F., Veronesi G., Bertu L, et al. Prevalence of abdominal aortic aneurysms and its relation with cardiovascular risk stratification: protocol of the Risk of Cardiovascular diseases and abdominal aortic Aneurysm in Varese (RoCAV) population based study. BMC Cardiovasc Disord. 2016;16(1):243. Published 2016 Nov 29. doi:10.1186/s12872-016-0420-2.

3.       Joanna Mikolajczyk-Stecyna, Aleksandra Korcz, Marcin Gabriel et al. Risk factors in abdominal aortic aneurysm and aortoiliac occlusive disease and differences between them in the Polish population. Scientific Reports (2013) volume3: 3528.

4.       Davidovic L Markovic M, Ilic N et al. Repair of abdominal aortic aneurysms in the presence of the horseshoe kidney. IntAngiol. 2011 Dec;30(6):534-40.

5.       Kumar Y, Hooda K, L.i S., Goyal P, et al. Abdominal aortic aneurysm: pictorial review of common appearances and complications. Ann TranslMed. 2017;5(12):256.

6.       Stephen P Reis, Bill S. Majdalany, Ali F. AbuRahma et al., ACR Appropriateness Criteria Pulsatile Abdominal Mass Suspected Abdominal Aortic Aneurysm. J Am Coll Radiol 2017;14:S258-S265

7.       CHekhoeva O.A., Buryakina S.A., Alimurzaeva M.Z., Gontarenko V.N. Aneurysm of the infrarenal aorta in combination with a horseshoe-shaped kidney: case report. Medicinskaya vizualizaciya №3 2016. C.: 63-70. [In Russ.] 

8.       B.V. Fadin, A.B. Mal'gin, S.V. Berdnikov i dr. Aneurysm of the abdominal aorta in combination with a horseshoe-shaped kidney. ZHurnal angiologiya i sosudistaya hirurgiya . 2002 TOM 8 №3 Str. 113-119. [In Russ.]

9.       Ignat'ev I.M., Volodyuhin M.YU., Zanochkin A.V. Endoprosthetics of the abdominal aortic aneurysm in a patient with a horseshoe-shaped kidney. Arhitektura zdorov'ya. [Internet souce] http://www.archealth.ru/ tekushchee-izdanie/zdorove-i-meditsina/klinicheskie- issledovaniya/11-endoprotezirovanie-anevrizmy-bryush- noj-aorty-u-patsienta-s-podkovoobraznoj-pochkoj

10.     Troickij V.I., Habazov R.I., Lysenko E.R. i dr. Surgical treatment of abdominal aortic aneurysm in a patient with a horseshoe-shaped kidney. Angiologiya i sosudistaya hirurgiya. 2003; 9 (2): 122-125. [In Russ.]

 

 

Abstract:

The article presents a case report of endovascular treatment of acute superior mesenteric artery occlusion in a patient with long reception of new oral anticoagulants. Despite the low incidence of this condition (3-5%), mortality in patients with this pathology is extremely high (80-85%). In this case combination of percutaneous mechanical thrombaspiration from superior mesenteric artery by coronary thrombaspiration system and intravenous GP IIb/IIIa antagonists demonstrated satisfactory outcome. Endovascular interventions proved to be effective, minimally invasive and safe technique in patients with acute mesenteric ischemia in superior mesenteric artery system.

 

References

1.      Akberov RF, Sharafeev AZ, Mikhailov MK. Progressive multifocal atherosclerosis: etiology, clinical and radiation diagnosis, modern aspects of treatment. Kazan: Idel-Press. 2008: 214 [In Russ].

2.      Lyubskiy AS. Thrombectomy for superior mesenteric artery thrombosis. Hirurgiya. 1964; 11: 118-121 [In Russ].

3.      Savelyev VS, Spiridonov IV. Acute disorders of mesenteric circulation М.: Medicine; 1979: 232 [In Russ].

4.      Arthurs ZM, Titus J, Bannazadeh M. et al. A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia. J Vasc Surg. 2011; 53 (3): 698-704.

5.      Klas AA. Embolectomy in acute mesenteric occlusion. Ann Surg. 1951; 134: 913-917.

6.      Shaw RS, Maynard EP Acute and chronic thrombosis of the mesenteric arteries associated with malabsorption: A report of two cases successfully treated by thromboendarterectomy. N Engl J Med. 1958; 258 (18): 874-878.

7.      Acosta S. Surgical management of peritonitis secondary to acute superior mesenteric artery occlusion. World J Gastroenterol. 2014; 20(29): 9936-9941.

8.      Revesz ES. Acute mesenteric ischemia: analysis of cases admitted to a hospital during 10 years (20012010). OrvHetil. 2012; 153(36): 1424-1432.

9.      Corcos O, Castier Y Sibert A et al. Effects of a multimodal management strategy for acute mesenteric ischemia on survival and intestinal failure. Clin Gastroenterol Hepatol. 2013; 11 (2): 158-165.

10.    Furrer J, Gruntzig A, Kugelmeier J et al. Treatment of abdominal angina with percutaneous dilatation of an arteria mesenterica superior stenosis. Cardiovasc Intervent Radiol. 1980; 3(1):43-44.

11.    Khripun AI, Mironkov AB, Pryamikov AD. et al. Endovascular surgery in the treatment of superior mesenteric artery acute occlusion (literature review). Diagnosticheskaya iinterventsionnaya radiologiya. 2014; 8 (3): 6771 [In Russ].

12.    Shipovskiy VN, Tsitsiashvili MSh, Khuan Ch. и др. Rheolytic thrombectomy and stenting of the superior mesenteric artery in acute mesenteric thrombosis (clinical observation). Angiologiya i sosudistaya khirurgiya. 2010; 16(3): 49-54 [In Russ].

13.    Kuhelj D, Kavcic P, Popovic P Percutaneous mechanical thrombectomy of superior mesenteric artery embolism. Radiol Oncol. 2013; 47(3): 239-243.

14.    Cortese B, Limbruno U. Acute mesenteric ischemia: primary percutaneous therapy. Catheter CardiovascInterv. 2010; 75(2): 283-285.

  

Abstract:

Background: clinical case of a rarely encountered pathology (0.1-3.5%) in cardiac surgery, such as the aneurysm of the left coronary artery (LCA), is presented. It was detected and analyzed by coronary angiography and coronary CT angiography

Aim: was to show possibilities of radiation research methods in identifying and evaluating of coronary artery aneurysms.

Materials and methods: a 67-year-old patient was referred to the Federation National Center of Cardiovascular Surgery (Penza) for follow-up examination (coronary angiography) and to decide on the choice of management due to the presence of critical aortic valve stenosis. Performed coronary angiography and subsequent coronary CT angiography for demonstrate the topography of the aneurysm.

Results: according to the data of coronary angiography at the region of trifurcation of the LCA or the anterior descending artery, intermediate and circumflex arteries a large-sized aneurysm is visualized. Due to coronary CT angiography data, the one is located at a distance of 1.0 cm from the entrance of the LCA in the area of trifurcation. It's presented by an aneurysmal dilatation of a rounded shape 1.3 cm in diameter with locally calcific walls.

Conclusion: coronary angiography and coronary CT angiography made it possible to identify anc examine individual morphological features of the anatomy of the coronary artery aneurysm, as well as demonstrate and take apart its topography to clearly, which in turn made it possible to rationally determine the management of the patient.

 

References

1.      Markis JE, Joffe CD, Cohn PF. et al. Clinical significance of coronary arterial ectasia. Am. J. Cardiol. 1976; 37 (2): 217-222.

2.      Newburger JW, Takahashi M, Gerber MA. et al. Diagnosis, treatment, and longterm management of Kawasaki disease: a statement for health profes sionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004; 114(6): 1708-1733.

3.      Pahlavan PS, Niroomand F. Coronary artery aneurysm: a review. Clin. Cardiol. 2006; 29 (10): 439-443.

4.      Swaye PS, Fisher LD, Litwin P. et al. Aneurysmal coronary artery disease. Circulation. 1983; 67(1): 134-138.

5.      Japanese Ministry of Health and Welfare, Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo, Japan: Japanese Ministry of Health and Welfare, 1984.

6.      Hartnell GG, Parnell BM, Pridie RB. Coronary artery ectasia. It’s prevalence and clinical significance in 4,993 patients. Br. Heart J. 1985; 54 (4): 392-395.

7.      Morgagni JB. The seats and causes of diseases investigated by anatomy. Italy: Ex typographia Remondiniana. Venice. 1761. Epis 27. Art 28.

8.      Falsetti HL, Carrol RJ. Coronary artery aneurysm: a review of the literature with a report of 11 new cases. Chest. 1976; 69(5): 630-636.

9.      Aqel RA, Zoghbi GJ, Iskandrian A. Spontaneous coronary artery dissection, aneurysms, and pseudoaneurysms: a review. Echocardiography. 2004; 21(2): 175182.

10.    Jha NK, Ouda HZ, Khan JA. et al. Giant right coronary artery aneurysm - case report and literature review. J. Cardiothorac. Surg. 2009; 4: 18.

11.    Alcock R, Naoum C, Ng A.C. Giant right coronary aneurysm: a case of mistaken identity. Eur. Heart J. 2011; 32: 2712.

12.    Topaz O, Rutherford MS., Mackey-Bojack S. et al. Giant aneurysms of coronary arteries and saphenous vein grafts: angiographic findings and histopathological correlates. Cardiovasc. Pathol. 2005; 14: 298-302.

13.    Kato H, Sugimura T, Akagi T. et al. Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation. 1996; 94: 1379-1385.

14.    Williams MJ, Stewart RA. Coronary artery ectasia: local pathology or diffuse disease? Cathet. Cardiovasc. Diagn. 1994; 33(2): 116-119.

15.    Cohen P, O’Gara PT. Coronary artery aneurysms. A review of the natural history, pathophysiology, and management. Cardiol. Rev. 2008; 16(6): 301-304.

16.    Doustkami H, Maleki N, Tavosi Z. Left main coronary artery aneurysm. J. Tehran. Heart Cent. 2016; 11(1): 41-45.

17.    Li D, Wu Q, Sun L. et al. Surgical treatment of giant coronary artery aneurysm. J. Thorac. Cardiovasc. Surg. 2005; 130 (3): 817-821.

18.    Baman TS., Cole JH, Devireddy CM. Risk factors and outcomes in patients with coronary artery aneurysms. Am. J. Cardiol. 2004; 93: 1549-1551.

19.    Alfonso F, Perez-Vizcayno MJ, Ruiz M. et al. Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings. J. Am. Coll. Cardiol. 2009; 53: 2053-2060.

20.    Slota PA, Fischmann DL, Savage MP, et al. Frequency and outcome of development of coronary artery aneurysm after intracoronary stent placement and angioplasty. Am. J. Cardiol. 1997; 79:1104-1106.

21.    Senzaki H. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch. Dis. Child. 2006; 91 (10): 847-851.

22.    Sharma BK, Jain S, Suri S. et al. Diagnostic criteria for Takayasu arteritis. Int. J. Cardiol. 1996; 54: 141-147.

23.    Hsi DH, Ryan GF, Hellems SO. et al. Large aneurysms of the ascending aorta and major coronary arteries in a patient with hereditary hemorrhagic telangiectasia. Mayo. Clin. Proc. 2003; 78 (6): 774-776.

24.    Onoda K, Tanaka K, Yuasa U. et al. Coronary artery aneurysm in a patient with Marfan syndrome. Ann. Thorac. Surg. 2001; 72 (4): 1374-1377.

25.    Hisham MF. Sherif, Ray A. Blackwell. Successful Coronary Artery Bypass in Ehlers-Danlos Type IV Syndrome Case Report and Review of the Literature. Tex. Heart. Inst. J. 2012; 39 (5): 699-702.

26.    Davis GG, Swalwell CI. Acute aortic dissections and ruptured berry aneurysms associated with methamphetamine abuse. J. Forensic. Sci. 1994; 39 (6): 1481-1485.

27.    Villines TC, Avedissian LS, Elgin EE. Diffuse non-atherosclerotic coronary aneurysms. Cardiol. Rev. 2005; 13: 309-311.

28.    Nazareth J, Weinberg L, Fernandes J, et al. Giant right coronary artery aneurysm presenting with non-ST elevation myocardial infarction and severe mitral regurgitation: a case report. J. Med. Case Rep. 2011; 5: 442.

29.    Manginas A, Cokkinos DV. Coronary artery ectasias: imaging, functional assessment and clinical implications. Eur. Heart J. 2006; 27 (9): 1026-1031.

30.    Sokmen G, Tuncer C, Sokmen A. et al. Clinical and angiographic features of large left main coronary artery aneurysms. Int. J. Cardiol. 2008; 123 (2): 79-83.

31.    Topaz O, DiSciascio G, Cowley MJ. et al. Angiographic features of left main coronary artery aneurysms. Am. J. Cardiol. 1991; 67 (13): 1139-1142.

32.    Mata KM, Fernandes CR, Floriano EM. et al. Coronary artery aneurysms: an update. Novel Strategies in Ischemic Heart Disease. Rijeka, Croatia: In. Tech. 2012; 381-404.

33.    Tunick PA, Slater J, Kronzon I. et al. Discrete atherosclerotic coronary artery aneurysms: a study of 20 patients. J. Am. Coll. Cardiol. 1990; 15: 279-282.

34.    Bhindi R, Testa L, Ormerod OJ, Banning A.P. Rapidly evolving giant coronary aneurysm. J. Am. Coll. Cardiol. 2009; 53 (4): 372.

35.    Chia HM, Tan KH, Jackson G. Non-atherosclerotic coronary artery aneurysms: two case reports. Heart. 1997; 78 (6): 613-616.

36.    LaMotte LC, Mathur VS. Atherosclerotic coronary artery aneurysms: 8-year angiographic follow-up. Tex. Heart Inst. J. 2000; 27 (1): 72-73.

37.    Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N. Engl. J. Med. 2001; 345 (26): 1863-1869.

38.    Mavrogeni S, Markousis-Mavrogenis G., Kolovou G. Contribution of cardiovascular magnetic resonance in the evaluation of coronary arteries. World J. Cardiol. 2014; 6 (10): 1060-1066.

  

Abstract:

We present a clinical case, demonstrating the importance of x-ray technician compliance with rules of laying when performing x-ray examination of the mammary glands. According to the plain analog mammography with low quality, with positioning of not of all parts of the breast - the pathology was not revealed. In repeated mammographic study, conducted by all rules and all methodological aspects, in the upper-outer quadrant of the right breast, nodular newgrowth category BI-RADS 4c, highly suspicious on breast cancer was revealed. After the expansion of the diagnostic algorithm by echography and core-biopsy, low-differentiated breast cancer with high mitotic activity was verified.

 

Referenses

1.      Kaprin AD, Starinskiy V V, Petrova G V. Malignant neoplasms in Russia in 2017 (morbidity and mortality). М. 2018; 263 p [In Russ].

2.      Kanaev CV, Novikov SN, Semiglazov VF. Possibilities of early detection of breast cancer tumors using ultrasound and radionuclide diagnostic methods. Voprosy onkologii. 2011; 57(5): 622-626 [In Russ].

3.      Chernaya AV. Comparative analysis of informative value of digital mammography and mammoscintigraphy in breast cancer diagnostics. Dis. kand. med. nauk. SPb.: FGBU «NMITsO im. N. N. Petrova» MZ RF, 2018; 112 p [In Russ].

4.      Zuy VS, Solov'ev VI, Alieva FV., Garmot'ko AA, Nikitonova NV. Diagnostic sectoral resection as a method for verifying breast cancer in the Smolensk region (20102014). Vestnik Smolenskoy gosudarstvennoy meditsinskoyakademii. 2018; 17(2): 148-151 [In Russ].

5.      Rozhkova N I. The priority of women's health in the national program for the development of oncological services. Medicinskijalfavit. 2018; 2(29), (366): 6-9 [In Russ].

6.      Vasil’ev AYu., Мanuylova ОО. Stereoscopic mammography. An alternative method for the breast cancer early diagnosis. Radiologiya-praktika. 2017; 61(1): 6-14 [In Russ].

7.      Pavlova T V, Vasil'ev A Yu, Manuylova O O. Method of Сone-Вeam Breast Computed Tomography (Literature Review). Radiologiya - praktika. 2019;73(1): 21-27 [In Russ].

8.      Shumakova TA, Solntseva IA, Safronova OB, Savello VE, Serebryakova SV. The practical application of the international classification of Bi-RADS in mammology practice. Rukovodstvo dlya vrachey. SPb NII skoroy pomoshchi im. I.I.Dzhanelidze. SPb., 2018; 217 p. [In Russ].

9.      Sadykov S S, Bulanova Yu A, Zakharova E А. Methods of breast cancer detection. Algoritmy, metody i sistemy obrabotkidannykh. 2012;19(1): 168-178 [In Russ].

10.    Myakin'kov V B. World radiological experience. Radiologicheskiy visnik. 2012;44(3): 43-47 [In Russ].

  

Abstract:

Background: we present a literary review of foreign articles on the strategy of treating of patients with blunt abdominal trauma and/or pelvic fractures, without laparotomic access using endovascular diagnosis and treatment.

Aim: was to analyze the modern approach in the diagnosis and treatment of arterial bleeding Г patients with blunt abdominal trauma and/or pelvic fractures according to literary sources. Materials and methods: article reviewed 3 studies, 1 literary review of articles by foreign authors and guidelines of the Eastern Association of Traumatology

Results: computed tomography with contrast enhancement was the method of choice for diagnosing blunt abdominal trauma and pelvic fractures, endovascular treatment of arterial hemorrhage has proven its effectiveness and is increasingly included in routine practice in both hemodynamically stable patients and patients with unstable hemodynamics.

Conclusion: catheter embolization for arterial bleeding can be used as monotherapy or as a stage of stabilizing the patient before open surgical treatment.

 

References

1.      Hrupkin VI, Hanevich MD, Zubrickij VF i dr. Urgent endovascular surgery in gastroduodenal bleeding. Petrozavodsk: Izd-vo «IntelTek», 2002 [In Russ].

2.      Health Topics: Injuries, World Health Organization. 2015. ISBN 978 92 4 156506 6.

3.      Upadhyaya P. Splenic trauma in children J. Surg. Gynecol. Obsted. 1968; 126(8): 781 - 790. PMID:5643159.

4.      Stylianos S. Evidence-based guidelines for resource utilization in childrenwith isolated spleen or liver injury. The APS A Trauma J. Pediatr. Surg. 2000; 35 (2): 164-167. PMID:10693659

5.      Stylianos S. Compliance with evidence-based guidelines in children with isolated spleen or liver injury: a prospective study J. of Pediatr. Surg. 2002; 37(3): 453 - 456. PMID:11877665.

6.      Mohamed A.Z., Morsi H.A., Ziada A.M., et al. Management of major blunt pediatric renal trauma: single-center experience. J. Pediatr. Urol. 2010; 6(3): 301-305. PMID:19854105. D0I:10.1016/j.jpurol.2009.09.009

7.      Cogbill T.H., Moore E.E., Jurkovich G.J., et al. Nonoperative management of blunt splenic trauma: a multicenter experience. J. Trauma. 1989; 29(10): 1312-1317. PMID:2681805.

8.      Croce M.A., T.C. Fabian, PG. Menke, et al. Nonoperative management of blunt hepatic trauma is the treatment of choice for hemodynamically stable patients. Results of a prospective trial. Ann. Surg. 1995; 221(6): 744-753. PMID: 7794078

9.      Stassen N.A., BhullarI., Cheng J.D., et al. Nonoperative management of blunt hepatic injury: an Eastern association for the surgery of trauma practice management guideline. J. Trauma Acute Care Surg. 2012; 73(5): PP 288-293. D0I10.1097/TA.0b013e318270160d.

10.    Stassen N.A., Bhullar I., Cheng J.D., et al. Selective nonoperative management of blunt splenic injury: an Eastern association for the surgery of trauma practice management guideline J. Trauma Acute Care Surg. 2012; 73(5): 294-300. PMID:23114484.

11.    Van der Vlies C.H., OlthofD.C., van Delden O.M., et al. Management of blunt renal injury in a level 1 trauma centre in view of the European guidelines Injury. 2012;43(10): 1816-1820. PMID: 21742328.

12.    Karmazanovskij GG, Kokov LS, Stepanova YUA, i dr. Aneurysms of visceral vessels and arrosive bleeding into postnecrotic cysts of pancreas. Annaly hirurgicheskoj gepatologii. 2007; 12(2): 85-95 [In Russ].

13.    Sclafani S.J., Shaftan G.W., Scalea T.M., et al. Nonoperative salvage of computed tomography-diagnosed splenic injuries: utilization of angiography for triage and embolization for hemostasis J. Trauma. 1995; 39(5): 818825. PMID:7473996.

14.    Velmahos G.C., Toutouzas K., Radin R., et al. High success with non-operative management of blunt hepatic trauma: the liver is a sturdy organ. Arch Surg. 2003; 138: 475-480. PMID: 12742948 D0I:10.1001/archsurg. 138.5.475.

15.    Hellins T.E., Morse G., McNabney W.K., et al. Treatment of liver injuries at Level I and II centers in a multi-institutional metropolitan trauma system. J Trauma. 1997; 42: 1091-1096. PMID:9210547

16.    Carrillo E.H., Platz A., Miller FB., et al. Non-operative management of blunt hepatic trauma. Br J Surg. 1998; 85: 461-468. PMID: 9607525 D0I:10.1046/j.1365- 2168.1998.00721.x

17.    Brasel K.J., DeLisle C.M., Olson C.J., et al. Trends in the management of hepatic injury. Am J Surg. 1997; 174: PP 674-677. PMID:9409595.

18.    Coimbra R., Hoyt D.B., Engelhart S., et al. Nonoperative management reduces the overall mortality of Grades 3 and 4 blunt liver injuries. Int Surg. 2006; 91: 251-257. DOI: 10.11648/j.js.20170506.16.

19.    Velmahos G.C., Toutouzas K., Radin R., et al. Nonoperative treatment of blunt injury to solid abdominal organs: a prospective study. Arch Surg. 2003; 138: 844-851. PMID: 12912742 DOI:10.1001/archsurg. 138.8.844.

20.    Mohseni S., et al. The diagnostic accuracy of 64-slice computed tomography in detecting clinically significant arterial bleeding after pelvic fractures. Am Surg. 2011; 77(9): 1176-1182. PMID:21944627.

21.    Stephen D.J., et al. Early detection of arterial bleeding in acute pelvic trauma. J Trauma. 1999; 47(4): 638-642. PMID:10528596.

22.    Brasel K.J., et al. Significance of contrast extravasation in patients with pelvic fracture. J Trauma. 2007; 62(5): 1149-152. PMID: 17495715 DOI:10.1097/ TA.0b013e3180479827 .

23.    Pereira S.J., et al. Dynamic helical computed tomography scan accurately detects hemorrhage in patients with pelvic fracture. Surgery. 2000; 128 (4): 678-685. PMID: 11015102 DOI:10.1067/msy.2000. 108219

24.    Brun J., et al. Detecting active pelvic arterial haemorrhage on admission following serious pelvic fracture in multiple trauma patients. Injury. 2014; 45(1): 101-106. PMID: 23845571 DOI: 10.1016/j.injury 2013.06.011.

25.    Verbeek D.O., et al. Management of pelvic ring fracture patients with a pelvic «blush» on early computed tomography. J Trauma Acute Care Surg. 2014; 76(2): 374-379. PMID:24458044 DOI:10.1097/TA. 0000000000000094

26.    Brown C.V., Kasotakis G., Wilcox A. et al. Does pelvic hematoma on admission computed tomography predict active bleeding at angiography for pelvic fracture? Am Surg. 2005; 71(9): PP 759-762. PMID:16468513.

27.    Fu C.Y, Wang YC., Wu S.C., et al. Angioembolization provides benefits in patients with concomitant unstable pelvic fracture and unstable hemodynamics. Am J Emerg Med. 2012; 30(1): 207-213. PMID:21159470 DOI: 10.1016/j.ajem.2010.11.005

28.    Sarin E.L., Moore J.B., Moore E.E., et al. Pelvic fracture pattern does not always predict the need for urgent embolization. J Trauma: Inj Infect Crit Care. 2005; 58(5): 973-977. PMID:15920411

29.    Salim A., Teixeira P.G., DuBose J., et al. Predictors of positive angiography in pelvic fractures: a prospective study. J Am Coll Surg. 2008; 207(5): 656-662. PMID:18954776 D0I:10.1016/j.jamcollsurg.2008.05.025

30.    Hallinan J.T., Tan C.H., Pua U. et al. Emergency computed tomography for acute pelvic trauma: where is the bleeder? Clin Radiol. 2014; 69(5): 529-537. PMID:24581961 D0I:10.1016/j.crad.2013.12.016.

31.    Cerva Jr D.S., Mirvis S.E., Shanmuganathan K., et al. Detection of bleeding in patients with major pelvic fractures: value of contrast-enhanced CT. AJR Am J Roentgenol. 1996; 166( 1): 131-135. PMID:8571861 D0I:10.2214/ajr. 166.1.8571861.

32.    Dormagen J.B., Totterman A., Roise O., et al. Efficacy of plain radiography and computer tomography in localizing the site of pelvic arterial bleeding in trauma patients. Acta Radiol. 2010; 51(1): 107-116. PMID: 20001476 DOI:10.3109/02841850903286703.

33.    Fu C.Y, Hsieh C.H., WuS.C., et al. Anterior-posterior compression pelvic fracture increases the probability of requirement of bilateral embolization. Am J Emerg Med. 2013; 31(1): 42-49. PMID:22944536 DOI: 10.1016/ j.ajem.2012.05.026

34.    Hagiwara A., Murata A., Matsuda T., et al. The usefulness of transcatheter arterial embolization for patients with blunt polytrauma showing transient response to fluid resuscitation. J Trauma. 2004; 57: PP. 271-276. PMID:15345972

35.    Froberg L., Helgstrand F., Clausen C., et al. Mortality in trauma patients with active arterial bleeding managed by embolization or surgical packing: An observational cohort study of 66 patients. J Emerg Trauma Shock. 2016; 9(3): 107-114. PMID:27512332 DOI:10.4103/0974-2700.185274.

36.    Salcedo E.S., Brown I.E., Corwin M.T., et al. Angioembolization for solid organ injury: A brief review. Int J Surg. 2016; 33: 225-230.

37.    Fu C.Y, Hsieh C.H., Shih C.H., et al. Selective computed tomography and angioembolization provide benefits in the management of patients with concomitant unstable hemodynamics and negative sonography results.World J. Surg. 2012;36(4): PP. 819-825. PMID:22350476 DOI:10.1007/s00268-012-1457-8.

38.    Olthof D.C., van der Vlies C.H., Joosse P., et al. Consensus strategies for the nonoperative management of patients with blunt splenic injury: a Delphi study J. Trauma Acute Care Surg. 2013; 74(6): 1567- 1574.PMID:23694889 DOI:10.1097/TA. 0b013e3182921 627.

39.    Li M., Yu W.K., Wang X.B., et al. Non-operative management of isolated liver trauma. Hepatobiliary Pancreat. Dis. Int. HBPD INT. 2014; 13(5): 545-550. PMID:25308366.

40.    Lin H.L., Lee K.T., Chen C.W., et al. Management of motorcycle accident-related blunt hepatic injury-a different strateg. Am. J. Emerg. Med. 2010; 28(2): 177-182. PMID:20159387 DOI:10.1016/j.ajem.2008.11.001.

41.    Gamanagatti S., Rangarajan K., Kumar A., et al. Blunt abdominal trauma: imaging and intervention. Curr. Problems Diagnostic Radiol. 2015; 44(4): 321-336. PMID:25801463 DOI:10.1067/j.cpradiol.2015.02.005.

42.    Stassen N.A., BhullarI., Cheng, J.D., et al. Nonoperative management of blunt hepatic injury: An Eastern Association for the Surgery of Trauma practice management guideline. Journal of Trauma and Acute Care Surgery. 2015; 73(5): 288-293.

43.    Katsura M., Yamazaki S., Fukuma S., et al. Comparison between laparotomy first versus angiographic embolization first in patients with pelvic fracture and hemoperitoneum: a nationwide observational study from the Japan Trauma Data Bank. Scand J Trauma Resusc Emerg Med. 2013; 21: 82-84. PMID:24299060 DOI: 10.1186/ 1757-7241-21-82.

  

Abstract:

Aim: was to identify risk factors of early adverse cerebral events after carotid artery stenting anc endarterectomy

Materials and methods: 908 patients who underwent isolated carotid stenting (N = 522) and carotid endarterectomy (N = 386) were included in this retrospective analysis. Patients with simultaneous cardiac surgery and patients with symptomic stenosis of CA were excluded from research. The primary end point was ipsilateral perioperative ischemic stroke, proved by neurologist and CT/MRI data. To identify predictors, multivariate regression was used, with factors that could influence endovascular and surgical methods of treatment.

Results: patients from two groups were similar in main clinical and demographic characteristics. There were no deaths and cerebral hemorrhagic complications. The stroke rate in the endovascular and surgical groups was 1.7% and 1.04% respectively (p = 0.5). The total rate of strokes and transitory ischemic attack (TIA) using two methods was 1.4%. The TIA rate was higher in the endovascular group without statistically difference (1.3% vs. 0.3%, p = 0.1). The regression analysis showed that predictor of the adverse cerebral events was the degree of carotid artery stenosis in endovascular group (OR 1.318, 95% CI: 1.131-1.535, p <0.001). There were no any predictive factors of TIA or stroke in the surgical group.

Conclusions: the independent predictor of early TIA and stroke in endovascular group, unlike endarterectomy, was the degree of carotid stenosis.

 

References

1.      Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. 2011 ASA/ACCF/AHA/AANN/ AANS/ACR/ ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease:executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force of Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventionalSurgery, Society for Vascular Medicine, and Society for VascularSurgery. Developed in collaboration with the American Academyof Neurology and Society of Cardiovascular Computed Tomography Catheter Cardiovasc Interv 2013; 81:76-123.

2.      Sakai N, Yamagami H, Matsubara Y et al. Prospective registry of carotid artery stenting in Japan: investigation on device and antiplatelet for carotid artery stenting. J Stroke Cerebrovasc Dis.2014; 23: 1374-1384.

3.      Jhang K, Huang J, NforIs O et al. Is Extended Duration of Dual Antiplatelet Therapy After Carotid Stenting Beneficial? Medicine 2015; 94:40.

4.      Mo D, Wang B, Ma N, et al. Comparative outcomes of carotid artery stenting for asymptomatic and symptomatic carotid artery stenosis: a single-center prospective study. J Neurointerv Surg. 2016; 8(2): 126-129.

5.      Bonati LH, Dobson J, Featherstone RL, et al. Longterm outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the Internation al Carotid Stenting Study (ICSS) randomised trial. Lancet. 2015; 385: 529-538.

6.      Stingele R, Berger J, Alfke K, et al. Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study. Lancet Neurol 2008; 7: 216-222.

7.      Howard VJ, Lutsep HL, Mackey A, et al. Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Lancet Neurol 2011; 10: 530-537.

8.      Setacci C, Chisci E, Setacci F, et al. Siena carotid artery stenting score: a risk modeling study for individual patients. Stroke 2010; 41: 1259-1265.

9.      AbuRahma AF, Alhalbouni S, Abu-Halimah S, et al. Impact of chronic renal insufficiency on the early and late clinical outcomes of carotid artery stenting using serum creatinine vs glomerular filtration rate. J Am Coll Surg 2014; 218: 797- 805.

10.    Kofoed SC, Wittrup HH, Sillesen H, Nordestgaard BG. Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: the Copenhagen City Heart Study. Eur Heart J 2003;24:567-576.

11.    Dosa E, Rugonfalvi-Kiss S, Prohaszka Z, Szabo A, Karadi I, Selmeci L, et al. Marked decrease in the levels of two inflammatory markers, hs-C-reactive protein and fibrinogen in patients with severe carotid atherosclerosis after eversion carotid endarterectomy. Inflamm Res 2004; 53:631-635.

12.    Maresca G, Di Blasio A, Marchioli R, Di Minno G. Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol 1999; 19:1368-1377.

13.    Gray WA,Yadav JS, Verta P, et al. The CAPTURE registry: predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting. Catheter Cardiovasc Interv 2007; 70: 1025-1033.

14.    Theiss W, Hermanek P, Mathias K, et al. Predictors of death and stroke after carotid angioplasty and stenting: a subgroup analysis of the Pro-CAS data. Stroke 2008; 39: 2325-2330.

15.    Chaturvedi S, Matsumura JS, Gray W, et al. Carotid artery stenting in octogenarians: periprocedural stroke risk predictor analysis from the multicenter Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events (CAPTURE 2) clinical trial. Stroke 2010; 41: 757-64.

16.    Mathur A, Roubin GS, Iyer SS, et al. Predictors of stroke complicating carotid artery stenting. Circulation 1998; 97: 1239-1245.

17.    Nicolaides AN, Kakkos SK, Kyriacou E, Griffi n M, Sabetai M, Thomas DJ, et al. Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. J Vasc Surg 2010;52:1486-1496.

18.    Obeid T, Arnaoutakis DJ, Arhuidese I, et al. Poststent ballooning is associated with increased periprocedural stroke and death rate in carotid artery stenting. J Vasc Surg 2015; 62: 616-623.

19.    Aronow HD, Gray WA, Ramee SR, et al. Predictors of neurological events associated with carotid artery stenting in high-surgical-risk patients. Circ Cardiovasc Interv 2010; 3: 577-584.

  

Abstract:

Aim: was to evaluate immediate and long-term results of using the catheter-directed thrombosis (CDT) in patients with acute iliofemoral thrombosis.

Materials and methods: the study included 26 patients (9 men and 17 women aged 31-70) with primary or iliofemoral thrombosis, which was made by CDT Assessment of immediate results was conducted and long-term results were tracked after 12 months.

Results: technical success of treatment was achieved in 22 (84,6%) patients. In 7 (26.9%) patients after the completion of CDT, hemodynamically significant stenoses were identified and addition stenting of iliac veins were performed. Preservation of primary permeability after 12 months was observed in 26 patients (96.2%). The presence of pathological venous reflux was observed in 6(23.1%) cases. Development of post-thrombotic disease (PTD) of mild and medium severity was observed in 7 (26.9%) patients.

Conclusion: catheter-directed thrombolysis in combination with traditional anticoagulant therapy is a safe and effective method of treatment in patients with acute iliofemoral thrombosis, and allows quickly to restore venous patency and also to reduce risk of development and severity of clinical manifestation of PTD.

 

References

1.      Vedantham S, Thorpe PE, Cardella JF, Grassi CJ, Patel NH, Ferral H, et al. Quality Improvement Guidelines for the Treatment of Lower Extremity Deep Vein Thrombosis with Use of Endovascular Thrombus Removal. Journal of Vascular and Interventional Radiology. 2006; 17: 435-48.

2.      Henke PK, Comerota AJ. An update on etiology, prevention, and therapy of postthrombotic syndrome. Journal of Vascular Surgery. 2011; 53: 500-509.

3.      Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed Thrombolysis for Lower Extremity Deep Venous Thrombosis: Report of a National Multicenter Registry. Radiology. 1999; 11: 39-49.

4.      Kahn SR, Partsch H. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. Journal of Thrombosis and Haemostasis. 2009; 7: 879-83.

5.      Comerota AJ, Kamath V. Thrombolysis for iliofemoral deep venous thrombosis. Expert Review of Cardiovascular Therapy. 2013; 12:1631-1638.

6.      Semba CP, Dake MD. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology. 1994; 191: 487-494.

7.      Vedantham S., Sista A.K., Klein S.J., Nayak L., Razavi M.K., Kalva S.P., et al. Quality Improvement Guidelines for the Treatment of Lower-Extremity Deep Vein Thrombosis with Use of Endovascular Thrombus Removal. Journal of Vascular and Interventional Radiology. 2014; 25: 1317-1325.

8.      Vedantham S, Goldhaber S, Julian J. ATTRACT Trial Investigators. Pharmacomechanical catheter-directed thrombolysis deep-vein thrombosis. N Engl J Med. 2017; 23: 2240-2252.

9.      Kolbel T, Alhadad A, Acosta S, Lindh M, Ivancev K, Gottsдter A. Thrombus Embolization Into IVC Filters During Catheter-Directed Thrombolysis for Proximal Deep Venous Thrombosis. Journal of Endovascular Therapy. 2008; 15: 605-613.

  

Abstract:

Background: the use of vascular closure devices (VCD) reduces the time of hemostasis, accelerates activation and discharge of the patient. Suture-mediated closure devices are closest in it's structure to the traditional surgical method of hemostasis. Advantages and disadvantages of these devices are mainly associated with design features. Stenoses, atherosclerosis, calcification and scars at the site of access are predictors of complications in the use of suturing devices. Although the effectiveness of these devices has been proven in several foreign studies, their data are not sufficient to draw clear conclusions.

Aim: was to evaluate advantages and disadvantages of using the suture-mediated closure devices after PCI.

Material and methods: study enrolled 208 adult patients, who underwent PCI in City Clinical Hospital named after M.P Konchalovsky, Moscow; FSBI «3 Central clinical military hospital n.a. A. A. Vishnevsky» Defense Ministry RF and SMRC preventive medicine of Department of Healthcare. Study group, where hemostasis after PCI was achieved by means of suture-mediated closure devices Perclose Pro Glide (Abbott Vascular), consisted of 90 patients, control group - 118 patients with manual hemostasis. Subjective feelings (pain, numbness, etc.) were assessed using a rating scale. The incidence of complications in the study group was 5.56%, in the control group - 6.78%. The comfort level of patients was higher in the study group

Results of the study: showed that the use of the Perclose device to achieve hemostasis after PC does not increase the frequency of regional vascular complications in compatison with manual hemostasis. But, at the same time, the use of VCD is an effective way to reduce the time of hemostasis, reduces the period of immobilization of the patient, which increases the patient's comfort and reduces patient's hospital stay.

 

 

References

1.      Caputo RP: Currently approved vascular closure devices. Card Interv Today: 70-76, 2012.

2.      Bechara CF, Annambhotla S, LinP H:Access site management with vascular closure devices for percutaneous transarterial procedures. J VascSurg 2010; 52:1682-1696. http://dx.doi.org/10.1016/j.jvs. 2010. 04.079.

3.      Sheth RA, Walker TG, Saad WE, et al: Quality improvement guidelines for vascular access and closure device use. J Vasc Interv Radiol. 2014; 25: 73-84. http://dx.doi.org/10.1016Zj.jvir.2013.08.011.

4.      Haas PC, Krajcer Z, Diethrich Edward B: Closure of large percutaneous access sites using the Prostar XL percutaneous vascular surgery device. J Endovasc Surg. 1999; 168-170.

5.      Barbetta I, van den Berg J: Access and hemostasis: femora and popliteal approaches and closure devices — Why, what, when, and how? Semin Interv Radiol 2014; 31:353-360. http://dx.doi.org/10. 1055/s-0034-1393972.

6.      Boschewitz J M, Pieper CC, Andersson M, et al: Efficacy and time-to-hemostasis of antegrade femoral access closure using the exoseal vascular closure device: A retrospective single-center study. Eur J Vasc Endovasc Surg 2014; 48:585-591. http://dx.doi.org/10.1016/ j.ejvs.2014. 08.006.

7.      Gutzeit A, van Schie B, Schoch E, et al: Feasibility and safety of vascular closure devices in an antegrade approach to either the common femoral artery or the superficial femoral artery. 2012; Cardiovasc Intervent Radiol 35:1036-1040. http://dx.doi.org/10.1007/s0 0270012-0454-5.

8.      Ward TJ, Weintraub J L: Vascular closure device update. Endovasc Today: 2015; 54-60.

9.      Hon LQ, Ganeshan A, Thomas SM, et al: An overview of vascular closure devices: What every radiologist should know. Eur J Radiol. 2010; 73:181-190,. http://dx.doi.org/10.1016/j.ejrad.2008.09.023.

10.    Krajcer Z: The preclose technique for AAA repair. Endovasc Today: 2011; 46-54.

11.    Gerckens U, Cattelaens N, Lampe EG, Grube E. Management of arterial puncture site after catheterization procedures: evaluating a suture-mediated closure device. Am J Cardiol. 1999; 83:1658-63.

12.    Baim DS, Knopf WD, Hinohara T, et al. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate and discharge (STAND I and STAND II) trials. Am J Cardiol. 2000; 85:864-9.

13.    Fram D.B., Giri S., Jamil G., et al. Suture closure of the femoral arteriotomy following invasive cardiac procedures: a detailed analysis of efficacy, complications, and the impact of early ambulation in 1200 consecutive, unselected cases. Cathet Cardiovasc Interv. 2001; 53:163-73.

14.    Balzer J.O., Scheinert D., Diebold T., et al. Postinterventional transcutaneous suture of femoral artery access sites in patients with peripheral arterial occlusive disease: a study of 930 patients. Cathet Cardiovasc Interv. 2001;53.

  

Abstract:

Aim: was to study possibilities of transabdominal ultrasonography in the diagnostics of the first phase of acute pancreatitis.

Material and methods: for the period 2010-2016, 7488 patients which required a differential diagnosis of disease with acute pancreatitis were urgently hospitalized. Transabdominal ultrasonography was made in 100% of patients in first hours and days of after hospitalization. 3519(47%) of patients were hospitalized during first 7 days from the beginning of the disease. Acute pancreatitis was confirmed in 458 patients (13%).

Results: new ultrasound signs were discovered and on the basis of them - a new method of transabdominal ultrasonography of acute pancreatitis was developed, which is based on the identification of hypoechoic areas corresponding to the vitreous edema of loose connective tissue, more than 2 mm thickness and more than 5 mm length. When identifying these signs at least in one of fixed parapancreatic areas - we diagnose acute pancreatitis.

Conclusions: the patented new method of transabdominal ultrasonography of acute pancreatitis in the first phase of the disease (patent # 2622611) allows to confirm or reject acute pancreatitis during the direct visualization of the pancreas. The method makes possible to establish an exact diagnosis when it is required to differentiate acute pancreatitis from another urgent pathology ir case of the absence of anamnesis, specific laboratory changes, the inability to apply other visualization methods, with changes in organs caused by concomitant pathology and background diseases, in patients with overweight.

 

References

1.      Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013; 13(4 Suppl 2): e1-15.

2.      Еrmolov AS, Ivanov PA, Blagovestnov DA. i dr. Diagnosis and treatment of acute pancreatitis. M.: Vidar-M. 2013; 384 [In Russ]

3.      Baker ME, Nelson RC, Rosen MP et al. ACR Appropriateness Criteria® acute pancreatitis. Ultrasound Q. 2014; 30(4): 267-273.

4.      Diagnosis and treatment of acute pancreatitis (Russian clinical guidelines). SPb. 2014 [In Russ].

5.      Fedoruk A.M. Ultrasonography in the diagnosis and treatment of acute pancreatitis. Mn.: Belarus'. 2005; 126 [In Russ].

6.      Savel'ev VS, Filimonov MI, Burnevich SZ. Pancreatonecrosis. M.: Medicinskoe informacionnoe agentstvo. 2008; 264 [In Russ].

7.      Vinnik YU.S., Dunaevskaya S.S., Antyufrieva D.A. Possibilities of modern methods of visualization of acute severe pancreatitis. Novosti hirurgii. 2014; 22(1): 58-62. [in Russ]

8.      Kajsarov VR. Features of the defeat of the retroperitoneal tissue in acute destructive pancreatitis: Cand. Med. sci diss. Sankt-Peterburg, 2005; 106 [In Russ].

9.      Lipatov VA. The severity of parapancreatic fiber, depending on body type. Medicine Online.Ru.- 01.07.2002. URL: http://www.medicina-online.ru/articles/43352/ [In Russ].

10.    Nigaj NG, Borovskij VV. Method for ultrasound diagnosis of acute pancreatitis forms. Patent KZ24337. 2011 [In Russ].

11.    Baranov AI, Еrmolaev YU.D., ZHerlov GK. Method for the diagnosis of acute pancreatitis. Patent RF №2242929. 2004 [In Russ].

12.    Bibik IL, Nikolaev NЕ. Modern algorithm for the diagnosis of acute pancreatitis]. Medicinskij zhurnal. 2006; (2): 23-25 [In Russ].

13.    Block S, Maier W, Bittner R, et al. Identification of pancreas necrosis in severe acute pancreatitis: imaging procedures versus clinical staging. Gut. 1986; 27(9): 10351042.

14.    Bertilsson S, Kalaitzakis E. Use of Pancreatitis - Associated Drugs Is Very Common in Patients With Acute. Pancreatitis but Is Not Related to Pancreatitis Etiology, Severity or Recurrence: A 10-Year Population-Based Cohort Study. Gastroenterology. 2014; 146(5): 95.

15.    Bertilsson S, Kalaitzakis E. Acute Pancreatitis and Use of Pancreatitis - Associated Drugs: A 10-Year Population-Based Cohort Study. Pancreas. 2015; 44(7): 10961104.

16.    Agrawal A, Alagusundarmoorthy SS, Jasdanwala S. Pancreatic Involvement in Critically ill Patients. J Pancreas (Online) 2015; 16(4): 346-355.

17.    Rybachkov VV, Dubrovina DЕ, SHvecov RV, Utkin AK. Pancreas injury and post-traumatic pancreatitis. Al'manah Instituta hirurgii imeni A.V. Vishnevskogo. 2007; Suppl 1: 780-781 [In Russ].

18.    Mathur AK, Whitaker A, Kolli H, Nguyen T. Acute Pancreatitis with Normal Serum Lipase and Amylase: A Rare Presentation. J Pancreas (Online). 2016; 17(1): 98101.

19.    Ranson JHC. The Role of Surgery in the Management of Acute Pancreatitis. Ann Surg. 1990; 211(4): 382393.

20.    Wilson C, Imrie CW, Carter DC. Fatal acute pancreatitis. Gut. 1988; 29(6): 782-788.

21.    Kirillova MS, Novikov SV. Ultrasound diagnosis of acute pancreatitis in the first phase of the disease. Patent RF № 2622611. 2017 [In Russ].

  

Abstract:

Aim: was to analyze own experience of differential diagnostics of cardiac tumors by using cardiac CT.

Materials and methods: 354 cardiac CT were made in «Fedorovich Klinikasi» in 2011-2017. The age of patients ranged from 5 month to 69 years (mean 27,2). There were 200(56,5%) men and 154 (43.5%) women. The study was carried out on MDCT scanners Brilliance 64 and Brilliance i-CT 256 (PHILIPS). Iodine containing contrast agent «Unihexol 350» was injected intravenously by means of «Ulrich» automatic injector.

Results: primary benign cardiac masses were detected in 10(2,8%) cases. Most of them were myxomas - 6 cases (60%), located in the left atrial cavity in 2 cases, in the mitral valve region - in 1, in the right atrium - in 2, and in the right ventricle - in 1case. Cardiac lipomas were detected in 2 (20%) patients. Papillary fibroelastoma of the aortic valve (1 case) and rhabdomyoma of the right

ventricle (1 case) also occurred in our study Intracardiac spreading of malignant neoplasms was noted in 5(1,4%) patients. Thrombosis of cardiac chambers was found in 7(2%) patients.

Conclusion: cardiac CT provides useful anatomical and functional information in evaluating cardiac masses, providing an accurate picture of the disease, allowing to assess localization and structure of the tumor, the condition of the tumor-free heart chambers, mediastinum, and lungs.

 

References

1.      Yuan SM, Shinfeld A, Lavee J, Kuperstein R, Haizler R, Raanani E. Imaging morphology of cardiac tumors. Cardiology Journal. 2009; 16 (1): 26-35.

2.      Puchkova EN, Sibirskiy VY Goncharova MA, Gajonova VE. Imaging diagnostics of the primary cardiac tumors. Kremlyovskaya meditsina. Klinicheskiyvestnik. 2009; 3: 7476 [In Russ].

3.      Colucci WS, Schoen FJ, Braunwald E. Primary tumors of the heart. 5th ed In: Brauwald E, editor., Heart Disease. A Textbook of Cardiovascular Medicine. Philadelphia, PA: WB Saunders; (1998). p. 1464-78.

4.      Roever L, Dourado PM, Resende ES, Chagas AC. Cardiac Tumors: A Brief Commentary Front Public Health. 2014; 2:264.

5.      Konradi YV, Ryzhkova DV. Imaging diagnostics of cardiac tumors. Translyatsionnaya meditsina. 2015; 2(4): 28-40 [In Russ].

6.      Kassop D, Donovan MS, Cheezum MK, Nguyen BT, Gambill NB, Blankstein R, Villines TC. Cardiac Masses on Cardiac CT: A Review. Curr Cardiovasc Imaging Rep. 2014; 7:9281

7.      Angulo CD, Diaz CM, Garcia ER, Fernandez RS, Siso AR, Diaz MM. Imaging findings in cardiac masses (Part I): Study protocol and benign tumors. Radiologia. 2015; 57(6):480-488.

8.      Grebenc ML, Rosado-De-Christenson ML, Green CE, et al. Cardiac myxoma: imaging features in 83 patients. Radiographics. 2002; 22: 673-89.

9.      Yu K, LiuY Wang H, Hu Sh, Long C. Epidemiological and pathological characteristics of cardiac tumors: a clinical study of 242 cases. Interactive Cardio Vascular and Thoracic Surgery. 2007; 6: 636-639.

10.    Butany J, Nair V, Naseemuddin A, Nair G, Catton C, Yau T. Cardiac tumors: diagnosis and management. Lancet Oncol. 2005; 6:219-228.

11.    Cheezum MK, Jezior MR, Carbonaro S, Villines TC. Lipomatous hypertrophy presenting as superior vena cava syndrome. J Cardiovasc Comput Tomogr. 2014.

12.    Howard RA, Aldea GS, Shapira O.M, et al. Papillary fibroelastoma: Increasing recognition of a surgical disease. Ann Thorac Surg. 1999;68:1881-5.

13.    Ghadimi Mahani M, Lu JC, Rigsby CK, Krishnamurthy R, Dorfman AL, Agarwal PP. MRI of pediatric cardiac masses. AJR Am J Roentgenol. 2014;202:971-81.

14.    Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastases. J Clin Pathol 2007; 60:27-34.

15.    Goldberg AD, Blankstein R, Padera RF Tumors metastatic to the heart. Circulation. 2013; 128: 1790-4.

16.    Kim DH, Choi S, Choi JA, Chang JH, Choi DJ, Lim C. Various findings of cardiac thrombi on MDCT and MRI. J Comput Assist Tomogr. 2006;30:572-577.

17.    Scheffel H., Baumueller S., Stolzmann P., et al. Atrial myxomas and thrombi: comparison of imaging features on CT. Am J Roentgenol. 2009;192: 639-45.

 

Abstract:

A 57-year-old woman was on the waiting list of Orthotopic Liver Transplantation (OLT) due to cirrhosis of viral etiology MSCT with contrast enhancement showed two aneurysms of the splenic artery, stenosis of the celiac trunk with aneurysm of the pancreaticoduodenal artery Taking into account asymptomatic course, we decided to eradicate vascular changes during the forthcoming OLT OLT performed 6 month later, was technically difficult and complicated by massive blood loss and episodes of unstable hemodynamics, so surgical correction of aneurysms was not performed because of high risk. The patient was well and asymptomatic for 2 years after the OLT, but then she developed abdominal pain. MSCT showed progression of vascular changes. Successful endovascular treatment included celiac trunk stenting and embolization of aneurysms. 

 

References

1.      Unger L, Stork T, Bucsics T, et al. The role of TIPS in the management of liver transplant candidates. United Eur. Gastroenterol. J. 2017; 5 (8): 1100-1107.

2.      Garcia-Pagan JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N. Engl. J. Med. 2010; 362 (25): 2370-2379.

3.      Bacalbasa N, Balescu I, Brasoveanu V. Celiac Trunk Stenosis Treated by Resection and Splenic Patch Reconstruction - A Case Report and Literature Review. In Vivo. 2018; 32 (3): 699-702.

4.      Degheili J., Chediak A., Dergham M, et al. Pancreaticoduodenal Artery Aneurysm Associated with Celiac Trunk Stenosis: Case Illustration and Literature Review. Hindawi. Case reports in radiology. Volume 2017, Article ID 6989673,7 pages.

5.      Uchida H, Sakamoto S, Matsunami M., et al. Hepatic artery reconstruction preserving the pancreaticoduodenal arcade in pediatric liver transplantation with celiac axis compression syndrome: report of a case. Pediatr. Transplant. 2014; 18 (7): 232-235.

6.      Katsura M, Gushimiyagi M, Takara H, et al. True aneurysm of the pancreaticoduodenal arteries: a single institution experience. Journal of Gastrointestinal Surgery. 2010; 14 (9): 1409-1413.

7.      Chiang K, Johnson C, McKusick M, et al. Management of inferior pancreaticoduodenal artery aneurysms: a 4-year, single centre experience. CardioVascular and Interventional Radiology. 1994; 17 (4): 217-221.

8.      Koganemaru M, Abe T, Nonoshita M, et al. Follow-up of true visceral artery aneurysm after coil embolization by three-dimensional contrast-enhanced MR angiography. Diagnostic and Interventional Radiology. 2014; 20 (2): 129-135.

9.      Bastante D, Raya M, Rabelo V., et al. Analysis of ischemic cholangiopathy after treatment of arterial thrombosis in liver transplantation in our series. Transplant Proc. 2018; 50 (2): 628-630.

10.    Polikarpov AA, Tarazov PG, Granov DA, Polysalov VN. Arterial aneurysm of internal organs: the role of angiography and transcatheter embolization. Regional blood circulation and microcirculation. 2002; 1 (2): 30-36 [In Russ].

11.    Tien Y-W, Kao H-L, Wang H-P. Celiac artery stenting: a new strategy for patients with pancreaticoduodenal artery aneurysm associated with stenosis of the celiac artery. Journal of Gastroenterology. 2004; 39 (1): 81-85.

12.    Granov AM, Granov DA, Zherebcov FK, Polysalov VN, Gerasimova OA et al. Experience of 100 liver transplantation in RSCRST. Herald of surgery I.I. Grekov. 2012; 171 (2): 74-77 [In Russ].

13.    Gautier SV, Moysuk YG, Homyakov SM. Organ donation and transplantation in Russian Federation in 2014. 7-th report of National Register. Russian Journal of Transplantology and Artificial Organs. 2015; 17 (2): 7-22 [In Russ].

14.    Tarazov PG, Granov DA, Polikarpov AA, Generalov MI. Orthotopic liver transplantation: The role of interventional radiology. Herald of transplantology and artificial organs. 2009; 3: 42-50 [In Russ]. 

 

Abstract:

Background: expansion of tourism business in countries of South and Southeast Asia, Africa, and South America led to the appearance of rare parasitic diseases in Russia, Europe, and the United Kingdom. In our country, more than 1.3 million patients with various parasitosis are officially registered annually, among which there is an increase in the incidence of intestinal protozoa.

Aim: was to show features of the diagnosis of acute manifestations of necrotic amebic colitis, which simulated severe intoxication with manifestation of clinics of acute surgical disease and intestinal bleeding

Material and methods: using the example of case report of a 70-year-old woman, the possibility of complex diagnostics using abdominal ultrasound, abdominal computed tomography, colonoscopy with biopsy of intestinal ulcers and parasitological research methods is shown. Results: detoxification, anti-inflammatory therapy in a surgical hospital and instrumental examination allowed us to objectively evaluate and conduct targeted therapy avoiding serious complications.

Discussion: primary lesions with acutely occurring both local and general body reactions lead to severe intoxication, which does not allow to exclude acute surgical pathology, and in some cases dictate the need for urgent surgical intervention.

Differential diagnosis of an amoeba with a colon cancer only on the basis of x-ray symptoms is almost impossible. Specific anti-ameba therapy leads to the disappearance of amoeba.

Conclusion: only on the basis of a complex of clinical and epidemiological data, ultrasound, CT, colonoscopy, histological analysis and parasitological methods of research, pathology can be correctly identified. 

 

References

1.      Bronshtejn A.M., Malyshev N.A., Luchshev V.I. Amebiasis: clinical features, diagnosis, treatment. Klinicheskaya mikrobiologiya i antimikrobnaya himioterapiya. 2001; 3(3): 215-222 [In Russ.].

2.      Gostishchev V.K., Khrupkin V.I., Afanas'ev A.N., Gorbacheva I.V. The complicated intestinal amebiasis in emergency surgery. Xirurgiya. 2009; (5): 4-9 [In Russ.].

3.      Lisicyn K.M., Revskoj A.K. Urgent abdominal surgery for infectious and parasitic diseases. M: Medicina, 1988: 237-271 [In Russ.].

4.      Petridou C, Al-Badri A, Dua A, et al. Learning points from a case of severe amoebic colitis. Infez Med. 2017; 25(3): 281-284. PMID: 28956549

5.      Cook G.C. Parasitic infections of gastrointestinal tract: a worldwide clinical problem. Curr Opin Gastroenterol.1989; 2(Is1): 126-139.

6.      Ozereczkovskaya N.N. Organ pathology in the acute stage of tissue helminthiases: the role of blood and tissue eosinophilia, immunoglobulinemia E, G4 and factors that induce an immune response. Medicinskaya parazitologiya iparazitarny'e bolezni. 2000; (3): 3-8 [In Russ.].

7.      Romanenko N.A. Modern tasks of sanitary parasitology. Medicinskaya parazitologiya i parazitarny'e bolezni. 2001; (4): 25-29 [In Russ.].

8.      Sergiev V.P, Filatov N.N. Infectious diseases at the turn of the century: an awareness of the biological threat. Moskva: Nauka, 2006; 572 s [In Russ.].

9.      Kry'lov M.V. The determinant of parasitic protozoa (human, domestic animals and agricultural plants). Sankt-Peterburg: ZIN, 1996; 602 s [In Russ.].

10.    Eryuxin I.A., Xrupkij V.I. (red.) Experience of medical support of troops in Afghanistan 1979-1989 V. 2: Organization and scope of surgical care for the wounded. Moskva, 2002: 379-386 [In Russ.].

11.    Scherbakov I.T., Leonteva N.I., Chebyshev N.V., i dr. Pathomorphology of colonic mucosa in patients with chronic post-parasitic colitis. Aktual'ny'e voprosy' infekcionnojpatologii. 2014; 95(6): 934- 938 [In Russ.].

12.    Ellyson J.K, Bezmalinovic Z., Parks S.N, Lewis F.R. Necrotizing amebic colitis: a frequently fatal complication. Am J Surg. 1986; 152(1): 21-26. PMID: 3728812.

13.    Shirley DA, Moonah S. Fulminant amebic colitis after corticosteroid therapy: a systematic review. PLoS Negl Trop Dis. 2016; 10(7): e0004879.

14.    Guzeeva T.M. Status the incidence of parasitic diseases in the Russian Federation and tasks in terms of the reorganization of the service. Medicinskaya parazitologiya i parazitarny'e bolezni. 2008; (1): 3-11 [In Russ.].

15.    Weitzel T, Carbera J, Rosas R, et al. Enteric multiplex PCR panels: A new diagnostic tool for amoebic liver abscess? New Microbes New Infect. 2017; 18: 50-53. PMID: 28626584 DOI:10.1016/j.nmni.2017.05.002.

16.    Abbas М.А., Mulligan D.C., Ramzan N.N., et al. Colonic perforation in unsuspected amebic colitis. Dig Dis Sci. 2000; 45(9): 1836-1841. PMID: 11052328.

17.    Sinharay R., Atkin G.K., Mohamid W., Reay-Jones N. Caecal amoebic colitis mimicking a colorectal cance. J Surg Case Rep. 2011; (11): 1. PMID: 24972391 DOI:10.1093/jscr/2011.11.1.

18.    Delabroussea E., Ferreirab F., Badeta N., et al. Coping with the problems of diagnosis of acute colitis. Diagn Intervent Imaging. 2013; 94(7-8): 793—804. PMID: 23751227 DOI:10.1016/j.diii.2013.03.012. 

 

Abstract:

Aim: was to analyze the first experiment and estimate the tolerability of intra-arterial use of the Abraxane in oil chemoembolization in patients with pancreatic adenocarcinoma.

Material and methods: for the period January 2018 - August 2018 г on the basis of the FSCU RIS RHT named after academician A.M. Granov, 19 patients with histologically verified ductal adenocarcinoma of the pancreas received treatment: intra-arterial oil chemoembolization with the use of the Abraxane.

Results: in 14 (73.6%) patients appeared mild pain syndrome that was not accompanied by marked laboratory changes, against the background of standard conservative prophylaxy. In 5 (26.4%) cases, patients had clinical and laboratory signs of postembolization syndrome, which was regarded as adverse events of grade 3 antitumor therapy, manifested by clinical and laboratory signs of mild acute pancreatitis, treated in all cases conservatively

The treatment of the postembolization syndrome lasted up to 7 days, until complete laboratory markers normalization, consisting in reducing the activity of blood amylase and urinary diastase to normal values. In all cases, postembolization syndrome was stopped conservatively In described 5 (26.4%) patients, adverse events of intra-arterial oil chemoembolization were regarded as mild postembolization pancreatitis. After treatment, a decrease in the tumor marker CA 19-9 was observed in 9 (90%) patients.

At the next stage, all patients with localized forms of the tumor underwent surgical treatment in the volume of pylorus-preserving pancreatoduodenal resection (n = 13) from 7 to 15 days after intra- arterial oil chemoembolization.

Conclusion: the procedure of oil chemoembolization with Abraxane can be considered as safe if dosages of the oil radiopaque drug Lipiodol are adeqate. There was a tendency to a decrease in the level of the tumor marker CA 19-9 in the blood of patients after the procedure. 

 

References

1.      Davydov MI, Aksel' EM. Statistics of malignant tumors in Russia and the CIS countries in 2012. Izdatel'skaya gruppa RONTs. 2014; 4: 226 [In Russ].

2.      Siegel R.L., Jemal А. Cancer statistics. CA. Cancer J Clin. 2018; 68: 7-30.

3.      Kaprin AD, Starinsky VV, Petrova GV. Statistics of malignant tumors in Russia 2016 (morbidity and mortality) M.: MNIOI im. PA. Gertsena filial FGBU «NMITs radiologii» Minzdrava Rossii. 2018; 250 p [In Russ].

4.      Alexakis N. Current standards of surgery for pancreatic cancer. Br J Surg. 2004; (11) 91: 1410-27.

5.      Dennison AR. Laparoscopic pancreatic surgery: a review of present results and future prospects. HPB (Oxford). 2010; 4(12): 239-43.

6.      Yang ZYYuan JQ, Di MY Zheng DY Chen JZ, Ding H, Wu XY, Huang YF, Mao C, Tang J.L. Gemcitabine plus erlotinib for advanced pancreatic cancer: a systematic review with meta-analysis. PLoS One. 2013;8(3):e57528. doi: 10.1371/journal.pone.0057528. Epub 2013 Mar 5.

7.      Hidalgo M. Pancreatic cancer. N Engl j med. 2010; 362: 1605-17.

8.      Burris H.A. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J ClinOncol. 1997; 2403-13.

9.      Popova AS, Pokataev I A, Tyulyandin S.A. Combined chemotherapy regimens for pancreatic cancer. Zhurnal Meditsinskii sovet, Izdatel'stvo «GRUPPA REMEDIUM». 6: 62-70 [In Russ].

10.    Pokataev I A, Bazin I S, Popova A S, Podluzhnyi D V. Efficacy and safety of induction chemotherapy according to the FOLFIRINOX scheme with borderline resectable and unresectable pancreatic cancer. Nauchno-prakticheskii zhurnal po onkologii «Zlokachestvennye opukholi». 2018; 8(1): 38-47[ In Russ].

11.    Conroy T, Desseigne F, Ychou M. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011; 19(364): 1817-25.

12.    Stocken DD. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer. 2005; 8(92): 1372-81.

13.    Desai N, Trieu V, Yao Z. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res. 2006; 1(4): 1317-24.

14.    Dranitsaris G, Yu B, Wang L. Abraxane versus Taxol for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective. J Oncol Pharm Pract. 2016; 2: 205-11

15.    Giordano G, Pancione M, Olivieri N. Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions. World J Gastroenterol. 2017; 23(32): 5875-5886.

16.    Ottaiano A. Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples. Anticancer Res. 2017; 4(37): 1975-1978.

17.    Von Hoff DD. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. ClinOncol. 2011; 29(34): 454854.

18.    Granov DA, Polikarpov AA, Pavlovskij AV, Moiseenko VE, Popov SA. Evaluation of the safety of intra-arterial chemotherapy with gemcitabine and oxaliplatin in the combined treatment of pancreatic head adenocarcinoma. Annaly khirurgicheskoy gepatologii. 2017; 22 (2): 54-59 [InRuss].

19.    Granov DA., Pavlovskij AV, Suvorova JuV, Gulo AS, Popov SA, Shapoval SV, Tlostanova MS. Neoadjuvant intra-arterial oil chemoembolization and adjuvant regional chemoinfusion in combined treatment of pancreatic cancer. Voprosioncologii. 2008; 54(4): 501-503.

 

Abstract:

Aim: was to improve diagnostics of neck vessels' damage, by methods of traditional and CT-angiography

Material and methods: 65 injured patients with suspected damage of neck major vessels underwent examination. 52 persons had open traumas of the neck, 13 persons had closed traumas of the neck. Radiological diagnostics included CT-angiography and traditional angiography Main aim of examination was in determination of damage including both vessels and other structures of the neck, their localization and the nature of damage.

Results: CT-angiography gave possibilities:

           to give exact characterictics of all traumatic injures of the neck and to choose the group of patients with vessel traumas (23 patients)

           to define exactly the nature of the damage of neck vessels (aneurysm, thrombosis, rupture);

           to control the effectiveness of the surgical intervention.

Traditional angiography was applied in 10 observations of the traumatic aneurysm of neck vessel, for search of the additional diagnostic information. In comparison with results of CT- angiography any other precise information was not received.

Conclusions: analysis of the traditional and CT-angiography diagnostic possibilities of vessels damage, accompanying cervical trauma demonstrated high effectiveness of both methods. Traditional angiography should be used in absence of CTA in diagnostic arsenal. 

 

Referenses

1.      Korzhuk M.S., Kozlov K.K., Tkachev A.G. at al. Problems of medical care for injuries of major vessels of the neck. Sovremennye problemy nauki i obrazovaniya. 2014; 6: 1039 [In Russ].

2.      Mosyagin V.B., Slobozhankin A.D., Chernysh A.V et al. Experience in surgical treatment of closed lesions of major vessels of the neck. Vestnik Rossijskoj voenno-medicinskojakademii. 2013; 1 (41): 80-83 [In Russ].

3.      Vereshchagin S.V., Ahmad M.M.D., Kucher V.N. et al. The first experience of endovascular treatment of posttraumatic false aneurysms of aortic arch branches. Endovaskulyarna nejrorentgenohirurgiya. 2014; 2 (8): 64-70 [In Russ].

4.      Abakumov M.M. Multiple and combined wounds of the neck, chest, abdomen. Rukovodstvo dlya vrachej. 2013; 688 [In Russ].

5.      Mosyagin V.B, Chernysh A.V, Ryl'kov V.F. et al. Experience of surgical treatment of wounds of the neck. Vestnik Rossijskoj voenno-medicinskoj akademii. 2012; 3 (39): 86-90 [In Russ].

6.      Shabonov A.A., Trunin E.M. Treatment of wounds and injuries of major vessels of the neck. Vestnik Avicenny. 2011; 2 (47): 135-141 [In Russ].

7.      Sayyed Ehtesham Hussain Naqvi, Eram Ali, Mohammed Haneef Beg et al. Successful Resuscitation of a Cardiac Arrest following Slit Neck and Carotid Artery Injury: A Case Report. Journal of Clinical and Diagnostic Research. 2016; 10 (6): 25-27.

8.      Halimova A.A. Post-traumatic dissection of vertebral and major arteries as a complication of mechanical injury of the carotid artery on the background of a light traumatic brain injury. Nejrohirurgiya i nevrologiya Kazahstana. 2012; 4 (29): 29-32 [In Russ].

9.      Komelyagin D.Yu., Dubin S.A., Vladimirov F.I. et al. Clinical case of treatment of a patient with post-traumatic arteriovenous fistula in the neck. Detskaya hirurgiya. 2015;19 (5): 50-53 [In Russ].

10.    Griessenauer C.J., Foreman P.M, Deveikis J.P. et al. Optical coherence tomography of traumatic aneurysms of the internal carotid artery: report of 2 cases. J Neurosurg. 2016; 124 (2): 305-9.

11.    Shtejnle A.V., Alyab'ev F.V., Duduzinskij K.Yu. at al. History of surgery damages blood vessels of the neck. Sibirskij medicinskij zhurnal. 2008; 23 (2): 87-97 [In Russ]

 

Abstract:

Background: study presents data of recanalization of occlusions of access vein in patients after pacemaker implantation.

Material and methods: for the period of 2010-2018 a total of 461 patients underwent repeated antiarrhythmic device implantation. In 82(17,8%) patients we found malfunctioning leads. Total venous occlusion was found in 8(10%) cases. Attempt of recanalization was performed in 4 patients, in rest 4 cases recanalization was not performed, because of different reasons, and in 1 case it was unsuccessful.

Results: In 3 cases successful recanalization of venous occlusion and leads reimplantation were performed. In 2 cases - recanalization was performed using a guidewire and in 1 case a dilator for leads extraction was used. 5 patients underwent the contralateral implantation of a completely new system were performed.

Conclusions: recanalization of venous occlusion using a guidewire or a dilator is an effective method of treatment. These techniques allow to save contralateral access for other lifesaving procedures. However, recanalization using a dilator sheath might be associated with greater risk of complications such as perforation of subclavian vein, innominate vein or superior vena cava.

Thus, the choice of one or another strategy of recanalization is associated with technical difficulties and requires specialized tools and special skills of operating surgeon.

 

References

1.      Stoney W.S., Addlestone R.B., Alford Jr. W.C., Burrus G.R., Frist R.A., Thomas Jr C.S. The incidence of venous thrombosis following long-term transvenous pacing. The Annals of Thoracic Surgery. 1976; 22 (2): 166170.

2.      Mitrovic V., Thormann J., Schlepper M., Neuss H. Thrombotic complications with pacemakers. International Journal of Cardiology. 1983; 2: 363-374.

3.      Basil Abu-El-Haija, MD; Prashant D. Bhave, MD, FHRS; Dwayne N. Campbell, MD, FHRS; Alexander Mazur, MD; Denice M. Hodgson-Zingman, MD, FHRS; Vlad Cotar- lan, MD; Michael C. Giudici, MD, FHRS. Venous Stenosis After Transvenous Lead Placement: A Study of Outcomes and Risk Factors in 212 Consecutive Patients. Journal of the American Heart Association. 2015; 1-6.

4.      Jose M. Marcial, MD, Seth J. Worley, MD, FHRS. Venous System Interventions for Device Implantation. Cardiac Electrophysiology Clinics. 2018; 10: 163-177

5.      Haran Burri. Overcoming the challenge of venous occlusion for lead implantation. Indian pacing and electrophysiology journal. 2015; 15: 110-112.

6.      Lars Lickfett, Alexander Bitzen, Aravind Arepally. Khurram Nasir. Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. EP Europace. 2004; 6: 25-31.

7.      Mehrdad Golian, Minh Vo, Amir Ravandi, Colette M. Seifer. Venoplasty of a chronic venous occlusion allowing for cardiac device lead placement: A team approach. Indian pacing and electrophysiology journal. 2016; 6: 197-200.

8.      Marcio GK, MD, MSc, PhD, Ricardo Luiz Lima Andrade, MD, Gustavo Ramalho da Silva, MD, Hanry Barros Souto, MD. ICD Leads Extraction and Clearing of Access Way in a Patient With Superior Vena Cava Syndrome. Medicine. 2015; 38: 1-4.

9.      Maytin M, Epstein LM, Henrikson CA. Lead extraction is preferred for lead revisions and system upgrades: when less is more. Circulation: Arrhythmia and Electrophysiology. 2010; 3(4): 413-424.

10.    Worley SJ, Gohn DC, Pulliam RW. Excimer laser to open refractory subclavian occlusion in 12 consecutive patients. Heart Rhythm. 2010; 7(5): 634-638.

11.    Mathur G, Stables RH, Heaven D, Ingram A., Sutton R. Permanent pacemaker implantation via the femoral vein: an alternative in cases with contraindications to the pectoral approach. EP Europace. 2001; 3: 56-59.

12.    Agosti S, Brunelli C, Bertero G. Biventricular pacemaker implantation via the femoral vein. Journal of Clinical Medicine Research. 2012; 4: 289-291.

13.    Elayi CS, Allen CL, Leung S, Lusher S, Morales GX, Wiisanen M, et al. Inside-out access: a new method of lead placement for patients with central venous occlusions. Heart Rhythm. 2011; 8: 851-857.

14.    Auricchio A, Delnoy PP, Butter C, Brachmann J, Van Erven L, Spitzer S, et al. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study. Europace. 2014; 16: 681-688.

15.    Reddy VY Exner DV, Cantillon DJ, et al. Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. The New England Journal of Medicine. 2015; 373: 1125—1135.

16.    Worley SJ, Gohn DC, Pulliam RW, et al. Subclavian venoplasty by the implanting physicians in 373 patients over 11 years. Heart Rhythm. 2011; 8(4): 526-533.

17.    Ozyer U, Harman A, Yildirim E, Aytekin C, Karakayali F, Boyvat F. Long-term results of angioplasty and stent placement for treatment of central venous obstruction in 126 hemodialysis patients: a 10-year single-center experience. American Jounnal of Rentgenology 2009; 193(6): 1672-1679. 

 

Abstract:

Despite advances made in the treatment of renal cell carcinoma, kidney cancer still remains a «surgical» disease. Radical surgery is the only cure for this pathology If it is technically impossible to perform a resection of the kidney in situ, it is preferable to use the latter treatment option, since it avoids chronic hemodialysis, the need for kidney transplantation and improve the quality of life. The central and intraparenchymal location of tumors does not allow the organ-preserving operation due to the necessity of resection of segmental vessels, cups and renal pelvis, which prolongs the time of thermal ischemia. Conducting extracorporeal resection of the kidney in conditions of chemo-cold ischemia allows you to expand indications for organ-preserving treatment of patients with localized kidney cancer.

Aim: was to evaluate possibilities of ultrasound monitoring during extracorporeal resection of the kidney with orthotopic nephropexy and replantation of renal vessels at all stages of surgical treatment.

Material and methods: 47 patients (74% of men, 26% of women) with a histologically confirmed diagnosis of kidney cancer were hospitalized for treatment at the period from March 2012 to the present in A.V Vishnevsky National Medical Research Center of Surgery All patients underwent extracorporeal resection of the kidney under conditions of pharmaco-cold ischemia without intersection of the ureter with orthotopic replantation of renal vessels. Ultrasound examination (in B-mode, Color and Energy Doppler Imaging and pulsed Doppler) was performed for all patients in the pre-, intra- and postoperative stages.

Results: the analysis of the ultrasound data obtained during the surgical treatment of patients at its stages allowed us to develop an algorithm for examining patients at stages of extracorporeal resection of the kidney under conditions of pharmaco-cold ischemia without crossing the ureter with orthotopic replantation of the renal vessels, taking into account technical features of surgical intervention

Conclusion: extracorporeal resection of the kidney with orthotopic nephropexy and replantation of renal vessels requires constant dynamic monitoring of the functional state of the renal blood flow Doppler ultrasound, performed according to the developed method, is a highly informative method in the qualitative and quantitative assessment of intrarenal blood flow. Ultrasound monitoring allows you to determine the functional state of the kidneys during the preoperative stage, intraoperatively assess the state of vascular anastomoses and monitor changes in the kidneys and the resectior zone in the postoperative period. 

 

References

1.      Clinical oncourology. Ed. B.P Matveyev. M .: Verdana, 2003; 717 p [In Russ].

2.      Sukonko OG, Tkachev LP, Krasny SA, Rolevich AI, Polyakov SL, Poluyanchik AV. Extracorporeal resection of the kidney with autotransplantation in a cancer patient of a horseshoe kidney (clinical case). Oncourology. 2010; 4: 83-87 [In Russ].

3.      Calne RY. Tumour in a single kidney: nephrectomy, excision, and autotransplantation. Lancet 1971; 2: 761-762.

4.      Gittes RF, McCullough D.L. Bench surgery for tumor in a solitary kidney. J Urol 1975; 113: 12-15.

5.      Teplov AA, Gritskevich AA, Pianikin SS. Extracorporeal kidney resection in pharmaco-cold ischemia without intersecting the ureter with orthotopic vascular replantation in renal cell carcinoma. Experimental and clinical urology. 2015; 52-62 [In Russ].

6.      Ultrasound diagnosis in abdominal and vascular surgery. Ed. GI. Kuntsevich. - Minsk: Cavalier Publishers, 1999; 256 p [In Russ].

7.      Lelyuk VG, Lelyuk SE. Ultrasound angiology. - M .: Real time, 2003; 322 p [In Russ].

8.      Kvyatkovsky EA, Kvyatkovskaya TA. Ultrasonography and Doppler in the diagnosis of kidney disease. - Dnepropetrovsk: New Ideology, 2005; 318 p [In Russ].

9.      Radiological diagnosis of diseases of the heart and blood vessels: a national guide. Ch. ed. L.S. Kokov - Moscow: GEOTAR-Media, 2011; 688 p [In Russ].

10.    Practical guide to ultrasound diagnostics. General ultrasound diagnostics. Ed. Mitkova VV. - M .: Publishing House Vidar -M, 2005; 720 p [In Russ].

11.    Hirai T, Ohishi H, Yamada R, Imai Y Hirohashi S, Hirohashi R, Honda N, Uchida H. Usefulness of color Doppler imaging in differential diagnosis of multilocular cystic lesions of the kidney. J. Ultrasound Med. E. 1995; 14(10): 771-776.

12.    Krainnik NA. Ultrasound diagnosis of vascular complications of renal allografts in the intraoperative and early postoperative periods. Diss. ... cand. med. scie., - Moscow, 2016; 127 p [In Russ].

 

Abstract:

Aim: was to evaluate the efficacy of MSCT in assessment of long-term graft patency after coronary artery bypass graft surgery (CABG).

Material and methods: 25 patients with multi-vessel coronary artery disease were included in the research. To assess the 5-year graft patency, MSCT arteriography was performed.

Results: a total of 96 grafts (22 left internal thoracic artery (LITA) and 74 saphenous venous grafts (SVG)) were analyzed using MSCT There were 12 venous sequential grafts and 19 venous Y-shaped grafts determined. During the assessment of graft patency, 13 occlusions of venous grafts and 1 hemodynamically significant stenosis were detected. Occlusion and hemodynamically significant stenosis of mammary grafts were not observed.

Conclusion: MSCT arteriography, allows to determine occlusive and hemodynamically significant stenoses of SVG. Results of study shows the prevalence of SVG occlusions and stenosis over arterial grafts. CT angiography can be highly informative for assessing the patency of grafts in late periods after CABG. 

 

References

1.      Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1, 388 patients during 25 years. J Am Coll Cardiol. 1996; 28: 616-626.

2.      Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, Golding LA, Gill CC, Taylor PC, Sheldon WC. Influence of the internal mammary artery graft on 10-year survival and other cardiac events. N Engl J Med 1986; 314: 1-6.

3.      Ropers D, Pohle FK, Kuettner A, Pflederer T, Anders K, Daniel WG, Bautz W, Baum U, Achenbach S. Diagnostic accuracy of noninvasive coronary angiography in patients after bypass surgery using 64-slice spiral computed tomography with 330-ms gantry rotation. Circulation. 2006;114: 2334-2341.

4.      Dikkers R, Willems TP, Tio RA, Anthonio RL, Zijlstra F, Oudkerk M. The benefit of 64-MDCT prior to invasive coronary angiography in symptomatic post-CABG patients. Int J Cardiovasc Imaging. 2007; 23(3): 369-377.

5.      Lee R, Lim J, Kaw G, Wan G, Ng K, Ho KT. Comprehensive noninvasive evaluation of bypass grafts and native coronary arteries in patients after coronary bypass surgery: accuracy of 64-slice multidetector computed tomography compared to invasive coronary angiography. J Cardiovasc Med (Hagerstown). 2010; 11(2): 81-90.

6.      Laynez-Carnicero A, Estornell-Erill J, Trigo-Bautista A, Valle-Mutz A, Nadal-Barangй M, Romaguera-Torres R, Planas del Viejo A, Corb-Pascual M, Payб-Ser- rano R, Ridocci-Soriano F. Non-invasive assessment of coronary artery bypasss grafts and native coronary arteries using 64-slice computed tomography: comparison with invasive coronary angiography. Revista espanola de cardiologia. 2010; 63(2): 161-169.

7.      Heye T, Kauczor HU, Szabo G, Hosch W. Computed tomography angiography of coronary artery bypass grafts: robustness in emergency and clinical routine settings. Acta Radiol. 2014; 55(2): 161-170.

8.      Bourassa MG. Fate of venous grafts: the past, the present and the future. J Am Coll Cardiol. 1991; 5: 1081-1083.

9.      Nikonov ME. Possibilities of multispiral computed tomography in assessing the patency of coronary grafts in early and late periods in patients undergoing aortic and mammarocoronary bypass graft surgery. REJR. 2013; 3 (1): 18-27 [In Russ].

10.    ACC/AHA/ACP — ASIM Practice guidlines. ACC/AHA/ACP — ASIM Guidelines for the management of patients with chronic stable angina. Am Coll Cardiac. 1999; 33(7): 2092-2097.

11.    Tochii M, Takagi Y Anno H, Hoshino R, Akita K, Kondo H, Ando M. Accuracy of 64-slice multidetector computed tomography for diseased coronary artery graft detection. Annals of Thoracic Surgery. 2010; 89(6): 1906-1911.

12.    Shimanovsky NL. Safety of iodine-containing radiopaque agents in the light of new recommendations from international associations of experts and clinicians. REJR. 2012; 2 (1): 12-19 [In Russ].

13.    Campbell PG, Teo KS, Worthley SG, Kearney MT, Tarique A, Natarajan A, Zaman AG. Non-invasive assessment of saphenous vein graft patency in asymptomatic patients. Br J Radiol. 2009 Apr; 82(976):291-5. doi: 10.1259/bjr/19829466.

14.    Frazier AA, Qureshi F, Read KM, Gilkeson RC, Poston RS, White CS. Coronary artery bypass grafts: assessment with multidetector CT in the early and late postoperative settings. Radiographics. 2005 Jul-Aug; 25(4): 881-896. Review.

15.    Tinica G, Chistol RO, Enache M, Leon Constantin MM, Ciocoiu M, Furnica C. Long-term graft patency after coronary artery bypass grafting: Effects of morphological and pathophysiological factors. Anatol J Cardiol. 2018 Nov;20(5):275-282. doi: 10.14744/AnatolJCardiol.2018. 51447.

16.    Drouin A, Noiseux N, Chartrand-Lefebvre C, Soulez G, Mansour S, Tremblay JA, Basile F, Prieto I, Stevens LM. Composite versus conventional coronary artery bypass grafting strategy for the anterolateral territory: study protocol for a randomized controlled trial. Trials. 2013 Aug 26; 14: 270. doi: 10.1186/1745-6215-14270.

17.    Deb S, Cohen EA, Singh SK, Une D, Laupacis A, Fremes SE RAPS Investigators. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol. 2012 Jul 3;60(1):28-35. doi: 10.1016/j.jacc.2012.03.037.

 

Abstract:

Background: the optimal method for radiological diagnosis of prostate cancer (PCa) in planning multifocal biopsy is multiparametric magnetic resonance imaging (mpMRI)

Aim: was to improve the diagnosis of clinically significant PCa (csPCa) in patients with a negative primary biopsy, proceeding from mpMRI findings analysis based on results of the repeated procedure (24 cores) with targeted sampling of suspicious lesions.

Materials and methods: 732 patients were examined, 714 of them had been included in data of analysis. Prostatic mpMRI found suspicious foci with PI-RADS 3-5 in 396/714 (55.5%) patients. Results: The detection of PCa with a Gleason score of >7, PI-RADS 4 and 5 accounted for 65.9% and 80.0%, respectively Diagnostic sensitivity of mpMRI with a PI-RADS >4 in the diagnosis of PCa in patients with suspicious foci (n=396) was 83.6%, specificity - 84.9%; in the whole of 714 patients it was 46.4% and 86.7%, with a Gleason score of >7 - 75.3% and 89.3%, respectively In 73/290 (25.2%) patients with PI-RADS 3-5, PCa was detected in a systematic rather than in targeted biopsy, 17/73 (23.3%) of them having Gleason score >7. In 70/318 (22.0%) patients with PI-RADS 1-2, PCa was detected in systematic biopsy, in 11/70 (15.7%) cases Gleason score being >7.

Conclusion: mpMRI diagnostic accuracy for csPCa in patients with negative primary biopsy making it possible to refrain from repeated biopsy in males with PI-RADS 1-3; if repeated biopsy is necessary, the systematic one may be recommended.

 

References

1.      World Health Organization. International Agency for Research on Cancer. Cancer today. Available at: https://gco.iarc.fr/today/explore (accessed 31 July 2018).

2.      Okeanov AE, Moiseev PI, Levin LF. Statistics of oncologic diseases in the Republic of Belarus (2007-2016). Minsk. 2017: 286 [In Russ].

3.      Mottet N, Bellmunt J, Bolla M. et al. EAU-ESTRO-SIOG Guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent. Eur. Urol. 2017; 71 (4): 618-629.

4.      Standardized indicators of oncoepidemiological situation 2016. Evraziyskiy onkologicheskiy zhurnal. 2018; 6(2). Avaiable at: http://cisoncology.org/files/stat_oncology_2016.pdf (accessed 31 July 2018) [In Russ].

5.      Parker C, Gillessen S, Heidenreich A, Horwich A. Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. of Oncol. 2015; 26 (suppl. 5): v69-v77.

6.      NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) with NCCN Evidence Blocks™. Prostate Cancer. 2018; Ver. 3. Available at: https://www.nccn.org/evidenceblocks/ (accessed 31 July 2018).

7.      Karman AV, Leusik EA. Comprehensive diagnostics for prostate cancer patients with negative primary biopsy. Early findings of a prospective study. Onkologicheskiy zhurnal. 2013; 7 (4): 65-71 [In Russ].

8.      Karman AV, Leusik EA. Diagnostic potential of PI-RADS for patients with negative results of initial multifocal biopsy. Onkologicheskii zhurnal. 2014; 8 (2): 20-27 [In Russ].

9.      Futterer JJ, Briganti A, de Visschere P. et al. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur. Urol. 2015; 68 (6): 1045-1053.

10.    Karman AV, Krasny SA, Leusik EA. et al. Our experience in employing the second version of PI-RADS scale in prostate cancer diagnosis in patients with negative initial multifocal biopsy. Onkologicheskiy zhurnal. 2015; 9 (2): 63-69 [In Russ].

11.    Kasel-Seibert M, Lehmann T, Aschenbach R. et al. Assessment of PI-RADS v2 for the Detection of Prostate Cancer. Eur. J. Radiol. 2016; 85 (4): 726-731.

12.    Moldovan PC, van den Broeck T, Sylvester R. et al. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel. Eur. Urol. 2017; 72 (2): 250-266.

13.    Karman AV, Krasnyy SA, Shimanets SV. Targeted histology sampling from atypical small acinar proliferation area detected by repeat transrectal prostate biopsy. Onkourologiya. 2017; 3 (1): 91-100 [In Russ].

14.    Boesen L, Noergaard N, Chabanova E. et al. Early experience with multiparametric magnetic resonance imaging-targeted biopsies under visual transrectal ultrasound guidance in patients suspicious for prostate cancer undergoing repeated biopsy. Scand. J. Urol. 2015; 49 (1): 25-34.

15.    Junker D, Schwfer G, HeideggerI. et al. Multiparametric magnetic resonance imaging/transrectal ultrasound fusion targeted biopsy of the prostate: preliminary results of a prospective single-centre study. Urol. Int. 2015; 94 (3): 313-318.

16.    Prostate Imaging Reporting and Data System (PI-RADS). Available at: http://www.acr.org/Quality- Safety/Resources/PIRADS/ (accessed 31 July 2018).

17.    Bjurlin MA, Meng X, Le Nobin J. et al. Optimization of prostate biopsy: the role of magnetic resonance imaging targeted biopsy in detection, localization and risk assessment. J. Urol. 2014; 192 (3): 648-658.

18.    Franiel T, Stephan C, Erbersdobler A. et al. Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding - multiparametric MR imaging for detection and biopsy planning. Radiology. 2011; 259 (1): 162-172.

19.    Karman AV, Leusik EA., Dudarev VS. Saturation transrectal biopsy in prostate cancer diagnosing in men with negative primary multifocal biopsy. Onkologicheskij zhurnal. 2014; 8 (31): 31-40 [In Russ].

20.    Simmons LAM., Kanthabalan A, Arya M. et al. The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy. Br. J. Cancer. 2017; 116 (9): 1159-1165.

21.    Brown LC, Ahmed HU, Faria R. et al. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study. Health Technol. Assess. 2018; 22 (39): 1-176.

 

Abstract:

Aim: was to study motor-evacuation and reservoir functions after gastrectomy followed by jejuno- gastroplasty by x-ray method in late-postoperative period.

Material and methods: for the period from 2011 to 2017 inA.VVishnevskyNationalResearchScientificSurgicalCenter, stomach was totally replaced with a segment of the intestine in 154 patients, after gastrectomy - 144, after extirpation of the stomach stump - 8, after resection of the esophagus - in 2 cases. Indications for surgery were gastric cancer in 142 (92.2%) patients, stump cancer and cancer recurrence in esophagojejunoanastomosis - in 8(5,2%), diseases of the operated stomach - in 4(2,6%). There were 94(61,1%) men and 60(38,9%) women. The follow-up period ranged from 6 months up to 5 years, the average value was 17±2.5 months. In different terms of the long-term period, the evaluation of the evacuation (motor) and reservoir (depositing) function of the intestinal graft was carried out by means of a standard x-ray contrast study with per oral barium suspension on an empty stomach. After that, the patient took the whole portion of barium suspension (200 ml) and was examined after 20 minutes, 45, and 2 hours.

Results: evaluation of reservoir capability of the reconstructed upper digestive tract was made according to rate of complete emptying of the jejunal segment and the duodenum.The speed of emptying remained within normal limits at 133(86,3%), did not exceed 20 min. and was considered to be fast - in 21(13,7%) patients. None of patients had a slow evacuation. To assess the motor function of the small intestine in new conditions of digestion, the time of passage of barium suspension through its loops was studied in 56(36,3%) patients in the long-term period, and 13(23,6%) patients revealed accelerated evacuation, and 43(76,4%) evacuation time approached the physiological norm.

Conclusion: X-ray examination carried out in the remote period after gastrectomy, shows that the EGP (esophagogastro plastic) restores the normal anatomical and physiological pathway of fooc promotion in the gastrointestinal tract, and the interpolated segment of the jejunum in combination with the duodenum compensates for the reservoir function of the stomach, creating conditions for portion evacuation of food to the underlying intestine. Thus, motor-evacuation function of the gastrointestinal tract in patients with EGP in the long term is approaching the physiological norm.

 

 

References

1.     Zakharov EI. On the issue of gastrectomy using a new method. Protocols of the Pirogov Surgical Society in Leningrad on December 18, 1938. Vestnik khirurgii im. I.I. Grekova. 1939; 58(1): 75 [In Russ].

2.     Henley FA., Hudson RV. Gastrectomy with replacement. A preliminary communication with an introduction. British Journal of Surgery. 1952; 40(160): 118-128.

3.     Mateshuk RV. Symposium materials on gastroplasty in gastrectomy and resection of the stomach. Simferopol. 1962; 21-28 [In Russ].

4.     Kurtseitov NE. The role of reduodenization with the formation of areflux anastomoses in the treatment of certain forms of diseases of the operated stomach. Dis. . dokt. med. scie. Tomsk, 2013; 330 p [In Russ].

5.     Yan Tsin. Jejunogastroplasty as a method of reconstruction of the digestive tract after gastrectomy. Dis. ... kand. med. Scie. Moscow, 2015; 154 p [In Russ].

6.     Busalov AA., Komorovskiy Yu.T. Pathological syndromes after gastrectomy. - M.: Meditsina, 1966; 240 p [In Russ].

7.     Zherlov GK., Koshel' АР Primary and reconstructive jejunogastroplasty in surgery of diseases of the stomach. Tomsk: Izd-vo Tomskogo un-ta, 1999; 212 p [In Russ].

8.     Gaiton AK., Kholl Dzh. E. Medical physiology. Trans. engl.; Ed. by V.I. Kobrina. - M.: Logosfera, 2008; 1296 p [In Russ].

9.     Ganichkin AM., Reznik SD. Methods for restoring gastrointestinal continuity during gastrectomy. - Leningrad: Meditsina. 1973; 178 p [In Russ].

10.   Frolkis AV. Functional diagnosis of bowel disease. - M.: Meditsina, 1973; 265 p [In Russ].

11.   Zherlov GK. Basics of functional surgical gastroenterology: pract. guide for doctors. - Tomsk: Izd-vo Tom. un-ta, 2009; 274 p [In Russ].

12.   Yang YS. Chen LQ., Yan XX., Liu YL. Preservation versus Non-preservation of the Duodenal Passage Following Total Gastrectomy: A Systematic Review. Journal of Gastrointestinal Surgery. 2013; 17(5): 877-886. DOI: 10.1007/s11605-013-2174-9.

 

 

Abstract:

Article presents a case report of successful antegrade x-ray surgical access to the biliary tree ir order to eliminate partial clipping of the common bile duct as a complication of endoscopic cholecystectomy

Percutaneous transhepatic puncture of the unexpanded biliary tree was made under ultrasounc control without auxiliary contrast enhancement of the bile tree. After punction - antegrade cholangiography revealed partial clipping of common bile duct. Patient underwent balloon dilatation, internal-external transpapillaty drainage. Three-times balloon dilatation after each 2 months made it possible to avoid the formation of posttraumatic stricture and the long-frame external-internal drainage of the biliary tree.

The use of antegrade percutaneous transhepatic access to restore adequate passage of bile to the duodenum, including cases without dissection of the papilla, is advisable in clinical situations that do not allow the use of retrograde endoscopic access, or if it is ineffective. 

 

References

1.      Kuznecov N.A., Sokolov A.A., Brontvein A.T., Artemkin EH.N. Diagnostics and treatment of early biliary complications after a cholecystectomy. Khirurgiya. 2011; 3: 3-7 [In Russ].

2.      Eisenstein S, Greenstein AJ, Kim U, Divino CM. Cystic duct stump leaks: after the learning curve. Arch Surg. 2008; 143( 12): 1178-83. doi: 10.1001/archsurg. 143.12.1178.

3.      Shaikh IA, Thomas H, Joga K (et al.). Post-cholecystectomy cystic duct stump leak: a preventable morbidity. J Dig Dis. 2009 Aug; 10(3):207-12. doi: 10.1111/j. 1751 - 2980.2009.00387.x.

4.      Barband AR, Kakaei F, Daryani A, FakhreeMB. Relaparoscopy in minor bile leakage after laparoscopic cholecystectomy: an alternative approach? Surg Laparosc Endosc Percutan Tech. 2011 Aug; 21 (4):288-91. doi: 10.1097/SLE.0b013e31822a2373.

5.      Shawhan RR, Porta CR, Bingham JR (et al.). Biliary leak rates after cholecystectomy and intraoperative cholangiogram in surgical residency. Mil Med. 2015 May; 180(5):565-9. doi: 10.7205/MILMED-D-14-00426.

6.      Lo Nigro C, Geraci G, Sciuto A, (et al.).Bile leaks after videolaparoscopic cholecystectomy: duct of Luschka. Endoscopic treatment in a single centre and brief literature review on current management. Ann Ital Chir. 2012 Jul-Aug; 83(4):303-12.

7.      Doumenc B, Boutros M, Dйgremont R, Bouras AF. Biliary leakage from gallbladder bed after cholecystectomy: Luschka duct or hepaticocholecystic duct? Morpholo- gie. 2016 Mar; 100(328):36-40. doi: 10.1016/j.morpho.2015.08.003.

8.      Pancyrev YU.M., SHapoval'yanc S.G., CHernyakevich S.A., et al. Functional disorders of a sphincter of Oddi after a cholecystectomy. RGGK. 2011; 3(21):28-34 [In Russ].

9.      Ohotnikov O.I., YAkovleva M.V., Grigor'ev S.N. X-ray surgery of «small» damages of bilious channels during cholecystectomy. Annaly hirurgicheskoj gepatologii.2017; 1(22):64-70 [In Russ].

10.    Sinha R, Chandra S. Cystic duct leaks after laparoendoscopic single-site cholecystectomy. J Laparoendosc Adv Surg Tech A. 2012 Jul-Aug; 22(6):533-7. doi: 10.1089/lap.2012.0094.

11.    Kim KH, Kim TN. Endoscopic management of bile leakage after cholecystectomy: a single-center experience for 12 years. Clin Endosc. 2014 May; 47(3):248-53. doi: 10.5946/ce.2014.47.3.248.

12.    Beburishvili A.G., Zubina E.N., Akinchits A.N., Vedenin YI. External biliary leakage after different types of cholecystectomy: diagnostics and treatment. Annaly khirurgicheskoy gepatologii. 2009; 14 (3): 18-21 [In Russ].

13.    Gwon D, Ko GY Sung KB, Kim JH, Yoon HK. Percutaneous transhepatic treatment of postoperative bile leaks: prospective evaluation of retrievable covered stent. J Vasc Interv Radiol. 2011 Jan;22(1 ):75-83. doi: 10.1016/ j.jvir. 2010.10.004.

14.    de Jong EA, Moelker A, Leertouwer T, Spronk S, Van Dijk M, van Eijck CH. Percutaneous transhepatic biliary drainage in patients with postsurgical bile leakage and nondilated intrahepatic bile ducts. Dig Surg. 2013;30(4- 6):444-50. doi: 10.1159/000356711.

15.    Ohotnikov O.I. YAkovleva M.V. Grigor'ev S.N. Transhepatic cholangiostomy in nondilated intrahepatic bile ducts. Annaly hirurgicheskoj gepatologii. 2015; 1(20): 84-90 [In Russ]. 

 

Abstract:

Background: leiomyosarcoma of veins is a rare group of sarcomas of mesenchymal origin, which develops from smooth muscle cells of vascular . Vascular leiomyosarcoma occurs in 2-5% and have a slow growth. It is rather difficult to diagnose this disease on the basis of only clinical symptoms, most often patients are worried about oedema and pain in lower limbs. To establish the diagnosis, it is necessary to use data of instrumental methods of examination, such as ultrasound, magnetic resonance imaging (MRI) and multispiral computed tomography (MSCT) with intravenous contrast enhancement, which allow to determine the tumor localization, prevalence, involvement of the vessel wall in the process, as well as to exclude distant metastases. The final diagnosis is made according to immunohistochemical studies.

Aim: was to study the importance of radiadiagnostics methods in case of such rare disease as leiomyosarcoma of the external iliac vein.

Material and methods: 67-year-old woman with complaints of oedema of the lower limb, was examined: an ultrasound study of inferior vena cava and veins of lower limbs, magnetic resonance imaging (MRI) and multispiral computed tomography (MSCT) with contrast enhancement, fine-needle aspiration biopsy Patient underwent operation: «removal of the pelvic retroperitoneal tumor with resection of the external iliac vein' segment and pelvic lymph node dissection.» Histological examination: leiomyosarcoma, G2 FNCLCC.

Results: control MSCT - data on the recurrence of the iliac vein tumor and metastatic lesion of organs of chest, abdominal and pelvic cavity were not obtained.

Conclusions: a complex of diagnostic methods allows you to properly diagnose. And among these methods, multiphase computed tomography is one of the best imaging method, which shows not only the localization of the tumor, but also helps in staging, excluding or confirming vein thrombosis, solving the issue of resectability of the tumor and identifying distant metastasis. 

 

References

1.      Le Minh T, Cazaban D, Michaud J. et al. Great saphenous vein leiomyosarcoma: a rare malignant tumor of the extremity-two case reports. Ann Vasc Surg. 2004; 18(2): 234-236.

2.      Yucel Yankol, Nesimi Mecit, Turan Kanmaz et al. Leiomyosarcoma of the retrohepatic vena cava: Report of a case treated with resection and reconstruction with polytetrafluoroethylene vascular graft. Ulus Cerrahi Derg 2015; 31: 162-165.

3.      Tripodi E, Zanfagnin V, Fava C. et al. Leiomyosarcoma of the Right Iliac Veins presenting as a pelvic mass: a case report. Obstet. Gynecol. cases Rev. 2015; 2 (3): 1-4.

4.      Mei Zhang, MDa, Feng Yan et al. Multimodal ultrasonographic assessment of leiomyosarcoma of the femoral vein in a patient misdiagnosed as having deep vein thrombosis: a case report. Medicine. 2017: 96(46): 1-5.

5.      Pavlov A.YU., Garmash S.V., Isaev T.K. i dr. Sovremennye predstavleniya o lejomiosarkomah ven zabryushinnogo prostranstva. Obzor klinicheskih sluchaev. [Modern ideas about leiomyosarcoma veins retroperitoneal space. Review of clinical cases.] Onkourologiya. 2016; 12(2): 92-96 [in Russ].

6.      Watanabe K, Tajino T, Sekiguchi M. et al. h-Caldesmon as a Specific Marker for Smooth Muscle Tumors. Am. J. Clin. Pathol. 2000; 113 (5): 663-668.

7.      Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Soft Tissue Tumors. 6th ed. Philadelphia. 2014; 549-568.

8.      Gonzales-Cantu Ye.M., Tena-Suck M.L., Serna-Reyna S. et al. Leiomyosarcoma of vascular origin: case report. Case Rep. in Clinical Pathology. 2015; 2(4): 60-64

9.      Мацко Д.Е. Современные представления о морфологической классификации сарком мягких тканей и их практическое значение. Практическая онкология. 2013; 14 (2): 77-86.

10.    Чуканов Е., Никитина О., Марио Таха. Лейомиосаркома нижней полой вены. Променева дагностика, променева терапiя. 2014; 4: 69-72.

11.    Ahluwaliya A., Saggar K., Sandhu P. et al. Primary leiomyosarcoma of inferior vena cava: an unusual entity.. Indian Journal of Radiology and Imaging. 2002; 12(4): 515-516.

12.    Dzsinich C., Gloviczki P., Van Heerden J. A. et al. Primary venous leiomyosarcoma: a rare but lethal disease. Journal of Vascular Surger. 1992; 15(4): 595-603.

13.    Kaprin A.D., Galkin V.N., Zhavoronkov L.P., Ivanov V.K., Ivanov S.A., Romanko Yu.S. Synthesis of basic and applied research is the basis of obtaining high-quality findings and translating them into clinical practice. Radiation and risk. 2017; 26(2): 26-40.

 

Abstract:

A clinical case of right atrial diverticulum in a 34-year-old patient is presented, which was suspected during echocardiography and confirmed during magnetic resonance imaging of the heart. Main main features of the anomaly and clinical and radiation features of the atrial diverticulum are presented in discussion. 

 

References

1.      Podzolkov VP, Cheban V N, Kokshenev IV, Katsadze NG, Serov RA. Congenital giant aneurysm of the right atrium. Thoracic and cardiovasc. surg. 2012; 4: 44-47 [In Russ].

2.      Soroka NV, Shelestova IA, Kosmacheva ED, Porkhanov VA. Case report of a giant aneurysm of the right atrium in a patient of seventy-eight years. Pathology of blood circulation and cardiac surgery. 2014; 18(2): 66-68 [In Russ].

3.      Binder TM, Rosenhek R, Frank H.et al. Congenital malformations of the right atrium and the coronary sinus: an analysis based on 103 cases reported in the literature and two additional cases. Chest. 2000; 117(6): 1740-1748.

4.      Hofmann S.R., Heilmann A., Hдusler H. J., Dahnert I. et all Congenital idiopathic dilatation of the right atrium: antenatal appearance, postnatal management, long-term follow-up and possible pathomechanism. Fetal Diagn. Ther. 2012; 32: 256-261.

5.      Sanchez-Brotons J.A., Lуpez-Pardo F. J., Lуpez-Haldуn J. E., Rodmguez-Puras M. J. Giant Right Atrial Diverticulum: Utility of Contrast-enhanced Ultrasound. Rev. Esp. Cardiol. 2013; 6(03): 222-223.

 

 

 

Abstract:

Aim: was to perform a retrospective comparative analysis of clinical and angiographic results of primary endovascular treatment of ischemic stroke in patients who had contraindications for adjuvant thrombolytic therapy, and results of applying standard pharmaco-invasive (thrombolysis and thrombus extraction) treatment.

Material and methods: angiography was performed in 61 patients. The main criterion for the selection of patients for cerebral angiography according to MSCT-angiography, was a confirmed occlusion of a large intracranial vessel (the internal carotid artery or the middle cerebral artery at M1-2 segment). After MSCT-angiography, in the absence of contraindications, (STT) systemic throbolytic therapy (Alteplaza in the standard dose) was started and patients were sent to an endovascular operation, where selective angiography of the syndrome-responsive artery was performed, followed by an endovascular procedure, according to standard procedure. For endovascular treatment, Penumbra Reperfusion catheters - ACE 68 , were used in combination with 3MAX catheters, or stent-retrievers (Trevo, PRESET, ERIC). In a number of cases, the use of retrievers was supplemented with an assisting thrombus aspiration («Solumbra» method). The criterion for the effectiveness of endovascular treatment was the achievement of blood flow in the syndrome-responsible artery TICI 2b - 3. 6 patients with lesion of distal segments of middle cerebral artery (M3-4) or with no occlusion of large intracranial occlusion were excluded from the study.

Results: all 55 patients who received endovascular treatment, retrospectively were divided into two groups depending on the performance of adjuvant STT Group of combined treatment (STT and endovascular procedure (EVP)) included 24 patients; 31 patients were included in the primary EVP group.

Conclusions: basing on results of the study it can be supposed that primary endovascular treatment of ischemic stroke without thrombolysis can provide comparable efficacy and safety of treatment.

 

References

1.      Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke. 2010; 41:2254-2258.

2.      Coutinho JM, Liebeskind DS, Slater LA, Nogueira RG, Clark W, Dбvalos A. Combined intravenous thrombolysis and thrombectomy vs thrombectomy alone for acute ischemicstroke: a pooled analysis of the SWIFT and STAR studies. JAMA Neurol. 2017;74:268-274.

3.      Broeg-Morvay A, Mordasini P, Bernasconi C, Bьhlmann M, Pult F, Arnold M. Direct mechanical intervention versus combined intravenous and mechanical intervention in large artery anterior circulation stroke: a matched-pairs analysis. Stroke. 2016; 47:1037-1044.

4.      Bellwald S, Weber R, Dobrocky T, Nordmeyer H, et al Direct Mechanical Intervention Versus Bridging Therapy in Stroke Patients Eligible for Intravenous Thrombolysis: A Pooled Analysis of 2 Registries. Stroke. 2017 Nov 7.

5.      Merlino, G., Sponza, M., Petralia, B. et al. Short and long-term outcomes after combined intravenous thrombolysis and mechanical thrombectomy versus direct mechanical thrombectomy: a prospective single-center study. J Thromb Thrombolysis. 2017; 44: 203.

6.      Guedin P, Larcher A, Decroix JP, Labreuche J, Dreyfus JF, Evrard S. Prior IV thrombolysis facilitates mechanical thrombectomy in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2015; 24:952-957.

7.      Behme D, Kabbasch C, Kowoll A, Dorn F, Liebig T, Weber W, Mpotsaris A. Intravenous thrombolysis facilitates successful recanalization with stent-retriever mechanical thrombectomy in middle cerebral artery occlusions. J Stroke Cerebrovasc Dis. 2016; 25:954-959.

8.      Desilles JP, Loyau S, Syvannarath V, Gonzalez-Valcarcel J, Cantier M, Louedec L. Alteplase reduces downstream microvascular thrombosis and improves the benefit of large artery recanalization in stroke. Stroke. 2015; 46:3241-3248.

9.      Kass-Hout T, Kass-Hout O, Mokin M, Thesier DM, Yashar P, Orion D. Is bridging with intravenous thrombolysis of any benefit in endovascular therapy for acute ischemic stroke? WorldNeurosurg. 2014; 82:e453-458.

 

Abstract:

Aim: was to show results of visceral revascularization in patients with chronic abdomina ischemia.

Materials and methods: 24 patients with chronic abdominal ischemia underwent endovascular revascularization.

Results: technical success was 100%. After endovascular revascularization, 19 (90%) of symptomatic patients noted improvement in the state of health in the form of a significant decrease of dyspepsia and abdominal pain. In the long-term period, 15 patients were examined (within 1 year). All examined patients underwent ultrasound of the abdominal cavity and CTA of the aorta. All patients had no symptoms of abdominal ischemia and signs of restenosis.

Conclusions: endovascular methods should be considered as the first line in the treatment of atherosclerotic lesions of superior mesenteric artery (SMA) and celiac trunk, which are accompanied by fewer periprocedural complications and mortality, better rates of rehabilitation and shorter hospital stay. 

 

References

1.      Pokrovskij A.V., Kazanchan P.O., Dujikov A.A. Diagnosis and treatment of chronic abdominal ischemia. Rostov-on-Don: Rostov State University Publ., 1982; 321 [In Russ].

2.      Furrer J, Grhntzig A, Kugelmeier J, Goebel N. Treatment of abdominal angina with percutaneous dilatation of an arteria mesenterica superior stenosis. Cardiovasc Intervent Radiol. 1980; 3: 434.

3.      Gavrilenko A.V., Kosenkov A.N. Diagnosis and surgical treatment of chronic arterial ischemia. M.: Graal, 2000; 308 [in Russ].

4.      Aouini F, Bouhaffa A, Baazaoui J, Khelifi S, Ben Maamer A, Hoaus N, Cherif A. Acute mesenteric ischemia: study of predictive factors of mortality. Tunis Med., 2012; 90(7): 533-6.

5.      Rabkin I.H. Angiography guideline. M.: Meditsina, 1977; 279 [in Russ].

6.      Shaws RS, Maynard EP Acute and chronic thrombosis of mesenteric arteries associated with malabsorption: a report of two cases successfully treated by thromboendarterectomy. N Engl. J. Med. 1958; 258: 8748

7.      Pokrovskij A.V. Diseases of aorta and its branches. M.: Meditsina, 1979; 324 [in Russ].

8.      Kougias P, El Sayed HF, Zhou W, Lin PH. Management of chronic mesenteric ischemia. The role of endovascular therapy. J. Endovasc. Ther. 2007; 14 (3): 395-405.

9.      Beaulieu R.J., Arnaoutakis K.D., Abularrage C.J., Efron D.T., Schneider E., Black J.H. Comparison of open and endovascular treatment of acute mesenteric ischemia. J. Vasc. Surg. 2014; 59 (1): 159-64.

10.    Schermerhorn M.L., Giles K.A., Hamdan A.D., Wyers M.C., Pomposelli F.B. Mesenteric revascularization: management and outcomes in the United States, 19882006. J. Vasc. Surg. 2009; 50: 341-8.

11.    Moghadamyeghaneh Z., Carmichael J.C., Mills S.D., Dolich M.O., Pigazzi A., Fujitani R.M., et al. Early outcome of treatment of chronic mesenteric ischemia. Am. Surg. 2015;81:1149-56

12.    Grilli C.J., Fedele C.R., Tahir O.M., et al. Recanalization of chronic total occlusions of the superior mesenteric artery in patients with chronic mesenteric ischemia: technical and clinical outcomes. J. Vasc. Interv. Radiol. 2014; 25(10):1515-1524

13.    Sharafuddin M., Nicholson R., Kresowik T., Amin P.B., Hoballah J.J., Sharp W.J. Endovascular recanalization of total occlusions of the mesenteric and celiac arteries. J. Vasc. Surg. 2012; 55(6):1674-1681.

 

Abstract:

Aim: was to assess the accuracy of the diagnosis of malformations of the fetus at early stages of pregnancy

Materials and methods: 26,404 pregnant women who came to the Republican Center for Screening Mothers and Children on a routine basis in terms of 11 to 20 weeks of pregnancy were examined. Among them, 25,956(98,3%) women were pregnant with a physiological course of pregnancy, 269(1,0%) pregnant women with fetal malformations and 179(0,7%) with pathological pregnancy

Prenatal diagnostics included ultrasound, biochemical, invasive and cytogenetic research methods. Initially, a primary ultrasound study of pregnant women was conducted, with the purpose of measuring fetometric, biometric and dopplerometric parameters. In case of deviation of above mentioned parameters from the norm, a second stage-biochemical screening was carried out. When biochemical parameters changed from normative values, the third stage was carried out - invasive and cytogenetic diagnostics.

Results: based on results of studies, all women were divided into 3 groups. The first group included women with a physiological course of pregnancy - 25,956(98,3%). In the second group of patients (n=269) with single fetal malformations, there were 230(85,5%), with multiple - 39 (14,5%). In the third group of women (n=179), in most cases, a non-developing pregnancy was registered - 99(55,31%), females with uterine fetal death were 69(38,5%), with bladder drift - 11 (6,2%).

Conclusions: every pregnant woman should be examined individually, regardless of age. When carrying out prenatal diagnosis of malformations of the fetus, doctors should use a single algorithm for performing an ultrasound examination. Practitioners should not rely on the age of the pregnant woman; regardless of the age of the pregnant woman, to conduct a more detailed examination for fetal malformations, both 35 years of age and older and younger than 35 years. In order to avoid undeveloped pregnancy, and intrauterine fetal death, as well as early detection of fetal malformations, there is a need for screening in the first trimester of pregnancy Inclusion of the first trimester in the screening program in a timely manner will create risk groups for the birth of children with malformations of the fetus, timely resolve the issue of further introduction of pregnancy, thereby reducing obstetric complications, and also reduce maternal and infant mortality.

 

References

1.      Аilamazyan EK, Baranov VS. Prenatal diagnosis of hereditary and congenital diseases. М .: MEDpress-inform. 2006; 74-82 [In Russ].

2.      Prenatal diagnosis of congenital malformations of the fetus. Ed. R. Romero et al. M .: Medicine. 1994; 448 р. [In Russ].

3.      Snyders R.J.M., Nicolaides K.K.H. Ultrasound markers of chromosomal defects of the fetus. M .: Vidar. 1997; 13-21 [In Russ].

4.      Medvedev MV, Yudina EV. Retardation of intrauterine development of the fetus. Moscow: RAVUZDPG. 1998; 204 р. [In Russ].

5.      Teratology of human. Ed. G.I. Lazyuk. M .: Medicine. 1991; 315 р. [In Russ].

6.      Ginter EK. Medical genetics. Textbook. M .: Medicine. 2003; 445 р. [In Russ].

7.      Baranov VS, Kuznetsova TV. Cytogenetics of human embryonic development. S-Pb: N-L. 2007; 640 р. [In Russ].

8.      Prenatal diagnosis of congenital malformations in early pregnancy. Ed. M.V. Medvedev M .: RAVUZDPG. Real time. 2000; 160 р. [In Russ].

9.      Medvedev MV, Altynnik NA. About ultrasound evaluation of fetal anatomy in early pregnancy. Prenat. Diagn. 2002; 1(2): 158-159 [In Russ].

10.    Medvedev MV. Fundamentals of ultrasound in obstetrics. Moscow: Real Time. 2006; 94 р. [In Russ].

11.    Medvedev MV. Ultrasonic fetometry: reference tables and nomograms. Moscow: Real Tim^ 2002; 80 р. [In Russ].

12.    Esetov MA. Ultrasound diagnosis of congenital malformations of the fetus in early pregnancy. Avtoref....doct. med. scie. Moscow, 2007; 26 р. [In Russ].

13.    Medvedev MV. What influences early prenatal diagnosis of skeletal dysplasia? Prenat. Diagn. 2003; 2(3): 237-240 [In Russ].

14.    Nicolaides KH, Sebire NJ, Snijders RJM. The 1113+6 weeks scan. London: Fetal Medicine Foundation. 2004; 192 р.

15.    Kamalidinova Sh M. Development of regional standards for ultrasonic fetometry in the 16-40 weeks of pregnancy in the Republic of Uzbekistan. Doctor-Postgraduate student. 2009; 9(36): 728-734 [In Russ].

16.    Carvalho MHB, Brizot ML., Lopes LM, Chiba CH, Miyadahira S, Zugaib M. Detection of fetal structural abnormalities at the 11-14 week ultrasound scan. Prenat. Diagn. 2002; 22(1): 1-4.

17.    Den Hollander NS, Wessels MW, Niermeijer MF, Los FJ, Wladimiroff JW Early fetal anomaly scanning in a population at. increased risk of abnormalities. Ultrasound Obstet. Gynecol. 2002; 19(4): 570-574.

 

Abstract:

Aim: was to optimize technics of ultrasound-guided vacuum-aspiration breast biopsy at 3 and 4A categories of BI-RADS scale and subsequent maintenance of patients.

Materials and methods: vacuum-aspiration breast biopsy was performed on 100 female patients aged 23-66 years. Long acting anesthetics were used for anesthesia. After the biopsy no residual tissue was detected.

Results: in 15% of cases (n=15), complications requiring different treatment tactics were revealed. According to histological studies 97% of tumors were benign. 3 patients were diagnosed with breast cancer classified into BI-RADS category 3. For 24% (n=24) of women, long-term results were obtained in 6 months with no signs of relapse.

Conclusions: ultrasound-guided vacuum-aspiration breast biopsy is an effective technics, that doesn't require complex preparation and doesn't take a long time to conduct. With sufficient training of the operator, it is possible to effectively control the completeness of the removal of mass. Using of long acting anesthetics allows ensuring good acceptability of the procedure and providing comfort to patients.

 

 

References

1.     Papathamelis T, Heim S, Lux MP. et al. Minimally Invasive Breast Fibroadenoma Excision Using an Ultrasound-Guided Vacuum-Assisted Biopsy Device. Geburtshilfe und Frauenheilkunde 2017; (2):176-181.

2.     Lakoma A, Kim ES, Minimally invasive surgical management of benign breast lesions. Gland surgery. 2014; (2):142-8.

3.     ACR BI-RADS Atlas® 5th Edition. www.acr.org

4.     Bennett I. C. The Changing Role of Vacuum-assisted Biopsy of the Breast: A New Prototype of Minimally Invasive Breast Surgery. Clinical breast cancer. 2017; (5): 323-325

5.     Seo J, Kim SM, Jang M, et al. Ultrasound-guided cable-free 13-gauge vacuum-assisted biopsy of non-mass breast lesions. Public Library of Science one. 2017; 12 (6)

6.     Jung I, Min JK, Hee J M, et al. Ultrasonography-guided 14-gauge core biopsy of the breast: results of 7 years of experience. Ultrasonography. 2018; (1):55-62

7.     Hui-ping Huo., Wen-bo Wan., Zhi-li Wang., et al. Percutaneous Removal of Benign Breast Lesions with an Ultrasound-guided Vacuum-assisted System: Influence Factors in the Hematoma Formation. Chinese medical sciences journal. 2016; (1):31-36.

8.     Zhang YJ, Wei L, Li J., et al. Status quo and development trend of breast biopsy technology. Gland surgery. 2013; (1):15-24.

9.     Xiao-Fang He, Feng Y Jia-Huai Wen, et al. High Residual Tumor Rate for Early Breast Cancer Patients Receiving Vacuum-assisted Breast Biopsy. Journal of Cancer. 2017; 3: 490-496.

10.   Liu S, Zou JL, Zhou FL., et al. Efficacy of ultrasound-guided vacuum-assisted Mammotome excision for management of benign breast diseases: analysis of 1267 cases. Journal of Southern Medical University. 2017; (8):1121-1125.

11.   Brennan M.E., Turner R.M., Ciatto S., et al. Ductal Carcinoma in Situ at Core-Needle Biopsy: Meta-Analysis of Underestimation and Predictors of Invasive Breast Cancer. Radiology 2011; (1):119-128.

12.   Safioleas PM, Koulicheri D, Michalopoulos N, et al. The value of stereotactic vacuum assisted breast biopsy in the investigation of microcalcifications. A six-year experience with 853 patients. Journal of Balkan Union of Oncology. 2017; (2): 340-346.

 

Abstract:

Aim: was to establish methods of coronary artery bypass graft (CABG) with use of internal thoracic artery (ITA), that influenced high risk of continued diaphragmatic dysfunction in early post-operative period, on the base of analysis of dynamics of diaphragmatic dysfunction after operation.

Materials and methods: the retrospective study included 880 patients in the early period after CABG with use of ITA. The mobility of diaphragm domes was estimated on 2,8±0,88 day after the surgery, when transferred from the intensive care unit to the in-patient department and again on 7,7±1,9 day when transferred to the rehabilitation department. Patients were divided into 3 groups. The first group with normal diaphragm mobility with an initial study of 529(60,1%) patients. The second group with diaphragmatic dysfunction in the initial study and the restored mobility of the diaphragm in a re-examination of 249(28,3%) patients. The third group with diaphragmatic dysfunction, which persists in the re-examination of 102(11,6%) patients. The criterion for diaphragmatic dysfunction was the amplitude of the diaphragm's movement ess than 10 mm. Using the model of logistic regression, the influence of the CABG methods on the probability of maintaining diaphragmatic dysfunction at the end of the early postoperative period was determined. Two CABG methods were included in the model: «in situ» and autograft.

Results: in the primary study, 39,9% of patients had diaphragmatic dysfunction, 21,1% left-sided, 8,0% right-sided, and 10,8% bilateral. The prevalence of diaphragmatic dysfunction during the early postoperative period decreases threefold, from 39,9% to 11,5%, and was persisted more often as a unilateral lesion: left-sided in 7,2% of patients or right-sided in 3,4%, Less often, bilateral dysfunction persists in 0,9% of patients. Restoration of the function of the diaphragm during repeated examination was observed in 71,2% of cases of initial dysfunction. A different effect was established on the persistence of unilateral and bilateral diaphragmatic dysfunction by the end of the early postoperative period, depending on methods of CABG with use of ITA and their combination. High likelihood conservation diaphragmatic dysfunction by the right harvest of ITA was observed after bypass «in situ» (OR 4.4; CI 2,2-8,9) and by the harvest of ITA left after bypass graft (OR 4.1; CI 1,6-10,6). Other methods of grafting either did not have an effect on the preservation of dysfunction on the part of the ITA harvest, or the effect was traced, but was statistically insignificant.

Conclusion: dysfunction of the diaphragm acquired after CABG with use of ITA is reversible. During the early postoperative period, 71,2% of patients undergo full restoration of diaphragm mobility, the prevalence of diaphragmatic dysfunction decreases three-fold, the frequency of bilateral diaphragm dysfunction decreases by 10 times. Methods of CABG with use of ITA, «insitu» and autograft, affect the likelihood of the dysfunction of the diaphragm retained during the early postoperative period by surgical manipulation. Results of the study indicate that chances of maintaining diaphragmatic dysfunction were 4,4 times higher by grafting the right ITA «in .situ» and 4,1 times by grafting the left ITA with a graft. While the likelihood of maintaining diaphragmatic dysfunction was low by grafting the right ITA with a graft and was absent from the grafting of the left ITA «in situ».

 

References

1.      Paramonova T.I., Vdovkin A.V., Pal'kova V.A. Factors, influencing the development of diaphragmatic dysfunction in the early postoperative period after cardiac surgery. Diagnosticheskaya I interventsionnaya radiologia. 2016; 10(2):11-16.

2.      Canbaz S, Turgut N, Halici U, et al. Electrophysiological evaluation of phrenic nerve in-jury during cardiac surgery - a prospective, controlled, clinical study. BMC Surgery. 2004, 4:2

3.      Deng Y Byth K, Paterson HS. Phrenic nerve injury associated with high free right internal mammary artery harvesting. Ann Thorac Surg. 2003; 76(2):459-463

4.      Bazylev V.V., Paramonova T.I., Vdovkin A.V., i soavt. Ocenka faktorov, vliyayushchih na razvitie dispnoeh v rannem posleoperacionnom periode posle kardiohirurgicheskih vmeshatel'stv. [Factors affecting the development of dyspnea in the early postoperative period after cardiac surgery] Diagnosticheskaya i intervencionnaya radiologiya. 2016; 10(4):19-27.

5.      Bonacchi M, Prifti E, Giunti G, et al. Respiratory dysfunction after coronary artery bypass grafting employing bilateral internal mammary arteries: the influence of intact pleura. Eur J Cardiothorac Surg. 2001; 19:827-833.

6.      Matsumoto M., Konishi Y, Miwa S., et al. Effect of different methods of internal thoracic artery harvest on pulmonary function. Ann Thorac Surg. 1997; 63: 653-655.

7.      Uzun K, Kara H, Ugurlu D. The Effects Of Internal Mammary Artery Harvesting Techniques On Pulmonary Functions. Ko§uyolu Kalp Dergisi. 2011; 14(3):76-78.

8.      Diehl JL, Lofaso F, Deleuze P, et al. Clinically relevant diaphragmatic dysfunction after cardiac operations. J Thorac Cardiovasc Surg. 1994; 107:487-498

9.      Bazylev V.V., Paramonova T.I., Vdovkin A.V. Analiz polozheniya i podvizhnosti diafragmy u vzroslyh s normal'noj funkciej legkih do i posle kardiohirurgicheskih operacij. [Analysis of position and mobility of the diaphragm in adults with normal lung function before and after cardiac surgery.] Luchevaya diagnostika i terapiya. 2017;(1):53-63.

10.    Davison A., Mulvey D. Idiopathic diaphragmatic weakness. BMJ 1992; 304:492-494

11.    McCool F.D., McCool G.E. Dysfunction of the Diaphragm. N Engl J Med. 2012; 366:932-942

12.    Kim WY Suh HJ, Hong SB, et al. Diaphragm dysfunction assessed by ultrasonography: Influence on weaning from mechanical ventilation. Critical Care Medicine. 2011; 12:2627-2630.

13.    Bazylev V.V., Nemchenko E.V., Karnahin V.A., i soavt. Floumetricheskaya ocenka koronarnyh shuntov v usloviyah iskusstvennogo krovoobrashcheniya i na rabotayushchem serdce. [Flowmetric estimation of coronary grafts in conditions of extracorporeal circulation and on a working heart.] Angiologiya i sosudistaya hirurgiya. 2016; 22(1):67-72.

14.    Rankin JS, Tuttle RH, Wechsler AS. et al. Techniques and benefit of multiple internal mammary artery bypass at 20 year of follow up. Ann Thorac Surg. 2007; 83:1008-1015.

15.    Buxton BF, Tatoulis J, Fuller JA. The right internal thoracic artery: the forgotten conduit - 5,766 patients and 991 angiograms. The Annals of Cardiothoracic Surgery. 2011; 92: 9-17.

16.    Lytle BW, Blackstone EH, Sabik JF. et al. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg 2004;78(6):2005-2014.

17.    Tripp HF., Sees DW, Lisagor P.G, et al. Is phrenic nerve dysfunction after cardiac surgery related to internal mammary harvesting? J Card Surg. 2001, 16(3):228-231

18.    Calafiore AM, Di Giammarco G., Teodori G, et al. Bilateral internal thoracic artery grafting with and without cardiopulmonary bypass: six-year clinical outcome. J Thorac Cardiovasc Surg. 2005; 130(2):340—345.

19.    Cygel'nikov S.A. Vnutrennyaya grudnaya arteriya v hirurgicheskom lechenii ishemicheskoj bolezni serdca: varianty i taktika ispol'zovaniya, rezul'taty. [Internal thoracic artery in the surgical treatment of ischemic heart disease: options and tactics of use, results.] Avtoreferat Dis. dok. med. nauk. M., 2010; 49.

20.    Buxton BF, Ruengskulrach P, Fuller J, et al. The right internal thoracic artery graft - benefits of grafting the left coronary system and native vessels with a high-grade stenosis. The European Journal of Cardio-Thoracic Surgery. 2000; 18:255-261.

21.    Bazylev V.V., Nemchenko E.V., Pavlov A.A., i soavt. Sravnitel'nye rezul'taty revaskulyarizacii bassejna pravoj koronarnoj arterii s ispol'zovaniem bimammarnogo Y- grafta i autoveny. [Comparative results of revascularization of right coronary artery basin using bimammary Y-graft and autovein.] Grudnaya i serdechno-sosudistaya hirurgiya. 2014; 5:11-18.

22.    Vecherskij YU.YU., Andreev S.L., Zatolokin V.V. Taktika ispol'zovaniya pravoj vnutrennej grudnoj arterii «in situ» pri koronarnom shuntirovanii. [Tactics of using the right internal thoracic artery «in situ» in CABG surgery.] Angiologiya isosudistaya hirurgiya. 2015; 1(21):148-154.

23.    O'Brien JW, Johnson SH, VanSteyn SJ, et al. Effects of internal mammary artery dissection on phrenic nerve perfusion and function. Ann Thorac Surg. 1991; 52: 182-188.

24.    Sharma AD, Parmley CL, Sreeram G, et al. Peripheral nerve injuries during cardiac surgery: risk factors, diagnosis, prognosis, and prevention. Anesth Analg. 2000; 91(6):1358

25.    Wilcox PG, Pardy RL. Diaphragmatic weakness and paralysis. Lung. 1989; 167:323-341

26.    Buxton BF, Hayward PA. The art of arterial revascularization - total arterial revascularization in patients with triple vessel coronary artery disease. The Annals of Cardiothoracic Surgery. 2013; 2: 543-551.

27.    Paterson HS, Naidoo R., Byth K, et al. Full myocardial revascularization with bilateral internal mammary artery Y grafts. The Annals of Cardiothoracic Surgery. 2013; 2: 444-452.

28.    Akchurin R. S., Shiryaev A. A., Brand YA. B., i soavt. Hirurgiya koronarnyh arterij - krajnosti i algoritmy revaskulyarizacii. [Surgery of coronary arteries - extremes and algorithms of revascularization.] Grudnaya i serdechno-sosudistaya hirurgiya. 2001; 2:13-17

 

Abstract:

It is known that the first transvenous probing of the right atrium of own heart in 1929 was conducted by the German physician W. Forsmann. In 1966, with the help of this technique, the American radiologist WJ. Rashkind first conducted atrioseptostomy of congenital heart disease.

Aim: was to search for priorities of Russian physicians in this field of interventional radiology

Materials and methods: articles of W Forsmann (1929), WJ. Rashkind (1966), two Soviet physicians: the therapist A.I. Yarotsky and surgeon I.P Dmitriev, published respectively in 1925 and 1926, and a number of other sources were studied. Their content-analysis was carried out using methods adopted in historical medical research.

Results: It was determined that in 1925 Soviet therapist A.I. Yarotsky from the Moscow Clinical Institute (now MONIKI) proposed to penetrate in the right atrium through the jugular vein for intracardiac procedures, in particular, to create a hole in the interatrial septum with the help of some instrument. In 1926 this idea in the experiment on animals and on the human corpse was realized by his scholar I.P Dmitriev from the Institute of Operative Surgery of the 1st MSU (now - Sechenov University). At the same time, both authors noted that in the absence of visual methods of monitoring the position of the instrument in right chambers of the heart transthoracic approach is preferable to the endovascular one. In 1929 independently of Soviet physicians W Forsmann from Eberswalde (Germany) developed a technique for probing the right heart, which conceptually repeated the method of Yarotsky-Dmitriev In the practice of children cardiac surgery, the technique was introduced in 1966 by WJ. Rashkind from the Children's Hospital in Philadelphia (USA).

Conclusion: thus A.I. Yarotsky who in 1925 formulated the idea of transvenous approach to the right atrium and I.P Dmitriev who in 1926 realized this idea in an experiment are the pioneers of the concept of catheter atrioseptostomy The lack of methods at their disposal for visual control of procedures inside the heart did not allow authors to introduce the technique into the clinic. 

 

Reference

1.      Forssmann W. Die Sondierung des rechten Herzen. Klin. Munch. Med. Wochenschr. 1929; 8: 2085-9.

2.      Bokeriya L.A., Rabotnikov V.S., Glyantsev S.P., Alshibaya M.D. Ocherki istorii koronarnoj hirurgii. [Essays on the history of coronary surgery.] M.: NCSSKH im. A.N. Bakuleva RAMN, 2002: 201 - 4 [In Russ].

3.      YArotskij A.I. K voprosu ob operacii vnutri serdca pri suzhenii levogo venoznogo otverstiya. [On the question of surgery inside the heart during the narrowing of the left venous opening.] Vrachebnaya gazeta. 1925; XXIX(21): 498 [In Russ].

4.      Litvinov A.V. A.I. YArotskij (1866 - 1944) i ego rol' v stanovlenii i razvitii otechestvennoj terapevticheskoj shkoly. [A.I. YArotskij (1866 - 1944) and his role in the formation and development of the national therapeutic school.] 2001. EHlektronnyj resurs: http://sgma.alpha-design.ru/ MMORPH/N-7-html/LITVINOV/litvinov.html [In Russ].

5.      Dmitriev I.P. Eksperimental'nye nablyudeniya po voprosu ob operativnyh podstupah k klapanam serdca i peregorodke predserdij. Novyj hirurgicheskij arhiv. 1926; XI (1-2): 3-11 [In Russ].

6.     Bokeriya L.A., Podzolkov V.P., Kokshenev I.V., Glyantsev S.P. Istoriya ucheniya o vrozhdennyh porokah serdca. [History of the doctrine of congenital heart defects.] M.: NCSSKH im. A.N. Bakuleva RAMN, 2011: 278-9 [In Russ].

7.      Rushkind W. J., Miller W. W. Creation of an atrial septal defect without thoracotomy: a palliative approach to complete transposition of the great arteries. JAMA. 1966; 196: 991-2.

8.      Bokeriya L.A., Alekyan B.G., Glyantsev S.P., Pursanov M.G. Rentgenoehndovaskulyarnaya hirurgiya serdca i sosudov: ot istokov do segodnyashnego dnya. CHast' 2. [X-ray endovascular surgery of the heart and blood vessels: from the beginnings to the present day. Part 2. Heart surgery (on the 50th anniversary of the first endovascular cardiac surgery. 1953-2003).] Hirurgiya serdca (k 50-letiyu pervoj ehndovaskulyarnoj operacii na serdce. 1953-2003 gg.). Grudnaya i serdechno-sosudistaya hirurgiya. 2005; 2: 33-42 [In Russ].

9.      Timofeeva N.I., Lobanov A.YU. Professor A.I. YArotskij i ego vklad v razvitie klinicheskoj mediciny (k 150-letiyu so dnya rozhdeniya). [Yarotsky and his contribution to the development of clinical medicine (on the 150th anniversary of his birth).] Byull. NNII OZ im. N.A. Semashko. 2016; 2: 35-357. [In Russ].

10.    Shumacker H.B. The Evolution of Cardiac Surgery. Indianapolis: Indiana Press, 1992: 108. 

 

Abstract:

The report is about giant false aneurysm of an extracranial part of the left internal carotid artery (ICA) in a patient aged one year and nine months. The reason of the complexity of diagnostics in this case was that the dissection of the ICA with formation of false aneurysm imitated the peritonsillar abscess' clinic. We have not found any descriptions of a similar cases of patients at such an early age in modern literature.

 

References

1.      Nikitina T.G., Kochurkova E.G., Petrosyan K.V., Alekyan B.G. Application of a stent-graft to correct a false aneurysm of the internal carotid artery. Creative. cardiol. 2015; 1: 66 [In Russ].

2.      Kalashnikova L.A. Dissection of arteries, blood supplying the brain, and disorders of cerebral circulation. Ann. clin. and exper. neurology. 2007; 1 (1): 41-49 [In Russ].

3.      Schievink W.I. Spontaneous dissection of the carotid and vertebral arteries. N. Engl. J. Med. 2001; 344: 898— 906. doi.org/10.1056/NEJM200103223441206.

4.      Fullerton HJ, JohnstonSC, Smith WS. Arterial dissection and stroke in children. Neurology, 2001; 57: 1155-1160.

5.      Kalashnikova L.A., Dobrynina L.A., Chechetkin A.O., Dreval M.V., Krotenkova M.V., Zakharkina M.V. Disorders of cerebral circulation in the dissection of the internal carotid and vertebral arteries. Algorithm of diagnostics. Nerve. disease. 2016; 2: 10-15 [In Russ].

6.      Kieslich M., Fiedler A., Heller C. et al. Minor head injury as cause and co-factor in the aetiology of stroke in childhood: a report of eight cases. J. Neurol. Neurosurg. Psychiatry 2002; 73: 13-6.

7.      Seerig M.M., Chueiri L., Jacques J. et alt. Bilateral Peritonsillar Abscess in an Infant: An Unusual Presentation of Sore Throat. Case Rep Otolaryngol. 2017; 2017: 467015. doi.org/10.1155/2017/4670152.

8.      Mazur E, Czerwinska E, Korona-Gtowniak I, Grochowalska A, Koziot-Montewka M. Epidemiology, clinical history and microbiology of peritonsillar abscess. Eur J Clin Microbiol Infect Dis. 2015 Mar; 34(3):549-54. doi.org/10.1007/s10096-014-2260-2.  

 

Abstract:

Article presents a clinical case of 83-year old woman with successful aspiration thrombectomy from the superior mesenteric artery due to its thromboembolism with the help of endovascular reperfusion catheter ACE68. Due to the satisfactory angiographic and clinical results - additional manipulations (artery stenting, selective thrombolysis) were not performed. Time from the onset of the disease to the restoration of blood mesenteric flow in the basin of the superior mesenteric artery was 24 hours, laparotomy or laparoscopy in post-operative period were not necessary. This article also discusses indications for endovascular treatment of acute occlusion of the superior mesenteric artery.

 

References

1.      Aboyans V., Ricco J.-B., M.-L. E.L. Bartelink, Bjorck M., Brodmann M., Cohnert T., Collet J.-Ph., Czerny M. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). European Heart Journal. 2018; 39: 763-821.

2.      Bjorck M., Koelemay M., Acosta S. et al. Manage ment of the Diseases of Mesenteric Arteries and Veins. Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2017; 53: 460-510.

3.      Erben Y, Protack C.D., Jean R.A. et al. Endovascular interventions decrease length of hospitalization and are cost-effective in acute mesenteric ischemia. J Vasc Surg. 2018; 68 (2): 459 - 469.

4.      Karkkainen J.M., Manninen H., Paajanen H. Treatment options for acute mesenteric ischemia have improved. Duodecim. 2017; 132 (2): 150 - 158.

5.      Lawson R.M. Mesenteric ischemia. Crit Care Nurs Clin North Am. 2018; 30 (1): 29 - 39.

6.      Schermerhorn M.L., Giles K.A., Hamdan A.D. et al. Mesenteric revascularization: management and outcomes in the United States, 1988-2006. J Vasc Surg. 2009; 50 (2): 341-348.e1.

7.      Freitas B., Bausback Y, Schuster J. et al. Thrombectomy devices in the treatment of acute mesenteric ischemia: initial single-center experience. Ann Vasc Surg. 2018;51:124 - 131.

8.      Mendes B.C., Oderich G.S., Tallarita T. et al. Superior mesenteric artery stenting using embolic protection device for treatment of acute or chronic mesenteric ischemia. J Vasc Surg. 2018; S0741-5214 (18): 30276-3.

9.      Bala M., Kashuk J., Moore E.E. et al. Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery. World J Emerg Surg. 2017; 12: 38.

10.    Singh M., Long B., Koyfman A. Mesenteric ischemia: a deadly miss. Emerg Med Clin North Am. 2017; 35 (4): 879 - 888.

11.    Khripun A.I., Salikov A.V., Mironkov A.B., Pryamikov A.D. Endovascular interventions in the treatment of patients with acute mesenteric ischemia. Angiologiya i sosydistaya khirurgiya. 2017; 23 (4): 43-48 [In Russ].

12.    Shipovskiy V.N., Tsitsiashvili M.Sh., Juan C. et al. Rheolytic thrombectomy and stenting of the superior mesenteric artery in acute mesenteric thrombosis (case report). Angiologiya i sosydistaya khirurgiya. 2010; 16 (3): 49-54 [In Russ].

13.    Chen T.Y, Wu C.H., Hsu W.F. et al. Primary endovascular intervention in acute mesenteric ischemia performed by interventional cardiologists - a single center experience. Acta Cardiol Sin. 2017; 33 (4): 439-446.

14.    Kerzman A., Haumann A., Boesmans E. et al. Acute mesenteric ischemia. Rev Med Liege. 2018; 73 (5-6): 300-303.

15.    Bagdasarov V.V., Bagdasarova E.A. Acute intestinal occlusion in ischemic bowel disease. Almanakh Instituta khirurgii im. A.V. Vishnevskogo; 2018; 1: 222-223 [In Russ].

16.    Schegolev AA, Papoyan SA, Mitichkin A.E. et al. Endovascular treatment of acute mesenteric ischemia in thrombosis of the superior mesenteric artery. Angiologiya i sosydistaya khirurgiya; 2017; 23 (4): 50-54 [In Russ].

17.    Puippe G.D., Suesstrunk J., Nocito A. et al. Outcome of endovascular revascularisation in patients with acute obstructive mesenteric ischaemia - a single-center experience. Vasa. 2015; 44 (5): 363-370.

18.    Khripun A.I., Salikov A.V., Shurygin S.N. et al. Possibilities of endovascular surgery in the treatment of acute mesenteric ischemia. Angiologiya i sosudistaya khirurgiya. 2014; (2) 2: 68-77 [In Russ]. 

 

Abstract:

Background: article presents a case of 11-month-old baby weighing 6,590, with phenomena of circulatory decompensation, and non-standard hybrid intervention using retroperitoneal open access to the infrarenal aorta - stent implantation with the potential for increasing its diameter as the child grows

Materials and methods: the patient underwent examination - echocardiography (Echo-CG), multispiral computed tomography (MSCT), angiography Indication for the operation was the restenosis of the distal aortic anastomosis after the stage-by-stage surgical correction of hypoplastic left heart syndrome (Norwood procedure). This tactic was chosen taking into account the extremely high risk of re-surgery, as well as the impossibility of stent implantation with the potential for increasing the diameter through access to the femoral artery (body weight of the child is 6.6 kg). The patient underwent stenting of restenosis of the distal aortic anastomosis through retroperitoneal open access to the infrarenal aorta.

Results: good early postoperative period, against the background of disaggregant therapy (aspirin 5 mg/kg per day) and antibiotic therapy In control echocardiography (Echo-CG), the systolic pressure gradient in the stent implantation zone is 22 mm hg. The patient was discharged to an outpatient stage, followed by examination after 6 months and possible re-intervention (stent dilatation with a larger diameter balloon) as the pressure gradient rises as the child grows. Proposed hybrid approach in a child 11 months with a body weight of 6,590 kg allowed to avoid the risk of re-surgery in conditions of circulatory arrest and demonstrated a satisfactory angiographic and clinical result.

Conclusion: stenting of restenosis in distal aortic anastomosis using retroperitoneal access can be considered as a surgery of choice in specialized centers.

 

References

1.      Sakurai T., Rogers V., Stickley J. et. al. Single-center experience of arch reconstruction in the setting of Norwood operation. Ann.Thorac. Surg. 2012; 94:1534-1539.

2.      Pavlichev G.V., Podoksenov A.YU., Krivoshchekov E.V. Obstruction of the aortic artery after Norwood surgery in children with hypoplastic left heart syndrome. Patologiya krovoobrashcheniya i kardiohirurgiya. 2014;18(2):13-16 [In Russ].

3.      Bartram U., Granenfelder J., Van Praagh R. Causes of death after the modified Norwood procedure: a study of 122 postmortem cases. Eur. Vasc. Endovasc. Surg. 2017; 53(5):617-625.

4.      Vitanova K., Cleuziou J., Pabst von Ohain J. et. al. Recoarctation After Norwood I Procedure for Hypoplastic Left Heart Syndrome: Impact of Patch Material. Ann. Thorac. Surg. 2017; 103(2):617-621.

5.      Thomas P, Doyle M.D., William E. et al.Aortic obstructions in infants and children. Progress in Pediatric Cardiology. 1994; 3(1): 37-44.

6.      Rothman A., Galindo A., Evans W.N. et. al. Effectiveness and safety of balloon dilation of native aortic coarctation in premature neonates weighing <or = 2,500 grams. Am. Cardiol. 2010; 105:1176- 80.

7.      Atalay A., Pac A., Avci T.et. al. Histopathological evaluation of aortic coarctation after conventional balloon angioplasty in neonates. Cardiol. Young. 2018; 18:1-5.

8.      Dijkema E.J., Sieswerda G.T., Takken T.et. al. Longterm results of balloon angioplasty for native coarctation of the aorta in childhood in comparison with surgery. Eur. Cardiothorac. Surg. 2018 1; 53(1): 262-268.

9.      Fiore A.C., Ficher L.K., Schwartz T. et. al. Comparison of angioplasty and Surgery for Neonatal Aortic Coarctation. The society of the thoracic surgeons. 2005; 80:1659-65.

10.    Shaddy R., Boucek M., Sturtevant J., et.al. Comparison of angioplasty and surgery for unoperated coarctation of the aorta. Circulation.1993; 87:793-9.

11.    Attia I.M., Lababidi Z.A. Transumbilicalballon coarctation angioplasty. Am. Heart. 1988; 166:1623-4.

12.    Redington A.N., Booth P, Shore D.F., Rigby M.L., Primary ballon dilatation of coarctation of aorta. A multi-institutional study. Thor. Cardiovasc. Surg. 1994;108:841-51.

13.    Richard E.R., Gauvreau K., Moses H., et.al. Coarctation of the Aorta Stent Trial (COAST): Study design and rationale. Am. Heart. 2012; 164 (1): 7-13.

14.    Coulson J.D.,Vricella L.A., Alekyan B.G. Аlternative arterial and venous access for catheterization in children and infants. Endovaskulyarnaya hirurgiya. 2016;4: 24-39 [In Russ].

15.    Pursanov M.G., Svobodov A.A., Levchenko E.G. et. al. New Approach for Hybrid Stenting of the Aortic Arch in Low Weight Children. Structural Heart Disease. 2017;(3)5:147-151.

16.    Dorfer C., Standhardt H., Gruber A., et. al. Direct Percutaneous Puncture Approach versus Surgical Cutdiwon Technique for Intracranial Neuroendovascular Procedures: Technical Aspects. World Neurosur. 2012; 77(1): 192-200.

17.    Chakrabati S., Kenny D., Morgan G. et. al. Balloon expandable stent implantation for native and recurrent coarctation of the aorta - prospective computed tomography assessment of stent integrity, aneurysm formation and stenosis relief. Heart. 2010; 96 (15): 1212-6.

18.    Davenport J.J., Lam L., Whalen-Glass R., et. al. The successful use of alternative routes of vascular access for performing pediatric interventional cardiac catheterization. Cathet. Cardiovasc. Interv. 2008; 72 (3): 392-8.

19.    Sivanandam, S., Mackey-Bojack S.M., Moller J.H. Pathology of the aortic arch in hypoplastic left heart syndrome: surgical implications. PediatrCardiol. 2011; 32: 189-192.

20.    Hammel J.M., Duncan K.F., Danford D.A. et.al. Two- stage biventricular rehabilitation for critical aortic stenosis with severe left ventricular dysfunction. Eur. Cardiothorac. Surg. 2012; 1-6.

21.    Alekyan B.G. X-ray endovascular surgery. National Guidelines. M: Litterra. 2017; 1: 247-262 [In Russ].

22.    Feltes T.F., Bacha E., Beekman R.H. et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease. А scientific statement from the Am. Heart Association. Circulation. 2011: 7;123(22): 2607-52.

 

Abstract:

The review is devoted to possibilities of ultrasound and functional diagnostic methods in the diagnosis of ischemic stroke of unknown etiology. Main causes of cryptogenic ischemic stroke are highlighted in the article. Advances in high resolution ultrasound of extracranial and intracranial vessels and of the heart, prolonged heart rhythm monitoring are instrumental techniques to identify arterial and cardiac hidden causes of stroke. We reviewed literature, on the basis of available data, designed a diagnostic algorithm for patients with patent foramen ovale (PFO) and risk of embolism from atherosclerotic plaque. 

 

References

I.       Petrikov S.S., Chamidova L.T. O conferencii «Neotlozhnaya pomosh bolnim s ostrimi narusheniaymi mozgovogo krovoobrasheniaya». [About conferention «Urgent treatment of patients with acute stroke»] Zhurnal im. N.V. Sklifisivskogo Neotbzhnayapomosh. 2015; 1:10-18 [In Russ].

2.      Grau A.J., Weimar C., Buggle F. et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke. 2001; 32(11): 2559-66.

3.      Li L., Yiin G.S., Geraghty O.C., et al. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. The Lancet Neurology. 2015; 14(9): 903-13.

4.      Hart R.G., Diener H.C., Coutts S.B., Easton J.D. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4): 429-38.

5.      Tegeler C.H., Hart R.G. Atrial size, atrial fibrillation and stroke. Ann. Neurol. 1987; 21: 315- 316.

6.      Hohnloser S.H., Capucci A., Fain E. et. al. ASSERT Investigators and Committees ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). Am Heart J. 2006; 152(3): 442-447.

7.      Yaghi S., Elkind M.S. Cryptogenic stroke: a diagnostic challenge. Neurol Clin Pract. 2014(4): 386-393.

8.      Favilla C.G., Ingala E., Jara J. et al. Predictors of finding occult atrial fibrillation after cryptogenic stroke. Stroke. 2015(46): 1210-1215.

9.      Miller D.J., Khan M.A., Schultz L.R. et al. Outpatient cardiac telemetry detects a high rate of atrial fibrillation in cryptogenic stroke. J Neurol Sci. 2013(324): 57-61.

10.    Gladstone D.J., Dorian P, Spring M. et al. Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the embrace trial. Stroke. 2015; 46: 936-941.

11.    Keach J.W., Bradley S.M., Turakhia M.P, Maddox TM. Early detection of occult atrial fibrillation and stroke prevention. Heart.2015; 101: 1097-102.

12.    Gladstone D.J., Dorian P, Spring M. et al. Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the embrace trial. Stroke.2015; 46:936-941.

13.    Brambatti M., Connolly S.J., Gold M.R. et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation.2014; 129: 2094-2099.

14.    Kamel H., O’Neal W.T., Okin PM., et al. Electrocardiographic left atrial abnormality and stroke subtype in atherosclerosis risk in communities study. Ann Neurol.2015; 78(5): 670-678.

15.    Kamel H., Soliman E.Z., Heckbert S.R. et al. P- wave morphology and the risk of incident ischemic stroke in the multi-ethnic study of atherosclerosis. Stroke. 2014; 45:2786-2788.

16.    Sinner M.F, Stepas K.A., Moser C.B. et al. B-type natriuretic peptide and c-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF consortium of community-based cohort studies. Europace. 2014; 16: 1426-1433.

17.    Kernan W.N., Ovbiagele B., Black H. R., Bravata D. M. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2014; 45: 2160-2236.

18.    Melkumova E., Thaler D.E. Cryptogenic Stroke and Patent Foramen Ovale Risk Assessment. Interv Cardiol Clin. 2017; 6(4): 487-493.

19.    Alsheikh-Ali A.A., Thaler D.E., Kent D.M. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009; 40: 2349-2355.

20.    Overell J.R., BoneI., Lees K.R. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000; 55(8): 1172-1179.

21.    Ahmed N., Steiner T., Caso V., Wahlgren N. Recommendations from the ESO-Karolinska Stroke Update Conference. European Stroke Journal. 2016; 0(0): 1-8.

22.    Spencer M.P, Moehring M.A., Jesurum J. et al. Power m-mode transcranial Doppler for diagnosis of patent foramen ovale and assessing transcatheter closure. J Neuroimaging. 2004; 14(4): 342-349.

23.    Katsanos A.H., Patsouras D., Tsivgoulis G. et al. The value of transesophageal echocardiography in the investigation and management of cryptogenic cerebral ischemia: a single-center experience. Neurol Sci. 2016; 37(4): 629-32.

24.    Wei-jan C., Peiliang K.,Wen-Pin L., Fang-¥ue U. Detection Of Patent Foramen Ovale By Contrast Transesophageal Echocardiography. Chat. 1992; 101: 1515-20.

25.    Schnabel R.B., Yin X., Gona P, Larson MG. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015; 386(9989):154-62.

26.    Arboix A., Alio J. Acute cardioembolic cerebral infarction: answers to clinical questions. Curr Cardiol Rev. 2012;8(1):54-67.

27.    Christian T. R.Stroke Prevention in Atrial Fibrillation. Circulation. 2012; 125(16): e588-90.

28.    Zabalgoitia M., Halperin J.l., Pearce L. A. et al. Transesophageal Echocardiographic Correlates of Clinical Risk of Thromboembolism in Nonvalvular Atrial Fibrillation. Journal of the AmericanCollege of Cardiology. 1998; 31(7): 1622-1626.

29.    diesebro J.H., Fuster V. Valvular heart disease and prosthetic heart valves. Thrombosis in cardiovascular disorders. Eds V. Fuster, M. Verstraete.- Philadelphia: W.B.Saunders, 1992; 191-214.

30.    Tunick P.A., Kronzon I. Protruding atherosclerotic plaque in the aortic arch of patients with systemic embolization: a new finding seen by transesophageal echocardiography. Am Heart J. 1990; 120: 658-660.

31.    Tunick P.A., Culliford A.T., Lamparello P.J., Kronzon I. Atheromatosis of the aortic arch as an occult source of multiple systemic emboli. Ann Intern Med. 1991; 114: 391392.

32.    Amarenco P., Cohen A., Tzourio C. et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med. 1994; 331(22): 1474- 1479.

33.    Bulwa Z., Gupta A. Embolic stroke of undetermined source: The role of the nonstenotic carotid plaque. J Neurol Sci. 2017; 15(382): 49-52.

34.    Viguier A., Pavy le Traon A., Massabuau P. et al. Asymptomatic cerebral embolic signals in patients with acute cerebral ischaemia and severe aortic arch atherosclerosis. Journal of Neurology. 2001; 248: 768-771.

35.    Rundek T., Di Tullio M.R., Sciacca R.R. et al. Association between large aortic arch atheromas and high-intensity transient signals in elderly stroke patients. Stroke. 1999; 33: 2683-2686.

36.    Gupta A., Gialdini G., Lerario M.P.et al. Magnetic resonance angiography detection of abnormal carotid artery plaque in patients with cryptogenic stroke. J Am Heart Assoc. 2015; 4(6): e002012.

37.    Freilinger T.M., Schindler A., Schmidt C.et al. Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke. JACC Cardiovasc Imaging. 2012; 5: 397-405.

38.    Casadei A., Floreani M., Catalini R. et al. Sonographic characteristics of carotid artery plaques: Implications for follow-up planning?J Ultrasound. 2012; 15(3): 151-157.

39.    Rafailidis V., Charitanti A., Tegos T. et al. Contrast-enhanced ultrasound of the carotid system: a review of the current literature. J Ultrasound. 2017; 20(2): 97-109.

40.    Nedeltchev K., der Maur T.A., Georgiadis D. et al. Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry. 2005; 76(2): 191-195.

41.    Caplan L.R. Dissections of brain-supplying arteries. Nat Clin Pract Neurol. 2008; 4(1): 34-42.

42.    Gunther A., Witte O.W., Freesmeyer M. et al. Eur Neurol. 2016; 76(5-6): 284-294.

43.    Clevert D.A., Horng A., Jung E.M. et al. Contrast-enhanced ultrasound versus conventional ultrasound and MS-CT in the diagnosis of abdominal aortic dissection. Clin Hemorheol Microcirc. 2009; 43: 129-139.

44.    Graus F., Rogers L.R., Posner J.B. Cerebrovascular complications in patients with cancer. Medicine. 1985; 64(1): 16-35.

45.    Kurabayashi H., Hishinuma A., Uchida R et al. Delayed manifestation and slow progression of cerebral infarction caused by polycythemia rubra vera. Am J Med Sci. 2007; 333(5): 317-320.

46.    Giray S., Sarica F.B., Arlier Z., Bal N. Recurrent ischemic stroke as an initial manifestation of an concealed pancreatic adenocarcinoma: Trousseau’s syndrome. Chin Med J. 2011; 124(4): 637-640.

Abstract:

Aim: was to analyze long-term resuts of true lumen reconstruction in complicated aortic dissections type В with help of balloon-expandable stents under intravascular ultrasonic (IVUS) guidance as a preoperative evaluation of anatomy and morphology of lesion.

Materials and methods: 47 patients witn type В aortiс dissections underwent endovascular treatment in our departmert n 20 cases - IVUS was used for irtraoperative anatomy and morphology verification. Complications developed n 16 patients, and true lumen was reconstructed by stent-graft implantation (to cover proximal fenestration) followed by balloon-expandable stents implantation at the level of visceral arteries under IVUS control at every stage. 87,5% of patents were man, mean ago 51 8—16,2 years.

Results: Technical success was 100% True lumen total reconstruction was reached in every case under precise IVUS control. Visceral arteries malperfusion was not observed at hospital period or follow-up. З0-day mortality rate was 6,25% (1 case due to aortic rupture in uncovered part of aorta - 7 days after procedure). All 15 discharged patients survived for 1st year. Mean follow-up period is 3,3±1,6 years. One patient died due to aortobronchial fistula, 1 due to repeated stroke and 1 due to cancer. At CT-scan 2 years after implantation (10 cases) fractures of balloon-expandable stents were observed, without аnу influence on intraluminal size or stenotic lesion. True lumen size stayed stable for 1 year.

Conclusion: true lumen reconstruction under IVUS control seems to be feasible and effective in complicated Type B dissections, even with the use of balloon-expandable stents. The usage of additional intraoperative visualization - intraaortic IVUS is the key point in the development of advanced endovascular methods.

 

References

1.      Erbel R., Aboyans V., Boileau C., et al. Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. Eur Heart J. 2014;35:2873-926.

2.      Fattori R., Cao P., De Rango P, et al. Interdisciplinary expert consensus document on management of type B aortic dissection. J Am Coll Cardiol. 2013; 61: 1661-78.

3.      Eggebrecht H., Nienaber C.A., Neuhauser M., et al. Endovascular stent graft placement in aortic dissection: a metaanalysis. Eur Heart J. 2006; 27: 489e98.

4.      Mossop P.J., McLachlan C.S., Amukotuwa S.A., Nixon I.K. Staged endovascular treatment for complicated type B aortic dissection. Nat Clin Pract Cardiovasc Med. 2005;2:316-21.

5.      Canaud L., Faure E.M., Ozdemir B.A., Alric P., Thompson M. (2014) Systematic review of outcomes of combined proximal stent-grafting with distal bare stenting for management of aortic dissection. Ann Cardiothorac Surg. 3: 223-233.

6.      Nienaber C.A., von Kodolitsch Y, Nicolas V., et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med. 1993; 328: 1-9.

7.      Evangelista A., Flachskampf F.A., Erbel R., et al. Echocardiography in aortic diseases: EAE recommendations for clinical practice. Eur J Echocardiogr. 2010; 11: 645-658.

8.      Fattori R., Caldarera I., Rapezzi C., et al. Primary endoleakage in endovascular treatment of the thoracic aorta: importance of intraoperative transesophageal echocardiography. J Thorac Cardiovasc Surg. 2000; 120: 490-5.

9.      Rocchi G., Lofiego C., Bigini E., et al. Transesophageal echocardiography-guided algorithm for stent-graft implantation in aortic dissection. J Vasc Surg. 2004; 40: 880-5.

10.    Morton J.B., Sanders P., Sparks P.B., et al. Usefulness of phased-array intracardiac echocardiography for the assessment of left atrial mechanical “stunning” in atrial flutter and comparison with multiplane transesophageal echocardiography. Am J Cardiol. 2002; 90: 741-6.

11.    Marrouche N.F., Martin D.O., Wazni O., et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circ 2003; 107: 2710-6.

12.    Caldararu C., Balanescu S. Modern Use of Echocardiography in Transcatheter Aortic Valve Replacement: an Up-Date. M&dica. 2016; 11(4): 299-307.

13.    Jongbloed MR.M., Schalij M.J., Zeppenfeld K., et al.Clinical applications of intracardiac echocardiography in interventional procedures. Heart. 2005; 91(7): 981-990. doi:10.1136/hrt.2004.050443.

14.    Kang S.J., Ahn J.M., Kim W.J., et al. Intravascular ultrasound assessment of drug-eluting stent coverage of the coronary ostium and effect on outcomes. Am J Cardiol. 2013; 111: 1401-7.

15.    Hitchner E., Zayed M.A., Lee G., et al. Intravascular ultrasound as a clinical adjunct for carotid plaque characterization. J Vasc Surg 2014; 59: 774-80.

16.    Diethrich E.B., Irshad K., Reid D.B. Virtual histology and color intravascular ultrasound in peripheral interventions. Semin Vasc Surg. 2006; 19: 155-62.

17.    Song T.K., Donayre C.E., Kopchok G.E., White R.A. Intravascular ultrasound use in the treatment of thoracoabdominal dissections, aneurysms, and transections. Semin Vasc Surg. 2006; 19: 145 9.

18.    Pearce B.J., Jordan W.D. Jr. Using IVUS during EVAR and TEVAR: Improving patient outcomes. Semin Vasc Surg. 2009; 22: 172 80.

19.    Lee J.T., White R.A. Basics of intravascular ultrasound: An essential tool for the endovascular surgeon. Semin Vasc Surg. 2004; 17: 110 8.

20.    Gol'dina I.M., Trofimova E.Yu., Kokov L.S., Parxomenko M.V., Chernaya N.R., Sokolov V.V., Redkoborody'j A.V., Rubczov N.V. Possibilities of intravascular ultrasound examination using a phased array catheter sensor in the diagnosis and treatment of aortic dissection. Ultrazvukovaya i funktsiomalnaya diagnostika. 2016; 1: 78-89 [In Russ].

21.    Martin Z.L., Mastracci T.M. The evaluation of aortic dissections with intravascular ultrasonography. Vascular Disease Management. 2011; 03(31). Available at: http://www.vasculardiseasemanagement.com/content/ev aluation-aortic-dissections-intravascular-ultrasonography/ (accessed 10 march 2018).

22.    Eggebrecht H., Nienaber C.A., Neuhauser M., et al. Endovascular stent graft placement in aortic dissection: a metaanalysis. Eur Heart J. 2006; 27: 489e98.

23.    Mossop P.J., McLachlan C.S., Amukotuwa S.A., Nixon I.K. Staged endovascular treatment for complicated type B aortic dissection. Nat Clin Pract Cardiovasc Med. 2005; 2: 316e22.

24.    Nienaber C.A., Kische S., Zeller T., et al. Provisional extension to induce complete attachment after stent graft placement in type B aortic dissection: the PETTICOAT concept. J Endovasc Ther. 2006; 13: 738e46.

25.    Lombardi J.V., Cambria R.P, Nienaber C.A., et al. Prospective multicenter clinical trial (STABLE) on the endovascular treatment of complicated type B aortic dissection using a composite device design. J Vasc Surg. 2012; 55: 629e40.

26.    Hoshina K., Kato M., Miyahara T., et al. Retrospective study of intravascular ultrasound use in patients undergoing endovascular aneurysm repair: Its usefulness and a description of the procedure. Eur J Vasc Endovasc Surg. 2010; 40: 559-63.

27.    Guo B-L., Shi Z-Y, Guo D-Q., et al. Effect of Intravascular Ultrasound-assisted Thoracic Endovascular Aortic Repair for «Complicated» Type B Aortic Dissection. Chinese Medical Journal. 2015; 128(17): 2322-2329.

authors: 

 

Abstract:

According to current recommendations and orders of the Russian Ministry of Health, in the department of ultrasound diagnostics of the oncological center, it is necessary and lawfully to perform invasive manipulations to obtain a morphological verification of the oncological process. Nevertheless, there are significant gaps in the existing normative acts concerning organizational aspects.

Aim: to conduct an analysis of the organization and results of morphological testing of malignant neoplasms in conditions of separation of ultrasonic diagnostics of the Kursk Regional Clinical Oncology Center.

Materials and methods: 5,114 results of histological and immunohistochemical studies of material obtained with biopsies under ultrasound in the period 2012 - 2016 were analyzed. For the first time we included into department - 2 manipulation rooms, corresponding to sanitary requirements for conducting sterile manipulations. We first install Sonoscape S40 scanners in the manipulation rooms. All invasive examinations were performed by ambulatory and resident patients by ultrasound specialists who have a primary specialization in surgery, gynecology or urology Core biopsy was performed under local anesthesia with semi-automatic needles 14G or 16G; a gun-needle system biopsy was performed using a Bard-Magnum biopsy gun, 18 G needle, and a biopsy attachment to the rectal sensor. The material was preserved in a 10% solution of neutral formalin, labeled and sent to the department of oncomorphology with application of the direction to the intravital pathological anatomical study of the biopsy material. Statistical processing of the data was carried out using the SPSS program «STATISTICS 20.0». Conjugation tables were compiled to determine the relationship between variables. Pearson's x2 was used as the communication criterion, and its asymptomatic two-sided significance was estimated.

Results. During the research, high efficiency of the proposed organizational model is revealed. A statistical relationship is revealed between the informativeness of the material and the physiciar who manipulates and organ-object. Ways of development are offered.

 

References

1.      Kaprin A.D., Starinskij V.V., Petrova G.V. The state of oncological care for the population of Russia in 2013. M.: FGBU «MNIOI im. PA. Gercena» Minzdrava Rossii. 2014; 235 s [In Russ].

2.      Order of the Ministry of Health of the Russian Federation of 04.07.2017 No. 379n «On Amending the Procedure for the provision of medical care to the population in the field of oncology, approved by Order of the Ministry of Health of the Russian Federation of November15, 2012No.915n»].URL.:http://www.consultant.ru/document/cons_doc_LAW_220809/f891655c8c9f6864b656ef 38dba5a212e7e2b0e6/ (Data obrashhenija 23.10.2017) [In Russ].

3.      Chissov V.I., Dar'jalova S.L. [Oncology]. M.: «GJeOTAR-Media». 2007; 560 s [In Russ].

4.      Ponedel'nikova N.V., Korzhenkova G.P, Letjagin VP, Vishnevskaja Ja.V. Choice of the method of verifying the volume of newgrowth of the mammary gland at the preoperative stage. Opuholi zhenskoj reproduktivnoj sistemy. 2011; 1: 41-45 [In Russ].

5.      Nazarenko G.I., Hitrova A.N. Ultrasonic diagnostics of the prostate in modern oncological practice. M.: Izdatel'skij dom Vidar-M. 2012; 288s [In Russ].

6.      About the improvement of the service of radiation diagnosis: the order of the Ministry of Health of the RSFSR of August 2, 1991 № 132. URL.:http:// www.rasudm.org /information/docs.htm (Data obrashhenija 23.10.2017) [In Russ].

7.      Order of the Ministry of Health of the Russian Federation of December 27, 2011 N 1664n "ОП the approval of nomenclature of medical services". URL.:http://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=LAW&n=27 8063&fld=134&dst=1,0&rnd=0.05494875175266367#0 (Data obrashhenija 04.11.2017) [In Russ].

8.      Decree of the Chief State Sanitary Doctor of the Russian Federation of May 18, 2010 No.58 «On approval SanPiN 2.1.3.2630-10» Sanitary and epidemiological requirements for organizations engaged in medical activities «with amendments and additions from: March 4, June

10,    2016. URL.: http://base.garant.ru/12177989/ #ixzz4xU73XzAB (Data obrashhenija 04.11.2017) [In Russ].

9.      Attachment №2 to the order of the Ministry of Health of the Russian Federation of March 24, 2016 N 179n «On the Rules of Pathology and Anatomical Research» (registered by the Ministry of Justice of the Russian Federation on April 14, 2016, registrationN41799). URL.:http://pravo.gov.ru/proxy/ips/?docbody=&nd= 102396069 (Data obrashhenija 04.11.2017) [In Russ].

10.    SPSS: the art of information processing. Analysis of statistical data and restoration of hidden regularities. Ahim Bjujul', Peter Cefel'.- DiaSoft, 2005; 608 s [In Russ].

 

Abstract:

Aim: was to analyze long-term results of carotid endarterectomy (CEA) in patients with unilateral lesion of the internal carotid artery (ICA), the lack of/or insignificant lesion on the contralateral side on statin therapy.

Materials and methods: for the period January 2009-December 2010, 262 CEA performed in 262 patients. Evaluated results of survival rate, stroke and myocardial infarction, condition of carotid arteries, effect of various factors on features of atherosclerotic lesions and effect of statin therapy on these processes.

Results: in late follow-up period - 245(93,5%) survivors. Patients were divided into groups: simvastatin - 60(24,5%) patients, atorvastatin - 134(54,7%) observations, rosuvastatin - 51(20,8%) cases. 14 patients died, data were obtained on the 13, average loss of 6.06%. The frequency of cardiovascular events leading to death is seven cases. Non-fatal stroke of any location - 5(1,9%) observations. The influence of hypertension (p=0,019), smoking (p=0,004), type 2 diabetes (p=0,03), dyslipidemia: hypercholesterolemia (p=0,05), hypertriglyceridemia (p=0,02), low-density lipoprotein (LDL) level is higher than normal (p=0,015), high-density lipoprotein (HDL) is below normal (p = 0,03) and other factors. Lowering cholesterol by 5,9% is marked in the atorvastatin group, maintaining at recommended values throughout the period from the initial selection in the rosuvastatin group (p = 0,0001). LDL cholesterol decreased by 19,1% in the mean value in the atorvastatin group (p = 0,0001), the increase of HDL level of 3,4% in the rosuvastatin group (p=0,02). Achievement of recommended levels of cholesterol was more often observed in the rosuvastatin group at 64,7% compared with simvastatin (p = 0,03). Risk factors influenced the incidence of restenosis ipsilateral side in 3 patients (1,2%). The greatest influence of risk factors was determined in the atorvastatin group (4,1%, p=0,001). Atorvastatin therapy stabilized the wall of the ICA 17,6% more often (p=0,05) and contralateral common carotid artery, leaving it intact at 84,6% (p=0,002) compared with other groups of statins.

Conclusion: the purpose of statin therapy depends on the severity of the atherosclerotic process the characteristics of the lipid profile and the need correction of risk factors. The most effect is provided by the group of synthetic statin above semisynthetic. Atorvastatin therapy is effective with moderate hypercholesterolemia; rosuvastatin prescribed with severe dyslipidemia.

 

References

1.      Rothwell P.M., Eliasziw M., Gutnikov S.A., Fox A.J., Taylor D.W., Mayberg M.R. et al. Analysis of pooled data from the randomized controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003; 361: 107-116.

2.      AbuRahma A.F., Srivastava M., Stone P.A. Effects of Statins on Early and Late Clinical Outcomes of Carotid Endarterectomy and the Rate of Post-Carotid Endarterectomy Restenosis. J Am Coll Surg. 2015;220:481-488.

3.      Sillesen H., Amarenco P., Hennerici M.G., Callahan A., Goldstein L.B., Zivin J. et al. Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008; 39: 3297-3302.

4.      O'Regan C., Wu P., Arora P., Perri D., and Mills E.J. Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am J Med. 2008; 21: 24-33.

5.      Perler B.A. The effect of statin medications on perioperative and long-term outcomes following carotid endarterectomy or stenting. Semin Vasc Surg. 2007; 20: 252-258.

6.      McGirt M.J., Perler B.A., Brooke B.S., Woodworth G.F., Coon A., Jain S. et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J. Vasc Surg. 2005; 42: 829-836.

7.      Paraskevas K.I., Athyros V.G., Briana D.D., Kakafika A.I., Karagiannis A., and Mikhailidis, D.P. Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Curr Drug Targets. 2007; 8: 942-951.

8.      Koh K.K. Effects of statins on vascular wall (vasomotor function, inflammation, and plaque stability). Cardiovasc Res. 2000; 47: 648-657.

9.      Amarenco P., Labreuche J., Lavallee P., and Touboul, P.J. Statins in stroke prevention and carotid atherosclerosis (systematic review and up-to-date meta-analysis). Stroke. 2004; 35: 2902-2909.

10.    Amarenco P. and Labreuche J. Lipid management in the prevention of stroke: review and updated metaanalysis of statins for stroke prevention. Lancet Neurol. 2009; 8: 453-463.

11.    Pokrovsky A.V., Beloyartsev D. F., Talibli O. L. Analysis of long-term results of eversion carotid endarterectomy. Angiology and vascular surgery. 2014; 20 (4): 100-108 [In Russ].

12.    Efthymios D. Avgerinos Rabih A., Abdallah Naddaf, Omar M. El-Shazly, Luke Marone, Michel S. Makaroun. Primary closure after carotid endarterectomy is not inferior to other closure techniques. Presented at the Vascular and Endovascular Surgery Society 2015 Summer Meeting, Chicago, Ill, June 17-20, 2015.

13.    Taylor A.J., Kent S.M., Flaherty P.J., Coyle L.C., Markwood T.T., and Vernalis, M.N. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation. 2002; 106: 2055-2060.

14.    Taylor A.J., Sullenberger L.E., and Lee H.Y ARBITER 3: Atherosclerosis regression during open-label continuation of extended-release niacin following ARBITER 2. Circulation. 2005; 112: II-179.

15.    Jones P., Davidson M., Stein E. et al. STELLAR Study Group. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR  Trial). Am. J. Cardiol. 2003; 92(2): 152-160.

16.    Crouse J.R. III, Raichlen J.S., Riley W.A. et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA. 2007;297:1344-1353.

17.    Radak D., Tanaskovic S., Matic P., et al. Eversion Carotid Endarterectomy - Our Experience After 20 Years of Carotid Surgery and 9897 Carotid Endarterectomy Procedures. Ann. Vasc. Surg. 2012; 26(7): 924-928.

18.    Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995; 273: 1421-1428.

19.    Sever P.S., Poulter N.R., Dahlof B. et al. Different Time Course for Prevention of Coronary and Stroke Events by Atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA). Am J Cardiol. 2005; 96: 39-44.

20.    Paraskevas K.I., Hamilton G., Mikhailidis D.P. Statins: an essential component in the management of carotid artery disease. J Vasc Surg. 2007; 46: 373-386.

 

Abstract:

Aim: was to assess chances of the development of postoperative diaphragmatic dysfunction (DD), depending on methods of coronary artery bypass graft (CABG), by estimation the probability of development of DD according to the side of internal thoracic artery (ITA) harvest.

Materials and methods: evaluation of the mobility of domes of the diaphragm in the early perioc after 3051 CABG operations (with use of ITA) was made. Control group included patients with normal mobility of the diaphragm. Study group included patients with right-sided, left-sided and bilateral DD. Using a logistic regression model we evaluated the influence of the method of CABG (with use of ITA) in the development of DD from the side of the ITA harvest. The model included two ways of CABG - «in situ» and autograft.

Results: there are differences in chances of development of unilateral and bilateral DD, depending on the method of CABG (with use of ITA) and combinations thereof. High possibility of developing DD after CABG with right ITA was observed after CABG «in situ» (OR 5,4; CI 4,3-6,8), and smaller after CABG with ITA autograft (OR 1,8; CI 1,4-2,3). High possibility of DD was observed after CABG with left ITA autograft (OR 3,5; CI 2,2-5,6); after CABG «in situ», there was no DD.

Conclusion: methods of CABG using ITA, «in situ» and autograft, differently affect the mobility of the diaphragm from the side of surgical procedure. Results of the study indicate a high probability of DD after CABG with left ITA autograft and right ITA «in situ». It is established that possibility of DD was low in case of CABG with right ITA as autograft and was absent in left ITA «in situ».

 

References

1.      Bazylev V.V., Paramonova T.I., Vdovkin A.V. Analysis of position and mobility of the diaphragm in adults with normal lung function before and after cardiac surgery. Luchevaya diagnostika i terapiya. 2017;(1):53-63. [In Russ].

2.      Paramonova T.I., Vdovkin A.V., Pal'kova V.A. Factors, influencing the development of diaphragmatic dysfunction in the early postoperative period after cardiac surgery. Diagnosticheskaya i intervencionnaya radiologiya. 2016; 10(2):11-16. [In Russ].

3.      Canbaz S., Turgut N., Halici U., et al. Electrophysiological evaluation of phrenic nerve injury during cardiac surgery - a prospective, controlled, clinical study. BMC Surgery. 2004, 4:2

4.      Deng Y, Byth K., Paterson H.S. Phrenic nerve injury associated with high free right internal mammary artery harvesting. Ann Thorac Surg. 2003; 76(2):459-463.

5.      Bazylev V.V., Paramonova T.I., Vdovkin A.V., et al. Factors affecting the development of dyspnea in the early postoperative period after cardiac surgery. Diagnosticheskaya i intervencionnaya radiologiya. 2016; 10(4):19-27. [In Russ].

6.      Bonacchi M, Prifti E, Giunti G, et al. Respiratory dysfunction after coronary artery bypass grafting employing bilateral internal mammary arteries: the influence of intact pleura. Eur J Cardiothorac Surg. 2001; 19:827-833.

7.      Matsumoto M., Konishi Y, Miwa S., et al. Effect of different methods of internal thoracic artery harvest on pulmonary function. Ann Thorac Surg. 1997; 63:653-655.

8.      Uzun K., Kara H., Ugurlu D. The Effects Of Internal Mammary Artery Harvesting Techniques On Pulmonary Functions. Ko§uyolu Kalp Dergisi. 2011; 14(3):76-78.

9.      Ozkara A., Hatemi A., Mert M.,et al.The effects of internal thoracic artery preparation with intact pleura on respiratory function and patients' early outcomes. Anadolu Kardiyol Derg. 2008; 8: 368-373.

10.    Bazylev V.V., Nemchenko E.V., Karnahin V.A.. et al. Flowmetric estimation of coronary bypass grafts in conditions of extracorporeal circulation and on a working heart.] Angiologiya i sosudistaya hirurgiya. 2016;22(1): 67-72. [In Russ].

11.    Rankin J.S., Tuttle R.H., Wechsler A.S. et al. Techniques and benefit of multiple internal mammary artery bypass at 20 year of follow up. Ann Thorac Surg. 2007; 83:1008-1015.

12.    Buxton B.F., Tatoulis J., Fuller J.A. The right internal thoracic artery: the forgotten conduit - 5,766 patients and 991 angiograms. The Annals of Cardiothoracic Surgery. 2011; 92: 9-17.

13.    Lytle B.W., Blackstone E.H., Sabik J.F. et al. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg 2004;78(6):2005-2014

14.    Tatoulis J. Total arterial coronary revascularization - patient selection, stenoses, conduits, targets. The Annals Cardiothoracic Surgery. 2013;2:499-506.

15.    O'Brien J.W., Johnson S.H., VanSteyn S.J., et al. Effects of internal mammary artery dissection on phrenic nerve perfusion and function. Ann Thorac Surg. 1991; 52: 182-188.

16.    Sharma A.D., Parmley C.L., Sreeram G., et al. Peripheral nerve injuries during cardiac surgery: risk factors, diagnosis, prognosis, and prevention. Anesth Analg. 2000; 91(6):1358

17.    Calafiore A.M., Di Giammarco G., Teodori G., et al. Bilateral internal thoracic artery grafting with and without cardiopulmonary bypass: six-year clinical outcome. J Thorac Cardiovasc Surg. 2005; 130(2):340-345.

18.    Cygel'nikov S.A. Internal thoracic artery in the surgical treatment of ischemic heart disease: options and tactics of use, results. Avtoreferat Dis. dok. med. nauk. M., 2010; 49. [In Russ].

19.    Buxton B.F., Ruengskulrach P., Fuller J., et al. The right internal thoracic artery graft - benefits of grafting the left coronary system and native vessels with a high-grade stenosis. The European Journal of Cardio-Thoracic Surgery. 2000; 18: 255-261.

20.    Bazylev V.V., Nemchenko E.V., Pavlov A.A., et al. Comparative results of revascularization of right coronary artery basin using bimammary Y-graft and autovein. Grudnaya i serdechno-sosudistaya hirurgiya. 2014; 5: 11-18. [In Russ].

21.    Vecherskij YU.YU., Andreev S.L., Zatolokin V.V. Tactics of using the right internal thoracic artery «in situ» in CABG surgery.] Angiologiya i sosudistaya hirurgiya. 2015;1(21):148-154. [In Russ].

22.    Buxton B.F., HaywardPA. The art of arterial revascularization - total arterial revascularization in patients with triple vessel coronary artery disease. The Annals of Cardio-thoracic Surgery. 2013;2:543-551.

23.    Paterson H.S., Naidoo R., Byth K., et al. Full myocardial revascularization with bilateral internal mammary artery Y grafts. The Annals of Cardiothoracic Surgery. 2013;2:444-452.

24.    Akchurin R. S., Shiryaev A. A., Brand YA. B., et al. Surgery of coronary arteries - extremes and algorithms of revascularization. Grudnaya i serdechno-sosudistaya hirurgiya. 2001; 2:13-17. [In Russ]. 

 

Abstract:

Background: the cause of the development of traumatic hernias of the diaphragm is its damage due to open or closed injury In modern conditions, the diaphragm injury is most common trauma in falling from height and car accidents (multiple trauma), and can be unnoticed in againts the background of other injuries.

The dislocation of abdominal organs into the pleural cavity occurs in various, sometimes long, time periods after trauma. This situation is determined by the gradual increase in the size of the defect due to the difference in pressure in the abdominal and pleural cavities.

Aim: was to study the importance of radiodiagnosis of traumatic hernias of the diaphragm.

Materials and methods: two rare clinical cases of traumatic diaphragmatic hernias are presented. In one observation - a woman of 81 years, in the second - a 66 years old man. Results: a woman with a history of trauma as a result of a car accident 10 years ago, basec on a comprehensive survey, revealed posttraumatic hernia of the right half of the diaphragm with a dislocation into the pleural cavity of the small and large intestine.

In the second case report (male), an old rupture of the left half of the diaphragm of unknowr prescription of injury was revealed with the dislocation of the greater part of the intestine and the left kidney

Conclusion. To diagnose traumatic hernias of the diaphragm, a comprehensive examination of patients is necessary. Plain radiography can detect the dislocation of abdominal organs into the pleural cavity, and examination of the gastrointestinal tract with a water-soluble contrast drug is a violation of the passage.

Multi-slice computed tomography (MSCT) in case of such pathology, has a greater importance, because thin sections give the highest resolving power. The construction of multiplanar reformation allows obtaining more complete information on the dislocation of organs, visualizing the defect of the diaphragm and determining its exact localization.

 

References

1.      Abdominalnaia travma. Rukovodstvo dlia vrachei [Abdominal trauma. Guide-book for doctors](Pod red. A.S. Ermolova). M.: Vidar-M. 2010; 386-399. [In Russ].

2.      Korabelnikov I.D. Travmaticheskie diafragmalnye gryzhi [Traumatic diaphragmatic hernias] (Pod red. V.A. Chernavskogo). M.: Medgiz. 1951; 5-62 [ In Russ].

3.      Borisov A.E., Kubachev K.G., Kukushkin A.V. i dr. Diafragmalnye gryzhi. Diagnostika i khirurgicheskoe lechenie [Diaphragmatic hernias. Diagnosis and surgical treatment.] Vestnik khirurgii im. 1.1. Grekova. 2012; 171 (6): 38-42 [In Russ].

4.      Plekhanov A.N. Khirurgiia travmaticheskikh diafragmalnykh gryzh [Surgery of traumatic diaphragmatic hernias.] Vestnik khirurgii im 1.1. Grekova. 2012; 171(5): 107-110 [In Russ].

5.      Aliev S.A., Bairamov N.Iu., Aliev E.S. Osobennosti diagnostiki i taktiki khirurgicheskogo lecheniia razryvov diafragmy pri zakrytoi sochetannoi travme grudi i zhivota [Features of diagnosis and tactics of surgical treatment of diaphragm ruptures with closed combined injury of chest and abdomen.]. Vestnik khirurgii im. 1.1. Grekova. 2014; 173 (4): 66-72 [In Russ].

6.      Thiam O., Konate I., Gueye M.L. et al. Traumatic diaphragmatic injuries: epidemiological, diagnostic and therapeutic aspects. Springer Plus. 2016; 5 (1): 1614. doi: 10.1186/s40064-016-3291-1.

7.      Al Skaini M.S., Sardar A., Haroon H. et al. Traumatic diaphragmatic hernia: delayed presentation with tension viscerothorax - lessons to learn. Ann R Coll Surg Engl. 2013; 95 (2): 27-29. doi: 10.1308/ 003588413X 13511609955337.

8.      Fischer N.J., Aiono S. Delayed presentation of a traumatic diaphragmatic hernia presenting as a large bowel obstruction: a case report. ANZ J Surg. 2016; 86 (1-2): 9798. doi: 10.1111/ans.125968.

9.      Kubachev K.G., Kukushkin A.V, Zaitsev D.A. Diagnostika i khirurgicheskoe lechenie ushchemlennykh diafragmalnykh gryzh [Diagnosis and surgical treatment of strangulated diaphragmatic hernias.]. Vestnik SPbGU. 2012; Ser. 11. Vyp. 1: 89-97 [In Russ].

10.    Chikinev Iu.V., Drobiazgin E.A. Posttravmaticheskie diafragmalnye gryzhi (diagnostika i lechenie) [Post-traumatic diaphragmatic hernia (diagnosis and treatment).]. Acta Biomedical Scientifica. 2017; 2 (6): 163-166. [In Russ].

11.    Aissa A., Hassine A., Hajji H. et al. Complication rare d'une hernie diaphragmatique gauche post-traumatique. Rev Pneumol Clin. 2013; 69(6): 331-335. doi: 10.1016/j.pneumo.2013.04.006.

12.    Hajong R., Baruah A. Post-traumatic diaphragmatic hernia. Indian J Surg. 2012; 74 (4): 334-335. doi: 10.1007/s12262-012-0418-7.

13.    Ercan M., Aziret M., Karaman K. et al. Dual mesh repair for a large diaphragmatic hernia defect: An unusual case report. Int J Surg Case Rep. 2016; 28: 266-269. doi: 10.1016/j.ijscr. 2016.10.015.

14.    Al-Koudmani I., Darwish B., Al-Kateb K., Taifour Y Chest trauma experience over eleven-year period at al-mouassat university teaching hospital-Damascus: a retrospective review of 888 cases. J Cardiothorac Surg. 2012; 7: 35. doi: 10.1186/1749-8090-7-35.

15.    Akar E., Kaya H. Traumatic rupture of the diaphragm: A 22-patient experience. Biomedical Research. 2017; 28 (20): 8706-8710.

16.    Mikheev A.V., Trushin S.N., Bazzaev T.M. i dr. Ushchemlennaia pravostoronniaia travmaticheskaia diafragmalnaia gryzha [Strangulated right-sided traumatic diaphragmatic hernia.]. Al'manakh instituta khirurgii im. A.V. Vishnevskogo. 2017; 2: 148-149 [In Russ].

17.    Plaksin S.A., Kotelnikova L.P Dvustoronnie posttravmaticheskie diafragmalnye gryzhi [Two-sided post-traumatic diaphragmatic hernia.]. Vestnik khirurgii im. 1.1. Grekova. 2015; 174 (1): 47-51 [In Russ].

18.    Gali B.M., Bakari A.A., Wadinga D.W., Nganjiwa U.S. Missed diagnosis of a delayed diaphragmatic hernia as intestinal obstruction: a case report. Niger J Med. 2014; 23 (1): 83-85.

19.    Demuro J.P A delayed traumatic diaphragmatic hernia presenting with a bowel obstruction 20 years postinjury. J Clin Diagn Res. 2013; 7(4): 736-738. doi: 10.7860/JCDR/2013/4755.2898.

20.    De Nadai T.R., Lopes J.C., Inaco Cirino C.C. et al. Diaphragmatic hernia repair more than four years after severe trauma: Four case reports. Int J Surg Case Rep. 2015; 14: 72-76. doi: 10.1016/j.ijscr.2015.07.014.

21.    Wadhwa R., Ahmad Z., Kumar M. Delayed traumatic diaphragmatic hernia mimicking hydropneumothorax. Indian J Anaesth. 2014; 58 (2): 186-189. doi: 10.4103/ 0019-5049.130825.

22.    Falidas E., Gourgiotis S., Vlachos K., Villias C. Delayed presentation of diaphragmatic rupture with stomach herniation and strangulation. Am J Emerg Med. 2015; 33 (9): 1329. e1-3. doi: 10.1016/j.ajem.2015.02.052.

23.    Gao J.M., Du D.Y, Li H. et al. Traumatic diaphragmatic rupture with combined thoracoabdominal injuries: Difference between penetrating and blunt injuries. Chin J Traumatol. 2015; 18 (1): 21-26.

24.    Liao C.H., Chu C.H., Wu YT. et al. The feasibility and efficacy of laparoscopic repair for chronic traumatic diaphragmatic herniation: introduction of a novel technique with literaturereview. Hernia. 2016; 20 (2): 303-309. doi: 10.1007/s10029-015-1405-2.

 

Abstract:

The article presents an analysis of the choice of strategy for the treatment of ischemic stroke in the acute period, based on literature review.

Aim: was to develop the concept of effective thromboextraction (TE), based on the evaluation of factors influencing results of reperfusion treatment of ischemic stroke (IS), methods of endovascular restoration of cerebral blood flow

Materials and methods: meta-analysis of 44 sources of domestic and foreign literature is performed. The analysis of factors limiting the effectiveness of various reperfusion approaches and the analysis of modern methods of thrombectomy are performed.

Results: it is established, that SMAT (Solumbra) and PROTECT techniques have an advantage in comparison with aspiration approaches to thrombectomy in reducing the period to full reperfusion; methods with temporary occlusion of the source vessel (BGC) SAVE and PROTECT significantly reduce the risk of stroke spread to new vascular areas of the brain and increase the frequency of successful recanalization.

Conclusion: at present time, the PROTECT is the most effective technique in the frequency of successful recanalization, the degree and speed of achieved reperfusion, as well as in the prevention of distal embolization. Extrapolation of experience and principles from other sections of interventional radiology, development of new methods and strategies of brain reperfusion, depending on the morphology of thromboembolism, its size, localization and extent may contribute to improving results of endovascular treatment of ischemic stroke.

 

References

1.      Newsletter of the WHO №317, 2015 January.

2.      Jansen O., von Kummer R., Forsting M. et al. Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR Am J Neuroradiol. 1995; Nov-Dec; 16(10): 1977-86.

3.      Furlan A., Higashida R., Wechsler L. et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999 Dec; 282(21): 2003-11.

4.      Domashenko M.A., Maksimova M.Yu., GafarovaM.E. i dr. Personifikatsiya podkhodov k reperfuzionnoj terapii ishemicheskogo insul'ta [Personification of approaches to reperfusion therapy of ischemic stroke.] Annaly klinicheskojI experimental'noj nevrologii. 2017; 11(1): 7-13.

5.      Domashenko M.A., Panova K.V., Murtazalieva D.M. i dr. Personifikatsiya tromboliticheskoj terapii patsientov s ishemicheskim insulom [Personification of thrombolytic therapy in patients with ischemic stroke.] Medica mente. 2017; 3(1): 45-48.

6.      Emberson J. et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. - 2014; 384(9958): 1929-1935.

7.      Fransen P.S., Berkhemer O.A., Lingsma H.F. et al. Time to Reperfusion and Treatment Effect for Acute Ischemic Stroke: A Randomized Clinical Trial. JAMA Neurol. 2016 Feb; 73(2): 190-196.

8.      Seet R.C., Rabinstein A.A. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Cerebrovasc Dis. 2012; 34: 106-114.

9.      Yaghi S., Eisenberger A., Willey J.Z. Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment. JAMA Neurol. 2014; 71(9): 1181-1185.

10.    Yaghi S., Boehme A.K., Dibu J. et al. Treatment and Outcome of Thrombolysis-Related Hemorrhage: A Multicenter Retrospective Study. JAMA Neurol. 2015; 72(12): 1451-1457.

11.    Hacke W., Kaste M., Bluhmki E. et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359: 1317-1329.

12.    Nikoubashman O., Reich A., Pjontek R. et al. Postinterventional subarachnoid haemorrhage after endovascular stroke treatment with stent retrievers. Neuroradiology. 2014; Dec; 56(12): 1087-1096.

13.    Kornienko V.N., Pronin I.N. Diagnosticheskaya nejroradiologiya. [Diagnostic Neuroradiology]. Moscow. 2006: 1317 [In Russ].

14.    Urbach H. et al. Local intra-arterial thrombolysis in the carotid territory: does recanalization depend on the thromboembolus type? Neuroradiology 2002; 44: 695-699.

15.    Riedel C.H., Zimmermann P., Jensen-Kondering U. et al. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke. 2011;Jun; 42(6):1775-1777.

16.    Del Zoppo C.J. et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann. Neurol. - 1992, 32: 78-86.

17.    Mori E. et al. Intravenous recombinant tissue plasminogen activator in acute carotid territory stroke. Neurology, 1992; 42: 976-982.

18.    Shamalov N.A. Optimizatsiya reperfusionnoj terapii u patsientov s ishemicheskim insultom. Diss. dokt. med. nauk [Optimization of reperfusion therapy in patients with ischemic stroke. Dr. med. sci. diss.]. Moscow. 2012: 47 [In Russ].

19.    Lansberg M.G. et al. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke. - 2007; 38: 2275-2278.

20.    Bracard S., Ducrocq X., Mas J.L., et. al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016; Oct; 15(11): 1138-1147.

21.    Powers W.J., Rabinstein A.A., Ackerson T. et al. 2018 Guidelines for the Early Management of Patients with Acute Ischemic Stroke A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke 2018 Mar; 49(3): 46 - 99.

22.    Eva A. Mistry, Akshitkumar M. Mistry, Mohammad Obadah Nakawah, Mechanical Thrombectomy Outcomes with and without Intravenous Thrombolysis in Stroke Patients. Stroke. 2017 Sept; 48(9): 2450-2456.

23.    Kaesmacher J., Boeckh-Behrens T., Simon S. et al. Risk of Thrombus Fragmentation during Endovascular Stroke Treatment. AJNR Am J Neuroradiol. 2017 May; 38(5): 991-998.

24.    Nikoubashman O., Reich A., Pjontek R. et al. Postinterventional subarachnoid haemorrhage after endovascular stroke treatment with stent retrievers. Neuroradiology. 2014 Dec; 56(12): 1087-1096.

25.    Kang D.H., Park J. Endovascular Stroke Therapy Focused on Stent Retriever Thrombectomy and Direct Clot Aspiration: Historical Review and Modern Application J Korean Neurosurgical Society 2017 May; 60(3): 335-347.

26.    Kang D.H., Hwang YH., Kim YS. et al. Direct thrombus retrieval using the reperfusion catheter of the penumbra system: forced-suction thrombectomy in acute ischemic stroke. AJNR Am J Neuroradiol. 2011 Feb; 32(2): 283 - 287.

27.    Hwang YH., Kang D.H., Kim YW. et al. Outcome of forced-suction thrombectomy in acute intracranial internal carotid occlusion. J Neurointervent Surg. 2013; 5 (Suppl 1): 81-84.

28.    Turk AS, Spiotta A, Frei D, et al. Initial clinical experience with the ADAPT technique: a direct aspiration first pass technique for stroke thrombectomy. J Neurointervent Surg. 2014 Apr; 6(3): 231-237.

29.    Lee D.H., Sung J.H., Kim S.U. et al. Effective use of balloon guide catheters in reducing incidence of mechanical thrombectomy related distal embolization. Acta Neurochirurgica 2017 Sept; 159(9): 1671-1677.

30.    Kang D.H., Kim YW., Hwang YH. et al. Switching strategy for mechanical thrombectomy of acute large vessel occlusion in the anterior circulation. Stroke. 2013; Dec; 44(12): 3577-3579.

31.    Deshaies EM. Tri-axial system using the Solitaire-FR and Penumbra Aspiration Microcatheter for acute mechanical thrombectomy. J Clin Neurosci. 2013; 20(9): 1303-1305.

32.    Humphries W., Hoit D., Doss V.T. et al. Distal aspiration with retrievable stent assisted thrombectomy for the treatment of acute ischemic stroke. J Neurointerv Surg. 2015; 7(2): 90-94.

33.    Lee J.S., Hong J.M., Lee S.J. et al. The combined use of mechanical thrombectomy devices is feasible for treating acute carotid terminus occlusion. Acta Neurochir (Wien) 2013; 155(4): 635 - 641.

34.    Jadhav A.P, Aghaebrahim A., Horev A. et. al. Jovina, Stent Retriever-Mediated Manual Aspiration Thrombectomy for Acute Ischemic Stroke. Interv Neurol. 2017 Mar; 6(1-2): 16 - 24.

35.    Maegerlein C., Mцnch S., Boeckh-Behrens T. et al. PROTECT: PRoximal balloon Occlusion TogEther with direCt Thrombus aspiration during stent retriever thrombectomy - evaluation of a double embolic protection approach in endovascular stroke treatment. J Neurointerv Surg. 2017; 0: 1 - 5.

36.    Maus V., Behme D., Kabbasch C. et al. Maximizing First-Pass Complete Reperfusion with SAVE. Clin Neuroradiol. 2017 Feb 13. doi: 10.1007/s00062-017-0566-z.

37.    Wiesmann M., Brockmann M.A., Heringer S. et al. Active push deployment technique improves stent/vesselwall interaction in endovascular treatment of acute stroke with stent retrievers. J Neurointerv Surg. 2017 Mar; 9(3): 253 - 256.

38.    Nikoubashman O., Alt J.P, Nikoubashman A. et al. Optimizing endovascular stroke treatment: removing the microcatheter before clot retrieval with stent-retrievers increases aspiration flow. J Neurointerv Surg. 2017 May; 9(5): 459-462.

39.   Volodyukhin M.U., Novozhilova A.A. Sposob vosstanovleniya krovotoka pri sochetannom tromboze vnutrennej sonnoj I srednej mozgovoj arterij [A method for restoring of blood flow in a combined thrombosis of the internal carotid and middle cerebral artery]. Patent RF №2629046, 2016.

40.    Volodyukhin M.U. Rentgenendovaskulyarnyj metod vosstanovleniya cerebral'nogo krovotoka pri ostroy tandemnoj okklyuzii vnutrennej sonnoj arterii s razvitiem embolii v srednyuyu mozgovuyu arteriyu. [Endovascular method of cerebral blood flow restoration in acute tandem occlusion of the internal carotid artery with embolism development in the middle cerebral artery.] Kazanskij meditsinskijzhurnal. 2016; 97(3): 457-460.

41.    Noser EA, Shaltoni HM, Hall CE, et al. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke 2005; 36: 292-296.

42.    Nakano S., Iseda T., Yoneyama T. et al. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis. Stroke 2002; 33: 2872-2876.

43.    Qureshi AI, Siddiqui AM, Suri MF. et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002; 51: 1319-1329.

44.    von Gadow N., Nikoubashman O., Freiherr J. et al. Endovascular stroke treatment now and then-procedural and clinical effectiveness and safety of different mechanical thrombectomy techniques over time. Quant Imaging Med Surg. 2017 Feb; 7(1): 1-7.

 

Abstract:

Article is devoted to a problem of radiation dose during multi-spiral computed tomograpy of abdominal cavity. This review describes the basic and additional methods of reducing the radiation exposure at CT with intravenous contrast enhancement. Results of researches conducted in recent years were considered and analyzed. Nuances of reduction of radiation exposure in specific cases were analyzed. Prospects of reducing the dose of contrast agent in abdominal MDCT with IV contrast media administration were estimated. The importance of control of radiation exposure of patients is proved.

 

References

1.      Mettle Г F.A., Jr. Bhargavan M., Faulkner K., Gilley D.B. et al. Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other radiation sources-1950-2007. Radiology. 2009; (253): 520-531.

2.      National Council on Radiation Protection and Measurements. Ionizing radiation exposure of the population of the United States (NCRP Report No 160) // National Council on Radiation Protection and Measurements. - 2009.

3.      Brenner D.J. Minimising medically unwarranted computed tomography scans. Ann ICRP. 2012 Oct-Dec; 41(3- 4):161-169.

4.      Ng M., Fleming T., Robinson M, Thomson B. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Aug 30; 384(9945): 746.

5.      Yu L., Fletcher J.G., Grant K.L., Carter R.E. et al. Automatic Selection of Tube Potential for Radiation Dose Reduction in Vascular and Contrast-Enhanced Abdominopelvic CT. Medical physics 37.1 (2010): 234-243.

6.      Yanaga Y, Awai K., Nakaura T., Utsunomiya D. et al. Hepatocellular Carcinoma in Patients Weighing 70 kg or Less: Initial Trial of Compact-Bolus Dynamic CT With Low-Dose Contrast Material at 80 kVp. AJR Am J Roentgenol. 2011 Jun;196(6): 1324-1331.

7.      Hur S., Lee J.M., Kim S.J., Park J.H. et al. 80-kVp CT using Iterative Reconstruction in Image Space algorithm for the detection of hypervascular hepatocellular carcinoma: phantom and initial clinical experience. Korean J Radiol.(2012);13: 152-164.

8.      Winklehner A., Karlo C., Puippe G., Schmidt B. Raw data-based iterative reconstruction in body CTA: evaluation of radiation dose saving potential. Eur Radiol. 2011 Dec;21(12): 2521-2526.

9.      Brenner D.J., Hall E.J. Computed tomography an increasing source of radiation exposure. N Engl J Med. 2007 Nov 29; 357(22): 2277-2284.

10.    Scialpi M., Cagini L., Pierotti L., De Santis F. et al. Detection of small (<2 cm) pancreatic adenocarcinoma and surrounding parenchyma: correlations between enhancement patterns at triphasic MDCT and histologic features. BMC Gastroenterol. 2014 Jan (21): 14-16.

11.    Cabrera F., Preminger G.M., Lipkin M.E. As low as reasonably achievable: Methods for reducing radiation exposure during the management of renal and ureteral stones. Indian J Urol. 2014 Jan; 30(1): 55-59.

12.    Marin D., Choudhury K.R., Gupta RT, Ho L.M. et al. Clinical impact of an adaptive statistical iterative reconstruction algorithm for detection of hypervascular liver tumours using a low tube voltage, high tube current MDCT technique. Eur Radiol. 2013; (23): 3325-3335.

13.    Baker M.E., Dong F., Primak A., Obuchowski N.A. et al. Contrast-to-noise ratio and low-contrast object resolution on full- and low-dose MDCT: SAFIRE versus filtered back projection in a low-contrast object phantom and in the liver. AJR Am J Roentgenol. 2012 Jul; 199(1): 8-18.

14.    Li Q., Gavrielides M.A., Zeng R., Myers K.J. et al. Volume estimation of low-contrast lesions with CT: a comparison of performances from a phantom study, simulations and theoretical analysis. Phys Med Biol. 2015 Jan 21; 60(2): 671-688.

15.    Noda Y, Kanematsu M., Goshima S., Kondo H. et. al. Reducing iodine load in hepatic CT for patients with chronic liver disease with a combination of low-tube- voltage and adaptive statistical iterative reconstruction. Eur J Radiol. 2015 Jan; 84(1): 11-18.

16.    Noda Y, Kanematsu M., Goshima S., Kondo H. et. al. Reduction of iodine load in CT imaging of pancreas acquired with low tube voltage and an adaptive statistical iterative reconstruction technique. J Comput Assist Tomogr. 2014 Sep-Oct;38(5): 714-20.

17.    Choi J.W., Lee J.M., Yoon J.H., Baek J.H. et al. Iterative reconstruction algorithms of computed tomography for the assessment of small pancreatic lesions: phantom study. J Comput Assist Tomogr. 2013; (37): 911-923.

18.    Desmond A.N., O’Regan K., Curran C., McWilliams S. et al. Crohn’s disease: factors associated with exposure to high levels of diagnostic radiation. Gut. 2008 Nov; 57(11): 1524-1529.

19.    Patino M., Fuentes J.M., Singh S., Hahn P.F. et al. Iterative Reconstruction Techniques in Abdominopelvic CT: Technical Concepts and Clinical Implementation. AJR Am J Roentgenol. 2015 Jul; 205(1): W19-31.

20.    Lambert L., Ourednicek P., Jahoda J., Lambertova A. et al. Model-based vs hybrid iterative reconstruction technique in ultralow-dose submillisievert CT colonography. Br J Radiol. 2015 Apr; 88(1048): 20140667.

21.    Fletcher J.G., Hara A.K., Fidler J.L., Silva A.C. Observer performance for adaptive, image-based denoising and filtered back projection compared to scanner-based iterative reconstruction for lower dose CT enterography. Abdom Imaging. 2015 Jun; 40(5): 1050-1059.

22.    Habibzadeh M.A., Ay M.R., Asl A.R., Ghadiri H. et al. Impact of miscentering on patient dose and image noise in x- ray CT imaging: phantom and clinical studies. Phys Med. 2012 Jul; 28(3): 191-199.

23.    Goo H.W. CT radiation dose optimization and estimation: an update for radiologists. Korean J Radiol. 2012 Jan-Feb; 13(1): 1-11.

24.    Aznaurov V.G., Kondratiev E.V., Oganesyan N.K., Karmazanovsky G.G. MSKT gepatopankreatoduodenalnoj zony s ponizhennoj luchevoj nagruzkoj: opyt prakticheskogo primenenija. [Low-Dose Hepatopancreatic MDCT: Practical Experience of Applicability]. Medical Visualization. 2017 ;(2): 28-35 [In Russ.].

 

Abstract:

Aim: was to evaluate the importance of pre-procedural cephalic vein (CV) angiography for pacemaker (PM) implantation better results.

Methods: 94 patients (pts) (55 women) aged 23-93 years old were included into the study Pts were randomized into two groups (1:1). Group I (n=47; 24 females): angiography of CV was made before PM implantation. In Group II PM implantation was performed without previously angiography Endpoints: time of procedure, efficacy doses

Results: fluoroscopy time and length of procedure in group I were less than in group II (p=0.0002 and p<0.0001 respectively). Four types of CV anatomy were found. Thus, I type of CV anatomy was most favorable for procedure due to angle between v.cephalica and subclavian vein less then 900. Conclusion: the acute angle of cephalic-axillary confluence is the most common type of CV anatomy and is associated with most success of procedure. Implantation of PM taking into consideration variants of anatomical structure of v cephalica in the subclavian area can reduce the radiation dose, possibility of complications, as well as reduce the duration of the intervention. Preoperative evaluation of the anatomical structure of veins of upper limbs before implantation of permanent pacemakers is a rational approach that allows choosing the method of conducting endocardial electrodes in the right heart.

 

 References

1.      Raatikainen M.J., Arnar D.O., Zeppenfeld K., et al. Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association. Europace. 2015 Jan; 17, i1-i75.

2.      Hindricks G., Camm J., Merkely B., et al. The current status of cardiac electrophysiology in ESC members countries. The EHRA White Book 2016.

3.      Hindricks G., Camm J., Merkely B., et al. The current status of cardiac electrophysiology in ESC members countries. The EHRA White Book 2017.

4.      Poole J., Gleva M., Mela T., et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010 Oct 19; 122 (16): 1553-1561.

5.      Bongiorni M., Proclemer A., Dobreanu D., et al. Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey. Europace. 2013 Nov; 15 (11): 1664-1668.

6.      Furman S. Venous cutdown for pacemaker implantation. Ann Thorac Surg. 1986 Apr; 41 (4): 438-439.

7.      Parsonnet V., Bernstein A., Lindsay B., et al. Pacemaker-implantation complication rates: an analysis of some contributing factors. J Am Coll Cardiol. 1989 Mar 15; 13 (4): 917-921.

8.      Atlas sravnitelnoy rentgenohirurgicheskoy anatomii. [Atlas of comparative radiosurgical anatomy] Pod red. L.S. Kokova. M.: Radiologiya-Press. 2012; 388 s [ In Russ].

9.      Bokeriya L.A., Revishvili A.Sh., Golitsyn S.P., Egorov D.F., Popov S.V., Sulimov V.A., et all. Klinicheskiye rekomendatsii po provedeniyu elektrofiziologicheskikh issledovaniy. kateternoy ablyatsii i primeneniyu implantiruyemykh antiaritmicheskikh ustroystv. Vserossiyskoye nauchnoye obshchestvo spetsialistov po klinicheskoy elektrofiziologii. Aritmologii i kardiostimulyatsii (VNOA). [Clinical recommendations for conducting electrophysiological studies, catheter ablation and the use of implantable antiarrhythmic devices. All-Russian scientific society of specialists in clinical electrophysiology, arrhythmology and pacemaking (VNOA)] 2013; 15 s [ In Russ].

10.    Magney J., Flynn D., Parsons J., et al. Anatomical mechanisms explaining damage to pacemaker leads, defibrillator leads, and failure of central venous catheters adjacent to the sternoclavicular joint. Pacing Clin Electrophysiol. 1993 Mar;16 (3 Pt 1):445-457.

11.    Chan N., Kwong N., Cheong A., et al. Venous access and long-term pacemaker lead failure: comparing contrast-guided axillary vein puncture with subclavian puncture and cephalic cutdown. Europace (2016), euw147.

12.    Shima H., Ohno K., Shimizu T., et al. Anatomical study of the valves of the superficial veins of the forearm. J Craniomaxillofac Sur 1992; 20: 305-309.

13.    Tse H., Lau C., Leung S., et al. A cephalic vein cutdown and venography technique to facilitate pacemaker and defibrillator lead implantation. Pacing Clin Electrophysiol. 2001 Apr; 24 (4 Pt 1): 469-473.

14.    Knight B., Curlett K., Oral H., et al. Clinical predictors of successful cephalic vein access for implantation of endocardial leads. J Interv Card Electrophysiol. 2002 Oct; 6 (2): 177-180.

 

 

Abstract:

Aim: was to assess efficiency of mechanical thrombectomy using stent-retriever pREset in patients with acute ischemic stroke (AIS).

Materials and methods: study included 27 patients with AIS. The average age of patients was 66 years, female - 12(44,4%). The average NIHSS was 20. Occlusion of middle cerebral artery (MCA) was observed in 21(77,8%) patients, internal carotid artery (ICA) - 4 patients, basilar artery - 2 patients.

Results: effective recovery of cerebral blood flow (TICI2b-3) was achieved in 22 patients (81,5%). The frequency of distal embolisms was 11,1%. The frequency of symptom hemorrhagic transformation was 7,4%. A favorable neurological outcome (mRs 0-2) was observed in 29,6% of patients, mortality was 25,9%.

Conclusions: the use of stent-retriever pREset allows to efficiently restore blood flow during occlusion of large cerebral arteries.

 

References

1.      Powers W., Rabinstein A., Ackerson T., et al. 2018 Guidelines for the early management of patients with acute ischemic stroke a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2018; (49): DOI 10.1161/ STR.0000000000000158.

2.      Savello A.V., Voznyuk I.A., Svistov D.V. Vnutrisosudistoe lechenie ishemicheskogo insul'ta v ostrejshem periode (klinicheskie rekomendacii) [Intravascular treatment of ischemic stroke in the acute period (clinical recommendations)]. Sankt-Peterburg. 2015; [In Russ].

3.      Volodyuhin M.YU., Hasanova D.R., Dyomin T.V., i dr. Vnutriarterial'naya reperfuzionnaya terapiya u pacientov s ostrym ishemicheskim insul'tom [Intraarterial reperfusion therapy in patients with acute ischemic stroke.]. Medicinskij sovet. 2015; (10): 6-11 [In Russ].

4.      Krylov V.V., Savello A.V., Volodyuhin M.YU. Rentgenehdovaskulyarnoe lechenie ostrogo ishemicheskogo insul'ta [Endovascular treatment of acute ischemic stroke.]. Rukovodstvo. Moskva. 2017; 120 s [In Russ].

5.      Schwaiger B., Kober F., Gersing A., et al. The pREset stent retriever for endovascular treatment of stroke caused by MCA occlusion: safety and clinical outcome. Clin Neuroradiol. 2016; (26): 47-55.

6.      Machi P., Jourdan F., Ambard D., et. al. Experimental evaluation of stent retrievers mechanical properties and effectiveness. J. Neurolntervent. Surg. 2016; (0): 1-7.

7.      Prothmann S., Schwaiger B., Gersing A., et al. Recanalization of Thrombo-Embolic Ischemic Stroke with pREset (ARTESp): the impact of occlusion time on clinical outcome of directly admitted and transferred patients. J. Neuro. Intervent. Surg. 2017; (9): 817-822.

8.      Shams T., Zaidat O., Yavagal D., et al. Society of Vascular and Interventional Neurology (SVIN) Stroke Interventional Laboratory Consensus (SILC) criteria: A 7M management approach to developing a stroke interventional laboratory in the era of stroke thrombectomy for large vessel occlusions. Intervent. Neurol. 2016; (5): 1-28.

9.      Seker F., Pfaff J., Wolf M., et al. Correlation of thrombectomy maneuver count with recanalization success and clinical outcome in patients with ischemic stroke. Am. J. Neuroradiol. 2017; (38): 1368-1371.

10.    Mokin M., Nagesh S., Ionita C., et al. Comparison of modern stroke thrombectomy approaches using an in vitro cerebrovascular occlusion model. Am. J. Neuroradiol. 2016; (36): 547-551.

11.    Raymond J., Ghostine J., Khoury N., et al. Endovascular interventions for acute stroke: past practice and current research. J. Neurolntervent.Surg. 2017; (9): 1-4.

 

Abstract:

Aim: was to evaluate possibilities of dual-energy multislice computed tomography (MSCT) in determining the composition of kidney stones.

Materials and methods: a dual-energy MSCT was performed in 60 patients with urolithiasis of different locations (63.3% male, 36.7% female). Two groups of patients were identified: with mixed (simultaneously, the patient was diagnosed with stones of urate and non-urate structure) and nonurate composition of stones. Out of 60 patients, 16 (10 patients from a mixed group and 6 from a

non-urate) were subjected to chemical analysis of stones by IR-spectrometry and X-ray phase analysis. Obtained data were compared with data of the dual-energy MSCT Results: in most cases (93,7 %), results of the chemical analysis of stones confirmed the structure of uroliths obtained by the dual-energy MSCT method.

Conclusions: The method of dual-energy multislice computed tomography is effective in determining the composition of stones of the urinary system, appears to be a promising method in the diagnosis of urolithiasis, and expands possibilities of modern urology in planning patients with urolithiasis.

 

References

1.      Akopyan A.V., Zorkin S.N., Vorobyova L.E., Shakhnovsky D.S., Mazo A.M. Ocenka sostava konkrementa v lechenii mochekamennoj bolezni. [Evaluation of the concrement in the treatment of urolithiasis.] Detskaya khirurgiya. 2015; 19(1): 42-45 (in Rus).

2.      Turk C., Knoll Т., Petrik А., Sarica K., Straub M., Seitz C. Guidelines on urolithiasis. European Association of Urology. 2014; 128 p.

3.      Suslyaeva N.M. Vozmozhnosti luchevyh metodov issledovaniya v diagnostike visceral'nogo ozhireniya. [Possibilities of radiation research methods in the diagnosis of visceral obesity.] Bulleten Sibirskoy Meditsini. 2010; 9(5): 121-128 (in Rus).

4.      Klimkova M.M., Sinitsin V.V., Mazurenko D.A., Bernikov E.V. Vozmozhnosti luchevyh metodov Perspektivy primeneniya dvuhehnergeticheskoj komp'yuternoj tomografii v diagnostike mochekamennoj bolezni i opredelenii himicheskogo sostava mochevyh kamnej (obzor literatury). v diagnostike visceral'nogo ozhireniya. [Prospects for the use of dual-energy computed tomography in the diagnosis of urolithiasis and the determination of the chemical composition of urinary stones (literature review).] Medical Imaging. 2016; 6: 84-92 (in Rus).

5.      Graser A. Dual energy CT characterization of urinary calculi: initial in vitro and clinical experience. Invest Radiol. 2008; 43(2): 112-119.

6.      Kapsargin F.P., Dyabkin E.V., Berezhnoy A.G. Sovremennye podhody hirurgicheskogo lecheniya mochekamennoj bolezni. [Modern approaches to the surgical treatment of urolithiasis.] Novosti khirurgii. 2013; 21(1): 101-106 (in Rus).

7.      Yanenko E.K., Merinov D.S., Konstantinova O.V., Epishov V.A., Kalinichenko D.N. Sovremennye tendencii v ehpidemiologii, diagnostike i lechenii mochekamennoj bolezni. [Modern trends in the epidemiology, diagnosis and treatment of urolithiasis]. Eхperim. I klinich. urology. 2012; 3: 19-24 (in Rus).

8.      Gucuk. A., Uyeturk U. Usefulness of hounsfield unit and density in the assessment and treatment of urinary stones. World J. Nephrol. 2014; 3(4): 282-286.

9.      Kapanadze L.B., Serova N.S., Rudenko V.I. Aspekty primeneniya dvuhehnergeticheskoj komp'yuternoj tomografii v diagnostike mochekamennoj bolezni. [Aspects of the use of dual-energy computed tomography in the diagnosis of urolithiasis.] Russian electronic journal of radiation diagnostics. 2017;1(3):165-173 (in Rus).

10.    Kambadakone A.R., Eisner B.H., Catalano O.A., Sahani D.V. New and evolving concepts in the imaging and management of urolithiasis: urologists' perspective. Radiographics. 2010; 30(3):603-623. DOI: 10.1148/rg. 303095146.

11.    Eliahou R., Hidas G., Duvdevani M., Sosna J. Determination of renal stone composition with dual-energy computed tomography: an emerging application. Seminars in Ultrasound, CT and MRI. 2010; 31(4): 315-320. DOI: 10.1053/j.sult.2010.05.002.

12.    Leng S., Huang A., Cardona J.M., Duan X., Williams J.C., McCollough C.H. Dual-Energy CT for Quantification of Urinary Stone Composition in Mixed Stones: A Phantom Study. American Journal of Roentgenology. 2016;207: 321-329. DOI: 10.2214/AJR.15.15692.

13.    Yadav B., Maharjan S. Characterization of Urinary Tract Stones with Dual Energy Computed Tomography. Radiography Open. 2017; 3(1): 11. DOI: 10.7577 /radopen.2001

 

Abstract:

Aim: was to identify features of disorders of brain perfusion and diffusion in venous stroke anc arterial stroke by CT and MRI.

Material and methods: in groups with acute venous stroke due dural sinustrombosis without primary hemorrhage (n=39) and atherothrombotic stroke (n=33) were performed perfusion CT (with relative MTT, CBV CBF) and MRI (with relative DWI and ADC), besides routine CT and CTA.

Results: rMTT in central areas were not different, but in venous stroke perifocal zone rMTT=1.27±0.2 vs. 1.68±0.6 in arterial stroke (p=0.00001); rCBF=0.76±0.5 vs. 0.36±0.2 focal and 1.28±0.25 vs. 0.69±0.26 perifocal (p=0.00001); rCBV=0.89±0.4 vs. 0.55±0.25 focal (p=0.0000001) and perifocal 1.28±0.25 vs. 1.07±0.42 (p=0,0006); rDWI = 1.69±0.34 vs. 2.11±0.47 focal (p=0.0001) and rDWI=1.1±0.4 vs. 2.14±0.32 perifocal (p=0.0039); rADC in central zone of venous lesions average 1.26±0.99 vs. 0.63±0.25 arterial stroke (p=0.0018); perifocal no different. A high correlation (r=0.95) was found when comparing the area affected (cm2) on CBV and DWI maps.

Conclusion: MR or CT perfusion and MR diffusion imaging in acute stroke make it possible to distinguish between primary arterial ischemic brain damage from congestive plethora due venous stroke. Perfusion-diffusion mismatch venous stroke has a different origin than in arterial stroke. If infarction is not formed benign hyperemia (not oligemia) - early vasogenic edema identified like basis of venous stroke. Venous ischemia is secondary and is associated with an externally constriction of microcirculation.

 

References

1.      Palena L.M., F.Toni, V.Piscitelli et al. CT Diagnosis of Cerebral Venous Thrombosis: Importance of the First Examination for Fast Treatment. The Neuroradiology J. 2009;22 :137-49.

2.      Hacke W., Hennerici M.G., Gelmers H.J., Kramer G. Cerebral ischemia. Springer Verlag BerlinHeidelberg. 1991; 238.

3.      Tarulli A. Neurology. A Clinician’s Approach. CambridgeUniversity Press. 2010; 240.

4.      Saposnik G., Barinagarrementeria F., Brown R.D. et al. Diagnosis and management of cerebral venous thrombosis: A statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42: 1158-92.

5.      Kawaguchi T., Kawano T., Kaneko Y et al. Classification of venous ischemia with MRI. J. Clin. Neurosci. 2001; 8(Suppl. 1): 82-88.

6.      Nentwich L.M., Veloz W. Neuroimaging in acute stroke. Emerg Med Clin North Am. 2012; 30: 659-80.

7.      Luby M., Ku K.D., Latour L. Et al. Visual perfusion-diffusion mismatch is equivalent to quantitative mismatch. Stroke. 2011;42:1010-14.

8.      Semenov S.E., Kovalenko A.V., Khromov A.A. et al. Kriterii diagnostiki negemorragicheskogo venoznogo insul'ta metodami rentgenovskoj mul'tispiral'noj komp'yuternoj (MSKT) i magnitno-rezonansnoj tomografii (MRT). [Non-haemorrhagic venous stroke diagnosis criteria by multisliced computed tomography (MSCT) and magnetic resonsnce imaging (MRI).] Complex Issues of Cardiovascular Diseases. 2012;1:43-53 [In Russ.].

9.      Portnov YU.M., Semenov S.E., Kokov A.N. Perfuzionnaya komp'yuternaya tomografiya v ocenke sostoyaniya cerebral'noj gemodinamiki u pacientov s ishemicheskoj bolezn'yu serdca, perenesshih koronarnoe shuntirovanie v usloviyah iskusstvennogo krovoobrashcheniya. [Perfuison CT in assessment of cerebral hemodynamics in coronary artery disease patients undergoing on-pump CABG.] Sibirskii meditsinskii zhurnal. 2016;31(2):34-37 [In Russ.]

10.    Shatohina M.G. Magnitno-rezonansnaya i komp'yuternaya tomografiya v diagnostike negemorragicheskogo insul'ta, vyzvannogo cerebral'nym venoznym trombozom. [MRI and CT in diagnosis of non-hemorrhagic stroke, caused by venous thrombosis]Diss. kand. med. nauk. Tomsk. 2012; 193 [In Russ].

11.    Koenig M., Kraus M., Theek C. et al. Quantitative assessment of ischemic brain by means of perfusion related parameters derived from perfusion CT. Stroke. 2001; 322: 431-7.

12.    Nguyen T.B., Lum C., Eastwood J.D. et al. Hyperperfusion on perfusion computed tomography following revascularization for acute stroke. Acta Radiol. 2005; 46(6):610-15. doi: 10.1080/02841850510021607.

13.    Semenov S., MoldavskayaI., Shatokhina M. et al. How to distinguish between venous and arterial strokes and why? The Neuroradiology J. 2011; 24: 289-99.

14.    Oray D., Limon O., Ertan C. et al. Inter-observer agreement on diffusion-weighted magnetic resonance imaging interpretation for diagnosis of acute ischemic stroke among emergency physicians. Turk J Emerg Med. 2015; 15(2): 64-68. doi: 10.5505/1304.7361.2015.32659.

15.    Semenov S.E., Moldavskaya I.V., Semenov A.S., Barbarash L.S. Kriterii MR- i KT-differencial'noj diagnostiki venoznogo I arterial'nogo insul'ta. [The MR- and CT-Differential Diagnostic Criteria of Venous and Arterial Insult.] Meditsinskaya vizualizatsiya. 2010; 6: 41-9 [In Russ.].

16.    Mullins M.E., Grant P.E., Wang B. et al. Parenchymal abnormalities associated with cerebral venous sinus thrombosis: assessment with diffusion-weighted MR imaging. Am J Neuroradiol. 2004; 25: 1666-75.

17.    Semenov S.E., Moldavskaya I.V., Kovalenko A.V. et al. Ocenka rutinnyh topomorfometricheskih kriteriev mul'tispiral'noj komp'yuternoj tomografii i magnitno-rezoansnoj tomografii v diagnostike negemorragicheskogo insul'ta, vyzvannogo cerebral'nym venoznym trombozom. [Evaluation of routine topomorphometric criteria of multispiral computed tomography and magnetic resonance imaging in the diagnosis of non-hemorrhagic stroke, caused by cerebral venous thrombosis.] Clinical Physiology of Circulation. 2013; 3: 37-45 [In Russ.].

18.    Leach J.L., Fortuna R.B., Jones B.V., Gaskill-Shipley M.F. Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics. 2006; 26(suppl 1): 19-41.

19.    Bousser M.G., Ferro J.M. Cerebral venous thrombosis: an update. Lancet Neurol. 2007; 6: 162-70.

20.    Semenov S., Portnov Yu., Semenov A. et al. Neuroimaging patterns of cerebral hyperperfusion. IOP Conf. Series: Journal of Physics: Conf. Series. 2017; 886: 012014 doi :10.1088/1742-6596/886/1/012014

21.    Gonzalez R.G., Hirsch J.A., Koroshetz W.J. et al. Acute Ischemic Stroke Imaging and Intervention. Springer. Verlag. Berlin. Heidelberg. 2006; 268.

22.    Semenov S.E., Moldavskaya I.V., Shatokhina M. G. et al. CT and MRI patterns of focal hyperemia in venous insult. Neuroradiology. 2012; 54 (Suppl. 1): 176.

23.    Powers W.J., Derdeyn C.P, Biller J. et al. 2015 American heart association/American stroke association focused update of the 2013. Guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment. A guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2015; 46: 3024-39. DOI: 10.1161/STR.0000000000000074.

24.    Luchevaya diagnostika i terapiya zabolevanij golovy i shei: nacional'noe rukovodstvo [Radiation diagnostics and therapy of head and neck diseases: the national leadership ] / gl. red. toma T. N. Trofimova. M.: GEOTAR-Media, 2013; 888 s. (Seriya «Nacional'nye rukovodstva po luchevoj diagnostike i terapii» / gl. red. serii S.K. Ternovoj) [In Russ].

25.    Bogdanov EH.I., Hasanov I.A. Differencial'naya diagnostika infarktov v bassejne zadnih mozgovyh arterij i sindroma zadnej obratimoj lejkoehncefalopatii. [Differential diagnosis of infarctions in the basin of the posterior cerebral arteries and the syndrome of posterior reversible leukoencephalopathy] Mat. Rossijsk. nauchn.-prakt. konf. «Narusheniya mozgovogo krovoobrashcheniya: diagnostika, profilaktika, lechenie». Irkutsk. 2011; 54-5 [In Russ.].

 

Abstract:

Aim: was to evaluate the prognostic effectiveness of the method of cardiac magnetic resonance imaging (MRI) in patients with ischemic heart disease (IHD) with dysfunctional myocardium after endovascular interventions

Materials and methods: a total of 114 patients were included in the study Inclusion criteria: myocardial infarction in previously; myocardial ischemia according to stress tests; occlusion or subtotal stenosis of one or more coronary arteries according to digital angiography (SYNTAX score <32); viable myocardium in the zone of the occluded/stenotic artery; heart failure of I-III functional class (NYHA); left ventricular ejection fraction (LVEF) less than 50%. Patients were randomized into 2 equivalent groups: in the I group, myocardial viability was determined by cardiac magnetic resonance imaging (MRI) with delayed contrast, in the II group - by stress-echocardiography with dobutamine. All patients underwent stenting of coronary arteries in the zone of the viable myocardium with drug-eluting stents. Long-term results of treatment were followed to 12 months after endovascular intervention in all patients.

Results: all patients had a significant improvement in the local contractility of the myocardium after performed endovascular myocardial revascularization. After 12 months, a significant decrease in the mass fraction of ischemic viable myocardium in the peri-infarction zone was noted among patients from group I, compared with preoperative data (32.8 ± 2.4 and 24,3±2,3%, respectively, p<0.05). Thus, in I group the volume of ischemic myocardium decreased by 26%. In all studied groups, there was a significant increase in LVEF, compared with data obtained when the patient was discharged from the hospital. Survival in the I group was 100%, whereas in the II group - 97.3% (p> 0.05). The incidence of non-fatal MI was 0.88 and 3.5% in groups I and II, respectively (p <0.05).

Conclusion: cardiac MRI with delayed contrast is more effective and sensitive for diagnosis of myocardial viability and patient prognosis after endovascular intervention, compared with stress echocardiography with dobutamine. 

 

References

1.      Mironkov A.B. Revaskulyarizatsiya miokarda v lechenii patsientov s sistolicheskoi disfunktsiei levogo zheludochka: sostoyanie problemy. [Myocardial revascularization in the treatment of patients with left ventricular systolic dysfunction: the state of the problem]. Vestnik transplantologii i iskusstvennykh organon 2013; XV(2): 156-163 [In Russ].

2.      Katritsis D.G., loannidis J.P. Percutaneous coronary intervention versus conservative therapy in non-acute coronary artery disease: a meta-analysis. Circulation. 2005; 111(22):2906-2912.

3.      Pitt M., Dutka D., Pagano D. The natural history of myocardium awaiting revascularisation in patients with impaired left ventricular function. Eur Heart J. 2004; 25: 500 -507.

4.      Saidova, M.A., Belenkov Yu.N., Akchurin R.S. Diagnosticheskaya tsennost i prognosticheskie vozmozhnosti dobutaminovoi stress-ekhokardiografii i prefuzionnoi stsintigrafii miokarda v vyyavlenii zhiznesposobnogo miokarda u bol'nykh ishemicheskoi bolezn'yu serdtsa s vyrazhennoi disfunktsiei levogo zheludochka i otbore patsientov na khirurgicheskuyu revaskulyarizatsiyu. [Diagnostic value and prognostic possibilities of dobutamine stress echocardiography and myocardial perfusion scintigraphy in the detection of viable myocardium in patients with coronary heart disease with severe left ventricular dysfunction and selection of patients for surgical revascularization]. Kardiobgiya. 1999; (8):4-12 [In Russ].

5.      Vorozhtsova I.N., Bukhovets I.L., Bezlyak V.V. et al. Sopostavlenie rezultatov stress-ekhokardiografii i stsintigrafii miokarda s 99m-tekhnetrilom i probe s sublingval'nym priemom nitroglitserina v otsenke zhiznesposobnosti miokarda u bol'nykh s postinfarktnym kardiosklerozom. [Comparison of results of stress echocardiography and myocardial scintigraphy with 99m-technetril and a sample with sublingual nitroglycerin intake in assessing the viability of the myocardium in patients with postinfarction cardiosclerosis]. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2001;(3):15-20 [In Russ]

6.      Shinkel A.F., Bax J.J., Poldermans D. et al. Hibernating myocardium: diagnosis and patient outcomes. Curr. Probl. Cardiol. 2007; (32):375-410.

7.      Saurabh J., Scott D.F., Deborah H.K. Revascularization in heart failure in the post-STICH era. Curr. Heart Fail. 2013; (10):365-372.

8.      Kwon D.H., Hachamocitch R., Popovic Z.B. et al. Survival in patients with severe ischemic cardiomyopathy undergoing revascularization versus medical therapy: association with end-systolic volume and viability. Circulation. 2012; (126):3-8.

9.      Windecker S., Kolh P., Alfonso F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2014; (35):2541-2619.

10.    Dickstein K., Cohen-Solal A., Filippatos G.,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology: Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart. J. 2008; 29: 2388-2442.

11.    Got'e S.V., Mironkov A.B., Sakhovskii S.A. Sostoyanie problemy revaskulyarizatsii miokarda u patsientov s vyrazhennoi sistolicheskoi disfunktsiei levogo zheludochka [The state of the problem of myocardial revascularization in patients with severe left ventricular systolic dysfunction.] Vestnik transplantologii i iskusstvennykh organov. 2017; 19(1): 103-110 [In Russ].

12.    Camici P.G., Kumak S.P., Rimoldi O.E. Stunning, Hybernating and Assesment of Myocardial Viability. Circulation. 2008; (117):103-114.

13.    Trufanov G.E., Rud' S.D., Zheleznyak S.E. MRT v diagnostike ishemicheskoi bolezni serdtsa: ucheb.posobie. [MRI in the diagnosis of coronary heart disease: education guidance]. SPb.: Izd-vo «ELBI-SPb». 2012;. 63s [In Russ].

14.    West A.M., Kramer C.M. Cardiovascular magnetic resonance imaging of myocardial infarction, viability and cardiomyopathies. Curr. Probl. Cardiol. 2010; (35): 176-220.

15.    Kramer C.M., Schulz-Menger J., Bluemke D.A., et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustee's task force on standardized protocols. J. Cardiovasc. Magn. Reson. 2013; 15(1): 35.

16.    Wellnhofer E., Olariu A., Klein C. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation. 2004; 109(18): 2172-4.

17.    Gerber B.L., Rousseau M.F., Ahn S.A., et al. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy. Journal of the AmericanCollege of Cardiology. 2012; 59(9): 825-835.

18.    Bax J.J., Poldermans D., Elhendy A., et al. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Current Problems in Cardiology. 2001; 26 (2): 141-186.

19.    Underwood S.R., Bax J.J., vom Dahl J., et al. Imaging techniques for the assessment of myocardial hibernation: report of a Study Group of the European Society of Cardiology. European Heart Journal. 2004; 25(10): 815836.

20.    Romero J., Xue X., Gonzales W. et al. CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective. JACC Cardiovasc. Imaging. 2012; 5(5): 494-508.

 

Abstract:

Aim: to study the contractility of left ventricle (LV) and left atrium (LA) by speckle tracking imaging (STI), vector analysis and the diagram method in patients with mitral regurgitation (MR).

Materials and methods: we examined 63 patients (39 males, 24 females), mean age 53±11 years with 3-4 degree MR and control group of 26 healthy volunteers (15 males, 11 females), mean age 39±7 years. Transthoracic echocardiography was performed by a standard technique at rest. Sizes and volumes of LV, LA, ejection fraction (EF), degree of MR, pulmonary artery (PA) pressure were evaluated. LV and LA images were analyzed by STI with LV global longitudinal strain (GS), peak atrial longitudinal (PALS) and contraction strain (PACS), and by vector analysis of myocardial displacement and «Flow-Volume» diagrams. Rates of volume change in LV (dVol/dt) and LA (LAdVol/dt), rates of long axis change in LV (dLA/dt) and LA (LAdLA/dt), LA long axis size (LA) were calculated in systole (reservoir phase) and diastole (conduit phase). Statistical analysis (Statistica,10.0; JMP).

Results: left heart sizes and volumes, PA pressure compared to the norm were increased(p<0,(0)), but the EF was preserved. GS and PACS in patients with MR was normal, but PALS was reduced (p<0,(0)), while dVol/dt and LAdVol/dt were increased and shown in «Flow-Volume» diagrams. But, dLA/dt was normal, LAdLA/dt was reduced in the conduit phase, LA size was increased (p<0,(0)).

Conclusion: STI, vector analysis and diagram method parameters are the criteria for efficiency of LV and LA function in patients with MR.

 

References

1.      Nishimura R. A., Otto C. M., Bonow R. O., et.al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. Circulation. 2017; 135: e1159-e1195.

2.      Voigt, J.U., Pedrizzetti G. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. J.U. Voigt, G. Pedrizzetti, P. Lysyansky [et al.] Eur. Heart J. Cardiovasc. Imaging. 2015; 16 (1): 1-11.

3.      Kalinin A., Alekhin M. N., Bakhs G. idr. Otsenka deformatsii levogo predserdiya u bolnyh arterialnoy gipertoniey i aortalnym stenozom s razlichnoy stepenyu gipertrofii levogo zheludochka [Left atrial deformation assessment in patients with arterial hypertension and aortic stenosis with varying degrees of left ventricle hypertrophy]. Ter. arhiv. 2012; 4: 23-29 [In Russ].

4.      Pavlyukova E.N., Kuzhel D.A., Matyushin G.V. Funktsiya levogo predserdiya: sovremennye metody otsenki i klinicheskoe znachenie [Left atrial function: new assessment methods and clinical significance]. Ratsionalnayafarmakoterapiya v kardiologii. 20l7;13(5):675-683 [ In Russ].

5.      Sokhibnazarova V.H.,Saidova M.A., Tereschenko S.N. Primenenie novykh ekhokardiograficheskikh tehnologiy nedopplerovskogo izobrazheniyamiokarda v dvumernom i trekhmernom rezhimakh u bolnykh KHSN s sokhrannoy i snizhennoy frakciey vybrosa levogo zheludochka [Application of new echocardiographic technologies of non-doppler myocardial images in 2D and 3D modes in patients with chronic heart failure with preserved and reduced ejection fraction]. Evraziyskiy kardiologicheskiy zhurnal. 2017; 2: 42-47 [In Russ].

6.      Cameli M., Incampo E., Mondillo S., Left atrial deformation: Useful index for early detection of cardiac damage in chronic mitral regurgitation, IJC Heart&Vasculature. 2017; 17: 17-22.

7.      Sandrikov V.A., Kulagina T. Yu., Ivanov V.A. i soavt. Fenomenologicheskie zakonomernosti v otsenke funkcii levogo zheludochka serdca pri nedostatochnosti mitralnogo klapana [Phenomenological regularities in left ventricle function assessment at mitral valve insufficiency]. Zh. Kardiologija. 2018; 58(1): 32-40 [In Russ].

8.      Pathan F., Elia N., Nolan M.T., et.al. Normal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysis. J. Am Soc. Echocar- diogr. 2017;30(1): 59-70.

9.      Leischik R., Littwitz H., Dworrak B. Echocardiographic Evaluation of Left Atrial Mechanics: Function, History, Novel Techniques, Advantages, andPitfalls. 2015; 1-8.

10.    Debonnaire P, Leong D. P, Witkowski T. G. et al.Left atrial function by two-dimensional speckle-tracking echocardiography in patients with severe organic mitral regurgitation: association with guidelines-based surgical indication and postoperative (long-term) survival. Journal of the American Society of Echocardiography. 2013.26 (9): 1053-1062.

 

Abstract:

Background: article describes possibilities of computed tomography (CT) in diagnosis of wide specter of acute surgical diseases.

Materials and methods: basing on CT data of 645 patients (period jan.2015-feb.2016, S.P Botkin Clinical Hospital) an analysis was made: analyzed frequency of different nosologies in practice of doctors in CT department of emergency hospital, discussed results of method.

Results: most frequent diseases: acute intestinal obstruction - 238 cases (37%), acute pancreatitis and pancreonecrosis - 168 cases (26%), urolithiasis - 84 cases (13%), traumatic injuries of abdominal organs - 51 cases (8%), other diseases - 104 cases (16%).

Conclusion: taking into consideration non-specific clinical features of acute abdomen that doesn't need urgent operation, CT appeared to be an indespensable diagnostic method in planing of treatment in group of such patients. Complex approach in diagnosis can decrease a level of unreasonable operations and increase level of medical care quality.

 

References

1.      Ziedses des Plantes CM, van Veen MJ, van der Palen J, Klaase JM, Gielkens HA, Geelkerken RH. The Effect of Unenhanced MRI on the Surgeons' DecisionMaking Process in Females with Suspected Appendicitis. World J Surg. 2016; 40(12):2881-2887.

2.      Shabunin A.V., Arablinskij A.V, Bedin V.V., Sidorova Ju.V., Lukin A.Ju., Shikov D.V. Klinicheskaja ocenka dannyh KT i MRT pri ostrom pankreatite [Clinical analysis of CT and MRI data in acute pancreatitis]. Rossijskij jelektronnyj zhurnal luchevoj diagnostiki. 2015; 18(2): 20-32 [In Russ].

3.      Gadeev A.K., Dzhordzhikija R.K., Lukanihin V.A., Ignat'ev I.M., Bredihin R.A., Damocev V.A. Nereshennye voprosy neotlozhnoj sosudistoj hirurgii [Indeterminate issues of urgent vascular surgery]. Vestnik sovremennoj klinicheskoj mediciny. 2013; 6: 137-142. [In Russ].

4.      Hubutija M.Sh., Jarcev P.A., Ermolov A.S., Guljaev A.A., Samsonov V.T., Levitanskij V.D. Neotlozhnaja laparoskopicheskaja hirurgija [Urgent laparoscopic surgery]. Zhurnal im. N.V. Sklifosovskogo Neotlozhnaja medicinskaja pomoshh'. 2011; 1: 36-39 [In Russ].

5.      Weir-McCall J., Shaw A., Arya A., Knight A., HowlettD.C. The use of preoperative computed tomography in the assessment of the acute abdomen. The Annals of The RoyalCollege of Surgeons of England. 2012; 94(2): 102-107.

6.       A.D., Vilson Dzh.I., Medvedev V.E. Radiologicheskij monitoring i rezul'taty miniinvazivnogo lechenija abscessov pecheni [Radiological monitoring and results of minimally invasive management of liver abscesses]. Promeneva diagnostika, promeneva terapija. 2015; 2: 50-56. [In Ukr].

7.      Parfenov V.E. i dr. Informacionnye materialy po neotlozhnoj hirurgicheskoj pomoshhi pri ostryh hirurgicheskih zabolevanijah organov brjushnoj polosti v Sankt-Peterburge za 2015 god [Information materials of urgent surgical treatment in acute surgical abdominal diseases in Saint Petersburg, 2015]. Sankt-Peterburg, 2016; 1-16 [In Russ].

8.      Vlasov A.P., Kukosh M.V., Saraev V.V. Diagnostika ostryh zabolevanij zhivota [Diagnostics of acute abdominal diseases ]. rukovodstvo. M., 2012: 448 [In Russ].

9.      Charyshkin A.L., Jakovlev S.A. Problemy diagnostiki i lechenija ostrogo appendicita [Problems in diagnostics and treatment of acute appendicitis ]. Ul'janovskij mediko-biologicheskij zhrnnal. 2015; 92-100 [In Russ].

10.    Jagin M.V. Diagnostika i lechenie neoslozhnennyh destruktivnyh form ostrogo appendicita [Diagnostics and treatment of uncomplicated destructive forms of acute appendicitis]. ZhurnalEducatio. 2015; 9-3(2): 135 [In Russ].

11.    Ramalingam V., Bates D.D., Buch K., Uyeda J., et. al. Diagnosing acute appendicitis using a nonoral contrast CT protocol in patients with a BMI of less than 25. Emerg Radiol. 2016 Oct;23(5):455-62. doi: 10.1007/s10140- 016-1421-2. Epub 2016 Jul 8.

 

Abstract:

Persistent sciatic artery (SA) is recognized as a minority variant of embryogenesis of lower limb artery. Article describes a clinical case of complex treatment of a patient with persistent SA, critical ischemia of lower limb and with diabetic foot. The patient underwent diagnostics of lesion, that helped to find out possible ways of disease progression, endovascular revascularization and step-by-step surgery treatment that allowed to keep support function of the limb.

 

References

1.      Patel S.N., Reilly J.P Persistent sciatic artery - a curious vascular anomaly. Catheter Cardiovasc. Interv. 2007; 70(2): 252-5

2.      Sultan S.A. et al. Endovascular management of rare sciatic artery aneurysm. J. Endovasc. Ther. 2000; 7(5): 415-22.

3.      van Hooft I.M. et al. The persistent sciatic artery. Eur. J. Vasc. Endovasc. Surg. 2009; 37, 585-591.

4.      Shutze W., Garrett W., Smith B. Persistent sciatic artery: collective review and management. Ann. Vasc. Surg. 1993; 7: 303-10

5.      Yang S. et al. Bilateral persistent sciatic artery with aneurysm formation and review of the literature. Ann. Vasc. Surg. 2014; 28: 264, 1-7

6.      Pillet, J. et al. The sciaticopopliteal arterial trunk: Persistent axial artery. Bull. de l'Association des Anatomiste. 1980; 64: 97-110.

7.      Gauffre S., Lasjaunias P, Zerah M. Sciatic artery: a case, review of literature and attempt of systemization. Surg. Radiol. Anat. 1994; 16: 105-9.

8.      Ikezawa T. et al. Aneurysm of bilateral persistent sciatic arteries with ischemic complications: case report and review of the world literature. J. Vasc. Sur. 1994; 20: 96 -103.

9.      Bower E.B., Smullens S.N., Parke W.W. Clinical aspects of persistent sciatic artery: report of two cases and review of the literature. Surgery. 1977; 81: 588-595.

10.    Ahnc S. et al. Treatment Strategy for Persistent Sciatic Artery and Novel Classification Reflecting Anatomic Status. Eur. J. Vasc. Endovasc. Surg. 2016; 52: 360-369.

11.    Rezayat C. et al. Ruptured persistent sciatic artery aneurysm managed by endovascular embolization. Ann. Vasc. Surg. 2010; 24: 115.e5-9.

12.    Modugno P et al. Endovascular treatment of persistent sciatic artery aneurysm with the multilayer stent. J. Endovasc. Ther. 2014; 21:410-3. 

 

Abstract:

This article spotlights problems of diagnostic and treatment of rare vascular complication: false aneurysm of transplanted kidney artery We describe a case of successful treatment using stent-assisted aneurysm embolization. Our case is illustrated with ultrasound, computed tomography and angiographic images and 30-day follow-up data.

 

References

1.      Tomilina N., Bikbov B. Sostojanie zamestitel'noj terpapii pri hronicheskoj pochechnoj nedostatochnosti v Rossii v 1998-2011 gg. (po dannym registra Rossijskogo dializnogo obshhestva) [The status of substitutive therapy in chronic renal insufficiency in Russia in 1998-2011. (according to the register of the Russian Dialysis Society).]. Vestnik transplantologii i iskusstvennyh organov. 2015; 17(1):35-58 [In Russ].

2.      Streeter E.H., Little D.M., Cranston D.W. and Morris P.J. The urological complications of renal transplantation: a series of 1535 patients. BJU International. 2002; 90: 627634.

3.      Verstova A.I., Kokov L.S., Parhomenko M.V., Pinchuk A.V. Klinicheskij sluchaj jembolizacii lozhnoj anevrizmy arterii pochechnogo transplantata Materialy VII nauch.-obr. foruma 2015 g [Clinical case of embolization of a false aneurysm of an artery of a transplanted kidney.]. Rossijskij Jelektronnyj Zhurnal Luchevoj Diagnostiki = Russian Electronic Journal of Radiology (REJR). 2015; 5(2) Pril.:231-232[ In Russ].

4.      Matas A.J., Payne W.D., Sutherland DER, et al. 2,500 Living Donor Kidney Transplants: A Single-Center Experience. Annals of Surgery. 2001; 234(2):149-164.

5.      Orlic P., Vukas D., Curuvija D., Markic D., Merlak-Prodan Z., Maleta I., Zivcic-Cosic S., Orlic L., Blecich G., Valencic M., Spanjol J., Budiselic B. Pseudoaneurysm after renal transplantation. Acta Med Croatica. 2008; 62(1):86-9.

6.      Fujikata S., Tanji N., Iseda T., Ohoka H., Yokoyama M. Mycotic aneurysm of the renal transplant artery. Int J Urol. 2006;13: 820e3.

7.      Al-Wahaibi K.N., Aquil S., Al-Sukaiti R., Al-Riyami D., Al-Busaidi Q. Transplant Renal Artery False Aneurysm: Case Report and Literature Review. Oman Medical Journal. 2010; 25(4):306-310.

8.      Bracale U.M., Santangelo M., Carbone F., Del Guercio L., Maurea S., Porcellini M., Bracale G. Anastomotic pseudoaneurysm complicating renal transplantation:treatment options. Eur J Vasc Endovasc Surg. 2010 May; 39(5):565-8.

9.      Dimitroulis D., Bokos J., Zavos G., Nikiteas N.Karidis P., Katsaronis P., et al. Vascular complications in renal transplantation: a single-center experience in 1367 renal transplantations and review of the literature. Transplant Proc. 2009; 41:1609e14.

10.    Burkey S.H., Vazquez M.A., Valentine R.J. De novo renal artery aneurysm presenting 6 years after transplantation: a complication of recurrent arterial stenosis? J Vasc Surg. 2000; Aug;32(2):388-391 10.1067/mva.2000. 106943.

11.    McIntosh B.C., Bakhos C.T., Sweeney T.F., DeNa- tale R.W., Ferneini A.M. Endovascular repair of transplant nephrectomy external iliac artery pseudoaneurysm. Conn Med. 2005; Sep;69(8):465-466.

12.    Bracale U.M., Carbone F., del Guercio L., Viola D., D’Armiento F.P., Maurea S. et al. External iliac artery pseudoaneurysm complicating renal transplantation. Interact Cardiovasc Thorac Surg. 2009. Jun; 8(6):654-660 10.1510/icvts.2008.200386.

13.    Asztalos L., Olvaszto' S., Fedor R., Szabo' L., Bala 'zs G., Luka' cs G. Renal artery aneurysm at the anastomosis after kidney transplantation. Transplant Proc. 2006; 38:2915e8.

 

Abstract:

Aim: was to optimize treatment of patients with acute myocardial infarction without significant stenotic lesions of coronary arteries.

Materials and methods: authors present a clinical case of treatment of patient, who was admitted in few hours from onset of myocardial infarction. At first-stage, patient underwent manual vacuum thrombectomy, and it revealed the absence of significant stenotic lesions of coronary arteries. Patient underwent coronary angiography, left ventriculography, optical-coherence tomography of the infarct-dependent artery

Results: in this clinical case the cause of myocardial infarction in patient without significant stenotic coronary lesions was the presence of intramural fibrecalcific plaque without signs of instability

Conclusions: according to authors, in order to reduce the incidence of re-thrombosis of coronary arteries in patients with myocardial infarction without stenotic lesions of coronary arteries, it is recommended to perform optical-coherence tomography to reveal unstable atherosclerotic plaque; in such cases it may be warranted stenting of coronary artery.

 

References

1.      Sidel'nikov A.V., Chernysheva I.E., Koledinskij A.G.. Sravnitel'nyj analiz ehffektivnosti primeneniya tromboliticheskih preparatov: poisk prodolzhaetsya [Comparative analysis of efficacy of thrombolytic therapy: further search]. Mezhdunarodnyj zhurnal intervencionnoj kardioangiologii. 2014, 39:48-56 [In Russ].

2.      Chandrasekaran B., Kurbaan A. S. Myocardial infarction with angiographically normal coronary arteries. Journal of Royal Society of Medicine. 2002 Aug; 95(8): 398-400.

3.      Reynolds H. R. Myocardial infarction without obstructive coronary artery disease. Current Opinion in Cardiology. 2012, 27:655-660.

4.      Widimsky P., Stellova B., Groch L. et al. Prevalence of normal coronary angiography in the acute phase of suspected ST-elevation myocardial infarction: Experience from the PRAGUE studies; on behalf of the PRAGUE Study Group Investigators. Can J Cardiol. 2006; 22(13): 1147-1152.

5.      Da Costa A., Isaaz K., Faure E. et al. Clinical characteristics, aetiological factors and long-term prognosis of myocardial infarction with an absolutely normal coronary angiogram; a 3-year follow-up study of 91 patients. Eur Heart J. 2001; 22(16): 1459-1465.

6.      Jamil G., Jamil M., Abbas A. et al. «Lone aspiration thrombectomy» without stenting in young patients with ST elevation myocardial infarction - Am J Cardiovasc Dis. 2013; 3(2):71-78.

7.      Escaned J, Echavarrna-Pinto M, Gorgadze T et al. Safety of lone thrombus aspiration without concomitant coronary stenting in selected patients with acute myocardial infarction. EuroIntervention. 2013;8: 1149-1156.

8.      Talarico G. P., Burzotta F., Trani C. et al. Thrombus Aspiration without Additional Ballooning or Stenting to Treat Selected Patients with ST-Elevation Myocardial Infarction. J Invasive Cardiol. 2010; 22(10): 489-492.

9.      Berger J.S., Elliott L., Gallup D. et al. Sex differences in mortality following acute coronary syndromes. JAMA. 2009; 302(8): 874-882.

10.    Dey S., Flather M.D., Devlin G. et al. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart. 2009; 95(1): 20-26.

11.    Roger V.L., Go A.S., Lloyd-Jones D.M. et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation. 2012; 125:e2-e220.

12.    Glagov S., Weisenberg E., Zarins C. et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987; 316: 1371-1375.

13.    Bentzon J. F., Otsuka F., Virmani R., Falk E. Mechanisms of Plaque Formation and Rupture. Circ Res. 2014; 114: 1852-1866.

14.    Shmatkov M.G., Morozova E.V. Opticheskaya kogerentnaya tomografiya: novye vozmozhnosti vnutrisosudistoj vizualizacii (obzor literatury) [Optical cpherence tomography: new possibilities of intravascular imaging (literature review)]. Diagnosticheskaya i intervencionnaya radiologiya, 2013, 7(4): 89-100 [In Russ] .

15.    Virmani    R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006; 47: 13-18.

16.    Dhume A.S., Soundararajan K., Hunter W.J. III, Agrawal D.K. Comparison of vascular smooth muscle cell apoptosis and fibrous cap morphology in symptomatic and asymptomatic carotid artery disease. Ann Vasc Surg 2003; 17:1-8.

17.    Burke A.P, Farb A., Malcom G.T. et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997; 336: 1276-1282.

18.    Lam M. K., Sen H., Tandjung K. et al. Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium: Insights From 2-Year Follow-up of the TWENTE Trial/ Catheterization and Cardiovascular Interventions 2015; 85:524-531.

 

Abstract:

Aim: was to determine indications for transpapillary external-internal drainage of the biliary tree in benign diseases of the peripapillary region.

Material and methods: results of the use of externally-internally transpapillary drainage of the biliary tree from 256 patients with distal obstruction of the biliary tract were analyzed. In 154 (60,2%) cases the peripapillary obstruction was caused by tumor pathology, in 102(39,8%) cases (39.8 %) - by peripapillary benign stenotic diseases (stenosis of Vater papilla, choledocholithiasis, chronic pancreatitis, parapapillary diverticula) that have not managed to eliminate with the help of endoscopy or endoscopic benefit was initially ineffective.

Results: endoscopic papillosphincterotomy after the external-internal drainage due to syndrome of Vater papilla «acute blockage» required in 7(4,5%) patients of 154 patients with peripapillary tumor obstruction. Endoscopic papillotomy was performed in 80(78,4%) patients among 102 patients with benign distal block of common biliary duct after the external-internal drainage for same indications. In 7 cases of «acute blockage» of papilla we were forced to return to the outside cholangiostomy due to endoscopic unattainable of papilla. In summary, the syndrome of papilla «acute blockage» occurred in 87(85,3%) patients with transpapillary external- internal drainage of the biliary tree on the background of the peripapillary benign obstruction. There were no complications of papillotomy

Conclusion: the external-internal drainage of the biliary tree with the syndrome of obstructive jaundice remains an effective and pragmatic method of return of bile into the lumen of the duodenum. The most common complication of the external-internal drainage with transpapillary drainage placement is a syndrome of «acute blockage» of Vater papilla which requires endoscopic papillotomy With high frequency this syndrome occurs when forced transpapillary the external-internal drainage of the distal benign disorders of patency of the biliary tree. Minimal risk of this syndrome developing has been reported during transpapillary drainage in patients with obstructive jaundice due to peripapillary cancer.

 

References

1.      Jendobiliarnaja intervencionnaja onkoradiologija pod red. Dolgushina B.I. [Endobiliary interventional oncoradiology under edition of Dolgushin B.I.]. Moscow. 2004: 224 [In Russ].

2.      Intervencionnaja radiologija v onkologii (puti razvitija i tehnologii): Nauchno-prakticheskoe izdanie. Gl. red.: Granov A.M. i Davydov M.I.; red.: Tarazov P.G. i Granov D.A. 2- e izd., dop [Interventional radiology in oncology (the path of development and technology): Scientific-practical publication. hl. еd.: Granov A.M. and Davydov MI; еd .: Tarazov P.G. and Granov D.A. 2nd ed, dop.]. St. Petersburg. 2013: 560 [In Russ].

3.      Qian X.J., Zhai R.Y, Dai D.K, et al. Treatment of malignant biliary obstruction by combined percutaneous transhepatic biliary drainage with local tumor treatment. World J Gastroenterol. 2006; 12(2):331-5.

4.      Luchevaja diagnostika i maloinvazivnoe lechenie mehanicheskoj zheltuhi. Rukovodstvo pod red. Kokova L.S., Chernoj N.R., Kuleznevoj Ju.V. [Radiological diagnosis and minimally invasive treatment of obstructive jaundice. Guide. Under edition of Kokov L.S., Chernaya N.R., Kulezneva Ju.V.]. Moscow. 2010: 288 [In Russ].

5.      Jo J.H., Park B.H. Suprapapillary versus transpapillary stent placement for malignant biliary obstruction: which is better? J Vasc Interv Radiol. 2015; 26(4):573-582.

6.      Lee D.H., Yu J.S., Hwang J.C., Kim K.H. Percutaneous placement of self-expandable metallic biliary stents in malignant extrahepatic strictures: indications of transpapillary and suprapapillary methods. Korean J Radiol. 2000;1(2):65-72.

 

Abstract:

Background: most accurate visualization of tumor, determination of stage and spread of tumor process is substantially significant for children who undergo treatment in accordance to protocols of the international SIOPEL group. According to SIOPEL criteria, patients with hepatoblastoma are stratified into risk groups based on diagnostic results. The allocation of patients into risk groups is based on the definition of the stage of the disease in the PRETEXT system (Pre-Treatment Extent of Disease - the spread of the tumor before treatment) and the level of alpha-fetoprotein (AFP)

Aim: was to present the main criteria of PRETEXT hepatoblastoma staging, based on results of magnetic resonance imaging (MRI).

Material and methods: study includes 74 patients with diagnosed hepatoblastoma aged 1 month to 14 years (median 3.1 years). All patients underwent MRI of the abdominal cavity before and after polychemotherapy (PCT) courses. MRI studies were performed on the scaner Magnetom Avanto (Siemens Healthcare) with a magnetic field strength of 1.5T

Results: hepatoblastoma staging was performed according to PRETEXT criteria. Stage I of the Pretext with lesion of one liver sector was revealed in 3 (4%) cases. Stage II of the Pretext - the presence of a tumor in two adjacent sectors was revealed in 26(35,1%) cases. Pretext III - the presence of a tumor in three adjacent sectors of the liver or in two non-adjacent liver sectors was identified in 23(31%) cases. Pretext IV - lesion of all liver sectors, was revealed in 22(29,7%) cases. Conclusions: MRI is a significantly informative method that allows to achieve data not only location, size, prevalence of the tumor process, but it also enables to give an accurate pre-operative stage evaluation using the PRETEXT system. Surgical removal of the tumor is the only way to achieve a complete cure, thus it is important to get an accurate image of the tumor, its anatomical location and determine the prevalence of the tumor process.

 

 

 

References  

1.      Men' T.H., Rykov M.Ju., Poljakov V.G. Zlokachestvennye novoobrazovanija u detej v Rossii: osnovnye pokazateli i tendencii. [Malignant neplasm in children in Russian Federation: tendensies and basic parameters]. Rossijskij onkologicheskijzhurnal. 2015;2:43-47 [ In Russ].

2.      Kaprin A.D., Starinskij V.V., Petrova G.V.. Zlokachestvennye novoobrazovanija v Rossii v 2015 godu (zabolevaemost' i smertnost') [Malignant neoplasms in Russian Federation in 2015 (morbidity and mortality)]. MNIOI im. P. A. Gercena. 2017; 250 s [In Russ]

3.      Hadzic N, Finegold MJ. Liver neoplasia in children. Clin Liver Dis. 2011; 15:443-462.

4.      Spector L.G., Birch J. The epidemiology of hepatoblastoma . Pediatr. Blood Cancer. 2012; 59(5):776-779.

5.      Tomlinson G.E., Kappler R. Genetics and epigenetics of hepatoblastoma. Pediatr Blood Cancer. 2012;59: 785-792

6.      Chung E.M., Lattin G.E. Jr, Cube R. et al. From the archives of the AFIP: pediatric liver masses: radiologic-pathologic correlation. Part 2. Malignant tumors. Radiographics. 2011;31:483-507.

7.      Meyers R.L. Tumors of the liver in children. Surgical Oncology. 2007;16:195-203.

8.      Jon Pritchard, Julia Brown, Elizabeth Shafford, Giorgio Perilongo, Penelope Brock, Claire Dicks-Mireaux, Jean Keeling, Angela Phillips, Anton Vos, Jack Plaschkes . Predictive Value of the Pretreatment Extent of Disease System in Hepatoblastoma: Results From the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 Study. Journal of Clinical Oncology. 2005; 23(6):1245-52.

9.      Czauderna P. Hepatoblastoma throughout SIOPEL trials - clinical lessons learnt. Frontiers in Bioscience (Elite Ed). 2012; 4: 470-9.

10.    Roebuck D.J., Aronson D., Clapuyt Pet al.; International Childrhood Liver Tumor Strategy Group. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. PediatrRadiol. 2007; 37(2):123-32.

11.    Couinaud С. Liver anatomy: portal or biliary segmentation. Dig Surg. 1979; 16( 6):459-467.

12.    Couinaud C. The surgical anatomy of the liver revisited. Paris: Maugein&Cie, 1989:84-89. 96-101. 108-117.

13.    Kim Je. F., Filin A. V., Semenkov A. V. i dr. Hirurgija ochagovyh obrazovanij pecheni u detej: organosohranjajushhaja operacija ili transplantacija?[ Surgery of focal lesions of liver in children: organ-preserving intervention or transplantology?.] Klinicheskaja i jeksperimental'naja hirurgija. 2017;1:22-30. 

 

Abstract:

In the article considers modern commercial method of production is demanded used in oncology medical product radiopharmaceutical 18F-fluorodeoxyglucose (2-fluoro,18F-2-deoxy-D-glucose, 18F-FDG), are presented the process steps and operation of synthesis, quality control procedures, briefly described the requirements for packaging and labeling of radiopharmaceutical.

 

 

References

1.     Kam Leung. [18F]Fluoro-2-deoxy-2-D-glucose in Molecular Imaging and Contrast Agent Database (MICAD). National Center for Biotechnology Information, NLM, NIH, Bethesda, MD. 2005.

2.     Min-Fu Yang, Diwakar Jain, Zuo-Xiang He. 18F-FDG Cardiac Studies for Identifying Ischemic Memory. Curr Cardiovasc Imaging Rep. 2012; Dec, 5:383-389.

3.     Ghesani M., Depuey E. G., Rozanski A. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability. Echocardiography. 2005 Feb; 22(2): 165-77.

4.     Nose H., Otsuka H., Otomi Y et al. Evaluation of normal physiologic left ventricular myocardial 18F-FDG uptake at fasting state. European Congress of Radiology. 2012. Vienna, Austria. URL: http://posterng.netkey.at/esr/ viewing/index.php?module=viewing_poster&doi=10.1594 /ecr2012/C-1192 2012.

5.     Dong Soo Lee, Sang Kun Lee, Myung Chul Lee. Functional Neuroimaging in Epilepsy: FDG PET and Ictal SPECT. Korean Med Sci. 2001;16: 689-96.

6.     Teune L. K., Bartels A. L., Leenders K. L. FDG-PET Imaging in Neurodegenerative Brain Diseases // Functional Brain Mapping and the Endeavor to Understand the Working Brain edited by Francesco Signorelli and Domenico Chirchiglia, 2013.

7.     Sanchez-Catasis C. A., Vallez, Garcha D., Le Riverend Morales E., Galvizu Sбnchez R. Traumatic Brain Injury: Nuclear Medicine Neuroimaging .PET and SPECT in Neurology. 2014; 923-946.

8.     Masangkay N., Basu S., Moghbel M. et al. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings. Nucl Med Commun. 2014 Oct; 35 (10): 1038-46.

9.       Statistika zlokachestvennyh novoobrazovanij v Rossii i stranah SNG v 2012 g. Pod redakciej M.I. Davydova, E.M. Aksel'. [Statistics of malignant neoplasms in Russia and CIS countries in 2012. Edited by M.I. Davydova, E.M. Axel.] Moskva, 2014. - 226 s [In Russ].

10.   Jones S. C., Alavi A., Christman D. et al. The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man. J Nucl Med. 1982; 23, 613-617.

11.   Kuwabara H., Gjedde A. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate. J Nucl Med. 1991 Apr; 32(4): 692-8.

12.   Data are from International Commission on Radiological Protection. Radiation Dose to Patients from Radiopharmaceuticals. St. Louis, MO. Elsevier; 2000:49. ICRP publication 80.

13.   Ido T., Wan C. N., Fowler J. S. Fluorination with F2: convenient synthesis of 2-deoxy-2-fluoro-d-glucose. J Org Chem. 1977; 42: 2341-2.

14.   Hamacher K., Coenen H. H., Stacklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]- fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986; 27: 235-8.

15.   Toorongian S. A., Mulholland G. K., Jewett D. M. et al. Routine production of 2-deoxy-2-[18F]fluoro-D- glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. Int J Rad Appl Instrum B. 1990; 17 (3): 273-9.

16     Normy radiacionnoj bezopasnosti (NRB-99/2009). [Norms of radiation safety (NRB-99/2009).] SP 2.6.1.2523-09.[In Russ].

17.   Osnovnye sanitarnye pravila obespecheniya radiacionnoj bezopasnosti (OSPORB-99/2010). [Basic sanitary rules for ensuring radiation safety (0SP0RB-99/2010)]. SP 2.6.12612-10 [In Russ].

18.   SanPiN 2.6.1.3288-15 «Gigienicheskie trebovaniya po obespecheniyu radiacionnoj bezopasnosti pri podgotovke i provedenii pozitronnoj ehmissionnoj tomografii». [Hygienic requirements for ensuring radiation safety in the preparation and conduct of positron emission tomography.] [ In Russ].

19.   N.A. Gomzina, D.A. Vasil’ev, R.N. Krasikova. Optimization of Automated Synthesis of 2-[18F]Fluoro- 2-deoxy-D-glucose Involving Base Hydrolysis. Radiochemistry. 2002; 44 (4): 403-409.

20.   Gopal B. Saha. Basics of PET Imaging: Physics, Chemistry and Regulations. - 3th ed. - New York: Springer International Publishing, 2016; 165.

 

Abstract:

Aim: was to assess the consistency of measurements of anatomic and functional parameters performed with EchoCG and MRI and to determine the possibility of MRI to visualize the coaptation of valve leaflets after reconstruction of the aortic valve (AV) using the Ozaki technique.

Material and methods: the study included 124 patients who underwent MRI of the heart anc transthoracic EchoCG, 9,3±4,0 days after the Ozaki operation. With EchoCG and MRI, EDV and LV EF were calculated. Dopplerography determined the area of AV opening and the transaortal pressure gradient. At MRI, the area of AV opening was planetically measured, and the transoortal pressure gradient was calculated from results of phase contrast study To assess the consistency of measurement results, the Blend-Altman method was used.

Results: mean values obtained with EchoCG and MRI were statistically significantly different (p<0,001) only when measuring LV EDV The greatest accordance between measurements of EchoCG and MRI was observed in the evaluation of the transaortal pressure gradient (0,04±3,7 mm Hg). Less coordinated were measurements of the opening area of AV (0,22±0,79 cm2) and LV EF (0,22±8,9%). Less consistency was in measurement of EDV (26,4±33,0 ml). The mean value of the difference was statistically significantly different from zero when measuring the opening area of AV (p=0,180) and the transaortal pressure gradient (p=0,120). The article presents 5 clinical examples of visual evaluation of leaflets coaptation after AV reconstruction by the Ozaki method.

Conclusions: differences in consistency in the assessment of the opening area of the AV and the transaortal pressure gradient in echocardiography and MRI are not clinically significant, indicating that these measurement methods can be used interchangeably after AV reconstruction using the Ozaki technique.

Results of measurements of EDV size and LV EF in EchoCG and MRI are less consistent and not interchangeable, therefore, measurement results should be interpreted in the context of the specific method

MRI should be a part of the diagnostic algorithm after Ozaki surgery, but its use in the early postoperative period may be limited to cases of poor quality or inconsistent Echocardiography

 

References

1.      Salem M. A.; Abd El-Razek M. A.; Bassiouny M. I. et al. Diagnostic Value of Cardiac MRI in Aortic Valve Stenosis in Comparison with Echocardiography. Med J Cairo Univ., 2016; 84 (2):271-278.

2.      Sondergaard L., Hildebrandt P., Lindvig K., et al. Quantification by magnetic resonance velocity mapping. Am Heart J., 1993; 26(5):156-1164.

3.      Bellenger N.G., Burgess M.I., Ray S.G. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionucleide ventriculography and cardiovascular magnetic resonance. Are they interchangeable?. Eur Heart J., 2000; 21:1387-1396.

4.      Bellenger N.G., Francis J.M., Davies L.C. et al. Establishment and performance of a magnetic resonance cardiac function clinic. J Cardiovasc Magn Reson. 1999; 1(4):323-330.

5.      Bernard Y, Meneveau N., Boucher S. et al. Lack of agreement between left ventricular volumes and ejection fraction determined by two-dimensional echocardiography and contrast cineangiography in postinfarction patients. Echocardiography. 2001;18:113-122.

6.      Darasz K.H., Underwood S.R., Bayliss J. et al. Measurement of left ventricular volume after anterior myocardial infarction: comparison of magnetic resonance imaging, echocardiography, and radionuclide ventriculography. The Int J of Cardiovasc Imaging. 2002;18(2):135-142.

7.      Gardner B., Bingham S., Allen M. et al. Cardiac magnetic resonance versus transthoracic echocardiography for the assessment of cardiac volumes and regional function after myocardial infarction: an intrasubject comparison using simultaneous intrasubject recordings. The J of Cardiovasc ultrasound. 2009;7:38-44.

8.      Li C., Lossnitzer D., Katus H.A. et al. Comparison of left ventricular volumes and ejection fraction by monoplane cineventriculography, unenhanced echocardiography and cardiac magnetic resonance imaging. Int J Cardiovasc Imaging. 2012; 28(5):1003-1010.

9.      Malm S., Frigstad S., Sagberg E.; et al. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography a comparison with magnetic resonance imaging. J Am Coll Cardiol. 2004; 44(5):1030-1035.

10.    Ozaki S. Pathophysiology of calcification of bioprosthetic heart valves: an experimental investigation. LeuvenUniversity Press. 2001;238.

11.    Ozaki S., KawaseI., Yamashita H., et al. A total of 404 cases of aortic valve reconstruction with glutaraldehyde-treated autologous pericardium. J. Thora Cardiovasc Surg. 2014; 147(1):301-306.

12.    Rossejkin E.V., Bazylev V.V., Batrakov P.A. i dr. Neposredstvennye rezul'taty protezirovanija stvorok aortal'nogo klapana autoperikardom po metodike Ozaki [Immediate results of aortic valve leaflets replacement with auto pericardium due to Ozaki technique]. Patobgija krovoobrashhenija i kardiohirurgija. 2016; 20(2):44-48 [ In Russ].

13.    Ozaki S., Kawase I., Yamashita H., et al. Aortic Valve Reconstruction Using Autologous Pericardium for Aortic Stenosis. Circ J. 2015; 79(7):1504-1510.

14.    Izgi C. MRI evaluation of aortic stenosis: flow evaluation. https://www.escardio.org/Education/PracticeTools/ EACVI-toolboxes/Valvular-Imaging/Atlas-of-valvular-imaging/Aortic-stenosis/MRI-evaluation-of-aortic- stenosis-flow-evaluation

15.    La Manna A., Sanfilippo A., Capodanno D. et al. Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study. J Cardiovasc Magn Reson. 2011;13: 82-90.

16.    Rajani R., Hancock J., Chambers J.B. The art of assessing aortic stenosis. Heart. 2012;98(4):14-22.

17.    Oosterhof T, Mulder B.J.M., Vliegen H.W. et al. Cardiovascular magnetic resonance in the follow-up of patients with corrected tetralogy of Fallot. American Heart J. 2006;151:265-272.

18.    Bazylev V.V., Paramonova T.I., Vdovkin A.V., Pal'kova V.A. Pri kakom razmere KDO u bol'nyh s sistolicheskoj disfunkciej levogo zheludochka predpochtitel'no vypolnenie magnitno-rezonansnoj tomografii [What dimensions of EDV in patients with systolic dysfunction of the left ventricle is preferable to perform MRI?.]. Diagnosticheskaja i intervencionnaja radiologija. 2017;11(2):30-37 [In Russ].

19.    Bazylev V.V., Paramonova T.I., Vdovkin A.V., Karpuhin V.G., Pal'kova V.A. Soglasovannost' JehoKG i MRT v ocenke mitral'noj regurgitacii i KDO u bol'nyh s dilataciej levogo zheludochka [Accordance of MRI and EchoCG in estimation of mitral regurgitation and EDV in patients with left ventricle dilatation]. Luchevaja diagnostika i terapija. 2017;1 (8): 64-68 [ In Russ].

 

Abstract:

Study presents data about bone quality in patients before and after lengthening of shin by transosseous osteosynthesis method.

Materials and methods: 168 patients with shortening or limb deformity, before treatment and after lengthening, underwent multislice computed tomography, with estimation of anatomical and radiological-morphological features of shin.

Results: according to data of X-ray examination and MSCT, patients with diagnosed achondroplasia, congenital or acquired shortenings - have initial restructuring of meta-diaphyseal tibial bone, that worsen during lengthening. Patients with subjectively insufficient growth, radiological-morphological changes developed in knee joint during lengthening, which appeared as bone density 

reduction, appearence of resorption areas, architectonics change and persisted in late period in patients older 35 years. Cortical plate density of tibial diaphysis in patients with shortening of different etiology, during MSCT, was characterized by age, nosological and topographic features and is one of the important parameter of the bone quality before and during treatment stages. Maximum density is marked in the middle third of diaphysis. Density and structure of cortical plate are changed during lengthening. Severe cortical plate density reduction is up to 350 HU on the line of maternal bone and regenerate.

Conclusion: bone quality in patients with different etiology of shin shortening, is determined by structure of meta-diaphyseal bone and structural and density features of cortical plate anc determine, in the greater degree, strength bone criteria changing during lengthening of shin.

 

References

1.      Aleksandrov Yu.M., Alekberov D.A., D'yachkov K.A. Rengenomorfologicheskie osobennosti dlinnykh kostey i perestroyka ikh struktury pri ustranenii deformatsii kolennykh sustavov u detey s posledstviyami gematogennogo osteomielita [Roentgenomorphological features of long bones and reorganization of their structure when correction of the knee deformities in children with hematogenous osteomyelitis consequences]. Vestnik khirurgii im. Grekova. 2014;173(2):61-65 [In Russ].

2.      Rodionova S.S., Torgashin A.N., Solod E.N. et al. Strukturnye parametry proksimal'nogo otdela bedrennoy kosti v otsenke ee prochnosti [Structural parameters of the proximal femur in the evaluation of its strength]. Vestnik travmatologii i ortopedii im. N.N. Priorova. 2014; (1):77-81 [In Russ].

3.      Bala Y, Chapurlat R., Cheung A.M. et al. Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women. J. Bone Miner. Res. 2014; 29 (2):380-388.

4.      Baum T, Grande Garcia E., Burgkart R. et al. Osteoporosis imaging: effects of bone preservation on MDCT- based trabecular bone microstructure parameters and finite element models. BMC Med. Imaging. 2015; 15:22.

5.      Garkavenko Yu.E., Yanakova O.M., Bergaliev A.N. Kompleksnyy monitoring protsessov osteogeneza distraktsionnogo regenerata u detey s posledstviyami gematogennogo osteomielita pri udlinenii nizhnikh konechnostey [Complex monitoring of the processes of distraction regenerated bone osteogenesis in children with hematogenous osteomyelitis consequences during the lower limb lengthening]. Travmatologiya i ortopediya Rossii. 2011;1(59):106-111 [In Russ].

6.      Gostishchev V.K., Lipatov K.V., Pisarenko L.V. et al. Prognozirovanie izmeneniy prochnosti dlinnykh trubchatykh kostey v khirurgii khronicheskogo osteomielita [Predicting changes in long tubular bone strength in chronic osteomyelitis surgery]. Khirurgiya. Zhurn. im. N.I. Pirogova. 2010;(2):4-6 [In Russ].

7.      D'yachkov K.A., D'yachkova G.V., Novikov K.I. et al. Dinamika pokazateley kostnoy plotnosti bedrennoy i bol'shebertsovoy kostey u bol'nykh posle udlineniya nizhney konechnosti [Dynamics of femoral and tibial bone density values in patients after lower limb lengthening]. Ilizarovskie chteniya: materialy nauch.-prakt. konf. [Ilizarov readings: materials of scientific-practical conference]. Kurgan. 2012; 107-108 [In Russ].

8.      Stupina T.A., Shchudlo N.A., Petrovskaya N.V. et al. Gistomorfometricheskiy analiz sustavnogo khryashcha i sinovial'noy obolochki kolennogo sustava pri metadiafizarnom udlinenii goleni: (eksperimental'no-morfologicheskoe issledovanie) [Histomorphometrical analysis of the knee articular cartilage and synovium for metadiaphyseal lengthening of the leg: (an experimental and morphological study)]. Travmatologiya i ortopediya Rossii. 2013;1:80-86 [In Russ].

9.      Ahmed L.A., Shigdel R., Joakimsen R.M. et al. Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures. Osteoporos. Int. 2015; 26 (8): 2137-2146.

10.    Bala Y, Bui Q.M., Wang X.F. et al. Trabecular and cortical microstructure and fragility of the distal radius in women. J. Bone Miner. Res. 2015; 30(4): 621-629.

11.    Baumgartner R., Heeren N., Quast D. et al. Is the cortical thickness index a valid parameter to assess bone mineral density in geriatric patients with hip fractures? Arch. Orthop. Trauma Surg. 2015;135(6): 805-810.

12.    D'yachkov K.A., D'yachkova G.V. Remodelirovanie kosti pri udlinenii konechnosti: kolichestvennaya i kachestvennaya otsenka [Bone remodeling during limb lengthening: a qualitative and quantitative evaluation]. Zhurn. klinich. i eksperiment. ortopedii im. G.A. Ilizarova (Geniy Ortopedii). 2015; 4: 53-60 [In Russ].

13.    Nikitinskaya O.A. Rol' kortikal'noy kosti i ee mikrostruktury v prochnosti kosti [The role of cortical bone and its microstructure in bone strength]. Consilium Medicum. 2010; 12 (2): 132-135 [In Russ].

14.    Chuyko A.N., Kopytov A.A. Komp'yuternaya tomografiya i osnovnye mekhanicheskie kharakteristiki kostnykh tkaney. [Computed tomography and basic mechanical features of bone tissues] Med. vizualizatsiya. 2012;1:102-107 [In Russ].

15.    Chappard D., Bas^ M.F., Legrand E. et al. New laboratory tools in the assessment of bone quality. Osteoporos. Int. 2011; 22(8):2225-2240.

16.    Chen H., Zhou X., Shoumura S. et al. Age- and gender-dependent changes in three-dimensional microstructure of cortical and trabecular bone at the human femoral neck. Osteoporos. Int. 2010;21(4):627-636.

17.    Burr D.B. Bone quality: understanding what matters. J. Musculoskel. Neuronal Interact. 2004;4(2):184- 186.

18.    Hernandez C.J., Keaveny T.M. A biomechanical perspective on bone quality. Bone. 2006; 39(6): 11731181.

19.    Misch C.E. Bone density: A key determinant for clinical success. In: Contemporary Implant Dentistry. 2nd ed. (Ed. by C.E. Misch). St Louis: Mosby. 1999;109-118.

20.    Rebaudi A., Trisi P., Cella R., Cecchini G. Preoperative evaluation of bone quality and bone density using a novel CT/microCT-based hard-normal-soft classification system. Int. J. Oral Maxillofac. Implants. 2010;25(1):75- 85.

21.    D'yachkov K.A., D'yachkova G.V., Aranovich A.M. et al. Dinamika remodelirovaniya kosti u bol'nykh akhondroplaziey posle udlineniya nizhnikh konechnostey po dannym MSKT [Dynamics of bone remodeling in patients with achondroplasia after lower limb lengthening according to MSCT data]. Geniy ortopedii. 2014;4:67-71 [In Russ].

22.    Ogarev E.V., Morozov A.K. Diagnosticheskie vozmozhnosti mul'tispiral'noy komp'yuternoy tomografii v otsenke sostoyaniya tazobedrennogo sustava u detey i podrostkov [Diagnostic potentials of multispiral computed tomography in the evaluation of the hip condition in children and adolescents]. Vestnik travmatologii i ortopedii im. N.N. Priorova. 2013; 4: 68-75 [In Russ].

23.    Chang G., Honig S., Liu Y et al. 7 Tesla MRI of bone microarchitecture discriminates between women without and with fragility fractures who do not differ by bone mineral density. J. Bone Miner. Metab. 2015; 33(3): 285-293.

24.    Tjong W., Nirody J., Burghardt A.J. et al. Structural analysis of cortical porosity applied to HR-pQCT data. Med. Phys. 2014;41(1):013701.

25.    Wichmann J.L., Booz C., Wesarg S. et al. Quantitative dual-energy CT for phantomless evaluation of cancellous bone mineral density of the vertebral pedicle: correlation with pedicle screw pull-out strength. Eur. Radiol. 2015; 25(6): 1714-1720.

26.    Griffith J.F., Genant H.K. New imaging modalities in bone. Curr. Rheumatol. Rep. 2011;13(3):241-250.

27.    Gee C.S., Nguyen J.T., Marquez C.J. et al. Validation of bone marrow fat quantification in the presence of trabecular bone using MRI. J. Magn. Reson. Imaging. 2015; 42(2): 539-544.

28.    Rubin G.D. Computed tomography: revolutionizing the practice of medicine for 40 years. Radiology. 2014; 273, 2 Suppl.: S45-S74.

29.    D'yachkov K.A., D'yachkova G.V., Kutikov S.A. Sposob opredeleniya lokal'noy plotnosti korkovoy plastinki dlinnykh kostey [A technique for determination of the local density of long bone cortical plate]. Patent RF, No 2539424, 2015 [In Russ].

30.    D'yachkov K.A., D'yachkova G.V., Aleksandrov Yu.M. Sposob opredeleniya stepeni rezorbtsii kortikal'noy plastinki kosti posle distraktsionnogo udlineniya konechnosti [A technique for determination of the degree of bone cortical plate resorption after limb distraction lengthening]. Patent RF, No 2484772, 2013 [In Russ].

authors: 

 

Article exists only in Russian.

 Article exists only in Russian.

 

Abstract:

Pancreatic cancer (PC) is one of the most aggressive malignant neoplasms, results of treatment of which remain extremely unsatisfactory, in view of the low (20%) possibility of tumor resectability A relatively new method of treatment of pancreatic cancer, which showed in practice an increase in tumor resectability in patients with borderline resectable forms of the disease and an increase ir survival mediana of inoperable patients is transartorial chemoembolization (TACE).of pancreatic arteries.

Authors first used transradial vascular access for TACE of a malignant pancreatic tumor.

As the first stage of the intervention - performed redistribution embolization of the right gastroomental artery distally to branches feeding the tumor, with two pushable coils Azur (Terumo) sized 4x60 mm and 5x60 mm in order to prevent embolization of non-target vessels and achieve total embolization of the tumor.

The second stage - performed chemoembolization with lipiodol - 5 ml and gemcitabine - 1000 mg, as a result - accumulation of chemotherapy in the head of the pancreas.

The duration of the procedure and the radiation dose in the patient were 52 minutes, respectively and 0.57 mSv and were comparable to those for similar interventions through transfemoral access. At the same time, all the main advantages of access through the radial artery remained, including: a higher level of psychological and functional comfort for the patient, its early activation and a minimal risk of vascular complications. The patient's discharge was made on the 10th day after the intervention. 

 

References

1.    Kubyshkin V.A., Vishnevskiy V.A. Rak podzheludochnoi zhelezy [Pancreatic cancer]. Moscow. 2003: 375 [In Russ].

2.     Nitecki S.S., Sarr M.G., Colby T.V. et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann. of Surg. 1995; 221(1):59-66

3.     Ishikawa O., Ohigashi H., Imaoka S. et al. Is the longterm survival rate improved by preoperative irradiation prior to Whipple’s procedure for adenocarcinoma of the pancreatic head? Arch. Surg. 1994; 129(10):1075-1080.

4.     Pavlovskiy A.V. Maslyanaya khimioembolizatsiya arteriy podzheludochnoi zhelezy pri mestnorasprostranennom rake. [Oily chemoembolization of pancreatic arteries in patients with locally advanced cancer]. Prakticheskaya onkologiya. 2004; 5(2):108-114 [In Russ].

5.     A.A., Tarazov P.G., Ivanova A.A., Alejnikova O.V. Diagnostika I lechenie toksicheskih oslozhnenij regionarnoj himioterapii, provodimoj cherez chreskozhno implantiruemye sistemy. [Diagnostics and treatment of toxic complications of regional chemotherapy through port-system] Diagnosticheskaya i intervencionnaya radiologiya. 2007; 1 (3): 46-51. [In Russ].

6.     Chandrasekar B., Doucet S., Bilodeau L. et al. Complications of cardiac catheterization in the current era: a single-center experience. Catheter Cardiovasc. Interv. 2001; 52(3):289-295.

7.     Sherev D.A., Shaw R.E., Brent B.N. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc. Interv. 2005; 65(2): 196-202.

8.     Tavris D.R., Gallauresi B.A., Lin B. et al. Risk of local adverse events following cardiac catheterisation by hemostasis device use and gender. J. Invasive Cardiol. 2004; 16(9):459-464.

9.     Mclvor J., Rhymer J.C. 245 transaxillary arteriograms in arteriopathic patients: success rate and complications. Gin. Radiol. 1992; 45: 390-394.

10.   Jolly S.S., Yusuf S., Cairns J. et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011; 377(9775):1409-1420.

11.   Kanei Y, Kwan T.,  NakraN.C. et al. Transradial cardiac catheterization: A review of access site complications. Catheter Cardiovasc. Interv. 2011.

12.   Caputo R.P., Tremmel J.A., Rao S. et al. Transradial arterial access for coronary and peripheral procedures: Executive summary by the transradial committee of the SCAI. Catheter Cardiovasc. Interv. 2011.

 

Abstract:

Article describes a case report of successful treatment of coronary artery perforation using handmade stent-graft, ex tempore made of coronary balloon and two bare-metal stents. Article also reports results of follow-up, including control angiography and optical coherence tomography 3 months later. 

 

References

1.     Ellis S.G., Ajluni S., Arnold A.Z., Popma J.J., Bittl J.A., Eigler N.L. et al. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation. 1994; 90(6):2725-30.

2.     Shirakabe A., Takano H., Nakamura S., Kikuchi A., Sasaki A., Yamamoto E. et al. Coronary perforation during percutaneous coronary intervention. Int Heart J. 2007; 48(1):1-9.

3.     Lansky A.J., Yang YM., Khan Y, Costa R.A., Pietras C., Tsuchiya Y et al. Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft. Am J Cardiol. 2006; 98(3): 370-4.

4.     Sarli B., Baktir A.O., Saglam H., Kurtul S., Dogan Y., Aring H. Successful Treatment of Coronary Artery Perforation with Hand-Made Covered Stent. Erciyes Med J. 2013; 35(3):164-6 • DOI: 10.5152/etd.2013.20.

5.     Copeland K.A., Hopkins J.T., Weintraub W.S., Rahman E. Long-term follow-up of polytetrafluoroethylene-covered stents implanted during percutaneous coronary intervention for management of acute coronary perforation. Catheter Cardiovasc Interv. 2012; 80(1):53-7.

 

 

 

Abstract:

Results of successful surgical treatment of a patient with an extremely rare disease - Parkes-Weber- Rubashov syndrome, manifestating by arteriovenous malformations of the lower limb and spinal cord are presented. Endovascular embolization of arteriovenous malformation of the lower limb was treated with use of three Flipper coils due to the severity of the clinical symptoms. A conclusion about the effectiveness of this method of treatment is presented. 

 

References

1.     Ferrero E., Ferri M., Viazzo A. Parkes-Weber syndrome and giant superficial femoral artery aneurysm. Treatment by endovascular therapy and follow-up of 8 years. Ann Vasc Surg. 2011; 25(3): 384.e9-384.e15.

2.     Boon L.M., Mulliken J.B. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum. Mol. Genet. 1994; 3: 1583-1587.

3.     Brouillard P, Vikkula M. Genetic causes of vascular malformations. Hum. Mol. Genet. 2007; 16: R140-R149.

4.     Volz K.R., Kanner C.D., Evans J. Klippel-Tmnaunay Syndrome: Need for Careful Clinical Classification. J. Ultrasound Med. 2016; 10: 7863/ultra.15.08007.

5.     Namba K. and Nemoto S. Parkes Weber Syndrome and Spinal Arteriovenous Malformations. AJNR Am. J. Neuroradiol. 2013; 34: E110-E112.

6.     Djindjian M., Djindjian R. Spinal cord arteriovenous malformations and the Klippel-Trenaunay-Weber syndrome. Surg Neurol. 1977; 8:229-37.

7.     Greene A.K., Kieran M., Burrows PE. Wilms Tumor Screening Is Unnecessary in Klippel-Trenaunay Syndrome. Pediatrics. 2004; 113: e326 - e329.

8.     Fernandez-Pineda I., Lopez-Gutierrez J.C. Parkes-Weber syndrome associated with a congenital short femur of the affected limb. Ann Vasc Surg. 2009; 23(2): 257.e1-2.

9.     Revencu N., Boon L.M., Mulliken J.B. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat. 2008; 29(7): 959-65.

10.   Revencu N., Boon L.M. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat. 2008; 29:959-65.

11.   Thiex R., Mulliken J.B. A novel association between RASA1 mutations and spinal arteriovenous anomalies. AJNR Am J Neuroradiol. 2010; 31:775-79.

12.   Sato T.N., Tozawa Y Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 1995; 376: 70-74.

13.   Lelievre E., Bourbon PM. Deficiency in the p110alpha subunit of PI3K results in diminished Tie2 expression and Tie2(-/-)-like vascular defects in mice. Blood. 2005; 105: 3935-3938.

14.   Boon L.M., Mulliken J.B. RASA1: Variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev. 2005; 15(3): 265-269.

15.   Revencu N. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat. 2008; 29(7):959-965.

16.   Burrows PE., Gonzalez-Garay M.L., Rasmussen J.C. Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man. PNAS. 2013; 110: 8621-8626.

17.   Konyushevskaya A.A., Yaroshenko S.Ya. Klinicheskiy sluchay redkoy nasledstvennoy patologii - sindrom Klippelya-Trenone-Vebera-Rubashova v praktike vracha-pediatra [Rare hereditary pathology in practice of pediatrics - Klippel-Trenone-Weber-Rubashov syndrome (case report)]. Zdorov'ye rebenka. 2014; 2(53): 117 - 122 [In Russ].

18.   Behr G.G. CM-AVM syndrome in a neonate: Case report and treatment with a novel flow reduction strategy. Vasc Cell. 2012; 4(1): 19.

19.   Wijn R.S. Phenotypic variability in a family with capillary malformations caused by a mutation in the RASA1 gene. Eur J Med Genet. 2012; 55(3):191-195.  

 

Abstract:

Open surgery is a basis of treatment of major vascular injuries, although some of injuries can be treated by means of endovascular surgery

Aim: was to investigate the possibility of endovascular treatment of full transection of major arteries. Material and methods: а retrospective analysis of patients histories of 52 patients with limbs' vascular injuries was performed. Opinions of physicians of different surgical specialties about practicability of endovascular technologies use in trauma surgery were investigated. Using a created stand-desk, consisted with container filled with gelatin mass, simulating a hematoma in a zone of vascular rupture, plunged into gelatin ends of silicone tubes 6 mm in internal diameter, and a web-camera fixed above the stand, comparative analysis of efficacy of 6 different methods of vessel recanalization was done.

Results: еndovascular methods of treatment can be performed in 42,3% of patients with major arterial injuries. Of those, 13,5% of patients may need to undergo recanalization of full vascular transection followed by stent-graft implantation. Our study demonstrated the possibility of through-and-through recanalization of the full major vascular transection, and most effective methods of recanalization - methods with use of a special endovascular loop, a retrieval device, and a standard folded guidewire. Preliminary balloon inflation inside a proximal part of the artery should be considered in case of unstable hemodynamics of a patient.

The questionnaire showed that integration of endovascular surgical methods is perspective for the future of trauma surgery; however, there are some retaining obstacles such as organizational and fiscal issues. It is likely that training of general surgeons in basic endovascular skills is practical. 

 

References

1.     Soroka V.V. Neotlozhnye serdechno-sosudistye operatsii v praktike obshhego khirurga [Emergency cardiovascular operations in practice of a general surgeon]. Volgograd: Izd-vo VolGU. 2001; 204 [In Russ].

2.    Samokhvalov I.M. Boevye povrezhdeniya magistral'nykh sosudov: diagnostika i lechenie na etapakh meditsinskoj evakuatsii. Diss. doct. med. nauk [Wartime major vascular injuries: diagnosis and treatment on echelons of care. Doct. med. sci. diss.]. St.Petersburg. 1994; 389 [In Russ].

3.     White J.M., Stannard A., Burkhardt G.E. et al. The epidemiology of vascular injury in the wars in Iraq and Afghanistan. Ann. Surg. 2011; 263(6):1184-1189. 

4.     Eastridge B.J., Mabry R.L., Seguin P et al. Death on the battlefield (2001-2011): Implications for the future of combat casualty care. J. Trauma Acute Care Surg. 2012; 73(6):431-437.

5.     Holcomb J.B., Fox E.E., Scalea T.M. et al. Current opinion on catheter-based hemorrhage control in trauma patients. J. Trauma Acute Care Surg. 2013; 76(3): 888-893.

6.     Lumsden A.B. Commentary on «Endovascular management of vascular trauma». Perspect. Vasc. Surg. Endovasc. Ther. 2006; 18(2):130-131.

7.     Rasmussen T.E., Woodson J., Rich N.M. et al. Vascular trauma at a crossroads. J. Trauma. 2011; 70(5): 1291-1293.

8.     Reva V.A., Samokhvalov I.M. Endovaskulyarnaya khirurgiya na vojne. [Endovascular surgery in the war]. Angiologiya i sosudistaya khirurgiya. 2015; 21(2):166-175 [In Russ].

9.     Reva V.A., Semenov E.A., Petrov A.N. et al. Endovaskulyarnaya ballonnaya okklyuziya aorty: primenenie na statsionarnom i dogospital'nom ehtapakh skoroj meditsinskoj pomoshhi. [Endovascular balloon occlusion of the aorta: the use at in-hospital and pre-hospital stages of emergency medical care]. Skoraya meditsinskayapomoshh,'. 2016; 3:30-38.

10.   Reva V.A., Kiselev M.A., Platonov S.A. et al. Selektivnaja embolizacija vetvej glubokoj arterii bedra pri koloto-rezanom ranenii. [Selective angioembolization of the branches of the deep femoral artery in its stab injury]. Vestn. chir. irn. Grekova. 2015; 174(3):67-69 [In Russ].

11.   Bocharov S.M. Angiograficheskaya diagnostika i endovaskulyarnoe lechenie pri travme arterij. Diss. kand. med. nauk [Angiographic diagnosis and endovascular treatment in arterial trauma. Cand. med. sci. diss.]. Moscow. 2008: 103 [In Russ].

12.   Chernaya N.R., Muslimov R.Sh., Selina I.E. et al. Endovaskulyarnoe i khirurgicheskoe lechenie bol'nogo s travmaticheskim razryvom aorty i pechenochnoj arterii. [Endovascular and surgical treatment of a patient with traumatic rupture of the aorta and the hepatic artery]. Angiologiya i sosudistaya khirurgiya. 2016; 22(1):176-181 [In Russ].

13.   Reva V.A., Petrov A.N., Samokhvalov I.M. Stentirovanie poverhnostnoj bedrennoj arterii pri ee bokovom povrezhdenii. [Stenting of superficial femoral artery in correction of its side damage]. Diagn. Intern Radiol. 2014; 8(3):105-108 [In Russ].

14.   Villamaria C.Y, Eliason J.L., Napolitano L.M. et al. Endovascular Skills for Trauma and Resuscitative Surgery (ESTARS) course: curriculum development, content validation, and program assessment. J. Trauma Acute Care Surg. 2014; 76(4):929-935.

15.   Brenner M., Hoehn M., Pasley J. et al. Basic endovascular skills for trauma course: bridging the gap between endovascular techniques and the acute care surgeon. J. Trauma Acute Care Surg. 2014; 77(2):286-291.

16.   Reva V.A. Obuchajushhie kursy po hirurgii povrezhdenij i endovaskuljarnoj hirurgii pri travmah v Jerebru (Shvecija). [Educational course on trauma surgery and endovascular surgery for trauma in Orebro (Sweden)] . Voen.-med. Jowrn. 2015; 336(12):78-81 [In Russ].

17.   Tsurukiri J., Ohta S., Mishima S. et al. Availability of on-site acute vascular interventional radiology techniques performed by trained acute care specialists: A single-emergency center experience. J. Trauma Acute Care Surg. 2017; 82(1):126-132.

18.   Julien M., Emilie L., Dominique M. et al. Evaluation of femoro-popliteal angioplasties with the need for retrograde approach in a twin center series of 26 consecutive cases. J. Vasc. Endovasc. Surg. 2016; 1(4):1-10.

19.   Rohlffs F., Larena-Avellaneda A.A., Petersen J.P et al. Through-and-through wire technique for endovascular damage control in traumatic proximal axillary artery transection. Vascular. 2015; 23 (1): 99-101.

20.   Shalhub S., Starnes B.W., Tran N.T. Endovascular treatment of axillosubclavian arterial transection in patients with blunt traumatic injury. J. Vasc. Surg. 2011; 53(4): 1141-1144.

21.   Gilani R., Tsai PI., Wall M.J. Jr., Mattox K.L. Overcoming challenges of endovascular treatment of complex subclavian and axillary artery injuries in hypotensive patients. J. Trauma Acute Care Surg. 2012; 73(3): 771-773. 

 

Abstract:

This review is focused on the problem of the angiosome principle of revascularization in critical limb ischemia.

The blood circulation of the foot is described in accordance with the angiosome concept. Different opinions on the application of the angiosome principle of revascularization in critical lower limb ischemia are presented.

Features of the angiosome principle that limit its routine use in clinical practice are described. Also, methods of perfusion evaluation that can be applied at all stages of the treatment process, allow to assess the severity of macro- and microcirculation impairment and result of revascularization are described. 

 

 References 

1.     Taylor G.I., Pan W.R.. Angiosomes of the leg: anatomic study and clinical implications. Plast. Reconstr. Surg. 1998; 102(3):599-616.

2.     Hinchliffe R.J., Brownrigg J.R.W., Apelqvist J.et al. IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes. Diabetes. Metab. Res. Rev. 2016; 32 (Suppl. 1): 37-44.

3.     Galstyan G.R., Tokmakova A.Yu., Egorova D.N. et al. Klinicheskie rekomendatsii po diagnostike i lecheniyu sindroma diabeticheskoy stopy. [Clinical guidelines on diagnostics and treatment of the diabetic foot syndrome]. Rany i ranevye infektsii. 2015; 2(3):63-83 [In Russ].

4.     Pokrovskiy A.V., Abugov S.A., Alekyan B.G. et al. Natsionalnye rekomendatsii po vedeniyu patsientov s zabolevaniyami arteriy nizhnikh konechnostey. [National guidelines on treatment of patients with lower limbs arterial disease]. Angiologiya i sosudistaya khirurgiya. 2013; 19 (Pril. 2):38. [In Russ].

5.     Gerhard-Herman M.D., Gornik H.L., Barrett C. et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2017; 135(12):e726-e779.

6.     Eroshkin I.A. Rentgenokhirurgicheskaya korrektsiya porazheniy arteriy nizhnikh konechnostey u bolnikh sakharnym diabetom i ee rol v kompleksnom lechenii sindroma diabeticheskoy stopy. [Endovascular correction of lower limbs arterial lesions in diabetics and its role in complex treatment of the diabetic foot syndrome]. Mezhdunarodnyy endokrinologicheskiy zhurnal. 2011; 36(4):139-148. [In Russ].

7.     Platonov S.A., Kaputin M.Yu., Ovcharenko D.V. et al. Rol kollateralnogo krovosnabzheniya stopy v zazhivlenii troficheskikh defektov i sokhranenii konechnosti u bolnykh s kriticheskoy ishemiey nizhnikh konechnostey. [The role of foot collaterals in ulcer healing and limb salvage in patients with critical limb ischemia]. Med. akad. zhurn. 2011; 11(3): 105-111. [In Russ].

8.     Alexandrescu V.A., Vincent G., Azdad K. et al. A reliable approach to diabetic neuroischemic foot wounds: below-the-knee angiosome-oriented angioplasty. J. Endovasc. Ther. 2011; 18 (3): 376-387.

9.     Ferrufino-Merida A.L., Rodrnguez-Trejo J.M., Escotto-Sanchez I., Rodriguez-Ramhrez N.. Angioplastia infrapoplitea: correlaciуn entre el vaso tratado y el angio- soma lesionado. Rev. Mex. Angiol. 2012; 40 (4): 123-134.

10.   Iida O., Nanto S., Uematsu M.. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia. Catheter. Cardiovasc. Interv. 2010; 75(6):830-836.

11.   Iida O., Soga Y, Hirano K. et al. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. J. Vasc. Surg. 2012; 55 (2):363-370.

12.   Kabra A., Suresh K.R., Vivekanand V. at al. Outcomes of angiosome and non-angiosome target revascularization in critical lower limb ischemia. J. Vasc. Surg. 2013; 57 (1): 44-49.

13.   Kret M.R., Cheng D., Azarbal A.F. et al. Utility of direct angiosome revascularization and runoff scores in predicting outcomes in patients undergoing revascularization for critical limb ischemia. J. Vasc. Surg. 2014; 59(1): 121-128.

14.   Lejay A., Georg Y, Tartaglia E. et al. Long-term outcomes of direct and indirect below-the-knee open revascularization based on the angiosome concept in diabetic patients with critical limb ischemia. Ann. Vasc. Surg. 2014; 28(4):983-989.

15.   Neville R.F., Attinger C.E., Bulan E.J. et al. Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann. Vasc. Surg. 2009; 23(3): 367-373.

16.   Spillerova K., Biancari F., Leppдniemi A. et al. Differential impact of bypass surgery and angioplasty on angiosome-targeted infrapopliteal revascularization. Eur. J. Vasc. Endovasc. Surg. 2015; 49(4):412-419.

17.   Soderstrom M., Alback A., Biancari F. et al. Angiosome-targeted infrapopliteal endovascular revascularization for treatment of diabetic foot ulcers. J. Vasc. Surg. 2013; 57(2):427-435.

18.   Varela C., Achn F., J. de Haro et al. The role of foot collateral vessels on ulcer healing and limb salvage after successful endovascular and surgical distal procedures according to an angiosome model. Vasc. Endovascular Surg. 2010; 44(8):654-660.

19.   Biancari F., Juvonen Т.. Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis. Eur. J. Vasc. Endovasc. Surg. 2014; 47(5):517-522.

20.   Bosanquet D.C., Glasbey J.C., Williams I.M., Twine C.P.. Systematic review and meta-analysis of direct versus indirect angiosomal revascularization of infrapopliteal arteries. Eur. J. Vasc. Endovasc. Surg. 2014; 48(1):88-97.

21.   Jongsma H., Bekken J.A., Akkersdijk G.P. et al. Angiosome directed revascularization in patients with critical limb ischemia. J. Vasc. Surg. 2017; 65 (4): 1208-1219.

22.   Rashid H., Slim H., Zayed H. et al. The impact of arterial pedal arch quality and angiosome revascularization on foot tissue loss healing and infrapopliteal bypass outcome. J. Vasc. Surg. 2013; 57 (5): 1219-1226.

23.   Azuma N., Uchid H., Kokubo T. et al. Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery? Eur. J. Vasc. Endovasc. Surg. 2012; 43(3):322-328.

24.   Pave M., Benadiba L., Berger L. et al. Below-the-knee angioplasty for critical limb ischemia: results of a series of 157 procedures and impact of the angiosome concept. Ann. Vasc. Surg. 2016;36:199-207.

25.   Soares R. de A., Brochado Neto F.C., Matielo M.F. et al. Concept of angiosome does not affect limb salvage in infrapopliteal angioplasty. Ann. Vasc. Surg. 2016; 32: 34-40.

26.   Fossaceca R., Guzzardi G., Cerini P et al. Endovascular treatment of diabetic foot in a selected population of patients with below-the-knee disease: is the angiosome model effective? Cardiovasc. Intervent. Radiol. 2013; 36(3):637-644.

27.   Zheng X.T., Zeng R.C., Huang J.Y et al. The use of the angiosome concept for treating infrapopliteal critical limb ischemia through interventional therapy and determining the clinical significance of collateral vessels. Ann. Vasc. Surg. 2016; 32:41-49.

28.   Graziani L., Silvestro A., Bertone V. et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur. J. Vasc. Endovasc. Surg. 2007; 33(4):453-460.

29.   Alexandrescu V.A., Sцderstrцm M., Venermo M. Angiosome theory: fact or fiction? Scand. J. Surg. 2012; 101(2):125-131.

30.   Spillerova K., Biancari F, Settembre N. et al. The prognostic significance of different definitions for angio- some-targeted lower limb revascularization. Ann. Vasc. Surg. 2017; 40:183-189.

31.   Spillerova K., Sarderstram M., Albeck A., Venermo M.. The feasibility of angiosome-targeted endovascular treatment in patients with critical limb ischemia and foot ulcer. Ann. Vasc. Surg. 2016; 30:270-276.

32.   Alexandrescu V.A.. The angiosome concept: anatomical background and physiopathological landmarks in CLI. In: Angiosomes applications in critical limb ischemia: in search for relevance. Torino: Minerva Medica S.p.A. 2013; 1-9.

33.   Bregovskiy V.B., Karpova I.A., Alekseeva E.S.. Narusheniya kozhnoy mikrocirkulyacii v nizhnikh konechnostyakh pri sakharnom diabete: patofiziologicheskiy fenomen ili obekt dlya lecheniya? [Microcirculation disturbance in lower limbs in diabetics: pathophysiological phenomenon or subject of treatment?]. Sakharnyy diabet. 2011;14 (3):49-53. [In Russ].

34.   Utsunomiya M., Takahara M., Iida O. et al. Wound blush obtainment is the most important angiographic endpoint for wound healing. JACC Cardiovasc. Interv. 2017; 10 (2):188-194.

35.   Iezzi R., Santoro M., Dattesi R. et al. Foot  CT perfusion in patients with peripheral arterial occlusive disease (PAOD): A feasibility study. Eur. J. Radiol. 2013; 82(9): e455-e464.

36.   Reekers JA, The Role of Interventional Radiology in the Treatment of Arterial Diabetic Foot Disease. Cardiovasc inter rad 2016;39(10):1369-1371.  

 

Abstract:

Introduction: for assessment of the significance of coronary artery stenosis, it is necessary to determine the minimum area of the residual square of the vessel lumen (VLRS) that can provide adequate blood flow to myocardial needs. This value is called «threshold» or «borderline». Numerous studies on this issue using modern intravascular and isotope techniques, randomized clinical trials have shown that the values of the «borderline» value of VLRS for proximal coronary arteries are within 3-4 mml. According to the literature, the angiographic method for assessing the severity of stenosis is not sufficiently informative and unreliable. In this article, a combination of coronary angiography with use of balloon catheter is proposed, that allows to eliminate disadvantages of the angiographic method in solving the task is shown.

Aim: was to investigate possibilities of the method of determining the VLRS of coronary artery (CA) in the stenosis region and to assess its hemodynamic significance based on coronary angiography (CG) using a balloon catheter

Materials and methods: the essence of the proposed approach is the obstruction of the artery at the site of stenosis with a balloon catheter with a known cross-sectional area; the VLRS value in this case is equal to or smaller than the area of the balloon catheter. In case of obstruction of the artery by balloon catheter with a transverse area up to 4 mm2, stenosis was considered to be hemodynamically significant and revascularization was recommended; with preserved intensive blood flow, stenosis is considered hemodynamically insignificant.

Results: angiogram evaluation was performed in 120 patients with IHD with «intermediate» stenoses of proximal coronary arteries (from 40 to 70%) using the described technique. In 84% of cases, VLRS was estimated at 3,14 mm2 or less; in 8% of the VLRL was 3,86 mm2 or less. In such areas of coronary arteries, stenosis was considered hemodynamically significant. These patients underwent revascularization of the myocardium - balloon angioplasty and stenting of the coronary artery In 8% of cases, VLRS was more than 4 mm2, coronary stenosis in such cases was recognized as hemodynamically insignificant, and endovascular treatment was not performed in these patients.

Conclusion: the proposed approach for assessment of the area of the residual square of coronary artery lumen at the site of constriction provides an opportunity for an optimal choice of treatment tactics. 

 

References 

1.     Shaw L.J., Berman D.S., Maron D.J., Mancini G.B., Hayes S.W., Hartigan PM. et al. Optimal medical therapy with or without percutantous coronary intervention to reduce ischemic burden: result from the Clinical Outcomes Revascularization and Aggressive Drug Evalution (COURAGE) trial nuclear study. Circulation. 2008; 117 (10): 1283-1291.

2.     Shaw L.J., Iskandrian A.E. Prognostic value of gated myocardial perfusion SPECT. J. Nucl. Cardiol. 2004; 11(2): 171-85.

3.     Tobis J., Azarbal B., Slavin L. Assessment of intermediate sеverity coronary lesion in the cateterisation laboratory. J. Am. Coll. Cardiol. 2007; 49(8): 839-848.

4.     Ivanov V.A., Belyakin S.A., Vityazev S.P. i dr. Algoritm prinyatiya resheniya pri vyyavlenii pogranichnyx porazhenij koronarnogo rusla [Decision-making algorithm for patients with intermittent coronary artery lesions .] . Diagnosticheskaya i intervencionnaya radiobgiya. 2013; 7(3): 109-112 [In Russ].

5.     Bech G.J., De Bruyne B., Pijls N.H., de Muinck E.D., Hoorntje J.C., Escaned J. et al. Fractional flow reserve to determine the appropriateeness if angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001; 103(24): 2928-2934.

6.     Pijls N.H., van Schaardenburgh P, Manoharan G., Boersma E., Bech J.W., van't Veer M. et al. Percutaneus coronary intervention of functionally nonsignificant stenosis. 5-year follow-up of the DEFER study. J. Am. College of Cardiology. 2007; 49(21): 2105-2111.

7.     Iskander S., Iskandrian A.E. Risk assessment using single - photon emission computed tomografic technetium - 99m sestamibi imaging. J. Am. College of Cardiology. 1998; 32(1): 57-62.

8.     Abizaid A., Mintz G.S., Pichard A.D., Kent K.M., Satler L.F., Walsh C.L. et al. Clinical, intravascular ultrasound, and quantitative angiographic determinants of the coronary flow reserve befom and after percutaneous transluminal coronary angioplasty. Am. J. Carliology. 1998; 82(4):423-842.

9.     Abizaid A.S., Mintz G.S., Mehran R., Abizaid A., Lansky A.J., Pichard A.D. et al. Long-term follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings: importance of lumen dimensions. Circulation. 1999; 100 (3):256-261.

10.   Toshihiko Nishioka et al., Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity. Cоmparison with stress myocarlial perfusion imaging. JAAC 1999; 33:1870-1878.

11.   Ben-Dor I., Torguson R., Gaglia M.A. Jr., Gonzalez M.A., Maluenda G., Bui A.B. et al. Correlation between fractional flow reserve and intravascular ultrasound lumen area in intermediate coronary artery stenosis. Eurointervention. 2011; 7(2):225-233.

12.   Pijls N.H., De Bruyne B., Peels K., Van Der Voort PH., Bonnier H.J., Bartunek J. et al. Measurement of fractional flow reserve to assess the functional severity of coronary - artery stenoses. N. Engl. J. Med. 1996; 334 (26):1703-1708.

13.   Pijls N.H.,Van Gelder B.,Van der Voort P,Peels K.,Bracke F.A.,Bonnier H.J. et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995; 92 (11): 3183-3193.

14.   Bech G.J., Pijls N.H., De Bruyne B., Peels K.H., Michels H.R., Bonnier H.J. et al. Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation. 1999; 99(7):883-888.

15.   Lachance P, Dery J.P, Rodes-Cabau J., Potvin J.M., Barbeau G., Bertrand O.F. et al. Impact of fractional flow reserve measurement on the clinical management of patients with coronary artery disease evaluated with noninvasive stress tests prior to cardiac catheterization. Cardiovasc. Revasc. Med. 2008; 9 (4):229-234.

16.   Guagliumi G., Sirbu V., Petroff C., Capodanno D., Musumeci G., Yamamoto H. et al. Volumetric assessment of lesion severity with optical coherence tomography: relationship with fractional flow. EuroIntervention. 2013; 8(10): 1172-1181.

17.   Ozaki Y, Violaris A.G., Kobayashi T., Keane D., Camenzind E., Di Mario C. et al. Comparison of coronary luminal quantification obtained from intracoronary ultrasound and both geometric and videodensitometric quantitative angiography before and after balloon angioplasty and directional atherectomy. Circulation. 1997; 96(2): 491-499.

18.   Nissen S.E., Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical application. Circulation. 2001; 103(4):604-616.

19.   Ma YF., Fam J.M., Zhang B.C. Critical analysis of the correlation between optical coherence tomography versus intravascular ultrasound and fractional flow reserve in the management of intermediate coronary artery lesion. Int. J. Clin. Exp. Med. 2015; 8(5):6658-6667.

20.   Waksman R, Legutko J, Singh J et al. Fractional Flow Reserve and intravascular Ultrasound Relationship Study. J. Am. Coll. Cardiol. 2013; 61:917-923.

21.   Ivanov V.A., Movsesyants M. Yu., Trunin I. V. Vnutrisosudstye metody issledovaniya v intervencionnoj kardiologii [Intravascular methods of investigation in interventional cardiology.]. M., GEOTAR-Media. 2008: с. 212. [In Russ].

22.   СЫ M., Zhu D., Guo L.J. et al. Usefulness of lumen area parameters determined by intravascular ultrasound to predict functional significance of intermediate coronary artery stenosis. Chin. Med. J. (Engl) 2013; 126: 1606-1611.

23.   Hanekamp C.E., Koolen J.J., Pijls N.H., Michels H. R., Bonnier H.J. Comparison of quantitative coronary angiography, intravascular ultrasound, and coronary pressure measurement to assess optimum stent deployment. Circulation. 1999; 99 (8): 1015-1021.

24.   Voros S., Rinehart S., Vazquez-Figueroa J.G., Kalynych A., Karmpaliotis D., Qian Z. et al. Prospective, head-to-head comparison of quantitative coronary angiography, quantitative computed tomography angiography, and intravascular ultrasound for the prediction of hemodynamic significance in intermediate and severe lesions, using fractional flow reserve as reference standard (from the ATLANTA I and II Study). Am. J. Cardiol. 2014; 113 (1): 23-29.

25.   Pijls N.H., Fearon W.F., Tonino P.A., Siebert U., Ikeno F., Bornschein B. et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J. Am. Coll. Cardiol. 2010; 56 (3):177-84.

26.   Waller B.F. The eccentric coronary atherosclerotic plaque: morphologic observations and clinical relevance. Clin. Cardiol. 1989; 12(1):14-20.

 

Abstract:

Aim: was to study immediate and medium-term results of using of stent Calypso in patients with acute coronary syndrome (ACS).

Materials and methods: 274 patients with ACS were included in study and were divided into 2 groups. The first group consisted of 140 patients, who underwent implantation of Calypso (Angioline, Russia). The other group consisted of 134 patients who underwent revascularization with further implantation of Xience (Abbot Vascular, USA). During first 24 hours after admission to the hospital all patients underwent percutaneous coronarography intervention (PCI). Their health state was monitored by phone during the 6, 9-12 months period. The majority of patients underwent coronary angiography during 9-12 months period.

Results: immediate results of the first group: incomplete stent apposition - in 0,6% cases, difficulties of delivery - in 3 cases, artery dissection - 2, occlusion of the side branch - 2 cases, acute thrombosis - 0,6% cases. Immediate results of the second group: incomplete stent apposition - in 0,5% cases, difficulties of delivery - in 2 cases, artery dissection - 2, occlusion of the side branch - 1 case, acute thrombosis - none. Confirmatory angiography in 9-12 months was done in 89 patients from the first group and 94 patients from the second group. The frequency of MACE in first group was 4,3%, in second group was 3,7%.

Conclusions: taking into consideration immediate and medium-term results it can be concludec that domestic stents can be successfully used in different clinical situations in different severity of lesions of coronary arteries. Calypso could be used in urgent PCI and they have minor percentage of complications in medium-term results.

  

 Reference 

1.     Chernjaev M.V., Koledinskij A.G. i dr. Koronarnye stenty: proshloe, nastojashhee, budushhee. Otechestvennye razrabotki v jendovaskuljarnoj hirurgii (obzor literatury). [Coronary stents: past, present, future. Domestic elaborations in endovascular surgery (literature review)]. Diagnosticheskaja i intervencionnaja radiologija. 2016; 10(4):51-56 [In Russ].

2.     Kudrjashov A.N., Lopotovskij P.Ju. Sravnitel'naja ocenka mehanicheskih svojstv koronarnogo stenta «Sinus». [Comparative estimation of mechanical properties of coronary stent «Sinus»]. Diagnosticheskaja i intervencionnaja radiologija.. 2014; 8(1)1:70-77 [In Russ].

3.     Lopotovskij P.Ju., Parhomenko M.V., Kokov L.S. Predvaritel'nye rezul'taty Registra retrospektivnogo issledovanija praktiki primenenija rossijskih stentov «Sinus» i «Kalipso». [Preliminary results of a retrospective study register for the use of Russian stents «Sinus» and «Calypso»]. Vestnik Roszdravnadzora. 2015; 5:44-49 [In Russ].

 

Abstract:

Background: article describes methodology of a selective ophtalmic arterieal infusion (SOAI) ir organ-preserving treatment of children with an intraocular retinoblastoma and demonstrates various ways of delivery of chemotherapeutic agent to a tumor.

Aim: was to increase efficacy of SOAI in treatment of children with intraocular retinoblastoma Material and methods: 289 SOAI procedures to 127 children (143 eyes) have been performed from 2013 to 2017. 2 methods of a SOAI were applied: 1) the microcatheter technique (n=223) - superselective catheterization of an eye artery or collateral branches of an external carotid artery (ECA) at blood flow hemodynamic redistribution; 2) the microballoon technique - balloon-occluder on ipsilateral internal carotid artery (ICA) for prevention of chemoinfusion of brain arteries (n=58). Results: technical success was 96,5%(279 procedures). From 223 procedures with using of a microcatheter infusion was carried out in: a. ophthalmica - 156(70%), a.meningea media - 44 (20%), a.infraorbitalis - 20(11%), a. temp. superficialis - 2, a.facialis - 1. From 58 procedures with using of microballoon - 56 were successful. We didn't manage to put a balloon more distally than the place of an entry of an eye artery in 2 cases. Unsuccessful attempts - 10 cases: failure of catheterization of a femoral artery - in 2, a kinking of the ICA - in 2, a vascular collapse as a result of reaction to injection of contrast agent and/or mechanical impact on ICA - in 2, lack of contrasting of a retina - in 3, an occlusion of an ICA - in 1.

Conclusion: possession and use of various techniques for chemotherapeutic agent delivery to an eye tumor allows to achieve the maximum effect and doesn't depend on anatomy options and blood flow hemodynamic redistribution in main vessels of an eye.

 

References

1.     Abramson D.H., Dunkel I.J., Brodie S.E., et al. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115:1398-404, 1404.e1. Epub 2008 Mar 14.

2.     Abramson D.H., Dunkel I.J., Brodie S.E., et al. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandemtherapy. Arch Ophthalmol 2010;128:370-72. AJNR Am J Neuroradiol. 33:1608-14.

3.     Abramson D.H., Dunkel I.J., Brodie S.E., et al.Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010; 117:1623-29.

4.     Abramson D.H. Super selective ophthalmic artery delivery of chemotherapyfor intraocular retinoblastoma: ‘chemosurgery’ the first Stallard lecture. Br J Ophthalmol. 2010; 94: 396-99.

5.     Gobin YP., Dunkel I.J., Marr B.P, et al.Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011;129: 732-37.

6.     Reese A.B., Hyman G.A., Merriam G.R. Jr, et al. Treatment of retinoblastoma by radiation and triethylenemelamine. AMA Arch Ophthalmol 1954; 53:505-13с.

7.     Hyman G.A., Reese A.B. Combination therapy of retinoblastoma with triethylene melamine and radiotherapy. J Am Med Assoc.1956; 162:1368-73.

8.     Meyer F., Zur anatomie der orbitalarteien. Morphologia Jahr. 1887; 12: 414-458.

9.     Hayreh S.S. The ophthalmic artery. III. Branches. British Journal of Ophthalmology. 1962; 46(4):212-247.

10.   Hayreh S.S. The ophthalmic artery: II. Intraorbital course. British Journal of Ophthalmology. 1962; 46(4): 212-247.

11.   Perrini P, Cardia A., Fraser K., Lanzino G. A microsurgical study of the anatomy and course of the ophthalmic artery and its possibly dangerous anastomoses. Journal of Neurosurgery. 2007; 106(1):142-150.

12.   Lang J. and Kageyama I. The ophthalmic artery and its branches, measurements and clinical importance. Surgical and Radiologic Anatomy. 1990; 12(2):83-90.

13.   Hayrehand S.S., Dass R. Theophthalmicartery: I.Origina and intra—cranial and intra—canalicular course. The British Journal of Ophthalmology. 1962; 46(2):65-98.

14.   Louw L. Different ophthalmic artery origins: embryology and clinical significance. Clinical Anatomy. 2015; 28(5): 576- 83.

15.   Hayreh S. S. Orbital vascular anatomy. Eye. 2006; 20(10):1130 -1144.

16.   Naeini R.M., De J., Satow T., Benndorf G. Unilateral agenesis of internal carotid artery with ophthalmic artery arising from posterior communicating artery. American Journal of Roentgenology. 2005; 184(2):571-573.

17.   Shimada K., Kaneko Y, Sato I., Ezure H., Murakami G. Classification of the ophthalmic artery that arises from the middle meningeal artery in Japanese adults. Okajimas Folia Anatomica Japonica. 1995; 72(2-3):163-176.

18.   Lasjaunias P, Vignaud J., Hasso A. N. Maxillary artery blood supply to the orbit: normal and pathological aspects. Neuroradiology. 1975; 9(2): 87-97.

19.   Geibprasert S., Pongpech S., Armstrong D., Krings T. Dangerous extracranial-intracranial anastomoses and supply to the cranial nerves: vessels the neurointerventionalist needs to know. American Journal of Neuroradiology. 2009; 30(8): 1459-1468.

20.   Klufas M.A., Gobin YP., Marr B., Brodie S.E., Dunkel I. J., Abramson D. H. Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization. American Journal of Neuroradiology. 2012; 33(8):1608-1614.

21.   Picard L., Vignaud J., Lombardi G., Roland J. Radiological anatomy of the origin of the ophthalmic artery. Modern Problems in Ophthalmology. 1975; 4:164-169.

22.   Hassler W., Zentner J., Voigt K. Abnormal origin of the ophthalmic artery from the anterior cerebral artery: neuroradiological and intraoperative findings. Neuroradiology. 1989; 31(1): 85-87.

23.   Islak C., OgE G., Numan F., Cokyuksel O., Kuday C. Persistent nonmigrated ventral primitive ophthalmic artery. Report on one case. Journal of Neuroradiology. 1994; 21(1):46-49.

24.   Hannequin P, Peltier J., Destrieux C., Velut S., Havet E., Le Gars D. The interoptic course of a unique precommunicating anterior cerebral artery with aberrant origin of Anatomy Research International 7 an ophthalmic artery: an anatomic case report. Surgical and Radiologic Anatomy. 2013; 35(3): 269-271.

25.   Li Y, Horiuchi T., Yako T., Ishizaka S., Hongo K. Anomalous origin of the ophthalmic artery from the anterior cerebral artery. Neurologia Medico-Chirurgica. 2011; 51(8):579-581.

26.   Ogawa A., Tominaga T., Yoshimoto T., Kiyosawa M. Intraorbital ophthalmic artery aneurysm: case report. Neurosurgery. 1992; 31(6): 1102-1104.

27.   Kam C. K., Alvarez H., Lasjaunias P Double internal carotid origin of the ophthalmic artery with ruptured aneurysm of the posterior communicating artery. A case report. Interventional Neuroradiology. 2003; 9(4): 383-388.

28.   Uchino A., Saito N., Kurita H., Ishihara S. Double ophthalmic arteries arising from the internal carotid artery. Surgical and Radiologic Anatomy. 2013; 35(2): 173-175.

29.   Louw L., Steyl J., Loggenberg E. Imaging of dual ophthalmic arteries: identification of the central retinal artery. Journal of Clinical Imaging Science. 2014; 4(1): 40.

30.   Nakata H., Iwata Y Agenesis of the left internal carotid artery with an ophthalmic artery arising from the posterior communicating artery. No Shinkei Geka. 1987; 15(1):57- 62.

31.   Priman J., Christie D. H. A case of abnormal internal carotid artery and associated vascular anomalies. The Anatomical Record. 1959; 134(1):87-95.

32.   Sade B., Tampieri D., Mohr G. Ophthalmic artery originating from basilar artery: a rare variant. American Journal of Neuroradiology. 2004; 25(10):1730-1731.

33.   Schumacher M., Wakhloo A. K. An orbital arteriovenous malformation in a patient with origin of the ophthalmic artery from the basilar artery. American Journal of Neuroradiology. 1994; 15(3):550-553. 

 

Abstract:

Aim: was to assess dynamics of markers of endothelial dysfunction after open reconstructive and endovascular operations on the aortoiliac segment.

Material and methods: the study included 36 patients, who were divided into two groups depending on the method of performed operations. Patients of the first group (n = 20) underwent open surgery - aortofemoral bypass, the second group (n = 16) underwent endovascular stenting and angioplasty of iliac arteries. We examined the level of the endothelial dysfunction markers: homocysteine, oxidized low density lipoprotein, adhesion molecules of vascular endothelium type 1 (sVCAM-1) Annexin V the inhibitor (PAI-1) and tissue plasminogen activator (t-PA) in the systemic circulation and in operated limb before the operation and in the early postoperative period.

Results: an expression of endothelial dysfunction after reconstructive surgery on the aortoiliac segment was established in both, systemic and local blood flow. Carrying of X-ray-endovascular operations was accompanied by endothelial dysfunction, which was comparable with open repair. Increased concentration of sVCAM-1 after surgery was revealed in all groups with greater dynamics in the operated limb. Annexin V content in the local blood flow in patients of the second group is significantly lower than of the first (at 42,66%, p <0.05).The most significant changes were found in the fibrinolytic activity in the performance of X-ray-endovascular interventions. A significant increase in systemic and local concentrations of PAI-1 was marked in the second group. The level of PAI-1 in the operated limb after stenting was 1,93 times higher than that in an open procedure. In contrast, post-operative changes in t-PA in patients undergoing endovascular surgery, showed an increase in t-PA compared to open surgery group.

Conclusion: in the complex examination of patients with atherosclerosis obliterans before anc after reconstructive surgery is necessary to monitor markers of endothelial dysfunction with the aim of personalized correction.

 

References

1.     Zatevahin I.I., Shipovskiy V.N., Magomedov Sh.G., Dzhurakulov Sh.R. Rezultatyi endovaskulyarnogo lecheniya ateroskleroticheskih porazheniy podvzdoshnyih arteriy. [Endovascular treatment for iliac arteries atherosclerotic lesions]. Diagnosticheskaya i interventsionnaya radiologiya. 2010; 4: 2: 29-37 [In Russ].

2.     Pokrovskiy A.V., Gontarenko V.N. Sostoyanie sosudistoy hirurgii v Rossii v 2014 godu. [Status of vascular surgery in Russia in 2014]. Moscow. 2014; 99 [In Russ].

3.     Habazov R.I., Amirov N.Sh., Amirova A.V. et al. Otdalennyie rezultatyi endoprotezirovaniya i stentirovaniya podvzdoshnyih arteriy posle gibridnyih vmeshatelstv. [Long-term results of endoprosthesis replacement and stenting of iliac arteries after hybrid procedures]. Vestnik Natsionalnogo mediko-hirurgicheskogo Tsentra im. N.I. Pirogova. 2016; 11:1: 22-26 [In Russ].

4.     Karpenko A.A., Starodubtsev V.B., Ignatenko P.V. et al. Maloinvazivnyie vmeshatelstv u patsientov so steno-okklyuzionnyimi porazheniyami aorto-podvzdoshnogo segmenta. [Minimally invasive interventions in patients with steno-occlusive lesions of the aorto-iliac segment]. Materialyi XXX mezhdunarodnoy konferentsii Rossiyskogo obschestva angiologov i sosudistyih hirurgov. Novyie napravleniya v lechenii sosudistyih bolnyih (25-27 iyunya 2015 g.,  g. Sochi). Angiologiya i sosudistaya hirurgiya (prilozhenie). [Materials of XXX of international conference of Russian society of angiologists and vascular surgeons. New directions in treatment of vascular patients (on June, 25-27 2015, Sochi). Angiology and vascular surgery (annex)]. 2015; 21:2:283-285 [In Russ].

5.     Troitskiy A.V., Behtev A.G., HabazovR.I. et al. Rezultatyi gibridnyih operatsiy pri etazhnyih porazheniyah arteriy aorto-podvzdoshnogo i bedrenno-podkolennogo segmentov. [Results of hybrid operations in leveled lesions of arteries of aorta-iliac and femoral-popliteal segments]. Angiologiya i sosudistaya hirurgiya. 2013; 19: 1: 39-43 [In Russ].

6.     Shipovskiy V.N. Ezhegodnyiy kongress Obschestva serdechno-sosudistyih hirurgov i interventsionnyih radiologov Evropyi CIRSE-2009 (18-21 sentyabrya 2009g. Lissabon, Portugaliya). [Annual Congress of the Society of cardiovascular surgeons and interventional radiologists Europe CIRSE- 2009 (September 18-21, 2009, Lisbon, Portugal).]. Angi- ologiya i sosudistaya hirurgiya. 2010; 16: 1: 57-64 [In Russ].

7.     Greiner A., Dessl A., Klein-Weigel P. et al. Kissing- stents for treatment of complex aortoiliac disease. Eur. J. Vasc. Endovasc. Surg. 2003; 26(2):161-165.

8.     M. Saha S., Gibson, Torrie E.P.H. et al. Stenting for localized arterial stenosis in the aorto-iliac segment. Eur. J. Vasc. Endovasc. Surg. 2001; 22(1):37-40.

9.     Byilov K.V., Drozdov S.A., Dundua D.P. et al. Mesto angioplastiki pri lechenii okklyuzirovannyih (dlinoy bolee 10 sm) bedrennyih arteriy. [The place of angioplasty in the treatment of occlusion (length 10 cm) femoral arteries]. Mezhdunarodnyiy zhurnal interventsionnoy kardioangiologii. 2004; 5:26-31 [In Russ].

10.   Ignatovich I.N., Kondratenko G.G., Sergeev G.A. et al. Vliyanie revaskulyarizatsii na rezultatyi lecheniya hronicheskoy kriticheskoy ishemii pri neyroishemicheskoy forme sindroma diabeticheskoy stopyi. [The effect of revascularization on outcomes of treatment of chronic critical ischemia in the neuroischemic form of diabetic foot syndrome]. Angiologiya i sosudistaya hirurgiya. 2011; 17: 1:71-75 [In Russ].

11.   Maksimov A.V., Plotnikov M.V. Intraoperatsionnyie oslozhneniya i prichinyi konversiy pri rekonstruktsiyah aortobedrennogo segmenta cherez minilaparotomiyu. [Intraoperative complications and causes of conversion in reconstructions of the aortofemoral segment using minila parotomy]. Hirurgiya. Zhurnalim. N.I. Pirogova. 2011; 5: 19-24 [In Russ].

12.   Karpenko A.A., Starodubtsev V.B., Ignatenko P.V. et al. Rezultatyi endovaskulyarnyih vmeshatelstv u bolnyih s okklyuzionno-stenoticheskimi porazheniyami arteriy aorto-podvzdoshnogo segmenta. [Results of endovascular interventions in patients with occlusive-stenotic lesions of arteries in the aorto-iliac segment]. Angiologiya i sosudistaya hirurgiya. 2016; 22:2:77-82 [In Russ].

13.   Arzamastsev D.D. Chreskozhnaya angioplastika, provospalitelnyie faktoryi i endotelialnaya disfunktsiya v effektivnosti revaskulyarizatsii nizhnih konechnostey. Avtoreferat. Diss. kand. med. [Percutaneous angioplasty, pro-inflammatory factors and endothelial dysfunction in efficiency of revascularization of lower limbs. Abstract of thesis of Diss. of candidate of med. sci.]. Novosibirsk. 2012; 23 [In Russ].

14.   Kozyireva V.S., Subbotovskaya A.I., Shilova A.N., Karpenko A.A. Immunologicheskie aspektyi formirovaniya restenozov posle povrezhdeniya endoteliya. [Immunological aspects of formation of restenoses after endothelial damage]. Angiologiya i sosudistaya hirurgiya. 2014, 20(1):21-26 [In Russ].

15.   Norgren L., Hiatt W.R., Dormandy J.A. et al. TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J. Vasc. Surg. 2007; 45:5-67.

16.   Kuznetsov M.R., Boldin B.V., Koshkin V.M. et al. Prognozirovanie otdalennyih rezultatov operativnogo lecheniya bolnyih s obliteriruyuschim aterosklerozom arteriy nizhnih konechnostey. [Prediction of remote results of surgical treatment of patients with obliterating atherosclerosis of lower limb arteries.]. Angiologiya i sosudistaya hirurgiya. 2008; 14 (1): 106-112 [In Russ].

17.   Diagnostika i korrektsiya narusheniy lipidnogo obmena s tselyu profilaktiki i lecheniya ateroskleroza. Rossiyskie rekomendatsii V peresmotr. [Diagnostics and correction of violations of lipid exchange as a prophylaxis and treatment of atherosclerosis. Russian recommendations of V are a revision]. М. 2012; 50 [In Russ].

18.   Reiner Z., Alberico L. Catapano, Backer G. et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur. Heart J. 2011; 32 (14). 1769-1818.

19.  Arakelyan V.S., Demidova O.A., Sergeev S.Yu. Sovremennaya strategiya lecheniya patsientov s hronicheskoy ishemiey nizhnih konechnostey: Transatlanticheskiy mezhdunarodnyiy konsensus (Trans-Atlantic inter-Society Consensus) (obzor literaturyi). [Modern strategy of treatment of patients with the chronic ischemia of lower limbs: the Transatlantic international consensus (Trans -  Atlantic inter - Society Consensus) (review of literature)]. Angiologiya i sosudistaya hirurgiya. 2009; 15: 3: 127-133 [In Russ].

20.   Kazakov Yu.I., Lukin I.B., Sokolova N.Yu., NefYodov V.I. Vyizhivaemost bez amputatsii posle otkryityih i endovaskulyarnyih vmeshatelstv na infraingvinalnom segmente u bolnyih s kriticheskoy ishemiey nizhnih konechnostey. [Survival without amputation after open and endovascular interventions for infrainguinal segment in patients with critical limb ischemia]. Grudnaya i serdechno-sosudistaya hirurgiya. 2015; 1: 42-46 [In Russ].

21.   Bradbury A.W., Adam D.J., Bell J. et al. BASIL Trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making. J. Vasc. Surg. 2010; 51 (5): 52S-68S. 

22.   Menard M. The role of endovascular therapy in the treatment of critical limb ischemia. Angiol. Vasc. Surg. 2014; 20 (1): 53-59.

23.   Buziashvili Yu.I., Koksheneva I.V., Samsonova N.N. et al. Dinamika urovnya faktorov vospalitelnoy reaktsii v rannem posleoperatsionnom periode pri razlichnyih metodikah koronarnogo shuntirovaniya. [Dynamics of level of factors of inflammatory reaction in an early postoperative period at different methodologies of the coronal by-passing]. Kardiologiya i serdechno-sosudistaya hirurgiya. 2015; 8(1) :4-11 [In Russ].

24.   Vasina L.V. Mehanizmyi disfunktsii endoteliya pri ostrom koronarnom sindrome. Avtoreferat. Diss. dokt. med. nauk. [Mechanisms of endothelial dysfunction in acute coronary syndrome. Dr. med. sci. Diss.].St.Petersburg 2008; 25 [In Russ].

25.   Gotto A.M. Contemporary Diagnosis and Management of Lipid Disorders: Handbooks in Health Care Co. Pennsylvania, 2001; 238

26.   Suhanov S.G., Tauber O.N. Gipergomotsisteinemiya i koronarnyiy ateroskleroz. [Hyperhomocysteinemia and coronary atherosclerosis]. Vestnik SamGU - Estestvennonauchnaya seriya. 2007; 2(52):285-293 [In Russ].

27.   Ridker P.M., Rifai N., Rose L., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. - Vol. 347 (20): 1557-1565.

28.   Lankin V.Z.,Tihaze A.K., Kumskova E.M. Osobennosti modifikatsii lipoproteinov nizkoy plotnosti v razvitii ateroskleroza i saharnogo diabeta tipa 2. [Modification of low density lipoproteins in atherosclerosis and diabetes mellitus type 2]. Kardiologicheskiy vestn. 2008; 3(1): 60- 68 [In Russ].

29.   Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nature Medicine. 2002; 8:1211-1218.

30.  Petrischev N.N. Disfunktsiya endoteliya: prichinyi, mehanizmyi, farmakologicheskaya korrektsiya. [Endothelial dysfunction: causes, mechanisms, pharmacological correction]. St-Peterburg: Izd-vo SPbGMU. [St.Petersburg]. 2003; 184 [In Russ].

31.   Dansky H.M., Barlow C.B., Lominska C. et al. Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler. Thromb. Vasc. Biol. 2001; 21(10):1662-1667.

32.   Maksimov A.V., Feyshanov A.K., Plotnikov M.V. Ob'ektivnyie kriterii invazivnosti minidostupa pri aortobedrennyih rekonstruktsiyah. Prospektivnoe issledovanie. [Objective criteria of invasiveness in aortofemoral reconstructions. A prospective study.]. Angiologiya i sosudistaya hirurgiya. 2011; 17:1:127-130 [In Russ].  

 

Abstract:

Breast cancer is the most frequent malignant disease in women in the Russian Federation. To reduce the mortality from breast cancer, various measures were used, of which mammographic screening proved its effectiveness. In recent decades, the active process of informatization of health care system in the Russian Federation has predetermined the need to introduce various information systems, including in the screening processes. Thus, on the basis of Research Institute of Clinical and Experimental Radiology of the federal state budget institution «National Research Center of Oncology N.N.Blokhin» the Ministry of Health of the Russian Federation it was developed a system SDRR-MS (System Description, Recommendations and Reporting of Mammography Screening), which can be used both in screening and in diagnostic processes. The system focused on educational process and standardization of a routine practice of radiologists and X-ray technicians in the breast examination. The system allows to unite an unlimited number of hospitals, while standardization processes are realized by means of a formalized description protocol, elaborated on the basis of the existing international standard BI-RADS. This article is focused on one of system component, intended for the description of x-ray breast examination. 

  

References 

1.     Klinicheskie rekomendacii AOR po raku molochnoj zhelezy. Klinicheskie rekomendacii Associacii Onkologov Rossii [Recommendations of the AOR for breast cancer. Clinical recommendations of the Association of Oncologists of Russia.]. 2014; 84S [In Russ].

2.    Prikaz Ministerstva zdravoohranenija RF №36an ot 03 fevralja 2015 goda «Ob utverzhdenii porjadka provedenija dispanserizacii opredelennyh grupp vzroslogo naselenija» [Order of the Ministry of Health of the Russian Federation No. 36an of February 3, 2015 «On approval of the procedure for the clinical examination of certain groups of adults».] [In Russ] https://www.rosminzdrav.ru/documents/8542-prikazministerstva-zdravoohraneniya-rossiyskoy-federatsii-ot-3-fevralya- 2015-g-36an-ob-utverzhdenii-poryadkaprovedeniya-dispanserizatsii-opredelennyh-grupp-vzroslogo-naseleniya

3.     Kochergina N.V., Ivankina O.V., Zamogil'naja Ja.A., Bludov A.B. Pervye rezul'taty distancionnogo mammograficheskogo skrininga raka molochnoj zhelezy [First results of remote mammographic screening of breast cancer.]. Rossijskij onkologicheskijzhurnal. 2014; 3: 15-18 [In Russ].

4.     Kochergina N.V., Bludov A.B, Shhipahina Ja.A., Ivankina O.V. Novye napravlenija uluchshenija skrininga raka molochnoj zhelezy [New directions for improving of screening for breast cancer.] Vestnik rentgenologii i radiologii. 2016; 97(6): 333-339 [In Russ].

5.     Breast Cancer Surveillance Consortium (DCSC) http://www.bcsc-research.org/data/ptlong6.pdf

6.     Perri N. Evropejskoe rukovodstvo po obespecheniju kachestva pri skrininge i diagnostike raka molochnoj zhelezy [European guidelines for quality assurance in the screening and diagnosis of breast cancer.]. Health & Consumer Protection, Directorate-General. 2010. 4th edition [In Russ].

7.    Sinicyn V.E. Sistema opisanij i obrabotki dannyh issledovanija molochnoj zhelezy [Система описаний и обработки данных исследований груди.]. Mammologicheskij atlas. Izd. Medpraktika-M. 2010; 464S [In Russ].

8.     Metodicheskie rekomendacii k prikazu №154 ot 15 marta 2006 goda «O merah sovershenstvovanija medicinskoj pomoshhi pri zabolevanijah molochnoj zhelezy» [Methodical recommendations to the order number 154 from March 15, 2006 «On measures to improve medical care for breast diseases».] [In Russ].

9.     Koljadina I.V., Poddubnaja I.V., Komov D.V. Skrining raka molochnoj zhelezy:mirovoj opyt i perspektivy [Breast cancer screening: world experience and perspectives.] Rossijskij onkologicheskijzhurnal. 2015; 1:42-46 [In Russ].

10.   Poddubnaja I.V., Koljadina I.V., Kalashnikov N.D., Borisov A.A., Makarova M.V. Populjacinnyj cionnyj «portret» raka molochnoj zhelezy v Rossii: analiz dannyh rossijskogo registra [Population «portrait» of breast cancer in Russia: data analysis of the Russian register.]. Sovremennaja onkologija. 2015; 17(1):25-29 [ In Russ].

 

 Abstract:

Aim: was to compare endothelialization of stents with permanent and biodegradable coatings at an early stage with help of optical coherence tomography (OCT).

Materials and methods: this study is a prospective, randomized trial that includes a comparative analysis of OCT data in patients after implantation of coronary stents with biodegradable (study group) and permanent coatings (control group). 98 patients were randomized 1:1 into 2 groups. After 3 months, 10 patients from each group - were randomized to conduct OCT.

Results: we analyzed OCT data of 10 studies in the biodegradable group (1,776 struts and 247 sections) and 10 studies in the permanent coating group (1562 struts and 226 sections). There were no differences in proportion of uncovered (8,9% vs. 8,5%, p=0,49) and non-exposed struts (1,6% vs. 1,3%, p=0,2). Thus, 98,4% of struts in study group and 98.7% in control group were endothelialized.

Conclusions: according to OCT data, similar results were obtained in both groups. After 3 months of observation in two groups, the overwhelming number of struts were endothelialized. At the early stage of observation, none of groups, achievement of endpoints was detected. 

 

References

1.     Mauri L., Kereiakes D., Yeh R. et al. Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents. N Engl J Med. 2014; 371:2155-2166.

2.     Authors/Task Force members , Windecker S., Kolh P., et al. ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541-619.

3.     Kim S., Kim J.S., Shin D.H., et al. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography. Am J Cardiol. 2013;111:1-5.

4.     Izumi D., Miyahara M., Sakai M., Fukuoka S. OCT- based comparison of early strut coverage between zotarolimus- and everolimus-eluting stents with second stent designs. Eurointervention. 2014;5;20.

5.     Ormiston J., Webster M., Stewart J. et al. First-inHuman Evaluation of a Bioabsorbable Polymer-Coated Sirolimus-Eluting Stent. JACC: Cardiovasc int 2013; 6(10): 1026-1034.

6.     Karjalainen P, Varho V., Nammas W. et al. Early Neointimal Coverage and Vasodilator Response Following Biodegradable Polymer Sirolimus-Eluting vs. Durable Polymer Zotarolimus-Eluting Stents in Patients With Acute Coronary Syndrome. Circulation Journal .2015;79(2): 360-367. 

authors: 


Article exists only in Russian.

authors: 


Article exists only in Russian.

 

Article exists only in Russian.

 

Article exists only in Russian.


Article exists only in Russian.


Article exists only in Russian.

 

Abstract:

The article presents analysis of 1500 cases of varicocele endovascular occlusion (EO) in children and adolescents, giving the exhaustive account of varicocele diagnostics and treatment. Standardization of the endovascular procedure was performed, and algorithm proposed for choosing the occlusion technique and embolization agent depending on the lesion anatomy.

The authors specify 5 anatomical varieties of left testicular vein (LTV), each having some particularities in occlusion procedure. For the first time in pediatric practice the Foam-form was used for LTV occlusion against the background of prominent veno-venous reflux, which considered to be one EO contraindications. The causes were specified for false and true varicocele recurrence: the former is shown to occur due to technical imperfections, and the causes of the latter can be LTV lumen recanalization or formation of the bridging collaterals.

EO of LTV is proved to be the effective for recurrent varicocele after conventional surgery in children and adolescents.   

 

Reference 

1.     Ерохин АП. Варикоцеле у детей (клинико-эксперементальное исследование). Дис.д-ра мед. наук. М. 1979.

2.     Тарусин Д.И. Факторы риска репродуктивных расстройств у мальчиков и юношей-подростков. Автореф. д-ра мед. наук. М. 2005.

3.     Кондаков В.Т., Пыков М.И., Годлевский Д.Н. Андрологические аспекты хирургического лечения варикоцеле у подростков. Медицина и здравоохранение. 2004;     10.9: 35-39.

4.     Годлевский Д.Н. Сперматогенная функцияяичек и органный кровоток при варикоцеле у детей и подростков. Автореф. канд. мед. наук. М. 2003.

5.     Корзникова И.И. Эндоваскулярная склеротерапия в лечении варикоцеле у детей.Автореф. канд. мед. наук. М. 1988.      12.

6.     Страхов С.Н. Варикозное расширение венгроздевидного сплетения и семенногоканотика. М. 2001.

7.     Лопаткин Н.А., Морозов А.В., Дзеранов Н.К. Трансфеморальная эндоваскулярная облитерация яичковой вены в лечении варикоцеле. Урол. нефрол. 1983; 6: 1-53.

8.     Tauber R., Johnsen N. Antegrade scrotal sclerotherapy for the treatment of varicocele. Technique and late results. J. Urol. 1994; 51 (2): 386-390.

9.     Palomo A., Bernard C.A. A practical resource in the surgical treatment of the scrotalrgans. Rev. Col. Med. Guatem. 1959; 10: 246-247.

10.   Esposito C, VallaJ.S., Najmaldin A. et al. Incidence and management of hydrocele following varicocele surgery in children. J. Urol. 2004; 171 (3): 1271-1273.

11.   Tessari L., Cavezzi A., Frullini A. Preliminary. Еxperience with a new sclerosing foam in the treatment of varicose veins. Dermatol. Surg. 2001; 27 (1): 58-60.

12.   Mali W.P., Oei H.Y., Arndt J.W. et al. Hemodynamics of the varicocele. II. Correlation among the results of renocaval pressure measurements, varicocele scintigraphy and phlebography. Urol. 1986; 135 (3): 489-493.

 

Abstract:

Infra-popliteal lesions rarely were the zone of interest in first years of endovascular era. Nowadays, broad worldwide experience of transluminal interventions and appearance of low-profile instruments allowed broadening of the indications for transluminal repair of the below-the-knee arteries. The method is proved to be safe and effective.

Results of 121 angioplasties in 70 patients with chronic ischemia of the legs (12 years work of a city hospital) are analyzed in the article. The main indication was stenotic and occlusive infrapopliteal lesions excluding the possibilities of bypass surgery. It was shown that the endovascular approach is extremely effective, and in cases of diabetic angiopathy and critical lower extremities ischemia, an endovascular intervention can be not only the way to save a leg, but the only way to save the patient's life.

 

Reference

1.     Sprayregen S., Sniderman K.W., Sos Т.А. et al. Popliteal artery branches: percutaneous transluminal angioplasty. Am. I. Roentgenol. 1980; 135: 945-950.

2.     Sivananthan U.M., Browne T.F., Thorley P.J., Rees M.R. Percutaneous transluminal angioplasty of the tibial arteries. Br. J. Surg. 1994; 81 (9): 1282-1285.

3.     Baum S., Pentecost M.J. Infrapopliteal revascularization. Abrams angiography interventional radiology second edition. 2006;348-261.

4.     Dorros G., Jaff M.R., Kelly K.J. et al. The acuteoutcome of tibioperoneal vessel angioplasty in417 cases with claudication and critical limbischemia. Cathet. Cardiovasc. Diagn. 1998; 45: 251-256..

5.     Alfkel H. Long-term results after infrapopliteal/CIRSE. Италия. 2006.Покровский А.В. Состояние сосудистой хирургии в России в 2006 году. М. 2007; 9-13.

6.     Rizzati R., Tartari S.. Infra-popliteal revascu larization in critical limb ischemia: three year experience in endovascular and surgical treatment/CIRSE. Италия. 2006; 191.

7.     Tsetis D., Belli A.M. The role of infrapopliteal angioplasty. Br. J. Radiol. 2004; 77 (924): 1007-1015.

8.     Затевахин И.И., Шиповский В.Н., Золкин В.Н. Баллонная ангиопластика при ишемии нижних конечностей. М.: Медицина. 2004; 231-249.

9.     Siablis D., Karпabatidis D., Katsanos К. Infrapopliteal paclitaxel-eluting stents for critical limb ischemia: six-month clinical and angiographic results/CIRSE. Италия. 2006; 196.

10.   Зеленов М.А., Ерошкин И.А., Коков Л.С. Особенности ангиографической картины у больных с сахарным диабетом с окклюзионно-стенотическим поражением артерий нижних конечностей. Диагностическая и интервенционная радиология: 2007; 1 (2): 22-30.

 

Abstract:

Recent decades exhibit a tendency to the rise of gynecological malignant tumors occurence, which makes a substantial contribution to women mortality rate. Wide application of surgery makes it crucial to specify the nature of a lesion, its location, and the degree of the neighboring tissue and lymphatic nodes involvement. Early recognition, accurate staging and localization, and timely recurrent tumor detection are the primary tasks of radiodiagnostics. Computed tomography and magnetic resonance imaging show good results in gynecological tumors detection.

Clinical application of new radiological methods develops the diagnostic accuracy, decreases the number of errors and improves the survival rate. The basic radiological diagnostic procedures and the possibilities of their clinical application are discussed in the article in a form of the survey of literature.

 

Reference

1.     Альбицкий В.Ю. и др. Репродуктивное здоровье и поведение женщин в России. Казань: Медицина. 2001; 25-27.

2.     Parker S.L. et al. Cancer statistics. Cancer. J. Clin.1996; 65: 5-27.

3.     Берека Дж. и др. Гинекология по Эмилю Новаку. Пер. с англ. М. 2002; 731-770.

4.     Карселадзе А.И. Морфология эпителиальныхяичников. Дис. д-ра мед. наук. М. 1989; 10-12.

5.     Хендлер Ф. Карцинома яичников. Пер. с англ.М. 2004; 1045-1067.

6.     Онкологическая гинекология. Тексты клинических лекций. М.: Изд-во Университетадружбы народов. 1985; 256.

7.     БолдогоеваИ.М. Совершенствование инструментальных методов в диагностике ракаяичников. Дис. кан. мед. наук. Уфа. 2007.

8.     Жорданиа К.И. Некоторые аспекты диагностики и лечения рака яичников. Русскиймедицинский журнал. 2003; 5: 7-8.

9.     Озолиня Л.А. и др. Цитостатики при ракеяичников и решение проблемы безопасности их применения для медицинского персонала. Русский врач. 2004; 3: 5-6.

10.   Bourne Т.Н., Reynolds K., Campbell S.Ovarian cancer screening. Curr. Opin. Radiol.1991; 3 (2): 216-224.

11.   Урманчеева А. Ф., Кутушева Г. Ф. Диагностика и лечение опухолей яичника. Монография. М. 2003.

12.   Edelman R. et al. Clinical MagneticResonance Imaging. Philadelphia: W.B.Saunders. 2006; 3: 2974-3002.

13.   Урманчеева А.Ф., Мешкова И.Е. Вопросыэпидемиологии и диагностики рака яичников. Практическая онкология. 2000; 4: 8-20.

14.   Reznek Rodney et al. Cancer of the Ovary.Cambridge university press. 2007-2177.

15.   BerekJ.S., Hacker N.F. Ovarian and fallopiantubes. In: C.M. Haskell (ed.). CancerTreatment (4th ed.). Philadelphia: W. B.Saunders. 1995.

16.   Hamm B., Ferstner R. MRI and CT of thefemele pelvis. Germany: Springer. 2007; 50-75.

17.   Sohaib S. A., Sahdev A., Van Trappen P. O. etal. Characterization of adnexal mass lesionson MR imaging. Am. J. Roentgenol. 2003; 180:1297-1304.

18.   Kurjak A. et al. Transvaginal ultrasound colorflow and Doppler waveform of the post-menopausal adnexal mass. Obstet. Gynecol.1992;80: 917-921.

19.   Brown D.L., Frates M.C., Laing F.C. et al. Ovarian masses: can benign and malignant lesions be differentiated with color and pulsed Doppler US? Radiology. 1994; 190: 330-336.

20.   Демидов В.И. и др. Пограничные опухоли,рак и редкие опухоли яичников. М. 2005;5-106.

21.   Marret H., Sauget S., Giraudeau B. et al.Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses. J. Ultrasound. Med. 2004; 23:1629-1639.

22.   Hillaby K. et al. The value of detection ofnormal ovarian tissue (the «ovarian crescentsign») in the differential diagnosis of adnexalmasses. Ultrasound. Obstet. Gynecol. 2004; 23:63-67.

23.   Guerriero S., Alcazar J.L., Ajossa S. et al.Comparison of conventional colour Dopplerimaging and power Doppler imaging for thediagnosis of ovarian cancer: results of aEuropean study. Gynecol. Oncol. 2001; 83:299-304.

24.   Low R.N., Carter W.D., Saleh E et al. Ovariancancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy and CT. Radiology.1995; 195: 391-400.

25.   Williams S.D. Germ cell tumors. In: R.F. Ozols(ed.), Ovarian Cancer. Philadelphia: W.B.Saunders. 1992; 967-974.

26.   Thurnher S., Hodler J., Baer S. et al.Gadolinium-DOTA enhanced MR imaging ofadnexal tumors. J. Comput. Assist. Tomogr. 1990;14: 939-949.

27.   Rohren E.M., Turkington T.G., Coleman R.E.Clinical applications of PET in oncology.Radiology. 2004; 231: 305-332.

28.   Therasse S. G. et al. New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research andTreatment of Cancer, National CancerInstitute of the United States, NationalCancer Institute of Canada. J. Natl. Cancer.Inst. 2000; 92: 205-216.

29.   Avril А., Sassen S., Schmalfeldt B. et al.Prediction of response to neoadjuvantchemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer.J. Clin. Oncol. 2005; 23: 7445-7453.

30.   Willemse P.H. et al. Interaperitoneal humanrecombinant interferon alfa-2b in minimal residual ovarian cancer. Eur. J. Cancer. 1990; 26: 353-358.

31.   Yamashita Y., Torashima M., Hatanaka Y. et al.Adnexal masses: accuracy of characterizationwith transvaginal US and precontrast andpostcontrast MR imaging. Radiology. 1995;194: 557-565.

32.   Forstner R., Hricak H., Powell C.B. et al.Ovarian cancer recurrence: value of MRimaging. Radiology. 1995; 196: 715-720.

33.   Komatsu T. et al. Adnexal masses: transvaginalUS and gadolinium-enhanced MR imaging assessment of intratumoral structure. Radiology. 1996; 198: 109-115.

34.   Low R.N., Saleh F., Song S.Y. et al. Treatedovarian cancer: comparison of MR imagingwith serum CA-125 level and physical examination - a longitudinal study. Radiology. 1999;211:519-528.

35.   Prayer L., Kainz C., Kramer J. et al. CT andMR accuracy in the detection of tumorrecurrence in patients treated for ovariancancer. J. Comput. Assist. Tomogr. 1993; 17:626-632.

authors: 

 

Abstract:

Integrated approach to radiologic diagnostics of the Alzheimer's disease used in 87 patients, 42 of which were at risk or at different stages of the disease, and 45 patients had various cerebral pathology not connected to the Alzheimer's disease. Computed tomography (CT) with temporal lobe volume calculation followed by scintigraphy, rheoencephalography and digital subtractional angiography (DSA) were done in all the patients.

Temporal and hippocampal atrophy (1), fronto-parietal and temporal capillary vascular bed reduction (2) with multiple arteriovenous shunts (3), as well as venous congestion with anomalous fronto-parietal veins formation (4) were the characteristic radiological features of the Alzheimer's disease. It is important that the above were seen not only in patients with late, but also in early and preclinical stages. These phenomena were also shown to be specific for the Alzheimer disease.

 

Reference

1.     Винблад Б. Болезнь Альцгеймера: эпидемиология, экономические затраты и терапевтические стратегии. Болезнь Альцгеймера и старение: от нейробиологии к терапии. Материалы 2-й российской конференции 18-20 октября 1999 г. М.: Пульс. 1999; 24.

2.     Altzheimer's Disease Facts and Figures, 2007.A Statistical abstract of U. S. data on Altzeimer's disease published by the Altzheimer'sAssociation. М.: Washington. 2008; 1-30.

3.     Гаврилова С.И., Калын Я.Б., Брацун А.Л. Эпидемиологические аспекты болезниАльцгеймера и других деменций позднеговозраста. XII съезд психиатров России. М. 1995;424-425.

4.     Гаврилова С.И. Фармакотерапия болезниАльцгеймера. М.: Пульс. 2003; 337.

5.     Вавилов С.Б. Компьютерная томографияголовного мозга в психиатрии: методы морфометрии. Компьютерная томография и другие современные методы диагностики(возможности и перспективы). Материалымеждународного симпозиума. М. 1989; 60-67.

6.     Колыхалов И.В. Клинические и компьютерно-томографические сопоставления при деменциях альцгеймеровского типа. Автореф. дис. канд. мед. наук. М. 1993; 25.

7.     Ахадов Т.А., Тютин Л.А., Панов В.О. и др. Объемные поражения головного мозга. Клиническое применение магнитно-резонансной томографии с контрастным усилением. Опыт использования парамагнитного средства «Магневист». М.: Видар. 1996; 21-28.

8.     Дамулин И.В., Левин О.С., Яхно Н.Н. Болезнь Альцгеймера: клинико-МРТ-исследование. Неврологический журнал. 1999; 2: 34-38.

9.     Ойфа А.И. Патологический анализ компьютерно-томографических изменений мозга в геронтопсихиатрии. Независимый психологический журнал. 2003; 2: 68-73.

10.   Bradley W.G., Waluch V., Yadley R.A. et al. Comparison of CT and MR in 400 patients with suspected disease of the brain and cervical spinal cord. Radiology. 1984; 152: 695-702.

11.   Bowen B.C. et al. MR signal abnormalities in memory disorder and dementia. Am. J. Roentgenol. 1990; 6: 1285-1292.

12.   Tsuchiya K., Makita K., Furui S., Nitta K. MRIappearances of calcified lesions within intracranial tumors. Neuroradiology. 1993; 35:341-344.

13.   Tzika A.A., Robertson R.L., Barnes P.D. et al.Childhood moyamoya disease: hemodynamicMRI. Pediatr. Radiology. 1997; 27: 727-735.

14.   Rusinek H., de Leon M.J., George A.E. et al.Alzheimer disease: measuring loss of cerebralgray matter with MR imaging. Radiology. 1991;178: 109-114.

15.   Kesslak J.P., Nalcioglu O., Cotman C.W.Quantification of magnetic resonance scansfor hippocampal and parahippocampalatrophy in Alzheimer's disease. Neurology.1991; 41: 51-54.

16.   Jack C.R., Petersen R.C., Xu Y.C. et al. Medialtemporal atrophy on MRI in normal agingand very mild Alzheimer's disease. Neurology.1997; 49: 786-794.

17.   Jack C.R., Bentley M.D., Twomey C.K., Zinsmeister A.R. MR imaging-based volume measurements of the hippocampal formation andanterior temporal lobe: validation studies.Radiology. 1990; 176: 205-209.

18.   Jack C.R. Structural imaging approaches toAlzheimer's disease. Early diagnosis of Alzheimer's disease / ed. S. Daffner. Humana. N.J.2000.

19.   Kalaria R.N. Cerebral vessels in ageing andAlzheimer's disease. Pharmacol. Ther. 1996;3 (72): 193-214.

20.   Kalaria R.N. Small vessel disease and Alzheimer's dementia: pathological considerations.Cerebrovascular. Disies. 2002; 3 (2): 48-52.

21.   Rodriguez G., Vitali P., Calvini P. et al. Hippocampal perfusion in mild Alzheimer's disease.Psychiatry Res. 2000; 100: 65-74.

22.   Гаврилова С.И. Практическое руководствопо диагностике и лечению болезни Альцгеймера. М.: Медицина. 2002; 43.

23.   Жариков Г.А., Рощина И.Ф. Диагностикадеменции альцгеймеровского типа на ранних этапах ее развития. Психиатрия и психофармакотерапия. 2001; 2: 23-27.

24.   Максимович И.В., Овсянников С.А., ГотманЛ.Н. Особенности микроциркуляции головного мозга у лиц с повышенным рискомвозникновения и ранними стадиями болезни Альцгеймера. Ангиология и сосудистаяхирургия. 2004; 4: 20-21.

25.   Максимович И.В., Готман Л.Н., Масюк С.М.Транслюминальная лазерная ангиопластика в лечении микроциркуляторных нарушений при болезни Альцгеймера. Ангиология и сосудистая хирургия. 2004; 10 (3): 89-90.

26.   Максимович И.В., Готман Л.Н. Отдаленныерезультаты применения транслюминальной лазерной ангиопластики в леченииболезни Альцгеймера. Бюл. НЦССХ им.А.Н. Бакулева. 2005; 6 (3): 103.

27.   Максимович И.В., Масюк СМ. Динамические изменения кровоснабжения и микроциркуляции головного мозга у больных,страдающих болезнью Альцгеймера, в отдаленном периоде после проведения транслюминальной лазерной ангиопластики.Сердечно-сосудистые заболевания. Бюл.НЦССХ им. А.Н. Бакулева. 2007; 8: 197.

28.   Максимович И.В., Готман Л.Н. Способ комплексной лучевой диагностики доклинических и клинических стадий болезни Альцгеймера. № 2315559 Патент РФ. 2008.

29.   Максимович И.В., Готман Л.Н. Применение метода транслюминальной лазернойангиопластики в лечении болезни Альцгеймера. Бюл. НЦССХ им. А.Н. Бакулева. 2004;5 (10): 210-211.

30.   Максимович И.В., Готман Л.Н., Масюк С.М.Репоративные изменения головного мозгау больных, страдающих болезнью Альцгеймера, в отдаленном периоде после проведения транслюминальной лазерной ангиопластики. Бюл. НЦССХ им. А.Н. Бакулева.2006; 6 (3): 103.

31.   Максимович И.В., Готман Л.Н., Масюк С.М.Способ определения размера височныхдолей головного мозга при болезни Альцгеймера. № 2306102. Патент РФ. 2007.

32.   Пономарева Н.В., Селезнева Н.Д., Колыхалов И.В. Нейрофизиологические механизмы деятельности мозга при болезни Альцгеймера. Вопросы геронтопсихиатрии. М.:Медицина. 1991; 58-66.

33.   McKhann G., Drachman D., Folstein M. et al.Clinical diagnosis of Alzheimer's disease:report of the NINCDS-ADRDA WorkGroup under the auspices of Department ofHealth and Human Services Task Force onAlzheimer's Disease. Neurology. 1984; 7 (34):939-944.

34.   Mirra S.S., Gearing M., McKeel D.W. et al.Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a studyof the Consortium to Establish a Registry forAlzheimer's Disease (CERAD).J. Neuropathol.Exp. Neurol. 1994; 3 (53): 303-315.

35.   Corey-BloomJ.,Thal L., Galasko D. et al. Diagnosis and evaluation of dementia. Neurology.1995; 45: 211-218.

36.   Morris J.C. The Clinical Dementia Rating(CDR): current version and scoring rule.Neurology. 1993; 11 (43): 2412-2414.

           37.   Kesslak J.P., Nalcioglu O., Cotman C.W. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology. 1991; 41: 51-54.


Abstract:

The aim of the study was to assess the potential of nuclear imaging for long-term results assessment in myocardial infarction (MI) surgical treatment. 35 patients were included in the study: the main group (n = 15) of patients underwent bypass surgery in 3-4 weeks after MI, and the control group (n = 20) with conventional conservative MI treatment. Radionuclide angiopulmonography and radionuclide ECG-synchronized ventriculography was performed in all the patients in 1 month, 6 months, and 12 months after MI.

Scintigraphic markers of post-operative complications were the following: (1) prolongation of minimal pulmonary circulation time 1 month after operation followed by (2) right chamber passage prolongation and (3) ejection fraction decrease. Stability of the mentioned parameters can serve as a predictor of smooth postoperative course. Feebleness of pulmonary circulation occurs earlier that the ejection fraction decrease, so it can be mentioned among the earliest symptoms of heart failure in patients with MI.

 

Reference 

 

1.     Гиляревский С.Р., Орлов В.А., ГвинджилияТ.В. Коррекция постинфарктного ремоделирования сердца ингибиторами ангиотензинпревращающего фермента.  Кардиология. 1993; 12: 37-47.

 

2.     Mazzotta G., Vecchio С. Angiotensin converting enzyme inhibitors during acute phase ofmyocardial infarction.  G. Ital.  Cardiol.  1994;24 (1): 59-70.

 

3.     McKay R.G., Pfeffer M.A., Pasternak R.C. et al. Left ventricular remodelling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986; 74: 693-702.

 

4.     Claes M.J., Vrints C.J.,  Bosmans J.  et al.Corinary flow reserve during coronary angioplasty in patients with a recent myocardial infarction: relation to stenosis and myocardial viability.J. Am. Coll. Card. 1996; 28: 1712-1719.

 

5.     Gersh B.J., Chesebro J.H., Braunwald E. et al.Coronary artery bypass  graft surgery afterthrombolytic therapy in the Thrombolysis inMyocardial Infarction Trial, Phase II (TIMI II).J. Am. Coll. Card. 1995; 25 (2): 395-402.

 

6.     Van`t Hof A.W.J., Liem A., Suryapranata H. etal.  Clinical presentation  and  outcome  of patients with early,  intermediate  and  late reperfusion  therapy by  primary  coronary angioplasty for acute myocardial infarction. Eur. Heart. J. 1998; 19: 118-123.

 

7.     Goldberg R.J., Gore J.M., Alpert J.S. et al. Cardiogenic  shock after acute  myocardial infarction:  incidence and mortality from a community-wide perspective,  1975 to 1988. N. Engl.J. Med. 1991; 325: 1117-1122.

 

8.     Touboul P., Andre-Fouet X., Leizoroviczt A. et al. Risk stratification after myocardial infarction. Eur. Heart. J. 1997; 18: 99-107.

 

9.     Taylor S.H. Congestive heart failure. Towards a comprehensive  treatment.  Eur.  Heart. J. 1996; 17 (B): 43-56.

 

10.   Матвеева Г.К. Артериальное давление в легочной артерии у больных ИБС, перенесших крупноочаговый и трансмуральный инфаркт миокарда, и его прогностическое значение. Aвтореф. дис. канд. мед. наук. М. 1988; 25.

11.   Hakim T.S., Michel R.P. et al. Site of pulmonary hypoxic vasoconstriction studied with arterial and venous occlusion. / Appl. Physiol. 1983; 54 (5): 1298-1302.


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.

 

Abstract:

Inferior vena cava (IVC) abnormalities are reported to occur in 3% of the population, and bilateral IVC is the most common one. We presented a case of a patient with bilateral IVC and pulmonary embolism threat due to deep vein thrombosis of the left leg and thrombus flotation in the left external iliac vein. Two cava-filters were placed. The need of two devices is obvious, because emboli can easily reach the pulmonary artery via either right or left IVC.

 

Reference

1.     Tore H.G., Tatar I., Celik H.H. et al. Two casesof inferior vena cava duplication. FoliaMorphol. 2005; 64: 55-58.

2.     Taniguchi H., Miyauchi Y., Kobayashi Y. et al.Pulmonary embolism from thrombosis in aduplicated inferior vena cava developing afteran electrophysiologic procedure. J. Interv. Card. Electrophys. 2001; 5: 75-79.

3.     Tatar I., Tore H.G., Celik H.H., KarcaaltincabaM. Magnetic resonance venography of doublenferior vena cava. Saudi Med. J. 2005; 26: 101-103.

4.     Artico M., Lorenzini D., Mancini P. et al.Radiological evidence of anatomical variation of the inferior vena cava. Surg. Radiol. Anat. 2004; 26: 153-156.

5.     Rohrer M., Cutler B. Placement of twoGreenfield filters in a duplicated vena cava. Surgery. 1988; 104: 572-574.

6.     Saito H., Sano N., Kaneda I. et al. Multisegmental anomaly of the inferior vena cava withthrombosis of the left inferior vena cava.Cardiovasc. Intervent. Rad. 1995; 18: 410-413.

7.     Ferris E.J., Hipona F.A., Kahn P.C. et al.Venography of the Inferior Vena Cava and itsBranches. Baltimore. Williams & Wilkins. 1969; 32.

8.     Chuang V.P., Mena C.E., Hoskins P.A.Congenital anomalies of the inferior vena - cava. Review of embryogenesis and presentation of a simplified classification. Br. J. Radiol. 1974; 47: 206-213.

9.     Bass J.E., Redwine M.D., Kramer L.A. et al.Spectrum of congenital anomalies of the inferior vena cava: cross-sectional imaging findings. Radiographics. 2000; 20: 639-652.

10.    Trigaux J.P., Vandroogenbroek S., De Wispelaere J.F. et al. Congenital anomalies of the inferior vena cava and left renal vein: evaluation with spiral CT. J. Vasc. Interv. Radiol. 1998; 9: 339-345.

11.    KaufmanJ.A., Lee MJ. Vascular and interventional radiology - the requisites. Philadelphia. PA: Mosby. 2004; 350-355.

12.    Nagashima T., Lee J., Andoh K. et al. Right double inferior vena cava. J. Comput. Assist. Tomogr. 2006; 30: 642-645. Sugimoto K., Imanaka K., Kawabe T., Hirota S. Filter placement in double inferior vena cava. Cardiovasc. Intervent. Radiol. 2000; 23: 79-82.

13.    Mano A., Tatsumi T., Sakai H. et al. A case of deep venous thrombosis with a double inferior vena cava effectively treated by suprarenal filter implantation. Jpn. Heart. J. 2004; 45: 1063-1069.

14.    Rohrer M.J., Culter B.S. Placement of two Greenfield filters in a duplicated vena cava. Surgery. 1988; 104: 572-574. Soltes G.D., Fisher R.G., Whigham C.J. Placement of dual bird's nest filters in an unusual case of duplicated inferior vena cava. J. Vasc. Interv. Radiol. 1992; 3: 709-711.

15.    Sartori M.T., Zampieri P., Andres F.L. et al. Double vena cava filter insertion in congenital duplicated inferior vena cava: a case report and literature review. Haematologica. 2006; 91 (6):e85-e86.


 

Article exists only in Russian.


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.

 

Abstract:

Company Endogene Pty. Ltd. designd an endoluminal stapler. The purpose of the study was to report the use of device in a living canine model and appraise the technology in a living canine model, and to assess reliability of the delivery system and deployment process, security of the rings discharge and fixation, as well as maintenance of the vessel patency and abcence of thrombotic complications.

 

Reference:

1.     Slonim S.M., Nyman U., Semba C.P., Miller D.C., Mitchell R.S., Dake M.D. Aortic dissection: percutaneous management of ischemic complications with endovascular stents and balloon fenestration. J. Vasc. Surg. 1996; 23:241-253.

2.     Leurs L.J., Buth J., Laheij R.J.F. Long-term results  of endovascular  abdominal  aortic aneurysm treatment with the first generation of commercially available stent grafts. Arch. Surg. 2007; 142: 33-41.

3.     Brewster D.C.,Jones J.E., Chung T.K., Lamuraglia G.M., Kwolek C.J., Watkins M.T., Hodgman T.M., Cambria R.P. Long-term outcomes after endovascular abdominal aortic aneurysm repair. Ann. Surg. 2006; 244 (3): 426-438

 

 

Abstract:

The aim of the study was to assess the powers of complex ultrasonography in different stages of endovascular closure of atrial septal defects (ASD). 31 patients 13-56 years old (mean age 23,65 ±5,2 years) with septal defects were included into the study. Ultrasound (US) monitoring performed during the procedure of endovascular closure, and as a follow-up. There were prevalence (35,4%) of the patients with central ASD with rims of 5 mm and more. Abcence of anterio-superior or aortic rim, or its deficiency, noted in 19,2% of cases. Patent foramen ovale (PFO) registered in 25,81% of patients. Incidence of multiple ASDs and ASD in aneurysm occurred to be similar and was as high as 9,67%. In 2 cases of multiple ASDs, and 2 cases of PFO, transseptal puncture was used as an approach to left atrium, for the reason of complex anatomy of the septum. After the closure, transthoracic US showed reliable decrease of the right atrium, right ventricle, and pulmonary artery (PA) size. The majority of patients (64%) showed normalization of PA pressure and left ventricle enlargement in a week after the procedure. Two-dimensional echocardiography (EchoCG) with color Doppler mapping (CDM) is the key method for ASD imaging and assessing its suitability for endovascular closure. Transesophageal EchoCG can help in verification of the ASD anatomy and refinement of the ASD rims. Ultrasound guidance during the procedure of endovascular closure allows optimal positioning of the device, immediate assessment of the homodynamic effects, and timely diagnosis of complications.

 

Reference

1.     Банкл Г. Врожденные пороки сердца икрупных сосудов. М.: Медицина, 1980; 312.

2.     Белоконь Н.А., Подзолков В.П.Врожденные пороки сердца. М.: Наука, 1991; 351.

3.     Kannan B.R., Francis E., Sivakumar K., AnilS.R., Kumar R.K. Transcatheter closure ofvery large (> or = 25 mm) atrial septal defectsusing the Amplatzer septal occluder. Catheter.Cardiovasc. Interv. 2003; 59 (4): 522-527.

4.     Maron B.J., Bonow R.O. et al. Hyperterophic cardiomyopathy: interrelations of clinicalmanifestations, pathophysiology and therapy. New. Engl.J. Med. 1987; 316: 844-852.

5.     Бокерия Л.А. Эндоваскулярная иминимально инвазивная хирургия сердца исосудов у детей. М. 1999; 226-233.

6.     Дземешкевич С.Л., Синицин В.Е., КоролевС.В., Мершина Е.А., Пустовойтова Т.С.,Фролова Ю.В., Терновой С.К., АкчуринР.С. Септальные дефекты у взрослых:современная диагностика и лечебнаятактика. Грудная и сердечно-сосудистая хирургия. 2001; 2: 40-45.

7.     Пурецкий М.В., Иванов А.С., Тараян М.В.,Балоян Г.М., Плотицин А.А., РодионовА.С., Аксюк М.А., Ревуненков Г.В. Опытиспользования Amplatzer septal occluderдля закрытия дефектов межпредсерднойперегородки. Хирургия. 2008; 2: 10-14.

8.     Mazic U., Gavora P., Masura J. The role of transesophageal echocardiography in transcatheter closure of secundum atrial septal defects by the Amplatzer septal occluder. Am. Heart J. 2001; 142 (3): 482-488.

9.     Belkin R.N., Pollak B.D., Ruggiero M.L., et al. Comparison of esophageal and transthoracic echocardiography with contrast and color flow Doppler in the detection of patent foramen ovale. Amer. heart J. 1994; 128 (3): 520-525.

10.   Droste D.W., Lakemeier S., Wichter T., Stypmann J., Dittrich R., Ritter M., Moeller M., Freund M., Ringelstein E.B. Optimizing the technique of contrast transcranial Doppler ultrasound in the detection of right-to-left shunts. Stroke. 2002; 33 (9): 2211-2216.

11.   Hofer C.K., Furrer L., Matter-Ensner S., Maloigne M., Klaghofer R., Genoni M., Zollinger A. Volumetric preload measurement by thermodilution: a comparison with transoesophageal echocardiography. Br.J. Anaesth. 2005; 94 (6): 748-755.

12.   Augoustides J.G., Weiss S.J., Ochroch A.E., WeinerJ., Mancini J., Savino J.S., Cheung A.T. Analysis of the interatrial septum by transesophageal echocardiography in adult cardiac surgical patients: anatomic variants and correlation with patent foramen ovale. J. Cardiothorac. Vasc. Anesth. 2005; 19 (2): 146-149.

13.   Augoustides J.G., Weiss S.J., Weiner J., Mancini J., Savino J.S., Cheung A.T.Diagnosis of patent foramen ovale with multiplane transesophageal echocardiography inadult cardiac surgical patients.J. Cardiothorac.Vasc. Anesth. 2004; 18 (6): 725-730.

14.   Carlson K.M., Justino H., O'Brien R.E.,Dimas V.V., Leonard G.T., Pignatelli R.H.,Mullins C.E., Smith E.O., Grifka R.G.Transcatheter atrial septal defect closure:modified balloon sizing technique to avoid     18.overstretching the defect and oversizing theAmplatzer septal occluder. Catheter.Cardiovasc. Interv. 2005; 66 (3): 390-396.

15.   Chen C.Y., Lee C.H., Yang M.W., Chung H.T., Hsieh I.C., Ho A.C. Usefulness of transesophageal echocardiography for transcatheter closure of ostium secundum atrial septum defect with the amplatzer septal occluder. Chang. Gung. Med.J. 2005; 28 (12): 837-845.

16.   Dewhirst W.E., Stragand J.J., Fleming B.M. Mallory-Weiss tear complicating intraoperative transesophageal echocardiography in a patient undergoing aortic valve replacement. Anesthesiology. 1990; 73 (4): 777-778.

17.   Mehta R.H., Helmcke F., Nanda N.C., Hsiung M., Pacifico A.D., Hsu T.L. Transesophageal Doppler color flow mapping assessment of atrial septal defect. J. Am. Coll. Cardiol. 1990; 16(4): 1010-1016.

18.   Radhakrishnan S., Marwah A., Shrivastava S. Non surgical closure of atrial septal defect using the Amplatzer septal occluder in children-feasibility and early results. Indian Pediatr. 2000; 37 (11): 1181-1187.

 

Abstract:

From January 2003 till January 2008 transhepatic endobiliar stenting was performed in 62 patients with obstructive jaundice due to high post-operative malignant strictures of hepaticocholedochus duct. In 49 cases (79 %) two-step intervention performed (biliary drainage followed by endobiliary stenting), 13 patients (21 %) underwent single-stage intervention. In 60 patients (96,8%) balloon dilatation was done prior to stent implantation. In 59 cases (95,2%) the procedure was completed by control drainage placement. Hospital stay for the endobiliary stenting procedure was 12,7-22,3 days (average hospital stay 17,5 days). Mortality was as high as 12,9% (8 cases). Average post-implantation life span appeared to be 9,7 months. In 5 patients (8,1%) mechanical jaundice relapse occurred, so they needed hospitalization for reintervention. Direct dependence found between the effectiveness of endobiliary stenting and the technical characteristics of stents, anatomy of biliary strictures, as well as the methods and techniques of the intervention. Single-stage endobiliary stenting, without prior drainage, decreases the complication rate, improves the quality of life during the hospital stay, and prolongs the post-implantation life expectancy. Single-stege interventions are also shown to decrease the hospital stay and reduce the costs. Balloon dilatation is the required stage of the intervention, especially if self-expandable stents are used in torturous biliary ducts. Post-implantation drainage placement can be skipped if the wall of the hepatico-choledochus duct is not edematous, there are no signs of tumor prolapse into the lumen, if the stent is completely expanded, and the contrast media evacuates easily into the intestine.

 

Reference

1.     Wiechel К. Percutaneous transhepatic cholangiography: technique and application withstudies of the hepatic venous and biliary ductpressures, the chemical changes in blood andbile and clinical results in a series of jaundicedpatients. Acta Chir Scand Suppl. 1964; 330(11): 1-99.

2.     Fern6ndez-Aguilar J., Santoyo J., Su6rezMuсoz M. et al. Biliary reconstruction in livertransplantation: is a biliary tutor necessary. Cir Esp. 2007; 82 (6): 338-340.

3.     Kasahara M., Egawa H., Takada Y. et al. Biliaryreconstruction in right lobe living-donor livertransplantation: Comparison of differenttechniques in 321 recipients. Annals of Surgery. 2006; 243 (4): 559-566.

4.     Alsharabi A., Zieniewicz K., Patkowski W. et al.Assessment of early biliary complications afterorthotopic liver transplantation and their relationship to the technique of biliary reconstruction. Transplantation proceedings. 2006; 38 (1): 244-246.

5.     Bahra M., Jacob D. Surgical palliation ofadvanced pancreatic cancer. Recent. Results. Cancer. Res. 2008; 177: 111-120.

6.     Das A., Sivak M.J. Endoscopic palliation forinoperable pancreatic cancer. Cancer. Control.2000; 7 (5): 452-457.

7.     Maire E, Hammel P., Ponsot P. et al. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas. Am J Gastroenterol. 2006; 101 (4):735-742.

8.     Katsinelos P., Paikos D., Kountouras J. et al. Tannenbaum and metal stents in the palliative treatment of malignant distal bile duct obstruction: a comparative study of patency and cost effectiveness. SurgicalEndoscopy. 2006; 20 (10): 1587-1593.

9.     Hatzidakis A., Tsetis D., Chrysou E. et al. Nitinol stents for palliative treatment of malignant obstructive jaundice: Should we stent the sphincter of oddi in every case? Cardiovasc. Intervent. Radiol. 2001; 24: 245-248.

10.   Kaassis M., Boyer J., Dumas R. et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc. 2003; 57: 178-182.

11.   Ikeda S., Maeshiro K. Interventional treat ment of biliary stricture. Nippon. Geka. Gakkai. Zasshi. 2004; 105 (6): 374-379.

12.   Brountzos E., Ptochis N., Panagiotou I. et al. A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc. Intervent. Radiol. 2007; 30(1): 66-73.

13.   Nakamura T., Hirai R., Kitagawa M. et al. Treatment of Common Bile Duct Obstruction by Pancreatic Cancer Using Various Stents: Single-Center Experience. Cardiovasc. Intervent. Radiol. 2002; 25: 373-380.

14.   Tesdal I., Roeren T., Weiss С et al. Metallic stents for treatment of benign biliary obstruction: a long-term study comparing different stents. J. Vasc. Interv. Radiol. 2005; 16 (11): 1479-1487.

15.   Oikarinen H., Leinonen S., Karttunen A. et al. Patency and complications of percutaneously inserted metallic stents in malignant biliary obstruction.J. Vasc. Intervent. Radiol. 1999; 10: 1387-1393.

16.   Yoshida H., Taniai N., Mamada Y. et al. One-step palliative treatment method for obstructive jaundice caused by unresectable malignancies by percutaneous transhepatic insertion of an expandable metallic stent. J. World. J. Gastroenterol. 2006; 21; 12 (15): 2423-2426.

17.   Cowling M., Adam A. Internal stenting in malignant biliary obstruction. World. J. Surg. 2001; 25: 355-361.

18.   Isayama H., Komatsu Y., Tsujino T. et al. Polyurethane-covered metal stent for management of distal malignant biliary obstruction. Gastrointest. Endosc. 2002; 55 (3): 366-370.

19.   Yoon W., Lee J., Lee K. et al. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest. Endosc. 2006; 63 (7): 996-1000.

20.   Chen J., Sun C, Liao C, Chua C. Self-expandable metallic stents for malignant biliary obstruction: efficacy on proximal and distal tumors.J. World. J. Gastroenterol. 2006; 7; 12 (1): 119-122.

21.   Inal M., Aksungur E., Akgьl E. et al. Percutaneous Placement of Metallic Stents in Malignant Biliary Obstruction: One-Stage or Two-Stage Procedure? Pre-Dilate or Not? Cardiovasc. Intervent. Radiol. 2003; 26: 40-45.

 

Abstract:

Accurate and timely diagnosis of benign renal tumors is often complicated, mainly because of the large variety of manifestations. 102 patients with various renal tumors were included in the study; in 9 of them (8.8%) tumors were verified as benign. Specimen were obtained by surgical tumor excision (8 cases), and ultrasound guided needle biopsy (1 case). The importance of pre-operative CT and MRI is shown for accurate diagnosis of benign renal tumors, in particular, angiomolipoma and multilocular cystous nephroma. Authors also discussed complicacies in radiodiagnostics of benign renal tumors.

 

Reference

1.     BenningtonJ.L., BeckwithJ.B. Tumors of thekidney, renal pelvis, and ureter. In: Atlas of 9.tumor pathology. Washington. Armed ForcesInstitute of Pathology. 1975; 12: 215.

2.     Xippel W.D. The incidence of benign renalnodules (a clinicopathological study).J. Urol. 10.1971; 106: 503.

3.     Harmon W.J., King B.F., Lieber M.M.Renal oncocytoma: magnetic resonance 11.imaging characteristics. J Urol. 1996; 155 (3):863-867.

4.     Kettritz U., Semelka R.C., Siegelman E.S.,Shoenut J.P., Mitchell D.G. Multilocular cysts 12.nephroma MR imaging appearance with current techniques including gadolini. J. Magn.Reson. Imaging. 1996; 6 (1): 145-148.

5.     Semelka R.C. Abdominal - Pelvis MRI. New- 13.York. Wiley-Liss. 2002; 379-469.

6.     Wegener O.H. Whole Body ComputedTomography. Boston. Blackwell ScientificPublication. 1994; 369-400.

7.     Michalko T., Zelenak P., Valansky L. et al.Renal oncocytoma and its morphology, diagnosis and therapy. Bratisl. Lek. Listy. 1994; 95 (6): 267-269.

8.     Muramoto M., Uchida T., Kyuuno H., IshidaH., Utsunomiya T., Egawa S., Mashimo S.,Koshiba K. et al. A case of renal oncocytoma. Hinyokika Kiyo. 1994; 40 (1): 47-50.

9.     Perez-Ordonez В., Hamed G., Campbell S. Renal oncocytoma: a clinicopathologic study of 70 cases. Am. J. Surg. Pathol. 1997; 21 (8): 871-883.

10.   Saucher-Chapado M., Angulocuesta J. et al. Sunhronous bilateral renal oncocytoma. Arch. Esp. Urol. 1995; 48 (9): 909-913.

11.   Davidson A.J., Hayews W.S., Hartman D.S. et al. Renal oncocytoma and carcinoma. Failure of differentiation with CT. Radiology. 1993; 186, 693-696.

12.   Ball D.S., Friedman A.C., Hartman D.S. et al. Scar sign of renal oncocytoma. Magnetic resonance imaging appearance and lack of specificity. Urol. Radiol. 1986; 8: 46-48.

13.   Sakai Y., Gotoh S., Suzuki S., Ozawa T. A case of unilateral and synchronous occurrence of oncocytoma and renal cell carcinoma. Hinyokika Kiyo. 1997, 43 (9): 651-653.

14.   Sasakis Т., Hayashi T., Tsugaya M., Okamura T, Sakakura T, Kohri K. Radiological diagnosis of renal oncocytoma. Hinyokakiyo. 1995; 41 (9): 731-735.

15.   Wang Y.T., Liu K.L., Chuch S.C., Tsang Y.M. Giant renal oncocytoma: differential diagnosis.J. Formos. Med. Assoc. 2003; 102 (1): 46-48.

 

Abstract:

Technological advance in multislice computed tomography (MSCT) set the radiologists all over the world thinking of its application in patients with ischemic heart disease. Proved diagnostic efficiency of 64-slice MSCT coronary angiography nominates the technique to be a first-line screening method for coronary atherosclerosis: it allows quick, accurate, and non-invasive imaging and quantitative assessment of coronary lesions. Though the indications for MSCT has already defined, there still are contro-versies about its place in diagnostic strategy. The aim of our study was to picture the state-of-the-art MSCT capabilities, focusing on MSCT coronary angiography and its place in contemporary clinical medicine.

 

Reference

1.     Achenbach S. et. al. Top 10 indications forcoronary СТА. Supplement to Applied Radiology.2006; 35 (12): 22-31.

2.     Gaspar T., Halon R., Rubinshtein N. Clinicalapplications and future trends in cardiacСТА. Eur. Radiol. Suppl. 2005; 15 (l4): 10-14.

3.     Jacobs J.E. How to perform coronaryСТА: A to Z, Supplement to Applied Radiology.2006; 12: 10-17.

4.     Синицын В.Е., Воронов Д.А., Морозов С.П.Степень кальциноза коронарных артерийкак прогностический фактор осложнений сердечно-сосудистых заболеваний без клинических проявлений: результаты метаанализа. Терапевтический архив. 2006; 9: 22-27.

5.     Терновой С.К., Синицын В.Е., Гагарина Н.В. Неинвазивная диагностика атеросклероза и кальциноза коронарных артерий. М: Атмосфера. 2003; 144.

6.     Синицын В.Е., Устюжанин Д.В. КТ-ангиография коронарных артерий. Кардиология. 2006; 1: 20-25.

7.     Ehara M., Surmely J.F., Kawai M. et al.Diagnostic accuracy of 64-slice computedtomography for detecting angiographicallysignificant coronary artery stenosis in an unselected consecutive patient population:Comparison with conventional invasiveangiography. Circ.J. 2006; 70: 564-571.

8.     Leschka S. et al. Accuracy of MSCT coronaryangiography with 64-slice technology: firstexperience. Eur. Heart. J. 2005; 26: 1482-1487.

9.     Wann S. Cardiac CT for risk stratification,Supplement to Applied. Radiology. 2006; 12: 41-44.

10.   Hoffmann U., Moelewski F., Cury R.C. et al.Predictive value of 16-slice multidetector spiral computed tomography to detect significant obstructive coronary artery disease 17.in patients at high risk for coronary artery disease. Patient-versus segment-based analysis. Circulation. 2004; 110: 2638-2643.

11.   Rienmuller R., Brekke O., Kampenes V.B. et al. Dimeric versus monomeric nonionic contrast agents in visualization of coronary arteries. Eur.J. Radiol. 2001; 38 (3): 173-178.

12.   Dewey M. et al. Head-to head comparison of multislice computed tomography angiography and exercise electrocardiography for diagnosis of coronary artery disease. Eur. Heart. 2007; 10, 28 (20): 2485-2490.

13.   Schlosser T., Konorza T., Hunold P. et al. Noninvasive visualization of coronary artery bypass grafts using 16-detector row computed tomography. JACC. 2004; 44: 1224-1229.

14.   Chabbert V., Carrie D., Bennaceur M. et al. Evaluation of in-stent restenosis in proximal coronary arteries with multidetector computed tomography (MDCT). Eur Radiol. 2007; 17: 1452-1463.

15.   Schijf J.D., Bax J.J., Jukema J.W. et al. Feasibility of assessment of coronary stent patency using 16-slice computed tomography. Am.J. Cardiol. 2004; 94: 427-430.

16.   Mahnken A.H., Buecker A., WildbergerJ.E. et al. Coronary artery stents in multislice computed tomography: in vitro artefact evaluation. Invest Radiol. 2003; 39: 27-33.

17.   Cademartiri F., Marano R., Runza G. et al. Non-invasive assessment of coronary stent patency with multislice CT: preliminary experience. Radiol. Med. (Torino). 2005; 109 (5-6): 500-507.

authors: 


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.

 

Abstract:

The purpose of the study is to evaluate the immediate and long-term effectiveness of percutaneous transluminal angioplasty (PTA) in patients with diabetes mellitus (DM) and critical lower limbs ischemia (CLLI).

Since November 2004 till February 2008 42 PTA were performed in 40 patients with CLLI; 28 (70%) of them had ischemic ulceration, in 6 patients (15%) there were foot gangrene, and 6 patients suffered of ischemic rest pain. 30 patients (75%) had the insulin-dependent DM, 8 patients (20%) took antihyperglycemic drugs, 2 (5%) kept to antihyperglycemic diet. There were the following comorbidities: CAD - 30 patients (75%); arterial hypertension - 31 (77,5%); cerebrovascular insufficiency - 15 (37,5%); chronic renal failure - 8 (20%), and 3 patients (7,5%) were on chronic hemodialisis.

One patient (1,4%) had iliac localization of the lesion, 38 (51,4%) - femoropopliteal disease, and there were infrapopliteal lesions in 35 (47,3%) patients. There were prevalence of TASC type C and type D lesions (89,2%), and 81,5% of all infrapopliteal lesions were occlusions. Subintimal tracking was used in 31,5% of lesions. Stenting performed in 2 cases. Angiography success rate was 92,7% - 37 patients. Clinical improvement registered in 36 (90%) patients. 12-month follow-up showed absence of critical ischemia in 72,8% of cases. 

 

 

Reference

 

 

1.     Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur. J. Vasc. Endovasc. Surg. 2007; 33 (1): 39.

 

2.     Jonason T., Ringqvist I. Factors of prognosticimportance for subsequent rest pain in patient with intermittent claudication. Acta. Med.Scand. 1985; 218: 27-33.

 

3.     Hughson W.G., MannJ.I., Garrod A. Intermittent claudication: prevalence and risk factors,tent claudication: prevalence and risk factors. Br. Med.J. 1978; 1: 1379-1381.

 

 

4.     LoGerfo F.W., Gibbons G.W., PomposelliJ.F.B., Campbell D.R., Miller A., Freeman D.V.et al. Trends in the care of the diabetic foot.Expanded role of arterial reconstruction. Arch. Surg. 1992; 127: 617-620.

 

5.     Blair J.M., Gewertz B.L., Moosa H., Lu C.T.,Zarins C.K. Percutaneous transluminal angioplasty versus surgery for limb-threateningischemia.J. Vasc. Surg. 1989; 9 (5): 698-703.

6.     Treiman G.S., Treiman R.L., Ichikawa L., Van Allan R. Should percutaneous transluminal angioplasty be recommended for treatment of infrageniculate popliteal artery or tibioperoneal trunk stenosis?J. Vasc. Surg. 1995; 22 (4): 457-463, 464-465.

 

7.     Parsons R.E., Suggs W.D., Lee J.J., Sanchez L.A., Lyon R.T., Veith F.J. Percutaneous transluminal angioplasty for the treatment of limbthreatening ischemia: do the results justify anattempt before bypass grafting? / Vase. Surg. 1998; 28 (6): 1066-1071.

 

8.     Molloy K.J., Nasim A., London N.J., Naylor A.R., Bell PR., Fishwick G., Bolia A., Thornpson M.M. Percutaneous transluminal angioplasty in the treatment of critical limb ischemia.J. Endovasc. Ther. 2003; 10 (2): 298-303.

 

9.     Nasr M.K., McCarthy R.J., Hardman J., Chalmers A., Horrocks M. The increasing role ofpercutaneous transluminal angioplasty in theprimary management of critical limb ischaemia. Eur. J. Vasc. Endovasc. Surg. 2002; 23 (5):398-403.

 

 

10.   Adam D.J., Beard J.D., Cleveland T.T. Bypassversus angioplasty in severe ischaemia of theleg (BASIL): multicentre, randomised controlled trial. Lancet. 2005; 366 (9501):1925-1934.

 

11.   Faglia E., DallaP.L., Clerici G., ClerissiJ., Gra ziani L., Fusaro M., Gabrielli L., Losa S., Stella A., Gargiulo M., Mantero M., Caminiti M., Ninkovic S., Curci V., Morabito A. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur. J. Vasc. Endovasc. Surg. 2005; 29 (6): 620-627.

 

12.   Bolia A., Miles K.A., Brennan J. et al. Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by dissection. Cardiovasc. Intervent. Radiol. 1990; 13: 357-363.

 

13.   Rutherford R.B., Baker J.D., Ernst C., Johnston K.W., PorterJ.M., Ahn S.,Jones D.N. Recommended standards for reports dealing with lower extremity ischemia: revised version. [Erratum in: / Vase. Surg. 1997; 26 (3): 517-538.] J. Vasc. Surg. 2001; 33 (4): 805.

14.   Капутин М.Ю., Овчаренко Д.В., Сорока В.В. и др. Субинтимальная ангиопластика в лечении больных с критической ишемией нижних конечностей. Медицинский академический журнал. 2007; 6 (3): 103-108.

15.   Graziani L., Silvestro A., Bertone V., Manara E., Alicandri A., Parrinello G., Manganoni A. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease. Nephrol. Dial. Transplant. 2007; 22 (4): 1144-1149.

16.   Graziani L., Silvestro A., Bertone V., Manara E., Andreini R., Sigala A., Mingardi R., De Giglio R. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur. J. Vasc. Endovasc. Surg. 2007; 33 (4): 453-460.

17.   Long-term mortality and its predictors in patients with critical leg ischaemia. The I.C.A.I. Group (Gruppo di Studio dell'Ischemia Cronica Critica degli Arti Inferiori). The Study Group of Criticial Chronic Ischemia of the Lower Exremities. Eur. J. Vasc. Endovasc. Surg. 1997; 14 (2): 91-95.

 

Abstract:

Our experience of percutaneous vertebroplasty - one of the most up-to-date methods of vertebral tumors treatment - is presented in the article.

The purpose of the work was to assess vertebroplasty as a method, improving quality of life. In the years 2001-2007 235 vertebroplasty procedures (168 patients) were done in Blokhin's Cancer Research Center. The most common diagnoses were metastases of renal carcinoma, breast carcinoma or multiple myeloma. The main indications for vertebroplasty procedure were chronic pain due to vertebral tumor progression and the loss of vertebral supporting function. Quality of life is shown to improve in the majority of the operated patients.

Relative simplicity of the percutaneous vertebroplasty and high effectiveness of the method allow us to recommend its widespread adoption in clinical practice. 

 

 

Reference

 

1.     Sundaresan S.N., Krol G., DiGiacinto G.V.,Hughes. J. Metastatic tumors of the spine. In: S.N. Sundaresan, H.H. Scmidek, A.L. Schiller et al. Tumors of the Spine. Diagnosis and Clinical Management. Philadelphia: WB Saunders. 1990: 279-304.

2.     Wingo P.A., Ries L.A., Rosenberg H.M., Miller D.S., Edwards B.K. Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer. 1998; 1197-1207.

3.     Coleman R., Bone Metastases From BreastCancer and Other Solid Tumors. ASCO 2001, San-Fransisco, May 12-15. Education Book.152-163.

4.     Deramond H., Depriester C., Galibert P. et al. Percutaneous vertebroplasty with polymethylmetacrylate. Technique, indications and results. Radiol. Clin. North. Am. 1998; 36 (3): 533-546.

 

5.     Anselmetti G.C., Corrao G., Patrizia D.M., Tartaglia V. et al. Pain Relief Following Percutaneous Vertebroplasty. Results of Series of 283 Consecutive Patients Treated in Single Institution. Card. Vasc. and Int. Radiol. 2007; 30 (3): 441-447.

 

6.     Weill A., Chiras J., Simon J.M. Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement. Radiology. 1996; 199: 241-247.

7.     Robertson R.C., Ball R.P. Destructive spine lesions: diagnosis by needle biopsy.J. Bone. Joint. Surg. 1969; 51: 1531-1544. Martin H.E, Ellis E.B. Biopsy by needle puncture and aspiration. Ann. Surg. 1930; 92: 169-181.


Abstract:

In this paper the use of spiral computed tomography (SCT) in dental implantation is discussed. It is shown that scanning itself and, what is even more important, post-processing of the images should be planned individually for each patient. SCT is declared to be a substantial part of the diagnostic strategy in patients with upper and lower dental arches defects, and with complete adentia. It is also crucial in assessment of long-term results of sinus lift procedure, and for detection of immediate and remote dental implant complications. 

 

 

Reference

 

1.     Адонина О.В. Долгалев А.А., Епанов В.А., Гречишников. Клинико-рентгенологичеекая оценка результатов операции внутрикостной имплантации с поднятием дна.верхнечелюстных пазух: дис. канд. мед. наук. М. 2004; 147.

2.     В.И. Компьютерная оценка состояния челюстных костей при планировании дентальной имплантации. Актуальные проблемытеории и практики в стоматологии. 1998;237-240.

3.     Долгалев А.А., Епанов В.А., Гречишников В.И. Компьютерная оценка состояния челюстных костей при планировании дентальной имплантации. Актуальные проблемы теории и практики в стоматологии. 1998;237-240.

4.     Лосев Ф.Ф., Пьянзин В.И., Буланников А.С.Применение компьютерных технологий вдентальной имплантологии при планировании ортопедического лечения после множественного удаления зубов. Труды II Всероссийского конгресса по дентальной имплантологии. Самара, 2002; 73-75.

5.     Abrahams J.J. Dental implants and multiplanar imaging of jaw. Gt. Louis; Mosby Head and Neck imaging. 1996; 362-363.

6.     Clark D.E., Danforth R.A., Barnes P.W., Durtch M.L. Radiation absorbed from dental implant radiography, CT scan, and panoramic, and intra-oral-tehniques. J. Oral. Implantol. 1990; 16: 156-164.

7.     Fanuscu M.J., Lida K., Caputo A.A. et al. Load tranter by an implant in a sinus-gratted maxillary model. J. Oral. Maxillofac. Implants. 2003; 18(5): 667-674.

8.     Mupporapu M., Singer S.R. Implant imaging for dentist.J. Can. Dent. Assoc. 2004; 70 (1): 32-35.

9.     Ronhman S. Dental application of computerized tomography surgical planning for implant placement. Quintessence Publishing. 1998; 246.

10.   Stephen L.G., Rothman M.D. Dental application of computerized. Tomography surgical planning for implant placement. USA. 1998; 360.

 

Abstract:

The aim of the study is to evaluate the potentialities of MRI in prenatal differential diagnosis of congenital abnormalities (CA). Results of 65 MR I-studies were analyzed. Ultrasound findings of CA were the indications for MRI. MR-images were obtained on GESigna Execute II (1,5T). The final diagnoses were made by postnatal autopsy, which served as a «golden standard» of neonatal CA diagnostics. Sensitivity of the MRI for fetal CA detection was 96,7%, specificity - 100%, diagnostic accuracy - 96,9%. Predicting reliability of the method for positive results was 100%, for negative results- 71,4%. In 46,2% of cases MRI and echo results agreed, in 23,1% MRI findings changed the diagnosis, and in 16,2% MRI provided additional information, which in 10,8% changed the pregnancy management strategy. Thus, MRI is shown to be highly informative in diagnosis of the fetal CA, and be able to refine the ultrasound findings. Using the MRI improves substantially the results of prenatal testing for CA, decreases the need for invasive procedures, and allows adequate planning of antenatal and postnatal management. 

 

 

Reference

 

1.     Демикова В.П., Лапина А.С. Система мониторинга врожденных пороков развития в Российской Федерации. Лекция на II Российском конгрессе «Современные технологии в педиатрии и детской хирургии». М. 2003.

2.     Панов В.О. Методические особенности ивозможности магнитно-резонансной томографии в антенатальной диагностике нарушений внутриутробного плода. Радиология-практика. 2006; 2: 12-23.

3.     Levine D. Ultrasound versus magnetic resonance imaging in fetal evaluation. Top. Magn. Reson. Imaging. 2001; 12: 25-38.

4.     Юсупов К.Ф., Ибатуллин М.М., МихайловИ.М., Панов В.О. МРТ в диагностике аномалий развития внутриутробного плода. Радиология-практика. 2006; 2: 24-42.

5.     Munoz H., Ortega X., Soto G. et al. OC19:Ultrasound versus magnetic resonance imaging in prenatal diagnosis of fetal malformations. Ultrasound. Obstet. Gynecol. 2007; .30: 373.

6.     Whitby E.H., Paley M.N., Sprigg A. et al. Comparison of ultrasound and magnetic resonance imaging in 100 singleton pregnancies with suspected brain abnormalities. Bjog. 2004;111:784-792.

7.     Терновой С.К., Волобуев А.И., Куринов С.Б., Панов В.О., Шария М.А.Магнитно-резонансная пельвиометрия. Медицинская визуализация. 2001; 4: 6-12.

8.     Breysem L., Bosmans H., Dymarkowski S. et al. The value of fast MR imaging as an adjunct to ultrasound in prenatal diagnosis. Eur. Radiol. 2003; 13: 1538-1548.

9.     Huisman ТА, Martin E., Kubik-Huch R., Marincek B. Fetal magnetic resonance imaging of the brain: technical considerations and normal brain development. Eur. J. Radiol. 2002;12: 1941-1951.

10.   Brugger PC, Prayer D. Fetal abdominal magnetic resonance imaging. Eur. J. Radiol. 2006; 57: 278-293.

11.   Prayer D., Kasprian G., Krampl E. et al. MRI of normal fetal brain development. Eur. J. Radiol. 2006; 57: 199-216.

12.   Wang G.B., Shan R.Q., Ma Y.X. et al. Fetal central nervous system anomalies: comparison of magnetic resonance imaging and ultrasonography for diagnosis. Engl. Chin. Med.J. 2006; 119:1272-1277.

13.   Kasprian G., Balassy C., Brugger P.C., Prayer D. MRI of normal and pathological fetal lung development. Eur. J. Radiol. 2006; 57: 261-270.

14.   Brugger P.C., Stuhr F., Lindner C., Prayer D. Methods of fetal MR: beyond T2-weighted imaging. Eur.J. Radiol. 2006; 57: 172-181.

15.   Hormann M., Brugger PC, Balassy C, Witzani L., Prayer D. Fetal MRI of the urinary system. Eur.J. Radiol. 2006; 57: 303-311.

 

Abstract:

In this study the potentialities of quantitative computed tomography (QCT) in bone densitometry is reported. QCT was performed in patients receiving glucocorticoid therapy and in postmenopausal women (55 patients all in all). Special software was used for the mineral density loss assessment: surrounding tissues were automatically subtracted, and calculating of the vertebral body density done in cross-sectional view. QCT allows specifying pathological changes in any vertebral structures and so serves as a good contribution to the diagnosis of osteoporosis. 

 

 

Reference

 

1.     Иванов Е.Г. Диагностика и лечение остеопороза. AW.J. Med. 2001; 90: 170-210.

2.     Насонов Е.Л., Скрипникова И.А., Насонова В.А. Проблема остеопороза в ревматологии. М.: Стин. 1997.

 

3.     Andresen R., Haidekker M. A., Radmer S.,Banzer D. CT determination of bone mineraldensity and structural investigations on the axial skeleton for estimating the osteoporosis-related fracture risk by means of a risk score. Br.J. Radiol. 1999; 72 (858): 569-578.

 

 

4.     Genant H. K., Guglielmi G., Jergas M. et al. Bone Densitometry and Osteoporosis. Springer. 1998; 604.

 

5.     Белосельский Н. Н. Рентгеновская морфометрия позвоночника в диагностике остеопороза. Остеопороз и остеопатии. 2000.

6.     Скрипникова И.А. Профилактика и лечение остеопороза. Материалы итоговойконференции по остеопорозу. Амстердам.1996.

7.     Consensus development conference: diagnosis, prophylaxis and treatment of osteoporosis. Am. J. Med. 1993; 94: 646-650.

8.     Древаль А.В., Марченкова Л.Д., Мылов Н.М. Сравнительная информативность денситометрии осевого и периферического скелета и рентгенографии в диагностике постменопаузального остеопороза. Остеопороз и остеопатии. 1998; 2: 48-53.

9.     Оценка риска переломов и ее применение для скрининга постменопаузального остеопороза. Доклад Рабочей группы ВОЗ. Женева. 1994; 184.

10.   Benitez С. L., Schneider D. L., Barrett-Connor E., Sartoris D. J. Hand ultrasound for osteoporosis screening in postmenopausal women. Osteoporos. Int. 2000; 11 (3): 203-210.

11.   Krane St. M. Assessment of mineral and matrix turnover. In: B. Frame, J.T. Potts et al. Clinical disorders of bone and mineral metabolism. Excerpta medica. Internat. Congress Series 617. Amsterdam. Oxford, Princeton. 1983; 95-98.

authors: 


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.

 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.

 

Abstract:

The preclinical evaluation of the 0,5 M solution of the manganese(II)-DTPA [Mn(II)-DTPA] complex (mangapentetate) has been carried out in order to test the ability of Mangenese to be employed as substiute of potentially toxic Gadolinium in paramagnetic contrast agents for the MRI clinical routines. The toxicologic tests of the Mn(II)-DTPAwere carried out in mice, rats and rabbits. Saline phantoms served for calculation of the R1 -relaxivity of the Mn(II)-DTPA, in comparison to the Gd(III)-DTPA (Magnevist). Normal healthy rabbits (n = 12), healthy dogs (n = 5) and dogs with tumors (n = 5) served for quantification of imaging abilities of the Mn(II)-DTPA in vivo in animals. The LD50 in rats was over 10 ml/kg, essentially close to that one of Gd(III)-DTPA. The increase in intensity oftheTI-weighted images induced by addition of the Mn(II)-DTPA in phantom tests did not differ significantly from the values obtained with gadopentetate. Mn(II)-DTPA delivered prominent enhancement of normal kidneys in healthy rabbits as well as chest tumors in dogs. We conclude the mangapentetate can be employed as paramagnetic contrast agent in routine MRI studies and is worth clinical testing. 

 

 

Reference

 

 

 

1.     Синицын В.Е., Корниенко В.Н., Никитин В.Г. и др. Применение Омнискана (гадодиамида) в магнитно-резонансных исследованиях центральной нервной системы. Вест. рентгенол. радиол. 1995; 4: 5-11.

 

 

2.     Runge V.M., Muroff L.R., JinkinsJ.R. Central nervous system: review of clinical use of contrast media. Top. Magn. Reson. Imaging. 2001; 12 (4): 231-263.

 

3.     Griebsch I., Brown J., Boggis C. et al. Costef-fectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br. J. Cancer. 2006; 95 (7): 801-810.

4.     Скальный А.В. Химические элементы в физиологии и экологии человека. М.: Мир. 2004.

5.     Solomon G.J., Rosen P.P., Wu E. The roleof gadolinium in triggering nephrogenicsystemic fibrosis/nephrogenic fibrosingdermopathy. Arch. Pathol. Lab. Med. 2007;131 (10): 1515-1516.

6.     Grobner T, Prischl F.C. Gadolinium andnephrogenic systemic fibrosis. Kidney. Int.2007; 72 (3): 260-264.

 

7.     Kimura J., Ishiguchi T., Matsuda J. et al.Human comparative study of zinc and copperexcretion via urine after administration ofmagnetic resonance imaging contrast agants.Radiat. Med. 2005; 23 (5): 322-326.

 

 

8.     Kang J.F., Young S.; Gorg C. et al. Studies offactors affecting the design of NMR contrastagents: manganese in blood as a modelsystem. Magn. Reson. Med. 1984; 1 (3): 396-409.

 

 

9.     Koenig S.H., Baglin C., Brown R.D. et al.Magnetic field dependence of solvent protonrelaxation induced by gadolinium (3+) andmanganese (2+) complexes. Magn. Reson. Med.1984; 1: 496-501.

 

 

10.   Lin Y.J., Koretsky A.P. Manganese ionenhances Tl-weighted MRI during brain acti-vation: an approach to direct imaging of brainfunction. Magn. Res. Med. 1997; 38 (3): 378-388.

 

 

11.   Silva A.C., Lee J.H., Aoki I., Koretsky A.P.Manganese-enhanced magnetic resonanceimaging (MEMRI): methodological and practical considerations. NMR Biomed. 2004;17 (8): 532-543.

 

 

12.   Rocklage S.M., Cacheris W.P., Quay S.C. et al.Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis (phosphate).Synthesis and characterization of a paramagnetic chelate for magnetic resonance imagingenhancement. Inorg. Chem. 1989; 28:477-485.

 

 

13.   Elizondo G., Fretz C.J., Stark D.D. et al.Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent forMR imaging. Radiology. 1991; 178 (1): 73-78.

 

 

14.   Pomeroy O.H., Wendland M., Wagner S. et al. Magnetic resonance imaging of acute myocar dial ischemia using a manganese chelate, Mn-DPDP. Invest. Radiol. 1989; 24: 531-536.

 

 

15.   Toft K.G., Hustvedt S.O., Grant D. et al.Metabolism and pharmacokinetics of MnDPDP in man. Acta. Radiol. 1997; 38: 677-689.

 

 

16.   Small W.C., DeSimone-Macchi D., Parker J.R.et al. A multisite phase III study of the safetyand efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRIof the abdomen and pelvis. J. Magn. Reson.Imaging. 1999; 10: 15-24.

 

 

17.   Gallez B., Baudelet C., Adline J. et al.Accumulation of manganese in the brainof mice after intravenous injection of manganese-based contrast agents. Chem. Rev.Toxicol. 1997; 10 (4): 360-363.

 

 

18.   Досон Р., Эллиот Д., Эллиот У., Джонс К.Справочник биохимика. М.: Мир. 1991; 338.

 

19.   Caravan P., EllisonJ.J., McMurry Th.J., LaufferR.B. Gadolinium (III) Chelates as MRIContrast Agents: Structure, Dynamics, andApplications. Chem. Rev. 1999; 99: 2315.

2 0. Касаткин А.Г. Основные процессы и аппараты химической технологии. М.: Химия. 1998.

21.   Petersson H., Slone R.M., Spanier S. et al.Musculoskeletal tumors: T1 and T2 relaxationtimes. Radiology, 1988; 167 (4): 783-785.

22.   Кармазановский ЕЕ Компьютерная томография - основа мощи современной рентгенологии. Мед. визуализация. 2005; 6: 139-145.

23.   Ленская О.П. Радиоизотопные и термографические исследования при раке молочнойжелезы. Мед. радиол. 1981; 26 (12): 35-38.

24.   Максимов Н.И., Лясс Ф.М. Гамма-энцефалография в диагностике рецидивов опухолей мозга. Мед. радиол. 1977; 22 (6):75-82.

 

25.   Jenkinsson I.S., Wright P., Sorby P. 99mTc-DTPA in cerebral scanning. Int. J. Nucl. Med.ol. 1975; 2 (4): 175-178.

 

 

26.   Wolfstein R.S., Tansescu D., Sakimura I.T. et al.Brain imaging with 99mTc-DTPA: a clinicalcomparison of early and delayed studies. J.Nucl. Med. 1974; 15 (12): 1135-1137.

 

 

27.   Kim E.E., Domstad P.A., Choy Y.C. et al.Differential accumulation of 99mTc-DTPAand 99mTc-pyrophosphate within cerebraland cranial lesions: concise communication. J.Nucl. Med. 1980; 21 (9): 838-840.

 

 

28.   Weinmann H.J., Brasch R.C., Press W.R.,Wesbey G.E. Characteristics of gadolinium-DTPA coplex: a potential NMR contrast agent. Am.J. Roentgenol., 1984; 142 (3): 619-624.


 

 

Abstract:

The aim of the study was to assess effectiveness and safety of ioversol (Optiray). The contrast media used for angiography and endovascular interventions in 286 patients with coronary disease, peripheral atherosclerosis, liver and biliary disease, hysteromyoma etal. Optiray provided good visualization in 100% of cases at all vascular territories; it did not cause significant hemodynamic changes and was shown to have low allergenic capacity. As a rule, Optiray also did not affect aminotransferases serum concentrations or renal function, but in 1,4% of patients, in preexisting renal function impairment or known risk factors (diabetes, arterial hypertension) a rise of blood creatinine level was seen.

The results allow the authors to conclude that Optiray (Ioversol) satisfies all the requirements for modern contrast media. 

 

 

Reference

 

 

1.     Сергеев П.В., Cвиридов Н.К., ШимановскийН.Л. Контрастные средства. М. 1993; 256.

2.     Сергеев П.В., Юдин А.Л., Поляев Ю.А.,Шимановский Н.Л. Разработка контрастно-диагностических средств для внутрисосудистого введения: от первых опытов донаших дней. Вестник рентгенологии и радиологии. 2002; 1: 48-61.

3.     Morris T.W. X-ray contrast media. Wherearewe now and where are we going? Radiology.1993; 188: 11-16.

4.     Floriani I.E., Ciceri M.A., Torri V.A., TinazziA.M., Jahn, H.S., Noseda A.M. ClinicalProfile of Ioversol: A Metaanalysis of 57 Randomized, Double-Blind Clinical Trials. Invest.Radiology. 1996; 31 (8): 479-491.

5.     Schild H.H., Kuhl C.K., Hubner-Steiner U.A., Bohm I.M. Adverse Events after Unenhanced and Monomeric and Dimeric Contrast-enhanced CT: A Prospective Randomized Controlled Trial. Radiology. 2006; 240: 56-64.

6.     Ralston W. The acute and subacute toxicity ofioversol (Optiray) in laboratory animals.Invest. Radiology. 1989; 24 (2): 231-240.

7.     Hosoya T., Yamaguchi K., Akutsu T. et al.Delayed adverse reactions to iodinated contrast media and their risk factors. Radiat. Med.2000; 18: 39-45.

8.     Stacul F., Cova M., Assante M. et al.Comparison between the efficacy of dimericand monomeric non-ionic contrast media(iodixanol vs iopromide) in urography inpatients with mild to moderate renal insufficiency. Brit.J. Radiol. 1998; 71: 918-922.

9.     Enzweiler C.N., Hohn S.A., Lembcke A.E. etal. Contrast enhancement in electron beamtomography of the heart: comprasion of amonomeric and a dimeric iodinated contrast agent in 59 patients. ActaRadiol. 2006; 13: 95-103.

10.   Lassers E.C., Lyon S.G. Reports of contrastmedia reactions: analysis of data from reports to the U.S. Food and Drug Administrations Radiology. 1997; 203: 605-610.

 

 

11.   Bettmann M.A., Heeren T., Greenfield A.,Goudey C. Adverse events with radiographiccontrast agents, results of SCVIR Contrast agents Registry. Radiology. 1997; 203: 611- 620.

 

 

 

 

 

12.   Carraro M., Malalan F., Antonione R. et al.Effects of a dimeric vs a monomeric nonioniccontrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial. Eur. Radiol. 1998; 8: 144-147.

 

 

 

 

 

13.   Deray G., Bagnis C., Jacquiaud C. et al. Renal effects of low and isoosmolar contrast media on renal hemodynamic in normal and ischemicdog kidney. Invest. Radiology. 1999; 34: 1-4.

 

 

 

 

 

14.   Hayami I.S., Ishigooka1 M.G., Suzuki1 Y.T., Mitobe K.I. Comparison of the nephrotoxicity between ioversol and iohexol. International Urology and Nephrology. 1996; 3: 615-619.

 

 

 

15.   Misawa M., Sato Y., Hara M. et al. Use of nonionic contrast medium, iopromide (Proscope 370), in pediatric cardiovascular angiography. Nihon ShoniHoshasen Gakkai Zasshi. 2000; 16: 42-44.

16.   Кармазановский Г.Г. «Старое» неионное рентгеноконтрастное вещество иоверсол -«новый игрок» на российском рынке контрастных средств. Медицинская визуализация. 2007; 2: 135-139.

17.   Корниенко В.Н., Пронин И.И., Такуш С.В., Фадеева Л.М. Новые возможности контрастирования в нейрорадологии. Медицинская визуализация. 2006; 6: 126-133.

 

Abstract:

Hepatic artery embolization was perfomed in 14 patients. In 11 of them indications were the following: chronic pain, arterial hypertension, anemia resistant to conservative treatment, portal hypertension. In 3 nearly asymptomatic patients with angioma size of 12 cm and more, the intervention aimed to prevent possible complications of the disease. All in all, 23 interventions were done, Spongostan и Ivalon used for peripheral embolization, and Gianturco coils for feeding vessel occlusion. 16-46 month follow-up showed quality of life improvement (decrease of pain) in 12 of 14 cases. In 3 patients hepatic artery embolization resulted in normalizing of systemic arterial and portal pressure due to arteriovenous shunt cessation. Thus, feeding arteries embolization makes hepatic angiomas amenable to surgery and could be seen as a first-line treatment performed prior to hepatic resections.

 

 

Reference

 

1.     Гранов А.М., Поликарпов А.А., Таразов П.Г. Ангиография и чрескатетерная эмболизация в лечении опухолей печени, осложненных артериопортальными фистулами.Междунар. науч. конф. «Актуальные вопросы диагностики и лечения заболеваний гепатобилиарной зоны». Санкт-Петербург Эндоскоп. хирургия. 1996; 42.

2.     Веронский Г.И. Лечение гемангиом печени.Анналы хирургической гепатологии. 1996; 1:15-18.

3.     Эргашев Х.К. Компьютерно-томографическая характеристика гемангиом печени.Груд, и серд.-сосуд, хирургия. 1997; 2: 234.

4.     Чикотеев СП., Мюв С.А. Хирургия гемангиом печени. Новосибирск. 1999; 152. 5.Полысалов В.Н., Гранов ДА. Лечение гемангиом печени: зависимость хирургической тактики от формы заболевания. Вопросы онкологии. 2003; 5 (49): 630-633.

6.     Шойхет Я.Н., Крылова Н.П., Москвитина Л.Н. Хирургическое лечение обширных гемангиом печени. Хирургия. 1991; 2: 66-69.

7.     Журавлев В.А. Особенности хирургического лечения гигантских гемангиом печени. Тезисы докладов научной конференции «Диагностика и лечение печени». С.-Пб. 1999; 64.

 

Abstract:

122 cases of gastroesophageal bleeding due to portal hypertension are analyzed in the article. It is shown that transcatheter interventions, as a part of the complex hemostasis strategy, can significantly improve the results. Keeping to algorithms and acting in accordance with protocols developed for any diagnostic procedure or intervention are declared to be crucial to success. The complex approach to profuse bleeding management, that included transcatheter procedures, decreased mortality rate from 72,2% to 22,1% and reduced rebleeding rate from 47,2% to 31,4%. 

 

 

Reference

 

 

1.     Хрупкин В.И., Ханевич М.Д., Зубрицкий В.Ф., Теканадзе А.Н. Неотложная эндоваскулярная хирургия гастродуоденальных кровотечений. Петрозаводск, 2002; 90.

2.     Бабенков Г.Д., Усов С.Н., Глазунов В.К. и др.Результаты лечения больных циррозом печени, осложненного кровотечением. Анналыхирургической гепатологии. 2000; 5 (2): 210-211.

3.     Ерамишанцев А.К., Щерцингер А.Г., Китенко Е.А. и др. Консервативная терапия острых пищеводно-желудочных кровотеченийу больных портальной гипертензией. Клиническая медицина. 1998; 7: 33—37.

4.     Оноприев В.И., Дурлештер В.М., УсоваО.А., Ключников О.Ю. Хирургическое лечение кровотечений из варикозно-расширенных вен пищевода и желудка. Хирургия. 2005; 1: 38-42.

5.     Прокубовский В.И., Черкасов В.А. Результаты эндоваскулярной эмболизации венжелудка у больных с портальной гипертензией. Вестник хирургии. 1993; 712: 16-19.

6.     Акилов Х.А., Хашимов Ш.Х., Девятов А.В.Роль отдельных факторов в патогенезе ВРВП и кровотечений из них у больных циррозом печени. Анналы хирургической гепатологии. 1998; 3 (3): 130.

7.     Пациора М.Д. Хирургия портальной гипертензии. Ташкент. Медицина. 1984; 319.

8.     Петров В.П., Ерюхин И.А., Шемякин И.С. Кровотечения при заболеваниях пищеварительного тракта. М.: Медицина. 1987; 256.

9.     Шалімов О.О., Каліта М.Я., Буланов К.І. таінші. Лікування хворих з ускладненнями цирозу печінки в стадії декомпенсації. Клінічна хірургія. 1997; 3 (4): 4-8.

10.   Ерамишанцев А.К. Развитие проблемы хирургического лечения кровотечений из варикозно-расширенных вен пищевода и желудка. Анналы хирургической гепатологии. 2007; 12 (2): 8-15.

11.   Любинский В.Л., Андреев Г.Н., Оспанов А., Турмаханов СТ. Агрегатное состояние крови и значение его нарушений при кровотечениях портального генеза. Вестник хирургии. 2005; 164 (3): 65-69.

12.   Бойко В.В., Васильев Д.В. Профилактика рецидивов кровотечения из варикозно-расширенных вен пищевода и желудка при циррозе печени. Хірургія України. 2007; 2: 108-113.

13.   Горбузенко Д.В. Лечебная тактика при кровотечениях из варикозно-расширенных вен желудка. Анналы хирургической гепатологии. 2007; 12 (1): 96-101.

 

14.   Щеголев А.А., Шиповский В.Н., Аль-Самбунчи О.А., Шагинян А.К. Эндоскопический и эндоваскулярный гемостаз при кровотечениях из варикозно-расширенных вен пищевода. М.: РГМУ. 2003; 238.

 

15.   Stiegmann G. Update of endoscopic band lig ation therapy for treatment of esophageal varices. Endoscopy. 2003; 35: 5-8.

 

16.   Каримов Ш.И., Ким В.Ф., Ахтаев А.Р. Эндоваскулярная диагностика и катетерная хирургия профузных пищеводных кровотечений у больных с портальной гипертензией. Ташкент. Изд-во Ибн Сина. 1992; 124.

 

 

17.   Kiyosue H., Matsumoto S., Yamada Y. et al.Transportal intravariceal sclerotherapy withN-Butyl-2-Cyanoacrylate for Gastric Varices. J. Vasc. Interv. Radiol. 2004; 15 (5): 505-509.

 

 

18.   Ninoi T., Nakamura K., Kaminou T. et al.TIPS versus transcatheter sclerotherapy forgastric varices. AJR. 2004; 183: 3693-3776.

 

 

19.   Tripathi D., Therapondos G., Jackson E., 29.Redhead D.N., Hayes P.C. The role of thetransjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut. 2002; 51: 270-274.

 

 

20.   Vidal V., Joly L., Perreault P. et al. Usefulnessof transjugular portosystemic shunt in themanagement of bleeding ectopic varices in cirrhotic patients. Cardiovasc. Intervent. Radiol. 2006; 29: 216-219.

 

 

21.   Haciyali M., Genc H., Halici H. et al. Resultsof modifickend sugiura operation in varicealbleeding in cirrhotic and noncirrhotic patients. Hepatogastroenterology. 2003; 50 (51):748-788.

 

 

22.   Wolff M., Hirner A. Current state of portosystemic shunt surgery. Langenbecks. Arch. Surg. 2003; 388 (3): 141-149.

 

 

23.   Hert C., Fisher L., Broering D. et al. Livertransplantation in patients with liver cirrhosisand esophageal bleeding. Langenbecks. Arch. Surg. 2003; 388 (3): 150-154.

 

 

24.   Li M.K., Sunf J.J., Woo K.S. et al. Somatostatinreduces gastric mucosal blood flow in patientswith portal hypertensive gastropathy: a randomized, doubl-blind crossover study. Dig.Dis. Sci. 1996; 41: 2440-2446.

 

25.   Калита Н.Я., Буланов К.И., Весненко А.И.Прогнозирование исхода полостной операции у больных с декомпенсированным пиррозом печени. Клінічна хірургія. 1995; 1: 4—6.

26.   Зубарев П.Н., Котив Б.Н., Хохлов А.В. и др.Выбор способа портокавального шунтирования. Анналы хирургической гепатологии..2000; 3 (3): 23-27.

27.   Борисов А.Е., Рыжков В.К., Кащенко В.А. идр. Малоинвазивные операции в лечениипищеводно-желудочных кровотечений портального генеза. Анналы хирургической гепатологии. 2006; 5 (2): 214.

28.   Зубрицкий В.Ф. Регионарная внутриартериальная перфузия и малоинвазивная рентгенохирургия локальных патологических процессов. Автореф. дис. д-ра мед. наук. С.-Пб., 2000; 43.

29.   Ханевич М.Д., Зубрицкий В.Ф., Овчинников А.А. Эндоваскулярные вмешательства при кровотечениях из варикозно-расширенных вен пищевода и кардиального отдела желудка у больных портальной гипертензией. В кн.: Актуальные вопросы малоинвазивной хирургии. Владимир, 2004; 49-55.

30.   Овчинников А.А. Эндоваскулярный гемостаз при кровотечениях из варикозно-расширенных вен пищевода и желудка у больных портальной гипертензией. Автореф. дис. канд. мед. наук. М., 2004; 25.

31.   Шерцингер А.Г., Жигалова С.Б., Мусин РА. и др. Осложнения после эндоскопических вмешательств у больных с портальной гипертензией. Анналы хирургической гепатологии. 2007; 12 (2): 16-21.

32.   Братусь В.Д. Дифференциальная диагностика и лечение острых желудочно-кишечных кровотечений. Киев: Здоровье. 1991; 272.

33.   Авдосьев Ю.В., Бойко В.В., Лазирский В.А. Рентгенэндоваскулярные методы гемостаза в комплексе хирургического лечения кровотечений из флебэктазий пищевода и кардии, развившиеся на фоне внутрипеченочной и допеченочной портальной гипертензии. Врачебная практика. 2006; 6: 21-30.

 

34.   Ninoi Т., Nishida N., Kaminou Т. et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR. 2005; 184:1340-1346.

 

 

35.   Sugimori K., Morimoto M., Shirato K. et al. Retrograde transvenous obliteration of gastric varices associated with large collateral veins or a large gastrorenal shunt.J. Vasc. Interv. Radiol. 2005; 16: 113-118.

 

 

 

Abstract:

19 males with unilateral symptomatic internal carotid artery stenosis were stented in 2007 using Mo.Ma cerebral protection device (Invatec, Italy). Angiographic success rate was 100%, average procedure time 53,7±9,9 min, ICA occlusion time 53,7±19,9 min. 2 patients presented transitory ischemic attack. Clinical improvement achieved in all cases. Our experience demonstrates that the Mo.Ma device effectively prevents intraprocedural cerebral embolism in carotid stenting, and the idea of proximal protection seems to be safe, user-friendly and very promising. 

 

 

Reference

 

1.     Brown M., Rogers J., Bland J. et al.Endovascular versus surgical treatment inpatients with carotid stenosis in the Carotidand Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial.The Lancet. 2001; 357: 1729-1737.

2.     Brooks W., McClure R., Jones M. et al. Carotidangioplasty and stenting versus caroti-dendarterectomy: randomized trial in a comnity hospital.J. Am. Coll. Cardiol. 2001; 38 (6):1589-1595.

3.     Wholey M.H., Al-Mubarek N., Wholey M.H.Updated review of the global carotid arterystent registry. Catheter. Cardiovasc. Interv. 2003.60 (2): 259-266.

4.     Roubin G., New G., Iyer S. et al. Immediateand late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-yearanalysis. Circulation. 2001; 103 (4): 532-537.

5.     McKevitt F.M., Macdonald S., Venables S. Et al. Complications following carotid angioplasty and carotid stenting in patients with symptomatic carotid artery disease. Cerebrovasc. Dis. 2004; 17 (1): 285-34.

6.     Ahmadi R., Willfort A., Lang W. et al. Carotidartery stenting: effect of learning curve and intermediate-term morphological outcome./Endovasc. Ther. 2001; 8 (6): 539-546.

7.     Reimers B., Schluter M., Castriota F. et al.Routine use of cerebral protection duringcarotid artery stenting: results of a multicenterregistry of 753 patients. Am. J. Med. 2004;116 (4): 217-222.

 

8.     Cremonesi A., Manetti R., Setacci F. et al.Protected carotid stenting: clinical advantagesand complications of embolic protectiondevices in 442 consecutive patients. Stroke.2003; 34 (8): 1936-1941.

 

9.     Aronow Н., Yadav J. Embolic Protection forCarotid Artery Stenting. A 'No Brainer'.Actachir. belg. 2004; 104: 65-70.

 

 

Abstract:

The authors report of 126 patients with organic hyperinsulinism operated on in 1998-2004 (84 males, 42 females, mean age 44,5-4,2 years). Insulinoma was found in 114 patients (90,5%), beta-cells hyperplasiaand microadenomatosis in 12 (9,5%), solitary tumor in 106, and multiple tumors in 8 cases. 46 of 125 insulinomas (36,8%) were localized in pancreatic head, 45 (36,0%) in the body, and 34 (27,2%) in the tail of pancreas.

Angiography (highly selective contrast injections to celiac artery, its branches and upper mesenteric artery) with digital subtraction and magnification was performed in all cases. Selective intra-arterial injection of Calcium Gluconate (1,8-3,6 mg) with sampling of right hepatic vein immunoreactive insulin (30 sec, 1 min, 2 min and 3 min after stimulation) was done to 110 patients. Sensitivity of the angio-graphic method was as high as 79,9%. Intra-arterial Calcium stimulation test helped to regionalize 108 of 121 «sources of hyperinsulinism». Combination of angiography and Calcium stimulation test shown to be effective in 96,8% cases. 

 

 

References

1.     Boden G. Glucagonomas and insulomas.Gastroenterol. Clin. N. Amer. 1989; 18:831-845.

2.     Service F. J. Hypoglycemic disorders. N. Engl.J. Med. 1995; 332: 1144-1152.

3.     Уголев А.М., Радбиль О.С. Гормоны пищеварительной системы. М.: Медицина, 1995;101-115.

4.     Reznik Y., Coffin С, Courtheoux P. et al. Topographical diagnosis of insulinoma of the pancreas. Value of the test of intra-arterialcalcium infusion. Presse Med. 1997; 26:848-851.

5.     Brown C.K., Bartlett D.L., DoppmanJ.L. et al.Intraarterial calcium stimulation and intraoperative ultrasonography in the localizationand resection of insulinomas. Surgery. 1997;122: 1189-1193.

6.     Semelka R.C., Cumming M.J., Shoenut J.P.et al. Islet cell tumors: comparison of dynamic contrast enhanced CT and MR imagingwith dynamic gadolinium enhancementand fat suppression. Radiology. 1993; 186:799-802.

7.     Service F.J., McMahon M.M., O'Brien P.C.,Ballard D.J. Functioning insulinoma - incidence, recurrence, and long-term survivalof patients: a 60-year study. Mayo Clin. Proc.1991; 66: 711-719.

8.     Антонов А.В. Возможности и клиническоезначение топической диагностики инсулином. Автореф. дис. канд. мед. наук. М.1981; 21.

9.     DoppmanJ.L., Chang R., Fraker D. L. et al.Localization of insulinomas to regions of the-pancreas by intra-arterial stimulation with calcium. Ann. Intern. Med. 1995; 123: 269-273.

10.   Galiber A.K., Reading C.C., Charbonneau J.W.et al. Localization of pancreatic insulinoma: comparison of pre- and intraoperative US with CT andangiography. Radiology. 1988; 166: 405-408.

11.   Grosembacher L., Garcia Monaco R., Sivori E.et al. A new methodology for the preoperative-localization of occult insulinomas. Medicina(B. Aires). 1997; 57: 651-656.

12.   Junginger Тh., Bottger Тh., Beyer Т., ThelenM. Der organische Hyperinsulinismus. Dtsch.-Arzteblatt. 1990; 44: 341-343.

13.   Pitre J., Soubrane O., Dousset B. et al. [Pancreatic echoendoscopy and preoperative-localization of insulinomas] [article inFrench]. Ann. Chir. 1998; 52; 369-373.

14.   Hiramoto J.S., Feldstein V.A., LaBergeJ.M., Norton J.A. Intraoperative ultrasoundand pre operative localization detects alloccult insulinomas. Arch. Surg. 2001; 136:1020-1025.

15.   Roche A., Raisonier A., Gillon-Savouret M.C.Pancreatic venous sampling and arteriography in localizing insulinomas and gastrinomas: procedure and results in 55 cases.Radiology. l982; 145: 621-627.

16.   Марков И.Н., Привезенцева Т.В. Ангиография в диагностике инсулином поджелудочной железы. Хирургия. 1981; 11: 6-10.

17.   Doppman J.L., Shawker T.H., Miller D.L.Localization of islet cell tumors. Gastrointest.Clin. North. Am. 1989; 18: 793-804.

18.   Yamauchi H., Miyagava K., Maeda M. et al.Surgical management of insulinoma: diagnosis of tumor location and high incidence ofmalignancy. Jpn.J. Surg. 1986; 1: 8-15.

19.   Кондрашин С.А., Егоров А.В. Сочетаннаяангиографическая диагностика инсулином. Мед. радиол. 1996; 6: 23-25.

20.   Мадан А. Ангиография и артериально-стимулированный забор крови в топической диагностике органического гиперинсулинизма.Афтореф. дис. канд. мед. наук. М. 1999; 23.

21.   Brunt L.M., Veldhuis J.D., Dilley W.G. et al.Stimulation of insulin secretion by a rapid-intravenous calcium infusion in patients with beta-cell neoplasms of the pancreas. J. Clin.-docrinol. Metab. 1986; 62: 210-216.

22.   Doppman J.L., Miller D.L., Chang R. et al.Insulinomas: localization with selective-intraarterial injection of calcium. Radiology.1991; 178: 237-241.

23.   Paivansalo M., Makarainen H., Siniluoto T.et al. Ultrasound compared with computed-tomography and pancreatic arteriography in detection of endocrine tumours of the pancreas. Eur.J. Radiol. 1989; 9: 173-178.

24.   Rossi P., Baert A., Passariello R. et al. CT offunctioning tumors of the pancreas. Am. J.-Roentgenol. 1985; 144: 57-60.

25.   Angeli E., Vanzulli A., Castrucci M. Et al.Value of abdominal sonography and MRimaging at 0.5 T in preoperative detection ofpancreatic insulinoma: a comparison withdynamic CT and angiography. Abdom. Imaging.1997; 22: 295-303.

26.   Lo C.Y., Lam K.Y., Kung A.W. et al. Pancreaticinsulinomas. A 15-years experience. Arch.Surgery. 1997; 132: 926-930.

27.   Pereira P.L., Roche A.J., Maier G.W. et al.Insulinoma and islet cell hyperplasia: value ofthe calcium intraarterial stimulation testwhen finding of other preoperative studiesare negative. Radiology. 1998; 206: 703-709.

28.   Defreyne L., Konig K., Lerch M.M. et al.Modified intra-arterial calcium stimulation-with venous sampling test for preoperativelocalization of insulinomas. Abdom. Imaging.1998; 23: 322-331.

29.   Baba Y, Miyazono N., Nakajo M. et al. Localization of insulinomas. Comparison of conventional arterial stimulation with venoussampling (ASVS) and superselective ASVS.Acta Radiol. 2000; 41: 172-177.

30.   Pedrazzoli S., Pasquali C., Miotto D. et al.Transhepatic portal sampling for preoperative localization of insulinomas. Surg. Gynecol.Obstet. 1987; 165: 101-106.

31.   Won J.G., Tseng H.S., Yang AH. et al. Intraarterial calcium stimulation test for detectionof insulinomas: detection rate, responses ofpancreatic peptides, and its relationship to differentiation of tumor cells. Metabolism. 2003;52:1320-1329.

32.   Sung Y.M., Do Y.S., Shin S.W. et al. Selective intra-arterial calcium stimulation with hepatic-venous sampling for preoperative localizationof insulinomas. Korean J. Radiol. 2003; 4: 101-108.

33.   O'Shea D., Rohrer-Theurs A.W., Lynn J.A.et al. Localization of insulinomas by selective intra-arterial calcium injection. J. Clin.Endocrinol. Metab. 1996; 81: 1623-1627.

34.   Lee W.L., Won J.G., Chiang J.H. et al. Selective intra-arterial calcium injection in the-investigation of adult nesidioblastosis: acase report. DiabetMed. 1997; 14: 985-988.

35.   Ito K., Takada T., Amano H. et al. Localization of islet-cell hyperplasia: value of pre- and intra operative arterial stimulation and venous sam pling./ Hepatobiliary Pancreat. Surg. 2004; 11:203-206.

 

Abstract:

Internal carotid artery (ICA) pathological kinking considered to be one of the main causes of stroke. Aim of our study was to assess endovascular possibilities to manage this condition. Carotid stenting performed in 15 non-fixed human corpses with ICA kinking (6 - L-shaped, 5 - S-shaped, 4 - looping) under hydrodynamic monitoring.

It is shown that endovascular correction (stenting) of kinked ICA straightens the artery, considerably reduces pressure gradient, and increases volume of flow. At the same time carotid stenting, performed for ICA kinking, does not distress the vessel wall, in particular, it causes no significant intimal trauma. 


Reference

 

 

1.     Riser M.M., Gerause J., Ducoudray J., Ribaunt L. Dolicho-carotide interne avec syndrome vertigneux. Neurology. 1951; 85: 145-147.

 

 

 

2.     Quattlebaum J.L., Upson E.T., Neville R.L. Stroke associated with elongation and kinking of the internal carotid artery: report of three cases treated by segmental resection of the carotid artery. Ann. Surg. 1959; 150:824-832.

 

 

 

3.     Hurwitt E.S. Clinical evolution and surgical correction of obstruction in the branches of arteries. Ann. Surg. 1960; 152:472-475.

 

 

 

4.     Lorimer W.S. Internal carotid artery angioplasty. Surg., Gynecol., Obstet. 1961; 113:783-784.

 

 

 

5.     Паулюкас П.А., Бараускас Э.М. Хирургическая так ика при выпрямлении петель внутренних сонных артерий. Хирургия. 1989; 12: 12-18.

 

 

 

6.     Покровский А.В. Патологическое удлинение и извитость (петлеобразование, кольцеобразование) брахиоцефальных артерий. В кн.: Е.И. Чазов «Болезни сердца и сосудов». Руководство для врачей. М.: Медицина. 1992; 299-302.

 

 

 

7.     Булынин В.И., Мартемьянов С.В., Ласкаржевская М.А. Диагностика и хирургическое лечение различных вариантов патологической извитости внутренних сонных артерий. В сб. 2-й всерос. Съезд серд.-сосуд. хирургов. С.-Пб. 1993; 1: 34-35.

 

 

 

8.     Долматов Е.А., Дюжиков А.А. Хирургическое лечение патологической извитости внутренних сонных артерий. Кардиология. 1989; 3: 45-47.

 

 

 

9.     Еремеев В.П. Хирургическое лечение патологических извитостей, перегибов и петель сонных артерий. Ангиология и сосудистая хирургия. 1998; 2:82-94.

 

 

 

10.   Баркаускас Э.М., Паулюкас П.А. Способ реконструкции устья сонных артерий. Хирургия. 1988; 12: 98-102.

 

 

 

11.   Berger R. Surgical reconstruction of the extracranial carotid internal artery: Management and outcome.J. Vascular Surgery. 2000; 31: 9-18.

 

 

 

12.   Mascoli F., Mari C., Liboni A., VirgiliT., Аrcello D., Mari F., Donin I. The elongation of the internal carotid artery. Diagnosis and surgical treatment. J. Cardiovasc. Surg. 1987; 28 (1): 9-11.

 

 

 

13.   Zanneti P.P., Cremonesi V., Rollo S., Inzani E., Civardi C., Baratta V., Accordino R., Rosa G. Surgical therapy of the kinking of the internal carotid artery. Minerva Chir. 1989; 44 (11): 1561-1567.

 

 

 

14.   Freemann T., Zippit W. Carotid artery syndrome due to kinking: Surgical treatment in 44 cases. Amer. Surg.1962; 28 (11): 745-748.

 

 

 

15.   Derrick. J., Estess M., Williams D. Circulatory dynamics in kinking of the carotid artery. Surgery. 1965; 58 (2): 381-383.

 

 

 

16.   Vannis R.,Joergenson E., Carter R. Kinking of the ICA. Clinical significance and surgical management. Am. J. Surg. 1997; 134(1): 82-89.

 

 

 

17.   Негрей В.Ф., Чернявский А.М., Серкина А.В. Хирургическое лечение патологической извитости брахиоцефальных артерий. Тез. конф. «Диспансеризация и хирургическое лечение больных облитерирующими заболеваниями брахиоцефальных артерий». Москва - Ярославль. 1986; 96-97.

 

 

 

18.   Chino A. Simple method for combined carotid endarterectomy and correction of internal carotid artery kinking.J. Vasc. Surg. 1987; 6 (2): 197-199.

 

 

 

19.   Poindexter J., Patel K., Clauss R. Management of kinked extracranial cerebral arteries. J. Vasc. Surg. 1987; 6 (2): 127-133.

 

 

 

20.   Gyurko G., Reverz J. New surgical procedures for the management of carotid kinking. Acta.Chir. Hung. 1990; 31 (4): 325-331.

 

 

 

21.   Вагнер Е.А., Суханов С.Г., Цемехин Б.Д. Хирургическое лечение патологической извитости брахиоцефальных артерий. В 6 томах. Тез. док. IV съезданевропатологов. 1991; 18-20.

 

 

 

22.   Грозовский Ю.Л., Куперберг Е.Б.,Мучник М.С., Лясс С.Ф., Абрамов И.С., Грибов М.Ю. Тактика и показания к хирургическому лечению больных с сочетанными экстра- и интракраниальными поражениями сонных артерий. Невропатология и психиатрия. 1991; 7: 67-75.

 

 

 

23.   Фокин А. А. Современные аспекты диагностики и хирургического лечения окклюзионно-стенотических поражений ветвей дуги аорты. Дис. д-ра мед. наук. Челябинск. 1995; 320.

 

 

 

24.   Mathias K., Staiger J.,Thon A. et al. Perkutane Katheter Angioplastik der a. Subclavia.Dtsch. med. Wschr. 1980; 105(1): 16-18.

 

 

 

25.   Bachman D., Kim R. Transluminal dilatation for subclavian steal syndrome Amer. J. Roentgenol. 1980; 135: 995-996.

 

 

 

26.   Freitag G., Freitag J., Koch R. et al. Percutaneous angioplasty of carotid artery stenoses. Neuroradiology. 1986; 28 (2): 126-127.

 

 

 

27.   Galichia J. et al. Subclavian artery stenosis treated by transluminal angioplasty. Six cases cardiovasc. Intervent. Radiol. 1983; 6: 78-81.

 

 

28.   МашковскийМ.Д.Лекарственныесредства.М. 1984;2: 101.

 

 

Abstract:

РТА and stenting of lower limb s arteries was performed in 28 diabetic patients with critical limb ischemia. Technical success rate of interventions was 96,3%. Clinical success rate after the procedure was 64,3%. Mean values of basal ТсРО2 on the foot after operation increased on 11 mm of mercury. At a favorable outcome of treatment ankle-brachial index values increased on 0,2-0,4. Ischemia recurrence rate was 25%. All recurrences of ischemia were observed in period of 3 to 9 months. Cumulative limb salvage rate in 6 months was 80 %, in 12 months - 75%.

In short period of observation PTA and stenting in diabetic patients is able to eliminate the necessity of amputation in majority of patients. Considering weight of the general condition of such patients, presence of accompanying diseases, risk of development of complications of surgical treatment, РТА can be considered as operation of the first choice. 

 

Reference

 

 

1.     Rutherford R.B., Durham J. Percutaneous balloon angioplasty for arteriosclerosis obliterans: Long-term results. In Pearce W.H. (eds). Technologies in Vascular Surgery. 1992; 32-345.

 

 

2.     Шиповский В.Н. Баллонная ангиопластика в лечении хронической ишемии нижних конечностей.Дис. д-ра мед. наук. 2002; 16-17.

 

 

3.     Jeans W.D., Armstrong S. Fate of patients undergoing transluminal angioplasty for lower-limb ischemia. Radiology. 1990; 177: 559-564.

 

 

4.     Krepel V.M., van Andel G.J. et al. Percutaneous transluminal angioplasty of the femoropopliteal arteries: initial and long-term results. Radiology. 1985; 156:25-28.

 

5.     Харазов А Ф. Диагностика и результаты лечения пациентов с критической ишемией нижних конечностей при атеросклеротическом и диабетическом поражении артерий ниже паховой связки. Дис. канд.мед. наук. 2002; 12.

 

Abstract:

The authors report 44 successful implantations of original retrieval Nitinol stent-filters, unique "closed" design of which comprehensively described in the article. All the devices placed for pulmonary embolism (PE) management in patients with lower extremity and pelvic deep vein (DV) thrombosis. Authors announce absolute efficiency of their stent-filters for PE prophylaxis, and the procedure itself declared to be safe and minimally invasive.

Stent-filter implantation into iliac veins compared to standard filter placement in inferior vena cava (IVC) excludes risks of total infrarenal IVC thrombosis - the major complication of such procedures. It is also associated with early DV recanalization, that in sum radically reduces disability rate. Moreover, in case of IVC abnormalities, kinking or external compression stent-filter into iliac position remains the only option for endovascular PE management. All the above can be mentioned as advantages of using stent-filters.

At the same time authors observe that stent-filters quick incorporation into vessel wall prevented endovascular retrieval of the device in quite a number of cases. Persistent PE threat, requiring prolonged antithrombotic therapy under endovascular protection, might also contribute for low retrievability of the device. 

 

Reference

 

 

1.     Ballew K.A., Philbrick J.T., Becker D.M. Vena cava filters devices. Clin. Chest. Med. 1995; 16: 295-305.

 

 

2.     Becker D.M., Philbrick J.T., Selby J.B. Inferior vena cavafilters. Indications, safety, effectiveness. Arch. Intern. Med.1992; 152 (10): 1985-1994.

 

 

3.     Streiff M.B. Vena caval filters: a comprehensive review.Blood. 2000; 95: 3669-3677.

 

 

4.     Ferris E.J., McCowanT.C., Carver D.K., McFarland D.R.Percutaneous inferior vena caval filters: Follow-up ofseven designs in 320 patients. Radiology. 1993; 188:851-856.

 

 

5.     Mismetti P., Rivron-Guillot K., Quenet S., D cousus H.,Laporte S., Epinat M., Barral, F.G. A рrospective long-term study of 220 patients with a retrievable vena cava-filter for secondary hrevention of venous thromboembolism. Chest. 2007; 131:223-229.

 

 

6.     Rosenthal D., Wellons E.D., Lai K.M., Bikk A., Henderson V.J. Retrievable Inferior vena cava-filters: initial clinical results. Ann. Vasc. Surg. 2006; 20: 157-165.

 

 

7.     Asch M.R. Initial experience in humans with a new retrievable inferior vena cava filter. Radiology. 2002; 225:835-844.

 

 

8.     Binkert C.A., Sasadeusz K., Stavropoulos S.W. Retrievability of the recovery vena cava-filter after dwell times longer than 180 days. J. Vasc. Interv. Radiol. 2006;17: 299-302.

 

 

9.     De Gregorio M.A. et al. Retrieval of g nther tulip optional vena cava-filters 30 days after Implantation: Aprospective clinical study. J. Vasc. Interv. Radiol. 2006;17: 1781-1789.

 

 

10.   Oliva V.L., Szatmari F.et al. The jonas study: evaluationof the retrievability of the cordis optease inferio venacava-filter./ Vase. Interv. Radiol. 2005; 16: 1439-1445.

 

 

11.   Guglielmo ЕЕ, Kurtz A.B., Wechsler R.J. Prospectivecomparison of computed tomography and duplex sonography in the evaluation of recently inserted Kim-ray - Greenfield filters into the inferior vena cava. Clin.Imaging. 1990; 14:216-220.

 

 

12.   Kinney T.B., Rose S.C., Weingarten K.W. et al. IVC filter tilt and asymmetry: comparison of the the over-the-wire stainless-steel and titanium Greenfield IVC filters.J. Vasc. Interv. Radiol. 1997; 8: 1080-1082.

 

 

13.   Kinney T.B., Rose S.C. Regarding «limb asymmetry intitanium Greenfield filters».J. Vasc. Surg. 1998; 16:436-444.

 

 

14.   Прокубовский В.И., Капранов С.А., Савельев В.С.,Балан А.Н., Защеринская Н.А., Ломков С.С., Никитина А.В., Поликарпов О.В., Поликарпов И.В.Внутрисосудистый стент-фильтр. Патент РФ№ 2143246, приоритет от 03.06.99 г.

 

 

15.   Капранов С.А., Кузнецова В.Ф., Златовратский А.Г. Удаляемый стент-фильтр для профилактики тромбоэмболии легочной артерии. Международный журнал интервенционной кардиоангиологии. 2005; 7: 44.

 

 

16.   Кузнецова В.Ф., Капранов С.А., Златовратский А.Г. Применение стента-фильтра в эндоваскулярной профилактике тромбоэмболии легочной артерии. В сб. Новые технологии в хирургии. Ростов-на Дону.2005; 297.

 

 

17.   Прокубовский В.И., Капранов С.А. Эндоваскулярные вмешательства при тромбозе и эмболии. В кн.Флебология (руководство для врачей). Под ред. акад.В.С. Савельева. М.: Медицина, 2001; 351-390.

 

 

18.   Grams J., The S.H., Torres V.E.,. Andrews J.C. Nagor-ney D.M. Inferior vena cava-stenting: A safe and tffec-tive treatment for intractable ascites in patients with polycystic liver disease.J. Gastrointest. Surg. 2007; 11:985-990.

 

 

19.   Kishi K., SonomuraT., Fujimoto H., Kimura M., Yamada K., Sato M., Juri M. Physiologic tffect of stent therapy for Inferior vena cavajbstruction due to valignant liver tumor. Cardiovasc. Intervent. Radiol. 2006; 29: 75-83.

 

 

20.   Heijmen R., Bollen T., Duyndam D. et al. Endovascular venous stenting in May-Thurner syndrome.J. Cardiovasc. Surg. 2001; 42 (1): 83-87.

 

 

21.   Прокубовский В.И., Капранов С.А., МоскаленкоЕ.П. Анатомические и гемодинамические изменения нижней полой вены при профилактике тромбоэмболии легочной артерии. Ангиология и сосудистая хирургия. 2003; 2 (9): 51-60.

 

22.   Marcy P., Magne N., Frenay M. et al. Renal failure secondary to thrombotic complications of suprarenal inferior vena cava filter in cancer patients. Cardiovasc. Intervent. Radiol. 2001; 24: 257-259.

 

Abstract:

Between May 2005 and March 2007, catheter-port systems were placed in 20 pts for continuous hepatic artery infusion chemotherapy in the treatment of unresectable colorectal liver metastases. Carboplatin (or oxaliplatin) plus 5-fluorouracil and systemic leucovorin were administered. No complications occurred during the implantation procedures. The mean number of intrahepatic chemotherapy cycles per patient was 10 (4-25). The mean follow-up period was 412 (100-853) days. During the follow-up period, complications occurred in 9 patients (45%), but surgical or interventional radiological correction was successful in all but one case. At present, 14 patients are alive within 4 and 41 months and continue to receive intraarterial chemotherapy, while 6 patients died in 5 to 21 months from tumor progression. The common 1 -year survival is 90% (18 patients). Percutaneous implantation is potentially effective treatment for patients with CLM.

 

Reference 

 

1.     Поликарпов А.А. Рентгеноэндоваскулярные вмешательства в лечении нерезектабельных злокачественных опухолей печени. Дис. д-ра мед. наук. С.-Пб. 2006; 161.

 

 

2.     Таразов П.Г. Роль методов интервенционной радиологии в лечении больных с метастазами колоректального рака в печень. Практ. онкол. 2005; 6 (2):119-126.

 

 

3.     Hashimoto M., Watanabe O., Takahashi S. et al. Efficacy and safety of hepatic artery infusion catheter placement without fixation in the right gastroepiploic artery.J. Vasc. Intervent. Radiol. 2005; 16 (4): 465-470.

 

 

4.     Habbe T., McCowan T., Goertzen T. et al. Complicationsand technical limitations of hepatic arterial infusioncatheter placement for chemotherapy.J. Vasc. Interv. Radiol. 1998; 9 (2): 233-239.

 

 

5.     Sullivan R. Continuous arterial infusion cancer chemotherapy. Surg. Clin. N.Amer. 1962; 42: 365-388.

 

 

6.     Watkins E., Khazei A., Nahra K. Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver. Surg. Gynecol. Obstet. 1970; 130 (4): 581-605.

 

 

7.     Балахнин П.В.,Таразов П.Г., Поликарпов А. А. и др.Варианты артериальной анатомии печени по данным 1511 ангиографий. Анналы хирургической гепатологии. 2004; 9 (2): 14-21.

 

 

8.     Curley S.A., Chase J.L., Pharm D. et al. Technical consideration and complications associated with the placement of 180 implantable hepatic arterial infusion devices. Surgery. 1993; 114 (5): 928-935.

 

 

9.     Hildebrandt B., Pech M., Nicolaou A. et al. Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal livermetastases: A phase II-study and historical comparisonwith the surgical approach. BMC Cancer. 2007; 24 (7): 69.

 

 

10.   Allen P., Nissan A., Picon A. et al. Technical complications and durability of hepatic artery infusion pumpsfor unresectable colorectal liver metastases. An institutional experience of 544 consecutive cases. J. Am.Coll. Surg. 2005; 201 (1): 57-65.

 

 

11.   Zhu A., Liu L., Piao D. et al. Liver regional continuouschemotherapy: Use of femoral or subclavian artery for percutaneous implantation of catheter-port systems.World.J. Gastroenterol. 2004; 10 (11): 1659-1662.

 

 

12.   Tajima T., Yoshimitsu K., Kuroiwa T. et al. Percutaneous femoral catheter placement for long-term chemotherapy infusions: Preliminary technical results. Am. J.  Roentgenol. 2005; 184 (3): 906-914.IduchiT., Inaba Y., Arai Y. et al. Radiologic removal andreplacement of port-catheter system for hepatic arterial infusion chemotherapy. Am. J. Roentgenol. 2006;187 (6): 1579-1584.

 

 

13.   Yamagami T., Kato T., Iida S. et al. Interventional radiologic treatment for hepatic arterial occlusion afterrepeated hepatic arterial infusion chemotherapy viaimplanted port-catheter system. J. Vasc. Interv. Radiol.2004; 15 (6): 633-639.

 

 

14.   Herrmann K., Waggershauser T., Sittek H. et al. Liverintraarterial chemotherapy. Use of the femoral artery for percutaneous implantation of catheter-port systems.Radiology. 2000; 215 (1): 294-299.

 

 

15.   Grosso M., Zanon C., Mancini A. et al. Percutaneous implantation of a catheter with subcutaneous reservoir for intraarterial regional chemotherapy :Technique and preliminary results. Cardiovasc. Intervent. Radiol. 2000; 23 (3): 202-210.

 

 

16.   Oi H., Kishimoto H., Matsushita M. et al. Percutaneous implantation of hepatic artery infusion reservoir by sonographically guided left subclavian artery puncture. Am.J. Roentgenol. 1996; 166 (4): 821-822.

 

 

17.   Chen Y., He X., Chen W. et al. Percutaneous implantation of a port-catheter system using the left subclavian artery. Cardiovasc. Intervent. Radiol. 2000; 23 (1): 22-25.

 

18.   Proietti S., De BaereT., Bessoud B. et al. Intervetionalmenagement of gastroduodenal lesions complicating intra-arterial hepatic chemotherapy. Eur. Radiol. 2007;17 (8): 2160-2165.

 

 

Abstract:

Immediate and long-term results of pharmacologically "facilitated" percutaneous coronary inter-ventions (PCI) evaluated in 172 patients with myocardial infarction (MI). Pharmacological reperfusion tried prior to PCA with thrombolytic therapy (TLT, streptokinase or tenecteplase) in 81% of patients, and combination TLT + glycoprotein IIb/IIIa inhibitors (abciximab) in 19%. Average symptom onset to reperfusion time was 197±103 min.

Immediately after PCI 88% patients in both groups presented TIMI - 3 flow (р<0.01 to the initial). Repeated PCI during the hospital stay performed in 4 patients (3 in TLT group, 1 in TLT + abciximab group) with recurrent ischemia or subacute vessel occlusion as a cause of intervention. CABG needed in 2 cases. In-hospital survival rate after 'facilitated' PCI was 98,6 - 100%. 6 months clinical follow-up done in 67% of survivors, 16% of them required admission to hospital (recurrent angina due to restenosis), in 9% patients repeated PCI was performed, 6% underwent coronary bypass grafting. All the repeated procedures were success. Overall 6 months mortality was 5%. This prospective study has shown both immediate and long-term safety and efficiency of "facilitated" coronary interventions in patients with myocardial infarction.

 

Reference 

 

1.     Lincoff A.M., Topol E.J. Illusion of reperfusion: does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation. 1993; 87: 1792-1805.

 

 

2.     FibrinolyticTherapy Trialist's (FTT) Collaborative Group. Indication for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1,000 patients. Lancet. 1994; 343: 311-322.

 

 

3.     Gibbons R.J., Holmes D.R., Reeder G.S. et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N. Engl.J. Med. 1993; 328: 685-691.

 

 

4.     Grines C.L., Browne K.F., Marco J. et al. For the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial Infarction. N. Engl. J. Med. 1993; 328: 673-679.

 

 

5.     Simoons M.L., Serruys P.W., van den Brand M. et al. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J. Am. Coll. Cardiol. 1986; 7: 717-728.

 

 

6.     The GUSTO IIb Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N. Engl.J. Med. 1997; 336: 1621-1628.

 

 

7.     GUSTO Angiographic Investigators.The comparative effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after myocardial infarction. N. Engl. J.Med. 1993; 329: 1615-1622.

 

 

8.     Vermeer F., Oude Ophuis A.J.M. et al. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart. 1999; 82: 426-431.

 

 

9.     CORAMI Study Group. Outcome of attempted rescue coronary angioplasty after failed thrombolysis for acute myocardial infarction. Am. J. Cardiol. 1994; 74: 172-174.

 

 

10.   Ellis S.G., Da Silva R.E., Heyndrickx G. et al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation. 1994; 90: 2280-2284.

 

 

11.   Ross A.M., Lundergan C.F., Rohrbeck S.C. et al. Rescue angioplasty after failed thrombolysis: technical and clinical outcomes in a large thrombolysis trial. J. Am. Coll. Cardiol. 1998; 31: 1511-1517.

 

 

12.   Ellis S.G., Da Silva E.R., Spaulding C.M. et al. Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am. Heart. J. 2000; 139: 1046-1053.

 

 

13.   Lefkovits J., Ivanhoe R.J., Califf R.M. et al. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial in farction. Am.J. Cardiol. 1996; 77: 1045-1051.

 

 

14.   Neumann F.J., Blasini R., Schmitt C. et al. Effect of glycoprotein I Ib/II Ia receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation. 1998; 98: 2695-2701.

 

 

15.   Antoniucci D., Santoro G.M., Bolognese L. et al. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: Results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial.J. Am. Coll. Cardiol. 1998; 31: 1234-1239.

 

 

16.   Antoniucci D., Valenti R., Santoro G.M. et al. Primary coronary infarct artery stenting in acute myocardial in farction. Am.J. Cardiol. 1999; 84: 505-510.

 

 

17.   Pershukov I., Batyraliev T., Niyazova-Karben Z. et al. Efficacy and Safety of Direct Stenting in Patients with Acute Myocardial Infarction. Catheter. Cardiovasc. Intervent. 2003; 59: 125-126.

 

 

18.   Rodriguez A., Bernardi V., Fernandez M. et al. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Am.J. Cardiol. 1998; 81:1286-1291.

 

 

19.   Stone G.W., Brodie B.R., Griffin J.J. et al. Clinical and angiographic follow-up after primary stenting in acute myocardial infarction. Тhe Primary Angioplasty in Myocardial Infarction (PAMI) Stent Pilot Trial. Circulation. 1999; 99: 1548-1554.

 

 

20.   Petronio A.S., Musumeci G., Limbruno U. et al. Abciximab Improves 6-Month Clinical Outcome After Rescue Coronary Angioplasty. Am. Heart.J. 2002; 143 (2): 334-341.

 

 

21.   Miller J.M., Smalling R., Ohman M. et al. Effectivennes of early coronay angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III Trial). Am.J. Cardiol. 1999; 84: 779-784.

 

 

22.   Jong P., Lazzam C., Cohen E. et al. Bleeding risks with abciximab post thrombolysis in rescue or urgent angioplasty for acute myocardial infarction [abstract 971]. Circulation. 1999; 100: 188.

 

 

23.   Sundlof D.W., Rerkpattanapitat P., Wongprapanut N. et al. Incidence of bleeding complications associated with abciximab use in conjunction with thrombolytic therapy in patients requiring percutaneous transluminal coronary angioplasty. Am.J. Cardiol. 1999; 83: 1569-1571.

 

 

24.   Neumann F.J., Blasini R., Schmitt С et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation. 1998; 98: 2695-2701.

 

 

25.   Keeley E.C., Boura J.A., Grines C.L. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet. 2006; 367: 579-588.

 

 

26.   Stone G.W., Gersh B.J. Facilitated angioplasty: paradise lost. Lancet. 2006; 367: 543-546.

 

 

27.   Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acutemyocardial infarction (ASSENT-4 PCI): randomized trial. Lancet. 2006; 367: 569-578.

 

           28.   Шпектор А.В., Васильева Е.Ю., Артамонов В.Г. и др. Комбинированная реперфузия у больных острым инфарктом миокарда. Кардиология. 2007; 6: 27-30.

 

 

Abstract:

To evaluate the extent and distribution of focal fibrosis by delayed contrast-enhanced magnetic resonance imaging (DCE MRI) in patients with severe left ventricle hypertrophy caused by genetically determined hypertrophy cardiomyopathy (HCP) and compare it with global and regional myocardial function. 15 patients with HCP were studied using 1,5 T MR-scanner (Avanto, Siemens Medical Solution). 80% patients with HCP had foci of delayed CE, which were predominantly located in the anteroseptal. 33% patients with HCP had foci of perfusion defects. Septal walls with DCE foci were significantly thicker than non-enhanced segments (19,0±6,4 and 10,6±4,7, p < 0,001). Significant correlations were observed between end-diastolic segment's thickness and extent of DCE (r = 0,26, p < 0,05). Significant reverse correlation was found between extent of contrast enhancement and stroke volume in patients with HCP (r = -0,57, r < 0,05). Mean volume DCE regions was 18,4±8,5 cm3 (Mean±SE), maximum volume of hyperenhanced area was 127,9 cm3. Abnormal signal intensity from first-pass myocardial perfusion correlates with the delayed enhancement foci in patients with HCM. The extent of focal scarring in patients with HCP may reflect the severity of myocardial damage associated with the regional hypertrophy and hypokinesia of these segments.

 

Reference 

 

1.     Report of the 1995 WHO/IFSC. Task force of the definition and classification of cardiomyopathies. Circulation. 1996; 93: 841-889.

 

 

2.     Elliott P., Sharma S. et al. Survival agter cardiac arrestor sustained ventricular tachycardia in ptc with hypertrophic cardiomyopathy. JACC. 1999; 33: 1596-1601.

 

 

3.     Maron B.J. Hypertrophic cardiomyopathy. A systematic review. JAMA. 2002; 287: 1308-1320.

 

 

4.     Maron B.J. Hypertrophic cardiomyopathy and suddendeath: new perspectives on risk stratification and prevention with implantable cardioverter-defibrillator. Eur.Heart.J. 2000; 201: 1979-1983.

 

 

5.     Maron B.J., Epstein S.E., Roberts Wc. Hypertrophic cardiomyopathy and transmural myocardial infarction without signicant atherosclerosis of the extramural coronary arteries. Am. J. Cardiol. 1979; 43: 1086-1102.

 

 

6.     Tanaka M., Fujiwara H., Onodera E. et al. Quantitative analysis of myocardioal fibrosis in normal, hypertensive hearts and hypertrophic cardiomyopathy. Br.Heart. J. 1986; 55: 575-581.

 

 

7.     Rickers K., Wilke N., Jerosh-Herold M. et al. Utiliye of magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005; 112:855-861.

 

 

8.     Gupta A., Lee V.S., Chung Y.C. et al. Myocardial in arction: optimization of inversion times at delayed contrast-enhanced MR imaging. Radiology. 2004;   233:1001-1004.

 

 

9.     Kuhl H.P., Papavasiliu T.S., Beek A.M. et al. Myocardial viability: rapid assessment with delayed contrast-enhanced MR imaging with three-dimensional inversion-recovery prepared pulse sequence. Radiology. 2004; 230:576-582.

 

 

10.   Moon J., Reed E., Sheppard M. et al.The histologic basis of late enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.JACC. 2 004; 43: 2260-2264.

 

 

11.   Беленков Ю.Н., Терновой С.К., Синицын В.Е. Магнитно-резонансная томография сердца и сосудов. М.: Видар. 1998.

 

 

12.   Simonetti O.P., Kim R.J., Fieno D.S., Hillenbrand H.B.,Wu E., Bundy J.M., Finn J.P., Judd R.M. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001; 218: 215-223.

 

 

13.   Cerqueira M.D., Weissman N.J., Dilsizian V. et al. Standardised myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation. 2002;105: 539-542.

 

 

14.   Choudhury L., Mahrholdt H., Wagner A., Choi K.M.,Elliott M.D., Klocke F.J., Bonow R.O., Judd R.M., Kim R J. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J.Am. Coll. Cardiol. 2002; 40: 2156-2164.

 

 

15.   Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M.,Smith G.C., Pennell D J.Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 2003; 41: 1561-1567.

 

 

16.   Debl K., Djavidani B., Buchner S., Lipke C., Nitz W., Feuerbach S., Riegger G., Luchner A. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart. 2006; 92: 1447-1451.

 

17.   Dumont C.A., Monserrat L., Soler R., Rodriguez E.,Fernandez X., Peteiro J., Bouzas B., Pinon P., Castro-Beiras A. Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance inpatients with hypertrophic cardiomyopathy. Rev. Esp.Cardiol. 2007; 60: 15-23.

 

Abstract:

In this article our first experience of the application of the endoscopic ultrasound (EUS) and of the fine-needle aspiration (FNA) in the oncological practice using the diagnostic complex EVIS EXERA-140 + GF-UC140P-AI5 + SSD-a5 ALOKA worked out by Olympus is presented. The aims of the investigations were: to determine the effectiveness of the EUS/EUS-FNA in the examination of different lesions of the gastrointestinal tract, of the surrounding organs and of the mediastinum; to get the adequate tissue samples for the morphological checkup for the following treatment. The problems resolved with the help of the EUS/EUS-FNA are: 1) the diagnosis of the neoplasia of the gastrointestinal tract, of the panctreatobiliary tract and of the mediastinum; 2) the confirmation of a neoplasia, the estimation of its expansion on the surrounding organs and tissue sampling; 3) the differentiation of the benign and the malignant tissues.

EUS was performed on 27 patients and EUS-FNA - on 14 of them. All tissue samples were examined by a pathologist in real time operation mode. From all the patients who underwent the EUS-FNA we have taken the adequate morphological samples.

EUS/EUS-FNA is a secure and perspective diagnostic method of investigation in the oncological practice.

 

Reference 

 

1.     Bhutani M.S., Barde C.J., Markert R.J., Gopalswamy N. Length of esophageal cancer and degree of luminal stenosis during upper endoscopy predict T stage by endoscopic ultrasound. Endoscopy. 2002; 34 (6): 461-463.

 

 

2.     Chu K.-M. Endosonographic appearance of gastric adenomyoma. Endoscopy. 2002; 34 (8): 682.

 

 

3.     Harada N., Hamada S., Kubo H. et al. Preoperative evaluation of submucosal invasive colorectal cancer usinga 15-MHz ultrasound miniprobe. Endoscopy. 2001;33 (3): 237-240.

 

 

4.     Hizawa K., Matsumoto T., Kouzuki T. et al. Cystic submucosal tumors in the gastrointestinal tract: Endosonographic findings and endoscopic removal. Endoscopy. 2000; 32 (9): 712-714.

 

 

5.     Pfau P.R., Chak A. Endoscopic ultrasonography. Endoscopy. 2002; 34(1): 21-28.

 

 

6.     Rosch T., Lorenz R., Dancygier H. et al. Endosonographic diagnosis of submucosal upper gastrointestinal tracttumors. Scan.J. Gastroenterol. 1992; 27: 1-8.

 

 

7.     Bhutani M.S., Hawes R.H., Hoffmann B.J. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest. Endosc. 1997; 45: 474-479.

 

 

8.     Chak A. Endoscopic ultrasonography. Endoscopy. 2000; 32 (2): 146-152.

 

 

9.     Fritscher-Ravens A., Sriram P. V.J., Topalidis T. et al. Endoscopic ultrasonography-guided fine-needle cytodiagnosis of mediastinal metastases from renal cell cancer. Endoscopy. 2000; 32 (7): 531-535.

 

 

10.   Silvestri G.A., Hoffman B.J., Bhutani M.S. et al. Endoscopic ultrasonography-guided fine-needle aspiration in the diagnosis and staging of lung cancer. Ann. Thorac. Surg. 1996; 61: 1441-1446.

 

 

11.   Koike E.,Yamashita H., NoguchiS. et al. Endoscopic ultrasonography in patients with thyroid cancer: Its use fulness and limitations for evaluating esophagopharyn-geal invasion. Endoscopy. 2002; 34 (6): 457-460.

 

 

12.   Sadamoto Y., Oda S.,Tanaka M. et al. A useful approach to the differential diagnosis of small polypoid lesions of the gallbladder, utilizing an endoscopic ultrasound scoring system. Endoscopy. 2002; 34 (12): 959-965.

 

 

13.   Bhutani M.S. Emerging indications for interventional endoscopic ultrasonography. Endoscopy. 2003; 35 (1): 45-48.

 

 

14.   Chen V.K., Eloubeidi M.A. Endoscopic ultrasound guided fine-needle aspiration of intramural and extraintestinal mass lesions: diagnostic accuracy, complication assessment, and impact on management. Endoscopy. 2005; 37 (10): 984-989.

 

 

15.   Itoi T., Itokawa F., Sofuni A. et al. Puncture of solid pancreatic tumors guided by endoscopic ultrasonography: a pilot study series comparing trucut and 19-gauge and 22-gauge aspiration needles. Endoscopy. 2005; 37 (4): 362-366.

 

 

16.   Polkowski M. Endoscopic ultrasound and endoscopic ultrasound-guided fine-needle biopsy for the diagnosis of malignant submucosal tumors. Endoscopy. 2005; 37 (7): 635-645.

 

 

17.   Schmulewitz N., Hawes R. EUS-guided celiac plexus neurolysis - technique and indication. Endoscopy. 2003; 35(1): 49-53.

 

 

18.   Varadarajulu S., Eloubeidi M.A. Endoscopic ultrasound guided fine-needle aspiration in the evaluation of gallbladder masses. Endoscopy. 2005; 37 (8): 751-754.

 

19.   Vilmann P, Hancke S, Henriksen EW et al. Endoscopic ultrasonography with guided fine-needle aspiration biopsy of malignant lesions in the upper gastrointestinal tract. Endoscopy. 1993; 25: 523- 527.

authors: 


 

Article exists only in Russian.

 

Abstract:

By authors it is resulted results of application of system for Angojet rheolytic trombectomy in treatment of acute thromboses of the main veins and pulmonary embolism. On the basis of the data received with use rheolytic trombectomy in system vena cava superior and vena cava inferior and pulmonaty artery thrombosis? Authors conclude, that system Jet-9000 is a modern and highly effective method of treatment of venous tromboses of varios localisation and their complications. Authors specify? That tactic of the use of this method can provide as its isolated, and conjaction application with trombolytic therapy, ballon angyoplasty, stenting and others endovascular techniques. Besides rheolytic trombectomy is an alternative at existence contraindications for standard methods of treatment acute venouse thromboses. At the same time, authors emphasize, that in some cases rheolytic thrombectomy can be main method of treatment of patients with venous patology, before considered incurable (a thrombosis vena cava inferior after cavafilter-implantation, massive pulmonary artery thrombosis).

 

 

 

Reference 

 

 

 

 

1.     Persson А.V, Davis R J., Villavicencio J.L. Deep venous thrombosis and pulmonary embolism. Surg. Clin. North Am. 1991; 71: 1195-1209.

 

 

2.     O'Donnell T.F., Browse N.L., Burnard K.G., Thomas M.L. The socioeconomic effects of an iliofemoral thrombosis./ Surg. Res. 1977; 22: 483-488.

 

 

3.     Plate G., Ohlin P., Eklof B. Pulmonary embolism in the acute iliofemoral venous thrombosis. Br. J. Surg. 1985; 72:912-915.

 

4.     Robinson D.L.,Teitelbaum G.P. Phlegmasia cerulea dolens: reatment by pulse-spray and infusion thrombolysis. Am.]. Roentgenol. 1993; 160: 1288-1290.

5.     Weaver F.A., Meacham P.W., Adkins R.B., Dean R.H. Phlegmasia cerulea dolens: therapeutic considerations. South. Med.J. 1988; 81: 306-312.

 

6.     Linder D.J., Edwards J.M., Phinney E.S. et al. Long-term hemodynamic and clinical sequelae of lower extremity deep vein thrombosis. / Vase. Surg. 1986; 4: 436-442.

 

7.     Kasirajan K., Gray В., Ouriel K. Percutaneous angiojet thrombectomy in the management of extensive deep venous thrombosis./ Vase. Interv. Radiol. 2001;12: 179-185.

 

8.     Hyun S., Kim M.D. et al. Adjunctive percutaneous mechanical thrombectomy for lower extremity deep vein thrombosis: clinical and economic outcomes. / Vase. Interv. Radiol. 2006; 17: 1099-1104.

 

 

9.     Becker G., Holden R., Rabe F. et al. Local thrombolytic therapy for subclavian and axillary vein thrombosis: treatment of thoracic inlet syndrome. Radiology. 1983; 149: 419-423.

 

 

10.   Beygui R., Olcott C., Dlaman R. Subclavian vein thrombosis: outcome analysis based on ethiology and modality of treatment. Ann. Vase. Surg. 1997; 11: 247-255.

 

 

11.   A consensus document. Thrombolysis in the management of lower limb peripheral arterial occlusion / Vase Interv. Radiol 2003; 14: 337-349.

 

12.   Watson L., Armon M. Thrombolysis for acute deepvein thrombosis. Cochrane Database Syst. Rev. 2004; CD 002783.

13.   Савельев B.C. Роль хирурга в профилактике и лечении венозного тромбоза и легочной эмболии. В кн.: 50 лекций по хирургии. Под ред. B.C. Савельева. М.: Media Medica. 2003; 92-99.

14.   Кривинш Д.К., Бейгай Р.Е., Катлапс Г.Дж., Фогарти Т.Дж. Какова роль тромбэктомии при тромбозах полой вены и илеофеморального сегмента? Ангиология и сосудистая хирургия. 1997; 1: 83-97.

 

15.   Кириенко А.И., Матюшенко А.А., Андрияшкин В.В. Тромбоз в системе нижней полой вены. В кн.: Флебология (руководство ДЛЯ врачей). Под ред. акад. B.C. Савельева. М.: Медицина. 2001; 208-279.

 

 

16.   May R., Thurner J. Ein gefassporn in der vena iliacacommunis sinistra als wahrscheinliche ursache deruberwiegende linksseitigen beckenvenenthrombose. Z. Kreisl-Forsch. 1956; 45: 912-922.

 

 

17.   Baron H.C., Sharms J., Wayne M. Iliac vein compression syndrome: A new method of treatment. Am. Surg. 2000; 66: 653-655.

 

 

18.   Burroughs K.E. New considerations in the diagnosis and therapy of deep vein thrombosis. South. Med. J. 1999; 92: 517-520.

 

 

19.   O'Donnell T.E, Browse N.L., Burnand K.G., Thomas M.L. The socioeconomic effects of iliofemoral throm bosis./ Surg. Res. 1987; 22: 483-488.

 

 

20.   Patel N.H., Stookey K.R., Ketcham D.B., Cragg A.H. Endovascular management of acute extensive iliofemoral deep venous thrombosis caused by May-Thurner syndrome./ Vase. Interv. Radwl. 2000; 11: 1297-1302.

 

 

21.   Thomas В., Kinney M.D. Update on inferior vena cava-filters./ Vase. Interv. Radiol. 2003; 14: 425-440.

 

 

22.   Becker D.M. Inferior vena cava-filters: Indication, so-fety effectivness. Arch. Intern. Med. 1992; 152: 1985-1994.

 

23.   Kaufman J.A., Kinney ТВ. et al. Guidelines for the use of retrievable and convertible vena cava-filters. Report from the society of Interventional radiology multidisciplinary consensus conference. / Vase. Interv. Radiol. 2006; 17: 449-459.

 

24.   Златовратский А.Г., Капранов С.А. Анализ причин развития тромботических окклюзии нижней полой вены после имплантации кава-фильтров. В кн.: Новые технологии в хирургии. Ростов-на Дону. 2005;281-282.

 

 

25.   Rahimtoola A., Bergun J.D. Acute pulmonary embolism: an update on diagnosis and management. Curr. Probl. Cardiol. 2005; 30: 61-114.

 

 

26.   Sharafuddin M., Hicks M. Current status of percutaneous mechanical thrombectomy. Part I. General principles./ Vase. Interv. Radiol. 1997; 8: 911-921.

 

 

27.   Sharafuddin M., Hicks M. Current status of percutaneous mechanical thrombectomy. Part II. Devices and mechanisms of action. J. Vase. Interv. Radiol. 1998; 9: 15-31.

 

 

28.   Fava M., Loyola S., Flores P. et al. Mechanical frag mentation and pharmacologic thrombolysis in massive pulmonary embolism. / Vase. Interv. Radiol. 1997; 8: 261-266.

 

 

29.   Greenfield L., Proctor M., Williams D. et al. Long-term experience with transvenous catheter pulmonary embolectomy. / Vase. Interv. Radiol. 1993; 18: 450-458.

 

 

30.   Michalis L., Tsetis D., Rees M. Case report: percuta neous removal of pulmonary artery thrombus in a patient with massive pulmonary embolism using the Hydrolyser catheter: the first human experience. Clin.Radiol. 1997; 52: 158-161.

 

 

31.   Voigtlander Т., Rupprecht H., Nowak B. et al. Clinical application of a new rheolytic thrombectomy catheter system for massive pulmonary embolism. Catheter Cardiovasc. Interv. 1999; 47: 91-96.

 

 

32.   Schmitz-Rode T, Tanssens U., Schild H. et al. Framentation of massive pulmonary embolism using pigtail rotation catheter. Chest. 1998; 114: 1427-1436.

 

 

33.   Rocek M., Peregrin J., Velimsky T Mechanical thrombectomy of massive pulmonary embolism using an Arrow-Trerotola percutaneous thrombolytic device. Eur. Radiol. 1998; 8: 1683-1685.

 

 

34.   Uflacker R., Strange C, Vujic I. Massive pulmonary embolism. Preliminary results of treatment with the Amplatz thrombectomy device. / Vase. Interv. Radiol. 1996; 7: 519-528.

 

35.   Schmitt H.-E., Jager K., Jacob A. et al. A new rotational thrombectomy catheter: system design and first clinical experiences. Cardiovasc. Interv. Radiol. 1999; 22: 504-509.

 

 

36.   Капранов С.А., Бобров Б.Ю. Эндоваскулярная роторная дезобструкция при массивной эмболии легочных артерий. В кн.: 1-й Российский съезд интервенционных кардиоангиологов. М. 2002; 12.


 

 

 

Abstract:

The aim of the study was to evaluate results of percutaneous coronary interventions (PCI) in patients with ischemic cardiomyopathy (ICMP) - potential candidates for heart transplantation. The study included 37 patients with ICMP. All the patients before PCI and within the 7 days after it undergo ec-hocardiography and ECG-gated SPECT. The amount of irreversibly damaged myocardium of the left ventricle (LV) was about 50 % of its volume. In these patients ECG-gated SPECT did not show sufficient amount of the viable myocardium, capable to restore the heart function after revascularization. The main result of intervention was increase in survival rate of patients with ICMP within 4 years of observation in comparison with traditional methods of conservative therapy. The first clinical effect of PCI was disappearance or reduction of dyspnea, noted in the majority of the patients. These changes had been confirmed by improvement of a functional class of patients (NYHA class score increase to 3,2±0,5 from 1,7+65; p=0,007) and increase of tolerance to physical excersise. Positive changes of a clinical condition after PCI have taken place due to decrease in rigidity of LV myocardium: It became apparent due to decrease of LV end-diastolic pressure (35,7+9,3 vs. 23,5+9,9 Hg mm; p=0,04) and pressure in pulmonary artery (44+1 2 vs. 33+7 Hg mm; p=0,03). No changes of LV volumes and ejection fraction values in the given category of patients were seen.

 

 


Reference 

 

 

 

1.    Трансплантология. Руководство. Под ред. акад. В.И. Шумакова. М.: «ООО Медицинское информационное агентство». 2006.

 

 

2.    Allman K.C., Shaw L.J., Hachamovitch R., Udelson J.E. Myocardial Viability Testing and Impact of Revascularization on Prognosis in Patients With Coronary Artery Disease and Left Ventricular Dysfunction: A Meta-Analysis. J.Am. Coll. Cardiol. 2002; 39 (7): 1151-1158.

 

 

3.    Sciagra R., Leoncini M. Gated single-photon emission computed tomography. The present-day «one-stop-shop» for cardiac imaging. The quarterly journal of nuclear medicine. 2005; 49: 19-29.

 

 

4.    Гуреев СВ. Аортокоронарное шунтирование и трансплантация аутологичных стволовых клеток костного мозга в лечении ишемической сердечной недостаточности. Дис. д-ра мед. наук. М., 2004.

 

 

5.    Schinkel A., Poldermans D., Rizzello V, Vanoverschelde J., Elhendy A., Boersma E., Roelandt J., Bax J. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? J. Thorac. Cardiovasc. Surg. 2004; 127 (2): 385-390.

 

 

6.    Беленков Ю.Н., Агеев Ф.Т., Мареев В.Ю. Динамик диастолического наполнения и диастолического резерва левого желудочка у больных с хронической сердечной недостаточностью при применении различных типов медикаментозного лечения: сравнительное допплер-эхокардиографическое исследование. Кардиология. 1996; 9: 38-50.

 

 

7.    Grossman W Diastolic dysfunction in congestive heart failure. New Engl.J. Med. 1991; 325: 1557-1564.

 

 

8.    GerdesA.M.,KellermanS.E.,MooreJ.A,MufflyK.E., Clark L.C., Reaves P.Y., Malec K.B., McKeown P.P., Schocken D.D. Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation. 1992; 6 (2): 426-430.

 

9.    Beltrami C.A., Finato N., Rocco M., Feruglio G.A. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation. 1994; 89 (1): 151-163.

 

 

Abstract:

The aim of the study was to define the factors, having influence to results of repeated percutaneous coronary interventions (PCI) such as isolated balloon angioplasty (BA) and BA in combination with rotational atherectomy (RA), used for treatment of stenosis inside stented segments of coronary arteries. 133 patients, submitted to repeated PCI due to development of stenosis in the stented coronary segments, were included in the study. Clinical and angiographic data were registered three times: at time of initial stenting, during repeated PCI and after 18 monthes of follow-up. Repeated PCI were done together with intracoronary ultrasonography. Decrease of neointimal volume and degree of balloon hyperinflation had not any influence on clinical end-points. Cross-luminal area of the vessel was the only significant prognostic facor for success of repeated PCI. Borderline value of the area was 4,7 sq.mm. Combined technique of PCI (BA + RA) had advantages over isolated BA only in those cases, when large cross-sectional lumen area must be achieved. Good clinical results of patients with cross-sectional lumen area >4,7 sq.mm, obtained after repeated PCI, give possoibility not to use additional interventions. If sufficient increase of the vessel lumen area can not be achieved, an active approach to therapy of such patients should be used after PCI.

The only significant beneficial prognostic factor for success of repeated PCA of the stenosed stented coronary segments was area of the vessels's lumen. It did not depend on technique of revascularisation. Such factors, as decrease of neointimal volume and degree of balloon hyperinflation, had not influence on frequency of restenosis and clinical end-points. 

 

References

1.     Bauters С, Banos J.L., Van BelleE., McFadden E., Lablanche J.M., Bertrand M. Six months outcome after successful repeat percutaneous intervention for in stent restenosis. Circulation.1998; 97: 318-321.

2.     Elchaninof H., Koning R., Tron C, Gupta V, Cribier A. Balloon angioplasty for the treatment of coronary in stent restenosis: immediate results and 6-month angiographic recurrent restenosis rate. J. Am. Coll. Cardiology .1998; 32:980-984.

3.     Reimers В., Moussa I., Akiyama T. et al. long term clinical follow-up after successful repeat percutaneous intervention for stent restenosis. J. Am. Coll. Cardiology.1997; 30: 186-192.

4.     Sharma S., Kini A., Garapati A. et al. Randomized trial of rotational atherectomy vs balloon angioplasty for in stent restenosis (Abstr.). Circulation.1998; 98 (1): 511.

5.     Yokoi H., Kimura Т., Nakagawa Y, Nosaka H., Nouyoshi M. Long term clinical and quantitative angiographic follow-up after the Palmaz-Schatz stent restenosis. / Am. Coll. Cardiology.1993; 76: 618-622.

6.     Mehran R., Dangas G., Mintz G. et al. In stent restenosis: «the great equalizer». Disappointing clinical outcomes with all interventional strategies (Abstr.). J. Am. Coll. Cardiology. 1999; 33: 1129-1191.

7.     Mehran R., Mintz G.S., Popma JJ. et al. Mechanisms and results of balloon angioplasty for the treatment of in stent restenosis. Am. J. Cardiology. 1996; 78; 618-622.

8.     Schiele E, Vuillemenot A., Meneveau N., Pales-Espinosa D., Gupta S., Bassand J.P. Effects of increasing balloon pressure on mechanism and results of balloon an gioplasty for treatment of restenosis after Palmaz-Schatz stent implantation. An angiographic and intra vascular ultrasound study. Cathet. Cardiovasc. Diagn. 1999; 46 (4): 3321.

9.     Goldberg S.L., Berger P.B., Cohen DJ. et al. balloon angioplasty versus rotational atherectomy for in stent restenosis (abstr.). Circulation. 1998; 98 (1): 363.

10.   Mehran R., Mintz G., Satler L. et al. Treatment of in stent restenosis with eximer laser coronary angioplasty. Mechanism and results compared to PTCA alone. Cir culation. 1997; 96: 2183-2189.

11.   Dauerman H., Bairn D., Cutlip E. et al Mechanical debulking versus balloon angioplasty for the treatment of diffuse in stent restenosis. Am.]. Cardiol. 1998; 82: 277-284.

12.   Lee S., Whan C, Cheong S. et al. Immediate and long term outcomes of rotational atherectomy versus balloon angioplasty alone for treatment of diffuse in stent restenosis. Am. J. Cardiology.1998; 82: 140-143.

13.   Mahdi N.A., Pathan A.Z., Harrel L. et al. Directional atherectomy for the treatment of Palmaz-Schatz in stent restenosis. Am.]. Cardiology. 1998; 82: 1345-1351.

14.   Kini A., Sharma S.K., Dangas G., Vidhun R., Duvvuri S. Marmur J. Predictors of restenosis after rotational at herectomy for in-stent restenosis (abstr.). Circulation.1998; 98 {!): 111.

15.   Vom Dahl J., Radke P., Haage P. et al. Clinical and an giographic predictors of recurrent restenosis after percutaneous transluminal rotational atherectomy for treatment of diffuse in stent restenosis. Am. J. Cardiology.1999; 833: 862-867.

16.   Schiele E, Meneveau N., Vuillemenot A. et al. Impact of intravascular ultrasound guidance in stent deployment on 6 month restenosis rate. J. Am. Coll. Cardiology. 1998; 32: 320-328.

 

Abstract:

To show possibilities to diagnose and treat toxic complications of continuous hepatic artery chemoinfusion using percutaneous implanted catheter-port system.

Materials and methods: Between May 2005 and March 2007, 20 patients (pts) underwent percutaneous transfemoral implantation of the catheter-port system for treatment of unresectable colorectal liver metastases. Toxic complications (gastritis, pancreatits or stomach ulcer) occurred in three pts (each in one). Endoscopy (after arterial injection of methylene blue) and scintigraphy (after arterial injection of technetium-99m macroaggregated albumin) showed abnormal liver perfusion. Visceral angiography was performed for verification and embolization of non-targeted vessels. Angiography with embolization of collateral arteries resulted in normalization of liver perfusion and resolution of complications. At present, all pts continue to receive intraarterial chemotherapy. Transcatheter coil embolization of non-targeted arteries is effective for the management of the catheter-port system misperfusion.

 

 

Reference 

 

1.     Таразов П.Г. Артериальная химиоинфузия в лечении нерезектабельных злокачественных опухолей печени (обзор литературы). Вопр. онкол. 2000; 46 (5): 521-528.

2.     Балахнин П.В., Генералов М.И., Полысалов В.Н. и др. Применение чрескожных имплантируемых инфузионных систем для регионарной химиотерапии метастазов колоректального рака. Анн. хир. гепатол. 2006; 11 (2): 41-48.

 

3.     Таразов П.Г. Роль методов интервенционной радиологии в лечении больных с метастазами колоректального рака в печень. Практ. онкол. 2005; 6 (2): 119-126.

 

 

4.     Herrmann К., Waggershauser Т., Heinemann V, Reiser М. Interventional radiological procedures in impaired function of surgically implanted catheter-port systems. Cardiovasc. Intervent. Radiol. 2001; 24: 31-36.

 

 

5.     Venturini M., Angeli E., Salvioni M. et al. Complications after percutaneous transaxillary implantation of a catheter for intraarterial chemotherapy of liver tumors: Clinical relevance and management in 204 patients. Am. J. Roentgenol. 2004; 182: 1417-1426.

 

 

6.     Chuang V, Wallace S., Stroehlein J. et al. Hepatic artery infusion chemotherapy: Gastroduodenal complication. Am.]. Roentgenol. 1981; 137: 347-350.

 

 

7.     Cohen A., Kemeny N., К hne C. et al. Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases? Eur.J. Cancer. 1996; 32: 2195-2205.

 

 

8.     Doria M., Doria L., Faintuch J., Levin B. Gastric mucosal injury after hepatic arterial infusion chemotherapy with floxuridine: A clinical and pathologic study. Cancer. 1994; 73 (8): 2042-2047.

 

9.     Bledin A., Kantarjian H., Kim E. et al. 99mTc-labeled macroaggregated albumin in intrahepatic arterial chemotherapy. Am.]. Roentgenol. 1982; 139:711-715.

10.   Kaplan W, Ensminger W, Come S. et al. Radionuclide angiography to predict patient response to hepatic artery chemotherapy. Cancer Treat. Rep. 1980; 64: 1217-1222.

11.   Frye J., Venook A., Ostoff J. et al. Hepatic intra-arterial methylene blue injection during endoscopy: A method of detecting gastroduodenal misperfusion in patients re ceiving hepatic intra-arterial chemotherapy via implan ted pump. Gastrointestinal Endoscopy. 1992; 38 (1): 52-54.

 

12.   Tanaka Т., Arai Y, Inaba Y. et al. Radiologic placement of side-hole catheter with tip fixation for hepatic arterial infusion chemotherapy. J. Vase. Interv. Radiol. 2003; 14: 63-68.

 

 

13.   Yamagami Т., Kato Т., Iida S. et al. Value of transcatheter arterial embolization with coils and n-butyl cyanoacrylate for long-term hepatic arterial infusion chemotherapy. Radiology. 2004; 230: 792-802.

 

 

14.   Herrmann K., Waggershauser Т., Sittek H. et al. Liver intraarterial chemotherapy: Use of the femoral artery for percutaneous implantation of catheter-port systems. Radiology. 2000; 215: 294-299.

 

 

 

 

 

Abstract:

Since 2001 to 2006 38 patients with inoperable cancer of the pancreas have been treated. They had pancreatic cancer of stage T2-4 N1 MO-l(HEP). Patients with mechanical jaundice (n=28) had beforehand undergone transdermic transhepatic external- internal drainage of the bile ducts. Patients with cancer, which gets its basic source of blood supply out of gastroduodenal artery, got cathete-rization of the celiac trunk with the following intravascular chemotherapy within 2 days. If the basic source of blood supply to pancreas was the inferior pancreatoduodenal artery, then its selective catheterization was carried out together with bolus injection of cytostatics. Chemotherapy was carried out with the help of Gemzar (1 g), Cisplatin (1 OOmg), 5- FU (4g). The level of bilirubin normalized in the blood of the patients with mechanical jaundice due to transdermic endobiliary intervention. As a result of regional chemotherapy, the intensity of the patients' pain syndrome reduced considerably and resumed only in case of the tumor progression.

 

The best treatment results were achieved in the group of patients with the programmed injections of regional chemotherapetic drugs that enabled to prolong survival of patients up to 19 months and more. Conclusion. The transfemoral selective catheterization of the pancreatic arteries is a simple, non-traumatic and safe operation. The use of programmed regional endarterial chemoinfusion in patients with inoperable pancreatic cancer is a promising method of treatment of these pathology. 

 

 

 

 

 

Reference 

 

 

 

1.     Путов Н.В., Артемьева Н.Н., Коханенко Н.Ю. Ракподжелудочной железы. Санкт-Петербург: «Питер». 2005; 15.

 

 

2.     Гранов Д.А., Павловский А.В., Таразов П.Г. Новые возможности регионарной химиотерапии рака поджелудочной железы. Материалы конференции. X Российский онкологический конгресс. М. 2006; 29-31.

 

 

3.     Гранов Д.А., Павловский А.В., Таразов П.Г. Масляная артериальная химиоэмболизация: новый способ терапии рака поджелудочной железы. Вопросы онкологии. Санкт-Петербург. 2003; (49) 5: 579-583.

 

 

4.     Павловский А.В. Обоснование селективной артериальной рентгеноконтрастной масляной химиоэмболизации в лечении рака поджелудочной железы. Автореф. дис. дра мед. наук. Санкт-Петербург. 2006; 16.

 

 

5.     Долгушин Б.И., Авалиани М.В., Буйденок Ю.В. и др. Эндобилиарная интервенционная радиология. М. Медицинское информационное агентство. 2004; 113.

 

 

6.     Гранов A.M., Полысалов В.Н.,Таразов П.Г., Гранов Д.А., Карелин М.И. Интервенционная радиология в онкологической клинике: обзор научных исследований в ЦНИРРИ. Вопросы онкологии. Санкт-Петербург. 2003; (49) 5: 537-539.

 

 

7.     Гарин A.M. Рак поджелудочной железы: состояние, проблемы. Материалы конференции. X Российский онкологический конгресс. М. 2006; 35-37.

 

 

 

Abstract:

Authors present results of simultaneous transluminal coronary interventions (TCI) (stenting) in coronary patients with triple vessel disease. Stenting of right coronary artery (RCA) and major branches of left coronary artery (LCA) was performed in 44 patients with coronary artery disease, having angina of III—IV functional classes. In total 1 83 coronary stents were implanted (1 66 «Cypher» and 17 «BxVelocity»). Stents «Bx Velocity» were used only coronary arteries with diameter > 3,5 mm. 3 stents were implanted in 22 cases, 4 — in 9, 5 — in 4, 6 — in 4 and 7 — in 7. TCI were successful in all patients, with restoration of coronary blood flow up to TIMI III through stented segments. Clinical effectiveneness of TCI during long-term follow-up (up to 32 months) was 100%, patient's survival — 90,9%. In 3 patients (6,8%) restenosis developed inside drug-coated stents (4,8%). Repeated stenting was performed with satisfactory clinical and angiographic results. Complete transluminal coronary revascularization is an effective method for treatment of patients with multiple coronary lesions. It provides return to high level of life quality.

 

 

Reference 

 

 

1.     Бокерия Л. А., Гудкова Р.Г. Сердечно-сосудистая хирургия-2004. Болезни и врожденные аномалии системы кровообращения. М.: НЦССХ им. А.Н. Бакулева РАМН. 2005; 118.

 

 

2.     Daemen S., Serruys P.W. Optimal revascularization strategies for multivessel coronary artery disease. Curr. Opin. Cardiol. 2006; 21(6): 595-601.

 

 

3.     Vaina S., Touchida K., Serruys P.W Treatment options for multivessel coronary artery desease. Expert Rev. Cardiovasc. Ther. 2006; 4(2): 143-147.

 

 

4.     Serruys P.W, Unger E, Sousa J.E. et al. Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularization Therapies study part II (ARTS II). Heart. 2004; 90(9): 995-998.

 

5.     Legrand VH., Serruys P.W, Unger E et al. Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation. 2004; 109(9): 1079-1081.

6.     Алекян Б.Г., Бузиашвили Ю.И., Стаферов А.В. Ангиопластика при множественном поражении коронарных артерий. М.: НЦССХ им. А.Н. Бакулева РАМН. 2002; 146-178.

7.     Меркулов Е.В., Ширяев А.А., Самко А.Н. и др. Сравнительная оценка результатов ангиопластики и коронарного шунтирования у больных ИБС с многососудистым поражением коронарного русла. Материалы 1-й межрегиональной конференции по проблемам кардиологии. Ханты-Мансийск. 2003; 65. 

 

8.     Babunashvili A.M., Iudin I.E., Dundua D.P., Kartashov D.S., Kavteladze Z.A. Efficacy of the use of sirolimus covered stents in the treatment of diffuse atherosclerotic lesions of coronary arteries. Cardiology. 2006; 46 (11): 21- 29.

 

 

 

 

Abstract:

199 patients with ASD were included in the study. In 102 cases ASD was closed with Amplatzer system and in 97 cases cardiac surgery was performed. Analysis and comparison of ASD correction results (both short- and long-term) have been done, according to patient's age and type of ASD.

 

 

Reference 

 

1.     Амикулов Б.Д. Врожденные пороки сердца бледного типа у взрослых. Сердечно-сосудистая хирургия. 2004; 2: 3-9.

2.     Мутафьян О.А. Врожденные пороки сердца удетей. Санкт-Петербург: «Невский диалект». 2002; 331.

3.     Бокерия Л.А. Минимально инвазивная хирургия сердца: состояние проблемы и возможные перспективы. Мат. всероссийской конференции «Минимально инвазивная хирургия сердца и сосудов». 1997.

4.     Алекян Б.Г., Машура И., Пурсанов М.Г. и др. Первый в России опыт закрытия дефектов межпредсердной перегородки с использоанием «Amplatzer Septal Occluder». Мат. международного симпозиума. «Минимально инвазивная хирургия сердца и сосудов». 1998; 23.

5.     Бураковский В.П., Бухарин В.А., Подзолков В.П. и др. Врожденные пороки сердца. В кн.: Сердечно сосудистая хирургия. Под ред. В.И. Бураковского, Л.А. Бокерия. М.: Медицина. 1996; 768.

6.     Усупбаева Д.А. и др. Ремоделирование сердца после транскатетерного закрытия вторичного межпредсердного дефекта системой Amplatzer. Терапевтический архив. 2006; 6.

7.     Усупбаева Д.А. и др. Двухмерная эхокардиоскопия в транскатетерном закрытии вторичного межпредсердного дефекта окклюдером Амплатца. Ультразвуковая и функциональная диагностика. 2005; 4: 74-81.

8.     Chan К.С, Godman MJ. Morphologic a variations of fossa ovalis atrial septal defects (secundum): feasibility for transcutaneous closure with the clamshell device. Br. Heart J. 1993; 69 (1): 52-55.

 

Abstract:

At 246 patients with coarctation of the aorta the ultrasonic semiotics of disease has been investigated. Are systematized echocardiographycal attributes of defect: are determined direct and indirect (displays directly reflecting morphology), the estimation of their sensitivity and specificity is lead. The certain combination of the specified attributes has allowed to allocate three variants of a ultrasonic picture coarctation of the Aorta, reflecting various anatomic forms of defect. The semiotics and diagnostic attributes of each ultrasonic variant of defect is described by echocardiography. 

 

 

Reference 

 

1.     Шиллер Н., Осипов М. А. Клиническая эхокардиография. М. 1993.

2.     Митьков В. В., Сандриков В. А. Клиническое руководство по ультразвуковой диагностике в 5 т. М.: Видар. 1998; 5: 96-297.

3.     Бураковский В. И., Бокерия Л. А. Сердечно-сосудистая  хирургия   (руководство).   М.:   Медицина.1989; 298-310.

4.     Kaine S. E, Smith E. О., Mott A. R. et al. Quantitative echocardiographic analysis of the aortic arch predicts outcome of balloon angioplasty of native coarctation of the aorta. Circulation. 1996;   94 (5): 1056-1062.

5.     Фейгенбаум X. Ультразвуковая диагностика. М.: Медицина. 1999; 1123-1145.

 


Abstract:

Radiological examinations are used as a major tool for diagnosis of congenital and acquired facial bone defects and deformations. The results of the paper are based on analysis of x-ray examinations of 2000 patients. Panoramic zonography was the most frequently used procedure. Zonography shows origin and size of defects, their external contours, structure of mandibula. Use of spiral CT is obligatory in cases of nazo-orbital deformatoions, defects of facial and brain scull bones. CT helps to define extact size of bone defects and to make caclulations for planning surgical interventions. Algorithm for examinations of patients with congenital facial bone deformations should include films, made in anterior and lateral projections, made in teleroentgenographgic mode for vizualisation of soft tissues. In cases of systemic bone diseases, standart films and zonogramms of most informative regions are sufficient.

 

authors: 


 

Article exists only in Russian.

 

Abstract:

The work was aimed at determining the possibilities of multislice computed tomography (MSCT) in diagnosis and staging of acute pyelonephritis (AP) for studying the role of concomitant congenital renal anomalies in development of AP and therapeutic decision-making. A total of 59 patients presenting with AP and suspected pyodestructive complications were subjected to MSCT, with 7 seven of these having undergone it twice in order to control therapeutic efficacy. The study showed that ultrasonography as well as excretory urography are not always informative enough as to the possibility of revealing purulent forms of an inflammatory process having developed on the background of renal developmental defects, especially anomalies of the shape, localization, and structure. The obtained findings made it possible to define proper indications for performing MSCT in patients with AP. Improved diagnosis achieved by means of MSCT made it possible to decrease the number of operations and avoid unnecessary nephrectomies.  

 

Reference

 

 

1.     Буйлов В.В., Крупин И.В., Тюзиков И.А. Алгоритмы ультразвукового сканирования экскреторной урографии при острых формах пиелонефрита (Екатеринбург, 15 - 18 октября 1996). М., 1996; 26-27.

 

 

2.     Быковский В.А. Ультразвуковая диагностика острого пиелонефрита и его хирургических осложнений у детей. Дисс. канд. мед. наук. М., 1996.

 

 

3.     Игнашин Н.С. Ультрасонография в диагностикеи лечении урологических заболеваний. М., 1997.

 

 

4.     Пытель А.Я., Пытель Ю.А. Рентгендиагностика урологических заболеваний. М., 1966; 480.

 

 

5.     Хитрова А.Н. Клиническое руководство по ультразвуковой диагностике. Т. 1 (Под ред. В.В. Митькова). М.: Издательский дом Видар-М, 1996; 200-256.

 

 

6.     MМrild S., HellstrЪm M., Jacobsson B., et al: Influence of bacterial adhesion on ureteral width in children with acute pyelonephritis. J. Pediatr. 1989a; 115: 265-268.

 

 

7.     Morin D., Veyrac C., Kotzki P., et al: Comparison of ultrasound and dimercaptosuccinic acid scintigraphy changes in acute pyelonephritis. Pediatr. Nephrol. 1999; 13:219-222.

 

 

8.     Schaeffer A.J. Infections of the Urinary Tract. Campbell`s urology. 8th ed. Philadelphia, Saunders. 2002; (l): 515-603.

 

 

9.     Shortliffe L. M. D. Urinary tract infections in infants and children. Campbell`s urology. 8th ed. Philadelphia, Saunders. 2002; (3): 1846-1885.

 

 

10.   Назаренко Г.И., Хитрова А.Н., Краснова Т.В. Допплерографические исследования в уронефрологии. М.: Медицина, 2002; 49-55.

 

 

11.   Чалый М.Е. Оценка органного кровообращения при урологических заболеваниях с применением эходопплерографии. Дисс. докт. мед. наук. М., 2005.

 

 

12.   Чалый М.Е., Амосов А.В., Газимиев М.А. Диагностика острого пиелонефрита в послеоперационном периоде с применением цветной эходопплерографии. Материалы Пленума правления Российского общества урологов. (Киров, 20-22 июня). М., 2000; 105-106.

 

 

13.   Dacher J.N., Pfister С, Monroe M., et al: Power Doppler sonographic pattern of acute pyelonephritis in children: Comparison with CT. AJR Am. J. Roentgenol. 1996; 166: 1451-1455.

 

 

14.   Синякова Л.А. Гнойный пиелонефрит (современная диагностика и лечение). Дисс. докт. мед. наук. М., 2002.

 

 

15.   Little P.J., McPherson D.R., Wardener H.E.: The appearance of the intravenous pyelogram during and after acute pyelonephritis. Lancet., 1965; 1: 1186.

 

 

16.   Silver T.M., Kass E.J., Thornbury J.R., et al: The radiological spectrum of acute pyelonephritis in adults and adolescence. Radiology. 1976; 118: 65.

 

 

17.   Barth K.H., Lightman N.I., Ridolfi R.L., et al: Acute pyelonephritis simulating poorly vascularized renal neoplasm, non-specificity of angiographic criteria. J. Urol. 1976; 116: 650.

 

 

18.   Teplick J.G., Teplick S.K., Berinson H., et al: Urographic and angiographic changes in acute unilateral pyelonephritis. Clin. Radiol. 1978.

 

 

19.   Тиктинский О.Л., Калинина С.Н. Пиелонефриты. СПб.: СПбМАПО, Медиа Пресс. 1996.

 

 

20.   Baumgarten D.A., Baumgarten B.R. Imaging and radiologic management of upper urinary tract infec tions. Uroradiology. 1997; 24: 545.

 

 

21.   Schaefer-Prokop C., Prokop M. Spiral and multislice tomography. Computed tomography of the body. Thieme, Stuttgard - New York. 2003; 641-678.

 

           22.   Фоминых Е.В. Мультиспиральная компьютерная томография в диагностике заболеваний мочевых путей. Дисс. канд. мед. наук, М., 2004.

 

Abstract:

The systolic pressure gradient at the level of aortic narrowing, determined by non-invasive methods was measured in 110 patients with aortic coarctation and compared with its value in direct measurement before and during various terms after correction of the defect. It was determined that Doppler ultrasonography of arteries of the limbs is the most informative non-invasive method of assessing the degree of narrowing/restoration of the aortic isthmus. Also showed was various informative value of Doppler cardiography as a method aimed at evaluating the efficacy of removing the defect in patients with good, satisfactory and poor therapeutic outcomes. 

 

Reference

 

 

1.     Углов Ф.Г., Некласов Ю.Ф., Герасин В.А. Катетеризация сердца и селективная ангиокардиография. Л., 1974.

 

 

2.     Покровский А.В. Клиническая ангиология. - М.: Медицина, 1979; 63-83.

 

 

3.     Lerberg D. В., Hardesty R. L., Siewers R. D., Zuberbuhler J. R. Coarctation of the aorta in Infants and Children: 25 Years of Experience. Ann. Thorac. Surg. 1982; 33 (2): 159-170.

 

 

4.     Фейгенбаум Х. Ультразвуковая диагностика. М.: Медицина, 1999; 1123-1145.

 

 

5.     Шиллер Н., Осипов М.А. Клиническая эхокардиография. М.: 1993.

 

 

6.     Stephen F.K., et al. Quantitative echo cardiographic analysis of the aortic arch predicts outcome of balloon angioplasty of native coarctation of the aorta. Circulation. 1996; 94: 1056-1062.

 

 

7.      Шахов Б.Е., Рыбинский А.Д., Шарабрин Е.Г. Критерии оценки результатов коррекции коарктации аорты. Нижегород. мед. журнал. 2003; 3: 7-11.

 

8.      Рыбинский А.Д. Отдаленные результаты хирургического лечения коарктации аорты в возрастном аспекте. Дисс. канд. мед. наук. Горький. 1977.

 

Abstract:

Presented herein is a dynamic ultrasonographic study of soft tissue state in the area of a postoperative wound in 165 patients in order to determine rational policy of postoperative following up of the patient. The patients were subdivided into three groups: Group I - after an operative intervention for surgical pathology of abdominal and retroperitoneal organs; Group II - after herniotomy with combined plasty with a meshed endograft (Surgpro-mesh); Group III - after allografting of the aorta, major arteries of the lower limbs and neck. All patients after the surgical intervention were subjected to an ultrasonographic study of soft tissues of the abdominal wall, lower extremities, and neck in the B-mode in order to reveal pathological alterations, with determining the size, structure and indication of localization in relation to the surface of the skin; five cases suspected for infection of the process were subjected to duplex scanning of soft tissues around the focus revealed; detecting pathological alterations around the vessel or the graft after grafting of major vessels was followed by duplex scanning in order to determine the haemodynamic situation in the vessel or graft. The findings obtained suggest specificity of postoperative alterations characteristic of different surgical interventions, the revealing of which allows the surgeons to determine the policy of rational management of the patient, thus decreasing the risk of purulent complications in the area of the postoperative wound.

  

Reference

1.     Федоров В.Д., Светухин А.М. Стратегия и тактика лечения обширных гнойных ран. Избранный курс лекций по гнойной хирургии. М., Миклош. 2003; 18-30.

2.     Шляпников С.А. Хирургические инфекции мягких тканей - старая проблема в новом свете. Инфекции в хирургии. 2003; 1(1): 14 - 21.

3.     Белобородов В.Б.,Джексенбаев О.Ш.Эндотоксины грамотрицательных бактерий. Цитокины и концепция септического шока; современное состояние проблемы. Анестезия и реаниматология. М., 1991; 4:41 -43.

4.     Белобородова Н.В., Бачинская Е.Н. Иммунологические аспекты послеоперационного сепсиса. Анестезия и реаниматология. 2000; 1: 59 - 66.

5.     Измайлов С.Г., Измайлов Г.А., Тюдушкина И.В. и др. Лечение ран. - Казань: изд-во Казанского государственноготехнического университета. 2003; 137 - 144.

6.     Ерюхин И.А., Гельфанд Б.Р., Шляпников С.А. Хирургические инфекции: руководство. С-Пб.: издательский дом «Питер» (Серия «Спутник врача»), 2003; 864.

7.     Hedrick WR, Hykes L, Starchman DE. Static imaging principles and instrumentation. In: Ultrasound physics and instrumentation. St Louis (MO): Mosby. 1995; 71 -87.

8.     Евдокимова Е.Ю., Жестовская С.И. Роль ЦДК в диагностике стадий раневого процесса мягких тканей у больных с хирургической патологией Материалы краев. науч. практ. конференции, посвященной 50-летию общества рентгенологов и радиологов. Красноярск. 2000; 37 - 38.

9.     Lavoipierre AM, Kremer S. Cabrini Hospital, Melbourne The expanding role of ultrasound in medicine. Aust. Fam. Physician. 1999; 28 (11): 1121 - 7.

10.   Loyer E.M., Kaur H., David C.L., DuBrow R. et al. Importance of dynamic assessment of the soft tissues in the sonographic diagnosis of echogenic superficial abscesses. Department of Diagnostic Radiology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. Journal ofUltrasound in Medicine. 1995; 14(9): 669 - 671.

11.   Сажин В.П., Жаболенко В.П., Авдовенко А.Л. и др. Роль сонографии в оценке течения раневого процесса у больных после эндовидеохирургического лечения постинъекционных абсцессов ягодиц. Институт хирургии им. А. В. Вишневского РАМН. Материалы конференции, посвященной 10-летию отделения ультразвуковой диагностики: Современные методы ультразвуковой диагностики заболеваний сердца, сосудов и внутренних органов. М., 4-6 октября. 2004; 126 -127.

12.   Sisley Amy С, Bonar J.P. Ultrasound in the Acute Seffing. Ultrasound for Surgeons. Second edition. Lippincott Williams & Wilkins. 2005; (1015): 179 - 191.

13.   Bureau NJ, Cardinal E, Chhem RK. Ultrasound of Soft Tissue Masses. Department de Radiologie, Hopital St-Luc, Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada. Semin Musculoskelet Radiol. 1998; 2(3): 283 - 298.

14.   Chhem R.K, Kaplan P.A, Dussault R.G. Ultrasonography of the musculoskeletal system. Radiol. Clin. North Am. 1994; 32 (2): 275 - 89.

15.   Primack S.J. Musculoskeletal ultrasound. The clinician's perspective. North Suburban Rehabilitation Unit, Colorado Rehabilitation and Occupational Medicine, Aurora, USA. Radiol.Clin. North Am. 1999l; 37(4): 617-22.

16.   Newman J.S., Adler R.S., Bude R.O, Rubin J.M. Detection of soft-tissue hyperemia: value of power Doppler sonography. AJRAm. J. Roentgenol. 1994; 163 (2):385-9.

17    Breidahl W.H, Newman J.S, Taljanovic M.S, Adler R.S. Power Doppler sonography in the assessment of musculoskeletal fluid collections. AJR Am. J. Roentgenol. 1996; 166 (6): 1443 -6.

18.   Latifi H.R, Siegel M.J. Color Doppler flow imaging of pediatric soft tissue masses. J. Ultrasound Med. 1994; 13 (3): 16–— 9.

19.   Rubin J.M. Musculoskeletal power Doppler. Eur. Radiol. 1999; 9(3): 403 - 405.

20.   Волчанский А.И. Диагностика и лечение внутрибрюшных гнойно-воспалительных осложнений после операций на печени и желчных путях. Дисс. канд. мед. наук. М., 1997; 143.

21.   Жестовская С.И., Евдокимова Е.Ю. Ультразвуковая диапедевтика послеоперационных гнойных осложнений. Тезисы докладов 4-го съезда Российской ассоциации специалистов ультразвуковой диагностики в медицине. М., 2003; 87-88.

22.   Бордаков В.Н., Абрамов Н.А., Савицкий Д.С. и др. Диагностика и лечение абсцессов брюшной полости. Сб. науч. трудов IV Всеармейской международной конференции: Интенсивная терапия и профилактика хирургических инфекций: М., 23 -24 сентября, 2004; 132 -133.

23.   Чебышева Э.Н. Оценка состояния аорты и ее ветвей убольныханевризмойбрюшнойаортыпо данным ультразвукового исследования. Автореферат дисс. канд. мед. наук. М., 2005; 25.

24.   Минайчев В. Ю, Конон Т. М. Абсцесс передней брюшной стенки. Новости лучевой диагностики. М., 2000; 30 -31.

25.   Биссет Р.А., Хан А.Н. Дифференциальный диагноз при абдоминальном ультразвуковомисследовании. (Под редакцией проф. Пиманова С.И.) М., Мед. литература. 2003; 232 - 233.

26.   Евдокимова Е.Ю. Лечебно-диагностические вмешательства под контролем ультразвука у больных с послеоперационными гнойными осложнениями. Автореферат дисс. канд. мед. наук.Красноярск. 2003; 26.

27.   Hill Robert MD, Conron Richard DO, Greissinser Paul DO, Heller Michael MD. Ultrasound for the Detection of Foreign Bodies in Human Tissue. Annal of Emergency Medicine. 1997; 29(3): 178 - 179.

28.   Цветков В.О. Парапротезная инфекция. Клиника, диагностика, лечение. Дисс. докт. мед. наук. М., 2003; .96 - 104.

29.   Кунцевич Г.И. Оценка результатов хирургического лечения окклюзирующих поражений артерий. Ультразвуковая диагностика в абдоминальной и сосудистой хирургии. (Под редакцией проф. Г.И. Кунцевич). М., Кавалер Паблишерс. 1999; 191 - 195.

 

 

Abstract:

Thrombolytic therapy (TLT) is the most efficient method of reperfusion therapy in ischemic stroke (IS), considerably increasing the number of patients with good functional restoration obtained. Carrying out selective intraarterial TLT (IA TLT) is feasible within the framework of a wider therapeutic window (up to 6-8 hours from the onset of the disease) under angiographic control and a possibility of individual dosing of a fibrinolytic employed. The present study demonstrated high efficiency of selective IATLT based on two clinical examples of patients presenting with IS. In the first case, a 55-year-old male patient with occlusion of M1 segment of the right median cerebral artery (MCA) and a baseline NIH score equalling 13 underwent IA TLT preformed 7 hours after the onset of IS, which led to complete recanalization of the vessel after 40 minutes, and resulted in a considerable clinical improvement (8 points by the NIH scale after TLT). The second case describes a 64-year-old female patient presenting with segment C7 stenosis of the left internal carotid artery and occlusion of segment M1 2 of the left MCA (20 points by the NIH scale). Carrying out IA TLT also promoted restoration of the blood flow after 60 minutes and restoration of the disordered functions (NIHSS score 14). Hence, the described examples demonstrate high efficacy of intra-arterial thrombolysis in management of patients with ischemic stroke.

  

Reference

1.     Гусев Е.И., Скворцова В.И., Киликовский В.В., Стаховская Л.В., Айриян Н.Ю.«Проблема инсульта в Российской Федерации». Качество жизни. 2006; (13): 10- 14.

2.     European Stroke Initiative Recommendations for stroke Management - Update 2003. Cerebrovasc Dis. 2003; 16:311-337.

3.     del Zoppo G. J., Higashida R.T., Furlan A.J., Pessin M.S., Rowley H.A., Gent M. PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery Stroke. Stroke. 1998; 29: 4 - 11.

4.     Arnold M., Schroth G., Nedeltchev K., Loher T.J., Stepper E, Remonda L., Sturzenegger M., Mattle H. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke. 2002; 33: 1828-1833.

5.     Arnold M., Nedeltchev K., Mattle H.P., Loher T.J., Stepper E, Schroth G., Brekenfeld C., Sturzenegger M., Remonda L. Intra-arterial thrombolysis in 24 consecutive patients with internal carotid artery T-occlusions. J. Neurol Neurosurg Psychiat. 2003; 74: 739-742.

6.     Lee D.H., Jo K.D., Kim H.G., Choi S.J., Jung S.M., Ryu D.S., Park M.S. Local intra-arterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study. J. Vasc Interv Radiol. 2002; 13: 769 - 774.

7.     ThОron J., Coskun O., Huet H., Oliveira G., Toulas P., Payelle G. Local intra-arterial thrombolysis in the carotid territory. Interventional Neuroradiology. 1996; 2: 111 - 126.

8.     Zeumer H., Freitag H.J., Zanella E, Thie A., Arning C. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (rt-PA). Neuroradiology. 1993; 35: 159- 162

9.     Lisboa C., Borko D. Jovanovic, Mark J.Alberts. Analysis of the Safety and Efficacy of Intra-Arterial Thrombolytic Therapy in Ischemic Stroke. Stroke. 2002; 33: 2866.

10.   Волынский Ю.Д., Гаврилов А.В. Оценка гемодинамики и перфузии на основе компьютерного анализа ангиографических изображений. Материалы конференции «Современные технологии в клинической медицине» Санкт-Петербург. 2003; 151 - 152.

11.   Волынский Ю.Д., Гаврилов А.В. Рентгеновидеоденситометрия - метод оценки кровотока по плечеголовным и внутримозговым сосудам. Материалы конференции «Повреждения и заболевания шейного отдела позвоночника». 2004; 9-11.

 

 

Abstract:

Lesions of the LCA stem are found in 2,5-4 % of patients with coronary heart disease who endured coronography, and are accompanied by more severe symptomatology, higher morbidity and mortality rates, and difficulty of radical correction. According to the generally accepted guidelines, the operation of coronary artery bypass has up to now been a method of choice in treatment of the LCA stem. Nevertheless, endovascular methods of treatment for LCA stem lesions have relatively long been used, while implementation into clinical practice of drug-eluding stents has considerably improved the remote outcomes, which made it possible to consider LCA stem stenting as a real alternative to ACB. Hence, the problem concerning indications for and contraindications to LCA stem stenting remains unsolved today. We retrospectively analysed a total of 75 endovascular interventions on the LCA stem in 67 patients, with an isolated lesion of the LCA stem being found only in 7,4 % of the patients. The remaining subjects had lesions of the LCA stem on the background of a multivascular lesion of the coronary bed, including occlusion of the RCA observed in 16,4 % of cases. Successive revascularization was performed in 98,64 % of cases, with no lethal outcomes. One patient required urgent ACB due to development of occluding dissection of the circumflex branch. Complications in the immediate postoperative period were observed in two patients and were represented by non-Q myocardial infarction and stroke. LCA stem stenting proved an efficient and safe method of treatment for coronary heart disease. A comparative analysis of the immediate results of LCA stem stenting and ACB revealed advantages of stenting, consisting in no lethal outcomes (in our series) and a lower short-term rate of postoperative complications.

  

Reference

1.     Cohen МУ Cohn PF, Herman MV, Gorlin R. Diagnosis and prognosis of main left coronary artery obstructtion. Circulation 1972; 45 (Suppl 1): 57 - 65.

2.     Gruentzig A.R. Transluminal dilatation of coronary artery stenosis. Lancet 1978; 1: 263.

3.     O'Keefe JH, Harztler GO, Rutherford BD, et al. Left main coronary angioplasty: early and late results of 127 acute and elective procedures. Am. J. Cardiol. 1989; 64: 144 - 147.

4.     Seung-Jung Park, MD, PHD, Young-Hak Kim, MD, Bong-Ki Lee, MD et al. Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis Comparison With Bare Metal Stent Implantation. Journal of the American College of Cardiology. 2005; 3 (45): 351-6.

5.     Seung-Jung Park, Young-Hak Kim, Bong-Ki Lee, Seung-Whan Lee, Cheol Whan Lee, Myeong-Ki Hong, Jae-Joong Kim, Gary S. Mintz, MD, Seong-Wook Park. Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Stenosis. J. Am. Coll. Cardiol. 2005; 45: 351-6.

6.     Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004; 109: 1244-9.

7.     Arampatzis CA, Hoye A, Saia F, et al. Elective sirolimus-eluting stent implantation for left main coronary artery disease: six-month angiographic follow-up and 1-year clinical outcome. Cathet. Cardiovasc. Interv. 2004; 62: 292 - 6.

8.     Joseph P. Ornato, Richard L. Page, Barbara Riegel etal. A Report of the American College of ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary. Circulation. 2006; 113: 156 - 175.

9.     Caracciolo EA, Davis KB, Sopko G, Kaiser GC et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease: Long-term CASS experience. Circulation. 1995; 91: 2335-44.

10.   Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994; 344: 563 - 570.

11.   Park S, Hong M, Lee CW, et al. Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance. J. Am. Coll. Cardiol. 2001; 38: 1054 - 1060.

12.   TakagiT, Stankovic G, Finci L, Toutouzas K, Chieffo A, Spanos У Liis-tro F, Briguori C, Corvaja N, Albero R, Sivieri G, Paloschi R, Di Mario C, Colombo A. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation. 2002; 106: 698 - 702.

13.   Sorin J. Brener, MD; Bruce W Lytle, MD; Ivan P. Casserly, MD; Jakob P. Schneider, RN; Eric J. Topol, MD; Michael S. Lauer, MD. Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk Features. Circulation. 2004; 109: 2290 -2295.

14.   Silvestri M, LefПvre T, Labrunie P, Khalife K, Bayet G, Morice MC, Bedossa M, Chmait A.. On behalf of the FLM registry investigators. The French registry of left main coronary artery treatment: Preliminary results. J. Am. Coll. Cardiol. 2003; 41: 45.

15.   Brigouri C, Sarais C, Pagnotta P, Airoldi F, et al. Elective versus provisional pumping in high-risk percutaneus transluminal coronary angioplasty. Am. Heart J. 2003; 145 (4): 700 - 7.

16.   Бокерия Л. А., Алекян Б. Г., Бузиашвили Ю. И. и др

 

 

Abstract:

Endovascular methods of treatment for coronary heart disease are of considerable current use. Stenting of coronary arteries is the most widely used intervention in management of coronary heart disease. Present-day models of coronary stents make it possible to selectively perform direct stenting in certain roentgenomorphology of the lesion concerned. The authors analysed the outcomes of direct and conventional stenting of coronary arteries in 74 patients presenting with coronary heart disease. No differences as to the mortality rate were observed between the groups. The group of direct stenting demonstrated lower percentage of ischemic events: myocardial infarction on the background of acute or subacute thrombosis of the stent (1 - in the direct-stenting group, 3 - in the conventional-stenting group), transitory myocardial ischaemia (1 case in the direct-stenting group, 3 cases in the conventional-stenting group). Of the angiographic peculiarities, dissection complicated a total of three procedures of traditional stenting, and did not occur in the direct-stenting group. The no-reflow syndrome was noted to have developed in one case in the stenting group with predilatation. Of the technical peculiarities in the direct-stenting group, we observed a statistically reliable decrease in the average duration of the intervention by 11,76 minutes (P = 0,039), that of roentgenoscopy by 5,91 minutes (P = 0,027), a decrease in the average consumption of the radiopaque medium by 68,36 ml (P < 0,01), and a decrease in the average expenditure of coronary balloon catheters by 0,59 pc. (P < 0,001). Hence, the method of direct stenting of coronary arteries turned out to offer advantages over the conventional-stenting technique with predilatation in the clinical, angiographic and economic aspects, provided a careful selection of patients is performed.

  

Reference

1.     Фуфаев Е.Н. К вопросу о методике клинико-социальных исследований по изучению потребности в кардиохирургической помощи. Качественная Клиническая Практика. 2003; (31) 2: 13-108.

2.     Бокерия Л.А., Гудкова Р.М. Сердечно-сосудистая хирургия - 2004. Болезни и врожденные аномалии системы кровообращения. М., НЦССХ им. А.Н. Бакулева РАМН. 2005; 118.

3.     Rogers С, Parikh S., Seifert P. Edelman E. Endogenous cell seeding. Remnant endothelium after stenting enhances vascular repair. Circulation. 1996; (94).2909-2914.

4.     Villegas B., Morice M.C., Hernandez S. et al. Triple Vessel Stenting for Triple Vessel Coronary Disease. The Journal of Invasive Cardiology. 2002; (14): 1-5.

5.     Chauhan A., Vu E., Ricci D.R., et al. Early and intermediate term clinical outcome after multiple coronary stenting. Heart. 1998; (79): 29-33.

6.     Kastrati A., Hall D., SchЪmig A. Long-term outcome after coronary stenting. Curr. Control Trials Cardiovasc Med. 2000; (1): 48-54.

7.     La Manna A., Di Mario C. Therapeutic Strategies in Multiple Vessel Coronary Artery Disease. E-Journal of European Society of Cardiology. 2005; (29): 17-23.

8.     Triantis G.S., Tolis V.A., Michalis L.K. Direct Implantation of Intracoronary Stents. Hellenic J. Cardiol. 2002; (43): 156-160.

9.     Weaver W.D., Reisman M.A., Griffin J.J., et al., for the OPUS-1 Investigators. Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial. Lancet. 2000; (355): 203-219.

10.   Schuhlen H., Kastrati A., Dirschinger J. Intracoronary Stenting and Risk for Major Adverse Cardiac Events During the First Month. Circulation. 1998; (98): 104-111.

 

 

Abstract:

Department of Obstetrics and Gynaecology of the Therapeutic and Moscow Faculties of Scientific Research Practical Laboratory of intracardiac and contrast methods of roentgenological studies under the Federal Facility Russian State Medical University of the Russian Ministry of Public Health, Moscow.

This article opens a new series of publications dedicated to a currently important issue of endovascular treatment of uterine myoma - uterine artery embolization (UAE). The authors presently possessing the most abundant hands-on experience in UAE in Russia, based on own experience and literature data discuss herein the most urgent problems related to UAE in treatment for uterine myoma and other obstetrical and gynaecological pathology. Amongst them are the problems of determining the indications for and contraindications to an intervention, outcomes of UAE (including that combined with other therapeutic methods), problems of optimization of the technique and development of technical procedures allowing for UAE to be performed virtually in any situation, as well as the problems related to selection of embolizing substances. The authors also give a detailed consideration to the so-called "myths" about UAE - currently existing negative views on certain aspects of intervention, which are based on outdated and inexact evidence. The authors draw a conclusion that endovascular methods are highly promising in obstetrical and gynaecological pathology.

 

References

1.     Oliver J. A. Jr, Lance J.S. Selective embolization to control massive hemorrhage following pelvic surgery. Am. J. Obstet. Gynecol. 1979; 135: 431-432.

2.     Ravina J., Merland J., Herbreteau D. et al. Preoperative embolization of uterine fibroma. Preliminary results [10 cases] [letter, in French]. Presse Med. 1994; 23: 1540.

3.     Goodwin S., McLucas B., Lee M. et al. Uterine artery embolization for the treatment of uterine leiomyomata midterm results. J. Vasc. Intervent. Radiol. 1999; 10: 1159-1165.

4.     Goodwin S., Vedantham S., McLucas B. et al. Preliminary experience with uterine artery embolization foruterine fibroids. J. Vasc. Interv. Radiol. 1997; 8: 517-526.

5.     Spies J., Scialli A., Jha R. et al. Initial results from uterine fibroid embolization for symptomatic leiomyomata.J.Vasc.Intervent.Radiol. 1999; 10: 1149-1157.

6.     Uterine Artery Embolization Survey: 10,500 Procedures Performed Worldwide, FairfaxVA: Society ofInterventional Radiology. 2000.

7.     Hovsepian D., Siskin G., Bonn J. et al. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. J. Vasc. Interv. Radiol. 2004; 15: 535-542.

8.     Wong G.C., Muir S.J., Lai A.P., Goodwin S.C. Uterine artery embolization: a minimally invasive technique for the treatment of uterine fibroids. J. Womens Health Gend. Based Med. 2000; 4(9): 357-362.

9.     Савельева Г.М., Бреусенко В.Г., Капранов С.А., Краснова И.А., Бобров Б.Ю., Шевченко Н.А., Аксенова В.Б., Алиева А.А. Эмболизация маточных артерий у больных с миомой матки. Акушерство и гинекология. 2004; 5: 21-24.

10.   Worthington-Kirsch R. Uterine artery embolization: state-of-the-art and new developments. Intervention. 2000; 2(4): 35-38.

11.   Beinfeld M.T., Bosch J.L., Isaacson K.B., Gazelle G.S. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology. 2004; 1(230): 207-213.

12.   Al-Fozan H., Dufort J., Kaplow M. et al. Cost analysis of myomectomy, hysterectomy and uterine artery embolization. Am. J. Obstet. Gynecol. 2002; 5(187): 1401-1404.

13.   Капранов С.А., Беленький А.С., Бобров Б.Ю., Доброхотова Ю.Э., Журавлева А.Д., Алиева А.А., Кайфаджан М.М. Эмболизация маточных артерий в лечении миомы матки: 126 наблюдений. Бюллетень НЦ ССХ им. А.Н. Бакулева РАМН «Сердечно-сосудистые заболевания». 2003; 11(4): 219.

14.   Тихомиров А.Л., Лубнин Д.М. Эмболизация маточных артерий в лечении миомы матки. Вопросы гинекологии, акушерства и перинатологии. 2002; 2(1): 83-85.

15.   Билан М.И., Козюра О.П. Эмболизация маточных артерий при миоме матки: особенности катетеризационной техники. Международный журнал интервенционной кардиоангиологии. 2004; 4: 43-46.

16.   Кавтеладзе З.А., Дроздов С.А., Былов К.В. и др. Эмболизация маточных артерий при фибромиоме матки. Международный журнал интервенционной кардиоангиологии. 2005; 7: 55.

17.   Бреусенко В.Г., Краснова И.А., Капранов С.А., Бобров Б.Ю., Аксенова В.Б., Шевченко Н.А., Арютин Д.Г. Некоторые дискуссионные вопросы эмболизации маточных артерий при лечении миомы матки. Акушерство и гинекология. 2006; 3: 23-26.

18.   Коков Л.С., Самойлова Т.Е., Ситкин И.И., Цыганков В.Н., Гус А.И. Динамика редукции миоматозных узлов в зависимости от их локализации у пациенток, перенесших эмболизацию маточных артерий по поводу миомы матки. Материалы конференции «Радиология 2006» 25-27 апреля 2006; 235.

19.   Lohle P.N.M., Lapmann L., Boekkooi F.P., Vervest H.A.MSpecialists collaborate in fibroid treatmentDiagnostic Imaging Europe. 2002; 23-25.

20.   David M., Ebert A.D. Treatment of uterine fibroids by embolization - advantages, disadvantages, and pitfalls. Eur. J.Obstet. Gynecol. Reprod Biol. 2005; 2(122): 144-150.

21.   Nikolic B., Spies J.B., Campbell L. et al. Uterine artery embolization: Reduced radiation with refined technique. J. Vasc. Intervent. Radiol. 2001; (12): 39-44.

22.   Brunereau L., Herbreteau D., Gallas S. et al. Uterine artery embolization in the primary treatment of uterine leiomyomas: technical features and prospective follow-up with clinical and sonographic examinations in 58 patients. AJR. 2000; 175: 1267-1272.

23.   Pelage J., Le Dref O., Soyer P. et al. Arterial anatomy of the female genital tract: Variations and relevance to transcatheter embolization of the uterus. AJR. 1999; 172: 989-994.

24.   Katsumori T., Nakajima K., Mihara T., Tokuhiro M. Uterine artery embolization using gelatin sponge particles alone for symptomatic uterine fibroids: Midterm results. AJR. 2002; 178: 135-139.

25.   Du J., Zuo Y., Chen X. et al. Clinical observation of transcatheter uterine artery embolization for uterine myoma. Zhonghua Fu Chan Ke Za Zhi. 2002; 1(37): 12-15.

26.   Belenky A., Cohen M., Bachar G. Uterine arterial embolization for the management of leiomyomas. IsrMed.Assoc.J. 2001; 10(3): 719-721.

27.   Доброхотова Ю.Э., Капранов С.А., Бобров Б.Ю., Алиева А.А., Гришин И.И. Эмболизация маточных артерий - постэмболизационный синдром. Российский вестник акушера-гинеколога. 2005; 2(5): 44-49.

28.Nagao T., Ohwada T., Kitazono M., Ohshima K., Shimizu H., Katayama MThoracic epidural analgesia is effective in perioperative pain relief for uterine artery embolizationMasui. 2005; 2(54): 156-159.

29.   Saito S., Chiba A., Hayakawa S.,Toyoshima M., Enomoto A. Pain control with epidural anesthesia for uterine artery embolization. Masui. 2004; 4(53): 391-395.

30.   Ryan J.M., Gainey M., Glasson J., DohertyJ., Smith T.P. Simplified pain-control protocol after uterine artery embolization. Radiology. 2002; 2(224): 610-611, discussion 611-613.

31.   Rasuli P., Jolly E.E., Hammond I., French G.J., Preston R., Goulet S., Hamilton L., Tabib M. Superior hypogastric nerve block for pain control in outpatient uterine artery embolization. J. Vasc. Interv. Radiol. 2004; 12(15): 1423-1429.

32.   Keyoung J.A., Levy E.B., Roth A.R. et al. Intraarterial lidocaine for pain control after uterine artery embolization for leiomyomata. JVascIntervRadiol 2001; 9(12): 1065-1069.

33.   Капранов С.А., Бреусенко В.Г., Бобров Б.Ю., Краснова И.А., Шевченко Н.А., Алиева А.А., Аксенова В.Б. Применение эмболизации маточных артерий при лечении миомы матки: анализ 258 наблюдений. Международный журнал интервенционной кардиоангиологии. 2005; 7: 56.

34.   Walker W.J., Pelage J.P. Uterine fibroid embolization: Results in 400 women with imaging follow-up. J. Vasc. Interv. Radiol. 2002; 13 (Suppl. 2): 18.

35.   Доброхотова Ю.Э., Капранов С.А., Алиева А.А., Бобров Б.Ю., Гришин И.ИНовый органосохраняющий метод лечения миомы матки — эмболизация маточных артерийЛечебное дело. 2005; 2: 24—27. 36.Jha R.C., Ascher S.M., Imaoka I., Spies J.B. Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization. Radiology. 2000; (217): 228-235.

37.   Бреусенко В.Г., Краснова И.А., Капранов С.А., Аксенова В.Б., Бобров Б.Ю., Шевченко Н.А. Спорные вопросы эмболизации маточных артерий при миоме матки. Вопросы гинекологии, акушерства и перинатологии. 2005; 4(4): 44—48.

38.   Kim M.D., Kim N.K., Kim H.J., Lee M.HPregnancy following uterine artery embolization with polyvinylalcohol particles for patients with uterine fibroid or adenomyosis. Cardiovasc. Intervent. Radiol. 2005; 5(28): 611-615.

39.   D'Angelo A., Amso N.N., Wood A. Spontaneous multiple pregnancy after uterine artery embolization for uterine fibroid: case report. Eur. J. Obstet. Gynecol. Reprod. Biol. 2003; 2(110): 245-246.

40.   Nabeshima H., Murakami T., Sato Y., Terada Y., Yaegashi N., Okamura K. Successful pregnancy after myomectomy using preoperative adjuvant uterine artery embolization. Tohoku J. Exp. Med. 2003; 3(200): 145-149.

41.   Carpenter T.T., Walker W.J. Pregnancy following uterine artery embolisation for symptomatic fibroids: a series of 26 completed pregnancies. BJOG. 2005; 3(112): 321-325.

42.   Price N., Gillmer M.D., Stock A., Hurley P.A. Pregnancy following uterine artery embolisation. J. Obstet. Gynaecol. 2005; 1(25): 28-31.

43.   Stringer N.H., Grant T., Park J., Oldham L. Ovarian failure after uterine artery embolization for treatment of myomas. J. Am. Assoc. Gynecol. Laparosc. 2000; 3(7): 395-400.

44.   Hascalik S., Celik O., Sarac K., Hascalik M. Transient ovarian failure: a rare complication of uterine fibroid embolization. Acta Obstet. Gynecol. Scand. 2004; 7(83): 682-685.

45.   Payne J.F., Robboy S.J., Haney A.F. Embolic microspheres within ovarian arterial vasculature after uterine artery embolization. Obstet. Gynecol. 2002; 5(100): 883-886.

46.   Healey S., Buzaglo K., Seti L., Valenti D., Tulandi T. Ovarian function after uterine artery embolization and hysterectomy. J. Am. Assoc. Gynecol. Laparosc. 2004; 3(11): 348-352.

47.   Tropeano G., Di Stasi C., Litwicka K., Romano D., Draisci G., Mancuso S. Uterine artery embolization for fibroids does not have adverse effects on ovarian reserve in regularly cycling women younger than 40 years. Fertil. Steril. 2004; 4(81): 1055-1061.

48.   Ahmad A., Qadan L., Hassan N., Najarian K. Uterine artery embolization treatment of uterine fibroids: effect on ovarian function in younger women. J. Vasc. Interv. Radiol. 2002; 10(13): 1017-1020.

49.   Pelage J.P., Walker W.J., Le Dref O., Rymer R. Ovarian artery: angiographic appearance, embolization and relevance to uterine fibroid embolization. Cardiovasc. Intervent. Radiol. 2003; 3(26): 227-233.

50.   Barth M.M., Spies J.B. Ovarian artery embolization supplementing uterine embolization for leiomyomata. J. Vasc. Interv. Radiol. 2003; 9(14): 1177-1182.

51.   Andrews R.T., Bromley P.J., Pfister M.E. Successful embolization of collaterals from the ovarian artery during uterine artery embolization for fibroids: a case report. J. Vasc. Interv. Radiol. 2000; 5(11): 607-610.

52.   YangJ.J., Xiang Y., Wan X.R., Yang X.Y Diagnosis and management of uterine arteriovenous fistulas with massive vaginal bleeding. Int. J. Gynaecol. Obstet. 2005; 2(89): 114-119. 53.Rubod C., Mubiayi N., Robert Y., Vinatier D. Uterine arteriovenous malformation. A rare cause of recurrent metrorrhagia. Gynecol. Obstet. Fertil. 2005; 7-8(33): 511-513.

54.   Lipari C.W., Badawy S.Z. Arteriovenous malformation in a bicornuate uterus leading to recurrent severe uterine bleeding: a case report. J. Reprod. Med. 2005; 1(50): 57-60.

55.   Amagada J.O., Karanjgaokar V, Wood A., Wiener J.J. Successful pregnancy following two uterine artery embolisation procedures for arteriovenous malforma tion. J. Obstet. Gynaecol. 2004; 1(24): 86-87.

56.   Lambert P., Marpeau L., Jan net D. et al. Cervical pregnancy: conservative treatment with primary embolization of the uterine arteries. A case report. Review of the literature. J. Gynecol. Obstet. Biol. Reprod. 1995; 1(24): 43-47.

57.   Suzumori N., Katano K., Sato T. et al. Conservative treatment by angiographic artery embolization of an 11-week cervical pregnancy after a period of heavy bleeding. Fertil. Steril. 2003; 3(80): 617-619.

58.   Sherer D.M., Lysikiewicz A., Abulafia O. Viable cervical pregnancy managed with systemic Methotrexate, uterine artery embolization, and local tamponade with inflated Foley catheter balloon. Am. J. Perinatol. 2003; 5(20): 263-267.

59.   Itakura A., Okamura M., Ohta T., Mizutani S. Conservative treatment of a second trimester cervicoisthmic pregnancy diagnosed by magnetic resonance imaging. Obstet. Gynecol. 2003; 5(101): 1149-1151.

60.   Hong T.M., Tseng H.S., Lee R.C., Wang J.H., Chang C.Y Uterine artery embolization: an effective treat ment for intractable obstetric haemorrhage. Clin. Radiol. 2004; 1(59): 96-101.

61.   Liu X., Fan G., Jin Z., Yang N., Jiang Y., Gai M., Guo L., Wang Y., Lang J. Lower uterine segment pregnancy with placenta increta complicating first trimester induced abortion: diagnosis and conservative management. Chin. Med. J. 2003; 5(116): 695-698.

62.Sugawara J., Senoo M., Chisaka H., Yaegashi N., Okamura K. Successful conservative treatment of a cesarean scar pregnancy with uterine artery embolization. Tohoku J. Exp. Med. 2005; 3(206): 261-265.

63.   Kapranov S.A., Kurtser M.A., Bobrov B.Y., Alieva A.A., Zlatovratsky A.G. Non-fibroid indications for UAE: twelve cases. CIRSE 2006: 244.

 

Abstract:

Traumas, complicated with the injury of blood vessels are the most grave situations in traumatology. Occurrence rate of such complicated traumas increased two or three times within past decade. The experience of angiographic evaluation of blood vessels injuries is represented in this article. 208 patients with vascular injuries underwent angiography within the period since 2003 till 2006. There were 177 men and 31 women. Angiographic findings were: false aneurism (pseudoaneurism) in 38% of cases, arteriovenous communication (fistula) in 7,2% of cases, occlusion of arterial lumen in 28,8% of cases, soft tissue hematoma in 6,2%, full transversal rupture of vessel in 1,5%, intimal dissection in 0,96% and absence of angiographic findings in 17,3% of cases. Angiography is the most informative diagnostic option in vascular trauma, which provides the possibility to determine the most optimal treatment option immediately.

 

References

1.     Немытин Ю.В., Кохан Е.П. Лечение раненых по опыту локальных войн. В сб. «Оказание специализированной хирургической помощи при травмах и ранениях сосудов». Красногорск. 2002; 8-12.

2.     Малышев Н.Н., Лазаренко В.И., Пулин А.Г. с соавт. Специализированная помощь и реабилитация больных с сочетанной травмой магистральных сосудов конечностей. Материалы 15-й международной конференции «Ангиология и сосудистая хирургия». Петрозаводск - Кондопога, 2004; 179-180.

3.     Белозеров Г.Е., Климов А.Б., Бочаров С.М., Черная Н.Р., Рябухин В Е., Прозоров С.А. Эндоваскулярные вмешательства при травме периферических артерий. Бюллетень НЦССХ им. А.Н.Бакулева РАМН. «Сердечно-сосудистые заболевания. 10-й Всероссийский съезд сердечнососудистых хирургов»: Тезисы докладов. 2004; 5 (11): 198.

4.     Прокубовский В.И., Черкасов В.А., Дубовик С.Г. Чрескожная катетерная эмболизация в лечении ранений артерий и их последствий. Ангиология и сосудистая хирургия. 1997; 1: 39-43.

5.     Коротков Д.А., Михайлов Д.В. Рентгенэндоваскулярная окклюзия пульсирующих гематом и ложных аневризм. Ангиология и сосудистая хирургия. 1998; 4 (1): 134-136.

6.     Сосудистое и внутриорганное стентирование. Руководство. Под редакцией Л.С. Кокова, С.А. Капранова, Б.И. Долгушина, А.В. Троицкого, А.В. Протопопова, А.Г. Мартова. М.: Издательский дом «ГРААЛЬ», 2003; 154-155.

 

Abstract:

The importance of using minimally invasive techniques in management of pancreatic pseudocysts is evident today. In order to evaluate the efficacy of puncture-draining interventions, analysed herein are therapeutic outcomes in 102 patients. The patients were subdivided depending on the causes of pathology, localization, forms and presence of complications. Diagnosis included an ultrasonographic study. Suspected for neoplastic cysts, 21 patients underwent computed tomography, 42 - duodenoscopy, 17 - endoscopic retrograde pancreatocholangiography. Taking into consideration a high risk of pancreatic fistulas formation, after external drainage, we isolated a high-risk group comprising 36 people, and a group of 66 subjects with no risk of this complication. The latter underwent ultrasonography-controlled external drainage. Of these, 49 patients were subjected to drainage by the Seldinger technique, 12 - large-calibre percutaneous external drainage. Complications were observed in 3 subjects. Patients at risk of a complication underwent ultrasonographically and endoscopically controlled internal drainage. Complications were noted in 4 cases. Of these, two, during transduodenal drainage, developed bed-sores of the superior mesenteric artery branches, and one patient developed abdominal haemorrhage. In this connection we refused carrying out transduodenal drainage. The long-term results in patients with cystoduodenal stents were followed-up in 19 subjects. By month six, the stent detached spontaneously in 6 patients, being removed endoscopically in 8 subjects. Fifteen patients with intrapancreatic hypertension were subjected to endoscopic papillosphincterotomy. The duration of the hospital stay amounted to 23-28 days. Hence, internal drainage of pancreatic pseudocysts, followed by cystoduodenal stenting in patients at risk of an external pancreatic fistula within the described therapeutic-and-diagnostic algorithm is an operation of choice.

 

References

1.     Багненко С.Ф., Гольцов В.Р. Лечение острого панкреатита в ферментативную фазу заболевания. Вестник хирургии им. И.И. Грекова. 2006; 165 (1): 117.

2.     Акилов Х.А., Ваккасов М.Х. Лечебная тактика при поздних осложнениях панкреонекроза. Материалы 9 Всероссийского съезда хирургов. Волгоград. 2000; 7.

3.     Кадощук, Т.А., Кадощук Ю.Т., Бондарчук О.И. Диагностика и лечение кист поджелудочной железы. Анналы хирург. гепатологии. 1999; 4 (2): 159-160.

4.     Погребняков В.Ю. Малоинвазивное хирургическое лечение ложных кист поджелудочной железы, связанных с панкреатическими протоками. Анналы хирург. гепатологии. Материалы 5-й конф. хирургов - гепатологов. Томск. 1997; 2: 114.

5.     Kloppe G. Pseudocysts and other non-neoplastic cysts of the pancreasSemin. Diagn. Pathol. 2000; 17 (1): 7-15.

6.     Багненко С.Ф., Курыгин Ф.Ф., Рухляда Н.В., Смирнов А.ДХронический панкреатитРуководство для врачей. СПб.: Питер. 2000; 416.

7.     Данилов М.В., Федоров В.Д. Хирургия поджелудочной железы. М.: Медицина, 1995; 512.

8.     Froschle G., Doris H., Kremer B. et al. Pancreas-pseudozysten und hire interdiszinare therapy. Zbl. Chir. 1991; 116.359-368.

9.     Дадвани С.А., Лотов А.Н., Мусаев Г.Х., Заводнов В.Я. Отдаленные результаты цистогастро- и цистодуоденостомий под ультразвуковым и эндоскопическим контролем в лечении псевдокист поджелудочной железы. Анналы хирургической гепатологии. 1999; 4 (2): 153.

10.   Мишин, В.Ю., Квезерова А.П. Современный подход к лечению псевдокист поджелудочной железы. Анналы хирургии. 2000; 3: 32-39.

11.   Русин В.И., Болдижар А.А. Эндоскопические способы лечения псевдокист поджелудочной железы. Материалы X юбилейного конгресса по эндоскопической хирургии. 2006; 185.

 

Abstract:

Eighteen experimental animals (9 rabbits and 9 mongrel dogs) were used in a feasibility study of heparin and a polymer belonging to polyoxyalkanoates class - homopolymer of в-oxybutyric acid - polyoxybutyrate (POB) to be applied onto the surface of the nitinole self-expanding stent "Alex" ("Komed", Russia) in order to decrease responsiveness of the vascular wall. During a three-month chronic experiment at various terms following implantation, we examined the degree of biocompatibility of the coat-free stents, heparin-treated stents, and those coated with the above polymer. The studies were carried out by means of arteriography, binocular light microscopy, histological examination, electron microscopy; and the study of the ultrastructure of thestented segmentsof the vessels. The experiments carried out on animals showed that: 1. The coating of the stents may positively influence structural alterations in the vascular wall, which improve the conditions of the blood flow along the vessel; 2. Using POB-coated stents is accompanied by lesser intimal hyperplasia, relatively decreased leukocytic infiltration, and development of vasa vasorum; 3. POB may safely be considered the most favourable coating for stents because of minimal structural alterations in the vascular wall. The obtained findings would make it possible to plan future research on polyoxyalkanoatesas modifiers of the histological responseof the vascular wall tissues while implanting stents.

 

       References

1.     Holmes D.RJr., Leon M.B., Moses J.W., Popma J.J., Cutlip D., Fitzgerald P.J., Brown C., Fischell T., Wong SC., Midei M., Snead D., Kuntz R.E.. Analysis of 1-Year Clinical Outcomes in the SIRIUS Trial. A Randomized Trial of a Sirolimus-Eluting Stent Versus a Standard Stent in Patients at High Risk for Coronary Restenosis. Circulation. 2004; 109: 634-640.

2.     Machan L. Drug eluting stents in the infrainguinal circulation. Tech. Vasc. Interv. Radiol. 2004; 7: 28-32.

3.     Tanabe K., Serruys P., Grube E., Smits P.C., Selbach G., van der Gissen W.J., Staberock M., de Feyter P., Muller R., Reger E., Degertekin M., Ligthart J.M.R., Disco C., Backx B., Russell M.ETAXUS III Trial. In-Stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formation. Circulation. 2003; 107: 559-564.

4.     Grube E., Silber S., Hauptmann K.E., Mueller R., Buellesfeld L., Gerckens U., Russell M.E. TAXUS I. Six- and twelve-months results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003; 107: 38-42.

5.     Kerner A., Gruberg L., Kapeliovich L., Grenadier E. Late stent thrombosis after implantation of a sirolimus-eluting stent. Catheter Cardiovasc. Interv. 2003; 60: 505-508.

6.     Jeremias A., Sylvia B., Bridges J., Kirtane A.J, Bigelow B., Pinto D.S., Ho K.K., Cohen D.J., Garcia L.A., Cutlip D.E., Carrozza J.P. Jr. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation. 2004; 109: 1930-1932.

7.     Шишацкая Е.ИМедико-биологические свойства биодеградирующих бактериальных полимеров полиоксиалканоатов для искусственных органов и клеточной трансплантологииДисс. канд. мед. наук 2003; 156.

8.     Протопопов А.В. Разработка и клиническое внедрение метода эндопротезирования сосудов саморасширяющимся нитиноловым стентом (клинико-экспериментальное исследование). Диссдокмеднаук. 2002; 240.

9.     Peck P. Concerns About Subacute Thrombosis and the Sirolimus-Eluting Stents: Hype or Reality? Posted 12.10.2003. Available at:http//www.medscape.com/viewarticle/465210 - 50k.

10.   FDA Public Health Web Notification: Information for Physicians on Sub-acute Thromboses (SAT) and Hypersensitivity Reactions with Use of the Cordis CYPHER™ Coronary Stent. Issuing Date: October 28, 2003. Available at:http: //www.fda.gov/cdrh/safety/cypher.html.

11.   FDA Public Health Web Notification: Updated information for physicians on sub-acute thromboses (SAT) and hypersensitivity reactions with use of the Cordis CYPHER™ sirolimus-eluting coronary stent. Issuing Date: November 25, 2003. Available at: http://www.fda.gov/cdrh/safety/cypher2.pdf.

12.   Babinska A., Markell M.S., Salifu M.O. Enhancement of human platelet aggregation and secretion induced by rapamycin. Nephrol. Dial. Transplant. 1998; 13: 1353-1359.

13.   U.S. Food and Drug Administration, Center for devices and radiological health, Cypher sirolimus-eluting coronary stent on RAPTOR over-the-wire delivery system. Available at:http://www.fda.gov/cdrh/ pdf3/p020026.html.

14.   Lau W.C., Waskell L.A., Watkins P.B. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Circulation. 2003; 107: 32-37.

15.   van der Giessen W.J., van Beusekom H.M., van Hoeten C.D., van Woerens L.J., Verdouw P.D., Serruys P.W. Coronary stenting with polymer-coating and uncoated self-expanding endoprostheses in pigs. Coronary artery disease. 1992; 3: 631-640.

16.   van der Giessen W.J., Slager C.J., van Beusekom H.M., van Ingen Schenau D.S., Huuts R.A., Schuurbiers J.C., de Klein W.J., Serruys P.W Development of a polymer Endovascular prosthesis and its implantation in porcine arteries. J. Interven. Cardiol. 1992; 5: 175-185.

17.   Unverdorben M., Spielberger A., Schywaisky M., Labahn D., Hartwig S., Schneider M., Lootz D., Behrend D., Schmitz K., Degenhardt R., Schaldach M., Vallbracht C. A polyhydroxybutyrate biodegradable stent: preliminary experience in the rabbit. CVIR.2002; 25: 127-132.

18.   Tamai H., Igaki K., Kyo E., Kosuga K., Kawashima A., Matsui S., Komori H.,TsujiT., Motohara S., Uehata H.. Initial and 6-month results of biodegradable poly-L- lactic acid coronary stents in human. Circulation. 2000; 102: 399-404.

authors: 

 

Abstract:

The article gives account of coronary stenting impact on the dynamics of left ventricle index. The study covered 94 postinfarction patients, including 80 men and 14 women. Among them 52 patients with Q-forming myocardium infarction and 42 with non-Q myocardium infarction were observed. 1 3 patients that suffered Q-forming myocardium infarction didn't show any segment contractility disorders (group 1), while 39 showed contractility disorders (group 2). The analysis revealed that index improvement of the left ventricle is observed in the 1st group in 77% cases after stenting, while the 2nd group shows no improvements. Among the 2nd group of patients the full recovery is observed in 21% cases, the partial recovery - in 46% and 1 3% didn't overcome any dynamics.

The EchoCG study performed on 42 patients revealed that 31 men have no segmental activity disorders (group 3) and 1 1 suffered segmental activity disorder (group 4). Stenting procedure improved the myocardium function in the 3rd group in 65% cases. In the long prospect 1 0 patients of the 4th group fully recovered their myocardium function and only 1 man showed no dynamics in contractility improvement. Taking into consideration what has been said one can be sure that EchoCG proves to be an effective method of valuing the left ventricle function improvement before and after coronary stenting.

 

References

1.     Бокерия А.А. Современное общество и сердечно-сосудистая хирургия. Тезисы докладов V Всероссийского съезда сердечно-сосудистых хирургов. М., 1999; 3-6.

2.     Чазов Е.И. Проблемы борьбы с сердечно-сосудистыми заболеваниями. Кардиология. 1973; 2: 5-10.

3.     Белов Ю.В., Вараксин В.А. Современное представление о постинфарктном ремоделировании левого желудочка. Русский медицинский журнал. 2002; 10: 469-471.

4.     Самко А.Н. Применение интракоронарных стентов ДЛЯ лечения больных ишемической болезнью сердца. Русский медицинский журнал. 1998; 6(14): 923-927.

5.     Мазур Н.А. Эффективные и безопасные методы лечения больных хронической ишемической болезнью сердца. Русский медицинский журнал. 1998; 6(14): 908-913.

6.     Петросян Ю.С., Зингерман Л.С. Классификация атеросклеротических изменений коронарных артерпи. Тезисы докл. 1 и 2 Всесоюзных симпозиумов по современным методам селективной ангиографии и их применение в клинике. М., 1973; 16.

7.     Петросян Ю.С., Иоселиани Д.Г. О суммарной оценке состояния коронарного русла у больных ишемической болезнью сердца. Кардиология. 1976; 12(16): 41-46.

8.     Петросян Ю.С., Шахов Б.Е. Коронарное русло у больных с постинфарктной аневризмой левого желудочка сердца. Горький. 1983; 17-20.

9.     Bourdillon P.D.V, Broderick T.M., Sawada S.G, Armstrong WE, Ryan., Dillon J.C., Fineberg N.S., and Feigenbaum H.: Regional wall motion index for infarct and noninfarct regions after reperfusion in acute myocardial infarction: Comparison with globalwall motion index./. Am. Soc. Echocardiogr. 1989; 2: 398.

10.   Фейгенбаум Харви «Эхокардиография». М.: Видар. 1999; 115-119.

11.   Otto СМ., Pearlmann A.S. Textbook of clinical echocardiograph. Philadelphia: L: Toronto etc.: WB. Saunders Co. 1995; 30-45, 50-62.

 

Abstract:

A group of patients, including 88 diabetics and 93 non-diabetics (patients were diagnosed according to A. Bollinger system) was studied in terms of occlusive-stentic lesions. The occlusive-stentic affection of low-extremities combined with diabetes is characterized by a number of distinctive features. The majority of diabetics are suffering the distal type of arterial lesion, while atherosclerotics suffer the proximal type. Diabetes functions as a complicating factor, forcing the development of occlusive-stentic process largely in distal segments of low extremities, meaning popliteal and crural arteries. This process eventually leads to the ischemia of low extremities.

 

References

1.     Gensler S.W, Haimovici H, Hoffert P., Steinman С, Beneventano Т.С. Study of vascular lesions in diabetic, nondiabetic patients. Clinical, arteriographic, and surgical considerations. Arch. Surg. 1965; 91:617 - 622.

2.     Haimovici H. Patterns of arteriosclerotic lesions of the lower extremity. Arch. Surg. 1967; 95:918 - 933.

3.     Conrad M.C. Large and small artery occlusion in diabetics and nondiabetics with severe vascular disease. Circulation. 1967; 36:83 - 91.

4.     Bollinger A., Breddin K., Hess H., Heystraten F.M.J., Kollath J., Kontilla A., Pouliadis G., Marshall M., Mey Т., Mietaschk A., Roth F.-J. Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images. Atherosclerosis. 1981; 38: 339-346.

5.     Van der Feen C, Neijens F.S., Kanters S.D.J.M., Mali WP.Th.M., Stolk R.P., Banga J.D. Angiographic distribution of lower extremity atherosclerosis in patients with and without diabetes. Diabetic Medicine. 2002;19:366-370.

6.     Покровский А.В., Дан В.Н., Чупин А.В.. Ишемическая диабетическая стопа. Синдром диабетической стопы. Клиника, диагностика, лечение и профилактика. Москва. 1998; 18 - 35.

7.     Балаболкин М.И.. Эндокринология. М.: Универсум паблишинг. 1998; 421, 423.

8.     Атанов Ю.П., Шамычкова А.А.. Диабетическая ангиопатия нижних конечностей. Российский медицинский журнал. 2001;5: 14- 15.

9.     Donnelly R. Vascular complications of diabetes. B.M.J. 2000; 320:1062- 1066.

10.   Faglia E. et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. Journal of Internal Medicine. 2002; 252: 225 - 232

11.   Awad S., Karkos CD., Serrachino-Inglott E, Cooper N.J., Butterfield J.S., Ashleigh R., Nasim A. The impact of diabetes on current revascularisation practice and clinical outcome in patients with critical lower limb ischaemia. European journal of vascular and endovascular surgery. 2006; 32 (1): 51-59.

12.   Bosiers M, Hart J.P, Deloose K., Verbist J., Peeters P. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. Vascular. 2006; 14 (2):63 - 69.

 

Abstract:

The research covered the results of the endovascular surgical operations in 81 patients with CHD aged 36-76 with bifurcational stenoses of coronary arteries. The peculiarity of the method was the primary delivery of the guides for balloon catheters behind the stenosis area in the "main" and side branches of the left coronary artery. This was prophylaxis of the side artery occlusion after implantation of the "Cypher select" stent into the "main" branch. During the post-operational period (after 6-8 months) 69 patients have passed the examination including coronaroventriculography. The results of the endovascular surgical treatment were successful, no deaths or myocardial infarctions were registered. According to coronarography data, hemodynamically significant stenosis in the stent lumen was observed in 1,2 % cases.

 

References

1.      Puel J., Joffre E, Rousseau H. et al. Endoprostheses coronariennes autoexpansives dans le prevention das restenoses apres angioplastie transluminele. Arch. Mai. Coeur, 1987; 8: 1311 - 1312.

2.      Serruys P.W, De Jaegere P.P.T., Kiemeneij E et al. Comparison of Balloon-expandabie stent implantation with balloon angioplasty in patients with coronary artery disease. N. Engl. J. Med., 1994; 331, 489 - 495.

3.      Kastrati A., Dirschinger J., Boekstegers P. et al. Influens of stent design on 1 year outcome after coronary stent placement: A randomized comparisone of five stent types in 1147 unselected patients. Caih. Cardiovasc. Interv., 2000; July, 50(03): 290 - 297.

4.      Reimers В., Colombo A., Tobis J. Bifurcation lesions. In: Colombo A, Tobis J, eds. Techniques in Coronary Artery Stenting. London, Martin Dunitz Ltd, 2000; 171 -204.

5.      Schofer J., Schluter M., Gershlick A.H. et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS). Lancet, 2003; 362: 1093 - 1099.

6.      Colombo A., Moses J.W, Morice M.C. et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation, 2004; 109: 1244- 1249.

7.      Ge L., Tsagalou E., Iakovou I. et al. In-Hospital and Nine- Month Outcome of Treatment of Coronary Bifurcational Lesions With Sirolimus-Eluting Stent. Am. ]. CardwL, 2005; 95: 757 - 760.

 

Abstract:

The article aimes at determining the scope of multyspiral computer tomography (MSCT) in diagnostics of iatrogenic traumas of ureter and ureterovaginal fistulae (UVF) and establishing the efficiency of mini-invasive method of treatment UVF. The study covered 9 patients suffering the iatrogenic trauma of ureter, 8 of which have passed through MSCT. The mini-invasive methodic was applied to these patients and let the researchers restore the ureter tissue after the iartogenic trauma and eliminate the UVF without performing any open operations.

 

References

1.     Вайнберг З.С. Травма органов мочеполовой системы. Москва, Медпрактика-М, 2006 гл.10.

2.     Raney A. M. Ureteral trauma: Effects of ureteral ligation with and without deligation — experimental studies and case reports. / Urol. 1978; 119: 326 - 329.

3.     Spirnak J. P., Hampel N., Resnick M. I. Ureteral injuries complicating vascular reconstructive surgery: Is repair indicated?/ Urol, 1989; 141: 13 - 14.

4.     Канн Д.В. Руководство по акушерской и гинекологической урологии. М 1986; 481 - 6.

5.     Петров СБ., Шпиленя Е.С., Какушадзе З.А., Богданов А.Б. Повреждения мочеточников в гинекологической и акушерской практике. Журн. акушерства и жен. болезней. 2000; (49) 4: 31 - 34.

6.     Переверзев А.С. Актуальные проблемы оперативной урогинекологии. Современные проблемы урологии: Материалы VI Международного конгрессса урологов. Харьков, Факт., 1998; 3-9.

7.     Franke J.J., Smith J.A. Surgery of urether. Campbell's Urologie Walsh P.C. et al. - 7 th Ed., Vol.3., Philadelphia: WB.Saunders, 1998; 3062-3084.

8.     Bright ТС Emergency management of the injured ureter. Urol Clin North Am. 1982;9(2):285 - 291.

9.     Комяков Б.К., Гулиев Б.Г., Новиков А.И., Дорофеев С.Я., Лебедев М.А., Аль-Исса А. Оперативное лечение повреждений мочевых путей и их последствий в  акушерско-гинекологической  практике. Акушерство и гинекология 2004; 39 - 42.

10.   Еургеле Т., Симич П. Риск мочеточнико-пузырных повреждений в хирургии живота и таза. Бухарест 1972; 165-170.

11.   Gurin J. I., Garcia R. L., Melman A., Leiter E. The pathologic effect of ureteral ligation with clinical imply cations./ Urol, 1982;128: 1404- 1406.

12.   Hoch W H., Kursh E. D., Persky L. Early aggressive management of intraoperative ureteral injuries. J. Urol, 1975;114:530-532.

13.   Spirnak J. P., Hampel N., Resnick M. I. Ureteral injuries complicating vascular reconstructive surgery: Is repair indicated?/ Urol, 1989; 141: 13 - 14.

 

Abstract:

A multicentered study based on retrospective data covered 2012 patients and aimed at ascertaining the eficiency of various methods of treating patients with coronary restenosis after stenting. The average percent of complications after restenosis was about 20% during the period of study (1 1+4 months). The metaregression data analysis showed the positive correlation between the stage of residual stenosis of the stentet segment and the probability of complications. As the residual stenosis decreased at 1%, the frequency of complications diminished at 0,9%. Another factors under analysis did not show any evident influence, although we have registered a tendency towards better outcomes of the recurring operations as the diameter of the vessel increased. The recurring balloon angioplasty in cases of short restenosis and intracoronar radiation in cases of diffused restenotic lesions have proved to be the most effective operations. The indications for implanting the additional stents must be given very carefully, especially in cases of diabetes.

 

References

1.     Fischman D.L., Leon M.D., Baim D.S., et al. A randomized comparison of coronary stent placement and balloon angioplasty in treatment of coronary artery disease. N. Engl. J. Med. 1994; 331: 496 - 501.

2.     Serruys P.W, de Jaeger P., Kimeneij E, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary heart disease. N. Engl]. Med. 1994; 331: 489 - 495.

3.     Di Mario C, Marsico E, Adamian M. et al. New recipes for in-stent restenosis: cut, grate, roast, or sandwich the neointima? Heart. 2000; 84: 471 - 475.

4.     Hoffmann R., Mintz G. S. Coronary in-stent restenosis-predictors, treatment and prevention. Eur. Heart J. 2000; 21: 1739- 1749.

5.     Leon M.B., Tierstein P.S., Moses J.W et al. Localized intracoronary gamma-radiation therapy to inhibit the occurrence of restenosis after stenting. N. Egl. J. Med. 2001; 344: 250-256.

6.     Waksman R., White R.L., Chan R.C., et al. Intracoronary gamma-radiation therapy after angioplasty inhibits reccurence in patients with in-stent restenosis. Circulation. 2000; 101: 2165 - 2171.

7.     Sousa J. E., Costa M.A., Abizaid A., et al. Lack of neoitimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2001; 10: 192 - 195.

8.     Kuntz R.E., Gibson СМ., Nobuyoshi M., et al. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J. Am. Coll. Cardiology. 1993; 21: 15 - 25.

 

Abstract:

Endovascular interventions operations of coronary arteries are a long-term and fast-developing branch of surgical treatment of ischemic disease. Radiational skin damage is a rare and grave complication caused by endovascular interventions operations. The risk factors for this disorder are diabetes, disorders of conjunctive tissue and obesity. Complicated anatomy of coronary vessels prolonges the surgical intrusion, thus increasing the impact of radiation. Radiated areas are treated by excision of diseased soft tissues. Afterwards the defect is covered with vascularised scraps. Three patients suffering radiation sores on the back were examined during the research. They were diseased with chronical coronar occlusions, and one of the patients had the reocclusion inside the previously implanted stent. All individuals were overweight and required more strickt radiation than usual to obtain accurate images. That is why a precise control over the dosage of radiation is crucial. If radiation damage is developing, an active surgery is an effective treatment that must be applied.

 

References

1.     La Manna A., Di Mario С. Therapeutic Strategies in Multiple Vessel Coronary Artery Disease. E-Journal of European Society of Cardiology. 2005; 29: 17 - 23.

2.     Wagner L.K., McNeese M.D., Marx M.V, Siegel E.L. Severe Skin Reactions from Interventional Fluoroscopy: Case Report and Review of Literature. Radiology. 1999; 213: 773-776.

3.     Koenig T.R., Wolff D., Mettler F.A., Wagner L.K. Skin Injuries from Fluoroscopically Guided Procedures: Part 1, Characteristics of Radiation Injury. American Journal of Radiology. 2001; 177: 3 - 11.

4.     Бардычев М. С, Кацалап С. Н., Курпешева А. К. и др. Диагностика и лечение местных лучевых повреждений. Медицинская радиология. 1992; 12: 22-25.

5.     Kuon E., Glaser С, Damn J.B. Effective techniques for reduction of radiation dosage to patients undergoing invasive cardiac procedures. The British Journal of Radiology. 2003; 76: 406-413.

6.     Iyer PS. Acute radiation injury caused by faulty x-ray fluoroscopy during cardiac procedures. Health Phys. 1976; 31: 385-387.

7.     Wolff D., Heinrich K.W Strahlenschaden der Hautnach Herzkatheterdiagnostik und: therapie 2 Kasuis-tiken. Hautnah Derm. 1993; 5: 450 - 452.

8.     Lichtenstein D.A., Klapholz L., Vardy D.A., et al. Chronic radiodermatitis following cardiac catheterization. Arch. Dermatol. 1996; 132: 663 - 667.

9.     ShopeT.B. Radiation-induced skin injuries from fluoroscopy RadioGraph-ics. 1996; 16: 1195 - 1199.

10.   Sovik E., Klow N-E., Hellesnes J, Lykke J. Radiation-induced skin injury after percutaneous transluminal coronary angioplasty. Ada Radiol. 1996; 37: 305 - 306. ll.D'Incan M., Roger H. Radiodermatitis following cardiac catheterization. Arch. Dermatol. 1997; 133: 242 -243.

12.   Poletti J.L. Radiation injury to skin following a cardiac interventional procedure (letter). Australas Radiol. 1997; 41: 82-83.

13.   Gironet N., Jan V, Machet M.C. et. al. Radiodermite chronique post catheterisme cardiaque: role favorisant du ciprofibrate (Lipanor)? Ann. Dermatol. Venereol. 1998; 125:598-600.

14.   Granel E, Barbaud A., Gillet-Terver M.N., et al. Radio-dermites chroniques apres catheterisme interventionnel cardiaque: quatre observations. Ann. Dermatol. Venereol. 1998; 125: 405 - 407.

15.   Stone M.S., Robson K.J., LeBoit PE. Subacute radiation dermatitis from fluoroscopy during coronary artery stenting: evidence for cytotoxic lymphocyte mediated apoptosis. J. Am. Acad. Dermatol. 1998; 38: 333-336.

16.   Dandurand M., Huet P., Guillot B. Radiodermites secondaires aux explorations endovasculaires: 5 observations. Ann Dermatol Venereol. 1999; 126: 413 - 417.

17.   Dehen L., Vilmer C, Humiliere C. et. al. Chronic radio-dermatitis following cardiac catheterisation: a report of two cases and a brief review of the literature. Heart. 1999; 81: 308-312.

18.   Miralbell R., Maillet P., Crompton N.E., et. al. Skin radionecrosis after percutaneous transluminal coronary angioplasty: dosimetric and biological assessment. J.Vasc. Interv. Radiol. 1999; 10: 1190 - 1194.

19.   Pezzano M, Duterque M, Lardoux H, et al. Radiodermite thoracique en cardiologie interventionnelle: a propos de 6 cas. Arch Mai Coeur Vaiss. 1999; 92: 1197 - 1204.

20.   Sajben FP, Schoelch SB, Barnette DJ. Fluoroscopicin-duced radiation dermatitis. Cutis. 1999; 64: 57 - 59.

 

Abstract:

The minute methodical details and technical aspects of uterine arteries embolization, crucial for successful intervention, are reviewed in this article. The text provides detailed descriptions of roentgen anatomy of the internal iliac arteries, different variants of blood circulation in uterus and ovaries and various types of anastomozes between uterine and ovarian arteries. The techniques indispensable for successful embolization of uterine arteries in complex anatomic cases and in peculiar ways of uterine arteries formation are thoroughly described.

 

References

1.     Pelage J., Le Dref О., Soyer P. et al. Arterial anatomy of the female genital tract: variations and relevance to transcatheter embolization of the uterus, AJR. 1999; 172: 989 - 994.

2.     Nikolic В., Spies J., Campbell L. et al. Uterine artery embolization: reduced radiation with refined technique,/ Vase. Intervent. Radiol. 2001; 12: 39 - 44.

3.     Капранов С.А., Бреусенко В.Г., Бобров Б.Ю. и соавт. Применение эмболизации маточных артерий при лечении миомы матки: анализ 258 наблюдений. Международный журнал интервенционной кардиоангиологии. 2005; 7: 56.

4.     Stringer N., Grant Т., Park J., Oldham L. Ovarian failure after uterine artery embolization for treatment of myomas./. Am. Ass. Gynecol. Laparose. 2000; 7(3): 395 - 400.

5.     Payne J., Robboy S., Haney A. Embolic microspheres within ovarian arterial vasculature after uterine artery embolization. Obstet. Gynecol. 2002; 100 (5): 883 - 886.

6.     Barth M., Spies J. Ovarian artery embolization supple-meriting uterine embolization for leiomyomata. J. Vase. Interv. Radiol. 2003; 14 (9): 1177-1182. 7. Pelage J., Walker W, Le Dref O., Rymer R. Ovarian artery: angiographic appearance, embolization and relevance to uterine fibroid embolization. Cardiovasc. Interv. Radiol 2003; 26(3): 227-233.

authors: 


 

Article exists only in Russian.

 

Abstract:

We presented results of pulmonary arteriovenous fistula's endovascular correction of right lung in patient with subcardiac form of partial anomalous drainage of pulmonary veins, complicated with chronic pulmonary infection of hypoplastic right lung and hemoptysis.

 

References

1.     R.C. Anomalies of great vessels associated with lung hypoplasia: the scimitar syndrome. Am. J. Dis. Child. 1966; 111: 35-44.

2.     Neill C.f., Ftrencz C., Sabiston D.S., Sheldon H. The familial occurrence of hypoplastic right lung with systemic arterial supply and venous drainage «scimitar syndrome». Bull. Jons. Hopkins. Hosp. 1960; 107: 1-20.

3.     Dupuis C., Charaf L.A.C., Breviere G. et al. The «- adult» form of the scimitar syndrome. Am. J. Cardiol. 1992; 70: 502-507.

4.     Gao Y., Burrows P.E., Benson L.N. et al. Scimitar syndrome in infancy. J. Am. Coll. Cardiol. 1993; 22: 873-882.

5.     Thibault C., Perrault L.P., Delistle P.A. The continuum of pulmonary developmental anomalies. Radiographics. 1987; 7: 747-772.

6.     Herlong J.R., Jaggirs J.J., Ungleider R.M. Congenital heart surgery nomenclature and database project: pulmonary venous anomalies. Ann. Thorac. Surg. 2000; 69: 56-59.

7.     Korostelev A.N., Kokov L.S., Il'ina M.V. i dr. Anomal'noe vpadenie nizhnedolevoj pravoj legochnoj veny i perifericheskie stenozy legochnoj arterii. Hirurgija [Anomalies of v. pulmonalis inferior and stenosis of pulmonal artery]. 2008; 6: 76-78 [In Russ].

8.     Le Rochais J.P., Icard P., Davani S. et al. Scimitar syndrome with pulmonary arteriovenous fistulas. Ann. Thorac. Surg. 1999; 68: 1416-1418.

9.     Reddy R., Shah R., Thorpe J.A.C., Gibbs J. Scimitar syndrome: a rare cause of haemoptysis. Eur. J. Cardiothorac. Surg. 2002; 22: 821.

10.   Najm H.K., Williams W.G., Coles J.G. et al. Scimitar syndrome: twenty years experience and results of repair. J. Thorac. Cardiovasc. Surg. 1996; 112: 161-168.

11.   Berna P., Cazes A., Bagan P., Riquet M. Intralobar sequestration in adult patients. Interact. Cardiovasc. Thorac. Surg. 2011; 12: 970-972.

12.   Tortoriello T.A., Wesley Vick G., Chang T. et al. Meandering right pulmonary vein to the left atrium and inferior vena cava. Texa.s Heart Institute]. 2002; 29: 319-323.

13.   Kalmer M., Kerkhoff G., Budde T., Jakob H. Scimitar syndrome in the adults: diagnosis and surgical treatment. Interactive Cardiovasc. Thoracic Surg. 2003; 2: 350-351.

14.   Hulkic N., Cuenoud P.F., CorthesyM.E. et al. Рulmonary sequestration: a review of 26 cases. Eur. J. Cardiovasc. Surg. 1998; 14: 127-133.

15.   Izzillo R., El Yajjam M., QanadliS.D. et al. Intralobar sequestration of the lung in the adults (type 1 of Pryce). Treatment by coil embolization. J. Radiol. 2000; 81: 996-999.

16.   Yong Wey, Fan Li. Pulmonary sequestration: a retrospective analysis of 2625 cases in China. Eur. J. Cardiothorac Surg. 2011; 40: 39-42.

17.   Gonzalez M., Bize P., Ris H.B., Krueger T. Scimitar syndrome in association with intrapulmonary sequestration. Eur. J. Cardiothorac. Surg. 2011; 40: 273.

18.   Savic B., Birtel F.J., Tholen W. et al. Lung sequestration: report of seven cases and review of 540 published cases. Thorax. 1979; 34: 96-101.

19.   Zin'kovskij M.F., Gorjachev A.G., Piwurin O.O. Hirurgicheskoe lechenie sindroma «jatagana» (scimitar syndrome). [Surgical treatment of Scimitar syndrome]. Manual «Cardiovascular surgery» Kiev: 2010; 114-119 [In Russ].

20.   Murphy J.W., Kerr A.R., Kirklin J.W. Intracardiac repair for anomalous pulmonary venous connection of right lung to inferior vena cava. Ann. Thorac. Surg. 1971; 11: 38-42.

21.   Torres A.R., Dietl C.A. Surgical management of the scimitar syndrome: an age-dependent spectrum. Cardiovasc. Surg. 1993; 1: 432-438.

22.   Torsten W., Lichtenberg A., Shirada K., KlimaU. Combined correction of an adult scimitar syndrome and coronary artery bypass grafting. Ann. Thorac. Surg. 2002; 73: 640-642.

23.   Brown J.W., Ruzmetov M., Minnich D.J. et al. Surgical management of scimitar syndrome: an alternative approach. J. Thorac. Cardiovasc. Surg. 2003; 125:238-245.

24.   Muramatsu T., Furuichi M., Nishii T., Shiono M.  Type 1 congenital pulmonary airway malformation with a partial anomalous pulmonary venous connection. Eur. J. Cardiothorac. Surg. 2001; 39: 792.

25.   Munos J.J., Garcia J.A., Bentabol M. et al. Endovas. cular treatment of hemoptysis by abnormal systemic pulmonary supply. Cardiovasc. Intervent. Radiol.2008; 31: 427-430.

26.   Curros F., Chigot V., Emond S. et al. Role of ambolization in the treatment of bronchopulmonare sequestration. Pediatr. Radiol. 2000; 30: 769-733. Chien K.J., Huang T.C., Lin C.C. et al. Early and late outcome of coil embolization of pulmonary sequestration in children. Circulation. 2009; 73: 98-942.

27.   Morse C., Ishitani M., Cassivi S.D. Vidio assisted resection of bilateral intralobar pulmonary sequvestration. J. Thorac. Cardiovasc. Surg. 2006; 131: 917-918. Mudhusudhan K.S., Chandan J.D., Dutta R., Kumar A. Endovascular embolization of pulmonary sequestration in an adults. J. Vasc. Interv. Radiol. 2009; 20: 1640-1642.

28.   Leoncini G., Rossi U.G., Ferro C., Cytssa L. Endovascular treatment of pulmonary sequestration in adults using Amplatzer vascular plugs. Interact. Cardiovasc. Thorac. Surg. 2011; 12: 98-100.

 

Abstract:

Retroperitoneal fibrosis (RPF) is a relatively rare disease which shows enlarged periaortic adipose in the retroperitoneal area. The diagnosis of RPF is a challenge for the clinicians. The symptoms and signs associated with RPF are nonspecific, and diagnosis requires a high degree of suspicion. A definitive diagnosis can only be made based on biopsy findings, although US, CT scanning or MRI are essential for evaluating the disease process, for determination whether the retroperitoneal mass is due to idiopathic or secondary RPF. Article presents 2 cases of idiopathic RPF occurring in patients who was suspected of abdominal aortic aneurysm.

 

References

1.     Albarran J. Retention renale par periureterite. Liberation externe de l’uretrne. Assoc. Fr. Urol. 1905; 9: 511-517.

2.     Ormond J.K. Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process. J. Urol. 1948; 59: 1072-1079.

3.     Kottra J.J., Dunnick N.R. Retroperitoneal fibrosis. Radiol. Clin. North. Am. 1996; 34(6): 1259-75.

4.     McDougal W.S., MacDonell R.C. Treatment of idiopathic retroperitoneal fibrosis by immunosuppression. J. Urol. 1991; 145(1): 112-4.

5.     Dedeoglu F. et al. Successful treatment of retroperitoneal fibrosis with tamoxifen in a child. J. Rheumatol. 2001; 28(7): 1693-5.

6.     Keith D.S., Larson T.S. Idiopathic retroperitoneal fibrosis. J. Am. Soc. Nephrol. 1993; 3: 1748-52.

7.     Jones J.H. et al. Retroperitoneal fibrosis. Am. J. Med. 1970; 48: 203-8.

8.     Vaglio A. et al. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am. J. Med. 2003; 114:.454-462.

9.     Katz S.M. et al. Immune complex glomerulonephritis in a case of retroperitoneal fibrosis. Am. J. Clin. Pathol. 1977; 67(5): 436-9.

10.   Parums DV, et al. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch. Pathol. Lab. Med. 1990; 114(4): 383-7.

11.   Neild G.H. et al. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med. 2006; 4: 23.

12.   Pryor J.P. et al. Do beta-adrenoceptor blocking drugs cause retroperitoneal fibrosis? Br. Med. J. 1983; 287: 639-641.

13.   Higgins P.M., Aber G.M. Idiopathic retroperitoneal fibrosis - an update. Dig Dis. 1990; 8(4): 206-22.

14.   Uibu T. et al. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet. 2004; 363(9419): 1422-6.

15.   Katz R. et al. Primary and postoperative retroperitoneal fibrosis? experience with 18 cases. Urology. 2002; 60: 780-783.

16.   Mitchinson M.J. Chronic periaortitis and periarteritis. Histopathology. 1984; 8(4): 589-600.

17.   Parums D.V. The spectrum of chronic periaortitis. Histopathology. 1990; 16: 423-31.

18.   Lepor H., Walsh P.C. Idiopathic retroperitoneal fibrosis.J. Urol. 1979; 122(1): 1-6.

19.   Vaglio A. et al. Retroperitoneal fibrosis: evolving concepts. Rheum. Dis. Clin. North. Am. 2007; 33(4): 803-17.

20.   Moussavian B., Horrow M.M. Retroperitoneal fibrosis. Ultrasound Q. 2009; 25(2): 89-91.

21.   Arrive L. et al. Malignant versus nonmalignant retroperitoneal fibrosis: differentiation with MR imaging. Radiology. 1989; 172 (1): 139-43.

22.   Mikhaylov S.Kh. Retroperitoneal'nyy fibrozbolezn’ Ormonda. Avtoreferat....kand. med. nauk, Moskva.1981: 19 [In Russ].

23.   Inaraja L. et al. CT findings in circumscribed upper abdominal idiopathic retroperitoneal fibrosis. J. Comput. Assist. Tomogr. 1986; 10 (6): 1063-4.

24.   Hulnick D.H. et al. Retroperitoneal fibrosis presenting as colonic dysfunction: CT diagnosis. J. Comput. Assist. Tomogr. 1988; 12 (1):159-61.

25.   Khan A.N. et al. Retroperitoneal Fibrosis. 2004. http://emedicine.medscape.com/article/380772-overview.

26.   Dixon A.K. et al. Computed tomographic observations in periaortitis: a hypothesis. Clin. Radiol. 1984; 35(1):39-42.

27.   Ozgen A., Cila A. Renal involvement in multifocal fibrosclerosis: CT and MRI. J. Comput Assist Tomogr. 1999; 23(6): 937-8.

28.   Ayuso J.R. et al. Atypical retroperitoneal fibrosis: MRI findings. Eur. Radiol. 1999; 9(5): 937-9.

29.   Elsayes K.M. et al. Retroperitoneal masses: magnetic resonance imaging findings with pathologic correlation. Curr. Probl. Diagn. Radiol. 2007; 36(3): 97--106.

 

 

Abstract:

On the base of a case report article shows the role of interventional and diagnostic radiology in treatment of patients with multifocal atherosclerosis. Application of modern interventional cardiology methods expands the possibilities in treatment of patients with multifocal atherosclerosis, often in severe condition, and in senile group. Article provides literary data on the prevalence of multifocal atherosclerosis.

 

References

 1.    Bjerrum I.S., Sand N.P., Poulsen M.K., et al. Non-invasive assessments reveal that more than half of randomly selected middle-aged individuals have evidence of subclinical atherosclerosis: a DanRisk substudy. Int. J. Cardiovasc. Imaging. 2012. [Epub ahead of print].

2.     Sumin A.N., Gaifulin R.A., Bezdenezhnykh A.V., Mos'kin M.G., Korok E.V., Karpovich A.V., Ivanov S.V., Barbarash O.L., Barbarash L.S. Rasprostranennost multifokalnogo ateroskleroza v razlichnyh vozrastnyh gruppah. [Prevalence of multifocal atherosclerosis in different age groups] Кардиология. Kardiologiia. 2010; 52(6): 28-34 [In Russ].

3.     Belov U.V., Carchan E.R., Krasnikov M.P. Odnomomentnoe hirurgicheskoe lechenie porazhenia voshodiaschej dugi aorty, koronarnyh i sonnyh artetij u bolnogo s multifokalnym aterosklerozom) [Single-step surgical management of lesions of the ascending aorta and aortic arch, coronary and carotid arteries in a male patient with multifocal atherosclerosis]. Angiol. Sosud. Khir. 2012;18(1): 131-135[In Russ].

4.     Helgadottir A., Gretarsdottir S., Thorleifsson G., et al. Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism. Am. Coll. Cardiol. 2012; 60(8): 722-729.

5.     Lammeren G.W., Catanzariti L.M., Peelen L.M., et al. Clinical prediction rule to estimate the absolute 3-year risk of major cardiovascular events after carotid endarterectomy. Stroke. 2012; 43(5): 1273-1278.

6.     Giugliano G., Di Serafino L., Perrino C., et al. Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease. Int. J. Cardiol. 2012. [Epub ahead of print].

7.     Matsuo Y, Takumi T, Mathew V, et al. Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems. Atherosclerosis. 2012; 223(2): 365-371.

8.     Karimov Sh.I., Sunnatov R.D., Ganiev A.M., Keldierov B.K., Irnazarov A.A., Asrarov U.A., Iulbarisov A.A., Alidzhanov Kh. Diagnostika i taktika hirurgicheskogo lechenia bolnyh s multifokalnym aterosklerozom) [Diagnostics and strategy of surgical treatment of multifocal atherosclerosis]. Vestn. Ross. Akad. Med. Nauk. 2011; 1:14-18 [In Russ]. 

 

Abstract:

The article presents case report of step-by-step treatment of patient with coronary arteries disease (CAD). Male, 47 yrs in 1996 underwent aorto-coronary bypass with making of 7 bypasses. Due to progression of atherosclerotic disease in postoperative perion patient underwent percutaneous transluminal coronary angioplastics (PTCA). Despite of all procedures new coronary arteries and bypasses defeat appeared and restenosis of previously implanted stents was pointed. Patient was treated in different countries (Israel, Germany Japan, Russia) with different methods, including: drug-eluting stents, angioplasty with the help of excimer laser and rotational atherectomy Application of physical and mechanical isolation of hyperplastic intima (excimer laser, rotational atherectomy) did not give significant decrease of restenosis repeat. Implantation of drug-eluting stents also had no effect. Stent-in-stent implantation in case of drug-eluting stent restenosis led to repeated restenosis in this patient.

Thus, restenosis is a serious problem for interventional cardiologists. Any of available interventional methods provide optimum direct results, and the long-term results are even poorer.

 

References

1.     Andres, Vicente & Wessely,Rainer (2009, January 15). In-stent restenosis: Molecular mechanisms and therapeutic principles. SciTopics. Retrieved March 9, 2011, from http://www.scitopics.com/ In_stent_restenosis_Molecular_mechanisms_ and_therapeutic_principles.html.

2.     Sigwart U., Puel J., Mirkovitch V. et al. Intravascular stents to prevent occlusion and restenosis after transluminal angio-plasty. N. Engl. J. Med. 1987; 316: 701-6.

3.     Fischman D.L., Leon M.D., Baim D.S. et al. for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in treat-ment of coronary artery disease. N. Engl. J. Med. 1994; 331: 496-501.

4.     Till F.V., Aliabadi D., Kinn J.W., Kaplan B.M., Benzuly K.H., Safian R.D. Real life stenting: a comparison of target vessel revascularization in Benestent-Stress lesions to non Benestent-Stress lesions. Circulation. 1996; 94: I-332.

5.     Fenton S.H., Fischman D.L., Savage M.P. et al. Long-term angiographic and clinical outcome after implantation of balloon expandable stents in aortocoronary saphenous vein grafts. Am. J. Cardiol. 1994; 74: 1187-91.

6.     Serruys P.W., de Jaeger P., Kiemeneij F. et al. for the Benestent Study Group. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary heart disease. N. Engl. J. Med. 1994; 331: 489-95.

7.     Hoffmann R. and Mintz G. S. Coronary in-stent restenosis - predictors, treatment and prevention. European Heart Journal. 2000; 21: 1739-1749.

8.     Vom Dahl J., Dietz U., Haager P.K. et al. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the Angioplasty versus Rotational Atherectomy for Treatment of Diffuse In-Stent Restenosis Trial (ARTIST). Circulation. 2002; 105:583-588

9.     Waksman R., Cheneau E., Ajani A.E. et al. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies. Circulation. 2003; 107:1744-1749.

10.   Radke P.W., Kobella S., Kaiser A. et al. Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary beta-radiation therapy. Eur. Heart J. 2004; 25:920-925.

11.   Lemos P.A., Hoye A., Goedhart D. et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation. 2004; 109:1366-1370.

12.   Scott N.A., Cipolla G.D., Ross C.E. et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation. 1996; 93: 2178-87.

13.   Axel D.I., Kunert W., Goggelmann C. et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997; 96:636-645.

14.   Scheller B., Speck U., Romeike B. et al. Contrast media as carriers for local drug delivery: successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur. Heart J. 2003; 24:1462-1467

15.   Scheller B., SpeckU., Schmitt A., Bohm M., Nickenig G. Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. J. Am. Coll. Cardiol. 2003; 42:1415-1420.

16.   Osiev A.G., Mironenko S.P., Krestyaninov O.V., Vereshagin M.A., Kretov E.I., Biryukov A.V., Grankin D.S., Prokopenko R.N. Clinical and angiographic efficacy of the coated balloon catheters in patients with restenosis of the coronary stents. Pathology of blood circulation and heart surgery. 2010; 4: 29-35 [In Russ]. 

 

Abstract:

One of the most significant problems in interventional cardiology is a correct drug-support after held procedure. First of all it is the prevention of stent thrombosis - application of anticoagulants and antiaggregants. The variety of these drugs on sale constantly grows - that leads to have clear ideas of their properties.

Article presents the review of clinical researches devoted to the recently appeared and early not used in Russia, drug Angioks (Bivalirudin), which has the same efficiency as well-known drugs, but is more safe.

 

References

1.     Maraganore J.M., Bourdon P., Jablonski J., Ramachandran K.L., Fenton J.W. 2nd. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry. 1990; 29(30): 7095-101.

2.     Bates S.M., Weitz J.I. Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin. Am. J. Cardiol. 1998; 82(8B): 12P-18P. Review.

3.     Sciulli T.M., Mauro V.F. Pharmacology and clinical use of bivalirudin. Ann. Pharmacother. 2002; 36(6): 1028-41. Review.

4.     Topol E.J., Bonan R., Jewitt D., Sigwart U., Kakkar V.V., Rothman M., de Bono D., Ferguson J., Willerson J.T., Strony J., et al. Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty. Circulation. 1993; 87(5): 1622-1629.

5.     Bates E.R. Bivalirudin: an anticoagulant option for percutaneous coronary intervention. Expert. Rev. Cardiovasc. Ther. 2004; 2(2): 153-62. Review.

6.     Bittl J.A., Strony J., Brinker J.A., Ahmed W.H., Meckel C.R., Chaitman B.R., Maraganore J., Deutsch E., Adelman B. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators. N. Engl. J. Med. 1995; 333(12): 764-9.

7.     Bittl J.A., Chaitman B.R., Feit F., Kimball W., Topol E.J. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. Am. Heart. J.2001;142(6): 952-9.

8.     Lincoff A.M., KleimanN.S., Kottke-Marchant K., Maierson E.S., Maresh K., Wolski K.E., Topol E.J. Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). Am. Heart. J. 2002; 143(5): 847-53.

9.     Lincoff A.M., Bittl J.A., Harrington R.A., Feit F., Kleiman N.S., Jackman J.D., Sarembock I.J., Cohen D.J., Spriggs D., Ebrahimi R., Keren G., Carr J., Cohen E.A., Betriu A., Desmet W., Kereiakes D.J., Rutsch W., Wilcox R.G., de Feyter P.J., Vahanian A., Topol E.J. REPLACE-2 Investigators. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA. 2003; 289(7):853-63. Erratum in: JAMA. 2003; 289(13):1638.

10.   Gibson C.M., Morrow D.A., Murphy S.A., Palabrica T.M., Jennings L.K., Stone PH., Lui H.H., Bulle T., Lakkis N., Kovach R., Cohen D.J., Fish P,  McCabe C.H., Braunwald E. TIMI Study Group. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30trial. J. Am. Coll. Cardiol. 2006; 47(12): 2364-73.

11.   Pinto D.S., Stone G.W., Shi C., et al. on behalf of the ACUITY Investigators. Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. J. Am. Coll. Cardiol. 2008; 25: 1758-1768.

12.   Kastrati A., Neumann F.J., Schulz S., Massberg S. et al. Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. N. Engl. J. Med. 2011; 365: 21: 1980-1989.

13.   Stone G.W., Witzenbichler B., Guagliumi G., Peruga J.Z., Brodie B.R., Dudek D., Kornowski R., Hartmann F., Gersh B.J., Pocock S.J., Dangas G., Wong S.C., Kirtane A.J., Parise H., Mehran R. HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N. Engl. J. Med. 2008; 358(21): 2218-30.

14.   Mahaffey K.W., Lewis B.E., Wildermann N.M., Berkowitz S.D., Oliverio R.M., Turco M.A., Shalev Y., Ver Lee P., Traverse J.H., Rodriguez A.R., Ohman E.M., Harrington R.A., Califf R.M. ATBAT Investigators. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results. J. Invasiv. Cardiol. 2003; 15(11): 611-6.

15.   Waksman R., Wolfram R.M., Torguson R.L., Okubagzi P., Xue Z., Suddath W.O., Satler L.F., Kent K.M. Switching from Enoxaparin to Bivalirudin in Patients with Acute Coronary Syndromes without ST-segment Elevation who Undergo Percutaneous Coronary Intervention. Results from SWITCH- a multicenter clinical trial. J. Invasiv. Cardiol. 2006; 18(8): 370-5.

16.   Andreas Koster, Bruce Spiess, Michael Jurmann, MD, Cornelius M. Dyke, Nicholas G. Smedira, MD, Sol Aronson and Michael A. Lincoff. Bivalirudin Provides Rapid, Effective, and Reliable Anticoagulation During Off-Pump Coronary Revascularization: Results of the «EVOLUTION OFF» Trial. Anesth Analg. 2006; 103(3): 540-4. 

 

Abstract:

This article presents a review of the literature on treatment of multifocal atherosclerosis of iliac arteries and arteries of lower extremities. Adequate correction of arterial inflow provides normal functioning of distal reconstructions. Combination of endovascular correction of arterial inflow with open surgical reconstructions of arterial outflow maximizes limb revascularization and this leads to less surgical trauma and less complications. Hybrid operations allow to achieve maximum results in terms of hemodynamics in patients with multi-segmental lesions. Immediate and long-term results of such operations are not worse than similarly isolated interventions in each segments. Hybrid operations show their worth and effectiveness in all lesions of aorto-iliac segment, including TASC C and D. Reduced operational trauma during hybrid operations, compared with one-stage surgical reconstruction, and the possibility to perform interventions under regional anesthesia, are particularly important in patients at high risk of comorbidity

 

References

1.     Savel'ev B.C., Koshkin V.M. Kriticheskaja ishemija nizhnih konechnostej [Critical ischemia of the lower limbs]. M.: Medicina. 1997; 8 [In Russ].

2.     McDermott M.M. The ankle brachial index is associated with leg function and physicial activity: the Walking and Leg Circulation Study. Ann. Intern. Med. 2002; 136: 873-83.

3.     Levy PJ. Epidemiology and pathology of peripheral arterial disease. Clin. Cornerstone. 2002; 4(5): 1-15.

4.     Zatevahin I.I., Ciciashvili M.Sh., Shipovskij V.N. et al. Novye perspektivy sosudistoj hirurgii - sochetannye jendovaskuljarnye i otkrytye operacii v rekonstrukcii arterial'nogo rusla. [New perspectives of vascular surgery - combining endovascular and open surgery in the reconstruction of arteries]. Annaly hirurgii. 1999; 6: 77-84 [In Russ].

5.     Strandness D.J., Sumner D. Hemodynamics for surgeons. New York: Grune & Stratton. 1975; 278-281.

6.     Norgren L., Hiatt W.R., Dormandy J.A. et al. InterSociety Consensus for the Management of Peripheral Arterial Disease (TASC II). J.Vhsc. Surg. 2007; 45 Suppl S: S5-67.

7.     Kirienko A.I., Koshkina V.M., Bogacheva VJu. Ambulatornaja angiologija. [Ambulatory Angiology]. M.: Litterra. 2007; 199-200 [In Russ].

8.     Pell J.P., Lee AJ. Impact of angioplasty and arterial reconstructive surgery on the quality of life of claudicants. The Scottish Vascular Audit Group. Scott. Med. J 1997; 42(2): 47-48.

9.     Troitskiy A.V., KhabazovR.I., Parshin PJu. Sochetannye operacii pri jetazhnyh porazhenijah aorto- podvzdoshnogo i bedrenno-podkolennogo segmentov. V rukovodstve: Sosudistoe i vnutriorgannoe stentirovanie. [Combined surgery of multilevel aorta-iliac and femoral-popliteal arterial segments. In the manual: Vascular and intraorganic stenting]. M.: Izdatel'skij dom «Graal'». 2003; 191-210 [In Russ].

10.   Reed A.B., Conte M.S., Donaldson M.C. et al. The impact of patient age and aortic size on the results of aortobifemoral bypass grafting. J. Vasc. Surg. 2003; 37(6): 1219-1225.

11.   Dominjak A.B., Hirurgicheskaja taktika pri trombozah, reokkljuzijah i anevrizmah anastomozov posle aorto-bedrennyh rekonstrukcij. Povtornye rekonstruktivnye operacii. Travmaticheskie povrezhdenija sosudov: Materialy 6-oj mezhdunarodnoj konferencii Rossijskogo obwestva angiologov i sosudistyh hirurgov. [Surgical Management of thrombosis, reocclusion and anastomotic aneurysms after aorto-femoral reconstructions. Repeated reconstructive operations. Traumatic vascular injury: Proceedings 2nd International Conference of the Russian Society Angiologists and vascular surgeons]. Angiologija i sosudistaja hirurgija. 1997; 3: 34-35 [In Russ].

12.   Onohara T., Komori K., Kume M. et al. Multivariate analysis of long-term results after an axillobife- moral bypass in patients with aortoiliac occlusive disease. J. Cardiovasc. Surg. 2000; 41(6): 905-910.

13.   Kuzin M.I., Uspenskij L.V., Kurguzov O.P. Rekonstruktivnye operacii pri okkljuzionnyh porazhenijah magistral'nyh arterij nizhnih konechnostej. [Reconstructive surgery in occlusive lesions of arteries of the lower extremities]. Hirurgija. 1980; 8: 17-21 [In Russ].

14.   Diehl J.T., Cali R.F., Hertzer N.R. et al. Complication of abdominal aortic reconstruction. Analysis of perioperative risk factors in 557 patients. Ann. Surg. 1983; 197: 49-56.

15.   Szilagyi E., Elliot J., Smith R. et al. A thirty survey of the reconstructive surgical treatment of aortoiliac occlusive disease. J. hsc. Surg. 1986; 3(3): 421-436.

16.   Wong D.H., Weber E.C., Schell M.J. et al. Factors associated with postoperative pulmonary complications in patients with severe chronic obstructive pulmonary disease. Anesth. Analg. 1995; 80: 276-84.

17.   Mulholland M.W., Doherty G.M. Complicatios in surgery. Lippincott Williams&Wilkins. 2006; 321-335.

18.   Van der Vliet J.A., Schara D.M., de Waard J.W. et al. Unilateral vascular reconstruction for iliac obstructive disease. J .Vasc. Surg. 1994; 19: 610-614.

19.   Vollmar J., Lauhach K., Gems J. The technique of the thrombendarterectomy (spiraling disobliteration). Brims. Beiler. Klin. Chir. 1969; 217: 678-690.

20.   Koval' O.A. Sravnitel'naja harakteristika mediko-jekonomicheskih parametrov intraoperacionnogo i blizhajshego posleoperacionnyh periodov poluzakrytoj jendarterjektomii i otkrytyh arterial'nyh rekonstrukcij. Aktual'nye voprosy serdechno-sosudistoj patologii: materialy regional'noj nauch.- prakt. konf. s mezhdunarodnym uchastiem. [Comparative characteristics of medical and economic parameters of intraoperative and immediate postoperative period semiclosed endarterectomy and open arterial reconstruction. Topical issues of cardiovascular disease: Proceedings of the regional scientific-practical. Conf. with international participation]. Kemerovo. 2006; 149-150 [In Russ].

21.   Losev R.Z., Burov I.A., Mikul'skaia E.G. et al. Multilevel revascularization of the lower extremities using loop endarterectomy. Vestn. Khir. Im. 11 Grek. 2006; 165(5): 21-4.

22.   Smeets L., Ho G.H., Moll F.L. Remote endarterectomy for occlusive iliac and superficial femoral artery disease. Future Cardiol. 2007; 3(1): 43-51.

23.   Beno M., Rumenapf G. Retrograde endarterectomy of iliac arteries. Bratisl Lek Listy. 2010; 111(2): 83-89.

24.   Moll F.L., Ho G.H. Infrainguinal technical improvements. Remote endarterectomy. In: Greenhalgh RH, Powell J.T., Mitchell A.W., editors. Vascular and endovascular opportunities. Philadelphia: Saunders. 2000; 455-462.

25.   Luis A. Queral, Frank J. Criado, Peggy Patten. Retrograde iliofemoral endarterectomy facilitated by balloon angioplasty. J. Vаsc. Surg. 1995; 22: 742-750.

26.   OzkanU., Oguzkurt L., Tercan F. Technique, Complication, and Long-Term Outcome for Endovascu- lar Treatment of Iliac Artery Occlusion. Cardiovasc. Intervent. Radiol. 2010; 33: 18-24.

27.   Kashyap V.S., Pavkov M.L., Bena J.F. et al. The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction. JVasc Surg. 2008; 48(6): 1451-1457.

28.   Indes J.E., Tuggle C.T., Mandawat A., Sosa J.A. Age-stratified outcomes in elderly patients undergoing open and endovascular procedures for aortoiliac occlusive disease. Surgery. 2010; 148(2): 420-428.

29.   Matsi P.J., Manninen H.L. Complications of lower- limb percutaneous transluminal angioplasty: a prospective analysis of 410 procedures on 295 consecutive patients. Cardiovasc. Int. Radiol. 1998; 21:361-366.

30.   Saket R.R., Razavi M.K., Padidar A. et al. Novel intravascular ultrasound-guided method to create transintimal arterial communications: initial experience in peripheral occlusive disease and aortic dissection. J. Endorvasc. Ther. 2004; 11(3): 274-280.

31.   Adam D.J., Beard J.D., Cleveland T. et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005; 366(9501): 1925-1934.

32.   Palmaz J.C., Garsia O.J., Schatz R.A. et al. Placement of balloon-expandable intraluminal stents in iliac arteries: first 171 procedurs. Radiology. 1990; 174: 969-975.

33.   Reekers J.A., Vorwerk D., Rousseau H. et al. Results of a European multicentre iliac stent trial with a flexible balloon expandable stent. Eur. J. Vasc. Endo vasc. Surg. 2002; 24(6): 511-515.

34.   Timaran C.H., Stevens S.L., Freeman M.B., Goldman M.H. External iliac and common iliac artery angioplasty and stenting in men and women. J. Vasc. Surg. 2001; 34(3): 440-446.

35.   Powell R.J., Fillinger M., Walsh D.B. et al. Predicting outcome of angioplasty and selective stenting of multisegment iliac artery occlusive disease. J. Vase Surg. 2000; 32(3): 564-569.

36.   Jorgensen B., Skovgaard N., Norgard J. et al. Percutaneous transluminal angioplasty in 226 iliac artery stenoses: role of the superficial femoral artery for clinical success. Vasa. 1992; 21(4): 382-386.

37.   Donas K.P., Schwindt A., Pitoulias G.A. et al. Endovascular treatment of internal iliac artery obstructive disease. J. hsc. Surg. 2009; 49(6): 1447-1451.

38.   Iida O., Uematsu M., Nagata S. et al. Stent fracture, TASC II CD lesion as restenosis factors, and cilostazol as a negative-restenosis factor within a year following nitinol stent implantation in the superficial femoral artery. JACC. 2010; 55: 180.

39.   Hans S., DeSantis D., Siddiqui R., Khoury M. Results of endovascular therapy and aortobifemoral grafting for Transatlantic Inter-Society type C and D aortoiliac occlusive disease. Surgery. 2008; 144(4): 583-590.

40.   Mwipatayi B.P., Hockings A., Hofmann M. et al. Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease : A meta-analysis. J. Vasc. Surg. 2008; 47: 461-469.

41.   Schillinger M., Minar E. Past, Present and Future of Femoropopliteal Stenting. J. Endovasc. Ther. 2009; 16 (1): 147-152.

42.   Cvetanovski M.V., Jovev S., Cvetanovska M. et al. Femoropopliteal bypass vs percutaneous transluminal angioplasty and stenting in treatment of peripheral artery diseases of infrainquinal segment - short-term results. Priozi. 2009; 30(1): 105-118.

43.   Bull P.G., Schlegl A., Mendel H. Combined iliac transluminal angioplasty and femoropopliteal reconstruction for multilevel arterial occlusive disease. Int. Surg. 1993; 78(4): 332-337.

44.   Grandjean J.G. Hybrid Cardiac Procedure: the ultimate cooperation. Neth. Heart J. 2007; 15(10): 327 - 328.

45.   Hirsch R. The hybrid cardiac catheterization laboratory for congenital heart disease: From conception to completion. Catheter Cardiovasc. Intern 2008; 71(3): 418-428.

46.   Griffith C.D., Harrison J.D., Makin G.S. et al. Transluminal iliac angioplasty with distal bypass surgery in patients with critical limb ischaemia. J. R.Col. Surg. Edinb. 1989; 34(5): 253-255.

47.   Chang R.W., Goodney P.P., Baek J.H. et al. Longterm results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease. J. Vasc. Surg. 2008; 48(2):362-367.

48.   Mousa A., Abdel-Hamid M., Ewida A. et al. Combined Percutaneous Endovascular Iliac Angioplasty and Infrainguinal Surgical Revascularization for Chronic Lower Extremity Ischemia: Preliminary Result. Vascular. 2010; 18(2): 71-76.

49.   Sinci V., Kalaycioglu S., Halit V. et al. Long-term effects of combined iliac dilatation and distal arterial surgery. Int. Surg. 2000; 85(l): 13-17.

50.   Aburahma A.F., Robinson P.A., Cook C.C., Hopkins E.S. Selecting patients for combined femorofemo- ral bypass grafting and iliac balloon angioplasty and tenting for bilateral iliac disease. J. Vasc. Surg. 2001; 33(2): S93-99.

51.   Lau H., Cheng S.W. Intraoperative endovascular angioplasty and stenting of iliac artery: an adjunct to femoro-popliteal bypass. J. Am. Coll. Surg. 1998; 186(4): 408-414.

52.   Min Su Kim, Yoon Sung Joo, Ki Hyuk Park. Results of Simultaneous Hybrid Operation in Multi-level Arterial Occlusive Disease. J. Korean Surg. Soc. 2010; 79: 386-392.

53.   Cotroneo A.R., Iezzi R., Marano G. et al. Hybrid therapy in patients with complex peripheral multifocal steno-obstructive vascular disease: two-year results. Cardiovasc. Intervent. Radiol. 2007; 30(3): 355-361.

54.   Dosluoglu H.H., Lall P., Cherr G.S. et al. Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease. J. Vasc.Surg. 2010; 51(6): 1425-1435.

55.   Nishibe T., Kondo Y., Dardik A. et al. Hybrid surgical and endovascular therapy in multifocal peripheral TASC D lesions: up to three-year follow- up. J. Cardiovasc. Surg. 2009; 50(4): 493-499.

56.   Brewster D.C., Cambria R.P., Darling R.C. et al. Long-term results of combined iliac balloon angioplasty and distal surgical revascularization. Ann. Surg. 1989; 210(3): 324-330.

57.   Parshin PJu. Odnomomentnye rentgenjendovaskuljarnye i rekonstruktivnye operacii pri jetazhnyh porazhenijah arterij aorto-podvzdoshnogo i bedrenno-podkolennogo segmentov: Avtoreferat. Dis. kand. med. nauk. [One-stage endovascular and reconstructive surgery for multi leveled arterial disease aorto-iliac and femoral-popliteal segments. PhD sci. diss.]. Moscow. 2004; 105 [In Russ]. 

 

Abstract:

Background. Significant coronary artery disease (CAD), occurring in 7-10% of patients with obstructive hypertrophic cardiomyopathy (HCM), deteriorates the clinical course and survival rates. Until recently, such combination of abnormalities was an indication for coronary artery bypass graft (CABG) and septal myoseptecmy

Aim: was to investigate the efficacy, safety and technique of combined percutaneous intervention in patients with obstructive HCM and CAD. Materials and methods. We have performed 15 combined percutaneous interventions: alcohol septal ablation (ASA) and coronary revascularization. All patients had a marked asymmetric hypertrophy of LV with outflow tract obstruction at rest, as well as severe coronary lesions (75% - 95%). During the procedure, we performed consistently ASA of target zone in charge of obstruction and coronary stenting (10 stents in LAD, 8 stents in RCA, 4 stents in LCX).

Results. Among the effects of interventions were disappearance of angina pectoris and dyspnea, reduction of the pressure gradient in the LV outflow tract and a significant decrease in the thickness of septum. No serious complications (such as MI, complete av-block, ventricular tachiarrhythmias) occured

Conclusion. These results indicate efficacy and safety of ASA combined with coronary revascularization in patients with obstructive HCM who have concomitant CAD.

 

References

1.    Maron B.J. Diagnosis and Managment of Hypertrophic Cardiomyopathy. Massachusetts: BlackwellFutura., 2004; 506.

2.    Romeo F., Pelliccia F., Cristofani R. et al. Hypertrophic cardiomyopathy: Is a left ventricular outflow tract gradient a major prognostic determinant? Eur. Heart J. 1990; 11: 233-240.

3.    Maron M.S., Olivotto I., Betocchi S. et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N. Engl. J. Med. 2003;348: 295-303.

4.    Sigwart U. Non surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995; 346: 211-214.

5.    Knight C., Kurbaan A., Seggewiss H. et al. Non surgical septal reduction for hypertrophic obstructive   cardiomyopathy. Circulation. 1997; 95: 2075 -2081.

6.    Burry Х., Sigwart U. Alcohol ablation of interventricular septum as a method of treatment of hypertrophic obstructive cardiomyopathy. International. Journal of Interventional Cardioangiology. 2004; 4: 11-17 [In Russ].

7.    Shloydo E.A., Sukhov V.K., Kochanov I.N. Transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Report to the XII All-Russian Congress of cardiovascular surgeons. The Bulletin of Bakoulev CCVS for Cardiovascular Surgery «Cardiovascular diseases». 2006; 7(5): 84 [In Russ].

8.    Sorajja P., Ommen S.R., Nishimura R.A. et al. Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease. Circulation. 2003; 108: 2342-2348.

9.    Cokkinos D.V., Krajcer Z., Leachman R.D. Hypertrophic Cardiomyopathy and Associated Coronary Artery Disease. Texas Heart Institute Journal. 1985; 2: 12.

10.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy. J. Am. Coll,. Cardiol. 2011; 58 (25): 212-260.

11.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. J. Am Coll. Cardiol. 2011; 58(24): 44-122.

12.  Honda T., Sakamoto T., Miyamoto S. et al. Successful Coronary Stenting of the Left Anterior Descending Artery at the Branching Site of the Targeted Septal Perforator Immediately after Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy. Internal. Medicine. 2005; 44: 722-726.

13.  Nambi V., Buergler J.M., LakkisN.M. et al. Effectiveness of Percutaneous Intervention for Patients With Obstructive Hypertrophic Cardiomyopathy and Coronary Artery Disease. Am J. Cardiol. 2005; 96: 580-581.

 

 

 

Abstract:

Aim: was to investigate the application of decompression interventions conducted under ultrasound control in patients with acute cholecystitis in elderly including methods of obliteration of gallbladder with «MM-ge».

Materials and methods. For the period from July 2008 to September 2011 in City Hospital №68 mini-invasive methods have been appliec in 173 elderly and senile age patients with clinical and echographic picture of acute destructive cholecystitis. There were performed 219 minimally invasive procedures. In this study we performed obliteration of the gall bladder through the implantation of a porous crosslinked polyvinyl alcohol («MM-gel»), intended for use in medicine.

Results. On the base of experience we developed tactics of treatment of elderly and senile patients with acute cholecystitis with the use of mini-invasive ultrasound-guided interventions. Study showed that it is optimum to make gallbladder puncture under ultrasound guidance for sanitation and decompression. In case of failure percutaneous ultrasound-cholecystostomies were performed. Obliteration of gallbladder cavity with implantation of «MM-gel» were successfully performed in 5 cases.

Conclusions. During the research, efficiency and safety of minimally invasive treatment of acute cholecystitis in elderly and senile patients were proved, there was no negative impact on quality of life. Obliteration of the gallbladder cavity with plastic «MM-gel» can be the method of choice for surgical treatment of these patients and requires further development and study of long-term results.

 

References

1.     Vasiliev V.V.,Perunov A.B. Acute colecystitis: modern technologies of treatment. Consilium Medicum. 2001; 6: 279-284 [In Russ].

2.     Gallinger Yu.I., Karpenko V.I.,Mizikov V.N. Laparoscopic cholecystectomy in patients with high operational-anestesialogical risk. Annals of Surgical Hepatology. 2002;1: 97 [In Russ].

3.     Ermolov A.S., Gulyaev A. A., Acute cholecystitis : modern methods of treatment. Treating physician. 2005; 2: 16-18 [In Russ].

4.     Ermolov. S. Ivanov, P. A., Turco A.P.. The main causes of mortality in acute cholecystitis in a hospital in Moscow. Proceedings of the urban scientific conference. M. 1999: 5-11 [In Russ].

5.     Kapralov S.V., Ismailov U.Z., Shapkin J.G. The role and place diapevticheskih decompression operations in the surgery of acute cholecystitis in patients with high-risk surgery and anesthesia. Modern problems of science and education. 2010;2: 47-52 [In Russ].

6.     Privalov V. A., Shramchenko V.A., Gubnitsky A .V. Surgical tactics in acute cholecystitis in elderly patients and old age. Surgery. 1998; 7: 28 - 30 [In Russ].

7.     Altmeir G., Die akute Cholecystitis. G. Altmeir. Chirurg. 2001; 3(52): 450-453.

8.     Zatevakhin 1.1., Tsitsiashvili M.S., Dzarasova G.J. Acute cholecystitis : diagnosis and treatment. Journal of MedicalUniversity. 2000; 3: 21-26 [In Russ].

9.     9. Pantsirev J.M., Nozdrachev V.I., Lagunchik B.P. Decompression of the gallbladder in acute cholecystitis in elderly patients and old age. Surgery. 1990; 2: 17-20 [In Russ].

10.   Tagiyeva M.M. Diagnosis and treatment of acute cholecystitis. Surgery. 1998; 1:15-19 [In Russ].

11.   Fedorov V.D., Danilov M.V., Glabay V.P. Emergency surgery of cholelithiasis. In book Cholecystitis and its complications. Cholecystitis and its complications. Bukhara. 1997: 28-29 [In Russ].

12.   Shulutko A.M. ,Lukomski G.I.,Surin Y.V. Predicting the risk of surgery in acute cholecystitis. Surgery. 1989; 1: 29-32 [In Russ].

13.   Kuznetsov N.A., Ignatenko S.N., Brontveyn A.T., Rodoman G.V. Modern technologies of treatment of acute cholecystitis . Actual problems of practical medicine : Sat. researcher. Tr./ MoscowStateMedicalUniversity. 2000: 77-87 [In Russ].

14.   Zhidkov S.A. Clinical management of acute cholecystitis in patients over 60 years. Medical News. 2005; 7: 68-70 [In Russ].

15.   Zatevakhin I.I. , Magomedov E.G. Therapeutic tactics in acute cholecystitis. Russian Journal of Medicine. 2005; 4: 17-20 [In Russ].

16.   Kuznetsov N.A., Brontveyn A. T., Aronov L.S. Laparoscopic cholecystectomy in acute cholecystitis. Russian Journal of Medicine. 2003; 3: 19-22 [In Russ].

17.   Korovin A.J., Andreev A.V., Kulish V.A., Meshesha Berhane Reda. Ultrasonography in the diagnosis and evaluation of the effectiveness of percutaneous decompression of the gallbladder in patients with acute cholecystitis. In Sat: New Technologies in Medicine (morphological, experimental, clinical and social aspects). Volgograd: Print. 2005: 182-183 [In Russ].

18.   Chadayev A.P., Lyubsky A.S. Two-stage treatment of acute cholecystitis in elderly patients. Int. researcher. conference.: «Actual issues of diagnosis and treatment of diseases of the hepatobiliary area. Endoscopic Surgery.» Proc. Reports. St. Petersburg. 1996: 162-163 [In Russ].

19.   Ichikawa M., Takahara О., Ishihara A. et al. Percutaneous transhepatic ultrasound-guided puncture of the gallbladder for acute cholecystitis. Brit. Med. J. 1996; 8: 8-16.

20.   Gulyaev A.A., Shapovalyants S.G., Burov V.A., Mihaylusov S.V. Obliteration of the lumen of the gallbladder in patients with high operative risk. Surgery. 1998; 9: 42-44 [In Russ].

21.   Emelianov S.I., Fedorov A.V., Fedenko V.V. Technological aspects of endoscopic surgery of the billiary tract. Annals of Surgical Hepatology. 1996; 1: 115-119 [In Russ].

22.   Nikulenkov S. Yu., Belkov A.V., Efimkin A.C. Endoscopic obliteration of the gallbladder in patients with acute cholecystitis with high operativ risk. Endoscopic Surgery. 1998; 1: 34 [In Russ].

 

 

 

Abstract:

Article presents the results of analysis of risk factors associated with early stent thrombosis after percutaneous coronary intervention (PCI) ir patients with acute myocardial infarction (AMI). The study is designed as an observational cohort study prospectively including 140 patients with a PCI treated AMI admitted to our hospital. Patients were divided into two groups: with and without type 2 diabetes rnellitus (DM). A number of early stent thrombosis risk factors including a complete or not complete revascularization and myocardial blush grade during PCI, based on the predictive model were analyzed. The results of the study show that DM in patients with AMI who underwent PCI was not associated with a high risk of early stent thrombosis, however, incomplete revascularization was.

 

References

1.     Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005; 293: 2126-2130.

2.     McFadden E. P., Stabile E., Regar E., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004; 364: 1519-21.

3.     Virmani R., Guagliumi G., Farb A., et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004; 109: 701-5.

4.     Keith A.A., Philippe Gabriel Steg., Kim A. Eagle, et al. For the GRACE investigators decline in rates of death and heart failure in acute coronary syndromes. JAMA. 2007; 297: 1892-1900.

5.     Iakovou I., Schmidt T., Bonizzoni E., Ge L. et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005; 293(17): 2126-30.

6.     Carr M. E. Diabetes mellitus: a hypercoagulable state. J. Diabetes Complications. 2001; 15: 44-54.

7.     Georgios Sianos, Marie-AngMe Morel, Arie Pieter Kappetein The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. Eurolnterv. 2005; 1: 219-227.

8.     Petrosjan Ju S, Ioseliani D G. O summarnoj ocenke sostojanija koronarnogo rusla u bol'nyh ishemicheskoj bolezn'ju serdca. [Complex estimation of coronary arteries condition in patients with CAD.]. Kardiologija. 1976; 12(16): 41-46 [In Russ].

9.     Svilaas T. Thrombus aspiration during primary percutaneous coronary intervention. N. Engl. J. Med. 2008; 358: 557.

10.   Mauri L., Hsieh W., Massaro J. M. et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N. Engl. J. Med. 2007; 356: 1020-9.

11.   Rebrova O. Ju. Statisticheskij analiz medicinskih dannyh. [Statistic analysis of medical data]. Izd. Media Sfera. Moskva. 2003 [In Russ].

12.   Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41.

13.   Norhammar A., Malmberg K., et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J. Am. Coll. Cardiol. 2004; 43(4): 585-91.

14.   Haim D. Danenberg, Greghana Marincheva, Boris Varshitzki, Hisham Nassar, Chaim Lotan Stent Thrombosis: A Poor Man's Disease? IMAJ. 2009; 11: 529-532.

15.   Isaac Moscoso, Lazaro Claudiovino Garcia, Gilvan Oliveira Dourado, et al. Influence of Diabetes Mellitus on Immediate Results of Coronary Stent: NationalCenter for Cardiovascular Interventions (CENIC) Data Analysis Arquivos Brasileiros de Cardiologia. 2008; 86: 24-35.

16.   Aoki J., Lansky A. J., Mehran R. et al. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circulation. Febr. 10, 2009; 119(5): 687-98.

17.   Shaw R. E., Anderson. V., Brindis R.G. Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) Experience: 1998-2000. J. Am. Coll. Cardiol. 2002; 39: 1104-12.

 

Abstract:

Methods of beam diagnostics play an important role in examination of patients with dental anomalies. Reliably establish dental anomaly is possible due to radiological examination. However, according to orthopantomography not always possible to identify the true cause of the anomaly, correct localization of abnormal tooth, preservation of periodontal ligament. All this leads to an incorrect treatment planning and the occurance of complications; in this regard all of our patients underwent addition cone-beam computed tomography Under our observation were 60 patients aged 15-30 years with a complex form anomaly of the position and the eruption of teeth. Half of patients had an anomaly of upper canines, remaining patients, the anomaly of upper premolars, canines and premolars in the mandible. The main cause of anomalies of teeth was due to lack of space in the dentition, less abnormalities were associated with the presence of obstacles in the way of the eruption, with congenital abnormalities of the maxillofacial region.

Possibilities of orthodontic and surgical interventions are limited and therefore it is very important accurate and reliable diagnosis of abnormalities. Cone-beam computed tomography allows to obtain all necessary information about the position of the tooth in the bone, its structure, shape, spatial relationship with roots of adjacent teeth and important anatomic structures, which makes it possible to properly plan for the further treatment strategy and reduce the risk of possible complications.

 

References

1.     Persii L.S. Vidy zubocheljustnyh anomalij i ih klassificirovanie. [Types of dentoalveolar anomalies and their classification]. M.: MGMSU. 2002: 32 [In Russ].

2.     Uiljam R. Profit. Sovremennaja ortodontija. Per. s angl. jaz.: (Pod red. Persina L.S.) [Contemporary orthodontics] M.: MEDpress-inform, 2006; 95-123 [In Russ].

3.     Horoshilkina FJa. Ortodontija. Defekty zubov, zubnyh rjadov, anomalii prikusa, morfofunkcional'nye narushenija v cheljustno-licevoj oblasti i ih kompleksnoe lechenie [The defects of teeth, dentition, abnormal bite, morpho-functional disorders in the maxillofacial region, and their combined treatment]. M.: Medicinskoe informacionnoe agentstvo. 2006: 544 [In Russ].

4.     Shuk Mazen. Kliniko-rentgenologicheskaja diagnostika i apparaturno-hirurgicheskoe lechenie retencii klykov [Clinical and radiographic diagnosis and surgical treatment for hardware-retention canines]:Avtoref. Dis. kand. med. Nauk [thesis PhD] Tver'. 2004: 102 [In Russ].

5.     Flint, DJ. A diagnostic comparison of panoramic and intraoral radiographs. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1998; 85(6): 731-5.

6.     Vasil'ev AJu., Vorob'ev Ju.I., Serova N.S. Luchevaja diagnostika v stomatologii [Radiodiagnostics in dentistry.] M.: GJeOTAR-Media. 2008: 201-220 [In Russ].

7.     Minjaeva V.A. Posledstvija rannej utraty zubov u detej bez zamewenija defektov ortopedicheskimi apparatami [The consequences of early loss of teeth in children without defects in replacement orthopedic devices]. Stomatologija detskogo vozrasta i profilaktika. 2003; 1(2): 61-64 [In Russ].

8.     Sergeeva L.B. Peremewenie treh retinirovannyh klykov v zubnoj rjad s pomowju nesemnoj ortodon gicheskoj tehnikoj [Moving the three impacted canine tooth in the series with non-removable orthodontic appliances]. Ortodontija. 2001; 3: 40-41. [In Russ].

9.     Fridrih A. Pasler, Hajko Vissler. Rentgenodiagnostika v praktike stomaloga. Per. s nem. jaz. (Pod red. Rabuhinoj N.A.) [X-ray diagnostics in the practice of stomaloga. (Translated from German. lang. (Eds. Rabuhinoy NA)] M.: MED- press-inform. 2007: 118-131 [In Russ].

10.   Chaushu S. The use of panoramic radiographs to localize displaced maxillary canines. Oral Surg.Oral Med. Oral Pathol. Oral Radiol. Endod. 1999; 88(4): 511-516.

11.   Garcia M.A.S., Wolf U., Heinicke F. Cone-beam computed tomography for routine orthodontic treatment planning: A radiation dose evaluation. American Journal ofOrthodontics and Dentofacial (Orthopedics. 2008; 133(5): 640.e1-640.e5.

12.   Haney E., Gansky S.A., Lee J.S. et al. Comparative analysis of traditional radiographs and cone-beam computed tomography volumetric images in the diagnosis and treatment planning of maxillary impacted canines. American Journal of Orthodontics and Dentofacial Orthopedics. 2010; 137(5): 590-597.

13.   Volchek D.A. Sovremennye metody obsledovanija pacientov s retenciej klykov verhnej cheljusti [Modern methods of examination of patients with retentions canines of the upper jaw.] Ortodontija. 2006; 1: 24-26 [In Russ].

14.   Chibisova M.A. Algoritmy obsledovanija pacientov pri primenenie dental'noj ob#emnoj tomografii v ambulatornoj stomatologicheskoj praktike [Algorithms for evaluation of patients with the use of dental volumetric imaging in ambulatory dental practice]. Dental Market. 2010; 76-78 [In Russ].

15.   Danforth R.A. Cone beam volume tomography: an imaging option for diagnosis of complex mandibular third molar anatomical relationships. J. Calif. Dent Assoc. 2003; 31(11): 847- 852.

16.   Dodson T.B. Role of computerized tomography in management of impacted mandibular third molars. NY State Dent. J. 2005; 71(6): 32-35.

17.   Mah J.K., Alexandroni S. Cone-Beam Computed Tomography in the Management of Impacted Canines. Seminars in Orthodontics. 2010; 16(3): 199-204.

authors: 

 

Abstract:

Aim. For determination of Alzheimer's disease (AD) stages, we offer a morphologically determined scale - The Tomography Dementia Rating scale (TDR) based on the severity of atrophic changes in the temporal lobes of the brain revealed during CT and MRI. Materials and methods. The research involved 140 patients aged 28-79. The Test Group included 81 patients aged 34-79 with AD various stages. The Control Group included 59 patients aged 28-78 with various types of brain lesions accompanied by manifestations of dementia and cognitive impairment, but not suffering from AD.

Results. CT and MRI data allowed to compose the TDR scale determining the severity of atrophic changes in the temporal lobes at each AD stage:

•          Pre-clinical AD stage TDR-0: temporal lobes atrophy with 4-8% tissue mass decrease (26-28 MMSE points).

•          Early AD stage - mild dementia TDR-1: temporal lobes atrophy with 9-18% tissue mass decrease (corresponds to CDR-1; 20-25 MMSE points).

•          Middle AD stage - mild dementia TDR-2: temporal lobes atrophy with 19-32% tissue mass decrease (corresponds to CDR-2; 12-19 MMSE points). 

 

References

1.     Alzheimer’s Disease Facts and Figures, 2007. A Statistical Abstract of US Data on Alzheimer’s Disease published by the Alzheimer’s Association http://www.alz.org/national/documents/Report_2007FactsAndFigures.pdf.

2.     Alzheimer’s Disease Facts and Figures 2009 Alzheimer’s Association. http://www.alz.org/national/documents/report_alzfactsfigures2009.pdf.

3.     Alzheimer's Disease Facts and Figures

3.     2010 Alzheimer’s Association. http://www.alz.org/ documents_custom/report_alzfactsfigures2010.pdf.

4.     2011 Alzheimer’s Disease Facts and Figures. http://www.alz.org/downloads/facts_figures_2011.pdf.

5.     Generation Alzheimer’s: The Defining Disease of the Baby Boomers http://act.alz.org/site/Doc-Server/ALZ_BoomersReport.pdf/docID=521.

6.     Jun G., Naj F.C., Beecham G.W., et al. Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch. Neurol. 2010; 67 (12):1473-1484.

7.     Saykin A.J, Wishart H.A. Mild cognitive impairment: conceptual issues and structural and functional brain correlates. Seminars in Clinical. Neuropsychiatry. 2003; 8 (1): 12-30.

8.     Saykin A.J., Wishart H.A., Rabin L.A., et all. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology. 2006; 12 No. 67 (2): 834-842.

9.     Shen L., Fipri H.A., Saykin AJ.,West J.D. Parametric surface modeling and registration for comparison of manual and automated segmentation of the hippocampus. Hippocampus. 2009; 19 (6): 588-595.

10.   Maksimovich I.V. Vozmoznosti covremennoy kompiuternoy tomografii v diagnostike bolezni Alzheimra.[Possibilities of computed tomography in diagnostics of Alzheimer’s diseases.] Nevrologicheskiy vestnik .2009; 1: 5-10 [In Russ].

29.   Maksimovich I.V. Dyscirculatory Angiopathy of the Brain of Alzheimer's Type. Eurointerventional. 2011; 7: M 253.

30.   Maksimovich I.V. Endovascular Application of Low-Energy Laser in the Treatment of Dyscirculatory Angiopathy of Alzheimer’s Type. Journal of Behavioral and Brain Science. 2012; 2 (1): 67-81.

11.   Mayeux R., Reitz C., Brickman A.M., Haan M.N., Manly J.J. et. all. “Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment. Part 1. Alzheimers & Dementia. 2011; 7 (1): 15-34.

12.   Seashadri S., Beaser A., Au R., Volf P.A., Evans D.A. et.al. Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment. Part 2. Alzheimers & Dementia. 2011; 7 (I): 35-52.

13.   2012 Alzheimer’s Disease Facts and Figures. http://www.alz.org/downloads/facts_figures_2012.pd.

14.   National Plan to Address Alzheimer's Disease http: / /www.whitehouse.gov/ blog/2012/05/17/national-plan-address- alzheimers-disease.

15.   Morris J.C. The clinical dementia rating (CDR): current version and scoring rule. Neurology. 1993; 43 (II):2412-2414.

16.   Maksimovich I.V. Gotman L.N. Sposob kompleksnoy luchevoy diagnostiki doklinicheskih I klinicheskih stadiy bolezni Alzheimera. [Method of complex beam-diagnostics of subclinical and clinicas stages of Alzheimer’s disease.] Russian patent, №. 2315559 [In Russ].

17.   Maksimovich I.V., Gotman L.N., Masiuk S.M. Sposob opredelenia razmera visochnich doley golovnogo mozga pri bolezni Alzheimera [Measuring the size of the temporal lobes in patients with Alzheimer's disease] Russian patent № 2306102 [In Russ].

18.   Maksimovich I.V. Luchevaia diagnostika bolezni Alzheimera. [Beam-diagnostics of Alzheimer’s disease.] Diagnosticheskaia i intervencionnaia radiologia [Diagnostic and interventional radiology. ]. 2008; 2 (4): 27-38 [In Russ].

19.   Maksimovich I.V. Dyscirculatory Angiopathy of Alzheimer's Type. Journal of Behavioral and Brain Science. 2011; 1 (2): 57-68.

20.   Dickerson B.C. Functional magnetic resonance imaging of cholinergic modulation in mild cognitive impairment. Current Opinion in Psychiatry. 2006; 19: 299-306.

21.   Chiang G.C., Insel Ph.S, Tosun D., Schuff N., Truran-Sacrey D., Raptentsetsang S., Jack C.R., Weiner M.W. Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes. Radiolog. 2011; 259 (3): 844-51.

22.   Schuff N., Insel Ph., Chiang G., Truran D, Gamst A., Jack C., Aisen P., Petersen R., Shaw L., Trojanowski J., Weiner M. Acceleration of brain atrophy rates with advancing cognitive deterioration from normal aging to MCI to Alzheimer's disease. J. Alzheimer's &Dementia. 2011; 7 (4): S223.

23.   Trojanowski J.Q., Vandeerstichele H., KoreckaM., et all. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimer's & Dementi. 2010; 6 (3): 230-238.

24.   Meyer P.T., Hellwig S., Amtage F., et al. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B. J. Nucl. Med. 2011; 52 (3): 393-400.

25.   Perrin R.J., Craig-Schapiro R., Morris J.C., et al. Identification and validation of novelcerebrospinal fluid biomarkers for staging early Alzheimer's disease. Public Library of Science On. 2011; 12 (6): e16032.

26.   Jack C., Vemuri P., Viste H., et al. Ordering of Alzheimer's disease biomarkers. Alzheimer's & Dementia. 2011; 7 (4): S4-S5.

27.   Mayeux R., Reitz C., Brickman A.M., Haan M.N., ManlyJ.J. et. al. Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment. Part 1. Alzheimers & Dementia. 2011; 7 (1): 15-34.

28.   Folstein M.F., Folstein S.E., McHugh P.R. Minimental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975; 12 (3): 189-98.

29.   Maksimovich I.V. Dyscirculatory Angiopathy of the Brain of Alzheimer's Type. Eurointerventional. 2011; 7: M 253.

30.   Maksimovich I.V. Endovascular Application of Low-Energy Laser in the Treatment of Dyscirculatory Angiopathy of Alzheimer’s Type. Journal of Behavioral and Brain Science. 2012; 2 (1): 67-81. 

 

Abstract:

Results of minimal invasive percutaneus drainage interventions under US-control in 45 children, aged 1-4 years with intraabdominal abscesses of different genesis are presented. Intraabdominal abscesses were identified as subdiaphragmatic (16), intrafilar (22) and pelvic (19). Difference between US-characteristics of intraabdominal abscesses, preoperative planning peculiarities and interventional technologies, that depend on localization of abscesses are presented.

The usage of 3D-echography results data in 13,3% of children increased the value of diagnostics: for optimization of surgical approach, kind and volume of intervention.

Percutaneus drainage intervention under ultrasound control is effective and non-traumatic method of treatment. 

 

    References

1.     Libov S.L. Localised peritonitis in children L., Medicina. 1983:184 [In Russ].

2.     Evdokimova E.Ju. US diagnostic and therapeutic nterventions in patients with postoperative inflammatory outcomes. Abstract of dissertation for the degree «Doctor of Philosophy». Krasnojarsk. 2003: 298[In Russ].

3.     Barsukov M.G. Transcutaneus US-guided draining of abdominal cavity abscesses. Abstract of dissertation for the degree «Doctor of Philosophy». Moskva. 2003: 29 [In Russ].

4.     Judin Ja.B., Prokopenko, Ju.D., Fedorov, K.K., Gabinskaja T.A. Ostryj appendicit u detej Acute appendicitis in children. M.: Medicina. 1998: 256 [In Russ].

5.     Witinin V.E. Localised peritonitis of appendicular genesis in children. Hirurgija 1980; 7: 12-16 [In Russ].

6.     Dvorjakovskij I.V., Beljaeva O.A. US diagnostics in pediatric surgery. M., Profit. 1997: 243 [In Russ].

7.     Beljaeva O.A., Lotov A.N., Musaev G.H., Rozinov V.M. US-guided mini-invasive interventions in children with urgent abdominal patology. Manual for physicians. M.: ANMI. 2002: 25 [In Russ].

8.     Pediatric surgery: national guidance. M.: «GJeOTAR-Media». 2009: 1168 [In Russ].

9.     Vajner Ju.S., Egorov A.B., Vardosanidze V.K. Treatment of abdominal cavity’ abscesses with the help of US-guided mini-invasive interventions. Scientific-practical conference «Transcutaneus and endoscopic interventions in surgery»: abstracts. Moskva. 2010: 48-49 [In Russ].

10.   Shulutko A.M., Nasirov F.N., Natroshvili A.G. Possibilities of US in diagnostics and treatment of abdominal cavity’ abscesses. Scientific-practical conference «Transcutaneus and endoscopic interventions in surgery»: abstracts. Moskva. 2010: 91-92 [In Russ].

11.   Kulezneva Ju.V., Izrailov R.E., Lemeshko Z.A. US in deiagnostics and treatment of acute appendicitis. Moskva: «GJeOTAR-Media». 2009: 72 [In Russ].

12.   Grigovich I.N., Derbenev V.V., Leuhin M.V. Vise conservatism in urgent pediatric surgery. Rossijskij vestnik detskoj hirurgii, anesteziologii i reanimatologii. 2011; 4: 16-19 [In Russ].

 

 

 

Abstract:

Article is devoted to the analysis of life, scientific and practical activities of professor Leonid Semenovich Zingerman - one of pioneers in diagnostic and interventional radiology in Russia, the founder of scientific and practical school in the sphere of diagnostic and interventional radiology in urgent situations. The article shows the role of professor Zingerman in development of radiological and diagnostic interventions in cardiac surgery neurosurgery, abdominal surgery and gynecology on the base of Bakoulev Scientific Center for Cardiovascular Surgery (1958-1977) and Scientific and Research Institute of emergency medicine (1977-1992).


 

Abstract:

Traumatic lesions of peripheral arteries which lead to pseudoaneurysm formation is the rare pathology Originally surgical treatment was the main method of pseudoaneurysms' treatment. However, now endovascular procedures are preferable as a method such patients' treatment. The case of successful endovascular treatment of posttraumatic pseudoaneurysm of subclavian artery with stent-graft implantation is shown This clinical case report demonstrates main advantages of endovascular method of such location pseudoaneurysms treatment.

 

 

 

Abstract:

We have developed and assessed effectiveness of principles of planning a trajectory for the fine-needle aspiration biopsy of splenic focal lesions due to data of three-dimensional imaging. It is shown that the choice of fine-needle puncture trajectory for access of splenic focal lesions due to three-dimensional data allows to reach optimum combination of security, and informativeness of aspiration biopsy.

 

Reference 

1.       Karaguljan S.R., Grzhimoloyskij A.V., Danishjan K.I. Hirurgicheskie dostupyk selezenke [Surgical access to the spleen]. Amnaby hirurgichsskoj gepatologii. 2006; 11(2): 92-99 [In Russ].

2.       Greschus S., Hackstein N., Puille M.F., Discher T., Rau WS. Extensive abdominal splenosis: imaging features. Abdom. Imaging. 2003; 28(6): 866-7.

3.       Usol'cevJu. K. Atipichnaja rezekcija selezenki. Diss. . k.m.n. [Atypical resection of the spleen]. Irkutsk. 1998: 129 [In Russ].

4.       Harnas S.S., Lotov A.N., Kondrashin S.A. Lecheniepacientov s neparazitarny mikistami selezenki. [Treatment of patients with non-parasitic cysts of the spleen]. Annaly hirurgicheskoj gepatologii. 2008; 13( 2): 36-43 [In Russ].

5.       Napoli A., Catalano C., Silecchia G., Fabiano P., Fraioli F., Pediconi F., Venditti F., Basso N.,Passariello R. Laparoscopic splenectomy: multidetector row CT for preoperative evaluation. Radiology. 2004; 232(2): 361.

6.       Lal A., Ariga R., Gattuso P., Nemcek A.A., Nayar R. Splenic fine needle aspiration and core biopsy. A review of 49 cases. Acta. Cytol. 2003; 47(6):

7.       Cigel'nik A.M., Moshneguc S.V. Trehmernaja vizualizacija v predoperacionnom planirovanii laparoskopicheskoj splenjektomii. [Three-dimensional imaging in the preoperative planning for laparoscopic splenectomy]. Medicinskaja vizualizacija. 2006; 6: 122-125 [In Russ].

8.       Xu W.L., Li S.L., Wang Y., Li M., Niu A.G. Role of color Doppler flow imaging in applicable anatomy of spleen vessels. World J. Gastroenterol. 2009; 15(5): 607-11.

 

 

Abstract:

We present the clinical case of the effective and safe application of the «Filterwire EZ» embolic protection device (Boston Scientific, USA) for prevention of «no-reflow» phenomenon during primary percutaneous coronary angioplasty in a patient with acute myocardial infarction.

During performing of balloon angioplasty of infarct-related segment of the circumflex left coronary artery with the protection of the distal segments of artery by «Filterwire EZ» device the embolic event was observed. After the final stent implantation the thrombus was removed by embolic protection device, size of the thrombus - 3x4 mm. Control coronarography confirmed the TIMI 3 blood flow in the infarct-related coronary artery.

Presence of different types of devices for capturing or removing of thrombotic masses in the arsenal of interventional cardiologist can improve the results of primary percutaneous coronary angioplasty in patients with acute myocardial infarction. 

 

References 

1.     Jerlih A.D., Gracianskij N.A. i uchastniki registra REKORD. Nezavisimyj registr ostryh koronarnyh sindromov REKORD. Harakteristika bol'nyh i lechenie do vypiski iz stacionara. Aterotromboz 2009; 1: 105-119 [In Russ].

2.     Jerlih A.D., Gracianskij N.A. i uchastniki registra REKORD. Lechenie bol'nyh s ostrym koronarnym sindromom s pod#emom ST v stacionarah imejuwih i ne imejuwih vozmozhnosti vypolnenija chreskozhnyh koronarnyh vmeshatel'stv (dannye registra «REKORD»). Aterotromboz. 2009; 1: 120-122 [In Russ].

3.     Jerlih A.D., Gracianskij N.A. ot imeni uchastnikov registra REKORD. Registr ostryh koronarnyh sindromov REKORD. Harakteristika bol'nyh i lechenie do vypiski iz stacionara. Kardiologija. 2009; 7: 4-12 [In Russ].

4.     Anderson J.L., Adams C.D., Antman E.M. et al. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction — executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction). J. Am. Coll. Cardiol. 2007; 50: 652-726.

5.     Bhatt D.L., Roe M.T., Peterson E.D. et al. Utilization of early invasive management strategies for high-risk patients with non-ST segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004; 292: 2096-104.

6.     Birkhead J.S., Walker L., Pearson M. et al., on behalf of the MINAP Steering Group Improving care for patients with acute coronary syndromes: initial results from the National Audit of Myocardial Infarction Project (MINAP). Heart. 2004; 90: 1004-1009.

7.     Elbarouni B., Goodman S.G., Yan R.T. et al. on behalf of the Canadian Global Registry of Acute Coronary Events (GRACE/GRACE2) Investigators. Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada. Am. Heart. J. 2009; 158: 392-399.

8.     Hasdai D., Behar S., Wallentin L. et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur. Heart. J. 2002; 23: 1190-1201

9.     Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with STsegment elevation acute myocardial infarction (ASSENT-4 PCI): randomized trial. Lancet. 2006; 367: 569-578.

10.   Gershlick A.H., Stephens-Lloyd A., Hughes S. et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N. Engl. J. Med. 2005; 353: 2758-2768.

11.   Kushner F.G., Hand M., Smith S.C. et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the  American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2009; 54: 2205-2241.

12.   Eeckhout E., Kern M.J. The coronary no-reflow phenomenon: a review of mechanisms and therapies. European. Heart. Journal. 2001; 22: 729-739.

13.   Van de WF, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation. Acute Myocardial Infarction of the European Society of Cardiology. Eur. Heart. J. 2008; 29: 2909-2945.

14.   Baim D.S., Braunwald E., Feit F., Knatterud G.L., Passarnani E.R., Robertson T.L., et al. The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: additional information and perspectives. J. Am. Coll. Cardiol. 1990; 15: 1188-1192.

15.   Leonardo Galiuto, Antonio G. Rebuzzi, Filippo Crea. The no-reflow phenomenon. JACC. 2009; 2(1): 85-86.

16.   Rogers W.J., Baim D.S., Gore J.M., Brown B.G., Roberts R., Williams D.O., et al. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation. 1990; 81: 1457-1476.

17.   Hori M., Inoue M., Kitakaze M. et al. Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am. J. Physiol. 1986; 250: 509-518.

18.   Tanaka A. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation. 2002; 105: 2148-2152.

19.   Henriques J., Zijlstra F., Ottervanger J. et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur. Heart. J. 2002; 23: 1112-1117.

20.   Karila-Cohen D., Czitrom D., Brochet E. et al. Decreased no-reflow in patients with anterior myocardial infarction and pre-infarction angina. Eur. Heart. J.1999; 20: 1724-1730.

Modern approaches to diagnostic and treatment of vasorenal hypertension chapter III: perspective trends in endovascular interventions on renal arteries



DOI: https://doi.org/10.25512/DIR.2012.06.3.05

For quoting:
Zyatenkov A.V., Schutikhina I.V., Kokov L.S. "Modern approaches to diagnostic and treatment of vasorenal hypertension chapter III: perspective trends in endovascular interventions on renal arteries". Journal Diagnostic & interventional radiology. 2012; 6(3); 63-71.

 

Abstract:

Renal artery stenosis is a common condition that can cause renovascular hypertension or ischemic nephropathy. Endovascular treatment for atherosclerotic renal artery stenosis is performed frequently and its usage has rapidly increased during the last few years. However clinical benefit of renal artery stenting is questionable. Many researchers suppose that clinical outcomes after renal artery stenting may be improved. Several potential ways to this improvement is discussed: the evaluation of hemodinamical parameters of the stenosis, viability of the renal tissue, prophylactic of the atheroembolisation and restenosis. This article reviews the recent data concerning perspective trends in endovascular procedures on renal arteries that can improve long-term clinical outcomes after renal artery stenting. 

 

References 

1.     Wheatley K., Phil D., Ives N. Revascularization versus medical therapy for renal-artery stenosis. N. Engl. J. Med. 2009; 36: 1953 - 62.

2.     Textor S. Despite results from ASTRAL, jury still out on stenting for atherosclerotic renal artery stenosis. Nephrology. Times .2010; 3: 2-7.

3.     Kapoor N., Fahsah I., Karim R et al. Physiological assessment of renal artery stenosis: comparisons of resting with hyperemic renal pressure measurements. Catheter. Cardiovasc. Interv. 2010; 76(5): 726-32.

4.     Rundback J.H., Sacks D., Kent K.C., et al. Guidelines for the reporting of renal artery revascularization in clinical trials. American Heart Association. Circulation. 2002; 106: 1572-1585.

5.     Jones N., Bates E., Chetcuti S. Usefulness of tran- slesional pressure gradient and pharmacological provocation for the assessment of intermediate renal artery disease. Catheter. Cardiovasc. Interv. 2006; 68(3): 429-34.

6.     Mitchell J., Subramanian R., White C. et al. Predicting blood pressure improvement in hypertensive patients after renal artery stent placement: renal fractional flow reserve. Catheter. Cardiovasc. Interv. 2007; 69(5):685-9.

7.     Kadziela J., Witkowski A., Januszewicz A. Assessment of renal artery stenosis using both resting pressures ratio and fractional flow reserve: relationship to angiography and ultrasonography. BloodPress. 2011; 20(4): 211-7.

8.     Drieghe B., Madaric J., Sarno G. et al. Assessment of renal artery stenosis: side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements. European. Heart. Journal. 2007; 29 (4): 517-24.

9.     Subramanian R., White C.J., Rosenfield K. et al. Renal fractional flow reserve: a hemodynamic evaluation of moderate renal artery stenoses. Catheter. Cardiovasc. Interv. 2005; 64: 480-486.

10.   Leesar M., Varma J., Shapira A. Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. J. Am. Coll. Cardiol. 2009; 53(25): 2363-71.

11.   Radermacher J., Chavan A., Bleck J. et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N. Engl. J. Med. 2001; 344: 410-417.

12.   Doi Y., Iwashima Y., Yoshihara F. Et al. Renal resistive index and cardiovascular and renal outcomes in essential hypertension. Hypertension. 2012; Jul 23. Epub ahead of print.

13.   Zeller T., Ulrich F., Mflller C., Bbrgelin K., Sinn L. Angioplasty of severe atherosclerotic ostial renal artery stenosis: predictors of improved renal function after percutaneous stent-supported intervention. Circulation 2003; 108: 2244-2249.

14.   Liew Y., Bartholomew J. Atheromatous embolization. hsc. Med. 2005; 10: 309-326.

15.   Holden A. Is there an indication for embolic protection in renal artery intervention? Tech. Vasc. Interv. Radiol. 2011; 14(2): 95-100.

16.   Rocha-Singh K., Eisenhauer A.,Textor S. Atherosclerotic peripheral vascular disease symposium II: intervention for renal artery disease. Circulation. 2008; 118: 2873-2878.

17.   Feldman R., Wargovich T., Bittl J. No-touch technique for reducing aortic wall trauma during renal artery stenting. Catheter. Cardiovasc. Interv. 1999; 46(2): 245-8.

18.   Kolluri R., Goldstein J., Rocha-Singh K. Percutaneous vascular interventions in renal artery diseases. Minerva. Cardioangiol. 2006; 54: 95-107.

19.   Hiramoto J., Hansen K., Pan X. Atheroemboli during renal artery angioplasty: an ex vivo study. J. Vhsc. Surg. 2005; 41(6): 1026-30.

20.   Holden A., Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. Journal Vascular. Surgery. 2003; 38: 962-968.

21.   Perkovic V., Thomson K., Mitchell P. et al. Treatment of renovascular disease with percutaneous stent insertion: long-term outcomes. Austral. Radiol. 2001; 45: 438-43.

22.   Paulsen D., Klow N., Rogstad B. et al. Preservation of renal function by percutaneous transluminal angioplasty in ischaemic renal disease. Nephrol. Dial Transplant. 1999; 14: 1454-61.

23.   Leertouwer T., Gussenhoven E., Bosch J. et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology. 2000; 216: 78-85.

24.   Vignali C., Bargellini I., Lazzereschi M. et al. Predictive factors of in-stent restenosis in renal artery stenting: a retrospective analysis. Cardiovasc. Intervent. Radiol. 2005; 28: 296-302.

25.   Corriere M., Edwards M., Pearce J. et al. Restenosis after renal artery angioplasty and stenting: incidence and risk factors. J. Vasc. Surg. 2009; 50(4): 813-819.

26.   Leertouwer T., Gussenhoven E., van Overhagen H. et al. Stent placement for treatment of renal artery stenosis guided by intravascular ultrasound. J. Vasc. Interv. Radiol. 1998; 9: 945-952.

27.   Zeller T., Rastan A., Rothenpieler U. et al. Restenosis after stenting of atherosclerotic renal artery stenosis: is there a rationale for the use of drug-eluting stents? Catheter. Cardiovasc. Interv. 2006; 68(1): 125-30.

28.   Sapoval M., Zghringer M., Pattynama P. et al. Low- profile stent system for treatment of atherosclerotic renal artery stenosis: the GREAT trial. J. Vasc. Intern Radiol. 2005; 16(9): 1195-202.

Percutaneous transhepatic puncture cholangiostomy: systematization ideas



DOI: https://doi.org/10.25512/DIR.2012.06.3.04

For quoting:
Dolgushin B.I., Nechipay A.M., Kukushkin A.V., Hachaturov A.A. "Percutaneous transhepatic puncture cholangiostomy: systematization ideas". Journal Diagnostic & interventional radiology. 2012; 6(3); 31-60.

 

Abstract:

The article makes an attempt to summarise variants of the PTBD that allows to change perceptions of this procedure as it is not a simple method as it seems in routine usage. A meaningful and reasonable use of PTBD combined with all modern technical possibilities in interventional radiology and professional personnel potential can significantly expand the scope of application for this technology and allows by using «small means» to deal with complicated clinical cases, optimizing the conditions for effective hi-tech medical support. Reducing PTBD options to the «common denominator» can optimize it's planning and accounting, can improve the quality and efficiency and can facilitate the clinical and scientific analysis of the results.

 

References 

1.     Remolar J., Katz S., Rybak B., et al: Percutaneous transhepatic cholangiography. Gastroenterology 1956; 31:39-46.

2.     Ivsin V.G., Jakunin A.Ju., Lukichev O.D. Chreskoghnie diagnosticheskie i ghelcheotvodjaschie vmeshatelsnva u bolnih mehanicheskoy gheltuhoy [Percutaneous diagnostic and zhelcheotvodyaschie intervention in patients with obstructive jaundice]. Tula, 2000; 312. [In Russ].

3.     Molnar W, Stockhum AE: Relief of obstructive jaundice through percutaneous transhepatic catheter - a new therapeutic method. AJR. 1974; 122: 356—367.

4.     Pereiras RV, Rheingold OJ, Huston D, et al: Relief of malignant obstructive jaundice by percutaneous insertion of a permanent prosthesis in the biliary tree. Ann. Intern. Med. 1978; 89: 589.

5.     Kukushkin A.V. Profilaktika i lechenie osloghneniy antegradnih rentgenoendobiliarnih vmeshatelstv u bolnih s mehanicheskoy gheltuhoy opuholevoy etiologii. [Prevention and treatment of complications of antegrade rentgenendobiliary interventions in patients with obstructive jaundice of tumor etiology.] Dissertacia kandidata medicinskih nauk, Moskva, 2005; 233 s. [In Russ].

6.     International classification of procedures in medicine. Volume 1 World Health Organization, Geneva, 1978.

7.     Cheng Y.E, Chen C.L., Huang T.L. Single imaging modality evaluation of living donors in liver transplantation: magnetic resonance imaging. Transplantation 2001; 15: 1527—1533.

8.     Couinaud C. Intrahepatic biliary ducts. In: Couinaud C (ed). Surgical anatomy of the liver revisited. Paris 1989; 61—74.

9.     Couinaud C. (translated by Nimura Y.) Couinaud’s surgical anatomy of the liver. Tokyo: Igaku Shoin 1996; 1.

10.   Gadzijev E.M., Ravnik D. Atlas of applied internal liver anatomy. Springer, Vienna New York Heidelberg Berlin Tokyo 1996.

11.   Healey J.E., Schroy PC. Anatomy of the biliary ducts within the human liver. Arch. Surg. 1953; 66: 599—616.

12.   Ishiyama S., Yamada Y., Narishima Y. et al. Surgical anatomy of the hilar bile duct carcinoma (in Japanese). Tan to Sui (J.Biliary Tract and Pancreas) 1999; 20: 811—829.

13.   Kawarada Y., Das B.C., Onishi H. et al. Surgical anatomy of the bile duct branches of the medial segment (B4) of the liver in relation to hilar carcinoma. J Hepatobiliary Pancreat Surg. 2000; 7: 480—485.

14.   Kawarada Y., Das B.C., Taoka H. Anatomy of the hepatic hilar area: the plate system. J. Hepatobiliary Pancreat. Surg (2000); 7: 580—586.

15.   Kida H., Uchimura M., Okamoto K. Intrahepatic architecture of bile and portal vein (inJapanese). Tan to Sui (J Biliary Tract and Pancreas) 1987; 8: 1—7.

16.   Mizumoto R., Suzuki H. Surgical anatomy of the hepatic hilum with special reference to the caudate lobe. World J. Surg. 1988; 12: 2—10.

17.   Nimura Y., Hayakawa N., Kamiya J. Clinical significance of selective cholangiography from the viewpoint of liver segment concept. Shokakibyo Gaku no Saikin no Shinpo. Tokyo 1986; 35—36.

18.   Smadja C., Blumgart L.H. The biliary tract and the anatomy of biliary exposure. In: Blumgart L.H., ed. Surgery of the liver and biliary tract; 2nd ed. Edinburgh: Churchill Livingstone 1994; 1: 11—24.

19.   Semenkov A.V., Bekbauov S.A., Eilin A.V. Anatomiya vnutripechenochnih ghelchnih protokov, variantnost stroeniya [Anatomy of the intrahepatic bile ducts, the variability of the structure]. Hirurgiya, 2009, 8, 67—72 [in russ].

20.   Wong J.H., Krippaehne W.W., Elechter W.S. Percutaneous transhepatic biliary decompression: results and complication in 30 patients. Am. J. Surg. 1984; 147: 615—617.

21.   Berquist T.H., May G.R., Johnson CM, Adson MA, Thistle J.L. Percutaneous biliary decompression: internal and external drainage in 50 patients. Am. J. Roentgenol. 1981; 136: 901—906.

22.   Clark RA, Mitehell SE, Colley DP, Alexander E: Percutaneous catheter biliary decompression. Am J. Roentgenol. 1981; 137:503—509.

23.   Eerucci J.T. Jr., Mueller PR., Harbin W.P.: Percutaneous transhepatic biliary drainage. Technique, results and applications. Radiology. 1980; 135: 1—13.

24.   Hamlin J. A., Friedman M., Stein M.G., Bray J.E: Percutaneous biliary drainage: complications of 188 consecutive catheterizations. Radiology. 1986; 158:199—202.

25.   Reimann J.E. Complications of percutaneous bile drainage. In: Classen, M., Geenen J., Kawai K.: Non surgical Biliary Drainage, Berlin: Springier. 1984; 29—35.

26.   Yee A.C.N., Ho Ch. S. Complications of percutaneous biliary drainage: benign vs. malignant diseases. AJR. 1987; 148: 1207—1209.

27.   Mueller PR., van Sonnenberg E., Eerrucci J.T. Jr.: Percutaneous biliary drainage. Technical and catheter related problems in 200 procedures. Am J. Roentgenol. 1982; 138:17—23.

28.   Passariello R., Rossi P., Simonetti G., Pavone P.: Cooperative study of percutaneous biliary drainage: statistical data on 731 patients. Radiology, in press, 1984.

29.   Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J. Surg.. 1982; 6: 3—12.

Performance evaluation of diagnostic methods for beam diagnostics for severe pelvis trauma



DOI: https://doi.org/10.25512/DIR.2012.06.3.03

For quoting:
Balitskaya N.V. "Performance evaluation of diagnostic methods for beam diagnostics for severe pelvis trauma". Journal Diagnostic & interventional radiology. 2012; 6(3); 19-26.
authors: 

 

Abstract:

Arm. In order to improve the quality of severe pelvis fractures' diagnostics, detection of pelvic organs' lesion, preoperative examination and monitoring of treatment, we have made a retrospective analysis of radiological data of 70 patients (46 males, 24 females) aged between 24 and 54 years who were treated in emergency departments of hospital.

Results. The diagnostic efficiency of X-rays for injuries of the pelvis in case of lesions of the acetabulum is less than MDCT (specificity - 70.4%, accuracy - 61.3%, sensitivity - 56.3%). At the same time, traditional X-rays should only be used to diagnose fractures without displacement and for the control of metal after the surgery It is established that multidetector CT is the method of choice and the first stage in the diagnosis of associated injuries and hidden pelvic fractures, and has the best indicators of diagnostic value (specificity - 69% accuracy - 95% predictive of a positive result - 90%).

Conclusion. It was established that radiography is a method of screening and monitoring of treatment in patients with injuries of the pelvic ring and acetabulum, and in the first place during the provision of urgent specialist care. However, existing X-ray examination methods are not sufficiently informative, particularly in the diagnosis of posterior half-ring damage and hip; early and complete radiodiagnostics of pelvic and intrapelvic organs' injures is the leader in terms of examination of patients. A differentiated approach to the assessment of individual semiotic signs of pelvic fractures with MSCT improves informative value not only from the standpoint of initial diagnostics, but also helps to predict possible complications.

 

References 

1.     Gumanenko E.K., Shapovalov V. M., Dulaev A.K., Dudykin A.V. Sovremennye podhody k lecheniju postradavshih s nestabil'nymi povrezhdenijami tazovogo kol'ca. [Current approaches to the treatment of patients with unstable pelvic ring injuries] Voenno-med. zhurnal. 2003; 4: 17. [In Russ].

2.     Ratnikov V.A. SYNGO-MR-tehnologija: metodika i vozmozhnosti vizualizacii organov brjushnoj polo- sti i taza na vysokopol'nom (1,5 T) magnitnom tomografe «MAGNETOM SYMPHONY» [SYNGO- MR-Technology: methodology and visualization of the abdomen and pelvis in the 1.5 T magnetic tomography «MAGNETOM SYMPHONY»]. ( V.A. Ratnikov, G.E. Trufanov, S.V. Serebrjakova). Materialy Nevskogo radiologicheskogo foruma «Iz buduwego v nastojawee». SPb, 2003; 343 [In Russ].

3.     Balogh Z., Voros E., Suveges G. Stent graft treatment of an external iliac artery injury associated with pelvic fracture. A case report. J. Borne Joint Surg. Am. 2003; 5: 919-922.

4.     Serebrjakova S.V. Spiral'naja komp'juternaja tomografija v diagnostike povrezhdenij vertluzhnoj vpadiny (S.V. Serebrjakova, V. M. Cheremisin, O. F. Pozdnjakova) [Spiral computed tomography in the diagnosis of acetabulum lesions]. Materialy Nevskogo radiologicheskogo foruma «Iz buduwego v nastojawee». SPb, 2003; 113-115 [In Russ].

5.     Djatlov M. M. Luchevaja diagnostika povrezhdenij tazovogo kol'ca v ostrom periode perelomov vert- luzhnoj vpadiny. [Radiological diagnosis of pelvic ring injuries in acute acetabular fractures]. Ortop., travm im Priorova 2003; 3: 72-74 [In Russ].

6.     Miller P. R, Moore P. S., Mansell E., Meredith J. W. С External fixation or arteriogram in bleeding pelvic fracture: initial therapy guided by. Clin. Imaging. 2003; 18(4): 533-536.

7.     Loberant N., Goldfeld M. A pitfall in triple contrast CT of penetrating trauma of the flank. Clin. Imaging. 2003; 27(5): 351-352.

8.     Tile M. Fracture of pelvis. The Rationale of operative Fracture Care. Spinger Verlag. 1987: 441.

 

 

Abstract:

Retained cotton foreign bodies (gossypibomas) after abdominal surgery are rare postoperative complication. However gossypiboma can be infected, that leads to pyogenic inflammation, sharply worsens the condition of the patient and requiring re-operation. In late postoperative period gossypibomas can simulate neoplasms of the abdominal cavity In connection with this, the detection of foreign bodies is actual diagnostic problem. MDCT is one of the most effective non-invasive methods in diagnostics of retained foreign bodies. Such diagnostics needs to be careful in examination of the patient's anamnesis and to know variants of computed tomography imaging. The use of radiopaque tags for marking surgical materials, probably, is the optimal solution of gossypiboma disgnostics' problem.

 

References

1.     Pessaux P., Msika S. Risk Factors for Postoperative Infectious Complications in Noncolorectal Abdominal Surgery. Arch Swrg. 2003; 138: 314-324.

2.     Whang G., Mogel G.T., Tsai J. et all. Left Behind: Unintentionally Retained Surgically Placed Foreign Bodies and How to Reduce Their Incidence Pictorial Review. AJR. 2009; 193: 79-89.

3.     Lauwers P.R, Van Hee R.H. Intraperitoneal gossypibomas: the need to count sponges. World J Surg. 2000; 24: 521-527.

4.     Manzella A., Filho P.B., Albuquerque E., et al. Imaging of Gossypibomas: Pictorial Review. AJR. 2009; 193: 94-101.

5.     Marcy P-Y., Hericord O., Novellas S. Lymph Node-Like Lesion of the Neck After Pharyngolaryngectomy. AJR. 2006; 187: 135-136.

6.     Dux M., Ganten M., Lubienski A. Retained surgical sponge with migration into the duodenum and persistent duodenal fistula. Eur Radiol. 2002; 12 : 74-77.

7.     Gonzalez-Ojeda A., Rodriguez-Alcantar D.A., Arenas-Marquez H., et al. Retained foreign bodies following intra-abdominal surgery. Hepatogastroenterology. 1999;.46 : 808-812.

8.     O'Connor A. R., Coakley F. Imaging of Retained Surgical Sponges in the Abdomen and Pelvis. AJR. 2003; 180: 481-489.

9.     Thurley P. D., Dhingsa R. Laparoscopic Cholecystectomy: Postoperative Imaging. AJR. 2008; 191: 794-801.

 

authors: 


 

Article exists only in Russian.

Abstract:

Pancreatic transcutaneous necrosectomy from postnecrotic cavities can be a mini-invasive methods of treatment. Such method leads to fast sanation of lesions and is objectivelly a good monitoring method of control.

Aim: was to demonstrate possibilities of transcutaneous pancreatic necrosectomy after spread anc infected pancreatic necrosis.

Results: one of the most illustrative cases of successful mini-invasive treatment of spread infected pancreatic necrosis using transcutaneous necrosectomy under combined control (ultrasound, X- ray and endoscopy) is presented

Conclusion: the use of mini-invasive surgical techniques such as percutaneous drainage under combined control is possbile for panreatic necroectomy in patients with spread infected pancreatic necrosis (necrotic parapancreatitis).  

 

References 

1.    Rossiyskoe obschestvo hirurgov, Assotsiatsiya gepa- topankreatobiliarnyih hirurgov stran SNG, Rossiyskoe obschestvo skoroy meditsinskoy pomoschi. Diagnostika i lechenie ostrogo pankreatita. (Rossiyskie klinic- heskie rekomendatsii) g. Sankt-Peterburg, 2014. (ssyilka:http://xn—9sbdbejx7bdduahou3a5d.xn-- p1ai/stranica-pravlenija/unkr/urgentnaja-abdominalnaja- hirurgija/nacionalnye-klinicheskie-rekomendaci-po-ostromu-pankreatitu.html [In Russ].

2.    KuleznyovaYu. V., MorozO. V., IzrailovR. E., SmirnovE. A., EgorovV. PChreskozhnyievmeshatelstvaprignoyno-nekroticheskih oslozhneniyahpankreonekroza. Annalyi hirurgicheskoy gepatologii. 2015; 2: 90 (ssyilka http://vidar.ru/ Article.asp?an=ASH_2015_2_90) [In Russ].

3.    Ivshin V.G., Ivshin M.V., Malafeev I.V., Yakunin A.Yu., Kremyanskiy M. A., Romanova N. N., Nikitchenko V.V. Originalnyie instrumentyii metodiki chreskozhnogo lecheniya bolnyih pankreonekrozom i rasprostranennyim parapankreatitom. Annalyi hirurgicheskoy pankreatologii. 2014; 19(1): 30-39. [In Russ].

4.    Andreev A. V., Ivshin V. G., Goltsov V. R. Lechenie infitsirovannogo pankreonekroza s pomoschyu miniinvazivnyih vmeshatelstv. Annalyi hirurgicheskoy gepatologii. 2015; 3: 110 (ssyilka http://vidar.ru/Article.asp?an=ASH_2015_ 3_110) [In Russ].

5.    Rogal M.L., Novikov S.V., Gyulasaryan S.G., Kuzmin A.M., Shlyahovskiy I.A., Bayramov R.Sh. Optimizatsiya etapov minimalno invazivnogo chreskozhnogo hirurgicheskogo lecheniya ostrogo pankreatita. Tezisyi s'ezda ROH Rostov- na-Donu. 2015, 1161-1162 [InRuss].

 

Abstract:

Aim: was to evaluate diagnostic significance of current methods of radiological diagnostics in examination of patients with Monckeberg's sclerosis of the femoral artery

Material and methods: lower limb arteries and femoral bone of patient with Monckeberg's sclerosis of the femoral artery, femoral neck pseudarthrosis, 8 cm lower limb shortening, Cushing syndrome, secondary steroid osteoporosis, diabetes, hypercorticism and hyperparathyroidism were examined before and after double staged treatment using methods of radiography, ultrasonography and multi-slice CT (MSCT).

Results: the study of the femoral artery using ultrasonography and MSCT, processing the data with special filter, indicated patent femoral artery lumen, structure of sclerotic middle coat of the artery similar to the bone structure (layer of lateral cortical plate, osteon layer and the layer of the medial cortical plates) and did not reveal sonographic «drop-out defects». Healing of the femoral neck pseudarthrosis and 5 cm femoral lengthening was achieved in the patient.

Conclusion: data obtained by MSCT and USD gave possibility to perform doubles-staged surgical intervention, to achieve healing of the femoral neck non-union and to lengthen the limb for 5 cm. 

 

References 

1.    Monckeberg J.G. Virchows Arch. (Pathol. Anat.). 1903; Bd. 171:141-167.

2.    Egorov I.V. Senil'nyi aortal'nyi stenoz: sovremennoe sostoianie problemy (k 110-letiiu publikatsii I.G. Menkeberga) [Senile aortic stenosis: current state of the problem (to the 100th anniversary of J.G. Monckeberg’s publication)]. Consilium Medicum. 2014; (1):17-23 [In Russ].

3.    Molitvoslovova N.A., Galstian G.R. Rol' distal'noi diabeticheskoi polineiropatii v razvitii mediakal'tsinoza u patsientov s sakharnym diabetom [The role of distal diabetic polyneuropathy in mediacalcinosis development in patients with diabetes mellitus]. Sakhar. diabet. 2012; (2):64-69 [In Russ].

4.    Sergoventsev A.A. Kal'tsinirovannyi aortal'nyi stenoz: itogi 15-letnego izucheniia v Rossii [Calcified aortic stenosis: results of 15-year studying in Russia]. Rus. med. zhurn. 2013; 27:1314-1319 [In Russ].

5.    Castling B., Bhatia S., Ahsan F. Menckeberg's arteriosclerosis: vascular calcification complicating microvascular surgery. Int J Oral Maxillofac Surg. 2015 Jan; 44(1):34-36.

6.    Sage AP, Tintut Y Demer LL. Regulatory mechanisms in vascular calcification. Nat Rev Cardiol. 2010 Sep;7(9): 528-36.

7.    Kurabayashi M.Vascular Calcification - Pathological Mechanism and Clinical Application - Role of vascular smooth muscle cells in vascular calcification. Clin Calcium. 2015 May; 25(5):661-669.

8.    Wu M., Rementer C., Giachelli C.M. Vascular Calcification: An Update on Mechanisms and Challenges in Treatment. Calcif Tissue Int. 2013; 93(4): 365-273.

9.    Persy V., D’Haese P. Vascular calcification and bone disease: the calcification paradox // Trends Mol. Med.- 2009.- Vol. 15 (9).- P 405-416;

10.  Tsai CW, Kuo CC, Hwang JJ. Menckeberg's sclerosis. Acta Clin Belg. 2010 Sep-Oct;65(5):361.

11.  Sagalovsky S. Bone remodeling: cellular-molecular biology and cytokine RANKL-RANK-Osteoprotegerin (OPG) system and growth factors. Crimean J. Exp. Clin. Med. 2013; 3 (1-2):36-44.

12.  Paccou J., Brazier M., Mentaverri R., Kamel S., Fardellone P, Massy Z.A. Vascular calcification in rheumatoid arthritis: prevalence, pathophysiological aspects and potential targets. Atherosclerosis. 2012; 224:283-290.

13.  Ando G., Tripodi R., Vizzari G., Trio O. Calcific Monckeberg's arteriosclerosis: an uncommon cause of radial access failure. Int J Cardiol. 2015 Mar 1;182:211-2.

14.  Bittencourt M.S. The Denser the Merrier? The Developing Story of Vascular Calcification. Circ Cardiovasc Imaging. 2016; Nov; 9(11).

15.  Vasuri F., Fittipaldi S., Pacilli A., Buzzi M., Pasquinelli G. The incidence and morphology of Monckeberg's medial calcification in banked vascular segments from a monocentric donor population. Cell Tissue Bank. 2016 Jun; 17(2):219-223.

16.  Micheletti R.G., Fishbein G.A., Currier J.S., Fishbein M.C. Menckeberg sclerosis revisited: a clarification of the histologic definition of Monckeberg sclerosis. Arch Pathol Lab Med. 2008 Jan; 132(1):43-7.

17.  Henaut L., Mentaverri R., Liabeuf S., Bargnoux A.S., Delanaye P, Cavalier Й., Cristol J.P, Massy Z., Kamel S. Groupe de Travail Biomarqueurs des Calcifications Vasculaires de la SFBC et de la Societe de Nephrologie.. Pathophysiological mechanisms of vascular calcification. Ann Biol Clin (Paris). 2015 May-Jun; 73(3):271-87.

18.  Top C., 3ankir Z., §ilit E., Silit E., Yildirim S., Danaci M. Monckeberg's sclerosis: an unusual presentation. Angiology. 2002; 53:483-486.

19.  Lanzer P, Boehm M.,Sorribas V., Thiriet M., Janzen J., Zeller T., St Hilaire C., Shanahan C. Medial vascular calcification revisited: review and perspectives. Eur Heart J. 2014 Jun 14; 35(23):1515-1525.

20.  Tahmasbi-Arashlow M., Barghan S., Kashtwari D., Nair M.K. Radiographic manifestations of Menckeb

Abstract:

Cardiovascular disease is a leading cause of mortality and morbidity in octogenarian patients. The number of such patients and the number of percutaneous coronary interventions are increasing.

Methods: literature report is based on data, searched in PubMed database, Elibrary, electronic catalog of the Russian State Library, published until January 2017.

Results: review showed reasons why this group of patients refers to high-risk patients. Also, we analyzed modern approaches to the treatment of such patients, significance of PCI, intraoperative factors affecting the outcome of treatment of patients with myocardial infarction.

Conclusion: worse results of PCI in elderly patients in comparison with younger group have multifactorial reasons. Different authors point on higher percent of comorbidity, and previous MI, worse cardiac function, higher iatrogenity Based on received data, we showed clinical problems in these patients, the solution of which would improve results of treatment of this group of challenging patients. 

 

References

1.     Mark Mather, Linda A. Jacobsen, and Kelvin M. Pollard. Aging in the United States. Population Bulletin 70, no. 2 (2015).

2.     Predpolozhitel'naja chislennost' naselenija Rossijskoj Federacii do 2030 goda. [Presumptive population of the Russian Federation until 2030]. Statisticheskij bjulleten'. Federal'naja sluzhba gosudarstvennoj statistiki. M., 2016 [In Russ].

3.     Roth, Gregory A. et al. «Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality.» The  New England journal of medicine 372.14(2015):1333-1341. PMC. Web. 9 Jan. 2017.

4.     Zdravoohranenie v Rossii 2015. [Healthcare in Russia 2015]. Statisticheskij sbornik. Federal'naja sluzhba gosudarstvennoj statistiki. M., 2015 [In Russ].

5.     Bogomolov A.N. Retrospektivnyj analiz rezul'tatov koronarnogo stentirovanija u bol'nyh pozhilogo i starcheskogo vozrasta. Dis. kand. med. nauk. [Retrospective analysis of coronary stenting in elderly and very elderly patients. Cand. of Dr. med. sci. diss]. SPb. 2013 [In Russ].

6.     Bauer T., Mollmann H., Weidinger F., Zeymer U., SeabraGomes R., Eberli F., Serruys P, Vahanian A., Silber S., Wijns W., Hochadel M., Nef H.M., Hamm C.W., Marco J., Gitt A.K. Predictors of hospital mortality in the elderly undergoing percutaneous coronary intervention for acute coronary syndromes and stable angina. Int J Cardiol. 2011; 151:164-169.

7.     Antonsen L., Jensen L.O., Terkelsen C.J., Tilsted H. H., Junker A., Maeng M., Hansen K.N., Lassen J.F., Thuesen L., Thayssen P Outcomes after primary percutaneous coronary intervention in octogenarians and nonagenarians with STsegment elevation myocardial infarction: from the Western Denmark heart registry. Catheter Cardiovasc Interv. 2013; 81:912-919.

8.     Daniel I. Bromage, Daniel A. Jones, Krishnaraj S. Rathod. Outcome of 1051 Octogenarian Patients With STSegment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Observational Cohort From the London Heart Attack Group. Journal of the American Heart Association. 2016;5:e003027.

9.     Caretta G., Passamonti E., Pedroni PN., Fadin B.M., Galeazzi G.L., Pirelli S. Outcomes and predictors of mortality among octogenarians and older with ST-segment elevation myocardial infarction treated with primary coronary angioplasty. Clin Cardiol. 2014; 37:9:523-529.

10.   Spoon D.B., Psaltis PJ., Singh M., et al. Trends in cause of death after percutaneous coronary intervention. Circulation. 2014; 129:1286-1294.

11.   Goch A., Misiewicz P, Rysz J., Banach M. The clinical manifestation of myocardial infarction in elderly patients. Clin Cardiol. 2009; 32:E46-E51

12.   Dangas G.D., Singh H.S. Primary percutaneous coronary intervention in octogenarians: navigate with caution. Heart. 2010; 96:813-814.

13.   Semitko S.P. Metody rentgenjendovaskuljarnoj hirurgii v lechenii ostrogo infarkta miokarda u bol'nyh starshego

Abstract:

Aim: was to estimate the expediency of one-time sanation of the gallbladder, performed under ultrasound control in patients with acute cholecystitis as a preoperative preparation.

Material and methods. For the period 2007-2016, 1365 sanations of the gallbladder were performed in 1289 patients with acute cholecystitis. In 1284 cases (94.1%), the manipulation was single-staged, performed under local anesthesia by echo-puncture needles, caliber of 17.5 G under ultrasound control by the "free hand" method or using a program of biopsy cursor, percutaneously transhepatic. Access was made through the hepatic parenchyma with a thickness of at least 10 mm. Results. Sanation of the gallbladder was effective in all 1365 cases. Repeated sanitation in a day was necessary in 76 patients. Cholecystectomy within the current hospitalization was performed ir 1132 of (87.8%) 1289 patients, in terms from 1 to 4 days after initial manipulation. The dislocation of the blocking gall-stone from the cervical region of the gallbladder into its lumen was made with a rigid 0.035" gidewire in order to restore cystic duct flow was effective in 122 cases (35.2%). Complications: subcapsular hematomas of the liver in the puncture zone - 4 (0.3%), bilomus of the gallbladder bed - 1 (0.07%), bleeding to the gallbladder lumen - 11 (0.8%) were treated conservatively. There were no lethal outcomes.

Conclusion: one-time sanation of gallbladder allows to decompress safely the gallbladder, to stop pain syndrome, to conduct a full pre-examination and preoperative preparation of patient and perform cholecystectomy in the most comfortable and safe conditions in a delayed or planned order. 

 

References

1.     Buyanov V.M., Ishutinov V.D., Zinyakova M.V., Titkova I.M. Ultrazvukovaya klassifikatsia ostrogo holetsistita. [Ultrasound classification of acute cholecystitis.] Vserossijskaja konferencija hirurgov: Tezisy dokladov. [Proc. Conf. Surgeons: All-Russian conference of surgeons: Tez. dokl]. Yessentuki. 1994; 51-52 [In Russ].

2.     Takada T., Strasberg S.M., Solomkin J.S., Pitt H.A., Gomi H., Yoshida M., Mayumi T., Miura F., Gouma D.J., Garden O.J., Bьchler M.W., Kiriyama S., Yokoe M., Kimura Y, Tsuyuguchi T., Itoi T., Gabata T., Higuchi R., Okamoto K., Hata J., Murata A., Kusachi S., Windsor J.A., Supe A.N., Lee S., Chen X.P., Yamashita Y, Hirata K., Inui K., Sumiyama Y Tokyo Guidelines Revision Committee. TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013; 20(1): 1 -7. doi: 10.1007/s00534-012-0566-y. PMID: 23307006.

3.     Yokoe M., Takada T., Strasberg S.M., Solomkin J.S., Mayumi T., Gomi H., Pitt H.A., Garden O.J., Kiriyama S., Hata J., Gabata T., Yoshida M., Miura F., Okamoto K., Tsuyuguchi T., Itoi T., Yamashita Y, Dervenis C., Chan A.C., Lau W.Y, Supe A.N., Belli G., Hilvano S.C., Liau K.H., Kim M.H., Kim S.W., Ker C.G. Tokyo Guidelines Revision Committee. TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2013; 20(1):35-46. doi: 10.1007/s00534-012-0568-9. PMID: 23340953.

4.     Kimura Y, Takada T., Strasberg S.M., Pitt H.A., Gouma D.J., Garden O.J., Bьchler M.W., Windsor J.A., Mayumi T., Yoshida M., Miura F., Higuchi R., Gabata T., Hata J., Gomi H., Dervenis C., Lau W.Y, Belli G., Kim M.H., Hilvano S.C., Yamashita Y TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013; 20( 1 ):8-23. doi: 10.1007/s00534-012-0564-0. PMID: 23307004.

5.     Mayumi T., Someya K., Ootubo H., Takama T., Kido T., Kamezaki F., Yoshida M., Takada T. Progression of Tokyo Guidelines and Japanese Guidelines for management of acute cholangitis and cholecystitis. J UOEH. 2013; 35(4):249-57. PMID: 24334691.

6.     Briskin B.S., Minasyan A.M., Vasilieva М.А., Barsukov M.G. Chreskozhnaja chrespechenochnaja mikroholecistostomija v lechenii ostrogo holecistita. [Percutaneous transhepatic microcholecystostomy in acute cholecystitis treatment]. Annaly khirurgicheskoy gepatologii. 1996; 1(1):98-107 [In Russ].

7.     Ivanov S. V., Okhotnikov O.

Abstract:

Aim: was to evaluate frequency and features of pedal arteries lesions in diabetic patients with critical limb ischemia (CLI).

Materials and methods: a retrospective review of feet angiograms of 144 diabetic patients with ischemic ulcer-necrotic lesions was performed. We evaluated rate of different variants and features of pedal arterial lesions. Also, we analyzed lesion characteristics of the source artery and the frequency of the plantar arch occlusion.

Results: 219 hemodynamically significant lesions were detected, 179 of which were occlusions (82%). The majority of occlusions (140(78%)) were an extension of tibial arterial lesions. The rate of occlusions of more than 5 cm in length was 86%(154). There were no passable vessel segments in 38 cases (21% of occlusions). Single-vessel occlusive disease was revealed in 67 patients (46%), double-vessel defeat - in 56 (39%) patients. The source artery occlusion was observed in 110 cases (76%). In 92% of cases the length of the source artery occlusion was more than 5 cm. The occlusion of a non-feeding artery was found in 69 cases (48%). The plantar arch occlusion was revealed in 37 patients (26%).

Conclusion: in diabetic patients with CLI the arterial lesion of the foot is predominantly establishec by long occlusions, often with two-vessel involvement. The most often occluded vessel is a feeding artery It explains difficulties with the direct revascularization. The plantar arch is occluded in one quarter of cases. 

 

References

1.     Van Den Berg J., Waser S., Trelle S. et al. Lesion characteristics of patients with chronic critical limb ischemia that determine choice of treatment modality. J. Cardiovasc. Surg. 2012; 53(1):45-52.

2.     Rossiyskiy consensus «Diagnostika i lechenie patsientov s kriticheskoy ishemiey nizhnikh konechnostey». [The diagnosis and treatment of patients with critical limb ischemia]. Moscow. 2002: 40 [In Russ].

3.     Graziani L., Silvestro A., Bertone V. et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur. J. Vasc. Endovasc. Surg. 2007; 33(4): 453-460.

4.     Zhu YQ., Zhao J.G., Liu F. et al. Subintimal angioplasty for below-the-ankle arterial occlusions in diabetic patients with chronic critical limb ischemia. J. Endovasc. Ther. 2009; 16(5):604-612.

5.     Ferraresi R., Centola M., Ferlini M. et al. Long-term outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia. Eur. J. Vasc. Endovasc. Surg. 2009; 37(3):336-342.

6.     Eroshkin I.A., Eroshenko Al.V., Eroshenko An.V. et al. Rol rentgenoendovaskulyarnogo vosstanovleniya arteriy nizhnikh konechnostey v lechenii sindroma diabeticheskoy stopy. [The role of endovascular restoration of lower limb arteries in the treatment of diabetic foot syndrome]. Meditsinskaya vizualizatsiya. 2009; 5:99-105 [In Russ].

7.     Pomposelli F.B., Kansal N., Hamdan A.D. et al. A decade of experience with dorsalis pedis artery bypass: Analysis of outcome in more than 1000 cases. J. Vasc. Surg. 2003; 37(2):307-315.

8.     lida O., Soga Y, Hirano K. et al. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. J. Vasc. Surg. 2012; 55(2):363-370.

9.     Soderstrom M., Alback A., Biancari F. et al. Angiosome-targeted infrapopliteal endovascular revascularization for treatment of diabetic foot ulcers. J. Vasc. Surg. 2013; 57(2):427-435.

10.   Rashid H., Slim H., Zayed H. et al. The impact of arterial pedal arch quality and angiosome revascularization on foot tissue loss healing and infrapopliteal bypass outcome. J. Vasc. Surg. 2013; 57(5):1219-1226.

11.   Nakama  T., Watanabe N., Haraguchi T. et al. Clinical outcomes of pedal artery angioplasty for patients with ischemic wounds: results from the multicenter RENDEZVOUS registry. JACC: Cardiovasc. Interv. 2017; 10(1):79-90.

 

 

Abstract: 

Aim: was to decrease rate of early and late complications after implantaion of venous post-system for long-term infusion therapy in patients with adverse vascular access by estimations of complications and prophylaxis.

Materials and methods: research group included 25 patients with early and late postoperative complications, from data of retrospective analysis of 1690 cancer patients with implanted venous port-system. 15 port-systems (0,9%) were removed because of infection. Pressure sores in the soft tissues because of thinned subcutaneous fatty tissue or incorrect selection of the port-system model were revealed in 3 patients (0,17%), catheter migration to the right atrium or a. pulmonalis (pinch-off syndrome) was observed in 3 cases(0,17%),, 4 patients (0,23%) developed early complications in the form of pneumothorax.

Conclusions: importance of aseptic and antiseptic rules while performing puncture of the port chamber, methods for implantation of venous port systems - should decrease rate of early and late post-operative complications in patients with adverse vascular access. 

 

References

1.    Jugrinov O.G. Polnostju implantiruemye infuzionnye sistemy central'nogo venoznogo dostupa (porty) [Full-implanted infusion systems in central veins]. Klinicheskaja onkologija. 2011; 2(2): 18-22 {In Russ].

2.     Marcy P.Y, Magne N., Castadot Р. et al. Radiological and surgical placement of port devices: a 4-year institutional analysis of procedure performance, quality of life and cost in breast cancer patients. Breast Cancer Res Treat. 2005; 92:61-67.

3.     Gebauer B., El-Sheik M., Vogt M. et al. Combined ultrasound and fluoroscopy guided port catheter implantation-high success and low complication rate. Eur Radiol. 2009; 69:517-522.

4.     Cil B.E., Canyigit M., Peynircioglu В. et al. Subcutaneous venous port implantation in adult patients: a single center experience. Diagn Interv Radiol. 2006; 12: 93-98.

5.     Orsi F., Grasso R.F., Arnaldi P. et al. Ultrasound guided versus direct vein puncture in central venous port placement. Vase Access 2000; 1:73-77.

6.     Dede D., Akmangit I., Yildirim Z.N., Sanverdi E., Sayin B. Ultrasonography and fluoroscopy-guided insertion of chest ports. Eur. Surg Oncol. 2008; 34:1340-1343.

7.     Ignatov A., Hoffman O., Smith В. et al. An 11 -year retrospective study of totally implanted central venous access ports: complications and patient satisfaction. Eur.Surg Oncol. 2009; 35:241-246.

8.     Fischer L., Knebel P., Schroder Set al. Reasons for explantation of totally implantable access ports: a multivariate analysis of 385 consecutive patients. Ann Surg Oncol. 2008,15:1124-1129.

9.     Evangelos Perdikakis, Elias Kakhegis, Dimitrios Tsetis. Obshie i spetsificheskie oslozhnenia, voznikaushie pri ispolzovanii polnost’u implantiruemikh tsentralnikh venoznikh portov dostupa. [General and specific complications, occuring during implantation of cental venous port-systemts] J. Vasc Access 2012;13 (3): 345-350 DOI: 10.5301/jva.5000055

10.   Iее I.H., Kim YB., Lee M.K. et al. Catastrophic hemothorax on the contralateral side of the insertion of an implantable subclavian venous access device and the ipsilateral side of the removal of the infected port A case report. Korean Anesthesiol. 2010; 59:214-219.

9.     Teichgra ber U.K., Gebauer B., Benter T. et al. Longterm central venous lines and their complications. Roto 2004; 176:944-992.

10.   Ener R.A., Meglahtery S.B., Styler M. Extravasation of systemic emato-oncological therapies. Ann Oncol. 2004:15:858-862.

11.   Kreis H., Loehberg C.R., Lux M.P. et al. Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies. Eur. Surg Oncol. 2007; 33:39-43.

12.   Yildizeli B., Lacin T., Batirel H.F. et al. Complications and management of long-term central venous access catheters and ports.) Vase Access 2004; 5:174-178.

13.   Zhang 0., Liao L., Zhou H. Comparison of implantable central venous ports with catheter insertion via external jugular с ut down and subclavian puncture in children: single center experience. Pediatr Surg Int. 2009; 25: 499-501.

14.   Paoletti F., Ripani U., Antonelli M., Nicoletta С. Central venous catheters. Observations on the implantation technique and its complications. Minerva Anestesiol. 2005; 71: 555-560.

15.   Lorch H., Zwaan M., Kagel С. et al. Central venous access ports placed by interventional radiologists: experience with 125 consecutive patie

Abstract:

Aim: was to increase efficacy of diagnostics of oculomotor muscles injury in pre- and postoperative period with use of multislice computed tomography (MSCT).

Material and methods: for the petiod 2015-2016, 63 patients with maxillofacial trauma were admitted to the I.M.Sechenov hospital, within 24-48 hours after injury (55 males and 8 females, aged 18-59 years). All patients underwent MSCT of facial skeleton at the day of admittion and on 7-10 day after surgical treatment. Patients examination was made on 640-slice CT scanner and was added by multiplannar and 3D-reconstruction

Results: preoperative MSCT revealed oculomotor muscles injury in 29 patients (46%). Muscles injuries were presented with herniation into the maxillary sinus (n=20, 32%), damaged lateral, inferior and medial muscles by small bone fragments (n=17, 27%), unilateral thickening of muscles in 13 patients (21%).

Postoperative MSCT revealed oculomotor muscle damage caused by incorrectly implantation of prostheses of inferior orbital wall in 7 cases (11%).

Conclusion: MSCT is the modality of choice in pre- and postoperative diagnostics in patients with oculomotor muscles injury. MSCT provides the effective diagnostic solution in prevention of possible ocular movement impairment.  

 

References 

1.    Natsional’nie rukovodstva po luchevoi diagnostike i terapii (pod red.S.K.Ternovogo). [National guidance of radiology and radiotherapy. (Ed. By S.K. Ternovoy)] М.: GEOTAR- Media, 2013; 1000S. [In Russ].

2.    Nikolaenko V.P., Astakhov Yu.S. Orbital’nie perelomi: rukovodstvo dlya vrachei [Orbital fractures: guidance for the clinicians.] St. Petersburg: Eco-Vector; 2012; 303-328 [In Russ].

3.    Serova N.S. Luchevaya diagnostika sochetannikh povrezhdeniy kostey litsevogo cherepa i orbiti. [Radiodiagnostics of complex trauma of facial skeleton and orbit.] Cand. Diss. О. 2006 [In Russ].

4.    Pavlova O.Yu, Serova N.S. Protokol multispiral’noi komp’uternoi tomografii v diagnotike travm srednei zoni litsa. [MSCT diagnostic protocol in trauma of mid-face.] REJR 2016; 6(3):48-53. [In Russ].

5.    Chupova N.A. Funktsional’naya multispiralnaya komp’uternaya tomografia v otsenke mishts glaza pri mehanicheskom povrezhdenii. [Functional multislice computed tomography in assessment of oculomotor muscles within trauma.] Cand. Diss. М. 2013; 141S. [In Russ].

6.    Pavlova O.Y., Serova N.S. Mnogosrezovaya komp’uternaya tomografia v diagnostike perelomov glaznits. [Multislice computed tomography in the diagnosis of orbital fractures.] Journal of radiology. 2015; 3:12-17 [In Russ].

7.    Stuchilov V.A., Nikitin A.A. Optimizatsia diagnostiki I hirurgicheskogo lechenia bol’nikh pri perelomakh glaznits. Posobie dlya vrachei [Optimization of diagnostics and surgical treatment in orbital fractures. Guidance for the clinicians.] М.: 2015, 36S. [In Russ].

8.    Mikhaylyukov V.M., Davidov D.V., Levchenko O.V. Posttravmaticheskie defekti I deformatsii glaznitsi. Osobennosti diagnostiki I printsipi lechenia (obzor literaturi). Golova I sheya. [Posttraumatic orbital defects and deformations. Diagnostics features and treatment principles (literature review). Head and neck.] Rossijskoe izdanie. Zhurnal Obsherossijskoi obshestvennoi organizatsii «Federatsia spetsialistov po lecheniyu zabolevaniy golovi I shei». 2013; 2: 40-48 [In Russ].

9.    Wayne S. Kubal. Imaging of Orbital Trauma. RadioGraphics. 2008; 28:1729-1739.

10.  Nastri A.L., Gurney B. Current concepts in midface fracture management. Curr Opin Otolaryngol Head Neck Surg. 2016; 24(4):368-75.

 

 

Abstract:

A reduced level of female sex hormones at menopause leads to development of atherosclerotic manifestations as well as to reduction of bone mineral density The total estimation of changes in blood vessels and bone tissue on the basis of comparison of SCORE scale and FRAX® program ir a single two-dimensional coordinate system makes it possible to determine degree of risks of cardiovascular complications and fractures in the near future of each individual patient.

 

Aim: was to assess risks of cardiovascular complications and fractures in women in the early postmenopausal period based on the data of SCORE scale and FRAX® program.

Materials and methods: research included 25 women in the variable menopause period without a previous cardiovascular disease (CVD) and osteoporosis (OP). A standard clinical examination, laboratory tests of lipid spectrum, determination of pulse wave velocity, doppler ultrasound of main arteries of the head with the definition of the thickness of the intima-media complex (IMC) of common carotid arteries(CCA), dual energy X-ray absorptiometry were carried out, risk calculations on the basis of SCORE scale and FRAX® computer program were studied. Re-examination of 25 patients was carried out not less than 12 months after the cessation of menses.

Results: baseline characteristics: low risk (less than 1%) was observed in 72% of women on SCORE scale, and 100% of women (less than 10%) was observed on FRAX®. An increasing number of risk factors enhances the performance of «early» markers of atherosclerosis (CPV-13,0 + 3,4 m/s; thickness IMA of CCA-0.95+0,11 mm) and statistically significant (p <0,05) decrease of mineral bone density (BMD). In the early stage of menopause, an increase in the total risk of cardiovascular complications and fractures in coming 10 years was observed. So poor performance risk was observed in 64% of women on SCORE scale, and risk of fractures was observed in 96% of patients on FRAX®.

Conclusion: distribution of studied parameters in a two-dimensional table in accordance with results of the SCORE scale and FRAX® program revealed the prevalence of patients with low values. After 12 months, the growth of BMD was noted in the decrease of number of patients (64%) with low risks and the occurrence of women (8%) with moderate risk of fractures and no cardiovascular risk. BMD study in the early postmenopausal period found a slight decrease in BMD in 48% of women, osteopenia - 44%, osteoporosis - 8%. The comparison of results of both methods makes it possible to assess objectively risks of cardiovascular disease and risk of fractures in each individual patient in next 10 years of their lives. 

 

References

1.     Evropeyskiye rekomendatsii po profilaktike serdechno-sosudistykh zabolevaniy v klinicheskoy praktike. [The European guidelines for prevention of cardiovascular disease in clinical practice]. Rational pharmacotherapy in cardiology. 2008; 4(3):111-128 [ In Russ].

2.     Nikulina N. N., Yakushin S. A., Frumento G. I."Women's health issues and their solutions. Materials of V Russian conference «Sravnitel'nyy analiz smertnosti ot ostrykh form IBS u muzhchin i zhenshchin»[Comparative analysis of mortality from acute forms of CHD in men and women]. Moscow.2011; 13-14 [ In Russ].

3.     Nikulina N. N., Yakushin S. S., Akinina, S. A. Women's health issues and their solutions.Materials of V Russian conference «Analiz urovnya vyyavlyaemosti v prakticheskom zdravoohranenii ostrykh form IBS u zhenshchin (v sravnenii s muzhchinami)»[Analysis of the detection rate in public health practice acute forms of CHD in women (compared to men)]. Moscow. 2011; 14-15 [In Russ].

4.     Kontsevaya A.V., Kalinina, A. M., Pozdnyakov Yu. M.Klinicheskaya i ehkonomicheskaya celesoobraznost' ocenki serdechno-sosudistogo riska na rabochem meste.[Clinical and economical rationales of cardiovascular risk evaluation at workplace]. Rational pharmacotherapy in cardiology. 2009; (3):36-41[In Russ].

5.     Glezer M. G., Tkacheva O. N. Scientific society of specialists on women's health «Rekomendatsii po snizheniyu obshego riska razvitiyazabolevaniy i oslozhneniy u zhenshchin)» [Recommendations for reducing overall risk of development of diseases and complications in women]. M. 2010;48 [In Russ] .

6.     Conroy R.M., Pyorala K., Fitzgerald A.P Estimation of ten-year risk off at al cardiovascular disease in Europe: the SCORE project. Eur.Heart.J. 2003; 24:987-1003.

7.     Assman G., Barter., Bellosta S., et al. Rukovodstvo po profilaktike ishemicheskoy bolezni serdtsa. Mezhdunarodnaya rabochaya gruppa po orofilaktike ishemicheskoy bolezni serdtsa [Guidelines to prevention of coronary heart disease. International working group for prevention of coronary heart disease].  Germany. STADA. Thomson Reuters. 2011; 130.

8.     Skripnikova I. A. Osteoporosis and osteopathy. Abstracts of the IV Russian Congress on osteoporosis «Chto svyazyvaet osteoporoz i serdechno-sosudistyye zabolevaniya, obuslovlennyye aterosklerozom (CCZ-AS)?»[What connects osteoporosis and cardiovascular disease caused by atherosclerosis (CVD-al)?]. Moscow. 2010; (1):66. [In Russ].

9.     Ershova O. B. Kommentarii k prakticheskomu ispol'zovaniyu Rossiyskikh klinicheskikh rekomendaciy po osteoporozu. [Comments to the practical use of the Russian clinical recommendations for osteoporosis]. Osteoporosis and osteopathy. Scientific-practical journal. 2010; (1):34-46 [In Russ].

10.   Skripnikova I. A., Oganov R.G. Osteoporoz i serdechno-sosudistyye zabolevaniya, obuslovlennyye aterosklerozom, u zhenshchin postmenopauzal'nogo perioda: obshchnost' povedencheskikh i social'nykh faktorov riska. [Osteoporosis and cardiovascular diseases caused by atherosclerosis, postmenopausal women: a community behavior al and social risk factors]. Osteoporosis and osteopathy. 2009; (2):5-9 [In Russ].

Abstract:

Aim: was to reveal factors, influencing high cnance of dysfuntion of diaphragm domes in further patient examination by estimation of dynamics of acqired diaphragmatic dysfunction after different cardiac surgical interventions.

Material and methods: research included 642 patients after different cardiac surgical interventions. We estimated mobility of diaphragm domes at the moment of patients discharge from intensive care unit and secondly before transporting to rehabilitation center. All patients were devided into 3 groups. 1st group: patients with normal mobility of diaphragm at initial examination - 395 (61,5%). 2nd group - diaphragmatic dysfunction at initial examination and recovered mobility at further examination - 173 patients (26,9%). 3rd group - patients with diaphragmatic dysfunction at both stages of examination - 74 (11,5%). Criteria for diaphragmatic dysfunction - mobility amplitude of domes less than 10 mm. We estimated chances of extant dysfunction, under the influence of complex of clinical and surgical factors.

Results: at initial examination diaphragmatic dysfunction was revealed at 38,5%, left dome - 18,2%, right dome - 10,3%, bilateral dysfunction - 10,0%. At further examination diaphragmatic dysfunction persisted in 11,5% of patients, left-sided - 7,5%, right-sided - 3,9%, bilateral - in one case. Recovery of diaphragmatic function was achieved in 70% of initial dysfunction. High and statistically significant chances of extant dysfunction were evaluated only in case of unilateral separation of internal thoracic artery (ITA). Other surgical and clinical factors had no statistically sugnificant influence.

Conclusions: aquired diaphragmatic dysfunction after different cardiac surgical interventions ir 70% of cases is reversible. Recovery of diaphragm mobility was full. Prevalence of diaphragmatic dysfunction decreases for 5 days from 38,5% to 11,5% and persists usually unilateral: left-sided - 7,5%, right-sided - 3,9%.

The only statistically significant surgical factor, influencing high risk of appearance and extantion of post-operative domes dysfunction is unilateral separation of ITA. 

 

References

1.    Bazylev V.V., Paramonova T.I., Vdovkin A.V. Ocenka faktorov, vlijajushhih na razvitie dispnoje v rannem posleoperacionnom periode posle kardiohirurgicheskih vmeshatel'stv. [Factors affecting the development of dyspnea in the early postoperative period after cardiac surgery.] Diagnosticheskaja i intervencionnaja radiologija. 2016;10(4):19-27 [In Russ].

2.    Davison A., Mulvey D. Idiopathic diaphragmatic weakness. BMJ 1992; 304:492-494.

3.    McCool F.D., McCool G.E. Dysfunction of the Diaphragm. N Engl J Med. 2012; 366:932-942.

4.    Canbaz S., Turgut N., Halici U., et al. Electrophysiological evaluation of phrenic nerve injury during cardiac surgery - a prospective, controlled, clinical study. BMC Surgery. 2004, 4:1-5.

5.    Diehl J.L., Lofaso F., Deleuze P., et al. Clinically relevant diaphragmatic dysfunction after cardiac operations. J Thorac Cardiovasc Surg. 1994; 107:487-498.

6.    McCool F.D., Mead J. Dyspnea on immersion: mechanisms in patients with bilateral diaphragm paralysis. Am Rev Respir Dis. 1989; 139:275-276.

7.    Steier J., Jolley C.J., Seymour J., et al. Sleep-disordered breathing in unilateral diaphragm paralysis or severe weakness. Eur Respir J. 2008; 32:1479-1487.

8.    Kim W.Y, Suh H.J., Hong S.B., et al. Diaphragm dysfunction assessed by ultrasonography: Influence on weaning from mechanical ventilation. Critical Care Medicine. 2011;12:2627-2630.

9.    Deng Y, Byth K., Paterson H.S. Phrenic nerve injury associated with high free right internal mammary artery harvesting. Ann Thorac Surg. 2003; 76(2):459-463.

10.  Mazzoni M., Solinas C., Sisillo E., et al. Intraoperative phrenic nerve monitoring in cardiac surgery. Chest. 1996; 109(6):1455-1460.

11.  Tripp H.F., Sees D.W., Lisagor P.G., et al. Is phrenic nerve dysfunction after cardiac surgery related to internal mammary harvesting? J Card Surg. 2001; 16(3): 228-231.

12.  Metzner A., Rausch P., Lemes C., et al. The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon. J Cardiovasc Electrophysiol. 2014; 25(5):466-470.

13.  Merino-Ramirez M.A., Juan G., Rair^n M., et al. Electrophysiologic evaluation of phrenic nerve and diaphragm function after coronary bypass surgery: prospective study of diabetes and other risk factors. J Thorac Cardiovasc Surg. 2006; 132:530-536.

14.  Paramonova T.I., Vdovkin A.V. Faktory, vlijajushhie na razvitie diafragmal'noj disfunkcii v rannem posleoperacionnom periode posle kardiohirurgicheskih vmeshatel'stv [Factors, influencing the development of diaphragmatic dysfunction in the early postoperative period after cardiac surgery.] Diagnosticheskaja i intervencionnaja radiologija. 2016; 10(2): 11-16 [In Russ].

15.  Chetta A., Rehman A.K., Moxham J., et al. Chest radiography cannot predict diaphragm function. Respir. Med. 2005; 99:39-44.

16.  O'Brien J.W., Johnson S.H., VanSteyn S.J., et al. Effects of internal mammary artery dissection on phrenic nerve perfusion and function. Ann Thorac Surg. 1991; 52: 182-8

17.  Sharma A.D., Parmley C.L., Sreeram G., et al. Peripheral nerve injuries during cardiac surgery: risk factors, diagnosis, prognosis, and prevention. Anesth Analg. 2000; 91(6):13

Abstract: 

Aim: was to give a literature review normal coronary anatomy, described patterns of anomalous coronary arteries by using multislice computed tomography (MSCT).

Materials and methods: 1104 computed tomography coronary angiography (CCTA) was made in «Fedorovich Clinikasi» for the period of 2011-2016. The age of patients ranged from 7 to 82 years. Men were 790 (71.5%), women - 314 (28.5%). The study was carried out on the multislice spiral CT scanners Brilliance 64 and Brilliance i-CT 256 (PHILIPS).

Results. In 32 (2,9%) cases we detected anatomical variations as conus artery high take-off of a coronary ostium, myocardial bridging, shepherd's crook deformation of right coronary artery 23 (2%) patients had coronary artery anomaly (CAA) as a single coronary artery, absence of circumflex artery, hypoplasia of coronary artery, intra-atrial location, origin from the opposite coronary sinus of Valsalva, separate discharge of the LAD and circumflex from aorta, Blunt-White-Garland syndrome, coronary fistulas, aneurysms of coronary arteries. When a CAA is found, the exact origin, course and its position with other cardiac structures must be described in detail.   

 

References

            1.    Belozerov Yu.M. Detskaya kardiologiya [Pediatric cardiology]. MEDpress-inform. 2004; 600 [In Russ].

2.    Villa A., Sammut E., Nair A., Rajani R., Bonamini R. and Chiribiri A. Coronary artery anomalies overview: The normal and the abnormal. World J Radiol. 2016; 8(6): 537-555.

3.    Braat H.J.M. A coronary anomaly. Neth. Heart J. 2007; 15:267-268.

4.    Loukas M., Groat C., Khangura R. et al. The normal and abnormal anatomy of the coronary arteries. Clin. Anat. 2009; 22:114-128.

5.    Cheitlin, Mac Gregor J. Congenital Anomalies of coronary arteries: role in the pathogenesis of sudden cardiac death. Herz. 2009; 34:268-279.

6.    Ferreira M., Santos-Silva PR., de Abreu L.C. et al. Sudden cardiac death athlets: a systematic review. Sports Med. Arthrosc. Rehabil. Ther. Technol. 2010; 2:19.

7.    Frommelt PC. Congenital coronary artery abnormal ities predisposing to sudden cardiac death. Pacing Clin. Electrophysiol. 2009; 32 63-66.

8.    Tseluyko V.I., Mishuk N.E., Kinoshenko K.Yu. Anomalii stroeniya koronarnyh arteriy. [Coronary artery anomalies]. Diabet i serdtse. 2012; 10(166):44-51 [In Russ].

9.    Angelini P. Coronary artery anomalies: an entity in search of an identity. Circulation. 2007; 115:1296-1305.

10.  Angelini P. Coronary Artery Anomalies - Current Clinical Issues. Definitions, Classification, Incidence, Clinical Relevance and Treatment Guiedlines. Tex. Heart Inst. J. 2002; 29:271-278.

11.  Chiu I.S., Anderson R.H. Can we better understand the known variations in coronary arterial anatomy? Ann Thorac Surg. 2012; 94:1751-1760.

12.  Vatutin N.T., Bahteeva T.D., Kalinkina N.V., Perueva I.A. Vrojdennye anomalii koronarnyh arteriy. [Congenital anomalies of coronary arteries]. Serdtse isosudy. 2011; 3: 94-99 [In Russ].

13.  Hlavacek A., Loukas M., Spicer D. et al. Anomalous origin and course of the coronary arteries. Cardiol. Young. 2010; Vol.3:20-25.

14.  Rigatelli G., Docali G., Rossi P. et al. Validation of a clinical-significance-based classification of coronary artery anomalies. Angiology. 2005; 56:25-34.

15.  Joshi S.D., Joshi S.S., Anthavale SA. Origins of the coronary arteries and their significance. Clinics (Sao Paulo). 2010; 65:79-84.

16.  Young P.M., Gerber T.C., Williamson E.E., Julsrud P.R., Herfkens R.J. Cardiac imaging: Part 2, normal, variant, and anomalous configurations of the coronary vasculature. AJR Am J Roentgenol. 2011; 197:816-826.

17.  Fujibayashi, Daisuke, Morino, Yoshihiro. A case of acute myocardial infarction due to coronary spasm in the myocardial bridge. J. Invasive Cardiol. 2008; 20: 217-219. 18.Morales A.R., Romanelli R., Tate L.G., Boucek R.J., de Marchena E. Intramural left anterior descending coronary artery: significance of the depth of the muscular tunnel. Hum Pathol. 1993; 24:693-701.

19.  Roberts W.C. Major anomalies of coronary arterial origin seen in adulthood. Am Heart J. 1986; 11:941-963.

20.  Yurtda§ M., Gulen O. Anomalous origin of the right coronary artery from the left anterior descending artery: review of the literature. Cardiol J. 2012;19:122-129.

21.  Kuhn A., Kasnar-Samprec J., Schreiber C. Anomalous origin of the right coronary artery from pulmonary artery. Int. J. Cardiol. 2010; 39: 27-28.

 

 

Abstract:

Aim: was to assess computed tomography angiography (CTA) abilities in analysis of internal carotid artery (ICA) critical atherosclerotic lesions.

Material and method: for the period 2014-2016 - 321 patients underwent examination (ultrasound and CTA of brachiocephalic arteries) prior to surgical treatment of ICA occlusive disease. CTA was made on Philips iCT 256-slice (noncontrast examination, arterial and venous phases), 50 ml on nonionic contrast agent was injected (4-4,5 ml/sec). We distinguished several types of ICA changes: stenosis more than 60% and 70%, critical stenosis, subocclusion (also with distal collapse), local occlusion.

Results: CTitical ICA stenosis was detected in 82 patients (26% of all observed cases); ICA changes with diffuse decrease of upper segments - in 20 cases (6,2% of cases). Among group of decreased diameter we saw subocclusion (18 patients) and local occlusion (2 patients). In the setting of local occlusion ICA contrast-enchanced through atypical ascending pharyngeal artery In patients with diffuse decrease of upper ICA segments all elements of circle of Wills were detected in 70% of cases. During surgery CTA results were confirmed, but atherosclerotic plaque extension was higher than observed at CT approximately at 10 mm.

Conclusion: we can refer critical stenosis, subocclusion and local occlusion to critical atherosclerotic ICA changes. The one should consider CTA limitations in differentiation of upper part of atherosclerotic plaque. In majority of cases decrease in ICA diameter was associated with severe atherosclerotic involvement and not with congenital changes CTA is necessary for preoperative assessment of carotid occlusive disease, especially in critical ICA changes.

 

References

1.     John J. Ricotta, Ali AbuRahma, Enrico Ascher, Mark Eskandari, Peter Faries and Brajesh K. Lal. Washington, DC; Charleston, WV; Brooklyn, NY; Chicago, Ill; New York, NY; and Baltimore, Md Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease. J Vasc Surg. 2011: Sep; 54(3):1-31.

2.     Nacional'nye rekomendacii po vedeniyu pacientov s zabolevaniyami brahiocefal'nyh arterij [National recommendations on treatment of brachicephalic arteries disease]. Rossijskij soglasitel'nyj dokument. 2013; 72S [ In Russ].

а)  Nacional'nye rekomendacii po vedeniyu pacientov s zabolevaniyami brahiocefal'nyh arterij [National recommendations on treatment of brachicephalic arteries disease] [Elektronnyj resurs]: ros. soglasit. dok. /Ros. o-vo angiologov i sosudistyh hirurgov, Assoc. serdech.-sosudistyh hirurgov Rossii, Ros. nauch. o-vo rentgenehndovaskulyar. hirurgov i intervencion. radiologov, Vseros. nauch. o-vo kardiologov, Assoc. flebologov Rossii ; L. A. Bokeriya, A. V. Pokrovskij, G. YU. Sokurenko [i dr.]. - M., 2013. - 72 s. - Rezhim dostupa: www. url: http://www.angiolsurgery.org /recommendations2013/recommendations_brachio- cephalic.pdf . 03.04.2015 [In Russ].

b)  Nacional'nye rekomendacii po vedeniju pacientov s zabolevanijami brahiocefal'nyh arteriT [National recommendations on treatment of brachicephalic arteries disease]. M.2013 [In Russ].

3.     Johansson E. and A.J. Fox., Carotid Near-Occlusion: A Comprehensive Review, Part 2-Prognosis and Treatment, Pathophysiology, Confusions, and Areas for Improvement. American Journal of Neuroradiology 2016; 37(2):200-204.

4.     Johansson E. and A.J. Fox., Carotid Near-Occlusion: A Comprehensive Review, Part 1- Definition, Terminology, and Diagnosis. American Journal of Neuroradiology Jan 2016; 37(1):2-10.

5.     Vishnyakova M.V., Pronin I.N., Lar'kov R.N., Zagarov S.S. Komp'yuterno-tomograficheskaya angiografiya v planirovanii rekonstruktivnyh operacij na vnutrennih sonnyh arteriyah [CT-angiography in planning of reconstructive operations on internal carotid arteries]. Diagnosticheskaya i intervencionnaya radiologiya. 2016; 10(3):11-19 [In Russ].

6.     Suzie M. El-Saden, Edward G. Grant, Gasser M. Hathout, Peter T. Zimmerman, Stanley N. Cohen, and J. Dennis Baker. Imaging of the internal carotid artery: the dilemma of total versus near total occlusion. Radiology 2001; 221(2):301-308.

7.     Mamedov F.R., Arutyunov N.V., Usachev D. YU, Lukshin V.A., Mel'nikova-Pickhelauri T.V., Fadeeva L.M., Pronin I.N., Kornienko V.N. Sovremennye metody nejrovizualizacii pri stenoziruyushchej i okklyuziruyushchej patologii sonnyh arterij [Modern methods of neurovisualization in stenotic and occlusive pathology of carotid arteries.]. Luchevaya diag nostika i terapiya. 2012; 3(3):109-116 [In Russ].

8.     Vishnyakova M.V. (ml), Pronin I.N., Lar'kov R.N., Vishnyakova M.V.. Detalizaciya okklyuziruyushchego porazheniya vnutrennej sonnoj arterii pri komp'yuternoj tomograficheskoj angiografii dlya planirovaniya rekonstruktivnyh operacij [Detalization of occlusive lesion of internal carotid artery in CT angiography for planning of reconstrutive operations]. Vestnik rentgenologii i radiologii. 2017; 98(2):69-77 [In Russ].

9.     Lippman H.H., Sundt T.M. Jr., Holman C.B.. The poststenotic carotid slim sign: spurious internal carotid hypolasia. Mayo Clin Proc. 1970; 45:762-767.

10.   Fox Allan J., Michael Eliasziw, Peter M. Rothwell, Matthias H. Schmidt, Charles P. Warlow, Henry J.M. Barnett. Identification, Prognosis, and Management of Patients with Carotid Artery Near Occlusion. American Journal of Neuroradiology. Sep 2005; 26(8):2086-2094

11.   Johansson E., Chman K., Wester P.. Symptomatic carotid near-occlusion with full collapse might cause a very high risk of stroke. J Intern Med 2015; 277:615-623.

 

authors: 

Abstract:

Timely diagnosis of iatrogenic injury of kidneys remains a challenge. Article is devoted to the study of diagnostic possibilities of radiological methods in the evaluation of patients with iatrogenic injuries of kidneys and postoperative complications in urology.

Materials and methods: study included 38 patients with kidney injury and postoperative complications, which were treated at the urological departments, were studied diagnostic capabilities of intravenous urography, ultrasound, CT Defined indicators of efficiency of MSCT in the diagnosis of these pathological conditions relative to data obtained intraoperatively (n = 16; 42,1%) and during follow-up (n= 22; 57,9%). According to research MSCT has the best indicators of the diagnostic value (sensitivity - 97%, specificity - 98%).

Results: defined indicators of efficiency of MSCT in the diagnosis of these pathological conditions relative to data obtained intraoperatively (n = 16; 42,1%) and during follow-up (n= 22; 57,9%). According to research MSCT has the best indicators of the diagnostic value (sensitivity - 97%, specificity - 98%). 

 

References 

1.    Russian Electronic Journal of Radiology. 2013; 3(4):88-93. Nechiporenko A.S., Nechiporenko A.N., Varec I.G. Komp'juternaja tomografija v diagnostike zakrytoj travmy pochek. [CT in diagnostics of renal blunt trauma]. Russian Electronic Journal of Radiology. 2013; 3(4):88-93 [In Russ].

2.    Komjakov B. K., Soroka I. V., Savello V. E. i dr. Osobennosti kliniko-luchevoj diagnostiki oslozhnenij sochetannyh povrezhdenij pochek v raznye periody travmaticheskoj bolezni. [Features of clinical and beam diagnostics of complications of combined renal trauma in different terms of traumatic disease]. Biomedicinskij zhurnal www.medline.ru. 2011; 12:1450-1466 [In Russ].

3.    Merinov D.S., Pavlov D.A., Fatihov R.R. i dr. Miniinvazivnaja perkutannaja nefrolitotripsija: delikatnyj i jeffektivnyj instrument v lechenii krupnyh kamnej pochek. [Miniinvasive percutaneous nephrolitotripsia: delicate and effective way to treat large renal stones]. Jeksperimental'naja i klinicheskaja urologija. 2013; 3:94-98 [In Russ].

4.    Mudraja I.S., Gurbanov Sh.Sh., Merinov D.S. Peristal'tika mochetochnika u pacientov s kamnjami pochki i urodinamika verhnih mochevyvodjashhih putej posle perkutannoj nefrolitolapaksii. [Peristalsis of the ureter in patients with renal stones and urodynamics of the upper urinary tract after percutaneous nephrolitholapaxy]. Jeksperimental'naja i klinicheskaja urologija. 2014; 1:67-71 [In Russ].

5.    Rossolovskij A.N., Chehonackaja M.L., Zaharova N.B. i dr. Dinamicheskaja ocenka sostojanija pochechnoj parenhimy u bol'nyh posle distancionnoj udarno-volnovoj litotripsii kamnej pochek. [Dynamic assessment of renal parenchyma in patients after extracorporeal shock wave lithotripsy of kidney stones]. Vestnik urologii. 2014; 2:3-14 [In Russ].

6.    Janenko Je.K., Katibov M.I., Merinov D.S. i dr. Prognosticheskie faktory dlja jeffektivnosti i bezopasnosti perkutannoj nefrolitotripsii krupnyh i korallovidnyh kamnej edinstvennoj pochki. [Prognostic factors for the efficacy and safety of percutaneous nephrolithotripsy of large and coral stones of a single kidney]. Jeksperimental'naja i klinicheskaja urologija. 2015; 3:42-47 [In Russ].

Abstract:

Aim: was to review the efficiency of complex methods of bleeding prevention in elderly patients with acute coronary syndrome (ACS) receiving combined anticoagulant and antiplatelet therapy during percutaneous coronary interventions (PCI).

Materials and methods: between January of 2011 to 2015 in «Pokrovskaya City Hospital» of St. Petersburg, 1435 PCI were performed in patients with ACS, the percentage of patients older than 80 years was more than 9%. To reduce bleeding risk we used: transradial access, diminished time of eptifibatide infusion, bivalirudin, intraoperative control of activated clotting time (ACT).

Results: significant decrease of bleeding episodes in patients with high risk of bleeding requiring transfusion at 0, 25% in the early postoperative period was shown.

Conclusions: the reduction of the bleeding risk will increase management efficiency among patients undergoing PCI.  

 

References 

1.    Biostatistical Fact Sheet: Older Americans and Cardiovascular Diseases. Chicago, AHA, 1998.

2.    Rich M.W. et al. PRICE-2 Investigators. Am. J. Geriart. Cardiol. 2003;12(5):307-18, 327.

3.    Angeja B., Rundle A., Death or nonfatal stroke in patients with acute myocardial infarction. Am. J. Card. 2001 Mar 1;87(5):627-30.

4.    Tiefenbrunn A.J. et al. A report from the NRMI -2. J. Am. Coll. Card. 1998;31: 1240.

5.    Thiemann D.R., Coresh J., et al.: Lack of benefit for intravenous thrombolysis in patients with MI who are older than 75 years. Circulation. 2000;101: 2239.

6.    Brown D. Deaths associated with platelet glycoprotein 11 b/111 a treatment. Heart. 2003 May;89(5): 535-7.

7.    ESPRIT Investigators. Lancet. 2000;356:2037-44

8.    Fung et al. The Brief-PCI Trial. JACC 53: 2009: 837-45.

9.    Gibson C.M., Morrow D.A., Murphy S.A., et al. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI 30 trial. J. Am. Coll. Cardiol. 2006; 47:2364-73.

10.  Bertrand O.F. Meta-Analysis Comparing Bivalirudin Versus Heparin Monotherapy on Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention. Am. J. Cardiol. 2012; 110:599-606.

11.  Marso S.P, Amin A.P Assotiation between of bleeding avoidance strategies and risk of bleeding among patients undergoing PCI. JAMA. 2010 2; 303 (21): 2156-64.

12.  Mehran R., Lansky A.J., Witzenbichler B., et al. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomized controlled trial. Lancet. 2009; 374:1149-59.

13.  Reduction in Cardiac Mortality With Bivalirudinin Patients With and Without Major Bleeding. Gregg W. Stone et all. J. Am. Coll. Cardiol. 2014;63:15-20.

14.  Michael Lincoff A., John A. Bittl. Bivalirudin and Provisional Glycoprotein 11 b/111 a Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockad During Percutaneous Coronary Intervention. REPLACE-2 Randomized Trial. JAMA. 2003 February; 289: 19.

15.  Stone G.W., White H.D., Ohman E.M., et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet. 2007; 369:907-19.

16.  Lopotovskiy P.Yu., Parkhomenko M.V., Larin A.G., Korobenin A.Yu. Primenenie bivalirudina v klinicheskoi praktike. [The use of bivalirudin in clinical practice.] Diagnosticheskaya i intervencionnaya radiologia. 2012 (6) #4: 79-88 [in Russ].

 

Abstract:

We present a case report of successful transcatheter closure of patent foramen ovale (PFO) by transcatheter suturing device «Noblestitch EL».

Materials and methods: cryptogenic stroke may be the consequence of the PFO. Percutaneous PFO closure, being less invasive than surgical closure, is increasingly performed; there are, however, early and long-term risks including: device embolization, fracture, thrombosis, infection, erosions of free atrial wall, arrhythmias. Furthermore, device implantation may complicate future percutaneous access to the left atrium. Partially reabsorbable devices and tissue welding to close PFO have recently been introduced. We present a case report of 33-year-old woman with a history of cryptogenic stroke. Echocardiography imaging with bubble study demonstrated a right-to-left shunt through the PFO at rest. The right femoral vein was cannulated. A «Noblestitch EL» device was advanced across the PFO and thread was passed through the septum primum and secundum. Threads were exteriorized and a knot was advanced to the right atrial septum and cut.

Results: successful closing of PTO was confirmed by transesophageal echocardiogram. Later it was shown complete PFO closing, no right-to-left shunt, even during the Valsalva maneuver, no residual shunt was observed.  

 

References 

1.    McKenzie J.A., Edwards W., Hagler D.J. Anatomy of the patent foramen ovale for the interventionalist. Catheter Cardiovasc Interv. 2009; 73:821-826.

2.    Messe S.R., Silverman I.E., Kizer J.R. et al. Practice parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004; 62:1042-1050.

3.    Del Valle-Fernбndez R., Ruiz C.E. Frontiers of Patent Foramen Ovale Closure and New Design Improvements - A Review of the Literature. Interventional Cardiology Review. 2008; 3(1): 24-27. DOI: 10.15420/icr. 2008.3.1.24

4.    Calvert PA., Rana B.S., Kydd A.C. et al. Patent foramen ovale: anatomy, outcomes and closure. Nat Rev Cardiol. 2011; 8:148-160.

5.    Scacciatella P, Butera G., Meynet I. et al. Percutaneous closure of patent foramen ovale in patients with anatomical and clinical high-risk characteristics: longterm efficacy and safety. J Interv Cardiol. 2011; 24:477-484.

6.    Sievert H., Fischer E., Heinisch C. et al. Transcatheter closure of patent foramen ovale without an implant: Initial clinical experience. Circulation. 2007; 116:1701-1706.

7.    Sigler M., Jux C. Biocompatibility of septal defect closure devices. Heart. 2007; 93:444-449.

8.    Verma S.K., Tobis J.M. Explantation of patent foramen ovale closure devices. A multicenter survey. JACC Cardiovasc Interv. 2011; 4:579-585.

9.    Onorato E., Casilli F., Berti M., Anzola GP Patent foramen ovale closure. Pro and cons. Neurol. Sci. 2008. 29:S28-S32. DOI 10.1007/s10072-008-0881-x

10.  Rana B.S., Thomas M.R., Calvert PA. et al. Echocardiographic evaluation of patent foramen ovale prior to device closure. JACC Cardiovasc Imaging. 2010; 3:749-760.

11.  Slottow T.L., Steinberg D.H., Waksman R. Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on patent foramen ovale closure devices. Circulation. 2007; 116:677-682.

12.  Onorato E., Casilli F. Influence of PFO Anatomy on Successful Transcatheter Closure. Interv. Cardiol. Clinic. 2013. 2 (1): 51-84. DOI: http://dx.doi.org/10.1016/j.iccl. 2012.09. 009

13.  Ruiz C.E., Kipshidze N., Chiam P, Gogorishvili I. Feasibility of Patent Foramen Ovale Closure With NoDevice Left Behind: First-In-Man Percutaneous Suture Closure. Catheterization and Cardiovascular Interventions. 2008; 71:921-926. DOI 10.1002/ccd.

 

authors: 

Abstract:

At present, in the Russian health care system remain serious problems that may impede the achievement of goals for improving the health status of the population and increasing life expectancy One of major problems is the lack of volume of high-tech and resource-intensive types of medical care for the population.

It is assumed that this resultant shortage will be covered from funds of the mandatory health insurance (MHI) in a single stream of funding for so-called «full» tariffs.

The article discusses the unreasonableness of the large-scale involvement of federal clinics to regional MHI system, clarification and rigid division of federal research and regional medical institutions are proposed.

Article' materials may be used for pilot projects in the formulation of public policy in relation to the choice of methods and mechanisms for financing federal medical clinics.  

 

References 

1.    Hal'fin R.A., Kuznecov P.P. Vysokotehnologichnaja medicinskaja pomoshh': problemy organizacii i ucheta [High-tech medical care: the problem of organization and accounting.]. M., 2008: 191[ In Russ].

2.    Perhov V.I., Stebunova R.V. Vozmozhnye posledstvija rasshirenija uchastija nauchnyh uchrezhdenij v programmah objazatel'nogo medicinskogo strahovanija. Kremlevskaja medicina [Possible consequences of increasing the participation of research institutions in programs of compulsory health insurance.]. Klinicheskij Vestnik. 2014; 2: 49-54 [In Russ].

3.    Perhov V.I. Problemy finansirovanija medicinskoj nauki v uslovijah razvitija strahovyh principov oplaty medicinskoj pomoshhi v federal'nyh gosudarstvennyh uchrezhdenijah zdravoohranenija [Problems of financing of medical science in the context of principles of insurance payment for medical care in the federal public health agencies.]. Zdravoohranenie. 2014; 10; 38-45 [In Russ].

4.    Kushh O.V., Artamonova G.V., Barbarash L.S. Social'naja jeffektivnost' innovacionnyh tehnologij okazanija medicinskoj pomoshhi pri boleznjah sistemy krovoobrashhenija v Kemerovskoj oblasti. Social'nye aspekty zdorovja naselenija [Social efficiency of innovative technologies of medical care for diseases of the circulatory system in the Kemerovo region. Social aspects of health] [jelektronnyj nauchnyj zhurnal] 2015;41(1). URL: http:// http://vestnik.mednet.ru /content/view/646/30/lang,ru/ (Data obrashhenija 23 ijunja 2015) [In Russ].

5.    Shalygina L.S. Jekspertnaja ocenka perspektiv razvitija vysokotehnologichnoj medicinskoj pomoshhi v sub#ekte RF [Expert assessment of prospects for the development of high-tech medical care in the subject of the Russian Federation.]. Vestnik Roszdravnadzora. 2015; 2: 52-55 [In Russ].

6.  

Abstract:

A standard X-ray is still the most affordable method of evaluation of patients, including those with spinal diseases since 1895 when X-rays were found and were introduced into general practice. In the standard X-ray examination of the spine and all the anatomical structures located at different depths and different distances, projected onto x-ray film or a screen in the form of planar image. In order to neutralize these drawbacks and to improve visualization, various tomographic techniques have been developed. The most modern and promising diagnostic method is a multisection linear imaging (tomosynthesis), in which a single pass X-ray tube is a series of slices. Digital X-ray tomography with multislice linear are used as a rule, in the world, for examination of breast and lungs. The article presents data on the different types of X-ray tomography in evaluation of patients with tuberculous spondylitis.

 

 

Abstract:

We performed the analysis of published data on the use of multislice computed tomography in diagnostics of coronary heart disease. The data on the development of the method, indicated that it its diagnostic efficiency is related to technological improvements, accompanied by the appearance of each successive generation of multislice computed tomography We described possibilities of using of scanners from 16 to 230-slice, devices with two sources of energy, advantages of «dual energy» regime application in the coronary disease diagnostics. Given constraints on the method diagnostic efficacy - artifacts associated with the movement and severe calcification. It is indicated that the implementation of the method in cardiology practice promotes its consideration as a promising alternative to invasive diagnostic coronary angiography, it is suggested becoming of further development of the technology that will allow multislice computed tomography to become the main method of diagnosis of coronary heart disease and other cardiovascular diseases.  

 

References 

1.    Paul J.F., Dambrin G., Caussin C. et al. Sixteen-slice computed tomography after acute myocardial infarction: from perfusion defect to the culprit lesion. Circulation. 2003; 108: 373-374.

2.    Sun Z., Choo G.H., Ng K.H. Coronary CT angiography: current status and continuing challenges. Br. J. Radiol. 2012; 85: 495-510.

3.    Costello P., Lobree S. Subsecond scanning makes CT even faster. Diag. Imaging. 1996; 18: 76-79.

4.    Taguchi K., Aradate H. Algorithm for image reconstruction in multi-slice helical CT. Med. Phys. 1998; 25: 550-561.

5.    Flohr T.G., Schaller S., Stierstorfer K. et al. Multidetector row CT systems and image-reconstruction techniques. Radiology. 2005; 235: 756-773.

6.    Haberl R., Tittus J., Bohme E. et al. Multislice spiral computed tomographic angiography of coronary arteries in patients with suspected coronary artery disease: an effective filter before catheter angiography? Am. Heart J. 2005; 149: 1112-1119.

7.    Goldman L.W. Principles of CT: multislice CT. J. Nucl. Med. Technol. 2008; 36: 57-68.

8.    Lewis M., Keat N., Edyvean S. 16 Slice CT scanner comparison report version 14, 2006. Available from: URL: http://www.impactscan.org/reports/Report06012.htm

9.    Achenbach S., Ropers D., Pohle F.K. et al. Detection of coronary artery stenoses using multi-detector CT with 16x0.75 collimation and 375 ms rotation. Eur. Heart J. 2005; 26: 1978-1986.

10.  Kuettner A., Beck T., Drosch T. et al. Image quality and diagnostic accuracy of non-invasive coronary imaging with 16 detector slice spiral computed tomography with 188 ms temporal resolution. Heart. 2005; 91: 938-941.

11.  Garcia M.J., Lessick J., Hoffmann M.H. Accuracy of 16-row mul-tidetector computed tomography for the assessment of coronary artery stenosis. JAMA. 2006; 296: 403-411.

12.  Flohr T.G., McCollough C.H., Bruder H. et al. First performance evaluation of a dual-source CT (DSCT) system. Eur. Radiol. 2006; 16: 256-268.

13.  Steigner M.L., Otero H.J., Cai T. et al. Narrowing the phase window width in prospectively ECG-gated single heart beat 320-detector row coronary CT angiography. Int. J. Cardiovasc. Imaging. 2009; 25: 85-90.

14.  Achenbach S., Marwan M., Schepis T. et al. High- pitch spiral acquisition: a new scan mode for coronary CT angiography. J. Cardiovasc. Comput. Tomogr. 2009; 3: 117-121.

15.  Ruzsics B., Lee H., Zwerner P. et al. Dual-energy CT of the heart for diagnosing coronary artery stenosis and myocardial ischemia-initial experience. Eur. J. Radiol. 2008; 18: 2414-2424.

16.  Jiang H.C., Vartuli J., Vess C. Gemstone-the ultimatum scintillator for computed tomography. Gemstone detector white paper. London: GEHealthcare. 2008: 1-8.

17.  Sun Z., Jiang W. Diagnostic value of multislice computed tomography angiography in coronary artery disease: a meta-analysis. Eur. J. Radiol. 2006; 60: 279-286.

18.  Pontone G., Andreini D., Bartorelli A. et al. Diagnostic accuracy of coronary computed tomography angiography: a comparison between prospective and retrospective electrocardiogram triggering. J. Am. Coll. Cardiol. 2009; 54: 346-355.

19.  Sun Z., Ng K.H. Diagnostic value of coronary CT angiography with prospective ECG-gating in the diagnosis of coronary artery disease: a systematic review and meta-analysis. Int. J. Cardiovasc. Imaging. 2012; 28: 2109-2119.

20.  Budoff M.J., Dowe D., Jollis J.G. et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J. Am. Coll. Cardiol. 2008; 52: 1724-1732.

21.  Miller J.M., Rochitte C.E., Dewey M. et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl. J. Med. 2008; 359: 2324-2336.

22.  Alkadhi H., Stolzmann P., Desbiolles L. et al. Low-dose, 128-slice, dual-source CT coronary angiography: accuracy and radiation dose of the high-pitch and the step-and-shoot mode. Heart. 2010; 96: 933-938.

23.  Hou Y, Yue Y, Guo W. et al. Prospectively versus retrospectively ECG-gated 256-slice coronary CT angiography: image quality a

authors: 

Abstract:

Contrast-induced encephalopathy is a rare complication of endovascular injection of contrast agent.

Aim: was to analyze available medical literature data, concerning the contrast-induced encephalopathy prevalence, etiology and pathogenesis, clinical and imaging manifestation.

Materials and methods: publications with key words «contrast-induced encephalopathy» were selected in Pubmed (wwwpubmed.com). From 34 articles, 15 full-text articles with avaliable description of contrast-induced encephalopathy were selected. We analyzed cases of contrast-induced encephalopathy described in literature, presented main causes and pathogenesis, clinical manifestation and imaging findings, prophylaxis and treatment.

Results: development of this complication could be observed after injection of contrast agent into lumen either cerebral arteries or extracerebral ones. Based on the literature analysis, two main types of contrast-induced encephalopathy described: stochastic (accidental) and deterministic (predefined).

Conclusion: contrast-induced encephalopathy recognition, differential diagnostic with stroke and intracranial hemorrhage allow making correct prognosis and getting an adequate treatment tactics, when everything is done promptly.  

 

References 

1.    Baik S.K. et al. Immediate CT findings following embolization of cerebral aneurysms: suggestion of blood-brain barrier or vascular permeability change. Neuroradiology. 2008 Mar;50(3):259-266.

2.    Yu J.; Dangas G. Commentary: New insights into the risk factors of contrast-induced encephalopathy. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists. 2011 Aug;18(4):545-546.

3.    Junck L.; Marshall W.H. Neurotoxicity of radiological contrast agents. Ann. Neurol. 1983 May;13(5):469-484.

4.    Yan J. Ramanathan V. Severe encephalopathy following cerebral arteriogram in a patient with end-stage renal disease. Seminars in dialysis. 2013 Mar-Apr; 26(2):203-207.

5.    Uchiyama Y et al. Blood brain-barrier disruption of nonionic iodinated contrast medium following coil embolization of a ruptured intracerebral aneurysm. AJNR Am.J. Neuroradiol. 2004 Nov-Dec;25(10):1783-1786.

6.    Leong S. Fanning N.F. Persistent neurological deficit from iodinated contrast encephalopathy following intracranial aneurysm coiling. A case report and review of the literature. Interv. Neuroradiol. 2012 Mar;18(1):33-41.

7.    Heyman S.N. et al. Radiocontrast agents induce endothelin release in vivo and in vitro. J. Am. Soc. Nephrol. 1992 Jul;3(1):58-65.

8.    Stanimirovic D.B. et al. Arachidonic acid release and permeability changes induced by endothelins in human cerebromicrovascular endothelium. Acta Neurochir Suppl (Wien). 1994;60:71-75.

9.    Touhami S. et al. Everolimus-induced posterior reversible encephalopathy syndrome and bilateral optic neuropathy after kidney transplantation. Transplantation. 2014 Dec 27;98(12):e102-104.

10.  Nishijima H. et al. Asymmetric Posterior Reversible Encephalopathy Syndrome due to Hypertensive Encephalopathy. Internal. medicine (Tokyo, Japan). 2015;54(8):993-994.

11.  Wagih A. et al. Posterior Reversible Encephalopathy Syndrome (PRES): Restricted Diffusion does not Necessarily Mean Irreversibility. Pol. J. Radiol. 2015;80:210-216.

12.  Yafour N. et al. Cyclosporine-related brainstem atypical posterior reversible leukoencephalopathy syndrome following hematopoietic stem cell transplant. Hematol. Oncol. Stem. Cell Ther. 2015 Apr 28.

13.  Guimaraens L. et al. Transient encephalopathy from angiographic contrast: a rare complication in neurointerventional procedures. Cardiovascular and interventional radiology. 2010 Apr;33(2):383-388.

14.  Nagamine Y et al. Contrast-induced encephalopathy after coil embolization of an unruptured internal carotid artery aneurysm. Internal medicine (Tokyo, Japan). 2014;53(18):2133-2138.

15.  Merchut M.P. Richie B. Transient visuospatial disorder from angiographic contrast. Archives of neurology. 2002 May;59(5):851-854.

 

Abstract:

Aim: was to evaluate the safety and efficacy of coronary stents «MedEng» and to compare them with results of the use of other coronary stents.

Materials and methods: the study included 147 patients with coronary artery disease, which in the period from January to March 2014 underwent coronary stenting. Stents «MedEng» were implanted in 61 patients (group 1). The second group (control) consisted of 86 patients who underwent implantation of stents «Driver». Average follow-up was 6,2±0,5 months. Endpoints were: the return or retention of not less than 2 angina functional class (on CCS); death by cardiac causes, myocardial infarction (MI), repeated intervention on the target vessel, restenosis> 50%, confirmed by angiography and/or the data of optical coherence tomography (OCT)

Results: success rate of stenting was 100%. Death and MI during follow-up were not observed. Restenosis was observed in 9(14,7%) patients in group «MedEng» and in 13 (15,1%) patients from «Driver» group (p = 0,9). The average degree of coronary restenosis was 76,1±8,4% and 76,2±6,4% in the first and second groups, respectively (p=0.9). According to results of logistic regression, stents «MedEng» was not a predictor of restenosis (OR=1,998; 95% CI (0,158-312,551); p = 0,314).

Conclusions: the use of stents «MedEng» is safe and effective in myocardial revascularization. Results of implantation of stents «MedEng» do not different from results of the use of stents «Driver».  

 

References 

1.    Hoffmann R., Mintz G. Coronary in-stent restenosis - predictors, treatment and prevention. European Heart Journal 2000; 21: 1739-1749.

2.    Ben-Dor I., Waksman R., Pichard A.et al. The Current Role of Bare-Metal Stents. Cardiac interv. 2011; 1: 57-62.

3.    Kastrati A., Sch^mig A., Elezi S., Dirschinger J et al. Prognostic Value of the Modified American College of Cardiology/American Heart Association Stenosis Morphology Classification for Long-Term Angiographic and Clinical Outcome After Coronary Stent Placement. Circulation. 1999; 100: 1285-1290.

4.    Lagerqvist B., James S., Stenestrand U., Lindbck J., Nilsson T., Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N. Engl. J. Med. 2007; 356: 1009-1019

5.    Sketch M., Ball M., Rutherford B., Popma J.J., Russell C., Kereiakes D.J. Driver Investigators. Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system. Am. J. Cardiol. 2005;95:8-12.

6.    Farb A., et al., Pathology of acute and chronic coronary stenting in humans. Circulation. 1999; 99(1): p. 44-52.

7.    Sarno G., et al. Lower risk of stent thrombosis and restenosis with unrestricted use of newgeneration drug-eluting stents: a report from the nation wide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur. Heart J. 2012; 33(5): p. 606-13.

8.    Camenzind E., Steg P., Wijns W. Stent thrombosis late after implantation of First-generation drug-eluting stents: a cause for concern. Circulation. 2007; 115: 1440-155.

9.    Lagerqvist B., James S., Stenestrand U., Lindbck J., Nilsson T., Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N.Engl. J. Med. 2007; 356: 1009-1019.

10.  Bavry A., Kumbhani D., Helton T., et al. Late thrombosis of drug-eluting stents: a metaanalysis of randomized clinical trials. Am. J. Med. 2006;119:1056-1061.

11.  Morice M., Urban P., Greene S., Schuler G., Chevalier B. Why are we still using Coronary Bare-Metal Stents? JACC. 2013;61;1122-3.

12.  Steinberg D., Mishra S., Javaid A., et al. Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (>3.5 mm) coronary arteries. Am. J. Cardiol. 2007;99:599-602.

13.  Kim T., Nam C., Hur S., et al. Two-year clinical outcomes after large coronary stent (4.0 mm) placement: comparison of bare-metal stent versus drug-eluting stent. Clin. Cardiol. 2010;33:620-625.

14.  Bocksch W., Pomar F., Dziarmaga M., Tresukosol D et al. Clinical safety and efficacy of a novel thin-strut cobalt-chromium coronary stent system: results of the real world Coroflex Blue Registry. Catheter Cardiovasc. Interv. 2010 Jan 1;75(1):78-85.

15.  Cassese S., Byrne R., Tada T. et al. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart.2014 Jan;100(2):153-9.

16.  Serruys P., Morice M., Kappetein A., et al. SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 2009;360:961-972.

 

 

Abstract:

Choice of treatment strategy in patients with recurrent angina after coronary artery bypass graft surgery (CABG) is still an actual question. Repeat CABG is associated with an increased risk of mortality and large cardiovascular events, so percutaneous coronary intervention (PCI) is the main strategy in these patients. Criteria for choosing between the bypass and the native vessel stenting are not fully understood, as well as not resolved the question of the differentiated approach to the choice of defeat for stenting

Aim: was to compare long-term results of stenting of bypass and native coronary arteries in patients with recurrent angina after CABG using the algorithm proposed in the study.

Materials and methods: study was conducted in 2010-2014 years. in «3rd Central Military Clinical Hospital named after A.A.Vishnevsky of Ministry of Military Defence». A total of 168 patients with the defeat of coronary bypass graft were operated: revascularization of the native vessel - 80 patients, stenting of coronary bypass graft was performed in 88 patients.

Treatment groups were comparable in all major clinical characteristics of patients, as well as on the number of affected arteries, the total number of bypasses, the number of working bypasses, and diffuse lesion of the native channel.

The degree of stenosis of the native vessel was significantly higher in the second group, and the degree of stenosis of bypasses was significantly higher in the first group. Diffuse lesions of coronary bypasses were significantly more frequent in the first group.

Long-term results of the study were followed up in patients in the observation period of 3 to 36 months (mean follow-up was 21(14-27) months). The average duration was not significantly different between treatment groups.

Results: the incidence of myocardial infarction was comparable between groups. In group of coronary bypass graft stenting, revascularization procedures frequency was higher than in the native vessel revascularization (20,45% and 16,25%, respectively, p = 0,0045), and also had a higher incidence of target lesion revascularization (11.36% and 6.25%, respectively, p = 0,0045).

The cumulative rate of major cardiovascular events did not differ significantly, but there was a certain tendency toward a lower incidence of major cardiovascular events in the group of revascularization of the native vessel. 

 

References 

1.    Goldman S., Zadina K., Moritz T., et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J. Am. Coll. Cardiol. 2004; 44:2149 -56.

2.    Бокерия Л.А., Алекян Б.Г. Руководство по рентгеноэндоваскулярной хирургии сердца и сосудов. Москва. Издательство НЦССХ им. А.Н. Бакулева РАМН. 2008. том 3; 592с.

Bokerija L.A., Alekjan B.G. Rukovodstvo po rentgenojendovaskuljarnoj hirurgii serdca i sosudov [Guideline for endovascular surgery of vesels and heart]. Moskva. Izdatel'stvo NCSSH im. A.N. Bakuleva RAMN. 2008. tom 3; 592s [In Russ].

3.    Brilakis E.S., de Lemos J.A., Cannon C.P., et al. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials). Am.J. Cardiol. 2008;102:552-8.

4.    Brilakis E.S., Wang T.Y, Rao S.V., et al. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry. JACC Cardiovasc Interv. 2010; 3:1068-73.

5.    Brodie B.R., Wilson H., Stuckey T., et al. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group. JACC Cardiovasc Interv. 2009; 2:1105-12.

6.    Brilakis E.S1, Rao S.V., Ba

Abstract:

Aim: was to carry out a comparative evaluation of results of stenting of bifurcation lesions in the segment of coronary chronic total occlusions (CTO) using different methods of percutaneous coronary intervention (PCI).

Materials and methods: present study is based on results of treatment of 146 patients (2010-2013) with coronary artery disease (CAD), who underwent CTO recanalization and had bifurcation with side-branch diameter more than 2mm. After successful recanalization of CTO, patients were randomized into two groups with respect to the used method of stenting: a group with stenting of major vessel and side branch with technique «Mini Crush», and a group with Provisional «Т-stenting» technique. The primary composite endpoint - incidence of major adverse cardiac and cerebrovascular events (MACCE), which includes thrombosis, restenosis, repeated intervention in the target vessel, acute myocardial infarction, stroke and cardiovascular death.

Results: absence of MACCE in the remote period of observation was significantly higher when using and amounted to 87,7% against 63,1% at 12 months after surgery

Conclusions: the use of technique «Mini crush» stenting is more effective (to reduce frequency of post-operative complications, risk of restenosis and repeat intervention in long term) in patients with bifurcation lesions in chronic total occlusion of coronary artery in comparison with using «T-provisional» stenting. 

 

References 

1.    Popma J., Mauri L., O’Shaughnessy C., et al. Frequency and clinical consequences associated with side branch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents. Circ. Cardiovasc. Interv. 2009; 2:133-9.

2.    Colombo A., Moses J., Morice M., et al. The randomized study to evaluate sirolimus-eluting stents implanted in coronary bifurcation lesions. Circ. 2004; 109:1244-9.

3.    Garot P, Lefevre T., Savage M., et al. Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) Trial. J. Am. Coll. Cardiol. 2005; 46:606-612.

4.    Nakamura S., Muthusamy T., Bae J., et al. Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusions: multicenter registry in Asia. J. Am. Coll. Cardiol. 2004; 43:35A.

5.    Werner G., Krack A., Schwarz G., et al. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. J. Am. Coll. Cardiol. 2004; 44: 2301-2306.

6.    Hoye A., Tanabe K., Lemos P, et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. J. Am. Coll. Cardiol. 2004; 43: 1954-1958.

7.    Kini A., Lee P, Marmur J., et al. Correlation of post-percutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am. J. Cardiol. 2004; 93:18-23.

8.    Osiev A.G., Baystrukov V.I., Biryukov A.V. Taktika endovaskulyarnogo lecheniya pri bifurkacionnom porazhenii posle rekanalizacii khronicheskoy okklyuzii koronarnyh arteriy.[ Endovascular treatment tactics in patients with bifurcation lesions after recanalization of chronic coronary arteries occlusions]. Diagnosticheskaya i intervencionnaya radiologiya. 2013; 7(1): 27-31[In Russ].

9.    Albiero R., Boldi E. Provisional Stenting Technique for Non-Left Main Coronary Bifurcation Lesions: Patient Selection and Technique. Tips and Tricks in Interventional Therapy of Coronary Bifurcation Lesions, 1st ed. By Issam D. Moussa and Antonio Colombo. London: Informa Healthcare. 2010; 48.

10.  Galassi A., Colombo A., Buchbinder M., et al. Long term outcome of bifurcation lesions after implantation of drug-eluting stents with the «Mini-Crush technique». Catheter. Cardiovasc. Interv. 2007; 69:976-83.

11.  Galassi A., Tomasello S., Capodanno D., et al. «Mini Crush» versus «T-provisional» techniques in bifurcation lesions: clinical and angiographic long-term outcome after implantation of drug-eluting stents. J. Am. Coll. Cardiol. Intv. 2009; 2: 185-94.

 

Abstract:

Stenting of the patent ductus arteriosus (PDA) is a relatively new method of palliative treatment ir children with congenital heart disease (CHD) and is an alternative to systemic-pulmonary shunt.

Aim: was to evaluate the efficacy of stenting in the PDA as a palliative care in children with pulmonary ductus-dependent hemodynamic in «Children Repubfcan Clinical Hospital» (CRCH).

Materials and methods: we analyzed data of 11 patients, with CHD and pulmonary ductus-dependent hemodynamics, who underwent stenting of PDA in CRCH for the period of 2007-2015. To assess the effectiveness of the procedure we took into consideration following data: clinical diagnosis; patient's condition before and after stenting of PDA.

Results: primary stenting of PDA was success in 10 patients, there was no severe complication and death. In 1 patient, there was a stent migration to the pulmonary artery, and due to the closure of the PDA and thus increasing cardiovascular insufficiency, child was taken to the corrective surgery, during which the stent was removed. As a result, in 10 successfully stented patients, in nearest follow-up observation period (15 to 28 days, mean 22 days), 7(70%) patients had a positive effect; in 3 patients progressing hypotension appeared on the 2nd day after the treatment, that leaded to pefrorming of endovascular procedures with Rashkind's method. In the later follow-up observation period, 6 of 7 patients had remaining satisfactory parameters of pulmonary hemodynamics (saturation ranged from 78% to 92%), before using of radical correction of pathology (in terms of 3 to 6 months.).

Conclusion: the stenting procedure for closing of PDA as a palliative treatment for infants with CHD and pulmonary ductus-dependent hemodynamics is effective to stabilize the severe clinical condition of patients prior to radical correction of defects in 60% of cases.  

 

References 

1.    Denise van der Linde, Elisabeth E.M. Konings, Maarten A. Slager, at al. Prevalence of Congenital Heart Disease Worldwide : A Systematic Review and Meta-Analysis. Journal of the American College of Cardiology. 2011; 58(21): 2241-2247.

2.    Emelyanchik E.Y., Kirilova Y.P., Yakshanova S.V., et al. Rezultaty primeneniya preparata prostoglandina E1 Vazaprostana v lechenii detey s duktus-zavisimym krovoobrascheniem. [Results of drug prostaglandin E1 Vazaprostan in treatment of children with ductus-dependent hemodynamics]. Sibirskoe meditsinskoe obozrenie. 2013; 6: 68-72. [In Russ].

3.    Mirolubov L.M. Vrozhdyennye poroki serdtsa u novorojdennykh I detey pervogo goda zhizni. [Congenital heart defects in newborns and infants]. Kazan. 2008: 33-51. [In Russ]

4.    Vakhvalova I.V., Idov Е.М., Shirogorova A.V.,et al. Duktus- zavisimye vrozhdennye poroki razvitiya serdtsa u detey: osobennosti klinicheskogo techeniya na etapakh do- i posleoperatsionnogo vykhazhivaniya. [Ductus-dependent congenital heart disease in children: clinical features at stages of pre- and postoperative nursing.] Vestnik uralskoy meditsynskoy akademicheskoy nauki. 2008; 2: 47-52. [In Russ]

5.    Bokeriya L.A., Alekyan B.G. Rukovodstvo po rentgenendovaskulyarnoy hirurgii serdtsa I sosudov. [Guidelines for endovascular surgery of the heart and blood vessels. The 3 volumes.] Т 2. Moskow. 2013; 289-303. [In Russ].

6.    Berishvili I.I., Garibyan V.A., Aleksii-Meskhishvili V.V., et al. Priobretyennaya deformastiya legochnoy arterii posle nalozheniya mezharterialnogo anastomoza u detey rannego vozrasta. [Acquired deformity of the pulmonary artery anastomosis after the imposition between arterial in infants]. Grudnaya khirurgiya. 1978; 5: 51-56. [In Russ]

The Present and Future of Radiation Diagnostics in Russia



For quoting:
Shutikhina I.V. "The Present and Future of Radiation Diagnostics in Russia ". Journal Diagnostic & interventional radiology. 2009; 3(2); 111-113.
authors: 


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

 

Article exists only in Russian.



 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.

 

Abstract:

Purpose. Evaluation of twelve-year results of abdominal aortic aneurysm treatment by Ella stent-grafts with regard to safety and effectiveness in relation to morphology of the aneurysm.

Methods. From a group of 297 patients with abdominal aortic aneurysm, for whom elective endovascular treatment was considered, 204 of them (68,68%) were found to be suitable for this type of therapy. The bifurcated type of stent-graft was implanted in 176 patients, uniiliacal type in 23 patients and only 5 patients were found to be suitable for tubular type of stent-graft. Additional necessary procedures (internal iliac artery occlusion or contra lateral common iliac artery occlusion in a group of patients with uniiliacal type of stent-graft) were performed surgically during the stent-graft implantation.

Results. Primary technical success was achieved in 193 of the 204 patients (94,6%). Primary endoleak was recorded in 11 patients (primary endoleak type I in 7 patients, type I b in 3 patients and type III a in one patient). Assisted technical success after reintervention or spontaneous seal was 99,02%.

Surgical conversion was indicated in 2 patients (0,98%). Perioperative mortality rate was 3,43%. In 20 patients (9,80%) secondary endoleak type II and in 4 patients (1,96%) secondary endoleak type III was found at control CT and in three patients partial thrombosis of the stent-graft was found. There was one aneurysm rupture during follow-up.

Conclusion. Treatment of abdominal aortic aneurysm with Ella stent-graft system is effective and safe. Bifurcated stent-graft is the most frequently used type. Uniiliacal type of stent-graft is used by us only in cases of complicated morphology. 

 

References

 

1.        Collin T., Araujo L., Walton J., Lindsell D. Oxford screening program for abdominal aortic aneurysm in men aged 65 to 74 years. Lancet. 1988; 2: 613–615.

 

 

2.        Scott R.A.P., Ashton H.A., Kay D.N. Abdominal aortic aneurysm in 4237 screened patients: prevalence, development and management over 6 years. Br. J. Surg. 1991; 78: 1122–1125.

 

 

3.        Taufelsbauer H., Prusa A.M., Wolff K., Polterauer P., Nanobashvili J., Prager M., Holzenbein T., Thurnher S., Lammer J., Schemper M., Kretschmer G., Huk I. Endovascular stent-grafting versus open surgical operation in patients with infrarenal aortic aneurysms. A propensity score – adjusted analysis. Circulation. 2002; 106: 782–787.

 

 

4.        Schumacher H., Allenberg J.R., Eckstein H.H. Morphological classification of abdominal aortic aneurysm in selection of patients for endovascular grafting. Br. J. Surg. 1996; 83: 949–950.

 

 

5.        White G.H., May J., Petrasek P. Specific complications of endovascular aortic repair. Semin. Intervent. Cardiol. 2000; 5: 35–46.

 

 

6.        Geller S.C. Imaging guidelines for abdominal aortic aneurysm repair with endovascular stent grafts. J. Vasc. Interv. Radiol. 2003; 14: 263–264.

 

 

7.        Blum U., Voshage G., Lammer J., Beyersdorf F., Tollner D., Kretschmer G., Spillner G., Polterauer P., Nagel G., Holzenbein T. Endoluminal stent-grafts for infrarenal abdominal aortic aneurysms. N. Engl. J. Med. 1997; 336: 13–20.

 

 

8.        Hausegger K.A., Mendel H., Tiessenhausen K., Kaucky M., Aman W., Tauss J., Koch G. Endoluminal treatment of infrarenal aortic aneurysms: Clinical experience with the Talent stentgraft system. J. Vasc. Interv. Radiol. 1999; 10: 267–274.

 

 

9.        Kato N., Dake M.D., Semba C.P., Razavi M.K., Kee S.T., Slonim S.M., Samuels S.L.W., Terasaki K.K., Zarins C.K., Mitchell R.S., Miller D.C. Treatment of aortoiliacal aneurysms with use of single-piece tapered stent-grafts. J. Vasc. Interv. Radiol. 1998; 9: 41–49.

 

 

10.      Tutein Nolthenius R.P., van Herwaarden J.A., van den Berg J.C., van Marrewijk C., Teijink J.A., Moll F.L. Three year single centre experience with the AneuRx aortic stent-graft. Eur. J. Vasc. Endovasc. Surg. 2001; 22: 257–264.

 

 

11.      Hill B.B., Wolf Y.G., Lee W.A., Arko F.

 

Abstract:

It has been described the experience of use of automatic injector Mark V Pro Vis (Medrad) for endovascular interventions in pediatry. The choice of optimal roentgen contrast media for angiography and endovascular interventions is considerated. It has been concluded that contrast enhancement by iopromide and automatic injector Mark V Pro Vis is effective and safety method of visualization of vessels, tumors and other pathology.  

  

References

1.      Поляев Ю.А., Мыльников А.А. Эндоваскулярная окклюзия в лечении гиперваскулярных образований головы. Практикующий врач. 2003; 1: 38–41.

2.      Поляев Ю.А., Щенев С.В. Опыт лечения некоторых форм ангиодисплазий периферической локализации у детей. Практикующий врач. 2003; 1: 42–45.

3.      Поляев Ю.А., Шимановский Н.Л., Лазарев В.В., Голенищев А.И. Десятилетний опыт использования неионного рентгеноконтрастного средства Ультравист в детской интервенционной радиологии. Детская больница. 2004; 1: 55–60.

4.      Сергеев П.В., Поляев Ю.А., Юдин А.Л., Шимановский Н.Л. Контрастные средства. М: Известия. 2007; 496.

5.      Liss P., Persson P.B., Hansell P., Lagerqvist B. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int. 2006;. 70: 1811–1817.

6.      Ultravist. Monograph, Schering AG, Berlin, Second edition. 2005; 72.

7.      Misawa M., Sato Y., Hara M. et al. Use of non-ionic contrast medium, iopromide (Proscope-370), in pediatric cardiovascular angiography. Nihion Shoni Hoshasen Gakkai Zasshi. 2000; 2: 42–48.

8.      Liss P., Hansell P., Lagerkvist B. Higher Incidence of Renal Failure in 23 224 Patients Using Iso-osmolar Compared to Low-osmolar Contrast Media during Coronary Interventions in Swedish Hospitals. RSNA, 2008; SSG 08–01.

 

 

Abstract:

Purpose. To assess the effectiveness of palliative endovascular interventions in patients with CTO anatomy infavorable for recanalisation.

Material and methods. The authors analyzed the results of interventions in 60 patients (50 male (83,3%), 10 female (16,7%)) aged 38 – 75 years (mean age 53,9±3,2), with occlusive coronary disease. Palliative revascularizations were performed in 30 patients, and CTO recanalization was done in 30 cases. The LV function was assessed echocardiographically in both groups before and after the intervention.

Results. 12 month follow-up showed significant improvement or normalization of LV function in both groups. Results of palliative interventions were shown to be as effective as recanalization of CTO.

Conclusions. Endovascular palliation is effective in treatment of patients with coronary CTO. It results in myocardial function improvement comparable to that in patients with complete coronary revascularization.   

 

References

1.        Danchin N., Angioi M., Rodriguez R. Angioplasty in chronic coronary occlusion. Arch. Mal. Coeur Vaiss. 1999, 99 (11): 1657–1660.

2.        Meier B. Chronic total coronary acclusion angioplasty. Cathet Cardiovasc. Diagn, 2006; 25: 1–11.

3.        Ганюков В.И., Осиев А.Г. Частные вопросы коронарной ангиопластики. Новосибирск. 2002; 4–23.

4.        Лопотовский П.Ю., Яницкая М.В. Клинический эффект эндоваскулярной реперфузии миокарда в бассейне длительно окклюзированной коронарной артерии. Между народный журнал интервенционной кардиоангиологии. 2006; 10: 22–26.

5.        Султан М.В. Реваскуляризация миокарда при остром коронарном синдроме. Авто-реф. дис. канд. мед. наук. М. 2006: 15–20.  

6.        Иоселиани Д.Г., Громов Д.Г., Сухоруков О.Е., Хоткевич Е.Ю., Семитко С.П., Исаева И.В., Верне Ж.-Ш., Арабаджян И.С., Овесян З.Р., Алигишева З.А. Хирургическая и эндоваскулярная реваскуляризация миокарда у больных с многососудистым поражением венечного русла: сравнительный анализ ближайших и среднеотдаленных результатов. Международный журнал интервенционной кардиоангиологии. 2008; 15: 22–31.

7.        Араблинский А.В. Степень реваскуляризации миокарда с помощью транслюминальной баллонной ангиопластики у больных с многососудистым поражением коронарного русла. Международный медицинский журнал. 2000; 1: 2–6.

8.        Ott R.A., Tobis J.M., Mills T.C., Allen B.J., Dwyer M.L. ECMO assisted angioplasty for cardiomyopathy patients with unstable angina. Department of Cardiothoracic Surgery, University of California. Irvine Medical Center. 2006.  

9.        Gaudino M., Santarelli P., Bruno P., Piancone F.L., Possati G. Palliative coronary artery surgery in patients with severe noncardiac diseases. Department of Cardiac Surgery, Catholic University. Rome. Italy. 2006.  

10.      Гринхальх Т. Основы доказательной медицины. Учебное пособие. М. 2004; 58.  

11.      Петросян Ю.С., Иоселиани Д.Г. О суммарной оценке состояния коронарного русла у больных ишемической болезнью сердца. Кардиология. 1976; 12 (16): 41–46.

12.      Петросян Ю.С., Шахов Б.Е. Коронарное русло у больных с постинфарктной аневризмой левого желудочка сердца. Горький. 1983; 17–37.

 

 

13.      Rahimtoola S.H. The hibernating myocardium. Ibid. 1989; 117: 211–221.

 

 

authors: 

 

Abstract:

The author presents the endovascular technique for treatment of the Alzheimer disease. 40 patients aged 34–78 years were included into the study 4 of them were at risk, 13 had early and moderate stage, 16 – full-scaled stage, and 7 had preterminal stage of the disease.

The survey design included computed tomography with temporal lobes volume calculation, brain scintigraphy, rheoencephalography, and digital cerebral angiography.

Temporal lobes atrophy and capillary flow reduction in fronto-parietal and temporal regions are shown to be the characteristic radiomorphological features of the Alzheimer disease. Indications and contrindications for the treatment are presented.

Interventions were pefformed in terms of 1 to 12 years after the disease manifestation. The aim of treatment was percutaneous revascularization and capillary bed restoration by means of transluminal low-energy laser.

Clinical improvement was seen in all the cases; however, it differed in each group of patients. Thus, it is possible not only suspend the advancement of the Alzheimer disease, but to achieve its regression, with regeneration of the brain tissues and to return the people into the active life.  

 

References 

1.        Винблад Б. Болезнь Альцгеймера: эпидемиология, экономические затраты и терапевтические стратегии. Материалы 2-й российской конференции «Болезнь Альцгеймера и старение: от нейробиологии к терапии» 18–20 октября 1999 г. М.: Пульс. 1999; 24.  

2.        Alzheimer’s Disease Facts and Figures 2007. A Statistical Abstract of US Data on Alzheimer’s Disease published by the Alzheimer’s Association. Washington. 2008; 1–30.

3.        Гаврилова С.И., Калын Я.Б., Брацун А.Л. Эпидемиологические аспекты болезни Альцгеймера и других деменций позднего возраста. XII съезд психиатров России. М. 1995; 424–425.

4.        Гаврилова С.И. Практическое руководство по диагностике и лечению болезни Альцгеймера. М.: Медицина. 2002; 43.  

5.        Galasko D. New approaches to diagnose and treat Alzheimer’s disease: a glimpse of the future. Clin. Geriatr. Med. 2001; 17 (2): 393–410.  

6.        Tsuchiya K., Makita K., Furui S., Nitta K. MRI appearances of calcified lesions within intracranial tumors. Neuroradiology. 1993; 35: 341–344.  

7.        Tzika A.A., Robertson R.L., Barnes P.D. et al. Childhood moyamoya disease: hemodynamic MRI. Pediatr. Radiology. 1997; 27: 727–735.  

8.        Rusinek H., de Leon M.J., George A.E. et al. Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology. 1991; 178: 109–114.  

9.        Kesslak J.P., Nalcioglu O., Cotman C.W. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer’s disease. Neurology. 1991; 41: 51–54.  

10.      Жариков Г.А., Рощина И.Ф. Диагностика деменции альцгеймеровского типа на ранних этапах ее развития. Психиатрия и психофармакотерапия. 2001; 2 (2): 3–27.

11.      Гаврилова С.И. Фармакотерапия болезни Альцгеймера. М.: Пульс. 2003; 337.  

12.      Grundman M. Current therapeutic advances in Alzheimer’s disease. In: Research and practice in Alzheimer’s disease. Paris. 2001; 5: 172–177.  

13.      Jacobsen J.S., Reinhart P., Pangalos M.N. Current Concepts in Therapeutic Strategies Targeting Cognitive Decline and Disease Modification in Alzheimer’s Disease. Neuro Rx. 2005; 2: 612–626.

14.      Wilkinson D. Drugs for treatment of Alzheimer’s disease. Int. J. Clin. 2001; 55 (2): 129–134.  

15.      Masse I., Bordet R., Deplanque D. et al. Lipid lowering agents are associated with a slower cognitive decline in Alzheimer’s disease. J. of Neurol., Neurosurg. and Psych. 2005; 76: 1624–1629.  

 

 

Abstract:

Purpose. Define the role of ultrasound diagnostics in preoperative evaluation, surgical approach, and postsurgical assessment in patients with cystous lesions of pancreas underwent various types of pancreatic distal resection (PDR).

Material and methods. Since 1995 till 2008 in Vishnevsky Institute of Surgery (Moscow) 54 patients with distal cystous lesions of pancreas received a course of treatment. Mean age was 50,6+1,2 years, 37 patients (68.5%) were women. Complex pre- and postoperative ultrasound study was performed in all the cases. Morphologically there were true cysts (2 cases), lymphocysts (1 case), postnecrotic cysts (21 patients), serous cystadenoma (9 cases), mucinous cystadenoma (16 cases), and mucinous cystadenocarcinoma (5 cases).

Results. After laparotomy and abdominal revision the following operations were performed:

1. Spleen-preserving distal pancreatic resection;

2. Distal pancreatic resection with splenectomy.

Pancreatic stump assessment revealed 2 possible complications: external pancreatic fistula and sub. phrenic abscess. Spleen-preserving interventions were shown to associate with fewer complication rate, than those with splenectomy.

Conclusions. The cardinal problem is that the PDR associates with repeatedly high complication rate, and the most common complications are external pancreatic fistulas and subphrenic abscesses. As far as the complication rate has the tendency to decrease in spleen-preserving interventions, it is advisable to avoid splenectomy in cases of benign pancreatic lesions.   

 

References

1.        Fahy B.N., Frey C.F., Ho H.S. et al. Morbidity, mortality and technical factors of distal pancreatectomy. Am. J. Surg. 2002; 183 (3): 237–241.

2.        Andren-Sandberg A., Wagner M., Tihanyi T. et al. Technical Aspects of Left-Sided Pancreatic Resection for Cancer. Dig. Surg. 1999; 16 (4): 305–312.

3.        Шалимов А.А. Хирургия поджелудочной железы. М.: Медицина. 1964.

4.        Mayo W.J. The Surgery of the Pancreas: I. Injuries to the Pancreas in the Course of Operations on the Stomach. II. Injuries to the Pancreas in the Course of Operations on the Spleen. III. Resection of Half the Pancreas for Tumor. Ann. Surg. 1913; 58 (2): 145–150.

5.        Алимов А.Н., Исаев А.Ф., Сафронов Э.П. и др. Обоснование безопасности органосохраняющего метода лечения разрыва селезенки в хирургии изолированной и сочетанной травмы живота. Хирургия. 2005; 10: 55–60.

6.        Lee S.Y., Goh B.K., Tan Y.M. et al. Spleen-preserving distal pancreatectomy. Singapore Maed. J. 2008; 49 (11): 883–885.

7.        Warshaw A.L. Conservation of the spleen with distal pancreatectomy. Arch. Surg. 1988; 123 (5): 550–553.

8         Буриев И.М., Икрамов Р.З. Дистальная резекция поджелудочной железы. Анналы хирургической гепатологии. 1997; 2: 136–138.

9.        Kimura W., Fuse A., Hirai I., Suto K. Spleen-preserving distal pancreatectomy for intraductal papillary-mucinoustumor. Hepatogastroenterology. 2004; 51 (55): 86–90.

10.      Edwin B., Mala T., Mathisen O. et al. Laparoscopic resection of the pancreas: a feasibility study of the short-term outcome. Surg. Endosc. 2004; 18 (3): 407–411.

11.      Vezakis A., Davides M., Larvin M., McMahon M.J. Laparoscopic surgery combined with preservation of the spleen for distal pancreatic tumors. Surg. Endosc. 1999; 13 (1): 26–29.

authors: 

 

 

Article exists only in Russian.

authors: 


Article exists only in Russian.

Abstract:

We present case report of patient, with recurrent pulmonary bleeding of malignant genesis and ineffective previous endoscopic hemostasis. During embolization of bronchial artery, to stop massive life-threatening pulmonary bleeding, transradial approach was used for the first time. Full bleeding control was reached after embolization of right bronchial artery with use of microspheres through microcatheter 2,8 Fr. During hospital stage, recurrence of bleeding was not notices; patient discharged on the 7th day in satisfactory condition.

Duration of procedure and radiation exposure at this patient were comparable with same parameters in case of transfemoral approach. Main advantages of this vascular access are increased comfort of the patient after the procedure and the possibility of early activization. Besides, use of transradial vascular approach provides decreased frequency of complications, that is very important among patients with signs of respiratory insufficiency, because of the inability of these patients to stay in bed within a day. 

 

References 

1.    Cowling M.G., Belli A.M. A potential pitfall in bronchial artery embolization. Clin. Radiol. 1995; 50: 105-107.

2.    Haponik E.F., Fein A., Chin R. Managing life-threatening hemoptysis: has anything really changed? Chest. 2000; 118: 1431-1435.

3.    Hirshberg B., Biran I., Glazer M. et al. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest. 1997; 112: 440-444.

4.    Saluja S., Henderson K.J., White R.I. Embolotherapy in the bronchial and pulmonary circulations. Radiol. Clin. North Am. 2000; 38: 425-448.

5.    Chandrasekar B., Doucet S., Bilodeau L. et al. Complications of cardiac catheterization in the current era: a single-center experience. Catheter Cardiovasc. Interv. 2001; 52(3): 289-295.

6.    Sherev D.A., Shaw R.E., Brent B.N. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc. Interv. 2005; 65(2): 196-202.

7.    Tavris D.R., Gallauresi B.A., Lin B. et al. Risk of local adverse events following cardiac catheterisation by hemostasis device use and gender. J. Invasive Cardiol. 2004; 16(9): 459-464.

8.    Mc. Ivor J., Rhymer J.C. 245 transaxillary arteriograms in arteriopathic patients: success rate and complications. Gin. Radiol. 1992; 45: 390-394.

9.    Jolly S.S., Yusuf S., Cairns J. et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011; 377(9775): 1409-1420.

10.  Kanei Y, Kwan T., Nakra N.C. et al. Transradial cardiac catheterization: A review of access site complications. Catheter Cardiovasc. Interv. 2011.

11.  Caputo R.P., Tremmel J.A., Rao S. et al. Transradial arterial access for coronary and peripheral procedures: Executive summary by the transradial committee of the SCAI. Catheter Cardiovasc. Interv. 2011.

 

Abstract:

Fetal with fetal growth restriction (FGR) are at increased risk for acidemia, hypoxemia and adverse perinatal outcomes. Placental insufficiency and FGR are the most common and important clinical problems in obstetrics and the leading causes of perinatal morbidity and mortality. Lots of diagnostic procedures are assessed to evaluate FGR, among them ultrasounds are the most relevant ones. Advances in Doppler velocimetry have improved possibility of assessing cerebral blood flow in this pathology This article discusses the clinical case of brain-sparing effect in fetuses with FGR. Assessment of the fetal cerebral circulation provides important information on the hemodynamic changes associated with chronic hypoxia, intrauterine growth restriction and their clinical management. 

 

References 

1.    Figueroa-Diesel H., Hernandez-Andrade E., Acosta- Rojas R. et al. Doppler changes in the main fetal brain arteries at different stages of hemodynamic adaptation in severe intrauterine growth restriction. Ultrasound Obstet. Gynecol. 2007; 30: 297-302.

2.    Hutter D., Kingdom J., Jaeggi E. Causes and Mechanisms of Intrauterine Hypoxia and Its Impact on the Fetal Cardiovascular System: A Review. J. Pediatr. 2010; 2010: 9 pages.

3.    Zayko N.N., Bytsya Y.V. Pathological physiology. M.: MED-press-inform; 2004; 63 5p [In Russ].

4.    Ageeva M.I. Diagnostic value of Doppler sonography in assessing the functional status of the fetus. Diss. ... dokt. med. nauk. M., 2008; 237 p [In Russ].

5.    Benavides-Serralde A., Hernandez-Andrade E., Fernandez-Delgado J. et al. Three-Dimensional sonographic calculation of the volume of intracranial structures in growth-restricted and appropriate-for-gestational age fetuses. J. Ultras. Obstet Gynecol. 2009; 33(5): 530-537.

6.    Feria L.A., Scheier M., Figueras F. et al. Reference values for Doppler parameters of the fetal anterior cerebral artery throughout gestation. Gynecol Obstet Invest. 2010; 69(1): 33-39.

7.    Lopez D.O. Perinatal and neurodevelopmental out come of late-onset growth restricted fetuses. Programa de Doctorat. Barcelona; 2010; 130 p.

8.    Kurjak A., Pooh R.K., Merce L.T. et al. Brain Vascularity Visualized by Conventional 2D and 3D Power Doppler Technology. J. of Ultrasound in Obstet. and Gynecol. 2010; 4(3): 249-258.

9.    Baschat A.A. Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet. Gynecol. 2011; 37: 501-514.

10.  Ageeva M.I. Doppler sonography study fetal hemodynamics: A guide for doctors. M.: RMAPO; 2006; 4-5[In Russ].

11.  Oros D., Figueras F., Cruz-Martinez R. et al. Middle versus anterior cerebral artery Doppler for the prediction of perinatal outcome and neonatal neurobehavior in term small-for-gestational-age fetuses with normal umbilical artery Doppler. Ultrasound Obstet. Gynecol. 2010; 35: 456-461.

12.  Gadelha-Costa, Spara-Gadelha P, Mauad-Filho F. The maximum systolic velocity increases in middle cerebral arteryof normal fetus from 22nd to 38th week of gestation. Acta MedPort. 2006; 19(2): 105-108.

13.  Cheema R., Dubiel M., Breborowicz G. et al. cerebral venous Doppler velocimetry in normal and high-risk pregnancy. Ultrasound Obstet Gynecol. 2004; 24: 147-153.

14.  Dubiel M., Gunnarsson G.O., Gudmundsson S. Blood redistribution in the fetal brain during chronic hypoxia. Ultrasound Obstet. Gynecol. 2002; 20(2): 117-121.

15.  Medvedev M.V. Fundamentals of Doppler in obstetrics. M: Real time; 2010; 44 p [In Russ].

16.  Rossi A., Romanello I.F., Fachech G. et al. Evaluation of fetal cerebral blood flow perfusion using power Doppler ultrasound angiography (3D-PDA) in growth-restricted fetuses. J Ultrasound in Ob. Gyn. 2011; 38: 175-180.

17.  Valkovich E.I. General and Medical Embryology. SPb.: Foliant; 2003; 317 p[ In Russ].

18.  Kornev M.A. Anatomy of the human embryology to maturity. SPb.: Foliant; 2003; 229 p [In Russ].

19.  Barashnev Y.I. Perinatal neurology. M.: Triada-X; 2005; 672 p[In Russ].

20.  Kurjak A., Pooh R.K., Merce L.T. Structural and functional early human development assessed by threedimensional and four-dimensional sonography. Fertil. Steril. 2005; 84(5): 1285-1299.

21.  Hernandez-Andrade E., Figueroa-Diesel H., Jansson T. et al. Changes in regional fetal cerebral blood flow perfusion in relation to hemodynamic deterioration in severely growth-restricted fetuses. Ultrasound Obstet Gynecol. 2008; 32: 71-76.

 

Abstract:

Aim: was to estimate the functionality of the nanokoloid drug labeled with technetium-99m for scintigraphy and intraoperative detection of «sentinel» lymph nodes (SLN) in experimental animals.

Materials and methods: the study was performed in 6 series of experiments, including 5 white male rats line «Wistar» weighing 300-350 g. Injection of radiopharmaceuticals (RPh) at a dose of 18-20 MBq were performed between the first and second fingers of the front paws of rats.

Results: in scintigraphic studies STL noted that RPh «Nanocolloid, 99mTc-Al2O3» accumulation reaches a plateau at the node (10.2%) for 2 hour study and its percentage content is stored at this level until 24 h. Intraoperative study, in all cases it was possible to visualize the STL.

Conclusions: results shows functional fitness RPh «Nanocolloids,99mTc-Al2O3» for scintigraphy and intraoperative detection of «sentinel» lymph nodes. 

 

References

1.     Semiglazov V.F. Novoe napravlenie v sberegatel'nom i organosohranjajushhem hirurgicheskom lechenii zlokachestvennyh opuholej. [A new trend in savings and organ-surgical treatment of malignant tumors]. Medicinskij vestnik 2009; 35 (504): 12-24 [In Russ].

2.     Abu-Rustum N.R., Knoury-Collado F., Gemignani M.L. Tehniques of sentinel lymph node identification for early-stage cervical and uterine cancer. Gynecol. Oncol. 2008; 111(2): 44-50.

3.     Altgassen C., Hertel H. et al. Multicenter valida- cion study of the sentinentel lymph node concept in cervical cancer: AGO Study Group. J. Clin. Oncol. 2008; 26: 2943-2951.

4.     Kuznecov V.V., Lebedev A.I., Morhov K.Ju., Gricaj A.N. Hirurgija invazivnogo raka shejki matki [Surgery is invasive cervical cancer]. Prakticheskaja onkologija. 2002; 3(3): 178-182 [In Russ].

5.     Hauspy J., Beiner M., Harley А. Sentinel Lymph Node in early stage cervical cancer. Gynecol. Oncol. 2008; l08 (1): 256-257.

6.     Takeda N., Sakuragi N., Takeda M. et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet. Gynecol. Scand. 2002; 81: 1144-1151.

7.     Seong S.J., Park H., Yang K.M. et al. Detection of sentinel lymph nodes in patients with early stage cervical cancer. J. Korean Med. Sci. 2007; 22 (1): 105-109.

8.     Baggish M.S., Karram M.K. Atlas anatomii taza i ginekologicheskoj hirurgii [Atlas of pelvic anatomy and gynecologic surgery]. London: Izd-vo Elsevier Ltd. 2009; 1172 [In Russ].

9.     Lawrenz B., Jauckus J., Kupka M.S. et al. Fertility preservation in >1,000 patients: patient’s characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch. Gynecol. Obstet. 2010; 283(3): 651-656.

10.   Klinicheskaja onkoginekologija: Rukovodstvo dlja vrachej. (Pod red. V.P Kozachenko) [Clinical cancers: A Guide for Physicians. (Ed. V. Kozachenko)]. M.: Medicina, 2005; 431[In Russ].

11.   Abu-Rustum N.R., Neubauer N., Sonoda Y et al. Surgical and pathologic outcomes of fertility-sparing radical abdominal trachelectomy for FIGO stage IB1 cervical cancer. Gynecol. Oncol. 2008; 111(2): 261-264.

Possibilities of multislice computed tomography in forensic sudden cardiac death



DOI: https://doi.org/10.25512/DIR.2015.09.3.09

For quoting:
Kokov L.S., Kinle A.F., Dubrova S.E., Filimonov B.A. "Possibilities of multislice computed tomography in forensic sudden cardiac death". Journal Diagnostic & interventional radiology. 2015; 9(3); 64-75.

Abstract:

Literature report provides a critical analysis of the literature on the use of multislice computec tomography (MSCT) as an alternative to conventional autopsy in forensic examination in case of sudden death associated with target-organ damage in arterial hypertension (AH). The review was made using Internet resources: Scientific Electronic Library (elibrary), SciVerse (ScienceDirect), Scopus, PubMed, and Discover. The review includes only those articles that discuss both advantages and limitations of MSCT in the posthumous forensic sudden death of adults.

During analysis of the available literature, authors discuss the problem of posthumous use of MSCT imaging in arterial hypertension complications: myocardial infarction, brain stroke, aneurysm rupture and separation of the aortic wall. Authors tried to answer the question about possibilities of posthumous MSCT as an alternative to the traditional autopsy

Conclusion: native MSCT is suitable for imaging of intracranial hemorrhage and differential diagnosis of traumatic brain injury Method is suitable with restrictions for diagnosis of ischemic strokes, aneurysms and aortic dissection. Possibilities of native MSCT in the diagnosis of sudden death associated with the pathology of coronary artery disease, myocardial infarction and pulmonary embolism is significantly limited. Using postmortem CTA, extends method in the diagnosis of lesions of the coronary arteries, aorta and pulmonary artery.

The main advantage of MSCT in the posthumous sudden death - the possibility of visualizing hidden mechanical damage in case of failure of the autopsy relatives. 

 

References 

1.    Sudebnaja medicina i sudebno-medicinskaja jekspertiza: nacional'noe rukovodstvo [Forensic medicine and forensic examination: national leadership.]. Pod red. Ju. I. Pigolkina. M.: Gjeotar-Media, 2014;.664-679 [In Russ].

2.    Rukovodstvo po sudebnoj medicine [Guide to Forensics.]. Pod red. V. N. Krjukova, I. V. Buromskogo. M.:OAO Izdatel'stvo Norma. 2014; 364-371[In Russ].

3.    Thali M. J., Yen K., Schweitzer W., Vock P., Boesch C.,Ozdoba C., Schroth G., Ith M., Sonnenschein M., Doernhoefer T., Scheurer E., Plattner T., Dirnhofer R. Virtopsy, a new imaging horizon in forensic pathology: virtual autopsy by postmortem multislice computed tomography (MSCT) and magnetic resonance imaging (MRI) a feasibility study. J. Forensic Sci. 2003; 48 (2): 386-403.

4.    Levy A.D., Harcke H.T., Mallak C.T. Postmortem imaging: MDCT features of postmortem change and decomposition. Am. J. Forensic Med. Pathol. 2010 Mar; 31(1):12-7.

5.    Grabherr S., Djonov V., Friess A., Thali M.J., Ranner G., Vock P., Dirnhofer R. Postmortem angiography after vascular perfusion with diesel oil and a lipophilic contrast agent. AJR. Am. J. Roentgenol. 187 (5): W515-23.

6.    Jackowski C., Persson A., Thali M.J. Whole body postmortem angiography with a high viscosity contrast agent solution using poly ethylene glycol as contrast agent dissolver. J.Forensic.Sci. 2008;53(2):465-8.

7.    Murakami T., Uetani M., Ikematsu K., Nagasaki J.P. Postmortem CT in emergency deparment: Influence of cardiopulmonary resuscitation. European Society of Radiology. EPOS. C-1440.

8.    Shiotani S., Kohno M., Ohashi N., Yamazaki K., Itai Y Postmortemintravascularhigh-densityfluidlevel (hypostasis): CTfindings. J. ComputAssistTomogr. 2002 NovDec; 26(6):892-3.

9.    Yamazaki K., Shiotani S., Ohashi N., Doi M., Honda K. Hepatic portal venous gas and hyper-dense aortic wall as postmortem computed tomography finding. LegMed (Tokyo). 2003 Mar; 5Suppl 1:S338-41.

10.  Shiotani S., Kohno M., Ohashi N., et al. Hyperattenuating aortic wall on postmortem computed tomography (PMCT). Radiat. Med. 2002; 20(4): 201-6.

11.  Christe A., Flach P., Ross S., Spendlove D., Bol- liger S., Vock P., Thali M.J. Clinical radiology and postmortem imaging (Virtopsy) are not the same: Specific and unspecific postmortem signs. LegMed (Tokyo). 2010 Sep;12(5):215-22.

12.  Takahashi N., Satou C., Higuchi T., Shiotani M., Maeda H., Hirose Y Quantitative analysis of brain edema and swelling on early postmortem computed tomography: comparison with antemortem computed tomography. Jpn. J. Radiol. 2010 Jun;28(5):349-54.

13.  Zerbini T., Ferrazda SilvaI L.F., Gongalves Ferro A.C., et al. Differences between postmortem computed tomography and conventional autopsy in a stabbing murder case. Clinics. 2014 SroPaulo Dec; 69:10.

14.  Schnider J., Thali M. J., Ross S., Oesterhelweg L., Spendlove D., Bolliger S.A. Injuries due to Sharp trauma detected by post-mortem multislice computed tomography (MSCT): a feasibility study. Leg Med (Tokyo). 2009;11(1):4-9.

15.  Cha J.G., Kim D.H., Kim D.H., Paik S.H., Park J.S., Park S.J., et al. Utility of postmortem autopsy via whole-body imaging: initial observations comparing MSCT and 3.0T MRI findings with autopsy findings. Korean J. Radiol. 2010;11(4)395-406.

16.  Takahiro Z., Teruhiko T., Miyamoto M., Yamaguchi S., Endo T., Inaba H. Intravascular gas in multipleorgans detected by postmortem computed tomography: effect of prolonged cardiopulmonary resuscitation on organ damage in patient swith cardiopulmonary arrest. Jpn. J. Radiol. 2011; 29(2):148-51.

17.  Shiotani S., Kohno M., Ohashi N., Atake S., Yamazaki K., Nakayama H. Cardiovascular gas on non-traumatic post-mortem computed tomography (PMCT): thein- fluence of cardiopulmonaryre suscitation. Radiat. Med. 2005 Jun;23(4):225-9.

18.  Pedal I., Moosmayer A. Mallach H.J., et al. Air embolism or putrefaction? Gas analysis ndings and their interpretation. Z. Rechtsmed. 1987;99:151-67.

19.  Patzelt D., Lignitz E., Keil W., et al. Diagnostic problem of air embolism in acorpse. Beitr Gerichtl Med. 1997;37:401-5.

20.  Ruder T.D., Ross S., Preiss U., Thali M.J. Minimally invasive post-mortem CT-angiography in a case involving a gunshot wound. LegMed (Tokyo). 2010;12(2):57-112.

21.  Ward A. Forensic radiology: The role of crosssectional imaging in virtual post-mortem examinations Joshua Higginbotham-Jones. Radiography. 2014; 1(20): 87-90.

22.  Pohlsgaard C., Leth PM. Post-mortem CT-coronary angiography. Scandinavian Journal of Forensic Science. 2007;13:8-9.

23.  Grabherr S.

authors: 

Abstract:

According to newest clinical studies, 20%-30% of acute coronary syndrome patients without БТ elevation have nonsignificant coronary artery stenosis

Aim: was to estimate the effectiveness of percutaneous intermittent coronary sinus occlusior (ICSO) in acute coronary syndrome patients without БТ elevation and nonsignificant coronary arteries stenosis.

Materials and methods: results of endovascular treatment of patients with acute coronary syndrome patients without БТ elevation, for the period 09.10.2014-02.02.2015 were analyzed. All patients underwent ICSO for 10-13 minutes until intravenous wedge pressure plateau was achieved.

Results: in the beginning of the intervention all patients had nonsignificant coronary arteries stenosis, peripheral coronary angiospasm and slow flow in left anterior descending arteries (LAD): Т1М1 frame count in LAD (TFCLAD) was 85,9±17,6 frm; distal diameter of LAD (DLAD) was 2,1±0,5 mm; quantitative blush evaluation score in LAD (QuBELAD) was 11,8±1,4. After the ICSO procedure coronary hemodynamic was improved: TFCLAD=59,5±9,8 frm; DLAD=2,5±0,4 mm; QuBELAD= 27,4±2,2; p=0,01).

Conclusion: ICSO procedure led to the both improvement of the antegrade blood flow in LAD anc myocardial blush flow and reduction of the peripheral coronary angiospasm. ICSO procedure significantly improved the electrocardiography and clinical conditions. 

 

References 

1.    2014 ESC/EACT Guidelines on myocardial revascularization/The Task Force on Myocardial Revascalarization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACT). European Heart Journal. 2014; 35(37): 2541-619.

2.    Moiseenkov G.V., Gajfulin R.A., Barbarash O.L., Berns S.A., Barbarash L.S. «Chistye» koronarnye arterii u bol'nyh ostrym koronarnym sindromom: [«Clean» coronary arteries in patients with acute coronary syndrome]. Mezhdunarodnyj zhurnalintervencionnoj kardioangiologii. 2008;14: 17 [In Russ].

3.    Ong P., Athanasiadis A., Hill S. Vogelsberg H. et al. Coronary Artery Spasm as a Frequent Cause of Acute Coronary Syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. JACC. 2008; 52 (7): 528-530.

4.    Antman E.M., Cohen M., Bernink PJ., McCabe C.H., Horacek T., Papuchis G., Mautner B., Corbalan R., Radley D., Braunwald E. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000; 284(7):835-42.

5.    Tang E.W., Wong C.K., Herbison P Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am. Heart J. 2007 Jan; 153(1): 29-35.

6.    Gibson C.M., Cannon C.P, Daley W.L., et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1995; 93 (5): 879-88.

7.    Porto I., Hamilton-Craig C., Brancati M., Burzotta F., et al. Angiographic assessment of microvascular perfusion-myocardial blush in clinical practice. Am. Heart J. 2010; 160(6):1015-22.

8.    Vogelzang M., Vlaar PJ., Svilaas T. et al. Computer-assisted myocardial blush quantification after percutaneous coronary angioplasty for acute myocardial infarction: a substudy from the TAPAS trial. European Heart Journal. 2009; 30: 594-599.

9.    Van de Hoef T.P, Nolte F., Delewi R. et al. Intracoronary Hemodynamic Effects of Pressure-Controlled Intermittent Coronary Sinus Occlusion (PICSO): Results from the First-In-Man Prepare PICSO Study. Journal of Interventional Cardiology. 2012; 25 (6): 549-556.

10.  Incorvati R.L., Tauberg S.G., Pecora M.G., et all. Clinical applications of coronary sinus retroperfusion during high risk percutaneous transluminal coronary angioplasty. JACC 1993; 22(1):127-34.

11.  Petrov V.I., Nedogoda S.V. «Medicina, osnovannaja na dokazatel'stvah»: Uchebnoe posobie: [Medicine, based on evidence]. Moskva: Gjeotar-Media, 2009; 144 s [In Russ].

12.  Meerbaum S., Lang T.W., Osher J.V., et al. Diastolic retroperfusion of acutely ischemic myocardium. Am. J. Cadiol. 1978; 41:1191-201.

13.  Mohl W., Gangl C., Jusi A., et al. PICSO: from myocardial salvage to tissue regeneration. Cardiovascular Revascularization Medicine. 2015; 16: 36-46.

14.  Valuckien Z., Vasylius T., Unikas R. Left anterior descending coronary artery spasm and «accordion effect» mimicking coronary artery dissection. Medicina. 2014; 50 (5): 309-311.

 

Abstract:

Aim: was to show possibilities of endovascular methods of treatment in patients with acute ischemic stroke in endovascular operation-room of cardiovascular surgical department.

Materials and methods: we present two case reports of treatment of patients with acute ischemic stroke, who were admitted to neurological department during first hours from onset.

Patients underwent CT perfusion, CT angiography of cerebral arteries. For blood-flow restoration, patients underwent thrombectomy

Results: thrombectomy from occluded artery was successful in both cases, that leaded to better recovery of neurological status.

Conclusions: wide application of endovascular techniques for restoration of cerebral blood flow in patients with ischemic stroke in the early hours of the onset of the disease, can lead to a more prosperous clinical outcomes, more rapid and complete recovery of the patient. Important is the presence of specialized personnel with appropriate skills and a wide spectrum of endovascular instruments.  

 

References 

1.    Feigin V.L., Lawes C.M.M., Bennet D.A., Anderson C.A. (Stroke epidemiology: a review of population-based studies of incidence, prevalence, and casefatality in the late 20th century. Lancet Neurol. 2003;2:43-53.

2.    Stulin I.D., Musin R.S., Belousov Ju.B. Insul't s tochki zrenija dokazatel'noj mediciny. [Stroke from viewpoint of evidence-based medicine]. Kachestvennaja klinicheskaja praktika. 2003; 4: 10-18 [In Russ].

3.    Varakin Ju.A. Jepidemiologicheskie aspekty profilaktiki narushenij mozgovogo krovoobrashhenija. [Epidemiological aspects of the stroke prevention]. Nervnye bolezni. 2005; 2: 4-9 [In Russ].

4.    Hripun A.V., Malevannyj M.V. i soavt. Pervyj opyt oblastnogo sosudistogo centra ROKB po jendovaskuljarnomu lecheniju ostorogo narushenija mozgovogo krovoobrashhenija po ishemicheskomu tipu [First Experience of Regional Vascular Center ROKB in Endovascular Treatment of ischemic stroke]. Mezhdunarodnyj zhurnal intentencionnoj kardiologii. 2010; 23: 32-42 [In Russ].

5.    Gusev E.I., Skvorcova V.I., Martynov M.Ju. Vedenie bol'nyh v ostrom periode mozgovogo insul'ta [The treatment of the acute phase of the stroke]. Vrach. 2003; 3: 8-24 [In Russ].

6.    Nakano S., Iseda T., Yoneyama T., et. Al. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombollysis. Stroke. 2002; 33: 2872-2876.

7.    White J., Cates Ch., Cowley M. et. al. Interventional stroke therapy: current state of the art and needs assessment. Catheterization and Cardiovascular Intervention. 2007; DOI 10.1002/ccd: 1-7.

8.    Suzuki S., et al. Access to intra-arterial therapies for acute ischemic stroke: an analysis of the US population. AJNR Am. J. Neuroradiol. 2004; 25: 1802-1806.

9.    Wholey M.H, et.al. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc. Interv. 2000; 50: 160-167

 

Abstract:

Percutaneous coronary intervention is a method of choice in patients with recurrence of angina after aorto-coronary bypass. Endovascular interventions after aorto-coronary bypass are associated with a high risk of distal embolism and technical difficulties. On the other hand, revascularization of native coronary arteries in patients after aorto-coronary bypass, leads to worse results than PCI in patients without prior cardiac operations.

Aim: was to compare results of stenting of coronary bypass graft and native artery stenting in patients with recurrence of angina after aorto-coronary bypass, with use of proposed algorithm.

Materials and methods: for the period 2010-2014, in 3rd Central Military Clinical Hospital named after A.A.Vishnevsky of Ministry of Military Defence, 168 patients with coronary bypass defeat underwent operation: in 80 patients native artery reconstruction and in 88 - aorto-coronary bypass graft stenting were performed.

Due to impossible endovascular revascularization, 14 patients underwent repeated aorto-coronary bypass; after that they were excluded from research.

Included into research patietns were treated by different stents: drug-eluting stents (DES), bare metal stents (BMS) and combination BMS+DES. In first group the rate of DES implantation was higher (60% vs 37,5%); in the second group stent placement was comparable (DES 46,6% vs BMS 50%).

The results of this study show that the choice of revascularization strategy according to the presented algorithm, the short-term outcomes of both tactics are comparable.  

 

References 

1.    Epstein A.J., Polsky D., Yang F., Yang L., Groeneveld P.W. Coronary revascularization trends in the United States, 2001-2008. JAMA 2011; 305:1769-76.

2.    Hong M.K., Mehran R., Dangas G., et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J. Am. Coll. Cardiol. 2001; 38:150-4.

3.    Morrison D.A., Sethi G., Sacks J., et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J. Am. Coll. Cardiol. 2002;40:1951-4.

4.    Harskamp R.E., Lopes R.D., Baisden C.E., de Winter R.J., Alexander J.H. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann. Surg. 2013; 257(5):824-833.

5.    Bryan A.J., Angelini G.D. The biology of saphenous vein graft occlusion: etiology and strategies for prevention. Curr. Opin. Cardiol. 1994;9:641-9.

6.    Brilakis E.S., Wang T.Y, Rao S.V., et al. Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry. JACC. Cardiovasc. Interv. 2010;3:1068-73.

7.    Brodie B.R., Wilson H., Stuckey T., et al. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group. JACC. Cardiovasc. Interv. 2009;2:1105-12.

8.    Nguyen T.T., O'Neill W.W., Grines C.L., et al. One-year survival in patients with acute myocardial infarction and a saphenous vein graft culprit treated with primary angioplasty. Am. J. Cardiol. 2003;91:1250-4

9.    Serruys P.W., Stoll H.P., Macours N. et al. Multivessel coronary revascularization in patients with and without diabetes mellitus 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. J. Am. Coll. Cardiol. 2008; 52(24): 1957-1967.

10.  Rodriguez A., Baldi J., Pereira C.F. et al. for the ERACI II Investigators: Five-Year Follow-Up of the Argentine Randomized Trial of Coronary Angioplasty With Stenting Versus Coronary Bypass Surgery in Patients With Multiple Vessel Disease (ERACI II). J. Am. Coll. Cardiol. 2005; 46: 582-588.

11.  Serruys P.W., Donohoe D.J., Wittebols K. et al. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II). Eur. Heart J. 2007; 28(4): 433-442.

12.  Iakovou I., Schmidt T., Bonizzoni E. et al. Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005; 293: 2126-2130.

13.  Banning A.P, Westaby S., Morice M.C. et al. Diabetic and Nondiabetic Patients With Left Main and/or 3- Vessel Coronary Artery Disease: Comparison of Outcomes With Cardiac Surgery and Paclitaxel-Eluting Stents. J. Am. Coll. Cardiol. 2010; 55: 1067-1075.

14.  Kappetein A.P, Dawkins K.D., Mohr F.W. et al. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease.: Insights from the SYNTAX run-in phase. Eur. J. Cardiothorac. Surg. 2006; 29: 486-491.

15.  Serruys P.W., Morice M.C., Kappetein A.P et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. N. Engl. J. Med. 2009; 360: 961-972.

16.  Serruys P.W., Ong A.T., Piek J.J. et al. A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: The SPIRIT fist trial. Eurointervention. 2005; 1: 58-65.

17.  Babunashvili A.M. Ivanov V.A.: Hronicheskie okkljuzii koronarnyh arterij: anatomija, patofiziologija, jendovaskuljarnoe lechenie:[ Chronic occlusion of coronary arteries: anatomy, pathophysiology, endovascular interventions.] Monografija. Moskva: Izdatel'stvo ACB. 2012; 487-509 s [In Russ].

18.  Rolf A., Werner G.S., Schuhback A., et al. Preprocedural coronary CT angiography significantly improves success rates of PCI for chronic total occlusion. Int. J. Cardiovasc. Imaging. 2013 29(8):18191827.

Abstract:

Aim: was to provide design and direct clinical outcomes of ORENBURG (Optimal dRug Eluting steNts implantation guided By combination of intravascular Ultrasound and optical coheRence tomoGraphy) - single-center randomized clinical trial.

Materials and methods: 1032 patients were included in this study These patients were treatec with 6 types of drug eluting stents. Patients were randomized not only to the type of implanted stent, but also to the type of guidance of the procedure: intravascular ultrasound (IVUS) - 676 patients, quantitative coronary arteriography (QCA) - 356 patients. Before the procedure was finished, all patients underwent optical coherence tomography (OCT) analysis. Regardless of its results no more adjacent procedures were performed.

Results: we provide characteristics of patients included in this study These characteristics showed an absence of significant differences between two groups of patients (IVUS and QCA groups) and between subgroups of patients, received different types of DES. While analyzing parameters of index procedure, it was emphasized that IVUS group involved a bigger number of patients with left main disease and bifurcation disease, and also a bigger number of stents per lesion, diameter of first stent, total length of used stents, maximal diameter of the postdilatation balloon. Characteristics of Nobori stent (range of sizes) can explain that significantly smaller diameter and length of the first and the second stent implanted, total length of stents per lesion, and maximal diameter of postdilatation balloon were recorded in the Nobori stent subgroup of patients. Besides that, in that subgroup were no patients with left main disease, smaller number of patients with angiographically evident calcifications, but was a bigger number of patients with circumflex artery disease. Immediate effect of the implantation was obtained in 100% of patients. According to the short-term follow-up, 1 patient died due to the myocardial infarction in the region of the untreated artery

Conclusion: angiographic data, and IVUS and OCT results of analyzed patients are going to be published in the next article.  

 

References 

1.    Mintz G.S. Intracoronary Ultrasound. London and New York: Taylor & Francis. 2005, 408.

2.    Colombo A., Tobis J. Techniques in Coronary Artery Stenting. London: Martin Dunitz. 2000, 422.

3.    Demin V.V. Klinicheskoe rukovodstvo po vnutrisosudistomu ultrazvukovomu skanirovaniyu [Clinical guide to intravascular ultrasound]. Orenburg: Yuzhnyj Ural [South Ural]. 2005; 400.[In Russ].

4.    Demin V.V., Zelenin V.V., Zheludkov A.N. et al. Vnutrisosudistoe ultrazvukovoe skanirovanie pri intervencionnyh vmeshatelstvah na koronarnyh arteriyah: optimalnoe primenenie i kriterii ocenki [Intravascular ultrasound scanning during coronary interventions: optimum application and assessment criteria]. International Journal of Interventional Cardioangiology.2003; 1: 66-72 [In Russ].

5.    Demin V.V., Demin D.V., Dolgov S.A. et al. Sravnenie informativnosti vnutrisosudistogo ultrazvukovogo issledovania I opticheskoj kogerentnoj tomografii vo vremj operacii stentirovanij koronarnyh arterij. [Comparison of intravascular ultrasound and optical coherence tomography informativeness in coronary stenting]. Ultrazvukovye i luchevye diagnostiki v klinicheskoj praktike [Ultrasound and radiology technic in clinical practice]. Ad by Sandrilov V.A., Fisenko E.P., Kulagina T.Yu. Moscow: «Firma STROM». 2012; 12-18 [In Russ].

6.    Demin V.V., Demin D.V., Dolgov S.A. et al. Primemenie vnutrisosudistogo ultrazvukovogo issledovania i opticheskoj kogerentnoj tomografii pri implantacii koronarnyh stentov s lekarstvennym pokrytiem. [Using of intravascular ultrasound and optical coherence tomography in coronary drug-eluting stents implantation]. Oblastnaj bolnitza v sisteme regionalnogo zdravoohranenij. [Regional clinic in regional health care system]. Orenburg: Gazprompechat. 2012; 73-77 [In Russ].

7.    Oemrawsingh P.V., Mintz G.S., Scalij M.J. et al. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenosis: Final results of randomized comparison with angiographic guidance (TULIP Study). Circulation. 2003; 107: 62-67.

8.    Gaster A.L., Slothuus Skjoldborg U., Larsen J. et al. Continued improvement of clinical outcome and cost effectiveness following intravascular ultrasound guided PCI: Insights from a prospective, randomized study. Heart. 2003; 89 (9): 1043-1049.

9.    Gil R.J., Pawlowski T., Dudek D. et al. Comparison of angiographically guided direct stenting technique with direct stenting and optimal balloon angioplasty guided with intravascular ultrasound. The multicenter, randomized trial results. Am. HeartJournal. 2007; 154 (4): 669-675.

10.  Frey A.W., Hodgson J.M., Muller C. et al. Ultrasound-guided strategy for provisional stenting with focal balloon combination catheter. Results from the randomized Strategy for Intracoronary ultrasound-guided PTCA and Stenting (SIPS) trial. Circulation. 2000; 102 (20): 2497-2502.

11.  Fitzgerald P.J., Oshima A., Hayase M. et al. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation. 2000; 102 (5): 523-530.

12.  Sousa A., Abizaid A., Mintz G.S. et al. The influence of intravascular ultrasound guidance on the in-hospital outcomes after stent implantation: results from the Brazilian Society of Interventional Cardiology Registry - CENIC. J. Am. Coll. Cardiol. 2002; 39: 54A.

13.  Russo R.J., Attubato M.J., Davidson C.J. et al. Angiography versus intravascular ultrasound-directed stent placement: final results from AVID. Circulation. 1999; 100: I-234.

14.  Russo R.J., Silva P.D., Teirstein P.S. et al. A Randomized Controlled Trial of Angiography versus Intravascular Ultrasound-Directed Bare-Metal Coronary Stent Placement (The AVID Trial). Cathet Cardiovasc Intervent. 2009; 2: 113-123.

15.  Schiele F., Meneveau N., Vuillemenot A. et al. Impact of intravascular ultrasound guidance in stent deployment on 6-month restenosis rate: a multicenter, randomized study comparing two strategies - with and without intravascular ultrasound guidance. RESIST Study Group. REStenosis after IVUS guided Stenting. J. Am. Coll. Cardiol.1998; 32: 320-328.

Abstract:

Aim: was to investigate possibilities of multislice computed tomography in estimation of stenosis degree in coronary arteries in patients with ischemic heart disease (IHD).

Materials and methods: we examined 64 patients (18 female, 46 male, mean age 62,4± 9,5 years), who primary had been admitted to hospital and had high risk of IHD; and those who had early diagnosed IHD of 1,2,3 and 4 functional class, they were hospitalized for condition correction. Mainly spreaded risk factor was arterial hypertention in 55 patients - (85,9%) with highest level 200/100 mm hg and minimal 140/80 mm hg. All patients underwent multislice computed tomography (MSCT) on the 256-slice tomography station «Somatom definition flash (Siemens, Germany)»: collimation 128 x 0,6, the temporal resolution of 75 ms and a spatial resolution of 0.33 mm, slice thickness of 0.6 mm, with simultaneous use of two tubes with different voltage (kV 120/100), the current mAs - with programs to reduce radiation exposure Care Dose - is calculated automatically according to the constitution of man.

Post-processing of obtained data was performed on a workstation Syngo Via, in the application of CT-Soronary with automatic longitudinal separation of each coronary artery In view of image quality was analyzed data from end-diastolic phase of the cardiac cycle (80% R-R), or evaluated complex of multiphase images. We analyze the state of the main arteries of the main coronary: left anterior descending artery, the circumflex artery and the right coronary artery (LAD, CA, RCA). We performed estimation of coronary artery stenosis of segments according to the American Heart Association (AHA). Results were displayed in percentage. Obtained data was compared with those obtained using the reference method - X-ray coronary angiography, which was performed according to standard protocol

Results: comparison of results of coronary angiography and MSCT using correlation analysis showed the presence of strong direct significant correlation coefficients in the evaluation of coronary artery disease according to two methods. It was demonstrated a high inter-operator and intraoperator reproducibility of MSCT in the study of vessels conditions. Following characteristics of the method related to the identification of coronary artery stenosis segments: sensitivity - 95.8%, specificity - 92.8%, diagnostic accuracy - 95.1%, positive predictive value - 97.9%, negative predictive value - 86.6 %.

It was concluded that the high importance of the method of MSCT in the diagnosis of cardiovascular diseases and the need for its widespread use in cardiology practice.  

 

References 

1.    Chazov E.I. Perspektivyi kardiologii v svete progressa fundamentalnoy nauki. [Prospects of Cardiology in light of the progress of fundamental science.] Ter. Archive. 2009; 9 : 5-8 [In Russ.]

2.    Данилов Н.М., Матчин Ю.Г. и др. Показания к проведению коронарной артериографии. Consilium Medicum. Болезни сердца и сосудов. 2006; 1(1). Danilov N.M., Matchin Yu.G. et al. Pokazaniya k provedeniyu koronarnoy arteriografii. Consilium Medicum. Bolezni serdtsa i sosudov. [Indications for coronary arteriography. Consilium Medicum heart disease and vascular. ]2006; 1(1) [In Russ.].

3.    Sun Z., Choo G.H., Ng K.H. Coronary CT angiography: current status and continuing challenges. Br. J. Radiol. 2012; 85: 495-510.

4.    Sun Z., Aziz YF., Ng K.H. Coronary CT angiography: how should physicians use it wisely and when do physicians request it appropriately. Eur. J. Radiol. 2012; 81: 684-687.

5.    Haberl R., Tittus J., Bohme E. et al. Multislice spiral computed tomographic angiography of coronary arteries in patients with suspected coronary artery disease: an effective filter before catheter angiography. Am. Heart J. 2005; 149: 1112-1119.

6.    Steigner M.L., Otero H.J., Cai T. et al. Narrowing the phase window width in prospectively ECG-gated single heart beat 320-detector row coronary CT angiography. Int. J. Cardiovasc. Imaging. 2009; 25: 85-90.

7.    Achenbach S., Marwan M., Schepis T. et al. High-pitch spiral acquisition: a new scan mode for coronary CT angiography. J. Cardiovasc. Comput. Tomogr. 2009; 3: 117-121.

8.    Budoff M.J., Dowe D., Jollis J.G. et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J. Am. Coll. Cardiol. 2008; 52: 1724-1732.

9.    Petcherski O., Gaspar T., Halon D. et al. Diagnostic accuracy of 256-row computed tomographic angiography for detection of obstructive coronary artery disease using invasive quantitative coronary angiography as reference standard. Am. J. Cardiol. 2013; 111: 510-515.

10.  De Graaf F.R., Schuijf J.D., Van Velzen J.E. et al. Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography in the non-invasive evaluation of significant coronary artery disease. Eur. Heart J. 2010; 31: 1908-1915.

 

Abstract:

Aim: was to estimate possibilities of the CT in patients with anomalies of dental system and asymmetric jaws and to offer a protocol analysis of CT data.

Materials and Methods: 100 patients with anomalies of dental system were examined. They were divided into 4 groups:

- 22 patients with II class without asymmetry of jaws (22%)

- 8 patients with II class with the asymmetry of jaws (8%)

- 52 patients with III class without asymmetry of jaws (52%)

- 18 patients with III class with asymmetry of jaws (18%)

At the stage of preoperative planning, computed tomography was performed. CT protocol of jaws symmetry estimation was developed.

Results: with the help of developed СТ protocol, asymmetry of the maxilla was determined in 11 patients (11.0%): 5 patents (5.0%) with II class, 6 patients (6.0%) with III class. The number of patients with signs of asymmetry of the mandible of II class was 9 patients (9.0%), III class — 13 patients (13.0%). Obtained measurements allowed to analyze degree of asymmetry and calculate required excision and moving of jaws. For planning of surgical stage, CT data of all patients was uploaded into special program «Surgicase CMF».

Conclusions: CT gives possibilities to estimate the anatomy of the facial skeleton and its symmetry; that allows to make plan of further orthognathic surgery.  

 

References 

1.    Posnick J.C. Orthognathic surgery: principles and practice. Elsevier. 2014; 1864 p.

2.    Persin L.S. Ortodontija. Sovremennye metody diagnostiki zubocheljustno-licevyh anomalij [Orthodontics. Modern methods of diagnosis maxillodental-facial anomalies.]. Moskva: OOO «IZPC «Informkniga». 2007; 248 s [In Russ].

3.    Proffit U.R. Sovremennaja ortodontija. Perevod s anglijskogo pod redakciej prof. L.S. Persina[Modern orthodontics. Under editio of prof. L.S. Persina]. M.: Medpress-inform, 2006; S559 [In Russ].

4.    Дробышев А.Ю., Анастассов Г. Основы ортогнатической хирургии. М.: Печатный город, 2007; С 55. Drobyshev A.Ju., Anastassov G. Osnovy ortognaticheskoj hirurgii[Basics of orthognathic surgery]. M.: Pechatnyj gorod, 2007; S55 [In Russ]

5.    Mani V. Surgical correction of facial deformities. JP Medical Ltd, 2010; 290 p.

6.    Ko E.W.C., Huang C.S., Chen YR.J. Characteristics and corrective outcome of face asymmetry by orthognathic surgery. J. Oral. Maxillofac. Surg. 2009; 67: 2201-2209.

7.    Bishara S.E., Burkey PS., Kharouf J.G. Dental and facial asymmetries: A review. Angle Orthod. 1994; 64: 89-98.

8.    Gordina G.S., Glushko A.V., Klipa I.A., Drobyshev A.Ju., Serova N.S., Fominyh E.V. Primenenie dannyh kompjuternoj tomografii v diagnostike i lechenii pacientov s anomalijami zubocheljustnoj sistemy, soprovozhdajushhimisja suzheniem verhnej cheljusti [The use of computed tomography data in the diagnosis and treatment of patients with anomalies of dental system, accompanied by a narrowing maxilla.]. Medicinskaja vizualizacija. 2014; 3: 104-113 [In Russ].

9.    Gateno J., Xia J.J., Teichgraeber J.F. A New ThreeDimensional Cephalometric Analysis for Orthognathic Surgery. J. Oral Maxillofac. Surg. 2012; 69: 606-622.

10.  Kau C. H., Richmond S. Three-dimensional imaging for orthodontics and maxillofacial surgery. Blackwell Publisheng Ltd., 2010; 320 p.

11.  Olszewski R., Zech F., Cosnard G. et al. Threedimensional computed tomography cephalometric craniofacial analysis: experimental validation in vitro. Int. J. Oral Maxillofac. Surg. 2007; 36: 828-833.

12.  Rooppakhun S., Piyasin S., Sitthiseriprati K., Ruangsitt C., Khongkankong W. 3D CT Cephalometric: A Method to Study Cranio-Maxillofacial Deformities. Papers of Technical Meeting on Medical and Biological Engineering. 2006; 6: 75-94, 85-89.

13.&

Abstract:

Aim: was to determine the level of bilateral asymmetry of mineral density of trabecular and cortical bones in lumbar spine in women as an additional diagnostic criterion for osteoporosis, using quantitative computed tomography

Material and methods: the study included 210 women, postmenopausal, who underwent bone densitometry by quantitative computed tomography Estimated total body BMD II-IV of the lumbar vertebrae (separately for trabecular and cortical bone), as well as bilateral asymmetry indices BMD - BMD ratio of the largest one-half of the vertebral BMD to the other half.

Results: with increasing age of the surveyed, noted the growth of bilateral asymmetry index values mineral density of the lumbar vertebrae for both trabecular and cortical bones. Decrease in bone mass of the lumbar vertebrae is associated with an increase in bilateral asymmetry of the BMD. The correlation between the BMD and bilateral asymmetry indices for trabecular bone was r = -0.52 (p=0.001) for cortical bone r = - 0.47 (p=0.001).

Conclusion: the index of bilateral asymmetry in bone mineral density of the vertebral bodies car serve as an additional diagnostic criterion for osteoporosis during bone densitometry by quantitative computed tomography in postmenopausal women.

 

References

1.    Hernlund E., Svedbom A., Ivergard M. et al. Osteoporosis in the European Union: Medical Management, Epidemiology and Economic Burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch. Osteoporos. 2013; 8: 136.

2.    Marshall D., Johnell O., Wedel H. Metaanalysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br. Med. J. 1996; 312: 1254-1259.

3.    Nguyen T., Sambrook P, Kelly P et al. Prediction of osteoporotic fractures by postural instability and bone density. BMJ. 1993; 307: 1111-1115.

4.    Siris E.S. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. Journal of the American Medical Association. 2001; 286 (22): 2815-2822.

5.    ACR-SPR-SSR practice parameter for the performance of quantitative computed tomography (QCT) bone densitometry. Available at: http://www.acr.org/-/media /ACR/Documents/PGTS/guidelines/QCT.pdf Res. 32-2013, Amended 2014 (Res. 39).

6.    These are the Official Positions of the ISCD as updated in 2013. Available at: http://www.iscd.org/official-positions/2013-iscd-official-positions-adult (accessed April 24, 2014).

7.    Zakharov I.S., Kolpinskij G.I., Shkaraburov A.S., Popova O.P. Kolichestvennaja kompjuternaja tomografija i dvuhjenergeticheskaja rentgenovskaja absorbciometrija v diagnostike postmenopauzal'nogo osteoporoza. [Quantitative computed tomography and dual-energy X-ray absorptiometry in the diagnosis of postmenopausal osteoporosis]. Diagnosticheskaja i intervencionnaja radiologija. 2015; 10 (2):19—22. [In Russ].

8.    Bansal S.C., Khandelwal N., Rai D.V. et al. Comparison between the QCT and the DEXA scanners in the evaluation of BMD in the lumbar spine. Journal of Clinical and Diagnostic Research. 2011; 5 (4): 694-699.

9.    Bauer J.S., Virmani S., Mueller D.K. Quantitative CT to assess BMD as a diagnostic tool for osteoporosis and related fractures. Medica Mundi. 2010; 54 (2): 31-37.

10.  Li N., Li X.M., Xu L. et al. Comparison of QCT and DXA: osteoporosis detection rates in post-menopausal women. International Journal of Endocrinology. 2013; March 27. Available at: http://www.ncbi.nlm.nih.gov /pubmed/23606843.

11.  Zaharov I


Article exists only in Russian.

Abstract:

We present report of successful full revascularization of heart during additional adjuvant extracorporeal revascularization (EcR) in case of difficult anatomy of anatomically difficult, multivessel lesions of coronary arteries and reduced ejection fraction (EF) of left ventricular (LV).  

 

Abstract:

Aim: was to improve results of treatment of patients with myocardial infarction who underwent emergency coronary stenting, by prevention of bleeding complications from puncture place.

Materials and methods: we present retrospective analysis of clinical case of interventional treatment of myocardial infarction, with late post-puncture bleeding complication (41 day after PCI). Its consequences caused the thrombosis of the external iliac vein with further pulmonary embolism, and acute reocclusion of previously stented coronary artery

Results: developed complications were surgically treated (recurrent coronary stenting, elimination of defect of the femoral artery, implantation of cava filter with its subsequent removal), and thrombolytic therapy Patient was discharged to outpatient care without any indications of cardiopulmonary insufficiency and compensated arterial and venous circulation of operated lower limb. After 11 months, the patient’s condition was without negative dynamics with a satisfactory quality of life.

Conclusion: this clinical example demonstrates how difficult is to detect bleeding from a puncture wound. In cases of femoral access, the routine use of vascular closure devices can reduce the risk of bleeding complications. 

 

References 

1.    Rekomendacii po lecheniju ostrogo koronarnogo sindroma bez stojkogo pod#joma segmenta ST Evropejskogo obshhestva kardiologov [European cardiological society recommendation: treatment of acute coronary syndrome without stable ST-segment elevation]. Racional'naja farmakoterapija v kardiologii. 2012; 2: 2-64[In Russ].

2.    Sulimov V.A. Antitromboticheskaja terapija pri chreskozhnyh koronarnyh vmeshatel'stvah [Antithrombotic therapy during percutaneous coronary interventions]. Racional'naja farmakoterapija v kardiologii. 2008; 3: 91-100 [In Russ].

3.    Goloshhapov-Aksjonov R.S., Sitanov A.S. Luchevoj arterial'nyj dostup - prioritetnyj dostup dlja vypolnenii chreskozhnoj koronarnoj angioplasti

Abstract:

In clinical practice, ischemic stroke still remains a difficult problem, being in most leading causes of death. Development of new treatments, founding of new therapeutic algorythmes and untiringly technical progress in sphere of instrumental support of operation-room allow to proceed endovascular intervention in group of patients with cardioembolic stroke.

Case report presents successful endovascular treatment of patient from cardio-surgical department of Belgorod Region Clinical Hospital named after St. loasaf, with cardioembolic stroke, onset in preoperative period (before aorto-coronary bypass).

Materials and methods: patient A., 59 years, diagnosis: «Ischemic heart disease. Exertional angina FC II. Post-infarction cardiosclerosis. (AMI in September 2014). Stenosis of coronary arteries according to coronary angiography (CAG), hemodynamically significant. Hypertensive heart disease III st., 2 degree, with the defeat of the heart and blood vessels of the brain, with the achievement of target blood pressure (BP). Diabetes mellitus type 2, the second insulin-depended, stage subcompensation. Risk factor 4. congestive heart failure 2a class, functional class III. Chronic gallstone disease. Chronic calculous cholecystitis without exacerbation». 05.02.15 - onset of ischemic stroke in left hemisphere of brain. Patient urgently underwent: multislice computed tomography (MSCT), MSCT-angiography of main brain arteries, direct angiography of main brain arteries. Survey showed: occlusion of proximal third of left common carotid artery (CCA) with TICI-0 blood flow; left middle cerebral artery (MCA) and anterior cerebral artery (ACA) were filled threw anterior communicating artery (ACoA) from right internal carotid artery (ICA). Patient underwent: recanalization of occlusion, thrombectomy from left CCA, stenting of CCA-ICA segment, selective thrombolythic therapy into left MCA.

Results: «Time-To-Treatment» was 4 hours 15 minutes. Made endovascular treatment leaded to regression of neurological deficit.

Conclusions: the use of endovascular methods in patients with cardioembolic stroke car decrease neurological deficit and increase quality of life of patients in this group.  

 

References 

 

1.    «10 ведущих причин смерти в мире». ВОЗ. Информационный бюллетень №310 от 05.2014.

 

 

2.    Parfenov V.A., Khasanov D.R.. Ishemicheskiy insult. [Ischemic stroke.] «Medicinskoe informacionnoe agenstov». 2012; 298 [In Russ].

 

3.    Fonyakin A.V., Geras'kina L.A. Profilaktika ishemicheskogo insulta. Rekomendacii po antitromboticheskoy terapii. [Prophylaxis of ischemic stroke. Recommendations for antithrombotic therapy] (Pod redaktsiei Z.A. Suslinoy). M: IMA-PRESS. 2014; 72.

 

4.    Michael J. Schneck et al. Overview cardioembolic stroke. Section 20.01.2015 http://emedicine. medscape.com /article/1160370-overview#aw2aab6b2

 

5.    Wilterdink J.L., Furie K.L., Easton D. Cardiak evaluation of stroke patients. Neurology 1998; 51(3): 23-26.

 

6.    Petty G.W., Brown R.D., Whisnant J.P. et al. Ischemic stroke subtypes. A populationbased study of functional outcome, survival and recurrence. Stroke. 2000; 31: 1062-1068.

 

7.    Kelley R.E., Minagar A. Cardioembolic Stroke: An Update. South Med J. 2003; 96(4): 343-349.

 

8.    Secades J.J. Citicoline: pharmacological and clinical review, 2010 update / J. Secades. Revista de Neurologia. 2011; 52(2): 1-62.

 

 

9.    Kuznetsov V.V., Egorova M.S., Fibrillyacia predserdiy kak patogeneticheskiy mekhanizm razvitiya kardioembolicheskogo insulta. [Atrial fibrillation - a pathogenetic mechanism of cardioembolic stroke.] Nevrologia. Kardiologia. 2011; 4(150): 46-49 [In Russ].

 

10.  Mooe Th., Tienen D., Karp K., et al. Long-term follow-up of patients with anterior miocardial infarction complicated by left ventricular thrombus in the thrombolytic era. Heart. 1996; 75(3):252-6.

 

 

11.  Vereshagin N.V., Piradov M.A., Suslina Z.A. (red). Insul’t. Principi diagnostiki, lecheniya I profilaktiki. [Stroke: principles of diagnosis, treatment and prophylaxis.]. M, Intermedika, 2002; 208.

 

 

12.  Suslina Z.A., Vereshagin N.V., Piradov M.A., Podtipi ishemicheskikh narusheniy mozgovogo krovoobrasheniya: diagnostika i lechenie. [Subtypes of ischemic cerebrovascular disorder: diagnosis and treatment]. Consilium medicum. - 2001; 3(5): 218-221.

 

 

13.  Albers G.W., Comess K.A., De Rook F.A. et al. Transesophageal echocardiographic findings in stroke subtypes. Stroke. 1994; 25: 23-28.

 

 

14.  Akhmedov A.D-O. Karotidnaya endarterektomiya u bol’nikh s visokim khirurgicheskim riskom. [Carotid endarterectomy in patients with high operation risk]. Diss. kand.med. Mos

Abstract:

One of complications of using hemodialysis catheters is stenosis or occlusion of central veins. This may cause dysfunction of an ipsilateral arteriovenous fistula in the future. Despite of high restenosis rate - balloon angioplasty is a method of choice.

Materials and methods: we present a case report of successful recanalization and balloon angioplasty of left brachiocephalic vein in a patient, undergoing chronic hemodialysis with a functioning arteriovenous fistula on left forearm .

Results: the absence of restenosis during a year is an evidence of the effectiveness of this methoc as a treatment of central vein stenosis or occlusion in order to preserve and increase duration of use of permanent vascular access. 

 

References

 

1.    Beljaev A.Ju., Kudrjavceva E.S. Rol' vrachej nefrologicheskih i gemodializnyh otdelenij v obespechenii postojannogo sosudistogo dostupa dlja gemodializa[The role of physicians of nephrology and hemodialysis departments in ensuring of permanent vascular access for hemodialysis]. Nefrologija i dializ. 2007; 9(3): 224-227 [In Russ].

 

2.    Hernandez D., Diaz F., Rufino M., Lorenzo V. et al. Subclavian vascular access stenosis in dialysis patients: natural history and risk factors. J. Am. Soc. Nephrol. 998; 9 (8): 1507-1510.

 

3.    Cimochowski G.E., Worley E., Rutherford W.E., Sartain J. et al. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron. 1990; 54 (2): 154-161.

 

4.    Barrett N., Spencer S., Mclvor J., Brown E.A. Subclavian stenosis: a major complication of subclavian dialysis catheter. Nephrol Dial Transplant. 1988; 3 (4): 423-425.

 

5.    Chan M.R., Yevzlin A.S., Asif A. Vascular Access for the General Nephrologist. Nova Science Publishers, Inc (US). 2013; 423.

 

6.    Surratt R.S., Picus D., Hicks M.E., Darcy M.D. et al. The importance of preoperative evaluation of the subclavian vein in dialysis access planning. AJR Am.J. Roentgenol. 1991; 156 (3): 623-625.

 

7.    Dheeraj K. Rajan. Essentials of Percutaneous Dialysis Interventions. Springer. 2011; 604.

 

8.    McNally PG., Brown C.B., Moorhead PJ., Raftery A.T. Unmasking of subclavian vein obstruction following creation of arteriovenous fistulae for haemodialysis. A problem following subclavian line dialysis? Nephrol Dial Transplant. 1987; 1 (4): 258-260.

 

9.    Abbasi M., Soltani G., Karamroudi A., Javan H. Superior Vena Cava Syndrome Following Central Venous Cannulation. International Cardiоvascular Research Journal. 2009; 3 (3): 172-174.

 

10.  KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: Hemodialysis Adequacy, Peritoneal Dialysis Adequacy and Vascular Access. Am. J. Kidney Dis. 2006; 48 (suppl 1): S1-S322.

 

11.  Kundu S. Central venous obstructionmanagement. Semin Intervent Radiol. 2009; 26(2): 115-121. 

12.  Scott O. Trerotola. Venous Interventions. Society of Cardiovascular & Interventional Radiology (SCVIR). 1995; 556.

 

Abstract:

Aim: was to assess dynamics of angiographic parameters of coronary artery rehabilitation, spasm throughout, below chronic coronary occlusion (CCO), after recanalization and balloon angioplasty, with survey of 8-10 weeks, basing on dynamics of anatomical and morphological characteristics of the artery with a major idea to optimize conditions for stenting.

Materials and methods: research analyzes results of two-stage treatment of 26 patients with CCO, complicated by a spasm, by which result after a recanalization of occlusion, was a contrasted artery with diameter less than 1 mm.

In these cases angioplasty with balloons with a diameter up to 3 mm doesn’t yield desirable results and diameter of an artery below a place of occlusion averaged 1,5 mm, and the difference of diameters of proximal and distally department averages 1,78 mm that is an adverse factor for stenting as is followed by high level of restenosis and thrombosis.

Results: within 4-8 weeks (on average 68 days) all arteries remained passable with equal contours, without angiographic signs of dissection, which took place right after balloon angioplasty Diameter of an artery increased with 1,5 mm to 2,64 mm; a difference of diameters of proximal and distally departments of an artery at the level of CCO decreased from 1,78 mm to 0,45 mm that was a favorable condition for stenting.

Conclusion: within 4-8 weeks after recanalization under normal pressure and blood flow occurs a readaptation of artery, expressed in a significant increase in the diameter of the artery below the CCO, which contributes to the optimization of stenting.

 

References

1.    Morino Y, Kimura T., Hayashi Y, Muramatsu T., Ochiai M., Noguchi Y, Kato K., Shibata Y, Hiasa Y, Doi O., Yamashita T., Morimoto T., Abe M., Hinohara T., Mitsudo K.; J-CTO Registry Investigators. In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan). JACC Cardiovasc Interv. 2010 Feb;3(2): pp. 143-51.

2.    Buller C.E., Dzavik V., Carere R.G., Mancini G.B., Barbeau G., Lazzam C., Anderson T.J., Knudtson M.L., Marquis J.F., Suzuki T., Cohen E.A., Fox R.S., Teo K.K. Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). Circulation. 1999 Jul 20;100(3): pp. 236-242.

3.    Gould K.L. Coronary collateral function assessed by PET. In: « coronary artery stenosis and reversing atherosclerosis», Ed. By Gould KL,2-nd edition, New York, NY: Oxford University Press, 1999; pp. 275-282.

4.    Pixmeo company. Dr. Antoine Rosset, Prof. Osman Ratib and Joris Heuberger ( Geneva, Switzerland ), 2004;

5.    Okabe T., Mintz G.S., Buch A.N., Roy P, Hong YJ., Smith K.A., Torguson R., Gevorkian N., Xue Z., Satler L.F., Kent K.M., Pichard A.D., Weissman N.J., Waksman R. Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am. J. Cardiol. 2007 Aug 15;100(4):615-20. Epub 2007 Jun 29.

6.    Costa M.A,, Angiolillo D.J., Tannenbaum M., Driesman M., Chu A., Patterson J., Kuehl W., Battaglia J., Dabbons S., Shamoon F., Flieshman B., Niederman A., Bass T.A.; STLLR Investigators. Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial). Am. J. Cardiol. 2008 Jun 15; 101 (12): 1704-11. doi: 10.1016/j.amjcard.2008.02. 053. Epub 2008 Apr 9.

7.    Hong M.K., Mintz G.S., Lee C.W., Park D.W., Choi B.R., Park K.H., Kim YH., Cheong S.S., Song J.K., Kim J.J., Park S.W., Park S.J. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur. Heart J. 2006 Jun;27(11):1305-10.

8.    Werner G.S., Jandt E., Krack A., Schwarz G., Mutschke O., Kuethe F., Ferrari M., Figulla H.R. Growth factors in the collateral circulation of chronic total coronary occlusions: relation to duration of occlusion and collateral function. Circulation Oct. 2004; 110(14): pp. 1940-1945.

9.    Sakurai R.L., Ako J., Morino Y, Sonoda S., Kaneda G., Terashima M., Hassan A.H., Leon M.B., Moses J.W.. Popma J.J., Bonneau H.N., Yock PG., Fitzgerald PJ., Honda Y. Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). SIRIUS Trial Investigators. Am. J. Cardiol. 2005 Nov 1;96(9):1251-3. Epub 2005 Sep 6.

10.  Cosby R.S., Giddings J.A., See J.R. Coronary collateral circulation. Chest Jul. 1974; 66(1): pp. 27-31.

11.  Kathryn Maiellaro, W. Robert Taylor. The role of the adventitia in vascular inflammation. Cardiovascular Research 2007 Sep 1;75(4): pp. 640-8.

 

Abstract:

Aim: was to improve the efficiency of external drainage in patients with biliary tree obstruction by tumor process in the porta hepatis zone.

Materials and methods: percutaneous transhepatic cholangiostomy under the combined sonofluoroscopic control with using on the first phase of the treatment of self-locking drainages pig tail №8Fr followed by external-internal drainage or endobiliary stenting were performed in 147 patients with «high» tumor block of the biliary tree.

Results: depending on the extent of biliary occlusion there were from 1 to 6 drainages. «Big» post-manipulating complication encountered in one patient (0.7%) - migration of cholangiostomic drainage with the development of biliary peritonitis.

«Small» complications (short-period haemobilia, migration of cholangiostomy amilazemiya at transpapillary insertion of an external-internal drainage) occurred in 20 patients (13.6%). Mortality rate was 6.1%. Death causes: common bile peritonitis (1 case), and the progression of hepatorenal insufficiency on the background of biliary decompression (8 cases).

Conclusion: antegrade cholangiostomy at «high» tumor obstruction of the biliary tree is a necessary manipulation as in palliative biliary decompression, and in the preparation of the patient for radical surgery for Klatskin tumors. Satisfactory performance of postmanipulating complications and in-hospital mortality involve the use of special techniques for effective external and external-internal drainage of bile ducts.  

 

References 

1.    Witzigmann H., Lang H., Lauer H. Guidelines for palliative surgery of cholangiocarcinoma HPB (Oxford). Jun 1, 2008; 10(3): 154-160. doi: 10.1080/13651820801992567 PMCID: PMC2504365.

2.    Rerknimitr R., Kullavanijaya P. Operable malignant jaundice: To stent or not to stent before the operation? World J. Gastrointest. Endosc. 2010 Jan 16;2(1):10-4. doi: 10.4253/wjge.v2.i1.10.

3.    Paik W.H., Loganathan N., Hwang J.H. Preoperative biliary drainage in hilar cholangiocarcinoma: When and how? World J. Gastrointest. Endosc. 2014 Mar 16;6(3):68-73. doi: 10.4253/wjge.v6.i3.68. Review.

4.    Liu F., Li Y, Wei Y, Li B. Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review. Dig. Dis. Sci. 2011 Mar; 56(3):663-72. doi: 10.1007/s10620-010-1338-7. Epub 2010 Jul 16.

5.    Kawakami H., Kondo S., Kuwatani M., Yamato H., Ehira N., Kudo T., Eto K., Haba S., Matsumoto J., Kato K., Tsuchikawa T., Tanaka E., Hirano S., Asaka M. Preoperative biliary drainage for hilar cholangiocarcinoma: which stent should be selected? J. Hepatobiliary Pancreat Sci. 2011 Sep; 18 (5):630-5. doi: 10.1007/s00534-011- 0404-7.

6.    Ustunda Y, Boyvat F. Debate continues over which method we should prefer for the preoperative biliary decompression in cases with hilar cholangiocarcinoma. J. Gastroenterol. 2012 Jan; 47(1):88-9; author reply 90-1. doi: 10.1007/s00535-011-0496-5. Epub 2011 Nov 15.

7.    Nuzzo G., Giuliante F., Ardito F., Giovannini I., Aldrighetti L., Belli G., Bresadola F., Calise F., Dalla Valle R., D’Amico D. F., Gennari L., Giulini S. M., Guglielmi A., Jovine E., Pellicci R., Pernthaler H., Pinna A.D., Puleo S., Torzilli G., Capussotti L., Improvement in perioperative and longterm outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian

Surgical correction of post-traumatic arteriovenous fistula with help of stent-grafts



DOI: https://doi.org/10.25512/DIR.2015.09.2.05

For quoting:
Ivanov V.A., Pinchuk O.V., Obrastchov A.V., Ivanov A.V. "Surgical correction of post-traumatic arteriovenous fistula with help of stent-grafts". Journal Diagnostic & interventional radiology. 2015; 9(2); 42-47.

Abstract:

Aim: was to assess the efficacy of surgical treatment of post-traumatic arteriovenous fistula with use of stent-grafts.

Materials and methods: stent-grafts were successfully used in treatment of 4 patients with post-traumatic arteriovenous fistula (AVF). In 2 cases AVF were located in iliac vessels, in 1 case in shin and in 1 case - thigh. In 3 cases, appearance of AVF was a result of gunshot wound, in 1 case - stab wound

Results: technical success was achieved in all cases. In 1 case after endovascular elimination of AVF on the level of iliac vessels, retroperitoneal hematoma with infection was revealed, that leaded to open surgical operation.

Conclusion: the use of stent-grafts in surgical correction of vessel injury can decrease operational trauma, and can achieve better clinical results and good long-term prognosis.  

 

References

1.    Petrovskij B.V., Milonov O.B. Hirurgija anevrizm perifericheskih sosudov [Surgery of peripheral vessels' aneurysms] M.: Medicina. 1970; 273S [In Russ].

2.    Kugukarslan N.L., Oz B.S., Ozal E.,Yildirim V., Tatar H. Factors affecting the morbidity and mortality of surgical management of vascular gunshot injuries: missed arterial injury and disregarded vein repair. Ulus Travma Acil Cerrahi Derg. 2007;13(1):43-48.

3.    Gavrilenko A.V. Travmaticheskie arteriovenoznye svishhi [Traumatic arteriovenous fistula]. OAO «Izdatel'stvo «Medicina» Klinicheskaja angiologija: Ruk. pod red. A.V. Pokrovskogo. 2004;2: 340-344 [In Russ].

4.    Gavrilenko A.V., Egorov A.A. Tradicionnaja hirurgija sosudov i rentgenjendovaskuljarnye vmeshatel'stva - konkurencija ili vzaimodejstvie, vedushhee k gibridnym operacijam? [Traditional sugery of vessels versus endovascular treatment: competition or cooperation, leading to the hybrid operation?] Angiologija i sosudistaja hirurgija. 2011; 17(4):152-156 [In Russ].

5.    Zotov S.P., Shherbakov A.V., Kugeev A.F., Zajcev S.S., Shakirov R.G., Semashko T.V., Zhabreev A.V., Panov I.O. Klinicheskie osobennosti posttravmaticheskih arterio- venoznyh svishhej [Clinical features of post-traumatic arteriovenous fistula]. Angiologija i sosudistaja hirurgija. 2011; 17(2):133-137 [In Russ].

6.    Li F., Song X., Liu C., Liu B., Zheng Y Endovascular stent-graft treatment for a traumatic vertebrovertebral arteriovenous fistula with pseudoaneurysm. Ann. Vasc. Surg. 2014; 2:489.

7.    Mensel B., Kuhn J.P, Hoene A., Hosten N., Puls R. Endovascular repair of arterial iliac vessel wall lesions with a self-expandable nitinol stent graft system. PLoS One. 2014; 9(8): journal.pone.0103980.

8.    Park H.K., Choe W.J., Koh YC., Park S.W. Endovascular management of great vessel injury following lumbar microdiscectomy. Korean J. Spine. 2013; 4:264-267.

9.    Sin'kov M.A., Murashkovskij A.L., Pogorelov E.A., Golovin A.A., Kalichenko N.A., Haes B.L., Kokov A.N., Heraskov V.Ju., Evtushenko S.A., Popov V.A., Barbarash L.S. Sluchaj uspeshnogo jendovaskuljarnogo zakrytija jatrogennogo arterio-venoznogo soust'ja podvzdoshnoj arterii i veny, projavljajushhegosja venoznym trombojembolicheskim sindromom i pravozheludochkovoj nedostatochnost'ju [Successful endovascular occlusion of iatrogenic arteriovenous fistula of the iliac artery and vein with thromboembolic syndrome and right ventricular insufficiency]. Diagnosticheskaja i intervencionnaja radiologija. 2014; 8(2):98-102 [In Russ].

 

Abstract:

Aim: was to show possibilities of magnetic resonance imaging (MRI) in the detection and characterization of neoplasms of the heart.

Materials and methods: we retrospectively studied clinical cases of heart neoplasms, diagnosed and operated in Federal National Center of Cardiovascular Surgery (FNCCS) (Penza) since 2008 tc 2014. All patients on admission underwent echocardiography, after which, in some cases to clarify the topography of neoplasms and features of individual anatomy - MRI was performed. In postoperative follow-up period, control studies were conducted. In all cases, the diagnosis was histologically verified. All operated patients were discharged in satisfactory condition. We made a search and analysis of scientific literature on beam diagnostics of space-occupying lesions of heart.

Results: for the period of 6 years, in FNCCS were examined and surgical treatment of more than 30 thousand patients, of which neoplasms of the heart were detected in 25(0.08%) cases. Cardiac myxoma was diagnosed in 19(76%) patients, of whom in 2(8%) cases, the echocardiographic picture was mixed, that had required magnetic resonance imaging. MRI has also been used in 2(8%) patients with benign and malignant transformation of mesenchyoma, and in few cases (4%) rhabdomyomas, lipomatous hypertrophy, atrial septum, epithelioid leiomyoma of the uterus in the germinating atrium and metastatic melanoma. Also, in some cases, the use of MRI allowed to rule out malignancy and to identify mural thrombus. In 1 case, MRI gave, a detailed study of the morphology and localization of tumors to evaluate its spatial relationship with neighboring structures, study of three-dimensional and functional parameters of the heart. Dynamic mode (Cine-SSFP), planar and volumetric reconstruction (MPR) demonstrated the topography of tumors. That helped a broad understanding of the pre-operative pathology and surgical simplified decision-making. MRI allowed to analyze results of surgical correction and implement dynamic monitoring during the early and late postoperative period.

Conclusions: MRI in the diagnosis of tumors of the heart significantly complements echocardiography, providing a non-invasive multi-modal visualization, necessary for a comprehensive assessment of the topography of lesions, detection of individual anatomical features of intracardiac and extracardiac structures. MRI should be included in the diagnostic algorithm of tumors of the heart, including to assess occured hemodynamic changes.  

 

References 

1.    Centofanti P, Rosa E.Di., Deorsola L. et al. Primary cardiac tumors: carly and late results of surgical treatment in 91 patients. Ann. Thorac. Surg. 1999; 68(4):1236-1241.

2.    Schaff H.V., Mullany C.J. Surgery for cardiac myxomas. Semin Thorac. Cardiovasc. Surg. 2000; 12:77-88.

3.    Moynihan T. J. Is there such a thing as heart cancer? http: www.mayoclinic.org/heart-cancer/expert-answers/ faq-20058130.

4.    Roberts W.C. Neoplasms involving the heart, their simulators, and adverse consequences of their therapy. Bayl Univ. Med. Cent. 2001; 14:358-376.

5.    Sutsch G., Jenni R., L. von Segesser, Schneider J. Heart tumors: incidence, distribution, diagnosis exemplified by 20,305 echocardiographies. Schweiz. Med. Wochenschr. 1991; 121:621-629.

6.    Goswami K.C., Shrivastava S., Bahl V.K., et al. Cardiac myxomas: clinical and echocardiographic profile intern J. Cardiol. 1998; 63 (3):251-259.

7.    Bogaert J., Dymarkowski S., Taylor A.M. Clinical Cardiac MRI. Springer 2005; 549.

8.    Buckley O., Madan R., Kwong R., et al. Cardiac Masses, Part 1: Imaging Strategies and Technical Consideration. AJR. 2011; 197:837-841.

9.    O’Donnell D.H., Abbara S., Chaithiraphan V., et al. Cardiac Tumors: Optimal Cardiac MR Sequences and Spectrum of Imaging Appearances. AJR. 2009; 193: 377387.

10.  Finn J.P, Nael K., Deshpande V., et al. Cardiac MR imaging: state of the technology. Radiology. 2006; 241:338-354.

11.  Fussen S., De Boeck B.W., Zellweger M.J., et al Cardiovascular magnetic resonance imaging for diagnosis and clinical management of suspected cardiac masses and tumours. Eur. Heart J. 2011; 32(12):1551-1560.

12.  Belenkov Ju.N., Sinicin V.E., Ternovoj S.K. Magnitno-rezonansnaja tomografija serdca i sosudov[MRI of heart and vessels]. Vidar. 1997; 144 р [In Russ].

13.  Bokerija L.A., Malashenkov A.I., Kavsadze V. Je., Serov R.A. Kardioonkologija [Cardiology]. NCSSH im. A.N. Bakuleva RAMN. 2003; 254 р [In Russ].

14.  Burke A., Virmani R. Atlas of Tumor Pathology. Tumors of the Heart and Great Vessels. Armed Forces Institute of Pathology. 1996.

15.  Butany J., Leong S.W., Carmichael K., Komeda M. A 30-year analysis of cardiac neoplasms at autopsy. Can. J. Cardiol. 2005; 21:675-680.

16.  Telen M., Jerbel R., Krejtner K-F., Barkhauzen J. Luchevye metody diagnostiki boleznej serdca [Beam methods of diagnostics of heart diseases]. MEDpress-inform. 2011; 408 р [in Russ].

17.  Hanson E.C. Cardiac tumors: a current perspective. NY State J. Med. 1992; 92:41-42.

18.  Amano J., Kono T., Wada Y, et al. Cardiac myxoma: its origin and tumor characteristics. Ann. Thorac. Cardiovasc. Surg. 2003; 9:215-21.

19.  Araoz PA., Mulvagh S.L., Tazelaar H.D., et al. CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics. 2000; 20:1303-19.

20.  Buckley O., Madan R., Kwong R., et al. Cardiac Masses, Part 2: Key Imaging Features for Diagnosis and Surgical Planning. AJR. 2011; 197:842-851.

Abstract:

Aim: was to demonstrate the unique case of tracheal transplantation using method of regenerative medicine.

Materials and methods: article presents results of clinical and diagnostic procedures of patient, shows images of trachea before and after transplantation. In order to detect possible complications after surgery were conducted MDCT and bronchoscopy

Results: using of MDCT and bronchoscopy can give all the necessary information about the status of the trachea, as in the pre-hospital period and in the early and late postoperative periods. This case demonstrates satisfactory results for the period of four years after trachea transplantation.

 

 

Abstract:

Aim: was to compare results of bone densitometry techniques, conducted by quantitative computed tomography (QCT) and dual-energy X-ray absorptiometry (DXA) in postmenopausal women.

Material and methods: the study included 210 women in postmenopausal period, who were divided by age into four groups: 50-59 years, 60-69 years, 70-79 years, 80 years and older. All patients underwent densitometry of the lumbar spine by quantitative computed tomography anc dual-energy X-ray absorptiometry in the range of 1-2 weeks.

Results: in the evaluation of bone mineral density by methods of QCT and DXA in the age group 50-59 years, there were no significant differences in results of densitometry During of QCT, osteoporosis was diagnosed in 20.5%, during DXA - 15.1% of patients. Since the age of 60 years and older - incidence of osteoporosis by QCT was higher than in the DXA. Evaluation of correlation indicators QCT and DXA, in all four groups showed a positive association of moderate strength, which decreases with increasing age (I group: r=0.68, p=0.001; II group: r=0.57, p=0.001; III group: r=0.40, p=0.003; IV group: r=0.40, p=0.04).

Conclusion: after 60 years, the incidence of osteoporosis, shown by quantitative computed tomography is higher in comparison with dual-energy X-ray absorptiometry.

 

 

Abstract:

Aim: was to identify features of echographic imaging in patients with suspicion on nonocclusive mesenteric blood-flow disorders.

Materials and methods: we analyzed ultrasound data of 50 patients with dynamic ileus (DI). Patients with severe bulging of the transverse colon and the presence of free gas in the abdominal cavity were not included into the research.

All patients underwent ultrasound examination. We evaluated the functional and morphological state of small intestine and colon, celiac trunk and the superior mesenteric artery (SMA). We also examined intraorganic blood flow in walls of small intestine and colon with the determination of the resistance index (RI) and the linear velocity of blood flow.

The ultrasonic data was verified in 34 cases intraoperatively and morphologically, in 12 cases - only morphologically.

Colonoscopy was performed in 4 patients whose ultrasound differential diagnosis between nonocclusive blood-flow disorders in colon walls and pseudomembranous colitis.

Results: in 3 cases nonocclusive blood-flow disorder was not confirmed. Based on endoscopic and bacteriological data we revealed pseudomembranous colitis (PMC). In 1 patient with ultrasound signs of inflammatory changes in walls of the descending colon at colonoscopy revealed necrotizing ulcerative colitis and suspected circulatory problems in the intestinal wall.

It was morphologically identified that 24 patients had nonocclusive blood-flow disorders in walls of the small intestine,10 patients had nonocclusive segmental infarction of small intestine and colon, in 12 patients had nonocclusive segmental infarction of colon.

Conclusion: ultrasound study, conducted in dynamics, in patients with DI, reveals inflammatory and ischemic changes in walls of the small intestine and colon, which provides an abillity to choose the optimal method of treatment of these patients, in some cases predicted for the pathological process.

Absolute symptoms of nonocclusion ischemia of intestine during ultrasound mode in colour doppler imaging (CDI) are: violation of diameter, lack or absence of blood flow in intraorganic walls of the affected intestine while maintaining its mesentery tissue, in a number of patients - bubbles of gas in the intestinal wall.

An indirect sign of circulatory disorders of the small intestine is a complex of ultrasonic signs as an extension of its diameter with liquid contents, wall thickening by submucosal edema, mucosal folds flattening and lack of peristalsis.

An indirect sign of circulatory disorders of the colon during US is identification of a fragment of the colon with thick walls layered structure haustrum smoothness, lack of blood flow in the structure of the wall in the presence of it in the mesentery

When comparing ultrasound, endoscopic and morphological data, in some cases it is possible to make differential diagnosis between nonocclusive intestinal blood-flow disorder and pseudomembranous colitis.

 


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.

 

Abstract:

Aim. Was to assess the safety and efficiency of ulnar artery catheterization for diagnostic coronarography and endovascular treatment in patients with coronary arteries diseases.

Materials and methods. The study includes 150 patients with coronary arteries disease middle aged 57±9 yrs, underwent diagnostic coronarography and ballon angioplasty with stenting from ulnar artery port (UAPo). Comparative group consisted of 150 patients middle age 58±9 with radial artery port (RAPo).

Results. Technical success of procedure was 96,7 % (145 pts) in group with UAPo and 95,3% (143 pts) in RAPo group. Ulnar artery puncture failed in 5 cases (3,3%): in 3 (2%) cases due to ulnar artery spasm; in 1 case due to impossibility of guide insertion; in 1 case due to failure of ulnar artery puncture. In RAPo group puncture failed in 7 cases (4,7%): in 4 cases due to artery spasm; in 2 cases of guide insertion impossibility and in 2 cases of ulnar artery puncture failure. Time of puncture in UAPo group was 2,6±1,1 min, in RAPo - 2,6±1,2. Time of radiation was 5,5±5,2 min against 6,0±4,6 min in RAPo group. Time of procedure was 29,5±18,4 min in UAPo group against 32,9±16,8 min. The difference of indicators was doubtful in all cases

Complications: thrombosis of ulnar artery appeared in 1 patients at the 2nd day after procedure, thrombosis of radial artery - in 4 cases (2,7%). Spasm of ulnar artery appeared more rarely, than radial artery: 6 cases (4%) against 25 cases (16,7%). In 1 case in RAPo group during puncture we noticed appearance of bradycardia and hypotonia. Local neurological complications were not noticed.

Conclusion: the use of ulnar artery catheterization for diagnostics and treatment is safe and effective. The quantity of complication is lover than in RAPo group. 

 

References 

 

1.      Чазов Е.И., Бойцов С.А. Пути снижения сердечно-сосудистой смертности в стране. Кардиологический вестник. 2009; 1(1): 5-10.

 

 

2.      Бойцов С.А., Руда М.Я. Национальный регистр острого коронарного синдрома: положение дел и перспективы. Кардиоваскул. тер. и профилак. 2007; 4: 115-20.

 

 

3.      Dowling K., Todd D., Siskin G. et al. Early ambulation after diagnostic angiography using 4-F catheters and sheaths: a feasibility study. J. Endovasc. Ther. 2002; 9: 618-621.

 

 

4.      Gall S., Tarique A., Natarajan A. et al. Rapid ambulation after coronary angiography via femoral artery access: a prospective study of 1,000 patients. J. Invasive Cardiol. 2006; 18: 106-108.

 

 

5.      Pierfrancesco Agostoni, Giuseppe G. L. et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: Systematic overview and metaanalysis of randomized trials. J. Am. Coll. Cardiol. 2004; 44: 349-356.

 

 

6.      Campeau L. Percutaneous radial artery approach for coronary angiography. Cathet Cardio- vasc Diagn. 1989; 16: 3-7.

 

 

7.      Cooper C.J., El-Shiekh R.A., Cohen D.J., et al. Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison. Am Heart J. 1999; 138: 430-6.

 

 

8.      Mann J.T., Cubeddu G., Schneider J.E., et al. Right radial access for PTCA: a prospective study demonstrates reduced complications and hospital charges. J Invas. Cardiol. 1996; 8: 40-4D

 

 

9.      Chatelain P., Arceo A., Rombaut E. et al. New device for compression of the radial artery after diagnostic and interventional cardiac procedures. Cathet. Cardiovasc. Diagn. 1997; 40: 297-300.

 

 

10.    Ochiai M., Sakai H., Takeshita S. et al. Efficacy of a new hemostatic device, Adapty, after transradial coronary angiography and intervention. J. Inva,sive Cardiol. 2000; 12: 618-622.

 

 

11.    Yokoyama N., Takeshita S., Ochiai M., et al. Anatomic variations of the radial artery in patients undergoing transradial coronary intervention. Catheter Cardiovasc Interv. 2000; 49: 357-362.

 

 

12.    Terashima M., Meguro T., Takeda H., et al. Percutaneous ulnar artery approach for coronary angiography: a preliminary report in nine patients. Cathet. Cardiovasc. Interv. 2001; 53:410-4.

 

 

13.    

 

Abstract:

Endovascular interventions became widespread for last decade. The directional atherectomy with a SilwerHawk device is one of such methods of possible vascular restoration. This method has some advantages than balloon angioplasty or stenting.

Aim: Was to evaluate the efficiency of directional atherectomy with a SilwerHawk device with iliac arteries disease and arteries of legs disease.

Materials and methods: We have included nine patients with peripheral arterial disease in our study the endovascular directional atherectomy with a SilwerHawk device (EV-3) was performed in all patients. We used different accesses to the artery and protocols of interventions. In all cases we used distal embolic protection device «Spider» (EV-3).

Results: The immediate results of intervention were evaluated. We developed operation algorithms in different cases of vessel disease. The article describes the technical aspects and nuances of work with SilwerHawk device. The perioperative tactics of treatment are also considered in it.

Conclusion: Endovascular atherectomy is a new and effective method in treatment of patients with different peripheral arteries disease. It provides allows considerably to expand the field of methodics application. 

 

References 

 

1.      Norgren L., Hiatt W., Dormandy J. et al. Inter Society Consensus for the Management of peripheral Arterial Disease (TASC II). J. Vasc. Surg. 2007; 1:1-75.

 

 

2.      Покровский А.В., Алекян Б.Г., Аралекян В.С. и соавт. Диагностика и лечение больных с заболеваниями периферических артерий. (Рекомендации Российского общества ангиологов и сосудистыххирурговМосква 2007.

 

 

3.      King S., Smith S., Hirshfeld J. et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J. Am. Coll. Cardiol. 2008; 51(2): 172-209.

 

 

4.      Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2010.Cardiovasc Intervent Radiol. 2010; 33(2):14-313.

 

 

5.      John L. Limitations of Percutaneous Transluminal Angioplasty and Stenting for the Treatment of Disease of the Superficial Femoral and Popliteal Arteries. Journal of Endovascular Therapy. 2006; 13(2): 30-40.

 

 

6.      Thomas Z. Current state of endovascular treatment of femoro-popliteal artery disease. Vasc Med. 2007; 12: 223.

 

 

7.      Adam D., Beard D., Cleveland T. et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2006; 367(9525): 14.

 

 

8.      Schillinger M, Minar E. Past, present and future of femoropopliteal stenting. J Endova,sc Ther. 2009; 16(1): 52-147.

 

 

9.      Cotroneo A., Pascali D., Santoro M. et al. Endovascular treatment of femoropopliteal steno-obstructive disease with percutaneous transluminal angioplasty: midterm results. Radiol. Med. 2008; 113(7): 1043-55.

 

 

10.    Furuichi S., Sangiorgi G., Colombo A. Early Occlusive Restenosis Due to Self- Expandable Stent Squeeze in the Popliteal Artery. J. Invasive Cardiol. 2007; 19(10): E300-2.

 

 

11.    Laird J., Katzen B., Scheinert D. et Al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelvemonth results from the RESIL

 

Abstract:

Lipid core coronary plaques (LCPs), which cannot be reliably detected by conventional diagnostic measures, are widely considered to be the cause of most acute coronary syndromes. Accumulating evidence also indicates that LCPs may increase the risk of stenting complications. A catheter-based near-infrared spectroscopy (NIRS) system is now available for the detection of LCPs in the arteries of patients undergoing coronary angiography The system, which uses the well-documented ability of NIRS to determine the chemical composition of unknown substances, has been validated in an autopsy study and a clinical trial. The system has now been used in more than 300 patients and has provided novel information for use in assessment of coronary disease. Multiple studies are in progress to assess the full clinical benefit of NIRS for the goals of 1) improving the safety of stenting, 2) preventing a second coronary event in patients with known coronary disease, and 3) use as a possible component in a strategy for the primary prevention of coronary events.
 

 

References 

 

1.      Lloyd-Jones D., Adams R., Carnethon M. et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009; 119:480-486.

 

 

2.      Clarke M.C., Figg N., Maguire J.J. et al. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006; 12:1075-1080.

 

 

3.      Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.

 

 

4.      Kagan A., Livsic A.M., Sternby N., Vihert A.M. Coronary-artery thrombosis and the acute attack of coronary heart-disease. Lancet 1968; 2:1199-1200.

 

 

5.      Goldsteinc J.A. CT angiography: imaging anatomy to deduce coronary physiology. Catheter Cardiovasc Interv 2009; 73:503-505.

 

 

6.      Giroud D., Li J.M., Urban P., et al. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol 1992; 69:729-732.

 

 

7.      Gonzalo N., GarcHa-GarcHa H.M., Ligthart J. et al. Coronary plaque composition as assessed by greyscale intravascular ultrasound and radiofrequency spectral data analysis. Int J Cardiova,sc Imaging 2008; 24:811-818.

 

 

8.      Schaar J.A., Mastik F., Regar E., et al. Current diagnostic modalities for vulnerable plaque detection. Curr Pharm Des 2007; 13:995-1001.

 

 

9.      Kips J.G., Segers P, Van Bortel L.M. Identifying the vulnerable plaque: a review of invasive and non-invasive imaging modalities. Artery Res 2008; 2:21-34.

 

 

10.    Uchida Y., Nakamura F., Tomaru T., et al. Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. Am. Heart J. 1995; 130:195-203.

 

 

11.    Ohtani T., Ueda Y., Mizote I., et al. Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome detection of vulnerable patients by angioscopy. J Am Coll Cardiol 2006; 47:2194-2200.

 

 

12.    Ishibashi F., Aziz K., Abela G., Waxman S. Update on coronary angioscopy: review of a 20-year experience and potential application for detection of vulnerable plaque. J. Interv. Cardiol. 2006; 19:17-25.

 

 

13.    Patel N.A., Stamper D.L., Brezinski M.E. Review of the ability of optical coherence tomography to characterize plaque, including a comparison with intravascular ultrasound. Cardiovasc Intervent Radiol 2005; 28:1-9.

 

 

14.    Yabushita H., Bouma B.E., Houser S.L., et al.Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002; 106:1640-1645.

 

 

15.    Tearney G.J., Yabushita H., Houser S.L., et al. Quantifi cation of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003; 107:113-119.

 

 

16.    Yun S.H., Tearney G.J., Vakoc B.J. et al. Comprehensive volumetric optical microscopy in vivo. Nat Med 2007; 12:1429-1433.

 

 

17.    Lavine B., Workman J. Chemometrics. Ana,l Chem 2008, 80:4519-4531.

 

 

18.    Williams P., Norris K. Near-Infrared Technology in the Agriculture and Food Industries, edn 2. St. Paul, MN: American

 

 

19.    Association of Cereal Chemists Inc.; 2001; Ciurczak EW, Drennen JK: Pharmaceutical and Medical Applications of Near-Infrared Spectroscopy. New York: Marcel Dekker, 2002;

 

 

20.    Mendelson Y: Pulse oximetry: theory and applications for noninvasive monitoring. Clin Chem 1992; 38:1601-1607.

 

 

21.    Moreno PR., Muller J.E.: Identification of high-risk atherosclerotic plaques: a survey of spectroscopic methods. Curr Opin Cardiol 2002; 17:638-647.

 

 

22.    Lodder R.A., Cassis L., Ciurczak E.W.: Arterial analysis with a novel near-IR fi ber-optic probe. Spectroscopy 1990; 5:12-17.

 

Dynamics of bone fabric mineral density in women after bilateral ovarioectomy in connection with hormonal replacement therapy for 10 years of monitoring



DOI: https://doi.org/10.25512/DIR.2012.06.2.05

For quoting:
Mitrokhina T.V., Yureneva S.V., Maichuk E.Ju., Kuznesov S.Yu., Voevodina I.V., Moiseenko S.V. "Dynamics of bone fabric mineral density in women after bilateral ovarioectomy in connection with hormonal replacement therapy for 10 years of monitoring". Journal Diagnostic & interventional radiology. 2012; 6(2); 31-38.

 

Abstract:

Aim: was to compare fabric mineral density in women after bilateral ovarioectomy with hormonal replacement therapy and without it after 10 years of monitoring.

Materials and methods: we have examined 87 women after bilateral ovarioectomy with hysterectomy Patients were divided into 2 groups: 50 women with hormonal replacement therapy (1st group) and 37 patients without it (2nd group). All the patients were comparable by age at the moment of operation. Patients from the 1st group underwent examination twice: before operation and 13,1+5,6 years after the operation. Patients from the first group were examined once -11,4±4,1 yrs after the operation. Bone fabric mineral density was measured in 3 regions: lumbar department of a backbone, in a neck of a hip and in proximal department of a femur.

Results: on the base of obtained data it was found out that decreasement of bone fabric mineral density is different due to region of skeleton. Hormonal replacement therapy can decrease the speed of osteoporosis in women after hysterectomy, and that leads to decreased level of fractures in the postoperative period. 

 

References 

 

 

1.      Боневоленская Л.И. Остеопороз - актуальная проблема медицины. Остеопороз и остеопатии. 1998; 1: 4-7.

 

 

 

2.      Руководство по остеопорозу. (Под ред. Боневоленской Л.И.) М.: Бином. Лаборатория знаний. 2003; 523.

 

 

 

3.      Руководство по климактерию. (Под ред. Кулакова В.И., Сметник В.П.) М.: Мед. информ.издат. 2001; 685.

 

 

 

4.      Лесняк О.М., Боневоленская Л.И. Остео- пороз. Диагностика, профилактика, лечение. Клинические рекомендации. М.: «ГЭОТАР». 2009; 219.

 

 

 

5.      Jilka R.L., Cytokines, bone remodeling and estrogen deficiency: a 1998 update. Bone. 1998; 23: 75-81.

 

 

 

6.      Riggs B. The mechanisms of estrogen regulation of bone resorption. J.Clin. Invest. 2000; 106: 120-126.

 

 

 

7.      Kimble R.B., Matayoshi A.B., Vannice J.L., et al. Simultanious block of interleikin-1 and tumor necrosis factor is reguered to completely prevent bone loss in the early postovarioectomy period. Endocronol. 1995; 136: 3054-61.

 

 

 

8.      Кулаков В.И., Юренева С.В., Майчук Е.Ю. Постовариоэктомический синдром. Клиническая лекция. М.: Орион корпорейшн. 2003; 15.

 

 

 

9.      Рябцева И.Т., Шаповалова К.А. Заместительная гормональная терапия при синдроме постовариэктомии. Вестник Росс. Ассоц. акушеров-гинекологов. 2000; 2: 92-94.

 

 

 

10.    Шварц ГЯ. Фармакотерапия остеопороза. М.: МИА. 2002; 53-64.

 

 

 

11.    Ершова О.Б. Комментарии к практическому использованию Российских клинических рекомендаций по остеопорозу. Остеопороз и остеопатии. 2010; 1: 34-46.

 

 

 

12.    Аметов А.С. Избранные лекции по эндокринологии. М.: МИА. 2009; 475-495.

 

 

 

13.    Castelo-Branco C., Figueras F., Sanjuan A. et al. Long-term compliance with estrogen replacement therapy in surgical postmenopausal women: benefits to bone and analysis of factors associated with discontinuation. Menopause: The J. of the North Am.Menop.Soc. 1999; 6(4): 307-311.

 

 

 

14.    Chittacharoen A., Theppisai U., Sirisriro R. et al. Pattern of bone loss in surgical menopause: a preliminary report. J. Med. Assoc. Thai. 1997; 80 (1):731-737.

15.    Hreshchychyn M., Hopkins A., Zystra S. et al. Effect of natural menopause, hysterectomy and oophorectomy on lumbar spine and femoral neck bone densities. Obstet Gynecol. 1998; 8: 631-638.

 

 

authors: 

 

Abstract:

Aim. Was to investigate phase-parameters of renal arteries blood flow in hypertensive patients.

Material and methods. We have examined 173 patients with arterial hypertension, aged 38-78 years, including associated ischemic heart disease or heart stroke in the past. Control group consisted of 27 almost healthy patients aged 39-76 yrs. Acceleration phase index AT/RR, systolic phase index ET/R-R, and flow propagation index RA/R-R (RA is the time from R wave of ECG to the beginning of the systolic flow in the main renal artery at the hilus of kidney) were derived from the Doppler ultrasound.

Results and conclusions. Acceleration phase index in hypertensive patients was higher and systolic phase index was lower than in healthy subjects. Changing in the phase parameters of renal flow depends on associated clinical conditions. The most expressed changes occur in hypertensive patients with old myocardial infarction. Correlations between the phase parameters, the age and the serum lipids were analyzed. Age dependent normal values of the phase indices of renal flow were established. 

 

References  

1.      Mourad J.J., Girerd X., Boutouyrie Pet alOpposite Effects of Remodeling and Hypertrophy on Arterial Compliance in Hypertension. Hypertension. 1998; 31: 529-533.

2.      Подзолков В.И., Булатов В.А. Миокард. Нефрон. Взгляд через призму эволюции артериальной гипертензии. Русский медицинский журнал. 2008; 11: 1517-1523.

3.      Riccabona M., Preidler K., Szolar D. et al. Evaluation of renal vascularization using amplitude-coded Doppler ultrasound. Ultraschall Med. 1997; 18(6): 244-248.

4.      Щетинин В.В., Берестень Н.Ф. Кардиосовместимая допплерография. М.: Медицина. 2002; 240.

5.      Макаренко Е.С. Анализ временных показателей кровотока в артериях каротидного бассейна у больных артериальной гипертензией. Вестник рентгенологии и радиологии. 2011;5:21-23.

6.      Макаренко Е.С., Неласов Н.Ю., Поморцев А.В. и др. Возможности комплексной ультрасонографии в оценке структурнофункциональных изменений общих сонных артерий (ОСА) у больных артериальной гипертензией (АГ). Кубанский научный медицинский вестник. 2010; 6(120): 78-84.  

7.      Мельникова Л.В., Бартош Л.Ф. Ранние допплерографические признаки структурнофункциональных изменений почечных артерий у больных с эссенциальной гипертензией. Артериальная гипертензия. 2010; 16 (3): 282-285.

authors: 

 

Abstract:

Introduction of reconstructive-plastic operationts in practice of breast cancer surgical treatment have led to the necessity of dynamic monitoring methods development in patients after such treatment. We have proposed technique of mammography after reconstructive-plastic operations and operations with the use of silicone implants. For the period of 8 yrs 167 patients underwent dynamic mammography monitoring.

Proposed methodics allows to reliably assess the results of reconstructive-plastic operations and predict the appearance of possible complications.

 

Abstract:

The question about revealing of breast diseases keeps value within many decades. In this connection search of investigation methods which have no damaging action on an organism of young women, has led to development of a radiothermometry microwave method (RTM), based on temperature asymmetry of superficial and deep areas of breast. For definition of diagnostic borders of this method were investigated 619 women aged 30 till 65 years were investigated, including comparison of RTM method with oncoepidemiological testing (a forecast method) and ultrasound (US) diagnostics, known to be wide spread in clinical practice.

Revealing Th 5 temperature asymmetry at young women with breast cancer allows to use this method for screening in risk group. Comparison of RTM and duplex scanning has shown advantages of RTM in revealing initial pathological proliferative displays, raising recognition opportunity of risk zone for 16% at absence of a bloodflow at duplex scanning and for 29% at presence of an individual feeding.
 

References 

 

1.      Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2004 г. Вестник РОНЦ. 2006; 17,3 (прил. 1): 132.

 

 

2.      Галил-Оглы ГА. Эпителиальные опухоли молочной железы (современная гистологическая классификация ВОЗ, 3 издание, 2003) Клиническая маммология. (Под ред. Харченко В.П., Рожковой Н.И.). Тематический сборник. 1-е издание. - М.: ООО «Фирма Стром», 2005; 7-27.

 

 

3.      Веснин С.Г, Каплан М.А., Авакян Р.С. Современная микроволновая радиотермометрия молочных желез. Опухоли женской репродуктивной системы. 2008; 3: 28-36.

 

 

4.      Авраменко ГВ. Роль радиотермометрии при хирургическом лечении непальпируемых новообразований молочной железы. Автореф. канд. мед. наук - М., 2009; 23 с.

 

 

5.      Бурдина Л.М., Пинхосевич Е.Г., Хайленко В.А. с соавт. Радиотермометрия в алгоритме комплексного обследования молочной железы. Современная онкология. 2006; 6(1): 8-10.

 

 

6.      Попов А.Н. Управление скринингом патологии молочных желез на основе компьютерной радиотерометрии. 05.13.01. Автореф. канд. мед. наук. - Воронеж. 2006; 17.

 

 

7.      Павлов А.С., Мустафин Ч.К., Вартанян К.Ф. Способ дифференциальной диагностики доброкачественных и злокачественных опухолей молочной железы патент A61B5/01. 2007.10.10. URL: http:/ /www1.fips.ru/wps/wcm/ connect/content_ru/ru.

 

 

8.      Смирнова Н.А. Возможности цветной допплерографии в комплексной диагностике заболеваний молочной железы. 14.00.19. Автореф. канд. мед. наук. - М.: МНИИДиХ. 1995; 22 с.'

 

 

9.      Yahara T., Koga T., Yoshida S. et al. Relationship Between Microvessel Density and Thermographic Hot Areas in Breast Cancer. Surgery Today. 2003; 33: 243-248.

 

 

10.    Gautherie M., Gros C.M. Breast Thermography and Cancer Risk Prediction. Cancer. 1980: 45: 51-56.

 

 

11.    Сайт Ассоциации Микроволновой Радиотермометрии. URL: http://www.radiometry.ru.

12.    Joe Abramson Win PEPI (PEPI-for-Windows). URL: http://www.brixtonhealth.com/pepi4windows.html.

 

 

authors: 


 

Article exists only in Russian.

 

Abstract:

Case report is devoted to atypical recanalization of chronic occlusions of the common iliac artery Today, there are several ways for recanalization of chronic occlusions of arteries of lower limbs. Recanalization is known to be the major point of endovascular procedures. The success of endovascular surgery at recanalization depends mainly on 2 factors. One of the most important factors is the choice of access. Another factor is the choise of recanalization method . In case of rare failures - performing open surgery.

 

Refrrences 

1.    Pokrovsky A.V. and other. Russian consensus. Recommended standards for the evaluation of patients with chronic lower limb ischemia. M. 2001; 16 [In Russ].

2.    Koshkin V.M. Outpatient treatment of atherosclerotic lesions of lower extremities. Angiology and Vascular Surgery. 1999; 1: 106-113 [In Russ].

3.    Saket R.R. et al. Novel intravaskular ultrasound-guided method to create transintimal arterial communications: initial experience in peripheral occlusive disease and aortic dissection. J.Endovasc. Ther. 2004; 11 (3): 274-280.

4.    Troickij A.V., Behtev A.G., Habazov R.I., Beljakov G.A., Lysenko E.R., Kolodiev G.P. Gibridnaja hirurgija pri mnogojetazhnyh ateroskleroticheskih porazhenijah arterij aorto-podvzdoshnogo i bedrenno-podkolennogo segmentov. Diagnosticheskaja i intervencionnaja radiologija. 2012; 6(4): 67-77 [In Russ].

5.    Zatevakhin 1.1., Shipovskiy V.N., Zolkin V.N. Balloon angioplasty for lower limb ischemia. M. 2004; 176-229 [In Russ].

 

 

Abstract:

In present time coronary angiography remains the "gold standart" in ischemic heart disease diagnostics. The correlation between angiographic or intravascular ultrasound (IVUS) variables and fractional flow reserve (FFR) in patients with intermittent lesion remain unclear. The aim of this article is to demonstrate complimentary use of fractional flow reserve evaluation and intravascular ultrasound for achieving optimal results during PCI.

 

 

 

Abstract:

Procedure of pre-operative ultrasonic imaging was conducted for nine patients with verified diagnosis of cervical adenocarcinoma. All the diagnosis were morphologically confirmed. A complex ultrasonic examination consisted of transabdominal and transvaginal echography of true pelvis organs as well as transabdominal examination of abdomen cavity and retroperitoneal space. All patients underwent true pelvis ultrasonic scanning including CDM mode, ED and Doppler pulse - wave mode. Based on the analyzed data, it was defined that echography makes it possible to determine the behavior of tumor local growth and to reveal metastases. We have traced a clear relationship of a disease stage on a ultrasonically fixed tumor size. An attempt is made to reveal specific echographic signs of adenocarcinoma of the cervix.

 

 

 

Abstract:

Acute severe pancreatitis is the most severe disease in urgent abdominal surgery In these conditions - diagnosis and treatment of this group of patients remains a high priority issue of urgent surgery and intensive care therapy It is extremely important to estimate severity of local changes and general conditions of patient in order to draw up efficient disease management and forecast the outcome of the disease. It can be done by the use of different scoring systems of severity: J.H.C. Ranson, Glasgow (Imrie), SOFA, APACHE I or II, SAPS, MODS and others. Instrumental methods of investigation are used to examine scale and type of disease of pancreas, retroperitoneum and abdominal: laparoscopy, ultrasonography, computed tomography (CT), magnetic resonance imaging. It is generally recognized that the most informative methods of diagnosis of acute severe pancreatitis and its complications are ultrasound diagnostics and computed tomography In 2008 in Mumbai the Acute Pancreatitis Classification Working Group identified two types of classification - clinical and morphological, the last is based on beam diagnostics. Clinical classification is used during the early stage of disease (within the first week of acute pancreatitis manifestation), morphological classification is applicable to the subsequent stage (usually after the first week of illness). This allows radiologists to describe the «morphology» while clinicians include the results of the examination into the overall clinical picture and draw up the plan of appropriate treatment.

 

 

 

Abstract:

Aim: was to estimate the efficiency and safety of stenting of subtotal stenosis of internal carotid artery

Materials and methods: we analyzed data of 31 patients who underwent stenting of subtotal stenosis of internal carotid artery. Middle age was 68,2±6,9 yrs. Research included 23 males (74,2%). 28 patients (90,3%) had ischemic stroke or transient ischemic attack in anamnesis. Asymptomatic patients (9,7%) in the pre-operative stage underwent single-photon emission computed tomography of the brain, which revealed the presence of subtotal stenosis of internal carotid artery complicated with ishemia. Stenting of internal carotid arteries were made with the help of embolic protection devices in all cases (100%), in 90,3% - with additional proximal protection. In 100% - predilatation of critical stenosis zones were performed. Two patients (6,4%) underwent simultaneous stenting of internal carotid artery and vertebral artery in 1 patient (3,2%) - stenting of internal carotid artery and subclavian artery The operative time was equal to the average 32,6±8,7 minutes. The results of endovascular interventions were assessed by the presence / absence of neurological symptoms during hospitalization and in the late postoperative period. Stent patency and the presence / absence of restenosis were determined by ultrasound, selective angiography of the brachiocephalic arteries. Before discharge in asymptomatic patients evaluated cerebral perfusion using single photon emission computed tomography

Results: successful stenting of subtotal stenosis of the internal carotid artery with blood flow restoration (TICI-3) achieved in 100% of cases. According to the single-photon emission computed tomography of the brain, performed before discharge in asymptomatic patients (9.7%) noted improvement in cerebral blood flow. During the observation period, which amounted to 11,6 ± 3,1 months, the new transient ischemic attacks or ischemic strokes were not observed, no deaths. According to the ultrasonic examination - stents in the internal carotid arteries are passable, with no signs of restenosis.

Conclusion: stenting of critical subtotal stenosis of the internal carotid artery is effective and safe. Application of the proximal cerebral protection can reduce the potential risk of embolism during stenting of subtotal stenosis of the internal carotid artery as it provides protection at all stages of the procedure. It is necessary to conduct large randomized studies to confirm the clinical efficacy and determine the indications for this kind of intervention in these group of patients. 

 

References 

1.    Berman S.S., Devine J.J., Erodes L.S. et al. Distinguishing carotid artery pseudo-occlusion with color flow Doppler. Stroke. 1995; 26:434-438.

2.    Dix J.E., McNulty B.J., Kalimes D.F. Frequency and significance of a small distal ICA in carotid stenosis. AJNR Am. J. Neuroradiol. 1998;19:1215-1218.

3.    Fox AJ. How to measure carotid stenosis. Radiology. 1993;186:316-318.

4.    Gabrielsen T.O., Seeger J.F., Knake J.E. et al.The nearly occluded internal carotid artery: a diagnostic trap. Radiobgy. 1981;138:611-618.

5.    Henderson R., Eliasziw M., Fox AJ. et al. The importance of angiographically defined collateral circulation in patients with severe carotid stenosis. Stroke. 2000; 31:128-132.

6.    Lee D.H., Gao F., Rankin R.N. et al. Duplex and color Doppler flow sonography of occlusion and near occlusion of the carotid artery. AJNR AmJ. Neuroradiol. 1996;17:1267-1274.

7.    Gonzalez A., Gil-Peralta A., Mayol А. et al. Internal carotid artery stenting in patients with near occlusion: 30-day and long-term outcome. AJNR Am.J. Neuroradiol. 2011;32:252-258.

8.    Fox A.J., Eliasziw M., Rothwell P.M. Identification, prognosis, and management of patients with carotid artery near occlusion. AJNR Am.J.Neuroradiol. 2005;26:2086-2094.

9.    North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N.Engl.J.Med. 1991; 325:445-453.

10.  Rothwell P.M., Gutnikov S.A., Warlow C.P., The European Carotid Surgery Trialists’ Collaboration. Reanalysis of the final results of the European Carotid Surgery Trial. Stroke. 2003;34:514-523.

11.  Berman S.S., Bernhard V.M., Erly W.K. et al. Critical carotid artery stenosis: diagnosis, timing of surgery, and outcome. J.Vasc.Surg. 1994;20:499-510. Samson R.H., Showalter D.P., Yunis J.P. et al. Color

12.  flow scan diagnosis of the carotid string sign may prevent unnecessary surgery. Cardiovasc.Surg. 1999; 7:236-241.

13.  Archie Jr J.P. Carotid endarterectomy when the distal internal carotid artery is small or poorly visualized. J.Va,sc.Surg. 1994;19:23-30.

14.  Barnett H.J., Meldrum H.E., Eliasziw M., North American Symptomatic Carotid Endarterectomy Trial (NASCET) collaborators. The appropriate use of carotid endarterectomy. CMAJ. 2002;166: 1169-1179.

15.  Pappas J.N. The angiographic string sign. Radiology. 2002; 222: 237-238.

16.  Giannoukas A.D., Labropoulos N., Smith F.C.T. et al. Management of the near total internal carotid artery occlusion. Eur.J.Vasc.Endovasc. Surg. 2005; 29: 250-255.

17.  O’Leary D.H., Mattle H., Potter J.E. Atheromatous pseudo-occlusion of the internal carotid artery. Stroke. 1989; 20:1168 1173.

18.  Houser O.W., Sundt T.M., Holman C.B. et al. Atheromatous disease of the carotid artery. Neurosurg. 1974;41:321-331.

19.  Heros R.C., Sekhar L.N. Diagnostic and therapeutic alternatives in patients with symptomatic «carotid occlusion» referred for extracranial-intracranial bypass surgery. J.Neurosurg. 1981; 54:790-796.

20.  Sekhar L.N., Heros R.C., Lotz P.R. et al. A

 

Abstract:

Aim: was to estimate the diagnostic performance of inferior petrosal sinus blood sampling with Desmopressin stimulation in patients with ACTH-dependent Cushing's syndrome.

Materials and Methods: all enrolled patients had clinically evident and biochemically proven ACTH-dependent Cushing's syndrome. The inclusion criteria was as follows: the absence of pituitary adenoma on MRI, pituitary adenoma less than 6 mm and/or negative high dose (8mg) dexamethasone suppression test or unsuccessful neurosurgery when the histological material was not informative. A petrosal sinus to peripheral ACTH gradient of at least 2,0 at baseline or at least 3 after Desmopressin administration suggested a pituitary source of ACTH. Plasma ACTH was measured by automated electrochemiluminescence immunoassay (F. Hoffmann-La Roche Ltd (Cobas e601).

Results: 117 patients were included in the present study (86 females (73,5%) and 31 (26,5%) males with a median age of 34 years (Q25-Q75 26-49 years). The youngest patient was 17 years old and the oldest 66 years old. The median of 24h urinary free cortisol was 2148 (1268-4129) nmol/24 hours; the morning plasma ACTH level -105,8 (67,7-150,8) ng/ml; late-night ACTH - 83,6 (51,8-126,2) ng/ml. A final histological diagnosis was available only in 110 patients (94 patients with Cushing's disease and 16 cases of ACTH-ectopic Cushing's syndrome). Only the data of patients with histological proven diagnosis was included in the final analysis. The sensitivity of bilateral inferior petrosal sinus blood sampling with Desmopressin stimulation was found to be 90,4% (95% DI 82,8-94,9), and the specificity- 93,7% (95% DI 71,7 - 98,9). The area under the curve (when the ratios before and after Desmopressin administration were analyzed) was 0,940 (95% DI 0, 893-0,988). The median duration of the procedure was 60 minutes and the median X-Ray dose was 4,7 mSv In general, the manipulation was well tolerated.

Conclusion: bilateral inferior petrosal sinus blood sampling with Desmopressin administration demonstrated the high values of sensitivity and specificity.

 

 

 

Abstract:

Aim: was to evaluate diagnostic results in patients with left-sided varicocele through the use of occlusive balloon catheter during the diagnostic phlebotesticulography.

Materials and methods: traditional venographic examination was performed in 29 patients with newly diagnosed varicocele. Basing on obtained data a new diagnostic venography approach was worked out, according that - 10 patients with left-sided varicocele underwent venography examination.

Results: Using the new diagnostic venography approach in 10 patients with left-sided varicocele was received complete information about the anatomy of the left internal spermatic vein, its collaterals, as well as hemodynamic changes of external iliac vein and spermatic vein it became possible to determine the type of hemodynamic disturbances of outflow of blood from the pampiniform plexus.

Conclusion. The developed method of diagnostic venography provides a complete picture of causes of changes in veins involved in the drainage of the pampiniform venous plexus. Obtained data of hemodynamic and angioarchitectonics changes of venous basins draining pampiniform plexus, contribute to the choice of the optimal method of surgical correction of venous blood flow spermatic veins.

Angiography is the «gold standard» in the diagnosis of varicocele. The developed method of diagnostic venography improves the efficiency of the method of diagnostic venography, which improves the results of treatment of varicocele.

 

 

 

Abstract:

Pulmonary embolism (PE) is a common cardiovascular disease with significant mortality Some patients with high-risk PE are not eligible for current treatment options, such as thrombolysis or surgical embolectomy; moreover, some patients with intermediate-risk PE may benefit from a more aggressive approach rather than the sole anticoagulation therapy In these settings, catheter thrombectomy is an evolving technology and is becoming part of the treatment options for the management of major PE. We report our experience of percutaneous AngioJet Rheolytic Thrombectomy (ART) for the treatment of high and intermediate-risk PE in patients ineligible for current treatment options.

Methods and results. Between September 2001 and October 2012 a total of 91 patients with major PE referred for ART to our catheterization laboratory were included. Twenty-eight patients presented with high-risk PE and 63 with intermediate-risk PE. Clinical data including medical history, procedural characteristics, in-hospital complications and survival were collected. Adjunctive local thrombolysis was performed in 15.4% of patients. Technical success was obtained in 94.5% of patients, with a significant reduction of Miller index (p<0.0001). Total in-hospital mortality occurred in 11 patients (12.1%), of whom 7 (63.6%) presented with high-risk PE. The rate of major bleeding complications was 7.7%. Laboratory experience was significantly associated to a lower rate of major bleedings (p=0.03).

Conclusions. In experienced hands ART can be an effective and safe treatment option for major (i.e. high and intermediate-risk) PE in patients who may not be eligible for thrombolytic therapy or surgical embolectomy, or who may benefit from a more aggressive approach on top of anticoagulation therapy.  

 

References 

1.    Torbicki A., Perrier A., Konstantinides S. et al. Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). European Heart Journal2008(29):2276-2315.

2.    Jaff M.R., McMurtry S., Archer S. et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011(123):1788-1830.

3.    Goldhaber S.Z., Visani L., De Rosa M. Acute pulmonary embolism: Clinical outcomes in the international cooperative pulmonary embolism registry (ICOPER). Lancet. 1999;353:1386-1389.

4.    Kucher N., Goldhaber S.Z. Management of massive pulmonary embolism. Circulation. 2005; 112:e28-e32.

5.    Pulmonary embolism thrombolysis study (PHEITO). From ACC 2013.

6.    Biederer J., Schoene A., Reuter M., Heller M., Muller-Hulsbeck S. Suspected pulmonary artery disruption after transvenous pulmonary embolectomy using a hydrodynamic thrombectomy device: clinical case and experimental study on porcine lung explants. J.Endovasc. Ther. 2003;10:99 -110.

7.    Vecchio S., Vittori G., Chechi T. et al. Trombectomia reolitica percutanea con AngioJet nell’embolia polmonare: metodologia e risutati nell’esperienza di un centro ad alto volume. G.Ital.Cardiol. 2008;9(5):355-363.

8.    Chechi T., Vecchio S., Spaziani G. et al. Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism. Catheter Cardiovasc. Intern. 2009;73:506-513.

9.    Bush R.L., Lin P.H. Percutaneous Mechanical Thrombectomy combine with Thrombolysis for the Treatment of Deep Venous. Thromboses. Vasc. Disease Manage. 2004;1:30-32.

10.  Miller G.A., Sutton G.C. Kerr I.H., Gibson R.V., Honey M. Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br. Med. J. 1971;2:681-4.

11.  Chesebro J.H. Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous stroptokinase. Clinical findings through hospital discharge. Circulation. 1987;76:142-154.

12.  Konstantinides S., Geibel A., Olschewski M. et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: Results of a multicenter registry. Circulation. 1997;96:882-888.

13.  Terrin M. Goldhaber S.Z., Thompson B. Selection of patients with acute PE for thrombolytic therapy: Thrombolysis in PE (TIPE) patients survey. The TIPE investigators. Chest. 1989;95(Suppl 5):279-S-281S.

14.  Levine M.N. Thrombolytic therapy for venous thromboembolism. Complications and contraindications. Clin. Chest Med. 1995;16:321-328.

15.  Wan S., Quinlan D.J., Agnelli G., Eikelboom J.W. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: A meta-analysis of the randomized controlled trials. Circulation. 2004;110:744-749.

16.  Fiumara K., Kucher N., Fanikos J., Goldhaber S.Z. Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. Am.J.Cardiol. 2006;97:127-129.

17.  Kucher N., Rossi E., De R.M., Goldhaber S.Z. Massive pulmonary embolism. Circulation. 2006; 113:577-82.

18.  Gulba D.C., Schmid C., Borst H.G. et al. Medical compared with surgical treatment for massive pulmonary embolism. Lancet. 1994;343:576-577.

19.  Aklog L., Williams C.S., Byrne J.G., Goldhaber S.Z. Acute pulmonary embolectomy: A contemporary approach. Circulation. 2002;105:1416-1419.

20.  Stein P.D., Alnas M., Beemath A., Patel N.R. Outcome of pulmonary embolectomy. Am.J.Cardiol. 2007;99:421-423.

21.  Sanchez O., Trinquart L., Colombet I., Durieux P Huisman M.V., Chatellier G., Meyer G. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur.Heart J. 2008;29: 1569 -1577.

22.  Becattini C., Vedovati M.C., Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation. 2007;116:427-433.

23.  Konstantinides S., Geibel A., Heusel G. et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N.Engl.J.Med. 2002;347:1143-1150.

24.  Uflacker

 

Abstract:

The basis of computed tomography diagnosis is the definition of densitometric parameters at different phases of the study.

Aim. Was to perform comparative analysis of computed tomography features of focal nodular hyperplasia and hepatocellular carcinoma.

Materials and methods. During the reseach clinical and morphological comparisons were performed on the base of 36 patients’ CT’s results: 21 patient with hepatocellular carcinoma (HCC) and 15 patient with focal nodular hyperplasia of the liver without associated liver cirrhosis. At the preoperative stage all patients underwent spiral computed tomography with bolus contrast enhancement (on the four phases of the study).

Results. During native phase of computed tomography HCC nodes are more often hipodense irrespective of the degree of histological differentiation and focal nodular hyperplasia - izodense. After intravenous injection of contrast agent, computed tomography picture of hepatocellular carcinoma and focal nodular hyperplasia depended on the phase of the study During the arterial phase tissue of focal nodular hyperplasia in the vast majority of cases was hiperdense relative to the surrounding liver parenchyma. Hepatocellular carcinoma had similar values much less frequently in contrast to the focal nodular hyperplasia. The venous phase was characterized by the presence of hiperdense characteristics in focal nodular hyperplasia areas and, conversely, in hepatocellular carcinoma tissue signs of hiperdense were not observed. Hyperdence formations in delayed phase of computed tomography indicate the presence of focal nodular hyperplasia, and vice versa, hypodense are sufficient to prevent its presence.

Conclusion. Estimation of densitometric parameters of focal nodular hyperplasia and hepatocellular carcinoma allows to determine features of computed tomography imaging of tumors at different phases of the examination, and this allows to make a differential diagnosis between them.

 

 

 

Abstract:

This article is devoted to results of beam diagnostics, namely, ultrasonic diagnostics and spiral computed tomography at patients with clinical manifestations of the local peritonitis as a complication of microperforation of a thick gut tumor.

Aim: was to define the main beam semiotic signs of microperforation of a tumor of a thick gut with allocation of characteristic symptom group.

Materials and methods: We analyzed data of beam diagnostics of 24 patients with microperforation of a tumor of a thick gut, complicated by local peritonitis. Researches were carried out on the Brilliance 64 tomograph (Philips, Holland, 2008) and ultrasonic Philips AU-22 scanners (Philips, the USA, 2007).

Results: were estimated following semiotics signs: changes of a gut in a zone of palpatory soreness, its walls were visualized in the form of non-uniform, hypoechoic swelling with indistinct contours. Round the changed gut, perifocal infiltrate was revealed, with the form of formation of an average echogenicity, decided on an indistinct external contour. Outside the changed gut, between it and perifocal infiltrate, congestions of liquid with the wrong form were visualized. Computed tomography with contrast enhancement allowed to specify prevalence of process and point extravasation of contrast agents out of limits of a wall of hollow body in a place of perforation of the affected gut. During ultrasonography in all patients, liquid congestions in the abdominal cavity were revealed, at 17 patients - with perifocal infiltrate. In 15 patients - changes of a wall of a gut in the form of hypoechoic swelling with indistinct contours.

Conclusions: computed tomography is a method of choice in detection of tumor' prevalence and an extravasation of contrast agents. Ultrasonography is more informative in diagnostics of liquid congestions and infiltrates.

 

 

Abstract:

Aim: was to study features of ultrasonic imaging of local and septic forms of acute hematogenic osteomyelitis (AHO) in children.

Materials and methods: 59 patients with AHO, treated in Children's hospital No. 4 of Tomsk, for the period from 2000 to 2010 - were examined. All patients with suspicion on osteomyelitis (n = 59; 100%) underwent x-ray of defeated area and ultrasonic diagnostics on the Ultrasonix 2,6 with the use of linear sensor of 9-12 MHz. All patients with AHO underwent surgical operation (n=59; 100%).

Results: 47 patients had local form of disease. Each patient had one phase of osteomyelitis. Extramedullary phase, the development of which was due to the disease duration - was prevalencing^^,^. Prevalence of quantity of AHO phases (n=19) over total number of patients with a septic forms of disease (n=12), reflected existence of multiple osteomyelitis in four patients. In each patient with septic form of the AHO we found defeat of several bones in identical or different phases of an inflammation.

Conclusion: obtained results will help the earlier identification of AHO signs and determination of disease phase in patients with local and generalized forms of disease. All that will help to proceed modern sanation of osteomyelitic defeat.

 

Reference

1.    Abaev Ju.K., Adarchenko A.A., Zafranskaja M.M. Gnojnaja hirurgija detskogo vozrasta. Menjajushhiesja perspektivy [Contaminated surgery of childhood. Changing perspectives.]. Detskaja hirurgija. 2004; 6: 4-7 [In Russ].

2.    Beljaev M.K., Prokopenko Ju.D., Fedorov K.K. K voprosu o vybore lechebnoj taktiki pri metafizarnom osteomielite u detej [The issue of choice of therapeutic tactics in the metaphyseal osteomyelitis in children.]. Detskaja hirurgija. 2007;4:27-29 [In Russ].

3.    Lobanov Ju.A., Cap N.A., Nagornyj E.A. Osnovnye principy diagnostiki i lechenija ostrogo gematogennogo osteomielita u detej [The basic principles of diagnosis and treatment of acute osteomyelitis in children.]. Konsilium 2007 g. Ural'skaja gosudarstvennaja medicinskaja akademija: 56-59 [In Russ].

4.    Zavadovskaja V.D., Polkovnikova S.A., Perova T.B. Vozmozhnosti ul'trazvukovogo issledovanija v diagnostike ostrogo gematogennogo osteomielita u detej [Possibility of ultrasonography in the diagnosis of acute osteomyelitis in children.]. Ul'trazvukovaja i funkcional'naja diagnostika. 2006;4:67-75 [In Russ].

5.    Brjuhanov A.V. MR-tomograficheskaja semiotika zabolevanij kostno-sustavnogo apparata [MR tomographic semiotics of diseases of bone and articular apparatus.]. Materialy Ill regional'noj konferencii 28--30 ijunja 2004 goda. Tomsk. 2004;248-250 [In Russ].

6.    Kotljarov P.M., Sencha A.N., Beljaev D.V. Ul'tra-zvukovaja diagnostika osteomielita [Ultrasound diagnosis of osteomyelitis.]. Ul'trazvukovaja i funkcional'naja diagnostika. 2008;5:110-120 [In Russ].

7.    Tas F., Oguz S., Bulut O. et al. Comparison of the diagnosis of plain radiography ultrasonography and magnetic resonance imaging in early diagnosis of acute osteomyelitis experimentally formed on rabbits. Eur. J. Radiol. 2005; 56 (1): 107-112.

8.    Fitoussi F., Litzelmann E., Ilharreborde B. et al. Hematogenous osteomyelitis of the wrist in children. J. Pediatr. (Orthop. 2007; 27(7): 810-813.

9.    Marochko N.V., Pykov M.I., Zhila N.G. Ul'trazvukovaja semiotika ostrogo gematogennogo osteomielita u detej [Ultrasonic semiotics of acute hematogenic osteomyelitis in children.]. Ul'trazvukovaja i funkcional'naja diagnostika. 2006;4:55-66 [In Russ].

 


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.

 

Abstract:

Aim. Was to describe the efficiency of conservative treatment of retinoblastoma (RB) by an association of local chemotherapy (LCT) as an alternative method for external beam radiation (EBR) therapy and enucleation. Also to reduce the local and systemic side effects of chemotherapy.

Materials and methods. Seven children (11 eyes) had intraocular RB. All of them underwent LCT at the Institute of pediatric oncology and hematology of the N.N. Blokhin Russian Cancer Research Center between February and 2011. There were two methods of LC -selective intra-arterial chemotherapy (Institute of clinical oncology of the N. N. Blokhin Russian Cancer Research Center) and intravitrea chemotherapy by melphalan.LCT was made after systemic chemotherapy in4of8 patients with advanced RB with clinica stages T2a or group С (n = 1), T2b or group D (n = 3), T2c or group E (n = 3) as an alternative to EBR therapy Other 4 of 8 patients were treated with LCT as alternative to enucleation because of new retinal, subretinal tumors and vitreous seeding after initial treatment - systemic chemotherapy with laser treatment or in combination with brachytherapy and/or EBR therapy. LCT was combined with brachytherapy (106Ru + 10^о) in one case (S. Fyodorov Eye Microsurgery Complex)

Results. Due to using of alternative conservative RB treatment we have saved 8 children with 10 of 11 eyes with indications for EBR therapy or enucleation. There were not systemic side effects of LCT. Ophthalmic complications were minimal, including lid and face hyperemia after intra-arterial chemotherapy.

Conclusion. LCT with melphalan has shown high effectiveness as a method of globe-conserving treatment of locally spread RB with a minimum of immediate complications. A small number of observations and the maximum period of observation 7 months do not allow to reliably estimate the long-term results of treatment that requires further research.  

 

References 

1.    Shields C.L. et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am. J. Ophthalmol. 2002; 133 (5): 657-664.

 

2.    Shields C.L. et al. The international Classification of Retinoblastoma predicts chemoreduction success. Ophthalmol. 2006; 113: 2276-2280.

 

3.    Shields C.L. et al. Chemoreduction for unilateral retinoblastoma. А. Ophthalmol. 2002;120: 1652-1658.

 

4.    Shields C.L. Development of new retinoblastomas after 6 cycles of chemo-reduction for retinoblastoma in 162 eyes of 106 consecutive patients. A. Ophthalmol. 2003;121: 1571-1576.

 

 

5.    Jehanne M. et al. Analisis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma. Pediat. Bl. Cancer. 2009; 52: 637-643.

 

 

6.    Bayer E.. et al. Unilateral retinoblastoma with acquired monosomy 7 and secondary acute myelomonosytic leukemia. Cancer Genet. Cytogenet. 1998; 105: 79-82.

 

 

7.    Yamane T., Kaneko A., Moori M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int. J.  Clin.  Oncol. 2004; 9: 69-73.

 

 

8.    Yamane T. Ophthalmic arterial injection therapy for retinoblastoma patients by using melphalan. Technique and eye preservation rates. T. Yamane, S. Suzuki, A. Kaneko, M. Mohri. ISOO Meeting 2009. Cambridge, UK. Abstracts book. 2009; 8-12: 283.

 

 

9.    Kane A., Suzuki S. Eye-preservation treatment of retinoblastoma with vitreous seeding. Jpn. J.Clin. Oncol. 2003; 33 (12): 601-607.

 

 

10.  Abramson D.H., Frank C.M., Dunkel I.J. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma. Ophthalmology.1999; 106: 1947-1950.

 

 

11.  Villablanca J.G., Jubran R., Murphree A.L. Phase I study of subtenon carboplatin I with systemic high dose carboplatin / etoposide / vincristine (CEV) for eyes with disseminated intraocular retinoblastoma (RB). Proceedings of the XIII Biannual Meeting of ISGED and the X International Symposium on Retinoblastoma. USA Fort Lauderdale, Fla. 2001; 4.

 

12.  Kaneko A. et al. Our recent modifications of local chemotherapies for preservation of eyes with retinoblastoma. ISOO Meeting. Cambridge, UK. Abstracts book. 2009; 8-12: 281.

13.  Abramson D.H. et al. A phase I/II study of direct intra-arterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115: 1398-1404.

14.  Abramson D.H. et al. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010; 117: 1623-1629.

15.  Shields C.L., Shields J.A. Intraarterial chemotherapy for retinoblastoma the beginning of a long journey. Clin. Exper. Ophthalmol. 2010; 38: 638-643.

16.  Suzuki S., Kaneko A. Ocular and systemic prognosis of selective ophthalmic arterial injection for intraocular retinoblastoma. ISOO Meeting. Cambridge, UK. Abstracts book. 2009; 8-12: 283.

 

 

Abstract:

Purpose. Was to improve results of aortic stenosis (AS) treatment by transluminalballoon valvuloplasty (TLBVP) technicalskill's mprovement

Materials and methods. The article reviews a group of 56 patients who underwent TLBVP of at Republic specialized surgery centre named after V. Vakhidov

Results. It is noted that after TLBVP the peak systolic pressure gradient drecreases from 136,0 ± 39,36 to 38,27 ± 12,55 mm Hg (67,1% shift., р < 0,001), that confirms efficiency of the AS TLBVP All the patients notice better health conditions, increased stability to physical activities and had been discharged from hospital in satisfactory condition.

Conclusions. TLBVP of aortic valve (AV) is an effective and safe method that can be used for treatment of aortic valve stenosis. Indication for the procedure is occurrence of peak systolic gradient at AV of over 50 (with average at 35-40) mm Hg. At the same time aortic regurgitation type 1 is not a contraindication for the procedure. 

 

References 

1.    Алекян Б.Г., Бондарев Ю.И., Ильин В.Н. и др. Опыт баллонных дилатаций при врожденном клапанном и подклапанном стенозах аорты. М. Грудная и сердечно-сосудистая хирургия. 1996; 1: 121-126.

2.    Бокерия Л.А., Гудкова Р.Г. Тенденции развития кардиохирургии в 2007 году. М.: Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2008; 3-4.

3.    Дземешкевич    С.Л.,    Стивенсон    Л.У., Алексин-Месхишвили В.В. Болезни аортального клапана. Функция, диагностика,  лечение.   М.:   Гэотар-Мед.   2004;267-299.

4.    Feldman T. Core curriculum for interventional cardiology. Percutaneous valvuloplasty Cath. Cardiovas. Interv. 2003; 60: 48-56.

5.    Gao W. et al. Percutaneous balloon aortic valvuloplasty in the treatment of congenital valvular aortic stenosis in   children.   Chin.   Med. J.   2001;   114: 453-455.

 

6.    Hidehiko H. et al. Percutaneous balloon аortic valvuloplasty. Revisited Circulation. 2007; 115: 334-338.

 

7.    Kusa J., Biaikowski J., Szkutnik M. Percutaneous balloon aortic valvuloplasty in children. Early and long-term outcome. Kardiol. Pol. 2004; 60: 48-56

 

 

Abstract:

Palliative surgery plays a major role as a stage of congenitalheart disease treatment.Palliative endovascular interventions are safe n neonates. Such treatment can stabilize patients and adequately prepare them for radical operation and in some cases it is an alternative to classic bypass methodic.

 

References

1.    Бокерия Л.А., Гудкова Р.Г. «Сердечно-сосудистая хирургия-2009». Врожденные пороки системы кровообращения. М.: изд-во НЦССХ им. А.Н. Бакулева РАМН. 2010; 76-115.

2.    Rosano A. et al. Infant mortality and congenital anomalies from 1950 to 1994. An international perspective. J. Epidemiol. Community Health. 2000; 54: 660-666.

3.    Шарыкин А.С. Врожденные пороки сердца. Руководство для педиатров, кардиологов, неонатологов. М.: изд-во «Теремок». 2005; 8-14, 224-234.

4.    Любомудров В.Г., Кунгурцев В.Л., Болсуновский В.А. и др. Коррекция врожденных пороков сердца в периоде новорожденности. Российский вестник перинатологии и педиатрии. 2007; 3: 9-13.

5.    Lacour-Gayet F., Anderson R.H. A uniform surgical technique  for transfer of both simple and complex patterns of the coronary arteries during the arterial switch procedure. Cardiol. in the Young. 2005; 15 (1): 93-101.

6.    Gibbs J.I. Treatment options for coarctation of aorta. Heart. 2000; 84: 11-13.

7.    Zales V.R., Muster A.J. Ballon dilatation angioplasty for the management of aortic coarctation. In C. Mavroudis, C.L. Backer et al. Coarctation and interrupted aortic arch. Cardiac surgery. State of art review. Philadelphia. Huley & Belfus. 1993; 7: 133.

8.    Chen Q., Parry A.J. The current role of hybrid procedures in the stage 1 palliation of patient with hypoplastic left heart syndrome. Eur. J.Cardiolthorac. Surg. 2009; 36: 77-83.

9.    Michel-Behnke I. et al. Stent implantation in the ductus arteriosus for pulmonary blood supply in congenital heart disease. Catheter. Cardiovasc. Interv. 2004; 61  (2): 242-252. 10.  

10.  Bisoi A.K. et al. Primary arterial switch operation in children presenting late with d-transposition of great arteriaes and intact ventricular septum. When is it too late for a primary arterial switch operation? Eur. J. Cardiothorac. Surg. 2010; 38: 707-713.

 

 

 

Abstract:

Aim. Was to analyze atherosclerotic disease dynamics and long-term results (up to 5 years) after implantation of bare-metal stents (BMS) and sirolimus-eluting stents (SES) in patients with multivascular coronary disease

Methods and results. We have analyzed clinicaland angiographic results data of percutaneous coronary interventions (PCI) of 585 patients with multivascular coronary disease during 5-years of follow-up period. 264 patients were treated with BMS, 321 - with SES We used Cypher drug-eluting stents (sirolimus-eluting stents) in the first group and BX Velocity bare-metal stents in the second group of patients

During first year of follow-up the incidence of symptoms reoccurrence in BMS and SES groups was 22,3% and 11,8% (р < 0,05) repeated PCI was performed in 15,6% and 3,9% (р < 0,05), CABG - 2,8% and 0,3% (р < 0,05), the incidence of myocardial infarction (MI) was 1,4% and 0,9%. The restenosis rate in BMS and SES groups was 19,7% and 2,3% (р < 0,05), late thrombosis (LT) - 0,3% and 1,4% The survival without MACE was higher in SES group

During 5 years of follow-up the cumulative incidence of symptoms reoccurrence in BMS and DES groups was 30,7% and 22,7% repeated PCI was performed in 23,9% and 18,1% (р < 0,05), CABG - 6,4% and 4,7%, the incidence of myocardial infarction (MI) was 6,5% and 7,8%. The progression of atherosclerosis in early stented segments in BMS and SES groups was 6,6% and 10,1%, late thrombosis (LT) - 0,4% and 2,1%. There was no difference in survival without MACE between groups

Conclusions. By the end of the first year of follow-up the incidence of angina reoccurrence and repeat revascularization in patients with multivascular coronary disease was higher in BMS group compared with SES group. The survival without MACE was also higher in SES group. By the end of the fifth year of follow-up there was no difference in angina reoccurrence, repeated revascularization and surviva without MACE because the late thrombosis and atherosclerosis progression in early stented segments was more common in DES group. 

 

References 

 

1     Henderson R.A. et al. Seven year outcome in the RITA-2 trial. Coronary angioplasty versus medical therapy. Ibid. 2003; 42: 1161-1170.

 

 

 

2.    Pocock S.J. et al. Quality of life after coronary angioplasty or continued medical treatment for anginan. Three year follow up in the RITA-2 trial. J. Am. Col. Cardiol. 2000; 35:907-914.

 

 

 

3.    Sculpher M.J. et al. Coronary angioplasty versus medical therapy for angina. Health service costs based on the Second Randomized Intervention Treatment oj Angina (RITA-2) trial. Eur. Heart. J. 2002; 23: 1237-1239.

 

 

 

4.    Serruys P. W. et al. For the Benestent Study Group. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N. Engl. J. Med. 1994; 331: 489-495.

 

 

 

5.    Hueb W. et а!. The medicine, angioplasty or surgery study (MASS-II). A randomized, controlled clinical trial of three therapeutic strategies for multivessel согоnary artery desease. J. Ат. СоИ. Cardiol.   2004;  43: 1743-1751.

 

 

 

6.    Orlich D. et al. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results. J. Am. Coll. Cardiol. 2004; 43: 1154-1160.

 

 

 

7.    Буза В.В., Лопухова В.В., Карпов Ю.А. Поздние тромбозы после имплантации стентов с лекарственным покрытиемКардиология. 2007; 6: 85-86.

 

 

 

8.    Camenzind E., Steg P.G., Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents. А cause for concern. Circulation. 2007; 115: 1440-1455.

 

 

 

Abstract:

Aim. Was to evaluate technicalfeasibility and safety of the internalmammary artery redistribution embolization during intra-artena chemotherapy in breast cancer

Materials and methods. Between 2000 and 2010 years 42 patients with inflammatory form of local-spread breast cancer received 48 courses of combined treatment, including systemic and arterial chemotherapy plus radiotherapy In 6 patients, blood flow redistribution n the internal mammary artery was performed to avoid undesirable extra-breast perfusion with possible complications such as neuralgia necrosis of the skin, organ dysfunction. Coil embolization of the internal mammary artery was made distally from branches supplying breast tumor. After that, infusion of chemotherapeutic drug-in-iodized oil was performed

Results. Technicalsuccess rate was 100%.There was no complication of embolization and intra-arterialtherapy During further repeated researches, a giography showed persistent occlusion of the embolized branches and compensatory dilation of tumor-feeding arteries.Survivalrate of patients starts from 2-22 months,with continuation of combined treatment.

Conclusion. Redistribution of blood flow in the internal mammary artery is safe and may be used to avoid complications of ntra-arterial chemotherapy in breast cancer. 

 

References 

1.    Гранов А.М., Давыдов М.И. Интервенционная радиология в онкологии. С.-Пб.: «Фолиант». 2007; 344.

2.    Chuang V.P., Wallace S. Hepatic arterial redistribution for intraarterial infusion of hepatic neoplasms. Radiology. 1980; 135 (2): 295-299.

3.    Таразов П.Г., Рыжков В.К. Эмболизация гастродуоденальной артерии при рентгеноэндоваскулярных вмешательствах по поводу цирроза и опухолей печени. Вестник хирургии. 1988; 140 (1): 83-85.

4.    Таразов П.Г., Павловский А.В., Гранов Д.А. Химиоэмболизация при раке головки поджелудочной железы. Вопросы онкологии. 2001; 47 (4): 489-491.

5.    Таразов П.Г. Эмболизация печеночной артерии при нетипичных анатомических вариантах ее строения у больных злокачественными опухолями печени. Вестник рентгенологии. 1990; 2: 28-32.

6.    Salem R., Thurston K.G. Radioembolization with 90 Yttrium microspheresa. Aa state-of-the-art brachytherapy treatment for primary and secondary liver malignancies, technical and methodologic considerations. J. Vasc. Intervent. Radiol. 2006; 17 (8): 1251-1278.

7.    Woods D. et al. Gluteal artery occlusion. Intraarterial chemotherapy of pelvic neoplasms. Radiology. 1985; 155 (2): 341-343.

8.    Корытова Л.И., Гранов А.М., Хазова Т.В. и др. Способ лечения инфильтративно-отечного рака молочной железы. 2177349, Б.И. 2001.

9.    Таразов П.Г., Корытова Л.И., Шачинов Е.Г Внутриартериальная терапия рака молочной железы (обзор литературы). Вопросы онкологии. 2011; 57 (1): 126-131.

10.  Doughty J.C. et al. Anatomical basis of intraarterial chemotherapy for patients with locally advanced breast cancer. Br. J. Surg. 1996; 83 (8): 1128-1130.

11.  McCarter D.H.A. et al. Angiographic embolization of the distal internal mammary artery as an adjunct to regional chemotherapy in inoperable breast carcinoma. J. Vasc. Intervent. Radiol. 1995; 6 (2): 249-251.

 

 

Abstract:

During our research we have studied x-ray and morphology features of lungs sarcoidosis (LS), levelof fibrosis disorders and rate of pulmonary hypertention (PHT) as a way of calculation pulmonary-thoracical index (PTI) during chest multi-slice computed tomography (MSCT). We have examined 50 patients aged 30-75 with different forms of lungs sarcoidosis. As a result of clinical aboratory, x-ray and morphologicaldata comparison patients were divided into 3 groups.During data analysis we found out that PHT leads to inverse connection of PTIdecrease with increase of interstitial fibrosis (the most expressed changes were in group of patients with chronic recur disease current

The analysis data allows to reveal early symptoms of PHT, that promotes well-timed tactics of treatment.

 

References 

1.    Архипова Д.В., Попова Е.Н., Осипенко В.И. и др. Легочная гипертензия при интерстициальных болезнях легких. 12-й Национальный конгресс по болезням органов дыхания. Москва. 2002; 135-136.

2.    Борисов С.Е. Дифференциальная диагностика саркоидоза. Вестник НИИ фтизиопульмонологии ММА им. И.М. Сеченова. 1999; 1: 34-39.

3.    Bartz R.R., Stern E.J. Airways obstruction in patients with sarcoidosis. Expiratory CT scan findings. J. Thorac. Imag. 2000; 15 (4): 285-289.

4.    Хоменко А.Г., Озерова Л.В., Романов В.В. и др. Саркоидоз. 25-летний опыт клинического наблюдения. Проблемы туберкулеза. 1996; 6: 64-68.

5.    Tan R.T. еt al. Utility of CT scan evalution for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical College of Winsconsin Lung Transplant Group. Chest.  1998; 113 (5):1250-1256.

6.    Саницкая Л.Н., Зубков А.А., Адамович В.Н. Особенности клиники и течения саркоидоза 1-й стадии. В сб. Дифференциальная диагностика саркоидоза и туберкулеза легких. Под ред. В. Н. Адамовича. М. 1998; 52-58.

7.    Соколина И.А., Дмитращенко А.А., Осипенко В.И., Шехтер А.И. Компьютер но-томографические признаки поражения плевры при саркоидозе. Международный союз по борьбе с туберкулезом и легочными заболеваниями (IUATLD). 3-й конгресс Европейского региона. Российское респираторное общество. 14-й Национальный конгресс. Сборник тезисов. Москва. 2004; 376-378.

8.    Коган Е.А., Козловская Л.В., Корнев Б.М. и др. Интерстициальные болезни легких. Под ред. Н.А. Мухина. 2007; 120-144.

9.    Hunninghake G.W. et al. Statement on sarcoidosis. Sarcoid. Vasc. Dif. L. Dis. 1999; 16 (2): 149-173.

10.  Коган Е.А., Деньгин В.В., Жак Г., Корнев Б.М. Клинико-морфологические и молекулярно-биологические особенности идиопатического фиброзирующего альвеолита и саркоидоза легких. Архив патологии. 2000; 6: 32-37.

11.  Шмелев Е.И. Дифференциальная диагностика интерстициальных болезней легких. Consil. medic. 2003; 5 (4): 176-181.

12.  Wells A.U., Padley S.P. A CT sing of chronic pulmonary arterial hypertension the ratio of main pulmonary artery to aortic diameter. J. Thorax. Imag. 1999; 14 (4): 270-278.

13.  Осипенко В.И., Попова Е.Н., Терновой С.К. и др. Способ компьютерной диагностики степени легочной гипертензии. Авт. св. № 2269931 РФ, 09.06.2004 г.

 

 

Abstract:

Purpose. Was to estimate the informative value of scintigraphy (SG) with labeled leukocytes (LL) in detection of osteomyelitis in patients with various forms of diabetic foot syndrome (DFS)

Materials and methods. This study includes results of scintigraphy with labeled leukocytes of 39 patients with diabetes mellitus and with suspicion of osteomyelitis in diabetic foot. Results were compared with morphological study in 22 patients

Results. SG with LL has high informative value rate in diagnostics of inflammatory process: sensitivity - 100%, specificity - 100% accuracy - 100%; and also high in the diagnostics of osteomyelitis: sensitivity - 100%, specificity - 64,7%, accuracy - 84,6%.

Conclusions. LL CG is a highly effective method of identifying the presence of an inflammatory process. During high rate of sensitivity the level of specificity decreases in case of intraosseous inflammation. The reason of decreased specifity is in that SG has low resolution in differentiation of radiopharmaceutical accumulation in bones and soft tissues.

 

References 

1.    Senneville E. et al. Needle puncture and transcutaneous bone biopsy cultures are inconsistent in patients with diabetes and suspected osteomyelitis of the foot. Clin. Infect. Dis. 2009; 48: 888-893.

2.    Gil H.C. MR imaging of diabetic foot infection. H.C. Gil, W.B. Morrison. Semin. Musculoskelet. Radiol. 2004; 8(3): 189-198.

3.    Craig J.G. et al. Osteomyelitis of the diabetic foot: MR imaging-pathologic correlation. Radiology. 1997; 203 (3): 849-855.

4.    Vesco L. et al. The value of combined radionuclide and magnetic resonance imaging in the diagnosis and conservative management of minimal or localized osteomyelitis of the foot in diabetic patients. Metabolism. 1999; 48 (7): 922-927.

5.    Hopfner S. et al. Preoperative imaging of Charcot neuroarthropathy. Does the additional application of (18) F-FDG-PET make sense? Nuklearmedizin. 2010; 45 (1):15-20.

6.    Завадовская В.Д., Зоркальцев М.А., Килина О.Ю., Шульга О.С. Возможности радионуклидной диагностики синдрома диабетической стопы (часть 1). Диагностическая и интервенционная радиология. 2010; 4 (4): 31-40.

 

 

Abstract:

Aim. Was to specify ultrasound diagnostic's possibilities in reasons' detection of lower-limbs (LL) varicose veins (VV) and grades of it s seventy

Materials and methods. We have analyzed ultrasound data of 1376 patients with lover-limb varicose veins. We have used Voluson 730 ultrasound machine (GE) with methods of color and power Doppler and described earlier B-flow technique. This is a highly-effective non-invasive diagnostic method of LL VV reasons, grade severity and expression of valve structure disorders. US allows to specify ocations of pathological veins with valve disorders, distorted blood flow, and that can promote radical treatment and decreases the risk of relapse

Conclusion. Conducted research shows, that visual control in connection with US Doppler is an optimal diagnostic method of this disease. 


References

 

1.    Алекперова Т.В. Ультразвуковая флебография - опыт применения в современной флебологической практике. Ангиология сегодня. 1999; 9: 2-9.

2.    Зубарев А.Р., Богачев В.Ю., Митьков В.В. Ультразвуковая диагностика заболеваний вен нижних конечностей. М.: Видар, 1999; 100.

3.    Зубарев А.Р. Ультразвуковая диагностика клапанной недостаточности вен нижних конечностей без применения допплеровских методов исследования. Ультразвуковая диагностика. 2000; 1: 47-53.

4.    Котляров П.М., Зубарев Р.П., Асеева И.А. и др. Ультразвуковая диагностика острых венозных тромбозов сосудов системы нижней полой вены. Эхография. 2002; 3 (2): 200-208.

5.    Котляров П.М., Зубарев А.Р., Дудин М.М. и др. УЗ-мониторинг вен нижних конечностей у пациентов с подозрением на острый тромбоз. Ультразвуковая и функциональная диагностика. 2002; 4: 71-76.

6.    Лелюк В.Г., Лелюк С.Э. Ультразвуковая ангиология. М.: Реальное время. 1999; 286.

7.    Henri P., Tranquart F. B-flow ultrasonographic imaging of circulating blood. J. Radiol. 2000; 81 (4): 465-467.

8.    Pugh N.D. ct al. Varickose veins-Clinical distribution and duplex ultrasound. Ultras. in medic. and biology. 2000; 26 (2): 82.

9.    May R. Modern varicose vein surgery. Forum. Med. 1971; 14: 81-87.

 

10.  Stuart W.P. et. al. The relationship between the number, competence and diameter of medial calf perforationg veins and the clinical status in healthy subjects and patients with lower-limb venous disease. J. Vasc. Surg. 2000;   32 (1):138-143.

 

11.  Zielinski P., Dzieciuchowicz L., Skibansca-Zielinsca M. The value of Duplex Doppler in the assessment varicose vein. Ultras. in medic. and biology. 2000; 26 (2): 82.

12.  Харченко В.П., Зубарев А.Р., Котляров П.М. Ультразвуковая флебология. М.: ЗАО «Эники». 2005; 176.

13.  Веденский А.Н. Новый способ коррекции патологического кровотока в венах голени. Вестник хирургии. 1988; 140 (4): 143-144.

 

 

Abstract:

We have performed a comparative analysis of magnetic resonance mammography (MRM) and traditional methods of diagnostics in detection of multifocal and multicentric kinds of breast cancer (BC) growth in 21 patients with difficult anatomy structure of mammary gland (MG) Breast-conserving surgery has been already planned for all these patients

Complex diagnostics included ultrasound(US), X-ray mammography (XRM), MRM with contrast enhancement, diagnostic needle biopsy Minimal size of identified breast tumors on the base of XRM data was 7 mm, ultrasound - 4 mm, at MR mammography - 2 mm XRM and US have detected multifocal tumor growth only in 1 case (5%). MRM revealed multifocal and multicentric tumor growth in 9 (43%) and 4 (19%) patients respectively According to revealed data the volume of surgical treatment has changed: 10 patients (48%) underwent radical resection, 10 (48%) mastectomy and 1 (5%) - partial resection

According to the conducted research it has been revealed that preoperative MR mammography is necessary for treatment planning in patients with breast cancer to avoid cancer recurrence after breast-conserving surgery.  

 

References 

1.    Аксель Е.М. Злокачественные образования молочной железы. Состояние онкологической помощи, заболеваемость и смертность. Маммология. 2006; 1: 9-15.

2.    Аблицова Н.В., Пак Д.Д., Сарибекян Э.К. Возможность выполнения органосохраняющих и реконструктивно-пластических операций при мультицентрическом раке молочной железы. Материалы II Всероссийской научно-практической конференции с международным участием «Научно-организационные аспекты и современные лечебно-диагностические технологии в маммологии». М., 2003; 176-177.

3.    Пак Д.Д., Аблицова Н.В. Лечебная тактика при первично-множественном раке молочной железы. Материалы Всероссийской научно-практической конференции с международным участием 3-4 июля 2007 г. «Профилактика и лечение злокачественных новообразований в современных условиях». Барнаул. 2007; 155.

4.    Brennan M.E. et al. MRI screening of the contralateral breast in women with newly diagnosed breast cancer. Systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J. Clin. Oncol. 2009.

5.    Kurtz J. et al. Breast conserving therapy for macroscopically multiple cancers. Ann. Surg. 1990;212: 38-44.

6.    Zhang Y. et al. The role of contrast-enhanced MR mammography for determining candidates for breast conservation surgery. Breast. Cancer. 2002; 9: 231-239.

7.    Холин А.В. Диагностика рака молочной железы. Перспективы. Маммология. 1996; 4: 5-33.

8.    Anastassiades O. et al. Multicentricity in breast cancer. A study of 366 cases. Am. J. Clin. Pathol. 1993; 99: 238-243.

 

9.    Drew P. et al. Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the preoperative detection of multifocal breast cancer. Ann. Surg. Oncol. 1999; 6: 599-603.

 

10.  Fischer U., Kopka L., Grabbe E. Breast carcinoma. Еffect of the preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology.  1999; 231: 881-888.

11.  Fischer U. et al. Preoperative MR-mammography in diagnosed breast carcinoma. Useful information or useless extravagance [in German]? Rofo Fortschr Geb RontgenstrNeuen Bildgeb Verfahr. 1994; 161: 300-306.

12.  Holland R., Veling S., Mravunac M., Hendrics J. Histlogic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985; 56: 979-990.

 

13.  Houssami N. et al. Accuracy and surgical impact of MRI in breast cancer staging. Systematic review and meta-analysis in detection of multifocal and multicentric cancer. J. Clin. Oncol. 2008; 26: 3248-3258.

 

 

14.  Moon W.K., Noh D.Y., Im J.G. Multifocal, multicentric and contralateral breast cancers. Вilateral whole-breast US in the preoperative evaluation of patients. Radiology. 2002; 224: 569-576.

 

15.  Rieber A. et al. MRI of histologically confirmed mammary carcinoma. Oinical relevance of diagnostic procedures for detection  of multifocal  or  contralateral secondary carcinoma. J. Comput. Assist. Tomogr. 1997; 21: 773-779.

16.  Schwartz G. et al. Multicentricity of nonpalpable breast cancer. Cancer. 1980; 45:2913-2916.

17.  Tillman G.F. et al. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J. Clin. Oncol. 2002;20: 3413-3423.

18.  Turnbull L. Magnetic resonance imaging in breast cancer. Results of the COMICE trial. Br. Cancer. Res. 2008; 10: 10.

 

19.  Lagios M.D., Westdahl P.R., Rose M.R. The concept and implications of multicentricity in breast carcinoma. Pathol. Annu. 1981; 16: 83-102.

 

20.  Vaidya J. et al. Multicentricity of breast cancer. Whole organ analysis and clinical implications. Br. J.  Cancer.  1996; 74: 820-824.

21.  Bedrosian I. et al. Magnetic resonance imaging-guided biopsy of mammographically and clinically occult breast lesions. Ann. Surg. Oncol. 2002; 9: 457-461.

22.  Kuhl C. et al. Interventional breast MR imaging. Oinical use of a stereotatic localization and biopsy device. Radiology. 1997; 204: 667

authors: 


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.

 

Abstract:

Purpose. Was to estimate the efficiency and sensitivity of X-ray-contrast (XRC), CT-angiography (CTAG) and colored duplex scanning (CDS) n diagnostics of patients with chronic abdominal ischemia (CAI)

Materials and methods. We have analyzed 1848 XRC, 436 CTAG and 181 CDS of patients with unpaired visceral artery branches of the abdominal aorta diseases, suffering from CAI.

Results. Due to CTAG, XRC and CDS we have revealed different levels of artery defeats, and also different types of stenotic and occlusion defeat.

Conclusions. CTAG is an effective screening method, and CDS - is an effective method of final diagnostics. Both of these methods should be included into algorithm CAI patients examination. 

 

References 

1.    Покровский А.В., Казанчан П.О., Дюжиков А.А. Диагностика и лечение хронической ишемии органов пищеварения. Ростов-на-Дону: Изд-во РостГУ. 1982; 321.

2.    Гавриленко А.В., Косенков А.Н. Диагностика и хирургическое лечение хронической артериальной ишемии. М.: Москва.2000; 308.

3.    Поташов Л.В., Князев М.Д., Игнашов A.M. Ишемическая болезнь органов пищеварения. М.: Медицина. 1985; 356.

4.    Ойноткинова О.Ш., Немытин Ю.В. Атеросклероз и абдоминальная ишемическая болезнь. М.: Медицина. 2001; 311.

5.    Шальков Ю.Л. Диагностика и хирургическое лечение хронических нарушений абдоминального артериального кровотока. Дис. д-ра мед. наук. Харьков. 1970; 340.

6.    Mikkelsen W.P., Zaro J.A. Intestinal angina, report of case with preoperative diagnosis and surgical relief. New. Engl. J. Med. 1959; 260 (5): 912-914.

7.    Аракелян В.С., Макаренко В.Н., Прядко С.И., Букацелло Р.Г. Возможности компьютерной томоангиографии в диагностике поражений непарных висцеральных ветвей аорты и определение показаний к их хирургической коррекции при хронической ишемии органов пищеварения. Ангиология и сосудистая хирургия. 2009; 15 (2 - прил.): 21.

8.    Егоров В.И., Яшина Н.И., Кармазановский Г.Г., Федоров А.В. КТ-ангиография как надежный метод верификации заболеваний, вариантов строения целиако-мезентериального бассейна. Медицинская визуализация. 2009; 3: 82-94.

9.    Mitchell E.L. et al. Duplex criteria for native superior mesenteric artery stenosis overestimate stenosis in stented superior mesenteric arteries. J. Vasc. Surg. 2009; 50 (2): 335-340.

10.  Moneta G.L. et al. Mesenteric duplex scanning. A blinded prospective stady. J. Vasc. Surg. 1993; 17: 79.

11.  Власов В.В. Введение в доказательную медицину. М.: Мед. Сфера. 2001; 392.

12.  Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. М.:Мед. Сфера. 2002; 305.

 

 

Abstract:

Purpose. Was to define the capability of multi-slice computed tomography angiography (MSCT-angiography) in diagnostics of arteriove-nosus conflict in patients with primary and recurrent varicocele.

Materials and methods. 46 patients with left-side varicocele were underwent MSCT-angiography: 36 had firstly diagnosed disease, 10 had recurrent types. Capability of MSCT-angiography in the zone of possible arteriovenosus conflicts was estimated on the base of imaging analysis: axial, multiplanar and 3D-imaging of left renal vein (LRV), a.mesenterica superior (AMS) in aortomesenterical zone, and crossing place of left iliaca communis vein(LICV) and right iliaca communis artery (LICA). We have investigated structure features of left testiculars vein (LTV) in patients with primary and recurrent varicocele.

Results. All the patients during axial imaging analysis we have investigated the crossing place of LRV and LICV with conflict arteries - AMS and LICA. We have revealed featured of LRV, compressed by AMS, on the base of axial and multiplanar imaging changes. Analysis of axial multiplanar and 3D-reconstruction has showed high capability in diagnostics of arteriovenosus conflict on the level LICV Study of multiplanar and CT-imaging in case of LICV valve insufficiency and different types of anatomy is possible

Conclusions. Taking into consideration diagnostic capability, technical simplicity and high sensitivity of MSCT-angiography in diagnostics of arteriovenosus conflicts in varicocele, this methodic must be included in algorithm of patients examination in case of primary and recurrent varicocele. MSCT-angiography in definition of haemodynamic types of disorders can promote the right choice of surgical correction.

 

References 

1.    Kim et al. Hemodynamic Investigation of the Left Renal Vein in Pediatric Varicocele. Doppler US, Venoaphy and   Pressure   Measurements.   Radiology. 2006; 241.

2.    Степанов В.Н., Кадыров З.А. Диагностика и лечение варикоцеле. М. 2001; 200.

3.    Бавильский В.Ф., Суворов А.В., Иванов А.В. и др. Выбор метода оперативного лечения варикоцеле.  Урология. 2003; 6: 40-43.

4.    Гарбузов Р.В., Поляев Ю.А., Петрушин А.В. Артериовенозный конфликт и варикоцеле у подростков. Диагностическая и итервенционная радиология. 2010; 4 (3): 31-36.

5.    Мазо Е.Б., Тирси К.А., Андранович С.В., Дмитриев Д.Г. Ультразвуковой тест и скротальная допплер-эхография в предоперационной диагностике гемо-динамического типа варикоцеле. Урология и нефрология. 1999; 3: 22-26.

6.    Лопаткин Н.А., Морозов А.В., Житникова Л.Н. Стеноз почечной вены. М.: Медицина. 1984.

7.    Коган М.И., Афоко А., Тампуори Д., Асанти-Асамани А., Пипченко О.И. Варикоцеле: противоречия проблемы. Урология. 2009; 6: 67-72.

8.    Кадыров З.А. Варикоцеле. М.: Медицина. 2006.

 

 

Abstract:

Primary hyperaldosteronism (PHA) is one of the most-spread reasons of arterial hypertension.

Comparative selective blood sampling froms adrenal gland's veins - is the only method of differential diagnostics of different form of PHA This methodic, its technical complexities and problems of data's interpretation are presented in the article. And a case report: aldosteron producing adenoma. 

 

References 

1.    Gordon R.D. Diagnostic investigations in primary aldosteronism. In: Zanchetti A (ed) Clinical medicine series on hypertension. McGraw-Hill International,   Maidenhead,   UK.   2001; 101-111.

2.    Young W.F. et al. Role for adrenal venous sampling in primary aldosteronism. Surg. 2004; 136: 1227-1235.

3.    Tan Y.Y. et al. Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas. World. J. Surg. 2006; 30: 879-885.

4.    Gross  M.D.   et  al.  Adrenal  glands.   In: Endocrine imaging. Norwalk, Conn: Appleton & Lange. 1992; 271, 349.

5.    Reznek R.H., Armstrong P. The adrenal gland.    Clin.    Endocrinol.    (Oxf.)    1994; 40: 561-576.

6.    Bookstein J.J. The roles of angiography in adrenal disease. In: Abram's angiography. 3rd ed. Boston, Mass: Little. Brown. 1983; 1395-1424.

7.    Johnstone F.R. The suprarenal veins. Am. J. Surg. 1957; 94: 615-620.

8.    Gagnon R. The venous drainage of the human adrenal gland. Rev. Can. Biol. 1956; 14: 350-359.

9.    Daunt N. Adrenal vein sampling: how to make it quick, easy, and successful. Radiograph. 2005, 25 (suppl 1): 143-158.

10.  Dunnick N.R. et al. Preoperative diagnosis and localization of aldosteronomas by measurement of corticosteroids in adrenal venous blood. Radiol. 1979; 133: 331-333.

11.  Spiritus T., Zaman Z., Desmet W. Iodinated contrastmedia interfere with gel barrier formation in plasma and serum. Clin. Chem. 2003; 49: 1187-1189.

12.  Rossi G.P. Current Hypertension Reports. 2007; 9: 90-97.

13.  Gordon R.D. Primary aldosteronism. J. Endocrinol. Invest. 1995; 18: 495-511.

14.  Mengozzi G. et al. Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism. Clin. Chem. 2007; 53: 1968-1971.

15.  Rossi G.P. et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J. Clin. Endocrinol. Metab. 2001; 86: 1083-1090.

16.  Ветшев П.С., Кондрашин С.А., Ипполитов Л.И. и др. Современные ангиологические технологии в диагностике и хирургическом лечении заболеваний   надпочечников.   Мед.   визуал. 2002; 1: 68-76.

17.  Покровский А.В., Торгунаков А.П., Торгунаков С.А. Многолетнее наблюдение за пациентами после односторонней портализации надпочечниковой и почечной крови при первичном гиперальдостеронизме. Хирургия. 2009; 3: 65-66.

18.  Nwariaku F.E. et al. Primary hyperaldosteronism. Effect of adrenal vein sampling on surgical outcome. Arch. Surg. 2006; 141: 497-502.

19.  Marlies J.E. еt al. Systematic Review: Diagnostic Proceduresto Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism. Ann. Intern. Med. 2009; 151 (Issue 5): 329-337.

 

 

Abstract:

Cardiovascular diseases of atherosclerotic genesis are one of the most actual problems of modern medicine. The purpose was to estimate the efficiency of interventional radiology treatment of stenosis and occlusions of arteria iliaca interna et externa (lat.) with self-extracting sten Jaguar SM

95 patients aged 44-79 years (71 male and 34 female) were included into experiment: during the period of 2005-2007 they were underwent nterventional radiology treatment of occlusion-stenosis arteria iliaca defeat. All patients in group had atherosclerotic genesis of disease Minimal length of stenosis was 10 mm, the longest stenosis - 90 mm

All the stenosis were estimated due to TASC II. 10 patients had stenosis type A$ 39 patients - type D, 36 patients - type C, and 10 patients - type D. Endovascular recanalization failed in 5 cases of type D stenosis, and these patients were sent for traditional surgical treatment n 1 case a complication occurred - artery perforation during pre-dilatation, and such problem demanded implantation of stent-graft Afterimplantation balloon dilatation was performed in 95% cases. All patients had angiographycally confirmed restored blood flow. Clinica estimation and angiographycal inspection were spent within 2 years. The inspection in 30 days showed the efficiency 100% in case of stenotic defeat and 80% in case of occlusion defeat. The success rate in 12 month was 87%, in 2 years - 82%.
 

 

References 

1.    Liapis C.D., Tzortzis E.A. Advances in the management of iliac artery occlusive disease. А short review. Vasc. Endovascular. Surg. 2004: 38 (6): 541-545.

2.    Gray B.H., Sullivan T.M. Aortoiliac occlusive disease. Surgical versus interventional therapy. Cur. Interv. Cardiol. Rep. 2001;3 (2):109-116.

3.    Adam D.J., Bradbury A.W. TASC II document on the management of peripheral arterial disease. Eur. J. Vasc. Endovasc. Surg. 2007; 33 (1): 1-2.

4.    Dotter C.T., Judkins M.P. Transluminal Treatment of arteriosclerotic obstruction. description of a new technic and a preliminary    report    of    its    application. Circulation. 1964; 30: 654-670.

5.    Gruntzig A., Hopff H. Percutaneous recanalization after chronic arterial occlusion with a new dilator-catheter (modification of the Dotter technique) (author's transl). Dtsch. Med. Wochenschr. 1974; 99 (49): 2502-2511.

6.    Palmaz J.C. et al. Expandable intraluminal graft. А preliminary study. Work in progress. Radiology. 1985;156 (1): 73-77.

7.    Mohler E., Giri J. Management of peripheral arterial disease patients. Comparing the ACC/AHA and TASC II guidelines. Cur. Med. Res. Opin. 2008; 24 (9): 2509-2522.

8.    Bosiers M. et al. Present and future of endovascular SFA treatment. Stents, stent-grafts, drug coated balloons and drug coated stents. J. Cardiovasc. Surg. 2008; 49 (2): 159-165.

9.    Lagana D. et al. Percutaneous treatment of complete chronic occlusions of the superficial femoral artery. Radiol. Med. 2008; 113 (4): 567-577.

10.  O'Sullivan G.J. Endovascular management of aorto-iliac occlusive disease. Abdom. Imaging. 2008; 4: 25.

11.  Tsetis D., Uberoi R. Quality improvement guidelines for endovascular treatment of iliac artery occlusive disease. Cardiovasc. Intervent. Radiol. 2008; 31 (2): 238-245.

12.  Kudo T., Chandra F.A., Aim S.S. Long-term outcomes and predictors of iliac angioplasty with selective stenting. J. Vasc. Surg. 2005; 42 (3): 466-475.

13.  Van Walraven L.A. et al. The use of vascular stents in the treatment of iliac artery occlusion. Int. J. Angiol. 2000; 9 (4): 232-235.'

14.  Carreira J.M. et al. Long-term follow-up of symphony nitinol stents in iliac arteriosclerosis obliterans. Minim. Invasive. Ther. Allied. Technol. 2008; 17 (1): 44-42.

15.  Norgren L. et al. Inter society consensus for the management of peripheral arterial disease (TASC II). J. Vasc. Surg. 2007; 45: S5-67.

16.  Diehm N. et al. TASC II section E3 on the treatment of acute limb ischemia. Commentary from European interventionists. J. Endovasc. Ther. 2008; 15 (1): 126-128.

17.  Mousa A.Y. et al. Endovascular treatment of iliac occlusive disease. Review and update. Vascular. 2007; 15 (1): 5-11.

18.  Karwowski J., Zarins C.K. Endografting of the abdominal aorta and iliac arteries for occlusive disease. J. Cardiovasc. Surg. 2005; 46 (4): 349-357.

19.  Sasaki Y. et al. Stenting for superficial femoral artery atherosclerotic occlusion. Long-term follow-up results. Heart. Vessels. 2008; 23 (4): 264-270.

20.  Sapoval M.R. et al. Self-expandable stents for the treatment of iliac arter. Am. J. Roentgenol. 1996; 166 (5): 173-1179.

21.  Sixt S. et al. Acute and long-term outcome of endovascular therapy for aortoiliac occlusive lesions stratified according to the TASC classification. А single-center experience. J. Endovasc. Ther. 2008; 15 (4): 408-416.

22.  Zana K. et al. Risk of embolism in diagnostic and therapeutic intravascular procedures - in vitro model. Orv. Hetil. 2001; 142 (34): 1837-1841.

23.  Zana K. et al. In vitro evaluation of the embolic risk of diagnostic and therapeutic intravascular procedures. Med. Sci. Monit. 2001; 7 (1): 148-152.

24.  Saratzis A. et al. Pharmacotherapy before and after endovascular repair of abdominal aortic aneurysms. Cur. Vasc. Pharmacol. 2008; 6 (4): 240-249.

25.  Harnek J. et al. Insertion of self-expandable nitinol stents without previous balloon angioplasty reduces restenosis compared with PTA prior to stenting. Cardiovasc. Intervent. Radiol. 2002; 25 (5): 430-436.

 

authors: 

 

Abstract:

For today it is possible to allocate two basic strategies of images primary analysis during virtual colonoscopy (VC): it means interpretation on the basis of 2D and 3D reconstruction data

Purpose. Was to compare 2D and 3D analysis programs during VC: they were compared on interpretation time,on sensitivity of polyp's detection

Materials and methods. The research consisted of 80 patients. All detected new growth during VC were put into protocols of interpretation, with instructions of quantity, form and size

All the patients were underwent VC, including biopsy and further histological research Also, time spent for analysis of each research was fixed

Conclusions. Sensitivity of 3D virtual dissection during primary imaging analysis in almost the same in comparison with 2D, but interpretation time is higher in 2D.  

 

References 

1.    Barish   M.A.,   Soto  J.A.,   Ferrucci  J.T. Consensus on current clinical practice of virtual colonoscopy. Am. J. Roentgenol. 2005; 184: 786-792.

2.    Pickhardt PJ. et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N. Engl. J. Med. 2003; 349: 2191- 2200.

3.    Taylor S.A. et al. Polyp detection with CT colonography. Primary 3D endoluminal analysis versus primary 2D transverse analysis with computer-assisted reader software. Radiology.2006; 239: 759-767.

4.    Yasumoto T. et al. Assessment of two 3D MDCT colonography protocols for observation of colorectal polyps. Am. J. Roentgenol. 2006; 186: 85- 89.

5.    Sorstedt E. et al. Computed tomographic colonography. Сomparison of two workstations. Acta. Radiol. 2005; 46: 671-678.

6.    Macari M. et al. Comparison of time-efficien CT colonography with two- and three-dimensional colonic evaluation for detecting colorectal polyps. Am. J.Roentgenol. 2000; 174: 1543-1549.

7.    Hoppe H. et al. Virtual colon dissection with CT colonography compared with axial interpretation and conventional colonoscopy. Preliminary results. Am. J. Roentgenol. 2004;182: 1151-1158.

8.    Paik D.S. et al. Visualization modes for CT colonography using cylindrical and planar map projections. J.Comput. Assist. Tomogr. 2000; 24: 79-188.

9.    Rottgen R. et al. Colon dissection. А new three-dimensional reconstruction tool for computed tomography colonography. Acta. Radiol. 2005; 46: 222-226.

10.  Dekel D., Durgan J., Fleiter T. Virtual endo-scopy (patent pending). Publication no 2006/000925. Geneva, Switzerland: World Intellectual Property Organization. 2006.

11.  Хомутова Е.Ю. и др. Устройство для раздувания толстой кишки. Патент на полезную модель № 71072 от 14.05.2007 г. 2008.

12.  Juchems M.S. et al. CT colonography. Сomparison of a colon dissection display versus 3D endoluminal view for the detection of polyps. Eur. Radiol. 2006; 16: 68-72.

13.  Pickhardt P.J. et al. Flat colorectal lesions in asymptomatic adults. lmplications for screening with CT virtual colonoscopy. Am. J. Roentgenol. 2004; 183: 1343-1347.

 

 

Abstract:

Purpose. For basic, purpose was to develop effective methods of exact diagnostics of an acute pancreatitis (AP), to work out classifications of disease, an establishment of patients' condition definitions, and also productive supervision over dynamics of its process by means of application computed tomography (СТ) and magnetic resonance imaging (MRI). Besides, on the base of obtained data, the optimum tactics of treatment was worked out

Materials and methods. More than 500 patients with AP were underwent CT and MRI with one-stage contrast agents' injection. During the research we have applied different variations of scanning modes and parameters. Results were analyzed in connection with supervision on patients conditions. Treatment tactics depended on obtained data

Results. We have worked out effective methods of AP diagnostics, optimal parameters of research in different clinical currents and we have developed an effective tactics of treatment in patients with severe AP Besides, on the base of obtained data, the optimum tactics of treatment was worked out

Conclusions. CT with intravenous contrasting is the best method of diagnostics or supervision in dynamics, which allows to work out the most productive treatment tactics. Using CT in combination with MRI in some cases can be specifying method of diagnostics.  

 

References

1.    Араблинский А.В., Черняков P.M., Хитрова А.Н., Богданова Е.Г. Лучевая диагностика острого панкреатита. Медицинская визуализация. 2000;         1-14.

2.    Прокоп М., Галански М. Спиральная компьютерная томография. 2009.

3.    Райан С., МакНиколас М., Юстеис С. Анатомия человека при лучевых исследованиях. 2009.

4.    Шабунин А.В., Мумладзе Р.Б., Чеченин Г.М., Тавобилов М.М. Этапное хирургическое лечение острого панкреатита, панкреонекроза алкогольной этиологии. Неотложная и специализированная хирургическая помощь. 1-й конгресс московских хирургов. Тез. док. М. 19-21 мая 2005 г. М.: ГЕОС. 2005; 122.

5.    Balthazar E. CT diagnosis and staging of acute pancreatitis. RadiolClin. North. Am. 1989; 27 (1): 19-37.

6.    Balthazar E.J., Megibov A.J., Pozzi R. Mucelli Imaging of the pancreas. Medical radiology.2009.

7.    Piironen A. et al. Detection of severe acute pancreatitis by contrast enhanced magnetic resonance imaging. European Radiology. 2000; 2: 354.

8.    Balthazar E. et al. Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990; 174 (2): 331-336.

9.    Bradley E.L. A clinically based classification system for acute pancreatitis. Summary of the international simposium on acute pancreatitis. Atlanta. G., Sept. 11-13. 1992: 586-590.

10.  Багненко С.Ф., Рухляда Н.В., Толстой А.Д., Гольцов В.Р. Лечение острого панкреатита на ранней стадии заболевания. НИИ СП им. И.И. Джанелидзе, С.-Пб. 2002; 24.

11.  Robinson PJ.A., Sheridan M.B. Pancreatitis computed tomography and magnetic resonance imaging. European Radiology. 2000; 3: 401.

12.  Balthazar E.J., Freeny P.C., Sonennberg E. Imaging intervention in acute pancreatitis. Radiology. 1994; 193: 197-306.

13.  Balthazar E.J. et al. Acute pancreatitis. Prognostic value of CT. Radiology. 1985; 156:767-772.

14.  Isenmann R., Rau B., Beger H.G. Infected necroses and pancreatic abscess. Surgical therapy. Kongressbd Dtsch Ges Chir Kongr. 2001; 118: 282-284.

15.  Кармазановский Г.Г., Федоров В.Д. Компьютерная томография поджелудочной

MRI in diagnostics of atypical uterine myomas



DOI: https://doi.org/10.25512/DIR.2011.05.2.02

For quoting:
Puchkova E.N., Mershina E.A., Sinitsyn V.E. "MRI in diagnostics of atypical uterine myomas". Journal Diagnostic & interventional radiology. 2011; 5(2); 9-14.

 

Abstract:

Purpose. Was to reveal atypical MRI-signs of leiomyomas.

Materials and methods. Kinds of degeneration: hyaline (60%), cystous (4%), hemorrhagic and myxomatous. In rare case of 8% myomas can be localized in uterine cervix and its surrounding structure - ligamentum uteri latus, vagina and retroperitoneal area. Connection between uterine and myomatic node can be lost due to torsion and necrosis. Such situation leads to wrong diadnosis ((retroperitoneal tumor with extraorganic localization*. Such tumors displace bladder, rectum and descending colon to the front. Due to surrounding fabrics pressure these tumors have irregular forms. Atypical myomas with extrauterine localization often have cystoid degeneration, necrosis and hemorrahages - such situation needs differential diagnostics firstly with leiomyosarcomas: these malignant newgrowth more often than simple leiomyomas have such localization and structure.

Discussion. We have described two cases of leiomyomas atypical localizations, which had been estimated as an extraorganic tumors during diagnostics' initial stages. It is very important to differentiate leiomyomas from other tumors of the same localization. In case of cancer-tumors - immediate surgical treatment is necessary

Conclusions. Histological structure and clinical current knowledge can help to differentiate this tumor with atypical signs from malignant gynecological new growth. MRI can be used in diagnostics of atypical leiomyomas.  

 

References

1.    Jiang G.H. et al. Atypical magnetic resonance imaging vs pathological findings of leio-myoma in the female reproductive system.Nan. Fang. Yi Ke Da Xue Xue Bao. 2009; 29 (2): 301-304.

2.    Wzkavukcu E et al. Pelvic retroperitoneal 6 angioleiomyoma mimicking a uterine mass. Diagn. Interv. Radiol. 2009; 15 (4): 262-265.

3.    Nidhanee S.V. et al. An unusual presentation of vaginal leiomyoma in a postmenopausal hysterectomised woman. А case report. Cases. J. 2009; 2: 6461-6464.

4.    Baert A.L., Knauth M., Sartor K. MRI and CT of the female pelvis. Springer. 2007; 388.

5.    Дуда И.В., Дуда Вл.И., Дуда В.И. Клиническая гинекология. В 2-х томах. Т. 1. Минск: «Вышэйшая школа». 1999; 302-325.

6.    Jashnani K.D., Kini S., Dhamija G. Perino-dular hydropic degeneration in leiomyoma. An alarming histology. Indian. J. Pathol. Microbiol. 2010; 53: 173-175.

7.    Кулаков В.И., Адамян Л.В., Мурватов К.Д. Магнитно-резонансная томография в гинекологии. Атлас. М.: Антидор. 1999; 59-98.


Article exists only in Russian.

authors: 


Article exists only in Russian.


Article exists only in Russian.

 

Abstract:

The prostate cancer is one of the most widespread forms of malignant new growths at men. Brachytherapy I125 is a modern, hi-tech, effective, rather safe and easily reproduced method of prostate cancer treatment. In the Russian Scientific Center of Roentgenoradiology implantation of microsources I125 in patients with localized and widespread prostate cancer is carried out by since 2003. For the last period 689 implantations of sources I125 were spent. The tumor-specific survival rate after brachytherapy significantly didn't differ from a tumor-specific survival rate after radical prostatectomy. Thus, brachytherapy is a hi-tech, modern method of treatment in patients with prostate cancer and quantity of undesirable postbeam effects is less than after radical prostatectomy.

 

References

1.     Каприн А.Д., Подшивалов А.В. Современные аспекты диагностики рака простаты. Андрол. и генит. хирургия. 2002; 1: 39–47.

2.     Сивков А.В., Ощепков В.Н., Патаки К.В. Интерстициальная лучевая терапия I125 локализованного рака предстательной железы. Урология. 2004; 1: 21–25.

3.     Чиссов В.И., Старинский В.В. Злокачественные новообразования в России в 2008 г. (заболеваемость и смертность). 2010; 256.

4.     Stone N.H. et al. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after I125 rostate brahytherapy. Brachytherapy. 2003; 2 (1): 32–39.

5.     De Reijke T.M., Laguna M.P. Department of Urology, Academic Medical Centre, Amsterdam. The Netherlands. Long-term complications of brachy-therapy in local prostate cancer. BJU International. 2003; 92 (8): 869–873.

 


 

 

Abstract:

We have retrospectively analyzed results of 100 patients’ interventional radiology methods in cases of difficulties during endoscopy choledocholithiasis treatment. It was determined that transcutaneous transhepatic cholangiostomy is a universal method of biliary decompression in case of dilatation of intrahepatic bile ducts, and can be the first stage of treatment in patients with choledocholithiasis which may be transformed consistently in endoscopic interventions, or – in case of its inefficiency or inexpediency may be transformed into percutaneous choledocholithotripsy and lithoextraction. The number of choledocholithotripsy and lithoextraction varied from 1 to 3 interference. Adequacy of lithoextraction from common bile duct was controlled by the repeated direct cholangioscopy and was confirmed by antegrade cholangiography. Complications of transhepatic method of choledocholithotripsy and lithoextraction included bacterial shock (6%), insignificant hemobilia (8%), migration (4%) and dislocation of cholangiostomy with disturbance of its drainage function (7%). Complications were eliminated successfully and didn’t change treatment tactic. There were no fatal outcomes in investigated group of patients. Antegrade percutaneous choledocholithotripsy and lithoextraction is the method of choice in case of impossibility of transpapillary endoscopical or traditional surgical treatment of choledoholithiasis.

 

References

1.     Нестеренко Ю.А., Лаптев В.В., Цкаев А.Ю. и др. Актуальные вопросы диагностики и лечения больных микрохоледохолитиазом. Анналы хирургической гепатологии. 2007; 12 (2): 62–68.

2.     Котовский А.Е., Глебов К.Г. Эндоскопическое транспапиллярное стентирование желчных протоков. Анналы хирургической гепатологии. 2008; 13 (1): 66–71.

3.     Шевченко Ю.Л., Ветшев П.С., Стойко Ю.М. и др. Диагностика и хирургическая тактика при синдроме механической желтухи. Анналы хирургической гепатологии. 2008; 13 (4): 96–105.

4.     Балалыкин А.С., Балалыкин В.Д., Гвоздик В.В. и др. Дискуссионные вопросы хирургических вмешательств на большом сосочке двенадцатиперстной кишки. Анналы хирургической гепатологии. 2007; 12 (4):45–50.

5.     Гальперин Э.И., Ветшев П.С. Руководство по хирургии желчных путей. М.: Издательский дом Видар-М. 2006; 568.

6.     Шулутко А.М. Хирургическое лечение желчнокаменной болезни. 50 лекций по хирургии. М.: Медиа Медика. 2003; 198–206.

7.     Истомин Н.П., Султанов С.А., Архипов А.А. Двухэтапная тактика лечения желчнокаменной болезни, осложненной холедохолитиазом. Хирургия. 2005; 1: 48–50.

8.     Chen C. et al. Reappraisal of percutaneous transhepatic cholangioscopic lithotomy for primary hepatolithiasis. Surg. Endosc. 2005; 19 (4): 505–509.

9.     Ell C. et al. Laser lithotripsy of difficult bile duct stones by means of a rhodamine-6G laser and integrated automatic stone-tissue detection system. Gastrointest Endosc. 1993; 39: 755–762.

10.   Nadler R.B. et al. Percutaneous hepatolithotomy. Тhe the Northwestern University experience. Endourol. 2002; 16: 293–297.

11.   Ogawa K. et al. Percutaneous trashepatic small-caliber choledochoscopic lithotomy. А safe and effective technique for percutaneous transhepatic common bile duct exploration in high-risk eldery patients. Hepatobiliary Pancreat Surg. 2002; 9 (2): 213–217.

12.   Долгушин Б.И., Патютко Ю.И., Нечипай А.М. и др. Антеградные эндобилиарные вмешательства в онкологии. Причины, профилактика и лечение осложнений. М.: Практическая медицина. 2005; 176.

 

 

 

 

Abstract:

The cardiac complications' risk factors and it’s stratifications in patients with non-ST elevation acute coronary syndrome are considered in detail. The interrelation between risk factors, features and character of defeat of coronary arteries is defined. Early selective coronarograthy is most informative to identify patients with culpite lesion in this category. Early interventional radiology treatment has allowed to reach more favorable in-hospital and 12-month follow-up period results (patients’s lethality, non-fatal MI).

 

 

Abstract:

Front abdominal wall (FAW) flap – is known to be the best method of mammary gland restoration. Classical TRAM flap are replaced by muscle-saving analogs. To decrease the risk of FAW weakness autotransplantates made of skin, hypodermic cellulose and vessels have been developed. Such flaps are optimal for mammary gland restoration, but, unfortunately, their practical usage is complicated due to technical difficulties, linked with microsurgical technique for anastamosis. Anatomic variability of blood system also complicates their usage. CT-angiography of FAW – is known to be recently used method in patients going to have restoration of mammary gland with FAW-anastamosis flap, in order to define epigastric artery inferior (EAI). The article consists of the scientific work comparative analysis, which are devoted to the preoperative FAW vessels features estimation. There are developed CT-angiographic modes, which allows to obtain high-quality EAI and all its branches visualization, almost in 100% cases and that provides an opportunity to decrease patient’s beam loading. Obtained EAI topographic data can decrease the time of intervention.  

 

 

References

1.     Hartampf C.R., Scheflan M.Jr., Black P.W. Breast reconstruction with a transverse abdominal island flap. Plast. Reconstr. Surg. 1982; 69: 216.

2.     Holmstrom H. The free abdominoplasty flap and its use in breast reconstruction. Scand. J. Plast. Reconstr. Surg. 1979; 13: 423.

3.     Боровиков А.М. Восстановление груди после мастэктомии. М.: Губернская медицина. 2000; 96.

 

4.     Maurice Y. Nahabedian. Breast reconstruction. А review and rationale for patient selection. Plast. Reconstr. Surg. 2009; 124 (1): 55–62.

5.     Blondeel P.N. et al. The donor site morbidity of free DIEAP flaps and free TRAM flaps for breast reconstruction. Br. J. Plast. Surg. 1997;50: 322–330.

6.     Gill P.S. et al. A 10-year retrospective review of 758 DIEP flaps for breast reconstruction. Plast. Reconstr. Surg. 2004; 113: 1153–1160.

7.     Nahabedian M.Y. et al. Breast reconstruction with the free TRAM or DIEP flap. Patient selection, choice of flap and outcome. Plast. Reconstr. Surg. 2002; 110: 466–477.

8.     Spiegel A.J., Khan F.N. An intraoperative algorithm for use of the SIEA flap for breast reconstruction. Plast. Reconstr. Surg. 2007; 120: 1450–1459.

9.     Holm C. et al. The versatility of the SIEA flap. А clinical assessment of the vascular territory of the superficial epigastric inferior artery. J.Plast. Reconstr. Aesthet. Surg. 2007; 60:946–951.

10.   Blondeel P.N. et al. Doppler flowmetry in the planning of perforator flaps. Br. J. Plast. Surg. 1998; 51: 202–209.

11.   Hallock G.G. Doppler sonography and color duplex imaging for planning a perforator flap. Clin. Plast. Surg. 2003; 30: 347–357.

12.   Giunta R.E., Geisweid A., Feller A.M. The value of preoperative Doppler sonography for planning free perforator flaps. Plast. Reconstr. Surg. 2000; 105: 2381–2386.

13.   Moon H.K. and Taylor G.I. The vascular anatomy of rectus abdominis musculocutaneous flaps based on the deep superior epigastric system. Plast. Reconstr. Surg. 1988; 82: 815.

 

14.   Phillips T.J. et al. Abdominal wall CT angiography. А detailed account of a newly established preoperative imaging technique. Radiology. 2008; 249 (1): 32–44.

15.   Masia J. et al. Multidetector-row computed tomography in the planning of abdominal perforator flaps. J. Plast. Reconstr. Aesthet. Surg. 2006; 59: 594–599.

16.   Alonso-Burgos A. et al. Preoperative planning of deep inferior epigastric artery perforator flap reconstruction with multislice-CT angiography. Imaging findings and initial experience. J. Plast. Reconstr. Aesthet. Surg. 2006; 59: 585–593.

17.   Rozen W.M. et al. Preoperative imaging for DIEA perforator flaps. A comparative study of computed tomographic angiography and Doppler ultrasound. Plast. Reconstr. Surg. 2008; 121: 9–16.

18.   Rozen W.M. et al. The DIEA branching pattern and its relationship to perforators. The importance of preoperative computed tomographic angiography for DIEA perforator flaps. Plast. Reconstr. Surg. 2008; 121: 367–373.

19.   Xin Minqiang et al. The value of multi-detector-row CT angiography for preoperative planning of breast reconstruction with deep inferior epigastric arterial perforator flaps. British Journal of Radiology. 2010; 83: 40–43.

20.   Masia J.

 

Abstract:

The major condition of neurosurgical intervention safe performance are adequacy of surgical access, exactness of orientation in anatomic structures, observance of principles of functional availability. Technical means to achieve these aims are known as «navigation systems». Such computer-assisted methods have found application in neuro-oncology, vascular neuro-surgery, spinal neurosurgery. Rational and complex methods of preoperative visualization are necessary for an effective use of computer-assisted neuronavigation. Volume and methods of preoperation patient’s inspection must be determined by characteristic of brain defeat and planned tactics of operative intervention. Correctness of protocol observance allows to construct the exact and correct virtual three-dimensional model and its exact accordance and subsequent combination with the anatomy of patient. The limiting factor in capacity utilization is neuronavigation shift – the phenomenon – the discrepancy neuroimaging data in the later stages of intracranial surgery, due to changes in the dislocation structures of the brain. Full alignment of this phenomenon is achieved by the use of intraoperative imaging – MRI and CT units.

 

 

References

1.     Barnett G.H., Maciunas R.J., Roberts D.W. Computer-assisted neurosurgery Taylor&Fracis. 2006.

2.     Eben A., Maciunas R.J. Advanced neuro-surgical navigation. Thieme Midical Publishers. 1999, 279–301.

3.     Кандель Э.И. Функциональная и стереотаксическая нейрохирургия. М.: Медицина. 1981; 41–45.

4.     Spiegel E.A. et al. Stereotactic apparatus for operations on the human brain. Science. 1947; 106: 349–350.

5.     Roberts D.W. et al. A frameless stereotaxic integration of computerized tomographic imaging and the operating microscope. J. Neurosurg. 1986; 65: 545–549.

6.     Nicolato A. Computerized tomography and magnetic resonance guided stereotactic brain biopsy in non-immunocompromised and AIDS patients. Surg. Neurol. 1997; 48:267–277.

7.     Дуэйн Хейнс. Нейроанатомия. Атлас структур, срезов и систем. М.: Логосфера. 2008; 4–8.

8.     Гайдар Б.В. Практическая нейрохирургия С.-Пб: Гиппократ. 2002; 167–172.

9.     Hernes T.A. et al. Stereoscopic navigation-controlled display of preoperative MRI and intraoperative 3D ultrasound in planning and guidance of neurosurgery. New technology for minimally invasive image-guided surgery approaches. SINTEF Unimed. Norway, Trondheim. Medical. Technical. Research. Centre. Giese A., Westphal M. Treatment of malignant glioma. А problem beyond the margins of resection. J. Cancer. Res. Clin. Oncol. 2001; 127: 217–225.

10.   Мацко Д.Е., Коршунов А.Г. Атлас опухолей центральной нервной системы. С.-Пб. 1998.

11.   Улитин А.Ю. Эпидемиология первичных опухолей головного мозга среди населения крупного города и пути совершенствования организации медицинской помощи больным с данной патологией (на модели Санкт-Петербурга). Автореф. дис. канд.мед. наук. С.-Пб. 1997.

 

Abstract:

Purpose. Was to investigate the radiodiagnostic features of ASD in different age groups and to evaluate the role of chest X-rays in diagnostics of this disease.

Materials and methods. 48 patients with ASD were studied (aged 15–71 yaers, mean 47,2 ± 15), including 16 men and 32 women. We have diagnosed ostium primum defect (3 pts), ostium secundum defect (42 pts), sinus venosus defect, combined with PAPVD (3 pts). All of them underwent chest x-rays, echocardiography and cardiac MRI (with phase-contrast sequences). Patients were divided into two groups: 1st group – older than 40 years (30 pts) and 2nd group – less than 40 years (18 pts).

Results. In the 1st group, heart failure, valve regurgitations and atypical radiographic findings were more common than in the 2nd group. The size of both atria, pulmonary arteries' diameter and systolic PAP levels were also greater in patients older than 40 yaers. Groups did not differ by the volume of intracardiac shunt and the size of the defect. 6 pts with small defects had no radiographical signs of CHD. 11 patients from the 1st group had signs of hypervolemic CHD, but significant heart chambers’ enlargement impeded more accurate diagnostics. Patients with marked pulmonary arterial hypertension differed significantly from patients with lower PAP levels by radiographical signs.

Conclusions. Specificity of chest x-rays in diagnostics of ASD is lower in patients of 2nd group. Chest x-rays is an effective screening method to reveal abnormalities of pulmonary circulation, such as pulmonary venous hypertension and pulmonary plethora.

 

References

1.     Russell I. A. et al. Congenital heart disease in the adult. А review with internet-accessible transesophageal echocardiographic images. Anesth Analg. 2006; 102: 694–723.

2.     Brickner E.M., Hillis D.L., Lange R.A. Congenital heart disease in adults. First of two parts. NEJM. 2000; 32 (4): 256–263.

3.     Rodstein M., Zeman F.D. Gerber I. Atrial septal defect in the aged. Circulation. 1961; 23: 665–674.

4.     Сердечно-сосудистая хирургия. Под ред. В.К. Бураковского, Л.А. Бокерия. М.: Медицина. 1989.

5.     Белоконь Н.А., Подзолков В. П. Врожденные пороки сердца. М.: Медицина, 1991.

6.     Laks H. Plunkett M., Myers J. Adult сongenital heart disease. Cardiac surgery in the adult. Ed. dy cohn L. New York: McGraw-Hill. 2008; 431–1464.

7.     Дземешкевич С. Л., Синицын В. Е., Королев С. В. и др. Септальные дефекты у взрослых: современная диагностика и лечебная тактика. Грудная и сердечно сосудистая хирургия. 2001; 2: 40–45.

8.     Houston A. et al. Echocardiography in adult congenital heart disease. Heart. 1998;80: 12–26.

9.     Currie P.J. et al. Continuous wave Doppler determination of right ventricular pressure. A simultaneous Doppler-catheterization study in 127 patients. J. Am. Coll. Cardiol. 1985;6: 750–756.

10.   Шиллер Н., Осипов М.А. Клиническая эхо-кардиография. 2-е изд. М.: Практика. 2005.

11.   Ruiz O. et al. Evaluation of congenital heart disease in adults. Rev. Esp. Cardiol. 2003; 56(6): 607–620.

12.   Беленков Ю.Н., Терновой С.К., Синицын В.Е. Магнитно-резонансная томография сердца и сосудов. М.: Видар. 1997.

13.   Wang Z.J. et al. Cardiovascular shunts: MR imaging evaluation. Radiographics. 2003;23: 181–194.

14. Коробкова И.З. Рентгенологические методы исследования сердечно-сосудистой системы. Функциональная диагностика сердечно-сосудистых заболеваний. Под ред. Ю.Н. Беленкова, С.К. Тернового. М.: ГЕОТАР-Медиа. 2007.

15.   Blount S. G., Davides H., Swan H. Atrial septal defect – results of surgical correction in one hundred patients. JAMA. 1959; 169: 210.

16.   Henry D.A., Jolles H., Berberich J.J. The post-cardiac surgery chest radiograph. А clinically integrated approach. J. Thorac. Imaging. 1989; 4 (3): 20–41.

17.   Sanders C. et al. Atrial septal defect in older adults. Аtypical radiographic appearances. Radiology. 1988; 167: 123.

 

Abstract:

Purpose. Was to compare beam loading and quality of coronary arteries’ imaging (CA) in case of using the 64-lise computed tomography (MSCT) in retro-and prospective electrocardiographic synchronization mode.

Materials and methods. 57 patients with coronar arteries disease suspicious were examined with the help of computed tomography (CT) coronarography in prospective (n = 27) and retrospective (n = 30) EKG-synchronization modes. All the experiments were held on multislice Discovery CT 750 MD («General Electric»). The quality of obtained CR images was estimated subjectively – from 1 (perfect quality) to 4 (non-

diagnostic).

Results. The analyses of obtained images during retro-and prospective EKG-synchronization did not reveal serious differences (1,4 ± 0,38

and 1,5 ± 0,46 accordingly). The effective dose during prospective EKG-synchronization was 59% less than during retrospective EKG-synchronization (3,8 ± 0,83 mSv and 9,3 ± 2,5 mSv, р < 0,05).

Conclusion. CT-coronarography in prospective EKG-synchronization mode leads to essential decrease in beam loading on the patient without deterioration of the received image quality.  

 

References 

1.    Gaemperli O. et al. Accuracy of 64-slice CT angiography for the detection of functionally relevant coronary stenoses as assessed with myocardial perfusion SPECT. Eur. J Nucl. Med. Mol. Imaging. 2007; 34: 1162–1171.

2.    Mollet N.R. et al. High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography. Circulation. 2005; 112: 2318–2323.

3.    Raff G.L. et al. Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography. J. Am. Col. Cardiol. 2005; 46: 552–557.

4.    Scheffel H. et al. Accuracy of dual-source CT coronary angiography. First experience in a high pre-test probability population without heart rate control. Eur. Radiol. 2006; 16: 2739–2747.

5.    Husmann L. et al. Comparison of diagnostic accuracy of 64-slice computed tomography coronary angiography in patients with low, intermediate and high cardiovascular risk.

6.    Acad. Radiol. 2008; 15: 452–461. Leschka S. et al. Low kilovoltage cardiac dual-source CT. Аttenuation, noise, and radiation dose. Eur. Radiol. 2008; 18: 1809–1817.

7.    Hausleiter J. et al. Radiation dose estimates from cardiac multislice computed tomography in daily practice. Impact of different scanning protocols on effective dose estimates. Circulation. 2006; 113: 1305–1310.

8.    Husmann L. et al. Feasibility of low-dose coronary CT angiography. First experience with prospective ECGgating. Eur. Heart. J. 2008; 29:191–197.

9.    Herzog B.A. et al. Accuracy of low-dose computed tomography coronary angiography using prospective electrocardiogram triggering. First clinical experience. Eur. Heart. J. 2008; 29: 3037–3042.

10.  Husmann L. et al. Diagnostic accuracy of computed tomography coronary angiography and evaluation of stress-only single-photon emission computed tomography / computed tomography hybrid imaging. Сomparison of prospective electrocardiogram-triggering vs. retrospective gating. Eur. Heart. J. 2009; 30:600–607.

11.  Hsieh J. et al. Step-and-shoot data acquisition and reconstruction for cardiac x-ray computed tomography. Med. Phys. 2006; 33:4236–4248.

12.  Earls J.P. et al. Prospectively gated trans-verse coronary CT angiography versus retrospectively gated helical technique. Improved image quality and reduced radiation dose. Radiology. 2008; 246: 742–753.

13.  Shuman W.P. et al. Prospective versus retrospective ECG gating for 64-detector CT of the coronary arteries.

Abstract:

Purpose. Was to determine the possibilities of transrectal ultrasound research (TUR) in grayscale-mode with the use of ultrasound angiography in diagnostics of rectitis and in monitoring its treatment in patients with prostate cancet (PC) after radiation therapy.

Materials and methods. The research consists of 62 patients with verified localized prostatic cancer (T13N01M0), which have already obtained conformed radiation therapy (RT) as a radical strategy. To estimate expressive radiation reaction patients were underwent transrectal ultrasound research before, during and after (in 3, 6, 12 months) radiation therapy. During the experiment, using grayscale-mode, the thickness of rectum front wall, its structure and echogenicity, and prostata capsula propria (lat.) tracking were estimated in dynamics. Vascularization of rectum front wall and pararectal cellulose was also analyzed in dynamics. Results of transrectal ultrasound were compared with clinical symptoms during the whole period of supervision, and were registered on the basis of patient’s personal note during and after treatment.

Results. Based on patients complaints we have noticed development of radiation rectitis (radiation therapy after-effect) which can be registered as higher thickness of rectum front wall, changes in its structure, decreasement of echogenicity and increased vascularization. The major part of patients with these changes noticed that such symptoms were therapeutically eliminated during supervision. Such echo-graphic changes won’t appear in case of prostate cancer progression and it can be used as a differential diagnostics between radiation therapy after-effect and prostate cancer growth.

Conclusion. Transrectal ultrasound allows to visualize early radiation rectitis implications in patients with prostatic cancer during radiation theraphy, and can promote the necessary treatment correction and advanced symptomatic therapy. 

 

References

1.    Орлова Л.П., Зарезаев О.А. Ультразвуковой метод исследования в оценке эффективности лечения больных геморроем. SonoAceInternational (Рус. верс.). 2006; 14: 3–34.

2.    Гранов А.М., Матякин Г.Г., Зубарев А.В. и др. Возможности современных методов лучевой диагностики и лечения рака предстательной железы. Кремл. мед. клин. вест. 2004; 16: 9–12.

3.    Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и в странах СНГ в 2007 г. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2009; 20 (3 – прил. 1): 8–138.

4.    Канделаки С.М., Гаджиев Г.И., Богомазов Ю.К. и др. Возможности эндоректальной эхографии с контрастным усилением в диагностике свищевой формы парапроктитов. SonoAceInternational (Рус. верс.). 2004; 12: 20–26.

5.    Pescatori M., Regadas F.S.P., Regadas S.M.M. Imaging atlas of the pelvic floor and anorectal diseases. SpringerVerlag Italy. 2008; 4–16, 27–34, 51–61, 73–81, 91–105.

6.    Трапезникова М.Ф., Голдобенко Г.В. Рак предстательной железы. Под ред. Н.Е. Кушлинского, Ю.Н. Соловьева, М.Ф. Трапезниковой. М.: Изд-во РАМН. 2002; 322–328.

7.    Yablon C.M. et al. Complications of prostate cancer treatment. Spectrum of imaging findings. Radiographics. 2004; 24: 181–194.

8.    Hulsmans F.-J.H. et al. Colorectal adenomas. Inflammatory changes that simulate malignancy after laser coagulation evaluation with transrectal US. Rad. 1993; 187: 367–371.

9.    Гранов А.М., Винокуров В.Л. Лучевая терапия в онкогинекологии и онкоурологии. С.-Пб.: ООО «Издательство ФОЛИАНТ». 2002; 178–208.

10.  Hricak H. et al. State of the art. Imaging prostate cancer. А multidisciplinary perspective. Rad. 2007; 243 (1): 28–53.

11.  Moore E.M., Magrino T.J., Johnstone P.A.S. Rectal bleeding after radiation therapy for prostate cancer – endoscopic evaluation. Rad. 2000; 217: 215–218. 

authors: 


Article exists only in Russian.

authors: 


Article exists only in Russian.



Article exists only in Russian.


Article exists only in Russian.


Article exists only in Russian.


Article exists only in Russian.

authors: 

 

Abstract:

Aortic aneurysms and dissections are life threatening problems and pose significant management challenges. Open operative repair is associated with significant morbidity and mortality and this has prompted an increasing interest in endoluminal solutions. There are well known and potentially catastrophic complications associated with failure to achieve a seal proximally at the time of insertion and with dislocation of the prosthesis.

A technique to improve fixation of the prosthesis in patients with short aortic “necks” in open and endoluminal procedures would be to staple the prosthesis to the aortic wall. A stapler would only be of value, especially for endoluminal procedures, if it could achieve transmural fixation with only endoluminal access.

It became possible because of the stapler construction, containing staples made from memory-shaped metals, which can form the rings after discharge.

The technology was designed by Australian company Endogene Pty. Ltd. in Russian and Australian research laboratories.

The study was performed over 6 years in separate experiments on 7 adult mongrel male dogs (average weight 20 kg), 5 sheep (average weight 47 kg) and 12 pigs (average weight 68 kg). Access to abdominal aorta was obtained by central laparotomy, with the animals under general anaesthesia (sodium phentobarbital, 30 mg/kg).

The deployment of the new stapler technology for graft fixation inside of animal aorta was successfully performed. The time taken for the procedure i.e., from introduction of the stapler into the aorta to removal was less than one minute. Observation of the anastomosis revealed complete staple penetration of the aortic wall and ring formation of the individual staples. There was no evidence of unexpected damage to the aortic wall and there was no bleeding at the sites of penetration of the staples through the aortic wall. In addition, there was no evidence of migration of the attached graft, or signs of thrombus formation or focal haemorrhages within the aortic wall.

The Endogene Pty. Ltd. stapler technique has been successfully used in an animal model with secure graft fixation being easily obtained.

Further research is required before this technology can achieve clinical application. 

 

References 

 

1.    Сутурин М.В., Григ М. Новая технология фиксации сосудистого протеза для лечения аневризмы аорты с применением внутрисосудистого степлера (экспериментальное исследование). Диагностическая и интервенционная радиология. 2008; 2 (3).

 

 

2.    Slonim S.M. et al. Aortic dissection: percutaneous management of ischemic complications with endovascular stents and balloon fenestration. J. of Vasc. Surg. 1996;23: 241–253.

 

 

3.    Upchurch G. et al. Endovascular Abdominal Aortic Aneurysm Repair Versus Open Repair. Why and Why Not? Pers. in Vasc. Surg. And Endovas. Ther. 2009; 21: 48–53.

 

 

4.    Brewster D. et al. Long-term Outcomes After Endovascular Abdominal Aortic Aneurysm Repair. Ann. Surg. 2006; 244 (3): 426–438.

 

 

5.    Leurs L. et al. Long-term Results of Endovascular Abdominal Aortic Aneurysm Treatment With the First Generation of Commercially Available Stent Grafts. Arch. Surg. 2007; 142:33–41.

 

 

6.    Sun Z.J. et al. Epithelioid hemangioendothelioma of the oral cavity. Oral Dis. 2007; 13 (2):244–250.

 

 

Abstract:

Case report of two-staged treatment of hard palate hemangioendoteliom when at 1st stage has been executed bilateral selective endovascular emblization of maxillar final branches arteries by PVA spheres, and on 2nd tumor has been cut.

In the foreign literature till now it is described only about 30 cases of such tumor hard palate lesion. The combination of endovasculat embolization and traditional surgery methods leads to good esthetic and functional results of treatment with minimum surgical risk.  

 

References 

 

1.    Gordуn-Núñcez M.A. et al. Intraoral epithelioid hemangioendothelioma. А case report and review of the literature. Med. Oral. Patol.Oral. Cir. Bucal. 2010; 15 (2): 340–346.

 

 

2.    Chatelain B. et al. Maxillary epithelioid hemangioendothelioma. Сase report and review of the literature. Rev. Stomatol. Chir. 2009; 110 (1): 45–49.

 

 

3.    Mohtasham N. et al. Epithelioid hemangioendothelioma of the oral cavity. А case report. J. Oral. 2008; 50 (2): 219–223.

 

 

4.    Chi A.C. et al. Epithelioid hemangioendothelioma of the oral cavity. Report of two cases and review of the literature. Med. Oral. Pathol. Oral. Radiol. End. 2005; 100 (6): 717–724.

 

 

5.    Flaitz C.M. et al. Primary intraoral epithelioid hemangioendothelioma presenting in childhood: review of the literature and case report. Ultrastruct. Pathol. 1995; 19 (4): 275–279.

 

 

6.    Sun Z.J. et al. Epithelioid hemangioendothelioma of the oral cavity. Oral Dis. 2007; 13 (2):244–250.

 

Abstract:

Purpose. Was to investigate ability of videodensitometry for assessment the effect of renal artery stenosis on parenchymal perfusion.

Materials and methods. Аngiographic data of 97 patients with and 55 patients without renal artery stenosis were analyzed by means of videodensitometry, using «Multivox» software. All patients underwent renal arteries duplex ultrasound and kidneys ultrasound examination.

Levels of blood pressure and kidney function as a clinical signs of renovascular hypertension were assessed. Risk factors of kidney parenchymal injury such as diabetes mellitus, chronic kidney diseases were monitored.

Results. Videodensitometric analysis allows to detect statistically significant differences in parenchymal perfusion between kidneys with and without renal artery stenosis. A grade of changes in parenchymal perfusion correlates with angiographicaly measured degree of renal artery stenosis and renal artery blood flow velocity.

Conclusion. Videodensitometric perfusion parameters can be used to assess the effect of renal artery stenosis on parenchymal blood flow.

Thus, videodensitometry extends diagnostic capability of angiographic study. 

 

References 

 

1.    Hansen K.J. et al. Prevalence of renovascular desease in eldery. А populaton based study. J. Vasc. Surg. 2002; 36: 443–451.

 

 

2.    Safian R.D., Textor S.C. Renal artery stenosis. N. Engl. J. Med. 2001; 344: 431–442.

 

 

3.    Rihal C.S. et al. Incedental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. May. Clin. Proc. 2002; 77:309–316.

 

 

4.    Olin J.W. et al. Prevalence of atherosclerotic RAS in patients with atherosclerosis else-where. Am. J. Med. 1990; 88: 46–51.

 

 

5.    Galaria I.I. et al. Percutaneous and open renal revascularizations have equivalent long-term functional outcomes. Ann. Vasc. Surgery. 2005; 19 (2): 218–228. 

 

 

 

6.    Weibull H. et al. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis. А prospective randomized study.J. Vasc. Surg. 1993; 18: 841–850.

 

 

7.    Murphy T.P. et al. Increase of utilization of percutaneous renal artery interventions. Am.J. of Roentgenol. 2004; 183: 561–568.

 

 

8.    Wheatley K. et al. Revascularization versus medical therapy for renal artery stenosis. N.Engl. J. Med. 2009; 361: 1953–1962.  

 

 

9.    Rocha-Singh K.J. et al. Atherosclerotic Peripheral Vascular Disease Symposium II: Intervention for Renal Artery Disease. Circulation. 2008; 118: 2873–2878.

 

10.  Волынский Ю.Д., Кириллов М.Г., Шамалов Н.А. и др. Анализ экстра- и интракраниальной гемодинамики с помощью метода рентгеноденситометрии. Спец. выпуск «Инсульт». Ж. невр. и псих. им. С.С.Корсакова. 2007; 243.

 

 

11.  Meier P., Zierler K.L. On the theory of the indicator-dilution method for measurement of blood flow and volume. J. Appl. Physiol. 1954; 12: 731–744.

authors: 

 

Abstract:

The work consists of 45 patient’s radiodiagnostics data: operation sinus-lifting has been executed before dental implantation to complete missing volume of bone fabric of maxilla alveolar process.

The analysis of cite data has shown an inefficiency of traditional ortopantomography and advantages of three-dimensional computed tomography in assessment of spent treatment.  

 

References 

1.    Параскевич В.Л. Дентальная имплантация. Итоги века. Новое в стоматологии. Спец.вып. 2000; 8: 7–15.

2.    Жусев А.И. Дентальная имплантация. М.: Медицина.1999.

3.    Bremke M. et al. Digital volume tomography (DVT) as a diagnostic modality of the anterior skull base. Acta Otolaryngolog. 2009; 129 (10):1106–1114.

4.    Паслер Ф., Виссер Х. Рентгенодиагностика в практике стоматолога. М.: Медпресс-информ. 2007.

5.    Albrektsson T. et al. The long-term efficacy of currently used dental implants. А review and proposed criteria of success. Int. J. Oral. Maxillofac. Implants. 1986; 1 (1): 11–25.

6.    Nevins M., Langer B. The successful application of osseointegrated implants to the posterior jaw. А long-term retrospective study. Int. J. of Oral. Maxillofac. Implants. 1993; 8: 428–432.

7.    Cacaci C., Frank E., Bumann A. DVT-Volumentomograph. Teamwork. 2007; 10 (3): 244–254.

8.    Khoury F. Augmentation of the sinus floor with mandibular bone block and simultaneous implantation. А 6-year clinical investigation. Int. J. Oral. Maxillofac. Implants. 1999;14: 557–564.

9.    Raghoebar G.M. et al. Maxillary bone grafting for insertion of endosseous implants. Results after 12–124 months. Clin. Oral. Implants. Res. 2001; 12: 279–286.

10.  Leckholm U., Zarb G.A. Patient selection and preparation. En: P.I. Branemark, G.A. Zarb, T. Albrektsson et al. Tissue integrated prostheses: osseointegration in clinical dentistry. Quintessence. 1985; 199–209.

 

 

11.  Wörtche R. et al. Clinical application of cone beam digital volume tomography in children with cleft lip and palate. Dentomaxillofac. Radiol. 2006; 35: 88–94.

 

 

 

Abstract:

Purpose. Was to еstablish the informative value of 3-phase scintigraphy in assessment of blood flow and identify pyo-inflammatory process in patients with neuropathic, ischemic, and mixed forms of diabetic foot.

Materials and methods. This study includes the results of three-phase scintigraphy of 76 patients with diabetes mellitus and with suspicion of osteomyelitis in diabetic foot. Results were verified with morphological study in 39 patients.

Results. In patients with diabetic foot the depression of the main vessels blood flow and blood flow prevalence the changes intraosseous blood flow. Three-phase scintigraphy revealed a lower specificity (66,7%) in the diagnosis of osteomyelitis in patients with diabetes mellitus at the sensitivity (94,7%) and accuracy (73,7%).

Conclusions. Three-phase scintigraphy is high-performance method in revealing the arterial and peripheral blood flow disorder in patients with diabetes mellitus. The low specificity of the three-phase scintigraphy with high sensitivity indicates the limited possibilities of the method in the identification of pyo-inflammatory process in patients with diabetes mellitus. The observed preservation of blood flow makes it possible to expand indications of methods of nuclear medicines and applies scintigraphy with labeled leukocytes for indication purulent infection in patients with complicated course. 

 

References

1.    Capriotti G. et al. Nuclear medicine imaging of diabetic foot infection: results of meta-analysis. Nucl. Med. Commun. 2006; 27 (10):757–764.

2.    Kaim A. et al. Chronic complicated osteomyelitis of the appendicular skeleton.Diagnosis with 99mTc labeled monoclonal anti-granulocyte antibody-immunoscintigraphy. Eur. J. Nucl. Med. 1997; 24 (7): 732–738.

3.    Unal S.N. et al. Comparison of 99mTc methylene diphosphonate, 99mTc human immuneglobulin, and 99mTc labeled white blood cell scintigraphy in the diabetic foot. Clin. Nucl. Med. 2001; 26 (12): 101–1021.

4.    Devillers A. et al. Contribution of 99mTc hex-amethylpropylene amine oximelabelled leucocyte scintngraphy to the diagnosis of diabetic foot infection. Eur. J. Nucl. Med. 1998; 25(2): 132–138.

5.    E-Maghraby T.A. Nuclear medicine methods for evaluation of skeletal infection among other diagnostic modalities. J. Nucl. Med. Mol. Imaging. 2006; 50 (3): 167–192.

6.    Soluri A. et al. High resolution mini-gammacamera and 99mTc [HMPAO] leukocytes for diagnosis of infection and radioguided surgery in diabetic foot. G. Chir. 2005; 26 (6–7): 246–250.

7.    Prandini N. et al. Nuclear medicine imaging of bone infections. Nucl. Med. Commun. 2006;27 (8): 633–644.

8.    Christopher J.P. et al. Osteomyelitis: Diagnosis with 99mTc labeled Antigranulocyte Anti-bodies Compared with Diagnosis with 111Inlabeled Leukocytes – Initial Experience. Radiology. 2002; 223: 758–764.

9.    Palestro C.J. et al. Rapid diagnosis of pedal osteomyelitis in diabetics with a technetium-99mTc labeled monoclonal antigranulocyte antibody. J. Foot. Ankle. Surg. 2003; 42 (1): 2–8.

10.  Stephen L.H. et al. The Effects of Peripheral Vascular Disease with Osteomyelitis in the Diabetic Foot. Am. J. of Surg. 1999; 177:282–286.

11.  Завадовская В.Д. Лучевая диагностика остеомиелита Дис. Д-ра мед. наук. Томск. 1995; 290.

 

 

Abstract:

Purpose. Was to evaluate possibilities of FDCTA as a method of colorectal liver metastases (CLM) detection and differentional diagnostics.

Materials and methods. FD-CT-A was performed to examine 41 patients. Patients with lobe CLM (n =15) were included into the 1-st group. Purpose was to exclude metastatic lesions of contralateral lobe before surgical treatment. Patients with bilobar metastatic spread (n = 26) were included into the 2-nd group. Purpose was to detect metastases before and during regional therapy. Scanning was performed on the hybryde angiographic system Innova-4100 «GЕ Нealthcare, USA» with 5 sec scanning time, fov 23 × 23 cm, delay from 10 to 22 sec during hepatic arteriography 15–40 ml Ultravist-370 «Bayer Schering Pharma, Germany» with rate 2–4 ml/sec.

Results. In the first group 40 CLM were detected. The number of metastases in each patient ranged from 1 to 12 (mean – 3). The size of metastases ranged from 9,1 mm to 150,0 mm (mean – 36,7 mm, median – 30,2 mm). 14 of all CLM (35%) were 20 mm and less. Right hemyhepatectomy was provided for 6 patients, left hemyhepatectomy – for one. In the second group 282 CLM were detected. The number of metastases in each patient ranged from 2 to 31 (mean – 11). The size of metastases ranged from 3,2 mm to 81,0 mm (mean – 17,4 mm, median – 12,7 mm). 209 of all CLM (74%) were equal or smaller then 20 mm in diameter.

Conclusion. FD-CT-A is the perspective method for detection and differentional diagnostics of CLM.
 

 

References 

1.    Гранов А.М., Таразов П.Г., Гранов Д.А. и др. Современные тенденции в комбинированном хирургическом лечении первичного и метастатического рака печени. Анн. хир.гепатол. 2002; 7 (2): 9–17.

2.    Paschos K., Bird N. Current diagnostic and therapeutic approaches for colorectal cancer liver metastasis. Hippokratia. 2008; 12 (3): 132–138.

3.    Kanematsu M. et al. Imaging liver metastases: review and update. Eur. J. Radiol. 2006; 58 (2): 217–228.

4.    Scaife C.L. et al. Accuracy of preoperative imaging of hepatic tumors with helical computed tomography. Ann. Surg. Oncol. 2006; 13 (4): 542–546.

5.    Regge D. et al. Diagnostic accuracy of portalphase CT and MRI with mangafodipirtrisodium in detecting liver metastases from colorectal carcinoma. Clinical. Radiology. 2006; 61 (4): 338–347.

6.    Kim K.W. et al. Small (≤ 2 cm) hepatic lesions in colorectal cancer patients. Detection and characterization on mangafodipir trisodium-enhanced MRI. AJR. 2004; 182 (5): 1233–1240.

7.    Bartolozzi C. et al. Detection of colorectal liver metastases. A prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur. Radiol. 2004; 14 (1): 14–20.

8.    Wiering B. et al. Comparison of multiphase CT, FDGPET and intraoperative ultrasound in patients with colorectal liver metastases selected for surgery. Ann. Surg. Oncol. 2007; 14 (2): 818–826.

9.    Kalender W.A., Kyriakou Y. Flatdetector computed tomography (FDCT). Eur. Radiol. 2007;17 (11): 2767–2779.

10.  Buhk J. et al. Angiographic computed tomography is comparable to multislice computed tomography in lumbar myelographic imaging. J. Comput. Assist. Tomogr. 2006; 30 (5):739–741.

11.  Housseini A.M. et al. Comparison of three dimensional rotational angiography and digital subtraction angiography for the evaluation of the liver transplants. Clinical. Imaging. 2009; 33 (2): 102–109.

12.  Rooij W.J. et al. 3D rotational angiography. The new gold standard in the detection of additional intracranial aneurysms. Am. J.Neuroradiol. 2008; 29 (5): 976–79.

13.  Meyer B.C. et al. Visualization of Hypervascular Liver Lesions During TACE. Comparison of Angiographic CArm CT and MDCT. AJR. 2008; 190 (4): 263–269.

14.  Orth R.C. et al. Carm conebeam CT: general principles and technical considerations for use in interventional radiology. J. Vasc. Interv.Radiol. 2008; 19 (6): 814–821.

15.  Irie K. et al. DynaCT softtissue visualization using an angiographic Carm system. Initial clinical experience in the operating room. Operative Neurosurg. 2008; 62 (3): 266–272.

16.  Meyer B.C. et al. Contrastenhanced abdominal angiographic CT for intraabdominal tumor embolization. A new tool for vessel and soft tissue visualization. Cardiovasc. Intervent. Radiol. 2007; 30 (4): 743–749.

17.  Meyer B.C. et al. The value of combined soft tissue and vessel visualisation before transarterial chemoembolisation of the liver using Carm computed tomography. Eur.Radiol. 2009; 19 (9): 2302–2309.

18.  Hirota S. et al. Conebeam CT with flatpanel detector digital angiography system/ Early experience in abdominal interventional procedures. Cardiovasc. Intervent. Radiol. 2006; 29 (6): 1034–1038.

19.  Wallace M.J. et al. Threedimensional Carm conebeam CT. Applications in the interventional suite. J. Vasc. Interv. Radiol. 2008;19 (6): 799–813.

20.  Raman S.S. et al. Improved characterization of focal liver lesions with liverspecific gadoxetic acid disodiumenhanced magnetic resonance imaging: a multicenter phase 3 clinical trial. J. Comput. Assist. Tomogr. 2010; 34 (2): 163–172.

21.  lrie T. et al. CT evaluation of hepatic tumors.Сomparison of CT with arterial portography, CT with infusion hepatic arteriography, and simultaneous use of both techniques. AJR. 1995; 164 (6): 1407–1412.

22.  Kanematsu M. et al. Detection and characterization of hepatic tumors: value of combined helical CT hepatic arteriography and CT during arterial portography. AJR. 1997; 168 (5): 1193–1198.

23.  Matsui O. et al. Liver metastases from colorectal cancers. Detection with CT during arterial portography. Radiology. 1987; 165 (1): 65–69.

24.  Soyer P. et al. Hepatic metastases from colorectal cancer: detection and falsepositive findings with helical CT during arterial portography. Radiology. 1994; 193 (1): 71–74.

25.  Valls C. et al. Helical CT versus CT arterial portography in the detection of hepatic metastasis of colorectal carcinoma. AJR. 1998; 170 (5): 1341–347.

26.  Semelka R.C. et al. Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology. 1999;213 (1): 86–91.

27.  Schwartz L. et al. Prospective, blinded comparison of helical CT and CT arterial portography in the assessment of hepatic metastasis from colorectal carcinoma. World. J. Surg.2006; 30 (10): 1892–1901.

 

Abstract:

The research is devoted to study the possibilities of functional multislice computed tomography (fMSCT) in a choice of treatment strategy, its planing and volume of surgical intervention at orbital trauma damage. MSCT and fMSCT examinations of the orbit were performed in 30 patients (60 orbits).

The obtained data allowed to develop the protocol of fMSCT, to study normal functional anatomy of the eye, to estimate normal contractile ability of extraocular muscles. The research showed the necessity of using the fMSCT of the eye of orbital trauma in assessment of contractile ability of extraocular muscles and their interest in relation to the crisis area. The improvement of diagnosis reached with the help of fMSCT, has allowed to choose an optimum tactics and volume of surgical intervention.  

 

References 

1.    Слободин К.Э. Лучевая диагностика по вреждений глаз. СПб. 2007.

2.    Красильников Р.Г., Варуск С.В., Жупан Б.Б. Возможности использования компьютерной и магнитнорезонансной томографии в диагностике повреждений орбит и глаза и их осложнений. Современные аспекты военной медицины. Киев. 2007; 12: 16–24.

3.    Александров Н.М., Аржанцев П.3. Травмы челюстнолицевой области. М. 1986.

4.    Слободин К.Э. Принципы, современные возможности и перспективы лучевой диагностики в офтальмологической практике. М. Вестник рентгенологии и радиологии. 2001; 1: 55–61.

5.    Бровкина А.Ф. Болезни орбиты. М. 2008.

6.    Бабий Я.С., Болгова И.М., Удовиченко В.В. Лучевые методы диагностики при заболеваниях глаза и орбиты. М. Вестник Российского научного центра рентгенологии. 2004; 3.

7.    Труфанов Г.Е., Бурлаченко Е.П. Лучевая диагностика заболеваний глаза и глазницы. СПб. 2009.

8.    Бровкина А.Ф., Яценко О.Ю., Мослехи Ш. и др. Оценка корреляции данных КТ и УЗИ при исследовании толщины экстраокулярных мышц у больных отечным экзофтальмом. М. Клиническая офтальмология. 2008; 2: 61.

9.    Бровкина А.Ф., Яценко О.Ю., Аубакирова А.С., Мослехи Ш. Компьютернотомографическая анатомия орбиты с позиции клинициста. Вестник офтальмологии. 2008; 124 (1): 11–14.

10.  Ozgen A., Ariyurec M. Normative measurements of orbital structures using CT. Am. J. Roentgenol. 1998; 170 (4): 1093–1096.

11.  Furuta M. Measurement of orbital volume by computed tomography. Еspecially on the growth of the orbit. Jpn. J. Ophthalmol. 2001; 45 (6): 600–606.

12.  Demer J.L., Miller J.M. Magnetic Resonance Imaging of the Functional anatomy of the Superiror Oblique Muscle. Investigative Ophthalmology & Visual Science. 1995; 36 (5): 209–913.

13.  Horton J.C. et al. Magnetic resonance imaging of superior oblique muscle atrophy in acquired trochlear nerve palsy [letter].

14.  Am. J. Ophthalmol. 1990; 110: 315–316.

15.  Koo E.Y. et al. MRI demonstrates normal contractility of superior rectus (SR) and inferior rectus (IR) in orbits with hypertropia. Ophthalmology. 1993; 100 (9A): 119.

 

authors: 


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.

authors: 

 

Abstract:

In 2010, Kawasaki T et al. presented a modification of the bifurcation technique named «culotte» - «cross-stenting» technique. The purpose of this technique - minimization of metal overlap in the proximal part of the main branch and, thus, reducing the risk of stent thrombosis and restenosis. In this article, we have present a case report of successful application of «cross-stenting» technique. Also we have described technical features of this technique and principles of choice stent for the side branch. 
 

 

References 

1.    Erglis A., Kumsars I., Niemela M., Kervinen K., Maeng M. et al. Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: The Nordic Stent Technique Study. Circ. Cardiovasc. Intervent. 2009; 2: 27-34.

2.    Chevalier B., Glatt B., Royer T., Guyon P. Placement of coronary stents in bifurcation lesions by the «culotte» technique. Am J. Cardiol. 1998; 82: 943-949.

3.    Hildick-Smith D., Lassen J.F., Albiero R., Lefevre Th., Darremont O., Pan M., Ferenc M., Stankovic G., Louvard Y. Consensus from the 5th European Bifurcation Club meeting. Eurolntervention. 2010; 6: 34-38.

4.    Iakovou I., Ge L, Colombo A. Contemporary stent treatment of coronary bifurcations. J. Am. Coll. Cardiol. 2008; 46: 1446-1455.

5.    Kawasaki T., Koga H., Serikawa T. Modified culotte stenting technique for bifurcation lesions: the cross-stenting technique. J. Invasive Cardiol. 2010; 22: 243-246.

6.    Examination of stent deformation and gap formation after complex stenting of left main coronary artery bifurcations using microfocus computed tomography. J.Interv. Cardiol. 2009; 22: 135-144.

 

 

Abstract:

46-year old man with obstructive jaundice has a complication of hemobilia after performed earlier percutaneous transhepatic biliary drainage (PTBD). Angiography failed to localize the bleeding site, that is why selective therapeutic embolization was not done. We performed implantation of Gore stent-graft into biliary ducts, and hemobilia stopped immediately.

 

 

 

 

Abstract:

Treatment of massive hemoptysis represents a major and important medical problem in surgery. Development of endovascular surgery allows to introduce principle new methods of minimally invasive treatment of this pathology Current review represents information about bronchial artery anatomy, pathologic features of the bronchial artery, material used during embolization procedure and possible complications of treatment.

 

 

 

 

Abstract:

The article describes results of analysis of five years of experience in the use of magnetic resonance angiography in the diagnosis of lesions of lower limb arteries. This method was used in survey of 489 patients with lesions of the abdominal aorta, arteries of the pelvis and lower limbs. Coverage of this study patients with abnormal lower limb arteries was 14.8%. Features of MR angiographic imaging, advantages and limitations of the method, the relationship with the method X-ray angiography are discussed.

 

 

authors: 

Abstract:

Aim. Was to investigate the efficiency of transluminal laser revascularization of brain in treatment of vascular dementia.

Materials and methods. We have examined and treated 665 patients aged 29 to 81 (average age 75) suffering from various kinds of atherosclerotic lesions of cerebral vessels accompanied by developed vascular dementia. The research included: CT, MRI, scintigraphy, rheoencephalography, poliprojectional angiography To perform endovascular treatment we selected 639 patients: Group 1 (CDR-1) - 352, Group 2 (CDR-2) - 184, Group 3 (CDR-3) - 103 patients. To conduct revascularization of main intracranial arteries high-energy laser systems were used; for revascularization of distal intracranial branches low-energy laser systems were used.

Results. The clinical outcome depended on the severity of dementia and timing of the intervention. A good clinical outcome in Group 1 was obtained in 281 (79.82%) cases, in Group 2 in 81 (44.02%) cases, in Group 3 in 9 (8.73%) cases. A satisfactory clinical outcome in Group 1 was obtained in 53 (15.34%) cases, in Group 2 in 62 (33.70%) cases, in Group 3 in 31 (30.09%) cases. A relatively satisfactory clinical outcome in Group 1 was obtained in 17 (4.83%) cases, in Group 2 in 41 (22.28%) cases, in Group 3 in 63 (61.16%) cases. No negative effects were observed after the interventions.

Conclusions. Evaluating the data obtained it can be concluded that the method of transluminal laser revascularization of cerebral blood vessels is an effective one for the treatment of atherosclerotic lesions of the brain accompanied by dementia.  

 

Reference 

1.    Gillum R.F, Kwagyan J, Obisesan Th.O. Ethnic and Geographic Variation in Stroke Mortality Trends. Stroke:. 2011; 42:3294-3296.

2.    Frolich A.MJ, Psychogios M.N, Klotz E, Knauth M, Knauth P. Angiographic Reconstructions From Whole-Brain Perfusion CT for the Detection of Large Vessel Occlusion in Acute Stroke. Stroke. 2012; 43:97-102.

3.    Жулев Н.М, Пустозерцев В.Г, Жулев С.Н. Цереброваскулярные заболевания. 2002, М. Москва, BINOM.

Zhulev N.M., Pustozertsev, V.G., Zhulev, S.N..(2002) Cerebrovascular Diseases. BINOM, Moscow [In Russ].

4.    Roman G.C. Facts, myths, and controversies in vascular dementia. J. Neurol. Sci. 2004; 226: 49-52.

5.    Folstein M.F, Folstein S.E, McHugh P.R. «Mini-mental state.» A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12(3):189-98.

6.    Skoog I. Psychiatric disorders in the elderly. Can. J. Psychiatry. 2011; 56 (7):387-97.

7.    Maksimovich I.V. Long-term Results of Brain Transluminal Laser Revascularization In The Treatment of Ischemic Stroke. J. Am Coll. Cardiol. 2010; 56; B49-0.

8.    Максимович И.В. Транслюминальная лазерная ангиопластика в лечении ишемических поражений головного мозга. дис. д-ра мед. наук М, 2004. Maksimovich, I.V. Transljuminal laser angioplasty in treatment of ischemic lesions of a brain. M. D. 2004, dissertation, Moscow [In Russ].

9.    Maksimovich I.V. Transluminal Laser Revascularization of Cerebral Blood Vessels in the Treatment of Ischemic Stroke. J. Am. Coll. Cardiol. 2010;56; B48-9.

10.  Mahoney F.I, Barthel D.W. Functional Evaluation: The Barthel Index. Md. State Med. J. 1965; 14: 61-65.

11.  El Ali A, Doeppner T.R, Hermann D.M. Increased Blood-Brain Barrier Permeability and Brain Edema After Focal Cerebral Ischemia Induced by Hyperlipidemia: Role of Lipid Peroxidation and Calpain-1/2, Matrix Metalloproteinase-2/9, and RhoA Overactivation. Stroke. 2011;42:3238-3244.

12.  Roman G.C, Kalaria R.N. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging. 2006; 27(12): 1769-85.

13.  Roman G.C. Facts, myths, and controversies in vascular dementia. J. Neurol. Sci. 2004; 226: 49-52.

14.  Skoog I. Psychiatric disorders in the elderly. Can. J. Psychiatry. 2011; 56 (7):387-97.

15.  Silver F.L, Mackey A, Clark W.M, Brooks W, Timaran C.H, Chiu D, Goldstein L.B, Meschia J.F, Ferguson R.D, Moore W.S, Howard G, Brott T.G. Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke. 2011; 42 (3): 675-80.

16.  Papanagiotou P, Roth C, Walter S, Behnke S, Grunwald I.Q, Viera J, Politi M, K^ner H, Kostopoulos P, Haass A, Fassbender K, Reith W. Carotid artery stenting in acute stroke. J. Am. Coll. Cardiol. 2011; 58 (23):2363-9.

17.  Biamino G., The excimer laser: science fiction fantasy or practical tool? J Endovasc Ther. 2004; 11; Suppl. 2 :II207-22.

18.  Benedek I., Hintea T. Current developments in interventional treatment of total terminal aortic occlusions-laser, stenting and balloon angioplasty: experience of cardiology clinic of Targu-Mures. Rom J. Intern. Med. 2005; 43 (3-4): 223-32.

19.  Ecanow J.S., Schwartz B.T., Park R. Tibial recanalization with excimer laser angioplasty. Semin InterventRadiol. 2007; 24(1):58-62.

20.  Amb

Abstract:

Radiofrequency (RF) ablation is a minimally invasive method. Application of RF ablation allowed to expand indications for more radical treatment of kidney tumors in patients, whom traditional nephrectomy or kidney resection are impossible, due to extremely adverse somatic status

Efficiency and safety of RF ablation are significantly increased if preceded in combination with superselective occlusion of blood vessels, supplying the tumor. We possess the experience of application of superselective embolization in combination with RF ablation of two patients with kidney tumors. In both cases a good result of combined treatment has been observed.

This combination (superselective embolization + RF ablation) can be an alternative to open operation on kidney in number of patients, expanding the arsenal of modern minimally invasive kidney tumor's treatment methods. 

 

Reference 

1.    Pavlov AJu., Klimenko A. A., Momdzhan B.K., Ivanov S.A. Radiochastotnaja intersticial'naja termoabljacija (RChA) raka pochki. [Radiofrequency interstitial termal ablation of renal cancer]. Jeksperimental'naja i klinicheskaja urologija. 2011; 2(3): 112-113 [In Russ].

2.    European Network of Cancer Registries. Eurocim version 4.0. European incidence database V2.3, 730 entity dictionary (2001). Lyon, 2001.

3.    Zlokachestvennye novoobrazovanija v Rossii v 2008 g. (zabolevaemost' i smertnost'). [Malignant neoplasms in Russian Federation in 2008 (morbidity and mortality)]. Pod red. V.I. Chissova, V.V. Starinskogo, G.V. Petrovoj. M. FGU «MNIOI im. P.A. Gercena Rosmedtehnologij». 2010 [ In Russ].

4.    Chow W.H., Devesa S.S., Warren J.L., Freumeni J.FJr. Rising incidence of renal cell carcer in the United States. JAMA. 1999; 281:1628-31.

5.    Nguyen M.M., ill I.S., Ellison L.M. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J. Urol. 2006; 176: 2397-400; discussion 2400.

6.    Kummerlin I.P., ten Kate F.J., Wijkstra H., de la Rosette J.J., Laguna M.P. Changes in the stage and surgical management of renal tumours during 1995-2005: an analysis of the Dutch national histopathology registry. BJU Int. 2008; 102 (8): 946-51. Epub 2008 Jun 28.

7.    Ankem M.K., Nakada S.Y. Needle-nephron-sparing surgery. BJU Int. 2005; 95 (2): 46-51.

8.    Havranek E., Anderson C. Future prospects for nephron conservation in renal cell carcinoma. In: Kirby R.S., O’Leary M.P., editors. Hot topics in urology. Amsterdam. The Netherlands: Elsevier. 2004; 227-38.

9.    Marberger M., Mauerman J. Energy ablation nephron-sparing treatment of renal tumors. AUA Update Series. 2004; 23:178-83.

10.  Reddan D.N., Raj G.V., Polascik TJ. Management of small renal tumors: an overview. Am. J. Med. 2001; 110: 558-62.

11.  Weld K.J., Landman L. Comparison of cryoablation, radiofrequency ablation and high-intensity focused ultrasound for treating small renal tumors. BJU Int. 2005; 96:1224-9.

12.  Uzzo R.G., Novick A.C. Nephron sparing surgery for renal tumors: indications techniques and outcomes. J. Urol. 2001; 166:6-18.

13.  Dolgushin B.I., Kosyrev VJu., Ramprabanant S. Radiochastotnaja ablacija v onkologii. Prakticheskaja onkologija. 2007; 8(4): 219-227 [In Russ].

14.  Vogl TJ., Helmberger T.K., Mack M.G., Reiser M.F. (Eds.) Percutaneous Tumor Ablation in Medical Radiology. ISBN 978-3-540-22518-8 Springer. Berlin. Heidelberg. New York. 2008.

15.  Winthrop H. Hal, John P. McGahan, Daniel P. Link and Ralph W. deVere White. Combined Embolization and Percutaneous Radiofrequency Ablation of a Solid Renal Tumor. AJR. 2000; 174:1592-1594.

16.  Yamakado K., Nakatsuka A., Kobayashi S., Akeboshi M., Takaki H., Kariya Z., Kinbara H., Arima K., Yanagawa M., Hori Y., Kato H., Sugimura Y., Takeda K. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience. Cardiovasc. Intervent. Radiol. 2006; 29(3): 389-94.

17.  Klingler H.C., Marberger M., Mauermann J. et al. ’Skipping’ is still a problem with radiofrequency ablation of small renal tumours. BJU Int. 2007; 99: 998-1001.

18.  Goldberg S.N., Gazelle G.S., Mueller P.R. Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques and diagnostic imaging guidance. Am. J. Roentgenol. 2000; 174: 323-31.

19.  Lee M. Ellis, Steven A. Curley, Kenneth K. Tanabe. Radiofrequency Ablation for Cancer.Current Indications, Techniques, and Outcomes. 2004; Springer-Verlag New York, Inc.

20.  Salagierski M., Salagierski M. Radiofrequency ablation partial nephrectomy: a new method of nephron-sparing surgery in selected patients. Int. J. Urol. 2006; 13(11): 1456-9.

21.  Veltri A., Garetto I., Pagano E., Tosetti I., Sacchetto P., Fava C. Percutaneous RF termal ablation of renal tumors: is US guidance really less favorable than other imaging guidance techniques? Cardiovasc. Intervent. Radiol. 2009; 32(1): 76-85. Epub 2008 Aug 15.

22.  Schirmang T.C., Mayo-Smith W.W., Dupuy D.E., Beland M.D., Grand D.J. Kidney neoplasms: renal halo sign after percutaneous radiofrequency ablation-incidence and clinical importance in 101 consecutive patients. Radiology. 2009; 253(1): 263-9. Epub 2009 Jul. 31.

Abstract:

Aim: was to study the diagnostic and prognostic importance of impedance indicators of a kidney parenchyma at acute (ARI) and chronic renal insufficiency (CRI).

Material and methods. Research was performed on the basis of a hemodialysis department. 51 patients were examined during the period from 2009 till 2010. They underewent a monopolar bioimpedance measurement of kidneys under ultrasound control.

Results. Changes of absolute and relative indicators of electric impedance of a kidney parenchyma show morphological violations in organ at acute and chronic renal insufficiency, characterize evidence of compensatory processes and give information on a tissue functional activity. These data are necessary for verification of the diagnosis, prescription of reasonable pharmacotherapy and definition of a pathological process forecast.

 

Abstract:

Aim. Was to define prognostically meaningful ultrasound criteria for embologenic thrombus.

Materials and methods. 780 patients (800 limbs) with acute venous thrombosis were investigated; first group consisted of 370 patients with pulmonary embolism (PE) confirmed by lungs perfusion scintigraphic study; second group included 410 patients without PE. During ultrasound examination - 545 patients with floating thrombus were detected: 302 patients with PE (1st group) and 243 without PE (2nd group).

Results. In the first group (with PE) floating thrombus were detected in 79,5% of patients, in 20,5% of patients occlusive and nonocclusive thrombus were detected. It turned out that embologenic thrombus were localized more in shin veins (87,5%), popliteal vein (87,5%) and femoral vein (55,7%). Free floating thrombus had a form of elliptic paraboloid (60,1%), irregular form (67,9%), unechogenic structure with unechogenic contour (44,0%) or heterogenic structure with unechogenic contour (33,8%), high mobility (66,5%) (p>0,05). The length of thrombus was the same in both subgroups (p>0,05).

Conclusions. Floating trombus in 55,4% are embologenic, and are often localized in shin veins, popliteal vein and femoral vein. The absence of a floating pieces after PE indicates that occurred fragmentation of thrombus. It is found that embologenic thrombus often have a form of elliptic paraboloid. The length of thrombus can not be used as single criterion for thrombus's embologenic.  

 

Reference 

1.    Kinney T.B. Update on Inferior Vena Cava Filters. J. Vasc. Intem Radiol. 2003; 14(4) 425-440.

2.    Зубарев А.Р., Богачев В.Ю., Митьков В.В. Ультразвуковая диагностика заболеваний вен нижних конечностей. М.: Видар, 1999;104. Zubarev A.R., Bogachev V.Yu., Mit’kov V.V. Ulytrazvukovaya diagnostika zabolevaniy ven nizhnikh konechnostey [Ultrasound diagnostics of lower limbs’ veins diseases.]. M.: Vidar. 1999; 104 [In Russ].

3.    Харченко В.П., Зубарев А.Р., Котляров П.М. Ультразвуковая флебология. М.: Эники, 2005. 176. Kharchenko V.P., Zubarev A.R., Kotlyarov P.M. Ulytrazvukovaya phlebologia [Ultrasonic phlebology]. M.: Eniki, 2005;176 [In Russ].

4.    Чуриков ДА., Кириенко А.И. Ультразвуковая диагностика болезней вен. М.: Литтерра, 2011; 92. Churikov D.A., Kirienko A.I. Ulytrazvukovaya diagnostika bolezney ven [Ultrasound diagnostics of veins diseases ]. M.: Littera, 2011; 92 [In Russ].

5.    Kirienko A.I., Leontyev S.G., Lebedev I.S. Algoritm vedeniya bolynykh s ostrym venoznym trombosom [Algorythm of treatment tactics in patients with acute vein thrombosis]. Phlebohgiya. 2008; 1:58-62 [In Russ].

6.    Elliott C.G., Goldhaber S.Z., Jensen R.L. Delays in diagnosis of deep vein thrombosis and pulmonary embolism. Chest. 2005;128(5): 3372-3376.

7.    Goodacre S., Sutton A.J., Sampson F.C. Meta-analysis: the value of clinical assessment in the diagnosis of deep venous thrombosis. Ann. Intern. Med. 2005; 143(2): 129-139.

8.    Yablokov E.G., Kirienko A.I., Bogachev V.Yu. Khronicheskaya venoznaya nedostatochnosty [Chronic vein insufficiency]. M.: Bereg.1999; 127 [In Russ].

9.    Savelyev V.S. Phlebologiya. Rukovodstvo dlya vrachey. (Pod redaktsiey) [Phlebology. Medical quide]. M.: Meditsina 2001; 660 [In Russ].

10.  Baldridge E.D., Martin M.A., Welling R.E. Clinical significance of free-floating venous thrombi. J. Vasc. Surg. 1990; 11(1): 62-67.

11.  Norris C.S., Greenfield L.J., Herrmann J.B. Free-floating iliofemoral thrombus. A risk of pulmonary embolism. Arch. Surg. 1985;120(7): 806-808.

12.  Jones T.K., Barnes R.W., Greenfield L.J. Greenfield vena caval filter: rationale and current indications. Ann. Thorac. Surg. 1986; 42(6): 48-55.

13.  Berry R.E., George J.E., Shaver W.A. Free-floating deep venous thrombosis. A retrospective analysis. Ann. Surg. 1990; 211(6): 719-723.

14.  Baud J-M., Stephas L., Ribadeau-Dumas C. et al. Short- and medium-term duplex sonography follow-up of deep venous thrombosis of the lower limbs.J. Clin.Ultrasound. 1998; 26(1):-13.

15.  Anderson D.R., Kovacs M.J, Dennie C. et al. Use of spiral computed tomography contrast angiography and ultrasonography to exclude the diagnosis of pulmonary embolism in the emergency department. J. Emerg. Med. 2005; 29(4): 399-404.

16.  Rossiyskie klinicheskie rekomendatsii po diagnostike, lecheniyu i prophilaktike venoznykh tromboembolicheskikh oslozhneniy [Russian clinical recommendations for diagnostics, treatment and prophylaxis thrombotic complications of veins' diseases]. Phlebologiya. 2010; 1(2): 5-37 [In Russ].

 

Abstract:

Article describes the need of independent assessment of professional qualification of specialists of medicobiological and pharmaceutical branch in The Rissian Federation which should be held by independent examiners (experts). Article presents results of the Federal Programme of Education Development (2011-2013) on the independent assessment of professional qualifications of doctors and nurses. Results of test certification of specialists showed, that 12% of therapeutics and general practice doctors failed the examination, and that showed the importance of independent expertise of professional competence.

 

 

 

 

References 

 

1.    Аганбегян А.Г., Варшавский Ю.В., Китаев В.В., Жуковский В.Д., Ершов В.В. Неизбежность реформы нормативно-правового регулирования здравоохранения. Экономическая политика. 2007; 1: 151-160.

 

 

2.    Балкизов З.З. Обзор технологий e-learning для медицинского образования. Медиц. образование и профессион. развитие. 2011; 1: 24-34.

 

 

3.    Варшавский Ю.В., Китаев В.В., Ершов В.В. Некоторые проблемы реформы здравоохранения с позиции лучевой диагностики. Радиология-практика. 2007; 1: 5-12.

 

 

4.    Варшавский Ю.В., Китаев В.В., Ершов В.В. К вопросу о правовом обеспечении введения в клиническую практику технологий лучевой диагностики. Радиология-практика. 2010; 6: 38-42.

 

 

5.    Вишнякова М.В., Шумский В.И. Лучевая диагностика: изучение и обучение. От традиционной рентгенологии к новым направлениям лучевой диагностики. Москва. 2012; 4-12.

 

 

6.    Линденбратен Л.Д. Универсальная и специальная подготовка врача-радиолога. Радиология-практика. 2003; 1: 2-9.

 

 

7.    Линденбратен Л.Д. Лучевая диагностика: достижения и проблемы нового времени. Радиология-практика. 2007: 3; 4-15

 

 

8.    Линденбратен Л.Д. Модификация клинической ординатуры по лучевой диагностике. Радиология-практика. 2010; 3: 4-17.

 

 

9.    Молчанов А.В., Сайткулов К.И. Электронно-библиотечная система для медицинского образования. Медиц. образование и профессиональное развитие. 2011; 1: 39-43.

 

 

10.  Основы медицинской информатики. Самара. 2006; 16.

 

 

11.  Постановление Правительства РФ от 16.04.2012 № 291«О лицензировании медицинской деятельности».

 

 

12.  Попович Л. Специалисты для современного здравоохранения. Медицина-целевые проекты 2012; 13: 16-17.

 

 

13.  Учебная программа клинической ординатурыпо лучевой диагностике. Радиология-практика. 2006; 1: 28-47.

 

 

14.  Элауэй Р., Мастерс К. Руководство АМЕЕ № 32: Электронное обучение в медицинском образовании. Часть 1: Обучение, преподавание и оценка знаний. Медиц. образование и профессионал. развитие. 2011; 4: 13-28.

 

 

15.  Элауэй Р., Мастерс К. Руководство АМЕЕ № 32: Электронное обучение в медицинском образовании. Часть 2: Проблемно-ориентированное обучение, преподавание и оценка знаний. Медиц. образование и профессионал. развитие. 2012; 1: 91-911.

 

 

16.  Элауэй Р., Мастерс К. Руководство АМЕЕ № 32: Электронное обучение в медицинском образовании. Часть 3: Технология, менеджмент, дизайн. Медиц. образование и профессионал. развитие. 2012; 2: 21-56.

 

 

authors: 


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.

 

Abstract:

This article presents a clinical case of successful prevention of distal embolization in patient with acute ST-elevation myocardial infarction with a combination of manual thromboaspiration and distal protection. We have presented own and literature data about possible additional sourse of distal embolization (contents of cavity plaque rupture) after successful thromboaspiration during stent implantation, which was the basis of a strategy combination of manual thromboaspiration and distal protection. As a device for distal protection we used the system «Emboshield NAV6» (Abbott Vascular, USA). We have described design features of the device, knowledge of which will help to make better use of it in native coronary arteries in such situations.

 

Reference 

1.    Mehta R.H., Harjai K.J., Boura J. et al., for the Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am. J. Cardiol. 2003; 92: 1445-1447.

2.    Niccoli G., Burzotta F., Galiuto L. et al. Myocardial no-reflow in humans. J. Am Coll. Cardiol. 2009: 21: 281-292.

3.    Piana R.N., Paik G.Y., Moscucci M. et al. Incidence and treatment of «no-reflow» after percutaneous coronary intervention. Circulation. 1994; 89: 2514-2518.

4.    Klonner R.A., Ganote C.E., Jennings R.B. The «no-reflow» phenomenon after temporary coronary occusion in the dog. J. Clin. Invest. 1974: 54: 1496-1508.

5.    Al'biero R. Oslozhnenija pri chreskozhnyh koronarnyh vmeshatel'stvah: ot prognoza k preduprezhdeniju i lecheniju. Rentgenojendovaskuljarnaja hirurgija ishemicheskoj bolezni serdca: Rukovodstvo po rentgenojendovaskuljarnoj hirurgii serdca i sosudov: V 3 t. (Pod red. L.A. Bokerija, B.G. Alekjana). M.: NCSSH im. A.N. Bakuleva RAMN. 2008; 3: 157-174 [In Russ].

6.    Burzotta F., Trani C., Romagnoli E. et al. Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J. Am Coll. Cardiol. 2005; 46: 371-376.

7.    The Thrombolysis in Myocardial Infarction (TIMI) trial, phase I findings: TIMI Study Group. N. Engl. J. Med. 1985; 312: 932-936.

8.    Kirma C., Izgi A., Dundar C. et al. Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions. Experience at a Single Center. Circ. J. 2008; 72: 716-721.

9.    Zalewski J., Bogaerts K., Desmet W. et al. Intraluminal thrombus in facilitated versus primary percutaneous coronary intervention: an angiographic substudy of the ASSENT-4 PCI (Assessment of the Safety and Efficacy of a New Treatment Strategy With Percutaneous Coronary Intervention) trial. J. Am. Coll. Cardiol. 2011; 57: 1867-1873.

10.  Svilaas T., Vlaar P.J., van der Horst I. et al. Thrombus aspiration during primary percutaneous coronary intervention. N. Engl. J. Med. 2008; 358: 557-567.

11.  Vlaar P.J., Svilaas G., van der Horst. et al. Cardiac death and reinfarction after 1 year in the Thrombus aspiration during primary percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1 - year follow - up study. Lancet. 2008; 371: 1915-1920.

12.  Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2010; 31: 2501-2555.

13.  Lee S.Y., Mintz G.S., Kim S.Y. et al. Attenuated plaque detected by intravascular ultrasound: clinical, angiographic, and morphologic features and post-percutaneous coronary intervention complication in patients with acute coronary syndromes. J. Am. Coll. Cardiol. 2009; 2(1): 65-72.

14.  Okura H., Taguchi H., Kubo T. et al. Atherosclerotic plaque with ultrasonic attenuation affects coronary reflow and infarct size in patients with acute coronary syndrome: an intravascular ultrasound study. CircJ.2007; 71: 648-653.

15.  Isshiki T., Kozuma K., Kyono H. et al. Initial clinical experience with distal embolic protection using «Filtrap’», a novel filter device with a self-expandable spiral basket in patients undergoing percutaneous coronary intervention. Cardiovasc. Intern and Ther. 2011; 26: 12-17.

16.  Markas'jan A.V., Petrushenko A.E., Val'ko A.S. i dr. Uspeshnaja aspiracija vnutrikoronarnyh trombov cherez provodnikovyj kateter HEARTRAIL II pri ostrom infarkte miokarda s pod#emom segmenta ST: tri klinicheskih sluchaja. Vest. rentgen. i radiol. 2012; 1: 38-44 [In Russ].

17.  Hadi H.M., Fraser D.G., Mamas M.A. Novel use of the Heartrail catheter as a thrombectomy Device. J. Invas. Cardiol. 2011; 23 (1): 35 - 40.

18.  Porto I., Choudhury R.P., Pillay P. et al. Filter no reflow during percutaneous coronary interventions using the Filterwire distal protection device. Int. J. Cardiol. 2006; 109: 53-58.

19.  Wu X., Mintz G.S., Xu K. et al. The Relationship Between Attenuated Plaque Identified by Intravascular Ultrasound and No-Reflow After Stenting in Acute Myocardial Infarction The HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial. J. Am. Coll. Cardiol. Intv. 2011; 4: 495-502.

20.  Endo M., Hibi K., Shimizu T. et al. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. Intv. 2010; 3: 540-549.

21.  Hara H., Tsunoda T., Moroi M. et al. Ultrasound attenuation behind coronary atheroma without calcication: mechanism revealed by autopsy. Acute Cardiac Care. 2006: 8: 110-112.

22.  Johnstone E., Friedl S.E., Maheshwari A. et al. Distinguishing characteristics of erythrocyte-rich and platelet-rich thrombus by intravascular ultrasound catheter system. J. Thromb. Thrombolysis. 2007; 24: 233-239.

23.  Ohshima K., Ikeda Sh., Kadota H. et al.

Abstract:

Aneurism of the splenic artery is a rare, but potentially life-threatening condition. In the majority of patients with an aneurism of unpaired visceral arteries the endovascular procedure is a treatment of choice. Of them stent graft implantation is considered as the most promising method. However, until recent only balloon-dilated stent grafts were used. Due to a rigid delivering system this type of grafts cannot be implanted in distal branches of visceral arteries, that is significant limitation of this technique. Technological advances and developing of low-profile soft self-expanding grafts allow overcoming this limitation. New type of grafts opens the possibility to exclude aneurisms even in conditions of marked vessel tortuosity and complex vascular anatomy

Conclusion: stent-graft implantation is an effective and safe method of treatment of splenic artery false aneurisms. This method allows to reliably exclude an aneurism from the circulation and is not associated with increased risk of thrombotic complications. Modern low-profile soft self-expanding grafts open new possibility in treatment of visceral arteries aneurisms even in conditions of marked vessel tortuosity and complex vascular anatomy.

 

References

1.    Pokrovskij A.V. Zabolevanija aorty i ee vetvej. M. Medicina. 1979; 324 [In Russ].

2.    Nosher J.L., Chung J., Brevetti L.S. et al. Visceral and renal artery aneurysms: a pictorial essay on endovascular therapy. RadioGraphics. 2006; 26: 1687-1704.

3.    Hossain A., Reis E.D., Dave S.P. et al. Visceral artery aneurysms: experience in a tertiary-care center. Am Surgr. 2001; 67(5): 432-437.

4.    Stanley J.C., Fry W.J. Pathogenesis and clinical significance of splenic artery aneurysms. Surgery. 1974; 76: 898-899.

5.    Messina L.M., Shanley C.J. Visceral artery aneurysms. Surg. Clin. North. Am. 1997; 77: 425-442.

6.    Meng WC.S., Chan M., Lau W.Y., Li A.K.C. Splanchnic aneurysms. H. K M. J 1995; 1(2): 173-177.

7.    Lai R., Mallery S. Primary splenic artery aneurysm diagnosed by EUS. Visible Human Journal of Endosonography. 2002; 4(1): 2-3.

8.    Kemmeter P., Bonnell B., VanderKolk W. et al. Percutaneous thrombin injection of splanchnic artery aneurysms: two case reports. J. Vasc. Interv. Radiol. 2000; 11(4): 469-472.

9.    Kasirajan K., Greenberg R.K., Clair D., Ouriel K. Endovascular management of visceral artery aneurysm. J. Endovasc. Ther. 2001; 8: 150-155.

10.  Janzen R.M., Simpson W.T. Visceral artery aneurysm. C. J. S. - 2004; 43(4): 301-302.

11.  Ikeda O., Tamura Y., Nakasone Y. et al. Coil embolization of pancreaticoduodenal artery aneurysms associated with coeliac artery stenosis: report of three cases. Cardiovasc. Intern Radiol. 2007; 30: 504-507.

12.  Chino O., Kijama H., Shibuya M. et al. A case report: spontaneous rupture of dissecting aneurysm of the middle colic artery. Tokai. J. Exp. Clin. Med. 2004; 29(4): 155-158.

13.  Babadzhanov B.R., Husainov B.R., Juldashev G.Ju. Anevrizma selezenochnoj arterii kak prichina segmentarnoj vnepechenochnoj portal'noj gipertenzii [Splenic artery aneurism as a cause of anhepatic segmentary portal hypertension]. Klinicheskaja hirurgija. 1989; 9: 62-63 [In Russ].

14.  Gavrilenko A.V. Hirurgicheskoe lechenie hronicheskoj abdominal'noj ishemii: Dis. dokt. med. nauk. M., 1990 [In Russ].

15.  Lishenko A.N., Ermakov E.A., Shalaginov S.I., Gofman A.V. Razryv anevrizmy selezenochnoj arterii [Splenic artery aneurism rupture]. Hirurgija. 2005; 7: 58-59 [In Russ].

16.  Pokrovskij A.V. Klinicheskaja angiologija: Rukovodstvo v 2-h tomah. M. Medicina. 2004;2: 117-128 [In Russ].

17.  Stanley J.C., Wakefield T.W., Graham L.M. et al. Clinical importance and management of splanchnic artery aneurysms. J. Vasc. Surg. 1986; 3: 836-840.

18.  Tochii M., Ogino H., Sasaki H. et al. Successful surgical treatment for aneurysm of splenic artery with anomalous origin. Ann. Thorac. Cardiovasc. Surg. 2005; 11(5). 346-349.

19.  Wagner W.H., Allins A.D., Treiman R.L. et al. Ruptured visceral artery aneurysms. Ann. Vasc. Surg. 1997; 11(4): 342-347.

20.  Weber C.H., Pfeifer K.J., Tato F. et al. Transcatheter coil embolization of an aneurysm of the pancreatico-duodenal artery with occluded celiac trunk. Cardiovasc. Intern Radiol. 2005; 2: 259-261.

21.  Karaman K., Onat L., Sirvanci M., Olga R. Endovascular stent graft treatment in a patient with splenic artery aneurysm. Diagn. Interv. Radiol. 2005; 11: 119-121.

22.  Jibiki M., Inoue Y., Iwai T. et al. Treatment of three pancreaticoduodenal artery aneurysms associated with coeliac artery occlusion and splenic artery aneurysm: a case report and review of the literature Eur. J. Vasc. Endovasc. Surg. 2005; 29(2): 213-217.

23.  Porcu P., Marongiu G.M., Bacciu P.P. Aneurysms of the celiac artery: case report and review of the literature . J. Mal. Vasc. 2002; 27(2): 88-92.

24.  Pulcini G., D’Adda F., Lanzi S. et al. Aneurysms of the superior mesenteric artery. Ann. Ital. Chir. 2002; 73(2): 129-136.

25.  Sakai H., Urasawa K., Oyama N., Kitabatake A. Successful covering of a hepatic artery aneurysm with a coronary stent-graft. Cardiovasc. Interv. Radiol. 2004; 27: 274-277.

26.  Duncan A.A. Median arcuate ligament syndrome. Curr. Treat. Options. Cardiovasc. Med. 2008; 10(2): 112-116.

27.  Gandini R., Pipitone V., Konda D. et al. Endovascular treatment of a giant superior mesenteric artery pseudoaneurysm using a nitinol stent-graft. Cardiovasc. Interv. Radiol. 2005;1: 102-106.

28.  Grego F.G., Lepidi S., Ragazzi R. et al. Visceral artery aneurysms: a single center experience. Cardiovasc. Surg. 2003; 11(1): 19-25.

29.  Troickij A.V., Bobrovskaja A.N., Orehov PJu. i dr. Uspeshnoe chreskozhnoe jendovaskuljarnoe lechenie razryva anevrizmy bedrennoj arterii [Succesfull endovascular treatment femoral artery aneurism rupture]. Angiologija i sosudistaja hirurgija. 2005; 11(1): 53-57 [In Russ].

30.  Chen F., Kriegshauser L.S., Huettl E.A., Roberts C.C. Percutaneous thrombin injection for treatment of a splenic artery aneurysm. Radiology. 2006; 1(1): 13-16.

31.  Cope C., Zeit R. Coagulation of aneurysms by direct percutaneous thrombin injection . A.J.R 1986; 147: 383-387.

32.  Guillon R., Garcier J.M., Abergel A. et al. Management of splenic artery aneurysms and false aneurysms with endovascular treatment in 12 patients . Cardiovasc. Interv. Radiol. 2003; 26: 256-260.

33.  Jenssen G.L., Wirsching J., Pedersen G. et al. Treatment of a hepatic artery aneurysm by endovascular stent-grafting. Cardiovasc. Interv. Radiol. 2007; 30: 523-525.

34.  Hyun-Ki Y., Mats L., Petr U. et al. Stent-graft repair of a splenic artery aneurysm. Cardiovasc. Interv. Radiol. 2001; 24: 200-203.

35.  Garg A., Banait S., Babhad S. et al. Endovascular treatment of pseudoaneurysm of the common hepatic artery with intra-aneurysmal glue (N-butyl 2-cyanoacrylate) embolization. Cardiovasc. Intern Radiol. 2007; . 30: 999-1002.

36.  Gabelmann A., Gorich J., Merkle E.M. Endovascular treatment of visceral artery aneurysm J. Endovasc. Ther. 2002; 9: 38-47.

 

 

Abstract:

The article provides a case report of the patient with mediastinitis. This case report shows the importance of multispiral computed tomography in the diagnostics of tumors of this localization, demonstrates the need of proper preparation of patient for examination and use of CT with intravenous contrast enhancement, multiplanar reconstruction images to obtain information about the nature of blood flow, determining the structure of esophagus walls and the ratio of detected changes with surrounding organs and vascular structures, which is particularly important for treatment planning.

 

References 

1.    Arslan E., Sank M., Iюэk A.F. et al. Treatment for esophageal perforations: analysis of 11 cases. Ulus. Travma Acil. Cerrahi. Derg. 2011; Nov 17(6): 516-20.

2.    Lyman D. Spontaneous esophageal perforation in a patient with mixed connective tissue disease. Open Rheumatol. J. 2011; 5: 138-43.

3.    S. M.P., Soares E.F., Santos C.A. et al. Risk factors for mediastinitis after coronary artery bypass grafting surgery. Rev. Bras. Cir. Cardiovasc. 2011; 26(1): 27-35.

4.    Komarov B.D., Kanshin N.N., Abakumov M.M. Povrezhdenija pishhevoda. [Injures of esophagus ]- М.: Medicina, 1981; 175. [In Russ]

5.    Petrov B.A. Khirurgija pishhevoda. [Surgery of the esophagus] Khirurgija. 1967; 10; 9-15

6.    Toshhakov R.A., Nechiporenko I.N., Putenikhin S.V. Mediastinit i rezul'taty ego khirurgicheskogo lechenija. [Mediastinitis and the results of surgical treatment] Zdravookhranenie Turkmenistana. 1992; 4; 41-43. [In Russ]

7.    Randjelovic T., Stamenkovic D. Mediastinitis-diagnosis and therahy. Acta Chir. Iugosl.2001 ; 48; 3; 55-59.

8.    Santiago E. Rossi, H. Page McAdams, Melissa L. Rosado-de-Christenson, Teri J. Franks, Jeffrey R. Galvin. Fibrosing Mediastinitis. RadioGraphics. 2001; 21: 737-757.

9.    Strohm P., Muller C., Jonas J., R. Bahr Esophageal perforation. Etiology, diagnosis, therapy. Chirurg. 2002; 73 (3): 217-222.

10.  Abakumov M.M. Mekhanicheskie povrezhdenija pishhevoda: Dis..dokt.med.nauk [The mechanical damage to the esophagus]:14.00.27 - Khirurgija . NII SP im. N.V. Sklifosovskogo. М., 1979; 434 [In Russ]

11.  Ivanov A.Ja. Abscessy i flegmony sredostenija. [Mediastinal abscess and phlegmon] Medgiz, 1959;147 [In Russ].

12.  Komarov B.D., Abakumov M.M., Pogodina A.N. Ostryjj gnojjnyjj mediastinit (klinika, diagnostika, lechenie). [Acute purulent mediastinitis (clinical picture, diagnosis, treatment)] Khirurgija. 1985; 10; 151-152 [In Russ].

13.  Braxton J.H., Marrin C.A., McGrath P.D. еt ак Mediastinitis and long-term survival after coronary artery bypass graft surgery. Ann. Thorac. Surg. 2000; 70 (6): 2004-7

14.  Vancjan Eh.N. , Chernousov A.F., Chissov V.I. Povrezhdenija pishhevoda pri buzhirovanii. [Damage to the esophagus during bougienage] Khirurgija.1976; 4: 83-88 [In Russ].

15.  Kvardakova O.V Znachenie rentgenologicheskogo issledovanija v ocenke techenija gnojjnogo mediastinita. [The value of radiologic studies to evaluate the flow of purulent mediastinitis ] Date of last access: March 19, 2012 at link: http://vestnik.rncrr.ru/vestnik/v9/papers/kMadrakova_v9.htm [In Russ].

16.  Shraer, T.I. Taktika khirurga pri perforacii grudnogo otdela pishhevoda. [Tactics of the surgeon with thoracic esophageal perforation.] Grudnaja khirurgija.1966; 5: 82-88 [In Russ].

17.  Demetriades D., Theodorou D., Cornwell E .et al. Evaluation of penetrating injuries of the neck: prospective study of 223 patients. World J. Surg.1997; 21(1): 41-47.

18.  Hunt D.R., Wills V.L.. Weis B. еt ак Management of esophageal perforation after pneumatic dilation for achalasia. Ulus. Travma Derg. 2001; 7(1): 22-7.

            19.  Robicsek, F. Postoperative sterno

Endovascular diagnostics and haemostasis of splenic artery arrosive bleeding into pancreatic enteroanastomosis in patient with chronic postnecrotic pancreatitis



DOI: https://doi.org/10.25512/DIR.2013.07.1.07

For quoting:
Ivanusa S.A., Lasutkin M.V., Alentev S.A., Shershen D.P., Kandyba D.V. "Endovascular diagnostics and haemostasis of splenic artery arrosive bleeding into pancreatic enteroanastomosis in patient with chronic postnecrotic pancreatitis". Journal Diagnostic & interventional radiology. 2013; 7(1); 61-65.

 

Abstract:

Article describes a rare clinical case: a successful endovascular haemostasis of splenic artery arrosive bleeding into pancreatic enteroanastomosis in early postoperative period in patient with chronic postnecrotic pancreatitis.

 

References 

1.    Karmazanovskij G.G. i dr. Anevrizmy visceral'nyh sosudov i arrozionnye krovotechenija v polost’ postnekroticheskih kist podzheludochnoj zhelezy. Zh. Annaly hirurgicheskoj gepatologii [Aneurysms of visceral vessels and arrosive bleeding into postnecrotic cysts of pancreas. Journal «Annals ofsurgical hepatology»]. 2007; 12(2) 85-95[In Russ] .

2.    Alfredo F.T. Acute pancreatitis at the beginning of the 21st century: The state of the art. WorldJ. Gastroenterol. 2009; 28 (15(24)): 2945-2959.

3.    Gubergric N.B. i dr. Sosudistye zabolevanija podzheludochnoj zhelezy i sosudistye oslozhnenija pankreaticheskoj patologii: luchevye, sonograficheskie i morfologicheskie sopostavlenija (obzor literatury). Zh. Medicinskaja vizualizacija [Vascular diseases of pancreas and vascular complications of pancreatic patology: beam-diagnostics, sonographic and morphological comparison. Jornal «Medical Visualisation»]. 2005; 5: 11-21 [In Russ].

4.    Andersson E., D. Ansari, R. Andersson. Major haemorrhagic complications of acute pancreatitis. The British journal of surgery. 2005; 97(9): 1379-84.

5.    De Perrot M., T. Berney, L. Buchler Management of bleeding pseudoaneurysms with pancreatitis. Brit. J. Surg. 1999; 86: 29-32.

6.    Vimalraj V., D.G. Kannan, R. Sukumar. Haemosuccus pancreatitis: diagnostic and therapeutic challenges. HPB. 2009; 4: 345-350.

7.    Kriger A.G., Karmazanovskij G.G., Kokov L.S. Lozhnye anevrizmy arterij bassejna chrevnogo stvola u bol'nyh hronicheskim pankreatitom. Zh. Hirurgija [False aneurysms of truncus coeliacus in patients with crhonic pancreatitis. Journal «Surgery»]. 2008; 12: 85—95 [In Russ].

8.    Sahakian A.B., S. Krishnamoorthy, T.H. Taddei. Necrotizing pancreatitis complicated by fistula and upper gastrointestinal hemorrhage. Clin. Gastroenterol. Hepatol. 2011; 9(7): 66-67.

9.    Vishnjakova M.V. i dr. Diagnostika i jendovaskuljarnoe lechenie psevdoanevrizmy selezenochnoj arterii. Zh. Diagnosticheskaja i intervencionnaja radiologija [Diagnostics and endovascular treatment of splenic artery pseudoaneurysm. Journal «Diagnostic and interventional radiology»]. 2010; 4( 4) 97 - 99 [In Russ].

10.  Tarazov P.G. i dr. Uspeshnaja arterial'naja jembolizacija posttravmaticheskoj psevdoanevrizmy pechenochnoj arterii. Zh. Diagnosticheskaja i intervencionnaja radiologija [Succesful arterial embolization of posttraumatic hepatic artery pseudoaneurysm. Journal «Diagnostic and interventional radiology»]. 2011; 5(3): 93-98 [In Russ].

11.  Tibilov M.A., Bajmatov M.S. Jendovaskuljarnye vmeshatel'stva v lechenii zheludochno-kishechnyh krovotechenij pri zabolevanijah pankreatoduodenal'noj zony. Zh. Diagnosticheskaja i intervencionnaja radiologija [Endovascular treatment of gastrointestinal bleeding in patients with pancreatoduodenal zone diseases. «Diagnostic and interventional radiology»]. 2009; 3(3) 45 - 50 [In Russ].

12.  Kalva S.P., K.Yeddula, S. Wicky. Angiographic intervention in patients with a suspected visceral artery pseudoaneurysm complicating pancreatitis and pancreatic surgery. Arch Surg. 2011; 146(6): 647-652.

13.  Mansueto G. et al. Endovascular treatment of arterial bleeding in patients with pancreatitis. Pancreatology.- 2007; 7(4): 360-369.

14.  Sethi H., P. Peddu, A. Prachalias. Selective embolization for bleeding visceral artery pseudoaneurysms in patients with pancreatitis. Hepatobiliary and pancreatic diseases international. 2007; 9(6): 634-638

 

 

Abstract:

The article presents literature data about splenic lesions, their morphological characteristics and occurrence. Methods of diagnostics of such lesions are considered. Rarely met pathology as lymphangioma of spleen is discussed. Article describes peculiarities of clinical and morphological classifications of lymphangiomas with different locations, their morphological structure, clinical features of this disease in children and adults. Detailed diagnostic algorithm for detection of splenic lymphangioma is described. Possibilities and advantages of modern methods of diagnostic testing, perspective and the leading role CT and MRI are described. Complexities in diagnostics were noted during the research; optimal combinations of diagnostic methods for better verification of such spleen lesions, for estimation of certain anatomical relation with other structures and tissues, spread of the affected area, as well as an assistance in definition of surgical tactics and volume of intervention, based on data were offered. Application of new technologies with the use SCT-dimensional reconstruction of the affected organ and area of further operation, and the 3D planning of intervention, conducting virtual operations for the optimal access, volume of interventions on the base of individual characteristics of vascular and anatomical features of the patient - gives significant advantages. Review of possible treatment methods is presented. As a case report we used obtained data of 26-years woman with identified during ambulatory ultrasound diagnostics lymphangioma of spleen. In conclusion it is pointed that early and accurate diagnostics is important for prevention of complications and for reduce of operational trauma.

 

References 

1.    Kubyshkin V.A., Ionkin D.A. Opuholi i kisty selezenki [Tumors and cysts of spleen] M.: Medpraktika- M, 2007 [In Russ].

2.    Cappellani A., Zanghi A., Di Vita M. et al. Spontaneous rupture of a giant hemangioma of the liver. Ann. Ital. Chir. 2000; 71: 379-383.

3.    Daltrey I.R., Johnson C.D. Cystic lymphangioma of the pancreas. Postgrad. Med. J. 1996; 72(851): 564-566.

4.    Panferova T.R. Jehografija v kompleksnoj diagnostike zabrjushinnyh vneorgannyh opuholej u detej . [Ultrasonography in complex diagnostics of retroperitoneal extraorganic tumors in children] Avto-ref. dis. kand. med. nauk. M., 1998 [In Russ].

5.    Brian K.P., Goh M., Y-Meng Tan et al. Intra-abdominal and retroperitoneal ymphangiomas in pediatric and adult patients. WTd J. Surg. 2000; 29: 837-840.

6.    Konen O., Rathans V., Dingy E. et al. Childhood abdominal cystic lymphangioma. Pediatr. Radiol. 2002; 32: 88-94.

7.    Christie J.P., Karlan M.S. Lymphangioma of the pancreas with symptoms of «acute surgical abdomen». Calif Med. 1969; 111(1): 22-24.

8.    Umap P. Intra! abdominal cystic lymphangioma. IndianJ. Cancer 1994; 31: 111-113.

9.    Volobuev N.N., Tihonov K.S., Minajkin V.I. Gigantskaja kistoznaja limfangioma brjushnoj polosti. Hirurgija. [Giant cystic lymphangioma of abdominal cavity] 1989;5: 127-128 [In Russ].

10.  Faul J.L., Berry G.J., Colby T.V. et al. Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis and lymphatic dysplasia syndrome. Am. J. Respir. Crit. Care Med. 2000; 161: 1037-1046.

11.  Wegner G. Veber Lymphangiome. Arch. Klin. Chir. 1877; 20: 641.

12.  Matjunin V.V. Limfangiomy cheljustno-licevoj oblasti u detej. [Lymphangiomas of maxillofacial area in children] Dissertation for degree of Doctor of Philosophy. M., 1993;150 [In Russ].

13.  Takeuchi Y., Fujinami S., Kitagawa S. et al. Laparoscopic observation of retroperitoneal cystic lymphangioma. J. Gastroenterol. Hepatol. 1994; 9(2): 198-200.

14.  Bliss D.P. Jr., Coffin C.M., Bower R.J. et al. Mesenteric cysts in children. Surgery. 1994; 115: 571-577.

15.  Hancock B.J., St. Vil D., Luks F.I. et al. Complication of lymphangiomas in children. J. Pediatr. Surg. 1992; 27(2): 220-226.

16.  Kurtz R.J., Heimann T.M., Holt J. et al. Mesenteric and retroperitoneal cysts. Ann. Swrg. 1986; 203: 109-111.

17.  Chou Y.H., Tiu C.M., Lui W.Y. et al. Mesenteric and omental cysts: an ultrasonographic and clinical study of 15 patients. Gastrointest. Radiol. 1991; 16: 311-314.

18.  Stepanova Ju.A. Diagnostika neorgannyh zabrjushinnyh obrazovanij po dannym kompleksnogo ul'trazvukovogo issledovanija: [Diagnostics of retroperitoneal newgrowth: complex US diagnostics.] Dissertation for degree of Doctor of Philosophy.M., 2002 [In Russ].

19.  Karmazanovskij G.G., Fedorov V.D. Kompjuternaja tomografija podzheludochnoj zhelezy i organov zabrjuwinnogo prostranstva [CT of pancreas and retroperitoneal organs]. M.: Paganel', 2000 [In Russ].

20.  Melihova M.V. Differencial'no diagnosticheskie vozmozhnosti spiral'noj kompjuternoj tomografii s boljusnym kontrastnym usileniem pri neorgannyh zabrjushinnyh obrazovanijah. [MCST with bolus contrast encashment in differential diagnostics of extraorganic retroperitoneal newgrowth.] Dissertation for degree of Doctor of Philosophy. M., 2005 [In Russ].

21.  Leung T.K., Lee C.M., Shen L.K., Chen Y.Y. Differential diagnosis of cystic lymphangioma of the pancreas based on imaging features. J. Formos. Med. Assoc. 2006; 105(6): 512-517.

22.  Khandelwal M., Lichtenstein G., Morris J. et al. Abdominal lymphangioma masquerading as a pancreatic cystic neoplasm. J. Clin. Gastmenterol. 1995; 20: 142-144.

23.  Casadei R., Minni F., Selva S. et al. Cystic lymphangioma of the pancreas: anatomoclinical, diagnostic and therapeutic consideration regarding three personal observations and review of the literature. Hepatogastroenterology. 2003; 50(53): 1681-1686

Estimation of biophysical parameters of a kidney parenchyma in rat at renal insufficiency in experiment



DOI: https://doi.org/10.25512/DIR.2013.07.1.05

For quoting:
Boukhniev Yu.Yu., Baranov V.M., Stepanova Ju.A., Panchenkov D.N., Leonov S.D., Baranov A.V., Boukhnieva L.V. "Estimation of biophysical parameters of a kidney parenchyma in rat at renal insufficiency in experiment". Journal Diagnostic & interventional radiology. 2013; 7(1); 41-48.

Abstract:

Aim: was to assess biophysical parameters of a renal parenchyma at experimental acute and chronic renal insufficiency at rats.

Material and methods. Experiment was carried out on 36 rats of both sexes in mass of 180-250 g. The bioimpedance analysis of a renal parenchyma was carried out in intraoperative way on the 7th day after modeling of acute renal insufficiency and 2 months later after modeling of acute renal insufficiency, using «G. Greven's method». Absolute and relative indicators of electric impedance were investigated.

Results. Chronic renal insufficiency in contrast to the acute renal insufficiency is characterized not only by reduction of absolute indicators of renal parenchyma electric impedance, but also by change of relative indicators. Apparently, relative indicators of the bioimpedance analysis reflect change of the renal parenchyma functional status and absolute peculiarities of its morphological structure.

Conclusion. The analysis of results of a bioimpedansometriya in separate zones of a kidney, showed that in a normal kidney the electric impedance in various parts of body is non-uniform, however at renal insufficiency indicators of an impedance are leveled. This phenomenon is necessary for checking in clinical researches and, in case of confirmation of experimental results, it can be used as diagnostic criterion at statement of the diagnosis of acute renal insufficiency.

 

References 

1.    Smirnov A.V., Dobronravov V.A., Kajukov I.G. i dr. Rekomendacii Nauchno-issledovatel'skogo instituta nefrologii Sankt-peterburgskogo gosudarstvennogo medicinskogo universiteta im. Akad. I.P. Pavlova: opredelenie, klassifikacija, diagnostika i osnovnye napravlenija profilaktiki hronicheskoj bolezni pochek u vzroslyh. Nefrologija [Recommendation of scientific-research institute of nephrology, of St.Petersburg medical univercity named after I.P.Pavlov: definition, classification, diagnostics and major ways of prophylaxis of chronic renal diseases in adults. Nephrology.]. 2008; 12(2): 75-93 [In Russ].

2.    Tomilina N.A., Podkorytova O.L. Ostraja pochechnaja nedostatochnost'. Nefrologija i dializ. [Acute renal insufficiency. Nephrology and dialysis.] 2009; 11(1): 4-20 [In Russ].

3.    Golidorsky M.S., Liberbal W. Pathophysiology-ischemic acute renal failure. In: Atlas of Diseases of the Kidney. Ed. By R.W. Schreier. 1999; 460.

4.    Pal'cev M.A., Anichkov N.M. Patologicheskaja anatomija: Uchebnik [Pathological anatomy.]. V 2-h t. T. 2. Ch. II. M.: Medicina. 2001; 680 [In Russ]..

5.    Stecjuk E.A. Sovremennyj gemodializ [Modern dialysis]. - M.: MID, 1998; 356 [In Russ].

6.    John T., Dandirdas., Kunig P. et al. Neurological disease of Renal Failure. Neurology and general medicine. - 3rd ed. 2002; 131-142.

7.    Ermolenko V.M., Nikolaev A.Ju. Ostraja pochechnaja nedostatochnost': rukovodstvo [Acute renal insufficiency. Guide-book.]. M.: GJeOTAR-Media, 2010; 240 [In Russ].

8.    Rjabov S.I., Natochin Ju.V. Funkcional'naja nefrologija [Functional nephrology...]. S-Pb.: Lan', 1997; 304 [In Russ].

9.    Shejman D.A. Patofiziologija pochki [Pathophysiology of kidney]. Per. s angl. 2-eizd., ispr.- M.- S-Pb.: «Izdatel'stvo BINOM» «Nevskij dialekt», 1999; 260 [In Russ].

10.  Spencer J.A., Giussani D.A., Moore P.J., Hanson M.A. In vitro validation of Doppler indices using blood and water. J. Ultr. Med. 1991; 10: 305-308.

11.  Nagao M., Murase K., Saeki H. Pulsating renal blood flow distribution measured using power Doppler ultrasound: correlation with hypertension. Hypertens. Res. 2002; 25: 697-702.

12.  Hascaev B.D. Impedansnyj metod v mediko-biologicheskih issledovanijah i ego pribornoe osnawenie. Medicinskaja tehnika [Impedance method of medical-biological investigation and its equipment.]. 1996; 3: 34-40 [In Russ].

13.  Livenec V.P. Impedansometrija nebnyh mindalin kak sposob ob#ektivizacii klinicheskih form hronicheskogo tonzillita. Dis. kand. med. Nauk [Impedancometry of glands as a method of objectivization of clinical forms of tonsillitis]. M., 2006; 159[In Russ].

14.  Noskova A.P. Vlijanie furosemida i mannitola na vyzhivaemost' krys pri ostroj pochechnoj nedostatochnosti. Farmakologicheskaja reguljacija funkcii pochek [The influence of furosemid on survival rate of rats with acute renal insufficiency. Pharmacological regulation of kidneys.]. Pod red. A.A. Lebedeva. - Kujbyshev, 1981; 40-44 [In Russ].

 

Abstract:

The aim of this research was to perform preoperative examination of distal arterial flow in patients with popliteal artery aneurysms. We performed 47 open surgery procedures in 38 patients with popliteal artery aneurysms. Patients underwent duplex scanning, CT and angiography Duplex scanning was performed in all cases while CT only in 14 (36,8%) cases. Angiography was performed in 29 (76,3%) cases (43 aneurysms).

We revealed that with the increasing duration of the disease increases the number of aneurysms with thrombus (71,8% vs 28,2%, p<0,05). Accordingly increases the number of patients with distal embolisation: 81,6% diseased shin arteries in patients with popliteal aneurysm vs 46,7% in patients without aneurysm (p<0,05). Therefore the longer aneurysm exists the more cases are complicated. In conclusion angiography still plays important role in diagnostics of popliteal aneurysms and helps to make decision for type of revascularization procedure.

 

Reference

1.    Duffy S.T., Colgan M.P., Sultan S., Moore D.J., Shanik G.D. Popliteal aneurysms: a 10-year experience. Eur. J. Vasc. Endovasc. Surg. 1998; 16: 218-222.

2.    Pulli R., Dorigo W., Troisi N., Innocenti A.A., Pratesi G., Azas L. et al. Surgical management of popliteal artery aneurysms: which factors affect outcomes? J. Vasc. Surg. 2006; 43: 481-487.

3.    Troitsky A.V., Bobrovskaya A.N., Orekhov PJ. et al he successful percutaneous endovascular treatment of ruptured femoral artery’aneurysm. Angiology and vascular surgery, 2005; 11(1): 53-60.

4.    Dent T.L., Lindenauer S.M. Ernst C.B., Fry WJ. Multiple arteriosclerotic arterial aneurysms. Arch. Surg. 1972; 105: 338-344.

5.    Spiridonov A.A., Morozov K.M.. Peripheral arteries aneurysms. Clinical angiology. Edited by prof. Pokrovsky A.V. Meditsina 2004; 262-284.

6.    Antonello M., Frigatti P., Battocchio P., Lepidi S., A.Dallrantonia, G.P.Deriu, Grego F. Endovascular treatment of asymptomatic popliteal aneurysms: 8-year concurrent with open repair. J. Cardiovasc. Surg. 2007; 48: 267-274.

7.    Dawson I., Sie R.B., Van Bockel J.N. Atherosclerotic popliteal aneurysm. Br. J. Surg. 1997; 84: 293-299.

8.    Stiegler H., Mendler G. Prospective study of 36 patients with 46 popliteal artery aneurysms with non-surgical treatment. Vasa. 2002; 31: 43-46.

9.    Carpenter J.P., Barker C.F., Roberts B., Berkowith H.D., Lusk E.J., Perloff L.J. Popliteal artery aneurysms: current management and outcome. J. Vasc. Surg. 1994; 19: 65-72.

10.  Tiellu I.F., Verhoeven E.L., Prins T.R., Post WJ., Hulsebos R.G., van den Dungen J.J. Treatment of popliteal artery aneurysms with the Hemobahn stent-graft. J. Endovasc. Ther. 2003; 10: 111-116.

 

Abstract:

Aim: was to determine indications for various methods of stenting on the base of conducted earlier interventions on bifurcation lesions after previously coronary artery occlusion.

Methods. In NRICP we studied a group of patients who underwent PCI for occluded arteries since 2009 to 2011. The study included patients with chronic total occlusion and bifurcation lesion with a diameter of side brunch more than 2 mm and stenosis >50%. Patients were divided into two groups (proximal and distal lesions) with respect of the proximal cap occlusion to the bifurcation. The primary end point was the emergence of MACE during the hospital period, including death, myocardial infarction, or repeat revascularization of the target vessel. Immediate angiographic success was considered in the case of blood flow TIMI II-III after stenting and residual stenosis of less than 50%.

Results. For the period of 2009-2011 PCI was performed. 307 patients were included in the study. The group of proximal lesions included 148 cases. The group of distal lesions consisted of 159 patients. Immediate angiographic success was observed in 98.3% of cases. Deaths, myocardial infarction, cerebrovascular accident, re-PCI, CABG during the hospital period were not noted.

Conclusion. Bifurcation lesions occure in 57,9% of cases after recanalization of chronic occlusions. In both groups one stent technique dominated, but in a group of proximal lesions two stents technique was used 5,8 times more often than in the distal lesions group. In both groups, MACE in hospital period were not noted.

 

References 

1.    Nakamura S., Muthusamy T.S., Bae J.H., Cahyadi Y.H., Udayachalerm W., Tresukosol D. Impact of sirolimus-eluting stent on the outcome of patients6. with chronic total occlusions. Am. J. Cardiol. 2005; 95: 161-166.

2.    Werner G.S., Krack A., Schwarz G., Prochnau D., Betge S., Figulla HR. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. J. Am. Coll. Cardiol. 2004; 44: 2301-2306.

3.    Valent R.I., Migliorini A., Signorini U., Vergara R., Parodi G., Carrabba N., et al. Impact of complete revascularization with percutaneous coronary intervention on survival in patients with at least one chronic total occlusion. Eur. Heart. J.2008; 29: 2336-2342.

4.    Kahn J.K. Angiographic suitability for catheter revascularization of total coronary occlusions in patients from a community hospital setting. Am. Heart J. 1993; 126: 561-4.

5.    Christofferson R.D., Lehmann K.G., Martin G.V. et al. Effect of chronic total coronary occlusions on treatment strategy. Am. J. Cardiol. 2005; 95: 1088-91.

6.    Garot P., Lefevre T., Savage M., Louvard Y., Bamlet W.R., Willerson J.T., Morice M.C., Holmes D.R. Jr. Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes(PRESTO) trial. J. Am Coll. Cardiol. 2005; 46: 606-12.

7.    Colombo A., Moses J.W., Morice M.C., Ludwig J., Holmes D.R. Jr., Spanos V., Louvard Y., Desmedt B., Di Mario C., Leon M.B. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004; 109:1244-9.

8.    Sharma SK., Sweeny J., Kini A.S. Coronary bifurcation lesions: a current update. Cardiol. Clin. 2010;28:.55-70

9.    Alfredo R. Galassi. Galassi’s Tips & Tricks. Second edition published in Republic of San Marino by Alpha s.r.l. 2010;.275

 

 


 

Abstract:

Article demonstrates possibilities of modern methods of medical visualization in diagnostics of reccurent uterine tumors. Data of 219 patients with invasive cancer of cervix and endometrium was analyzed. The period of analysis is 08.2006-07.2011 yrs. Article describes comparative analysis of MRI and US in diagnostics of reccurent endometrial and cervical cancer with different localizations. According to results of the study the sensitivity, specificity and accuracy of ultrasonography in the diagnosis of recurrent tumors in patients with cancer were 81%, 99% and 94%, respectively The sensitivity of MRI in detecting recurrent cancer of the uterus corresponded to 100%.

 

 

References

1.    Novikova E.G., Chulkova O.V, Antipov V.A. Rukovodstvo po onkologii. [Guide-book oncology] Moskva, MIA 2008: 518-540 [In Russ].

2.    Selman TJ., Mann C., Zamora J. et al. Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and metaanalysis. Canadian Medical Association Journal. 2008; 178(7): 855-62.

3.    Choi H.J., Kim S.H., Seo S. et al. MRI for Pretreatment Lymph Node Staging in Uterine Cervical Cancer. American J. of Radiology. 2006; 187: 538-43.

4.    Smith J.R., Healy J., Del Priore G. Perevod s anglijskogo pod redakciej E.G. Novikovoj.Onkoginekologicheskij atlas. [Oncologycal atlas] Moskva. Prakticheskaja medicina. 2010; 11-15, 24-27 [In Russ].

5.    Nemchushkina V.M., Kuznecov V.V., Barinov V.V., Bokina L.I. Lekcii po onkoginekologii. [Lectures on oncology.] Moskva. «MEDpress-inform». 2009; 226-255 [In Russ].

6.    Morow C.P., Bundy B.N., Kurman R.J. et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: gynecologic Oncology Group study. Gynecol. Oncol. 1991; 40(1): 55-65.

7.    Hulse P.A., Carrington B.M. MRI manual of pelvic cancer. MD 2004, London and New York.

8.    Ozsarlak O., Tjalma W., Schepens E., Corthouts B. et al. The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma. Eur. Radiol. 2003; 13(10): 2338-45.

9.    Chung H.H., Kang S.B., Cho J.Y. et al. Accuracy of MRI for the prediction of myometrial invasion of endometrial carcinoma. Gynecol. Oncol. 2007; 104(3): 654-9.

10.  Cabrita S., Rodrigues H., Abreu R., Martins M. et al. Magnetic resonance imaging in the preoperative staging of cervical carcinoma. Eur. J. Gynaecol. Oncol. 2008; 29(2): 135-7

11.  Savelli L., Ceccarini M., Ludovisi M., Fruscella E. et al. Preoperative local staging of cervical cancer: transvaginal sonography vs. magnetic resonance imaging. Ultrasound Obstet. Gynecol. 2008; 31(5): 560-6.

12.  Chang S.J., Lee E.J., Kim W.Y. et al. Value of sonogysterography in preoperative assessment of myometrial invasion for patiets with endometrial cancer. J. Ultrasound Med. 2010; 29(6): 923-9.

13.  Zandrino F., Paglia E., Musante F. et al. MRI in local staging of endometrial carcinoma: Diagnostic performance, pitfalls, and literature review. Tumori. 2010; 96(4): 601-8.

 

 

 

Abstract:

Introduction. 199Tl-chloride scintigraphy is used to visualize tumors. In addition to typical imaging of the musculoskeletal malignancy, unusually types of malignant tumor visualization were revealed by studies of diagnostic potentialities of 199Tl-chloride scintigraphy, analogue of 201Tl-chloride scintigraphy.

Aim. Was to study features of malignant tumor visualization of the musculoskeletal system with the help of 199Tl-chloride scintigraphy.

Materials and methods. 85 patients with diseases of musculoskeletal system underwent 199Tl-chloride scintigraphy. 107 localizations of malignant tumors (n=57) and benign lesion (n=50) were investigated. During the research in 107 patients malignant tumors were detected, 50 patients had bening tumors.

Results. Malignant tumors were visualized in 98.1%. Three types of malignant tumors' visualization were obtained - positive (82.4%) and rare negative (7.8%) and mixed (9.8%). Types of visualization were associated with tumor histological types, blood-flow, metabolism, and pharmacodynamic features of 199Tl-chloride. Negative and mixed visual types were high specific for primary and recurrent malignant tumors, but no metastasis.

Conclusion. Accounting to negative and mixed visual types - 199Tl-chloride scintigraphy sensitivity increased to 98.1% without decreasing of specificity in detection of malignant tumors of musculoskeletal system.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.

 

Abstract:

Pulmonary arteriovenosus aneurisms are rare congenital disorders. There are few scientific data about endovascular corrections. The aim of our study was to estimate possibilities and efficiency of endovascular occlusion with AZUR Peripheral Hydrocoil (TERUMO). Article describes methodics and results of endovascular correction on the base of case report.

 

References 

1.    Ливандовский Ю.А., Антонова М.А. Особенности клинического течения наследственной геморрагической телеангиэктазии. Трудный пациент. 2007; 4.

2.    Modaghegh M.-H.S., Kazemzadeh G.H., Jokar M.H. A case of Behcet disease with pulmonary artery pseudoaneurysm: long term follow-up еastern. Mediterranean Health. J. Vol. 2010; 16 (3): 346-349.

3.    Takahama M. et al. Successful surgical treatment of pulmonary artery aneurysm in Behcet's syndrome. Interact. CardioVasc. Thorac. Surg. 2009; 8: 390-392.

4.    Hama Y. et al. Endovascular management of multiple arterial aneurysms in Behcet's disease. The British J. of Radiology. 2004; 77: 615-619.

5.    Tzilalis А. et al. Use of an аmplatzer vascular plug in embolization of a pulmonary artery aneurysm in a case of Hughes-Stovin syndrome. A case report. J. of Medical Case Reports. 2011; 5: 425.

6.    Durak D. et al. Pulmonary artery aneurysm rupture. Bratisl. Lek. Listy. 2008; 109 (12): 582-583.

7.    Peter Corr Pulmonary Artery Aneurysm as a Cause of Massive Hemoptysis. Diagnosis and Management Case Reports  in Radiology Volume. 2011; 141563: 2.

8.    Jagia P. et al. Guleria transcatheter treatment of pulmonary artery pseudoaneurysm using a PDA closure device. Diagn. Interv. Radiol. 2011; 17: 92-94.

 

 

Abstract:

We have analyzed long-term results of different revascularization strategies in 171 patients with multivessel coronary artery defeat. Duration of follow up observation ranged from 12 to 18 months. Complete revascularization of the myocardium was performed in 63 pts, culprit vessel revascularization - in 86 and incomplete revascularization - in 22 patients. All patients undervwent SYNTAX scoring analysis to find out possible risks of transcutaneus coronary interventions. Survival rate, incidence of myocardial infarction, repeat myocardial revascularization procedures and major adverse cardiac events were comparable among the patients with low and intermediate SYNTAX Score. Among the patients with high SYNTAX Score the incidence of myocardial infarction (8,82%, р = 0,002), repeat PCI procedure (32,35%, р = 0,001) and major adverse cardiac events (32,35%, р = 0,002) was reliably higher compared to patients with low and intermediate SYNTAX Score. The mpact of the SYNTAX Score rate on the long-term results in the different revascularization strategy groups was also analyzed. In the 1st group the incidence of major adverse cardiac events among the patients was comparable. In the 2nd group patients with the high SYNTAX Score rate had reliably higher rate of major adverse cardiac events (43,75%, р = 0,002). The rate of major adverse cardiac events were higher in the 3rd group of patients with the high SYNTAX Score rate compared in patients with low and intermediate SYNTAX Score rate, but this difference didn't reach statistically reliable difference. Use of the strategy of culprit vessel revascularization in the patients with high SYNTAX Score rate, leads to increased rate of major adverse cardiac events and repeat PCI procedures in the long-term follow up period.

 

References 

1.    Silber S. et al. Guidelines for percutaneous        coronary interventions. Eur. Heart. J.2005; 26: 804-847.

2.    Bourassa M.G. et al. Strategy of complete revascularization in patients with multivessel coronary artery disease (a report from the 1985-1986 NHLBI PTCA Registry).

3.    Am. J. Cardiol. 1992; 70: 174. Bourassa M.G. et al. Long-term outcome of 5 patients with incomplete vs complete revascularization after multivessel PTCA (a report from NHLBI PTCA Registry). Eur. Heart. J. 1998; 19: 103-111.

4.    Hannan E.L. et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006; 113; 2406-2412.

5.    Hannan E.L. et al. Incomplete revascularization in the era of drug-eluting stents. Impact on adverse outcomes. J. Am. Coll. Cardiol. Intv. 2009; 2: 17-25.

6.    Ijsselmuiden A.J.J. et al. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease. A randomized comparison. Am. Heart. J.2004; 148: 467-474.

7.    Martuscelli E. et al. Revascularization strategy in patients with multivessel disease and a major vessel chronically occluded. Data from the CABRI trial. Eur. J. of Card.Thorac. Surg. 2008; 33: 4-8.

8.    Van den Brand M.J.B.M. et al. The effect of completeness of revascularization on event-free survival at one year in the arts trial. J. Am. Col. Cardiol. 2002; 39; 559-564.

9.    Беленков Ю.Н., Акчурин Р.С., Савченко А.П. и др. Результаты коронарного стентирования и хирургического лечения у больных ИБС с многососудистым поражением коронарного русла. Кардиология. 2002; 5: 42-45.

10.  Ong A.T.L., Serruys P.W. Coronary artery bypass graft surgery versus percutaneous coronaryintervention. Circulation. 2006; 114: 249-255.

11.  Patil C.V. et al. Multivessel coronary artery disease. Current revascularization strategies. Eur. Heart. J. 2001; 22: 1183-1197.

12.  Buda A.J. et al. Long-term results following coronary bypass operation. Importance of preoperative factors and complete revascularization. J. Thorac. Cardiovasc. Surg. 1981; 82: 383-290.

13.  Rodriguez A.E. et al. Revascularization strategies of coronary multiple vessel disease in drug eluting stent era. One year follow-up results of ERACI III trial. Eurointervention. 2006; 2: 53-60.

14.  Rodriguez A.E. et al. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery. 3 years follow-up of the ERACI III registry. Eur. Heart. J. 2007; 28: 2118-2125.

15.  Serruys P.W. et al. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent. Insights from the Arteкial Revascularization Therapies Study Fart II (ARTS II). Eur. Heart. J. 2007; 28 (4): 433-442.

16.  Serruys P.W. et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 2009; 360: 961-972.

17.  Serruys P.W. Sirolimus-eluting stents for the treatment of patients with multivessel de novocoronary artery lesions. EuroInterv. Arterial, Revascularis. Therap. Study PartII. 2005; 2: 147-156.

18.  Serruys P.W. et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009; 5 (1): 50-56.

 

Abstract:

We had analyzed percutaneous coronary intervention (PCI) of non-standard complications - coronary artery dissection with extension on the eft main coronary artery (LMCA) and aorta. There was the coronary dissection of LMCA and aorta after left internal thoracic arteries and left anterior descending anastomosis (LIMA-LAD) balloon predilatation. Satisfactory angiographic result was achieved with blood flow TIMI III after stent implantation. In connection with the stable condition of the patient there was no endovascular or surgical treatment. The patient had stable hemodynamics in hospital period. The angiografic control was performed after 8 days. There was no coronary and aorta dissection and stent-thrombosis.

In conclusion in can be said that conservative tactics may be useful in a case of retrograde coronary and aorta dissection after LIMA-LAD stent mplantation.

 

References 

1.    Geraci A.R. Krishnaswami V., Selman M.W. Aorto-coronary dissection complicating coronary arteriography. J. Thorac. Cardiovasc. 2 Surg. 1973; 65: 695-698.

2.    Alfonso F. et al. Aortic dissection occurring during coronary angioplasty. Angiographic and transesophageal echocardiographic findings. Cathet. Cardiovasc. Diagn. 1997; 42: 412-415.

3.    Roberts W.C. Aortic dissection. Anatomy, consequences and causes. Am. Heart. J. 1981;101: 195-214.

4.    Erbel R. et al. Task Force on aortic dissection. European society of cardiology. Diagnosis and management of aortic dissection. Europ. Heart. J. 2001; 22: 1642-1681.

5.    Cigarroa J.E. et al. Diagnostic imaging in the evaluation of suspected aortic dissection. Old standards and new directions. N. Engl. J. Med. 1993; 328: 35-43.

6.    Kwan T. et al. Combined dissection of right coronary artery and right coronary cusp during coronary angioplasty. Cathet. Cardiovasc. Diagn. 1995; 35: 328-330.

7.    Perez-Castellano N. et al. Dissection of the        aortic sinus of Valsalva complicating coronary catheterization. Cause, mechanism, evolution, and management. Cathet. Cardiovasc. Diagn. 1998; 43: 273-279.

8.    Varma V. et al. Transesophageal echocardiographic demonstration of proximal right coronary artery dissection extending into the aortic root. Am. J. Cardiol. 1992; 123: 1055-1057.

9.    Hearne S.E. et al. Internal mammary artery graft angioplasty. Acute and long-term outcome. Cathet. Cardiovasc. Diagn. 1998; 44: 153-156.

10.  Wei-Chin Hung et al. LIMA graft interventions. Chang. Gung. Med. J.2007; 30 (3): 235-241

11.  Moussa I. et al. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation. 1999; 99:

 

 

Abstract:

We have retrospectively analyzed results of 12 patients underwent radiological interventions for scarring strictures correction of biliodigestive anastomoses after reconstructive surgery due to iatrogenic damage of extra hepatic biliary ducts. It was determined that ultrasonography is the main technique of biliary hypertension diagnostics. Antegrade cholangiography gives an ability to determine the level and type of extrahepatic biliary ducts strictures. Adequate biliary decompression was achieved by transcutaneous transhepatic drainage of biliary tree with insertion of cholangiostomical drainage near the biliodigestive anastomoses. Antegrade recanalization technique and dilatation of biliodigestive anastomosis strictures was used for dilatation of scarring stricture. Balloon plastic of anastomoses was ended with forming of external-internal draining for 9-12 months with step-by-step balloon dilatations every 3 months. Stenting of biliodigestive anastomosis' strictures was made in 4 cases Postoperative period without relapses after radiological interventions lasts from 2 till 7 years of observing.

 

References 

1.    Хотиняну В.Ф., Фердохлеб А.Г., Хотиняну А.В. Хирургическое лечение больных со стриктурами внепеченочных желчных протоков. Анналы хирургической гепатологии. 2008; 13 (1): 61-65.

2.    Гальперин Э.И. Что должен делать хирург при повреждении желчных протоков? 50 лекций по хирургии. М.: Медиа Медика. 2003; 198-206.

3.    3. Гальперин Э.И., Чевокин А.Ю. Факторы, определяющие выбор операции при «свежих» повреждениях магистральных желчных протоков. Анналы хирургической гепатологии. 2009; 14 (1): 49-56.

4.    Руководство по хирургии желчных путей. Под ред. Э.И. Гальперина, П.С. Ветшева. М.: Издательский дом Видар-М. 2006; 568.

5.    Murr M.M. et al. Of biliary reconstruction after laparoscopic bile duct injuries. Arch. Surg. 1999; 134 (6): 604-610.

6.    Schmidt S.C. et al. Long-term results and risk factors influencing outcome of major bile duct injuries following cholecystectomy. Br. J.Surg. 2005; 92 (1): 76-82.

7.    McPherson S.J. et al. Percutaneous transjejunal biliary intervention. 10-year experience with access via Roux-en-Y loops. Radiology. 1998; 206: 665-672.

8.    Quintero G.A., Patino J.F. Surgical management of benign strictures of biliary tract.

9.    World. J. Surg. 2001; 25: 1245-1250. Корымасов Е.А., Богданов В.Е., Романов В.Е. и др. Эффективность эндобилиарных вмешательств при стриктурах протоков и анастомозов. Анналы хирургической гепатологии. 2008; 13 (3): 123-124.

10.  Хальзов А.В., Анищенко В.В., Штофин С.Г. Применение нитиноловых стентов для лечения посттравматических рубцовых стриктур внепеченочных желчных протоков. Анналы хирургической гепатологии. 2008; 13 (3): 144.

11.  Bismuth N., Majno P.E. Вiliary strictures. Classification based on the principle of surgical treatment.  World. J. Surg. 2001; 25  (10): 1241-1244.

 

 

Abstract:

Purpose: Was to observe the immediate and long-term results of hybrid operations in multilevel atherosclerotic lesions of aorto-iliac(AIS) and femoral-popliteal segments (FPS). Article describes the method of the hybrid intervention in the aorto-iliac segment

Materials and Methods: For the period of 2007-2011 - 40 patients with multilevel lesions of iliac arteries and lower limb arteries underwent hybrid operations. 57.5% of patients had aorto-iliac segment disease, classified as TASC C, and 42,5% - TASC D. Lesions of femoral-popliteal segment was divided in the following order: TASC A - 15,0%, TASC B - 35,0%, TASC C - 42,5% and TASC D - 7,5%. We applied loop endarterectomy with stenting for the correction of the aorto-iliac lesions. For arterial outflow correction we applied surgical operations. Follow-up period has been traced for 3 years.

Results: Primary technical success was achieved in 97.5%. Complications of the immediate postoperative period were noted in 15%. Long-term results were traced for 3 years in 70% of patients. Three-year assisted patency of aorto-iliac segment was 89%. All complications have been corrected only by endovascular procedure. Three-year cumulative patency of femoral-popliteal segment was 87%.

Conclusions: This technique allows achieving the best results in reducing lower limb ischemia. Simultaneous correction of both - inflow and outflow segments improved long-term results of each of the reconstruction. The method shows its effectiveness in patients with TASC C and TASC D lesions of aorto-iliac segment. Reduction of surgical trauma significantly affects the results in group of high risk patients. 

 

References 

1.    Trede M. Rekonstruktive behandlung peripherer durchblutungs-storungen. Radiology. 1973; 308-309.

2.    Савельев B.C., Кошкин В.М. Критическая ишемия нижних конечностей. М.: Медицина. 1997; 8.

3.    Черненко В.Ф., Гончаренко А.Г., Шувалов А.Ю. и др. Потеря трудоспособности и динамика инвалидизации больных с поражениями сосудов конечностей. Ангиология и сосудистая хирургия. 2005; 11 (2): 21-27.

4.    Затевахин И.И., Цициашвили М.Ш., Шиповский В.Н. и др. Новые перспективы сосудистой хирургии - сочетанные эндоваскулярные и открытые операции в реконструкции артериального русла. Анналы хирургии. 1999; 6: 77-84.

5.    Lindbom A. Arteriosclerosis and arterial thrombosis in the lower limb. А roentgenological study. Acta Radiol. Suppl. 1950; 80: 1-80.

6.    Strandness D.J., Sumner D. Hemodynamics for surgeons. New York: Grune & Stratton. 1975;278-281.

7.    Klein W.M., Buskens E., Moll F.L. Vascular and еndovascular rfLallenges. Edited by Roger M.   Greenhalgh.   BIBA   Publishing.   2004;275-281.

8.    Pell J.P., Lee A.J. Impact of angioplasty and arterial reconstructive surgery on the quality of life of claudicants. The Scottish Vascular Audit Group. Scott. Med. J. 1997; 42 (2): 47-48.

9.    Кириенко А.И., Кошкин В.М., Богачев В.Ю. Амбулаторная ангиология. М.: Лит-терра. 2007; 199-200.

10.  Scintu F. Inflow and outflow disease in aorto-femoral grafting. Ital. J. Surg. Sci. 1986; 16 (2): 139-142.

11.  Sumner D.S., Strandness D.E. Aortoiliac reconstruction in patients with combined iliac and superficial femoral arterial occlusion. Surgery. 1978; 84: 348-355.

12.  Kikta M.J. et al. Longterm follow-up of patients having infrainguinal bypass performed below stenotic but hemodynamically normal aortoiliac vessels. J.   Vasc.  Surg.  1987; 5:319-328.

13.  Diehl J.T. et al. Complication of abdominal aortic reconstruction. Analysis of perioperative risk factors in 557 patients. Ann. Surg. 1983; 197: 49-56.

14.  Cooperman M. et al. Cardiovascular risk factors in patients with peripheral vascular disease. Surg. 1978; 84: 5-8.

15.  Покровский А.В. Болезни аорты и ее ветвей. М.: Медицина. 1979; 52.

16.  Norgren L. et al. TransAtlantic Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur. J. Vasc. Endo-vasc. Surg. 2007; 33 (1): 67.

MRI in specified diagnostics of colorectal cancer local spread: distal parts of rectum and anal channel cancer



DOI: https://doi.org/10.25512/DIR.2012.06.1.05

For quoting:
Kotlayrov P.M., Chhikvadze V.D., Sergeev N.I., Grishkov S.M. "MRI in specified diagnostics of colorectal cancer local spread: distal parts of rectum and anal channel cancer". Journal Diagnostic & interventional radiology. 2012; 6(1); 29-38.

 

Abstract:

Purpose. Was to estimate the efficiency of MRI in specified diagnostics of colorectal cancer (CRC) local spread (distal parts of a rectum anc anal channel cancer). To develop diagnostic criteria of tumor local spread, lymph nodes' lesion and involvement of surrounding tissues and organs.

Materials and methods. Research included 25 patients with verified CRC. For specificied diagnostics of cancer local spread patients underwent MRI before and after paramagnetic contrast enhanced. All researches were spent on magnetic-resonance tomography platform GE Signa 1,5T.

Results. We have revealed and studied all the types of CRC local spread in connection with TNM classification due to MRI.

Conclusion. MRI gives the full information about tumor local spread. Application of paramagnetics gives additional information about expression degree of invasive process. MRI is effective technique as a diagnostic procedure during preoperative preparation.

 

References 

1.    Абелевич А. И. Новые технологии в диагностике и хирургическом лечении рака прямой кишки. Дис. на соис. д.м.н. Н. Новгород. 2004; 40-45.

2.    Мельников О. Р. Диагностика, клиника и лечение рака анального канала. Практическая онкология. 2002; 3 (2): 136-144.

3.    Онкология: национальное руководство. Под ред. В.И. Чиссова, М.И. Давыдова. М.: ГЭОТАР-Медиа. 2008; 710-718.

4.    Хубезов Д.А., Пучков К. В., Колесникова Н. О. Эффективность МРТ в дооперационном стадировании рака прямой кишки. Колопроктология. 2009; 2 (28): 38-41.

5.    Brown G. et al. Effectiveness of preoperative staging in rectal cancer. Digital rectal examination, endoluminal ultrasound or magnetic resonance imaging. Br. J. Cancer. 2004; 5(1): 23-29.

6.    Ho M.L., Liu J., Narra V. Magnetic resonance imaging of rectal cancer. Clin. Colon. Rectal. Surg. 2008; 21 (3): 178-187.

7.    Hoeffel C. et al. External phased-array MR imaging preoperative assessment of rectal  cancer. J.   Radiol.  2006;  87   (12): 1821-1830.

8.    Jemal A. et al. Cancer statistics, 2010. CA Cancer. J. Clin. 2010; 60 (5): 277-300. 2010; 7. Erratum in: CA Cancer. J. Clin. 2011; 61 (2): 133-134.

9.    Kapse N., Goh V. Functional imaging of colorectal cancer. Positron emission tomography, magnetic resonance imaging and computed tomography. Clin. Colorectal. Cancer. 2009; 8 (2): 77-87.

10.  Kim S.H. et al. Sonography transmission gel as endorectal contrast agent for tumor visualize tion in rectal cancer. Am. J. Roentgenol. 2008; 191 (1): 186-189.

11.  Klessen C., Rogalla P., Taupitz M. Local staging of rectal cancer. The current role of MRI. Eur. Radiol. 2007; 17 (2): 379-389.

12.  Koh D.M. et al. Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation. Br. J. Radiol. 2008; 81 (62):91-98.

13.  MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer. Results of the MERCURY study. Radiology. 2007; 243 (1): 132-139.

14.  Nagy V.M. Updating the management of rectal cancer. J. Gastrointestin. Liver. Dis. 2008; 17 (1): 69-74.

15.  Parkin D.M. et al. Global cancer statistics, 2002. CA Cancer. J. Clin. 2005; 55 (2): 74-108.

16.  Rao S.X. et al. Assessment of T staging and mesorectal fascia status using high-resolution MRI in rectal cancer with rectal distention. World.  J.   Gastroenterol.   2007;   13   (30): 4141-4146.

17.  Rousset P., Hoeffel C. Tumors of the rectum. MRI and CT features. J. Radiol. 2007; 88 (11): 1679-1687.

18.  Smith N.J. et al. MRI for detection of extramural vascular invasion in rectal cancer. Am. J. Roentgenol. 2008; 191 (5): 1517-1522.

19.  Suzuki C. et al. The importance of rectal cancer MRI protocols on interpretation accuracy. World. J. Surg. Oncol. 2008; 20 (6): 89.

20.  Yasui O., Sato M., Kamada A. Diffusion-weighted imaging in the detection of lymph node metastasis in colorectal cancer. Tohoku. J. Exp. Med. 2009l; 218 (3): 177-183.

 

 

Abstract:

The main part of the research is given to radiodiagnostics of tubercolisis lesion of backbone (traditional x-ray, ultrasound diagnostics, computed tomography, magnetic resonance imaging). We have exmined 452 patients: 40 patients (8,8%) had cervical spine lesions, 185 patients (41%) - thoracic spine lesions, thoracic-lumbar spine - 75 patients (16,8%), lumbar spine - 141 patients (31,1%), lumbar-sacral spine - 11 patients (2,5%). It is especially marked that combination of lungs tuberculosis and spondylitis is higher not only in patients with antibiotic resistant infection but n patients with tuberculosis combined with AIDS.

 

References 

1.    Митусова Г.М. Лучевая диагностика туберкулезного спондилита у взрослых, осложненного неврологическими расстройствами. Дис. на соиск. к.м.н. С.-Пб. 2002.

2.    Советова Н.А., Савин И.Б., Мальченко О.В. и др. Лучевая диагностика внелегочного туберкулеза. Проблемы туберкулеза. 2006; 11: 7-9.

3.    Руководство по легочному и внелегочному туберкулезу. Под ред. Ю.Н. Левашева и Ю.М. Репина. ЭЛБИ-С.-Пб. 2008; 273-283.

4.    Васильев А.В. Современные проблемы туберкулеза в регионе Северо-Запада России. Проблемы туберкулеза. 1999; 3: 5-7.

5.    Лавров В.Н. Диагностика и лечение больных туберкулезным спондилитом. Проблемы туберкулеза. 2001; 4: 30-32.

6.    Гусева Н.И., Иванов В.М., Потапенко Е.И. и др. Иммунный статус больных активным туберкулезным спондилитом. Проблемы туберкулеза и болезней легких. 2003; 6: 25-28.

7.    Селюкова Н.В. Зонография в диагностике туберкулеза позвоночника на поликлиническом этапе. Проблемы туберкулеза и болезней легких. 2008; 11, 21-23.

8.    Мердина Е.В., Митусова Г.М., Советова Н.А. Ультразвуковая диагностика забрюшинных абсцессов при туберкулезе позвоночника. Проблемы туберкулеза. 2001; 4: 19-21.

9.    Лукьяненок П.И. Магнитно-резонансная томография в диагностике туберкулезного спондилита. Руководство для врачей. 2008.

10.  Щ Советова Н.А., Джанкаева О.Б., Кравцова О.С. и др. Туберкулезный спондилит взрослых в условиях генерализации инфекции и лекарственной резистентности возбудителя. Невский радиологический форум 2-5 апреля 2011 г. С.-Пб.: Научные материалы. 2011; 223-224.

11.  Шилова М.В. Туберкулез в России в 2009 г. М. 2009; 159-161.

 

 

Abstract:

Aim. Was to analyze possibilities of CT diagnostics of patients with chronic diseases and cancer of pancreas.

Materials and methods. We have analyzed 42 patients with cancer of pancreas and chronic pancreatitis. 20 patients had verified cancer (10 male and 10 female aged 47-82 yrs) and 22 patients with chronic pancreatitis (16 male and 6 female aged 29-63 yrs). All the patients underwent CT for diagnosis specification, estimation of pancreas condition and stage of disease.

Results. Sarcopenia was detected in 14 patients (70%) with pancreas cancer (9 of 10 male, 5 of 10 female). There was no significant difference in postoperative complications. Complications were marked in 11 of 20 pts (55%), including 8 of 14 patients (57%) with sarcopenia. Postoperative morbidity marked in 3 cases sarcopenia was detected in 15 patients (68%) with chronic pancreatitis (13 of 16 male, 2 of 6 female). There was no postoperative morbidity or complications in this groups of patients.

Results. CT in good for standard diagnostics of pancreas diseases and can estimate sarcopenia degree. Due to obtained data the level of carcopenia in surgically treated patients with pancreas cancer and chronic pancreatitis reaches 70%. Application of CT gives new possibilities in diagnostics of metabolic disorders in patients with severe chronic pancreatitis and pancreas cancer.
 

 

References 

1.    Заводчиков А.А., Башкина А.С., Лаврухина А.А. и др. Пути противодействия саркопении. Лечебная физкультура и спортивная медицина. 2011; 50-59.

2.    Morley J.E., Thomas D.R., Wilson M.M. Cachexia: pathophysiology and clinical relevance. Am. J. Clin. Nutr. 2006; 83: 735-743.

3.    Tan B.H., Fearon K.C. Cachexia. Prevalence and impact in medicine. Curr. Opin. Clin. Nutr. Metab. 2008; 11: 400-407.

4.    Klaude M. et al. Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. London. Clin. Sci. 2007; 112: 499-450.

5.    Dodson S. et al. Muscle wasting in cancer cachexia. Clinical implications, diagnosis and emerging treatment strategies. Annu. Rev. Med. 2010; 62 (8): 1-15.

6.    Prado C.M. et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts. A population-based study. Lancet. Oncol. 2008; 9: 629-635.

7.    Baumgartner R.N. et al: Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 1998; 147: 755-763.

8.    Janssen I., Heymsfield S.B., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J. Am. Geriatr. Soc. 2002; 50: 889-896.

9.    Pichard C. et al. Nutritional assessment. Lean body mass depletion at hospital admission is associated with an increased length of stay. Am. J. Clin. Nutr. 2004; 79: 613-618.

10.  Cosqueric G. et al: Sarcopenia is predictive of nosocomial infection in care of the elderly. Br. J. Nutr. 2006; 96: 895-901.

11.  Metter E.J. et al. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J. Gerontol. a Biol. Sci. Med. Sci. 2002; 57: 359-365.

12.  Prado C.M. et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Cli. Cancer. Res. 2007; 13: 3264-3268.

13.  Heymsfield S.B. et al. Human body composition. Advances in models and methods. Ann. Rev. Nutr. 1997; 17: 527-558.

14.  Witt H. et al. Chronic Pancreatitis. Challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology. 2007; 132 (4): 1557-1573.

15.  Uomo G., Gallucci F., Rabitti P.G. Anorexia-cachexia syndrome in pancreatic cancer: recent development in research and management. JOP. 2006; 7: 157-162.

16.  Zamboni M. et al. Sarcopenic obesity. A new category of obesity in the elderly. Nutr. Metab. Cardiovasc. Dis. 2008; 18: 388-395.

17.  Roubenoff R. Sarcopenic obesity. Does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Ann. N.-Y. Acad. Sci. 2000; 904: 553-557.

18.  Cruz-Jentoft A.J. et al. Sarcopenia. European consensus on definition and diagnosis. Age and Aging. 2010; 39: 412-423.

19.  Baracos V.E. et al. Body composition in patients with non-small cell lung cancer. A contemporary view of cancer cachexia with the use of computed tomography image analysis. Am. J. Clin. Nutr. 2010; 91: 1133-1137.

20.  Antoun S. et al. Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann. of Oncology. 2010; 21: 1594-1598.

21.  Mitsiopoulos N. et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J. Appl. Physiol. 1998; 85: 115-22.

22.  Shen W. et al. Visceral adipose tissue. Relations between single-slice areas and total volume. Am. J. Clin. Nutr. 2004; 80: 271-278.

23.  Shen W. et al. Total body skeletal muscle and adipose tissue volumes. Estimation from a single abdominal cross-sectional image. J. Appl. Physiol. 2004; 7: 2333-2338.

24.  Mourtzakis M. et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl. Physiol. Nutr. Metab. 2008; 33: 997-1006.

25.  Eisenhauer E.A. et al. New response evaluation  criteria  in  solid  tumours.   Revised RECIST guideline (version 1.1). Europ. J.of Cancer. 2009, 45: 228-247.

26.  Bozzetti F. Screening the nutritional status in oncology. A preliminary report on 1,000 out-patients.   Support  Care  Cancer.   2009;   17:279-284.

27.  Bachmann J. et al. Cachexia worsens prognosis in patients with resectable pancreatic cancer. J. Gastrointest. Surg. 2008; 12: 1193-1201.

28.  Tan B.H.L. et al. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin. Cancer. Res. 2009; 15 (22): 6973-6979.

29.  Beger H.G. et al. Treatment of pancreatic cancer. Challenge of the facts. World. J. Surg. 2003; 27: 1075-1084.

30.  Beger H.G. et al. Diseases of the pancreas. Current surgical therapy. Berlin. Springer-Verlag Heidelberg. 2008; 301-311.

 

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.

 

Abstract:

Aim. Was to study long-term results of drug eluting stents implantation: angiographic frequency of prolong stenosis, frequency of restenosis, endotelization dynamics, and other morphological indicators on the base of intravascular ultrasound (IV-US)

Materials and methods. The research consisted of 220 patients with angina pectoris or/and myocardial ischemic indexes: all of them were after drug eluting stents implantation. 174 patients on the first year and 82 on the second were underwent coronaroventriculography Double antiaggregant theraphy was given on the first year to 198(90%) patients, on the second - 21(9,5%)

Results. The whole angiographic success was 89,5%. 44% patients were underwent of lateral arterial branches defense. Unsuccessfu stenting was due to technical impossibility of movement threw variated coronar arteries segment in 5%; 1,8% was due to incomplete disclosing of stent; 2,7% - occlusion of lateral arterial branch

Conclusions. On the base of IV-US, at the end of the 1st year, 40% stents had full endotelization, at the end of the 2nd - 91%. Double antiaggregant theraphy was given to 99,1% patients on the first year. All coronary situations (morbidity, heart stroke, restenosis) was much more ess, than on the 2nd years, on which drug therapy was given only to 9,6% patients.

 

References 

1.    G. Ertaio et al. Late stent thrombosis, endothelialisation and drug-eluting stents. Neth. Heart. J. 2009l; 17 (4): 177-180.

2.    Ako J. et al. Late incomplete stent apposition after sirolimus-eluting stent implantation. A serial intravascular ultrasound analysis. J. Am. Coll. Cardiol. 2005; 46 (6): 1002-1005.

3.    Virmani R. et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent. Should we be cautious? Circulation. 2004; 109 (6): 701-705.

4.    Lee S.H., Chae J.K., Ko J.K. Consecutively developed late stent malappositions following the implantation of two different kinds of drug-eluting stents associated with spontaneous healing. Int. J. Cardiol. 2009; 134 (1): 7-10.

5.    Yamen E. et al. Late incomplete apposition and coronary artery aneurysm formation following paclitaxel-eluting stent deployment. Does size matter? J. Invasive. Cardiol. 2007; 19 (10): 449-450.

6.    Yasumi U. and Yasuto U. Angioscopic evaluation of neointimal coverage of coronary stents. Curr. Cardiovasc. Imaging. Rep. 2010; 3 (5): 317-323.

7.    Mayraj A. et al. Comparison of one year clinical outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice. Can. J. Cardiol. 2008; 24 (10): 771-775.

8.    Kim J.S. et al. Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation. Circ. J. 2010; 74: 320-326.

9.    Suwaidi J.A. et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000; 101: 948-954.

10.  Hofma S.H. et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur. Heart. J. 2006; 27: 166-170.

11.  Togni M. et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J. Am. Col. Cardiol. 2005; 46: 231-236.

12.  Shin D.I. et al. Drugeluting stent implantation could be associated with long-term coronary endothelial dysfunction. Comparison between sirolimus-eluting stent and paclitaxel-eluting stent. Int. Heart. J. 2007; 48: 553-567.

13.  Takano M. et al. Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare-metal stents after 6-month implantation.     Eur.     Heart.    J.     2006; 27: 2189-2195.

14.  Moore P. et al. A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents. JACC Cardiovasc. Interv. 2009.

15.  Oyabu J. et al.   Angioscopic evaluation of neointimal coverage. Sirolimus drug-eluting stent      versus bare metal stent. Am. Heart. J. 2006; 52: 1168-1174.

16.  Kotani J. et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J. Am. Col. Cardiol. 2006; 47: 2108.

17.  Wilson G.J. et al. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation. 2009; 120: 141-149.

18.  Higo T. et al. Atherosclerotic and thrombogenic neointima formed over SES. JACC Cardiovasc. Imaging. 2009; 2: 616-624

19.  Latchumanadhas K. et al. Early coronary aneurysm with paclitaxel-eluting stent. Indian. Heart. J. 2006; 58 (1): 57-60.

20.  Levisay J.P., Roth R.M., Schatz R.A. Coronary artery aneurysm formation after drug-eluting stent implantation. Cardiovasc. Revasc. Med. 2008; 9 (4): 284-287.

21.  Chen D. et al. Spontaneous resolution of coronary artery pseudoaneurysm consequent to percutaneous intervention with paclitaxel-eluting  stent.   Tex.  Heart.   Inst. J.   2008; 35 (2): 189-192.

22.  Lee S.E. et al. Very late stent thrombosis associated with multiple stent fractures and peri-stent aneurysm formation after sirolimus-eluting stent implantation. Circ. J. 2008; 72 (7): 1201-1204.

23.  Kim J.S. et al. Delayed stent fracture after successful sirolimus-eluting stent (Cypher®)  implantation.  Korea

authors: 

 

Abstract:

Aim. Was to investigate features of interposition of coronary bifurcations with different localizations in the aspect of their endovascular corrections, on the base of angiographycal imaging

Materials and methods. For research 238 patients were selected (193 men, 36 women) with 255 bifurcations - all the patients before stenting were underwent coronar arteries angiography (KAG). Registration and imaging processing were made on Axiom Artis dFC («Siemens») and CS-60 («Omega»). Omnipaque 350 mgl/ml («Nycomed/GE Healthcare») was used as contrast agent on KAG Results. Dimensional structure of coronary bifurcations is very variable. Main branch (MB) rarely has rectilinear course. Most spread bifurcation angle was between proximal and distal MB segments, less spread - between distal segment of MB and lateral brunch (LB).

 

References 

1.    Dzavik V. et al. Predictors of long-term outcome after crush stenting of coronary bifurcation lesions. Importance of the bifurcation angle. Am. Heart. J. 2006; 152: 762-759.

2.    Chen S.-L. et al. Effect of coronary bifurcation angle on clinical outcomes in Chinese patients treated with crush stenting. А subgroup analysis    from DKCRUSH-1    bifurcation    study.    Chin. Med. J.2009; 122 (4): 396-402.

3.    Lefevre T. et al. Stenting of bifurcation lesions:    classification,    treatments, and results. Cath. Cardiovasc. Interv. 2000; 49 (3): 274-283.

4.    Johnston P.R., Kilpatrick D. The effect of branch angle on human coronary artery blood    flow.     MODSIM97    conference. 8-11 December, 1997. Proceeding of the International congress on Modelling and Simulation. University of Tasmania: Hobart. 1997; 1029-1034.

5.    Ramcharitar S. et al. A novel dedicated quantitative coronary analysis methodology for bifurcation lesion. Eurointervention. 2008; 3 (5): 553-557.

 

 

Abstract:

Aim. Was to estimate the role of transcutaneous interventions under the supervision of radiodiagnostics in the maintenance of all mini-nvasive kinds of operation stages of surgical treatment in patients with pancreatic and duodenal zone tumors

Materials and methods. For the period from January 2007 till march 2010, 21 patients, aged 49-75 (10 men, 11 women) - were under aparoscopic pancreaticoduodenectomy (LPDE)

Results. The use bile ducts drainage systems before LPDE in 95% cases leads to small hemorrhage (less than 1 liter). The presence of cholangiostomy also leads to early diagnostics of biliodigistive anastamosis (BDA) stenosis, and makes bile peritonitis – impossible.

Conclusion. Usage of non-vascular methods of interventional radiology allows to make effective and less traumatic biliar decompression in patients with biliopancreatic and duodenal zone tumors as a stage of LPDE preparations. The presence of decompression cholangiostomy prevents further BDA inconsistency, and makes pacreaticojejunoanastamosis healing faster in case of its' decompression.

 

References 

1.    Покровский А.В. Клиническая ангиология. Руководство. В двух томах. Т.2. М.: Медицина. 2004; 888.

2.    Савельев В.С., Кошкин В.М. Критическая ишемия нижних конечностей. М.: Медицина. 1997; 160.

3.    Jeans W.D. et al. Fate of patients undergoing transluminal angioplasty for lover-limb ischemia. Radiology. 1990; 177: 559-564.

4.    Hunink M.G. et al. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med. Decis. Making. 1994; 14: 71-81.

5.    Stokes K.R. et al. Five-year results of iliac end femoropopliteal angioplasty in diabetic patients. Radiology. 1990; 174: 977-982.

6.    Минкин С., Рабкин Д. Экспериментально-морфологическое исследование динамики «вживления» рентгеноэндоваскулярных протезов в сосудистую стенку. Материалы 8-го симпозиума по рентгеноэндоваскуляр-ной хирургии. Москва - Ереван. 1987; 12.

7.    Maas D. et al. Radiological follow-ap of transluminalli inserted vascular endoprothes-es. An experimental study using expanding spirals. Radiology. 1984; 152: 659-663.

8.    Blum U. et al. Percutaneous recanalization of iliac occlusions. Resultsof a prosrective study. Radiology. 1993; 189: 536-540.

9.    Henry M. et al. Stenting of femoral and popliteal arteries. Tenth international book of peripheral vascular intervention. 1995; 199: 368-369.

10.  Henry M. et al. Palmaz stent placement in iliac and femoropopliteal arteries. Primary and secondary patency in 310 patients 2-4 year follow-up. Radiology.  1995;  197: 167-174.

11.  Коков Л.С., Покровский А.В., Балан А.Н. и др. Отдаленные результаты клинического применения отечественного нитинолово-го стента для лечения стенозирующих поражений артерий. Ангиология и сосудистая хирургия. 2002; 8 (1): 41-46.

12.  Scheinert D. et al. Stent supported recanaliza-tion of chronic iliac artery occlusions. Tenth international book of peripheral vascular intervention. Edited by M. Hanry. M. Fmor.Paris. 1999; 303-313.

13.  Zeller T. Long-term results after recanalisation of thrombotic occlusions of native and stented arteries using a rotationals thrombectomy device. The Paris Course on Revascularization. Paris. 2002; 435-441.

14.  White C.J. Peripheral аtherectomi with the рullback аtherectomy сatheter. Procedural safety and efficacy in a multicenter trail. J. of Endovascular. Surgery. 1998; 5: 9-17.

15.  Yoffe B. et al. Preliminary experience with the Xtrak debulking device the treatment of peripheral occlusions. J. Endovasc. Ther. 2002; 9: 234-240.

16.  Zeller T. et al. Midterm results after atherectomy-assisted angioplasty of below-knee arteries with use of the silverhawk device. J. Intervent. Radiol. 2004; 15: 1391-1397.

17.  Ramaiah V. et al. Midterm outcomes from the TALON registry. Treating peripherals with «Silverhawk». Outcomes collection.J. Endovasc. Ther. 2006; 13 (5): 592-602.

 

Abstract:

Aim. Was to estimate the role of transcutaneous interventions under the supervision of radiodiagnostics in the maintenance of all mini-nvasive kinds of operation stages of surgical treatment in patients with pancreatic and duodenal zone tumors

Materials and methods. For the period from January 2007 till march 2010, 21 patients, aged 49-75 (10 men, 11 women) - were under aparoscopic pancreaticoduodenectomy (LPDE)

Results. The use bile ducts drainage systems before LPDE in 95% cases leads to small hemorrhage (less than 1 liter). The presence of cholangiostomy also leads to early diagnostics of biliodigistive anastamosis (BDA) stenosis, and makes bile peritonitis – impossible.

Conclusion. Usage of non-vascular methods of interventional radiology allows to make effective and less traumatic biliar decompression in patients with biliopancreatic and duodenal zone tumors as a stage of LPDE preparations. The presence of decompression cholangiostomy prevents further BDA inconsistency, and makes pacreaticojejunoanastamosis healing faster in case of its' decompression.
 

 

References 

1.    Barnett S.A., Collier N.A. Pancreaticoduodenectomy. Does preoperative biliary drainage, method of pancreatic reconstruction or age influence perioperative outcome? A retrospective study of 104 consecutive cases. ANZJ. Surg. 2006; 76 (7): 563-568.

2.    Sewnath M. et al. The effect of preoperative biliary drainage on postoperative complications after pancreaticoduodenectomy. J. of the Am. Col. of Surg. 2008. Volume 192, Issue 6, Pages. 726-734.

4.    Srivastava S. et al. Outcome following pan-creaticoduodenectomy in patients undergoing preoperative biliary drainage. Dig. Surg. 2001; 18 (5): 381-387.

5.    Laurent A.,  Tayar C.,  Cherqui D.  Cholangiocarcinoma:     preoperative     biliary drainage (Con). HPB (Oxford). 2008; 10 (2): 126-129.

6.    Tsai Y.F. et al. Effect of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy. Hepatogastroenterology. 2006; 53 (72): 823-827.

7.    Li Z. et al. Pancreaticoduodenectomy with preoperative obstructive jaundice. Drainage or not. Pancreas. 2009; 38 (4): 379-386.

8.    Chen D. et al. Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduo-denectomy. Ai. Zheng. 2008; 27 (1): 78-82.

9.    Wang Q. et al. Preoperative biliary drainage for obstructive jaundice. Cochrane Database Syst. Rev. 2008; 16 (3): CD005444.

 

Abstract:

Aim. Was to study X-ray computer tomography (X-CT) semiotics of lungs injure in patients with closed thoracic trauma.

Materials and methods. For the period of 2008-2009 in Moscow Institute of Emergency First Aid we have examined 90 patients with different forms of pulmonary hemorrhage: aged 15-83 years (middle age 33,8); 71 men (78,9%) and 19 women (21,1%).The diagnosis was established due to X-CT

Results. All the patients had pulmonary bruise with different Intensity and prevalence on the 1st day In 67% patients it was combined with bleeding or/and gas in the depth of lungs - hematoma, hemopneumatocele, pneumatocele. Supervision in dynamics showed gradually regression of bruise lesions and traumatic caverns structure transformation

Conslution. X-CT in patients with closed thoracic trauma can specify the localization, characteristic and volume of pulmonary injure; it can also document pathologic process in dynamics.
 

 

References 

1.      Ермолов А.С. Основные принципы диагностики и лечения тяжелой сочетанной травмы. 80 лекций по хирургии. Под ред. В.С.   Савельева.   М.:   Литтерра.   2008;507-514

2.      Collins J. Chest wall trauma. J. Thorac. Imaging. 2000; 15: 112-119.

3.      Miller D.L., Mansour K.A. Blunt traumatic lung injuries. Thorac. Surg. Clin. 2007; 17: 57-61.

4.      Неотложная лучевая диагностика механических повреждений. Руководство для врачей. Под ред. В.М. Черемисина, Б.И. Ищен-ко. С.-Пб.: Гиппократ. 2003; 448.

5.      Marts B. et al. Computed tomography in the diagnosis of blunt thoracic injury. Am. J. Surg. 1994; 168: 688-692.

6.      Wanek S., Mayberry J.C. Blunt thoracic trauma. Flail chest, pulmonary contusion and blast injury. Crit. Care. Clin. 2004; 20: 71-81.

 

Abstract:

Modern radiodiagnostics of carotid arteries (CA) defeat has very important value in such patients' treatment tactics. CA reconstruction operations are based on 3 general factors - clinic and arterial blood flow lack in dynamics, special methods of extra- and intracrania brachial arteries diagnostics, risk of arterial blood flow lack. We have pointed indications for surgical prophylactics and necessary patients diagnostic methods. 

 

References 

 1.   Alsheikh-Ali A.A.  et al.  The  vulnerable atherosclerotic   plaque.    Scope    of   the literature. Ann. Intern. Med. 2010; 153 (6):       7. 387-395.

2.    Cohen  J.E.,   Itshayek   E.   Asymptomatic carotid  stenosis.   Natural  history  versus therapy. Isr. Med. Assoc. J. 2010;  12 (4): 237-242.

3.    Delgado Almandoz J.E. et al. Computed tomography angiography of the carotid and cerebral circulation. Radiol. Clin. North. Am. 2010; 48 (2): 265-281.

4.    Hebb M.O. et al. Perioperative ischemic complications of the brain after carotid endarterectomy. Neurosurgery. 2010; 67 (2): 286-293.

5.    Kar S. et al. Safety and efficacy of carotid stenting in individuals with concomitant severe carotid and aortic stenosis.   Eurolntervention.   2010;   6   (4): 492-497.

 6.   Naylor A.R. Managing patients with symptomatic coronary and carotid artery disease. Perspect.   Vasc.  Surg. Endovasc.Ther.  2010; 22 (2): 70-76.

7.    Pokrovsky  A.V.,   Bogatov  Yu.P.   Vascular surgery in Russia. Pages of history. Eur. J. Vasc. Endovasc. Surg. 1997; 13 (2): 93-95.

8.    Rockman C., Riles T. Carotid artery disease: selecting   the   appropriate   asymptomatic patient for intervention. Perspect. Vasc. Surg. Endovasc. Ther. 2010; 22 (1): 30-37.

9.    Spence J.D. Secondary stroke prevention. Nat. Rev. Neurol. 2010; 6 (9): 477-486.

10.  Tallarita T., Lanzino G., Rabinstein A.A. Carotid   intervention   in   acute   stroke. Perspect.   Vasc.  Surg. Endovasc.   Ther. 2010;22 (1): 49-57.

11.  Tholen A.T. et al. Suspected carotid artery stenosis. Cost-effectiveness of CT angiography in work-up of patients with recent TIA or minor ischemic stroke. Radiology. 2010; 256 (2): 585-597.

12.  Walkup M.H., Faries P.L. Update on surgical management for asymptomatic carotid stenosis. Curr. Cardiol. Rep. 2010; 5.

 

 

Abstract:

We have analyzed 64 patients' MRI data: all the patients were after lumbar hearnioplasty, postoperative period from 2 to 14 years. Patients were divided into two groups, 1st - 46 patients with the presence of postoperative radicular cord compression pain (RCCP); 2nd - 18 patients without RCCP

18 of 46 patients from the 1st group had posterior disc hernias, situated in the overlying segment: 12 (26,0%) - in the underlying

Elastic protrusion (EP) at the level adjacent to the operated disc, was established in 25 (54,3%) patients in the overlying and in the underly-

ng segments. 11 patients (23,9%) had a combination of hernia and disc protrusion at other levels

There are general changes of the adjacent vertebral-motion segments (VMS) as later operation' after-effects: hypertrophy of the posterior ongitudinal and yellow ligaments, osteoarthritis of the intervertebral joints, intervertebral foramen stenosis, spondylosis deformans.

 

References 

1.    Кравцов А.К., Ахадов Т.А., Сачкова И.Ю. и др. Анализ послеоперационных изменений у больных, оперированных на позвоночнике, по данным МР-томографии. Материалы научно-практической конференции «Магнитно-резонансная томография в медицинской практике». М. 1995; 48.

2.    Труфанов Г.Е., Фокина В.А. Магнитно-резонансная томография. С.-Пб.: ООО «Издательство ФОЛИАНТ». 2007; 310-368.

3.    Истрелов А.К. Рецидив болевого синдрома после удаления грыж поясничных межпозвонковых дисков. Автореф. дис. канд. мед. наук. Нижний Новгород. 1998; 26.

4.    Щербук   Ю.А.   Значение   эндоскопического видеомониторинга в предупреждении рецидивов дискогенных пояснично-крестцовых радикулитов и их хирургическом лечении. Тезисы докл. VI международного симпозиума. С.-Пб. 1999; 281-284.

5.    Frymoyer J.F., Matteri R.E., Hanley E.N. Failed lumbar disk surgery reguiring a second operation. А long term follow-up study. Spine. 1978; 3: 7-11.

6.    Hochnauser   L.   et  al.   Recurrent, post-diskectomy  low  back  pain.   MR-surgical correlation. AJR 1988; 755-760.

7.    Djukis S. et al. Magnetic resonanse Imaging of the postoperative lumbar spines. Radiol. Glin. NA. 1990; 341-359.

8.    Цементис С.А., Гусев Е.И. Дифференциальная диагностика в неврологии и нейрохирургии. М.: Издательская группа «ГЭОТАР-Медиа». 2005; 268-310.

9.    Kahn Т., Quaschling U., Endelbrecht V. MRT diagnosis for degenerative changes in the spine. Radiolog. 2004; 789-799.

10.  Kaiser M.C., Ramos L. MRI of the spine. A Guide to Clinical applications. N.-Y.: Thieme. 1990.

11.  Parker S.L. et al. Long-term back pain after a single-level discectomy for radiculopathy. lncidence and health care cost analysis. J. of Neurosurg. Spine. 2010; 178-182.

 

 

Abstract:

We have studied the influence of catheterization technique on the quality of contrast imaging, on the base of 94 digital subtraction (DSS) and 30 analog sialograms (AS) in 83 patients. It has been established that catheter depth must be 10 mm. In case of deeper catheter inserting - some artifacts may appear. In case of DSS such problem could be corrected, but during AS such situation can ead to incorrect interpretation and diagnostic mistakes.

 

References 

1.    Кадочников Б.Ф. К вопросу о сиалографии. Стоматология. 1960; 6: 64-65.

2.    Язукявичюс Л.А. Электрорентгеносиалография в диагностике заболеваний слюнных желез. Стоматология. 1987; 66 (3): 39-41.

3.    Мингазов Г.Г., Шестаков Ю.М., Кузнецов О.Е. Использование полиэтиленовых катетеров для сиалографии. Вестник    рентгенологии    и    радиологии. 1989; 2: 67.

 

 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.

 

Abstract:

Purpose. Оf the study was to prevent complications and improve the results of left-sided varicocele treatment.

Material and methods. Severe complications of open surgery (Ivanisevich technique) and endovascular procedures (left internal testicular vein embolization with metal coils) were analyzed.

Results. In all these cases we performed control angiographywas perfomed and the degree of anatomical and functional disturbances was assessed. Ways of complication prevention and countermeasures were offered.

Conclusions. Visualization of testicular venous bed should be made before any surgical or endovascular intervention on left varicocele. A surgeon should be aware of all possible complications. If some complication occurs, urgent visualization of the vascular bed and tissues ought to be performed, angiography being the golden standard. Complications if diagnosed should be eliminated as soon as possible by specialists. 

 

References 

1.      Ivanissevich O., Gregorini H. Una neuva operation   para curar el varicocele. S.Semana med. (Buenos Aires).   1918;   20:575-576.

2.      Dubin   L., Amelan R.D. Varicocelectomi as   Therapy   in   Male   infertility Stady   of 504 cases.    J.     Urol.    1975;     133 (15):604-641.

3.      Hommonai  Z.T.  et  al.  Tecticula function after herniotomy. Herniotomy and fertility. Andrologia. 1980; 11: 115-120.

4.      Рыжков В.К., Карев А.В., Таразов П.Г. и др. Комбинированные методы внутрисосудистых вмешательств при лечении варикоцеле. Урология и нефрология. 1999; 3: 18-22.

5.      Артюхин А.А. Фундаментальные основы сосудистой андрологии. М.: «Академия».  2008; 222.

6.      Кадыров З.А. Лапароскопическая урологическая хирургия. Урология и нефрология.  1997; 1: 40-44.

7.      Ким В.В., Казимиров В.Г. Анатомо-функциональное обоснование оперативного лечения варикоцеле. М.: ИД «Медпрактика-М». 2008; 112.

8.      Bach D. et al. Spaterqebnise nach Sclerotherapie der Varicocele. Uroloqe. 1984; 23 (6): 338-341.

 

 

Abstract:

This article deals with the role of arterio-venous conflicts in case of varicocele development in children. As varicocele is a widespread disease, it is important to investigate the etiology of hemodynamic disturbances in renotesticular (RTT) and ileotesticular (ITT) fields in patients with varicocele. The number of procedures registered in Russian State Pediatric Hospital (Moscow) is more than 1600 including primary and recurrent cases. Pathophisiology of the disease is not quite clear, but hemodynamic changes in RTT and ITT were thoroughly investigated. Left renal vein compression between upper mesenterial vein and aorta causes renal venous hypertension in 24% of cases. In most cases etiology of varicocele was primary valve insufficiency. Ileofemoral vericocele is rare and occurs as a result of common iliac vein flow disturbance. Endovascular procedures should be performed only after diagnostic hemodynamic study, and should not be used in pediatric practice. 

 

References 

1.      May R., Thurner J. The cause of the predominately sinistral occurrence of thrombosis of the pelvic veins. Angiology. 1957; 8: 419-427.

2.      De Schepper A. Nutcracker phenomenon of the renal vein causing left renal vein pathology.J. Belg. Rad. 1972; 55: 507-511.

3.      Trambert J.J. et al. Pericaliceal varices due to the nutcracker phenomenon. AJR. 1990; 154:305-306.

4.      Scholbach T. From the nutcracker-phenome non of the left renal vein to the midline congestion syndrome as a cause of migraine, headache, back and abdominal pain and functional   disorders   of   pelvic   organs.   Medical. Hypotheses. 2007; 68: 1318-1327.

5.      Лопаткин Н.А., Морозов А.В., Житникова Л.Н. Стеноз почечной вены. М.: Медицина.1984.

6.      Страхов С.Н. Варикозное расширение вен гроздевидного   сплетения   и   семенного канатика (варикоцеле). М. 2001.

7.      Kim et al. Hemodynamic Investigation of the Left Renal Vein in Pediatric Varicocele. Doppler US, Venography and Pressure Measurements. Radiology. 2006; 241.

8.      Coolsaet l.E. The varicocele syndrome: Venography determining tin' optimal level for surgical management.J. Urol. 1980; 124: 833-839.

9.      Ерохин А.П. Варикоцеле у детей (клинико-экспериментальное исследование). Дис. д-ра мед. наук. М. 1979.

10.    Neglén А. et al. Stenting of the venous outflow in chronic venous disease. Long-term stent-related outcome, clinical and hemodynamic result.J. Vasc. Surg. 2007; 46: 979-990.

11.    Гарбузов Р.В. Ретроградная эндоваскулярная окклюзия при варикоцеле у детей и подростков. Дис. канд. мед. наук. М. 2007

 

 

Abstract:

Purpose. Оf the study was to determine abilities of multislice spiral tomography (MSCT) in detection coronary artery disease (CAD) in patients with atypical angina..

Material and methods. Sixty patients (39 men) with atypical chest pain and suspected ischemic heart disease underwent complex diagnostic strategy. Value of MSCT in detection of significant (more than 50%) coronary artery stenoses was assessed by segmental analysis, vascular bed involvement, and patient analysis.

Results. Significant CAD in 8% of patients with atypical angina was revealed. In 98,7% (58 of 60 cases) MSCT allowed to specify coronary anatomy. In 53 (88,3%) of patients no significant CAD was found, in 5 cases (8,3%) MSCT confirmed significant coronary artery stenoses. Sensitivity, specificity, positive and negative prognostic value of MSCT were correspondingly 100%, 99,3%, 71,4%, 100% in segmental analysis (n = 295). Vascular territory involvement analysis (n = 91) showed 100% sensitivity, 97,7% specificity, positive prognostic value 71,4% and negative prognostic value 100%.

Conclusions. High prognostic value, as well as high sensitivity and specificity of MSCT allow us to include this method into the CAD diagnostic algorithm in patients with atypical chest pain. This method is highly reliable in eliminating of significant CAD and detecting coronary artery stenoses.

 

References 

1.      Синицын В.Е., Устюжанин Д-В. КТ-ангио-графия коронарных артерий. Кардиология. 2006; 1: 20-25.

2.      Терновой  С.К.,  Синицын В.Е.,  Гагарина Н.В. Неинвазивная диагностика атеросклероза и кальциноза коронарных артерий.М.: Атмосфера. 2003; 144.

3.      Hoffman M.H. et al. Noninvasive coronary angiography with multislice computed tomography. JAMA. 2005; 293: 2471-2478.

4.      Leber A.W. et al. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography. A comparative study with quantitative coronary angiography and intravascular ultrasound. J. Am. Coll. Cardiol. 2005; 46: 147-154.

5.      Leschka S. et al. Accuracy of MSCT coronary angiography with 64-slice technology: first experience. Eur. Heart. J. 2005; 26: 1482-1487.

6.      Mollet N.R. et al. Highresolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography. Circulation. 2005; 112: 2318 -2323.

7.      Raff G.L. et al. Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography. J. Am. Coll. Cardiol. 2005; 46: 552-557.

8.      Kopp A.F. et al. Coronary arteries: retrospectively ECG-gated multi-detector row CT angiography with selective optimization  of the image reconstruction window. Radiology. 2001; 221:683-688.

9.      Austen W.G. et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad-Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery.   Circulation.   1975;  51:5-40.

10.    Patel M.R. et al. Low diagnostic yield of elective coronary angiography. N. Engl.J. Med. 2010; 362: 886-895.

11.    Leber A.W. et al. Diagnostic accuracy of dual-source multi-slice CT-coronary angiography in patients with an intermediate pretest likelihood for coronary artery disease. Eur. Heart. J. 2007; 28: 2354-2360.

12.    Hausleiter J. et al. Non-invasive coronary computed tomographic angiography for patients with suspected coronary artery disease. Тhe Coronary Angiography by Computed Tomography with the Use of a Submillimeter resolution (CACTUS) trial. Eur. Heart. J. 2007; 28: 3034-3041.

13.    Goldstein J.A. et al. A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. J. Am. Coll. Cardiol. 2007; 49: 863-871.

14.    Hoffmann U. et al. Predictive value of 16-slice multidetector spiral computed tomography to detect significant obstructive coronary artery disease in patients at high risk for coronary artery disease. Patient-versus segment-based analysis. Circulation. 2004; 110: 2638-2643.

 

 

Abstract:

Purpose. Was to investigate the role of diffusion weighted imaging (DWI) in focal hepatic lesions diagnostic.

Material and methods. Data of 70 patients (20 men) aged 28-78 years with focal hepatic lesions were analyzed. All of them underwent 1,5 T MRI; DWI obtained at b values of 50 s/mm2, 400 s/mm2, and 800 s/mm2. The results of MSCT data, intra-operative visual and ultrasound examination, histology of operation probes, and follow-up data were confermed.

Results. In 70 patients 203 focal lesions sized 3-168 mm: cysts (55), angiomas(36), metastases (89), nodal hyperplasia(5), primary tumors (5), abscesses (5), focal necroses (2) were revealed. DWI is capable of making differential diagnosis of focal hepatic lesions: cysts were not visualized at b = 800 s/mm2, and their ADC was (2,5 ± 0,2) × 10~3 s/mm2. Metastases were visible in all b-values, and had ADC lower than that for cysts (1,2 ± 0,5) × 10~3 s/mm2). Angiomas also were good visualized in all b-values, but ADC of angiomas was higher and varied from 1,5x 10~3 to 2,6 x 10~3 s/mm2. DWI is advantageous in detecting of small (less than 1 cm) foci: even if this kind of lesions was indistinct atT1 and T2 weighed images, DWI showed high intensity and well-defined edges.

Conclusions. Diffusion weighed MRI appeared to play additional role in differential diagnosis of focal hepatic lesions, enhancing detectabi-lity of the small (less than 1 cm) foci. The technique is simple, cost-effective and not time-consuming. 

 

     References 

1.     Патютко Ю.И. Хирургическое лечение злокачественных опухолей печени. М.: Практическая медицина. 2005; 11-27, 160-167, 216-291.

2.     Holzapfel К. et al. Detection and Characterization of Focal Liver Lesions using Respiratory-Triggered Diffusion-Weighted MR Imaging (DWI). MAGNETOM Flash. The Magazine of MR Issue. RSNA Edition. 2008; 2: 6-9.

3.     Ринкк П.А. Магнитный резонанс в медицине. М. «Гэотар-Мед». 2003; 138.

4.     Bruegel M. et al. Diagnosis of Hepatic Metastasis. Comparison of Respiration-Triggered Diffusion-Weghted Echo-Planar MRI and Five T2-Weighted Turbo Spin-Echo Sequences. Am. J. Roentgenol. 2008; 191: 1421-1429.

5.     Coenegrachts K. et al. Improved focal liver les ion detection: comparison of singleshot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Brit. J. ofRadiol. 2007; 80, 524-531.

6.     Qayyum A. Diffusion-weighted Imaging in the Abdomen and Pelvis. Concepts and Applications. RadioGraphics. 2009; 29: 1797-1810.

7.     Kandpal H. Respiratory-Triggered Versus Breath-Hold Diffusion-Weighted MRI of Liver Lesions. Comparison of Image Quality and Apparent Diffusion Coefficient Values. Am. J. Roentgenol. 2009; 192: 915-922.

8.     Koh D.M., Collins D.J. Diffusion-weighted MRI in the body: applications and challenges in oncology. Am. J. Roentgenol. 2007; 188: 1622-1635.

 

authors: 


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.

 

Abstract:

The authors present a new method of vascular stapling based on shape memory alloy — nitinol. The stapling device can be used for proximal and distal coronary anasthomoses in port-access coronary bypass grafting. Experimental use of the new stapler (Endogene Pty. Ltd., Australia) presented in live animal model. Attention was paid to reliability of staples discharge and release, ring formation and suture timing, vessel patency, and freedom of thrombosis and bleeding at the anastomosis site.

 

References 

1.  Сутурин М.,  Григ М.  Новая технология фиксации сосудистого протеза для лечения аневризмы аорты с применением внутрисосудистого степлера (экспериментальное исследование). Диагностическая и интервенционная радиология. 2008; 2 (3); 61-64.

2.  Eckstein F.S. et al. Two generations of the St. Jude   Medical   ATG   coronary   connector systems for coronary artery anastomosis in coronary artery bypass grafting. Ann. Thorac. Surg. 2002; 74:1363-1367.

3.  Chavanon O., Perrault L.P. Favorable aspect of stapled anastomosis. An endothelial function  study.  Ann.   Thorac.   Surg.   1999;  68:     1443-1444.

4.  Ferrari E. et al. The Vascular Join:  a new sutureless  anastomotic device to perform end-to-end  anastomosis. Preliminary results in   an   animal  model.   Interact.   Cardiovasc. Thorac. Surg. 2007; 6: 5-8.

5.  Tozzia P. et al. Progress in cardiovascular anastomosis. Will the vascular join replace Carrel's technique? Eur. J. of Cardiothorac. Surg. 2006; 30 (3): 425-430.

6.  Solem J.O. et al. Evaluation of a new device for quick sutureless coronary artery anastomosis in surviving sheep. Eur. J. Cardiothorac. Surg. 2000; 17: 1046-1048.

7.  Eckstein F.S. et al. Sutureless mechanical anastomosis of a saphenous vein graft to a coronary artery with a new connector device. Lancet. 2001; 357: 931-932.

8.  Androsov P.I. New method of surgical treatment of blood vessel lesions. AMA Arch. Surg. 1956; 73: 902-910.

9.  Calin Vicol M.D. et al. Early clinical results with a magnetic connector for distal coronary artery anastomosis. Ann. Thorac. Surg, 2005; 79 (5): 1738-1742.

 

 

Abstract:

Purpose. To assess early and late results of iliac arteries balloon angioplasty and stenting in patients with chronic lower limb ischemia.

Material and methods. We analyzed the results of terminal aortic and iliac lesions endovascular treatment in 222 patients. All the patients presented symptoms of lower-limb chronic ischemia: 2nd «b» grade - 51,2%; 3rd grade - 27,1%; 4th grade - 21,7%. Two hundred and fifty eight procedure were performed, including 98 (38%) balloon angioplasty and 160 (62%) stenting. The lesions were Type A -26%, Type B - 45%, Type C - 23%, and Type D - 51% according to TASC II classification.

Results. Immediate angiographic success rate was 99,4%, complication rate -1,3% (4 of 314). Cumulative primary patency after balloon angioplasty in terms of 1, 3 and 5 years were correspondingly 97,9%, 82,0% and 64,2%. After stenting it was as high as 98,1%, 85,2% and 71,8%. Secondary patency after balloon angioplasty in terms of 1, 3 and 5 years was correspondingly 99,0%, 89,4% и 75,6%. For stenting it was 99,4%, 93,0% and 85,6% (Kaplan - Meier). Long-term clinical success rates in 1 year, 3 and 5 years were correspondingly 97,9%, 98,7% and 88,8% for angioplasty and 92,6%, 63,7% and 72,6% for stenting. Five-year limb preservation rate was 92,4% for angioplasty and 98,6% for stenting.

Conclusions. Endovascular interventions are proved to be safe and efficient for iliac arteries atherosclerotic lesions, and to have good long-term results. 

 

References 

1.    Кошкин В.М. Амбулаторное лечение атеросклеротических      поражений сосудов нижних конечностей. Ангиология и сосудистая хирургия. 1999; 1: 106 -113.

2.    Покровский А.В. и др. Российский консенсус. Рекомендуемые стандарты для оценки результатов лечения пациентов с хронической ишемией нижних конечностей. М.2001; 16.

3.    Kannel W. et аl. Intermittent Claudication:incidence in the Framingham-Study. Circulation. 1970; 41: 875-883.

4.    Живарев Г.В., Коротков Н.И., Александров А.Л. и др. Исходы аортобедренного шунтирования при синдроме Лериша. III всероссийский съезд сердечно-сосудистых хирургов. М. 1996; 253.

5.    Казанчян П.О., Попов В.А., Дебелый Ю.В. и  др.  Аорто-подвздошно-бедренные   реконструкции       методом       эверсионной эндартерэктомии.   Разумный   возврат   к прошлому. Ангиология и сосудистая хирургия. 1999; 5: 71-80.

6.    Гуч А.А., Верещагин С.В., Кондратюк В.А. Определение   показаний   к   первичному рентгеноэндоваскулярному протезированию артерий подвздошно-бедренного сегмента. Эхография. 2000; 1 (2): 155-158.

7.    Bosch J.L., Hunink M.G.M. Metaanalysis of the   results   of   percutaneus   transluminal angioplasty and stent placement for aortoiliac occlusive   disease.    Radiology.    1997;    204: 87-96.

8.    TASC II. Transatlantic Intersociety Consensus (TASC)    document    on    management    of peripheral arterial disease. Eur. J. Vase. Endovasc. Surg. 2007; 1: 63-65.

9.    Saket    R.R.    et    аl.    Novel    intravascular ultrasound-guided      method      to      create transintimal arterial communications: initial experience in peripheral occlusive disease and   aortic   dissection.  J.   Endovasc.   Ther. 2004; 11 (3): 274-280.

10.  Becker G.J. et аl. Noncoronary angioplasty. Radiology. 1989; 170 (3): 921-940.

            11.  Затевахин И.И., Дроздов С.А., Хабазов Р.И. Допплеросфигмоманометрия в диагностике поражений глубокой артерии бедра. Клиническая хирургия. 1985; 7: 24-2

 

 

Abstract:

Purpose. To assess safety and efficiency of simultaneous RCA and major branches of LCA stenting in patients with myocardial infarction (MI).

Material and methods. Authors analyzed data of 237 patients. Coronary angiography (CAG) revealed triple vessel stenotic and/or occlusive disease. Pre-procedure systemic thrombolysis (streptokinase) used in 54 patients. Endovascular interventions (PTCA and stenting of the infarct related artery) performed in all the cases; in 24 patients, simultaneous complete anatomical coronary revascularization (CACR) attempted. In 30 cases, after PTCA of the infarct related artery (PTCA IRA) patients were transferred to other hospitals for bypass surgery as a second stage.

Results. Systemic thrombolysis efficiency was 40 %(22 patients) according to echocardiography and 26% (14 patients) by CAG. TIMI III flow restored in 100%, immediate clinical success rate was 97,5%. There were no procedural complications. Six patients died early after the PTCA for cerebral hemorrhage, acute LV failure, and LV rupture. Absence of myocardial ischemia in CACR subgroup was confirmed clinically and in treadmill test. Patients of PTCA IRA subgroup presented with angina of various functional class.

Conclusions. Endovascular interventions are highly efficient as a component of complex IM treatment. Primary CACR is proved to decrease symptoms of myocardial ischemia. 

 

References 

1.    Бокерия Л.А., Гудкова Р.Г. Тенденции развития кардиохирургии в 2007 году. Бюллетень НЦССХим. А.Н. Бакулева РАМН. 2008; 3-4.

2.    Бокерия Л.А., Гудкова Р.Г. Сердечно-сосудистая хирургия-2007. Болезни и врожденные    аномалии системы кровообращения. М.: НЦССХ им. А.Н. Бакулева РАМН.  2007; 144.

3.    Бокерия Л.А., Гудкова Р.Г. Сердечно-сосудистая хирургия-2007. Болезни и врожденные аномалии системы кровообращения. М.: НЦССХ им. А.Н. Бакулева РАМН. 2008; 161.        7.

4.    Carver A. et al. Longer-term follow-up of patients recruited to the REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) trial. J. Am. Coll. Cardiol. 2009; 54:1 18-126.

5.      Gershlick A.H. et al. Rescue angioplasty after failed thrombolytic therapy for acute myo-cardial infarction. N. Engl. J. Med. 2005; 353: 2758-2768.

6.     Cantor W.J. et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N. Engl.J. Med. 2009; 360: 2705-2718.

7.      Stone G.W. et  al. Paclitaxel-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents. The TAXUS V ISR Randomized Trial. JAMA. 2006; 295: 1253-1263.

8.    Holmes J.D.R. et al. Sirolimus-Eluting Stents vs Vascular Brachytherapy for In-Stent Restenosis Within Bare-Metal Stents. The SISR Randomized Trial. JAMA. 2006; 295: 1264-1273.

9.    Serruys P.W. et al. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months. J. Am. Coll. Cardiol. 1999; 34: 1067-1074.

10.  Бокерия Л.А., Алекян Б.Г.,  Коломбо А.,Бузиашвили Ю.И. Интервенционные методы лечения ишемической болезни сердца. М.: НЦССХ им. А.Н. Бакулева РАМН. 2002.

11.  Serruys P.W. et al. J. Amer. Cardiol. 2002; 39:393-399.

12.  Rensing B.J. et al. Eur. Heart. J.  2001; 22:2125-2130.

13.  Colombo A. et al. Sirolimus-Eluting Stents in bifurcation Lesions. Six-Month Angiographic Results According to the Implantation Technique. Presented at the American College of Cardiology 52nd Annual Scientific Session. 2003.

14.    Wilson W.S., Stone G. W. Amer.J. Cardiol. 1994; 73 (15): 1041-1046.

15.    Vаn den Brand M. et al. J. Amer. Coll. Cardiol. 2002; 39: 559-564.

16.    Lemos P.A. et al. Circulation. 2004; 109: 190-195.

17.    Degertekin M. et al. Circulation. 2002; 106: 1610-1613.

18.    Sousa J.E. et al. Circulation. 2003; 107; 381-383.

19.    Rogers W.J. et al. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation. 1990; 81: 1457-1476.

 

authors: 

 

Abstract:

MRI in aortic coarctation pre-operative assessment is safe, prompt, non-invasive and can be used instead of conventional angiography. Synchronization of MRI data acquisition to the cardiac cycle eliminates breathing and motion artifacts, and allows non-contrast enhanced imaging. The latter is essential in pediatric practice. 

 

References 

1.    Никитаев Н.С., Кармазановский Г.Г., Черняк Б.Б. Коарктация аорты – возможности спиральной КТ. Мед. визуализация. 2001; 1:54-61.

2.    Королев Б.А., Охтин И.К., Соловьев С.И. и др. Хирургическое лечение коарктации аорты у взрослых больных. Хирургия. 1983; 2: 3-6.

3.    Julsrud P.R. et al. Coarctation of the aorta. Collateral flow assessment with phase-contrast MR angiography. A.J.R. 1997; 169: 1735-1742.

4.    Березов Ю.И., Покровский А.В., Мельник И.З. Коарктации аорты атипичной локализации. Грудная хирургия. 1964; 5: 51-57.

5.    Евдокимов А.Г., Тополянский В.Д. Болезни артерий и вен. М.: Высшая школа.  1999; 103-139.

6.    Sans S., Kestcloot H. Task Force of the Europe an Society of Cardiology on cardiovascular mortality and morbidly statistics. Eur. Heart. J. 1997; 1231-1248.

7.    Erbel R. et al. Detection of dissection of the aortic intima and media after angioplasty of coarctation of the aorta. An angiographic, computertomographic and echocardiographic comparative study. Circulation. 1990; 81: 805-814.

8.    Glasow P.F. et.  al.  Surgery without angiography for neonates with aortic arch obstruction. Int.J. Cardiol. 1988; 18 (3): 417-425.

9.    Marchal G., Bogarert J. Non invasive imaging of great vessels of the chest. Eur. Radiol. 1998; 8 (7): 1099-1105.

10.  Синицин    В.Е.,    Дадвани    С.А.,    Артюхина Е.Г.  и др.  Компьютерная томографическая    ангиография    в    диагностике атеросклеротических поражений аорты и   артерий   нижних   конечностей.   Ангиология   и   сосудистая   хирургия.    2000;   6:37-44.

11.  Синицин В.Е., Дадвани С.А., Мершина Е.А. и др. Магнитно-резонансная ангиография в диагностике и хирургическом лечении заболеваний брюшной аорты и артерий нижних конечностей. Ангиология и сосудистая хирургия. 2001; 7: 23-33.

 

 

 Abstract:

 

Material and methods. Study population includes 47 women with arterial hypertension (AH) in the third term of pregnancy.

Results and сonclusion. High grade AG was shown to be associated with high resistive index and thus higher value of total peripheral vascular resistance (TPVR). Bisoprolol and Nifedipin GITS normalize blood pressure and alleviates endothelial dysfunction. Antihypertensive therapy tends to lower TPVR in fetal, placental and uterine circulation providing better flow. 

 

References 

1.      Генералов СИ. Прогнозирование, диагностика и лечение нарушений в системе мать - плацента - плод при заболеваниях сердечно-сосудистой системы. Автореф. дис. д-ра мед. наук. Киев. 1990; 54 с.

2.    Милованов А.И. Патология системы мать - плацента - плод. М.: Медицина. 1999; 446 с.

3.    Демченко Е. Ю. Течение и исход беременности, состояние центральной и маточно-плодово-плацентарной гемодинамики при неосложненном течении беременности и осложнении ее ОПГ-гестозом. Дис. д-ра мед. наук. М. 1996; 477 с.

4.    Hefler L.A. et al. Endothelial-derived nitric oxide and angiotensinogen. Вlood pressure and metabolism during mouse pregnancy. Am.J. Physiol. Regul. Integr. Comp. Physiol. 2001; 280 (10): 174-182.

5.    Шехтман М.М. Руководство по экстрагенитальной патологии у беременных. М.: Триада. 2003; 816 с.

6.    Николаева Е.И., Тахиян А.А. Оценка современных перинатальных технологий у беременных и рожениц высокого риска. Вестник Рос.   ассоц.  акушеров-гинекологов.  2003;1: 26-28. 

7.    Радзинский В.Е. Фармакотерапия плацентарной недостаточности.  Клинич.  фармакол. и терап. 1998; 7 (3): 91-96.

8.    Елисеев О.М.,  Шехтман М.М.  Беременность: дагностика и лечение болезней сердца,    сосудов   и   почек.    Ростов-на-Дону: Феникс. 1997; 640 с.

9.    Киншт Д.Н. Гёстоз как системная воспалительная реакция. Автореф. дис. канд. мед. наук. Новосибирск. 2000; 24 с.

10.  Blatla N. et al. Cardiac disease in pregnancy. Int.J. Gynecol. Obstet. 2003; 82 (10): 153.

11.  Стрижаков А.Н.,  Бунин А.  Т.,  Медведев M.B.,  Григорян Г.А.  Значение допплерометрии маточно-плацентарного и плодово-плацентарного   кровотока   в   выборе рациональной тактики ведения беременной и метода родоразрешения. Акушерство и гинекология. 1991; 3: 23-25.

12.  Bracero L.A. et al. Comparison of umbilical doppler velocimetry, nonstress testing, and biophysical profile in pregnancies complicated by diabetes. J. Ultrasound. Med. 1996; 15:301-308.

13.  Агеева М.И. Допплерометрическое исследование в акушерской практике. М.: Медицина. 2000; 111.

14.  Стрижакова М.А. Клинико-морфологическое обоснование допплерометрического исследования кровотока в маточных артериях при физиологическом и осложненном течении беременности. Автореф. дис.канд. мед. наук. М. 1992; 24 с.

15.  Blackburn S. Maternal, fetal and neonatal physiology. А Clinical perspective. St. Louis: Saunders. 2003; 360 с.

 16. Elkayam U. Pregnancy and cardiovascular disease. Ed. E. Braunwald. Heart disease: a textbook of cardiovascular medicine. 6-th ed. Philadelphia. 2001; 2181.

17.  Abalos E. et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy (Cochrane Review).  Coch. Datab. Syst. Rev. 2007; 1: 53-61.

18.  Perloff J.K. Pregnancy in women with congenital heart disease. Specific lesions. Режим доступа: http://www. uptodate. com.

19.  Макацария А.Д.,   Султанова И.О.,   Смирнова Л.М. Дифференциальная диагностика и принципы профилактики тромбоэмболических осложнений у беременных с искусственными клапанами сердца. Акуш. и гин. 1991; 11: 28-33.

20.  Свечников П.Д.  Маркеры повреждения эндотелия при беременности,  осложненной гестозом. Автореф. дис.  канд.  мед.наук. С.-Пб. 2000; 50 с.

21.  Радзинский В.Е., Смалько П.Я. Биохимия плацентарной недостаточности. М.: Медицина. 2001; 180 с.

22.  Alexander B. T. et al. Differential expression of renal nitric oxide synthase isoforms during pregnancy    in    rats.    Hypertension.     1999; 33 (4): 435-439.

23.  Brooks V.L. et al. Does nitric oxide contribute to the basal vasodilation of pregnancy in conscious rabbits? Am. J.  Physiol.  Regul.  Integr. Comp. Physiol. 2001; 281 (12): 1624-1632.

24.  Мартынов А.И., Аветяк Н.Г., Акатова Е.В. и    др.    Эндотелиальная    дисфункция и методы ее определения. Рос.  кардиол.  ж.2005; 4: 94-98.

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.

authors: 


Article exists only in Russian.

 

Article exists only in Russian.

 

Article exists only in Russian.


Article exists only in Russian.

 

Article exists only in Russian.


Article exists only in Russian.

 

Abstract:

Purpose: to prove the safety and efficiency of minimally invasive endovascular and puncture techniques in management of splen diseases in children.

Aims: to develop standard procedures and justify the necessity of splenic artery embolization (SAE) in hemangiomas, extrahepatic portal hypertension, and idiopathic thrombocytopenic purpura (ITP). Develop standard procedures for splenic cysts treatment in pediatric practice.

Materials and methods: there were 129 children aged 3-16 years treated in Endovascular Surgery Department of Russian State Pediatric Hospital (Moscow) with the following diagnoses: hemangiomas (4 patients), hereditary hemolytic globular-cell anemia - HHGCA (41 cases), extrahepatic portal hypertension - EHPG (25 cases), ITP (24 cases), and nonparasitic cysts (35 patients).

Results: SAE is shown to be effective in treatment the diseases where splenic hyperfunctioning is seen. In HHGCA and ITP no hemolytic crises were seen, and there was no need of substitution therapy after performing the SAE procedure. In cases of EHPG splenic artery embolization is proved to reduce the esophageal varices and decrease hypersplenia symptoms. Among the advantages of endovascular approach can be named minimal operation trauma and splenic tissue preservation. The authors present an algorithm for splenic cysts treatment in pediatric practice. It was shown that laparoscopy is effective in big (over 70-80 mm) subcapsular cysts, whereas intraparenchymatous cysts fewer than 70 mm in diameter are more suitable for puncture techniques.

Conclusions: the minimally invasive techniques are shown to be safe and effective in management of splen diseases in pediatric practice. It was shown that their effectiveness is comparable to the conventional methods, meanwhile they cause much less operation trauma, reduce the hospital stay and terms of rehabilitation.

 

References 

1.    LokichJ., Cosstello P. Splenic embolization to prevent dose limitation of cancer chemotherapy. Am.J. Roentgenol. 1983; 140: 159-161.

2.    Spigos  D.G., Jonasson  O.  Partial  splenic embolisation in the treatment of hypersplenism. Am.J. Roentgenol. 1979; 132: 777-782.

3.    Styrt B.  Infection associated with asplenia: risk, echanism and prevention. Am. J. Med.1990; 88: 5-33.

4.    Никаноров А.Ю.  Рентгеноэндоваскулярная окклюзия в подавлении патологической функции селезенки у детей. Дис. канд.мед. наук. М. 1990.    13.

5.    Григорьева Е.Г., Апарицина К.А.  Органосохраняющая хирургия селезенки.  Новосибирск. 2001; 23-78.

6.    Дергачев А.И. Абдоминальная эхография. М. 2002; 15-25.

7.    Журило И.П., Литовка В.П., Кононученко В.П.,  Москаленко  В.З.  Непаразитарные кисты селезенки у детей. Хирургия. 1993; 8:59-61

8.    Куликов Л.К.,  Филиппов А.Г. Хирургическая тактика при непаразитарных кистах селезенки. Хирургия. 1995; 2: 62-63.

9.      Fowler   R.H.   Nonparasitic   bening   cystic tumors of the spleen. Int. Abstr. Surg. 1953; 96: 209-227.

10.    Martel M., Cheuk W. Angiomatoid Nodular Transformation (SANT). Report of 25 Cases of Distinctive Begin Splenic Lesion. J. Surg. Pathol. 2004; 28 (10): 1268-1279.

11.    Кургузов О.П., Кузнецов Н.А., Артюхина Е.Г. Непаразитарные кисты селезенки. Хирургия. 1990; 6: 130-133.

12.    Папаскуа И.З. Возможности чрескожных пункционно-дренирующих вмешательств с ультразвуковым контролем в лечении кист печени, почек и селезенки. Дис. канд. мед. наук. С-Пб. 2003.

13.    Ратнер Г.Р. Непаразитарные кисты селезенки. Вестник хирургии.1997; 5: 104-105.

14.    Шишкин К.В. Хирургическое лечение непаразитарных кист печени и селезенки. Хирургия (журнал имени Н.И. Пирогова). 2006; 10: 62-66.

15.    Маннанов А.Г. Эндоскопическая хирургия непаразитарных кист селезенки у детей. Дис. канд. мед. наук. М. 2004.

16.    Филижанко В.Н.,  Шеменева Е.Г.,  Фомин А.М. и др. Лапароскопические вмешательства при кистах печени и селезенки. Эндоскопическая хирургия. 1998; 1: 56.

17.    Bove T., Delvaux G., Van Eijkelenburg P., De Backer A., Willems G. Laparoscopic-assisted surgery of the spleen: clinical experience in expanding indications. J. Laparoendosc. Surg. 1996; 6 (4): 213-217.

18.  Bean WJ., Rodan B.A. Hepatic cysts: Treatment with alcohol. AJR. 1985; 237-241.

19.  Gresik M.V.  Pathology of the spleen. New-York. 1989; 37.

20.  Velkova K., Nedeva A. Our experience in the diagnostiks of liver and spleen hemangiomas. Plovdiv. Folia. Med. 1997; 39 (1): 85-91.

21.  Levy A.D., Abbot R.M., Abbondanso S.L. Littoral cell angioma of the splen: CT features with clinicopatologic comparison. Radiology. 2004; 230 (2): 485-490.

22.  Yano H., Imasato M., Monde T. et al. Hand-assisted   laparoscopic splenectomy for splenic vascular tumors:  report of two cases.  Surg.Laparosc. Percutan. Tech. 2003; 13 (4): 286-289.

23.  Coon W.W. Splenectomy in the threatment of hemolitic   anemia.   Arch.   Surg.   1985;   120: 625-628.

 

 

Abstract:

Purpose: on the basis of long-term results of renal angioplasty and stenting, the authors define the indications for endovascular interventions in patients with renovascular hypertension (RVH).

Materials and methods: since 1992-2008 in Tashkent Medical Academy Vascular Surgery Center were performed 131 endovascular interventions in 119 patients for renal arteries (RA) stenoses of various origins. 97 patients underwent balloon angioplasty (BA) of renal arteries (105 interventions), and stenting was performed in 22 cases (26 stenting procedures). Systolic blood pressure varied from 170 to 300 mm Hg (219,4±23,1 mmHg), with diastolic blood pressure from 170 to 300 mm Hg (118,1±8,9 mm Hg). Average arterial hypertension history was 5,2±3,7 years (6 months - 16 years).

Results: technical success rate was 85,6% for balloon angioplasty, and 100 % for stenting procedures. Immediate hypotensive effect was good to satisfactory. Complication rate was 2,5% (3 patients). Long-term results were assessed in 76 cases of balloon angioplasty (78,4%), and in all patients with renal arteries stenting. The average follow-up was 72±32,5 months (6-144 months) for balloon angioplasty, and 6-24 months for stenting group. In the angioplasty group long-term hypotensive effect lasted in 54(71,1%) of patients, and the restenosis rate was as high as 28,9% (22 cases). In the stenting group, the long-term hypotensive effect was preserved in all the patients, and there were no cases of restenosis.

Conclusions: high rates of technical and clinical success, as well as low rates of restenosis, allow the renal artery stenting procedure to be seen as the method of choice for renovascular hypertension.

 

References

1.      Клиническая ангиология в 2 томах. Под редакцией А.В. Покровского. М.: Медицина. 2004; 2: 94-114.      

2.      Алекян Б.Г.,  Бузиашвили Ю.И.,  Голухова Е.З. и др. Ближайшие и отдаленные результаты стентирования почечных артерий у больных с вазоренальной гипертензией. Ангиология   и   сосудистая   хирургия.   2006;1: 55-62.

3.      Carmo M., Bower T.C. Surgical мanagement of renal fibromuscular dysplasia. Challenges    11.in the endovascular era. Ann. Vasc. Surgery. 2005; 19: 208-217.

4.      Baert A.L., Wilms G., Amery A., Vermylen J.,Suy R. Percutaneous transluminal renal angioplasty: initial results and long-term follow-up in 202 patients. Cardiovasc. Intervent. Radiol. 1990; 13: 22-28.

5.      WongJ.M., Hansen K.J., Oskin T.C. et al. Surgery after failed percutaneous renal artery angioplasty.J. Vasc. Surg. 1999; 30: 468-483.

6.      Yutan E., Glickerman D.J., Caps M.T. et al.Percutaneous transluminal revascularizationfor renal artery stenosis. Veterans affairs puget sound health care system experience. J. Vasc. Surg. 2001; 34: 685-693.

7.      Петровский Б.В., Гавриленко А.В. 40-летний опыт реконструктивных операций при вазоренальной гипертензии. Ангиология и сосудистая хирургия. 2003; 2: 8-12.

8.      Троицкий А.В., Елагин О.С., Хабазов Р.И. и др. Одномоментная реконструкция висцеральных ветвей аорты и почечных артерий. Ангиология и сосудистая хирургия. 2006; 2: 132-136.

9.      Крылов В.П., Реут Л.И., Дергачева И.М. и соавт. Отдаленные результаты хирургического лечения вазоренальной гипертензии. Клиническая кардиология. 2004; 2: 34-39.

10.    Bonelli F.S., McKusick M.A., Textor S.C. et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo. Clinic. Proc. 1995; 70: 1041-1052.

11.    Surowiec S.M., Sivamurthy N., Rhodes J.M. et al. Percutaneous therapy for renal artery fibromuscular dysplasia. Ann. Vasc. Surg. 2003; 17: 650-655.

12.    Galaria I.I., Surowiec S.M., Jeffrey M. Percutaneous and оpen renal revascularizations have equivalent long-term functional outcomes. Ann. Vasc. Surg. 2005; 25: 218-224.

 

 

Abstract:

Purpose: South Kazakhstan Regional Cancer Clinic presents the immediate results of hepatic artery chemotherapy infusion and chemoembolization in patients with hepatic tumors. 

Material and methods: hepatic artery chemoembolization and chemotherapy infusion was performed in 70 patients (47 males, 67,1%) with hepatic tumors since 2004-2008. There were all in all 42 cases (60%) of primary hepatic carcinoma, and in 28 patients (40%) the procedure was done for liver metastatic malignancies. Hepatic artery chemotherapy infusion (HACI) was performed in 50 cases, including 32 patients (45,7%) with primary hepatic carcinoma, and 18 patients (25,7%) with metastatic foci. Hepatic artery chemoembolization (HACE) performed in 20 patients, including 10 patients (17,1%) with primary hepatic carcinoma, and 8 cases (11,4%) of metastatic malignancies. 

Results: significant regression of primary cancer foci and uneventful 3 years follow-up were seen in 2 patients (4,76%), partial regression of the lesion - in 6 (14,3%) of cases, tumor stabilization - in 16 (38%), and tumor progression were found in 8 (19%) of patients. 12 months survival with tumor stabilization was 33,3% (14 patients), 18 months survival - 7,14% (3 patients). Post-procedure mortality in terms of 4 to 8 months made up as high as 30,9% (13 patients). HACE procedure resulted with tumor regression in 8 of 10 patients; the effect sustained for 3-5 months already. For the present moment, 2nd and 3d HACE session is scheduled for this group of patients.

Conclusions: HACI is shown to be effective in treatment of primary and to improve the quality of life in 45,2% of cases. Thus, wide use of the method could be recommended in such a complicated category of patients. HACE procedure results are also hopeful, tumor stabilization starting after the first session.

 

References

1.      Давыдов М.И., Гранов А.М., Таразов П.Г., Гранов    Д.А.    и    др.    Интервенционная радиология в онкологии (пути развития и технологии). С-Пб: Фолиант. 2007.

2.      Гранов Д.А.,  Таразов П.Г.  Рентгеноэндоваскулярные вмешательства в лечении злокачественных опухолей печени. С-Пб: Фолиант. 2002.

3.      Таразов П.Г. Артериальная химиоинфузия в лечении нерезектабельных злокачественных опухолей печени (обзор литературы).Вопр. онкол. 2000; 46 (5): 521-528.   

4.      Таразов П.Г. Роль методов интервенционной радиологии в лечении больных с метастазами колоректального рака в печень. Практическая онкология. 2005; 6 (2): 119-126.

5.      Bierman H.R., Miller E.R., Byron R.L. et al.Intra-arterial catheterization  of viscera in man. Amer.J. Roentgenol. 1951; 66 (4): 555-568.

6.      Chiba Т., Tokuuye K., Matsuzaki Y. et al. Proton beam therapy for hepatocellular carcinoma: A retrospective review of 162 patients. Clin. Cane. Res. 2005; 11 (10): 3799-3805.

            7.      Gianturco C., Anderson J.H., Wallace S. Mechanical devices for arterial occlusion. Amer.J. Roentgenol. 1975; 124 (3):428-435

 

authors: 

 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.

 

 

Abstract:

Authors present their first 3 cases of thoracoabdominal aneurysm hybrid repair. Endovascular procedure and open surgery were used either simultaneously, or as the steps of reconstruction.

 

References

1.           Crawford E.S., DeNatale R.W. Thoracoabdominal aortic aneurysm: Observations regarding the natural course of disease. J. Vasc. Surg. 1986; 3: 578.

2.           Nienaber C.A., Eagle K.A. Aortic dissection: new frontiers in diagnosis and management: part I: from etiology to diagnostic strategies. Circulation. 2003; 108 (5): 628-635.

3.           Kouchoukos N.T., Dougenis D. Surgery of the thoracic aorta. N. Engl. J. Med.  1997; 336: 1876-1888.

4.           Meszaros I. et al. Epidemiology and clinicopathology of aortic dissection.   Chest. 2000;117: 1271-1278.

5.           Coady M.A. et al. Surgical intervention criteria for thoracic aortic aneurysms. A study of growth rates and complications. Ann. Thorac. Surg. 1999; 67: 1922.

6.           Elefteriades J.A. Natural history of thoracic aortic aneurysms. Indications for surgery and surgical versus nonsurgical risks. Ann. Tho-rac.Surg. 2002; 74: 1877.

7.           Lobato A.C., Puech-Leao P. Predictive factors for rupture of thoracoabdominal aortic aneurysm.J. Vasc. Surg. 1998; 27: 446.

8.           Svensson L.G. et al. Experience with 1509 patients undergoing thoracoabdominal aortic operations.J. Vasc. Surg. 1993 ;17 (2): 357-370.

9.           Bavaria J. et al. Retrograde cerebral and distal aortic perfusion during ascending and thoracoabdominal aortic operations. Ann. Thorac. Surg. 1995; 60 (2): 345-353.

10.       Белов Ю. В., Хамитов Ф. Ф., Генс А. П., Степаненко А. Б. Защита спинного мозга и внутренних органов в реконструктивнойхирургии аневризм нисходящего грудного и торакоабдоминального отделов аорты. Ангиология и сосудистая хирургия. 2001; 7 (4):85-95.

11.       Hagan P.G. et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease.JAMA. 2000; 283: 897-903.

12.       FannJ.I. et al. Surgical management of aortic dissection during a 30"year   period. Circulation. 1995; 92 (2): 113-121.

13.       Dake M.D. et al. Endovascular stent-graft placement for the treatment of aortic dissection. New. Eng.J. Med. 1999; 340: 1546-1552.

14.       Buth J. et al. Neurologic complications associated with endovascular repair of thoracic aortic pathology: Incidence and risk factors. Аstudy from the European сollaborators on stent-graft techniques for aortic aneurysm repair  (EUROSTAR)  registry. J.   Vasc.  Surg. 2007; 46 (6): 1103-1111.

15.       Svensson L.G. et al. Experience with 1509 patients undergoing thoracoabdominal aortic operations.J. Vasc. Surg. 1993; 17: 357-370.

16.       Safi H.J. et al.  Distal aortic perfusion and cerebrospinal fluid drainage for thoracoabdominal and descending thoracic aortic repair.        Ten years of organ protection. Ann. Vasc. Surg. 2003; 238: 372-380.

17.       Chiesa R. et al. Spinal   cord   ischemia after elective stent-graft repair of the thoracic aorta. J. Vasc. Surg. 2005; 42: 11-17.

18.       Criado F.J., Clark N.S., Barnatan M.F. Stent graft repair in the aortic arch and descending thoracic aorta: A 4-year experience. J. Vasc. Surg. 2002; 36: 1121-1128.

19.       Najibi S. et al. Endoluminal versus open treatment of descending thoracic     aortic aneurysms.J. Vasc. Surg. 2002; 36: 732-737.

20.       Greenberg R.K. et al. Zenith AAA endovascular graft. Intermediate-term results of the US multicenter  trial. J. Vasc. Surg. 2004; 39: 1209-1218.

 

 

Abstract:

This report touches upon the pressing problem of endocardial leads removal. It is essential to free the leads safely and effectively of fibrous depositions on contact points of venous walls or cardiac structures. Main principles of retrieval are contratraction and contra0 pressure. Authors present a comprehensive review of all existing lead removal techniques, from simple traction to active extraction device application, discussing clinical efficiency, indications and possible complications of each method. Active extraction systems are declared to be most advantageous.

 

References

1.           BrugadaJ., Vardas P., Wolpert C. The Current Status of Cardiac Electrophysiology in ESC Member Countries. The EHRA White Book. 2009; 4-427.

2.           Бокерия Л.А.,  Ревишвили А.Ш.,  Дубровский И.А. и др. Интервенционное и хирургическое   лечение нарушений ритма сердца. М.: Российская и европейская базы данных.  НЦССХ им. А.И Бакулева РАМН.2007; 3-32.

3.           Path   to   growth.   Cardiac   Lead   Removal System.  Spectranetics annual report  2004. Colorado Springs. 2005.

4.           Imparato A., Kim G.E. Electrode complications in patients with permanent cardiac pacemakers. Arch. Surg. 1972; 105: 705-710.

5.           Myers  M.R.,  Parsonnet V.,  Bernstein A.D. Extraction of implanted transvenous pacing leads: a review of a persistent clinical problem. Am. Heart. J. 1991; 121: 881-888.

6.           Byrd C.L. et al. Lead extraction: indications and   techniques. Cardiol. lin. 1992;   10: 735-748.

7.           Hayes D.L. Extraction of permanent pacing leads. There are still controversies in Editorial. Eur. Heart.J. 1996; 75 (6): 539.

8.           Furman S. et al. Retained pacemaker leads. J.Thorac. Cardiovasc. Surg. 1987; 94: 770-771.

9.           Bellot P.H.  Introduction.  Endocardial lead extraction. A videotape and manual. Armonk. Futura. Pub. 1998; 3-11.

10.       Sonnhag C., Walfridsson H.  Extraction of chronically infected pacemaker leads:  two cases with serious complications. Pacing. Clin. Electrophysiol. 1989; 12: 1204.

11.       Lee M.E., Chaux A., Matloff J.M. Avulsion of a tricuspid valve leaflet during traction on an infected, entrapped endocardial pacemaker electrode.J. Thorac. Cardiovasc. Surg. 1977; 74: 433-435.

12.       Jarvinen A., Harjula A., Verkkala K. Intrathoracic surgery for retained endocardial electrodes. J. Thorac. Cardiovasc Surg. 1986; 34: 94-97.

13.       Shennib H. et al. The non-extractable tined endocardial pacemaker lead. Can. J. Cardiol. 1989; 5: 305-307.

14.       Bellot P.H. Endocardial Lead Extraction. In Cardiac pacing for the clinician. Eds. Kusumoto M., Goldschlager N.F. Springer. 2008; 280-281.

15.       Porstman N.W., Wierny L., Warnke H. Closure of persistent ductus arteriosus without thoracotomy. German. Med. Monthly. 1967; 12: 1.

16.       Massumi R.A., Ross A.N. Atraumatic nonsurgical technique for removal of broken catheters from the cardiac cavities. Med. Intel. 1967; 277: 195.

17.       Fearnot N.E. et al. Intravascular lead extraction using locking stylets, sheaths, and other techniques. Pacing. Clin. Electrophysiol. 1990; 13: 1864-1870.

18.       Sutton R., Bourgeois I. The foundation of cardiac pacing: an illustrated

 

Abstract:

Background: this report describes our experience in CT-perfision (CTP) use for evaluation of rectal tumors neoadjuvant treatment effectiveness. Tumor response for combination of radiation and chemotherapy was related to CTP pattern.

Material and Methods: five patients aged 48 - 62 years with rectal adenocarcinomas histologically verified (4 patients of T3N0M0 stage and 1 patient T3N1 M0) were included. All of them had combined neoadjuvant radiotherapy and chemotherapy followed by surgery. Before and after neoadjuvant treatment virtual colonoscopy (VCS) with CTP was done in all the cases prior to surgical intervention.

Results and Conclusions: comparing perfusion pattern in rectal tumor and in normal tissue, we saw blood volume (BV) to be significantly increased, and mean transit time (MTT) moderately shortened in tumor tissues. Tumor tissue BV in neoadjuvant therapy responders was much higher than in those for whom the therapy appeared to be ineffective. On combination of radio- and chemotherapy, BVin tumor tissue significantly decreased, and MTT elongated.

 

References

1.      Bosset J."F. et al. Chemotherapy with Preoperative Radiotherapy in Rectal Cancer. N. Engl. J. Med. 2007; 357 (7): 728.

2.      Чиссов В.И.,  Дарьялова С.Л.  Избранные лекции  по  клинической  онкологии.  М.2000; 736.

3.      Bellomi M. et al. CT Perfusion for the Monitoring of Neoadjuvant Chemotherapy and Radiation Therapy in Rectal Carcinoma. Initial Experience. Radiology. 2007; 244: 486-493.

4.      Sahani V. et al. Assessing Tumor Perfusion and Treatment Response in Rectal Cancer with Multisection CT. Initial Observations. Radiology. 2005; 234: 785-792.

5.      Yee J. Virtual colonoscopy. Ed. by Galdino G.2008; 219.

6.      Хомутова Е.Ю. и др. Устройство для раздувания толстой кишки. Патент на полезную модель № 71072 от 14-05-2007 г. 2008.

7.      Силантьева Н.И., Цыб А.Ф. и др. Компьютерная томография в онкопроктологии.М.: 2007; 144.

 

 

Abstract:

Contemporary methods of myocardial revascularization allow improving survival and quality of life in patients with multivessel disease. At the same time, there is still no satisfactory answer where and when one should perform complete myocardial revascularization. The latter is often a difficult task, and we consider well-reasoned incomplete adequate revascularization to be a valid alternative.

This study presents several methods of coronary flow assessment where regional ischemic deficiency is calculated in a mathematical model, evaluating thereby hemodynamic significance of coronary stenoses. Decision of complete or adequate incomplete revascularization can be rooted in these data. 

 

References

1.           Schaff H.V. et al. Survival and functional status after coronary artery bypass grafting. Results 10 to 12 years after surgery in 500 patients.

2.           Circulation. 1983; 68: 11-200. Archer R., Ott D.A. Parravinici R. Coronary artery revascularisation without cardiopulmonary bypass. Тех. Heart. Ins. J. 1984; 11:5257.

3.           Kapo К. и др. Механика кровообращения. М.: «Мир». 1981; 179-187.

4.           Кантор Б.Я., Кунделев А.Ю. Моделирование периодического течения вязкой жидкости в толстостенном сосуде. Проблемы машиностроения. 1998; 1 (1): 11-17.

5.           Cavalcanti S. Hemodynamics of an artery with midl stenosis.  J.   Biomech.   1995;   28   (4):387-399.

6.            Pedley T.J. The fluid mechanics of large blood vessels. London: Cambridge University Press. 1980; 540.

7.            Stergiopulos N., Meister J.J., Westerhof N. Simple and accurate way for estimating total and segmental arteria compliance.Тhe pulse pressure method. Ann. Biomed. Eng. 1994; 22: 369-375.

            8.            Wilcock D.F. Designing Turbulent Thrust Bearings For Reduced Power Loss. Proceedings of Leeds-Lyons Symposium. Sept. 1975.

 

 

Abstract:

We performed echocardiographic evaluation of 149 women with congenital and acquired heart defects prior to their pregnancy and during the 3d trimester of gestation, as the hemodynamic load reached its peak. It was shown that in patients with surgically corrected cardiac anomalies, echocardiographic findings could stay within physiological limits, otherwise we saw inadequate hemodynamic response and structu-ralchanges.

 

References 

1.            Абрамченко  В.В.  Беременность и  роды высокого риска. М.: «МИА». 2004; 212.

2.            Дидина Н. М., Ефимочкина В.И. Структура заболеваний сердца у беременных в современных условиях. Сб. науч. трудов «Эктрагенитальная патология и беременность».М. 1996; 26-29.     

3.            Егорян Д.С. Оптимизация подходов к ведению беременных, страдающих врожденными пороками сердца. Автореф. дис. канд.мед. наук. Ростов-на-Дону. 2006; 22.

4.            Макацария А.Д., Беленков Ю.Н., Бейлин А.Л. Беременность и врожденные пороки сердца. М.: Руссо. 2001; 305.

5.            Lieber S. et al. Eisenmengers syndrome and pregnancy. Acta Сardiol. 2003; 40: 421-424. 

6.           Затикян Е.П. Оценка нарушений гемодинамики у беременных и родильниц с врожденными пороками сердца. Акуш. и гин. 1998; 4: 64-66.

7.           Алексеева Л. Л. Особенности адаптации кардиореспираторной системы у беременных низкого акушерского риска. Дис. канд. мед. наук. Иркутск. 2004; 190. 

8.            Елисеев О.М. Сердечно-сосудистые заболевания у беременных. М.: Медицина. 1994; 246. 

9.           Жигунова И.А. Оценка неспецифических адаптационных механизмов у женщин в III триместре беременности. Автореф. дис.канд. мед. наук. Рязань. 2002; 15.

10.        Затикян Е.П. Врожденные и приобретенные пороки сердца у беременных. М.: Триада-Х. 2004; 294.

11.        Гриффин Б., Тополь Э. Кардиология. М.:Практика. 2008; 673.

12.        Кулавский В.А., Огий Т.И. Физиология и патология сердца у беременных. Уфа. 2000; 198.

13.        Тетелютина Ф.К. Прогнозирование, доклиническая диагностика и профилактика перинатальной патологии у беременных с пороками сердца. Дис. Д-ра мед. наук (Казанская государственная медицинская академия). 2002; 176.

 

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.

 

 Article exists only in Russian.

 

Abstract:

The article presents the experience of stenting the internal carotid arteries (ICA) in 45 patients. The patients' age ranged from 49 to 78 years, on average 64.8 years. The degree of ICA stenosis ranged from 60% to 95%, on average 72.7 ± 7.2%. 28 (62.2%) patients had a history of acute cerebrovascular accident, 17 (37.7%) patients had cerebral symptoms of circulatory disorders. After 48 endovascular procedures, neurological complications developed in 3 (6.2%) cases: transient ischemic attack - in 2 (4.1%) patients, minor stroke - in one (2%) patient. Hospital mortality was 2.2%. In the remote period, 13 (28.8%) patients were examined. There were no myocardial infarctions and strokes.  

 

 

 

Abstract:

Hemobilia is known as one of the most severe complications of percutaneous transhepatic biliary drainage. In the present case, the severe bleeding developed as a result of balloon dilatation and stenting of malignant stricture. Emergency transhepatic arterial embolization was performed with good results. We also discuss 7 cases of hemobilia in our hospital, 3 of which were successfully treated with transcatheter embolotherapy. We conclude that transhepatic arterial embolization appears to be effective and safe treatment for massive hemobilia.

 

References 

 

1.         Хачатуров А.А., Капранов С.А., Кузнецова В.Ф. и др. Актуальные вопросы чреспече-ночного эндобилиарного стентирования при злокачественных блоках желчеотделения. Диагностическая и интервенционная радиология. 2008; 2 (3): 33-47.

 

 

2.         Борисов А.Е., Борисова Н.А., Непомнящая С.Л. Диагностика и лечение гемобилии. Анн. хир. гепатологии. 2005; 10 (1): 40-45.

 

 

3.         Savader S.J., Trerotola S.O., Merine D.S. et al. Hemobilia after percutaneous transhepatic billiary drainage. Treatment with transcathe-ter embolotherapy. J.Vasc. Intervent. Radiol. 1992; 3 (2): 345-352.

 

 

4.         Winick A.B., Waybill P.N., Venbrux A.C. Complications of percutaneous transhepatic biliary interventions. Tech. Vasc. Intern Radiol. 2001; 4 (3): 200-206.

 

 

5.         Fidelman N., Bloom A.I., Kerlan R.K. et al.Hepatic arterial injuries after percutaneous biliary interventions in the era of laparoscopic surgery and liver transplantation. Experience with 930 patients. Radiology. 2008; 247 (3):880-886.

 

 

6.         Saad W.E., Davies M.G., Darcy M.D. Management of bleeding after percutaneous transhepatic cholangiography or transhepatic biliary drain placement. Tech. Vasc. Interv. Radiol. 2008; 11 (1): 60-71.

 

 

7.         Green M.H., Duell R.M., Johnson C.D, Jamieson N.V. Haemobilia. Br. J. Surg. 2001; 88 (6):773-786.

 

 

8.         Hsu K.L., Ko S.F., Chou F.F. et al. Massive hemo-bilia. Hepatogastroenterology. 2002; 49 (44): 306-310.

 

 

9.         Долгушин Б.И., Виршке Э.Р., Черкасов В.А.и др. Селективная эмболизация печеночных артерий при геморрагических осложнениях    чрескожной    чреспеченочной холангиографии. Анн. хир. гепатологии. 2007; 12 (4): 63-68.

 

 

10.     Eurvilaichit C. Iatrogenic hemobilia. Management with transarterial embolization using gelfoam articles. J. Med. Assoc. Thai. 1999; 82 (9): 931-937.

 

 

11.     Park J.Y., Ryu H., Bang S. et al. Hepatic artery pseudoaneurysm associated with plastic biliary stent. Yonsei. Med. J. 2007; 48 (3): 546-548.

 

 

12.     Hammer F.D., Goffette P.P., Mathurin P. Glue embolization of a ruptured pancreaticoduo-denal artery aneurysm. Case report. Eur. Radiol. 1996; (4): 514-517.

 

 

13.     Merrell S.V., Gibberston J.J., Albo D. et al. Atraumatic hemobilia arising from cirrhotic liver. Surgery. 1989; 106 (1): 105-109.

 

 

14.     Rai R., Rose J., Manas D. Potentially fatal hae-mobilia due to inappropriate use of an expanding biliary stent. World. J. Gastroenterol. 2003; 9 (10): 2377-2378.

 

15.     Dousset B., Sauvanet A., Bardou M. et al. Selective surgical indications for iatro-genic hemobilia. Surgery. 1997; 121 (1): 37-41.

 

 

Abstract:

For long time the only method of postinfarction myocardial «scars» topical diagnostics was ECG. Contrast-enhanced magnetic resonance (CE-CMR) is considered to be a highly informative technique for location and quantification of myocardial necrotic areas, but there are few studies comparing the method with conventional ECG. CE-MR/ECG correlation was studied in 59 patients with postinfarction changes. The global concordance between CE-MR and ECG was of 80%. In 5 cases (1 - anterolateral, 2 - inferior and 2 - inferolateral). ECG-pattern was misleading.

 

    References 

1.      Myers G.B. et al. Correlation of electrocardio-graphic and pathologic findings in anteroseptal infarction. Am. Heart. J. 1948; 36:5535-5575.

2.      Myers G., Howard A.K., Stofer B.E. Correlation of electrocardiographic and pathologic findings in lateral infarction. Am. Heart. J.1948; 37: 374-417.

3.      Myers G., Howard A.K., Stofer B.E. Correlation of electrocardiographic and pathologic findings in posterior infarction. Am. Heart. J.1948; 38: 547-582.

4.      Руда М.Я., Зыско А.П.. Инфаркт миокарда. М.: Медицина. 1981.

5.      Shalev Y. et al. Does the electrocardiographic pattern of «Anteroseptal» myocardial infarction correlate with the anatomic location of myocardial injury? Am. J. Cardiol .1995; 75: 763-766.

6.      Shen W., Tribouilloy C., Lesbre J.P. Relationship between electrocardiographic patterns and angiographic features in isolated left circumflex coronary artery disease. Clin. Cardiol. 1991; 14: 720-724.

7.      Gallik D.M. et al. Simultaneous assessment of muocardial perfusion and left ventricular dysfunction during transient coronary occlusion. J. Am. Coll. Cardiol. 1995; 25:.1529-1538.

8.      Zafrir B. et al. Correlation between ST elevation and Q waves on the predischarge electro cardiogram and the extent and location of MIBI perfusion defects in anterior myocardial infarction. Ann. Noninvasive Electrocardiol. 2004; 9: 101-112.

9.      Wu E. et al. Vusualization of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001; 357: 21--28.

10.   Moon J.C. et al. The pathological basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic resonance study. J. Am. Coll. Cardiol. 2004; 44: 554-560.

11.   Simonetti O.P. et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001; 218: 215-223.

12.   Cerqueira M.D. et al. Standardized myocardi-al segmentation and nomenclature for tomo-graphic imaging of the heart: a statement for healthcare professionals. Circulation. 2002; 105: 539-542.

13.   Kannel W.B., Abbot R.D. Incidence, precursors and prognosis of unrecognized myocardial infarction (Framingham Study). Adv. Car-diol. 1990; 37: 202-214.

14.   Sheifer S.E., Manolio T.A., Gersh B.J. Unrecognized myocardial infarction. Ann. Intern. Med. 2001; 135:. 801-811.

15 .  Беленков Ю.Н., Терновой С.К. Функциональные методы диагностики сердечно-сосудистых заболеваний. М.: «ГЭОТАР-МЕДИА». 2007.

 

Abstract:

Purpose. To perform complex and informative radiologic assessment of temporomandibular joints (TMJ)

Material and methods. Patients were divided into 2 groups: 1850 children and adolescents with malocclusions (Group 1), and 2150 adults with edentulous spaces or dental prostheses of different types (Group 2). Panoramic zonograhy spiral and conus computed tomography (CT), orthopantomography were performed in all the cases

Results. There were no osteal lesions of TMJ in Group 1. Intra-joint lesions of different types normalized on opening of mouth in the majority of cases, and only 22% of patients in Group 1 presented improper articular heads position. In Group 2 TMJ arthrosis was diagnosed in 29% of patients, and 25% presented uni- and bilateral restriction or uni- and bilateral subluxation.

Conclusions. The data indicates high incidence of muscles dysfunctions and TMJ lesions of muscular origin that demand orthopedic correction. 

 

References

1.    Петросов Ю.А. Дифференциальная диагностика заболеваний височно-нижнечелюстных суставов. Стоматология. 1977; 6:37-39.

 

 

2.    Пузин Л.М., Вязьмин А.Я. Болевая дисфункция височно-нижнечелюстных суставов. Медгиз. 2002; 160.

 

 

3.    Рабухина   Н.А.,   Аржанцев  А.П.,   Семкин   В.А.   Зонография   в   диагностике дисфункций    височно-нижнечелюстных суставов.   Екатеринбург.   Вопросы   организации и экономики в стоматологии. 1997.

 

4.      Семкин В.А., Рабухина Н.А., Кравченко Д.В. Диагностика дисфункций височно-нижнечелюстных суста-вов, обусловленных патологией окклюзии, и лечение таких больных. Стоматология. 2007; 1: 44-49.

5.      Tyndaee D., Renner Y., Philipps C. Positional changin of the pandibular condyle assessed wih three dimen-sional. Y. of Oral. Maxillofac. Sug. 1992; 50 (11): 1164-1172.

 

Abstract:

Joint trauma is one of the major causes of the temporary disability in economically and socially active groups of population. Definitive preoperative diagnosis allows correct surgery planning, decrease sick-lists duiauon and niipiove quality of patients' life. MRI is the method of chice for pre-operative examination of the knee joint. However it is associated with high variability of diagnostic effectiveness. In this paper we focus on principal diagnostic errors of the technique and provide recommendations for the appropriate application of MRI on the basis of mul-ticentre experience.

 

References 

 

1.     Миронов С.П., Орлецкий А.К., Цыкунов М.Б Повреждения связок коленного сустава, М. 1999; 207.

 

 

 

 

2.    Миронова З.С., Фалех Ф.Ю. Артроскопия и артрография коленного сустава. М.: Медицина. 1982; 111.

 

 

 

 

3.    Сайт Американской академии хирургов-ортопедов - www.aaos.org

 

 

 

 

4.    Kocabey Y. al. The value of clinical examination versus magnetic resonance imaging in the diagnosis of meniscet tears and anterior cruciate ligament rupture. Arthroscopy. 2004; 20 (7): 696-700.

 

 

 

 

5.    Vincken P.W. еt al. Effectiveness of MR imaging in selection of patients for arthroscopy of the knee. Radiology. 2002; 223 (3): 739-746.

 

 

 

 

6.    Терновой С.К., Синицын В.Е. Развитие компьютерной томографии и лучевой диагностики. Тер. архив. 2006; 1: 10-12.

 

 

 

 

7.    Krampla W. еt al. MRI of the knee: how do field strength and radiologist's experience influence diagnostic accuracy and interobser-ver correlation in assessing chondral and meniscal lesions and the integrity of the anterior cruciate ligament? Eur. Radiol. 2009; 19 (6): 1519-1528.

 

 

 

 

8.    Magee T., Shapiro M., Williams D. MR accuracy and arthroscopic incidence of meniscal radial tears. Skeletal. Radiol. 2002; 31 (12): 686-689.

 

 

 

9.    De Smet A.A., Graf B.K. Meniscal tears missed on MR imaging: relationship to meniscal tear patterns and anterior cruciate ligament tears. Am. J. Roentgenol. 1994; 162 (4): 905-911.

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


 

Article exists only in Russian.


Article exists only in Russian.

 

Article exists only in Russian.

 

Abstract:

Some authors point out that transcatheter arterial embolization is an effective method of hemostasis. In medical literature this method of hemostasis is not covered sufficiently.

The period under analysis is 200412008. During this period 13 patients with gastro1duodenal hemorrhage underwent endovascular interventon. Among those patients there were 6 women and 7 men at 43 to 85.

All the patients were initially in bad condition.

In 2 cases the source of bleeding was duodenal ulcer, in 2 cases it was pancreatolysis in the phase of mattery fusion of parapancre1atic infiltrate, in 1 case it was hemorrhage in the postoperative period after the operation, performed in the case of choledocholithiasis, in 3 cases it was hemorrhage from the cancerous growth of the duodenal mamelon, in 3 cases the source of bleeding was putres1 cent cancer of the head of pancreas, in 1 case it was cancer of gall bladder, attaching dodecadactylon, in 1 case it was ventrical vari1cosity accompanied by left portal hypertension, which developed after previous pancreatolysis.

Actions performed: 10 gastro1duodenal artery embolizations, in 2 cases combined with embolization of the common hepatic artery, in 1 case combined with embolization of the lower pancreaticoduodenal artery; in 1 case isolated infusion of haemostatics into the gastroduodenal artery was performed, in 1 case it was embolization of the lower pancreaticoduodenal artery, in 1 case it was truncal embolization of the splenic artery.

All the patients had hemostasis achieved. No recurrent hemostasis was observed during the whole period of the patient care.

 

 

References

 

1.     Агаев Б.А., Алиев В.М., Гараев Г.Ш. и др. Острые гастродуоденальные кровотечения язвенной этиологии. Методические рекомендации. Баку. 1997;

2.     Вербицкий В.Г., Багненко С.Ф., Курыгин А.А.Желудочно-кишечные кровотечения язвенной этиологии. Патогенез, диагностика, лечение.

3.     Санкт-Петербург: Политехника. 2004; 242.

4.     Борисов А.Е., Земляной В.П., Акимов В.П., Рыбкин А.К. Анализ хирургического лечения перфоративных и кровоточащих язв в Санкт-Петербурге за 20 лет. Материалы Всероссийской   конференции  хирургов, посвященной 75-летию проф. Б.С. Брискина. М. 2003; 10-13.

5.     Филин В.И., Костюченко А.Л. Неотложная панкреатология.  Справочник для врачей. Санкт-Петербург: Питер. 1994; 196.

6.     Нестеренко Ю.А., Лаптев В.В., Михайлусов СВ. Диагностика и лечение деструктивного панкреатита. М:. Бином-Пресс. 2004; 83.

7.     Хаджибаев A.M.,  Маликов A.M.,  Холматов P.M. и др. Роль эндоскопии в диагностике    и    лечении    гастродуоденальных кровотечений. Хирургия.  2005;  4:  24-27.         11.

8.     Казымов И.Л. Лечение язвенных гастродуоденальных   кровотечений.    Хирургия.2007; 4: 22-27.

9.     Гостищев В.К., Евсеев М.А. Рецидив острых гастродуоденальных кровотечений. Хирургия. 2003; 7: 42-43.

10.   Станулис А.И., Кузеев Р.Е., Гольдберг А.П. Хирургическая тактика и оперативное лечение при язвенной болезни двенадцатиперстной кишки, осложненной кровотечением. М.: Информедиа Паблишерз. 2005; 140.

11.   Ермолов А.С., Пахомова Г.В., Утешев Н.С. и др. Гастродуоденальные кровотечения язвенной этиологии как проблема современной хирургии. Организационные, диагностические и лечебные проблемы неотложных состояний. Т. 1. М. - Омск. 2000; 164-172.

12.   Ханевич М.Д., Хрупкий В.И., Жерлов Г.К. и др. Кровотечения из хронических гастродуоденальных язв у больных с внутрипеченочной портальной гипертензией. Новосибирск: Наука. 2003; 198.

 

Abstract:

Aim. Improvement of results of treatment sick of a stomach cancer a by application intraarterial regional chemotherapy.

Materials and methods. Direct results of treatment of 50 patients a cancer stomach are analyzed, middle age has made 58,1+0,8 years. Histologycal at 45 (90,0%) by patients it is revealed adenocarcinoma, at 5 (10,0%) skirrous cancer. All sick first stage leads neoadjuvant intraarterial chemotherapy under scheme ТРF (tаxoter 75 m2 + cisplatin 75 m2 + ftoruracili 1000 m2 in one day) 2 rates with an interval of 28 days, then operation.

Results. After 2 rates neoadjuvant intraarterial regional chemotherapy at 42 (84%) patients: partial regress is noted at 29 (58%) by patients and significant regress of process is noted at 13 (26%) by patients. This sick second stage of complex treatment leads radical operation - expanded gasterectomy with lymph node dissections D3.

Conclusions. Neoadjuvant intraarterial regional chemotherapy of a stomach cancer has appeared effective at 84% of patients. Thus radical surgical intervention was possible to lead all of them. At 54% of patients it is noted medical phathomorphosis 3-4 degrees. Neoadjuvant intraarterial regional chemotherapy at a cancer of a stomach is a method of a choice for increase of operability of process and improves direct results of treatment of patients. 

 

References: 

1.      Арзыкулов Ж.А., Сейтказина Г.Д. Показатели  онкологической  службы  Республики Казахстан за 2006 г. (статистические материалы). Алматы. 2005; 66.

2.      Гранов А.М., Давыдов М.И., Таразов П.Г., Гранов    Д.А.    и    др.    Интервенционная радиология в онкологии (пути развития и технологии). СПб.: Фолиант. 2007; 88-97.

3.      Давыдов   М.И.,  Алахвердян  А.С.,   Перевощиков   А.Г.   и   др.   Морфологическая и клиническая       оценка эффективности предоперационной регионарной полихимиотерапии у больных кардиоэзофагеальным раком. Вести ОНЦ АМН России. 1995;53-58.

4.      Зырянов Б.Н.,  Макаркин Н.А.,  Тихонов В.И. и др. Комбинированное лечение с внутриартериальной регионарной химиотерапией при местнораспространенном раке желудка. Российский онкологический журнал. 1997; 1: 17-20.

5.      Щепотин И.Б., Югринов О.Г., Галахин К.А. и др. Десятилетние результаты применения предоперационной суперселективной внутриартериальной химиотерапии в комбинированном и паллиативном лечении рака желудка. Практическая онкология. 2001; 7 (3); 67-71.

6.      Bonenkamp H.J., Hartgrink H.H., Van de Velde C.J. Influence of surgery on outcomes in gastric cancer. Surg. Oncol. Clin. N. Am. 2000; 1: 97-117.

 

Abstract:

Aim. To compare safety and efficiency of drug-eluting stents (DES) and bare metal stents (BMS) implantation for coronary artery disease (CAD).

Materials and methods. 230 patients with CAD were divided in 2 groups: patients in group 1 received DES; in group 2 we performed BMS implantation.

Results. Long-term results (over 12 months follow-up) of DES primary implantation reduces risk of the angiographic restenosis by 15% compared to BMS (р < 0,001).

Conclusions. Notwithstanding low basic risk of restenosis, DES demonstrate no statistically significant advantages in MACE rate. It is also shown that DES implantation is associated with higher mortality and greater risk of non-cardiac complications, related to prolonged antiplatelet therapy. Thus, decision of DES implantation should be made in consideration of the patients' tolerance for double antiplatelet therapy, risk of bleeding, possible elective surgery, as well as any pre-procedure immune system disturbances. 

 

References 

 

1.    Sigwart U., Puel J., Mirkovitch V., Joffre F. et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.New. Engl. Med. 1987; 316: 701-706.

 

 

 

 

2.    Van der Giessen W.J., Lincoff A.M., Schwartz R.S.  et al.  Marked inflammatory sequel to implantation of biodegradable and nonbiode-gradable polymers in porcine coronary arteries. Circulation. 1996; 94: 1690-1697.

 

 

 

 

3.    Бокерия Л.А., Алекян Б.Г., Голухова Е.З. и др. Применение стентов с лекарственным антипролиферативным покрытием в лечении больных ишемической болезнью сердца. Креативная кардиология. 2007; 1:193-198.

 

 

 

 

4.    Befeyter PJ. Percutaneous coronary intervention for unstable coronary artery disease. Text-book of interventional cardiology, 4th ed. by Topol E. Philadelphia. W.B. Saunders Company. 2003: 183-199.

 

 

 

 

5.    Bauters C., Lablanche J.M., McFadden E.P. et al. Clinical characteristics and angiographic follow-up of patients undergoing early or late repeat dilation for a first restenosis. J. Am. Coll. Cardiol. 1992; 20: 845-848.

 

 

 

 

6.    Бабунашвили А.М., Юдин И.Е., Дундуа Д.П. и др. Стенты с лекарственным покрытием при лечении диффузных атеросклеротиче-ских поражений коронарных артерий. Актуальные вопросы болезней сердца и сосудов. 2007; 4: 57-63.

 

 

 

 

7.    Waters R.E. 3 cases following DES for in-stent-restenosis (at 16, 20, 43 mo) - shortly after interruption of antiplatelet Tx. Catheter. Car-diovasc. Interv. 2005; 4: 107-115.

 

 

 

 

8.    PeterJ., Fitzgerald S. etal. Is angiographic late loss still a worthwhile surrogate endpoint in DES trials? Circulation. 2006; 54: 237-291.

 

 

 

High field MRI diagnosis of cranial nerves involvement



DOI: https://doi.org/10.25512/DIR.2009.03.3.03

For quoting:
Trofimova T.N., Yanovskaya I.V. "High field MRI diagnosis of cranial nerves involvement". Journal Diagnostic & interventional radiology. 2009; 3(3); 21-29.

 

Abstract:

Aim. The purpose of the study was to improve the MRI visualization of cranial nerves (CN) in normal state and in different pathological conditions. Tasks. Our tasks were to develop MRI protocols for CN visualization, describe MRI anatomical features of CN, and MRI symptoms of different CN involvement

Materials and methods. High field MRI was done in 252 patients, with 498 high quality images of CN. There were 202 patients with CN pathology, and 50 volunteers without CN involvement symptoms. Imaging was performed with «Signa Infinity» 1,5 Tl (General Electric). MRI protocol included 2 stages: basic for brain imaging, and special for CN visualization.

Results. The majority of the patients (112) had trigeminal nerve involvement, 51 - vestibulocochlear nerve, 16 - facial nerve, 9 - optic nerve, 5 - trochlear nerve, 4 - caudal CN involvement, 3 - olfactory nerve, 1 - oculomotor nerve, and 1 patients with abducent nerve disfunction. The etiology was vascular in 133 cases, tumorous in 45, demyelinating in 14, inflammatory and infection in 7, and congenital anomalies in 2 patients.

Conclusions. MRI is suitable for CN anatomical visualization and differentiation; the method is able to identify the level of CN involvement and surrounding tissues reaction. MRI protocol should include two steps - basic and special, the latter depending on the particular CN involvement.
 

 

References 

 

1.    Casselman J.W. The upper and lower cranial nerves. Erasmus course on magnetic resonance imaging. Syllabus. Vi-enna, Austria. 2006; 13: 123.

 

 

 

 

2.    Burchiel K.J., Slavin K.V. On the natural history of trigeminal neuralgia. Neurosurg. 2000; 46(1): 152-158.

 

 

 

 

3.    Casselman J.W. The upper and lower cranial nerves. Erasmus course on magnetic resonance imaging. Syllabus. Vi-enna, Austria. 2006; 13-17.

 

 

 

4.    Caillet H., Delvalle A., Doyon D. Visibility of cranial nerves at MRI. J. Neuroradiol. 1990; 17: 289-301.

 

 

Abstract:

Recently one can see higher incidence rate of fatty liver. The purpose of our study was to examine the abilities of raiodiagnostics (computed tomography and bolus contrast-enhanced CT angiography) in patients with different stages of non-alcoholic hepatic steatosis. Seventy four patients with morphologically verified diagnosis of non-alcoholic hepatic steatosis were included into the study. Hepatic parenchyma density was assessed quantitatively, as well as blood flow parameters at time-dencity curve in stages 1 (initial), 2 (moderate), and 3 (severe) of the disease. It was shown that hepatic time-dencity curve in patients with fatty liver was lower than splenic one. Thus, computed tomography and CT angiography are highly informative methods in diagnostics of hepatic steatosis, defying not only presence of the disease, but differentiating its stage and optimizing the therapeutic strategy.


References 

 

1.    Буеверов А.О. Некоторые патогенетические и клинические вопросы неалкогольного стеатогепатита. В кн. Клинические перспективы гастроэнтерологии, гепато-логии А.О. Буеверова, М.В. Маевской. 2003; 3: 2-7.

 

 

 

 

2.    Северов М.В. Неалкогольная жировая болезнь печени. В кн. Практическая гепа-тология под ред. акад. Н.А. Мухина. 2004; 145-149.

 

 

 

 

3.    Подымова С.Д. Болезни печени. Руководство для врачей. 2-е изд., перераб. и доп. М.: Медицина. 1993; 267-278.

 

 

 

 

4.    LudvigJ., Viggiano T.R., McGill D.B., Oh B.J. Nonalcoholic   steatohepatitis.   May   Clinic experiences with a hitherto unnamed disease. Мayo Clin. Proc. 1980; 55: 434-438.

 

 

 

 

5.    Ивашкин И.Т. Неалкогольный стеатогепатит. Российский медицинский журнал. 2000; 2:41-46.

 

 

 

 

6.    Логинов А.С., Аруин Л.И., Шепелева С.Д., Ткачев В.Д. Пункционная биопсия в диагностике хронических заболеваний печени.Тер. арх. 1996; 68 (2): 5-8.

 

 

 

 

7.    Логинов А.С., Аруин Л.И. Возможности и ограничения морфологической диагностики заболеваний печени.  Тер. арх. 1980; 2:3-8.

 

 

 

 

8.    Joe D. Diagnosis of fatty liver disease: is biopsy necessary? D. Joy, V.R. Thava, B.B. Scott. Eur. J.   Gastroenterol. Hepatol.  2003;   15   (5):         13.539-543.

 

 

 

 

9.    Кармазановский Г.Г., Вилявин М.Ю., Никитаев Н.С. Компьютерная томография печени  и желчных путей.  М.:   «ПАГАНЕЛЬ-БУК». 1997; 357.

 

 

10.  Мизандари М., Мтварадзе А., Урушадзе О. ,Маисая К., Тодуа Ф. Комплексная лучевая  диагностика диффузной патологии печени.   Медицинская   визуализация.   2002;   1:60-66.

 

 

11.  Габуния Р.И., Колесникова Е.К. Компьютерная томография в клинической диагностике. Руководство. М.: Медицина.   1995;234.

 

 

12.  Китаев В.М., Белова И.Б., Китаев СВ. Компьютерная томография при заболеваниях печени. М. 2006; 110-115.

 

 

13.  Лучевая диагностика заболеваний печени (МРТ, КТ, УЗИ, ОФЭКТ и ПЭТ) под ред. проф. Г.Е. Труфанова. М.: Изд. Группа «ГЭОТАР-Медиа». 2007; 193.

 

 

14.  Berland L.L. Slip-ring and conventional dynamic hepatic CT: contrast material and timing consideration. Radiology. 1995; 195: 1-8.

 

 

15.  Яковенко Э.П., Григорьев П.Я., Агафонова Н.А. и др. Метаболические заболевания печени: проблемы терапии. Фарматека. 2003; 10: 47-53.

 

16.  Петухов В.А., Каралкин А.В., Ибрагимов Т.И. и др. Нарушение функции печени и дисбиоз при жировом гепатозе и липидном дистресс-синдроме и их лечение препаратом Дюфалак (лактулоза). Российский гастроэнтерологический журнал. 2001; 2: 93-102.

 

authors: 


 

Article exists only in Russian.

 

Abstract:

A case report of successful treatment of a penetrating stab injury of the superficial femoral artery ir the adductor canal using uncovered stent. While stenting is usually used in major arteries for an intimal defeat and/or dissection due to blunt trauma, sometimes this type of penetrating injury pattern allows performing uncovered stent implantation. In this case report, it was a small side injury of vessel with the impression of the arterial wall inside the lumen resulting less than 50% stenosis and the absence of active extravasation during angiography Prior to stenting, balloon angioplasty was not effective to affect the intimal tear completely Good final angiographic and functional outcome with fast complete recovery let us draw a conclusion of the possibility of usage of uncovered stents Г certain cases with specific penetrating injury pattern.

 

Refernces

1.     Compton C., Rhee R. Peripheral vascular trauma. Perspect. Vasc. Surg. Endovasc. Ther. 2005; 17 (4): 297-307.

2.     Rasmussen T.E., Clouse W.D., Peck M.A. et al. Development and implementation of endovascular capabilities in wartime. J. Trauma. 2008; 64 (5): 1169-1176.

3.     Teixeira P.G., Inaba K., Hadjizacharia P. et al. Preventable or potentially preventable mortality at a mature trauma center. J. Trauma. 2007; 63 (6): 1338-1347.

4.     Bocharov S.MAngiograficheskaja diagnostika i jendovaskuljarnoe lechenie pri travme arterij. Diss. kand. med. nauk [Angiographic diagnosis and endovascular treatment in arterial trauma. Cand. med. sci. diss.]. Moscow. 2008: 103 [In Russ].

5.     Sin'kov M.A., Murashkovski A.L., Pogorelov E.A. et al. Endovaskulyarnoe zakrytie jatrogennogo arteriovenoznogo soust'ja podvzdoshnoj arterii i veny. [Endovascular closure of iatrogenic arteriovenous anastomosis of the iliac artery and vein]. Angiologiya i sosudistaya khirurgiya. 2014; 20 (1): 80-84. [In Russ].

6.     Chernyavskiy A.M., Osiev A.G., Grankin D.S. et al. Endovaskulyarniy metod lecheniya anevrizmy podkluchichnoi arterii s pomoschiu stent-graphta. [Endovascular method of treatment of subclavian artery aneurysm with stent-graft implantation]. Angiologiya i sosudistaya khirurgiya. 2003; 3: 122-123. [In Russ].

7.     Cynamon J., Lautin J.L., Wahl S.I. Covered stents for vascular injuries. Emerg. Radiol. 1999; 6: 244-248.

8.     Nicholson A.A. Vascular radiology in trauma. Cardiovasc. Intervent. Radiol. 2004; 27 (2): 105-120.

9.     Assali A.R., Sdringola S., Moustapha A. et al. Endovascular repair of traumatic pseudoaneurysm by uncovered self-expandable stenting with or without transstent coiling of the aneurysm cavity. Catheter. Cardiovasc. Interv. 2001; 53 (2): 253-258.

10.   Fox N., Rajani R.R., Bokhari F. et al. Evaluation and management of penetrating lower extremity arterial trauma: an Eastern Association for the Surgery of Trauma practice management guideline. J. Trauma Acute Care Surg. 2012; 73 (5, Suppl. 4): S315-S320.

11.   Sofue K., Sugimoto K., Mori T. et al. Endovascular uncovered Wallstent placement for life-threatening isolated iliac vein injury caused by blunt pelvic trauma. Jpn. J. Radiol. 2012; 30 (8): 680-683.

 

Abstract:

A case report of right ventricular outlet (RVO) stenting as palliative treatment of pulmonary artery atresia (PAA) in combination with interventricular septum defect (ISD), in situation when radical surgical intervention has high operative risk due to condition severity and low weight RVO stenting in newborn and children with low weight is made seldom and noted as a case reports. Peculiarity of this case is that intervention was made in patient with extremely low weight and age (age - 6 month, weight - 3 kg) after performed early central aorto-venous bypass and further palliative reconstruction of right ventricular outflow.

 

References

1.     Chang A.C., Hanley F.L., Lock J.E., et. al. Management and outcome of low birth weight neonates with congenital heart disease. J. Pediatr. 1994; 124: 461-6.

2.     Reddy V.M., Elhinney D.B., Sagrado T., et.al. Results of 102 cases of complete repair of congenital heart defects in patients weighing 700 to 2500 grams. Thorac. Cardiovasc. Surg. 1999; 117: 324-31.

3.     Wernovsky G., RubensteinS.D., Spray T.L. Cardiac surgery in the low-birth weight neonate: new approaches. Clin. Perinatol. 2001; 28:249-4.

4.     Laudito А., Varsha M., Bandisode J., Lucas F. et al. Right Ventricular Outflow Tract Stent as a Bridge to Surgery in a Premature Infant with Tetralogy of Fallot. Ann. Thorac. Surg. 2006; 81:744-746.

5.     Kirklin J. V., Barrat-Boyes. Cardiac surgery J V. New York: Churhill Livingstoun 2003.

6.     Sahu Raj., Syamasundar Rao., Transcatheter Stent Therapy in Children: An Update. Pediat. Therapeut. 2012, S5.

7.     Meadows J., Catheter-Based Interventions for Congenital Heart Disease Meadows Jeff. J. Clin. Exp. Cardiolog. 2012, S: 8.

8.     Gibbs J.L., Uzun O., BlackburnM.E., et. al. Right ventricular outflow stent implantation: an alternative to palliative surgical relief of infundibular pulmonary stenosis. Heart. 1997; 77:176-9.

9.     Sugiyama H., Williams W., Benson L.N. Implantation of endovascular stents for the obstructive right ventricular outflow tract Heart. 2005; 91:10581063.doi:10.1136/ hrt.2004.034819.

10.   Alwi M., Alwi M., Choo K.K., Latiff H.A., et. al. Initial results and medium-term follow-up of stent implantation in patent ductus arteriosus in ductdependent pulmonary circulation. J. Am. Coll. Cardiology 2004; 44(2):438-45. 

11.   Gladman G., Mc Crindle B.W., Williams W.G., et. al. The modified blalock-taussig shunt: clinical impact and morbidity in Fallot’s tetralogy in the currentera. J. Thorac. Cardiovasc. Surg. 1997; 114:25-30.

Abstract:

Aim: a case report of a 5-year experience of regional (arterial chemoembolization) treatment of a patient with isolated liver metastases of skin melanoma.

Materials and Methods: in 1994, the patient performed excision of melanoma in the right scapular region. Patient didn't undergo another treatment. During examination in 2006 metastasis in the liver was revealed. Patient recieved five rounds of chemotherapy Aranoza, Temodal, Kanglite. Metastatic tumer, sized 16,5 х14,5 х18,5 cm, occupied right liver lobe with deformation of it. After gaining this data - patient received 2 courses of liver chemoembolization in 2008.

Results: during the 5 years follow-up - progression of tumor lesion is not noticed.

Conclusion: the optimal transarterial chemoembolization creates possibilities for an efficient delivery of drugs and tumor embolization particles in the affected organ, particularly in the liver. In addition to surgery (with resectable formations) and systemic chemotherapy, above capabilities regional transarterial therapy can provide long term as new palliative treatment of patients with metastatic melanoma.

 

References

1.     Davydov M.I., Axel E.M. Mortality in Russia and the CIS countries from cancer in 2009 [Mortality of population in Russian Federation and CIS from malignant neoplasms in 2009]. Vestnik RCRC im. N.N. Blokhin RAMS. 2011; 22(3) 1: 57 [In Russ].

2.     Tuomaala S., Eskelin S., Tarkkanen A., Kivela T. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest. Ophthalmol. Vis Sci 43: 3399-3408, 2002.

3.     Becker J.C., Terheyden P., Kampgen E., Wagner S., Neumann C., Schadendorf D., Steinmann A., Wittenberg G., Lieb W., BrockerE.BTreatment of disseminated ocular melanoma with sequential fotemustineinterferon alphaand inter-leukin 2. Br. J. Cancer 2002;87: 8400-845.

4.     Bedikian A.Y, Legha S.S., Mavligit G., Carrasco C.H., Khorana S., Pager C., Papadopoulos N., Benjamin R.S. Treatment of uveal melanoma metastatic to the liver. Cancer 76: 1665-1670, 1995.

5.     Aubin J.M., Rekman J., Vandenbroucke-Menu F., Lapointe R., Fairfull-Smith R.J., Mimeault R., Balaa F.K., Martel G. Systematic review and meta-analysis of liver resection for metastatic melanoma. Br. J. Surg. 2013 Aug;100(9):1138-47. doi: 10.1002/bjs.9189. Epub 2013 Jun 17.

6.     Ramia J.M., Garcfa-Bracamonte B., de la Plaza R., Ortiz P., Garcfa-Parreno J., Vanaclocha F. Surgical treatment of melanoma liver metastases. Cir. Esp. 2013 Jan;91 (1 ):4-8. doi: 10.1016/j.ciresp.2012.10.002. Epub 2012 Dec 6.

7.     Gragoudas E.S., Egan K.M., Seddon J.M., Glynn R.J., Walsh S.M., Finn S.M., Munzenrider J.E., Spar M.D. Survival of patients with metastases from uveal melanoma. Ophthalmology. 1991 ; 98:383-389.

8.     Agarwala S.S., Eggermont A.M., O'Day S., Zager J.S. Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options. Cancer. 2013 Dec 2. doi: 10.1002/cncr.28480.

9.     Pyrhonen S. The treatment of metastatic uveal melanoma. Eur. J. Cancer 34(Suppl 3): S27-30, 1998.

10.   Mavligit G.M., Charnsangavej C., Carrasco C.H., Patt YZ., Benjamin R.S., Wallace S. Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA. 1988; 260:974 -976.

11.   Stuart K. Chemoembolization in the management of liver tumors. Oncologist. 2003;8 : 425-437.

12.   Ahrar J., Gupta S., Ensor J., Ahrar K., Madoff D.C., Wallace M.J., Murthy R., Tam A., Hwu P, Bedikian A.Y Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma. Cancer Invest. 2011 Jan;29(1 ):49-55. doi: 10.3109/07357907.2010.535052.

13.   Brown R.E., Gibler K.M., Metzger T., Trofimov I., Krebs H., Romero F.D., Scoggins C.R., McMasters K.M., Martin R.C. 2nd. Imaged guided transarterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for hepatic metastases from melanoma: early outcomes from a multi-institutional registry. Am. Surg. 2011 Jan;77(1):93-8.

14.   Sharma K.V., Gould J.E., Harbour J.W., Linette G.P., Pilgram T.K., Dayani PN., Brown D.B. Hepatic arterial chemoembolization for management of metastatic melanoma. AJR Am. J. Roentgenol. 2008 Jan; 190(1): 99-104.

15.   Patel K., Sullivan K., Berd D., Mastrangelo M.J., Shields C.L., Shields J.A., Sato T. Chemoembolization of hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study. Melanoma Res 15(4): 297-304, 2005. 

16.   Vogl T., Eicheler K., Zangos S., Herzog C., Hammerstingl R., Balzer J., Gholami A. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival. J. Cancer Res. Clin. Oncol. 133: 177-184, 2007.

 

Abstract:

The review presents literature data on the heparin-induced thrombocytopenia, its forms, the pathogenesis of condition and its clinical manifestations. Consideration of options for treatment of this complication and provisions recommendations of the American College of specialist doctors in diseases of the chest (ACCP), adopted at the IX Conference on antithrombotic therapy and prevention of thrombosis in 2012. 

 

Referenes

1.     Kelton J.G., Warkentin T.E. Heparin-induced thrombocytopenia: a historical perspective. Blood. 2008; 112 (7): 2607-16.

2.     Weismann R.E., Tobin R.W. Arterial embolism occurring during systemic heparin therapy. AMA Arch. Surg. 1958; 76 (2): 219-25; discussion 225-7.

3.     Natelson E.A., Lynch E.C., Alfrey C.P., Gross J.B. Heparin-induced thrombocytopenia. An unexpected response to treatment of consumption coagulopathy. Ann. Intern. Med. 1969; 71 (6): 1121-5.

4.     Rhodes G.R., Dixon R.H., Silver D. Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg. Gynecol. Obstet. 1973; 136 (3): 409-16.

5.     Jang I.K., Hursting M.J. When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation. 2005; 111 (20): 2671-83.

6.     Greinacher A., Warkentin T.E. Heparin-induced thrombocytopenia.New York, N.Y: Marcel Dekker, 2004; 627 р.

7.     Prechel М.М., Walenga М^ Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia. Thrombosis Journal. 2013; 11:7.

8.     Martel N., Lee J., Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood. 2005; 106 (8): 2710-15.

9.     Warkentin T.E., Greinacher A. So, does low-molecular-weight heparin cause less heparin-induced thrombocytopenia than unfractionated heparin or not? Chest. 2007; 132 (4): 1108-10.

10.   Warkentin T.E., Sheppard J.A., Sigouin C.S., et al. Gender imbalance and risk factor interaction in heparin-induced thrombocytopenia. Blood. 2006; 108 (9): 293741.

11.   Brieger D.B., Mak K.H., Kottke-Marchant K., Topol E.J. Heparin-induced thrombocytopenia. J. Am. Coll. Cardiol. 1998; 31 (7): 1449-59.

12.   Franchini M. Heparin-induced thrombocytopenia: an update. Thromb. J. 2005; 3: 14.

13.   Warkentin T.E., Kelton J.G.. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann. Intern. Med. 2001; 135 (7): 502-6.

14.   Warkentin T.E., Kelton J.G. Temporal aspects of heparin-induced thrombocytopenia. N. Engl. J. Med. 2001; 344 (17): 1286-92.

15.   Greinacher A., P^zsch B., Amiral J., Dummel V.. Eichner A., Mueller-Eckhardt C. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb. Haemost. 1994; 71 (2): 247-51.

16.   Warkentin T.E., Kelton J.G. A 14-year study of heparin-induced thrombocytopenia. Am. J. Med. 1996; 101 (5): 502-7.

17.   Warkentin T.E., Greinacher A., Koster A., Lincoff A.M. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133 (6 Suppl.): 340-80.

18.   Warkentin T.E. Heparin-induced thrombocytopenia: pathogenesis and management. Br. J. Haematol. 2003; 121 (4): 535-55.

19.   Linkins L., Dans A.L., Moores L.K., et al. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic therapy and prevention of thrombosis, 9th edition: American College of Chest Physicians evidence-based clinical practice Guidelines. Chest. 2012; 141 (2 suppl.): 495-530.

20.   Warkentin T.E., Roberts T.S., Hirsch J., Kelton J.G. Heparininduced skin lesions and other unusual sequelae of the heparininduced-thrombocytopenia syndrome: a nested cohort study. Chest. 2005; 127 (5): 1857-61.

21.   Bleasel J.F., Rasko J.E., Rickard K.A., Richards G. Acute adrenal insufficiency secondary to heparin-induced thrombocytopenia-thrombosis syndrome. Med. J. Aust. 1992; 157 (3): 192-3.

22.   Greinacher A., Juhl D., Strobel U. et al. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes. J. Thromb. Haemost. 2007; 5 (8): 1666-73.

23.   Warkentin T.E., Sheppard J.A.Testing for heparin-induced thrombocytopenia antibodies. Transfus. Med. Rev. 2006; 20 (4): 259-72.

24.   Tomer A., Masalunga C., Abshire T.C. Determination of heparin-induced thrombocytopenia: a rapid flow cytometric assay for direct demonstration of antibody-mediated platelet activation. Am. J. Hematol. 1999; 61 (1): 53-61.

25.   Meyer O., Salama A., Pittet N., Schwind P. Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4). Lancet. 1999; 354 (9189): 1525-6.

26.   Warkentin T.E., Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126 (3 Suppl.): 311-337.

27.   Greinacher A., Lubenow N., Eichler P. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia. Circulation. 2003; 108 (17): 2062-5.

28.   Lewis B.E., Matthai W.H., Cohen M., Moses J.W., Hursting M.J., Leya F. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Catheter Cardiovasc. Interv. 2002; 57 (2): 177-84.

29.   Campbell K.R., Mahaffey K.W., Lewis B.E. et al. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention. J. Invasive Cardiol. 2000; 12 Suppl. F: 14F-9.

30.   Warkentin T.E., Cook R.J., Marder V.J. et al. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Blood. 2005; 106 (12): 3791-6.

31.   Walenga J.M., Prechel M., Jeske W.P. et al. Rivaroxaban an oral, direct Factor Xa inhibitor has potential for the management of patients with heparin-induced thrombocytopenia. Br. J. Haematol. 2008; 143 (1): 92-9.

32.   Shantsila E., Lip G.Y, Chong B.H. Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management. Chest. 2009; 135 (6): 1651-64.

33.   Bokerija L.A., Chigerin I.N. Geparininducirovannaja trombocitopenija (sovremennoe sostojanie problemy) [Heparin-induced thrombocitopenia (modern condition of problem)]. M. Izd. NCSSH im. A.N. Bakuleva. 2007; 96 s [In Russ].

34.   Potzsch B., K^vekorn W.P., Madlener K. Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia. N. Engl. J. Med. 2000; 343 (7): 515. 

35.  Warkentin T.E., Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann. Thorac. Surg. 2003; 76 (6): 2121-31.

 

Abstract:

Diseases of the circulatory system in a few decades are one of the major causes of death and disability in the population in many countries around the world. In Russian Federation, a number of newly diagnosed cases of coronary heart disease and mortality of the working population of this pathology is growing. In clinical practice at the present time, various radiological techniques assess the condition of the heart and coronary vessels, determine the location and volume of lesions. In the available literature, however, we found no data on methods of research that would reveal the correlation between the X-ray anatomy of coronary vessels and structural and functional state of the heart muscle. Thus, the need for comprehensive scientific research is obvious. Results of this study will, on the basis of survey data, using the methods of radiation diagnosis, objectively assess the level of metabolic and structural and functional state of the cardiomyocytes in cardiac patients. This will improve the accuracy and informativeness of diagnosis, as well as the increase of the control of effectiveness of therapy and quality of patients' life with cardiac diseases. 

 

References

1.     Pakkal M., Raj V., McCann G.P Non-invasive imaging in coronary artery disease including anatomical and functional evaluation of ischemia and viability assessment. The British Journal of Radiology. 2011; 84: S280-S295.

2.     Boqueria L.A., Gudkova R.G. Cardiac Surgery - 2010. Diseases and congenital malformations of the circulatory system. Moscow: Publishing Bakoulev center for cardiovascular surgery of RussianAcademy of Medical Sciences. 2011. 192 p [In Russ].

3.     Lindenbraten L.D. Beam diagnostics: achievements and challenges of modern times. Radiology - practice. 2007, 3: 4-15[In Russ].

4.     Sharafeev A.Z. Diagnosis of associated atherosclerotic lesions of different pools in CHD patients. Kazan Medical Journal. 2009; XC (2), 145-148[In Russ].

5.     Shahov B.E., Krinina I.V., Matusowa E.I., Vostriakova L.V. Classic radiologic differential diagnosis of angina syndrome. Medical almanac. 2007, 1: 58-61[In Russ].

6.     Ternovoy S.K., Akchurin R.S., Fedotenkov I.S. et all. Multislice computed tomography in the diagnosis of non-invasive cross-mammaro and aortocoronary bypass grafts. Kuban Research Medical Bulletin. 2010, 6: 147-153 [In Russ].

7.     Nudnov I.N., Bolotov P.A., Rudenko B.A. Comparative analysis of the morphology after implantation of coronary atherosclerosis and uncovered stents drug according to coronary angiography and intravascular ultrasound. Medical imaging. 2011, 5: 104-113 [In Russ].

8.     Lishmanov J.B., Markov V.A., Krivonogov N.G. Possibilities of radionuclide methods in forecasting the results of coronary artery bypass grafting in patients after myocardial infarction. Diagnostic and Interventional Radiology. 2008, 2 (4): 17-25 [In Russ].

9.     The methods of radiologic diagnosis: a manual. S.K. Ternovoy and others (Ed. Ed. Sapozhkova L.P.). Rostov n / D: Phoenix. 2007, 137 p. [In Russ].

10.   Sinicyn V.E., Fomina I.G., Pisarev M.V., Gagarina N.V. Diagnostic and prognostic significance of detection of coronary calcification in the preclinical stage of ischemic heart disease. Cardiovascular therapy and prevention. 2004, 3 (5): 118-125 [In Russ].

11.   Kothawade K., Noel Bairey Merz C. Microvascular coronary dysfunction in women - pathophysiology, diagnosis and management. Curr. Probl. Cardiol. 2011; 36 (8): 291-318.

12.   Gorge G., Ge J., von Birgelen C., Erbel R. Intracoronary ultrasound - the new gold-standart? Zeitschrift fur Kardiologie. 1998; 87 (8): 575-585.

13.   Movsesyants M.Y, Ivanov V.A., Trunin I.V. Intravascular ultrasound with Virtual Histology in lesions of the coronary arteries. Cardiology. 2009, 12: 58- 61 [In Russ].

14.   Veselova T.N., Merkulova I.N., Yarovaya E.B., Ruda M. J. Evaluation of myocardial viability Metolit MSCT for the prediction of postinfarction left ventricular remodeling. Regional circulation and microcirculation. 2013, 1 (45): 17-24 [In Russ].

15.   Stukalova O.V., Vlasova, E.E., Tarasov L.V., Ternovoy S.K. Magnetic resonance imaging of the heart in patients with postinfarction cardiosclerosis preoperative surgical myocardial revascularization. Regional circulation and microcirculation. 2013, 1 (45): 36-41[ In Russ].

16.   Hofer M. Computed tomography. A basic guide. Moscow: Medlit. 2006, 208 p [In Russ].

17.   Galanski M., Prokop M. Spiral and multislice CT of the body. New York, Thieme. 2003.

18.   Ropers D., BaumU., Karsten P. et al. Detection of coronary artery stenoses with thin slice multi detector row spiral computed tomography and multiplanar reconstruction. Circulation. 2003; 107: 664-666.

19.   Morozov S.P., Nasnikova I.Y, Sinicyn V.E., Ternovoy S.K. Multidetector computed tomography. (Eds. Thorn SK). M: GEOTAR Media. 2009; 112 p [In Russ].

20.   Boev S.S., Dotsenko N.Y, Gerasimenko L.V., Shekhunova I.A. Coronary artery calcification as a marker of the risk of coronary artery disease and a predictor of cardiovascular events. Health Care in Chuvashia. 2012, 1: 74-79 [In Russ].

21.   Agatston A.S., Janowitz W.R., Hildner F.J. et al. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 1990; 15: 827-832.

22.   Lau G.T., Ridley L.J., Schieb M.C. et al. Coronary artery stenoses: detection with calcium scoring, CT angiography and both methods combined. Radiology. 2005; 235: 415-422.

23.   General and military radiology: a textbook. (Eds. Trufanova GE). St. Petersburg.: MMA, Medkniga ELBI SPB. 2008, 480 p [In Russ].

24.   Perioperative rehabilitation of patients with complicated forms of ischemic heart disease. (By red.prof. V. Burly.) - Ufa. 2012, 336 p [In Russ].

25.   Sicari R., Nihoyannopoulos P., Evangelista A. et al. Stress Echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur. J. Echocardiogr. 2008; 9: 415-37.

26.   Klein C., Nekolla S.G., Bengel F.M. et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation. 2002; 105: 162-167.

27.   Wagner A., Mahrholdt H., Holly T.A., Elliott M.D. et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003; 361: 374-379.

28.   Lishmanov J.B., Efimova I.J., Chernov V.I. et al. Scintigraphy as a tool for diagnosis, prognosis and monitoring of the treatment of heart disease. Siberian Journal of Medicine (Tomsk). 2007, 22 (3): 74-77 [In Russ].

29.   Ryzhkova D.V., Kolesnychenko M.G., Boldueva S.A., Kostin J.S. The study of coronary hemodynamics methods of positron emission tomography in patients with cardiac syndrome X. Siberian Medical Journal (Tomsk). 2012, 27 (2): 50-56 [In Russ].

30.   Nekolla S., Reder S., Saraste A. et al. Evaluation of the Novel Myocardial Perfusion Positron-Emission Tomography Tracer 18F-BMS-747158-02: Comparison to 13N-Ammonia and Validation With Microspheres in a Pig Model. Circulation. 2009; 119(17): 2333-2342. 

31.   Gerber B.L., Ordoubadi F.F., Wijns W. et al. Positron emission tomography using 18F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischemic left ventricular dysfunction. Results from the European Community concerted action multicenter study on use of 18F- fluorodeoxyglucose positron emission tomography for the detection of myocardial viability. Eur. Heart. J . 2001: 22: 1691-701.

Abstract:

The world data devoted to endovascular treatment of acute thrombotic or thromboembolic occlusion of the superior mesenteric artery are provided in article. Various methods of intra vascular interventions are described at acute mesenteric ischemia: mechanical and rheolytic thrombectomy, retrograde stenting, thrombolytic therapy and some others. Endovascular intervention, according to different authors, may consider as choice option in treatment of patients in a stage of intestine ischemia.

 

References

1.     Cho J.S., Carr J.A., Jacobsen G. et al. Long-term outcome after mesenteric artery reconstruction: a 37-year experience. J. Vasc. Surg. 2002; 35(3):453-460.

2.     Kougias P., Lau D., El Sayed H.F. et al. Determinants of mortality and treatment outcome following surgical interventions for acute mesenteric ischemia. J. Vasc. Surg. 2007;46(3): 467-474.

3.     Park W.M., Gloviczki P., Cherry K.J. et al. Contemporary management of acute mesenteric ischemia: factors associated with survival. J. Vasc. Surg. 2002; 35(3): 445-452.

4.     Sreedharan S., Tan YM., Tan S.G. et al. Clinical spectrum and surgical management of acute mesenteric ischaemia in SingaporeSingapore Med. J. 2007; 48(4): 319-323.

5.     Lepedat P. Infarkt kishechnika[Mesenteric necrosis]. Medicinskoe izdatel'stvo, Buharest. 1975; 282 s [In Russ].

6.     Савельев В.С., Петухов В.А., Сон Д.А. и соавт. Новый метод энтеросорбции при синдроме кишечной недостаточности. Анналы хирургии. 2005; 1; 29-32. Savel'ev V.S., Petuhov V.A., Son D.A. i soavt. Novyj metod jenterosorbcii pri sindrome kishechnoj nedostatochnosti [New method of enterosorbtion in acute mesenterial insufficiency]. Annaly hirurgii. 2005; 1; 29-32 [In Russ].

7.     Szabуnй Rйvйsz E. Acute mesenteric ischemia: analysis of cases admitted to a hospital during 10 years (2001-2010). Orv. Hetil. 2012;153(36):1424-1432.

8.     Corcos O., Castier Y, Sibert A. et al. Effects of a Multimodal Management Strategy for Acute Mesenteric Ischemia on Survival and Intestinal Failure. Clin. Gastroenterol. Hepatol. 2012;11(2):158-165.

9.     Markovich O.V., Shkodivskij N.IMorfofunkcional'nye izmenenija v stenke tonkoj kishki pri vremennom narushenii arterial'nogo krovoobrashhenija[Morphologic-functional changes in intestinal wall at temporary disorders of mesenterial blood circulation. Anatomija ta operativna hirurgija. 2005;4(1):12-15[In Russ].

10.   Pokrovskij A.V., Judin V.IOstraja mezenterial'naja neprohodimost'. Klinicheskaja angiologija: rukovodstvo pod red. Pokrovskogo A.V. [Acute mesenterial obstruction.] V 2-h tomah. Tom 2. M.: Izdatel'stvo «Medicina». 2004; 626-645[In Russ].

 

11.   Marston A. Sosudistye zabolevanija kishechnika. Patofiziologija, diagnostika i lechenie [Vascular diseases of bowel. Pathophysiology, diagnostics and treatment.]. M.: «Medicina».1989; 304 s [In Russ].

12.   Gol'dgammer K.K. Ostryj zhivot pri trombozah i jembolijah verhnih bryzheechnyh sosudov[«Acute abdomen» in thrombosis and embolism in superior mesenteric vessels]. M.: Medicina. 1966;184 s[In Russ].

13.   Давыдов Ю.А. Инфаркт кишечника и хроническая мезентериальная ишемия. М.: Медицина. 1997; 208 с. Davydov Ju.A. Infarkt kishechnika i hronicheskaja mezenterial'naja ishemija []. M.: Medicina. 1997; 208 s[In Russ].

14.   Savel'ev V.S., Spiridonov I.VOstrye narushenija mezenterial'nogo krovoobrashhenija[...]. M.: Medicina. 1979; 232 s[In Russ].

15.   Pokrovskij A.V., Belojarcev D.FIstorija hirurgii torakoabdominal'nogo otdela aorty i ego vetvej v Rossii [History of surgery of thoracic and abdominal aorta and its brunches]. Materialy 13 vserossijskogo s'ezda serdechno-sosudistyh hirurgov, Moskva. 25-28 nojabrja 2007; 368-369[In Russ].

16.   Shipovskij V.N., Ciciashvili M.Sh., Huan  Ch. I soavt. Reoliticheskaja trombjektomija i stentirovanie verhnej bryzheechnoj arterii pri ostrom mezenterial'nom tromboze (klinicheskoe nabljudenie) [Rheolytic thrombectomy and stenting of superior mesenteric artery in acute mesenterial thrombosis (case report)]. 

 

Abstract:

Importance: despite generally promising outcomes after stenting for unprotected left main coronary artery (ULMCA) disease, the ULMCA bifurcation lesions remain challenging, and their restenosis rate is still relatively high.

Objective: aim of the current study was to analyze possible factors influencing one year MACE rate in distal ULMCA patients.

Design, setting and patients: from year 2002 until end of year 2011 at Latvian Centre of Cardiology Pauls Stradins Clinical University hospital in ULMCA registry 1052 patients were enrolled. Interventions: In 723 patients distal bifurcations were treated, out of them in 449 patients one year follow-up were completed and those patients were included in current analyses Main outcome measures: cardiac death, target vessel revascularization (TVR), target lesion revascularization (TLR), major cardiac adverse events (MACE) were assessed at one year.

Results: two stent technique was used in 8,5% of cases. MACE, cardiac death, TVR and TLR rates at one year was 15,6%, 2,9%, 4,7% and 12,9%, respectively Cardiac death was associated with diabetes mellitus and NSTEMI, however, TLR was associated with SYNTAX score >30. MACE was associated with NSTEMI and 2 stent technique. True bifurcation was not associated with adverse cardiovascular outcomes.

Conclusions: Use of two stent technique and NSTEMI at presentation were associated of MACE at one year in distal ULMCA patients. 

 

References

1.     Tan W.A., Tamai H., Park S.J. et al. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation. 2001; 104(14):1609-14.

2.     Wijns W., Kolh P, Danchin N. et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2010;31 (20):2501-55.

3.     Chieffo A., Stankovic G., Bonizzoni E. et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation. 2005;111(6):791-5.

4.     Kim YH., Dangas G.D., Solinas E. et al. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. Am. J. Cardiol. 2008;101(6):801-6.

5.     Meliga E., Garcia-Garcia H.M., Valgimigli M. et al. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. J. Am. Coll. Cardiol. 2008;51(23):22 12-9.

6.     Palmerini T., Marzocchi A., Marrozzini C. et al. Preprocedural levels of C-reactive protein and leukocyte counts predict 9-month mortality after coronary angioplasty for the treatment of unprotected left main coronary artery stenosis. Circulation. 2005;112(15):2332-8.

7.     Park S.J., Kim YH., Lee B.K. et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J. Am. Coll.Cardiol. 2005; 45(3):351-6.

8.     Seung K.B., Park D.W., Kim YH., et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N. Engl. J. Med. 2008; 358(17):1781-92.

9.     Chieffo A., Park S.J., Valgimigli M. et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry. Circulation. 2007;116(2):158-62.

10.   Colombo A., Moses J.W., Morice M.C. et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004; 109(10):1244-9.

11.   Serruys P.W., Morice M.C., Kappetein A.P et al. ТЬю SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 2009;360:961-972.

12.   Medina A., Suarez de Lezo J., Pan M. A new classification of coronary bifurcation lesions. Rev Esp. Cardiol. 2006;59:183.

13.   Toyofuku M., Kimura T., Morimoto T., et al. J-Cypher Registry Investigators. Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease: insights from the j-Cypher registry. Circulation. 2009;120(19):1866-74.

14.   Palmerini T., Sangiorgi D., Marzocchi A. et al. Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology. Eur. Heart J. 2009;30(17):2087-94.

15.   Valgimigli M., Malagutti P, Rodriguez-Granillo G.A. et al. Distal Left Main Coronary Disease Is a Major Predictor of Outcome in Patients Undergoing Percutaneous Intervention in the Drug-Eluting Stent Era. J. Am. Coll. Cardiol. 2006;47:1530-7.

16.   Tamburino C., Capranzano P, Capodanno D. et al. Plaque Distribution Patterns in Distal Left Main Coronary Artery to Predict Outcomes After Stent Implantation. JACC Cardiovascular Interventions. 2010; 3(6) 624-631.

17.   Goldberg S., Grossman W. Markis J.E., Cohen M.V., Baltaxe H.A., Levin D.C. Total occlusion of the left main coronary artery. A clinical, hemodynamic and angiographic profile. Am. J. Med. 1978;64(1):3-8.

18.   Spiecker M., Erbel R., Rupprecht H.J., Meyer J. Emergency angioplasty of totally occluded left main coronary artery in acute myocardial infarction and unstable angina pectoris-institutional experience and literature review. Eur. Heart J. 1994;15(5):602-7.

19.   De Feyter P.J., Serruys P.W. Thrombolysis of acute total occlusion of the left main coronary artery in evolving myocardial infarction. Am. J. Cardiol. 1984;53(11):1727-8.

20.   Quigley R.L., Milano C.A., Smith L.R., White W.D., Rankin J.S., Glower D.D. Prognosis and management of anterolateral myocardial infarction in patients with severe left main disease and cardiogenic shock. The left main shock syndrome. Circulation. 1993;88(5):II65-70.

21.   Nagaoka H., Ohnuki M., Hirooka K., Shimoyama T. [Emergency coronary artery bypass grafting for left main coronary artery disease]. Kyobu Geka. 1999;52 (8 Suppl):634-8.

22.   Meliga E., Garcia-Garcia H.M., Valgimigli M. et al. Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The diabetes and drug eluting stent for LeFT main registry (D-DELFT). Eurolntervention. 2008; 4(1):77-83. 

 

Abstract:

Aim: was to submit a five-year experience in the treatment of vasospasm in patients after subarachnoid hemorrhage (SAH) due to rupture of a brain aneurysm.

Materials and methods: from 2007 to 2013 in clinic were operated 178 patients with acute SAH (87 patients underwent aneurysm clipping, 91 endovascular embolization).

Resavasospasm according to TCD was observed in 85% of patients. Mild vasospasm was observed in 55% , moderate in 31,8%, and 13,2% of patients had severe vasospasm. Chemical angioplasty was performed in 20 patients. Clinical manifestations of vasospasm in the form of ischemic neurological disorders observed in 8 patients. Five of them received balloon angioplasty of intracranial arteries. In 2 patients vasospasm was the cause of death. In 3 cases spasm was the cause of disability in the rough. In one case, when performing balloon angioplasty occurred fatal gap MCA.

Conclusion: treatment of vasospasm in patients with SAH remains a challenge and requires a comprehensive approach and multidisciplinary therapy.

 

References

1.     Hirurgija anevrizm golovnogo mozga[Surgery of brain aneurisms]. (Pod redakciej V.V. Krylova). M., 2011; t.1: 432 S [In Russ].

2.     Kurata A., Suzuki S., Iwamoto K. et all. Efficacy of endovascular surgery for ruptured aneurysms with vasospasm of the parent artery. J. NeuroIntervent Surg. 2012;4:190e195. doi:10.1136/neurintsurg-2011-010007.

3.     Wikholom G., Lindgren H., Rodriguez H. et al. Embolization with Guglielmi detachable coils during the period of increased risk for cerebral vasospasm: early outcome. Neuroradiology. 2000;42:833e7.

4.     Sander Connolly E., Jr, MD, FAHA, Chair; Alejandro A. Rabinstein, MD, Vice Chair; J. Ricardo Carhuapoma, MD, Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage Stroke. 2012;43:1711-1737.

5.  Konovalov A.N., Krylov V.V., Filatov Ju.MRekomendatel'nyj protokol vedenija bol'nyh s subarahnoidal'nym krovoizlijaniem vsledstvie anevrizm sosudov golovnogo mozga [Protocol of treatment of patients with subarachnoid hemorrhage as a result of rupture of a brain aneurysm.]. Zhurnal voprosy nejrohirurgii imeni N. N. Burdenko). 2006; 3: 3-10 [In Russ] .

6.     Todd Abruzzo, Christopher Moran, Kristine A. Blackham, Clifford J. Eskey. Invasive interventional management of post-hemorrhagic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage J. NeuroIntervent Surg. 2012;4:169e177.

7.     Sehy J.V., Holloway W.E., Lin S.P et al. Improvement in angiographic cerebral vasospasm after intra-arterial verapamil administration. AJNR. Am. J. Neuroradiol. 2010; 31:1923e8.

8.     Kimball M.W., Velat G.J., Hoh B.L. The participants in the international multidisciplinary consensus conference on the critical care management of subarachnoid hemorrhage. Critical care guidelines on the endovascular management of cerebral vasospasm. Neurocrit. Care 2011; 14:336e41.

9.     Todd Abruzzo, Christopher Moran, Kristine A. Blackham, Clifford J. Eskey. Invasive interventional management of post-hemorrhagic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage J. NeuroIntervent. Surg. 2012;4:169e177 

 

Abstract:

Aim: was to identify relationship between risk factors (RF) and severity of coronary artery (CA) defeat in patients, hospitalized with acute coronary syndrome (ACS), without the presence of ishemic heart disease (IHD) earlier.

Materials and methods: the research includes 201 patients, who were hospitalized to N.V Sklifosovsky Research Institute of Emergency Medicine from february 2011 to apri 2012 with the diagnosis «ACS». Main criteria of patients selection was the absence of IHD clinics in past. All patients underwent coronarography, obtained data was fixed in data base. At the time of arrival to hospital - risk factors were determined. To identify relationship between RF and CA defeat - statistic analyzes were made: the number of defeated CA (1,2 or 3); severity of CA defeat was measured with Syntax Score (SS) Scale (<22 and >22 points); praesence or absence of acute occlusion of CA of infarction zone.

Results: research consisted of 149 male (74,1%) and 52(25,9%) female, mean age of all patients was 56,6±10,6 yrs. ACS with elevation of ST-segment was diagnosed in 136 (67,7%) of patients. Haemodynamic significant stenosis (HSS) of 1, 2 or 3 CA were found in 56 (27,9%), 61 (30,4%) and 64 (30,8%) respectively In 20 (10%) patients - there was no HSS. Acute thrombotic occlusion (ATO) in myocardial infarction related(MI-related) CA was revealed in 146 (72,6%) of patients. It was noted, tht such RF as arterial hypertention (AH), smoking, low physical activity (LPA), was more spread with increasing numer of defeated CA. Patients with lot of defeated CA, were older, had higher figures of systolic arterial pressure (SAP). After examination and primary analysis, only age and number of RF had independent relation with prevalence of CA defeat. Patients with SS >22 points in comparison with patients <22 points, had higher AP, obesity, diabetes mellitus (DM), and more ofted had lack of fruits and vegetables. Also they were older had higher SAP, more RF. Analysis showed that only AH, DM, and age had independent relation with savere CA defeat (Syntax Score >22 points). Patients with ATO of CA, had higher such RF as smoking, LPA, DM. They also had more RF. After analysis - smoking and LPA were independently connected with ATO.

Conclution: such RF as age, AH, DM, LPA and number of combined RF in patient can have independent relation with volume and prevalence of CA defeat. Smoking and LPA can have relation with ATO, with clinics of ST-elevated ACS and macrofocal MI. Obtained data show necessity of inlarged reseach for a broad understanding og RF in connection with coronary atherosclerosis and thrombosis. All that can increase effectiveness of treatment and prophylaxis of cardiovascular morbidity and mortality.

 

References

1.     Ford E.S., Ajani U.A., Croft J.B., et al. Explaining the decrease in U.S. deaths from coronary disease, 19802000. N. Engl. J. Med. 2007; 356: 2388-2398.

2.     Kesteloot H., Sans S., Kromhout D., Dynamics of cardiovascular and all-cause mortality in Western and  Eastern Europe between 1970 and 2000. Eur. Heart. J. 2006; 27: 107-113.

3.     Беленков Ю.Н., Оганов РГ. Кардиология. Национальное руководство. Геотар-медиа. 2007: 37-52. Belenkov Ju.N., Oganov R.G.; Kardiologija. Nacional'noe rukovodstvo [Cardiology. National recommendations.] Geotar-mediaju. 2007: 37-52 [In Russ].

4.     John G. Canto, Catarina I. Kiefe., William J. Rogers., Eric D. Peterson, et al. Number of Coronary Heart Disease Risk Factors and Mortality in Patients With First Myocardial Infarction JAMA, November 16, 2011: Vol 306, No.19.)

5.     Kappetein A.P, Feldman T.E., Mack M.J., et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur. Heart J. 2011;32: 2125-2134.

6.     Frederick G. Kushner, Mary Hand, Sidney C. Smith, Jr, Spencer B. King, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J. Am. Coll. Cardiol. 2009;54;2205-2241; originally published online Nov 18, 2009; doi: 10.1016/ j.jacc.2009.10.015.

7.     Голощапов-Аксенов РС., Жамгырчиев Ш.Т., Терновых М.В., Лебедев А.В., Обидин А.В. Рентгенохирургия в комплексном лечении больных острым инфарктом миокарда с множественным атеросклеротическим поражением коронарных артерий. Диагностическая и интервенционная радиология. 2010; 4(2): 21-28. Goloshhapov-Aksenov R.S., Zhamgyrchiev Sh.T., Ternovyh M.V., Lebedev A.V., Obidin A.V. Rentgenohirurgija v kompleksnom lechenii bol'nyh ostrym infarktom miokarda s mnozhestvennym ateroskleroticheskim porazheniem koronarnyh arterij [Endovascular surgery in complex treatment in patients with acure myocardial infarction with multivessel coronary defeat.]. Diagnosticheskaja i intervencionnaja radiologija. 2010; 4(2): 21-28 [In Russ].

8.     Kennelly B.M., Gersh B.J., Lane G.K., Beck W. The relationship between angiographic findings and risk factors in young men with myocardial infarction. S. Afr. Med. J. 1982; 61(14): 508-512.

9.     Ryczek R., Dziuk M., Zagrodzka M., et al. Clinical and angiographic correlates of coronary calcium scoring in multislice computed tomography (MSCT). Pol. Arch. Med. Wewn. 2005; 113(3): 207-212.

10.   Koliaki С., Sanidas E., Dalianis N., Panagiotakos D., et al. Relationship Between Established Cardiovascular Risk Factors and Specific Coronary Angiographic Findings in a Large Cohort of Greek Catheterized Patients. Angiology. 2011; 62(1): 74-80

11.   Jin Z., Zhang Y, Chen J., et al. Study of the correlation between blood lipid levels and the severity of coronary atherosclerosis in a Chinese population sample. Acta Cardiol. 2006; 61(6): 603-606.

12.   Gensini G.G. The coronary artery disease scoring and retrrieval system. In: Gensini GG, ed. Coronary arteriography. Mount Kisco, New York: Futura Publishing Co.; 1975: 271-274. 

13.   Ning X.H., Xiang X.P, Lu N., et al. Relation of risk factors to coronary artery stenosis severity in coronary atherosclerotic heart disease. Zhonghua YiXue Za Zhi. 2008; 88(18): 1267-1269

14.   Wang X.L., Tam C., McCredie R.M., Wilcken D.E. Determinants of severity of coronary artery disease in Australian men and women. Circulation. 1994; 89(5): 1974-1981.

15.   Saleem T., Mohammad K.H., Abdel-Fattah M.M., Abbasi A.H. Association of glycosylated haemoglobin level and diabetes mellitus duration with the severity of coronary artery disease. Diab. Vasc. Dis. Res. 2008; 5(3): 184-189.

16.   Zornitzki T., Ayzenberg O., Gandelman G., et al. Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women. QJM. 2007; 100(9): 575-581.

17.   Mehta L., Devlin W., McCulloughPA., et al. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am. J. Cardiol. 2007; 99(7): 906-910.

18.   Rubinshtein R., Halon D.A., Jaffe R., Shahla J., Lewis B.S. Relation between obesity and severity of coronary artery disease in patients undergoing coronary angiography. Am. J. Cardiol. 2006; 97(9): 1277-1280.

19.   Phillips S.D., Roberts W.C. Comparison of body mass index among patients with versus without angiographic coronary artery disease. Am. J. Cardiol. 2007; 100(1): 18-22.

20.   Wessel T.R., Arant C.B., Olson M.B., et al. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. JAMA. 2004; 292(10): 1179-1187

21.   Niraj A., Pradhan J., Fakhry H., Veeranna V., Afonso L. Severity of coronary artery disease in obese patients undergoing coronaroangiography: «obesity paradox» revisited. Clin. Cardiol. 2007; 30(8): 391-396.

22.   O’Callaghan PA., Fitzgerald A., Fogarty J., et al. New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokers. Eur. J. Cardiovasc. Prev. Rehabil. 2005; 12(6): 542-547

23.   Peer A., Falkensammer G., Alber H., et al. Limited utilities of N-terminal pro B-type natriuretic peptide (NT- pro BNP) and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease. Heart. 2009; 95(4): 297-303.

24.   AHA. Heart disease and stroke statistics—2008 update. American Heart Association. Availableat: http://www.americanheart.org/presenter.jhtml? identifier 3000090. Accessed February 18, 2009.

25.   Nemetz PN., Roger V.L., Ransom J.E., Bailey K.R., Edwards W.D., Leibson C.L. Recent trends in the prevalence of coronary disease: a population-based autopsy study of non natural deaths. Arch. Intern. Med. 2008; 168: 264 -270

26.   Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation. 2011; 123: 18-209.

27.   Virmani R., Kolodgie F.D., Burke A.P, Farb A., Schwartz S.M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 2000; 20: 1262-1275

28.   El-Menyar A., Zubaid M., Shehab A., Bulbanat B., et al. Prevalence and Impact of Cardiovascular Risk Factors Among Patients Presenting With Acute Coronary Syndrome in the Middle East Clin. Cardiol. 2011; 34, 1, 51-58 

 

Abstract:

Surgical treatment of aortic valve pathology is an actual problem of modern medicine. Aortic valve pathology is widely spread in population on a stable high level. Due to a large amount of patients with no possibility of open surgical treatment of aortic valve pathology modern hybrid methods of treatment, such as transcatheter aortic valve implantation are being actively proposed and modified.

MSCT angiography before transcatheter aortic valve implantation is obligatory procedure. Data obtained by MSCT is extremely necessary to define the possibility and the access path of transcatheter aortic valve implantation. MSCT allows to select the size and type of aortic valve prosthesis.

Appearance of modern MSCT scanners with 320-640 row of detectors will increase the leading role of MSCT in preoperative inquiry of patients with planned transcatheter aortic valve implantation.

 

References

1.     Nkomo V.T., Gardin J.M., Skelton T.N. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005-1011.

2.     Charlson E., Legedza A.T.R., Hamel M.B. Decisionmaking and outcomes in severesymptomatic aortic stenosis. J. Heart Valve Dis. 2006; 15: 312-321.

3.     Iung B., Baron G., Butchart E.G., Delahaye F.. Gohlke-Barwolf C., Levang O.W., Tornos P., Vanoverschelde J.L., Vermeer F., Boersma E., Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 2003; 24: 1231-1243. 

4.     Varadarajan P., Kapoor N., Bansal R.C., Pai R.G. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann. Thorac. Surg. 2006; 82: 2111-2115.

5.     Andersen H.R., Knudsen L.L., Hasenkam J.M. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur. Heart J. 1992; 13:704-708.

6.     Cribier A., Eltchaninoff H., Bash A., Borenstein N., Tron C., Bauer F., Derumeaux G., Anselme F., Laborde F., Leon M.B. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002; 106: 3006-3008.

7.     Webb J.G., Pasupati S., Humphries K., Thompson C., Altwegg L., Moss R., Sinhal A., Carere R.G., Munt B., Ricci D., Ye J., Cheung A., Lichtenstein S.V. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007; 116: 755-763.

8.     Callander V. Computed tomography. M. Technosphere, 2006. C-17-23 [In Russ.]

9.     Ternovoy S.K., Sinitsyn V.E. Spiral CT and cathode ray angiography. M. Vidar, 1998. C-23-47 [In Russ.]

10.   Sinitsyn V.E., Achenbach S. Electron Beam Computed Tomography. In: M.Oudkerk (ed). Coronary Radiology. Berlin: Springer, 2004.

11.   Bridgewater B., Keogh B., Kinsman R., Walton P Sixth national adult cardiac surgical database report. 2008 [cited 2011 Feb 9].

12.   Ludman PF. British Cardiovascular Intervention Society audit returns: adult interventional procedures Jan 2009 to Dec 2009. BCIS Meeting; 2010 Oct: Cardiff, Wales. Рр17-34.

 

Abstract:

Article describes possibilities of MDCT for estimation of treatment effectiveness of antineoplastic therapy, for detection of rudementary or relapsing blastoma. High diagnostic potential of vizualization method for detection of rudementary or relapsing blastoma is shown. 

 

References

1.     Чиссов В.И., Старинский В.ВЗлокачественные новообразования в России в 2010 г М., 2012; 260 с. Chissov V.I., Starinskiy V.V. Malignant neoplasms in Russian Federation in 2010. - M., 2012. - S. 260. [In Russ.]

2.     Vasil'ev P.V. Multidetector computed tomography in the diagnosis of cancer of the larynx and hypopharynx: dis. d-ra. med. nauk. P.V. Vasil'ev. M., 2010. 317s. [In Russ.]

3.     Kushkhov O. A-K. Clinical value of multislice computed tomography in the considering treatment approaches and the amount of surgery for laryngeal cancer: dis. kand. med. nauk. Kushkhov O. A-K. M., 2010. 132s [In Russ.]

4.     Geets X., Daisne J.F., Tomsej M. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies. Radiother Oncol. 2006 Mar; 78(3): 291-7.

5.     Hadjiiski L., Mukherji S.K., Gujar S.K.Treatment response assessment of head and neck cancers on CT using computerized volume analysis.AJNR Am. J. Neuroradiol. 2010 Oct; 31(9):1744-51.

6.     Hermans R. Posttreatment imaging in head and neck cancer. Eur. J. Radiol. 2008;.66(3): 501-11.

7.     Karakullukcu B., Nyst H.J., van Veen R.L. et al. mTH- PC mediated interstitial photodynamic therapy of recurrent nonmetastatic base of tongue cancers: Development of a new method. Head Neck. 2012 Nov; 34(11):1597-606.

8.     Kevin G., King MD., Arpakorn Kositwattanarerk, MD, Eric Genden, MD. Cancers of the oral cavity and oropharynx: FDG PET with contrast-enhanced CT in the posttreatment setting. Radiographics. 2011 Mar-Apr; 31(2):355-73.

9.     Moureau-Zabotto L., Touboul E., Lerouge D. et al. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2005 Oct 1; 63(2):340-5.

10.   Paulino A.C., Koshy M., Howell R. et al. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int. J. Radiat. Oncol. Bio. Phys. 2005 Apr 1; 61(5):1385-92. 

 

Abstract:

Aim: was to evaluate the use of intraoperative ultrasound in examination of patients with liver cancer compared with preoperative diagnostic methods.

Materials and methods: the study involved 650 patients who received surgical treatment for the period 1998-2013 years. During surgical intervention, all patients underwent intraoperative ultrasonography (IOUS) of the liver.

Results: results of preoperative examination methods were compared with intraoperative data, IOUS and histological examination. Sensitivity and accuracy of IOUS is above all methods of preoperative diagnosis, surgical palpation and is 99.7% and 94.9%, respectively Analyzed causes of mistakes of preoperative methods. These related: long time interval before surgical intervention, diameter of formations less then 2 cm, chemotherapy, presence of concomitant cirrhosis, different location of lesions (subcapsular, on the capsular and on the diaphragm of the liver), benign or non-tumorous liver lesions. Changes of operation volume occurred in 38 % cases, 20 % of them - on the base IOUS data.

Conclusions: IOUS provides decisive diagnostic information for the surgeon during the operation which may lead to changes of operation volume, and thus affect outcomes of the disease. Contrast resolution IOUS is actual when oncological operations on the liver are made. Ultrasound professionals should be master of IOUS techniques due to the increasing necessity of its use in clinics dealing with oncological surgery of the liver. 

 

References

1.     Machi J., Oishi A.J., Furumoto N.L., Oishi R.H. Intraoperative ultrasound. Surg. Clin. North. Am. 2004; 84:1085-1111.

2.     Torzilli G., Makuuchi M. Intraoperative ultrasonography in liver cancer. Surg. Onco.l Clin.N Am. 2003; 12: 91-103.

3.     Komarov I.G., Komov D.V., Metastazy zlokachestvennyh opuholej bez vyjavlennogo pervichnogo ochaga. [Metastases of malignant tumors without identified primary lesion.]. M, «Triada H», 2002, 63-105 [InRuss].

4.     Kruskal J.B., Kane R.A. Intraoperative  US of the liver: techniques and clinical applications. Radiographics. 2006 Jul-Aug; 26(4):1067-84. 

5.     Silas A.M., Kruskal J.B., Kane R.A. Intraoperative ultrasound. Radiol. Clin. North. Am. 2001; 39:429-448.

6.     Lordan J.T., KaranjiaN.D. ‘Close shave’in liver resection for colorectal liver metastases. Eur. J. Surg. Oncol. 2010; 36:47-51.

7.     Tinkle C.L., Haas-Kogan D. Hepatocellular carcinoma: natural history, current management, and emerging tools. Biologics. 2012; 6:207-19.

8.     Xu L.H., Cai S.J., Cai G.X., Peng W.J. Imaging diagnosis of colorectal liver metastases. World J. Gastroenterol. 2011; 17(42):4654-9.

9.     Schmidt J., Strotzer M., Fraunhofer S. et al. Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: lesion-by-lesion analysis. World J. Surg. 2000; 24:43-47.

10.   Kulig J., Popiela T., Ktek S., et al. Intraoperative ultrasonography in detecting. Scand. J. Surg. 2007; 96: 51-5.

11.   Hata S., Imamura H., Aoki T., et al. Value of visual inspection, bimanual palpation, and intraoperative ultrasonography during hepatic resection for liver metastases of colorectal carcinoma. World J. Surg. 2011 Dec; 35(12):2779-87.

12.   Patel N.A., Roh M.S. Utility of intraoperative liver ultrasound. Surg.Clin. North Am. 2004 Apr; 84(2):513-24.

13.   Kaczmarek B., Petka B., Ostrowski M. Usefulness of intraoperative ultrasonography of the liver in patients with colorectal adenocarcinoma. Pol. Merkur. Lekarski. 2003 Mar; 14(81):229-32.

14.   Spiliotis J., Rouanet P., Deschamps F., et al. Accuracy of intraoperative ultrasonography in diagnosing liver metastasis from colorectal cancer: evaluation with postoperative follow-up results. World J. Surg. 1992 May-Jun; 16(3):545-6.

15.   Piccolboni D., Ciccone F., Settembre A., Corcione F. Liver resection with intraoperative and laparoscopic ultrasound: report of 32 cases. Surg. Endosc. 2008; 22:1421-1426.

16.   Lordan J.T., Stenson K.M., Karanjia N.D. The value of intraoperative ultrasound and preoperative imaging, individually and in combination, in liver resection for metastatic colorectal cancer. Ann. R. Coll. Surg. Engl. 2011 Apr; 93(3):246-9.

17.   Yang S., Hongjinda S., Hanna S.S. et al. Utility of preoperative imaging in evaluating colorectal liver metastases declines over time. HPB (Oxford). 2010 Nov; 12(9):605-9.

18.   Lin L.W., Ye Z., Xue E.S., et al. Intraoperative ultrasonography in hepatobiliary surgery. Hepatobiliary Pancreat Dis Int. 2002; 1:425-8.

19.   Van Vledder M.G., Pawlik T.M., Munireddy S. et al. Factors determining the sensitivity of intraoperative ultrasonography in detecting colorectal liver metastases in the modern era. Ann. Surg. Oncol. 2010 Oct; 17(10):2756-63.

20.   Stone M.D., Kane R., Bothe A. Jr., et al. Intraoperative ultrasound imaging of the liver at the time of colorectal cancer resection. Arch. Surg. 1994; 129:431-435.

21.   Sahani D.V., Kalva S.P., Tanabe K.K. et al. Intraoperative US in patients undergoing surgery for liver neoplasms: comparison with MR imaging. Radiology. 2004 Sep; 232(3):810-4.

22.   Bloed W., van Leeuwen M.S., Borel Rinkes IH. Role of intraoperative ultrasound of the liver with improved preoperative hepatic imaging. Eur. J. Surg. 2000; 166:691-695.

23.   D'Hondt M., Vandenbroucke-Menu F., Preville- Ratelle S. et al. Is intra-operative ultrasound still useful for the detection of a hepatic tumour in the era of modern preoperative imaging? HPB (Oxford). 2011 Sep; 13(9):665-9.

24.   Kruskal J.B., Kane R.A. Intraoperative  US of the liver: techniques and clinical applications. Radiographics. 2006 Jul-Aug; 26(4):1067-84.

25.   Cabula C., Nicolosi A., Calo P.G., et al. Intraoperative ultrasonography in the diagnosis of liver metastasis from gastrointestinal neoplasms. Minerva Chir. 1993; 48:1189-92.

26.   Boutkan H., Luth W. Meyer S., et al. The impact of intraoperative ultrasonography of the liver on the surgical strategy of patients with gastrointestinal malignancies and hepatic metastases. Eur. J. Surg. Oncol. 1992; 18: 342-346.

27.   Clarke M.P., Kane R.A., Steele G. Jr., et al. Prospective comparison of preoperative imaging and intraoperative ultrasonography in the detection of liver tumors. Surgery. 1989 Nov; 106(5):849-55.

28.   Kruszewski W.J., Walczak J., Szajewski M., et al., The value of intraoperative liver ultrasound assessment using an intraabdominal probe during laparotomy performed for oncological reasons. Pol. Przegl. Chir. 2013 Feb 1; 85(2):78-82.

29.   Liu L., Miao R., Yang H., et al. Prognostic factors after liver resection for hepatocellular carcinoma: a single-center experience from China. Am. J. Surg. 2012, 203:741-750. 

30.   Liska V., Treska V., Holubec L., et al. Recurrence of colorectal liver metastases after surgical treatment: multifactorial study. Hepatogastroenterology. 2007 Sep; 54(78):1741-4.

31.   Tao L.Y, He X.D., Qu Q., et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China. Liver Int. 2010; 30: 215-221.

32.   Kane R.A., Hughes L.A., Cua E.J., et al. The impact of intraoperative ultrasonography on surgery for liver neoplasms. J. Ultrasound Med. 1994; 13:1-6. 

33.   Solomon M.J., Stephen M.S., Gallinger S., White G.H. Does intraoperative hepatic ultrasonography change surgical decision making during liver resection? Am. J. Surg. 1994; 168:307-310.

34.   Cervone A., Sardi A., Conaway G.L. Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Am. Surg. 2000; 66:611-615.

35.   Conlon R., Jacobs M., Dasgupta D., Lodge J.P. The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur. J. Ultrasound. 2003; 16:211-216.

36.   Zacherl J., Scheuba C., Imhof M., et al. Current value of intraoperative sonography during surgery for hepatic neoplasms. World J.Surg. 2002; 26:550-554.

37.   Luck A.J., Maddern G.J. Intraoperative abdominal ultrasonography. Br. J. Surg. 1999 Jan; 86(1):5-16.

38.   Paul M.A., Mulder L.S., Cuesta M.A. et al. Impact of intraoperative ultrasonography on treatment strategy for colorectal cancer. Br. J. Surg. 1994; 81:1660-1663.

39.   Leen E., Angerson W.J., O’Gorman P., et al. Intraoperative ultrasound in colorectal cancer patients undergoing apparently curative surgery: correlation with two year follow-up. Clin. Radiol. 1996; 51:157-159.

40.   Stone M.D., Kane R., Bothe A. Jr., et al. Intraoperative ultrasound imaging of the liver at the time of colorectal cancer resection. Arch. Surg. 1994; 129:431-435.

Abstract:

Aim: was to evaluate morphological features of lesions in lower limb arteries before percutaneous transluminal angioplasty (PTA) and its arterial complications in patients with critical lower limb ischemia (CLI) combined with diabetes mellitus(DM).

Materials and methods: for the period from September 2010 to June 2013, a prospective single-center study was conducted involving 171 patients with CLI and DM (80(47%) men, mean age 64,1[54-68] years, mean HbA1c 8,3[7,4-9,6]%, mean duration of diabetes 16,5[8-23] years, diabetes type 1/2-18/153) who underwent PTA in 193 lower limbs. Myocardial infarction and brain stroke in anamnesis had 53(31%) and 19(11%) patients, respectively Chronic kidney disease (CKD) 3-4 stages had 40 patients(24%), end-stage renal disease - 16 cases (10%). Diagnosis of CLI was based on recommendation of TASC II. Patency of arteries of lower limbs was evaluated by duplex ultrasound (DU) before PTA and during early follow-up period (30 days). PTA in all patients was considered technically successful in restoring continuous arterial flow to the foot of at least one crural artery without residual stenosis >50%.

Results: stenosis>50% and occlusions of tibial arteries were found in all patients. Peripheral arterial disease 4-6 classes according Graziani L. classification was marked in 180(93%) cases. Extensive tibial arterial calcification was found in 123(64%) cases, in patients with residual stenosis (> 50% remaining diameter) -113 (89%). The mean value of transcutaneous oxygen pressure (tcpO2) before PTA was 14,7(8-25) mmHg, after PTA - 35,2 (31-38) mmHg. After PTA , residual stenosis (>50%) in treated arteries was in 125(79,1%) cases, thrombosis in treated arteries - 9(5,7%), intimal dissection - 18(11,4%), incomplete stent disclosure - 3(1,9%), incomplete capture stent area stenosis - 2(1,3%), dislocation of the stent - 1(0,6%). Repeat PTA in the early follow-up period was performed in 15 patients with clinically significant complications (6%).

Conclusion: CLI in diabetic patients is characterized by having severe morphological lesions of lower limb arteries, infrapopliteal arterial calcification. DU plays important role in evaluation of arterial patency and PTA complications in early follow-up period. The high level of residual stenosis of tibial arteries after PTA is associated with chronic complications of diabetes mellitus, including renal insufficiency Timely reintervention in diabetic patients with clinical significant PTA complications promotes optimal arterial patency and permission of CLI in theese cases. 

 

Reference

1.     Ajubova N.L., Bondarenko O.N., Galstjan G.R., Manchenko O.V., Dedov 1.1. Osobennosti porazhenija arterij nizhnih konechnostej i klinicheskie ishody jendovaskuljarnyh vmeshatel'stv u bol'nyh saharnym diabetom s kriticheskoj ishemiej nizhnih konechnostej i hronicheskoj pochechnoj nedostatochnost'ju [Peculiarities of arteries' lesions of lower limb, and clinical outcomes of PCI in patients with critical ishemia of lower limbs with diabetes mellitus and chronic renal insufficiency]. Saharnyj diabet. 2013; 4:85-94 [In Russ].

2.     TASC. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). J.Vasc Surg., 2000;31(1 part2):S1-287.

3.     Lumley J.S. Vascular management of the diabetic foot- a British view. Journal Annals of the Academy of Medicine, Singapore. 1993, Vol 22, N 6, P 912-6 

4.     M.Doherty T., Lorraine A.F., Inoue D., Jian-Hua Qiao, M.C.Fishbein, R.C.Detrano, PK.Shan, T.B. Rajavashisth. Molecular, endocrine, and genetic mechanisms of arterial calcification. Endocrine Reviews. 2004, 25 (4):629-672

5.  Bublik E.V., Galstjan G.R., Mel'nichenko G.A., Safonov V.V., Shutov E.V., Filipcev P.JaPorazhenija nizhnih konechnostej u bol'nyh saharnym diabetom s terminal'noj stadiej hronicheskoj pochechnoj nedostatochnostipoluchajushhih zamestitel'nuju pochechnuju terapiju [Lower limbs’ lesions in patients with diabetesmellitus with end-stage chronic renal insufficiencyreceiving replacement therapy]. Saharnyj diabet. 2008; 2: 17-23 [In Russ].

6.     Jager K.A., Phillips D.J., Martin R.L., Hanson C., Roederer G.O., Langlois YE. et al. Noninvasive mapping of lower limb arterial lesions. Ultrasound Med. Biol. 1985;11: 515-21.

7.     Ciaverella A., Silletti A., &Mustacchio A., et al. Angiographic evaluation of the anatomic pattern of arterial obstructions in diabetic patients with critical limb ischemia. Diabet. Metab. 1993;19:586-589.

8.     Jude E.B., Oyibo S.O. & Chalmers N., et al. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24:1433-1437.

9.     Bandyk D.F. Surveillance after lower extremity arterial bypass. perspect vasc surg endovasc ther. Eur Heart J. 2007;19:376-83.

10.   Faglia E., Mantero M. & Caminiti M. et al. Extensive use of peripheral angioplasty, especially infrapopliteal, in the treatment of ischemic foot ulcer: clinical results of a multicentric study of 221 consecutive diabetic subjects. J. Intern. Med. 2002; 252:225-232.

11.   Adam D.J., Beard J.D., Cleveland T., Bell J., Bradbury A.W., Forbes J.F. et al.; BASIL Trial Participants. Bypass versus Angioplasty in Severelschaemia of the Leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005; 366:1925-34.

12.   Norgen L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes FGR. Inter-society Consensus for the Management of Peripheral Arterial Disease (TASC II). J. Vasc. Surg. 2007; 45(Suppl S):S5-67.

13.   Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J. et al; American Association for Vascular Surgery/Society for Vascular Surgery;Society for Cardiovascular Angiography and Interventions;Society for Vascular Medicine and Biology; Society for Inerventional Radiology; ACC/AHA TASC Force on Practice Guidelines. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower exteremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA TASC Forc on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)-summary of recommendations. Circulation. 2006 113: e463-654,

14.   Dick F., Ricco J.B., Davies A.H.: Chapter VI: Follow-up after Revascularisation. Eur. J. Vasc. Endovasc. Surg. 2011; 42: S75-S90.

15.   Bondarenko O.N., Ajubova N.L., Galstjan G.R., Dedov 1.1. Dooperacionnaja vizualizacija perifericheskih arterij s primeneniem ul'trazvukovogo dupleksnogo skanirovanja u pacientov s saharnym diabetom i kriticheskoj ishemiej nizhnih konechnostej [Preoperative visualization of peripheral arteries with the help of ultrasonic duplex scanning in patients with critical ischemia of lower limbs and diabetes mellitus]. Saharnyj diabet. 2013; 2: 52-61 [In Russ].

16.   Arvela E., Dick F: Surveillance after Distal Revascularization for Critical Limb Ischemia. Scandinavian Journal of Surgery. 2012; 101:119-124. 

17.   Diehm N., Baumgartner I., Jaff M., Do D.D., Minar E., Schmidli J. et al. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischemia of lower limb arteries. Eur. Heart J. 2007; 28: 798-805.

authors: 

 

Article exists only in Russian.

 

Abstract:

Intraoperative vascular injury is infrequent complication (0.02-0.06%) during surgical operations on lumbar discs. We report a case of a 44-year-old man with oedema and varicose veins of the right lower limb. Despite an 4-year history of oedema and varicose veins, he appeared to be asymptomatic and could recollect no traumatic injury or surgery that might have caused it. Near the vertebral column, we found a small scar, the result of spinal disk surgery six years before. CT scan showed pseudoaneurysm of the right iliac artery with a 54 mm diameter. Thereafter, we located the suspected arteriovenous fistula by selective angiography of the aorta and its branches: a communication of the right iliac artery with the right iliac vein had resulted in a large shunt. This lesion was repaired by transluminal placement of stent-grafts Aorfix (Lombard Medical, UK). We had to use three stent-grafts due to the large difference in diameter between the common and external right iliac arteries. Hemodynamic improvement was immediate, and the postoperative course was uneventful. At the present time, almost six months postoperatively, the patient is asymptomatic. Sealing of pseudoaneurysm and arteriovenous fistula as a complication of lumbar-disc surgery with a stent graft is simple and is suggested as an excellent alternative to open surgery for iatrogenic vessel injuries. 

 

References

1.     Canaud L., Hireche K., Joyeux F., et al. Endovascular repair of aorto-iliac artery injuries after lumbar-spine surgery. Eur. J. Vasc, Endovasc. Surg. 2011; 42 (2): 167-171.

2.     Papadoulas S., Konstantinou D., Kourea H.P., et al. Vascular injury complicating lumbar disc surgery. A systematic review. Eur. J. Vasc. Endovasc. Surg. 2002; 24 (3): 189-195.

3.     Mulaudzi T., Sikhosana M. Arterio-venous fistula following a lumbar disc surgery. Indian J. Orthop. 2011; 45 (6): 563-564.

4.     Machado-Atias I., Fornes O., Gonzalez-Bello R., Machado-Hernandez I. Iliac arteriovenous fistula due to spinal disk surgery. Causes severe hemodynamic repercussion with pulmonary hypertension. Tex. Heart Inst. J. 1993; 20 (1): 60-64.

5.     Jarstfer B., Rich N. The challenge of arteriovenous fistula formation following disk surgery: A collective review. J. Trauma. 1976; 16: 726-733.

6.     Енькина Т.Н. Состояние сердечно-сосудистой системы у больных с хронической почечной недостаточностью на программном гемодиализе. Автореф. дис. ... канд. мед. Наук СПб. 1999. [En'kina T.N. Sostojanie serdechno-sosudistoj sistemy u bol'nyh s hronicheskoj pochechnoj nedostatochnost'ju na programmnom gemodialize [Condition of cardiovascular system in patients with chronic renal insufficiency on dialysis]. Avtoref. dis. ... kand. med. nauk SPb. 1999]. [In Russ].

7.     Brewster D., Cambria R., Moncure A., et al. Aortocaval and iliac arteriovenous fistulas: Recognition and treatment. J. Vasc. Surg. 1991; 13 (2): 253-264.

8.     Akpinar B., Peynircioglu B., Cil B., et al. Iliac vascular complication after spinal surgery: Immediate endovascular repair following CT angiographic diagnosis. Diagn. Inters. Radiol. 2009; 15 (4): 303-305.

9.     Hans S., Shepard A., Reddy P., et al. Iatrogenic arterial injuries of spine and orthopedic operations. J. Vasc. Surg. 2011; 53 (2): 407-413.

10.   Zajko A., Little A., Steed D., Curtiss E. Endovascular stent-graft repair of common iliac artery-to-inferior vena cava fistula. J. Vasc, Inters. Radiol. - 1995; 6 (5): 803-806 

 

Abstract:

Aim: was to evaluate mechanical properties of coronary stent «SINUS» and compare them with mechanical properties of coronary stents of foreign production.

Material and methods: experimental group included coronary stents «SINUS», made of cobalt-chromium alloy L605 laser cut (H design and L2). The comparison group included stents: MULTI-LINK Vision, MULTI-LINK 8 (Abbott Vascular), Presillion (Cordis, Medinol), Integrity (Medtronic). With the help of certified device tests were conducted on all stents: passage (ability to overcome the delivery system for corners) , the geometrical uniformity of diameter upon radial stability, rigidity on the long axis, the amount of self-reducing the diameter after removal of the pressure in the balloon («Recoil»); in relation to stents "SINUS" independent testing laboratory DynatekLabs (USA) was carried out endurance test under pulsating radial exposure for 380 million cycles in accordance with ASTM F2477-07, required to obtain the approval of FDA USA.

Results: а stents were successfully tested for passage through an angle of 90° with the radius of rotation from 30 mm to 7.5 mm. Indicator geometric irregularities along the length of the stent diameter for all stents in the range ±1,5%, which corresponds to the measurement error. Test results radial stability upon compression up to 80% of the nominal diameter of the stent have been least Multi-Link Vision 0,28±0,02 N / mm and the highest in stent Integrity 0,65±0,02 N/mm. Test results for radial stability of the stent, «SINUS» with H-design is similar to the results for the Multi-Link stent and stent 8 Presillion 0,37±0,02 N/mm , and the stent, «SINUS» with L2- close design 0.52±0,02 N/mm . Test results on the ability to repeat the curved shape of the stent showed the smallest vessel in stent rigidity «Sinus» H-design, the highest in the stent Multi-Link 8. Remaining stents ascending rigidity «SINUS» L2- design , Presillion, Integrity, Multi-Link Vision. Test «Recoil» showed the lowest value of 4.5% in the stent Multi-Link Vision, the largest in Multi-Link stent 8-5.4% , the variation of this parameter between stents insignificant - ±0,5%, within the error of measurement of diameter due to the complex geometry of the stent. Test results have shown persistence DynatekLabs mechanical integrity of the structure and the absence of stent migration«SINUS» after 380 million cycles (equivalent to 10 years of implantation with an average heart rate = 72 beats/min) radial pulsating effects .

Conclusion: this study showed that stents «SINUS» have significant differences from the comparison group of stents in terms of: Recoil, passage of 90° angular rotation, uniform diameter disclosed stent radial strength fatigue. In terms of radial stability stents «SINUS» meet or exceed stents comparison groups, second only to the stent «Integrity». In terms of adaptability, in the open state , the curved profile of the vessel stents «SINUS» have the best performance with respect to comparison groups. 

 

References

1.     Protopopov A.V., Kochkina T.A., Puzyr' A.P., Efremov S.P., Fedchenko Ja.O., Balan A.N., Kokov L.S. «Biomehanicheskie issledovanija stentov razlichnyh konstrukcij i materialov», v Rukovodstve «Sosudistoe i vnutriorgannoe stentirovanie» [«Biometric examination of stents with diffent construction and materials», in Manual «Vessel and intraorganic stenting» ]. 2003; 15-19 [In Russ].

2.     FDA: Federal Register/ Vol. 76, No. 49 / Monday, March 14, 2011 / Notices, page 13636. http://www.gpo.gov/fdsys/pkg/FR-2011-03-14/pdf/2011-5815.pdf

3.     Azarov A.A., Barbarash O.L., Ganjukov V.I., Barbarash L.S. Prediktory rannih trombozov stentov posle jekstrennogo chreskozhnogo koronarnogo vmeshatel'stva u pacientov s ostrym infarktom miokarda v sochetanii s saharnym diabetom 2-go tipa [Predictors of early stent trombosis after urgent PCI in patients with IM in combination with diabetes mellitus]. Diagnosticheskaja i intervencionnaja radiologija. 2012; 6(4): 43-50 [In Russ].

4.     Osiev A.G., Bajstrukov V.I., Birjukov A.V. Problema restenoza vnutri ranee implantirovannyh stentov koronarnyh artery [Problem in-stent restenosis in coronary artery]. Diagnosticheskaja iintervencionnajaradiologija. 2012; 6(4): 89-96 [In Russ].

5.     Barra J.A., Volant A., Leroy J.P., et al. Constrictive perivenous mesh prosthesis for presentation of vein integrity. J. Thorc. Cardiovasc. Surg. 1986; 92: 330-336.

6.     Barth K.H., Virmani R., Froelich J., Takeda Т., Lossef S.V., Newsome J., Jones R., Lindisch D. Pared comparision of vascular wall reactions to Palmaz stents, Strecker Tantalum stents and Wallstents in canine iliac and femoral arteries. Circulation. 1996; 93(12): 2161-2169.

7.     Leung D.Y.M., Glagov S., Mathews M.D. Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle coils in vitro. Science. 1976; 191: 475-477. 

 

Abstract:

Aim: was to study properties of nanostructured carbon coating stents in coronary arteries with the help of intravascular ultrasonic visualization.

Materials and Methods: experimental implantation of stents in coronary artery was performed on 8 yearling sheep. Estimation of bioinertness properties of stents was made by intravascular ultrasonic method on the 14, 28, 180 day. Bioinertness properties were estimated in comparison with analogical bare-metal stents.

Results: The analysis of results showed that in early stages (up to 28 days) experimental samples of stents cause less formation of trombus than simple balloon-extendable stents. In the period of late outcomes, coronary nanostructured carbon coating stents have lower level of «in-stent stenosis».

Conclusion: stent implantation with nanostructured carbon coating does not prevent the natural reparative processes taking place in the artery wall, does not cause the formation of thrombotic masses under standard doses of antiaggregants. Experimental stents significantly less affected in-stent stenosis, than stents without surface modification, indicating their higher bioinertness. 

 

References

1.     Libby P., Ganz P. Restenosis revisited.- new tsrgets, new therapies. - N. Egl.S.Med. 1997; 37: 418-419.

2.     Aref'eva T.I. et. al. Uvelichenie jekspressii monocitarnyh molekul adgezii i obrazovanija monocitotrombocitarnyh agregatov v krovi pri koronarnom restenoze [Increased expression of monocyte adhesion molecules and the formation of aggregates monotsitotrombotsitarnyh blood in coronary restenosis]. Terapevticheskijarhiv. 2002; 4:46-49 [In Russ].

3.     Morice M.C. A randomized comparison of sirolimus-eluting stent with a standard stent for coronary revesculazation. N. Engl. J. Med. 2002; 346:1773-1780.

4.     Topol E.J. Artery size, neointima and remodeling time for some standards. J. Am. Coll Cardiol. 1998; 32:2087-2094.

5.     Kremneva L.V. Vospalenie kak faktor riska restenoza i serdechno-sosudistyh oslozhnenij posle chreskozhnyh intrakoronarnyh vmeshatel'stv [Inflammation as a risk factor for restenosis and cardiovascular events after percutaneous intracoronary intervention]. Terapevticheskij arhiv. 2006; 3: 89-95 [In Russ].

6.     Lazarenko O.N. Vlijanie pokrytij stentov na tromboobrazovanie i razvitie restenozov [Tekst] [Influence of coatings on the stent thrombosis and restenosis. [Text]. Prakticheskaja angiologija. 2007; 2 (7): 10-13 [In Russ].

7.     Demin V.V. Klinicheskoe rukovodstvo po vnutrisosudistomu ul'trazvukovomu issledovaniju [Clinical guidelines for intravascular ultrasound]. O. IPK JuzhnyjUral. 2005; 400 s. [In Russ].

8.     Fedorchenko AN., Osiev A.G., Kochkina T.A., Protopopov A.V. Prognozirovanie klinicheskih rezul'tatov jendovaskuljarnogo vosstanovlenija prosveta stentirovannyh koronarnyh arterij. Diagnosticheskaja i intervencionnaja radiologija [Prediction of clinical results of endovascular stented recovery lumen of the coronary arteries. Diagnostic and intewentional Radiology. 2007; 3(1): 54-65 [In Russ].

9.     Vlodaver Z., French R., Van tassel R.A. et. al. Corellation of the atamortem coronary arteriogram and the postmortem specimen. Circulation. 1973; 47:162-9.

10.   Grondin C.M., dyrda I., Pasternac A. et al. Discrepancies between cineangiographic and postmortem findings in partients with coronary artery disease and recent myocardial revascularheart diseases: comparison of ciuneangiographic and necropsy findings. Ann. Intern. Med. 1979; 91:350-6.

12.   Isner J.M., Kishel J., Kent K.M. et. al. Accuracy of angiographic determination of left main coronary arterial narrowing. Angiographic - histologic correlative analisys in 28 patients. Circulation. 1981; 63: 1056-64.

13.   Ivanov V.A., Movsesjanc M.Ju., Trunin I.V. Vnutrisosudistye metody issledovanija v intervencionnoj kardiologii [Intravascular methods of research in interventional cardiology]. Medpraktika. M. 2008; 112S. [In Russ].

14.   Nakamura S., Colombo A., Gaglione A. et al. Intracoronary ultrasound observations during stent implantations. Circulation. 1994; 89; 2026-34.

15.   Colombo A., Hall P., Nakamura S. et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995; 91: 1676-88.

16.   Goldberg S.L., Colombo A., Nakamura S. et al. Benefit of intracoronary ultrasound in the deployment of Palmaz - Schatz stents. J. Am. Coll. Cardiol. 1994; 24:996-1003. 

 

Abstract:

Article presents data of modern literature concerning diagnostic efficiency of computed tomography and CT-angiography in diagnostics of acute disorders of mesenterial blood circulation. Article describes various groups of instrumental diagnostic signs indicating directly or indirectly on acute thrombotic and thromboembolic occlusion of mesenterial.

According to huge ammount of authors, CT-angiography can be considered as the first step in instrumental diagnostics of acute disorder of mesenterial blood circulation, due to demonstrated sensitivity and specificity, comparable in comparison with a standard angiography. 

 

References

1.     Pokrovskij A.V., Judin V.I. Ostraja mezenterial'naja neprohodimost'. Klinicheskaja angiologija: rukovodstvo pod redakciej Pokrovskogo A.V[Acute mesenterial obstruction. Clinical angiology: Manual, edited Pokrovskij A.V.]. V 2-h t. M.: Medicina. 2004; 2: 626-645 [In Russ].

2.     Burns B.J., Brandt L.J. Intestinal ischemia. Gastroenterol. Clin, North Am. 2003; 32 (4): 1127-1143.

3.     Cho J.S., Carr J.A., Jacobsen G. et al. Long-term outcome after mesenteric artery reconstruction: a 37-year experience. J. Vasc, Surg, 2002; 35 (3): 453-460.

4.     Oldenburg W.A., Lau L.L., Rodenberg T.J. et al. Acute mesenteric ischemia: a clinical review. Arch, Intern, Med, 2004; 164 (10): 1054-1062.

5.     Wang J.Y., Cheng K.I., Yu F.J. et al. Analysis of the correlation of plasma NO and ET-1 levels in rats with acute mesenteric ischemia. J. Invest. Surg. 2006; 19 (3): 155-161.

6.     Mamode  N., Pickford I., Leiberman P. Failure to improve outcome in acute mesenteric ischaemia: seven-year review. Eur. J. Surg. 1999; 165 (3): 203-208.

7.     Corcos O., Castier Y., Sibert A. et al. Effects of a Multimodal Management Strategy for Acute Mesenteric Ischemia on Survival and Intestinal Failure. Clin, Gastroenterol. Hepatol. 2012; 11 (2): 158-165.

8.     Ryer E.J., Kalra M., Oderich G.S. et al. Revascularization for acute mesenteric ischemia. J. Vasc. Surg. 2012; 55 (6): 1682-1689.

9.     Ozturk G., Aydinli B, Atamanalp S.S. et al. Acute mesenteric ischemia in young adults. Wien. Med. Wochenschr. 2012; 162 (15): 349-353.

10.   Schoots I.G., Koffeman G.I., Legemate D.A. et al. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br. J. Surg. 2004; 91 (1): 17-27.

11.   Zelenkov N.P., Mel'janov A.V., Esikov Ju.V. i soavt. Uspeshnoe hirurgicheskoe lechenie ostrogo narushenija mezenterial'nogo krovoobrashhenija [Successful surgical treatment of acute mesenterual blood circulation]. Materialy Mezhdunarodnogo hirurgicheskogo kongressa «Novye tehnologii v medicine». Rostov-na-Donu. 2005; 379 [In Russ].

12.   Savel'ev V.S., Petuhov V.A., Son D.A. i soavt. Novyj metod jenterosorbcii pri sindrome kishechnoj nedostatochnosti. [New method of internal absorbtion in patients with intestinal insufficiency] Annalyhirurgii. 2005; 1: 29-32 [In Russ].

13.   Murray S.P., Ramos T.K., Stoney R.J. Surgery of coliac and mesenteric arteries. In.: Enrico Ascher ed. Hamovici's Vascular Surgery, 5th edition. Blackwell Publishing. 2004; 72: 861-874.

14.   O'Mahony G.D., Gallucci M.R., Cordova-Fraga T. et al. Biomagnetic investigation of injury currents in rabbit intestinal smooth muscle during mesenteric ischemia and reperfusion. Dig. Dis. Sci. 2007; 52 (1): 292-301.

15.   Pompermayer K., Amaral F.A., Fagundes C.T. et al. Effects of the with glibenclamide, an ATP-sensetive potassium channel blocker, on intestinal ischemia and reperfusion injury. Eur. J. Pharmacol. 2007; 556 (1): P. 215-22.

16.   Kassahun W.T., Schulz T., Richter O. et al. Unchanged high mortality rates from acute occlusive intestinal ischemia: six year review. Langenbecks Arch. Surg. 2008; 393 (2): 163-171.

17.   American Gastrointestinal Association Medical Position Statement: guidelines on intestinal ischemia. Gastroenterology, 2000; 118: 951-953.

18.   Duber C., Wustner M., Diehl S.J. et al. Emergency diagnostic imaging in mesenteric ischemia. Chirurg. 2003; 74 (5): 399-406.

19.   Lock G. Acute mesenteric ischemia: classification, evaluation and therapy. Acta Gastroenterol, Belg, 2002; 65 (4): 220 - 225.

20.   Park W.M., Gloviczki P., Cherry K.J. et al. Contemporary management of acute mesenteric ischemia: factors associated with survival. J. Vasc, Surg, 2002; 35 (3): 445-452.

21.   Van Beers B.E., Danse E.M. Vascular lesions of the liver and gastrointestinal tract. Acta Gastroenterol. Belg. 2002; 65 (4): 226-229.

22.   Kortmann B., Klar E. Recognizing acute mesenteric ischaemia too late: reasons and diagnostic approach from a surgical point of view. Zentralbl. Chir. 2005; 130 (3): 223 - 226.

23.   Staib L. Intestinal ischemia - surgeon's view. Schweiz. Rundsch. Med. Prax. 2006; 95 (44): 1717-1721.

24.   Ataev S.D., Abdullaev M.R., Ataev D.S. Ostrye narushenija mezeneterial'nogo krovoobrashhenija [Acute mesenterial blood circulation disorders]. Materialy Mezhdunarodnogo hirurgicheskogo kongressa «Novye tehnologii v medicine». Rostov-na-Donu. 2005: 378 [In Russ].

25.   Savel'ev V.S., Spiridonov I.V., Boldin B.V. Ostrye narushenija mezenterial'nogo krovoobrashhenija. Infarkt kishechnika [Acute mesenterial blood circulation disorders. Intestinal infarction.]. Rukovodstvo po neotlozhnoj hirurgii pod redakciej Savel'eva V.S. M.: Triada H. 2005; 281-302 [In Russ].

26.   Alhan E., Usta A., Cekic A. et al. A study on 107 patients with acute mesenteric ischemia over 30 years. Int. J. Surg. 2012; 10 (9): 510-513.

27.   Hellinger J.C. Evaluating mesenteric ischemia with multidetector-row CT angiography. Tech. Vasc. Intev Radiol, 2004; 7(3): 160-166.

28.   Horton K.M., Fishman E.K. Multidetector CT angiography in the diagnosis of mesenteric ischemia. Radiol, Clin, North. Am. 2007; 45: 275-288.

29.   Shih M.C., Angle J.F., Leung D.A. et al. CTA and MRA in mesenteric ischemia: part 2, Normal findings and complications after surgical and endovascular treatment. Am. J. Roentgenol. 2007; 188 (2): 462-471.

30.   Smerud M.J., Johnson C.D., Stephens D.H. Diagnosis of bowel infarction: a comparison of plain films and CT scans in 23 cases. Am. J. Roentgenol. 1990; 154: 99-103.

31.   Turkbey B., Akpinar E., Cil B. et al. Utility of multidetector CT in an emergency setting in acute mesenteric ischemia. Diagn. Interv. Radiol. 2009; 15 (4): 256-261.

32.   Menke J. Diagnostic accuracy of multidetector CT in acute mesenteric ischemia: systematic review and meta-analysis. Radiology. 2010; 256 (1): 93-101.

33.   Zalcman M., Sy M., Donkier V. et al. Helical CT sings in the diagnosis of intestinal ischemia in small-bowel obstruction. Am. J. Roentgenol. 2000; 175: 1601-1607.

34.   Zandrino F., Musante F., Gallesio I. et al. Assessment of patients with acute mesenteric ischemia: multislise computed tomography sings and clinical performance in a group of patients with surgical correlation. Minerva Gastroenterol. Dietol. 2006; 52 (3): 317-325.

35.   Arroja B., Canhoto C., Silva F. et al. Acute mesenteric ischemia. Rev. Esp. Enfem. Dig. 2010; 5: 327-328.

36.   Ha H.K., LeeS.H., Rha S.E. et al. Radiologic features of vasculitis involving the gastrointestinal tract. Radiographics. 2000; 20: 779-794.

37.   Rosow D.E., Sahani D., Strobel O. et al. Imaging of acute mesenteric ischemia using multidetector CT and CT angiography in a porcine model. J. Gastrointest. Surg. 2005; 9 (9): 1262 - 1274.

38.   Johnson J.O. Diagnosis of acute gastrointestinal hemorrhage and acute mesenteric ischemia in the era of multi-detector row CT. Radiol, Clin, North Am. 2012; 50 (1): 173-182.

39.   Yikilmaz A., Karahan O.I., Senol S. et al.. Value of multislice computed tomography in the diagnosis of acute mesenteric ischemia. Eur. J. Radiol. 2011; 80 (2): 297-302. 

 

Abstract:

The presented research on studying the efficiency and safety of various anticoagulants used in patients with acute coronary syndrome during percutaneous coronary interventions (PCI). High efficiency of a Bivalirudin is shown, in comparison with Unfractionated Heparin and Monofram on the amount of bleeding arising in the postoperative period and main adverse coronary events (MACE). 

 

References

1.     Bolezni serdca: Rukovodstvo dlja vrachej [Heart diseases: Manual for doctors]. (Pod red. R.G. Oganova, I.G. Fominoj) M. Litera. 2006; 1328 [In Russ].

2.     Rukovodstvo po kardiologii. Pod red. V.N. Kovalenko [Manual on cardiology edited by V.N.Kovalenko]. K. MORION. 2008; 1424 [In Russ] .

3.     Volozh O.I., Deev A.D., Kal'juste T.I. Prognosticheskoe znachenie nekotoryh faktorov dlja smertnosti trudosposobnogo vozrasta (prospektivnoe jepidemiologicheskoe issledovanie) [Prognostic value of some factors for estimation of mortality of able-bodied age (prospective epidemiologic study)]. Kardiologija. 1997; 9: 43-48 [In Russ].

4.     Oganov R.G. Pervichnaja profilaktika ishemicheskoj bolezni serdca [Primary prophylaxis of ischemic heart disease]. M. Medicina. 1990; 160 [In Russ].

5.     Paolo G. Camici, Sanjay Kumak Prosad, Omela E. Rimoldi. Stunning, Hybernating and Assesment of Myocardial Viability. Circulation, 2008; 117: 103-114.

6.     Aasa M., Dellborg M., Herlitz J. et al. Risk reduction for cardiac events after primary coronary intervention compared with thrombolysis for acute ST elevation myocardial infarction (five year results of the Swedish early decision reperfusion strategy [SWEDES] trial). Am. J. Cardiol. 2010; 106 (12): 1685-1691.

7.     2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 - Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2011; 123: e426-e579.

8.     The Direct Thrombin Inhibitor Trialists' Collaborative Group. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data. Lancet. 2002; 359: 294-302.

9.     Doyle B.J., Rihal C.S., Gastineau D.A., Holmes D.R. Jr. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am. Coll. Cardiol. 2009; 53: 2019-2027.

10.   Kastrati A., Neumann F.J., Schulz S., Massberg S. et al. Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. N. Engl. J.Med. 2011; 365(21): 1980-1989.

11.   Kessler D.P., Kroch E., Hlatky M.A. et al. The effect of bivalirudin on costs and outcomes of treatment of ST-segment elevation myocardial infarction. Am. Heart. J. 2011; 162: 494-500.

12.   Linkins L.A., Warkentin T.E. Heparin-induced thrombocytopenia: real-world issues. Semin Thromb Hemost 2011; 37(6): 653-663.

13.   Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur. Hear. J. 2008; 29: 2909-2945.

14.   Budaj A., Eikelboom J.W., Mehta S.R. et al. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. Eur. Heart J. 2009; 30:655-661.

15.   Mehran R., Pocock S.J., Stone G.W. et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-eleva- tion acute coronary syndromes: a risk model from the ACUITY trial. Eur Heart J. 2009; 30:1457-1466.

16.   Bittle J.A., Chaitman B.R., Feit F. et al. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. Am. Heart J. 2001; 142(6):952-959.

17.   Montalescot G., Baldit-Solier C., Chibedit D. et al. for the ARMADA investigators. ARMADA study: a randomized comparison of enoxaparin, dalteparin and unfractional heparin on markers off cell activation in patients with unstable angina. Am. J. Cardiol. 2003; 91: 925-930.

18.   Montalescot G., Collet G.P., Lison L. et al. Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina. J. Am. Coll. Cardiol. 2000; 36:100-114.

19.   Kokov L.S., Lopotovsky P.Yu., Parkhomenko M.V., Larin A.G., Korobenin A.Yu. Experience with the Use of Angiox (Bivalirudin) in Acute Coronary Syndrome (ACS) Patients with Complications Caused by Percutaneous Coronary Intervention (PCI). International Journal of InterventionalCardioangiology, 2013; 34: 39-42.

20.   Manoukian S.V., Feit F., Mehran R. et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J. Am. Coll. Cardiol. 2007; 49(12): 1362-1368.

21.   Stone G.W., Witzenbichler B., Guagliumi G. et al. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicenter, randomized controlled trial. Lancet 2011; 377(9784): 2193-2204.

22.   Steg G., Stefan K. James, Atar D. et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012; 33:2569-2619. 

 

Abstract:

Current indications for transcatheter aortic valve replacement (TAVR) are limited for inoperable and high risk patients only. Meanwhile, TAVR may be successfully performed in young patients with low risk and with high technical and functional results according to short- and long-term follow-up.

54 patients underwent TAVR, 7 (12,9%) of them were younger than 65. Cause for endovascular procedure was the presence of oncological process in liver/autoimmune hepatitis/liver cirrhosis/severe bronchial asthma/atherosclerotic lesion of major vessels/severe diabetes mellitus. In 3 cases additional visualization method (intracardiac ultrasound examination) was necessary. All patients underwent implantation of CoreValve.

Technical success was 100%. Function of valves was satisfactory. Light near-valve regurgitation was found in 6 cases, valve regurgitation class II was found in 1 case with decrease to class I after treatment.

Intracardiac ultrasound examination is useful to attend successful results in this group of patients. 

 

References

1.     2012 ACCF/AATS/SCAi/STS Expert Consensus Document on Transcatheter Aortic Valve Replacement. JACC. 2012; 59: 1200-1254.

2.     Lemos PA, Lee CH, Degertekin M, et al. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. JACC. 2003; 41: 2093-2099.

3.     Ong A.T., Serruys P.W., Aoki J., et al. The unrestricted use of paclitaxel versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at RotterdamCardiologyHospital (T-SEARCH) registry. JACC. 2005; 45: 1135-1141.

4.     Hoye A., Tanabe K., Lemos P.A., et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. JACC. 2004; 43: 1954-1958.

5.     Rao S.V., Shaw R.E., Brindis R.G., Klein L.W., Weintraub W.S., Peterson E.D. On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]). Am. J. Cardiol. 2006; 97: 1478 -1481.

6.     Beohar N., Davidson C.J., Kip K.E., et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007; 297: 1992-2000.

7.     Grines C.L. Off-label use of drug-eluting stents putting it in perspective. JACC. 2008; 51: 615-617.

8.     Piazza N., Otten A., Schultz C., et al. Adherence to patient selection criteria in patients undergoing transcatheter aortic valve implantation with the 18F CoreValve ReValvingTM System: results from a single center study. Heart. 2010; 96: 19-26.

9.     Eltchaninoff H., Prat A., Gilard M., et al. Transcatheter aortic valve implantation: earlyresults of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur. Heart J. 2011; 32:19-197.

10.   Zahn R., GerckensU., Grube E., et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur. Heart J. 2011; 3:198-204.

11.   Rodes-Cabau J., Webb J.G., Cheung A., et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. JACC. 2010; 55:1080-1090.

12.   Tamburino C., Capodanno D., Ramondo A., et al. incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011; 123: 299-308.

13.   Webb J.G., Altwegg L., Boone R.H., et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation. 2009; 119: 3009-3016.

14.   Piazza N., Grube E., Gerckens U., et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008; 4: 242-249.

15.   Leon M.B., Smith C.R., Mack M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 2010; 363: 1597-1607.

16.   Smith C.R., Leon M.B., Mack M.J., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 2011; 364: 2187-2198.

17.   Lee D.H., Buth K.J., Martin B.J., et al. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation. 2010; 121: 973-978.

18.   Roques F., Nashef S.A., Michel P., et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur. J. Cardiothorac. Surg. 1999; 15: 816-822.

19.   Lange R., Bleiziffer S., Mazzitelli D., et al. improvements in Transcatheter Aortic Valve implantation Outcomes in Lower Surgical Risk Patients. JACC. 2012; 59: 280-287 

 

Abstract:

Introduction. The RECIST criteria, which are routinely used to assess results of treatment of colorectal liver metastases with the transarterial chemoembolization (TACE), are not based on the identification of the tumor necrosis, and therefore their objectivity is questionable.

Aim: was to develop method of assessment of tumor response, based on tumor necrosis after TACE.

Materials and Methods: own technique of assessment of the tumor responce, based on measurement of computed tomography density of metastatic lesions in native and post-contrast phases, before and after treatment («criteria of N») is offered. Data of 13 patients who have undergone treatment of metastases of a colorectal cancer in a liver by the TACE method with application of microspheres «DC Beads» and irinotekan are analysed. Comparison of results of treatment according to criteria of RECIST and «criteria of N» is carried out.

Results: аccording to RECIST criteria stable disease was achieved in 11(85%) patients, and 2(15%) patients had a partial response. Neither complete response, nor progressive disease was observed. Later, progressive disease occurred in 11 patients. The period from the start of treatment until progression fixation averaged 7-9 months. According to the «N criteria», 4 (31%) patients had a complete response, 6(46%) patients had a partial response: and in 3(23%) patients we detected stable disease. Then progressive disease was monitored in all 13 patients, the period from the start of treatment until the progression fixation averaged 3-6 months. In 4 cases the progression process according to «N criteria» was detected earlier than by RECIST criteria.

Conclusion: The usе of RECIST criteria may underestimate the objective response to treatment, and as a result - the progression of disease later on. The proposed method of tumor response assessment, based on the analysis of tumor necrosis («the N criteria»), proves to be more productive. 

 

References

 

1.     Pickren J.W., Tsukada Y., Lane W.W. Liver metastasis. in: Weiss L, Gilbert HA (eds) Analysis of autopsy data. GK Hall, Boston. 1982: 2-18.

2.     Vogl T.J., Zangos S., Balzer J.O., Thalhammer A., Mack M.G. Transarterial chemoembolization of liver metastases: indication, technique, results. Rofo. 2002; 174(6): 675-683.

3.     Pwint T.P., Midgley R., Kerr D.J. Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liver. Semin. Oncol. 2010; 37(2): 149-159.

4.     Cohen A.D., Kemeny N.E. An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist. 2003; 8(6): 553-566.

5.     Ji S.H., Park Y.S., Lee J., Lim D.H., Park B.B., Park K.W., Kang J.H., Lee S.H., Park J.O., Kim K., Kim W.S., Jung C., im Y.H. Kang W.K., Park K. Phase ii study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer. Jpn. J. Clin. Oncol. 2005; 35(4): 214-217.

6.     Kemeny N., Garay C.A., Gurtler J., Hochster H., Kennedy P., Benson A., Brandt D.S., Polikoff J., Wertheim M., Shumaker G., Hallman D., Burger B., Gupta S. Randomized multicenter phase ii trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. J. Clin.Oncol. 2004; 22(23): 4753-4761. Erratum in: J. Clin. Oncol. 2005; 23(1): 248.

7.     Liapi E., Geschwind J.F. Chemoembolization for primary and metastatic liver cancer. Cancer J. 2010; 16(2): 156-162.

8.     Fiorentini G., Aliberti C., Turrisi G., Del Conte A., Rossi S., Benea G., Giovanis P. intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase ii clinical study. in Vivo. 2007; 21(6): 10851091.

9.     Martin R.C., Joshi J., Robbins K., Tomalty D., Bosnjakovik P., Derner M., Padr R., Rocek M., Scupchenko A., Tatum C. Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBiRi) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study. Ann. Surg. Oncol. 2011; 18(1): 192-198.

10.   Narayanan G., Barbery K., Suthar R., Guerrero G., Arora G. Transarterial chemoembolization using DEBiRi for treatment of hepatic metastases from colorectal cancer. Anticancer Res. 2013; 33(5): 2077-2083.

11.   Martin R.C., Howard J., Tomalty D., Robbins K., Padr R., Bosnjakovic P.M., Tatum C. Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry. Cardiovasc Intervent Radiol. 2010; 33(5): 960-966.

 

Abstract:

Aim: was to estimate possibilities of the clinically developed method of diagnostic phlebography among patients with newly diagnosed and recurrent varicocele.

Materials and methods: phlebography was performed on 44 patients with left-sided varicocele . 24 of them have newly diagnosed varicocele and other 20 patients have recurrent varicocele. The age of patients varies from 12 to 48 years. During phlebographic studies the clinically developed method of diagnostic phlebography was applied to all patients. This method is based on the application of obturating balloon catheter installed in left internal spermatic vein.

Results: as a result of the study, structural features of left internal spermatic vein were revealed among patients with newly diagnosed and recurrent varicocele. Also, angioarchitecture variants of external spermatic vein and its hemodynamic features were defined. The pelvic venous basin angiographic characters of hemodynamic disorders were marked.

Conclusions: the phlebotesticulography through left internal spermatic vein balloon obturation gives the opportunity to get full information about left testis' venous circulation architecture and hemodynamics. The obtained information allows to choose both traditional methods of surgical treatment and inter-venous anastomosis microsurgery.

 

References

1.     Artjuhin A.A. Fundamental'nye osnovy sosudistoj andrologii [Fundamental basics of vascular andrology]. M.: Akademija. 2008; 222 S [In Russ].

2.     Kondakov V.T., Pykov M.I. Varikocele[Varicocele]. M. 2000; 91S [In Russ].

3.     Strahov S.N. Varikoznoe rasshirenie ven grozdevidnogo spletenija i semennogo kanatika (varikocele) [Varicose veins of uviform plexus and spermatic cord (varicocele)] M. 200; 234S [In Russ].

4.     Kim V.V., Kazimirov V.G. Anatomo-funkcional'noe obosnovanie operativnogo lechenija varikocele[Anatomic-functional justifications of operative treatment of varicocele]. M: Medpraktika. 2008; 112S [In Russ].

5.     Kulikov Ju.S. O patogeneze varikocele [About pathogenesis of varicocele.]. Urologija i nefrologija. 1970; 6: 39-43[In Russ].

6.     Stepanov V.N., Kadyrov Z.A. Diagnostika i lechenie varikocele [Diagnostics

and treatment of varicocele]. M: 2001; 3-206 [In Russ].

7.     Garbuzov R.V., Poljaev Ju.A., Petrushin A.V. Arteriovenoznye konflikty i varikocele u podrostkovn [Arteriovenous conflicts and varicocele in teen]. Diagnosticheskaja i intervencionnaja radiologija. 2010; 4 (3) 31-36 [In Russ].

8.     Coolsaet B.I. The varicocele sindrom: venography determining the optimal level surgical management J. Urol. 1980; 124: 833-834.

9.     Bomalaski M.D., Mills J., Argueso L.R., et al. Iliac vien compression syndrome: an unusual case of varicocele. J. Vasc. Surg. 1993; 18(6): 1064-1068.

10.   Osipov N.G., Obel'chak I.S. Sposob diagnosticheskoj flebografii pri varikocele. Patent na izobretenie №24890 12.08.2011 [Method of diagnostic phlebography in patients with varicocele. Patent on invention №24890 12.08.2011] [In Russ]. 

 

Abstract:

In order to check the efficiency of pharmacological prophylaxis of venous thromboembolism in 500 patients with multiple injuries we weekly performed ultrasonography of lower limb veins from 3-5 days after the accident date. Patients were divided into two groups. There were 186 patients with prophylaxis with LMWH in the first group, other group included 314 patients which took single antiplatelet therapy. Thrombosis occured in 29 (15.6%) cases in the first group. In 19 (61.2%) limbs thrombosis defeated the common femoral vein and it was floating in 67.7% of cases. In the second group thrombosis was found in 165 (52.5%) patients. Mural (46%) and occlusive (35.3%) changes from the proximal border, not reaching the common femoral vein - (62%) were dominating.

It was found that during fraxiparine treatment venous complications were 3.3 times less likely than with antiplatelet agents, however, 3.6 times increased the proportion of floating embologenic thrombosis. However, in these patients, the spread of the pathological process in the proximal direction noted in 2 times less, and the beginning of recanalization 1-2 weeks earlier and more effective restoration of the lumen.

 

References

1.     Van Hensbroek P.B., Haverlag R., Ponsen K.J. et al., Prevention of thrombosis in traumatology. Ned. Tijdschr. Geneeskd.2007; 4(151): 234-239.

2.     Lippi G., Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost. 2008; 8(34):747-761.

3.     Baeshko A.A. Risk i profilaktika venoznykh tromboembolicheskikh oslozhnenii v khirurgii [Risk and prophylaxis of venous thromboembolic complications in surgery] Khirurgiya. 2001; 4: 61-67 [In Russ].

4.     Anderson F.A., Spencer F.A. Risk factors for venous thromboembolism. Circulation. 2003;107: 33-38.

5.     Geerts W.H., Jay R.M., Code K.I. et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N. Engl. J. Med. 1996; 335: 701-707.

6.     Lazarenko V.A., Mishustin V.N. Pulmonary artery thromboembolism in patients with trauma. Angiol. Sosud. Khir. 2005; 11(4): 101-104.

7.     Geerts W.H., Pineo G.F., Heit J.A. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(3): 338-400.

8.     Giannadakis K., Leppek R., Gotzen L. et al. Thromboembolism complication in multiple trauma patients: an underestimated problem? Results of a clinical observational study of 50 patients. Chirurg. 2001;72:100-107.

9.     Knudson M.M., Lewis F.R., Clinton A. et al. Prevention of venous thromboembolism in trauma patients. J. Trauma. 1994; 37:11-15.

10.   Rogers F.B. Venous thromboembolism in trauma patients: a review. Surgery. 2001;130:74-78.

11.   Kearon, C. Natural history of venous thromboembolism. Circulation. 2003;107(1):22-30.

12.    Robinson D.M., Wellington K. Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolism. Am. J. Cardiovasc. Drugs. 2005; 5: 335-346.

13.    Shchelokov A.L., Zubritskii V.F., Nikolaev K.N i dr. Kombinirovannaya venoznykh tromboembolicheskikh oslozhnenii u postradavshikh s perelomami proksimal'nogo otdela bedrennoi kosti [Combined prophylaxis of venous tromboembolic complications in patients with fracture of proximal part of femur]. Vestniktravmatologiii ortopedii. 2007;1:16-21 [In Russ].

14.    Asamov R.E., Tulyakov R.P., Muminov Sh.M. i dr. Bessimptomnye flebotrombozy nasledstvennaya trombofiliya u bol'nykh so skeletnoi travmoi [Asymptomatic phlebothrombosis and hereditary thrombophilia in patients with skeletal trauma]. Angiologiya i sosudistaya khirurgiya. 2008; 3:73-76 [In Russ].

15.    Kruger K., Wildberger J., Haage P. et al. Diagnostic imaging of venous disease: Part I: methods in the diagnosis of veins and thrombosis. Radiologe. 2008; 48 (10): 977-992.

16.    Tomkowski W.Z., Davidson B.L., Wisniewska J. et al. Accuracy of compression ultrasound in screening for deep venous thrombosis in acutely ill medical patients. Thromb. Haemost. 2007; 97(2):191-194.

17.    Savel'ev V.S. Venoznye trombozy i tromboemboliya legochnoi arterii (venoznye tromboembolicheskie oslozhneniya): Metod. rekomendatsii. V.S.Savel'ev [Venous trombosis and pulmonary embolism (venous tromboembolic complications )]. M., 2007: 20 s [In Russ].

18.    Balakhonova T.V. Sovremennye instrumental'nye metody diagnostiki tromboza: ul'trazvukovoe dupleksnoe skanirovanie. Profilaktika tromboembolicheskikh oslozhnenii v travmatologii i ortopedii [Modern instrumental diagnostics of trombosis: ultrasonic duplex scanning. Prophylaxis of thromboembolic complications in traumatology and orthopedics.]: materialy gor. simp., Moskva. 2003; 12-17 [In Russ].

19.    Utverzhdenie otraslevogo standarta vedeniya bol'nykh. Profilaktika tromboembolii legochnoi arterii pri khirurgicheskikh i inykh invazivnykh vmeshatel'stvakh: Prikaz Ministerstva zdravookhraneniya Rossiiskoi Federatsii №233 ot 09.06.2003 [Approval of medical treatment standarts. Prophylaxis of pulmonary embolism in surgical and other interventions: order of Ministry of Health of the Russian Federation №233 since 09.06.2003] [In Russ]. 

 

Abstract:

Aim: was to investigate characteristics of ultrasound image of hydatidiform mole (HM).

Materials and methods: analyzed 15 cases of this type of gestational trophoblastic tumor, which was confirmed morphologically. Transvaginal ultrasound examination was carried out in the B-mode, using the technique of color and power Doppler.

Results: it was marked out 2 ultrasound types of the tumor node in case of HM: cellular and solid-cystic. We have seen that the structure depends on the nature of the tumor vasculature.

Conclusion: determination of nodes localization and vascular lacunae in it allows to identify the danger of massive bleeding. 

 

References

1.     Genest D.R., Berkowitz R.S., Fisher R.A. et al. Gestational trophoblastic disease . WHO Classification of Tumours. Pathology and Genetics of Tumours of the the Breast and Femal Genital Organs / Eds. F.A.Tavassolli, P.Devilee. Lyon: IARC, 2003; 250-254.

2.     John R. Lurain, Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. American Journal of Obstet. & Gynecol., 2010; 203(6): 531-539.

3.     Green C.L., Angtuaco TL, Shah HR, Parmley TH. Gestational trophoblastic disease: a spectrum of radiologic diagnosis. Radiographics. 1996; 16(6):1371-84.

4.     Kim Seung Hyup. Radiology Illustrated: Gynecologic Imaging 2nd ed. Springer-Verlag, New-York, 2012; 354.

5.     Wagner B.J., Woodward P.J., Dickey G.E. Gestational trophoblastic disease: radiologic-pathologic correlation. RadioGraphics. 1996; 16: 131-148.

6.     Mazur Michael Т., Kurman Robert J. Diagnosis of Endometrial Biopsies and Curettings: A Practical Approach., 2nd ed.. Springer. 2005; 67-99.

7.     Stern Jeffrey L. Trophoblastic Disease. Women's Cancer information center, Web site www.cancer.org от 26/9/2012.

8.     Meshherjakova L.A. Standartnoe lechenie trofoblasticheskoj bolezni [Standart treatment of trophoblastic disease] Prakticheskaja onkologija. 2008; 9(3): 160-170 [In Russ].

9.     Meshherjakova L.A. Zlokachestvennye trofoblasticheskie opuholi: sovremennaja diagnostika, lechenie i prognoz [Malignant trophoblastic tumors: modern diagnostics, treatment and prognosis] Dis.d-ra med. nauk. M.,2005 [In Russ].

10.   Cip N.P., Vorob'eva L.V. Hirurgicheskij metod v lechenii trofoblasticheskih opuholej [Surgical method in treatment of trophoblastic tumors]. Prakticheskaja onkologija. 2008; 9 (3): 179-185 [In Russ].

11.   Tasci Y., Dilbaz S., Secilmis O. et al. Routine histopathologic analysis of product of conception following first trimester spontaneous miscarriages. J. Obstet. Gynaecol. Res. 2005; 31(6) : 579-582.

12.   Callen Peter W., Saunders W.B. Ultrasonography in obstetrics and gynecology, 1994;621.

13.   Tatarchuk T.F., Sol'skij Ja.P. Jendokrinnaja ginekologija [Endocrinological gynecology]. Kiev: Zapovgg, 2003; 244 [In Russ].

14.   Mazur Michael Т., Kurman Robert J. Diagnosis of Endometrial Biopsies and Curettings: A Practical Approach., 2nd ed.. Springer, 2005; 67-99.

15.   Zhou Q., Lei XY, Xie Q., Cardoza J.D. Sonographic and Doppler imaging in the diagnosis and treatment of gestational trophoblastic disease: a 12-year experience. J. Ultrasound Med. 2005; 24(1):15-24.

16.   Kurjak A., Chervenak A. Fran. Donald School Textbook of Ultrasound in Obstetrics & Gynecology, 3rd Edition. Jaypee Brothers Medical Publishers, 2011; 158.

17.   Chekalova M.A. Ul'trazvukovaja diagnostika zlokachestvennyh opuholej tela matki [Ultrasound diagnostics of malignant uterus tumor]: Dis.d-ra med. nauk. M., 2,1998 [In Russ]. 

 

Abstract:

The article describes main epidemiological, clinical and morphological diagnostic features of a rare form of breast tumor - hamartoma. Current scientific data accompany results of own seven-year research. Diagnostic features (qualitative elastography) of breast hamartoma are described for the first time ever. Authors draw attention to morphological diversity of the breast hamartoma, which leads to complex radiological semiotics. 

 

References

 

1.     Malignant diseases in Russia in 2011 (morbidity and mortality). Edited by V.I. Chissov. V.V. Starinsky, G.V. Petrova. M.: FSBI «P.A. Herzen MSROI of the Ministry of Health and Social Development of the Russia», 2013; 289.

 

2.     Tavassoli F.A., Devilee P. (Eds.): World Health Organization classification of Tumours. pathology and genetics of tumours of the breast and female genital organs. IARC Press: Lyon. 2003; 103.

3.     Prym P. Pseudoadenome, Adenome and Mastome der weinblichen Brustdruse uber die Entstehung umschriebener adenomahnlicher Herde in die Mamma und uber die Nachahmung des Brustdrusengewebes durch echte Adenome und Fibroadenome. Beitr. Pathol. Anat. Pathol. 1928; 81: 221.

4.     Arrigoni M.G., Dockerty M.B., Judd E.S. The identification and treatment of mammary hamartoma. Surg. Gynecol. Obstet. 1971; 133: 577-582.

5.     Ruiz-Tovar J., Reguero-Callejas M.E., Arano-Bermejo J.I. et al. Mammary hamartoma. Cir. Esp. 2006; 79 (3): 186-188.

6.     Lee W.F., Sheen-Chen S.M., Chi S.Y. et al. Hamartoma of the breast: an underrecognized disease? Tumori. 2008; 94 (1): 114-115.

7.     Farrokh D., Hashemi J., Ansaripour E. Breast hamartoma: Mammographic findings. Iran J. Radiol. 2011; 8 (4): 285-260.

8.     Mizuta N., Sakaguchi K., Mizuta M. et al. Myoid hamartoma of the breast that proved difficult to diagnose: a case report. World J. Surg. Oncol. 2012; 10 (12): URL: http:www.wjso.com/content/10/1/12.

9.     Ravakhah K., Javadi N., Simms R. Hamartoma of the breast in a man: first case report. Breast J. 2001; 7 (4): 266-268.

10.   Harigopal M., Mudrovich S.A., Hoda S.A., Rosen P.P. Secondary tumors in mammary adenolipomas: a report of 2 unusual cases. Arch. Pathol. Lab. Med. 2003; 127 (3): e151-e154.

11.   Murugesan J.R., Joglekar S., Valerio D. et al. Myoid hamartoma of the breast: case report and review of the literature. Clin. Breast Cancer. 2006; 7: 345-346.

12.   Ko M.-S., Jung W.S., Cha E.S., Choi H.J. A rare case of recurrent myoid hamartoma mimicking malignancy: imaging appearances. Korean J. Radiol. 2010; 11 (6): 683-686.

13.   Kajo K., Zubor P., Danko J. Myoid (muscular) hamartoma of the breast: case report and review of the literature. Breast care. 2010; 5: 331-334.

14.   Ayva S.K., Ozturk F.K., Obut H. Adenohibernoma: a rare breast tumor. Int. J. Surg. Pathol. 2012; 20 (3): 280-283.

15.   Nasit J.G., Parikh B., Trivedi P., Shah M. Myoid (muscular) hamartoma of the breast with chondroid metaplasia. Indian J. Pathol. Microbiol. 2012; 55: 121-122.

authors: 


 

Article exists only in Russian.

 

Abstract:

Article describes the clinical case of a patient suffering from Takayasu's disease and stenotic lesion of the renal artery with early restenosis of renal artery after stenting, causes of mistakes in diagnosis and choice of treatment are also discussed.

 

References

1.     Клиническая ангиология. Под ред. акад. Покровского А.В. Москва. М., 2004; т. 1, с.697-734

2.     Caps M.T., Zierler R,E.,Polissar N.L. e.a. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int.1998; 53 (3):735-742.

3.     Olin J.W., Melia M., Young J.R. e.a. Prevalens of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Amer.J.Med. 1990; .88 (1):46-51.

4.     Sharma S.,Gupta H.,Saxena A. Results of renal angioplastic in nonspecific aortoarteritis (Taka- yasu disease). J. Vasc. Interv. Radiol. 1998; 9:429-435.

5.     Pokrovsky A.V., Sultanaliev T,A., Spiridonov A.A. Surgical treatment of vasorenal hypertension in nonspecific aortoarteritis (Takayasu disease). J.Cardiovasc. Surg. 1983; 24(1):111-118.

6.     Keiffer E., Piquois A., Bertal A. B. Reconstructive surgery of the renal arteries in Takayasu”s disease. Ann.vasc.surg. 1990; 4: 156-165.

7.     Liang P., Hoffman G.S. Advances in the medical and surgical treatment of Takayasu”s arteritis. Curr. Opin. Rheumatol.2005;17(1): 16-24.

8.     Ковалев И.А., Варваренко В.И., Мурзина О.Ю. Случай неспецифического аортоартериита у ребенка 3 лет. Педиатрия. 2005; 2:.88-90.

9.     Suk-Hee Yoo, Gi-Hyun Kim, Won-Ick Lee Successful percutaneous renal artery angioplasty and stenting for acute renal failure in a solitary functioning kidney caused by Takayasu”s arteritis. Korean Circ. J. 2010; 40(2): 414-417.

10.   Вачев А.Н., Сухоруков В.В., Фролова Е.В. Хирургическое лечение больного молодого возраста с артериальной гипертензией при неспецифическом аортоартериите с поражением почечных артерий. Ангиология и сосудистая хирургия. 2011; 4: 148-151. 

 

Abstract:

Aim. Was to demonstrate our experience of using the stent-assistant technology for treatment of thromboembolic complication during endovascular procedures in extra- and intracranial arteries.

Materials and methods. Five patients with thromboembolic complication were successfully treated using stent-assistant technology In one case thromboembolic complication appeared during stenting of ICA, another - during performing of diagnostic cerebral angiography In 3 cases thromboembolic complications appeared during endovascular occlusion of intracranial artery. In four cases we used stent Solitaire (Covidien) in one case - Enterprise (Codman).

Results. In all cases we achieved full restoration of blood flow in intracranial vessels. Three patients were discharged without any neurological deficit. Two patients were discharged with minimal neurological deficit (mRS 1).

Conclusion. Stent-assistant technology can be successfully used in treatment of thromboembolic complications during endovascular procedures in extra- and intracranial arteries.

 

References

1.     Connors J., Sacks D., Furlan A., et al. Training, competency, and credentialing standards for diagnostic сervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American academy of neurology, American association of neurological surgeons1, American society of interventional and therapeutic radiology, American society of neuroradiology, congress of neurological surgeons, AANS/CNS cerebrovascular section, and society of interventional radiology. Radiology. 2005; 234: 26-34.

2.     Qureshi I., Luft R., Sharna M., et al. Prevention and treatment of tromboembolic and ischemic complications associated with endovascular procedures: Part I. Pathophysiological and pharmacological features. Neurosurgery. 2000; 46: 1344-1359.

3.     Bracard S., Abdel-Kerim A., Thuillier L., et all. Endovascular coil occlusion of 152 middle cerebral artery aneurysms: initial and midterm angiographic and clinical results. J. Neurosurg. 2010; 112: 703-708.

4.     Fujii Y., Takeuchi S., Sasaki O., et al. Hemostasisin spontaneous subarachnoid hemorrhage. Neurosurgery. 1995; 37: 226-234.

5.     Blackham A., Meyers P., Abruzzo T., et al. Endovascular therapy of acute ischemic stroke: report of the standards of practice committee of the society of neurointerventional. J. NeturoIntevent. Surg. 2012; 4: 87-93.

6.     Costalat V., Machi P., Lobotesis K., et al. Rescue, combined, and stand-alone thrombectomy in the management of large vessel occlusion stroke using the solitaire device: a prospective 50-patient single-center study: timing, safety, and efficacy. Stroke. 2011; 42:1929-1935.

7.     Gonzalez F., Jabbour P., TJoumakaris S., et all. Temporary endovascular bypass: rescue technique during mechanical thrombolysis. Neurosurgery. 2012; 70: 245-252.

8.     Saver J., Jahan R., Levy E.I., et all. Primary results of the Solitaire With Intention for Thrombectomy (SWIFT) multicenter, randomised trial. Presented at the international stroke ranference 2012. 

 

Abstract:

The article presents a literature review of the use of optical coherence tomography in interventional cardiology. The method of optical coherence tomography is described in details, as well as its comparison with other methods of intravascular imaging. Direct results of the use of optical coherence tomography in clinical practice in the performance of percutaneous coronary intervention have been analyzed. Article describes possibilities of assessment of long-term results after interventional procedures using optical coherence tomography in patients with coronary heart disease. Article notes possibilities of using optical coherence tomography to assess the effectiveness of treatment of patients with atherosclerotic coronary pathology using biodegradable stents.

 

References:

1.     Hiram G. Bezerra., Marco A. Costa., Guagliuni G. et al. Intracoronary Optical Coherence Tomography: A Comprehencive Review: Clinical and Research Applications. J.Am.Col. Cardiol. Intv. 2009; 42:1035-1046.

2.     Rollings A.M.,Ung-arunyawee R., Chak A., Wong R.C.K., Kobayashi K., SWivak M.V., Izatt J.A. Real time in vivo imaging of human gastrointestinal ultrastructure by use of endoscopic optical coherence tomography with a novel efficient interferometer design. Opr.left. 1999;24(19): 1358-1360.

3.     Adam M., Nguyenet F. T., Daniel L. M. et.al. Optical coherence tomography: a review of clinical development from bench to bedside. Journal of Biomedical Optics. 2007; 12(5): 1-13.

4.     Stephen T. Sum, , Sean P. Madden, Michael J. Hendricks, BS, Steven J. Chartier, and James E. Muller, Near-infrared spectroscopy for the detection of lipid core coronary plaques. [Spektroskopija V Blizhne-Infrakrasnoj Oblasti V Vyjavlenii Nestabil'nyh Ateroskleroticheskih Bljashek V Koronarnyh Arterijah)]. Diagnosticheskaja i intervencionnaja radiologija. 2012; 6(2): 39-51 [In Russ].

5.     Barlis P. A., Gonzalo N., SerruysP.et al.Multi-Center Evaluation of the Safety of Intra-Coronary Optical Coherence Tomography. Eurointervention. 2009; 5: 90-95.

6.     Prati F., Imola F., Mallus M. et al. Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention. EuroIntervention.2010; 6:575-58.1

7.     Serruys P.W., Simon D. I., Costa M. et al. Clinical Research Compendium. A Summary of Cardiovascular Optical Coherence Tomography Literature. 2009; 3: 1-22.

8.     Prati F., Regar E., Gary Mintz S. et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. European Heart Journal. 2010; 31: 401-415.

9.     Kume T., Akasaka T., Kawamoto Т. е^ al. Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J2006; 152(4):755-4.

10.   Prati F., Cera M., Ramazzotti V. et al. Safety and feasibility- of a new non-occlusive technique for facilitated intracoronary optical coherence tomography (OCT) acquisition in various clinical and anatomical scenarios. Eurointerv. 2007;3:365-370.

11.   Gonzalo N., Patrick W., Serruys P.W., Peter Barlis., et al. Multi-modality intra-coronary plaque characterization: A pilot study. International Journal of Cardiology.2008; 138(1):32-9.

12.   Gonzalo N., Serruys P. W., Barlis P. et al. Multi-modality intra-coronary plaque characterization: A pilot study. 2008; Optical Coherence Tomography for the Assessment of Coronary Atherosclerosis and Vessel Response after Stent Implantation. 2010; 4.3:141-153.

13.   Chia S., Raffel O.C., Takano M. et al. Association of statin therapy with reduced coronary plaque rupture: An optical coherence tomography study. Coron Artery Dis. 2008; 19(4):237-42.

14.   Barlis P., Serruys P.W., Gonzalo N. et al. Assessment of culprit and remote coronary narrowings using optical coherence tomography with long-term outcomes. Am J Cardiol 2008; 15: 102(4):391-5.

15.   Jang I .K., Tearney G.J., MackNeill D. et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005; 111(12):1551-1555.

16.   MacNeill B., Briain D.,. Bouma B.E. et al.Focal and multifocal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J. Am. Coll. Cardiol. 2004; 44:972-9.

17.   Takarada S., Imanishi T., Kubo T. et al. Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: Assessment by optical coherencetomography study. Atherosclerosis. 2009; 202(2):4917.

18.   Kubo T., Imanishi T., Takarada S. et al. Assessment of culprit lesion morphology in acute myocardial infarction: Ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J. Am. Coll Cardiol.2001] 50(10):933-9.

19.   Larry J., Diaz-Sandov., Diaz-Sandoval. et al. Optical coherence tomography as a tool for percutaneous coronary interventions. Catheter Cardiovasc. Interv. 2005; 65(4):492-6.

20.   Gutierrez H., Arnold R., Gimeno F. et al. Optical coherence tomography: Initial experience in patients undergoing percutaneous coronary intervention. Rev. Esp. Cardiol. 2008; 61(9): 976-9.

21.   Tanigawa J., Barlis P., Kaplan S. et al. Stent strut apposition in complex lesions Using optical coherence tomography. Am. J. Cardiеl. 2006; 98(1) :97 M.

22.   Gonzalo N., Barlis P., Serruys P.W. et al. Incomplete Stent Apposition And Delayed Tissue Coverage Are More Frequent In Drug Eluting Stents Implanted During Primary Percutaneous Coronary Intervention For ST Elevation Myocardial Infarction Than In Drug Eluting Stents Implanted For Stable/Unstable Angina. Insights from Optical Coherence Tomography. Cardiovasc Interv. 2009; 2(5): 445-52.

23.   Gonzalo N., Serruys P.W. Optical coherence tomography (OCT) in secondary revascularisation: stent and graft assessment. Euro.Intervention. 2009; 5: D93-D100.

24.   Tanigawa J., Barlis P., Dimopoulos K., Di Mario. Optical coherence tomography to assess malapposition in overlapping drug-eluting stents. EuroInterv. 2008; 3: 580-583.

25.   Gonzalo N., Garcia-Garcia H.M., Serruys P.W. et al. Reproducibility of quantitative per strut stent analysis with OCT. EuroIntervention. 2009; 5(2): 224-32.

26.   Gonzalo N., Serruys P.W., Okamura T. et al. Optical Coherence Tomography Assessment Of The Acute E?ects Of Stent Implantation On The Vessel Wall. A Systematic Quantitative Approach. E.Heart. 2009; 95(23): 1913-1919.

27.   Gonzalo N., Serruys P.W., Okamura T. et al. Optical Coherence Tomography Patterns of Stent Restenosis. Am. Heart J. 2009; 158(2): 284-93.

28.   Gonzalo N., Serruys P.W., Okamura T. et al. Relation between plaque type and dissections at the edges after stent implantation: an optical coherence tomography study. Optical Coherence Tomography for the Assessment of Coronary Atherosclerosis and Vessel Response after Stent Implantation. 2010; 6.5:249-261.

29.   Xie Y., Takano M., Murakami D. et al. Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation. Am. J. Cardiol. 2008;102:27-31.

30.   Chen B.X., Ma F.Y., Luo W. et al. Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography. Heart. 2008; 94:566-70.

31.   Matsumoto D., Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur. Heart J. 2007; 28:96 1-7.

32.   Yao Z.H., Matsubara T., Inada T, et al. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography. Chin. Med. J. 2008;121:503-7.

33.   Takano M., Yamamoto M., Inami S. et al. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: douncovered struts persist. J. Am. Cardiol. 2008; 51(9):968-9.

34.   Finn A.V., Joner M., Nakazawa G. et al. Pathological correlates of late drug-elutingstent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115(18):2435-41.

35.   Stone G., Moses J.W., Ellis S.G. et al. Safety and ef?cacy of sirolimus- and paclitaxel-eluting coronary stents. J. Med. 2007; 356(10):998-10.

36.   Kubo T., Kitabata H., Kuroi A .et al. Comparison of vascular response after sirolimus eluting stent implantation between patients with unstable and stable angina pectoris. A serial optical coherence tomography study. J. Am. Coll. Cardiol. 2008;1.

37.   Guagliumi G., Sirbi V., Costa M.A. A Long -term Strut Coverage of Paclitaxel eluting Stents Compared with Bare-Metal Stents implanted During Primary PCI in Acute Myocardial infarction A PROSPECTIVE, Randomised, Controled Study Perfomed with OCT. Horizons- OCT. Circulation. 2008;118:231.

38.   Barlis P., Regar E., Serruys PW. et al. An Optical Coherence Tomography Study of a Biodegradable versus Durable Polymer-Coated Limus-Eluting Stent: A LEADERS Trial Sub-Study. Eur. Heart J. 2010; 31:165-76.

39.   Serruys PW., Ormiston J.A., Onuma Y. et al. Bioabsorbable everolimus-eluting system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009; 373(9667): 897-910. 

 

Abstract:

Since December 2010 till September 2012, 24 patients with III stage laryngeal carcinoma (T3_4NxxM0) underwent chemoradiation therapy Intra-arterial chemotherapy via both superior thyroid and laryngeal arteries with intermitting in 30-45 minutes infusions of cisplatin and 5-fluorouracil was done. Average doses of cisplatin consist 75mg/m2, and 5-fluorouracil dose was1000mg/m2. In 48 hours multifractional radiotherapy started (1,1Gy x 2 per day, 5 days per week) with planned total dose 74-78Gy Then total dose was 26-30Gy and 50Gy pauses for 2 or 3 days in radiotherapy established for repeated same intra-arterial chemotherapy In 21 patients (87,5%) total regress of the tumor was marked. In 3 patients (12,5%) sclerosis of residual volume developed without tumor cells in control biopsies. In the only patient (4,2%) after 6 months reoccurrence was marked and dissection laryngectomy managed. Stability of positive results we observe during 12 months following such chemoradiation therapy.

 

References

1.     Гаджиева А.К., Маджидов М.Г, Джамалутдинов Ю.А. Факторы риска рака гортани у населения разных климатогеографических зон южного региона Российской Федерации. Материалы XVII съезда оториноларингологов России, 26-28 апреля Санкт-Петербург. 2011;3:327-8.

2.     Шаньгина О.В., Сдвижков А.М., Кожанов Л.Г, Финкельштерн М.Р. Факторы риска развития рака гортани в странах восточной и Центральной Европы. Вопр.онкологии. 2007; 53(3):321-8.

3.     Пачес А.И. Опухоли головы и шеи. М.: Медицина. 2000; 467с.

4.     Brunin F., Rodriguez J., Jaulerry C. Laryngeal cancer and conservative treatment. Place of combined radiotherapy chemotherapy and modified fractionation radiotherapy. Bul Cancer. 1997; 84(2):191-8.

5.     Furness S., Glenny A.M., Worthington H.V., Pavitt S., Oiver R. et al. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. Cochrane Database Syst Rev.2010; Sept 8(9): CD006386. 20.

6.     Katori H., Tsukuda M., Taguchi T. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Cancer Chemother. Pharmacol. 2007;59(6): 789-94.

7.     Porceddu S.V. Is induction chemotherapy the new standard in organ preservation treatment for locally advanced head and neck cancer in 2010? Asia Pac. J. Clin. Oncol. 2010;6(2):75-6.

8.     Гаспарян С.А., Островерхов Г.Е., Трапезников Н.Н. Регионарная длительная внутриартериальная химиотерапия злокачественных опухолей. М.: Медицина. 1970; 207с.

9.     Пачес А.И. Регионарная внутриартериальная химиотерапия в лечении опухолей головы и шеи: Сб. науч. тр. М.: Медицина, 1971; 159с.

10.   Lee W.T., Alkureishi, Remco de Bree, Gary L. Ross RADPLAT: An alternative to Surgery? The Oncologist. 2006; 11(5): 469-80.

11.   Rapidis A.D., Trichas M., Stavrinidis E., Roupakia A. et al. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatine and 5-fluorouracil with a four-year follow-up. Oral. Oncol. 2006;42(7): 675-84.

12.   Van den Broek G.B., Balm A..J, van den Brekel M.W., Hauptmann M. et al. Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer. Radiother. Oncol. 2006; 81(2): 143-50.

13.   Corry J., Peters L.J., Rischin D. Optimising the therapeutic ratio in head and neck cancer. Lancet Oncol. 2010; 11(3): 287-91.

14.   Samant S., Robbins K.T., Kumar P. et al. Bone or cartilage invasion by advanced head and neck cancer: intra-arterial supradose cisplatin chemotherapy and concomitant radiotherapy for organ preservation. Arch. Otolarynogol. Head Neck Surg. 2001; 127: 1451-1456.

15.   Арыбжанов Д.Т., Сабуров А.Р. Непосредственные результаты неоадъювантной регионарной химиотерапии больных раком желудка. Диагностическая и интервенционная радиология. 2009; 3(3): 41-44.

16.   Balm A.J., Rasch C.R., Schornagel J.H. et al. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck. 2004; 26:485-93.

17.   Nashimura T., Sanada J., Furukawa M. Cervical radiculopathy due to inra-arterial unfusion of cisplatin. J. Laryngol. Otol. 2005; 119(8): 649-50.

18.   Madasu R., Ruckenstein M.J., Leake F., Steere E., Robbins K.T. Ototoxic effect of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer. Arch. Otolaryngol. Head and Neck Surg. 1997; 123(9): 978- 

 

Abstract:

Background: There are no randomized trials describing outcomes of multivessel percutaneous coronary interventions (PCI) (in primary anc staged revascularization) with second generation drug eluting stents (DES) in patients with ST-elevation myocardial infarction (STEMI). We are presenting preliminary results of randomized trial (NCT01781715)

Materials and methods: Six-month outcomes of 89 consecutive patients with STEMI and multivessel coronary artery disease (CAD) (SYNTAX 18.6±7.9 points) undergoing primary PCI with zotarolimus-eluting stents (Resolute Integrity; Medtronic) were studied. We used two strategies of multivessel stenting: in primary PCI (MS primary) and multivessel stenting in staged revascularisation (MS staged) (8.5±4.2 days).

Results: We evaluated results in the overall cohort of patients, including two study groups (MS primary and MS staged). During follow-up of 6 months there was no cardiac death in overall group. We observed 3 (3.4%) non-fatal myocardial infarction (MI) due to definite stent thromboses (ST) (1.3% on the number of stents). Target vessel revascularization (TVR) was performed in 2 cases (2.2%). Major adverse cardiac event (MACE) (cardiac death, MI, TVR) was diagnosed in 4.5%.

Conclusions: Resolute Integrity stents in STEMI patients with multivessel CAD are satisfactory safely and effectively as part of the strategy of multivessel stenting in primary PCI and multivessel staged PCI (8.5±4.2 days).

 

References

1.     Sorjja P., Gersh B.J., Cox D.A. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur. Heart J. 2007; 28:1709-16.

2.     Jang H.L., Hun S.P., Shung Ch.Ch. Wee Hyun Park and Korea Acute Myocardial Infarction Registry Investigators. Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Am. J. Cardiol. 2009;104:182-89.

3.     Rasoul S., Ottervanger J.P., de Boer M.J. Predictors of 30- day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Coron. Artery Dis. 2009; 20: 415-21.

4.     Webb J.G. Lowe A.M., Sanborn T.A. et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J.Am. Coll. Cardiol. 2003;42:138-86.

5.     Smith S.C., Jr., Feldman T.E., Hirshfeld J.W. Jr. et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Interventiondsummary article: a report of the AmericanCollege of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006;113:156-75.

6.     Ijsselmuiden A.J., Ezechiels J., Westendorp I.C., et al. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. Am.Heart.J. 2004;148:467-74.

7.     Politi L., Sgura F., Rossi R., et al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart. 2010; 96:662-67.

8.     Fox K., Garcia M.A., Ardissino D. Guidelines on the management of stable angina pectoris: executive summary. The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur. Heart J. 2006;27:1341-81.

9.     Gabriel S., Stefan K., James D.A. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). European Heart Journal. 2012. doi:10.1093/eurheartj/ehs215.

10.   Roe M.T., Cura F.A., Joski PS. Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am. J. Cardiol. 2001; 88:170-173.

11.   Corpus R.A., House J.A., Marso S.P et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am. Heart. J. 2004; 148:493-500.

12.   Widimsky P., Holmes Jr. David R. How to treat patients with ST-elevation acute myocardial infarction and multivessel disease? European Heart Journal Advance Access published November 30, 2010. European Heart Journal doi:10.1093/eurheartj/ehq410.

13.   Politi L., Sgura F., Rossi R. et al. A randomised trial of target-vessel versus multi-vessel revascularization in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart.2010;96:662-667.

14.   Varani E., Balducelli M., Aquilina M. et al. Single or multivessel percutaneous coronary intervention in ST-elevation myocardial infarction patients. Catheter Cardiovasc. Interv. 2008;72:927-933.

15.   Roe M.T., Cura F.A., Joski PS. Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am. J.Cardiol. 2001;88:170-173.

16.   Hannan E.L., Samadashvili Z., Walford G. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST- segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc. Interv. 2010; 3:22-31.

17.   Goldstein J.A., Demetriou D., Grines C.L. Multiple complex coronary plaques in patients with acute myocardial infarction. N. Engl. J. Med. 2000;343:915-22.

18.   Тарасов Р. С., Ганюков В. И., Шушпанников П. А. Исходы различных стратегий реваскуляризации у больных инфарктом миокарда с элевацией сегмента ST при многососудистом поражении в зависимости от тяжести поражения коронарного русла по шкале «- SYNTAX». Российский кардиологический журнал. 2013; 100(2):31-32. 

authors: 

 

Abstract:

 

Primary angioplasty in patients with ST elevation myocardial infarction reduces mortality and reinfarction rate. Immediate restoration of myocardial perfusion has a direct impact on one-year mortality Achieving TIMI 3 flow in epicardial arteries does not mean that the myocardial perfusion has normalized. In addition to that, it is vital to evaluate alternative markers such as rapid resolution of the ST-segment elevation and restoration of optimal distal flow, blush grade 2-3. The intracoronary infusion of adenosine, administered prior to the opening of the artery limiting the size of the infarction and decreases the incidence of no-reflow phenomenon. Direct stent implantation without pre dilation significantly minimizes the incidence of adverse effects. The Amicath catheter (IHT-Cordynamic, Spain) that we use in patients with ST elevation myocardial infarction allow us to obtain an effective myocardial reperfusion, in different clinical situations avoiding the displacement of the thrombus, or a distal embolism, and preventing the no-reflow phenomenon.

 

References

1.     Stone G.W., Grines C.L., Cox D., et al. A prospective, randomized trial comparing balloon angioplasty with or without abciximab to primary stenting with or without abciximab in acute myocardial infarction: primary endpoint analysis from the CADILLAC trial. Circulation 2000; 102: II-664 (abstract).

2.     Stone G.W., Peterson M.A., Lansky A.J., et al.. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J. Am. Coll. Cardiol. 2002 Feb. 20;39(4): 591-7.

3.     Napodano M., Pasquetto G., Saccа S., et al. Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction. J. Am. Coll. Cardiol. 2003; 42: 1395-1402.

4.     Svilaas T., Vlaar PJ., Iwan C., et al. Thrombus Aspiration during Primary Percutaneous Coronary Intervention. N. Engl. J. Med. 2008; 358:557-567 February 7, 2008 DOI: 10.1056/NEJ Moa 0706416.

5.     Mahaffey K.W., Puma J.A., Barbagelata N.A., et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J. Am. Coll. Cardiol. 1999 Nov 15; 34(6): 1711-20.

6.     Marzilli M., Orsini E., Maraccini P., Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation. 2000; 101: 2154-59.

7.     Loubeyre C., Morice M., Lefe'vre T., et al. A Randomized Comparison of Direct Stenting With Conventional Stent Implantation in Selected Patients With Acute Myocardial Infarction. JACC. 2002:39(1): 15-21.

8.     Gibson C.M., Maehara A., Lansky AJ., et al. Rationale and design of the INFUSE-AMI study: A 2Ч2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. Am. Heart. J. 2011 Mar; 161 (3): 478-486.e 7. doi: 10.1016/j. ahj. 2010.10.006. Epub 2011 Jan 28. 

 

Abstract:

In the treatment of macro-cystic forms of lymphangiomas, puncture methods have great value. Relapses occure in 50% of cases. The cause of lymphangiomas is the accumulation of liquid and spreading of cystic walls.

Aim. Was to develop and propose methods of interventional radiology in the diagnosis and treatment of macro-cystic lymphangiomas.

Materials and methods. In 2007-2011, in the radiological department of our hospital were examined and treated 31 children with macro-cystic forms of lymphangiomas. The proposed method of treatment was: puncture, catheterization of cyst, aspiration, performance of cystography and then sclerotherapy with 3% solute of Fibro-Vein or ethoxysclerol.Then - inserting active aspiration system into cyst. The system operated for 3-5 days, during which carried constant active aspiration with sclerotherapy sessions. The indications for catheter removal was the end of cyst liquid secretion. In 20 children we performed a single-stage treatment. In 6 - two-staged, and only in 5 cases, after the second phase of treatment, we observed a relapse of the disease, which leaded for the third phase of treatment.

Results. Good results were achieved in 15 of 19 children with lymphangioma of the head and neck, satisfactory - in 4 children. Unsatisfactory results were not noticed. In children with lymphangioma of internal organs a good result was achieved in 11 cases of 12. Only in 1 case remained a small residual cavity

Conclusion. The method of active aspiration of macro-cystic lymphangiomas showed very good results. The use of techniques of interventional radiology in the diagnosis of macro-cystic forms of lymphangiomas can assess the condition, shape and size of the cyst, and spend the most effective treatment. The use of interventional techniques as an alternative to surgical excision of the lymphangioma can significantly improve the quality of life.

 

References

1.     Schwartz R.A., Fern6ndez G. Lymphangioma. Medicine Dermatology [Journal serial online]. 2009. November 13 [cited 2009 Dec 9]. Available at ttp://emedicine.medscape.com/article/1086806-overview.

2.     Eijun Itakura & Hidetaka Yamamoto & Yoshinao Oda & Masutaka Furue & Masazumi Tsuneyoshi. VEGF-C and VEGFR-3 in a series of lymphangiomas: Is superficial lymphangioma a true lymphangioma? Virchows Arch. (2009) 454:317-325 DOI 10.1007/s00428-008-0720-8.

3.     Flanagan B.P., Helwig E.B. Cutaneous lymphangioma. Arch. Dermatol. 1977;113:24-30.

4.     Bond J., Basheer M.H., Gordon D. Lymphangioma circumscriptum: pitfalls and problems in definitive management. Dermatol. Surg. 2008;34:271-5.

5.     Khan Z.A., Melero-Martin J.M., Wu X. et al Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood. 2006;108:915-921.

6.     Weiss S.W., Goldblum J.R. Enzinger and Weiss’s soft tissue tumors, 4th edn. Mosby. St. Louis, MO. 2001. 

 

Abstract:

An important clinical challenge the management of patients with pulmonary embolism is to determine prognosis of the treatment generally, and thrombolytic reperfusion therapy as the main component of a specific pathogenetic treatment in particular. This knowledge is necessary to adjust the plan of remedial measures, the intensification of concomitant pharmacotherapy and provide a personalized approach to patients with thromboembolic lesions of the pulmonary circulation

Aim: was to identify reliable predictors of the onset of reperfusion in patients with pulmonary thromboembolism based on methods of radiographic diagnosis.

Materials and Methods: 138 patients (73 women and 65 men) underwent examination. Age of patients ranged from 20 to 80 years (mean age 55±25 years). The first group includes observation of 102 patients admitted to hospital in early stages of disease ( 1 month after onset of symptoms). The second group consisted of 36 patients admitted to the hospital at a later date (from 1.5 to 12 months). In groups we studied predictors of pulmonary reperfusion channel on the basis of direct angiography and multislice computed tomography As a control, a diagnostic method used direct angiography, which has a high sensitivity and specificity in identifying symptoms of pulmonary embolism. Using the method of multiple logistic regression odds ratios were prepared to achieve reperfusion in patients with certain diagnostic symptoms compared with patients who have no signs data in angiography

Results: diagnostic criteria, in presence of which on angio-pulmonography significantly increased the likelihood of reperfusion are «amputation» of segmental branches of the pulmonary artery ( p<0.05, 16,55(6,50-42,09 ) ), intraluminal defects of contrast staining (p < 0.05, 30.56 (8,66-107,84)) and the absence of distal blood flow (p<0,05; 6,16(2,47-15,40)). Signs, significantly reducing chances of achieving reperfusion are tortuosity of segmental branches of the pulmonary artery (p<0,05; 0,03(0,01-0,08)), slowing of contrast branches of the pulmonary artery (p<0,05; 0,11( 0.05-0.25)), and the presence of defects in the near-wall staining (p<0,05; 73,182 (9,606-557,542)).

Conclusions: basing on results of modern beam-diagnostics may reliably predict the likelihood of reperfusion in patients with pulmonary embolism.

 

Список литературы:

1.     Котельников М.В. Тромбоэмболия легочной артерии (современные подходы к диагностике и лечению). М.: Медицина. 2002; 136.

2.     Рекомендации Европейского Кардиологического Общества (ЕКО) по диагностике и лечению тромбоэмболии легочной артерии (ТЭЛА). European Heart Journal. 2008; 29: 2276-2315.

3.     Darryl Y. Sue, MD (ed.): Pulmonary Disease. In Frederic

S.    Dongard, MD (ed.): Current: Critical Care Diagnosis & Treatment. US: А Lange medical book. First Edition. 496.

4.     Kline JA, SteuerwaldMT, Marchick MR, et al. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. Chest. 2009; 136: 1202-1210.

5.     Grifoni S., Olivotto I. et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2000; 101: 2817-2822.

6.     Kreit J.W. The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism. Chest. 2004; 125: 1539-1545.

7.     Савельев В.С., Яблоков Е.Г, Кириенко А.И., Массивная эмболия легочных артерий. М.: Медицина. 1990; 336 


Abstract:

Laser Doppler flowmetry with functional tests and radionuclide clearance method can objectively measure the degree of microcirculatory disturbances in chronic venous insufficiency of lower limbs and to estimate perspectiveness of conservative therapy Methods allow to evaluate the microcirculation and may be applied in assessment of venous diseases, but radionuclide method has limitation in wide use.

 

References

1.     Кириенко А.И., Богачев В.Ю., Гаврилов С.Г Хронические заболевания вен нижних конечностей у работников промышленных предприятий г. Москвы. Ангиология и сосудистая хирургия. 2004; 10(1): 77-85.

2.     Савельев В.С., Гологорский В.А., Кириенко А.И. Флебология. Руководство для врачей. М.: «Медицина» 2001; 661.

3.     Ruckley C.V. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology. 1997; 48: 67-69.

4.     Савельев B.C.. Кириенко А.И.,. Богачев В.Ю. Венозные трофические язвы: мифы и реальность. Флеболимфология. 2000;11: 5-10.

5.     Крупаткин А.И., Сидоров В.В. Лазерная допплеровская флоуметрия микроциркуляции крови - М. Медицина, 2005; 94-110.

6.     Романовский А.В., Современное лечение больных варикозной болезнью нижних конечностей. Материалы II конференции Ассоциации флебологов России,

7.     Тверь. 1999; 68с. Покровский А.В. Значение оценки состояния микроциркуляции в клинической практике. Ангиология и сосудистая хирургия (приложение). 2004; 3: 3-4.

8.     Belcaro G., Cerarone M.R., De Sactis M.T. et al. Laser Doppler and transcutaneous oxymetry: modern investigations to assess drug efficacy in chronic venous insufficiency. Int. J. Microcirculation. 1995; 15 (1): 45-49.

9.     Куприянов В.В., Караганов Я.Л., Козлов В.И. Микроциркуляторное русло - М. Медицина, 1975. 213 с.

10.   Козлов В.И., Гурова О.А. Динамика микро-циркуляторных реакций при тепловой пробе. Материалы третьего всероссийского симпозиума «Применение лазерной допплеровской флоуметрии в медицинской практике». 2000; 77-78.

11.   Mayer M.F., Rose C.J., Hulsmann J.-O., Schatz h., Pfonl M. Impaired 0.1 - Hz vasomotion assessed by laser Doppler anemometry as an early index of peripheral sympathetic neuropathy in diabetes. Microvascular. Research. 2003; 65: 88-95.

12.   Наставшева О.Д. Регионарная макро и микрогемодинамика при ХВН нижних конечностей. Автореферат на соискание ученой ст. к. мед. наук. 2006. 

 

 

Abstract:

Acute severe pancreatitis remains one of the actual issue in urgent surgery Forecast of the disease is dependant on spread of purulent necrotic process in pancreas and retroperitoneal tissues. Therefore diagnosis of purulent complications becomes extremely important.

The aim of the study was to demonstrate and evaluate features of ultrasonography in diagnosis and treatment strategy definition of purulent necrotic complications of acute severe pancreatitis.

Materials and methods. The study included 115 patients with acute destructive pancreatitis aged of 21-81 years The major part of them (50%) were persons at most able-bodied (working) aged 32-59 years. All patients underwent ultrasound diagnostics for determination the spread of pathology and detection of complications of the disease.

Ultrasound scanning was carried out as follows:

1. inspection of pancreatic parenchyma;

2. inspection of cellular tissues;

3. detection of free liquid in the abdominal cavity;

4. evaluation of the abdomen and kidneys;

5. inspection of the pleural cavity

Results. Examination of the parenchyma revealed that the pancreas was often inlarged, had a fuzzy, uneven contours and heterogeneous structure. However, it should be noted that in some cases, the pancreas was normal size and structure. Infected necrosis, acute liquid accumulation and/or free liquid in the abdominal cavity had occurred in 100% of cases in various combinations during examination of cellular tissues. Regarding the abdominal organs following complications were revealed: obstructive jaundice - in 5(4.3%) cases; portal vein thrombosis - in 1 (0.9%) case; splenic abscess - in 1 (0.9%) case. The presence of liquid in the pleural cavity was determined by leaves dissociation of the parietal and visceral pleura. The volume of the liquid was determined according standard classification.

Conclusion. Ultrasound scanning allows to determine the presence and extent of local complications arising at the stage of purulent necrotic complications of acute severe pancreatitis and general complications as a result of systemic pathological effect on the body of the disease.

 

References

1.     Охотников О.И. Перкутанная диапевтика в неотложной абдоминальной хирургии органов панкреато-билиарной зоны. Автореф. ... дис. докт. мед. наук. Воронеж. 1998; 39 с.

2.     Echenique A.M., Sleeman D., Yrizarry J. et al. Percutaneous catheter-directed debridement of infected pancreatic necrosis in 20 patients. J. Vase. Interv. Radiol. 1998; 9: 565-571.

3.     Затевахин И.И., Цициашвили М.Ш., Будурова М.Д. Комплексное ультразвуковое исследование при остром панкреатите. Анналы хирургии. 1999; 3: 36-42.

4.     Scaglione M., Casciani E., Pinto A. et al. Imaging Assessment of Acute Pancreatitis. Semin Ultrasound CT MRI. 2008; 29:322-340.

5.     Багненко С.Ф., Курыгин А.А., Синенченко ГИХирургическая панкреатология. Санкт-Петербург: Речь. 2009; 608 с.

6.     Loser C., Folsch U.R. Acute pancreatitis: medical and endoscopic treatment. Pancreatic disease. State of the art and future aspects of research. 1998; 12: 66-78.

7.     Martines-Noguera A., Mohtserat E., Torruba S. etal. Ultrasound of the pancreas: update and controversies. Eur. Radiol. 2001; 11: 1594-1606.

8.     Mortele KJ, Girshman J, Szejnfeld D, et al. CT-guided percutaneous catheter drainage of acute necrotizing pancreatitis: clinical experience and observations in patients with sterile and infected necrosis. AJR Am. J. Roentgenol. 2009; 192(1): 110-116.

9.     Kumar P., Mukhopadhyay S., Sandhu M. et al. Ultrasonography computed tomography and percutaneous intervention in acute pancreatitis: A serial study. Austral. Radiology. 1995; 39(2): 145-152.

10.   Balthazar E.J., Freeny P.C., van Sonnenberg E. Imaging and intervention in acute pancreatitis. Radiology. 1994; 193: 297-306.

11.   Mortele K.J., Wiesner W., Intriere L. et al. Modified CT severity index for evaluating acute pancreatitis: improved correlation with patient outcome. Am. J. Roentgenol. 2004; 183(5): 1261-1265.

12.   Bharwani N., Patel S., Prabhudesai S. et al. Acute pancreatitis: The role of imaging in diagnosis and management. Clinical Radiology.2011; 66: 164-175.

13.   De Waele J.J., Delrue L., Hoste E.A. et al. Extrapancreatic inflammation on abdominal computed tomography as an early predictor of disease severity in acute pancreatitis: evaluation of a new scoring system. SourcePancreas. 2007; 34 (2): 185-190.

14.   Биссет Р., Хан А. Дифференциальный диагноз при абдоминальном ультразвуковом исследовании. Пер. с англ. под ред. С.И. Пиманова. М.: Медицинская литература. 2001; 272 с.

15.   Бенсман В.М. Облегченные способы статистического анализа в клинической медицине. Краснодар: Издательство КГМА. 2002; 30 с.

16.   Кармазановский ГГ, Степанова Ю.А. Классификация острого панкреатита - современное состояние проблемы и нерешенные вопросы. Медицинская визуализация. 2011; 4: 133-137.

17.   Сидорова Ю.В., Шабунин А.В., Араблинский А.В., Шиков Д.В., Бедин В.В., Лукин А.Ю. Острый панкреатит: некоторые вопросы диагностики и лечения. Диагностическая и интервенционная радиология. 2011; 5(2): 15-26. 

keywords: 

 

Abstract:

Aim: the aim of this study was to evaluate the diagnostic possibilities of the dynamic MDCT in the differential diagnosis of gastric diseases compared with conventional upper gastrointestinal barium study and endoscopy

Materials and methods: 130 patients with different gastric lesions underwent dynamic MDCT The detection rate of the gastric lesion and the diagnostic accuracy of each method were calculated by the use of surgical and histopathologic results as reference standards.

Results: diagnostic accuracies of methods in the differential diagnosis of gastric tumors with exophytic growth were: endoscopy - 91%, barium study - 50%, MDCT - 87%; in the differential diagnosis of ulceration: endoscopy - 78%, barium study - 84%, MDCT - 93%; and in the diagnosis of diffuse type of gastric cancer: endoscopy - 82%, barium study - 75%, MDCT - 100%.

Conclusion: integration of the dynamic MDCT in algorithms of diagnostics of gastric lesions can improve detection rates of stomach diseases and the accuracy of their differential diagnosis.

 

References

1.     Davidov M.I., Aksel’ E.M. The incidence of malignant tumors of the Russian population in 2009. Vestnik RONC N.N. Blokhina. 2011; 3(app 1): 60-65.

2.     Портной Л.М., Вятчанин О.В., Сташук ГА. Новые взгляды на лучевую диагностику рака желудка (методико-семиотические и организационные аспекты). М.: Видар-М, 2004; 284 с.

3.     Andaker L., Morales O., Hojer H., et al. Evaluation of preoperative computed tomograghy in gastric malignancy. Surgery. 1991; 109: 132-135.

4.     Chen C-Y., Hsu J-S., Wu D-C., et al. Gastric cancer: preoperative local staging with 3D multi-detector row CT- correlation with surgical and histopathologic results. Radiology. 2007; 242: 472-482.

5.     Kim A.Y., Kim H.J., Ha H.K. Gastric cancer by multidetector row CT: preoperative staging. Abdom. Imaging. 2005; 30: 465-472.

6.     Kim J.H., Eun H.W., Goo D.E., et al. Imaging of various gastric lesions with 2D MPR and CT gastrography performed with multi detect or CT. RadioGraphics. 2006; 26: 1101-1118.

7.     Insko E.K., Levine M.S., Birnbaum B.A., Jacobs J.E. Benign and malignant lesions of the stomach: evaluation of CT criteria for differentiation. Radiology. 2003; 228: 166-171.

8.     Ba-Ssalamah A., Prokop M., Uffmann M., et al. Dedicated multidetector CT of the stomach: spectrum of diseases. RadioGraphics. 2003; 23: 625-644.

9.     Бурдюков М.С., Нечипай А.М., Чистякова О.В., Юричев И.Н., Ульянов Д.Н. Тонкоигольная пункция под контролем эндоскопической ультрасонографии в онкологической практике. Диагностическая и интервенционная радиология, 2007; 1(4): 19-30.

10.   Gurin N.N., Logunov K.V. The effectiveness of differential diagnosis of benign and malignant gastric ulcers by endoscopy. Terapevticheskii arhiv. 1998; 4: 37-40.

11.   Черноусов А.Ф., Волынчик К.Е. Роль хронической язвы желудка в канцерогенезе. Рос. журн. гастроэнтерол., гепатол. и колопроктол. 2004; 3: 53-59. (Chernousov A.F., Volinchik K.E. The role of chronic gastric ulcer in carcinogenesis. Rossiiskii gurnal gastroenterologii, gepatologii i koloproktologii. 2004; 3: 53-59).

12.   Voutilainen M.E., Juhola M.T. Evaluation of the diagnostic accuracy of gastroscopy to detect gastric tumours: clinicopathological features and prognosis of patients with gastric cancer missed on endoscopy. Eur. J. Gastroenterol. Hepatol. 2005; 17(12): 1345-9.

13.   Kim Y.N., Choi D., Kim S.H., et al. Gastric cancer staging at isotropic MDCT including coronal and sagittal MPR images: endoscopically diagnosed early vs. advanced gastric cancer. Abdom. Imaging. 2009; 34: 26-34. 

 

Abstract:

Despite the comparatively low morbidity rate, skin melanoma is known for its high mortality rate. High metastatic potential of the tumor, urges the necessity of improving methods of diagnostics, which can identify metastasis and assess the degree of dissemination at the early stage of disease.

We have analyzed results of ultrasound imaging of one of the earliest and frequent types of progression of melanoma - metastasis in regional lymphatic nodes. The article presents results of examination of 182 patients with skin melanoma with early metastasis in lymphatic nodes, also - characteristics of the image of tumor changes are described.

The high informativeness of ultrasound research for timely identification of metastatic changes and, respectively, the increase of the rate of survival of patients with skin melanoma are demonstrated.

 

References

1.     American Cancer Society.: Cancer Facts and Figures 2012. [Электронный ресурс]//Atlanta, Ga: American Cancer Society, 2012. URL: http://www.cancer.org/Research/ CancerFactsFigures/CancerFactsFigures/cancer-facts-figures-2012 (дата обращения: 21.12.2012)

2.     Balch C.M., Gershenwald J.E., Soong S.J., Thompson J.F., Atkins M.B., Byrd D.R., et al. Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol. 2009; 27(36): 6199-6206.

3.     College of American Pathologists (CAP). Protocol for the Examination of Specimens from Patients with Melanoma of the Skin [Электронный ресурс]//Version 3.2.0.0. June 2011. URL: http://www.cap.org/apps/ docs/committees/cancer/cancer_protocols/2012/ SkinMelanoma_12protocol.pdf (дата обращения: 2012.12.21)

4.     Thompson J.F, Shaw H.M. Sentinel node mapping for melanoma: results of trials and current applications. Surg. Oncol Clin. N. Am. 2007;16(1): 35-54.

5.     Ferrone C.R., Panageas K.S., Busam K. et al. Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann. Surg. Oncol. 2002; 9(7): 637-645.

6.     Gershenwald J.E., Mansfield P.F., Lee J.E. et al. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma. Ann. Surg. Oncol. 2000; 7(2): 160-165.

7.     O’Brien CJ., Uren R.F, Thompson J.F. et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am. J. Surg. 1995; 170(5): 461-466.

8.     Uren R.F. Lymphatic drainage of the skin. Ann. Surg. Oncol. 2004; 11(3 Suppl): 179-185.

9.     Blum A., Schlagenhauff B., Stroebel W. et al. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma. Cancer. 2000; 88 (11): 2534-2539.

10.   Voit C.A., Van Akkooi A.C.J., Sc^fer-Hesterberg G. et al. Ultrasound Morphology Criteria Predict Metastatic Disease of the Sentinel Nodes in Patients With Melanoma. J. Clin. Oncology. 2010; 28 (5): 847-852.

11.   Voit C.A., van Akkooi A.C.J., Schaefer-Hesterberg G. et al. Rotterdam criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration (FNAC) cytology: Can US-guided FNAC replace SN staging in patients with melanoma? J. Clin. Oncol. 2009; 27: 4994-5000.

12.   Струков А.И., Серов В.В. Патологическая анатомия. 4-е изд. М.: Медицина, 1995. 688. 

 

 

Abstract:

Successful endovascular occlusion of iatrogenic arteriovenous fistula of the iliac artery and vein with tromboembolic syndrome and right ventricular insufficiency, occurred after surgical intervention on spine (mircodiscectomy of L4-L5, decompression of L5 radix). Disease spreaded under clinic of tromboembolic syndrome with formation of arteriovenous fistula and manifested like thromboembolic syndrome with right ventricular insufficiency.

 

References

1.     Papadoulas S., Konstantinou D., Kourea H.P, et al. Vascular injury complicating lumbar disc surgery: a systematic review. Eur. J. Vasc. Endovasc. Surg. 2002; 24: 189-195.

2.     Fruhwirth J., Koch G., Amann W., et al. Vascular complications of lumbar disc surgery. Acta Neurochir/ (Wien). 1996; 138: 912-916.

3.     Jarstfer B.S., Rich N.M. The challenge of arteriovenous fistula formation following disk surgery: a collective review. J. Trauma. 1976; 16: 726-733.

4.     Palmon S.C., Moore L.E., Lundberg J., Toung T. Venous air embolism: a review. J. Clin. Anesth. 1997; 9: 251-257.

5.     Goodkin R., Laska L.L. Vascular and visceral injuries associated with lumbar disc surgery: medicolegal implications. Surg. Neurol. 1998; 49: 358-372.

6.     Quigley T.M., Stoney R.J. Arteriovenous fistulas following lumbar laminectomy: the anatomy defined. J. Vasc. Surg. 1985; 2: 828-833.

7.     Jarstfer B.S., Rich N.M. The challenge of arteriovenous fistula formation following disk surgery: a collective review. J. Trauma. 1976; 16: 726-732.

8.     Ewah B., Calder I. Intraoperative death during lumbar discectomy. Br. J. Anaesth. 1991; 66: 721-723.

9.     Brewster D.C., May A.R., Darling R.C., et al. Variable manifestations of vascular injury during lumbar disk surgery. Arch. Surg. 1979; 114: 1026-1030.

10.   Epstein F.H., Post R.S., McDowell M. The effect of an arteriovenous fistula on renal hemodynamics and electrolyte excretion. J. Clin. Invest. 1953; 32: 233-241.

11.   McCarter D.H., Johnstone R.D., McInnes G.C., et al. Iliac arteriovenous fistula following lumbar disc surgery treated by percutaneous endoluminal stent grafting. Br. J. Surg. 1996; 83: 796-797.

12.   Burger T., Meyer F., Tautenhahn J., et al. Percutaneous treatment of rare iatrogenic arteriovenous fistulas of the lower limbs. Int. Surg. 1998; 83, 198-201. 

 

 

Abstract:

This case report is about endovascular treatment of pulmonary arteriovenous malformations accompanied by severe arterial hypoxemia in the newborn. The peculiarity of this case is the extreme rarity of manifestation and successful treatment of the pathology in infancy The second feature was the use of vascular occlude devices. Currently due to the sporadic clinical observations in newborn, we consider to appropriate description of this case, focusing on the technical aspects of the intervention. 

 

References

1.     Khurshid I., Downie G. Pulmonary arteriovenous malformation. Postgrad Med J 2002; 78:191-7.

2.     Andrade C., Ferreira H., Fischer G. Congenital lung malformations. Bras. Pneumol. 2011; 37: 259-271.

3.     Churton T., Multiple aneurysms of pulmonary artery. BMJ. 1897; 1: 1223.

4.     Mitchell R., Austin E. Pulmonary arteriovenous malformation in the neonate. J. Pediatr. Surg. 1993; 28: 1536-1538.

5.     Porstmann W. Therapeutic embolization of arteriovenous pulmonary fistula by catheter technique. Current concepts in pediatric radiology. Springer. 1977; 23-31.

6.     Pollak J.S., Saluja S., Thabet A. et al. Clinical and Anatomic Outcomes after Embolotherapy of Pulmonary Arteriovenous Malformations. J. Vasc. Interv. Radiol. 2006; 17: 35-45.

7.     Cirstoveanu C., Balomir A., Bizubac M., Costinean S. Pulmonary arteriovenous malformation - a rare cause of hypoxemia. Practic. Med. 2012; 7: 28.

8.     Koppen S., Korver C., Dalinghaus M., Westermann C. Neonatal pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasia. Arch. Dis. Child. Fetal Neonatal Ed. 2002; 87: 226-227.

9.     Guidone P., Burrows P., Blickman J. Pediatric case of the day. Congenital pulmonary arteriovenous malformation. Am. J. Roentgenol. 1999; 173: 818-819.

10.   Trivedi K., Sreeram N. Neonatal pulmonary arteriovenous malformation. Arch. Dis. Child. 1996; 74: 80.

11.   Ravasse P., Maragnes P., Petit T., et al. Total pneumonectomy as a salvage procedure for pulmonary arteriovenous malformation in a newborn: report of one case. J. Pediatr. Surg. 2003; 38: 254-255.

12.   Trerotola S., Pyyeritz R . PAVM Embolization: An Update. AJR. 2010; 195: 837-845

13.   Swanson K., Prakash U., Stanson A. Pulmonary arteriovenous fistulas: Mayo Clinic experience. Mayo Clinic Proc. 1999; 74: 671-680.

14.   Shapiro J., Paul C. Stillwell - Diffused Pulmonary arteriovenous malformation (Angiodysplasia) with unusual histologic features: Case report and review of the literature. Pediatric Pulmonology 1995; 21: 255-261.

15.   Белозеров Ю.М., Детская кардиология. М.: Медпрессинформ. 2004;167-180. Belozerov Ju. M., Detskaja kardiologija [Pediatrics cardiology]. M.: Med-pressinform. 2004;167-180 [In Russ]. 

 

 

Abstract:

Aim: was to improve results of a semi-closed loop endarterectomy from the superficial femoral artery (SFA).

Materials and methods: study is based on results of the examination and treatment of 85 patients with obliterating atherosclerosis of lower limbs, who underwent operations in FGBI «Russian Scientific Center of Radiology and Surgical Technologies» Health Ministry from 2008 to 2012.

All patients included in the study were divided into 2 groups :

• Main group - 30 patients operated on by a combination loop endarterectomy with simultaneous implantation of endovascular stent-grafts in SFA .

• The control group - 55 patients operated on a routine procedure loop endarterectomy .

Patients included in the comparison group were matched by gender, age, comorbidity , stage of ischemia and the outflow channel .

Results: The primary patency of the reconstructed area in the main group at 1 year was 73% after 1 years - 63% , cumulative - 76% at 1 year and 70% at 2 years, the limb is stored in 90% of cases (at 1 and 2 years of follow). Patients in the control group remained SFA patency at 1 year in 43% of cases, after 2 years - 32%.

Conclusion: Post-endarterectomy stent placement in SFA significantly improved results of loop endarterectomy

With a diameter of 8 mm and PBA more loop endarterectomy with implantation of stent grafts is a clinically and economically feasible. 

 

References

1.     Pokrovskiy A.V. Clinical angiology. Part II. M.: Medicina 2004, p.184

2.     National Recommendations for treating patients with Peripheral Arterial Disease. М.: Izdatelstvo NCSSKha im. A.N.Baculeva RAMN, 2010, 78 [In Russ].

3.     Flu H., van der Hage J.H., Knippenberg B. et al. Treatment for peripheral arterial obstructive disease: An appraisal of the economic outcome of complications. J. Vasc. Surg., 2008, 48, 368-376.

4.     TASC Working group. Management of peripheral arterial disease (PAD): TransAtlantic Inter-Society Consensus (TASC). Management Eur. J. Vasc. Endovasc. Surg. 2000; 19 Suppl: 1.

5.     Cotroneo A.R., Iezzi R., Marano G. Hybryd therapy in patients with complex peripheral multifocal stenoobstructive vascular desease: two-year results. Cardio-vasc. Intervent. Radiol., 2007, 30(3), 355-361.

6.     Haimovici H., Ascher E. Haimovici's vascular surgery, fifth ed. Wiley-Blackwell, 2003, 139, 534.

7.     Bockeria L.A., Temrezov M.B., Kovalenko V.I., Chemurziev Surgical treatment of patients with lower limbs arteries atherothrombotic lesions - graft choice for femoral-popliteal anastomosis. Annaly Khirurgii, 2010, 2, 5-8 [In Russ].

8.     Gavrilenko A.V., Skrylev S.I. Surgical management of patients with lower limb critical ischaemia induced by lesions of infrainguinal arteries J.Angiology and vascular surgery, 2008, 14 (3), 111-117 [In Russ].

9.     Morris-Stiff G., D'Souza J., Raman S. Update experience of surgery for acute limb ischaemia in a district general hospital - are we getting any better? Ann. R. Coll. Surg. Engl., 2009, 91(8), 37-40.

10.   Tagelder M.J. Risk factors for occlusion of infrainguinal bypass grafts. Eur. J. Vasc. Endovasc. Surg., 2000, 20(2), 118-124.

11.   Klinkert E.L., Post P.N., Breslau P.J. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur. J. Vasc. Endovasc. Surg., 2004, 27(4), 357-362.

12.   Rutherford R.B., Baker J.D., Ernst C.J. Recommended standarts for report dealing with lower extremity ischemia: revised version. J. Vasc. Surg., 1997, 26(3), 517-538.

13.   Szilagyi D.E., Smith R.F., Elliott J.P. Infection in arterial reconstruction with synthetic grafts. Ann. Surg., 1972, 176 (3), 321-333.

14.   Pokrovsky A.V., Dan V.N., Zotikov A.E. Femoropopliteal bypass above popliteal fossa with PTFE graft: which graft diameter is better? J. Angiology and vascular surgery, 2008, 14(4), 105-108 [In Russ]. 

 

 

Abstract:

A literature review is devoted to endovascular treatment of occlusive and stenotic lesions in arteries of femoral-popliteal segment.

Currently, 2-3% of the RF population suffer from atherosclerotic lesions of arteries of lower limbs. In the structure of cardiovascular disease, atherosclerosis of lower limbs has the level about 20%. In 82% the cause of vascular disease is atherosclerosis. In the structure of atherosclerotic arterial disease of lower limbs more often (47% to 65%) occurs defeat of the femoral-popliteal segment particularly in patients older than 60 years; that is confirmed by numerous statistical observations. The aim of the article was to compare results of endovascular treatment of arterial lesions of the femoral-popliteal segment.

This article presents results of a solo balloon angioplasty, balloon angioplasty with drug-eluting balloons, subintimal angioplasty, stenting drug-eluting and bare-metal stents, cryo-plastics,catheter atherectomy, hybrid interventions and compare results of open and endovascular interventions. Data of STAR register, published in 2001, show that the correction of lesions category C, TASC II, using balloon angioplasty is quite possible to count on similar results in category B.

According to Conrad M. et.al, Amato B. et.al and Dey C., despite the high incidence of the primary success of endovascular interventions for femoral-popliteal segment long-term results often look depressing.

Great importance is given to study the possibility of the use of drug-eluting stents, which have proven effectiveness in suppressing the inflammatory response and intimal hyperplasia after stenting of coronary arteries, as evidenced by research SIROCCO, SIROCCO II, STRIDES, Zilver PTX. Thus, the use of drug-eluting stents in the femoral-popliteal segment did not reduce the frequency of restenosis.

THUNDER, FemPac and LEVANT researches indicate that drug-eluting balloons provide some benefits that are absent in other endovascular techniques such as solo balloon angioplasty and stenting.

The final stage of a multicenter randomized trial BASIL, which carried out a comparative analysis of FPB and PTA groups, was reached in 2010. As a result, the preservation of limbs and survival did not differ significantly

Thus, the literature report reveals a clear tendency of domination of endovascular strategies in defeated limb blood-flow recovery Minimally invasive balloon angioplasty and stenting compared with results of bypass operations, reconstructions - is not worse and consider endovascular treatment strategy in the surgical treatment of femoral-popliteal segment to be method of first choice. 

 

References

1.     Pokrovskij A.V., Koshkin V.M., Kirichenko A.A. i dr. Vazaprostan (prostaglandin E1) v lechenii tjazhelyh stadij arterial'noj nedostatochnosti nizhnih konechnostej. [Vazaprostan (prostaglandin E1) in treatment of severe arterial insufficiency of lower limbs.] [in Russ.] Posobie dlja vrachej. M.: Medicina, 1999; 16 st.

2.     Haimovici's vascular surgery. -5th ed., p.139, 534.

3.     Zatevahin I.I., Shipovskij V.N., Zolkin V.N. Ballonnaja angioplastika pri ishemii nizhnih konechnostej. [Balloon angioplasty at ishemia of lower limbs] M.: Medicina, 2004; 83. [in Russ.]

4.     Diagnostika i lechenija bol'nyh s zabolevanijami perifericheskih arterij: rekomendacii Ros. Obshhestva angiologov i sosudistyh hirurgov. [Diagnostics and treatment of patients with peripheral arterial disease: recommendations of Rus. Society of Angiology and Vascular Surgery.] M., 2007; 135 S. [in Russ.]

5.     Norgen L., Hiatt W.R., Dormandy J.A., Nehler M.R. et. al. TASC II Working group. Inter-society consensus for the management of peripheral arterial disease (TASC II), Eur. J. Vasc. Endovasc. Surg. 2007; 33; suppl 1.

6.     Varty K., Nydahl S., Nasim A., Bolia A. et. al. Results of surgery and angioplasty for the treatment of chronic severe lower limb ischaemia. Eur. J. Vasc. Endovasc. Surg. 1998;16:159-163.

7.     Lenti A.F. et al. Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent. J. Vasc. Surg. 2007;45:32-9.

8.     Hallisey M.J., Parker C.B., van Breda A: Current status and extended applications of intravascular stents. Curr. Opin. Radiol. 1992; 4:7-12,

9.     Johnston K.W. et al. Femoral and popliteal arteries: Reanalysis of results of balloon angioplasty. Radiology 1992;183:767-771.

10.   Baril M. et al. Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions. J. Vasc. Surg. 2008; 48: 627-33.

11.   Liapis C.D., Balzer K., Benedetti-Valentini F., Fernandes e Fernandes J. European Manual of Medicine. Vascular Surgery (ed) 2007; 427-434.

12.   Becker G.J., Katzen B.T., Dake M.D. Noncoronary angioplasty Radiology. 1989; 170: 921-940.

13.   Clark T.W., Groffsky J.L., Soulen M.C. Predictors of long-term patency after femoropopliteal angioplasty: results form the STAR registry J. Vasc. Interv. Radiol. 2001; 12: 923-933.

14.   Conrad M.F., Cambria R.P., Stone D.H. Et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J. Vasc. Surg. 2006; 44(4): 762-769.

15.   Amato     B., Iuliano G.P., Markabauoi A.K. et.al. Endovascular proceduras in critical leg ischemia of elderly patients. Acta Biomed Ateneo Parmense. 2005: 76(1): 11-15.

16.   Dey C. Annual congress of the cardiovascular and interventional radiological society of Europe (CIRSE - 2009); Lisbon, Portugal.

17.   Duda S.H., Bosiers M., Lammer J., Scheinert D., Zeller T., Oliva V., Tielbeek A., Anderson J., Wiesinger B. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J. Endovasc. Ther. 2006; 13(6): 701-710.

18.   Dake M.D., Scheinert D., Tepe G., Tessarek J., Fanelli F., Bosiers M., http://www.ncbi.nlm.nih.gov/ pubmed?term=Ruhlmann%20C%5BAuthor%5D&cau- thor=true&cauthor_uid=21992630Kavteladze Z., Lottes A.E. et. al. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the ZilverPTX single-arm clinical study. J. Endovasc. Ther. 2011. 18(5):613-23.

19.   Diehm N.A., Hoppe H., Do D.D. Drug eluting balloons. Tech. Vasc. Interv. Radiol. 2010 Mar;13(1):59-63.

20.   Tepe G. Annual congress of the cardiovascular and interventional radiological society of Europe (CIRSE - 2011); Munich, Germany.

21.   Micari A., Cioppa A., Vadala G., Stabile E., et.al. A new paclitaxel-eluting balloon for angioplasty of femoropopliteal obstructions: acute and midterm

results. EuroIntervention. 2011. May; 7. Suppl K:K77-82.

22.   Wildgruber M.G., Berger H.J. Cryoplasty for the prevention of arterial restenosis Cardiovasc. Intervent. Radiol. 2008; 31; (6):1050-1058.

23.   Ansel G.M., SampleN.S., Botti III C.F. Jr et.al. Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia Catheter Cfrdiovasc. Interv. 2004; 61: 1-4.

24.   Florenes T., Bay D., Sandbaek T., Jorgensen J.J. et al. Subintimal angioplasty in the treatment of patients with intermittent claudication: long term results. Eur. J. Vasc. Endovasc. Surg. 2004; 28: 645-650.

25.   Minko P Annual congress of the cardiovascular and interventional radiological society of Europe (CIRSE - 2009); Lisbon, Portugal.

26.   Derksen W.J., Gisbertz S.S., Pasterkamp G., De Vries J.P, Moll F.L. Remote superficial femoral artery endarterectomy J. Cardiovasc. Surg.(Torino). 2008; 49(2): 193-8.

27.   Galaria I.I., Surowiec S.M., Rhodes J.M., Shortell C.K., Illig K.A., Davies M.G. Implications of early failure of superficial femoral artery endoluminal interventions. Ann. Vasc. Surg. 2005. Nov; 19(6): 787-792.

28.   Greiner A., Rantner B., Greiner K., Kronenberg F.. Schocke M., Neuhauser B., Bodner J., Fraedrich G., Schlager A. Neuropathic pain after femoropopliteal bypass surgery. J. Vasc. Surg. 2004. Jun; 39(6): 1284-1287.

29.     Forbes J.F., Adam D.J., Bell J., Fowkes F.G., Gillespie I., Raab G.M., Ruckley C.V., Bradbury A.W. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis. J. Vasc. Surg. 2010 May; 51(5 Suppl):43S-51S. 

 

 

Abstract:

Hepatocellular carcinoma (HCC) of liver is a widespread oncologic disease. The main risk factor of HCC development is liver cirrhosis. The aim of this article is to describe findings of HCCs in diagnostic imaging, including ultrasound, computed tomography, and magnetic resonance imaging. 

 

References

1.     Cruite I., Tang A., Sirlin C.B. Imaging-based diagnostic systems for hepatocellular carcinoma. Am.J. Roentgenol. 2013; 201(1): 41-55.

2.     Gomes M.A., Priolli D.G., Tralhro J.G., Botelho M.F. Hepatocellular carcinoma: epidemiology, biology, diagnosis, and therapies. Rev. Assoc. Med. Bras. 2013; 59(5): 514-524.

3.     Weinmann A., Koch S., Niederle I.M. et al. Trends in Epidemiology, Treatment, and Survival of Hepatocellular Carcinoma Patients Between 1998 and 2009: An Analysis of 1066 Cases of a German HCC Registry. J. Clin. Gastroenterol. 2013 Sep 25. [Epub ahead of print].

4.     Hyder O., Dodson R.M., Nathan H. et al. Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study. J. Am.Coll. Surg. 2013; 217(5): 896-906.

5.     Chamadol N., Somsap K., Laopaiboon V.. Sukeepaisarnjaroen W. Sonographic findings of hepatocellular carcinoma detected in ultrasound surveillance of cirrhotic patients. J. Med. Assoc. Thai. 2013; 96(7): 829-838.

6.     Семендяева М.И., Меркулов И.А., Пастухов А.И. с соавт. Гепатоцеллюлярная карцинома - день сегодняшний. Клиническая практика. 2013; 2: 35-49. Semendyaeva M.I., Merkulov I.A., Pastukhov A.I. et al. Hepatocellular carcinoma - day today's. Klinicheskaya praktika. 2013; 2: 35-49 [In Russ].

7.     Stepanova Yu.A. «Ultrasonic diagnostics of diseases of a liver» (manual). Ed. cor.-mem. of RAMSci L.S. Kokov. M.: «11-y FORMAT», 2013; 38-43 [In Russ].

8.     Willatt J.M., Hussain H.K., Adusumilli S. et al. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology. 2008; 247(2): 311-330.

9.     Asham E.H., Kaseb A., Ghobrial R.M. Management of hepatocellular carcinoma. Surg. Clin. North. Am. 2013; 93(6):1423-1450.

10.   Marks W.M., Jacobs R.P., Goodman PC. et al. Hepatocellular carcinoma: clinical and angiographic findings and predictability for surgical resection. Am. J. Roentgenol. 1979; 132(1): 7-11.

11.   Bruix J., Sherman M., Llovet J.M. et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver, Barcelona September 15-17, 2000. 2001; 35(3): 421-430.

12.   Mayev I.V., Dicheva D.T., Zhilyaev E.V. et al. Difficulties of diagnostics of a hepatocellular carcinoma. Consilium Med. 2010; 8: 63-66 43 [In Russ].

13.   Ayuso C., Rimola J., Garcia-Criado A. Imaging of HCC. Abdominal Imaging. 2012: 37(23): 215-230.

14.   Colombo M., Ronchi G. Clinico-pathological features of hepatocellular carcinoma. Focal Liver Lesions Detection, Characterization, Ablation. Ed by Lencioni R., Cioni D., Bartolozzi C. Springer-Verlag. Berlin, Heidelberg, 2005;169-176.

15.   Forner A., Vilana R., Ayuso C. et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008; 47(1): 97-104.

16.   Pang R., Poon R.T. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett. 2006; 242(2): 151-167.

17.   Tajima T., Honda H., Taguchi K. et al. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. Am. J. Roentgenol. 2002; 178(4): 885-897.

18.   Sahani D.V., Holalkere N.S., Mueller PR. et al. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue — initial experience. Radiology. 2007; 243(3): 736-743.

19.   Kim YK., Kwak H.S., Kim C.S. et al. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT Radiology. 2006; 238(2): 531-541.

20.   Iavarone M., Sangiovanni A., Forzenigo L.V. et al. Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation. Hepatology. 2010; 52(5): 1723-1730.

21.   Di Benedetto N., Peralta M., Alvarez E. et al. Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011. Ann. Hepatol. 2013 Jan-2014 Feb; 13(1): 38-44

22.   Okada M., Murakami T. CT Imaging Characteristics of Hepatocellular Carcinoma. In: Abdomen and Thoracic Imaging. Springer Science+Business Media New York. 2014; 317-346.

23.   Kim C.K., Lim J.H., Lee W.J. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients. J.Ultrasound. Med. 2001; 20(2): 99-104.

24.   Itoh Y, Akamatsu K. Relationships between echo level and histologic characteristics in small hepatocellular carcinomas. J. Clin. Ultrasound. 1998; 26(6): 295-301.

25.   Практическое руководство по ультразвуковой диагностике. Общая ультразвуковая диагностика. Под ред. В.В. Митькова. М. Видар. 2005; 33-132. Practical guidance on ultrasonic diagnostics. General ultrasonic diagnostics. Ed. V.V. Mitkov. M. Vidar. 2005; 33-132 43 [In Russ].

26.   Albrecht T., Blomley M., Bolondi L. et al. Guidelines for the use of contrast agents in ultrasound. Ultraschall. Med. 2004; 25(4): 249-256.

27.   Lencioni R., Cioni D., Bartolozzi C. Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound. Eur. Radiol. 2002; 12(1): 151-165.

28.   Kelekis N.L., Semelka R.C., Worawattanakul S. et al. Hepatocellular carcinoma in North America: a multi institutional study of appearance on T1-weigh- ted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. Am. J. Roentgenol. 1998; 170(4): 1005-1013.

29.   Choi B.I. The current status of imaging diagnosis of hepatocellular carcinoma. Liver Transpl. 2004; 10 (Suppl 1): 20-25.

30.   Iannaccone R., Laghi A., Catalano C. et al. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology. 2005; 234(2): 460-474.

31.   Kim C.K., Lim J.H., Park C.K. et al. Neoangiogenesis and sinusoidal capillarization in hepatocellular carcinoma: correlation between dynamic CT and density of tumor microvessels. Radiology. 2005; 237(2): 529-533 

authors: 

 

 

Abstract:

Aim: was to investigate the safety and efficacy of transarterial embolization in patients with hypervascular spinal metastases and primary tumors before surgical resection.

Materials and methods: 39 patients with spinal metastases and primary tumors underwent angiography and preoperative transarterial embolization with spherical particles, coils and the liquid cohesive composition before surgical resection. Following parameters were evaluated: types of tumor, gender, time interval between embolization and surgery, the influence of these parameters on intraoperative blood loss, surgical content, safety for the patient.

Results: Intraoperative blood loss in patients undergoing embolization was up to 500 ml - 29(74,4%), to 1000 mL - 2(5,1%), to 2000 mL - 3(7,7 %), 2000 mL - 5(12,8%). Average value of blood loss for RCC 546,2 ml, for other metastases - 373,5 mL, for primary tumors - 2488,8 mL. There have been no in-hospital mortality related with the intraoperative blood loss. All patients received standard supportive care, emergency blood transfusion was not performed. 3(7,7%) patients after endovascular interventions had complications in the form of temporary neurological deficit, 15 (38,5%) had postembolization syndrome.

Conclusion: In the embolization group, intraoperative blood loss was correlated with type of tumor and type of surgical resection. Preoperative embolization is safety and effectively to decrease intraoperative blood loss for patients with hypervascular spinal tumors. 

 

References

1.     Eastley N., Newey M., Ashford R.U. Skeletal metastases - The role of the orthopaedic and spinalsurgeon. Surgical Oncology. 21 2012; 21: 216-222.

2.     Galasko C.S.B., Norris H.E., Crank S. Spinal instability secondary to ^^asta^ cancer. Curr. Concepts Rev. J. Bone Jt Surg (Am) 2000; 82: 570-6.

3.     O’Donoghue D.S., Howell A., Walls J. Orthopaedic management of structurally significant bone disease in breast cancer metastases. British Orthopaedic Association; 2011 [guidelines].

4.     Aaron A.D. The management of cancer metastatic to bone. J. Am.Med. Assoc. 1994; 272: 1206-9.

5.     Coleman R., Rubens R. The clinical course of bone metastases in breast cancer. Br. J. Cancer. 1987; 77: 336-40.

6.     Benati A., Dalle Ore G., Da Pian R., et al. Transfemoral selective embolisation in the treatment of some cranial and vertebro-spinal vascular malformations and tumours: preliminary results. J. Neurosurg. Sci. 1974; 18: 233-38.

7.     Wilson M.A., Cooke D.L., Ghodke B. et al. Retrospective analysis of preoperative embolization of spinal tumors. AJNR Am. J. Neuroradiol. 2010 Apr; 31(4): 656-60. doi: 10.3174/ajnr.A1899. Epub 2009 Nov 26.

8.     Rangel-Castilla L., Shah A.H., Klucznik R.P et al. Preoperative Onyx embolization of hypervascular head, neck, and spinal tumors. Experience with 100 consecutive cases from a single tertiary center. J. Neurointerv. Surg. 2012; Dec 25. [Epub ahead of print].

9.     Guzman R., Dubach-Schwizer S., Heini P, et al. Preoperative transarterial embolization of vertebral metastases. Eur. Spine J. 2005; 14: 263-68.

10.   Manke C., Bretschneider T., Lenhart M., et al. Spinal metastases from renal cell carcinoma: effect of preoperative particle embolization on intraoperative blood loss. AJNR Am. J. Neuroradiol. 2001; 22: 997-1003.

11.   Gellad F.E., Sadato N., Numaguchi Y, et al. Vascular metastatic lesions of the spine: preoperative embolization. Radiology. 1990; 176: 683-86.

12.   Berkefeld J., Scale D., Kirchner J., et al. Hypervascular spinal tumors: influence of the embolization technique on perioperative hemorrhage. AJNR Am. J. Neuroradiol. 1999; 20: 57-63.

13.   Nair S., Gobin YP, Leng L.Z. et al. Preoperative embolization of hypervascular thoracic, lumbar, and sacral spinal column tumors: technique and outcomes from a single center. Interv. Neuroradiol. 2013 Sep; 19(3): 377-85. Epub 2013 Sep 26.

14.   Clarengon F., Di Maria F., Cormier E., et al.Onyx injection by direct puncture for the treatment of hypervascular spinal metastases close to the anterior spinal artery: initial experience. J. Neurosurg. Spine. 2013 Jun;.18(6): 606-10.

15.   Tokuhashi Y, Matsuzaki H., Oda H. et al. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine. 2005; 30: 2186-2191.

16.   Choi D., Crockard A., Tomita K. et al. Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group. Eur. Spine J. 2010; 19(2): 215-222.

17.   Chan P, Boriani S., Fourney D.R. et al. An assessment of the reliability of the Enneking and Weinstein-Boriani-Biagini classifications for staging of primary spinal tumors by the Spine Oncology Study Group. Spine (PhilaPa 1976). 2009; 34(4): 384-91.

18.   Tomita K., Kawahara N., Kobayashi T., et al. Surgical strategy for spinal metastases. Spine. 2001; 26: 298-306

 

 

Abstract:

Background: balloon angioplasty for coarctation of the aorta (CoA) in teenagers and adults is sometimes limited by significant residual pressure gradient (>20 mm Hg) in cause of vesse «elastic recoil». To avoid this complication intervention cardiologists use self- and balloon-expandable endovascular stents. In this report we demonstrate our experience in such method of aortic coarctation repair.

Materials and methods: in our instituton since December 2008 to Desember 2013 85 teenagers and adult patients were treated by endovascular stent placement to coarctatec aortic segment. The age of patients was 10 to 60 years (mean 20,3+7,4), weight 20 to 90 kgs (mean 53,2+14,6). Mean systolic arterial pressure was 166+7mm Hg. (range 140 to 200), mean systolic pressure gradient (SPG) was 60,6+9,0 mm Hg (range 25 to 85). The mean cross section at baseline of coarctation was 19,6±6,1 mm2 (range 1 to 95). 61 patients had native coarctation and 3 recoarctation after previous surgical repair. In 21 cases coartation was in combination with other cardiac pathology - patent ductus arteriosus (PDA), restrictive VSD, aortric and mitral valve lesions, and coronary vessel pathology Seven patients had hemodynamically significant aortic atresia. We used 20 Palmaz P-4014, 18 Genesis XD PG-2910 (Cordis Jonson & Jonson) and 45 - CP, CP covered stents, one - Intratherapeutic Doublestrut (EV3), and one Advanta V12 (Atrium) covered stent.

Results: 90 stents were implanted in 85 patients. Procedure was successful in all but one cases, one patient with postsurgical recoarctation had residual systolic pressure gradient > 25 mm Hg after stent placement. The peak systolic gradient decreased from a mean value of 60 mm Hg.(range 25 to 85) to a mean 7 mm Hg (range 0 to 25). Systolic blood pressure normalized in 64 cases, twenty one patients require additional drug therapy Coarctation site cross section increased from a mean of 19,6 mm2 to 236,3 mm2. PDA was closed simultaneously with the stenting by coils, and for eleven patients with other cardiac malformations endovascular coarctation repair was as a first step in complex cardiac surgical treatment. In one case of 56 years old male we had acute aortic dissection which was stabilized without surgical intervention. Two patients with complete hemodynamically significant aortic atresia developed stent fracture, which was recognized on CT scan 6 months after procedure. In one case it was treated with covered stent placement. In another patient stent fragment was treated surgically We had three stent migration with their safe deployment in thoracic aorta and followed by successful repair of aortic narrowing with additional stent.

Conclusion: stent implantation for aortic coarctation is safe and effective procedure. The early and intermediate term result are encouraging, with relatively low incidence of complication in teenagers and adult patients. 

 

References

1.     Campbell М.: Natural history of coarctation of the aorta. Br. Heart .J. 1970; 32: 633.

2.     Carr J. The Results of Catheter-Based Therapy Compared With Surgical Repair of Adult Aortic Coarctation. J. Am. Coll. Cardiol. 2006, 47: 1101-1107.

3.     Mullen M.S. Coarctation of the aorta in adults: do we need surgeons? Heart. 2003; 89: 3-5.

4.     Forbes T.J. Procedural Results and Acute Complications in Stenting Native and Recurrent Coarctation of the Aorta in Patients Over 4 Years of Age A Multi-Institutional Study. Cath. and Cardiovascular. Interventions. 2007; 70: 276-285.

5.     Golden А^. Coarctation of the Aorta: Stenting in Children and Adalts. Cath. and Cardiovascular Interventions. 2007; 69: 289-299.

6.     Chessa M., Carrozza M., Butera G., Piazza L., Carminati M. Results and mid-long-term follow-up of stent implantation for native and recurrent coarctation of the aorta. European Heart Journal. 2005; 26: 2728-2732.

7.     Rosenthal E. Stent implantation for aortic coarctation: the treatment of choice in adults? J. Am. Coll. Cardiol. 2001;38: 1524-1527.

8.     Beaton A.Z. Relation of Coarctation of the Aorta to the Occurrens of Ascending Aortic Dilation in Children and Young Adults With Bicuspid Aortic Valves. Am. J. Cardiol. 2009; 103: 266-270.

9.     Qureshi S.A. Stenting in aortic coarctation and transverse arch/isthmus hypoplasia; Percutaneous Interventions for Congenital Heart Disease, 2007: 475-489.

10.   Duke C., Rosenthal E. and Qureshi S.A. The efficacy and safety of stent redilatation in congenital heart disease. Heart. 2003;89: 905-912.

11.   Basil Vasilios Thanopoulos, Nicholaos Eleftherakis, Konstadinos Tzanos, Stent Implantation for Adult Aortic Coarctation. J. Am. Coll. Cardiol. 2008; 52: 1815-1816. 

 

 

Abstract:

Aim: was to evaluate possibilities and advantages of endovascular treatment of intracranial aneurysms (IA) and arteriovenous malformations (AVM) using three-dimensional navigation (3D-roadmapping).

Materials and methods: during 2010-2013 years 103 embolizations of IA and AVM ir 88 patients were performed in our angiography department. Embolizations of IA were managed by metallic detachable coils, embolizations of AVM - by Histoacryl : Lipiodol glue composition. 3D-roadmapping technique was applied for guidance of endovascular tools in cerebral arteries anc catheterization the IA cavity and AVM-feeding arteries during the procedure. 3D-roadmapping technique is based on creation of composite images that consist of two-dimensional fluoroscopic views superimposed on virtual three-dimensional model of the vessel.

Results: endovascular interventions with 3D-roadmapping were performed in 65(63%) cases. In 49 (75%) cases we used 3DRA data to create three-dimensional model of cerebral vessels and in 16 (25%) cases - CT-angiography data. Complex algorithm of diagnosis and endovascular treatment of IA and AVM using 3D-roadmapping was introduced.

Conclusion: our experience of the endovascular embolization of IA and AVM with 3D-roadmapping convincingly showed that usage of this technique is possible and effective. In comparison with two-dimensional navigation there was a tendency in reduction of the effective exposure dose, also there was a statistically significant decrease of amount of contrast material , and of time for superselective catheterization of AVM-feeding arteries and IA cavity. 

 

References

1.     Becske T., Jallo G.I. Chief Editor: Lutsep H.L. Subarachnoid Hemorrhage. Updated: Oct 20, 2011 Available at: http://www.emedicine.medscape.com.

2.     Krylov V.V., Prirodov A.V., Petrikov S.S. Netravmaticheskoe subarahnoidal'noe krovoizlijanie: diagnostika i lechenie [Nontraumatic subarachnoid hemorrhage: diagnosis and treatment.]. Consilium Medicum. Bolezni serdca i sosudou 2008; 1: 14-18 [In Russ].

3.     Методические Указания 2.6.1.2944-11 «Контроль эффективных доз облучения пациентов при проведении медицинских рентгенологических исследований». Metodicheskie Ukazanija 2.6.1.2944-11 «Kontrol jeffektivnyh doz obluchenija pacientov pri provedenii medicinskih rentgenologicheskih issledovanij»[«Control of effective patient dose in medical X-ray examinations»] [In Russ].

4.     JohnstonS.C., Higashida R.T., Barrow D.L., Caplan L.R., et al: Recommendations for the endovascular treatment of intracranial aneurysms. A statement for health care professionals from the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radio. Выходные данные?

5.     Debrun G.M., Aletich V.A., Kehrli P., et al: Selection of cerebral aneurysms for treatment using Guglielmi detachable coils: The preliminary University of Illinois at Chicago experience. Neurosurgery. 1998;43:1281-1295.

6.     Debrun G.M., Aletich V.A., Kehrli P., Misra M., Ausman J.I., Charbel F. Selection of cerebral aneurysms for treatment using Guglielmi detachable coils: the preliminary University of Illinois at Chicago experience. Neurosurgery 1998;43:1281-1295.

7.     Fernandez Zubillaga A., Guglielmi G., Vinuela F.. Duckwiler G.R. Endovascular occlusion of intracranial aneurysms with electrically detachable coils: correlation of aneurysm neck size and treatment results. AJNR Am. J. Neuroradiol. 1994;15: 815-820.

8.     Svistov D.V., Pavlov O.A., Kandyba D.V., Nikitin A.I., Savello A.V., Landik S.A., Arshinov B.V.. Znachenie vnutrisosudistogo metoda v lechenii pacientov s anevrizmaticheskoj bolezn'ju golovnogo mozga [Meaning of intravascular method in patients with aneurysmal disease brain.]. Nejrohirurgija. 2011; 1: 21-28 [In Russ].

9.     Gallas S., Januel A.C., Pasco A., Drouineau J., Gabrillargeus J., Gaston A., Cognard C., Herbreteau D. Long-term follow-up of 1036 cerebral aneurysms treated by bare coils: a multicentric cohort treated between 1988 and 2003. J. Amer. J. Neuroradiol. 2009; 30(10): 1986-1992. 

 

Abstract:

Background and purpose: flow-diverting devices are increasingly used for the treatment of giant and wide neck cerebral aneurysms. The aim of the research was to evaluate the feasibility of computed tomography angiography CTA in the postoperative evaluation of aneurysms treatec with Pipeline Embolization Device (PED).

Materials and methods: fifteen patients with 19 aneurysms treated by total of 17 PED were examined by means of CTA. Postprocessing of CTA acquisitions were done at workstation using maximum intensity projections, multiplanar reformations, curved planar reformations and volume rendering of PED region and other intracranial arteries. The position of PED and dergree of aneurysm occlusion were evalluated.

Results: CTA follow-up of at least 26 months demonstrated complete occlusion of aneurysms treated with the PED in 9 cases (50%). There were 2 cases (11,1%) of proximal stent migration and 2 cases (11,1%) of stent narrowing due to incomlete expansion. Flow reduction was observed in 4 aneurysms (22,2%). CTA was accurate in determining the position of PED and evaluating the patency of aneurysm.

Conclusions: CTA can be used as a reliable tool for postoperative evaluation of aneurysms treated with PED defining the stent position and aneurysmal flow reduction. Postprocessing using curved planar reformations with window width 1000-2500 and level 600-800 is optimal for stent visualization.  

 

References

1.     Suzuki S., Tateshima S., Jahan R., Duckwiler G.R., Murayama Y, Gonzalez N.R., V^uela F. Endovascular treatment of middle cerebral artery aneurysms with detachable coils: angiographic and clinical outcomes in 115 consecutive patients. Neurosurgery. 2009; 64(5): 876-88.

2.     V^uela F., Duckwiler G., Mawad M. Guglielmi detachable coil embolization of acute intracranial aneurysm: perioperative anatomical and clinical outcome in 403 patients. J. Neurosurgery. 2008; 108(4): 832-9.

3.     Kallmes D.F., Ding YH., Dai D., Kadirvel R., Lewis D.A., Cloft H.J. A new endoluminal, flow-disrupting device for treatment of saccular aneurysms. Stroke. 2007; 38(8): 2346-52.

4.     Lylyk P, Miranda C., Ceratto R., et al. Curative endovascular reconstruction of cerebral aneurysms with the Pipeline embolization device: the Buenos Aires experience. Neurosurgery. 2009; 64: 632- 42, discussion 642-43, quiz N636.

5.     Cloft H.J., Joseph G.J., Dion J.E. Risk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation: a meta-analysis. Stroke. 1999; 30(2): 317-20.12.

6.     Mayberg M.R., Batjer H.H., Dacey R., Diringer M., Haley E.C., Heros R.C., Sternau L.L., Torner J., Adams H.P Feinberg W. et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994; 25(11): 2315-28.

7.     Min J.K., Swaminathan R.V., Vass M., Gallagher S., Weinsaft J.W. High-definition multidetector computed tomography for evaluation of coronary artery stents: comparison to standard-definition 64-detector row computed tomography. Cardiovasc. Comput. Tomogr. 2009; 3(4): 246-51.

8.     Sun Z., Davidson R., Lin C.H. Multi-detector row CT angiography in the assessment of coronary in-stent restenosis: a systematic review. Eur. J. Radiol. 2009; 69(3): 489-95.

9.     Szikora I., Guterman L.R., Wells K.M., Hopkins L.N. Combined use of stents and coils to treat experimental wide-necked carotid aneurysms: preliminary results. AJNR Am. J. Neuroradiol. 1994; 15(6):1091-102.

10.   Ternovoy S.K., Akchurin R.S., Fedotenkov I.S., Veselova T.N., Nikonova M.E., Shiryaev A.A. Neinvazivnaya shuntografiya metodom mul’tispiral’noy komp’yuternoy tomografii. REJR. 2011; 1(1): 26-32 [In Russ].

11.   Lieber B.B., Stancampiano A.P, Wakhloo A.K. Alteration of hemodynamics in aneurysm models by stenting: influence of stent porosity. Ann. Biomed. Eng. 1997; 25(3): 460-9.

12.   Szikora I., Berentei Z., Kulcsar Z., et al. Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the Pipeline embolization device. AJNR Am. J. Neuroradiol. 2010; 31:1139-47.

13.   McAuliffe W., Wycoco V., Rice H., Phatouros C., Singh T.J., Wenderoth J. Immediate and midterm results following treatment of unruptured intracranial aneurysms with the pipeline embolization device. AJNR Am. J. Neuroradiol. 2012; 33(1):164-70.

14.   Saatci I., Yavuz K., Ozer C., Geyik S., Cekirge H.S. Treatment of intracranial aneurysms using the pipeline flow-diverter embolization device: a single-center experience with long-term follow-up results. AJNR Am. J. Neuroradiol. 2012; 33(8):1436-46.

15.   Deutschmann H.A., Wehrschuetz M., Augustin M., Niederkorn K., Klein G.E. Long-term follow-up after treatment of intracranial aneurysms with the Pipeline embolization device: results from a single center. AJNR Am. J. Neuroradiol. 2012; 33(3): 481-6. 

 

 

Abstract:

Aim: was to show capabilities of MDCT-angiography of coronary arteries in the detection and characterization of rare forms of anomalous coronary arteries from the pulmonary artery in adult patients

Materials and methods: we made retrospective study of anomalous coronary arteries from pulmonary arteries in patients who have been examined and operated in our Center for the period of 2008-2013. All patients on admission underwent: echocardiography, selective coronary angiography and MDCT coronarography Postoperatively - echocardiography and MDCT coronarography.

Results: for the period of 5 years about 30,000 patients underwent examination in our center, and congenital anomalous coronary arteries from the pulmonary artery was identified only in 6(0,02 %) cases. 4( 0,013%) of them had «infantile» type - ALCAPA. In adults, anomalous coronary arteries from the pulmonary artery revealed in 2 cases: a 31 year woman had «adult» type ALCAPA (0,003%) and 17-year boy - isolated form ARCAPA (0,003%). Preoperative MDCT provided direct visualization of anomalous coronary arteries from the pulmonary artery, displayed the spatial relationship of coronary vessels in the three-dimensional image that helped to clarify and demonstrate for cardiac surgeons individual characteristics of congenital disorder. Marked dilatation and tortuous course of trunks and branches of coronary arteries, the severity of which declined after surgical correction. Adult patients successfully underwent surgical correction: reimplantation of anomalous coronary arteries in orthotopic position in cardiopulmonary bypass with the creation of two-coronary blood supply of the heart

Conclusions: Even in cases where a definitive diagnosis of anomalous coronary arteries from the pulmonary artery can be diagnosed by echocardiography and coronary angiography, before surgery is recommended to perform MDCT angiography to clarify the anatomy and more specific spatial representation of the topography of the anomalous vessel. In the late postoperative period this method allows to assess in details the condition of coronary flow and effectiveness of coronary intervention. 

 

References

1.     Angelini P. Normal and anomalous coronary arteries: definitions and classification. Am. Heart J. 1989; 117: 418-434.

2.     Maron B.J. Triggers for sudden cardiac death in the athlete. Cardiol. Clin. 1996; 14: 195-210.

3.     Corrado D., Basso C., Rizzoli G., et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? J. Am. Coll. Cardiol. 2003; 42: 1959-1963.

4.     Jakobs T., Becker C., Ohnesorge B., et al. Multislice helical CT of the heart with retrospective ECG gating: reduction of radiation exposure by ECG-controlled tube current modulation. Eur. Radiol. 2002; 12: 1081-1087.

5.     Wollenek G., Domanig E., Salzer-Muar U., et al. Anomalous origin of the left coronary artery: a review of surgical management in 13 patients. J. Cardiovasc. Surg. 1993; 34: 399-405.

6.     Jurishica A.J. Anomalous left coronary artery; adult type. Am. Heart J. 1957; 54: 429-436.

7.     Kawara T., Tayama E., Hayashida N., et al. Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery: Successful Direct Reimplantation in a 50-year-old Man. Ann.Thorac Cardiovasc Surg. 2003, 9 (3): 197-201.

8.     Williams I.A., Gersony W.M., Hellenbrand W.E. Anomalous right coronary artery arising from the pulmonary artery: a report of 7 cases and a review of the literature. Am. Heart J. 2006; 152(5): 1004-1017.

9.     Maroules C.D., Adams D.Z., Whiting E.D., et al. Anomalous Origin of the Right Coronary Artery from the Pulmonary Artery Evaluation with Use of 64-Slice Multidetector Computed Tomography. Texas Heart Institute Journal. 2013; 40(1): 93-99.

10.   Burakovskij V.I., Sharykin A.S., Garibjan V.A. Anomal'noe othozhdenie pravoj koronarnoj arterii ot legochnoj arterii v sochetanii s defektom mezhzheludochkovoj peregorodki [Anomalous right coronary artery from the pulmonary artery in conjunction with a ventricular septal defect.]. Grudnaja hirurgija. 1981; 2: 1-10 [In Russ].

11.   Burakovskij V.I., Podlozkov V.P., Ragimov F.R. Diagnostika i hirurgicheskoe lechenie defektov aortolegochnoj peregorodki, sochetajushhihsja s drugimi vrozhdennymi porokami serdca [Diagnosis and surgical treatment of defects aorto-pulmonary septum, combined with other congenital heart defects.]. Grudnaja hirurgija. 1982; 6: 13-21 [In Russ].

12.   Kacitadze Z.D. Rezul'taty hirurgicheskogo lechenija anomaij othozhdenija koronarnyh arterij ot legochnoj arterii. Avtoreferat. Diss. kand. med. Nauk [Results of surgical treatment of coronary artery anomalies of divergence from the pulmonary artery.]. M.1998; 28 [In Russ].

13.   Modi H., Ariyachaipanich A., Dia M. Anomalous origin of right coronary artery from pulmonary artery and severe mitral regurgitation due to myxomatous mitral calve disease: a case report and literature review. Journal of Invasive Cardiology. 2010; 2(4): 49-55.

14.   Yao C.T., Wang J.N., Yeh C.N., et al. Isolated anomalous origin of right coronary artery from the main pulmonary artery. Journal of Cardiac Surgery. 2005; 20(5): 487-489.

15.   Angelini P. Coronary artery anomalies-current clinical issues: definitions, classification, incidence, clinical relevance, and treatment guidelines. Tex. Heart Inst. J. 2002; 29: 271-278.

16.   Abbott M.E. Congenital Cardiac disease. Modern Medicine. Philadelphia. 1908.

17.   Abrikossoff A. Aneurysma des linken Herzventrikels mit abnormer Abgangsstelle der linken Koronararterie von der Pulmonalis bei einem funsonatlichen Kinde. Virchows Arch. Pathol. Anat. 1911; 203: 413.

18.   Keith J.D. Diseases of coronary arteries and aorta. in: Keith J.D., Rowe R.D., Vlad P., editors. General cardiac disease. 3rd ed. New York; Macmillan Publishing Co. Inc; 1978.

19.   Bland E.F., White P.D., Garland J. Congenital anomalies of the coronary arteries: report of an unusual case associated with cardiac hypertrophy. Am. Heart J. 1933; 8: 787-801.

20.   Emmanouilides G.C., Riemenschneider T.A., Allen

H.    D., Gutgesell H.P Heart disease in infants, children, and adolescents. 5th edition. Williams and Wilkins (Publishers) Ltd, Baltimore 1995; 776-779.

21.   DeLeval M.R., Yacoub M., Georgakopoulos D.I., et al. Bland-White-Garland Syndrome: Definitive echocardiographic diagnosis of a surgical treatable form of dilatative cardiomyopathy. Hell. J. Cardiol. 1991; 32: 22.

22.   Frescura C., Basso C., Thiene G., et al. Anomalous origin of coronary arteries and risk of sudden death: a study based on an autopsy population of congenital heart disease. Hum. Pathol. 1998; 29: 689-695.

23.   Yau J.M., Singh R., Halpern E.J., Fischman D. Anomalous origin of the left coronary artery from the pulmonary artery in adults: a comprehensive review of 151 adult cases and a new diagnosis in a 53-year-old woman. Clin. Cardiol. 2011; 34: 204-210.

24.   Dodge-Khatami A., Mavroudis C., Backer C.L. Anomalous origin of the left coronary artery from the pulmonary artery: collective review of surgical therapy. Ann. Thorac. Surg. 2002; 74: 946-955.

25.   Brooks H.S.J. Two cases of an abnormal coronary artery of the heart arising from the pulmonary artery: with some remarks upon the effect of this anomaly in producing cirsoid dilatation of the vessels. J. Anat. Physiol. 1885; 20(Pt 1): 26-29.

26.   Mollet N.R., Cademartiri F., van Mieghem C.A., et al. High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography. Circulation. 2005; 112 (5): 2318-2323.

27.   Menahem S., Venables A.W., Anomalous left coronary artery from the pulmonary artery: a 15 year sample. Br. Heart J. 1987; 58: 78-84.

28.   Montaudon M., Latrabe V., Iriart X., et al. Congenital coronary arteries anomalies: Review of the literature and multidetector computed tomography (MDCT)-appearance. Surg. Radiol. Anat. 2007; 29: 343-355.

29.   Brijesh P, Kottayil M., Karunakaran J. et al. Anomalous Origin of Left Coronary Artery From Pulmonary Artery in Older Children and Adults: Direct Aortic Implantation. Ann. Thorac. Surg. 2011; 91: 549-553.

30.   Johnsrude C.L., Perry J.C., Cecchin F. Differentiating anomalous left coronary artery originating from the pulmonary artery in infants from myocarditis and dilated cardiomyopathy by electrocardiogram. Am. J. Cardiol. 1995; 75: 71-79.

31.   King D.H., Danford D.A., Huhta J.C., Gutgesell H.P Noninvasive detection of anomalous origin of the left main coronary from the pulmonary trunk by pulsed Doppler echocardiography. Am.J. Cardiol. 1985; 55: 608-717.

32.   Frommelt M.A., Miller E., Williamson J., Bergstrom S. Detection of septal coronary collaterals by color flow Doppler mapping is a marker for anomalous origin of a coronary artery from the pulmonary artery. J. Am. Soc. Echocardiogr. 2002; 15(3): 259-263.

33.   Schmidt K.G., Cooper M.J., SilvermanN.H., Stanger P Pulmonary artery origin of the left coronary artery: Diagnosis by two-dimensional echocardiography, pulsed Doppler ultrasound and colour flow mapping. J. Am. Coll. Cardiol. 1988; 11: 396-402.

34.   Tavakol M., Ashraf S., Brener S.J. Risks and Complications of Coronary Angiography: A Comprehensive Review. Global Journal of Health Science. 2012; 4(1): 65-93.

35.   Ternovoj S.K., Nikonova M. Je., Akchurin R.S., i dr. Vozmozhnosti mul'tispiral'noj komp'juternoj tomografii (MSKT) v ocenke koronarnogo rusla i ventrikulografii v sravnenii intervencionnoj koronaroventrikulografiej [Possibilities of MDCT in the evaluation of coronary disease and ventriculography in comparison intrvention coronaro ventriculography.]. REJR. 2013; 3(1): 28-35 [InRuss].

36.   Fine J.J., Hopkins C.B., Ruff N., et al. Comparison of accuracy of 64-slice cardiovascular computed tomography with coronary angiography in patients with suspected coronary artery disease. Am. J. Cardiol. 2006; 97: 173-174.

37.   Leschka S., Alkadhi H., Plass A., et al. Accuracy of MSCT coronary angiography with 64-slice technology: first experience. Eur. Heart J. 2005; 26: 1482-1487.

38.   de Jonge G.J., van Ooijen PM., Piers L.H., et al. Visualization of anomalous coronary arteries on dualsource computed tomography. Eur. Radiol. 2008; 18: 2425-243

39.   Nambi P, Sengupta R., Cheong B.Y Multislice computed tomography of a repaired anomalous left coronary artery arising from the pulmonary artery. Tex. Heart. Inst. J. 2008; 35: 485-486.

40.   Su C.S., Tsai I.C., Lin W.W., et al. Usefulness of multidetector-row computed tomography in diagnosis of anomalous origin of left coronary artery arising from the pulmonary artery. J. Chin.Med. Assoc. 2010; 73: 492-495.

41.   Schmitt R., Froehner S., Brunn J., et al. Congenital anomalies of the coronary arteries: imaging with contrastenhanced, multidetector computed tomography. Eur. Radiol. 2005; 15(6): 1110-1121. 

 

 

Abstract:

The aim of the study was to demonstrate possibilities of magnetic resonance imaging (MRI) with contrast enhancement and calculation of «index of contrast agent accumulation» in diagnostics of prostate cancer. Accumulation of contrast agent in malignant and benign tissues were analyzed in comparison and in details. Efficiency of provided method of diagnosis and definition of pathologic process localization is proved.

 

Reference

1.     Franiel Т., Stephan C., Erbersdobler A., Dietz E. Maxeiner A. et al. Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding-multiparametric MR imaging for detection and biopsy planning. Radiology. 2011; 259:162-172.

2.     Kitajima K., Kaji Y, Fukabori Y, Yoshida K., Suganuma N. et al. Prostate cancer detection with 3T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J. Magn. Reson. Imaging. 2010; 31: 625-631.

3.     Futterer J.J., Heijmink S.W., Scheenen T.W., Veltman J., Huisman H.J. et al. Prostate cancer localization with dynamic contrastenhanced MR imaging and proton MR spectroscopic imaging. Radiology. 2006; 241:449-458.

4.     Tanimoto A., Nakashima J., Kohno H., Shinmoto H., Kuribayashi S. Prostate cancer screening: the clinical value of diffusionweighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J. Magn. Reson. Imaging. 2007; 25:146-152.

5.     EL-Gabry E.A., Halpern E.J., Strup S.E., et al. Imaging prostate cancer; current and future applications. Oncology Huntingt. 2001; 15: 325-336.

6.     Engelbrecht MR, Huisman HJ, Laheij R.J. MR imaging Radiology 2003; 229: 248-254.

7.     Hara N., Okuizumi M. Koike H., Kawaguchi M., Bilim V. Dynamic contrast-enhanced magnetic resonance imaging (DCEMRI) is a useful modality for the precise detection and staging of early prostate cancer. Eur. Radiol. 2012; 22: 746-757.

8.     Nicholson B., Schaefer G., Theodorescu D. Angiogenesis in prostate cancer: biology and therapeutic opportunities. Cancer Metastasis Rev. 2001; 20: 297-319.

9.     Beyersdorff D., Taupitz M., Winkelmann B. et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology. 2002; 224: 701-706.

10.   Pasquier D., Hugentobler A., Masson P Which imaging methods should be used before salvage radiotherapy after prostatectomy for prostate cancer? Eur. Radiol. 2012; 22: 746-757.

11.   Cirillo S., Petracchini M., Scotti L. et al. Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur. Radiol. 2009; 19: 761-769

12.     ESUR prostate MR guidelines 2012 Jelle O. Barentsz & Jonathan Richenberg & Richard Clements & Peter Choyke & Sadhna Verma & Geert Villeirs & Olivier Rouviere & Vibeke Logager & Jurgen J. F^tere^ Engelbrecht M.R., Huisman H.J., Laheij R.J., et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast enhanced MR imaging. Radiology. 2003; 229: 248-254 

 

Abstract:

Background: according to the international registry ICOPER, right ventricular (RV) dysfunction is the most significant predictor of mortality in patients with pulmonary embolism (PE). Diagnosis of PE should include not only verification of thrombus in branches of pulmonary arteries, but also estimation of RV contractile function.

Aim: was to identify the most informative indicators of Gated Blood Pool SPECT (GBPS) for estimation of RV function in patients with PE.

Methods: 52 patients were included in the study Main group (n=37) included patients with PE; comparison group (n=15) included patients suffering from coronary heart disease (NYHA I-II). All patients received ventilation-perfusion lung scintigraphy, gated blood pool single photon emission computer tomography (GBPS), and estimation of plasma levels of endothelin-1, stable nitric oxide (NO) metabolites, and 6-keto-PG F1a.

Results: in patients with PE, RV end-systolic volume, stroke volume, ejection fraction, peak ejection rate, peak filling rate, and mean filling rate were significantly lower in comparison with patients without PE. In patients with PE volume from 3 to 7 bronchopulmonary segments, we have not found any correlations between PE volume and functional status of the right ventricle. In patients with PE, levels of endothelin-1, 6-keto-PG F1a, and stable NO metabolites were increased in comparison with patients without PE.

Conclusion: GBPS allows to verify RV dysfunction in patients without massive PE and severe pulmonary hypertension. Dissociation between volume of PE and the degree of RV dysfunction may be caused by humoral vasoactive factors disbalance. 

 

Reference

1.     Torbicki A., Perrier A., Konstantinides S., et al. ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur. Heart J. 2008; 29 (18): 2276-2315.

2.     Anderson F.A. Jr., Spencer F.A. Risk factors for venous thromboembolism. Circulation. 2003; 107: 9-16.

3.     Heit J.A. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J. Thromb Thrombolysis. 2006; 21: 23-29.

4.     White R.H. The Epidemiology of Venous Thromboembolism. Circulation. 2003; 107: 1-4.

5.     Golghaber S.Z. Echocardiography in the Management of Pulmonary Embolysm. Ann. Intern. Med. 2002; 136 (99): 691-700.

6.     Haddad F., Hunt S.A., Rosenthal D.N. et al. Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008; 117 (11): 1436-48.

7.     MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease: part one. Am. J. Respi. Crit. Care Med. 1994; 150: 833-852.

8.     Zavadovskij K.V., Pan'kova A.N., Krivonogov N.G. i dr. Radionuklidnaja diagnostika trombojembolii legochnoj arterii: vizualizacii perfuzii i ventiljacii legkih, ocenka sokratimosti pravogo zheludochka [Radionuclide diagnosis of pulmonary embolism: perfusion and ventilation, assessment of right ventricular contractility]. Sibirskij medicinskij zhurnal. 2011; 26(2), vypusk 1:14-21 [In Russ].

9.     Petri A., Sjebin K. Nagljadnaja statistika v medicine. Per. s angl. V.P. Leonova. M.: GJeOTAR-MED. 2003; 144 s.: il. (Serija «Jekzamen na otlichno») [In Russ].

10.   Mansencal N., Joseph T., Vieillard-Baron A., et al. Diagnosis of right ventricular dysfunction in acute pulmonary embolism using helical computed tomography. Am. J. Cardiol. 2005; 95 (10): 1260-1263.

11.   Contractor S., Maldjian P.D., Sharma V.K. Role of helical CT in detecting right ventricular dysfunction secondary to acute pulmonary embolism. J. Comput. Assist. Tomogr. 2002;

 

Abstract:

Article presents case report of successful bifurcation stenting of external and internal iliac arteries ir 64-year old patient, with expressed claudication and vasculogenic impotence. Article shows good immediate and nearest results. 

 

References

1.     Leriche Rene et Morel Andre: The Syndrome of Thrombotic Obliteration of the Aortic Bifurcation, in. Annals of Surgery 1948 fevrier; 127 (2): 193-206.

2.     Pokrovskij A.V. Klinicheskaja angiologija [Clinical angiology]: M. 2004; 2: 888 s [In Russ].

3.     Vourliotakis G., Mantas G., Katsargyris A., Aivatidi C., Kandounakis Y Endovascular reconstruction of iliac artery bifurcation atherosclerotic disease with kissing technique. http://vas.sagepub.com/content/early/2013/ 05/03/1708538113478748.full.pdf.

4.     Uchkin I.G., Krotovsky G.S., Turpitko S.A., et al. Surgical treatment and prevention of vasculopathic impotence in conjunction with revascularisation of the lower extremites in Lerische's syndrome. Cardiovascular Surgery. 1991; 3: 340-343.

5.     Konstantinos P. Donas, Arne Schwindt, Georgios A. Pitoulias, Thomas Schonefeld, Claudia Basner and Giovanni Torsello. Endovascular treatment of internal iliac artery obstructive disease. J. Vasc. Surg. 2009; 49:1447-51.

6.     Evans W.E., Hayes J.P., Vermilio D. Anastomotic femoral false aneurysms. In: Complication in Vascular Surgery, 2nd ed. New York: Grune & Stratton. 1985; 205-21. 

7.     Cardia G., Cianci V., Merlicco D. Reoperation on the femoral arterial bifurcation: technical notes and surgical strategy. Chir. Ital. 2002; 54: 4: 487-493.

8.     Shepard A.D., Jacobson G.M. Anastomic aneurysms. In: Complication in vascular surgery (second edition, revised and expanded). New York-Basel: Marcel Dekker, Inc. 2004; 139-154.

9.     Mulder E.J., van Bockel J.H., Maas J., van den Akker P.J., Hermans J. Morbidity and mortality of reconstructive surgery of noninfected false aneurysms detected long after aortic prosthetic reconstruction. Arch. Surg. 1998; 133: 45-9.

10.   Ten Bosch J.A., Waasdorp E.J., de Vries J.P., Moll F. L., Teijink J.A., van Herwaarden J.A. The durability of endovascular repair of para-anastomotic aneurysms after previous open aortic reconstruction. J. Vasc. Surg. 2011 Dec; 54(6):1571-8. doi: 10.1016/j.jvs.2011.04.072. Epub 2011 Sep 23.

11.   Nishibe T., Koizumi J., Kudo F., et al. Repair of false para-anastomotic aortic aneurysms using an endovascular stent graft technique in a patient with severe pulmonary disease: report of a case. Surg. Today. 2001; 31: 110-2.

12.   Morrissey N.J., Yano O.J., Soundararajan K, et al. Endovascular repair of para-anastomotic aneurysms of the aorta and iliac arteries: preferred treatment for a complex problem. J. Vasc. Surg. 2001; 4: 503-12.

13.   Zhilyaev R.A., Semenova T.V., Tyazhelov A.A., et al. Anatomicheskie varianti arterialnogo rusla verhney treti bedra. [Anatomic variants of arteries of upper third of femur.] Klinichna anatomia ta operativna hirurgia. 2008; 7(2):10-14.[In UKR]

14.   Dixit D., Kubavat D.M., Rathod S.P. et al. A study of variations in the origin of profunda femoris artery and its circumflex branches. Int. J. Biol. Med. Res. 2011; 2 (4): 1084-1089.

15.   Massoud T.F., Fletcher E.W.I. Anatomical variants of the profunda femoris artery: an angiographic study. Surg. Radiol. Anat. 1997; 19: 99-103.

16.   Prakash Kumari J., Bhardwaj A.K., et al. Variations in the origins of the profunda femoris, medial and lateral femoral circumflex arteries: a cadaver study in the Indian population. Romanian Journal of Morphology and Embryology. 2010; 51 (1): 167-170.

            17.     Siddharth P., Smith N.L., Mason R.A., et al. Variation anatomy of the deep femoral artery. Anat. Rec. 1985; 212 (2): 206-209. 

 

Abstract:

Case report indicates the usefulness of ultrasound for diagnostics of inorganic retroperitoneal tumor. It is necessary to use interventional methods under ultrasound control, because it gives an opportunity to clarify histological structure of tumor before surgical operation. 

 

References

1.     Klimenkov A.A., Gubina G.I. Neorgannye zabrjushinnye opuholi: osnovnye principy diagnostiki i hirurgicheskoj taktiki [Inorganic retroperitoneal tumor: basic diagnostic and surgical tactics]. Prakticheskaja onkologija. 2004; 4: 285-289 [In Russ].

2.     Babajan L.A. Neorgannye zabrjushinnye opuholi. Izbrannye lekcii po klinicheskoj onkologii [Inorganic retroperitoneal tumors. Elected lectures on clinical oncology] M.,2000; 420-436 [In Russ].

3.     Shhetinin V.V., Shejh Zh.V., Pachgin I.V., Kurzanceva O.O. Neorgannye mezenhimal'nye opuholi zabrjushinnogo prostranstva: osobennosti izobrazhenija i priznaki zlokachestvennosti. [Inorganic mesenchymal tumors or retroperitoneal space: features of imaging and signs of malignancy] Radiologija-praktika. 2004; 3:34-41 [In Russ].

4.     Vlasov P.V., Kotljarov P.M. Kompleksnaja luchevaja diagnostika zabrjushinnyh opuholej i opuholevidnyh sostojanij. [Complex beam diagnostics of retroperitoneal tumors and new-growth conditions.] Vestnik rentgenoogii i radiologii. 1998; 3: 30-40 [In Russ]

5.     Kilkenny J.W. IIIrd, Bland K.I., Copeland E.M. Retroperitoneal sarcoma: the Universitty Florida experience. J. Amer. Coll. Surg. 1996; 329-339.

6.     Singer S., Corson J.M., Demetri G.D., et al. Prognostic factors predictive of survival for truncal and retroperitoneal softtissue sarcoma. Ann. Surg. 1995; 185-195.

7.     Herman K., Kusy T. Retroperitoneal sarcoma - the continued for surgery and oncology. Surg. Oncol. 1998; 7(1-2): 77-81.

8.     Gvarishvili M.A. Ul'trazvukovoe issledovanie v diagnostike neorgannyh opuholej brjushnoj polosti i zabrjushinnogo prostranstva. [Ultrasound diagnostics of inorganic tumors of abdominal cavity and retroperitoneal space.] Diss. cand. med.nauk. M., 2010; 15-18. [In Russ].

 

 

authors: 

 

Abstract:

According to American Cancer Society lung cancer is the main "killer" among all types of cancer, five year survival rate of these patients in less than 15%. Thorough staging is necessary to make prognosis of disease and choose the way of treatment. In 2009 International Association for the Study of Lung Cancer ( IASLC) published the 7th system of lung cancer staging based on TNM classification data. Defining of lung cancer and its staging is an interdisciplinary process. Moreover clinical, endoscopic and radiological data are used for this purpose. Among them, the multislice computed tomography is a leading method for lung cancer staging. 

 

References

1.     Sobin L.H., Gospodarovich M.K., Vittekind K. TNM-classification of malignant tumors. [TNM-classification of malignant tumors.]. Logosfera, M., 2011; 122-134 [In Russ].

2.     Robert D.Su, Nanett A.Le, Kjetlin Braun i Majil S.Krishnam. Continous medical education: basic staging of lung cancer.. Novaja TNM-klassifikacija [Continous medical education: basic staging of lung cancer.]. Radiographics 2010; 30(5):1163-1181 [In Russ].

3.     Lung Cancer Staging Essentials: The New TNM Staging System and Potential Imaging Pitfalls. RadioGraphics Sep 2010; 30(5):1163-1181.

4.     Vershchakelen J.A., Bogaert J., De Wever W. Computed tomography in staging for lung cancer. Eur. Respir. J. 2002;40-48.

5.     Edward W. Bouchard, Steven Falen, MD, Paul L. Molina. Lung cancer: A radiologic overview. Аpplied radiology. 2008; [Edward W. Bouchard, Steven Falen, Paul L. Molina. Radiology plays a critical role in the detection, diagnosis, and staging of thoracic malignancies. This article reviews the use of chest radiography (CXR), computed http://www.applied-radiology.com/ Issues/2002/08/Articles/Lung-Cancer-A-radiologic-overview.aspx www.appliedradiology.com

6.     Matias Prokop, Mihajel' Galanski. Spiral and multislice computed tomography. Kompjuternaja tomografija [Spiral and multislice computed tomography]. «MEDpress-inform» M., 2007; 2: 92-104 [In Russ].

7.     Richard Webb W., Charles B. Higgins. Thoracic imaging. Pulmonary and Cardiovasular Radiology. Lippincott Williams and Wilkins 2005; 66-111.

8.     Valerie W. Rusch, Hisao Asamura, Hirokazu Watanabe, Dorothy J. Giroux, Ramon Rami-Porta, Peter Goldstraw, on Behalf of the members of the IASLC Staging Committee. The IASLC Lung Cancer Staging Project/ A Proposal for a New International Lymph Node Map in The Forthcoming Seven Edition of the TNM Classification for Lung Cancer. Journal of Thoracic Oncology. 2009; 4(5):568-577.

9.     Tjurin I.E. «Computed tomography of thoracic organs . SPb.:JeLBI-SPb [Computed tomography of thoracic organs]. 2003; 235-265 [In Russ]. 

 

Abstract:

We present case reports of patients with multiple metastatic lesions and multiple myeloma in vertebral column with pathological fractures of vertebral bodies and intense pain. Authors recommend to perform multilevel vertebroplasty because this approach allows to reduce pain severity, and to prevent pathological vertebral fracture and provides early rehabilitation of patient. 

 

References

1.     Biermann W.A., Cantor R.I., Fellin F.M. et al., An evaluation of the potential cost reductions resulting from the use of clodronate in the treatment of metastatic carcinoma of the breast. Bone. 1991; 12: 37-42.

2.     Galasko C.S. Incidence and distribution of bone metastases. Clin. Orthop. 1986; 210: 14-21.

3.     Chiras J., Cormier E., Baragan H., Jean B., Rose M. Interventional radiology in bone metastases. Journal de radiologie 2007; 94(2):161-9.

4.     Fadilah S.A. Fundamentals in the management of multiple myeloma. Med. J. Malaysia. 2010; 65(3):231-9.

5.     Kasperk C., Grafe I. Osteoplastic procedures for the treatment of vertebral complications in multiple myeloma patients. Review. Recent Results Cancer Res. 2011; 183:293-306.

6.     Kose K.C., Cebesoy O., Akan B., Altinel L., Dincer D., Yazar T. Functional results of vertebral augmentation techniques in pathological vertebral fractures of myelomatous patients. J. Neuroradiol. 2006; 98(10):1654-8.

7.     Kalyani A., Rohaizak M., Cheong S.K., Nor Aini U., Balasundaram V., Norlia A. Recurrent multiple myeloma presenting as a breast plasmacytoma. Med. J. Malaysia. 2010;65(3):227-8.

8.     Basile A., Cavalli M., Fiumara P, Di Raimondo F., Mundo E., Caltabiano G., Arcerito F., Patti M.T., Granata A., Tsetis D. Vertebroplasty in multiple myeloma with osteolysis or fracture of the posterior vertebral wall. Usefulness of a delayed cement injection. Skeletal Radiol. 2011 Jul; 40(7):913-9. Epub 2011 Feb 28.

9.     Anselmetti G.C., Manca A., Montemurro F., Hirsch J., Chiara G., Grignani G., Carnevale Schianca F., Capaldi A., Rota Scalabrini D., Sardo E., Debernardi F., lussich G., Regge D. Percutaneous Vertebroplasty in Multiple Myeloma: Prospective Long-Term Follow-Up in 106 Consecutive Patients. Cardiovasc .Intervent. Radiol. 2011 Feb 9. [Epub ahead of print].

10.   Cortet B., Boutry., N., et al. Percutaneous Vertebroplasty in patients with osteolytic metastases or multiple myeloma [see comments]. Rev. Rheum. Engl. Ed. 1997; 64(3):177-183.

11.   Hrabalek L., Bacovsky J., Scudla V., Wanek T., Kalita O. Multiple spinal myeloma and its surgical management. Rozhl. Chir. 2011; 90(5):270-6 [In Czech].

12.   Tepljakov V.V., Karpenko V.Ju., Buharov A.V. Intervencionnye metody lechenija pri opuholevom porazhenii kostej. Sarkomy kostej, mjagkih tkanej i opuholi kozhi [Interventional treatment methods of bone tumoral lesions] M., Izd-vo «Farmarus Print Media». 2010; 1: 21-25 [In Russ]. 

 

Abstract:

Coronary flow limitation during high risk angioplasty in acute coronary syndrome (ACS) patients is an important problem, connecting with inadequate myocardial protection during the coronary intervention.

Aim: was to compare intraoperative cardiohemodynamic in ACS patients during the high risk angioplasty of difficult stenoses in anterior heart arteries with- or without a coronary venous retroperfusion support.

Methods: intervention results of 14 ACS patients were analyzed. In 1st group there were 6 patients (42,9%) with intraoperative myocardial retroperfusion support. In 2nd group - 8 patients (57,1%) without any intraoperative myocardial perfusion support.

Results: during the retroperfusion support in the 1st group , «ST»-segment elevation at 60 sec left main (LM) or left anterior descending artery (LAD) occlusion was significantly lower (ST in V4-V6 - 1,9±1,7 mm) than in patients without retroperfusion (ST in V4-V6 - 3,1±1,7; p = 0,043). In the 2nd group, patients without coronary flow support the «ST»-segment elevation at 60 sec LM or LAD occlusion was significantly higher (ST в V4-V6 - 2,5±0,5; p = 0,043) than at 5 sec LM or LAD occlusion. No significant differences between «ST»-segment and «T»-wave deviation in the beginning and in the end of intervention were in both groups. The same dynamics was demonstrated at the time of blood pressure indexes measurement.

Conclusion: coronary venous retroperfusion is an effective method of coronary flow support during the high risk angioplasty in ACS patients. Retroperfusion technology had no influence on cardiohemodynamic, but reduced the risk of intraoperative adverse cardiac events. 

 

References

1.     Antman E.M., Anbe D.T., Armstrong P.W. et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J. Am. Coll. Cardiol. 2004; 44: E1-E211.

2.     Trusov V.V., Kazakova I.A., Kuznecov D.N. Analiz raboty pervichnogo sosudistogo centra na baze MUZ MSCh «ZhMASh» [Analysis of functioning of primary angiologic center on the base of medical-sanitary unit of «IZhMASh»]. PJeM . 2011; 43-44(3-4):20-22 [In Russ].

3.     Silber S., Albertsson P., Aviles F.F., et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur. Heart J. 2005; 26: 804-847. P05-04673.

4.     Kononov A.V., Kostjanov I.Ju., Kuznecova I.Je., Aligishieva Z.A., Abil'dinova A.Zh., Cereteli N.V., Koledinskij A.G., Gromov D.G., Suhorukov O.E., Ioseliani D.G. Stentirovanie stvola levoj koronarnoj arterii u bol'nyh s razlichnymi formami ishemicheskoj bolezni serdca: blizhajshie i sredneotdalennye rezul'taty [Stenting of left main coronary artery in patients with different forms of ischemic heart disease: early- and long-term results.]. Mezhdunarodnyj zhurnal intervencionnoj kardioangiologii (Moskva). 2013;23: 26-33 [In Russ].

5.     ACC/AHA Guidelines for the Management of Patients with Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). JACC. 2000; 36: 970-1062.

6.     ESC/EACTS Guidelines. Guidelines on myocardial revascularization/The Task Force on Myocardial Revascularization of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery (Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAP- CI). European Heart Journal.2010; 31: 2501-2555.

7.     Almany S.L. Interventional in patient with LV dysfunction. PI 57 in New manual of interventional radiology by Mark Freed et al. - Birmingham, Michigan: Physicians T. Press, 1997.

8.     ACC/AHA Guidelines for Percutaneous Coronary Intervention. PTCA Guidelines. JACC 2001; 37: 8: 2239-2306.

9.     Kardiologija: nacional'noe rukovodstvo [Cardiology: national guide-book] (pod red. Ju.N. Belenkova, R.G. Oganova) M.: GJeOTAR-Media, 2008; 1232 s [In Russ].

10.   Belov Ju.V. Varaksin V.A. Postinfarktnoe remodelirovanie levogo zheludochka serdca. Ot koncepcii k hirurgicheskomu lecheniju [Postinfarction remodeling of left atrium. From concept to surgical treatment]. M.: DeNovo, 2002; 5587 [In Russ].

11.   Shiller N.B., Osipov M.A. Klinicheskaja jehokardiografija [Clinical echocardiography]. M.: Praktika, 2005; 344 [In Russ].

12.   Serruys P.W., Onuma Y, Garg S. et all. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009; 5:50-56.

13.   Incorvati R.L., Tauberg S.G., Pecora M.G., et all. Clinical applications of coronary sinus retroperfusion during high risk percutaneous transluminal coronary angioplasty. JACC. 1993; 22(1): 127-34.

14.   Petrov V.I., Nedogoda S.V. «Medicina, osnovannaja na dokazatel'stvah»: Uchebnoe posobie [Medicine, based on evidence]. Moskva: Gjeotar-Media, 2009; 144 s [In Russ].

15.   Javelov I.S. Vybor antikoaguljanta dlja rannego lechenija ostrogo koronarnogo sindroma [Choise of anticoagulants for early treatment of acute coronary syndrome]. Trudnyj pacient (Moskva). 2013;11(10): 12-24 [In Russ].

16.   Lazar H.L. Coronary sinus retroperfusion: can forward progress still be achieved by using a backward technique? J. Thorac. Cardiovasc. Surg., 2004; 127(6): 1549-52.

17.   Zemgulis V., Wikstrom G., Bjerner T., Henze A., Lahtinen M., Waldens^m A., Thelin S., Ronquist G. Discrepant outcome between myocardial energy-related metabolites and infarct size limitation during retroperfusion of the coronary sinus. Scand. J. Clin. Lab. Invest. 2001; 61(8): 651-62.

18.   Leung W.H. Coronary and circulatory support strategies for percutaneous transluminal coronary angioplasty in high-risk patients. Am. Heart J., 1993; 125(6): 1727-38.

19.   Thiele H., Zeymer U., Neumann F.J. et all. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N. Engl. J. Med. 2013; 368:80-81. 

 

Abstract:

Article describes results of single-balloon angioplasty and stenting in patients with occlusive-stenotic lesions of femoral-popliteal segment for the period of 30 months. It was performed 209 endovascular interventions, single-balloon angioplasty in 95 patients; stenting - 114 patients. Long-term results of primary patency: 43,1% in group of single-balloon angioplasty 57,1% - in group with stenting.

 

References

1.     Рекомендуемые стандарты для оценки результатов лечения пациентов с хронической ишемией нижних конечностей. Российский консенсус. Казань 2001. Rekomenduemye standarty dlja ocenki rezul'tatov lechenija pacientov s hronicheskoj ishemiej nizhnih konechnostej. Rossijskij consensus [Recommended standarts for estimation of treatment results in patients with chronic ischemia of lower limbs. Russian Consensus]. Kazan' 2001 [ In Russ].

2.     Klinicheskaja angiologija [Clinical angiology]. Pod red. akad. Pokrovskogo A.V. M., 2004; 1: 69 [In Russ].

3.     Nacional'nye rekomendacii po vedeniju bol'nyh s zabolevanijami arterij nizhnih konechnostej [National recommendation for treatment of patients with diseases of lower limbs’ arteries.]. M., 2013[In Russ].

4.     Hunink M.M., Donaldson M.C., Meyerovitz M.F., et al. Risks and benefits of femoropopliteal percutaneous balloon angioplasty. J. Vasc. Surg. 1993; 17: 183-194.

5.     Becquemin J-P, Cavillon A., Haiduc F. Surgical transluminal femoropopliteal angioplasty: multivariate analysis outcome. J. Vasc .Surg .1994; 19: 495-502.

6.     Murray R.R., Hewes R.C., White R.I., et al. Long-segment femoropopliteal stenoses: is angioplasty a boom or a bust? Radiology .1987; 162: 473-476.

7.     Johnston K.W. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology. 1992; 183:767-71.

8.     Krankenberg H., Schluter M., Steinkamp H.J., et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to

10    cm in length: the Femoral Artery Stenting Trial (FAST). Circulation. 2007; 116:285-92.

9.     Dake M., Ansel G., Jaff M., et al. Zilver PTX: a prospective, randomized trial of the polymer-free paclitax-eleluting stent compared to balloon angioplasty with provisional bare metal stenting in patients with superficial femoral artery disease (abstr). Paper presented at: Twenty-Second Annual Transcatheter Cardiovascular Therapeutics Symposium;September 21-25; Washington, DC. J. Am. Coll. Cardiol. 2010;56:xiii.

10.   Bergeron P., Pinot J.J., Poyen V., et al. Long-term results with the Palmaz stent in the superficial femoral artery. J. Endovasc. Surg. 1995; 2: 161-167.

11.   Henry M., Amor M., Henry I., et al. Placement of Palmaz stent in femoropopliteal arteries: a six year experience. Factors influencing restenosis and longterm results. In: Abstract Book 6° International course on peripheral vascular intervention. Oct 1995, Nancy, France.

12.   Dake M., Ansel G., Jaff M., et al. Zilver PTX: a prospective, randomized trial of the polymer-free paclitax-eleluting stent compared to balloon angioplasty with provisional bare metal stenting in patients with superficial femoral artery disease (abstr). Paper presented at: Twenty-Second Annual Transcatheter Cardiovascular Therapeutics Symposium;September 21-25; Washington, DC. J. Am. Coll. Cardiol. 2010;56. 

 

Abstract:

Aim: was to estimate first own results of arterial radioembolization (RE) in patients with primary or metastatic liver malignancy.

Materials and methods: in 2009, RE of the right (n=3) or left (n=1) hepatic artery using Yttrium-90 glass microspheres (Therasphere) was performed in 4 patients: 3 with hepatocellular carcinoma on cirrhosis complicated by portal vein branch thrombosis (contraindication for chemoembolization), and 1 patient with colorectal liver metastases.

Results: all RE procedures were technically successful. The radiation dose to the tumor was 1 20-150 Gy The post embolization syndrome was minimal and uncomplicated. After RE, partial tumor response and stabilization were noted in 2 patients each. Patients survived from 14 to 32 months.

Conclusion: RE is well-tolerated and safe procedure causing significant local damage of liver tumor. According to our first experience, RE is a very promising method for treatment of hepatic malignancies. 

 

References

1.     Tarazov P.G. Arterial radioembolization of liver malignancies with ittrium-90 microspheres (review). Voprosy onkologii. 2013; 59(4): 428-434 [In Russ].

2.     Lewandowski R.J., Geschwind J.-F., Liapi E., Salem R. Transcatheter intraarterial therapies: Rationale and overview. Radiology. 2011; 259(3): 641-657.

3.     Powerski M.J., Scheurig-Muenkel C., Banzen J., Schnappauff D., Hamm B., Gebauer B. Clinical practice in radioembolization of hepatic malignancies: A survey among interventional centers in Europe. Eur. J. Radiol. 2012; 81(7): e804-e811.

4.     Seidensticker R., Seidensticker M., Damm R., Mohnike K., Schutte K., Malfwertheiner P., Van Buskirk M., Pech M., Amthauer H., Ricke J. Hepatic toxicity after radioembolization of the liver using 90Y-micro- spheres: Sequential lobar versus whole liver approach. Cardiovasc. Intervent. Radiol. 2012; 35(5): 1109-1118.

5.     Garin E. Radioembolisation of hepatocellular carcinoma patients using 90Y-labelled microspheres: Towards a diffusion of the technique? Eur. J. Nucl. Med. Mol. Imaging. 2011; 38(12): 2114-2116.

6.     Atassi B., Bangash A.K., Lewandowski R.J., Ibrahim, Kulik L., Mulcahy M.F., Ryu R.K., Sato K.T., Miller F.H., Omary R.A., Salem R. Biliary sequelae following radioembolization with Yttrium-90 microspheres. J. Vasc. Interv. Radiol. 2008; 19(5): 691-697.

7.     Jakobs T.F., Saleem S., Atassi B., Reda E., Lewandowski R.J., Yaghmai V., Miller F., Ryu R.K., Ibrahim

5.,    Sato K.T., Kulik L.M., Mulcahy M.F., Omary R., Murthy R., Reiser M.F., Salem R. Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90Yttrium microspheres. Dig. Dis. Sci. 2008; 53(9): 2556-2563.

8.     Naymagon S., Warner R.R.P., Patel K., Harpaz N., Machac J., Weintraub J.L., Kim M.K. Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: An institutional experience and review of the literature. Dig. Dis. Sci. 2010; 55(9): 24502458.

9.     Salem R., Lewandowski R.J., Mulcahy M.F., Riaz A., Ryu R.K., Ibrahim S., Atassi B., Baker T., Gates V., Miller F.H., Sato K.T., Wang E., Gupta R., Benson A.B., Newman S.B., Omary R.A., Abecassis M., Kulik L. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: A comprehensive report of long-term outcomes. Gastroenterology. 2010; 138(1): 52-64.

10.   Salem R., Gilbertsen M., Butt Z., Memon K., Vouche M., Hickey R., Baker T., Abecassis M.M., Atassi R., Riaz A., Cella D., Burns J.L., Ganger D., Benson A.B., Miulcahy M.F., Kulik L., Lewandowsi R. Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization. Clin. Gastroenterol. Hepatol. 2013; 11(10): 1358-1365.

11.   Kim YH., Kim D.Y Yttrium-90 radioembolization for hepatocellular carcinoma: What we know and what we need to know. Oncology. 2013; 84 (suppl.1): 34-39.

12.   Memon K., Kulik L., Lewandowski R.J., Mulcahy M.F., Benson A.B., Ganger D., Riaz A., Gupta R., Vouche M., Gates V.L., Miller F.H., Omary R.A., Salem R. Radioembolization for hepatocellular carcinoma with portal vein thrombosis: Impact of liver function on systemic treatment options at disease progression. J. Hepatol. 2013; 58(1): 73-80.

13.   Moreno-Luna L.E., Yang J.D., Sanchez W., Paz- Fumagalli R., Harnois D.M., Mettler T.A., Gansen D.N., de Groen P.C., Lazaridis K.N., Menon K.W.N., LaRusso M.F., Alberts S.R., Gores G.J., Fleming C.J., Slettedahl S.W.. Harmsen W.S., Therneau T.M., Wiseman G.A., Andrews J.C., Roberts L.R. Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. Cardiovasc. Intervent. Radiol. 2013; 36(3): 714-723.

14.   Tsai A.L., Burke C.T., Kennedy A.S., Moore D.T., Mauro M.A., Dixon R.D., Stavas J.M., Bernard S.A., Khandani A.H., O’Neil B.H. Use of yttrium-90 mocrospheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis. J. Vasc. Interv. Radiol. 2010; 21(9): 1377-1384.

15.   Mazzaferro V., Sposito C., Bhoori S., Romito R., Chiesa C., Morosi C., Maccauro M., Marchiano A., Bongini M., Lanocita R., Civelli E., Bombardien E., Camerini T., Spreafico C. Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study. Hepatology. 2013; 57(5): 1826-1837.

16.   Stubbs R.S., Wickremesekera S.K. Selective internal radiation therapy (SIRT): A new modality for treating patients with colorectal liver metastases (review). HPB. 2004; 6(3): 133-139.

17.   Bester L., Meteling B., Pocock N., Pavlakis N., Chua T.C., Saxena A., Morris D.L. Radioembolization versus standard care of hepatic metastases: Comparative retrospective cohort study of survival outcomes and adverse events in salvage patients. J. Vasc. Interv. Radiol. 2012; 23(1): 96-105.

18.   Mahnken A.H., Spreafico C., Maleux G.,Helmberger T., Jacobs T.F. Standards of practice in transarterial radioembolization. Cardiovasc. Intervent. Radiol. 2013; 36(3): 613-622.

19.   Brown R.E., Bower M.R., Metzger T.L., Scoggins C.R., McMaster K.M., Hall M.J., Tatum C., Martin R.C.G. Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: Is it safe? HPB. 2011; 13(2): 91-95.

20.   Ibrahim S.M., Kulik L., Baker T., Ryu R.K., Mulcahy M.F., Abecassis M., Salem R., Lewandowski R.J. Treating and downstaging hepatocellular carcinoma in the caudate lobe with yttrium-90 radioembolization. Cardiovasc. Intervent. Radiol. 2012; 35(5): 1094-1101.

21.   Tohme S., Sukato D., Chen H.-W., Amesur N., Zajko A.B., Humar A., Geller D.A., Marsh J.W., Tsung A. Yttrium- 90 radioembolization as a bridge to liver transplantation: A single-institution experience. J. Vasc. Interv. Radiol. 2013; 24(11): 1632-1638.

22.   Hoffmann R.-T., Jakobs T.F., Kubisch C.H., Stemmler H.J., Trumm C., Tatsch K., Helmberger T.K., Reiser M.F. Radiofrequency ablation after selective internal radiation therapy with yttrium 90 microspheres in metastatic liver disease - is it feasible? Eur. J. Radiol. 2010; 74(1): 199-205.

23.   Wasan H., Kennedy A., Coldwell D., Sangro B., Salem R. Integrating radioembolization with chemotherapy in the treatment paradigm for unresectable colorectal liver metastases (review). Am. J. Clin. Oncol. 2012; 35(3): 293-301.

24.   Edeline J., Lenoir L., Boudjama K., Rolland Y, Boulic A., Le Du F., Pracht M., Raoul J.-L., Clement B., Garin E., Boucher E. Volumetric changes after 90Y radioembolization for hepatocellular carcinoma in cirrhosis: An option to portal vein embolization in a preoperative setting? Ann. Surg. Oncol. 2013; 20(8): 2518-2525.

25.   Vouche M., Lewandowski R.J., Atassi R., Memon K., Gates V.L., Ryu R.K., Gaba R.C., Mulcahy M.F., Baker T., Sato K., Hickey R., Ganger D., Riaz A., Fryer J., Caicedo J.C., Abecassis M., Kulik L., Salem R. Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J. Hepatol. 2013; 59(5): 1029-1036.

26.   Lam M.G.E.H., Louie J.D., Iagaru A.H., Goris M.L., Sze D.Y Safety of repeated yrrium-90 radioembolization. Cardiovasc. Intervent. Radiol. 2013; 36(5): 13201328.

27.   Fiore F., Cappelli A., Rodrigues M., Ettorre G.M., Saltarelli A., Geatti O., Ahmadzadehfar H., Haug A.R., Izzo F., Giampalma E., Sangro B., Pizzi G., Notarianni E., Vit A., Wilhelm K., Jacobs T.F., Lastoria S. Comparison of the survival and tolerability of radioembolization in elderly vs younger patients with unresectable hepatocellular carcinoma. J. Hepatol. 2013; 59(4): 753-761. 

 

Abstract:

Article describes experience of Novosibirsk scientific-research institute of blood circulation pathology named after E.N.Meshalkin in hybrid interventions in aortic dissection.

Aim: was to estimate efficacy of hybrid methods in surgical treatment of aortic dissection .

Materials and methods: since 2011 - 17 operations on proximal aortic dissections and 8 operations on distal aortic dissection with use of hybrid methodics were made.

Results: mortality in early post-operative period - 2 patients and was determined by progression of heart insufficiency In late post-operative period, basing on MSCT data, thrombosis of false lumen of aortic dissection on the mark of stent-graft or bare-metal stent (descending thoracic aorta) was revealec in 7 of 10 patients (70%) and in all patients with hybrid endoprothesis. During observation in post-operative period, none of patients were marked as needed of operation on thoracic-abdominal aorta.

Conclusion: used techniques allow to gain number of advantages in this severe group of patients as n early post-operative period, and also in late post-operative period. Endovascular treatment, performing simultaneously with open surgical interventions - are safe for patient and easy for surgeon. More extended reconstruction of aorta in single-stage operation can exclude aneurysmatic degeneration and prevent operations on distal aorta. 

 

References

1.     Anagnostopoulos C., Prabhakar M., Kittle C. Aortic dissections and dissecting aneurysm. Am. J. Cardiol., 1972; 30:263-273.

2.     Borst H.G., Heinemann M.K., Stone C.D. Surgical treatment of aortic dissection. New York: Churchill Living- stone;1996. p.357.

3.     Tan M.E., Morshuis W.J., Dossche K.M.et al., Longterm results after 27 years of surgical treatment of acute type aortic dissection. Ann. Thorac. Surg. 2005; 80: 523-529.

4.     Driever R., Botsios S., Schmitz E., et al. Long-term effectiveness of operative procedures for Stanford type A aortic dissections. Cardiovasc. Surg. 2003;11:265-72.

5.     Ergin M.A., Phillips R.A., Galla J.D., et al. Significance of distal false lumen after type A dissection repair. Ann. Thorac. Surg. 1994;57(4):820-4.

6.     Safi H.J., Miller C.C., Reardon M.J., et al. Operation for acute and chronic dissection: recent outcome with regard to neurologic defect and death. Ann. Thorac. Surg. 1998; 66: 402.

7.     Di Bartolomeo R., Di Marco L., Armaro A., et al. Treatment of complex disease of the thoracic aorta: the frozen elephant trunk technique with the E-vita open prosthesis. Eur. J. Cardiothorac.Surg. 2009;35:671-675.

8.     Hirotani T., Nakamichi T., Munakata M., et al. Routine extended graft replacement for an acute type A aortic dissection and the patency of the residual false channel. Ann.Thorac.Surg. 2003; 76: 1957-1961.

9.     Milewicz D.M., Guo D.C., Tran-Fadulu V., et al. Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu. Rev. Genomics Hum. Genet. 2008;9:283-302.

10.   Kay-Hyun Park, Cheong Lim, Jin Ho Choi, et al. Midterm change of descending aortic false lumen after repair of acute type I dissection Ann. Thoracic Surgery. 2009; 87(1): 103-108.

11.   Kato M., Ohnishi K., Kaneko M. et al., New graft-implanting method for thoracic aortic aneurysm or dissection with a stented graft. Circulation. 1996; 94 (9): 188-193.

12.   Di Bartolomeo R., Di Marco L., Armaro A., et al. Treatment of complex disease of the thoracic aorta: the frozen elephant trunk technique with the E-vita open prosthesis. Eur. J. Cardiothorac.Surg. 2009;35:671-675.

13.   Chernjavskij A.M., Al'sov S.A., Ljashenko M.M. i dr. Hybrid prosthesis in reconstruction of the arch and the proximal thoracic aorta in aortic dissection De Bakey type I Grudnaja i serdechno-sosudistaja hirurgija. 2012; 5: 11-15 [In Russ].

14.   Chernjavskij A.M. , Al'sov S.A., Lomivorotov V.V. i dr. Hybrid approach in the treatment of chronic proximal aortic dissection. Kardiologija i serdechno-sosudistaja hirurgija. 2012; 6: 103-106 [In Russ].

15.   Leobon B., Roux D.,Saccani S. et al: Type A aortic dissection: New surgical strategy using intraoperative stenting. J. Thorac.Cardiovasc. Surg.2006;131:482-483.

16.   Fattouch K., Sampognaro R., Navarra E.et al. LongTerm results after repair of Type A acute aortic dissection according to false lumen patency. Ann. Thoracic Surgery. 2009; 88: 1244-1250.

17.   Geirsson A., Bavaria J.E., Swarr D. et al. Fate of the residual distal and proximal aorta after acute type A dissection repair using a contemporary surgical reconstruction algorithm. Ann. Thorac.Surg. 2007;84:1955-64.

18.   Chernjavsij A.M., Al'sov S.A., Ljashenko M.M. i dr. Status of the thoracoabdominal aorta after reconstruction of the ascending aorta at the dissection De Bakey type I. Patologija krovoobrashhenija i kardiohirurgija. 2013; 2: 29-35 [In Russ].

19.   Czerny M., Stohr S., Aymard T., Sodeck G., et al. Effect on false-lumen status of a combined vascular and endovascular approach for the treatment of acute type A aortic dissection. European Journal of Cardio-Thoracic Surgery. 2012; 41: 409-413.

20.   Upchurch G. R., Creado E. Aortic aneurysms. Pathogenesis and treatment. 2008; 156p.

21.   Chang Ch.-P, Liu J., Liou Y-.M. The role of false lumen size in prediction of in-hospital complication after acute type B aortic dissection JACC V. 2008; 52: 1170-1176.

22.   Trimarchi S., Tolenaar J., Jonker F. Importance of false lumen thrombosis in type B aortic dissection prognosis. J. of Thoracic and Cardiovascular Surgery. 2013; 145: 208-212. 

 

Abstract:

Aim: was to study influence of surgical reconstruction of left ventricular (LV) in patients with postinfarction LV aneurysm, on dynamics of stroke volume (SV) and determine basic predictors of its decreasement.

Materials and Methods: retrospective study included patients with various types of surgical reconstruction of post-infarction LV aneurysm who underwent cardiac MRI before surgery, and subsequent control study by the same method in the postoperative period (mean 17,6 ± 4,7 days ) from March 2010 to February 2014. For statistical analysis, patients were divided into 2 groups according to the postoperative increase or decrease of SV Performed statistical analysis of baseline and post-operative structure - geometric and functional parameters of LV A mathematical model, based on which the multivariate analysis was performed using an automated method of linear modeling tc identify the most important predictor of subsequent risk assessment and its impact on postoperative decrease SV

Results: the left ventricular reconstruction surgery in the early postoperative period leads to reduce of left ventricular end diastolic (LVED) and end-systolic volume (LVES), respectively 22,41% and 21,85% (p <0,001), and an increase in ejection fraction (EF) at 21,76% (p <0,001), that seemingly indicates improvement in the pumping function of the heart. But, however, pointed out that the stroke volume, which more accurately reflects the feature after reconstruction LV increases less than half of patients (42.6%), an average of 11,2±1,6%, (p <0,001) and the majority (57,4%) decreases in average 21,0 ± 1,6%. (p <0,001). Groups with a postoperative increase or decrease in the value of SV differed except its dynamics (p <0,001), for the volume reduction of LVES (p = 0.25) increase in EF (p <0,001), a decrease INLS (p = 0.006). Found that the most important predictor of postoperative dynamics affecting the SV is the surgical reduction of LV volume (LVED). With a decrease in LV volume more than 25% of the original LVED risk reduction SV becomes high (OR 0,53; 95% CI 0,35, 0,79). When surgical volume reduction ratio greater than 35% chance of postoperative improvement SV maximally reduced (RR 4,74; 95% CI 1,27; 17,73; p = 0,042).

Conclusion: after surgical reconstruction of postinfarction LV aneurysms in the early postoperative period increase SV occurs in less than half of patients (42.6%), despite an increase in ejection fraction and decreased LVED. Leading predictor of postoperative determining the dynamics of the SV, is surgical reduction of left ventricular volume. Reduction of the volume of the left ventricle during the operation of surgical correction of left ventricular aneurysm more than 25% of the original LVED increases the risk of postoperative decrease in stroke volume, and more than 35% reduces chances of his promotion. 

 

References

1.     Borisov N.A., Popov L.V., Bletkin A.N. Hirurgicheskoe lechenie postinfakrtnoj anevrizmy levogo zheludochka [Surgical treatment of postinfarction aneurysm of left ventricular]. Annaly hirurgii. 2002; 3:14-19 [ in Russ].

2.     Cooley D.A. Surgical restoration of left ventricular aneurysm. Oper. Tech. Cardiac. Thorac. Surg. 1997; 2:151-161.

3.     Otsuji Y, Handschumacher M.D., Liel-Choen N., et al Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: Three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J. Am. Coll. Cardiol. 2001; 37:641-648.

4.     Kalon K., Ho. L., Pinsky J.L., Karmd W.B., Levy D. The epidemiology of heart failure: the Framingham Study. J. of AmericanCollege of Cardiology. 1993; 22:6A-13A.

5.     Grigioni F., regurgitationEnriquez-Sarano M., Zehr K.J. et al. Ischaemic mitral. Circulation. 2001; 103: 1759-1764.

6.     Athanasuleas C.L., Buckberg G.D., Stanley A.W., et al. RESTORE group. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J. Am.Coll. Cardiol. 2004; 44:1439-1445.

7.     Di Donato M., Fantini F., Toso A., Castelvecchio S., Menicanti L., Annest L., Burkhoff D. Impact of surgical ventricular reconstruction on stroke volume in patients with ischemic cardiomyopathy. J. Thorac. Cardiovasc. Surg. 2010; 140:1325-1331

8.     Menicanti L., Castelvecchio S., Ranucci M., et al. Surgical therapy for ischemic heart failure: Single-center experience with surgical anterior ventricular restoration. J. Thorac. Сardiovasc. Surg. 2007; 134: 433-441.

9.     Annest L., Burkhoff D., JordeU., Wechsler A.S. Stroke volume alterations in patients undergoing left ventricular reconstructive surgery: a meta-analysis of 2131 cases. J. Card. Fail. 2007; 3:118.

10.   Cirillo M., Amaducci A., Brunelli F., et al. Determinants of postinfarction remodeling affect outcome and left ventricular geometry after surgical treatment of ischemic cardiomyopathy. J. Thorac. Cardiovasc. Surg. 2004; 127:1648-1656.

11.   Di Donato M., Toso A., Dor V., et al. Surgical ventricular restoration improves mechanical intraventricular dyssynchrony in ischemic cardiomyopathy. Circulation. 2004; 109:2536-2543.

12.   Menicanti L., Di Donato M. The Dor procedure: what has changed after fifteen years of clinical practice? J. Thorac. Cardiovasc. Surg. 2002; 124:886-890.

13.   O’Neill J.O., Starling R.C., McCarthy P.M., et al. The impact of left ventricular reconstruction on survival in patients with ischemic cardiomyopathy. Eur. J. Cardiothorac. Surg. 2006; 30:753-759.

14.   Patel N.D., Williams J.A., Nwakanma L.U., et al. Impact of lateral wall myocardial infarction on outcomes after surgical ventricular restoration. Ann.Thorac. Surg. 2007; 83:2017-2027.

15.   Tulner     S.A., Bax J.J., Bleeker G.B., et al. Beneficial hemodynamic and clinical effects of surgical ventricular restoration in patients with ischemic dilated cardiomyopathy. Ann. Thorac. Surg. 2006; 82:1721-1727.

16.   Athanasuleas C.L., Stanley A.W. Jr., Buckberg G.D., et al. Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. RESTORE group. Reconstructive Endoventricular Surgery, returning Torsion Original Radius Elliptical Shape to the LV. J. Am. Coll. Cardiol. 2001; 37:1199-1209.

17.   Dor V., Sabatier M., Montiglio F., Coste P., Di D.M. Endoventricular patch reconstruction in large ischemic wall-motion abnormalities. J. Card .Surg. 1999;14:46-52.

18.   Patel N.D., Williams J.A., Barreiro C.J., et al. Surgical ventricular remodeling for multiterritory myocardial infarction: defining a new patient population. J. Thorac. Cardiovasc. Surg. 2005; 130:1698-1706.

19.   Ribeiro G.A., da Costa C.E., Lopes M.M., et al. Left ventricular reconstruction benefits patients with ischemic cardiomyopathy and non-viable myocardium. Eur. J. Cardiothorac. Surg. 2006; 29: 196-201.

20.   Suma H., Isomura T., Horii T., et al. Nontransplant cardiac surgery for end-stage cardiomyopathy. J. Thorac. Cardiovasc. Surg. 2000; 119:1233-1244.

21.   Yamaguchi A., Adachi H., Kawahito K., et al Left ventricular reconstruction benefits patients with dilated ischemic cardiomyopathy. Ann. Thorac. Surg. 2005; 79:456-461.

22.   Yu H.Y, Chen YS., Tseng W.Y, et al. Why is the surgical ventricular restoration operation effective for ischemic cardiomyopathy? Geometric analysis withmagnetic resonance imaging of changes in regional ventricular function after surgical ventricular restoration. J. Thorac. Cardiovasc. Surg. 2009; 137:887-894.

23.   Rossejkin E.V., Kobzev E. E., Bazylev V. V. Neposredstvennye rezul'taty hirurgicheskoj rekonstrukcii levogo zheludochka [Immediate results of surgical reconstruction of left ventricular]. XIX Vserossijskij s#ezd serdechno-sosudistyh hirurgov. 2013. http://new.rassh.ru/report/neposredstvennye _rezultaty_khirurgi_cheskoy_rekonstruktsii_ levogo_ zheludochka/[In Russ].

24.   Shabalkin B.V., Rabkin I.H., Belov Ju.V. i dr. Prognozirovanie posleoperacionnoj serdechnoj nedostatochnosti pri hirurgicheskom lechenii anevrizm serdca. Krovosnabzhenie, metabolizm i funkcija organov pri reko struktivnyh operacijah. [Prognosis of post-operative heart insufficiency on surgical treatment of heart aneurysms. Blood circulation, metabolism and functioning of organs during reconstruction operations.] Erevan 1984; 166-168 [In Russ].

25.   Komeda M., David T.E., Malik A., Ivanov J., Sun Z. Operative risks and long-term results of operation for left ventricular aneurysm. Ann. Thorac. Surg. 1992; 53:22-29.

26.   Van         der Wall E.E., Bax J.J. Different imaging approaches in the assessment of left ventricular dysfunction: all things equal? Eur. Heart J. 2000; 21:1295-1297.

27.   Lorenz C.H., Walker E.S., Morgan V. L., Klein, S.S., Graham T.P. Jr. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J. Cardiovasc. Magn. Reson. 1999; 1:7-21.

28.   Belov Ju.V. Postinfarktnoe remodelirovanie levogo zheludochka serdca: ot koncepcii k hirurgicheskomu lecheniju [Postinfarction remodeling of left ventricular: from concept to surgical treatment.]. M., izd. De-Novo. 2002; S:194 [In Russ].

29.   Dor V., Sbatier M., DiDonato M., et al. Efficacy of endoventricular patchplasty in large post-infarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. J. Thorac. Cardiovasc. Surg. 1998;116:50-59.

30.   Dor V., Civaia F., Alexandrescu C., Sabatier M., Montiglio F. Favorable effects of left ventricular reconstruction in patients excluded from the Surgical Treatments for Ischemic Heart Failure (STICH) trial. J. Thorac. Cardiovasc. Surg. 2011; 141:905-9164.

31.   Bokerija L.A., Fedorov G.G. Hirurgicheskoe lechenie bol'nyh s postinfarktnymi anevrizmami serdca i soputstvujushhimi tahiaritmijam [Surgical treatment of patients with postinfarction aneurysms accompanying tachyarrhythmia.]. Grudnaja i serd.-sosud.hirurgija. 1994; 4:4-8 [In Russ].

32.   Cooley D.A. Repair of post-infarction aneurysm of the left ventricle. Cardiac surgery: state of the art reviews, Vol. 4, No. 2. Philadelphia: Hanley and Belfus, 1990; P. 309

33.   Dor V. Clinical, Sabatier M., Montiglio F., et al. Hemodynamic, and electrophysiologic results of 207 left ventricular patch reconstructions for infarction left ventricular aneurysm. l. Presented at the 72nd Annual Meeting of the American Association for Thoracic Surgery, Los Angeles, CA, April. 1992; 26-29.

34.   Artrip J.H., Oz M., Burkhoff D. Left ventricular volume reduction surgery for heart failure: a physiologic perspective. J. Thorac. Cardiovasc. Surg. 2001;122: 75-82.

35.   Burkhoff D., Wechsler A.S. Surgical ventricular remodeling: a balancing act on systolic and diastolic properties. J. Thorac. Cardiovasc. Surg. 2006;132:459-63.

36.   Ratcliffe M.B., Guy T.S. The effect of preoperative diastolic dysfunction on outcome after surgical ventricular remodeling. J. Thorac. Cardiovasc. Surg. 2007; 134:280-283

37.   Jones R.H., Velazquez E.J. Michler R.E., et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N. Engl. J .Med. 2009;360:1705-17.

38.   Chernjavskij A.M., Marchenko A.V., Karas'kov A.M. Raschet ploshhadi vykljuchenija postinfarktnoj anevrizmy levogo zheludochka [Calculation of area of postinfarction aneurism dismiss]. (Grudnaja i serdechnososudistaja hirurgija. 2002; 6. 54-58 [In Russ]. 

 

Abstract:

Aim: was to determine the possibility of ultrasound in the diagnosis of hepatocellular carcinoma (HCC).

Materials and methods: the study involved 140 patients who underwent surgical treatment for the period 1998-2013 years. HCC was confirmed in 127 patients, 12 patients had benign tumors, such as hepatocellular adenoma, focal nodular hyperplasia.

Results: ultrasound features of hepatocellular carcinoma were studied. To determine the informativeness, results were compared with preoperative methods of examination, intraoperative ultrasound (IOUS) and histological examination with surgical evaluation and histologic data. Number of tumor nodules, determined by ultrasound confirmed in 74% of cases with HCC and 83,3% for benign diseases. Dimensions, which were measured by ultrasound, were confirmed in majority cases (81,1%) with HCC and 100% of cases with benign tumors. Sensitivity and specificity of ultrasound were 99,2% and 25%, CT - 96,9% and 28,6%, MRI - 100% and 33,3% respectively Aspiration biopsy showed the most balanced performance: sensitivity - 94,9%, specificity 45,4%. Lack of true negative results during angiography, IOUS and surgical evaluation did not gave possibilities to calculate the specificity and predictive value of a negative result. Sensitivity of IOUS and surgical evaluation were 98,8% and 97,6%, respectively Of all tumor markers used in the diagnostic process, none of all showed any significant sensitivity, but they were characterized by high specificity and positive predictive method predictability

Conclusions: US strategy in the diagnosis of HCC is to identify neoplasm, conducting navigation during fine-needle aspiration biopsy, specifying diagnostics during surgery. Results showed highly informative diagnostic value of ultrasound at all stages of the examination and treatment of patients with HCC. 

 

References

1.     Ferlay J., Shin H.R., Bray F., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer. 2010;127(12):2893-2917.

2.     Dhanasekaran R., Limaye A., Cabrera R. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat. Med. 2012 May 8;4:19-37.

3.     Outwater E.K. Imaging of the liver for hepatocellular carcinoma. Cancer Control. 2010;17(2):72-82.

4.     Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011 Mar;53(3): 1020-2.

5.     Ding W., He X.J. Fine needle aspiration cytology in the diagnosis of liver lesions. Hepatobiliary Pancreat Dis Int. 2004;3:90-92.

6.     Glockner J.F. Hepatobiliary MRI: current concepts and controversies. J. Magn. Reson. Imaging. 2007;25: 681-695.

7.     Cabrera R., Nelson D.R. Review article: the management of hepatocellular carcinoma. Aliment. Pharmacol. Ther. 2010 Feb 15;31(4):461-76.

8.     Fracanzani A.L., Burdick L., Borzio M., et al. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology. 2001;34:1109-1112.

9.     Franga A.V., Elias Junior J., Lima B.L., et al. Diagnosis, staging and treatment of hepatocellular carcinoma. Braz. J. Med. Biol. Res. 2004;37:1689-1705.

10.   Saar B., Kellner-Weldon F. Radiological diagnosis of hepatocellular carcinoma. Liver Int. 2008;28:189-199.

11.   Yu S.C., Yeung D.T., So N.M. Imaging features of hepatocellular carcinoma. Clin Radiol. 2004;59:145-156.

12.   Bruix J., Hessheimer A.J., Forner A., et al. New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene. 2006;25:3848-3856.

13.   Gomaa A.I., Khan S.A., Leen E.L., et al. Diagnosis of hepatocellular carcinoma. World J. Gastroenterol. 2009 Mar 21;15(11):1301-14.

14.   Vilana R., Bru C., Bruix J., et al. Fine-needle aspiration biopsy of portal vein thrombus: value in detecting malignant thrombosis. AJR Am. J. Roentgenol. 1993;160: 1285-1287.

15.   Pompili M., Riccardi L., Semeraro S., et al. Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver. Dig. Liver Dis. 2008;40:206-215.

16.   Cryu S.W., Bok G.H., Jang J.Y, et al. Clinically useful diagnostic tool of contrast enhanced ultrasonography for focal liver masses: comparison to computed tomography and magnetic resonance imaging. Gut Liver. 2014 May;8(3):292-7.

17.   Roth C.G., Mitchell D.G. Hepatocellular Carcinoma and Other Hepatic Malignancies: MR Imaging. Radiol. Clin. North. Am. 2014 Jul;52(4):683-707.

18.   Snowberger N., Chinnakotla S., Lepe R.M., et al. Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis. Aliment Pharmacol. Ther. 2007;26:1187-1194.

19.   Jeong W.K., Kim YK., Song K.D., et al. The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase. Clin. Mol. Hepatol. 2013 Dec;19(4):360-6.

20.   Tumanova U.N., Karmazanovskij G.G., Schegolev A.I. Sravnitel'naja kompjuterno-tomograficheskaja harakteristika densitometricheskih pokazatelej gepatocelljuljarnogo raka i ochagovoj uzlovoj giperplazii pecheni [Comparative computed tomography characteristics of densitometric indications of hepatocellular carcinoma and focal nodular hyperplasia of liver] .Diagnosticheskaja i intervencionnaja radiologija. 2013; 7(3): 25-35 [In Russ].

21.   Bialecki E.S., Di Bisceglie A.M. Diagnosis of hepatocellular carcinoma. HPB (Oxford) 2005;7:26-34. 

 

Abstract:

Aim: was to evaluate possibilities of using of ultrasound classification of subcutaneous rupture of the Achilles tendon (AT) for hospital clinical practice.

Materials and methods: we examined 11 patients (9 men and 2 women). Clinical and X-ray examinations were done. Ultrasound examination was done by the standard method; modern sonographic classification of the rupture of AT was done with functional probe

Results: clinical signs of subcutaneous rupture of AT were obtained in each patient. According to sonographic classification, complete AT rupture was found in 27,2% patients (3 of 11), incomplete rupture was found in 72,8% (8 of 11). Tendinosis signs were found in 37,5% patients (3 of 8) with incomplete rupture.

Conclusions: obtained data prove the effectiveness of ultrasound method of diagnosis of subcutaneous rupture of AT, in detection various variants of its trauma. It is important for optimization of treatment strategy. 

 

References

1.      Hess G.W. Achilles tendon rupture: a review of etiology, population, anatomy, risk factors, and injury prevention. Foot Ankle Spec. 2010; 3(1): 29-32.

2.      Jarvinen T.A., Kannus P, Paavola M. et al. Achilles tendon injuries. Curr. Opin. Rheumatol. 2001;13(2): 150-155.

3.      Schepsis A.A., Jones H., Haas A.L. Achilles tendon disorders in athletes. Am. J. Sports Med. 2002; 30(2): 287-305.

4.      Miller T.T. Common tendon and muscle injuries: lower extremity. Ultrasound Clin. 2007; 2(4):595-615.

5.      Es'kin N.A. Ul'trazvukovaja diagnostika v travmatologii i ortopedii [Ultrasound diagnostics in traumatology and orthopedics]. M.: Social'no-politicheskaja mysl'. 2009; 440 s [In Russ].

6.      Robinson P Sonography of common tendon injuries. Am. J. Roentgenol. 2009;193(3): 607-618.

7.      Hartgerink P, Fessell D.P, Jacobson J.A., van Holsbeeck M.T. Full versus partial-thickness Achilles tendon tears: sonographic accuracy and characterization in 26 cases with surgical correlation. Radiology. 2001; 220(2):406-412.

8.      Paavola M., Paakkala T., Kannus P, Jarvinen M. Ultrasonography in the differential diagnosis of Achilles tendon injuries and related disorders. A comparison between pre-operative ultrasonography and surgical findings. Acta Radiol. 1998;39(6):612-619.

9.      Nielsen M.B. Musculoskeletal ultrasound in an European Journal. Ultraschall in der Medizin. 2006; 27(6): P533-534.

10.    Gibbon W.W., Cooper J.R., and Radcliffe G.S. Sonographic incidence of tendon microtears in athletes with chronic Achilles tendinosis. The British Journal of Sports Medicine. 1999; 33(2):129-130.

11.    Grechenig W., Clement H., Bratschitsch G. et al. Ultrasonography of the Achilles tendon. Orthopade. 2002; 31(3):319-332.

12.    Maffulli N. and Ajis A. Management of Chronic Ruptures of the Achilles Tendon. J. Bone Joint Surg. Am. 2008; 90(6):1348-1360.

13.    Ballas M.T., Tytko J., Mannarino F. Commonly missed orthopedic problems. Am. Fam. Physician. 1998; 57(2): 267-274.

14.    Nestorson J., Movin T., M^ler M., Karlsson J. Function after Achilles tendon rupture in the elderly: 25 patients older than 65 years followed for 3 years. Acta Orthop. Scand. 2000; 71: 64-68.

15.    Wijesekera N.T., Calder J.D., Lee J.C. Imaging in the Assessment and Management of Achilles Tendinopathy and Paratendinitis. Seminar in musculoskeletal Radiology. 2011; 15(1): 89-100.

16.    Koryshkov S.M., Platonov S.V. i dr. Lechenie zastarelyh povrezhdenij pjatochnogo (ahillova) suhozhilija [ Treatment of old lesions of Achilles tendon]. Travmatologija i ortopedija Rossii. 2012; 2 (64): 34-40 [In Russ].

17.    Amlang M.H., Zwipp H., Friedrich A. et al. Clinical Study. Ultrasonographic Classification of Achilles Tendon Ruptures as a Rationale for Individual Treatment Selection. International Scholarly Research Network ISRN Orthopedics Volume, 2011, Article ID 869703, 10 pages doi:10.5402/2011/869703.

18.    Bertolotto M., Perrone R., Martinoli C. et al. High resolution ultrasound anatomy of normal Achilles tendon. Br. J. Radiol. 1995; 68(813): 986-991.

19.    Kainberger F.M., Engel A., Barton P., Huebsch P. et al. Injury of the Achilles tendon: diagnosis with sonography. Am. J. Roentgenol. 1990;155(5):1031-1036.

20.    Koivunen-Niemela T., Parkkola K. Anatomy of the Achilles tendon (tendo calcaneus) with respect to tendon thickness measurements. Surg. Radiol. Anat. 1995; 17(13):263-268.

21.    Bleakney R.R., White L.M. Imaging of the Achilles tendon. Foot Ankle Clin. 2005;10(2):239-254.

22.    Daftary A., Adler R.S. Sonographic evaluation and ultrasound-guided therapy of the Achilles tendon. Ultrasound Q. 2009; 25(3):103-110.

23.    Crass J.R. van de Vegte G.L., Harkavy L.A. Tendon echogenicity: ex vivo study. Radiology. 1988; 167(2): 499-501.

24.    McNally E.G. The development and clinical applications of musculoskeletal ultrasound. Skeletal. Radiol. 2011; 40(9): 1223-1231.

25.    Bianchi S., Martinoli C., Gaignot C. et al. Ultrasound of the ankle: anatomy of the tendons, bursae, and ligaments. Semin Musculoskelet Radiol. 2005; 9(3): 243-259.

26.    Webb J.M., Bannister G.C. Percutaneous repair of the ruptured tendo Achilles. J. Bone Joint Surg. Br. 1999; 81(5): 877-880.

27.    Young J., Sayana K., McClelland D. et al. Percutaneous repair of acute Achilles tendon. Tech Foot Ankle Surg. 2006; 5(1): 9-14.

28.    Ebeling T., Farin P., Pyorala K. Ultrasonography in the detection of Achilles tendon xanthomata in heterozygous familial hypercholesterolemia. Atherosclerosis. 1992; 97(2-3): 217-228.

29.    Maffulli N., Regine R., Angelillo M. et al. Ultrasound diagnosis of Achilles tendon pathology in runners. Br. J. Sports Med. 1987;21(4):158-162.

30.    Giacomozzi C., D’Ambrogi E., Uccioli L, Macellari V. Does the thickening of Achilles tendon and plantar fascia contribute to the alteration of diabetic foot loading? Clin. Biomech. 2005; 20(5): 532-539.

31.    Brountzos E., Syrgiannis K., Panagiotou I. et al. Ultrasonographic alterations in Achilles tendon in relation to parathormone in chronic hemodialysis patients. J. Nephrol. 2009; 22(4):476-483.

32.    Genc H., Cakit B.D., TuncbilekI., Erdem H.R. Ultrasonographic evaluation of tendons and enthesal sites in rheumatoid arthritis: comparison with ankylosing spondylitis and healthy subjects. Clin. Rheumatol. 2005; 24(3): 272-277.

33.    Buckwalter J.A. Pharmacological treatment of soft-tissue injuries. J. Bone and Joint Surg. 1995; 77 (appl): 1902-1914.

34.    Fornage B.D. Achilles tendon: US examination. Radiology. 1986;159(3):759-764.

35.    Abate M., Silbernagel K.G., Siljeholm C. et al. Pathogenesis of tendinopathies: inflammation or degeneration? Arthritis Res. Ther. 2009; 11 (3)doi: 10.1186/ ar2723.

36.    Zanetti M., Metzdorf A., Kundert H.P. et al. Achilles tendons: clinical relevance of neovascularization diagnosed with power Doppler US. Radiology. 2003; 227(2):556-560.

37.    Nazarian L.N. The top 10 reasons musculoskeletal sonography is an important complementary or alternative technique to MRI. AJR Am. J. Roentgenol. 2008; 190(6): 1621-1626.

38.    Kainberger F., Mittermaier F., Seidl G. et al. Imaging of tendons: аdaptation, degeneration, rupture. Eur. J. Radiol. 1997; 25: 209-222.

39.    James S.L., Bates B.T., Osternig L.R. Injuries to runners. Am. J. Sports Med. 1978; 6(2): 40-50.

40.    Paavola M., Kannus P., Jarvinen T.A. et al. Achilles tendinopathy. J. Bone Joint Surg. Am. 2002; 84A(11): 2062-2076.

41.    Khan K.M., Forster B.B., Robinson J. et al. Are ultrasound and magnetic resonance imaging of value in assessment of Achilles tendon disorders? A two year prospective study. Br. J. Sports Med. 2003; 37:149-153.

42.    Asplund C.A., Best T.M. Achilles tendon disorders. BMJ. 2013; 346:f1262 doi: 10.1136/bmj.f1262

43.    Kuwada G.T. Classification of tendo Achillis rupture with consideration of surgical repair techniques. J.Foot Surg. 1990; 29(4): 361-365.

44.    Thompson J., Baravarian B. Acute and Chronic Achilles Tendon Ruptures in Athletes. Clin. Podiatr. Med. Surg. 2011; 28(1):117-135 

 

Abstract:

Aim: was to study possibilities of using thermographic equipment (TE) in coronary surgery (for evaluating coronary arteries' condition, quality of formed anastomosis and revascularization efficiency).

We examined 38 patients who underwent myocardial revascularization in condition of extracorporeal circulation.

Intraoperatively investigated 164 distal anastomosis of autotransplants with coronary artery (CA): 126 of which were vein autotransplant (great saphenous vein (GSV)), 38 - arterial autotransplant (left internal mammary artery (LIMA) - anterior interventricular branch (AIB)).

Absence of rough technical variations has been confirmed in all cases but one, when the leak as a thermal spot of extravasation was found.

In all 38 patients absence of thermal gradients on the surface of various myocardium area after reperfusion of myocardium was noted, which is perhaps (in our opinion) the sign of complete revascularization of myocardium.

Using of the TE was especially effective in detection of coronary arteries in cases when it was impossible by the conventional visual examination and epicardium palpation in patients with postinfarction adhesive process in pericardium (Dressler syndrome) or thick epicardium fat layer. In 2 patients with postinfarction in left ventricular aneurism the TE helped to distinguish viable myocardium from the scar.

Conclusion: the usage of the TE during a surgery is quite effective in examination of coronary arteries condition on a real-time basis, quality of distal anastomosis made, and adequacy of myocardial perfusion after its revascularization. 

 

References

1.     Detter C., Russ D., Iffland A. et al. Near-infrared fluorescence coronary angiography: a new noninvasive technology for intraoperative graft patency control. Heart Surg. Forum. 2002; 5(4): 364-369.

2.     Robicsek F., Masters T.N., Svenson R.H. et al. The application of thermography in the study of coronary blood flow. Surgery. 1978; 84(6): 858-864.

3.     Brydon J.W., Lambie A.K., Wheatley D.J. Thermographic visualisation of coronary artery blood flow during bypass surgery. J. Med. Eng. Technol. 1979; 3(2): 77-80.

4.     Daniel W., Klein H., Hetzer R. et al. Thermocardiography - a method for continuous assessment of myocardial perfusion dynamics in the exposed animal and human heart. Thorac. Cardiovasc. Surg. 1979; 27(1): 51-57.

5.     Ebner E., Sedlarik K., Danz J. Die Thermokardiographie-eine Moglichkeit der kontinuierlichen intraoperativen Uberwachung [Thermocardiography-a method for continuous intraoperative surveillance]. Z. Exp. Chir. 1980; 13(6): 363-367.

6.     Shabbo F.P., Rees G.M. Thermography in assessing coronary artery saphenous graft patency and blood flow. Cardiovasc. Res. 1982; 16(3): 158-162.

7.     Kyo S., Adachi H., Omoto R. Thermocardiography in the ischemic heart. Heart Vessels. 1985; 1(4): 244-245.

8.     Adachi H. Assessment of regional myocardial ischemia by thermocardiography in the dog. Nihon Kyobu Geka GakkaiZasshi. 1988; 36(11): 2408-2416.

9.     Mohr F.W., Falk V., Krieger H. et al. IMA-graft patency control by thermal coronary angiography during coronary bypass surgery. Eur. J. Cardiothorac. Surg. 1991; 5(10): 534-541.

10.   Falk V., Walter T., Philippi A. et al. Thermal coronary angiography for intraoperative patency control of arterial and saphenous vein coronary artery bypass grafts: results in 370 patients. J. Card. Surg. 1995;10(2): 147-160.

11.   Gordon N., Rispler S., Sideman S. et al. Thermographic imaging in the beating heart: a method for coronary flow estimation based on a heat transfer model. Med. Eng. Phys. 1998; 20(6): 443-451.

12.   Zehr K.J., Handa N., Bonilla L.F. et al. Pitfalls and results of immediate angiography after off-pump coronary artery bypass grafting. Heart Surg. Forum. 2000; 3(4): 293-299.

13.   Suma H., Isomura T., Horii T., Sato T. Intraoperative coronary artery imaging with infrared camera in off-pump CABG. Ann. Thorac. Surg. 2000; 70(5): 1741-1742.

14.   Baretti R., Eckel L., Krabatsch T. et al. Myocardial rewarming mirrors intraoperative mammary artery graft function. Card. Surg. 2003; 18(5): 404-409.

15.   Sonmez B., Arbatli H., Tansal S. et al. Real-time patency control with thermal coronary angiography in 1401 coronary artery bypass grafting patients. Eur. J. Cardiothorac. Surg. 2003; 24(6): 961-966.

16.   Diamantopoulos L., Liu X., DeScheerderI. et al. The effect of reduced blood-flow on the coronary wall temperature. Are significant lesions suitable for intravascular thermography? Eur. Heart J. 2003; 24(19): 1788-1995. Comment in: Eur. Heart J. 2004; 25(11): 993-994.

17.   Reuthebuch O., Haussler A., Genoni M. et al. Novadaq SPY: intraoperative quality assessment in off-pump coronary artery bypass grafting. Chest. 2004; 125(2): 418-424.

18.   Chernyshev D.V., Shiryaev A.A. Lepilin M.G., et al. Pervoe ispolzovanie teplovizora dlya opredeleniya effektivnosti shuntirovaniya koronarnih arteriy v OSSH RKNPK RF [The first use of the thermal imager for determination of efficiency of shunting of coronary arteries in OSSH RKNPK MZ of the Russian Federation]. Progress i problemy lecheniya v lechenii zabolevaniy serdca i sosudov:materialy yubileinoi konferencii,posvyaschennoy 100-letiyu SPbGU im. akad. I.P.Pavlova [Progress and treatment problems in treatment of diseases of heart and vessels: materials of the anniversary conference devoted to the 100 anniversary of St.Petersburg State University of Akkad. I.P. Pavlova], St. Petersburg, on December 8-11, 1997 SPb. 1997; 76-77. [In Russ]

19.   Akchurin R.S., Brand Ya.B., Lepilin M.G. et al. Termocoronarography in CABG. 18th Word Congress of the International Union of Angiology, Tokyo, Japan, 1998. Tokyo. 1998; 8.

20.   Akchurin R.S., Shiryaev A.A., Brand Ya.B. et al. Ispolzovanie termokoronarografii pri koronarnom shuntirovanii. [Termokoronaroangiografiya use at coronary shunting]. IV Vserossiyskiy sezd serdechno-sosudistykh khirurgov [IV All-Russian congress of cardiovascular surgeons], Moscow, on December 8-11, 1998 Moscow. 1998; 65. [In Russ]

21.   Akchurin R.S., Scherbakov M. I., Partigulov S.A. et al.Otsenka adekvatnosti zaschity miokarda pri pomoschi termocoronarografii. [Assessment of adequacy of protection of a myocardium by means of a termokoronaroangiografiya]. 2-y Vserossiyskiy sezd po ekstrakorporalnym tekhnologiyam.[The 2nd All-Russian congress on extracorporal technologies], Kazan, June, 1999 Kazan. 1999; 35-36. [In Russ] 

 

Abstract:

Aim: was to estimate the diagnostic value of PET with 18F-Choline and 18F-FDG in case of mixed hepatocellular (HCC) and cholangiocellular cancer (CCC).

Materials and methods: PET/CT with 18F-Choline and 18F-FDG was performed on 70 years old patient, with diagnosed hepatobilliary cancer. CT scan and MRI with intravenous contrast-enhanced, histological and immunohistochemical study of postoperative material (right-sided hemihepatectomy) were also performed.

Results: difference in the accumulation of 18F-Choline and 18F-FDG in some areas of mixed hepatocellular and cholangiocellular cancer was detected: in the field of cholangiocellular cancer and ir the field of poorly differentiated hepatocellular cancer.

Conclusions: 18F-choline has a low diagnostic value in the detection of cholangiocellular cancer and poorly differentiated HCC, in contrast to 18F-FDG, whereas at high differentiated HCC study, 18F-choline is more preferable. Diagnostic value of 18F-FDG at high differentiated HCC is extremely low.

 

References

1.     Patjutko Ju.I., Sagajdak I.V., Chuchuev E.S. Gepatocelljuljarnyj rak pecheni [Hepatocellular cancer]. Bjulleten' medicinskih internet-konferencij. 2011;1: 35-61 [In Russ].

2.     Chissov V.I. Onkologija [Oncology]. M.: Gjeotar-Media. 2007; 391-399 [In Russ].

3.     Sukonko O.G. Gepatocelljuljarnyj rak. Algoritm diagnostiki i lechenija zlokachestvennyh novoobrazovanij[Hepatocellular cancer. Algorithm of diagnostics and treatment of malignant neoplasms] M.: Media Sfera. 2012; 127-135 [In Russ] .

4.     Bosh F.X., Ribes J., Borras J. Epidemiology of primary liver cancer. Semin. Liverdis., vol.19. 1999; 271-285.

5.     Beasley R.P., Hwang L.Y Overview on the epidemiology of hepatocellular carcinoma. Viral hepatitis and liver disease. 1991; 532-535.

6.     Huo T.I., Lee S.D., Wu J.C. For hepatocellular carcinoma: look for a perfect classification system. J. Hepatol. 20-4; .40(6): 1041-1042.

7.     Barazani Y, Hiatt J.R., Tong M.J. et al. dironic viral hepatitis and hepatocellular carcinoma. World J. Surg. 2007; 31: 1245-250.

8.     Jeong S., Aviata H., Katamura Y Low-dose intermittent interferon - alpha-therapy for HCV - related liver cirrosis after curative treatment of hepatocellular carcinoma. World J. Gastroenterology. 2007;113; 5188-5195.

9.     Zogot S.R., Akberov R.F. Gepatocelljuljarnyj rak (jepidemiologija, luchevaja diagnostika, sovremennye aspekty lechenija). Lekcii dlja vrachej obshhej praktiki, onkologija, prakticheskaja medicina, hirurgija [Hepatocellular cancer (epidemiology, radiodiagnostics, modern aspects of treatment). Lectures for general practice doctors, oncology, practical medicine, surgery]. 2013; 112-115 [In Russ].

10.   Majstrenko N.A., Shejko S.B., Alent'ev A.V. Holangiocelljuljarnyj rak (osobennosti diagnostiki i lechenija) [Cholangiocellular cancer (features of diagnostics and treatment)]. Prakticheskaja onkologija. 2009; 9(4): 229-236 [In Russ].

11.   Ward J., Robinson P. How to detect hepatocellular carcinoma in cirrhosis. Eur. Radiology. 2002; 2258-2273.

12.   Zhang F., Chen X.-P., Zhang W. et al. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology. 2008; 52: 224-232.

13.   Caturelli E., Pompili M. Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patients. Radiology. 2001; 337-342.

14.   Matsui O., Kadoya M., Kameyama T. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology. 1991; 493-497.

15.   Xu H.X., Liu G.J., Lu M.D. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J. Clin Ultrasound. 2006; 261-272.

16.   Lencioni R., Piscaglia F. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. Journal Of Hepatology. 2008; 48: 848-857.

17.   Prokop M. Spiral and multislice computed tomography of the body. Georg Thieme Verlag. 2003; Р 234-240.

18.   Tiferes D., D’ippolito G. Liver neoplasms: imaging characterization. Radiol. Bras. 2008; 41(2): 119-127.

19.   Medvedeva B.M., Lukjanchenko A.B. Vozmozhnosti MRT v diagnostike gepatocelljuljarnogo raka u pacientov s cirrozom pecheni [Possibilities of MRI in diagnostics of hepatocellular cancer in patients with liver cirrhosis ]. Rejr. 2013; 3(2): 63 [In Russ].

20.   Jeong Y, Yim N., Kang H. Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: imaging spectrum and pitfalls of cirrhosis-related nodules. Ajr. 2005; 1024-1032.

21.   Lee M.H., Kim S.H., Park M.J., Park C.K. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. Ajr. 2011; 197: 868-875.

22.   Nasu K., Kuroki Y, Tsukamoto T. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. Ajr. 2009; 193: 438-444.

23.   Ferucci J. MRI of the liver. Amer. J. Roentgenol. 1985;147: 1103-1116.

24.   Yamamoto Y, Nishiyama Y Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET. The journal of nuclear medicine. 2008; 49(8): 1245-1248.

25.   Hwang K.H., Choi D.-J. Evaluation of patients with hepatocellular carcinomas using [11C]-acetate and [18F]-FDG PET/CT: a preliminary study. Radiation and isotopes. 2009; 67: 1195-1198.

26.   Talbot J., Gutman F. PET/CT in patients with hepatocellular carcinoma using [18F]- fluorocholine: preliminary comparison with [18F]-FDG PET/CT. Eur. J. Nucl. Med. 2006; 33: 1285-1289.

27.   Chang M., Seungmin B. Usefulness of 18F-fluo- rodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. Journal of gastroenterology and hepatology. 2008; 23: 759-765.

28.   Kluge R., Schmidt F., Caca K. Positron emission tomography with [18F]fluoro-2-deoxy-d-glucose for diagnosis and staging of bile duct cancer. Hepatology. 2001; 33:1029-1035.

29.   Kuang Y, Salem N. Transport and metabolism of radiolabeled choline in hepatocellular carcinoma. Molecularрharmaceutics. 2010; 6: 2077-2092.

30.   Trojan J., Schroeder O., Raedle J. Fluorine-18FDG positron emission tomography for imaging of hepatocellular carcinoma. Am. J. Gastroenterol. 1999; 94: 3314-3319.

31.   Esschert J.W., Bieze M. Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT. Eur. J. Nucl. Med. 2011; 38: 436-440.

32.   Lee J., Paeng J. Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma. J. Nucl. Med. 2009; 50: 682-687.

33.   Kuang Y, Salem N. Imaging lipid synthesis in hepatocellular carcinoma with [methyl-11C]-choline: correlation with in vivo metabolic studies. J. Nucl. Med. 2011; 52: 98-106.

34.   Bosman F., Carneiro F., Ruban R. Classification of tumors of the digestive system. 2010; 201-207.

 

Abstract:

Acute traumatic aortic rupture is associated with extremely high mortality and requires urgent diagnosis and treatment.

Materials and methods: patient P, 33 years 28.12.2013, fall from a height of 5 floors. On the day of admittion to hospital he was hospitalized to the reanimation department with a diagnosis of «multiple trauma, traumatic shock». For nearest hours after admission MSCT of head, neck, chest organs, abdomen and pelvis were performed.

Results: in series of images of the head and neck revealed multiple fractures of facial bones anc skull base, hemo-sinus.

MSCT chest without contrast enhancement: expanding boundaries revealed the presence of the upper mediastinum content density of 65 Hounsfield units (Ed.N) around the arch and descending aorta, in tissues of the posterior mediastinum. Volume of about 35 cm3 - in the pericardial cavity, ribs on the left with a displacement of fragments, left-sided hemothorax (260 cm3). During examination of abdomen and pelvis in the native phase: in subhepatic space in the liver portal, volume of about 50 cm3 with density of blood multiple fractures of the pelvis. CT with contrast-enhanced bolus revealed uneven expansion in the thoracic aorta isthmus length of 60 mm, with the presence at this level of linear structures intraluminal wall surface (wall laceration), and a narrow zone of extravasation of the contrast agent on the inner contour of the aorta. At the lever portal detected delimited zone of active extravasation of contrast material as a result of breaking its proper hepatic artery which is essentially as a thrombosis of pseudoaneurysm with zone of thrombosis around the periphery and subcapsular rupture of the left lobe of the liver

Ultrasound examination - left-sided hydrothorax, echo signs of free fluid in the abdominal cavity, liver hematoma in the area of the portal, diffuse changes in kidneys («shock» kidney).

Patient underwent primary surgical dressing of face wounds, osteosynthesis of right femur with external fixation device (EFD). Endoprothesis of descending thoracic aorta was performed 29.12.2013. After implantation of the prothesis, celiacography was performed, in which in liver portal, in the place of proper hepatic artery division to the right and left hepatic artery - large-size false aneurysm was revealed.

CT scanning, performed on the 5th day after aortic replacement: there are signs of segmental atelectasis of the lower lobe of the left lung, minimum infiltrative changes in fiber anterior mediastinum, hematoma of the posterior mediastinum (31 cm3. Previously was 191 cm3), and hemopericardium (15 cm3 compared with 35 cm3)

In the process of dynamic observation, it was found that up to 30 days, false aneurysm of proper hepatic artery increased in size, in this regard, the patient was operated on 24.01.14.

Follow-up CT scan with contrast enhancement: branches of the hepatic artery are well visualized, artery aneurysm is not defined

12.02.14, was the dismantling of EFD and manufactured fixation of the right femur pin. After 65 days after the injury and the start of treatment the patient was discharged under the supervision of the surgeon and cardiologist in the community.

 

References

1.          Andreeva T.M. Travmatizm v Rossiyskoy Federatsii na osnove dannykh statistiki FGU «TsITO im. N.N. Priorova Rosmedtekhnologiy». [Traumatism in the Russian Federation on the basis of statistical data of FGU «TsITO im. N.N. Priorova Rosmedtekhnologiy»]. Electronic scientific journal «Social aspects of health of the population». 2010; № 4(16). [In Russ]

2.         Kolesnikov E.S. Kliniko-epidemiologicheskaya kharakteristika tyazheloy sochetannoy kranio-torakalnoy travmy v krupnom promyshlennom tsentre. Avtoreferat. Diss. kand. tekh. nauk [The kliniko-epidemiologic characteristic of a severe combined kranio-thoracic trauma in the large industrial center: Abstract Dr. techn.sci.diss.]. Omsk. 2009: 23. [In Russ].

3.          Asif Huda Ansari, Ahmed S. Ahmed, Navin P. Lal. Traumatic aortic injury: a case report. Turkish Journal of Trauma & Emergency Surgery. 2009;15(6):621-623.

4.         Victor X. Mosquera, Milagros Marini, Javier Muniz et al. Blunt traumatic aortic injuries of the ascending aorta and aortic arch: A clinical multicentre study. Injury, Int. J. Care Injured. 2013; (44): 1191-1197.

5.         Kaavya N. Reddy, Tim Matatov, Linda D. Doucet et al. Grading system modification and management of blunt aortic injury. Chinese Medical Journal. 2013;126 (3):442-445.

6.         Дж. Э. Тинтиналли, РЛ. Кроум, Э. Руиз. Неотложная медицинская помощь. Перевод с англ. В.И. Кандрора, М.В. Неверовой, А.В. Сучкова, А.В. Низового, Ю.Л. Амченкова; М.:Медицина. 2001; 334.

7.         Dzh. E. Tintinalli, R.L. Kroum, E. Ruiz. Neotlozhnaya meditsinskaya pomoshch'. Perevod s angl. V.I. Kandrora, M.V. Neverovoy, A.V. Suchkova, A.V. Nizovogo, Yu.L. Amchenkova [Emergency medicine]. Moscow. 2001: 334. [In Russ].

8.      Jun Woo Cho, M.D., Oh Choon Kwon, M.D., Sub Lee, M.D., Jae Seok Jang, M.D. Traumatic Aortic Injury: Singlecenter Comparison of Open versus Endovascular Repair. Korean J. Thorac. Cardiovasc. Surg. 2012;45:390-395.

9.      Estrera A.L., Miller C.C., Salinas-Guajardo G., Coogan S.M. et al. Update on blunt thoracic aortic injury: 15-year single-institution experience. J. Thorac. Cardiovasc. Surg. 2012; doi: 10.1016/j.jtcvs.2012.11.074. [Epub ahead of print].

10.    O’Conor C.E. Diagnosing traumatic rupture of the thoracic aorta in the emergency department. Emerg. Med. J. 2004; 21:414-419.

11.     Panagiotis N. Symbas, Andrew J. Sherman, Jeffery M. Silver et al. Traumatic Rupture of the Aorta Immediate or Delayed Repair? Ann. Surg. Jun. 2002; 235(6): 796-802.

12.     Троицкий А.В., Хабазов РИ., Лысенко Е.Р, Беляков Г.А., Грязнов О.Г., Соловьева Е.Д., Азарян А.С. Первый опыт гибридных операций при торакоабдоминальных аневризмах аорты. Диагностическая и интервенционная Радиология. 2010; 4(1): 53-66.

13.     Troickij A.V., Habazov R.I., Lysenko E.R., Beljakov G.A., Grjaznov O.G., Solov'eva E.D., Azarjan A.S. Pervyj opyt gibridnyh operacij pri torakoabdominal'nyh anevrizmah aorty[Thoracoabdominal aneurysms: first experience of operation]. Diagnosticheskaja i intervencionnaja Radiologija. 2010; 4(1): 53-66 [In Russ].

14.     Woodring J.H. The normal mediastinum in blunt traumatic rupture of the thoracic aorta and brachiocephalic arteries. J. Emerg. Med. 1990; 8: 467-476.

 

 

Abstract:

Case report of successful endovascular treatment of pseudoaneurysm of common hepatic artery (patient underwent laparoscopic gastrectomy, cholecystectomy with lymph node dissection in treatment of gastric adenocarcinoma) is presented.

Materials and methods: patient E., 61 year. In anamnesis: ulcer disease for the period of 8 years. In 2013, gastric adenocarcinoma T4N0M0 had been revealed and in January 2014 patient underwent laparoscopic gastrectomy, cholecystectomy with lymph node dissection D2. Postoperative period was complicated by thrombosis of left branch of portal vein, external biliary fistula, left subdiaphragmatic abscess with further drainage. During CT-angiography - adenoma of left adrenal gland and aneurysm of proper hepatic artery were revealed. Selective angiography revealed aneurysm of common hepatic artery in middle third, sized 10x20 mm. Patient underwent double-staged treatment. Primary patient underwent embolization of aneurysm with Azur-18 coils, but aneurysm cavity had incomplete thrombosis. As a second stage patient underwent stent-graft implantation in hepatic artery.

Results: stent implantation was uncomplicated, aneurysm was excluded from blood flow. Patient was discharged in good condition, without any additional operation. Control angiography was performed in 3 months and thrombosis of stent with collateral blood flow were revealed. 

 

References

1.     Wagner W.H., Allins A.D., Treiman R.L., Cohen J.L., Foran R.F., Levin PM., Cossman D.V. Ruptured visceral artery aneurysms. Ann. Vasc. Surg. 1997 Jul; 11(4): 342-347.

2.     Hossain A., Reis E.D., Dave S.P, Kerstein M.D., Hollier L.H. Visceral artery aneurysms: experience in a tertiary-care center. Am. Surg. 2001 May;67(5):432-7.

3.     Kasirajan K., Greenberg R.K., Clair D., Ouriel K. Endovascular management of visceral artery aneurysm. J. Endovasc. Ther. 2001 Apr; 8(2):150-5.

4.     Gabelmann A., Gorich J., Merkle E.M. Endovascular treatment of pseudoaneurysm of the common hepatic artery with intra-aneurysmal glue (N-butyl 2-cyanoacrylate) embolization. Cardiovasc. Intervent. Radiol. 2007 Sep-Oct; 30(5):999-1002.

5.     Grego F.G., Lepidi S., Ragazzi R., Iurilli V., Stramanа R., Deriu G.P Visceral artery aneurysms: a single center experience. Cardiovasc. Surg. 2003 Feb;11(1):19-25.

6.     Garg A., Banait S., Babhad S., Kanchankar N.. Nimade P, Panchal C. Endovascular treatment of visceral artery aneurysms. J. Endovasc. Ther. 2002 Feb;9(1): 38-47.

7.     Sakai H., Urasawa K., Oyama N., Oabatake A., Successful covering of a hepatic artery aneurysm with a coronary stent graft. Cardiovasc. Intervent. Radiol. 2004 May- Jun;27(3):274-7.

8.     Jenssen G.L., Wirsching J., Pedersen G., Amundsen S.R., Aune S., Dregelid E., Jonung T., Daryapeyma A., Lax- dal E. Treatment of a hepatic artery aneurysm by endovascular stent-grafting. Cardiovasc. Intervent. Radiol. 2007 May-Jun;30(3):523-5.

9.     Suhny Abbara, T. Gregory Walker, Steven G. Imbesi. Diagnostic imaging, cardiovascular. First edition, 2008; II, 5: 62-65.

10.   Jecko V., Benali L., Vignes J.F., Vignes J.R. Hepatic artery aneurysm rupture after lumbar stenosis surgery. Medico-legal thinking. France Neurochirurgie. 2014 Feb- Apr;60(1-2):38-41.

11.   Fatic N., Music D., Zornic N., Radojevic N. Hepatic artery aneurysm developing after Billroth's operation. Ann. Vasc. Surg. 2014 May; 28(4):1033.e1-3.

12.   Asai K., Watanabe M., Kusachi S., Matsukiyo H., Saito T., Kodama H., Enomoto T., Nakamura Y, Okamoto Y, Saida Y, lijima R., Nagao J. Successful treatment of a common hepatic artery pseudoaneurysm using a coronary covered stent following pancreatoduodenectomy: report of a case. Surg. Today. 2014 Jan; 44(1):160-5.

13.   Lu PH., Zhang X.C., Wang L.F., Chen Z.L., Shi H.B. Stent graft in the treatment of pseudoaneurysms of the hepatic arteries. ^ina Vasc. Endovascular Surg. 2013 Oct; 47(7):551-4.

14.   Suvorova U.V., Tarazov P.G., Polikarpov A.A., Balahin P.V., Polehin A.S. Stentirovanie obschey pechenochnoy i verhney bryzheechnoy arterii dlia ostanovki massivnogo arterialnogo krovotechenia [Stenting of common hepatic artery and superior mesenteric artery for stopping of massive arterial bleeding.] Mezhdunarodniy zhurnal interventsionnoy kardioangiologii. 2013; 35: 73 [In Russ].

15.   Kokov L.S., Cygankov V.N., Shutihina I.V., Zjatenkov A.V. Implantacija samoraskryvajushhihsja stentov-graftov v lechenii lozhnyh anevrizm selezenochnoj arterii [Implantation of self-expanding stent-graft in treatment of pseudoaneurysm of splenic artery]. Diagnosticheskaja i intervencionnaja radiohgija. 2013; 7(1): 75-82 [ In Russ].

16.  Sundeep Punamia, Singapore Transhepatic arterial cannulation and embolisation of hepatic artery pseudoaneurism. poster report frome CIRSE 2014, Glasgow, UK.

 

Abstract:

Aim: was to analyse possibilities of multislice computed tomography in patients with coronary vessels' pathology

Results: we performed the analysis of published data on the use of multislice computed tomography in the coronary heart disease diagnostics. Data on the development of the method are presented: it is indicated that its diagnostic efficiency is related to technological improvements, accompanied by the appearance of each successive generation of multislice computed tomography The possibilities of using scanners from 16- to 230-slice scanners with two sources of energy, advantages of «dual energy» regime of application (dual-energy CT) in the coronary disease diagnostic are considered. Given constraints of the method diagnostic efficacy - artifacts associated with movements and severe calcification.

Conclusions: implementation of the method in cardiology practice can promote its consideration as a promising alternative to invasive diagnostic coronary angiography Further development of the technology can allow multislice computed tomography to become the main method of diagnosis of coronary heart disease and other cardiovascular diseases. 

 

References

1.     Paul J.F., Dambrin G., Caussin C. et al. Sixteen-slice computed tomography after acute myocardial infarction: from perfusion defect to the culprit lesion. Circulation. 2003; 108: 373-374.

2.     Sun Z., Choo G.H., Ng K.H. Coronary CT angiography: current status and continuing challenges. Br. J. Radiol. 2012; 85: 495-510.

3.     Costello P., Lobree S. Subsecond scanning makes CT even faster. Diag. Imaging. 1996; 18: 76-79.

4.     Taguchi K., Aradate H. Algorithm for image reconstruction in multi-slice helical CT. Med. Phys. 1998; 25: 550-561.

5.     Flohr T.G., Schaller S., Stierstorfer K. et al. Multidetector row CT systems and image-reconstruction techniques. Radiology. 2005; 235: 756-773.

6.     Haberl R., Tittus J., Bohme E. et al. Multislice spiral computed tomographic angiography of coronary arteries in patients with suspected coronary artery disease: an effective filter before catheter angiography Am. Heart J. 2005; 149: 1112-1119.

7.     Goldman L.W. Principles of CT: multislice CT. J. Nucl. Med. Technol. 2008; 36: 57-68.

8.     Lewis M., Keat N., Edyvean S. 16 Slice CT scanner comparison report version 14, 2006. Available from: URL: http://www.impactscan.org/reports/Report06012.htm

9.     Achenbach S., Ropers D., Pohle F.K. et al. Detection of coronary artery stenoses using multi-detector CT with 16 x 0.75 collimation and 375 ms rotation. Eur. Heart J. 2005; 26: 1978-1986.

10.   Kuettner A., Beck T., Drosch T. et al. Image quality and diagnostic accuracy of non-invasive coronary imaging with 16 detector slice spiral computed tomography with 188 ms temporal resolution. Heart. 2005; 91: 938-941.

11.   Garcia M.J., Lessick J., Hoffmann M.H. Accuracy of 16-row multidetector computed tomography for the assessment of coronary artery stenosis. JAMA. 2006; 296: 403-411.

12.   Steigner M.L., Otero H.J., Cai T. et al. Narrowing the phase window width in prospectively ECG-gated single heart beat 320-detector row coronary CT angiography. Int. J. Cardiovasc. Imaging. 2009; 25: 85-90.

13.   Flohr T.G., McCollough C.H., Bruder H. et al. First performance evaluation of a dual-source CT (DSCT) system. Eur. Radiol. 2006; 16: 256-268.

14.   Achenbach S., Marwan M., Schepis T. et al. High- pitch spiral acquisition: a new scan mode for coronary CT angiography. J. Cardiovasc. Comput. Tomogr. 2009; 3: 117-121.

15.   Ruzsics B., Lee H., Zwerner P. et al. Dual-energy CT of the heart for diagnosing coronary artery stenosis and myocardial ischemia-initial experience. Eur. J. Radiol. 2008; 18: 2414-2424.

16.   Jiang H.C., Vartuli J., Vess C. Gemstone - the ultimatum scintillator for computed tomography. Gemstone detector white paper.London: GE Healthcare, 2008: 1-8

17.   Mori       S., Endo M., Obata T. et al. Clinical potentials of the prototype 256-detector row CT-scanner. Acad. Radiol. 2005; 12: 148-154.

18.   Hoe J., Toh K.H. First experience with 320-row multidetector CT coronary angiography scanning with prospective electrocardiogram gating to reduce radiation dose. J. Cardiovasc. Comput. Tomogr. 2009; 3: 257-261.

19.   De Graaf F.R., Schuijf J.D., Van Velzen J.E. et al. Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography in the non-invasive evaluation of significant coronary artery disease. Eur. Heart J. 2010; 31: 1908-1915.

20.   Sun Z., Jiang W. Diagnostic value of multislice computed tomography angiography in coronary artery disease: a meta-analysis. Eur. J. Radiol. 2006; 60: 279-286.

21.   Pontone G., Andreini D., Bartorelli A. et al. Diagnostic accuracy of coronary computed tomography angiography: a comparison between prospective and retrospective electrocardiogram triggering. J. Am. Coll. Cardiol. 2009; 54: 346-355.

22.   Sun Z., Ng K.H. Diagnostic value of coronary CT angiography with prospective ECG-gating in the diagnosis of coronary artery disease: a systematic review and meta-analysis. Int. J. Cardiovasc. Imaging. 2012; 28: 2109-2119.

23.   Budoff M.J., Dowe D., Jollis J.G. et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J. Am. Coll. Cardiol. 2008; 52: 1724-1732.

24.   Miller J.M., Rochitte C.E., Dewey M. et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl. J. Med. 2008; 359: 2324-2336.

25.   Alkadhi H., Stolzmann P., Desbiolles L. et al. Low-dose, 128-slice, dual-source CT coronary angiography: accuracy and radiation dose of the high-pitch and the step-and-shoot mode. Heart. 2010; 96: 933-938.

26.   Hou Y, Yue Y, Guo W. et al. Prospectively versus retrospectively ECG-gated 256-slice coronary CT angiography: image quality and radiation dose over expanded heart rates. Int. J. Cardiovasc. Imaging. 2012; 28: 153-162.

27.   Hou Y, Ma Y, Fan W. et al. Diagnostic accuracy of low-dose 256-slice multidetector coronary CT angiography using iterative reconstruction in patients with suspected coronary artery disease. Eur. Radiol. 2014; 24: 3-11.

28.   Petcherski O., Gaspar T., Halon D. et al. Diagnostic accuracy of 256-row computed tomographic angiography for detection of obstructive coronary artery disease using invasive quantitative coronary angiography as reference standard. Am. J. Cardiol. 2013; 111: 510-515.

29.   Van Velzen J.E., De Graaf F.R., Kroft L.J. et al. Performance and efficacy of 320-row computed tomography coronary angiography in patients presenting with acute chest pain: results from a clinical registry. Int. J. Cardiovasc. Imaging. 2012; 28: 865-876.

30.   Pelliccia F., Pasceri V., Evangelista A. et al. Diagnostic accuracy of 320-row computed tomography as compared with invasive coronary angiography in unselected, consecutive patients with suspected coronary artery disease. Int. J. Cardiovasc. Imaging. 2013; 29: 443-452.

31.   Gaudio C., Pelliccia F., Evangelista A. et al. 320-row computed tomography coronary angiography vs. conventional coronary angiography in patients with suspected coronary artery disease: a systematic review and metaanalysis. Int. J. Cardiol. 2013; 168: 1562-1564.

32.   Li S., Ni Q., Wu H. et al. Diagnostic accuracy of 320-slice computed tomography angiography for detection of coronary artery stenosis: meta-analysis. Int. J. Cardiol. 2013;168: 2699-2705.

33.   Barrett J.F., Keat N. Artifacts in CT: recognition and avoidance. Radiographics. 2004; 24: 1679-1691.

34.   Earls J.P. How to use a prospective gated technique for cardiac CT. J. Cardiovasc. Comput. Tomogr. 2009; 3: 45-51.

35.   Leschka S., Stolzmann P., Schmid F.T. et al. Low kilovoltage cardiac dual-source CT: attenuation, noise, and radiation dose. Eur. Radiol. 2008; 18: 1809-1817.

36.   Ketelsen D., Thomas C., Werner M. et al. Dualsource computed tomography: estimation of radiation exposure of ECG-gated and ECG-triggered coronary angiography. Eur. J. Radiol. 2010; 73: 274-279.

37.   Dikkers R., Greuter M.J., Kristanto W. et al. Assessment of image quality of 64-row Dual Source versus Single Source CT coronary angiography on heart rate: a phantom study. Eur. J. Radiol. 2009; 70: 61-68.

38.   Hoffmann U., Moselewski F., Nieman K. et al. Non-invasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. J. Am. Coll. Cardiol. 2006; 47: 1655-1662.

39.   Sun Z. Cardiac CT imaging in coronary artery disease: Current status and future directions. Quant Imaging Med. Surg. 2012; 2: 98-105.

40.   Halpern E.J., Savage M.P., Fischman D.L., Levin D.C. Cost-effectiveness of coronary CT angiography in evaluation of patients without symptoms who have positive stress test results. AJR Am. J. Roentgenol. 2010; 194: 1257-1262.

41.   Sun Z., Aziz YF., Ng K.H. Coronary CT angiography: how should physicians use it wisely and when do physicians request it appropriately Eur. J. Radiol. 2012; 81: 684-687. 

 

 

Abstract:

Comparative analysis of transradial and transfemoral approach for uterine artery embolization is presented.

Materials and methods: for the period from september 2013 to december 2014, 58 women underwent uterine artery embolization (UAE). Age varied from 25 to 49. Transradial approach (TRA) was used in 26 patients (44,8%), transfemoral approach (TFA) - in 32 patients (55,2%).

Results: uterine artery embolization was successful in all patients in both groups. Operation duration was 20,7 minutes in TRA group and 26,3 in TFA group (p>0,05). Mean number of used catheters was lower in TRA group (1,2 and 2,3 respectively p>0,02). In early post-operative period there was no complication in access place in TRA group, in 2 cases (7,7%) small subcutaneous hematomas were noted. They didn't require any special treatment. In TFA group, in 1 case (3.1%) it was noted the presence of hematoma, 5 cm in diameter, and in 4 cases (12,5%) - there were small subcutaneous hematomas that didn't require any special treatment. The usage of TRA is associated with a statistically significant reduction in the incidence of all parameters of discomfort, associated with UAE and improving the quality of life of patients in the early post-operative period compared with TFA. Significantly more often in patients with TRA group compared to the group TFA completely absent from the discomfort associated with the procedure (61.5% and 6.25%, respectively, p <0,001).

Conclusions: the use of TRA allowed to decrease an average of 29.6% of total duration of the intervention, decrease up to 51.5% of time spent on the uterine artery catheterization and 40.8% patient radiation dose. In addition, TRA allowed early mobilization of patients and reduced by 59% the incidence of discomfort associated with the UAE.  

 

References

1.     Adamjan L.V., Tkachenko Je.R. Sovremennye aspekty lechenija miomy matki. [Modern aspects of treatment of uterine fibroid]. Med. Kafedra. 2003; 4 (8): 110-118 [In Russ].

2.     Kjerulff K.H., Langenberg P.W., Rhodes J.C. et al. Effectiveness of hysterectomy. Obstet. Gynecol. 2000; 95:319-326.

3.     Kiseljov S.I. Sovremennye podhody k hirurgicheskomu lecheniju bol’nyh miomoj matki. Aftoreferat. Diss. dokt. med. nauk [Modern approaches to surgical treatment of patients with uterine fibroid. Dr. med. sci. diss.]. Moscow/ 2003: 46 [In Russ].

4.     Hutchins F.L., Worthington-Kirsch R., Berkowits R.P. Selective uterine artery embolization as primary treatment for symptomatic leiomyomata uteri. J. Am. Assoc. Gynecol. Laparosc. 1999; 6: 279-284.

5.     Strizhakov A.N., Davydov A.I., Pashkov V.M., Lebedev V.A. Dobrokachestvennye zabolevanija matki [Benign disease of uterus]. Moscow 2011: 281 [In Russ].

6.     Oliver J.A.Jr., Lance J. Selective embolization to control massive hemorrhage following pelvic surgery. Am. J. Obstet. Gynecol. 1979; 135: 431-432.

7.     Ravina J.H., Herbreteau D., Ciraru-Vigneron N. et al. Arterial embolisation to treat uterine myomata. Lancet. 1995; 346(8976): 671-672.

8.     Worthington-Kirsch R.L., Andrews R.T., Siskin G.P. et al. Uterine fibroid embolization: technical aspects. Tech. Vasc. Interv. Radiol. 2002; 5: 17-34.

9.     Tavris D.R., Gallauresi B.A., Lin B. et al. Risk of local adverse events following cardiac catheterisation by hemostasis device use and gender. J. Invasive Cardiol. 2004; 16(9): 459-464.

10.   Mclvor J., Rhymer J.C. 245 transaxillary arteriograms in arteriopathic patients: success rate and complications. Gin. Radiol. 1992; 45: 390-394.

11.   Jolly S.S., Yusuf S., Cairns J. et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011; 377(9775): 1409-1420.

12.   Kanei Y, Kwan T., NakraN.C. et al. Transradial cardiac catheterization: A review of access site complications. Catheter Cardiovasc. Interv. 2011; 78(6): 840-846.

13.   Caputo R.P., Tremmel J.A., Rao S. et al. Transradial arterial access for coronary and peripheral procedures: Executive summary by the transradial committee of the SCAI. Catheter Cardiovasc. Interv. 2011; 78(6): 823-839.

Sherev D.A., Shaw R.E., Brent B.N. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc. Interv. 2005; 65(2): 196-202.

 

 

Abstract:

Aim: was to determine indications for use of the technique of retrograde recanalization of the occluded portion of the artery through tibial collateral branches.

Materials and methods: 71 years old patient, was admitted with complaints of pain at rest in the right foot, cold, lack of sensitivity of fingers of both feet, blackening of hallux of the right foot with ischemic gangrene of 1 toe of right foot. Multislice computed tomography angiography of lower limbs revealed shin artery occlusion on both sides. Regional systolic pressure (RSP) on the right anterior tibial artery (ATA) - 80 mm Hg., (ancle-brachial index (ABI) = 0.55) for posterior tibial artery (PTA) - 50 mm Hg., (ABI = 0.33). Diagnostic angiography: fibular artery and PTA occlusion throughout, occlusion of proximal and middle parts of ATA. We performed retrograde recanalization of the occluded artery of the transcollateral approach

Results: ATA patency restored all the way to the foot. RSP to ATA 140 mm Hg., (ABI = 0.9) for PTA RSP was 100 mm Hg., (ABI = 0.6).

Conclusions: transcollateral approach is an additional method of revascularization, which increases the rate of technical success after a failed antegrade revascularization, and this method can be an alternative to the retrograde approach.

 

References

1.     Carmona G.A., Hoffmeyer P., Hermann F.R. et al. Major lower limb amputations in the elderly observed over ten years: the role of diabetes and peripheral arterial disease. Diabetes Metab. 2005; 31: 449-454.

2.     Wolfe J.H., Wyatt M.G., Critical and subcritical ischemia. Eur. J. Vase Endovasc. Surg. 1997;13: 578-582.

3.     Goshima K.R., Mill J.L. Sr., Hughes J.D. A new look at outcomes after infrainguinal bypass surgery: Traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage. J. Vasc. Surg. 2004 Feb; 39(2): 330-335.

4.     Faglia E., Dalla Paola L., et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur. J. Vasc. Endovasc. Surg. 2005; 29: 620-627.

5.     Norgren L., Hiatt W.R., Dormandy J.A. et al. Intersociety consensus for the management of peripheral arterial disease (TASC II). J. Vasc. Surg. 2007; 45(suppl): S5-67.

6.     Shipovskij V.N., Zolkin V.N., Magomedov Sh.G. Ballonnaja angioplastika arterij Goleni [Balloon angioplasty of shin arteries]. Diagnosticheskaja i intervencionnaja radiologija. 2008; 2(4): 55-64 [In Russ].

7.     Graziani L., Silvestro A., Bertone V et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur. J. Vasc. Endovasc. Surg. 2007; 33:453-460.

8.     Sidhu R., Pigott J., Pigott M., Comerota A. Subintimal angioplasty for advanced lower extremity ischemia due to TASC II C and D lesions of the superficial femoral artery. Vasc. Endovascular Surg. 2010 Nov; 44(8): 633-7.

9.     Manzi M., Fusaro M., Ceccacci T., et al. Clinical results of below-the knee intervention using pedal-plantar loop technique for the revascularization of foot arteries. J. Cardiovasc. Surg. (Torino). 2009 Jun; 50(3): 331-7.

10.   Fusaro M., Dalla Paola L., Biondi-Zoccai G. Pedal-plantar loop technique for a challenging below-the-knee chronic total occlusion: a novel approach to percutaneous revascularization in critical lower limb ischemia. J. Invasive Cardiol. 2007; 19: E34-37.

11.   Ikushima I., Hirai T., Ishii A. et al. Confluent two-balloon technique: an alternative method for subintimal recanalization of peripheral arterial occlusion. J. Vasc. Interv. Radiol. 2011 Aug; 22(8): 1139-43.

12.   Montero-Baker M., Schmidt A., Brunlich S. et al. Retrograde approach for complex popliteal and tibioperoneal occlusions. J. Endovasc. Ther. 2008; 15: 594-604.

13.   Nicoloff A.D., Taylor L.M. Jr., McLafferty R.B., Moneta G.L., Porter J.M. Patient recovery after infrainguinal bypass grafting for limb salvage. J. Vasc. Surg. 1998; 27: 256-263.

14.   Zaheed T., DO. Transcollateral Approach for Percutaneous Revascularization of Complex Superficial Femoral Artery Chronic Total Occlusion. J. invasive cardiol. 2013; 25(5): E96-E100.

15.   Zander T., Rabellino M., Baldi S., Blasco O., Maynar M. Infrainguinal revascularization using the Crosser vibrational system. Minim Invas. Ther. Allied Techno. 2010; 19:231-236.

16.   Fusaro M., Dalla Paola L., Brigato C. et al. Plantar to dorsalis pedis artery subintimal angioplasty in a patient with critical foot ischemia: a novel technique in the armamentarium of the peripheral interventionist. J. Cardiovasc. Med. 2007; 8: 977-980.

17.   Fusaro M., Agostoni P., Biondi-Zoccai G. «Transcollateral» angioplasty for a challenging chronic total occlusion of the tibial vessels: a novel approach to percutaneous revascularization in critical lower limb ischemia. Cathet. Cardiovas. Interv. 2008; 71:268-272.

18.   Kaneda H., Takahashi S., Saito S. Successful coronary intervention for chronic total occlusion in an anomalous right coronary artery using the retrograde approach via a collateral vessel. J. Invas. Cardiol. 2007; 19:E1-E4.

19.     Chandra S., Chadha D.S., Swamy A. «Transcollateral» renal angioplasty for a completely occluded renal artery. Cardiovasc. Intervent. Radiol. 2011; 34 (suppl 2):S64-S66. 

 

 

Abstract:

Aim: was to study the safety and efficacy of the use of the drug bivalirudin in patients with acute coronary syndrome (ACS) with ST-segment elevation.

Materials and methods: the study included 20 patients which were admitted to hospital with a diagnosis of ACS with ST-segment elevation. Among patients - 3 women and 17 men. The age of patients ranged from 31 to 79 years, mean 56±10,8 years. Myocardial infarction of bottom wall of left ventricular (LV) was diagnosed in 9 (45%) patients, front wall - 11(55%) patients. All patients in the emergency order underwent coronary angiography (CA) with further PCI. Multivessel coronary disease was found in 35% of patients, occlusion of a coronary artery - in 20% of cases, bifurcation lesion - 15% of patients, the left main coronary artery - in 30% of cases. Before performing the PCI, 14(70%) of patients were given clopidogrel (600 mg), 6 (30%) of patients - ticagrelor (180 mg) in combination with aspirin. Intraoperative, patients received bivalirudin («Angioks») under the scheme: 0.75 mg/kg intravenous bolus, further - intravenous infusion at a rate of 1.75 mg/kg/h during the whole period of endovascular intervention.

Three patients due to technical features during the operation underwent intracoronary thrombolytic therapy In 2 cases, situation required the installation of intra-aortic balloon counterpulsation. Results: 20 patients underwent implanting of 27 stents (mean 1,35). Immediate technical success of endovascular intervention was 100%. In the intensive care unit for 4 hours after surgery lasted bivalirudin infusion at a dose of 0.25 mg/kg/h, after the transfer to the Department of Cardiology continued therapy with enoxaparin within five days. After endovascular intervention patients were converted to standard doses of clopidogrel (75 mg daily) or ticagrelor (90 mg, 2 times a day), depending on drug, that patient was given during PCI and aspirin (100 mg); and patients receive adequate medical therapy of main disease according to standards of the disease. We presented clinical experience that shows safety of bivalirudin: in the group of patients was not observed any hemorrhagic complication during the time that patients were in a hospital.

 

References

1.     Bolezni serdca: Rukovodstvo dlja vrachej [Cardiac diseases: guide-book for doctors]. (pod red. R.G. Oganova, I.G. Fominoj) M.: Litera. 2006; 1328 [In Russ].

2.     Byrne C.E., Fitzgerald A., Cannon C.P., Fitzgerald D. J., Shields D. C. Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes Text. BMC Med. Genet. 2004; 5: 13.

3.     Nacional'nye klinicheskie rekomendacii [National clinical recommendations] (pod red. R.G. Oganova, M.N. Mamedova) M.: MEDI-Jekspo, 2009; 390 [In Russ].

4.     Dovgalevskij P.Ja. Ostryj koronarnyj sindrom: patogenez, klinicheskaja kartina, aspekty lechenija. Chto my znaem i chto nado delat'? [Acute coronary syndrome: pathogenesis, clinical picture, aspects of treatment. What we know and what to do?] Serdce. 2002; 1(1): 1315 [In Russ].

5.     Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet. 2003; 361: 13-20.

6.     Steg G., Stefan K. James, Atar D. et al. ESC Guidelines for the management of acute myocardial infarction in patients with ST-segment elevation. Eur. Heart J. 2012; 33: 2569-2619.

7.     Wright R.S., Anderson J.L., Adams C.D. et al. 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2011; 57: 1920-59.

8.     Averkov O.V. Teoreticheskoe obosnovanie i prakticheskie aspekty ispol'zovanija bivalirudina pri chrezkozhnyh vnutrikoronarnyh vmeshatel'stvah u bol'nyh s ostrym koronarnym sindromom [Theoretical basis and practical aspects of the use of bivalirudin during PCI in patients with acute coronary syndrome.]. Rossijskij kardiologicheskij zhurnal. 2012; 3 (95): 102-112 [In Russ].

9.     Mehran R., Pocock S.J., Stone G.W. et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. Eur. Heart J. 2009; 30: 655-661.

10.   Bittle J.A., Chaitman B.R., Feit F. et al. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. Am. Heart J. 2001; 142(6): 952-959.

11.   Nicolas W. Shammas. Bivalirudin: Pharmacology and Clinical Applications. Cardiovascular Drug Reviews. 2005; 23( 4): 345-360.

12.   Kelton J.G., Warkentin T.E. Heparin-induced thrombocytopenia: a historical perspective. Blood. 2008; 112 (7): 2607-16.

13.   Montalescot G., Collet G.P, Lison L. et al. Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina. J. Am. Coll. Cardiol. 2000; 36: 100-114.

14.   Stone G.W., Witzenbichler B., Guagliumi G. et al. for the HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N. Engl. J. Med. 2008 May 22; 358 (21): 2218-30.

15.   Stone G.W., Witzenbichler B., Guagliumi G. et al. Heparin plus a glycoprotein 11 b/111 a inhibitors versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-years results from a multicenter, randomized controlled trial. Lancet. 2011; 377 (9784): 2193-2204.

16.   Guidelines on myocardial revascularization, Eur. Heart J. 2010; doi 10.1093/eurheartj/ehj277.

17.   Kushner F.G., Hand M., Smith S.C., et al. 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guidline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): A report of the American College of Cardiology Foundation/ American Heart Assotiation Task Force on practice guidelines. J. Am. Coll. Cardiol. 2009; 54: 2205-2241. 

 

 

Abstract:

Aim: was to analyze long-term results of coronary artery stenting with drug-eluting stents «Zotarolimus» and bare metal stents in patients with a concomitant diabetes mellitus type II.

Materials and methods: 37 patients with ischemic heart disease and concomitant diabetes mellitus type II were selected for analysis; they underwent implantation of stents without drug coverage («Intergrity» «Medtronic») or stents with drug-eluting «Zotarolimus» («Resolute Integrity» «Medtronic»). All patients were divided into 2 groups: first group consisted of 11 patients, who underwent implantation of bare metal stents, second group - 26 patients who underwent implantation of drug-eluting stents, «Zotarolimus». Follow-up period was 26±4 months. Criteria of stenting efficiency were: angiographic assessment of coronary arteries anatomy in control angiography after stent implantation, reccurence of angina or functional class increase, the survival rate in the nearest postoperative period, before discharge, but not more than 30 days, and in the early post-operative period up to 6 months. In the medium-distant post-operative period - 12 months, and in the late postoperative period - 24 months.

Results: all patients underwent successfully performed endovascular revascularization. The optimal angiographic result was achieved in all patients. Regression of ischemic changes on ECG data and increase myocardial contractility by echocardiography data also were marked in all patients. In long-term follow-up period, in 5 (45%) patients with bare metal stents we noted the appearence of hemodynamically significant restenosis, that needed performance of secondary angioplasty with stenting.

Conclusion: the use of antiproliferative drug-eluting stents «Zotarolimus» is possible in treatment of patients with coronary artery disease and comorbid diagnosis of diabetes mellitus type II. Bare metal stents in coronary stenting in patients with concomitant diagnosis of diabetes mellitus type II is impractical due to developing in-stent restenosis (45% of patients). 

 

References

1.     Kereiakes D.J., Cutlip D.E., Applegate R.J., Wang J., Yaqub M., Sood P., Su X., Su G., Farhat N., Rizvi A., Simonton C.A., Sudhir K., Stone G.W. Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Limus Eluting Coronary Stent System). J. Am. Coll. Cardiol. 2010 Dec 14; 56(25):2084-2089.

2.     Petrova K.N., Kozlov S.G., Ljakishev A.A., Savchenko A.P. Vlijanie saharnogo diabeta 2 tipa na rezul'taty jendovaskuljarnogo lechenija IBS s pomoshhju stentov s lekarstvennym pokrytiem (dannye godichnogo nabljudenija) [Influence of diabetes mellitus type 2 on results of endovascular treatment of IHD with help of drug-eluting stents (data monitoring for one year)]. Kardiohgija. 2006; 12: 22-6 [In Russ].

3.     Abizaid A., Costa M.A., Blanchard D. et al. Sirolimus-Eluting Stents Inhibit Neointimal Hyperplasia in Diabetic Patients. Insights from the RAVEL Trial. Eur. Heart J. 2004; 25: 107-12.

4.     Moussa I., Leon M.B., Baim D.S. et al. Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients. Circulation .2004; 109: 2273-8.

5.     Hermiller J.B., Raizner A., Cannon L. et al. TAXUS-IV Investigators. Outcomes With the Polymer-Based Paclitaxel-Eluting TAXUS Stent in Patients With Diabetes Mellitus: the TAXUS-IV trial. JACC. 2005; 45: 1172-9.

6.     Sabate M., Jim Onez-Quevedo P., Angiolillo D.J. et al. Randomized Comparison of Limus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients. Circulation. 2005; 112: 2175-83.

7.     Jensen J., Lagerqvist B., Aasa M., Sarev T., Nilsson T., Tornvall P. Clinical and angiographic follow-up after coronary drug-eluting and bare metal stent implantation. Do drug-eluting stents hold the promise? J. Intern. Med. 2006 Aug; 260(2):118-24.

8.     Jain A.K., Lotan C., Meredith I.T., Feres F., Zambahari R., Sinha N., Rothman M.T. E-Five Registry Investigators. Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five Registry. Heart. 2010 Jun; 96(11):848-53. doi: 10.1136/hrt.2009.184150.

9.     Stettler C., Allemann S., Egger M. et al. Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart. 2006; 92: 650-7.

10.   Scheen A.J., Warzee F. Diabetes Is Still a Risk Factor for Restenosis After Drug-Eluting Stent in Coronary Arteries. Diabetes Care. 2004; 27: 1840-1.

11.   Park K.W., Lee J.M., Kang S.H., Ahn H.S., Kang H.J., Koo B.K., Rhew J.Y, Hwang S.H., Lee S.Y, Kang T.S., Kwak C.H., Hong B.K., Yu C.W., Seong I.W., Ahn T., Lee H.C., Lim S.W., Kim H.S. Everolimus-eluting xience v/promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus. JACC. Cardiovasc. Interv. 2014 May;7(5):471-81. doi: 10.1016/j.jcin.2013.12.201. 

 

 

Abstract:

The article presents the experience of endovascular treatment of abdominal aortic atherosclerotic lesions using different types of stents, performed in the Central Military Clinical Hospital named after A.A.Vishnevskogo.

Materials and methods: nine patients underwent 11 operations - stenting of aorta. Direct stenting of terminal aorta was performed in 5 patients, 4 - bifurcation stenting of aorta and both iliac arteries. Endovascular surgery combined with the "open" reconstruction of arteries below the inguinal ligament (hybrid operation) were performed in 2 cases.

Results: technical perioperative success of interventions with the restoration of the aortic lumen was achieved in all cases. Our experience in endovascular treatment of atherosclerotic lesions of the abdominal aorta, allows to characterize this surgical intervention as a highly effective and low-impact.

 

References

1.     Grollman J.H., Del Vicario M., Mittal A.K. Percutaneous transluminal abdominal aortic angioplasty. Am.J.Roentgenol. 1980; 134(5):1053-1054.

2.     Velasquez G., Castaneda-Zuniga W., Formanek A., Zollikofer C., Barreto A., Nicoloff D., Amplatz K., Sullivan A. Nonsurgical aortoplasty in Leriche syndrome. Radiology. 1980;134(2) 359-360.

3.     Onder H., Oguzkurt L., Gur S., Tekba$ G., Gurel K., Co kun I., Ozkan U. Endovascular treatment of infrarenal abdominal aortic lesions with or without common iliac artery involvement. Cardiovasc Intervent Radiol. 2013; 36(1):56-61.

4.     Ritter J.C., Ghosh J., Butterfield J.S., McCollum C. N., Ashleigh R. Chimney stent technique for treatment of severe abdominal aortic atherosclerotic stenosis. J. Vasc. Interv. Radiol. 2011; 22(3): 391-394.

5.     Sabri S.S., Choudhri A., Orgera G., Arslan B., Turba U.C., Harthun N.L., Hagspiel K.D., Matsumoto A.H., Angle J.F. Outcomes of covered kissing stent placement compared with bare metal stent placement in the treatment of atherosclerotic occlusive disease at the aortic bifurcation. J. Vasc. Interv. Radiol. 2010; 21(7): 995-1003.

6.     Bruijnen R.C., Grimme F.A., Horsch A.D., Van Oostayen J.A., Zeebregts C.J., Reijnen M.M. Primary balloon expandable polytetrafluoroethylene-covered stenting of focal infrarenal aortic occlusive disease. J. Vasc. Surg. 2012; 55(3): 674-678.

7.     Donas K.P, Schonefeld T., Schwindt A., Troisi N., Torsello G. Successful percutaneous endovascular treatment of symptomatic infrarenal aortic stenosis caused by soft-plaque with the Endurant stent-graft. J. Cardiovasc. Surg. (Torino). 2011;52(1): 89-92.

8.     Gavrilenko A.V., Egorov A.A. Tradicionnaja hirurgija sosudov i rentgenjendovaskuljarnye vmeshatel'stva - konkurencija ili vzaimodejstvie, vedushhee k gibridnym operacijam? [Traditional angiosurgery and endovascular procedures - competition or cooperation] Angidogija i sosudistaja hirurgija. 2011; 17(4): 152-156 [In Russ].

9.     Masmoudi H., Mordant P, Francis F., Karsenti A., Paraskevas N., Cerceau P, Duprey A., Leseche G., Castier Y Focal atherosclerotic abdominal aortic stenosis. J. Mal. Vasc. 2011; 36(3):196-199.

10.   Schwindt A.G., Panuccio G., Donas K.P, Ferretto L., Austermann M., Torsello G. Endovascular treatment as first line approach for infrarenal aortic occlusive disease. J. Vasc. Surg. 2011; 53(6):1550-1556. 

 

 

Abstract:

Aim: was to combine results of surgical treatment of patients with primary reconstruction of arteries of lower limbs with patients who underwent reconstructive operations on early stented arteries.

Materials and methods: research included 93 patients with critical ischemia of lower limbs. All patients were devided into two groups with division to subgroups. Group 1a - 23 patients after stenting of iliac arteries. Group 1b - 23 patients with stenosis or occlusion of iliac arteries without previous operations. Group 2a - 22 patients with thrombosis or restenosis of arteries lower than inguinal ligament after previous endovascular treatment. Group 2b - 25 patients with primary atherosclerotic lesion of arteries of lower limbs lower than inguinal ligament .

Results: in early postoperative period and 6 months after reconstructive operation there were no difference in all groups and subgroups of treated patients. The level of complications in late post-operative period is lower in case of primary reconstruction of arteries lower than inguinal ligament in comparison with operations after endovascular interventions.  

 

References

1.     Bokeria L.A., Temrezov M.B., Kovalenko M.I. et al. Urgent problems of surgical treatment of patients with KINK solutions of (state the problem). Annals ofsurgery. 2011; 1: 5-9 [In Russ].

2.     Pokrovsky A.V., Gontarenko V.N. The condition of vascular surgery in Russia in 2013. 2014; Angiology and vascular surgery. 3-55 [In Russ].

3.     Gavrilenko A.V., Skrylev A.V. Surgical treatment of patients with critical limb ischemia (CLI caused by damage to the arteries infrainguinal localization. Angiology and vascular surgery. 2008; 14: 111-117 [In Russ].

4.     Diehm N., Baumgartner I., Jaff M., Do D.D, Minar E., Schmidli J., Diehm C., Biamino G., Vermassen F., Scheinert D., Van Sambeek M.R., Schillinger M. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur. Heart J. 2007; 28:798-805.

5.     Gruberg L., Hong M.K., Mintz G.S., Mehran R., Waksman R., Dangas G., Kent K.M., Pichard A.D., Satler L.F., Lansky A.J., Kornowski R., Stone G.W., Leon M.B. Optimally deployed stents in the treatment of restenotic versus de novo lesions. Am. J. Cardiol. 2000 Feb 1; 85(3):333.

6.     Bondarenko O.N., Galstjan G.R., Ajubova N.L., Egorova D.N., Dedov 1.1. Rol' ul'trazvukovogo dupleksnogo skanirovanija v ocenke ishodov jendovaskuljarnyh vmeshatel'stv u bol'nyh saharnym diabetom i kriticheskoj ishemiej nizhnih konechnostej v rannie sroki nabljudenija [The role of ultrasonic duplex scanning in estimation of results of endovascular interventions in patients with diabetus mellitus and critical ischemia of lower limbs in early postoperative period]. Diagnosticheskaja i intervencionnaja radiologija. 2014; 8(3)15-28 [In Russ]. 

 

 

Abstract:

Aim: was to study CT semiotic features of hepatocellular carcinoma (HCC) with varying degrees of differentiation in liver, unaffected by cirrhosis.

Materials and methods: the study is based on clinical and morphological comparisons of 29 patients (19 men and 10 women aged 19-68 years) suffering from HCC without associated cirrhosis. In the preoperative period all patients underwent multislice CT with bolus contrast enhancement (on four phases of the study). On CT scans were determined: localization, size, borders and structure of nodes, including features of the accumulation of contrast agent for determining the degree of histological differentiation.

Results: HCC had the appearance of a large solitary node, the average value of the largest diameter and the cross-sectional area amounted to 9.3 cm and 68.4 cm2 respectively in most of examined patients. In the native phase of CT quite distinct contour of the tumor node was determined in 40% of cases at highly differentiated and one-third of moderately differentiated HCC observations, at poorly differentiated variant contour is not expressed.The characteristic feature of CT HCC nodes is the heterogeneous nature of their internal structure, which is best visualized in the arterial phase. Most frequently in observations (in 67.6%) were detected areas of necrosis, rarely observed lesions sclerosis (23.5%) and calcifications (11.8%).

Conclusion: Computed tomographic characteristics of HCC in the absence of cirrhosis depenc on the phase of the study, and the degree of histological differentiation of tumors that should be considered in the differential diagnosis and prognosis of the disease.

 

References

1.     Siegel R., Ma J., Zou Z., Jemal A. Cancer Statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.

2.     Trevisani F., Frigerio M., Santi V., Grignaschi A., Bernardi M.: Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig. Liver Dis. 2010; 42: 341-347.

3.     Silva A.C., Evans J.M., McCullough A.E. et al. MR Imaging of hypervascular liver masses: A review of current techniques. RadioGraphics. 2009; 29: 385-402.

4.     Furlan A., Marin D., Vanzulli A. et al. Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout. Brit. J. Radiology. 2011; 84: 403-412.

5.     American College of Radiology website. Liver Imaging Reporting and Data System. www.acr.org/Quality- Safety/Resources/LIRADS. Accessed March 21, 2014

6.     Theise N.D., Curado M.P., Franceschi S. et al. (Eds.) WHO classification of tumours of the digestive system. Lyon: IARC, 2010; 205-216.

7.     Di Martino M., Saba L., Bosco S. et al. Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findings. Eur. Radiol. 2014; 24: 1446-1454.

8.     Gaddikeri S., McNeeley M.F, Wang C.L. et al. Hepatocellular Carcinoma in the Noncirrhotic Liver. AJR. 2014; 203: W34-W47

9.     TNM: classification of malignant tumours, 7th ed. Ed by L.H. Sobin et al. Transl. and ed. A.I. Shchegolev. Moscow: Logosfera, 2011. [In Russ].

10.   Honda H., Onitsuka H., Murakami J. et al. Characteristic findings of hepatocellular carcinoma: an evaluation with comparative study of US, CT, and MRI. Gastrointest Radiol. 1992; 17: 245-249.

11.   Hofer М. CT teaching manual. A systemic approach to CT reading. 3rd ed. Stuttgart et al: Thieme, 2007.

12.   Tumanova U.N., Karmazanovsky G.G., Shchegolev A.I. Densitometric characteristics of hepatocellular carcinoma at spiral computed tomography. Medicinskaja vizualizacija. 2012; 6: 42-50. [In Russ].

13.   Kudo M. Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin. Liver Dis. 1999; 19: 297-309.

14.   Hayashi M., Matsui O., Ueda K. et al. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology. 2002; 225: 143-149.

15.   Bolondi L., Gaiani S., Celli N. et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology. 2005; 42: 27-34.

16.   Tumanova U.N., Dubova E.A., Karmazanovsky G.G., Shchegolev A.I. Computed tomographic evaluation of the blood supply hepatocellular carcinoma at the liver. Annaly hirurgicheskojgepatologii. 2013; 4: 53-60. [In Russ].

17.   Tumanova U.N., Dubova E.A., Karmazanovsky G.G., Shchegolev A.I. Comparative analysis of the degree of vascularization hepatocellular carcinoma and focal nodular hyperplasia of the liver according to the computed-tomography and morphological studies. Vestnik Rossijskoj Akademii medicinskih nauk. 2013; 12: 9-15. [In Russ].

18.   Nzeako U.C., Goodman Z.D., Ishak K.G. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinic- histopathologic study of 804 North American patients. Am. J. Clin. Pathol. 1996; 105: 65-75.

19.   Shimada M., Hashimoto E., Taniai M. et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J. Hepatol. 2002; 37: 154-160.

20.   Smalley S., Moertel C., Hilton J. et al. Hepatoma in the noncirrhotic liver. Cancer. 1988; 62: 1414-1424.

 

 

Abstract:

Aim: was to estimate ultrasound signs of placental insufficiency in women whose pregnancy was the result of extracorporeal fertilization (ECF) and embryo replanting.

Materials and methods: the study involved 84 women who became pregnant as a result of ECF and replanting embryos. Terms of pregnancy were 18-40 weeks. Age of women was from 24 to 46 years. Ultrasound examination was performed by standard methods recommended for pregnant women, with an estimation of basic fetal metric parameters and their compliance with the term of pregnancy, the heart rate of the fetus, the degree of maturity of the placenta, thickness, location and sonographic features of the placenta (calcifications, cysts, heart attacks, expand the intervillous space varying degrees of severity) the quantity and quality of amniotic fluid.

Results: during ultrasound of women whose pregnancy was the result of ECF and embryos replanting, in 38 (35.6%) patients pathological changes in the placenta were diagnosed. It is evident in discrepancy of placenta maturity for a full-term pregnancy The combination of 3 or more of features identified during the ultrasound examination may indicate the development of placental insufficiency in women after ECF. Ultrasound features include: the degree of maturity mismatch placenta given gestational age; the thickness of the placenta; violation of utero-placental or fetus-placental blood flow; fetal growth retardation; amount of water.

 

References

1.     Nazarenko T.A., Suhih G.T. Besplodnyj brak. Sovremennye podhody i lechenie. Biblioteka vracha specialista [Infertility. Modern approaches and treatment. Library of doctor-specialist.]. Moskva, 2010; 11-20 [In Russ].

2.     Jakovenko E.M., Jakovenko S.A. Besplodie [Infertility]. Moskva. 2009; 197-198 [ In Russ].

3.     Kapustina M.V., Krasnopol'skij V.I. Ocenka vlijanija na vybor metoda razreshenija pri inducirovannoj beremennosti faktorov, svjazannyh s prichinoj i dlitel'nost'ju besplodija, vozrastom pacientok i kolichestvom vypolnennyh procedur jekstrakorporal'nogo oplodotvorenija [Estimation of influence on delivery method in case of induces pregnancy with factors, communicated with reason and duration of infertility, age of patients, and amount of proceed extracorporeal fertilization.]. Rossijskij vestnik akushera-ginekologa. 2011; 2: 44-48 [In Russ].

4.     Zhou C., KnightD.C., Tyler J.P et al. Factors affecting pregnancy outcome resulting from assisted reproductive technology (ART). J. Obstet. Gynaecol. Res. 1998; 24(5): 343-350.

5.     Тогок O., Lapinski R., Salafia C. M., Beraasko J., Berkowitz R.L. Multifetal pregnancy reduction is not associated with an increased risk of intrauterine growth restriction, except for very-high-order multiples. J. Obstet. Gynecol. 1998; 179: 221-225.

6.     Tunon K., Eik-Nes S.H., Grottum P et al. Gestational age in pregnancies conceived after in vitro fertilization: a comparison between age assessed from oocyte retrieval, crown-rump length and biparietal diameter. Ultrasound Obstet. Gynecol. 2000; 15(1): 41-47.

7.    Makarov I.O. Vedenie beremennosti posle primenenija vspomogatel'nyh reproduktivnyh tehnologij [Pregnancy supervision, after assistance of special reproductive technologies.]. M: 2010; 2: 44-48 [In Russ].

8.     Wennerholm U-B., Berg C., Hagberg H. et al. Gestational age in pregnancies after in vitro fertilization: comparison between ultrasound measurements and actual age. Ultrasound Obstet. Gynecol. 1998; 12: 170-174.

9.     Novikova S.V., Tumanova V.A., Krasnopol'skij V.I. Kompensatornye mehanizmy razvitija ploda v uslovijah placentarnoj nedostatochnosti [Compensatory mechanisms of fetal development in case of placental insufficiency]. Moskva. 2008; 7-15 [In Russ].

10.   Vnutriutrobnoe razvitie cheloveka [Natak development of human]. Moskva. 2006; 137-156[In Russ].

11.   Милованов А.П. Патология системы мать-плацента-плод. Руководство для врачей. Медицина. 2006; 7-153.

Milovanov A.P. Patologija sistemy mat'-placenta-plod. Rukovodstvo dlja vrachej [Patology of system «mother-placenta-fetus». Guide-book for doctors]. Medicina. 2006; 7-153 [In Russ].

12.   Krasnopol'skij V.I. Klinicheskaja, ul'trazvukovaja i morfologicheskaja harakteristika hronicheskoj placentarnoj nedostatochnosti [Clinical ultrasound and morphological characteristics of chronic placental insufficiency]. Akusherstvo i ginekologija. 2006; 1: 13-16 [In Russ].

13.   Granum P.A. Ultrasound examination of the placenta. Clin Obstet Gynaecol. 1983; 10(3): 459-473.

14.   Ivanec T.Ju. Vlijanie stimuljacii superovuljacii na gemostaz pri jekstrakorporal'nom oplodotvorenii i perenose jembriona v polost' matki: Avt.diss. kand. med.nauk. M.[Influence of superovulation stimulation on hemostasis in case of extracorporeal fertilization and embryo replanting in uterine cavity], 2004; 24 s [In Russ].

15.   Lenz S., Lauritsen J.G. Ultrasonically guided percutaneous aspiration of human follicles under local anesthesia: a new method of collecting oocytes for in vitro fertilization. Fertil. Steril. 2010; 6(2): 229-245.

16.   Huisman G.J., Fauser B.C.J.M., Eijkemans M.J.C. et al. Implantation rates after in vitro fertilization and transfer of a maximum of two embryos that undergone three to five days of culture. Fert. Ster. 2000; 73(1): 117-123.

17.   Kokolina V.F., Kartelishev A.F., Vasil'eva O.A. Fetoplacentarnaja nedostatochnost'. Rukovodstvo dlja vrachej [Fetoplacental insufficiency]. Moskva. 2006; 11-197[In Russ].

18.   Koudstaal J., Bruinse H.W., Helmerhorst F.M. et al. Obstetric outcome of twin pregnancies after in-vitro fertilization: a matched control study in four  DutchUniversity hospitals. Hun. Reprod. 2000; 15(4): 935-940.

19.   Mit'kov M.M., Medvedev M.V. Klinicheskoe rukovodstvo po ul'trazvukovoj diagnostike [Clinical guidebook: ultrasound diagnostics]. Moskva. Vidar. 1996; 2: 73-75 [In Russ].

20.   Artur Flejsher, Roberto Romero, Frjenk Menning, Filipp Dzhenti. Jehografija v akusherstve i ginekologii [Echography in obstetrics and gynecology]. Moskva. Vidar. 2005; 1: 447-458 [In Russ].

21.   Medvedev M.V., Judina E.V. Differencial'naja ul'trazvukovaja diagnostika v akusherstve [Differential ultrasound diagnostics in obstetrics]. Moskva. Vidar. 1997; 154-306 [In Russ].

22.   Guimarilis Fitho H.A., Araujo Junior E., Mattar R., et.al. Placental blood flow measured by three-dimensional power Doppler ultrasound at 26 to 35 weeks gestation in normal pregnancies. Fetal Neonatal Med. 2010; 23(1): 69-73.

23.   Bernirschke K., Kaufmann P. Pathology of the human placenta. New York: Springer-Verlag. 2000; 353-359.

24.  Makarov I.O., Judina E.V., Borovkova E.I. Zaderzhka rosta ploda [Fetal growth retardation]. Moskva, 2012; 54 [In Russ].

25.   Ya C.K.H., Khouri O., Onwudiwe N., et.al. Prediction of pre-eclampsia by uterine artery Doppler imaging relationship to gestation age at delivery and smallfor gestational age. Ultrasound Obstet. Gynecol. 2008; 31(3): 310-313.

26.   Radzinskij V. E

Percutaneous ethanol injection therapy under ultrasound guidance as a treatment of secondary hyperparathyroidism



DOI: https://doi.org/10.25512/DIR.2015.09.1.01

For quoting:
Polukhina E.V., Ezersky D.V. "Percutaneous ethanol injection therapy under ultrasound guidance as a treatment of secondary hyperparathyroidism". Journal Diagnostic & interventional radiology. 2015; 9(1); 11-19.

 

 

Abstract:

Aim: was to determine possibilities of ultrasound in estimation of the status of parathyroid glands (PTG) in patients with secondary hyperparathyroidism (SHPT) treated with percutaneous ethanol injections.

Materials and methods: we examined 200 patients with end-stage of renal disease on dialysis. Enlargement and structural alteration of PTG were noted in 125 patients (62,5 %). Higher level of intact parathyroid hormone (iPTH) over 300 pg/ml was noted in the majority of patients with diagnosed parathyroic hyperplasia (81,6 %). Percutaneous ethanol injection therapy under ultrasound guidance was performed in 13 patients with SHPT resistant to medical therapy Average number of injections was 2,8 (from 1 to 6). Treatment effect was assessed based on iPTH level, calcium-phosphorus product level, as well as ultrasound evaluation.

Results: statistically significant decrease of iPTH after injections was noted averaging by 57,3% (p=0,0007), calcium-phosphorus product - by 12,2% (p=0,003). The biggest effect was noted in case of single hyperplastic PTG. During the follow-up, tendency to continued decreasing in levels of iPTH remained in 61,5 %. Decrease of the largest dimension of PTG after ethanol injections was noted on average by 15,1%, decrease of volume by 31,6%. Significant decrease in systolic velocity as well as resistive index of the feeding artery of PTG were observed (p=0,001 and 0,03 respectively). An important sign of diminished functional activity in the injected gland was statistically significant decrease in the vascularization index as assessed by the color Doppler during the process of injections (p=0,002).

Conclusion: ultrasound method provides information necessary for patients' selection for conduction of percutaneous ethanol injection therapy It assists at the time of the manipulation as well as during the follow-up assessing the condition of PTG and effectiveness of treatment. 

 

References

1.     KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. 2009; 113: 1-130.

2.     Cunningham J., Locatelli F., Rodriguez M. Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options. Clin. J. Am. Soc. Nephrol. 2011;6: 913-921.

3.     Fukagawa M., Nakanishi S., Kazama J.J. Basic and clinical aspects of parathyroid hyperplasia in chronic kidney diseases. Kidney Int. 2006; 70 (102): 3-7.

4.     Tominaga Y, Matsuoka S., Sato T. et al. Clinical features and hyperplastic pattern of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy. Ther. Dial. Apher. 2007; 11: 266-273.

5.     Latus J., Renate Lehmann R., Roesel M. et al. Analysis of -Klotho, Fibroblast Growth Factor, Vitamin-D and Calcium-Sensing Receptor in 70 Patients with Secondary Hyperparathyroidism. Kidney Blood Press Res. 2013; 37: 84-94.

6.     Tokumoto M., Taniguchi M. The mechanisms of parathyroid hyperplasia and its regression. Clin. Calcium. 2007; 17 (5): 665-676.

7.     Onoda N., Fukagawa M., Tominaga Y et al. New clinical guidelines for selective direct injection therapy of the parathyroid glands in chronic dialysis patients. Nephrol. Dial. Transplant. Plus. 2008; 1 (3): 26-28.

8.     Solbiati L., Giangrande A., Pra L.D. et al. Percutaneous ethanol injection of parathyroid tumor under US guidance: treatment for secondary HPT. Radiology. 1985; 155: 607-610.

9.    Gerasimchuk R., Zemchenkov A., Kondakov S. Maloinvazivnyj metod korrekcii vtorichnogo giperparatireoza pri hronicheskoj bolezni pochek. [Miniinvasive technique in the correction of secondary hyperparathyroidism in cronic renal disease]. Vrach. 2009; 11: 15-22 [in Russ].

10.   Fukagawa M., Kitaoka M., Tominaga Y et al. Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients. Nephrol Dial Transplant. 2003; 18 (3): 31-33.

11.   Koiwa F., Kakuta T., Tanaka R. et al. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in hemodialysis patients with secondary HPT. Nephrol. Dial. Transplant. 2007; 22: 522-528.

12.   Yumita S. Intervention for recurrent secondary hyperparathyroidism from a residual parathyroid gland. Nephrol. Dial. Transplant. 2003; 18 (3): 62-64.

13.   Polukhina E.V., Glazun L.O. Ul'trazvukovaja diagnostika patologii parashhitovidnyh zhelez u bol'nyh hronicheskoj pochechnoj nedostatochnost'ju, nahodjashhihsja na zamestitel'noj pochechnoj terapii. [Ultrasound diagnosis of the parathyroid glands pathology in patients being on replacement therapy in case of chronic renal insufficiency]. Ul'trazvukovaja i funkcional'naja diagnostika. 2008; 1: 35-42 [in Russ].

14.   Anari H., Bashardoust B., Pourissa M. The Diagnostic Accuracy of High Resolution Ultrasound Imaging for Detection of Secondary Hyperparathyroidism in Patients with Chronic Renal Failure. Acta Medica Iranica. 2011; 49 (8): 527-530.

15.   Meola M., Petrucci I., Cup-isti A. Ultrasound in clinical setting of secondary hyperparathyroidism. J. Nephrol. 2013; 26 (5): 848-855.

16.   National Kidney Foundation. K/DOQI clinical practice guidelines for Bone Metabolism and Disease in Chronic Kidney Disease // Am. J. Kidney Dis. 2003; 42: 1-202.

17.   Kakuta T., Tanaka R., Kanai G. et al. Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism? Ther. Apher. Dial. 2009; 13 (1): 20-27.

18.   Kalinin A.P., Pavlov A.V., Aleksandrov Ju.K. et al. Metody vizualizacii okoloshhitovidnyh zhelez i paratireoidnaja hirurgija: rukovodstvo dlja vrachej; Pod. red. A.P. Kalinina. [Parathyroid imaging techniques and parathyroid surgery: The management for doctors. Ed. A.P. Kalinin]. M.: Vidar M, 2010; 311 [in Russ].

19.   Chen H.H., Lu K.C., Lin C.J. et al. Role of the Parathyroid Gland Vascularization Index in Predicting Percutaneous Ethanol Injection Efficacy in Refractory Uremic Hyperparathyroidism. Nephron Clin. Pract. 2010; 117 (2): 120-126. 

 

Abstract:

Malignant otitis externa is a rare but potentially fatal disease, that occurs mostly among elderly diabetic or immunocompromised patients.

Aim: was is to report the experience of the diagnosis of malignant otitis externa.

Materials and methods: we examined 5 patients with diagnosed malignant otitis externa with the help of computed tomography (CT) and magnetic resonance imaging (MRI). In both diagnostic methods, contrast enhancement was used.

Results: causative pathogen is mainly Pseudomonas Aeruginosa. The disease spreads rapidly to skull base region, inducting osteomyelitis and involving the cranial nerves. The diagnosis is based on the radiology methods, anamnesis, and biopsy

Conclusions: CT is a first-line method, which allows to detect the presence of bone erosion, which is critical for the diagnosis. Exact borders of a pathological infiltration, distribution on cranial nerves, brain covers and in a skull were defined on MRI. 

 

References

1.     Rosenfeld R.M., Brown L., Cannon C.R., et al. Clinical practice guideline: acute otitis externa. Otolaryngol. Head Neck Surg. 2006; 134 (4): 4-23.

2.     Sander R. Otitis externa: a practical guide to treatment and prevention. Am Fam. Physician. 2001; 1;63(5): 927-36.

3.     Franco-Vidal V., Blanchet H., Bebear C., et al. Necrotizing external otitis: a report of 46 cases. Otol Neurotol. 2007; 28:771-3.

4.     Meltzer P.E., Kelemen G. Pyocutaneous osteomyelitis of the temporal bone, mandible, and zygoma. Laryngoscope. 1959; 169: 1300-16.

5.     Chandler J.R. Malignant external otitis. Laryngoscope. 1968; 78: 1257-94.

6.     Nadol J.B. Jr. Histopathology of pseudomonas osteomyelitis of the temporal bone starting as malignant external otitis. Am J Otolaryngol 1980; 1: 359-71.

7.     Matthew J. Carfrae, MD, Bradley W. et al. Malignant Otitis Externa. Otolaryngol Clin N Am. 2008; 41: 537-549.

8.     Rubin Grandis J., Branstetter B.F. 4th, Yu V.L. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis. 2004; 4: 34-9.

9.     Castro R., Robinson N., Klein J., et al. Malignant external otitis and mastoiditis associated with an IgG4 subclass deficiency in a child. Del Med J. 1990; 62: 1417-21.

10.   Holder C.D., Gurucharri M., Bartels L.J., et al. Malignant external otitis with optic neuritis. Laryngoscope. 1986; 96: 1021-3.

11.   Slattery W.H., Brackmann D.E. Skull base osteomyelitis: malignant otitis externa. Otolaryngol Clin North Am. 1996; 29: 795-806.

12.   Singh A., Al Khabori M., Hyder M.J. Skull base osteomyelitis: diagnostic and therapeutic challenges in atypical presentation. Otolaryngol Head Neck Surg. 2005; 133: 121-5.

13.   Bovo R., Benatti A., Ciorba A., et al. Pseudomonas and Aspergillus interaction in malignant external otitis: risk of treatment failure. Acta Otorhinolaryngol Ital. 2012; 32(6): 416-419.

14.   Meyers B.R., Mendelson M.H., Parisier S.C., et al. Malignant external otitis. comparison of monotherapy vs combination therapy. Arch Otolaryngol Head Neck Surg. 1987; 113: 974-8.

15.   Kwon B.J., Han M.H., Oh S.H., et al. MRI findings and spreading patterns of necrotizing external otitis: is a poor outcome predictable? Clin Radiol.2006; 61: 495-504.

16.   Grandis J.R., Curtin H.D., Yu V.L. Necrotizing (malignant) external otitis: prospective comparison of CT and MR imaging in diagnosis and follow-up. Radiology. 1995; 196: 499-504.

17.   Strashun A.M., Nejatheim M., Goldsmith SJ. Malignant external otitis: early scintigraphic detection. Radiology. 1984; 150: 541-5. 

 

Abstract:

Aim: was to perform indirect estimation of pumping function of left ventricle (LV) in patients with ischemic heart disease (IHD), before and after mini-invasive intracoronary procedures or elimination of cardiac arrhythmias, basing on condition of pulmonary circulation.

Material and methods: research includes data of 44 patients with IHD (aged 43-89), who were admitted to the hospital with acute coronary syndrome (ACS) or cardiac arrhythmia. Estimation of pulmonary flow condition in IHD patients was made basing on data of chest multislice computec tomography (MSCT), changes of density of lung parenchyma in selected volume of lung before and after coronary stenting/placement of pacemaker, disruption of ectopic lesions and conduction pathway

Results: sighs of reliable changes in pulmonary circulation as local lung pneumatization changes with increased densitometric value within 10 hounsfield units (HU) after mini-invasive surgical treatment were found in 19 patients.

Conclusions: the study has showed high sensitivity of lung MSCT in diagnostics of left ventricular disfunction within coronary blood flow changes and normalization of cardiac rhythm. 

 

References

1.     Информационный бюллетень ВОЗ N 317 Март 2013г. http://www.who.int/mediacentre/factsheets/ fs317/ru/. Informacionnyj bjulleten' VOZ N 317 Mart 2013g [WHO Information bulletin # 317, march 2013]. http://www.who.int/mediacentre/factsheets/fs317/ru/ [In Russ]

2.    Demograficheskij ezhegodnik Rossii, 2012 [Demographic yearbook of Russian Federation, 2012]. Stat sb. Rosstat. M: 2012; 535 [In Russ].

3.     Oganov R.G., Maslennikova G.Ja. Demograficheskie tendencii v Rossijskoj Federacii: vklad boleznej sistemy krovoobrashhenija [Demographic trends in Russian Federation: the role of diseases of blood circulation]. Kardiovask. ter. i prof 2012; 1:5-10 [In Russ].

4.     Koncevaja A.V, Kalinina A.M., Koltunov I.E., Oganov R.G. Social'no-jekonomicheskij ushherb ot ostrogo koronarnogo sindroma v Rossijskoj Federacii.GNIC profilakticheskoj mediciny [Social-economic lesion of acute coronary syndrome in Russian Federation]. Racionarnaja farmakoterapija v kardiologii. 2011 7(2): 158-166 [In Russ].

5.     Salvador M.J., Sebaoun, F. Sonntag, P. et. al. European Study of Ambulatory Management of Heart Failure . Rev. Esp. Cardiol. 2004;57(12):1170-8.

6.     Obrezan A.G., Vologdina I.V. Hronicheskaja serdechnaja nedostatochnost [Chronic heart insufficiency]'. «Vita Nova». 2002; 320 s [In Russ].

7.     Belenkov Ju.N., Mareev VJu., Principy racional'nogo lechenija serdechnoj nedostatochnosti [Principles of heart insufficiency treatment]. M. 2000; 173s [In Russ].

8.     Rezcalla S.H., Kloner R.A. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc. Interv. 2008; 72: 950-957.

9.     Tihonov K.B. Funkcional'naja rentgenoanatomija serdca [Functional endovascular anatomy]. Izd. Medicina. M. 1990; 272 s [In Russ].

10.   Sebastian C.A., Bekkers M., Waltenberger J. Microvascular Obstruction: underlying pathophisiology and clinical diagnosis. J. Am. Coll. Car. 2010; 55:16491660.

11.   Abbate A., Kontos M.C. No-Reflow: the next challenge in treatment of ST-elevation acute myocardial infarction. Eur. Heart J. 2008; 29: 1795-1797.

12.   Beljalov F.I Aritmii serdca [Cardiac arrythmias]. RIO IMAPO. 2011; 333s [In Russ].

13.   Trufanov G.E., Zheleznjak I.S., Rud' S.D., Men'kov I.A. MRT v diagnostike ishemicheskoj bolezni serdca [MRI in diagnostics of ischemic heart diseases]. Jelbi-SPb. 2012; 64 s [In Russ].

14.   Гранов А.М., Тютин Л.А. Позитронно-эмиссионная томография. Издательстово Фолиант. 2008;368 c. Granov A.M., Tjutin L.A. Pozitronno-jemissionnaja tomografija [Positron Emission Tomography]. Izdatel'stovo Foliant. 2008;368 s [In Russ].

15.   Turner F., Lau F., Jacobson G. A method for estimation of pulmonary venosus and arterial pressures from the routine chest roentgenogram. Amer. J. Roentgenol. 1972; 116: 97-106.

16.   Petrenko I.E. Rentgenologicheskie projavlenija levozheludochkovoj nedostatochnosti serdca i rentgenodiagnostika nekotoryh oslozhnenij pri ostrom infarkte miokarda [Radiographic manifestations of left ventricle insufficiency and radiographic diagnostics of complications of acute coronary syndrome]. Avtoreferat. dis. uchen. ctep. kand. med. nauk L. 1982 [In Russ].

17.   Storto M.L., Kee S.T., Golden, J.A. Webb W.R. Hydrostatic pulmonary edema: high-resolution CT findings. AJR:165, October 1995: 817-820.

18.   Kato S., Nakamoto T., Iizuka M. Early diagnosis and estimation of pulmonary congestion and edema in patients with left-sided heart disease from histogram. Pulmonary CT Number. ST 1996; 109:1439-45.

19.   Pelosi P, Gama de Abreu M. Lung CT scan. The Open Nuclear Medicine Journal. 2010; 2: 86-98.

20.   Hanneman K., Nguyen E.T., Crean A.M. Hypertrophic cardiomyopathy complicated by pulmonary edema in the postpartum period. Hinduri рublishing corporation сase reports in radiology. V. 2013; Article ID 802352, 3 pages http://dx.doi.org/10.1155/2013/80235.

21.   Claudia M., Cunha R., Edson M., Rodrigeus R., Hydrostatic pulmonary edema: high-resolution computed tomography aspects. J. Bras. Pneumol. 2006; 32 (6): 515-22.

22.   Gonzales J., Verin A. Non-Cardiogenic Pulmonary Edema, Lung Diseases - Selected State of the Art Reviews, Ed. Dr. Elvisegran M. I. 2012, ISBN: 978-953-51-0180-2, InTech, Available from:http://www.intechopen.com/ books/lung-diseases-selected-state-of-the-art- reviews/non-cardiogenic-pulmonary-edema.

23.   Min'ko B.A., Vologdina I.V., Borodich P.L. Rol' kompjuternoj tomografii legkih u bol'nyh ishemicheskoj boleznju serdca v ocenke funkcii levogo zheludochka pri maloinvazivnyh hirurgicheskih vmeshatel'stvah [The role of computed tomography of lungs in estimation of left ventricle function during mini-invasive interventions in patients with ischemic heart disease]. REJR. 2015; 5(1): 64-67 [In Russ]. 

 

 

authors: 


 

Article exists only in Russian.


 

Article exists only in Russian.

authors: 


 

Article exists only in Russian.

 

Abstract:

Background: case report of a rare congenital anomaly - the diverticulum of the right ventricle of the heart, revealed by echocardiography and magnetic resonance imaging (MRI) of the heart.

Aim: was to show possibilities in detection and differential diagnosis of diverticulum of the right ventricle.

Materials and methods: patient, 23 years, during examination after passed pneumonia, underwent echocardiography wich revealed an aneurysm of right ventricle. Patient underwent further examination: MRI of heart in T1-WS and T2-WS, «gradient echo» and dynamical regime (Cine-SSFP) in standard positions. Demonstration of diverticulum is based on reconstruction imaging (MPR). Results: due to MRI data, in right ventricle we found a bulging 1,2х2,0 cm with clear contours, wich decreased in systole with myocardum of right ventricle - «true diverticulum of right ventricle». We marked difficulties in the diagnosis associated with the paucity of clinical manifestations.

Conclusions: MRI made it possible to study individual morphological anatomy of the diverticulum, to demonstrate and to assess in detail the topography that helped to make decisions on further management of the patient. 

 

References

1.      Cavalle-Garrido T., Cloutier A., Harder J., et al. Evolution of fetal ventricular aneurysms and diverticula of the heart: an echocardiographic study. Am. J. Perinatol. 1997; 14:393-400.

2.      Krasemann T., Gehrmann J., Fenge H., et al. Ventricular aneurysm or diverticulum? Clinical differential diagnosis. Pediatr. Cardio. 2001; 22:409-411.

3.      Rodts-Palenik S., Barrilleaux S., Jeanty Ph. Diverticulum of the right ventricle http://www.sonoworld.com/ fetus/page.aspx?id=1474

4.      Bankl H. Congenital malformation of heart and great vessels: Synopsis of Pathology, Embryology, and Natural History. Urban and Schwarzenberg. 1977; 263.

5.      Cumming G.R. Congenital diverticulum of the right ventricle. Am. J. Cardiol. 1969; 23:297.

6.      Wax J.R., Moran A., Pinette M.G., et al. Prenatal sonographic diagnosis of fetal right ventricular diverticulum. J. Ultrasound Med. 2007; 26(2):267-270.

7.      Pressoir R., Downing J. W. Congenital diverticula of the right ventricle of the heart: A case report. Journal of the National Medical Association. 1980; 72, 3: 262-264.

8.      Sangawa K., Aoki A., Yoshino T. Resection of a right ventricular diverticulum of fibrous type by off-pump cardiac surgery; report of a case. Kyobu Geka. 2009; 62(2):152-156.

9.      Farnsworth P.B., Lefkowitz M., Shehadi W., et al. Spontaneous rupture of fibrous diverticulum of the right ventricle. Am .J. Dis. Child. 1972; 123:248-250.

10.    Freedom R.M., Yoo S.J., Mikailian H. Cardiac diverticulum and aneurysm. The Natural and Modified History of Congenital Heart Disease. Blackwell Publishing. 2003:475-478.

11.    Rajs J., Thoren C., Kjellman M. Spontaneous rupture of a congenital diverticulum of the right ventricle in a 1-month-old child. Eur. J. Cardiol. 1977; 16(2): 131-137.

12.    Benatar A., Vorsselmans A. Foetal right ventricular outpouching associated with ventricular bigeminy. OA Case Reports. 2013; 12; 2(6):51.

13.    Marijon E., Ou Ph., Fermont L., et al. Diagnosis and outcome in congenital ventricular diverticulum and aneurysm. J. Thorac. Cardiovasc. Surg. 2006; 131: 433-437.

14.    Hamaoka, K., Onaka M., Tanaka T. Congenital ventricular aneurysm and diverticulum in children. Pediatric Cardiology 1987; 8:169-175.

15.    Uhl H.S. A previously undescribed congenital malformation of the heart: almost total absence of the myocardium of the right ventricle. Bulletin of the JohnsHopkinsHospital. 1952; 91 (3): 197-209.

16.    Bharati S., Rowen M., Camarata S.J., et al. Diverticulum of the right ventricle. Arch. Pathol. 1975; 99:383-386.

17.    Carter J.B., Van Tassel R.A., Moller J.H., et al. Congenital diverticulum of the right ventricle. Association with pulmonary stenosis and ventricular septal defect. Am. J. Cardiol. 1971; 28:478.

18.    Cantrell J.R., Haller J.A., Ravitch M.M. A syndrome of congenital defects involving the abdominal wall, sternum, diaphragm, pericardium, and heart. Surg, Gynecol, Obstet. 1958; 107:602-614.

19.    Okereke O.U., Cooley D.A., Frazier O.H. Congenital diverticulum of the ventricle. J. Thorac. Cardiovasc. Surg. 1986; 91:208-214.

20.    McAulife F.M., Hornberger L.K., Johnson J., et al. Cardiac diverticulum with pericardial effusion: report of two new cases treated by in utero pericardiocentesis and a review of the literature. Ultrasound Obstet. Gynecol. 2005; 25:401-404.

21.    Treistman B., Cooley D.A., Lufschanowski R., Leachman R.D. Diverticulum or aneurysm of left ventricle. Am. J. Cardiol. 1973; 32:119-123.

22.    Paronetto F., Strauss L. Aneurysm of the left ventricle due to congenital muscle defect in an infant: report of a case with discussion of pathogenesis of associated endocardial fibroelastosis. Am. J. Cardiol. 1963; 12:721-729.

23.    Archbold R.A., Robinson N.M., Mills P.G. Long-term follow-up of a true contractile left ventricular diverticulum. Am. J. Cardiol. 1999; 83:810-813.

24.    Hornberger L.K., Dalvi B., Benacerraf B. Prenatal sonographic detection of cardiac aneurysms and diverticula. J. Ultrasound Med. 1994; 13:967-970.

25.    Carrard C., Massardier J., Pangaud N. Fetal right ventricular diverticulum with pericardial effusion: report of a new case treated by in utero pericardiocentesis. Pediatr. Cardiol. 2010; 31(6):891-893.

26.    Bogaert J. Dymarkowski S., Taylor A.M. Clinical Cardiac MRI. Springer. 2005; 563.

27.    O’Donnell D.H., Abbara S., Chaithiraphan V., et al. Cardiac Tumors: Optimal Cardiac MR Sequences and Spectrum of Imaging Appearances. AJR. 2009; 193: 377-387.

28.    Finn J.P., Nael K., Deshpande V., et al. Cardiac MR imaging: state of the technology. Radiology. 2006; 241:338-354.

29.    Suilen C., Friedli B., Rutishauser W. Congenital intrathoracic left ventricular diverticulum in an adult. Chest. 1990; 98:750-751.

30.    Evans W., Madrid A., Castillo W., et al. All cardiac right ventricular outpouches are not created equal. Pediatr Cardiol. 2009; 30(7):954-957.

 

Abstract:

Literature review is dedicated to the diagnosis of prostate cancer (PCa), namely the use of Fusion-technology, a technique which allows you to combine real-time data of magnetic resonance imaging (MRI) and transrectal ultrasound (TRUS), as well as to perform biopsy of the prostate, taking into consideration previously detected changes.

Review includes russian-language and foreign articles that discuss not only benefits, but also limit of the use of methods of prostate biopsy in verification of malignant pathology Review is based on data of main online resources: PubMed, Scientific Electronic Library (elibrary), SciVerse (ScienceDirect), Scopus.

During analysis of available literature, authors discuss the problem of prostate cancer diagnostics, difficulties encountered when using of traditional biopsy methods.

Review pays special attention to MRI/TRUS Fusion-navigation in diagnosis of prostate cancer as an alternative to other, more widely used in practice methods as for initial biopsy and for repeated manipulations

Conclusions: A key aspect of the application of MRI/TRUS Fusion-navigation is the ability to perform precisely targeted biopsy of suspicious sites by the presence of malignant changes ir prostate tissue, which increases the accuracy of diagnosis of tumors. Above described method of biopsy is extremely promising as part of specifying diagnostics of localized forms of prostate cancer. Methodics appeared informative in identifying clinically significant prostate cancer and accurate for localization of process, especially in front parts of the prostate, compared with 12 traditional points of biopsy At the same time, this manipulation, compared with traditional biopsy technique, requires advanced equipment and highly skilled personnel. 

 

References

1.      Kaprin A. D., Starinskij V. V., Petrova G. V. (red.) Sostojanie onkologicheskoj pomoshhi naseleniju Rossii v 2012 godu [The condition of oncological service to the population of Russia in 2012]. Moskva. 2013; 128 S [In Russ]

2.      Schroder FH, Hugosson J, Roobol MJ, et al.; ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 2009 Mar 26; 360(13):1320-8.

3.      Hodge K.K., McNeal J.E., Terris M.K., et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J. Urol. 1989; 142: 71-75.

4.      Stamey T.A. Making the most out of sextant biopsies. Urology. 1995; 45: 2-12.

5.      Littrup P.J., Bailey S.E. Prostate cancer: the role of transrectal ultrasound and its impact on cancer detection and management. Radiol.Clin.N.Am. 2000;38(1): 87-113.

6.     Aljaev Ju.G., Sinicyn V.E., Grigor'ev N.A. Magnitno-rezonansnaja tomografija v urologii [Magnetic resonance imaging in urology]. Moskva. 2005; 160-189 [In Russ].

7.      Harchenko V.P., Kaprin A.D., Amosov F.R.; Rak predstatel'noj zhelezy: problemy diagnostiki [Prostate cancer problems in detection]. Lechashhij vrach. 1999; 1: 4-8 [In Russ].

8.      Taira A.V., Merrick G.S., Galbreath R.W., et al. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis. 2010; 13:71-77.

9.      Javed S.I., Chadwick E., Edwards A.A., et al. Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies. BJU Int. 2013 Nov 13. doi: 10.1111/bju.12568.

10.    Futterer J.J., Verma S., Hambrock Т., Yakar D. and Barentsz J.O.; High-risk prostate cancer: value of multimodality 3T MRI-guided biopsies after previous negative biopsies. Abdominal Imaging. 2012 Oct; 37(5):892-6.

11.    Bittencourt L.K., Hausmann D., Sabaneeff N., Gas- paretto E.L. and Barentsz J.O.; Multiparametric magnetic resonance imaging of the prostate: current concepts. Radiol Bras. 2014 Sep-Oct; 47(5):292-300.

12.    Hambrock Т., Somford D.M., Hoeks C., Bouwense S.A.W., et al. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. Journal of Urology. 2010 Feb; 183(2):520-7.

13.    Hambrock T., Hoeks C., Hulsbergen-Van de Kaa et al.; Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging-Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort. Eur. Urol. 2012 Jan; 61(1):177-84.

14.    Kaplan I., Oldenburg N.E., Meskell P., et al. Real time MRI-ultrasound image guided stereotactic prostate biopsy. Magn. Reson. Imaging. 2002;20:295-299.

15.    Singh A.K., Kruecker J., Xu S., et al. Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJUInt. 2007;101:841-845.

16.    Pinto P.A., Chung PH., Rastinehad A.R., et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J.Urol. 2011; 186:1281-1285.

17.    Miyagawa T., Ishikawa S., Kimura T., et al. Real-time virtual sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data. Int.J. Urol. 2010; 17: P855-860.

18.    Ukimura O., Hirahara N., Fujihara A., et al. Technique for a hybrid system of real-time transrectal ultrasound with preoperative magnetic resonance imaging in the guidance of targeted prostate biopsy. Int. J. Urol. 2010; 17: 890-893.

19.    Bax J., Cool D., Gardi L., et al. Mechanically assisted 3D ultrasound guided prostate biopsy system. Med. Phys. 2008; 35: 5397-5410.

20.    Mozer P, Rouprrt M., Le Cossec C., et al. First round of targeted biopsies with magnetic resonance imaging/ultrasound-fusion images compared to conventional ultrasound-guided transrectal biopsies for the diagnosis of localised prostate cancer. J Urol. 2014 Jul;192(1): 127-8.

21.    Sonn G.A., Margolis D.J., Marks L.S. Target detection: Magnetic resonance imaging-ultrasound fusion-guided prostate biopsy. Urol Oncol. 2014 Aug;32(6):903-11

22.    Schoots I.G., Bangma C.H. MRI/US-fusion for targeted prostate biopsy. Ned. Tijdschr Geneeskd. 2014; 158.

23.    Rastinehad A.R., Turkbey B., Salami S.S., et al. Improving Detection of Clinically Significant Prostate Cancer: Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Guided Prostate Biopsy. J Urol. 2014 Jun;191(6): 1749-54.

24.    Volkin D., Turkbey B., Hoang A.N., et al. Multiparametric MRI and Subsequent MR/Ultrasound Fusion-Guided Biopsy Increase the Detection of Anteriorly Located Prostate Cancers. BJU Int. 2014 Dec;114(6b):E43-9.

25.    Siddiqui M.M., Rais-Bahrami S., Truong H., et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol. 2013 Nov;64(5):713-9.

26.    Walton Diaz A., Hoang A.N., Turkbey B., et al. Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol. 2013 Dec;190(6):2020-5.

27.    Sonn G.A., Chang E., Natarajan S., et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol. 2014 Apr;65(4): 809-15.

28.    Lawrence EM1, Tang SY Barrett T et al. Prostate cancer: performance characteristics of combined T2W and DW-MRI scoring in the setting of template transperineal re-biopsy using MR-TRUS fusion. Eur Radiol. 2014 Jul;24(7): 1497-505.

29.    Durmus T., Stephan C., Grigoryev M., et al. Detection of prostate cancer by real-time MR/ultrasound fusion-guided biopsy: 3T MRI and state of the art sonography. Rofo. 2013 May;185(5):428-33.

30.    Hu J.C., Chang E., Natarajan S., et al. Targeted Prostate Biopsy to Select Men for Active Surveillance: Do the Epstein Criteria Still Apply? J Urol. 2014 Aug;192(2): 385-90

31.    Hong C.W., Walton-Diaz A., Rais-Bahrami S., et al. Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session. Diagn Interv Radiol. 2014 May-Jun;20(3):234-8.

authors: 

 

Abstract:

Aim: was to show literature review and personal data on endovascular anatomy of intracranial lesions in patients with acute ischemic stroke.

Material and methods: we present clinical data on endovascular revascularization in patients with ischemic stroke, who were operated in Interregional clinical-diagnostic center for the period 2007-2014.

Results and conclusion: during cerebral angiography, we should estimate arterial, parenchymal and venous phase. Degree of flow recovery after endovascular reperfusion, is estimated on mTICI score. 

 

References

1.     Shamalov N.A. Reperfuzionnaja terapija pri ishemicheskom insul'te. Jeffektivnaja farmakoterapija [Reperfusion therapy in ischemic stroke]. 2014; 31: 54-60[ In Russ].

2.     Berkhemer O., Fransen P., Beumer D., et al., A randomized trial of intraarterial treatment for acute ischemic stroke. The New England journal of medicine. 2015 1 (37): 2-11.

3.     Li-Ping Liu, An-Ding Xu, Wong K.S., et all., Chinese consensus statement on the evaluation and intervention of collateral circulation for ischemic stroke. CNS Neuroscience & Therapeutics. 2014 (20): 202-208.

4.     Hill M., Shobha N., Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke. 2010 41 (10): 2254-2258.

5.     Mortimer A.M., Bradley M.D., Renowden S.A. Endovascular therapy in hyperacute ischaemic stroke: history and current status department of neuroradiology. Interventional Neuroradiology. 2013 (19): 506-518.

6.     Gacs G., Fox A., Barnett H., et all. Occurrence and mechanisms of occlusion of anterior cerebral artery. Stroke. 1983 (14). 952-959.

7.     Mortimer A.M., Bradley M., Renowden S.A. Endovascular therapy for acute basilar artery occlusion: a review of the literature. J. NeuroIntervent. Surg. 2011 (10): 11-36.

8.     Haussen D.C., Dharmadhikari S.S., Snelling B. Posterior communicating and vertebral artery configuration and outcome in endovascular treatment of acute basilar artery occlusion. J. NeuroIntervent. Surg. 2014 (0):1-4.

9.     Archer C.R., Horenstein S. Basilar artery occlusion: clinical and radiological correlation. Stroke. 1977 (8): 383-390.

10.   Mordasini P., Brekenfeld C., Byrne J.V., et all. Technical feasibility and application of mechanical thrombectomy with the Solitaire FR revascularization device in acute basilar artery occlusion Am. J. Neuroradiol 2013 (34): 159 -163.

11.   Liebeskind D.S., Cotsonis G.A., Saver J.L., et al. Collateral circulation in symptomatic intracranial atherosclerosis. J. Cereb. Blood. Flow. Metab. 2011 (31): 1293-1301.

12.   Christoforidis G.A., Mohammad Y, Kehagias D., et all. Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. Am. J. Neuroradiol. 2005 (26): 1789-1797.

13.   Al-Ali F., Jefferson A., Barrow T., et al. The capillary index score: rethinking the acute ischemic stroke treatment algorithm. J. Neurointerv. Surg. 2013 (5): 139-143.

14.   McVerry F., Liebeskind D.S., Muir K.W. Systematic review of methods for assessing leptomeningeal collateral flow. Am. J. Neuroradiol. 2012 (33): 576-582.

15.   Chuang YM., Chan L., Lai YJ., et al. Configuration of the circle of Willis is associated with less symptomatic intracerebral hemorrhage in ischemic stroke patients treated with‘ intravenous thrombolysis. J. Crit. Care. 2013 (28): 166-172.

16.   Nogueira R.G., Gupta R., Jovin T.G. ET et al. Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients J. NeuroIntervent. Surg. 2015 (7): 16-21.

17.   R.G., Liebeskind D.S., Sung G., et all. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the mechanical embolus removal in cerebral ischemia (Merci) and multi Merci trials. Stroke. 2009 (40): 3777-3783.

18.   Jayaraman M.V., Hussain M.S., Abruzzo T., et al., Embolectomy for stroke with emergent large vessel occlusion (ELVO): report of the Standards and Guidelines Committee of the Society of NeuroInterventional Surgery J. NeuroIntervent. Surg. 2015 (0):1-6.

19.   Broderick J.P., Palesch YY, Demchuk A.M., et al. The interventional management of stroke (IMS) III investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N. Engl. J. Med. 2013 (368): 893-903.

20.   Yoo A.J., Simonsen C.Z., Prabhakaran S., et al. Refining angiographic biomarkers of reperfusion: modified TICI is superior to TIMI for predicting clinical outcomes after intra-arterial therapy. Stroke. 2013 (44): 62-66.

21.   Davalos A., Pereira V.M., Chapot R. et al. Retrospective multicenter study of Solitaire FR for revascularization in the treatment of acute ischemic stroke. Stroke. 2012 (43): 2699-2705.

22.   Humphries W., Hoit D., Doss V.T., et al. Distal aspiration with retrievable stent assisted thrombectomy for the treatment of acute ischemic stroke. J. NeuroIntervent. Surg. 2015 (7): 90-94.

 

Abstract:

In this study we have analyzed early and long-term results of endovascular abdominal aneurysm repair (EVAR) in the Department of cardio-vascular surgery of «Russian Cardiology Research anc Production Complex».

Material and methods: research includes 164 patients (February 2009-November 2015) with abdominal aortic aneurysm (AAA), who underwent endovascular abdominal aneurysm repair (EVAR), also with difficult anatomy Patients were operated with basic methodics and also hybrid techniques («chimney», «octopus», fenestrated and branched devices).

Results: 30-day mortality rate accounted for 1,2%, all mortality was 3%.

 

References

1.      Nacional'nye rekomendacii po vedeniju pacientov s anevrizmami brjushnoj aorty 2011[National recommendations on treatment of patients with aneurysm of abdominal aorta]. Pod. red. A.V. Pokrovskogo [In Russ].

2.      Klinicheskaja angiologija: rukovodstvo dlja vrachej [Clinical angiology: guide-book fo physicians]. Pod red. A. V. Pokrovskogo. v 2-h tomah. T. 2. M.: Medicina, 2004 [In Russ].

3.      Abugov S.A., Belov Ju.V., Pureckij M. V., Saakjan Ju.M., Poljakov R.S., Hovrin V.V., Strucenko M.V. Sravnitel'nye rezul'taty lechenija anevrizm brjushnogo otdela aorty jendovaskuljarnym i hirurgicheskim metodom [Comparative results of treatment of abdominal aorta aneurysms with endovascular and surgical methods]. Kardiologija i serdechno-sosudistaja hirurgija. 2011; 2: 27-31 [In Russ].

4.      Sweet M.P., Fillinger M.F., Morrison.T.M., Abel D. The influence of gender and aortic aneurysm size on eligibility for endovascular abdominal aortic aneurysm repair. J. Vascular Surg. 2011; 54:931-7.

5.      Arko F.R., Filis K.A., Seidel S.A., Gonzalez J., Lengle S.J., Webb R., et al. How many patients with infrarenal aneurysms are candidates for endovascular repair? The Northern California experience. J. EndovascTher. 2004;11:33-40.

6.      Armon M.P., Yusuf S.W., Latief K., Whitaker S.C., Gregson R.H., Wenham P.W., et al. Anatomical suitability of abdominal aortic aneurysms for endovascular repair. Br. J. Surg. 1997;84:178-80.

7.      Carpenter J.P., Baum R.A., Barker C.F., Golden M.A., Mitchell M.E., Velazquez O.C., et al. Impact of exclusion criteria on patient selection for endovascular abdominal aortic aneurysm repair. J. Vasc. Surg. 2001;34:1050-4.

8.      Elkouri S., Martelli E., Gloviczki P., McKusick M.A., Panneton J.M., Andrews J.C., et al. Most patients with abdominal aortic aneurysm are not suitable for endovascular repair using currently approved bifurcated stent-grafts. Vasc. Endovascular. Surg. 2004;38:401-12.

9.      Moise M.A., Woo E.Y, Velazquez O.C., Fairman R.M., Golden M.A., Mitchell M.E., et al. Barriers to endovascular aortic aneurysm repair: past experience and implications for future device development. Vasc. Endovascular. Surg. 2006;40:197-203.

10.    Schumacher H., Eckstein H.H., Kallinowski F., Allen-berg J.R. Morphometry and classification in abdominal aortic aneurysms: patient selection for endovascular and open surgery. J. Endovasc. Surg. 1997;4:39-44.

11.    Mehta M., Byrne W.J., Robinson H., Roddy S.P., Paty P.S., Kreienberg P.B., et al. Women derive less benefit from elective endovascular aneurysm repair than men. J. Vasc. Surg. 2010;55:906-13.

12.    AbuRahma A.F., Campbell J., Stone P.A., et al. The correlation of aortic neck length to early and late outcomes in endovascular aneurysm repair patients. J. Vasc. Surg. 2009;50:738-748.

13.    Moulakakis K. G., Mylonas S. N., Avgerinos E. et al.The chimney graft technique for preserving visceral vessels during endovascular treatment of aortic pathologies J. Vasc. Surg. 2012; 55(5): 1497-1503.

14.    Aburahma A.F., Campbell J.E., Mousa A.Y, et al. Clinical outcomes for hostile versus favorable aortic neck anatomy in endovascular aortic aneurysm repair using modular devices. J. Vasc. Surg. 2011;54:13-21. 

 

Abstract:

Aim: was to estimate possibilities of two-dimensional and three-dimensional transesophageal echocardiography (TEE) in the diagnosis of atrial septal defects (ASD).

Material and methods: 52 patients with atrial septal defect underwent TEE. In 32 cases - 3D TEE, 20-2D TEE. 44 patients further underwent endovascular closure of ASD, 8 underwent cardiac surgical correction of ASD with extracorporeal circulation.

Results: 3D TEE allows to make more accurately and correctly measure of ASD, to determine its location, shape, and number of defects and to quantify all edges, including top, and to measure the length of the partition in three standard areas and additional-caval from lower to upper edge.

Conclusions: 3D TEE gives the most correct estimation of localization, shape and size of the defect, as well as contributes the proper determination of the optimal tactics of surgical correction of the defect.

 

References

1.    Tkachev I.V., Kondrabulatova S.S., Tarasov D.S. Rol' trehmernoj jehokardiografii v predoperacionnoj ocenke defektov mezhpredserdnoj peregorodki[The role of 3D echocardiography in preoperative estimation of atrial septal defects] Patologija krovoobrashhenija i kardiohirurgija. 2014; 1:58-61 [In Russ].

2.     Klinicheskaja kardiologija: diagnostika i lechenie v treh tomah [Clinical cardiology: diagnostics and treatment in 3 volumes. Under edition of L.A. Bokeria, E.Z.Golukhov]. T 1. ( pod redakciej L.A. Bokerija., E.Z. Goluhova) M.: NCSSH im. A.N. Bakuleva RAMN. 2011; 518-52[ In Russ].

3.    Narcyssova G.P., Malahova O.Ju., Osiev A.G. Ul'trazvukovye kriterii otbora pacientov s defektom mezhpredserdnoj peregorodki na jendovaskuljarnuju korrekciju sistemoj AMPLATZER i ocenku rezul'tatov - medicinskaja tehnologija. [Ultrasound criteria for selection of patients with atrial septal defect for endovascular correction with AMPLATZER system and the evaluation of results.] Novosibirsk. 2012; 10-11 [In Russ]

4.    Prakticheskaja jehokardiografija[Practical echocardiography (under edition Frank A. Flaksamph, translation from germany - V.A. Sandrikova] (pod red. Franka A. Flaksampfa perevod s nem. pod obshhej red. V.A. Sandrikova) M.MED-press-inform. 2013; 224-234 [In Russ].

5.    Tkacheva A.V. Diagnostika i jendovaskuljarnoe zakrytie vtorichnogo defekta mezhpredserdnoj peregorodki ustrojstvom «AMPLATZER» [Diagnosis and endovascular closure of secondary atrial septal defect with «AMPLATZER» device] Avtoreferat. Diss. kand. med. nauk. M. 2008; 24 [In Russ]. 

 

Abstract:

Aim: was to show the role and possibilities of 128-slice computed tomography (MSCT) iirfhe dynamic observation of patients; after open and endovascular surgery of lower limb's arteries;

Material and methods: 1st group - 36 patients (30,5%) who (underwent endovascular procedures;, 2nd group - 51 patients; (44,2%) who underwent open reconstructive operations;, 3rd group - 31 patients; (26,3%) after hybrid operations;. 108 patients; were examined in post-operative period (7 women, 101 men), average age was 57,28±15,08. All patients underwent MSCT-angiography on the background of the contrast bolus;. 55 patients; had standard procedure, other patients; underwent examination with low-close protocol.

Results: obtained images of low-close protocol had satisfactory condition of information: arterial walls were visualized well, inner lumen and para-prosthesis space, atherosclerotic lesions were also visualized. Obtained results of MSCT-angiography during low-dose protocol were confirmed ntraoperatively Obtained data of MSCT-angiography: all patients; of 1st group had passable stents; but 2 patients; who had hernodynarnically non-significant stenosis. In 2nd group 5 patents; had restenosis of prosthesis and grafts;, 20 patients; had thrombosis. In 3rd group, 2 patients; had restenosis of prosthesism femoral-popliteal segment, 13 patient had thrombosis of prosthesis/grafts, 6 patients; had restenosis of stents;, 1 patient had stent thrombosis in femoral-popliteal segment, n case of hernodynarnically significant stenosis (50%) of the stent or prosthesis in the absence of clinical manifestations; we made correction of drug therapy. If the patent had a detected boundary stenosis (50-74%) with the absence of complaints;, the patient had correction of drug therapy, with the appointment of a dynamic MSCT-angiography in 3-6 months. Patents; with occlusion of the prosthesis, or a stent with a satisfactory distal vessels clue to good collaterals; we performed thrombectomy or repeated prosthetics. Patients who according to the MDCT-angiography, had identified thrombosis of prosthesis/grafts with poor distal vessels, absence of good collaterals; and the presence of clinical manifestations; of critical ischemia - amputation of the affected limb.

Conclusion: MSCT-angiography is a highly informative method of nornnvasive imaging of patency of stent, prosthesis/graft of mam arteries; of lower limbs;. Our study showed that using of a low-close protocol is; possible for the dynamic monitoring of patents; for the detection of postoperative complications;, early diagnosis and prevention of restenosis and thrombosis of prosthesis/grafts and stents Timely diagnosis of stenosis of stents; or grafts/prostheses of mam arteries; of lower limbs can determine tactics; and stages; of surgery (endovascular treatment, and re-open reconstructive vascular surgery, thrombectomy), not leading to the patient’s; disability. 

 

References

1.     Bokerija, L. A., Gudkova R.G. Serdechno-sosudistaja hirurgija - 2010. Bolezni i vrozhdennye anomalii sistemy krovoobrashhenija: Prakticheskoe rukovodstvo[Pathology and congenital anomalies of circulatory system. Practical guide-book]. M.: NCSSH im. A. N. Bakuleva RAMN. 2011; 191 c [In Russ].

2.     Pokrovskij A.V., Doguzhieva R.M., BogatovJu.P., i dr. Otdalennye rezul'taty aorto-bedrennyh rekonstrukcij u bol'nyh saharnym diabetom 2 tipa[Late outcomes of aorto-femoral reconstructions in patients with diabetes mellitus type 2]. Angiologija i sosudistajahirurgija. 2010; 16 (1): 48-52[In Russ].

3.     Poljancev A.A., Mozgovoi P.V., Frolov D.V., i dr. Trombofilicheskie sostojanija v patogeneze pozdnih tromboticheskih reokkljuzij u bol'nyh obliterirujushhim aterosklerozom arterii nizhnih konechnostej [Thrombofillic conditions in pathogenesis of late thrombotic occlusions in patients with atherosclerosis of lower limbs]. Vestnik jeksperimental'noj i klinicheskoj hirurgii. 2011; 2 (4): 208-211[ In Russ].

4.     Kokov L.S. Luchevaja diagnostika bolezni serdca i sosudov: nacional'noe rukovodstvo. [Radiodiagnostics of heart and vessels pathology. National guide-book] M.: GJeOTAR- Media. 2011; 688 [In Russ].

5.     Bokerija, L.A., AlekjanB.G. Rukovodstvo rentgenjendovaskuljarnoj hirurgii serdca i sosudov 3t [Guide-book of endovascular surgery of heart and vessels. Volume 3]. M: NCSSH im. A.N. Bakuleva RAMN. M. 2013; 598 [In Russ].

6.     Diagnosticheskajaj effektivnost' mul'tisrezovoj komp'juternoj tomografii-angiografii v dinamicheskom nabljudenii pacientov posle rekonstruktivnyh vmeshatel'stv na magistral'nyh arterij nizhnih konechnostej [Diagnostic efficacy of multislice computed tomographic angiography in dynamic post-operative supervision after reconstrictive procedures on main arteries of lower limbs]. MedicinskijvestnikMVD. 2014; 6 (73): 47-49[In Russ].

7.     Kayhan A., Palab y k F., Serinsoz S. et а!. Multidetector CT angiography versus arterial duplex USG in diagnosis of mild lower extremity peripheral arterial disease: is multidetectorCT a valuable screening tool? Eur. J. Radiol. 2012; 81(3): 542-546.

8.     Mamet'eva I.A., Miheev N.N. Diagnosticheskajaj effektivnost' mul'tisrezovoj komp'juternoj tomografii-angiografii v dinamicheskom nabljudenii pacientov posle rekonstruktivnyh vmeshatel'stv na magistral'nyh arterijah nizhnih konechnostej [Diagnostic efficacy of multislice computed tomographic angiography in dynamic post-operative supervision after reconstrictive procedures on main arteries of lower limbs]. Medicinskij vestnik MVD. M. 2015; 78 (5): 42-47[ In Russ].

9.     lezzi R., Santoro M., Dattesi R., et al. Diagnostic accuracy of CT angiography in the evaluation of stenosis in lower limbs: comparison between visual score and quantitative analysis using a semiautomated 3D software. J. Comput. Assist. Tomogr. 2013; 37 (3): 419-425.

10.   Pomposelli F. Arterial imaging in patients with lower-extremity ischemia and diabetes mellitus. J. Am. Podiatr. Med. Assoc. 2010; 100 (5): 412-23.

11.   Mamet'eva I.A., Miheev N.N., Obel'chak I.S. i dr. Primenenie nizkodozovogo protokola u pacientov posle rekonstruktivnyh vmeshatel'stv na magistral'nyh arterijah nizhnih konechnostej. Nash opyt[Low-dose protocol in patients after reconstructive procedures on main arteries of lower limbs]. REJR. Materialy IX Vserossijskogo kongressa luchevyh diagnostov i terapevtov «Radiologija 2015».M. 2015; 5 (2): 69 [ In Russ]

12.   Mahnken A.H., Bruners P., Mommertz G. Et al. Carbon dioxide contrast agent for CT arteriography: results in a porcine model. J. Vasc.Interv. Radiol. 2008; 19 (7):1055-1064.

13.   Mizuno A., Nishi Y, Niwa K. Total bowel ischemia after carbon dioxide angiography in a patient with inferior mesenteric artery occlusion. Cardiovasc. Interv. Ther. 2014; 6(3): 642-650. 

 

Abstract:

Aim: was to evaluate pedal vascularisation in diabetic patients with using contrast MR-angiography.

Material and methods: 23 patients (15 male, 8 female; mean age 56±14,6) with suspicion on osteomyelitis (OM) underwent MR-angiography (Gadobutrol 15ml). Imaging analysis included blood-flow's speed, vascular architectonic's condition and character of contrast's accumulation, microcirculation was especially estimated. Results were compared with white blood cells-scan in identification of pyoinflamation. Osteomyelitis was verified according to operations in all cases.

Results: all patients were divided in 3 groups: neuropathic (n=9; 39,0%), neuroischemic (n=10; 43,5%), ischemic (n=4; 17,5%) forms of diabetic foot. First-pass MR-angiography detected significant delay in contrast's arrival in ischemic group. There were no significant differences between values of neuropathic and neuroischemic forms of diabetic foot. There were no pedal vessels in patients in ischemic and neuroischemic groups. Contrast MR-angiography revealed three types of contrast distribution in soft tissues: uniform, local increase and local absence. Osteomyelitis was characterized as diffuse enhanced contrast accumulation in all cases.

Conclusions: MRI blood vessel imaging is a promising and valuable method for examining peripheral arterial changes in diabetic foot and may be useful for treatment planning in different forms of diabetic foot. 

 

References

1.     Ametov A.C. Diabetes mellitus type 2. Problems and Solution. Moscow: GEOTAR-Media. 2014; 1032 [In Russ].

2.     Malhotra R., Chan C.S., Nather A. Osteomyelitis in the diabetic foot. Diabet Foot Ankle. 2014; 30; 5.

3.     Bargellini I., Piaggesi A., Cicorelli A., et al. Predictive value of angiographic scores for the integrated management of the ischemic diabetic foot. J. Vasc. Surg. 2013; 57(5): 1204-12.

4.     Manzi M., Cester G., Palena L.M., et al. Vascular imaging of the foot: the first step toward endovascular recanalization. Radiographics. 2011; 31(6):1623-36.

5.     Rohrl B., Kunz R.P, Oberholzer K., et al. Gadofosveset-enhanced MR angiography of the pedal arteries in patients with diabetes mellitus and comparison with selective intraarterial DSA. Eur Radiol. 2009;19(12): 2993-3001.

6.     Prince M.R., Wang Y, Watts R., et al. Contrast travel times measured on 2D Projection MRA in patients with Peripheral Vascular Disease Proc. Intl. Soc. Mag. Reson. Med. 2001; 9: 47.

7.     Ranachowska C., Lass P., Korzon-Burakowska A., Dobosz M. Diagnostic imaging of the diabetic foot. Nucl Med Rev Cent East Eur. 2010; 13(1): 18-22.

8.     Li J., Zhao J.G., Li M.H. Lower limb vascular disease in diabetic patients: a study with calf compression contrast-enhanced magnetic resonance angiography at 3.0 Tesla. Acad Radiol. 2011; 18(6): 755-63. 

 

 

Abstract:

At the present level of development of medicine, a group of disorders of mesenteric blood flow remains extremely difficult to diagnose. High mortality at this disease is related to the late detectability, lesion volume, patient's age and the presence of severe comorbidity. However, modern specialized hospitals, with a large arsenal of diagnostic methods, as well as a high level of surgical care in this group of patients apply endovascular interventions for early detection of disease and its possible correction.

Case report describes a clinical case of the female patient A., 58 years old, who was treated at the neurovascular department of Belgorod regional clinical hospital named after St. Ioasaf, with acute stroke of ischemic type in the left hemisphere of the brain, cardioembolic subtype. On the 5th day of hospital treatment, the patient complained on a discomfort and further abdominal pain, bloating - suspected mesenteric ischemia. The patient underwent spiral computed tomography (CT) with bolus-enhansment: diagnosed significant stenosis of celiac trunk (CT), subtotal stenosis of the proximal segment of the superior mesenteric artery (SMA) with signs of local occlusion. As a matter of urgency, in endovascular operating room, patient underwent endovascular procedure: Angiography of visceral branches of the abdominal aorta, followed by thrombectomy and stenting. Control angiography - hemodynamics in the stented segment - is not disturbed, the width of the arterial lumen is fully restored, signs of dissection and distal embolism are absent.

Conclusions: angiographic diagnostic methods in patients with mesenteric arteries thromboembolism is a highly informative, they do not require special preparation of the patient and it can immediately perform a medical intervention. Endovascular diagnosis and treatment can be recommended as a method of choice in the diagnosis and treatment of such severe disease as acute mesenteric thrombosis and thromboembolism. 

 

References

1.     Atayan A.A. Optimizacia lechebno-diagnosticheskoy taktiki u bolnih s ostroy intestinalnoy ishemiei. [Optimization of treatment and diagnostic tactics in patients with acute intestinal ischemia]. Diss. kand. med. Moskva. 2013:124 s [In Russ].

2.     Ermolov A.S., Alekseechkina O.A., Abuchina V.M. i dr. Vozmozhnosti ultrazvukovogo issledovaniya v diagnostike neokkluzionnogo narusheniya krovoobrashenia kishechnika. [Possibilities of ultrasound in the diagnosis of nonocclusive mesenteric blood-flow disorders]. Diagnosticeskaya I intervancionnaya radiologia. 2015; 9(2): 10-15 [In Russ].

3.     Goleanu V, Alecu L, Lazar O. Acute mesenteric ischemia after heart surgery. Chirurgia (Bucur). 2014; 109(3):402-6.

4.     Pokrovskiy A.V., Yudin V.I. Ostraya mezenterial’naya neprokhodimost. Klinicheskaya Angiologia: rukovodstvo pod red. A.V.Pokrovskogo. [Acute mesenteric ischemia. Clinical angiology: under edition of A.V.Pokrovskiy]. V dvuh tomah. Tom 2. M: Meditsina. 2004; 626-645 [In Russ].

5.     Trotter LBG. Tiedemann: embolism and thrombosis of mesenteric vessels. Cambridge. Cambridge University Press. 1913: 143.

6.     Yushkevich D.V., Hryischanovich V.Ya., Ladutko I.M. Diagnostika i lechenie ostrogo narusheniya mezenterialnogo krovoobrasheniya: sovremennoe sostoyanie problemi. [Diagnostics and treatment of acute disorders of mesenterial blood flow: modern condition of problem]. Medicinskiy nauchniy zhurnal: nauchno-practicheskiy retsenziruemiy zhurnal. 2013; 3: 38-44 [In Russ].

7.     Andrew Oldenburg W., Louis Lau L., Thomas J. Rodenberg, Hope J. Edmonds, Charles D. Burger Acute Mesenteric Ischemia: A Clinical Review. Arch Intern Med. 2004;164(10):1054-1062.

8.     Eliot J.W. The operative relief of gangrene of the intestine due to occlusion of the mesenteric vessels. Ann. Surg. 1895;21:9-23.

9.     Davidov Yu.A. Infarkt kishechnika i hronicheskaya mesenterial’naya ishemiya. [Intestinal infarction and chronic mesenteric ischemia]. M: Medicina. 1997; 208 [In Russ].

10.   Savelev V.S., Spiridonov I.V. Ostrie narusheniaya mesenterialnogo krovoobrashenia. [Acute mesenteric blood-flow disorders]. M: Medicina. 1979; 232 [In Russ].

11.   Savelev V.S., Spiridonov I.V., Boldin B.V. Ostrie narusheniaya mesenterialnogo krovoobrashenia. Infarkt kishechnika. Rukovodstvo po neotlozhnoy hirurgii pod red. V.S. Savel’ev [Acute mesenteric blood-flow disorders. Intestinal infarction. Urgent surgery guideline under edition of V.S. Savel’ev]. Triada-X. 2005; 281-302 [In Russ].

12.   Shugaev A.I., Vovk A.V., Babkin V.Ya. Ostrie narusheniya mezenterialnogo krovoobrasheniya - aktualnaya problema v neotlozhnoi khirurgii organov brushnoi polosti. [Acute disorders of mesenteric blood flow - an actual problem of urgent abdominal surgery]. Ambulatornaya hirurgia. Statsionarzameshayushie tehnologii. 2005;20 (4):112 [In Russ].

13.   Grinberg A.A. Neotlozhnaya abdominalnaya hirurgia. [Urgent abdominal surgery (guide-book for phisicians)]. M: Triada-X. 2000: 496 S. [In Russ].

14.   Acosta S. Epidemiology of mesenteric vascular disease: clinical implications. Semin Vasc Surg. 2010 Mar; 23(1):4-8.

15.   Bradbury A.W., Brittenden, J.McBride, K.Ruckley, C.V. Mesenteric ischaemia: a multidisciplinary approach. Br. J. Surg. 1995;821446-1459.

16.   Solomentseva T.A.. Ostrie narusheniya mesenterialnogo kroovbrasheniya v terapevticheskoi clinike. [Acute disorders of mesenteric blood flow in therapeutic clinics.] Ostrie I neotlozhnie sostoyania v praktike vrachha. (Electronic version - http://urgent.com.ua/article/369.html) 2011: #2(26) [In Russ].

17.   Acosta S., Ogren M., Sternby N.H. et al. Mesenteric venous thrombosis with transmural intestinal infarction: a population-based study. J. Vasc. Surg. 2005; 41: 1683-1688.

18.   Timerbulatov Sh.V., Sagitov R.B., Sultanbaev A.Y., Asmanov D.I. Diagnostika ishemicheskih povrazhdeniy pri ostrih hirurgicheskih zabolevaniyah organov brushnoi polosti. [Diagnostics of ischemic lesions in patients with acute diseases of abdominal organs]. Klinicheskaya o eksperimentalsya hirurgia. 2012; 3: 40-52 [In Russ].

19.   Lubyanskiy V.G., Zharikov A.N., Kanteeva Ju.L.. Hirurgicheskoe lechenie bolnih s ostrim mesenterial’nim trombozom s nekrozom kishki I peritonitom. [Surgical treatment of patients with acute mesenteric thrombosis complicated by intestinal necrosis and peritonitis]. Kubanskiy nauchniy meditsinskiy vestnik. 2013; 138 (3): 85-89 [In Russ].

20.   AbuRahma A.F., Stone P.A., Bates M.C., Welch C.A. Angioplasty/stenting of the superior mesenteric artery and celiac trunk: Early and late outcomes. J Endovasc Ther. 2003;10:1046-1053.

21.   Hadi Rokni Yazdi, Fadi Youness, Sandeep Laroia, Shiliand Sun, Hicham Abada, Melhem Sharafuddin, Jafar Golzarian. Mesenteric Artery Stenting for Chronic Mesenteric Ischemia. Vascular disease management. 2007;4(6): 180-184.

22.   Hoffmann M., Keck T. Management of mesenteric ischemia and mesenteric vein thrombosis. Dtsch Med Wochenschr. 2014 Jul;139(30):1540-4.

23.   Cunningham C.G. et al. Chronic visceral ischemia. Ann Surg. 1991 Sep;214(3):276-87.

24.   Kubanov A.V., Rudman V.Ya., Grigoriev I.A., Shubin E.A., Polyarush V.P., Letskin A.Ya., Poshataev K.E. Sluchai uspeshnogo endovaskularnogo lesheniya ostrogo tromboza verkhney brizheechnoi arterii. [Case report: successful endovascular treatment of acute thrombosis of superior mesenteric artery]. Dalnevostochniy medicinskiy zhurnal. 2013; 2: 95-97 [In Russ].

25.   Arthurs Z.M., Titus J., Bannazadeh M. A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia, J. Vascular Surgery. 2011 № 53(3): 698-704.

26.   Urayama H, Ohtake H, Kawakami T, Tsunezuka Y Yokoi K, Watanabe Y Acute mesenteric vascular occlusion: analysis of 39 patients. Eur J Surg. 1998 Mar; 164(3): 195-200. 

 

 

Abstract:

Backgroud: endovascular implantation of the aortic stent-graft is a method of choice in treatment of aneurysms of the infrarenal abdominal aorta, especially in patients with high surgical risk.This strategy is characterized as less in-hospital complications, shorter in-hospital stay All these circumstances show some advantages of endovascular treatment compared with traditional «open» surgery. Besides that, there are some limitations for aortic endoprosthesis implantation, including short or conical proximal neck, severe angulation of aneurysmatic neck and tortuosity of arteries, insufficient diameter of iliac-femoral segment arteries for stent-graft delivery

Materials and methods: we report two clinical cases of successsful implantation of novel stent-graft OVATION PRIME in patients with adverse anatomy, precisely small diameter of crossing profile and original technology of proximal fixation of endoprosthesis.

Results: the use of innovative models of stent-grafts allows to proceed aortic endoprosthesis implantation with minimal risk of complications in certain patients with adverse vascular anatomy, who were previously deemed unsuitable for endovascular treatment.


References

1.     Jackson R.S., Chang D.C. Comparison of long-term survival after open vs endovascular repair of intact abdominal aortic aneurysm among Medicare beneficiaries. JAMA. 2012; 307: 1621-1628.

2.     Logevrove R.E., Javid M., Magee T.R., Galland R.B. A meta-analysis of 21,178 patient undergoing open or endovascular repair of abdominal aortic aneurysm. Br. J. Surg. 2008; 95:677-684.

3.     Brewster D.C., Cronenwett J.L., Hallett J.W. Jr, Johnston K.W., Krupski W.C., Matsumura J.S. Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J. Vasc.Surg. 2003;37:1106-17.

4.     Greenhalgh R.M., Brown L.C., Powell J.T., Thompson S.G., Epstein D., Sculpher M.J. Endovascular versus open repair of abdominal aortic aneurysm. N. Engl. J. Med. 2010;362:1863-71.

5.     Lederle F.A., Freischlag J.A., Kyriakides T.C., Padberg F.T. Jr, Matsumura J.S., Kohler T.R., et al. Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA. 2009; 302:1535-42.

6.     Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project (HCUP). Available at: http://ahrg.gov/data/hcup/. Accessed September 26, 2012.

7.     Arko F.R. Filis K.A., Seidel S.A., Gonzalez J., Lengle S.J., Webb R., et al. How many patients with infrarenal aneurysms are candidates for endovascular repair? The Northern California experience. J. Endovasc Ther. 2004;11:33-40.

8.     Armon M.P., Yusuf S.W. Latief K., Whitaker S.C., Gregson R.H., Wenham P.W., et al. Anatomical suitability of abdominal aortic aneurysms for endovascular repair. Br. J. Surg. 1997;84:178-80.

9.     Carpenter J.P., Baum R.A, Barker C.F., Golden M.A. Mitchell M.E., Velazquez O.C., et al. Impact of exclusion criteria on patient selection for endovascular abdominal aortic aneurysm repair. J. Vasc.Surg. 2001;34: 1050-4.

10.   Elkouri S., Martelli E., Gloviczki P., McKusick M.A. Panneton J.M., Andrews J.C., et al. Most patients with abdominal aortic aneurysm are not suitable for endovascular repair using currently approved bifurcated stent-grafts. Vasc. Endovascular. Surg. 2004;38:401-12.

11.   Moise M.A., Woo E.Y, Velazquez O.C., Fairman R.M., Golden M.A., Mitchell M.E., et al. Barriers to endovascular aortic aneurysm repair: past experience and implications for future device development. Vasc. Endovascular. Surg. 2006;40:197-203.

12.   Schumacher H., Eckstein H.H., Kallinowski F., Allenberg J.R. Morphometry and classification in abdominal aortic aneurysms: patient selection for endovascular and open surgery. J. Endovasc.Surg. 1997;4:39-44.

13.   Mehta M., Byrne W.J., Robinson H., Roddy S.P, Paty PS., Kreienberg P.B., et al. Women derive less benefit from elective endovascular aneurysm repair than men. J. Vasc. Surg. 2010;55:906-13.

14.   Morrison T., Fillinger M., Meyer C., et al. Gender disparities in endovascular treatment options for infrarenal abdominal aortic аneurysms. http://www.fda.gov/downloads/MedicalDevices/NewsEvents/Workshops Conferences/UCM359044.pdf. Published June 25, 2013. Accessed June 20, 2014.

15.   AbuRahma A.F., Campbell J., Stone PA., et al. The correlation of aortic neck length to early and late outcomes in endovascular aneurysm repair patients. J. Vasc. Surg. 2009;50:738-748.

16.   Aburahma A.F., Campbell J.E., Mousa A.Y, et al. Clinical outcomes for hostile versus favorable aortic neck anatomy in endovascular aortic aneurysm repair using modular devices. J. Vasc.Surg. 2011;54:13-21.

17.   Sweet M.P, Fillinger M.F., MorrisonT.M., Abel D. The influence of gender and aortic aneurysm size on eligibility for endovascular abdominal aortic aneurysm repair. J. Vascular Surg. 2011; 54:931-7. 

 

 

Abstract:

Acute cerebrovascular accident (CVA) is one of leading causes of death and disability in the population, both in Russia and around the world.

Aim: was to improve the effectiveness of the prevention of ischemic stroke (IS) in patients with asymptomatic stenosis of internal carotid arteries (ICA).

Materials and methods: this article is an analysis of the world literature on the subject of stroke in patients without focal or ocular symptoms (asymptomatic stenosis), medical and surgical (carotid stenting / carotid endarterectomy) correction of such stenotic lesions, postoperative complications, and the risk of stroke in the immediate and late postoperative period. We presented data on development of stroke, depending on the type of plaques, brain CT data, comorbidities in these patients, the method of surgical correction of stenosis. On the basis of international multicenter studies and experience of individual domestic and foreign clinics we performed evaluation of IS conservative anc surgical prophylaxis in this group of patients.

Results: performed analysis allowed to formulate recommendations on the tactics of treatment and examination of patients with asymptomatic internal carotid artery stenosis.

 

References

1.     Bokerija L.A., Gudkova R. G. Serdechno-sosudistaja hirurgija. 2010; Bolezni i vrozhdennye anomalii sistemy krovoobrashhenija. [Cardio-vascular surgery. 2010. Diseases and congenital abnormalities of blood circulation]. M.: NCSSH im. A.N. Bakuleva RAMN. 2011; 192 [In Russ].

2.     Pokrovskij A.V. Klinicheskaja angiologija. A.V. Pokrovskij. [Clinical Angiology]. Moscow; 2004;1; 808. [In Russ]. 

3.     Chernjavskij A.M. Programma bor'by s insul'tom, prehodjashhimi narushenijami mozgovogo krovoobrashhenija i discirkuljatornymi jencefalopatijami: metod. rekomendacii A.M.Chernjavskij, T.E.Vinogradova. [The program for prevention of stroke, TIA and encephalopathy: recommendations]. Novosibirsk; 2002;17. [In Russ].

4.     Go A.S., Mozaffarian D., Roger V.L. et al; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association. Circulation. 2014;129:e28-e292.

5.     Kleindorfer D., Panagos P, Pancioli A., et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke. 2005; 36:720-723.

6.     Suslina Z.A. Ocherki angionevrologii. [Angionevrology contexts] . Moscow: 2005; 126. [In Russ].

7.     Leljuk V.G., Leljuk S.Je. Cerebral'nyj rezerv pri ateroskleroticheskom porazhenii brahiocefal'nyh arterij. Jetjudy sovremennoj ul'trazvukovoj diagnostiki. [Mechanisms of development of cerebral vascular compensation due to atherosclerotic lesions of cerebral arteries]. Kiev; 2001; 4p. [In Russ].

8.     Nacional'nye rekomendacii po vedeniju pacientov s zabolevanijami brahiocefal'nyh arterij. Rossijskij soglasitel'nyj dokument. [National recommendations for treatment of patients with cerebrovascular disorders]. Angiologija i sosudistaja hirurgija. 2013; 19 (2): 70. [In Russ].

9.     Committee for the National Institute of Neurological Disorders and Stroke. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke. 1990;21:637-76.

10.   Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273(18): 1421-8.

11.   Halliday A., Harrison M.. Hayter E. et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010;376(9746): 1074-84.

12.   Chambers B.R. Donnan G.A. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev. 2005(4):CD001923.

13.   Barnett H.J., Meldrum H.E., Eliasziw M. North American Symptomatic Carotid Endarterectomy Trial collaborators. The appropriate use of carotid endarterectomy. CMAJ. 2002; 166(9):1169-79.

14.   Inzitari D., Eliasziw M., Gates P et al. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl. J. Med. 2000;342(23): 1693-700.

15.   Chaturvedi S., Bruno A., Feasby T. et al. Carotid endarterectomy an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the  AmericanAcademy of Neurology. Neurology. 2005;65(6):794-801.

16.   Pahigiannis К., Kaufmann P Koroshetz W. Carotid intervention: is it warranted in asymptomatic individuals if risk factors are aggressively managed? Stroke. 2014;45(3):e40-l.

17.   Abbott A.L. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke. 2009;40(10):e573-83.

18.   Spence J.D. Tamayo A. Lownie SP et al. Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke. 2005;36(ll):2373-8.

19.   Spence J.D. Coates V., Li H. et al. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol. 2010;67(2): 180-6.

20.   Markus H., King A., Shipley S.et al. Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. LancetNevrol. 2010; 9:663-71.

21.   Kakkos S.K., Sabetai M., Tegos T. et al. Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis. J. Vasc. Surg. 2009;49;903-909.

22.   Hougaku H., Matsumoto M., Handa N. et al. Asymptomatic carotid lesions and silent cerebral infarction. Stroke. 1994;25:566-70.

23.   Tegos T.J., Sabetai M.M., Nicolaides A.N. et al. Patterns of brain computed tomography infarction and carotid plaque echogenicity. J. Vasc. Surg. 2001;33:334-9.

24.   Hashimoto H., Tagaya M., Niki H. Htani H. Computer-assisted analysis of heterogeneity on В-mode imaging predicts instability of asymptomatic carotid plaque. Cerebrovasc. Dis. 2009;28:357-64.

25.   Liapis С., Kakisis J., Kostakis A. Carotid Stenosis. Factors Affecting Symptomatology. Stroke. 2001; 32:2782-2786.

26.   Nicolaides А., Kakkos S., Kyriacou E. et al. Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. J.Vasc. Surg. 2010;52:1486-96.

27.   Yi-Ning Qian, Yong-Ting Luo, Hong-Xia Duan et al. Adhesion Molecule CD146 and its Soluble Form Correlate Well with Carotid Atherosclerosis and Plaque Instability. CNS Neuroscience & Therapeutics 2014; 20:438-445.

28.   Jones C.B., SaneD.C., Herrington D.M. Matrix metalloproteinases: a review of their structure and role acute coronary syndrome. Cardiovasc. Res. 2003,59: 812-823. 

29.   Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068-2101.

30.   Inoue M., Ishida T., Yasuda T., et al. Endothelial cell-selective adhesion molecule modulates atherosclerosis through plaque angiogenesis and monocyte-endothelial interaction. Microvasc. Res. 2010;80:179-187.

31.   McEver R.P Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol. 2002;14:581-586.

32.   Hwang S.J., Ballantyne C.M., Sharrett A.R., et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997,96:4219-4225.

33.   Pelisek J., Rudelius M., Zepper P., et al. Multiple biological predictors for vulnerable carotid lesions. Cerebrovasc. Dis. 2009;28:601-610.

34.   Abbott A.L., Paraskevas K.I., Kakkos S.K. et al. Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis. Stroke. 2015 Nov;46(11):3288-301.

35.   Goldstein L.B. Bushnell C.D. Adams RJ. et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011 ;42(2): 517-84.

36.   Brott T.G., Hobson 2nd R.W. Howard G. et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N. Engl. J.Med. 2010;363(1): 11-23.

37.   Voeks J.H., Howard G., Ronbin G.S, Malas M.B et al. Age and outcomes after carotid stenting and endarterectomy: the carotid revascularization endarterectomy versus stenting trial. Stroke. 2011;42( 12):3484-90.

38.   Nallamothu B.K., Lu M., Rogers M.A. et al. Physician specialty and carotid stenting among elderly medicare beneficiaries in the United States. Arch. Intern. Med. 2011; 171 (20): 1804-10. 

39.   Gowri R., Denish M., Nira H. et al. Management Strategies for Asymptomatic Carotid Stenosis. Ann. Intern. Med. 2013;158:676-685.

40.   Pahigiannis К., Kaufmann P., Koroshetz W. Carotid intervention: is it warranted in asymptomatic individuals if risk factors are aggressively managed? Stroke. 2014;45(3):e40-l. 

 

 

Abstract:

This study was aimed to show effectiveness of endovascular procedures in patients with critical lower limb ischemia (CLI), caused by lesions of iliac and femoral-popliteal-tibial segment's of arteries.

Materials and methods: study includes results of treatment of 68 patients, who underwent endovascular procedures.

Results: primary technical success in group with A, B, C TASC II aortoiliac lesions was 100%, with D TASC II aortoiliac lesions was 91,7%. In group with infrainguinal lesions overall primary technical success was 91,9%. Regression of ischemia was marked in all patients. The average growth of the ankle-brachial index (ABI) was 0,3. During one year of follow-up period, 3 major amputations were performed (5,8% of follow-up patients) in group of interventions of shin arteries with one recanalized tibial artery Salvation of lower limbs was 94,2% without CLI signs reccurence.

Conclusion: endovascular interventions are effective, minimally invasive treatment for CLI. Endovascular procedures such as angioplasty with or without stenting showld be seen as a treatment of choise in patients with CLI for limb salvage.

 

References

1.   Nacional'nye rekomendacii po vedeniju pacientov s zabolevanijami arterij nizhnih konechnostej [National recommendation for treatment of patients with diseases of lower limbs’ arteries]. M. 2013; 74[ In Russ].

2.     Fowkes F.G., Housley E., Cawood E.H. Edinburgh artery study: prevalence о! asymptomatic and symptomatic peripheral arterial disease in the general population. Int. J. Epidimiol. 1991; 20: 38-92.

3.     ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2006; 113: 11: 463-654.

4.     Bokerija L.A., Gudkova R.G. Serdechno-sosudistaja hirurgija-2014. Bolezni i vrozhdennye anomalii sistemy krovoobrashhenija [Cardiovascular surgery - 2014. Congenital anomalies and diseases of blood circulation]. M.: NCSSH im. A.N. Bakuleva. 2015[In Russ].

5.    Gavrilenko A.V., Skrylev S.I., Kuzubova E.A. Ocenka kachestva zhizni u pacientov s KINK[Quality of life in patients with CLI]. Angiologija i sosudistaja hirurgija. 2001; 3: 8-13[In Russ].

6.    Papojan S.A., Abramov I.S., Majtesjan D.A. i dr. Gibridnye operacii pri mnogojetazhnyh porazhenijah arterij nizhnih konechnostej [Hybrid operations in multifocal lesions of lower limbs’ arteries]. Angiologija i sosudistaja hirurgija. 2012; 18 (2): 138-141[In Russ].

7.    Pokrovskij A.V. Klinicheskaja angiologija[Clinical angiology]. M: Medicina 2004; 808[ In Russ].

8.     Nasr M.K., McCarthy R.J., Budd J.S., Horrocks M. Infrainguinal bypass graft patency and limb salvage rates in critical limb ischemia: influence of the mode of presentation. Ann Vasc Surg 2003; 17: 192-197.

9.     Faries P.L., Logerfo F.W., Arora S., Hook S., Pulling M.C., Akbari C.M., et al. A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts. J. Vasc. Surg. 2000;32:1080-1090.

10.   Gavrilenko A.V., Kotov A.Je., Shatalova D.V. Rezul'taty otkrytyh rekonstruktivnyh vmeshatel'stv na ranee stentirovannom uchastke arterij u pacientov s kriticheskoj ishemiej nizhnih konechnostej [Results of open reconstructive operations on previously stented arteries of lower limbs in patients with critical ischemia]. Diagnosticheskaja i intervencionnaja radiologija. 2015; 9 (1): 34-38 [In Russ].

11.   Conte M.S., Geraghty P.J., Bradbury A.W. et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J. Vasc. Surg. 2009; 50: 1462-1473.

12.   Kudo T., Chandra F.A., Kwun W.H. et al: Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. Open bypass surgery. J. Vasc. Surg. 2006; 44: 304-313.

13.   Molloy K.J., Nasim A., London N.J. et al. Percutaneous transluminal angioplasty in the treatment of critical limb ischemia. J. Endovasc. Ther. 2003; 10 (2): 298-303.

14.   Nasr M.K., McCarthy R.J., Hardman J. et al. The increasing role of percutaneous transluminal angioplasty in the primary management of critical limb ischaemia. Eur. J. Vasc. Endovasc. Surg. 2002; 23 (5): 398-403.

15.   Faglia E., Dalla P.L., Clerici G., et al. Peripheral angioplasty as the first choice revascularizaion procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur. J. Vasc. Endovasc. Surg. 2005; 29 (6): 620-627.

16.   Giles K.A., Pomposelli F.B., Spence T.L., Hamdan A.D., Blattman S.B., Panossian H., Schermerhorn M.L. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J. Vasc. Surg. 2008; 48:128-136.

17.   Conrad M.F., Cambria R.P., Stone D.H. et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J. Vasc. Surg. 2006; 44:762-769.

18.   Adam D.J., Beard J.D., Cleveland T. et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005; 366: 1925-1934.

19.  Zatevahin I.I., Shipovskij V.N., Zolkin V.N. Balonnaja angioplastika pri ishemii nizhnih konechnostej [Ballon angioplasty in patients with CLI] M.: Medicina. 2004; 256 [In Russ].

20.   Kudo T., Chandra F.A., Ahn S.S. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J. Vasc. Surg. 2005; 41:423-35; discussion 435.

21.   Beard J.D. Which is the best revascularization for critical limb ischemia: endovascular or open surgery? J. Vasc. Surg. 2008; 48(6 Suppl):11S-6S.

22.   Xiaoyang Fu., Zhidong Zhang., Kai Liang et al. Angioplasty versus bypass surgery in patients with critical limb ischemia - a meta-analysis Int. J. Clin. Exp. Med. 2015; 8(7): 10595-10602.

23.   Philip B.Dattilo, Ivan P.Casserly. Critical Limb Ischemia: Endovascular Strategies for Limb Salvage. Progress in Cardiovascular Diseases. 2011; 54: 47-60.

24.   Faglia E., Clerici G., Caminiti M. et al. Mortality after major amputation in diabetic patients with critical limb ischemia who did and did not undergo previous peripheral revascularization Data of a cohort study of 564 consecutive diabetic patients. J. Diabetes Complications. 2010; 24(4): 265-269.

25.   Hinchliffe R.J., Andros G., Apelqvist J. et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes Metab Res Rev. 2012; 28 Suppl 1:179-217.

26.   Holman N., Young R.J., Jeffcoate W.J. Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia. 2012; 55(7): 1919-1925. 

 

 

Abstract:

Aim: was to provide data of examination of patients of single-center randomized clinical trial ORENBURG (results of angiography, intravascular ultrasound (IVUS), optical coherence tomography (OCT), which were made at different stages of primary operations).

Materials and methods: 1032 patients were enrolled into this trial and uniformly distributed into 6 subgroups, representing 6 different types of drug-eluted stents implanted. Patients in this study were also divided into IVUS guidance and angiography guidance subgroups in 2 to 1 ratio. All patients underwent the OCT examination at the final stage of the procedure, and according to OCT results, no additional interventions were performed. Data of instrumental studies was analyzed with use of modern statistical methods and programs.

Results: according to angiographic data, in-segment lesion length and lumen volume before the operation were higher in IVUS group. After intervention, lumen volume was still higher, and % diameter stenosis and % area stenosis were lower in IVUS group in comparison with angiography group. Comparison of IVUS and angiography data after predilatation showed that IVUS was associated with bigger absolute values of minimum lumen diameter (MLD) and minimum lumen area (MLA), while % diameter stenosis and % area stenosis were similar between two groups. At control IVUS and OCT studies the region of the maximum residual stenosis did not usually match with the site of the baseline maximum stenosis. Quantitative data in these segments significantly differed. According to control IVUS data, additional angioplasty in stent was needed in 10,1 % of patients. Additional procedure allowed to improve all quantitative indicators. Implantations of different types of stents were performed using similar interventional technic but randomized by selection of stent eluting. Nevertheless, initial technical parameters of endoprosthesis affected quantitative results of the implantation. Nobori stent showed biggest differences in quantitative results of implantation in comparison with other types of stents and to the whole group.

Conclusion: ORENBURG is second large trial in terms of volume, and second large trial that was initiated, and which was dedicated to the comparison of interventional strategies using drug-eluting stents under intravascular visualization or angiography guidance. The minimal incidence of MACE was registered during the period of in-hospital stay Only one case of cardiac death was registered, and it was not associated with the region of the treated artery. Results of ORENBURG trial confirm the tendency to absolute measures recieved by intravascular methods of visualization, and used for characterization of defeated vessel excess absolute measures received by angiography.

 

References

1.     Intravascular Ultrasound. Ad by Erbel R., Roelandt J.R.T.C., Ge J., Gorge G. London: Martin Dunitz. 1998, 284.

2.     Mintz G.S. Intracoronary Ultrasound. London and New York: Taylor & Francis. 2005, 408.

3.     Colombo A., Tobis J. Techniques in Coronary Artery Stenting. London: Martin Dunitz. 2000, 422.

4.     Demin V.V. Klinicheskoe rukovodstvo po vnutrisisudistomu ultrazvukovomu skanirovaniyu [Clinical guide to intravascular ultrasound]. Orenburg: Yuzhnyj Ural [South Ural]. 2005; 400 [In Russ].

5.     Demin V.V., Zelenin V.V., Zheludkov A.N. et al. Vnutrisosudistoe ultrazvukovoe skanirovanie pri intervencionnih vmeshatelstvah na koronarnih arteriyah: optimalnoe ptimenenie I kriterii ocenki. [Intravascular ultrasound scanning during coronary interventions: optimum application and assessment criteria]. International Journal of Interventional Cardioangiology. 2003; 1: 66-72 [In Russ].

6.    Sandrikov V.A., Demin V.V., Revunenkov G.V. Kateternaya echographia serdechno-sosudistoy sistemy I polostnyh obrazovaniy [Catheter echography of cardiovascular system and cavitary structures]. Moscow: «Firma Strom». 2005; 256 [In Russ].

7.     2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A Report of the AmericanCollege of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011; 124:e574-e651.

8.     2013 ESC guidelines on the management of stable coronary artery disease. The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal. 2013; 34: 2949-3003.

9.     2014 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EAPCI). European Heart Journal. 2014; 35: 2541-2619.

10.   Oemrawsingh P.V., Mintz G.S., Scalij M.J. et al. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenosis: Final results of randomized comparison with angiographic guidance (TULIP Study). Circulation. 2003; 107: 62-67.

11.   Gaster A.L., Slothuus Skjoldborg U., Larsen J. et al. Continued improvement of clinical outcome and cost effectiveness following intravascular ultrasound guided PCI: Insights from a prospective, randomized study. Heart. 2003; 89 (9): 1043-1049.

12.   Gil R.J., Pawlowski T., Dudek D. et al. Comparison of angiographically guided direct stenting technique with direct stenting and optimal balloon angioplasty guided with intravascular ultrasound. The multicenter, randomized trial results. Am. Heart Journal. 2007; 154 (4): 669-675.

13.   Frey A.W., Hodgson J.M., Muller C. et al. Ultrasound-guided strategy for provisional stenting with focal balloon combination catheter. Results from the randomized Strategy for Intracoronary ultrasound-guided PTCA and Stenting (SIPS) trial. Circulation. 2000; 102 (20): 2497-2502.

14.   Fitzgerald P.J., Oshima A., Hayase M. et al. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation. 2000; 102 (5): 523-530.

15.   Sousa A., Abizaid A., Mintz G.S. et al. The influence of intravascular ultrasound guidance on the in-hospital outcomes after stent implantation: results from the Brazilian Society of Interventional Cardiology Registry - CENIC. J. Am. Coll. Cardiol. 2002; 39: 54A.

16.   Russo R.J., Attubato M.J., Davidson C.J. et al. Angiography versus intravascular ultrasound-directed stent placement: final results from AVID. Circulation. 1999; 100: I-234.

17.   Russo R.J., Silva P.D., Teirstein P.S. et al. A Randomized Controlled Trial of Angiography versus Intravascular Ultrasound-Directed Bare-Metal Coronary Stent Placement (The AVID Trial). Cathet Cardiovasc Intervent. 2009; 2: 113-123.

18.   Parise H., Maehara A., Stone G.W. et al. Metaanalysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era. Am. J. Cardiol. 2011; 107 (3): 374-382.

19.   Casella G., Klauss V., Ottani F. et al. Impact of intravascular ultrasound-guided stenting on long-term clinical outcome: a meta-analysis of available studies comparing intravascular ultrasound-guided and angiographically guided stenting. Cathet Cardiovasc Intervent. 2003; 59: 314-321.

20.   Mintz G.S., Weissman N.J. Intravascular ultrasound in the drug-eluting stent era. JACC. 2006; 48 (3): 422-428.

21.   Claessen B.E., Mehran R., Mintz G.S., et al. Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. JACC; Cardiovasc Interv. 2011; 4 (9): 974-981.

22.   Hur S.-H., Kang S.-J., Kim Y-H., et al. Impact of intravascular ultrasound-guided percutaneous coronary intervention on long-term clinical outcomes in a real world population. Cathet Cardiovasc Intervent. 2013; 81: 407-416

23.   Roy P., Steinberg D.H., Sushinsky S.J., et al. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. European Heart Journal. 2008; 29: 1851-1857.

24.   Witzenbichler B., Maehara A., Weisz G. et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study. Circulation. 2014; 129 (4): 463-470.

25.   De la Torre Hernandez J.M., Baz Alonso J.A., Gomez Hospital J.M. et al. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries. JACC; Cardiovasc Interv. 2014; 7 (3): 244-254.

26.   Gao X.F., Kan J., Zhang J.J. et al. Comparison of one-year clinical outcome between intravascular ultrasound-guided versus angiography-guided implantation of drug-eluting stents for left main lesions: a single-center analysis of a 1,016-patient cohort. Patient Prefer Adherence. 2014; 8: 1299-1309.

27.   Park S.-J., Kim Y-H., Park D.-W. et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Intervent. 2009; 2: 167-177.

28.   Ahn S.G., Yoon J., Sung J.K. et al. Intravascular ultrasound-guided percutaneous coronary intervention improves the clinical outcome in patients undergoing multiple overlapping drug-eluting stent implantation. Korean Circ Journal. 2013; 43: 231-238.

29.   Chen S.-L., Ye F., Zhang J.-J. et al. Intravascular ultrasound-guided systematic two-stent techniques for coronary bifurcation lesions and reduced late stent thrombosis. Cathet Cardiovasc Intervent. 2013; 81: 456-463.

30.   Kim S.H., Kim YH., Kang S.J. et al. Long-term outcomes of intravascular ultrasound-guided stenting in coronary bifurcation lesions. Am. J. Cardiol. 2010; 106 (5): 612-618.

31.   Klersy C., Ferlini M., Raisaro A. et al. Use of IVUS guided coronary stenting with drug eluting stent: a systematic review and meta-analysis of randomized controlled clinical trials and high quality observational studies. Int J Cardiol. 2013; 170 (1): 54-63.

32.   Zhang Y, Farooq V., Garcia-Garcia H.M. et al. Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomized trial and ten observational studies involving 19,619 patients. EuroIntervention. 2012; 8 (7): 855-865.

33.   Ahn J.M., Kang S.J., Yoon S.H. et al. Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am. J. Cardiol. 2014; 113 (8): 1338-1347.

34.   Jang J.S., Song YJ., Kang W. et al. Intravascular ultrasound-guided implantation of drug-eluting stents to improve outcome: a meta-analysis. JACC: Cardiovasc Interv. 2014; 7 (3): 233-243.

35.   Hong S.-J., Kim B.-J., Shin D.-H. Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent ImplantationThe IVUS-XPL Randomized Clinical Trial. JAMA. 2015; 314 (20): 2155-2163.

36.   Demin V.V., Galin P.Yu., Demin D.V. et al. Sravnenie strategij implantazii stentov s lekarstvennym pokrytiem pod kontrolem vnutrisosudistogo ultrazvukovogo skanirovaniya ili angiografii: randomizirovannoe issledovanie «Orenburg». Chast’ 1. Aktual’nost’, dizajn issledovaniya, neposredstvennye klinicheskie resul’taty [The comparison of intravascular ultrasound guided and angiography guided implantation of drug-eluting stents: The randomized trial «Orenburg». Part 1: Study design, direct clinical results]. Diagnostic & Interventional Radiology. 2015; 9 (3): 31-43 [In Russ].

 

 

 

 

Abstract:

Acardiac fetus («acardiac monster», «acardiac vampire») - is rarely encountered pathology of pregnancy in which one of monochorionic fetuses (recipient) is formless mass, with absence of the heart and some internal organs, life and growth of which is related to parasitism on other fetus.

The main reason for the formation of this defect is an abnormal location of placental vessels ir monochorionic twins. Characteristic are the underdevelopment of the upper body of the recipient fetus (underdevelopment of the upper part of chest, the absence of heart or the presence of rudimentary heart) and acephaly

The article presents results of the analysis of the world literature data, and given own observation of acardiac fetus stillborn.

We specify frequency causes, as well as the clinical and morphological features such anomalies. Possibilities of the post-mortem magnetic resonance and computed tomography imaging in determining the type of acardiac fetus. According to results of the analysis, it was the most efficient construction and analysis of volumetric reconstruction of bone tissues.

Conclusion: post-mortem CT and MRI are advisable in some cases as a complement to the postmortem examination.

 

References

1.     Alderman B. Foetus acardius amorphus. Postgraduate Med. J. 1973; 49: 102-105.

2.     Chi J.G. Acardiac twins. J. Korean. Med. Sci. 1989; 4: 203-216.

3.     Benirschke K. The Monozygotic twinning process, the twin-twin transfusion syndrome and acardiac twins. Placenta. 2009; 3: 923-928.

4.     Obladen M. From monster to twin reversed arterial perfusion: a history of acardiac twins J. Perinat. Med. 2010; 38(3): 247-253.

5.     Dahiya P, Agarwal U, Sangwan K, Sen J. Antenatal diagnosis of twin-reversed arterial perfusion sequence (acardiac amorphous) in a triplet pregnancy: case report. Arch. Gynecol. Obst. 2004; 269: 147-148.

6.     Gillim D.L., Hendriks C.H. Holoacardius: review of the literature and case report. Obstet. Gynecol. 1953; 2: 647-653.

7.     Bhatnagar K.P, SharmaS.C., Bisker J. The holoacardius: a correlative computerized tomographic, radiologic, and ultrasonographic investigation of a new case with review of literature. Acta genet. med. Gemellot. 1986; 35: 77-89.

8.     Shchegolev A.I., Tumanova U.N., Shuvalova M.P., Frolova O.G. Vrozhdennie poroki kak prichina mertvorozhdeniya[Congenital anomalies as a cause stillbirth]. Mezhdunarodnyj zhurnal prikladnyh i fundamental'nyh issledovanij. 2015; 10 (2): 263-267 [In Russ].

9.     Demikova N.S., Lapina A.S. Vrozhdennie poroki razvitiya v regionah Rossiyskoi Federatsii (itogi monitoringa 2000-2010 gg. [Congenital malformations in regions of the Russian Federation (monitoring results for 2000-2010]. Rossijskij vestnik perinatologii i pediatrii. 2012; 2: 91-98 [In Russ].

10.   Fox H, Butler-Manuel R. A teratoma of the placenta. J. Pathol. Bacteriol. 1964; 88: 137-140.

11.   Thayyil1 S., Chitty L.S., Robertson N.J. et al. Minimally invasive fetal postmortem examination using magnetic resonance imaging and computerised tomography: current evidence and practical issues. Prenat. Diagn. 2010; 30: 713-718.

12.  Tumanova U.N., Fedoseeva V.K., Liapin V.M., Stepanov A.V., Voevodin S.M., Shchegolev A.I. Posmertnaya kompjuternaya tomographia mertvorozhdennikh s kostnoi patologiej [Computed Tomography of Stillborn with Bone Pathology]. Meditsinskaya vizualizatsiya. 2013; 5, 110-120 [In Russ].

13.  Fedoseeva V.K., Tumanova U.N., Liapin V.M. Voevodin S.M., Shchegolev A.I. Vozmozhnosti ispolzovaniya multispiralnoj kompjuternoi tomografii v posmertnoi diagnostike patologii plodov i novorozhdennikh. [Possibilities of use of a multispiral computer tomography in posthumous diagnosis of pathology of fetus and newborns]. REJR. 2014; 3 (S2): 448 [In Russ].

14.   Aghayev E., Staub L., Dirnhofer R., et al. Virtopsy - the concept of a centralized database in forensic medicine for analysis and comparison of radiological and autopsy data. J. Forensic. Leg. Med. 2008; 15: 135-140.

15.  Kokov L.S., Kinle A.F., Sinitsyn V.Y., Filimonov B.A. Voz- mozhnosti kompyuternoj i magnitno rezonansnoj tomografii v sudebno medicinskoj ehkspertize mekhanicheskoj travmy i skoropostizhnoj smerti obzor literatury. [Possibilities of computed tomography and magnetic resonance imaging in forensic medicalexamination of mechanical trauma and sudden death (a literature review)]. Zhwrnalim. N.V. Sklifosovskogo. Neotlozhnaya meditsinskaya pomoshch. 2015; 2: 16-26 [In Russ].

16.   Moore T.R., Gale S., Benirschke K. Perinatal outcome of forty nine pregnancies complicated by acardiac twinning. Am. J. Obstet. Gynecol 1990; 163: 907-912.

17.   Blickstein I., Keith G.L. Multiple pregnancy. Informa healthcare. 2005.

18.   Coulam С.В., Wright С. First trimester diagnosis of асаrdiас twins. Еагу Ргеgnаnсу 2000; 4: 261-270.

19.   Larsen W.J. Development of the heart. Human embryology. 2nd ed. Churchill Livingstone. 1997; 151-187.

20.   Baergen N.R. Manual of Pathology of the human placenta. 2nd ed. Springer Science+Business Media: LLC, 2011.

21.   Kamitomo М., Kouno S., Ibuka К. et al. First-trimester findings associated with twin reversed arterial perfusion sequence. Fetal Diagn. Ther. 2004; 19: 187-190.

22.  Ajlamazjan E.K., Pavlova N.G., Shelaeva E.V., Bezhenar V.F. Sindrom obratnoj arterialnoj perfuzii pri mnogoplodii obzor literatury i sobstvennyj opyt diagnostiki i fetalnoj hirurgii. [Syndrome of the return arterial perfusion at a mnogoplodiya: review of literature and own experience of diagnostics and fetalny surgery]. Prenat. diagn. 2012; 2: 178-184 [In Russ].

23.   Al-Malt А., Ashmead G., Judge N. et al. Color-ftow and Doppler velocimetry in prenatal diagnosis of acardiac triples. J. Ultrasound Med. 1991; 10: 341-345.

24.   Izquierdо I., Smith J., Gilson G. еt al. Twin, acardiac, acephalus. Fetus. 1992; 1: 1.

25.   Papa Т., Dao А., Bruner J.P Pathognomonic sign of twin reversed arterial perfusion using color Doppler sonography. J. Ultгаsоund Med. 1997; 16: 501-503.

26.   Sabourin J., DeDoming E., Chandra S., Jain V. Twin reversed arterial perfusion syndrome. J. Obstet. Gynaecol. Can. 2011; 33: 315.

27.   Mccurdy C.M., Childers J.M., Seeds J.W. Ligation of the umbilical cord of an acardiac-acephalous twin with an endoscopic intrauterine technique. Obstet. Gynecol. 1993; 82: S708-S711.

28.   Corbacioglu A., Gul A., Bakirci I.T. et al. Treatment of twin reversed arterial perfusion sequence with alcohol ablation or bipolar cord coagulation. Int. J. Gynaecol. Obstet. 2012; 117: 257-259.

29.   Weichert A., Kalache K., Hein P. et al. Radiofrequency ablation as a minimally invasive procedure in the treatment of twin reversed arterial perfusion sequence in twin pregnancy. J. Clin. Ultrasound. 2012; May 10. doi: 10.1002/jcu.21932.

30.   Tan T.YT., Sepulveda W. Acardiac twin: A systematic review of minimally invasive treatment modalities. Ultrasound Obstet. Gynecol. 2003; 22: 409-419.

31.   Sepulveda W., Sfeir D., Reyes M., Martinez J. Severe polyhydramnios in twin reversed arterial perfusion sequence: successful management with intrafetal alcohol ablation of acardiac twin and amniodrainage. Ultrasound Obstet. Gynecol. 2000; 16: 260-263.

 

 

 

 

Abstract:

Aim: was to evaluate the effeciency of adenomyosis treatment with magnetic resonance-guided focused ultrasound (MRgFUS) ablation.

Materials and methods: from March 2012 to November 2014 on the base of «Federal Center of Medicine and Rehabilitation» of Russian Ministry of Health we have examined and treated by MRgFUS ablation 50 patients with adenomyosis. Criteria for patient selection for treatment by MRgFUS ablation were: age 25-49 years, adenomyosis symptoms, confirmed diagnosis of the disease on MRI, ultrasound and gynecological examination, technical ability to perform FUS ablation. Dynamical observation after treatment included: vaginal examination, pelvic MRI with contrast performed at 3rd, 6th and 12th month after MRgFUS ablation. Also, within a specified time patients were asked to fill a questionnaire to assess the severity of adenomyosis symptoms anc quality of life (SF-36).

Results: against the background of the treatment, patients noted significant symptoms reduction. The best result was noted 3 months after treatment: 47% of women had less abundant menstruation; 26% of patients noted a decrease of pain during menstruation; 30% of patients had decreased duration of menstruation. Positive trend maintained during a year.

Control pelvic MRI after 3 months showed positive trend for majority of patients (85%): uterus size decrease (average by 30%). From 6th to 12th month of observation, it was noted that the uterus size in 73% patients increased in comparison' to the first control study (3 months after the procedure), uterus thus again starts accumulating a contrast agent in the ablation area, indicating the restoration of blood flow.

 

References

1.     Tomassetti C., Meuleman C., Timmerman D., D'Hooghe T. Adenomyosis and subfertility: evidence of association and causation. Semin. Reprod. Med. 2013; 31(2): 101-8.

2.     Linde V.A., Tatarova N.A., Lebedeva N.E., Grishanina O.I. Epidemiologicheskie aspekty genitalnogo endometrioza (obzor literaturi). [Epidemiological aspects of genital endometriosis (review)]. Problemy reproduktsii. 2008; 14(3): 68-72. [In Russ]

3.     Maheshwari A., Gurunath S., Fatima F., Bhattacharya S. Adenomyosis and subfertility: A systematic review of prevalence, diagnosis, treatment and fertility outcomes. Human Reproduction Update. 2012; 18(4): 374-392.

4.     Naftalin J., Hoo W., Pateman K., Mavrelos D., Holland T., Jurkovic D.. How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic. Hum. Reprod. 2012; 27(12): 3432-9.

5.     Damirov M.M. Genitalny endometrioz - bolezn aktivnikh i delovikh zhenschin [Genital endometriosis - disease of active and business women]. M.: Binom. 2010; 191 p. [In Russ].

6.     Strizhakov A.N., Davydov A.I., Pashkov V.M., Lebedev V.A. Dobrokachestvennye zabolevaniya matki [Benign uterine diseases]. M.: GEOTAR-Media. 2011; 288 p. [In Russ].

7.     Stamatopoulos C.P., Mikos T., Grimbizis G.F, Dimitriadis A.S., Efstratiou I., Stamatopoulos P., Tarlatzis B.C. Value of magnetic resonance imaging in diagnosis of adenomyosis and myomas of the uterus. J. Minim. Invasive Gynecol. 2012; 19(5) 620-6.

8.     Sudderuddin S., Helbren E., Telesca M., Williamson R., Rockall A. MRI appearances of benign uterine disease. Clin. Radiol. 2014; 69(11): 1095-1104.

9.     Heo S.H., Lee K.H., Kim J.W., Jeong YY Unusual manifestation of endometrioid adenocarcinoma arising from subserosal cystic adenomyosis of the uterus: emphasis on MRI and positron emission tomography CT findings. Br. J. Radiol. 2011. 84(1007): e210-2.

10.   Ischenko A. I., Zhumanova E. N., Ischenko A. A., Gorbenko O. Y., Chunaeva E. A., Agadzhanyan E. S., Saveleva Y. S. Sovremennye podkhody v diagnostike i organosokhranyayuschem lechenii adenomioza [Modern approach in the diagnosis of adenomyosis and conserving therapy]. Akusherstvo, ginekologiya i reproduktsiya. 2013; 7(3): 30-34. [In Russ].

11.   Nam J.H., Lyu G.S. Abdominal Ultrasound-Guided Transvaginal Myometrial Core Needle Biopsy for the Definitive Diagnosis of Suspected Adenomyosis in 1032 Patients: A Retrospective Study. J. Minim. Invasive Gynecol. 2015 Mar-Apr; 22(3):395-402.

12.   Marret H., Bleuzen A., Guerin A., Lauvin-Gaillard M.A., Herbreteau D., Patat F., Tranquart F.; French first results using magnetic resonance-guided focused ultrasound for myoma treatment. Gynecologie. Obs. Fertil. 2011;39: 12-20.

13.   Levy G., Dehaene A., Laurent N., Lernout M., Collinet P., Lucot JP, Lions C., Poncelet E. An update on adenomyosis. Diagn. Interv. Imaging. 2013; 94(1): 3-25.

14.   Tamai K., Koyama T, Umeoka S., Saga T., Fujii S., Togashi K. Spectrum of MR features in adenomyosis. Best Pract. Res. Clin. Obstet. Gynaecol. 2006; 20(4): 583-602. 

 

 

Abstract:

Aim: was to evaluate the influence of factors on the development of diaphragmatic dysfunction ir early periods after cardiac surgery

Materials and methods: study included 830 patients after various cardiac surgery in Federal National Center of Cardiovascular Surgery (Penza, Russian Federation). In the early postoperative period (3,9 ± 0,9 days) all patients underwent chest x-ray while transporting from intensive care unit. We evaluated differences between diaphragm contors in two consecutive shots - with a deep breath and exhale fully In the early postoperative period diaphragmatic dysfunction was detected in 172 cases (20.7%). Patients were divided into 4 groups depending on the presence or absence of a violation of the diaphragm function. The criterion of selection into the group with diaphragmatic dysfunction was size of amplitude motion, less than 10 mm. 1st group with normal mobility of the diaphragm included 658 patients (79.3%). 2nd group with dysfunction of the left dome of the diaphragm - 85 patients(10.2%). 3rd group with dysfunction of the right dome - 58 patients (7%). 4th group with bilateral diaphragmatic dysfunction - 29 patients (3.5%). Logistic regression model included 4 variables, the significance of which is reflected by the published data: preparation of internal thoracic artery (ITA) for graft, valve surgery, the use of radiofrequency ablation, the use of cardiopulmonary bypass. We made a multiple logistic regressive analysis of predictors for the development of diaphragmatic dysfunction.

Results: we have found that under the influence of complex predictors, greatest chance of dysfunction was observed in the group with bilateral violation of diaphragm mobility after two-sidec separation of ITA (OR 3.4; CI 1.60, 7.25). High chances of dysfunction were observed in groups with unilateral violation of diaphragm mobility after unilateral separation of ITA. Separation of left ITA had higher chances for diaphragmal dysfunction (OR 2.7; CI 1.36; 5.37) than in case of separation of right ITA (OR 2.0; CI 1.16, 3.47). After valve operations, radiofrequency ablation, and cardiopulmonary bypass chances of diaphragmatic dysfunction was statistically insignificant (p>0.05) in all study groups.

Conclusions: diaphragmatic dysfunction develops in 3.4 times greater in case of bilateral separation of ITA. Unilateral dysfunction of the diaphragm has a great chance in case of separation of ITA: left up to 2.7 times and right up to 2 times. Influence of cardiopulmonary bypass, valve operations and radiofrequency ablation for the development of diaphragmatic dysfunction is statistically insignificant.

 

References

1.     Berrizbeitia L.D., Tessler S., Jacobowitz I.J., et al. Effect of sternotomy and coronary bypass surgery on postoperative pulmonary mechanics. Chest. 1989, 96(4):873-876.

2.     Deng Y, Byth K., Paterson H.S. Phrenic nerve injury associated with high free right internal mammary artery harvesting. Ann. Thorac. Surg. 2003; 76(2):459-463.

3.     Mazzoni M., Solinas C., Sisillo E., et al. Intraoperative phrenic nerve monitoring in cardiac surgery. Chest. 1996, 109(6):1455-1460.

4.     O'Brien J.W., Johnson S.H., VanSteyn S.J., et al. Effects of internal mammary artery dissection on phrenic nerve perfusion and function. Ann.Thorac. Surg. 1991, 52(2):182-188.

5.     Tripp H.F., Sees D.W., Lisagor P.G., et al. Is phrenic nerve dysfunction after cardiac surgery related to internal mammary harvesting? J. Card. Surg. 2001, 16(3): 228-231.

6.     Canbaz S., Turgut N., Halici U., et al. Electrophysiological evaluation of phrenic nerve injury during cardiac surgery - a prospective, controlled, clinical study. BMC Surgery. 2004, 4:2.

7.     Merino-Ramirez M.A., Juan G., Rair^n M., et al. Electrophysiologic evaluation of phrenic nerve and diaphragm function after coronary bypass surgery: prospective study of diabetes and other risk factors. J. Thorac. Cardiovasc. Surg. 2006; 132:530-536.

8.     Metzner A., Rausch P, Lemes C., et al. The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon. J. Cardiovasc. Electrophysiol. 2014; 25(5):466-470.

9.     Diehl J.L., Lofaso F., Deleuze P, et al. Clinically relevant diaphragmatic dysfunction after cardiac operations. J. Thorac. Cardiovasc. Surg. 1994; 107:487-498.

10.   Efthimiou J., Butler J., Woodham C., et al. Diaphragm paralysis following cardiac surgery: role of phrenic nerve cold injury. Ann. Thorac. Surg. 1991; 52:1005-1008.

11.   Smith B.M., Ezeokoli N.J., Kipps A.K., et al. Course, Predictors of Diaphragm Recovery After Phrenic Nerve Injury During Pediatric Cardiac Surgery. Ann. Thorac. Surg. 2013; 96:938-42.

12.   Kim W. Y; Suh H. J.; Hong S.-B.; Koh Y; Lim C.-M. Diaphragm dysfunction assessed by ultrasonography: Influence on weaning from mechanical ventilation. Critical Care Medicine. 2011; 12:2627-2630.

13.   Davison A., Mulvey D. Idiopathic diaphragmatic weakness. BMJ. 1992; 304:492-494.

14.   McCool F.D., Tzelepis G.E. Dysfunction of the Diaphragm. N. Engl. J. Med. 2012; 366:932-942.

15.   McCool F.D., Mead J. Dyspnea on immersion: mechanisms in patients with bilateral dia-phragm paralysis. Am. Rev. Respir Dis. 1989; 139:275-276.

16.   Steier J., Jolley C.J., Seymour J., et al. Sleep-disordered breathing in unilateral diaphragm paralysis or severe weakness. Eur. Respir. J. 2008; 32:1479-1487.

17.   Wang C.S., Josenhaus W.T. Contribution of the diaphragmatic-abdominal displacement to ventilation in supine man. J. Appl. Physiol. 1971; 31:576-80.

18.   Stradling J.R., Warley A.R. Bilateral diaphragm paralysis and sleep apnoea without diurnal respiratory failure. Thorax. 1988; 43:75-77

19.   Summerhill E.M., El-Sameed YA., Glidden T.J. Monitoring recovery from diaphragm paralysis with ultrasound. Chest. 2008; 133:737-743.

20.   El-Sobkey S.B., Salem N.A. Can lung volumes and capacities be used as an outcome measure for phrenic nerve recovery after cardiac surgeries? J. Saudi. Heart Assoc. 2011; 23:23-30.

21.   Laroche C.M., Mier A.K., Moxham J., Green M. Diaphragm strength in patients with recent hemidiaphragm paralysis. Thorax. 1988; 43:170-174.

22.   Линденбратен Л.Д. Лучевая диагностика поражений диафрагмы. Радиология и практика. 2001; 2:6-21. Lindenbraten L.D. Luchevaja diagnostika porazhenij diafragmy[Beam diagnostics of diaphragm lesions]. Radiologija ipraktika. 2001; 2:6-21[In Russ].

23.     Suwatanapongched T., Gierada D.S., Slone R.M. et al. Variation in Diaphragm Position and Shape in Adults With Normal Pulmonary Function. Chest. 2003; 123(6): 2019-2027. 


 

Abstract:

Ischemic strokes are still the worldwide problem with high mortality and morbidity. Carotid endarterectomy that is used for revascularization of changed artery required precise visualization of carotid arteries at extra- and intracranial level, assessment of intracranial circulation.

 

References

1.     Insul't: Rukovodstvo dlja vrachei. Pod red. L.V. Stahovskoi, S.V. Kotova. [Stroke: guide for physicians. Under edition of L.V.Stakhovsky, V.Kotov] M.: OOO «Medicinskoe informacionnoe agentstvo», 2013;400S [In Russ].

2.     Nacional'nye rekomendacii po vedeniju pacientov s zabolevanijami brahiocefal'nyh arterii. [National recommendations for treatment of patients with pathology of brachiocephalic arteries.] ]2013; S 70 [In Russ].

3.     Vereshhagin N.V. Rol' porazhenij jekstrakranial'nyh otdelov magistral'nyh otdelov golovy v patogeneze narushenij mozgovogo krovoobrashhenija. Sosudistye zabolevanija nervnoj sistemy. [Role of extracranial arteries’ lesion in pathogenesis of disorders of cerebral circulation] Smolensk. 1980; 23-26 [In Russ].

4.     Gusev E.I., Skvorcova V.I. Ishemija golovnogo mozga. [Ischemia of brain]. Zhurn.nevropat. i psihiatr. 2003;9:66- 70 [In Russ].

5.     Harbaugh R.E., Schlusselberg D.S., Jeffery R., Hayden S., Cromwell L.D., Pluta D. Threedimensional computerized tomography angiography in the diagnosis of сerebrovascular disease. J. Neurosurg 1992; 76: 408-414.

6.     Heiserman J.E., Dean B.L., Hodak J.A. et al. Neurologic complications of cerebral angiography. AJNR Am Neuroradiol. 1994; 15: 1401-1407.

7.     Dzhibladze D.N. Patologija sonnyh arterii i problema ishemicheskogo insul'ta (klinicheskie, ul'trazvukovye i gemodinamicheskie aspekty). [ Pathology of carotid arteries and problem of ischemic stroke (clinical, ultrasonic and hemodynamic aspects)] Moskva. 2002; 208S [In Russ].

8.     John J. Ricotta, MD,a Ali AbuRahma, MD, FACS,b Enrico Ascher, MD,c Mark Eskandari, MD,d Peter Faries, MD,e and Brajesh K. Lal MD,f Washington, DC; Charleston, WV; Brooklyn, NY; Chicago, Ill; New York, NY; and Baltimore, Md Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease. J Vasc Surg. 2011 Sep; 54(3): 1-31.

9.     Buskens E., Nederkoorn P.J., Buijs-Van Der Woude T., Mali W.P., Kappelle L.J., Eikelboom B.C., Van Der Graaf Y, Hunink M.G. Imaging of carotid arteries in symptomatic patients: cost-effectiveness of diagnostic strategies. Radiology. 2004;233:101-112.

10.   Edward C. Jauch et al., Guidelines for the Early Management of Patient With Acute Ischemic Stroke. Stroke. 2013;44: 870-947.

11.   Gladstone D.J., Kapral M.K., Fang J., Laupacis A., Tu J.V. Management and outcomes of transient ischemic attacks in Ontario. CMAJ. 2004;170:1099-1104.

12.   North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med. 1991;325:445-453.

13.   Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998 May 9; 351 (9113): 1379-87.

14.   Osborn A.G.; Diagnostic Cerebral Angiography. 2nd edition Philadelphia, PA: Williams and Wilkins; 1999.

15.   Choi YJ., JungS.C., Lee D.H. Vessel Wall Imaging of the Intracranial and Cervical Carotid Arteries. Journal of Stroke. 2015; 17(3):238-255.

16.   Extracranial vascular-interventional: E. Johansson and A.J. Fox Carotid Near-Occlusion: A Comprehensive Review, Part 1—Definition, Terminology, and Diagnosis. AJNR Am. J Neuroradiol 2016 37: 2-10.

17.   The International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: risk of rupture and risks of surgical intervention. N Engl J Med. 1998; 339: 1725-1733

18.   Krylov V.V. Jepidemiologija i jetiopatogenez anevrizm i subarahnoidal'nyh krovoizlijanii. [Epidemiology and ethiopathogenesis of aneurysms and subarachnoid hemorrhage] Krylov V.V., Godkov I.M. Hirurgija anevrizm golovnogo mozga: v 3-h t. Pod red. V.V. Krylova. Tom 1. M.: Izd-vo T.A. Alekseeva. 2011; tom.I, Gl. 1: 12-41 [In Russ]. 

 

Abstract:

Currently, the combination of acute cholecystitis complicated by choledocholithiasis is quite common.

Aim: was to improve the efficiency of diagnosis of complicated forms of gallstone disease (acute cholecystitis complicated by choledocholithiasis).

Materials and methods: study included 118 patients with acute cholecystitis complicated by choledocholithiasis. The age of patients ranged from 16 to 92 years (mean age 61,5 ± 2,5 years). Women were 86(78.5%), men - 32 (21.5%). All patients underwent ultrasound examination of the abdominal cavity, hepatobiliary scintigraphy (HBSG), MRI-cholangiography (MRHG), endoscopic retrograde cholangiopancreatography (ERCP) and biochemical blood tests with determination of total bilirubin, amylase, alanine aminotransferase (ALT) and aspartate aminotransferase (AST), alkaline phosphatase (ALP), total protein and protein fractions.

Results: in the diagnosis of choledocholithiasis sensitivity of ultrasound was 86%; HBSG - 97% MRHG - 92%. Basing on these data of sensitivity of different diagnostic methods, we developed diagnostic algorithm of acute cholecystitis complicated by choledocholithiasis: US → HBSG (if inefficient US ir terms of visualization of the distal common bile duct) → MRHG (to clarify causes of focal disorders of transport of labeled bile, according to HBSG) → ERCP: endoscopic papillosphincterotomy (EPST) and lithoextraction (LE) (detected choledocholithiasis or lingering doubts in the diagnosis).

Conclusions: the use of the diagnostic algorithm for acute cholecystitis in many cases allows timely identification of choledocholithiasis, followed by the implementation of adequate endoscopic sanitation of biliary tract, before performing cholecystectomy . 

 

References

1.     Savel'ev B.C. Endoskopicheskie metody issledovaniya v diagnostike porazheniy vnepechenochnykh zhelchnykh protokov pri kal'kuleznom kholetsistite [Endoscopic techniques in the diagnosis of lesions of extrahepatic bile ducts in the calculous cholecystitis]. In: B.C. Savel'ev, M.I. Filimonov, A.S. Balalykin. Problemy khirurgii zhelchnykh putey [Problems of biliary tract surgery]. Moscow. 1982; 168-169 [In Russ].

2.    Gal'perin E.I. i Vetshev P.S. Rukovodstvo po khirurgii zhelchnykh putej [Guide for surgery of the biliary tract ]. M: Vidar. 2009; 568 S [In Russ].

3.     Аrdasenov T.B., Frejdovich DA., Pan'kov А.G., Brudzinskij SA., Orlova E.N. Dooperatsionnaya diagnostika skrytogo kholedokholitiaza [Preoperative diagnosis of latent choledocholithiasis]. Апп khir. gepatol. 2011; 2: 18-24 [In Russ].

4.    Dadvani S.А., Vetshev P.S., SHulutko АЖ., Prudkov M.I. ZHelchnokamennaya bolezn'. [Gallstone disease]. M. Izd. dom Vidar-M. 2000; 144S [In Russ].

5.     Ratnikov V.A., Cheremisin V.M., Shejko S.B. Sovremennye luchevye metody (ul'trazvukovoe issledovanie, rentgenovskaya komp'yuternaya i magnitno-rezonansnaya tomografiya) v diagnostike kholedokholitiaza (obzor literatury) [Modern radiation techniques (ultrasound, X-ray CT and MRI) in the diagnosis of choledocholithiasis (literature review)]. Meditsinskaya vizualizatsiya. 2002;3: 99-106 [In Russ].

6.     Popova I.E., SHarifullin FA. Primenenie magnitnorezonansnoj kholangiopankreatografii v diagnostike kholedokholitiaza. Moskva. [The use of magnetic resonance cholangiopancreatography in the diagnosis of choledocholithiasis ]. Materialy gorodskogo seminara «Aktualnie voprosy diagnostiki i lecheniya kholedokholitiaza, oslozhnennogo mekhanicheskoj zheltukhoj i kholangitom». 2009; 15-17 [In Russ].

7.     Аbdulamitov KH.K., Rogal' M.L., Moiseeva L.V. Popova I.E. SHavrina I.V. Kuprikov S.V. Rol' magnitnorezonansnoj kholangiografii v diagnostike patologii zhelchevyvodyashhikh protokov u bol'nykh v otdalennom periode posle videolaparoskopicheskoj kholetsistehktomii ["The role of magnetic resonance cholangiography in the diagnosis of biliary tract disease in patients in the late period after cholecystectomy videolaparoscopic ]. Rossijskij zhurnal Gastroehnterologii, Gepatologii, Koloproktobgii. 2008;18(5):111 [In Russ].

8.     Tham T.C., Lichtenstein D.R., Vandervoort J. et al. Role of endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis in patients undergoing laparoscopic cholecystectomy. Gastrointestinal Endoscopy. 1998; 47: 50-56.

9.     Sharma S.K., Larson K.A., Adler Z. et al. Role of endoscopic retrograde cholangiopancreatography in the management of suspected choledocholithiasis. Surgical Endoscopy. 2003; 17: 868-871.

 

 

 

 

Abstract:

Aim: was to estimate possibilities of optical coherence tomography (OCT) in diagnostics of pathology of bile ducts in combination with percutaneous transhepatic biliary drainage (PTBD).

Materials and methods: examined 5 patients with obstructive jaundice, suspected cancerous etiology OCT was performed during or 5-14 days after PTBD. For morphological confirmation of results we performed forceps intraductal biopsies.

Results: tomographic evidences of the malignant stricture were revealed in 4 (80%) patients anc in 1 patient benign stricture was determined. Diagnoses were confirmed histologically (80%) and clinically (20%). Sensitivity of the OCT was 100%.

Conclusion: percutaneous transhepatic OCT appeared to be a perspective method for differential diagnostics of biliary strictures. 

 

References

1.     Polikarpov A.A. Rentgenojendovaskuljarnye vmeshatel'stva v lechenii nerezektabel'nyh zlokachestvennyh opuholej pecheni. [Endovascular interventions in treatment of nonresectable malignant tumors of liver] Avtoreferat. Diss. dokt. med. nauk. S.Peterburg. 2006; S 26 [In Russ].

2.     Shajn A.A. Rak organov pishhevarenija. [Cancer of digestive organs] Tjumen'. Skorpion. 2000; 184-188 [In Russ].

3.     Soares K.C., Kamel I., Cosgrove D.P., et al. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014; 3 (1): 18-34.

4.     Madariaga J.R., Iwatsuki S.,Todo S. et al. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Annals of Surgery. 1998; 227 (1): 70-79.

5.     Heimbach J.K., Haddock M.G., Alberts S.R. et al. Transplantation for hilar cholangiocarcinoma. Liver Transplantation. 2004; 10 (2): 65 -68.

6.     Denisenko A.G. Opticheskaja kogerentnaja tomografija v diagnostike novoobrazovanij zheludochno-kishechnogo trakta. [Optical coherence tomography in diagnostics of neoplasms of digestive tract]Avtoreferat. Diss. kand. med. nauk. N. Novgorod. 2006; S 20 [In Russ].

7.     Zagajnova E.V. Diagnosticheskaja cennost' opticheskoj kogerentnoj tomografii v jendoskopii. [Diagnostic value of optical coherence tomography in endoscopy]Avtoreferat. Diss. dokt. med. nauk. N. Novgorod. 2007; S27 [In Russ].

8.     Arvanitakis M., Hookey L., Tessier G. et al. Intraductal optical coherence tomography during endoscopic retrograde cholangiopancreatography for investigation of biliary strictures. Endoscopy. 2009; 41: 696-701. [PMID: 19618343 D0I:10.1055/s-0029-1214950].

9.     de Bellis M., Sherman S., Fogel E. L. et al. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc. 2002; 56: 720-730 [PMID: 12397282 DOI: 10.1067/mge.2002.129219].

10.   Ross W.A., Wasan S.M., Evans D.B. et al. Combined EUS with FNA and ERCP for the evaluation of patients with obstructive jaundice from presumed pancreatic malignancy. Gastrointest Endosc. 2008; 68: 461-466 [PMID: 18384788 DOI: 10.1016/j.gie.2007.11.033].

11.   Shahova N.M. Kliniko-jeksperimental'noe obosnovanie primenenija opticheskoj kogerentnoj tomografii v medicinskoj praktike [Clinical and experimental basics of application of optical coherence tomography in medical practice]Avtoreferat. Diss. dokt. med. nauk. N. Novgorod. 2004; 19c  [In Russ].

12.   Demin V.V., Dolgov S.A., Demin D.V. Sravnenie informativnosti opticheskoj kogerentnoj tomografii i vnutrisosudistogo ul'trazvukovogo skanirovanija dlja ocenki rezul'tatov implantacii stentov s lekarstvennym pokrytiem. Materialy V rossijskogo s'ezda intervencionnyh kardioangiologov. [Comparison of informative value of optical coherence tomography and intravascular ultrasound in estimation of results of implantation of drug-eluting stents.] Mezhdunarodnyj zhurnal intervencionnoj kardioangiologii. 2013; 35: 41- 42 [In Russ].

13.   Mahmud S.M., May G.R., Kamal M.M. et al. Imaging pancreatobiliary ductal system with optical coherence tomography: A review. World J Gastrointest Endosc. 2013; 5(11): 540-550. ISSN 1948-5190 (online).

14.   Tearney G.J., Brezinski M.E., Southern J.F. et al. Optical biopsy in human pancreatobiliary tissue using optical coherence tomography. Dig DisSci. 1998; 43: 11931199 [PMID: 9635607 DOI: 10.1023/A:1018891304453].

15.   Testoni P.A., Mariani A., Mangiavillano B. et al. Main pancreatic duct, common bile duct and sphincter of Oddi structure visualized by optical coherence tomography: An ex vivo study compared with histology. Dig Liver Dis. 2006; 38: 409-414 [PMID: 16584931 DOI: 10.1016/j.dld. 2006.02.014].

16.   Testoni P.A., Mangiavillano B. Optical coherence tomography in detection of dysplasia and cancer of the gastrointestinal tract and bilio-pancreatic ductal system. World J Gastroenterol. 2008; 14: 6444-6452 [PMID: 19030194 DOI: 10.3748/wjg.14.6444].

17.   Testoni P.A., Mariani A., Mangiavillano B. Intraductal optical coherence tomography for investigating main pancreatic duct strictures. Am J Gastroenterol. 2007; 102: 269-274 [PMID: 17100970 DOI: 10.1111/j. 1572-0241. 2006.00940.x].

 

 

 

 

Abstract:

Aim: was to develop a classification of osteonecrosis of the midface, based on clinical and radiological examinations. Such classification can allow to make detailed planning of surgical intervention tactics and develop criteria for surgical intervention basing on the bone division of the facial skeleton, as well as to assess dynamics of changes in bones of the facial skull.

Materials and methods: the study included 87 drug-addicted patients with a diagnosis of «toxic phosphate osteonecrosis». All patients underwent clinical and radiological examination. Basing on MSCT data, tactics of surgical treatment was determined.

Results: basing on results of clinical and radiological methods of examination in 29 cases (33%) we observed toxic phosphate osteonecrosis of the upper and lower jaw. In 18 patients (21%) the disease occurred only in the upper jaw. Lesion of the upper jaw within the I and II parts below the infraorbital foramen was observed in 39 cases (45%). Lesion of the maxilla above the infraorbital foramen was determined in 8 cases (9%). In case of diffuse lesions of the maxilla in 23 cases (26%), different patterns of midface were involved in pathologic process.

Conclusion: creation and application in clinical practice of this classification of osteonecrosis of the midface bone in patients with drug-addiction on desomorphine and pervitin, based on the data of MSCT, allowed to pinpoint boundaries and the nature of the defeat of facial bones and choose the best tactics of surgical treatment in all patients. 

 

References

1.     Malanchuk V.O., Kopchak A.V., Brodec'kyj I.S. Klinichni osoblyvosti osteomijelitu shhelep u hvoryh z narkotychnoju zalezhnistju [Clinical features of osteomyelitis of the skull in patients with drug addiction]. Ukr. med. chasopys. 2007; 4 (60): 111-117 [In Ukr].

2.     Barannik N.G., Varzhapetjan S.D., Mosejko A.A. i dr. Opyt lechenija pacientov s osteomielitom cheljustej i vtorichnym immunodeficitom na fone prijoma narkotichskih preparatov [The experience of treatment of patients with osteomyelitis of jaws and secondary immunodeficiency on a background of drug-addiction]. Aktual''ni pytannja medychnoi' nauky ta praktyky. 2013; 1 (80): 12-20 [In Russ].

3.     Malanchuk V.O., Brodec'kyj I.S., Zabuds'ka L.R. Osoblyvosti rentgenologichnoi' kartyny osteomijelitu shhelep u hvoryh na foni narkotychnoi' zalezhnosti [Radiographic features of osteomyelitis of the skull in patients on the background of drug addiction]. Ukr. med. chasopys. 2009; 2 (70): 122-125 [In Ukr].

4.     Serova N.S., Kureshova D.N., Babkova A.A. et al. Mnogosrezovaja kompjuternaja tomografija v diagnostike toksicheskih fosfornyh nekrozov cheljustej [Multislice computed tomography in the diagnosis of toxic phosphate necrosis of the jaw]. Vestnik rentgenologii i radiologii. 2015; 5: 11-16 [In Russ].

5.     Ivashhenko A.L., Matros-Taranec I.N., Priluckij A.S. Sovremennye aspekty jetiopatogeneza, klinicheskoj kartiny i lechenija ostemielitov cheljustej u pacientov s narkoticheskoj zavisimost'ju i VICh-infekciej [Modern aspects of the etiopathogenesis, clinicals and treatment of osteomyelites of jaws in patients with drug-addiction and a hiv-infection]. Zbirnikstatej. 2009: 1 (13): 213-219 [In Russ].

6.     Malanchuk V. A., Brodeckij I.S. Kompleksnoe lechenie bol'nyh osteomielitom cheljustej na fone narkoticheskoj zavisimosti [Complex treatment of patients with osteomyelitis of jaws on background of drug-addiction]. Vestnik VGMU. 2014; 2 (13): 115-123 [In Russ].

7.     Serova N.S., Babkova A.A., Kureshova D.N. et al. Kompleksnaja luchevaja diagnostika osteonekrozov u dezomorfinzavisimyh pacientov [Complex radiological diagnosis of osteonecrosis in desomorphine-addicted patients]. REJR. 2015; 5 (4): 13-23 [In Russ].

8.     Medvedev Ju.A, Basin E.M., Sokolina I.A. Kliniko-rentgenologicheskaja klassifikacija osteonekroza nizhnej cheljusti [Clinical and X-ray classification of osteonecrosis of the lower jaw]. Vestnik rentgenologii i radiologii. 2013; 5: 21-25 [In Russ].

9.     Lesovaja I.G., Himenko V.M., Himenko V.V. Clinical experience in providing specialized aid to patients with atypical course of odontogenic osteomyelitis suffering from drug addiction and acquired immunodeficiency syndrome. Materialy Vseukrainskoj nauchno-prakticheskoj konferencii «Novye tehnologii v stomatologii i cheljustno-licevoj hirurgii» [Materials of Ukrainian scientific-practical conference «New technologies in stomatology and maxillofacial surgery»]. Har'kov. 2006; 77-82 [In Russ].

10.   Timofeev A.A., Dakal A.V. Klinicheskoe techenie gnojno- vospalitel'nyh zabolevanij cheljustej i mjagkih tkanej cheljustno-licevoj oblasti u bol'nyh, upotrebljajushhih narkotik «vint» [Clinical course of purulent inflammatory diseases of jaws and soft tissues of the maxillofacial area in patients using «vint»-drug]. Sovremennaja Stomatologija. 2010; 1: 96-102 [In Russ].

11.   Pogosjan Ju.M., Akopjan K.A., Gasparjan L.L.. Rentgenodiagnostika osteonekroza cheljustej u bol'nyh, upotrebljajushhih narkoticheskoe sredstvo «krokodil» [Radiographic diagnosis of jaw osteonecrosis at patients who use the drug «krokodil»]. Voprosy teoreticheskoj i klinicheskoj mediciny. 2013; 2 (78): 44-49 [In Russ].

12.   Ruzin G.P., Tkachenko O.V. Klinicheskie projavlenija toksicheskogo ostemielita v zavisimosti ot davnosti upotreblenija narkotika [Clinical symptoms of toxic osteomyelitis in connection on the time of drug use]. Ukrai'ns'kyj stomatologichnyj al'manah. 2015; 1: 47-52 [In Russ].

 

 

 

 

Abstract:

We analyzed literature data and demonstrate own clinical case of stillborn with prune belly syndrome. Development of prune belly syndrome is a rare but severe pathology of the fetus. We have indicated the frequency, causes of development and also clinical and morphological features of this anomaly, including in combination with the cloaca. Noted that such families need genetic testing due to the high of redevelopment of similar anomalies. We showed possibilities of postmortem computed tomography in identifying concomitant pathology, including three dimensional reconstruction of bone tissue. It was concluded that carrying out postmortem CT as complement to the autopsy is expedient.

 

References

1.     Hubinois P, Valayer J., Cendron J. A series of 34 cases of prune belly syndrome in children. Semaine des Hopitaux. 1983; 59 (40): 2769-2777.

2.     Routh J.C., Huang L., Retik A.B., Nelson C.P Contemporary epidemiology and characterization of newborn males with prune belly syndrome. Urology. 2010; 76 (1): 44-48.

3.     Goswami D., Kusre G., Kumar Dutta H., Sarma A. The prune belly syndrome in a female foetus with urorectal septum malformation sequence: a case report on a rare entity with an unusual association. J. Clinical and Diagnostic Research. 2013; 7 (8): 1727-1729.

4.     Reinberg Y, Manivel J.C., Pettinato G., Gonzalez R. Development of renal failure in children with the prune belly syndrome. J. Urology. 1991; 145 (5): 1017-1019.

5.     Wheatley J. M., Stephens F.D., Hutson J.M. Prune-belly syndrome: ongoing controversies regarding pathogenesis and management. Seminars in Pediatric Surgery. 1996; 5 (2): 95-106.

6.     Williams IV D.H., Fitchev P., Policarpio-Nicolas M.L.C., Wang E., Brannigan R.E., Crawford S.E. Urorectal septum malformation sequence. Urology. 2005; 66 (3), article 657.

7.     Wheeler P.G., Weaver D.D. Partial urorectal septum-malformation sequence: a report of 25 cases. Am. J. Medical Genetics. 2001; 103 (2): 99-105.

8.     Sarhan O.M., Al-Ghanbar M.S., Nakshabandi Z.M. Prune belly syndrome with urethral hypoplasia and vesicocutaneous fistula: a case report and review of literature. Urology Annals. 2013; 5 (4): 296-298.

9.     Smolkin T., Soudack M. Goldstein I., Sujov P., Makhoul I.R. Prune belly syndrome: expanding the phenotype. Clin. Dysmorph. 2008; 17 (2): 133-135.

10.   Thayyil1 S., Chitty L.S., Robertson N.J., Taylor A.M., Sebire N.J. Minimally invasive fetal postmortem examination using magnetic resonance imaging and computerised tomography: current evidence and practical issues. Prenat. Diagn. 2010; 30 (8): 713-718.

11.   Tumanova U.N., Fedoseeva V.K., Liapin V.M., Stepanov A.V., Voevodin S.M., Shchegolev A.I. Computed Tomography of Stillborn with Bone Pathology. Meditsinskaya vizualizatsiya. 2013; 5, 110-120 [In Russ].

12.   Fedoseeva V.K., Tumanova U.N., Liapin V.M. Voevodin S.M., Shchegolev A.I. Possibilities of use of a multispiral computer tomography in posthumous diagnosis of pathology of fetus and newborns. REJR. 2014; 3 (S2): 448[In Russ].

13.   Weber S., Thiele H., Mir S., Toliat M.R., Sozeri B., Reutter H. et al. Muscarinic acetylcholine receptor M3 mutation causes urinary bladder disease and a prune-belly-like syndrome. Am. J. Hum. Genet. 2011; 89: 668-674.

14.   Riccardi V.M., Grum C.M. The prune belly anomaly: heterogeneity and superficial X-linkage mimicry. J. Med. Genet. 1977; 14 (4): 266-270.

15.   Ramasamy R., Haviland M., Woodard J.R., Barone J.G. Patterns of inheritance in familial prune belly syndrome. Urology. 2005; 65 (6): article 1227.

16.   Lockhart J.L., Reeve H.R., Bredael J.J., Krueger R.P. Siblings with prune belly syndrome and associated pulmonic stenosis, mental retardation, and deafness. Urology. 1979; 14 (2): 140-142.

17.   Haeri S., Devers P.L., Kaiser-Rogers K.A., Moylan V.J.Jr., Torchia B.S., Horton A.L., Wolfe H.M., Aylsworth

A.S. Deletion of hepatocyte nuclear factor-1-beta in an infant with prune belly syndrome. Am. J. Perinatol. 2010; 27 (7): 559-563.

18.   Murray P. J., Thomas K., Mulgrew C.J., Ellard S., Edghill E.L., Bingham C. Whole gene deletion of the hepatocyte nuclear factor-1β gene in a patient with the prune-belly syndrome. Nephrology Dialysis Transplantation. 2008; 23 (7): 2412-2415.

19.   Kubota Y, Cho H., Umeda T., Abe H., Kurumi Y, Tani T. Abnormal development of intrinsic innervation in murine embryos with anorectal malformations. Pediatric Surgery International. 2012; 28 (3): 295-298.

20.   Leeners B.,  Sauer I., Schefels J., Cotarelo C.L., Funk A. Prune-belly syndrome: therapeutic options including in utero placement of a vesicoamniotic shunt. J. Clinical Ultrasound. 2000; 28 (9): 500-507.

21.   Drenes F.T., Arap M.A., Giron A.M., Silva F.A.Q., Arap S. Comprehensive surgical treatment of prune belly syndrome: 17 years’ experience with 32 patients. Urology. 2004; 64 (4): 789-793.

22.   Drenes F.T., Lopes R.I., Oliveira L.M., Tavares A., Srougi M. Modified abdominoplasty for patients with the prune belly syndrome. Urology. 2014; 83 (2): 451-454.

23.   Kamel M.H., Thomas A.A., Al-Mufarrej F.M., O’Kelly P., Hickey D.P. Deceased-donor kidney transplantation in prune belly syndrome. Urology. 2007; 69 (4): 666-669.

24.   Bargaje A., Yerger J.F., Khouzami A., Jones C. Cloacal dysgenesis sequence. Ann. Diagn. Pathol. 2008; 12 (1): 62-66.

25.   International statistical classification of diseases and related health problems; tenth revision. Geneva: World Health Organization, 1992. V. 1.

26.   Shchegolev A.I., Tumanova U.N., Shuvalova M.P., Frolova O.G. Congenital anomalies as a cause stillbirth. Mezhdunarodnyj zhurnal prikladnykh i fundamental'nykh issledonjanij. 2015; 10 (часть 2): 263-267 [In Russ].

27.   Shchegolev A.I., Pavlov K.A., Dubova E.A., Frolova O.G. Stillbirth rates in the subjects of the Russian Federation in 2010. Arkhiv patologii. 2013; 2: 20-24 [In Russ].

28.   Tumanova U.N., Fedoseeva V.K.,Ljapin V.M., Bychenko V.G., Voevodin S.M., Shhegolev A.N. Plod-akardius: posmertnaja komp'juternaja i magnitno-rezonansnaja tomografija [Acardiac fetus: postmortem computed and magnetic resonance tomography imaging]. Diagnosticheskaja intervencionnaja radiologija. 2016; 10(2): 23-30 [In Russ].

 

 

 

 

Abstract:

Aim: was to evaluate efficiency of stents-grafts in treatment of cerebral aneurysms.

Materials and methods: for the period of 2001-2012 implantation of stent-grafts was performedm 10 patients with cerebral aneurysms. Indications for implantation: huge or giant aneurysms; wide«neck» of aneurysm; difficult localization for neurosurgical techniques; absence of significant tortuosity of artery that could interfere successful stent delivery All patients underwent examination:

MSCT-angiography, MRI, cerebral angiography To predict possible stent thrombosis we performed angiographic tests with pinching of pathological artery and contrasting of opposite artery Then we assessed blood-flow of anterior and posterior communicating arteries and also changes in neurological status. Unsatisfactory condition of collateral blood-flow - was not a contraindication for stenting. In 8 patient, aneurysms were localized in internal carotid artery, and in 2 patients in the vertebrobasilar artery In 3 cases implantation of stent-graft was proceeded in acute period of hemorrhage; that caused late disaggregant therapy (immediately after implantation, drugs were injected through nasogastric tube instead of 4-5 days of preoperative treatment).

Results: exclusion of the aneurysm from the blood-flow was reached 100% of cases. In one case, implantation of micro-coils was necessary due to inability to cover the whole neck of the aneurysm because of tortuosity of artery In 1 case we had thrombosis of stent in vertebral artery with spreading of thrombosis on basilar artery with development of ischemic stroke and further death.

Conclusion: use of stent-grafts for exclusion of huge and giant aneurysms from cerebral blood- flow is a highly effective method.

 

References

1.     Zeb M., McKenzie D.B., Scott P.A., Talwar S. Treatment of coronary aneurysms with covered stents: a review with illustrated case. J. Invasive Cardiol. 2012; 24 (9): 465-469.

2.     Briguori C., Nishida T., Anzuini A. et al. Emergency polytetrafluoroethylene-covered stent implantation to treat coronary ruptures. Circulation. 2000; 102 (25): 30283031.

3.     Saatci I,.Cekirge H.S., Ozturk M.H. et al. Treatment of internal carotid artery aneurysms with a covered stent: experience in 24 patients with midterm follow-up results. AJNR Am. J. Neuroradiol. 2004; 25 (10): 1742-1749.

4.     Hirurgija anevrizm golovnogo mozga. V 3 tomah. T. 1. Pod red. V.V. Krylova [Brain aneurysms surgery. In three volumes. Vol. 1. Edited by V.V. Krylov]. Moscow. 2012; 432S [In Russ].

5.    Tissen T.P., Jakovlev S.B. Bocharov A.V. Buharin E.Ju. Ispol'zovanie stent-grafta v jendovaskuljarnoj nejrohirurgii. Voprosy nejrohirurgii im. N.N. Burdenko [The use of stent-graft in endovascular neurosurgery]. 2006; 2: 53-56. [In Russ].

6.     Vulev I., Klepanec A., Bazik R. et al. Endovascular treatment of internal carotid and vertebral artery aneurysms using a novel pericardium covered stent. Interv. Neuroradiol. 2012; 18 (2): 164-171.

7.     Greenberg E., Katz J.M., Janardhan V. et al. Treatment of a giant vertebrobasilar artery aneurysm using stent grafts. Case report. J. Neurosurg. 2007; 107 (1): 165-168.

8.     Li M.H., Li YD., Tan H.Q. et al. Treatment of distal internal carotid artery aneurysm with the willis covered stent: a prospective pilot study. Radiology. 2009; 253 (2): 470-477.

9.     Chalouhi N., Tjoumakaris S., Gonzalez L.F. et al. Coiling of large and giant aneurysms: complications and long-term results of 334 cases. AJNR Am. J. Neuroradiol. 2014; 35 (3): 546-452.

 

authors: 

 

 

Abstract:

The research investigates the possibility of restoring the blood supply in patients with atherosclerosis of the brain, as well as the treatment of chronic cerebrovascular insufficiency, both not burdened and the burdened development of small strokes, with use for this method of transcatheter laser revascularization.

The research involves 946 patients aged 29-81 (average age 74) suffering from various types of cerebral atherosclerosis. 568(60,04%) patients underwent transcatheter treatment - Test Group. 378 (39,96%) patients underwent conservative treatment - Control Group. The examination plan included laboratory diagnostics, assessment CDR, MMSE, IB, cerebral SG, REG, CT, MRI, MRA, MUGA. To restore the blood supply, the method of transcatheter laser revascularization was applied; high-energy pulsed lasers were used for major intracranial arteries treatment, and low-energy CW lasers - for distal intracranial branches treatment.

Test Group: 459(80,81%) patients had good clinical outcome, 91(16,02%) - satisfactory clinical outcome, 18(3,17%) - relatively satisfactory clinical outcome; relatively positive clinical outcome was not obtained in any case. Control Group: good clinical outcome was not obtained in any case; 65(17,20%) patients had satisfactory clinical outcome, 121(23,26%) - relatively satisfactory clinical outcome; 192(50,79%) - relatively positive clinical outcome.

The method of transcatheter laser revascularization of cerebral vessels is a physiological, effective and low-invasive treatment for patients suffering from atherosclerosis of the brain. Obtained results last up to 10 years and more; it causes regression of mental and motor disorders, promotes regression of dementia and largely improves patients' quality of life; it has virtually no alternative - which makes the proposed method significantly different from conservative treatment methods. 

 

References

1.     Gillum R.F., Kwagyan J., Obisesan Th.O. Ethnic and Geographic Variation in Stroke Mortality Trends. Stroke. 2011; 42(2): 3294-3296.

2.     Maksimovich I.V. Transcatheter Treatment of Atherosclerotic Lesions of the Brain Complicated by Vascular Dementia Development. World Journal of Neuroscience. 2012; 2(4): 200-209.

3.     Frolich A.M., Psychogios N.M., Klotz E., et al. Angiographic Reconstructions From Whole-Brain Perfusion CT for the Detection of Large Vessel Occlusion in Acute Stroke. Stroke. 2012; 43: 97-102.

4.     Abou-Chebl A. Management of acute ischemic stroke. Curr Cardiol Rep. 2013; 15(4): 348-354.

5.     Gjulev N.M., PustozertsevV.G., Gjulev S.N. Cerebrovaskuljarnye zabolevanija [Cerebrovascular Diseases]. M.: BINOM, 2002 [ In Russ].

6.     Qureshi A.I., Caplan L.R. Intracranial atherosclerosis. Lancet. 2014; 15, 383 (9921): 984-998.

7.     Caplan L.R., Thomas A.J., Inoa V. Interventional treatment of brain ischemia related to intracranial cerebrovascular occlusive lesions. Curr Opin Neurol. 2014; 27(1):1-7.

8.     Pendlebury S.T., Wadling S., Silver L.E., et al. Transient Cognitive Impairment in TIA and Minor Stroke. Stroke. 2011; 42: 3116-3121.

9.     Maksimovich I.V. Possibilities of transcatheter treatment of patients after extensive ischemic stroke. World Journal of Neuroscience. 2013; 3: 171-185.

10.   Hashmi J.T., Huang YY, Osmani B.Z., et al. Role of Low-Level Laser Therapy in Neurorehabilitation, PM& R. 2010; 2, 12 Suppl 2: S292-S305.

11.   Naeser M.A., Hamblin M.R. Potential for transcraniallaser or LED therapy to treatstroke, traumatic brain injury, and neurodegenerative disease. Photomed Laser Surg. 2011; 29(7): 443-446.

12.   Song S., Zhou F., Chen W.R. Low-level laser therapy regulates microglial function through Src-mediated signaling pathways: implications for neurodegenerative diseases. J Neuroinflammation. 2012; 18(9): 219.

13.   Stephan W., Banas L.J., Bennett M., et al. Efficacy of super-pulsed 905 nm Low Level Laser Therapy (LLLT) in the management of Traumatic Brain Injury (TBI): A case study, World Journal of Neuroscience. 2012; 2(4): 231-233.

14.   Konstantinovi L.M., Jeli M.B., Jeremi A., et al. Transcranial application of near-infrared low-level laser can modulate cortical excitability. Lasers Surg Med. 2013; 45(10):648-653.

15.   Klopfenstein J.D., Ponce F.A., Kim L.J., et al. Middle cerebral arterystenosis: endovascular and surgical options. Skull Base. 2005; 15(3):, 175-189.

16.   Takaiwa A., Kuwayama N., Akioka N., et al. Effect of carotid endarterectomy on cognitive function in patients with asymptomatic carotid artery stenosis. Acta Neurochirurgica. 2013; 155: 627-633.

17.   Altinbas A., Algra A., Martin M., et al. Effects of carotid endarterectomy or stenting on hemodynamic complications in the International Carotid Stenting Study: a randomized comparison. International Journal of Stroke, 2014; 9(3): 284-290.

18.   Muroi C., Khan N., Bellut D., et al. Extracranial-intracranial bypass in atherosclerotic cerebrovascular disease: Report of a single centre experience. British Journal of Neurosurgery. 2011; 25: 357-362.

19.   Papanagiotou P., Roth C., Walter S., et al. Carotid artery stenting in acute stroke. Journal of the AmericanCollege of Cardiology. 2011; 58: 2363-2369. 

20.   Matsumaru Y, Tsuruta W., Takigawa T., et al. Percutaneous Transluminal Angioplasty for Atherosclerotic Stenoses of Intracranial Vessels. IntervNeuroradiol. 2004; 10Suppl 2, 17-20.

21.   Derdeyn C.P., and Chimowitz M.I. Angioplasty and Stenting for Atherosclerotic Intracranial Stenosis: Rationale for a Randomized Clinical Trial. Neuroimaging Clin N Am. 2007; 17(3): 355-ix.

22.   Dorn F. Prothmann S., Wunderlich S., et al. Stent angioplasty of intracranial stenosis: single center experience of 54 cases. Clin Neuroradiol. 2012; 22(2):149-156.

23.   Maksimovich I.V. Vozmozhnosti ispol'zovanija transsljuminal'noj lazernoj revaskuljarizacii sosudov golovnogo mozga v lechenii vaskuljarnoj demencii. [Possibilities of Using Transluminal Laser Revascularization of Cerebral Vessels in the Treatment of Vascular Dementia]. Diagnostic & interventional radiology. 2013; 7(2): 65-67 [In Russ].

24.   Maksimovich I.V. Intracerebral Transcatheter Technologies in the Treatment of Ischemic Stroke. J Am Coll Cardiol. 2015; 66:15S.

25.   Morris J.C. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology. 1993; 43: 2412- 2414.

26.   Folstein M.F., Folstein S.E. and McHugh P.R. «Mini-mental state». A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 1975; 12: 189-198.

27.   Mahoney F.I. and Barthel D.M. Functional evaluation: The barthel index. Maryland State Medical Journal. 1965; 14: 61-65.

28.   Maksimovich I.V. Sposob transljuminal'noj lazernoj revaskuljarizacii golvnogo mozga pri ateroskleroticheskih porazhenijah. [Method for carrying out transluminal laser-induced brain revascularization in atherosclerotic injury cases]. 2006; RF Patent No. 2297861 [In Russ].

29.   Maksimovich I.V. Method of transluminal laser revascularization of cerebral blood vessels having atherosclerotic lesions. 2006; US Patent No. 7490612.

30.   Maksimovich I.V. Transcatheter Treatment of Patients after Extensive Ischemic Stroke. Journal of the Americal College of Cardiology. 2013; 62(18): S1: B155-B156. 

31.   Deviatkov  N.D., Rabkin I.Kh. Maksimovich, I.V. et al. Primenenie izluchenich lazera na parah medi dlja isparenija ateroskleroticheskih porazhenij magistral'nyh arterij in vitro. [Use of copper-vapor laser radiation for the evaporation of atherosclerotic lesions of the major arteries in vitro]. Surgery. 1986; 4: 116-121[In Russ].

32.   Petrovskiy B.V., Deviatkov N.D., Rabkin I.Kh., Maksimovich I.V. et al. Razrushenie ateroskleroticheskih porazhenij kadavernyh arterij cheloveka izlucheniem lazera na parah medi. [Destruction of arteriosclerotic lesions of human cadaveric arteries by laser irradiation with copper vapors]. Surgery, 1986; 5, 112-116 [In Russ].

33.   Kuleshov E.V., Maksimovich I.V. Jendovaskuljarnaja hirkrgija u pacientov starshe 65 let s rasprostranennym aterosklerozom sosdov taza i nizhnih konechnostej. [Endovascular surgery in patients over 65 with disseminated atherosclerosis of the vessels of the pelvis and lower extremities]. Vestnik Surgery Imeni 1.1. Grekova, 1994; 152: 27-30 [In Russ].

34.   Maksimovich I.V. Transljuminal'naja lazernaja angioplastika v lechenii ishemicheskih porazhenij golovnogo mozga. [Transljuminal laser angioplasty in treatment of ischemic lesions of a brain]. M.D. Dissertation, Russian University of Friendship of the People, 2004; Moscow [In Russ].

35.   Chizhov, G.K., Kovalskaia, N.I. and Kozlov V.I. Jeffekt jenergii izluchenija gelij-neonovogo lazera na metabolicheskie indeksy miokarda. [The effect of helium-neon laser radiation on the energy metabolic indices of the myocardium]. Bulletin of Experimental Biology and Medicine, 1991; 111: 302-305 [In Russ].

36.   Kozlov V.I., Azizov G.A. Patofiziologicheskie osobennosti mikrocirkuljatornyh narushenij v hronicheskoj arterial'noj ishemii nizhnih konechnostej. [Pathophysiological characteristics of microcirculatory disorders in chronic arterial ischaemia of lower limbs]. Angiology and Vascular Surgery. 2007; 13: 17-23 [In Russ].

37.   Moskvin S.V. Sistemnyj analiz jeffektivnosti upravlenija biologicheskimi sistemami nizkojenergeticheskim lazernym izlucheniem. [System analysis of efficiency in controlling biological systems with low-energy laser radiation]. Thesis for Degree of Doctor of Biological Sciences. 2008; City of Tula [In Russ].

38.   Mak M.C., Cheing G.L. Immediate Effects of Monochromatic Infrared Energy on Microcirculation in Healthy Subjects. Photomedicine and Laser Surgery. 2012; 30(4): 193-199.

39.   Barrett D.W, Gonzalez-Lima F. Transcranial infrared laser stimulation produces beneficial cognitive and emotional effects in humans. Neuroscience. 2013; 29(230):13-23.

40.   Yang X., Askarova S., Sheng, W., et al. Low energy laser light (632.8 nm) suppresses amyloid-peptide-induced oxidative and inflammatory responses in astrocytes. Neuroscience, 2010; 171, 3(15): 859-868.

41.   Starck T., Nissil J., Aunio A., et al. Stimulating brain tissue with bright light alters functional connectivity in brain at the resting state. World Journal of Neuroscience. 2012; 2: 81-90.

42.   Heinrich C., Blum R., Gascуn S., et al. Directing astroglia from the cerebral cortex into subtype specific functional neurons. PLOS Biology. 2010; 8, e1000373.

 

 

 

 

Abstract:

Aim: was to estimate changes in architectonic and hemodynamics of left common iliac vein (lCIV), caused by its crossing with right common iliac artery (rCIA), in patients with varicocele according to data of computed tomography angiography (CTA) and contrast venography.

Materials and methods: we analyzed results of CTA and contrast venography in the area of arte-riovenous crossing: 37 patients with newly diagnosed and 45 with recurrent varicocele. Analysis of topical changes was made on data of axial tomography, multiplanar and 3D reconstructions. Hemodynamic changes in lCIV, were determined by dynamic venogram and results of mesurement of pressure gradient between lCIV and vena cava inferior (VCI).

Results: it was found that CTA is the most informative for visualizing of lCIV narrowing caused by its compression by rCIA. This is due to the possibility of obtaining a same contrasting imaging of vessels involved in arteriovenous «conflict». Multiple view scanning reconstruction revealed a correlation between size of the lumbosacral angle and the degree of compression of lCIV caused by arteriovenous conflict. CT angiography with the use of utility model, allowed to change the state of the arteriovenous crossing, showed compression instability Dynamic contrast venography showed angiographic features typical for lCIV compression, and also visualized venous collaterals that compensate blood-flow disorders. Conducting direct measurement of venous pressure gradient in compression area allowed us to estimate the degree of hemodynamic changes in lCIV and explore the mechanism of compression generated by pulsating blood flow of rCIA.

Conclusions: severity of compression of lCIV at arteriovenous «conflict» is affected by constitutionally-static angle between L5-S1 vertebral bodies. Compression degree of lCIV is not constant and may vary depending on the patient's body position. Compression of lCIV promotes collateral blood flow through veins of sacral and external lumbar drainage. The more expressed compression of lCIV the more developed collateral blood flow in both drainage systems. Developed collaterals compensate hypertension caused by compression of lCIV Estimation of venous blood flow disorders, in case of varicocele, and choice of method of surgical treatment should be based on data from X-ray contrast studies and results of tensometry conducted at the area of arteriovenous «conflict» of lCIV.  

 

References

1.    Strahov S.N. Varikoznoe rasshirenie ven grozdevidnogo spleteniya i semennogo kanatika (varikotsele) [Varicose of internal spermatic vein and spermatic cord (varicocele)]. M. 2001; 235S [In Russ].

2.    Stepanov V.N., Kadyirov Z.A. Diagnostika i lechenie varikotsele [Diagnostics and treatment of varicocele]. M., 2001; 200S[In Russ].

3.    Lopatkin N.A., Morozov A.V., Jitnikova L.N. Stenoz pochechnoy venyi [Stenosis of renal veins]. M.: Meditsina. 1984; 102 S [In Russ].

4.     Coolsaet B.L. The varicocele sindrom: venographi determining the optimal ievel for surgical management. J. Urol. 1980; 124: 833-834.

5.     May R., Thurner J. The cause of predominantly sinistral occurrence of thrombosis of the pelvic veins. Minerva Cardioangiol. 1957; 3: 346-9.

6.     Cockett F.B. Thomas M.L. Negus D. Iliac vein compression: its relation to iliofemoral thrombosis and the postthromdotic syndrome. BMJ. 1967; 2: 14-19.

7.     Mazo E.B., Tirsi K.A., Andranovich S.V., Dmitriev D.G. Ultrazvukovoy test i skrotalnaya dopler-ehografiya v predoperatsionnoy diagnostike gemodinamicheskogo tipa varikotsele [Ultrasound test and doppler-echography of scrotum in preoperative diagnostics of hemodynamically type of varicocele]. Urologiya i nefrologiya 1999; 3: 22-26 [In Russ].

8.     Kim et al. Hemodynamic Investigation of the Left Renal Vein in Pediatric Varicocele. Doppler US, Venography and Pressure Measurements. Radiology. 2006; 241.

9.     Garbuzov R.V., Polyaev YU.A., Petrushin A.V. Arteriovenoznyiy konflikt i varikotsele u podrostkov [Arteriovenous conflict and varicocele in teenagers] Diagnosticheskaya i iterventsionnaya radiologiya 2010; 4(3): 31-36 [In Russ].

10.   Kogan M.I., Afoko A., Tampuori D., Asanti-Asamani A., Pipchenko O.I. Varikotsele: protivorechiya problemyi [Varicocele: conflict issues.]. Urologiya 2009; 6: 67-72 [In Russ].

11.   Kadyirov Z.A. Varikotsele [Varicocele]. M., 2007; 269S [In Russ].

12.   Tager I.L. Rentgenodiagnostika zabolevaniy pozvonochnika [X-ray diagnostics in diseases of vertebral colums]. M., 1983; 208S [In Russ].

13.   Reynberg S.A. Rentgenodiagnostika zabolevaniy kostey i sustavov [X-ray diagnostics in diseases of bones and joints]. M., 1964; t. II: 188-189 [In Russ].

14.   Korolyuk I.P. Rentgenanatomicheskiy atlas skeletal [Atlas of X-ray anatomy of skeleton.]. M., 1994; 192S [In Russ]. 

 

 

Abstract:

Development of multilayer digital tomosynthesis technology allows you to get a more accurate imaging of internal organs and tissues in comparison with other traditional radiological methods of investigation, and that is achieved by the possibility of layered imaging of selected anatomical region.

Aim: was to analyze possibilities of digital tomosynthesis in the assessment of lung structure in normal anatomy of organs of chest cavity

Materials and methods: study include patients without lesions of the chest cavity, who underwent digital tomosynthesis in frontal and lateral projections.

Results: basing on analyzed data, we identified features of normal radiological anatomy of the chest cavity using a technique of digital tomosynthesis. Schematically clarified lobar and segmental structure of lungs, as well as airways according to layered imaging. Advantages and disadvantages of the method in imaging of lungs and mediastinal structures are shown.

Conclusion: the use of digital tomosynthesis in the evaluation of chest organs allows to determine main anatomical structures of lungs in more detail, through layered imaging and a high spatial resolution.  

 

References

1.     Galea A. et al. Practical applications of digital tomosynthesis of the chest. Clinical radiology. 2014; 69(4): 424-430.

2.     de Koste J. R. S. et al. Digital tomosynthesis (DTS) for verification of target position in early stage lung cancer patients. Medical physics. 2013; 40(9): 091904.

3.     Dobbins III J. T. et al. Digital tomosynthesis of the chest for lung nodule detection: interim sensitivity results from an ongoing NIH-sponsored trial. Medical physics. 2008; 35(6): 2554-2557.

4.     Vikgren J. et al. Comparison of Chest Tomosynthesis and Chest Radiography for Detection of Pulmonary Nodules: Human Observer Study of Clinical Cases 1. Radiology. 2008; 249(3): 1034-1041.

5.     Quaia E. et al. Digital tomosynthesis as a problemsolving imaging technique to confirm or exclude potential thoracic lesions based on chest X-ray radiography. Academic radiology. 2013; 20(5): 546-553.

6.     Jung H. N. et al. Digital tomosynthesis of the chest: utility for detection of lung metastasis in patients with colorectal cancer. Clinical radiology. 2012; 67(3): 232-238.

7.     Nikitin M. M. Possibilities of digital tomosynthesis in the diagnosis of various forms of pulmonary tuberculosis. REJR. 2016; 6 (1): 35-47. [In Russ].

8.     F.Kovach F., Zhebek Z. X-ray anatomical basics of lungs’ examinations. Budapest, 1958; 364 p. [In Russ].

9.     Trofimova T. N. ed. Human X-ray anatomy. SPb.: Publishing house SPbMAPO. 2005; 496 p. [In Russ].

10.   Sapin M. R. ed. Human Anatomy. Moscow, M.: Medicine. 2001; 640 p. [In Russ].

11.   Sinelnikov R. D., Sinelnikov Ya. R. Atlas of human anatomy. M.: Medicine. 1996; 344 p. [In Russ].

12.   Kokov L. S., ed. X-ray Atlas of comparative anatomy. M.: Radiology-Press., 2012; 388 p. [In Russ].

 

 

Abstract:

Despite the fact that so far in the literature, many cases of endovascular closure of paravalvular leak (PVL), this type of intervention is unusual and is associated with a complex technical issues. In addition, the majority of publications devoted to the correction of mitral and aortic PVL, while the description of the closing of the tricuspid valve (TV) PVL are rare.

Below is a description of our first experience of endovascular correction of TV PVL in 54 years ole patient, who underwent TV repair with «Neokor-32» - supporting ring as a correction of atrial septal defect, TV insufficiency One year after surgery the patient reported a decrease in physical activity tolerance. Echocardiography diagnosed hemodynamically significant PVL of TV, 6mm size with leakage between the left ventricle and the right atrium and formation of pulmonary hypertension. PVL was successfully treated by endovascular correction with using of device for closure of ventricular septal defect.  

 

References

1.     Galea A. et al. Practical applications of digital tomosynthesis of the chest. Clinical radiology. 2014; 69(4): 424-430.

2.     de Koste J. R. S. et al. Digital tomosynthesis (DTS) for verification of target position in early stage lung cancer patients. Medical physics. 2013; 40(9): 091904.

3.     Dobbins III J. T. et al. Digital tomosynthesis of the chest for lung nodule detection: interim sensitivity results from an ongoing NIH-sponsored trial. Medical physics. 2008; 35(6): 2554-2557.

4.     Vikgren J. et al. Comparison of Chest Tomosynthesis and Chest Radiography for Detection of Pulmonary Nodules: Human Observer Study of Clinical Cases 1. Radiology. 2008; 249(3): 1034-1041.

5.     Quaia E. et al. Digital tomosynthesis as a problemsolving imaging technique to confirm or exclude potential thoracic lesions based on chest X-ray radiography. Academic radiology. 2013; 20(5): 546-553.

6.     Jung H. N. et al. Digital tomosynthesis of the chest: utility for detection of lung metastasis in patients with colorectal cancer. Clinical radiology. 2012; 67(3): 232-238.

7.     Nikitin M. M. Possibilities of digital tomosynthesis in the diagnosis of various forms of pulmonary tuberculosis. REJR. 2016; 6 (1): 35-47. [In Russ].

8.     F.Kovach F., Zhebek Z. X-ray anatomical basics of lungs’ examinations. Budapest, 1958; 364 p. [In Russ].

9.     Trofimova T. N. ed. Human X-ray anatomy. SPb.: Publishing house SPbMAPO. 2005; 496 p. [In Russ].

10.   Sapin M. R. ed. Human Anatomy. Moscow, M.: Medicine. 2001; 640 p. [In Russ].

11.   Sinelnikov R. D., Sinelnikov Ya. R. Atlas of human anatomy. M.: Medicine. 1996; 344 p. [In Russ].

12.   Kokov L. S., ed. X-ray Atlas of comparative anatomy. M.: Radiology-Press., 2012; 388 p. [In Russ].

 

 


 

Article is devoted to Forum "Medical Diagnostics 2016"

Article exists only in Russian. 

 

 

 

 

Article is devoted to anniversary of Iosif Khaimovich Rabkin.

Article exists only in russian.

 

 

 

Abstract:

In patients with severe multiple trauma, posttraumatic period is often complicated by the development of polyorgan insufficiency, development of which is connected with morpho-functional changes of the liver parenchyma.

Aim: was to identify dynamics of ultrasound signs of morphological and functional changes of liver in patients with multiple trauma.

Materials and methods: performed analysis of ultrasound data obtained in dynamics, in 28 patients with severe multiple trauma. From the analysis, we excluded patients with blunt abdominal trauma with injury of liver. In first 2 days, 21 patients underwent surgical operations in treatment of craniocerebral trauma and trauma of musculoskeletal system. All patients underwent ultrasound examination of the abdominal cavity and retroperitoneal space to exclude possibility of appearance of free liquid; also estimated condition of liver, spleen, functional and morphological condition of the gastrointestinal tract. In first days after trauma, ultrasound examination was performed 2-3 times. Color duplex scanning of vessels of liver and spleen was performed once a day or every other day for 2-3 weeks of a traumatic period. Evaluated arterial and venous blood flow of liver by measuring the linear blood flow velocity (LBFV) and resistance index (RI), portal blood flow by measurement of linear and volumetric flow rate.

Results: in all patients on admission to hospital, liver and spleen sizes had normal size. On the 3rd day after the injury, was revealed an increase in the cranio-caudal liver size by 2-4 cm and increased length of spleen by 5-8 cm, which lasts for 10-20 days. During dynamical ultrasound, 8 patients with 10-20 days against a background of increasing level of bilirubin and transaminases, in addition to increasing size of liver and spleen, we marked infiltration of tissues along hepatic veins with their narrowing and along branches of the portal vein with thickness from 0,25 to 0,7 cm. We marked LBFV decreasement by portal vein to 10-13 cm/sec and a volume flow to 250-400 ml / min, increased RI by hepatic artery In 3 patients in the liver parenchyma, we revealed avascular tissue regions with decreased echogenicity, indicating the formation of ischemic regions.

Conclusion: during dynamical ultrasound in patients with severe multiple trauma, on day 3 after injury, were diagnosed morphological changes in liver parenchyma with violation of its hemodynamics. Further progression of the process observed for 10-20 days from the date of trauma: the growth of intrahepatic portal hypertension, increased peripheral resistance in arteries of liver parenchyma, the appearance of ischemic areas of liver parenchyma. The totality of above ultrasonic signs of hemodynamic disorders of liver, characterize organic hepatocellular insufficiency, which is a poor prognostic sign in the development of polyorgan insufficiency.

 

References

1.     Marushhak E.A. Povrezhdenija pecheni i selezenki u bol'nyh s zakrytoj abdominal'noj travmoj [Injury of liver and spleen in patients with blunt abdominal traums]. Avtoreferat Diss. kand. med. nauk. M. 2009; 31 [In Russ].

2.     Abdominal'naja travma: rukovodstvo dlja vrachej (Pod red. A.S. Ermolov M.Sh. Hubutija, M.M. Abakumov) [Abdominal trauma: manual for physicians]M.: Vidar, 2010; 504 [In Russ].

3.     Travmaticheskaja bolezn' i ee oslozhnenija ( Pod red. S.A. Seleznev, S. F. Bagnenko, Ju.B. Shapot, A.A. Kurygin)[Traumatic disease and its complications] SPb.: Politehnika, 2004; 414 [In Russ].

4.    Gajduk S.V. Kliniko-patofiziologicheskoe obosnovanie rannej diagnostiki sindroma poliorgannoj nedostatochnosti i visceral'nyh oslozhnenij u postradavshih s politravmoj [Clinical-pathophysiological rationale of early diagnostics of polyorgan insufficiency and visceral complications in patients with polytrauma]. Avtoreferat Diss. kand. med. nauk. SPb., 2009; 47 [In Russ].

5.     Gajduk S.V., Sosjukin A.E., Bojarincev V.V. Travmaticheskaja bolezn' i sindrom poliorgannoj disfunkcii - aktual'nye problemy mediciny kriticheskih sostojanij [Traumatic disease and syndrome of polyorgan dysfunction - actual problems of medicine of critical conditions]. Vestnik Rossijskoj Voenno-medicinskoj akademii. 2008; 1(21): 66-70 [In Russ].

6.    Zolotokrylina E. S. Voprosy patogeneza i lechenija poliorgannoj nedostatochnosti u bol'nyh s tjazheloj sochetannoj travmoj, massivnoj krovopoterej v rannem post- reanimacionnom periode [Questions of pathogenesis and treatment of polyorgan insufficiency in patients with severe multiple trauma, massive bloodloss in early postreanimation period]. Anesteziologija i reanimatologija. 1996; 1: 9-13 [In Russ].

7.    Cibuljak G.N. Obshhaja hirurgija povrezhdenij: rukovodstvo [General surgery of trauma: manual]. SPb.: Gippokrat. 2005; 646 [In Russ].

8.     Chastnaja hirurgija mehanicheskih povrezhdenij (Pod redakciej G.N.Cibuljak) [Particularistic surgery of mechanical injury.].SPB.: Gippokrat. 2011; 570 [In Russ].

9.    Saenko V.F. Desjaterik V.I., Perceva T.A., Shapovaljuk V.V. Sepsis i poliorgannaja nedostatochnost [Sepsis and polyorgan insufficiency]'. Krivoj Rog: Mineral. 2005; 441[In Russ].

10.   Tokmakova T.O.,Kameneva E.A., Grigor'ev E.V. Narushenie mikrocirkuljacii kak prichina poliorgannoj nedostatochnosti u postradavshih s tjazheloj cherepno-mozgovoj travmoj[Microcirculatory disorders as a reason of polyorgan insufficiency in patients with severe craniocerebral trauma]. Politravma. 2011; 4: 47-50 [In Russ].

11.   Gel'fand E. B., Gologorskij V.A., Gel'fand B.R. Abdominal'nyj sepsis: integral'naja ocenka tjazhesti sostojanija bol'nyh i poliorgannoj disfunkci [Abdominal sepsis: estimation of severity of condition of patients and polyorgan disfunction]. Anesteziologija i reanimatologija. 2000;3:29-34 [In Russ].

12.   Chappell D., Jacob M., Hofmann-Kiefer K. et al. A rational approach to perioperative fluid management. Anesthesiology. 2008; 109(4): 723-740.

13.   Brealey D., SingerM. Multiorgan dysfunction in the critically ill: epidemiology, pathophysiology and management. J. Royal Coll. Physic. Lond. 2000; 34(5): 424-427.

14.   Baker S.P, O'Neill B., Haddon W. Jr., Long W.B. The Injury Severity Score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974; 14(3): 187-196.

15.   Trusov O.A. Patologicheskaja anatomija i patogenez poliorgannoj nedostatochnosti pri ostroj arterial'noj neprohodimosti konechnostej i peritonita (na materiale rannih autopsij)[Pathological anatomy and pathogenesis of polyorgan insufficiency in case of acute arterial failure of limb and peritonitis (based on early autopsy)]. Avtoreferat Diss. dokt. med. nauk. M., 2002; 41[In Russ].

 

 

Abstract:

Aim: was to reveal factors that cause dyspnea in the early postoperative period after cardiac surgery.

Materials and methods: the study included 818 patients after cardiosurgical interventions in «F^S» Penza from June 2014 to February 2015, with complaints of shortness of breath at rest. The degree of influence of variables was determined using ROC analysis and logistic regression analysis.

Results: dyspnea was noted in 169 patients (19.4 %). ROC-analysis revealed a very large influence on the occurrence of dyspnoea disturbances of the mobility of the diaphragm, the great influence of the frequency of respiratory movements, the average impact of the height of diaphragm domes and low impact of body mass index. Results of logistic regression analysis showed that odds increase in 327 times at a decreased mobility of the left dome of the diaphragm 49 times in dysfunction of the right dome, 4,4-times elevation in the left dome, 3,5 times at the elevation of the right dome, 3.9 times with tachypnea and 2,6 times for severe obesity, in 1,5 times in chronic heart failure II B degree. Other factors, included in research, didn't influence on dispnea appearance.

Conclusions: a leading factor in the occurrence of dyspnea is dysfunction of the diaphragm, especially when decreased mobility of the left dome. To a lesser extent, reasons can be the elevation of diaphragm domes and tachypnea. Obesity 2 and 3 degree and chronic heart failure II B degree, had a small effect on dyspnea.

 

References

1.     American Heart Society. Dyspnea mechanisms, assessment, and management: a consensus statement. Am RevResp Crit Care Med. 1999; 159: 321-340.

2.     Parshall M.B., Schwartzstein R.M., Adams L., et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012; 185:435.

3.     Elliott M.W., Adams L., Cockcroft A., et al. The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. Am Rev Respir Dis 1991;144: 826.

4.     Mahler D.A, Harver A., Lentine T., et al. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med. 1996; 154:1357.

5.     Simon P.M., Schwartzstein R.M., Weiss J.W., et al. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis. 1990; 142:1009-1014.

6.     Narin C., et al. Perioperative Considerations in Cardiac Surgery. InTech, 2012.

7.     Manning H.L., Schwartzstein R.M. Pathophysiology of Dyspnea. N Engl J Med.1995; 333:1547-1553.

8.     Schmidt M., Banzett R. B., Raux M., et al. Unrecognized suffering in the ICU: addressing dyspnea in mechanically ventilated patients. Intensive Care Medicine. 2014; 40(1): 1-10.

9.     West J.B. Pulmonary pathophysiology: the essentials (7 ed.). Baltimore: Lippincott Williams & Wilkins. 2008.

10.   Berrizbeitia L.D., Tessler S., Jacobowitz I.J., et al. Effect of sternotomy and coronary bypass surgery on postoperative pulmonary mechanics. Chest. 1989; 96(4): 873-876.

11.   Locke T.J., Griffiths T.L., Mould H., Gibson G.J. Rib cage mechanics after median sternotomy. Thorax. 1990; 45: 465-8.

12.   Shenkman Z., Shir Y, Weiss YG., et al. The effects of cardiac surgery on early and late pulmonary functions. Acta Anaesthesiol Scand. 1997; 41(9):1193-1199.

13.   Andrianova E.N., Reshetova T.G., Ryvkin A.I. i dr. Sposob diagnostiki podvizhnosti diafragmy pri bronhial'noj astme u detej [Method of diagnostics of diaphragm dome mobility in children with asthma]. Patent RU 2229845, 2004 [In Russ].

14.   Imanaka H., Kimball W.R., Wain J.C., et al. Recovery of diaphragmatic function in awake sheep after two approaches to thoracic surgery. J Appl Physiol. 1997; 83: 1733-1740.

15.   Ragnarsdуttir M., Kristjбnsdуttir Б., Ingvarsdуttir I., et al. Short-Term Changes in Pulmonary Function and Respiratory Movements after Cardiac Surgery via Median Sternotomy. Scandinavian Cardiovascular Journal. 2004; 38, 46-52.

16.   Davison A., Mulvey D. Idiopathic diaphragmatic weakness. BMJ. 1992; 304: 492-494.

17.   McCool F.D., Tzelepis G.E. Dysfunction of the Diaphragm. N Engl J Med.2012; 366: 932-942.

18.   Jaber S., Petrof B.J., Jung B., et al. Rapidly progressive diaphragmatic weakness and injury during mechanical ventilation in humans. Am J Respir Crit Care Med. 2011; 183: 364-371.

19.   Levine S., Budak M.T., Dierov J., Singhal S. Inactivity-induced diaphragm dysfunction and mitochondria-targeted antioxidants: new concepts in critical care medicine. Crit Care Med. 2011; 39:1844-1845.

20.   Levine S., Nguyen T, Taylor N., et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008; 358:1327-1335.

21.   Jiao W., Zhao Y, Wang M., et al. A retrospective study of diaphragmatic motion, pulmonary function, and quality-of-life following video-assisted thoracoscopic lobectomy in patients with nonsmall cell lung cancer. Indian J Cancer. 2015; 51 2: 45-48.

22.   McCool F.D., Mead J. Dyspnea on immersion: mechanisms in patients with bilateral diaphragm paralysis. Am Rev Respir Dis. 1989; 139: 275-276.

23.   Wang C.S., Josenhaus W.T. Contribution of the diaphragmatic-abdominal displacement to ventilation in supine man. J Appl Physiol. 1971; 31: 576-580.

24.   Diehl J.L., Lofaso F., Deleuze P., et al. Clinically relevant diaphragmatic dysfunction after cardiac operations. J Thorac Cardiovasc Surg. 1994; 107:487-498.

25.   Wheatcroft M., Shrivastava V., Nyawo B., et al. Does pleurotomy during internal mammary artery harvest increase post-operative pulmonary complications? Interact Cardiovasc Thorac Surg. 2005; 4: 143-146.

26.   Canbaz S., Turgut N., Halici U., et al. Diagnosis of phrenic nerve injury after cardiac surgery. Ann Thorac Surg. 2004; 78(4): 1517.

27.   O'Brien J.W., Johnson S.H., VanSteyn S.J., et al. Effects of internal mammary artery dissection on phrenic nerve perfusion and function. Ann Thorac Surg. 1991; 52(2): 182-188.

28.   Lindenbraten L.D. Luchevaja diagnostika porazhenij diafragmy [Beam diagnostics of diaphragm lesions]. Radiologija-praktika. 2001; 2: 6-21 [ In Russ].

29.   Nason L.K., Walker C.M., McNeeley M.F., et al. Imaging of the Diaphragm: Anatomy and Function. RadioGraphics. 2012; 32: 51-70.

30.   Suwatanapongched T., Gierada D.S., Slone R.M. et al. Variation in Diaphragm Position and Shape in Adults With Normal Pulmonary Function. Chest. 2003; 123, 6: 2019-2027.

 

 

 

 

Abstract:

Aim: was to increase the level of differential diagnosis of thyroid nodules by evaluating their rigidity according to two ultrasound techniques - compressive elastography and shear wave elastography.

Materials and methods: study is based on the result of analysis of complex clinical anc ultrasound diagnostics, performed for the period from 2010 to 2015 , on the base of ultrasound department of «Central Clinical Hospital of Ministry of Internal Affairs» of the RF in Moscow, and Medical Radiological Research Center named after AF Tsyba - FGBU branch of «National Medical Research Radiological Center» MoH Obninsk.

Results: performed shear wave elastography, obtained quantitative data of rigidity of benign nodules and papillary carcinoma. Used methods of nonparametric statistics and ROC-analysis. Statistical processing was performed in SPSS 13.0 program. For benign nodes median of regidity was 15.6; 2,5-97,5 percentiles - 3,6-81,3; for papillary cancer: median 112.92; 2,5-97,5 percentiles - 13,5-196,4. Then followed an orange and yellow-red: blue color was not more than 20%, but mostly he was absent. In case of papillary cancer we observed two-color, three-color, four-color and six-color color, with prevailing of two colors - purple and blue.

Conclusions: both types of elastography - compressive and shear wave elastography - help to improve the differential diagnosis of thyroid cancer. Informativeness of shear wave elastography is higher, in comparison with compressive elastography.

 

References

1.     Kotljarov P.M., Harchenko V.P., Aleksandrov Ju.K., Mogunov  M.S., Sencha A.N., Patrunov Ju.N., Beljaev D.V. Ul'trazvukovaja diagnostika zabolevanij shhitovidnoj zhelezy [Ultrasonic diagnosis of thyroid diseases.]. M.: VIDAR. 2009: 239S [In Russ].

2.     Mit'kov V.V., Huako S.A., Cyganov S.E., Kirillova T.A., Mit'kova M.D. Sravnitel'nyj analiz dannyh jelastografii sdvigovoj volnoj i rezul'tatov morfologicheskogo issledovanija tela matki (predvaritel'nye rezul'taty) [Comparative analysis of data of shear wave elastography and results of uterine body morphological study (preliminary results)]. Ul'trazvukovaja i funkcional'naja diagnostika. 2013; 5: 99-114 [In Russ].

3.     Sencha A.N., Mogutov M.S., Patrunov U.N. et al. Kolichestvennie i kachastvennie pokazateli ul’trazvukovoi jelastografii v diagnostike raka shhitovidnoj zhelezy [Quantitative and qualitative indicators of ultrasound elastography in the diagnosis of thyroid cancer.]. Ul'trazvukovaja ifunkcional'naja diagnostika. 2013; 5: 85-98 [In Russ].

4.     Osipov L.V. Tehnologii jelastografii v ul’trazvukovoi diagnostike. Obzor. [ Elastography technologies in ultrasound diagnostics. Overview.] Diagnosticheskaya radiologiya i onkoterapiya. 2013; 3,4: 5-23 [In Russ].

5.     Parshin V.S., Yamasita C, Cib A.F. Zob. Ul'trazvukovaja diagnostika. Klinicheskii atlas [Ultrasound diagnostics. Clinical atlas]. Nagasaki-Obninsk. Universitet Nagasaki, 2000; S 106 [In Russ].

6.     Parshin V.S., Cib A.F., Yamasita C. Rak shhitovidnoj zhelezy. Ul'trazvukovaja diagnostika. Klinicheskii atlas [Thyroid cancer. Ultrasound diagnostics. A clinical atlas. In Chernobyl materials.]. Po materialam Cyernobilya. Obninsk. MRNC RAMN. 2002; S 230 [In Russ].

7.     Parshin V.S.,Yamashita S., Tsyb A.F. Ultrasound Diagnosis of Thyroid Diseases in Russia. Obninsk-Nagasaki. 2013; S147.

8.     Cib A.F., Parshin V.S., Yamasita C. Ul'trazvukovaja diagnostika zabolevanij shhitovidnoj zhelezy [Ultrasonic diagnosis of thyroid diseases.]. M.: Medicina. 1997; S 329 [In Russ].

9.     Asteria C., Giovanardi A., Pizzocaro A., Cozzaglio L., Morabito A., Somalvico F., Zoppo A. US-elastography in the differential diagnosis of benign and malignant thyroid nodules. Thyroid. 2008; 18: 523-531.

10.   Cantisani V., D'Andrea V., Biancari F., Medvedyeva O., Di Segni M., Olive M., Patrizi G., Redler A., De Antoni E.E., Masciangelo R., Frezzotti F., Ricci P Prospective evaluation of multiparametric ultrasound and quantitative elastosonography in the differential diagnosis of benign and malignant thyroid nodules: preliminary experience. Eur. J. Radiol. 2012; 81: 2678-2683.

11.   Vorlander C., Wolff J., Saalabian S., Lienenluke R.H., Wahl R.A. Real-time ultrasound elastographya non-invasive diagnostic procedure for evaluating dominant thyroid nodules Langenbecks Arch. Surg. 2010; 395: 865-871.

12.   Bojunga J., Herrmann E., Meyer G., Weber S., Zeuzem S., Friedrich-Rust M. Real-time elastography for the differentiation of benign and malignant thyroid nodules: a metaanalysis Thyroid. 2010; 20: 1145-1150.

13.   Gharib H., Papini E., Paschke R., Duick D.S., Valcavi R., Hegedus L., Vitti P American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi and European Thyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr. Pract. 2010;16: 1-43.

14.   Moon H.J., Kim E.K., Yoon J.H., Kwak J.Y Clinical implication of elastography as a prognostic factor of papillary thyroid microcarcinoma. Ann. Surg. Oncol. 2012; 19: 2279-2287.

 

 

 

Abstract:

Aim: was to estimate the importance of restoring blood flow in vertebral arteries in the segment V1 by stenting in patients with multivessel lesions of extracranial arteries and vertebrobasilar insufficiency (VBI).

Material and methods: study include 59 patients with a dominant, long-existing clinic of vertebrobasilar insufficiency, with multivessel lesions of brachiocephalic arteries, lower brain tolerance to ischemia, with the presence of stenosis of segment V1 of vertebral artery more than 70%, which is regarded by neurologists, as the main reason for VBI. All patients should have been undergone carotid revascularization. However, due to multivessel lesions and low perfusion reserve, all patients as the first stage of treatment - underwent stenting of V1 segment of vertebral artery. In 38 patients bare-metal stent were used, in 14 - drug-eluting stents, in 7 - renal stents. Distal protection was used in 12 patients. In remaining patients - stenting was performed without protection.

Results: in immediate postoperative period, technical, angiographic success and clinical improvement were noticed in 100% of patients. All 59 patients underwent the second and subsequent stages of cerebral revascularization without ischemic episodes. The duration of follow-up was from 6 months to 6 years. After 3 months, 55(93,2%) patients sustained clinical improvement, with no restenosis in stents. 4 patients (6,8%) had no clinical improvement: in one patient after 3 months developed ischemic stroke (IS) in vertebrobasilar system(VBS), due to the occlusion of the stent. 1 patients had stent restenosis with the increase of clinical manifestations of VBI, which required additional stenting. After 14 months, 1 patient after stenting had IS in VBS due to stent fractures caused by bone compression.

Conclusion: stenting of V1 segment of vertebral artery in patients with multivessel lesions of brachiocephalic arteries and clinic of VBI, can be considered as the first stage of cerebral revascularization in case of significant stenosis segment V1 vertebral artery and low tolerance to cerebral ischemia.

 

References

1.     Savitz S.I., Caplan L.R. Vertebrobasilar disease. N Engl J Med. 2005, 352: 2618-2626.

2.     Caplan L.R., Wityk R.J., Glass T.A., Tapia J., Pazdera L., Chang H.M., Teal P, Dashe J.F., Chaves C.J., Breen J.C., Vemmos K., Amarenco P, Tettenborn B., Leary M., Estol C., Dewitt L.D., Pessin M.S. New England Medical

Center Posterior Circulation registry. Ann Neurol. 2004, 56: 389-398.

3.     Vereshhagin N.V. Patologija vertebral'no-baziljarnoj sistemy i narushenija mozgovogo krovoobrashhenija[Pathology of vertebrobasilar system and cerebral blood flow disorders]. M. 1980; S 28 [In Russ].

4.     Puzin M.N., Zinov'eva G.A., Metelkina L.P. Aspekty medikamentoznogo lechenija bol'nyh s vertebral'no-baziljarnoj nedostatochnost'ju [Aspects of pharmacotherapy in treatment of patients with vertebrobasilar insufficiency]. Klinicheskaja farmakologija i terapija. 2006; 2: 23-26 [In Russ].

5.     Berguer R., Morasch M., Kline R. A review of 100 consecutive reconstructions of the distal vertebraf artery for embolic and hemodynamic disease. J Vasc Surg. 1998, 27 (5): 852-859.

6.     Pokrovskiy A.V., Beloyartsev D.F., Otdalemmie rezultati operatsiy podkluchichno-sonnoi transpozitsii. [Longterm results of operations of the subclavian-carotid transposition.] Angiologia I sosudistaya khirurgia. 2002; 8(2): 84-91.

7.     He Y, Bai W., Li T. et al. Perioperative complications of recanalization and stenting for symptomatic nonacute vertebrobasilar arteryocclusion. Ann Vasc Surg. 2014 Feb; 28 (2): 386-393.

8.     European Stroke Organisation et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011 Nov; 32 (22): 2851-906.

9.     Natsionalnie rekomendacii po vedeniyu patsientov s zabolevaniyami brakhiotsefal’nikh arteriy. [National guidelines on the management of patients with diseases of brachiocephalic arteries.] Angiologia I sosudistaya khirurgia. 2013; 19 (2): attachment 70.

10.   Schonewille W.J., Algra A., Serena J., Molina C.A., Kappelle L.J. Outcome in patients with basilar artery occlusion treated conventionally. J Neurol Neurosurg Psychiatry. 2005, 76:1238-1241.

11.   Coward L.J., McCabe D.J., Ederle J., Featherstone R.L., Clifton A., Brown M.M. Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Stroke. 2007, 38: 1526-1530.

12.   Compter A., van der Worp H.B., Schonewille W.J., Vos J.A., Algra .A., Lo T.H., Mali WPThM, Moll FL. and Kappelle L.J. VAST: Vertebral Artery Stenting Trial. Protocol for a randomised safety and feasibility trial. Trials 2008, 9: 65.

13.   Clifton A., Markus H., Kuker W., Rothwell P. E-050. The Rationale for the Vertebral artery Ischaemia Stenting trial (VIST): NeuroIntervent Surg 2013; 5. Suppl 2 A56.

14.   Compter A., et al. VAST investigators. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial. Lancet Neurol. 2015 Jun; 14(6): 606-614.

15.   VIST (Vertebral artery Ischaemia Stenting Trial) ISRCT N 95212240.

 

 

 

 

Abstract:

Revascularization strategy definition in acute coronary syndrome in patients with multivessel coronary artery disease is a significant problem of modern intervention cardiology Aim: was to evaluate effectiveness of special PC programs «Sapphire 2015 - Right dominance» and «Sapphire 2015 - Left dominance» designed to the revascularization strategy definition ir acute coronary syndrome patients.

Materials and methods: revascularization strategy of 50 acute coronary syndrome patients was analyzed. In all cases the revascularization strategy was defined by the group of intervention cardiologists with the help of independent experts and special PC programs «Sapphire 2015 - Right dominance» and «Sapphire 2015 - Left dominance». Experts-, physicians-, and soft- based revascularization strategies were compared among themselves.

Results: complete coincidence between expert-based and soft-based revascularization strategies was registered in 66% patients and the incomplete coincidence - in 32% patients. Complete mismatch between expert-based and soft-based revascularization strategies was registered in 2% patients. The complete coincidence between physicians-based and soft-based revascularization strategies was registered in 42% patients and the incomplete coincidence - ir 52% patients. Complete mismatch between physicians-based and soft-based revascularization strategies was registered in 6% patients

Conclusion: as well as experts, special PC programs «Sapphire 2015 - Right dominance» and «Sapphire 2015 - Left dominance» provide success in the revascularization strategy definition 1г acute coronary syndrome patients with multivessel coronary artery disease.

 

References

1.     Hsieh V., Mehta S.R. How should we treat multi-vessel disease in STEMI patients? Curr. Treat. Options. Cardiovasc. Med. 2013; 15(1): 129-136.

2.     Sardella G., Lucisano L., Garbo R. et al. Singlestaged compared with multi-staged PCI in multivessel NSTEMI patients: The SMILE Trial. J. Am. Coll. Cardiol. 2016; 67(3): 264-272.

3.     Ayalon N., Jacobs A.K. Incomplete revascularization in patients treated with percutaneous coronary intervention. When enough is enough. J. Am. Coll. Cardiol. Intv. 2016; 9(3): 216-218.

4.     Iqbal M.B., Ilsley C., Kabir T. et al. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London. Circ. Cardiovasc. Qual. Outcomes. 2014; 7: 936-943.

5.     Kornowski R., Mehran R., Dangas G. et al. Prognostic impact of staged versus «one-time» multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J. Am. Coll. Cardiol. 2011; 58: 704-711.

6.     Tarasov R.S., Ganyukov V.I., Shilov A.A. i dr. Prognosticheskaya znachimost shkaly SYNTAX v ocenke iskhodov i vybora taktiki revaskulyarizacii u pacientov s infarktom miokarda i podemom segmenta ST pri mnogososudistom porazhenii koronarnogo rusla. [Prognostic impact of the SYNTAX scale in the evaluation of outcomes and choice of revascularization tactic in patients with myocardial infarction and ST-segment elevation with multi-vessel coronary artery disease]. Terapevtichesky arhiv. 2012; 84 (9): 17-21 [In Russ].

7.     Petrosyan Yu.S., Ioseliani D.G. O summarnoy ocenke sostoyaniya koronarnogo rusla u bolnyh ishemicheskoy boleznyu serdca. [About cumulative assessment of coronary arteries disease in patients with myocardial ischemia]. Mezhdunarodny zhurnal intervencionnoy kardioangiologii. 2013; 37: 49-55 [In Russ].

8.     Petrov V.I., Nedogoda S.V. Medicina, osnovannaya na dokazatelstvah: uchebnoe posobie. [Medicine-based evidence: a tutorial]. Moscow. 2009: 144 [In Russ].

9.     Kaul P., Ezekowitz J.A., Armstrong P.W. et al. Incidence of heart failure and mortality after acute coronary syndromes. Am. Heart J. 2013; 165(3): 379-385.

10.   El-Hayek G.E., Gershlick A.H., Hong M.K. et al. Metaanalysis of randomized controlled trials comparing multivessel versus culprit-only revascularization for patients with ST-segment elevation myocardial infarction and multivessel disease undergoing primary percutaneous coronary intervention. Am. J. Cardiol. 2015; 115(11): 1481-1486.

11.   Antman E.M., Anbe D.T., Armstrong P.W. et al. ACC/AHA Guidelines for the management of patients with ST-Elevation myocardial infarction-executive summary. A report of the American College of Cardiology / American Heart Association task force on practice guidelines (Writing Committee to revise the 1999 Guidelines for the management of patients with acute myocardial infarction). Circ. 2004; 110: 588-636.

12.   Windecker S., Kolh P., Alfonso F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. The task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2014; 35: 2541-2619.

13.   Bainey K.R., Mehta S.R., Lai T. et al. Complete versus culprit only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis. Am. Heart J. 2014; 167: 1-14.

 

 

 

 

Abstract:

Ischemic coronary artery cardiovascular disease is one of the main causes of the population's disability and mortality in Russian Federation and abroad. One of the most important treatment methods of ischemic coronary artery disease is myocardial revascularizationwith with usage of coronary stents. Nowadays there exist about 500 of coronary artery stent types, which differ in backing material, polymer technology, architecture, etc.

The overwhelming majority of stents used in Russian Federation are foreign-made stents, thus their cost is really high. According to plans of medicine developing as part of import substitution it is crucial to pay more attention to domestically produced stents, in particular to the first Russian drug-eluting stent «CALYPSO». Domestic stents cause minor complications and can be successfully used in emergency cases and various clinical settings for affections of different complexity.

 

References

1.     Bokerija L.A., Alekjan B.G. Rentgenjendovaskuljarnaja diagnostika i lechenie zabolevanij serdca i sosudov v Rossijskoj Federacii - 2014 god [Endovascular diagnosis and treatment of diseases of the heart and blood vessels in the Russian Federation]. M.: NCSSH im.A.N. Bakuleva; 2015 [In Russ].

2.     Matini M., Koledinsky A.G. And ect. Coronary stenting using XIENCE V DES: general problem, perspectives (a review). Mezhdunarodnyj zhurnal intervencionnoj kardiologii. 2011; 26: 25-33 [In Russ].

3.     Zhigalina L.A., Koledinskij A.G. i dr. Blizhajshie i sredneotdalennye kliniko-angiograficheskie rezul'taty koronarnogo jendoprotezirovanija arterij pri ispol'zovanii stentov s razlichnym lekarstvennym pokrytiem u pacientov v rannie sroki infarkta miokarda [Early and mid-term clinical and angiographic results of coronary arteries stenting using stents coated with different drugs in patients in the early stages of myocardial infarction.]. Mezhdunarodnyj zhurnal intervencionnoj kardiologii. 2013; 35: 43a [In Russ].

4.     Mardanjan G.V. Klinicheskaja jeffektivnost' i bezopasnost' chreskozhnyh koronarnyh vmeshatel'stv s ispol'zovaniem stentov s raznymi tipamilekarstvennogo pokrytija [Clinical efficacy and safety of percutaneous coronary intervention with stents with different types of drug-eluting]: Disc. kand. med. nauk. M., 2014; 12 [In Russ].

5.     Mazurova E.C., Koledinskij A.G. i dr. Sravnitel'naja ocenka jeffektivnosti stentov s razlichnym lekarstvennym antiproliferativnym pokrytiem v otdalennye sroki nabljudenija[Comparative evaluation of the effectiveness of stents with various antiproliferative drug-eluting in a long-term follow.]. Mezhdunarodnyj zhurnal intervencionnoj kardiologii. 2011; 24: 82-82 [In Russ].

6.     Gromov D.G., Koledinskij A.G. i dr. Stenty s biodegradirujushhim polimernym pokrytiem: obshhee sostojanie voprosa I perspektivy [Stents with biodegradable polymer coating: general state of the problem and prospects.]. Mezhdunarodnyj zhurnal intervencionnoj kardiologii. 2011; 25: 42-46 [In Russ].

7.    Zeynalov R., Koledinsky A.G. And ect. Results of coronary stenting using the stents with biodegradable polymer and antiproliferative (biolimus A9) coating. Mezhdunarodnyj zhurnal intervencionnoj kardiologii. 2011; 26: 16-21 [In Russ].

8.    Kudrjashov A.N., Lopotovskij PJu. Sravnitel'naja ocenka mehanicheskih svojstv koronarnogo stenta «Sinus» [ Comparative evaluation of mechanical properties of coronary stent «Sinus»]. Diagnosticheskaja intervencionnaja radiologija. 2014; 8(1): 70-77 [In Russ].

9.     Ioseliani D.G., Koledinskij A.G. i dr. Neposredstvennye i sredneotdalennye rezul'taty stentirovanija koronarnyh arterij golometallicheskimi stentami «Sinus» (opyt NPCIK) [Immediate and mid-term results of coronary artery stenting bare metal stents, «Sinus» (experience NPTSIK)]. Mezhdunarodnyj zhurnal intervencionnoj kardiologii. 2013; 35: 47b. [In Russ].

10.   Lopotovskij PJu., Parhomenko M.V., Kokov L.S. Predvaritel'nye rezul'taty Registra retrospektivnogo issledovanija praktiki primenenija rossijskih stentov «Sinus» i «Kalipso» [Preliminary results of a retrospective study of the Register practice of Russian stents «Sinus» and «Calypso»]. Vestnik Roszdravnadzora. 2015, 5:44-49 [In Russ].

 

 

 

 

Abstract:

Article describes the experience of X-ray-surgical treatment of patient with clinical and laboratory manifestations of cholestasis without a concomitant expansion of bile ducts. In anamnesis of disease - left-sided hemihepatectomy, hepaticojejunostomy on wireframe transhepatic drainage for treatment of portal cholangiocarcinoma III-b, 6 courses of adjuvant chemotherapy. Frame-drainage was removed after 6.5 months after surgery and 2 weeks before this hospitalization. Bilirubinemia (bilirubin 394.89 (233,00-161,89) mol/L) with signs dysproteinemia, cytolysis and anticoagulation were marked during the hospitalization. Lack of pneumobilia during sonography suggested that the most likely cause of cholestasis is a violation of the biliodigestive anastomosis patency Antegrade biliary decompression led to the development of hepatic failure, which was successfully treated by syndromic intensive therapy Following antegrade balloon dilatation of biliodigestive anastomosis area with its external-internal frame-drainage let us to eliminate clinical and laboratory manifestations of obstructive jaundice.

Conclusion: the need for a surgical biliary decompression in cancer patients with cholestasis without a significant expansion of bile ducts with a decrease of functional reserves of the liver is accompanied by the risk of development or progression of liver failure, which leads to complexity and ambiguity of the choice of treatment strategy in these patients.


References

1.    Yurchenko V.V. Javljaetsja li suprastenoticheskaja dilatacija objazatel'nym simptomom narushenija ottoka zhelchi? [Is suprastenotic dilatation a mandatory symptom of impaired bile outflow?] Vestnik rentgenologii i radiologii. 2015; 3: 18-22. [In Russ]. 

 

 

Abstract:

Endovascular correction of atrial septal defect (ASD) has become the «gold standard» of treatment, both in children and adults. In case of complicated anatomy of the defect (multiple defects, its large size, lack of edges, aneurysm of atrial septum), experts often chose surgical correction of such pathology Accumulated experience of interventional cardiology and appearance of specialized tools allow to perform a successful intervention in a non-standart situation.

Article describes cases of a successful endovascular correction of ASD in a two year child and adult patient with complicated anatomy factors. In both cases, during echocardiography, we diagnosed multiple ASD with aneurysm of atrial septum, accompanied by clinical symptoms. During multidisciplinary discussions, we identified indication for endovascular correction of the defect.

We performed successfull correction of ASD with occluder for closure of patent foramen ovale, and complete termination of left-to-right shunt on the operating table.

 

References

1.    Sharykin A.S. Vrozhdennye poroki serdca. [Congenital heart diseases] Moskva. Izdatel'stvo «Binom»,2009; S. 384 [In Russ].

2.     Medvedeva S.V. Metodicheskie rekomendacii. Dispansernoe nabljudenie detej s vrozhdennymi porokami serdca i sosudov [Guidelines. Clinical observation of children with congenital heart disease and blood vessels]. 2005; 5-20 [In Russ].

3.    Burakovskij V.I., Buharin V.A., Podzolkov V.I. i dr. Serdechno-sosudistaja hirurgija. Vrozhdennye poroki serdca [Cardiovascular surgery. Congenital heart diseases]. M. Medicina. 1989; 45-382 [In Russ].

4.    Dergachev A.V., Trojan V.V., Adzeriho I.Je., Kozlov O.A., Sprindzhuk M.V. Vrozhdennye poroki serdca s obednennym legochnym krovotokom. Uchebno-metodicheskoe posobie. Chast' 1 [Congenital heart diseases with depleted pulmonary circulation. Guidelines. Part 1.]. Mn.: BelMAPO. 2007; 29 il. 27 [In Russ].

5.    Amikulov B.D. Vrozhdennye poroki serdca blednogo tipa u vzroslyh [«Pale» congenital heart diseases in adults.]. Serdechno-sosudistaja hirurgija . 2004; 2: 3-9 [In Russ].

6.     Bokerija L.A., Gorbachevskij S.V. i dr. Nedostatochnost’ trikuspidal'nogo klapana i ee vlijanie na rezul'taty hirurgicheskogo lechenija defekta mezhpredserdnoj peregorodki u bol'nyh starshe 40 let. Serdechno-sosudistye zabolevanija [Tricuspid failure and its influence on results of surgical treatment of atrial septal defect in patients elder than 40]. 2009; 10 (2): 5-10 [In Russ].

7.     Nechkina I.V., Sokolov A.A. Kovalev I. A., Varvarenko V. I., Krivoshhekov E. V. Remodelirovanie serdca u detej posle jendovaskuljarnoj i hirurgicheskoj korrekcii defekta mezhpredserdnoj peregorodki [Cardiac remodeling in children after endovascular and surgical correction of atrial septal defect]. Sibirskij medicinskij zhurnal. 2012; 27(3): 77-81 [In Russ].

8.     Kurek V.V., Kulagin A.E. Anesteziologija i intensivnaja terapija detskogo vozrasta. Prakticheskoe rukovodstvo [Anesthesiology and intensive care of children]. M.: Medicinskoe informacionnoe agentstvo. 2011; S 992 [In Russ].

9.     Fredriksen P.M., Chen A., Veldtman G., Hechter S., Therrien J., Webb G. Exercise capacity in adult patients with congenitally corrected transposition of the great arteries. Heart. 85 (2). 191-195.

10.   Carole A., Warnes and ather. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). J Am CollCardiol. 2008; 52(23):1890-1947. doi:10.1016/j.jacc.2008.10.002

11.   ProkseljK., Kozelj M., ZadnikV., Podnar T. Echocardiographic characteristics of secundum-type atrial septal defects in adult patients: implications for percutaneous closure using Amplatzer septal occluders. J Am Soc Echocardiography. 2004.Nov. 17(11):1167-1172.

12.   Bokerija L.A., Kagramanov I.I., Alekjan B.G., i dr. Sravnitel'naja ocenka otdalennyh rezul'tatov korrekcii defekta mezhpredserdnoj peregorodki s pomoshhju otkrytogo i jendovaskuljarnogo metodov [Comparative estimation of long-term results of surgical and endovascular correction of atrial septal defect]. Bolezni serdca i sosudov. 2009; 3: 33-40 [In Russ].

13.   Baumgartner H., Bonhoeffer P, De Groot N.M. et al. ESC Guidelines for the management of grown-up congenital heart disease. (new version 2010).Eur Heart J. 2010; 31(23): 2915-57. doi:10.1093/eurheartj/ehq 249. Epub 2010 Aug 27.

14.   King T.D., Mills N.L. Nonoperative closure of atrial septal defects. Surgery. 1974; 75: 383-388.

15.   Kazmi T., Sadiq M., Asif-ur-Rehman, Hyder N., Latif F. Intermediate and long-term outcome of patients after device closure of ASD with special reference to complications. J Ayub Med CollAbbottabad. 2009; 21(3): 117-121.

16.   Rigatelli G., Dell'Avvocata F., Cardaioli P Five-year follow-up of transcatheterintracardiac echocardiography-assisted closure of interatrial shunts. Med. 2011; 12(6): 355-361. doi: 10.1016/j.carrev.2011.04.003. Epub2011 Jun 28.

17.   Jonas R.A. Comprehensive surgical management of congenital heart disease. London. 2004; р. 151-160.

18.   Tarasov R.S., Kartashjan Je.S., Ganjukov V.I.i dr. Transkateternaja korrekcija defekta mezhpredserdnoj peregorodki u detej razlichnyh vozrastnyh grupp[Transcatheter correction of atrial septal defect in different age children]. Rossijskij kardiologicheskij zhurnal. 2013; 3: 40-44 [In Russ].

 

 

 

 

Abstract:

Article presents a case of successful re-stenting of the left subclavian artery with good medium-term outcome in 59 years patient with a return of symptoms of vertebrobasilar insufficiency due to proximal fracture of previously implanted stent. The leading cause of stents destruction in the aortic arch branches are excessive mechanical load due to constant compression and/or vessel displacement, its compression due closeness of beating heart and movements of the shoulder girdle, which is likely had happened in our case - fracture of proximal segment. After analyzing the movement of vessels during the cardiac cycle, we found that stents in proximal aortic arch branches had been influenced mainly by bending, tension/compression. As a consequence - metal fatigue, which led it to the progressive destruction. Most stent fractures are asymptomatic, but in case of return of previous clinic - reintervention should be done. In this case, endovascular treatment is considered to be the method of first choice.


References

1.     Vilenskij B.S. Neotlozhnye sostoyaniya v nevrologii. Rukovodstvo dlya vrachej. [Emergencies in neurology. Guidelines for doctors]. SPb: Foliant. 2004; 512.

2.     Gusev E.I., Skvorcova V.I., Stahovskaya L.V. Problema insul'ta v Rossijskoj Federacii: vremya aktivnyh sovmestnyh dejstvij. [The problem of stroke in the Russian Federation: the time of active joint actions.] ZHurnal nevrologii i psihiatrii im S.S. Korsakova. 2007; 107(8): 4-10.

3.     Parfenov V.A. Ishemicheskij insul't. [Ischemic stroke]. M: MIA. 2011; 312.

4.     Skvorcova V.I. Medicinskaya i social'naya znachimost' problemy insul'ta: Kachestvo zhizni. [Medical and social importance of the problem of stroke: Quality of life]. M: Medicina. 2004; 4: 10-12.

5.     Pokrovskij A.V., Beloyarcev D.F. Sravnitel'noe izuchenie otdalennyh rezul'tatov otkrytyh operacij i ehndovaskulyarnyh vmeshatel'stv pri ateroskleroticheskih stenozah brahiocefal'nogo stvola. [Comparative study of remote results of open surgery and endovascular interventions for atherosclerotic stenoses of the brachiocephalic trunk.] Angiologiya i sosudistaya hirurgiya. 2004; 10(4): 53-60.

6.     Henry M., Henry I., Polydorou A., Polydorou Adio. Hugel Mю. Percutaneous transluminal angioplasty of the subclavian arteries. Int Angiol. 2007; 26: 324-40.

7.     Korner M., Baumgartner I., Do D.D. et al. PTA of the subclavian and innominates arteries: long-term results. Vasa. 1999; 28(2): 117-122.

8.     Motarjeme A. Percutaneous transluminal angioplasty of supra-aortic vessels. J Endovasc Surg. 1996; 3(2): 171-81.

9.     Chatterjee S., Nerella N., Chakravarty S., Shani J. Angioplasty alone versus angioplasty and stenting for subclavian artery stenosis-a systematic review and metaanalysis. Am J Ther. 2013; 20 (5): 520-3.

10.   Li Y, Yin Q., Zhu W., Wang Y, Fan X., Liu D., Chen M., Wang Q., Xu G., Yan B., Liu X. Endovascular stenting for atherosclerotic subclavian artery stenosis in patients with other craniocervical artery stenosis. J Thromb Thrombolysis. 2013; 35(1): 107-14.

11.   Linni K., Ugurluoglu A., Mader N., Hitzl W., Magometschnigg H, Holzenbein TJ. Endovascular management versus surgery for proximal subclavian artery lesions. Ann Vasc Surg. 2008; 22 (6): 769-75.

12.   Muller-Hulsbeck S., Both M., Charalambous N., Schafer P., Heller M., Jahnke T. Endovascular treatment of atherosclerotic arterial stenoses and occlusions of the supraaortic arteries: mid-term results from a single center analysis. Rontgenpraxis 2007; 56: 119-28.

13.   Patel S.N., White C.J., Collins T.J. et al. Catheter-based treatment of the subclavian and innominate Arteries. Catheterization and Cardiovascular Interventions 2008: 71: 963-968.

14.   Dуsa E., Nemes B., Burczi V. et al. High frequency of brachiocephalic trunk stent fractures does not impair clinical outcome. Journal of Vascular Surgery. 2014: 59(3): 781-785.

15.   Lee C.E., Shaiful A.Y, Hanif H. Subclavian artery stent fracture. Med J Malaysia 2009; 64(4): 330-332.

16.   Periard D., Haesler E., Hayoz D. et al. Rupture and migration of an endovascular stent in the brachiocephalic trunk causing a vertebral steal syndrome. Cardiovasc Intervent Radiol. 2008; 31: 53-6.

17.   Rits J., van Herwaarden J.A., Jahrome A.K. et al. The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings. Eur J Vasc Endovasc Surg. 2008; 36: 339-45.

18.   Shinozaki N., Langhoff R., Schulte K-L. Reocclusion caused by stent fracture implanted in the subclavian artery ostium: a case report. Cardiovasc Interv and Ther 2013; 28: 111-114.

19.   Vodop'yanov V.I., Savkin A.N., Kondrat'ev O.V. Kurs soprotivleniya materialov s primerami i zadachami. [Course of materials' resistance with examples and exercises]. Volgograd, 2012; 139. [In Russ].

 

 

authors: 

 

Article exists only in Russian.


 

 

Abstract:

Mediastinal lymphadenopathy is well diagnosed with diagnostic beam methods in primary care outpatient care. The problem is the heterogeneity of this group of diseases, requiring differential diagnosis, on the basis of which individual treatment plan is developed. Morphological verification is a prerequisite for the effective management of such patients

Aim: was to improve the diagnosis of patients with different mediastinal lymph node using endobronchial ultrasonography (EBUS) by evaluation of EBUS cabinet, algorithmization and improvement of its structure and working procedure.

Materials and methods: for the period 2012-2016, 115 patients underwent endobronchial ultrasonography, in 71 cases of which (45,8%) EBUS was accompanied by fine-needle aspiration biopsy (FNAB).

Results: we had investigated the capacity, efficiency Further development of and prospects were identified.

Conclusions: optimizing of structure of the EBUS cabinet, algorithmization of procedure can improve the level of the differential diagnosis in patients with mediastinal lymph node lesion anc reduce the time of examination of patients in this group.

 

References

1.     Chissov V.I., Dar'jalova S.L. Onkologija. [Oncology]. M.: «GJeOTAR-Media» 2007:560S. [In Russ].

2.     Davydov M. I., Machaladze Z. O., Polockij B. E. Et al. Mezenhimal'nye opuholi sredostenija (obzor literatury). [Mesenchymal tumors of the mediastinum (review)]. Sibirskij onkologicheskij zhurnal. 2008; 1:64-74 [In Russ].

3.     Nechipaj A. M., Orlov S. Ju., Fjodorov E. D. JeUS-buka. [EUS-book]. M.: Practicheskaya meditcina. 2013;243-245 [In Russ].

4.     Koroljov V. N., Burdjukov M. S., Surovcev I. Ju., Sazhina E. A. Jendobronhial'naja ul'trasonografija sredostenija i bronho-ljogochnoj sistemy. [Endobronchial ultrasonography of mediastinal and bronchial-pulmonary system]. Povolzhskij onkologicheskij vestnik. 2016;2:14-25 [In Russ].

5.     Prilozhenie k prikazu MZSr ot 27.12.2011 N1664n «Ob utverzhdenii nomenklatury medicinskih uslug» URL.: https://www.rosminzdrav.ru/documents/6975-prikaz-minzdravsotsrazvitiya-rossii-1664n-ot-27-dekabrya-2011-g (Data obrashhenija 23.10.2014) [In Russ].

6.     Prikaz Ministerstva zdravoohranenija RF ot 15 nojabrja  2012 g. N 915n «Ob utverzhdenii Porjadka okazanija medicinskoj pomoshhi naseleniju po profilju «onkologija» URL.: http://www.gov.cap.ru/UserFiles/orgs/ Grvid_11/oncologiya.pdf (Data obrashhenija 23.10.2014) [In Russ].

7.     Prikaz Ministerstva zdravoohranenija i medicinskoj promyshlennosti ot 31 maja 1996 g . №222 «O sovershenstvovanii sluzhby jendoskopii v uchrezhdenijah zdravoohranenija Rossijskoj Federacii» URL.: http://www.endoscopy.ru/doctor/222.html (Data obrashhenija 23.10.2016) [In Russ].

8.     Sanitarno-jepidemiologicheskie pravila SP 3.1.2659-10 «Izmenenija i dopolnenija N 1 k sanitarno-jepidemiologicheskim pravilam SP 3.1.1275-03 «Profilaktika infekcionnyh zabolevanij pri jendoskopicheskih manipuljacijah» URL.: http://pravo.gov.ru/proxy/ips/?docbody=&nd=102141277 &rdk=&backlink=1 (Data obrashhenija 10.10.2016) [In Russ].

9.     Podol'skij V. V., Podol'skaja E. A., Kiseljov I. L. Intervencionnaja jendobronhoul'trasonografija v diagnostike peribronhial'nogo raka ljogkogo. [Interventional endobronchial ultrasonography in the diagnosis of peribronchial cancer of lung]. VIII nauchno-prakticheskaja konferencija intervencionnyh onkoradiologov. [VIII scientific conference of interventional onkoradiology] M., 2015; S. 40-41 [In Russ].

 

 

 

Abstract:

Aim: was to estimate the diagnostic value of MRI (qualitative and tumor size analysis) in the evaluation of preoperative chemotherapy in patients with soft tissue sarcomas on different stages of examination.

Material and methods: we analyzed data of 74 patients with soft tissue sarcomas. All patients underwent MRI. Patients were examined before, in the middle and at the end of the course of the preoperative chemotherapy

Results: the sensitivity (predilection of Grade III-IV pathologic response) of qualitative MRI signs in the middle of the neoadjuvant chemotherapy (after 2-3 cycles) was 73%, the specificity (predilection of Grade I-II pathologic response) was 88%; 69% and 100% for maximum tumor size evaluation, correspondingly At the end of the preoperative treatment, values of the sensitivity and specificity of qualitative MRI signs decreased to 50% and 78%, respectively, the sensitivity of maximum tumor size estimation decreased to 31%, while specificity remained the same -100%.

Conclusion: MRI with qualitative and tumor size analysis is an informative method in assessment of preoperative chemotherapy of soft tissue sarcomas.

 

References

1.     Fletcher C.D.M. WHO Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon: IARC Press. 2002;312 p.

2.     Putnam J.B. Metastases from Sarcoma American Cancer Society Atlas of Clinical Oncology: Soft Tissue Sarcomas. Hamiliton-Ontario: BC Decker Inc. 2002; 266-278.

3.    Aliev M.D. Sovremennye podhody k lecheniju sarkommjagkih tkanej[Modern approaches to the treatment of soft tissue sarcomas.]. Prakticheskaja onkologija. 2004; 5(4):250- 255 [In Russ].

4.     Pisters P.W.T., Patel S.R, Varma D.G.K., et al. Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long term results from single institution. J. Clin.Oncol. 1997;15:3481-3487.

5.     Gortzak E., Azzarelli A., Buesa J. et al. A randomized phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma. Europ. J. Cacer. 2001; 37:1096-1103.

6.     Lucas D.R., Kshirsagar M.P., Biermann J.S. et al. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation. Oncologist. 2008;13( 4):451-458.

7.     WHO Handbook for reporting results of cancer treatment. WHO Publication, Geneva. 1979;48:1-45.

8.     Park J.O., Lee S.I., Song S.Y et al. Measuring response in solid tumors: comparision of RECIST and WHO response criteria. Jpn. J. Clin. Oncol. 2003; 33: 533-537.

9.     Therasse P., Arbuck S.G., Eisenhauer E.A., et al.New guidelines to evaluate the response to treatment in solid tumors (RECIST guidelines). J. Natl. Cancer Inst. 2000;92:205-216.

10.   Eisenhauer E.A., Therasse P., Bogaerts J., et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer. 2009;45: 228-247.

11.   Tuma R.S. Sometimes size doesn’t matter: reevaluating RECIST and tumor response end points. J. Natl. Cancer Inst. 2006; 98: 1272-1274.

12.   Gehan E.A., Tefft M.C. Will there be resistance to the RECIST (tumor Response Criteria in Solid Tumors. J. Natl. Cancer Inst. 2000; 92: 179-181.

13.   Vanel D., Lacombe M.J., Couanet D. et al. Musculoskeletal tumors: follow-up with MR imaging after treatment with surgery and radiation therapy. Radiology. 1987; 164(1): 243-245.

14.   Siegel M.J. Magnetic resonance imaging of musculoskeletal soft tissue masses. Radiol.Clin. North. Am. 2001; 39(4):701-720.

15.   Fletcher B.D., Reddick W.E., Taylor J.S. Dynamic MR imaging of musculoskeletal neoplasm. Radiology. 1997; 200:869-872.

16.   Biondetti P.R., Ehman R.L. Soft-tissue sarcomas: use of textural patterns in skeletal muscle as a diagnostic feature in postoperative MR imaging. Radiology. 1992:183(3):845-848.

17.   Wang X., Jacobs M., Fayad L. Therapeutic Response in Musculoskeletal Soft Tissue Sarcomas: Evaluation by Magnetic Resonance Imaging. NMR Biomed. 2011;24(6):750-763.

18.   Sanchez R.B., Quinn S.F., Walling A., et al Musculoskeletal neoplasms after intraarterial chemotherapy: correlation of MR images with pathologic specimens. Radiology. 1990;174:237-240.

19.   Erlemann R., Sciuk J., Bosse A., et al. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology. 1990; 175:791-796.

20.   Glazer H.S., Lee K.T. J., Levitt R.G. et al Radiation fibrosis: differentiation from recurrent tumor by MR imaging. Radiology. 1985;156:721-726.

21.   Glazkova T.G. Ocenka kachestva metodov diagnostiki i prognoza v medicine [Quality of assessment methods for diagnosis and prognosis in medicine.]. Vestnik ONC AMN Rossii. 1994;2:3-11 [In Russ].

22.   Eisenhauer E.A. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer. 2009;45:228-247.

23.   Tuma R.S. Sometimes size doesn’t matter: reevaluating RECIST and tumor response end points J. Natl. Cancer Inst. 2006;98:1272-1274.

24.   Gehan E.A. Will there be resistance to the RECIST (tumor Response Criteria in Solid Tumors). J. Natl. Cancer Inst. 2000;92:179-181.

25.   Stacchiotti S., Collini P., Messina A. et al. High- grade soft-tissue sarcomas: tumor response assessment - pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria. Radiology. 2009;251:447-456.

26.   Carl Jaffe C. Response assistment in clinical trials: Implications for sarcoma clinical trial design. Oncologist. 2008;13(2):14-18.

27.   Choi H. Response evaluation of gastrointestinal stromal tumors. H. Choi. Oncologist. 2008;13(2):4-7.

 

 

 

Abstract:

Aim: was to improve the efficiency of diagnosis of patients with coronary heart disease, by estimating of possibilities of cardiac multislice computed tomography in comparison with coronary angiography.

Materials and methods: study included 64 patients (18 women and 46 men, mean age 62,4 ± 9,5 years) with a high risk of developing coronary heart disease. In 34 patients - myocardial infarction in anamnesis (18 patients - in pool right coronary artery in 16 patients - in left anterior descending artery). Clinics of angina pectoris - in 40 patients (functional class (FC) I - 10; FC II - 22, FC III - in 6, FC IV - 2 patients). Selection criteria: the absence of disease progression for at least 6 weeks, and at least 3 months of optimal treatment. All patients underwent cardiac MSCT at 256-slice CT scanner. Obtained data was compared with data of reference method - x-ray coronary angiography.

Results: comparison of MSCT coronary angiography with invasive data showed a high comparability of results of two methods in the evaluation of coronary artery disease. It was revealed that discrepancies between cardiac MSCT and CAG in detection of hemodynamically insignificant stenoses ranging from 0 to 4%, hemodynamically significant stenoses - from 0 to 2.6%, subtotal stenosis - from 0 to 1%, occlusions - 0%. The presence of strong correlations between data of cardiac MSCT and coronary angiography of stenosis, demonstrated the high quality of MSCT imaging of coronary artery segments in the examination with a variety of modes of application method.

Conclusion: multislice computed tomography is a highly effective method for diagnosing of structural and anatomic changes of coronary arteries in patients with coronary heart disease.

 

References

1.     Chazov E.I. Perspektivy kardiologii v svete progressa fundamental'noj nauki [Cardiology prospects in sight of the progress of fundamental science.]. Ter. arhiv. 2009;9:5-8 [In Russ].

2.     Kokov L.S., Shutihina I.V., Timina I.E. Ispol'zovanie ul'trazvukovyh tehnologij v ocenke ateroskleroticheskih porazhenij sosudistoj stenki [The use of ultrasonic technology in the assessment of atherosclerotic lesions of the vascular wall.]. Molekuljarnaja medicina. 2013;4:15-25 [In Russ].

3.     Sinicyn V.E., Stukalova O.V., Docenko Ju.A. i dr. Kontrastnaja magnitno-rezonansnaja tomografija v ocenke rubcovyh porazhenij miokarda u bol'nyh IBS[Contrast magnetic resonance imaging in the evaluation of myocardial scarring lesions in patients with coronary artery disease.]. Diagnosticheskaja i intervencionnaja radiologija. 2009;3 (4):23-31 [In Russ].

4.     Fedotenkov I.S., Gagarina N.V., Veselova T.N., Sinicyn V.E., Ternovoj S.K. Kolichestvennyj analiz urovnja kal'cinoza koronarnyh arterij: sravnenie informativnosti mul'tispiral'noj komp'juternoj tomografii i jelektronno-luchevoj tomografii[Quantitative analysis of the level of calcification of the coronary arteries: comparison of informativeness of multislice computed tomography and electron beam tomography.]. Terapevticheskij arhiv. 2006;12:15-19 [In Russ].

5.     Ternovoj S.K., Veselova T.N., Sinicyn V.E. i dr. Rol' mul'tispiral'noj komp'juternoj tomografii v diagnostike infarkta miokarda [The role of multislice computed tomography in the diagnosis of myocardial infarction.]. Kardiologija. 2008; 1: 4-8 [In Russ].

6.     Sinicyn V.E., Ternovoj S.K., Ustjuzhanin D.V. i dr. Diagnosticheskoe znachenie KT-angiografii v vyjavlenii gemodinamicheski znachimyh stenozov koronarnyh arterij [The diagnostic value of CT angiography in the detection of hemodynamically significant stenoses of coronary arteries]. Kardiologija. 2008; 1: 9-14 [InRuss].

7.     Ustjuzhanin D.V., Veselova T.N., Sinicyn V.E. i dr. Cravnitel'nyj analiz diagnosticheskogo znachenija neinvazivnoj angiografii koronarnyh arterij s pomoshh'ju jelektronno-luchevoj i mul'tispiral'noj komp'juternoj tomografii [Comparative analysis of the diagnostic value of noninvasive coronary angiography using the electron beam and multislice computed tomography.]. Terapevticheskij arhiv. 2008; 4:12-15[In Russ].

8.     Veselova T.N., Merkulova I.N., Mironov V.M., Merkulov E.V., Ternovoj S.K., Ruda M.Ja. Neinvazivnaja ocenka ateroskleroticheskogo porazhenija koronarnyh arterij u bol'nyh s ostrym koronarnym sindromom metodom mul'tispiral'noj komp'juternoj tomografii[Noninvasive assessment of atherosclerotic lesions of coronary arteries in patients with acute coronary syndrome by multislice computed tomography.]. Medicinskaja vizualizacija. 2010; 4:100-109 [In Russ].

9.     Petcherski O., Gaspar T., Halon D. et al. Diagnostic accuracy of 256-row computed tomographic angiography for detection of obstructive coronary artery disease using invasive quantitative coronary angiography as reference standard. Am. J. Cardiol. 2013;111:510-515.

10.   Gaudio C., Pelliccia F., Evangelista A. et al. 320-row computed tomography coronary angiography vs. conventional coronary angiography in patients with suspected coronary artery disease: a systematic review and metaanalysis. Int. J. Cardiol. 2013;168:1562-1564.

11.   Fedotenkov I.S., Veselova T.N., Ternovoj S.K., Sinicyn V.E. Rol' mul'tispiral'noj komp'juternoj tomografii v diagnostike kal'cinoza koronarnyh arterij [The role of multislice computed tomography in the diagnosis of coronary artery calcification]. Kardiologicheskij vestnik. 2007; 11 (XIV): 45-48 [In Russ].

12.   Ternovoj S.K., Nikonova M.Je., Akchurin R.S. i dr. Vozmozhnosti mul'tispiral'noj komp'juternoj tomografii (MSKT) v ocenke koronarnogo rusla i ventrikulografii v sravnenii s intervencionnoj koronaroventrikulografiej [Possibilities of multislice computed tomography (MSCT) in the evaluation of coronary arteries and ventriculography in comparison with interventional coronaroventriculography.]. Rossijskij jelektronnyj zhurnal luchevoj diagnostiki. 2013;3 (9): 28-36 [In Russ].

13.   Ternovoj S.K., Veselova T.N. Vyjavlenie nestabil'nyh bljashek v koronarnyh arterijah s pomoshh'ju mul'tispiral'noj kompjuternoj tomografii [Identification of unstable plaques in coronary arteries using a multislice computed tomography.]. Rossijskij jelektronnyj zhurnal luchevoj diagnostiki. 2014:4(13):7- 14 [In Russ].

14.   Sabarudin A., Sun Z. Coronary CT angiography: Diagnostic value and clinical challenges. World J. Cardiol. 2013;26;5(12):473-483.

15.   Pelliccia F., Pasceri V., Evangelista A. et al. Diagnostic accuracy of 320-row computed tomography as compared with invasive coronary angiography in unselected. consecutive patients with suspected coronary artery disease. Int. J. Cardiovasc. Imaging. 2013;29(2):443-452.

16.   Obaid D.R., Calvert PA., Gopalan D. et al. Dualenergy computed tomography imaging to determine atherosclerotic plaque composition: a prospective study with tissue validation. J Cardiovasc Comput Tomogr. 2014; 8(3):230-237. [PubMed: 24939072]

17.   Gbaid D.R., CalvertPA., Gopalan D. et al. Atherosclerotic plaque composition and classification identified by coronary computed tomography: assessment of computed tomography-generated plaque maps compared with virtual histology intravascular ultrasound and histology. Circ Cardiovasc Imaging. 2013;6(5):655-664. [PubMed: 23960215] 

18.   Stehli J., Clerc O.F., Fuchs T.A. et al. Impact of monochromatic coronary computed tomography angiography from single-source dual-energy CT oncoronary stenosis quantification. J Cardiovasc Comput Tomogr. 2016;10(2):135-140.

19.   DanadI., Hartaigh B., Min J.K. Dual-energy computed tomography for detection of coronary artery disease. Expert Rev Cardiovasc Ther. 2015;13(12):1345- 1356.

20.   Petranovic M., Soni A., Bezzera H. et al. Assessment of nonstenotic coronary lesions by 64-slice multidetector computed tomography in comparison to intravascular ultrasound: evaluation of nonculprit coronary lesions. J Cardiovasc. Comput. Tomogr. 2009;3(1):24-31.

21.   Leber A.W., Knez A., Becker A. et al. Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound. J. Am. Coll. Cardiol. 2004;43(7):1241-1247.

22.   Wu Y, Zheng M., Zhao H. et al. Low-concentration contrast material for dual-source computed tomography coronary angiography by a combination of iterative reconstruction and low-tube-voltage technique: feasibility study. Zhonghua YiXueZaZhi. 2014;94(29):2260-2263.

 

 

Abstract:

Aim: was to evaluate results of endovascular treatment of patients with acute coronary syndrome (ACS) without ST-segment elevation, with multivessel coronary disease.

Materials and methods: 346 patients were enrolled in study and initially randomized into 3 groups. 1st group included 100 patients with complete myocardial revascularization which had been performed during initial PCI. 2nd group included 124 patients with complete myocardial revascularization, performed during initial hospitalization: 3rd group - 122 patients with complete revascularization, performed at different times after initial hospitalization. Inclusion criteria: ACS patients without ST-segment elevation; multivessel coronary disease (risk SYNTAX score = 23-32); high and medium risk for the GRACE scale; absence of previous myocardial revascularization.

Results: long-term results of treatment were evaluated in 192 patients. After 12 months, patients in 3rd group was significantly more likely to have greater cardiovascular complications and re-interventions on the target vessel. It was found that complete myocardial revascularization, performed after 30 days from the date of diagnosed acute coronary syndrome, has a negative impact on the prognosis of the disease (r = 0,58, p <0,05). Risk factors adversely affecting the prognosis of ACS patients without ST-segment elevation and presence of multivessel disease include: subtotal stenosis in non-symptomatic arteries; circulation failure Killip class III; myocardial infarction in past; high risk on GRACE scale; lesion length in non-symptomatic arteries more than 20 mm diabetes mellitus; degree of risk on a SYNTAX scale-score> 25; overweight/obesity; high cholesterol 6.5 mmol/l.

Conclusions: when performing PCI in patients with ACS without ST-segment elevation with multivessel coronary disease, performing a complete myocardial revascularization 30 days after the date of diagnosed acute coronary syndrome, has a negative impact on the prognosis of the disease.

 

References

1.     Bockeria L.A., Alekyan B.G.(eds). Rentgenjendovaskuljarnaja diagnostika i lechenie zabolevanij serdca i sosudov v Rossijskoj Federacii - 2015 god. [Endovascular diagnosis and treatment of the heart and blood vessels diseases in Russian Federation - 2015]. Moscow: Nauchnyy tsentr serdechno-sosudistoi khirurgii imeni A.N. Bakuleva; 2016 [In Russ].

2.     Filatov A.A, Krylov V.V. Rezul'taty jendovaskuljarnogo lechenija bol'nyh infarktom miokarda bez zubca Q na jelektrokardiogramme. [Results of endovascular treatment of patients with myocardial infarction without Q-wave on the ECG]. Mezhdunarodnyj zhurnal intervencionnoj kardioangiologii. 2012;30:29-32 [In Russ].

3.     Alfredsson J., LindbAck J., Wallentin L., Swahn E. Similar outcome with an invasive strategy in men and women with non-ST-elevation acute coronary syndromes: from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Eur Heart J. 2011;32:3128-36.

4.     Savonitto S., Cavallini C., Petronio A.S., et al. Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial. JACC: Cardiovasc Interv 2012;5:906-16.

5.     Tegn N., Abdelnoor M., Aaberge L. et al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomized controlled trial. Lancet. 2016;387:1057-65.

6.     Thiele H., Rach J., Klein N. et al. Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late Percutaneous coronary Intervention trial in NSTEMI (LIPSIA-NSTEMI Trial). Eur Heart J. 2012;33(16):2035-43.

7.      Henderson  R.A., Jarvis C., Clayton T. et al. 10-Year Mortality Outcome of a Routine Invasive Strategy Versus a Selective Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndrome: The British Heart Foundation RITA-3 Randomized Trial. J Am Coll Cardiol. 2015; 66(5):511-20. doi: 10.1016/j.jacc.2015.05.051.

8.     Damman P, Nan van Geloven, Wallentin L. et al. Timing of Angiography With a Routine Invasive Strategy and Long-Term Outcomes in Non-ST-Segment Elevation Acute Coronary Syndrome: A Collaborative Analysis of Individual Patient Data From the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials. J Am Coll Cardiol Intv. 2012;5(2):191-199. doi:10.1016/j.jcin.2011.10.016.

9.     Badings E.A., Salem H.K., Dambrink J.E. et al. Early or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trial. EuroIntervention. 2013;9:54-61.

10.   Roffi M., Patrono C., Collet J.P et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-seg- ment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016 Jan 14;37(3):267- 315. doi: 10.1093/eurheartj/ehv320.

11.   Sardella G., Lucisano L., Garbo R. et al. SingleStaged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial. J Am Coll Cardiol. 2016 Jan 26;67(3):264-72. doi: 10.1016/j.jacc.2015. 10.082.

12.   Tang E.W., Wong C.K., Herbison P Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J. 2007 Jan;153(1):29-35.

13.   Sumeet S., Bach R.G., Chen A.Y et al. Baseline Risk of Major Bleeding in Non-ST- Segment-Elevation Myocardial Infarction The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress Adverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score. Circulation. 2009;119:1873-1882.

14.   Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123:2736-2747.

15.   Martensson S., Gyrd-Hansen D., Prescott E. et al. Trends in time to invasive examination and treatment from 2001 to 2009 in patients admitted first time with non-ST elevation myocardial infarction or unstable angina in Denmark. BMJ Open. 2014.;4;3004052

16.   Ganjukov V.I., Tarasov R.S., Kochergin N.A., Barbarash O.L. Chreskozhnoe koronarnoe vmeshatel'stvo pri ostrom koronarnom sindrome bez pod’ema segmenta ST. [Percutaneous coronary intervention for acute coronary syndrome without ST-segment elevation]. Jendovaskuljarnaja hirurgija. 2016;3(1):19-5 [In Russ] .

17.   Amsterdam E.A., Wenger N.K., Brindis R.G et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes. JACC. 2014; 64(24):2645-87.

18.   E.B. Shahov, B.E. Shahov, E.B. Petrov. Opredelenie taktiki I ob’ema endovaskularnoi revaskularizatsii u patsientov s ostim koronarnim sindromom I mnogososudistim porazheniem venechnogo rusla serdtsa. [Revascularization strategy definition in acute coronary syndrome patients with multivessel coronary artery disease] Diagnosticheskaya I interventionnaya radiologia. Tom 10 (№3)2016:43-50.

 

 

Abstract:

Aim: was to estimate parameters of left ventricle (LV) perfusion and kinetics at ischemic chronic heart failure (CHF), which initial values are predictors of increased myocardial functional reserve and patients clinical status improvement as a result of revascularization.

Materials and methods: examined 157 patients (146 men and 11 women; age from 33 to 72 years) before and in 2 - 3 days after percutaneous coronary intervention with diagnosis: CAD, CHF with NYHA class III-IV echocardiography parameters of LV: ejection fraction less than 40%, end-diastolic volume is more than 200 ml. Perfusion and function disorders were estimated with use of ECG-gated single photon emission computed tomography (SPECT).

Results: in 48% of cases 6-minute walk test increased more than 150%; NYHA class decreased by 2 classes (group 1). In 52% cases 6-minute walk test increased less than 50% and the NYHA class decreased on 1 class or did not change (group 2). Comparison of initial LV condition and clinical effect revealed following conformities. The revascularization effect is limited not to extent of coronary blood flow recovery, but first of all a cardiac muscle condition, the quantitative relation of the functioning myocardium and a focal cardiosclerosis. Thus, critical size to define the favorable forecast of revascularization is perfusion disorder more than a half of LV and kinetics disorder more than a third of cardiac muscle volume. Prevalence of a cardiosclerosis over the functioning myocardium limits clinical effect of a revascularization and growth of a functional reserve.

Conclusion: degree of initial LV myocardium perfusion and movement disorders at patients with severe ischemic heart failure is the key indicator, influencing clinical efficiency of coronary intervention

 

References

1.     Ageev F.T., Belenkov Yu.N., Fomin I.V., et al. Rasprostranennost hronicheskoj serdechnoj nedostatochnosti v Evropejskoj chaste Rossijskoj Federacii - dannye JEPOHA-HSN [The prevalence of chronic heart failure in the European part of the Russian Federation - Data AGE-CHF]. Serdechnaya nedostatochnost. 2006;7(1):112-115 [In Russ].

2.     Bax J.J., Delgado V. Myocardialviability as integral-part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol. 2015 Apr;22(2): 229-45.

3.     Mareev V.Yu., Danielyan M.O., Belenkov Yu.N., Ot imeni rabochej gruppy issledovaniya JEPOHA-O-HSN. Sravnitelnaya harakteristika bolnyh s HSN v zavisimosti ot velichiny FV po rezultatam Rossijskogo mnogocentrovogo issledovaniya JEPOHA-O-HSN [On behalf of the working group study AGE-O-CHF. Comparative characteristics of patients with CHF, depending on the size of the PV on results of Russian studies mnogotsentrovogo AGE-O-CHF]. Serdechnaya nedostatochnost. 2006;7 (4):164-171 [In Russ].

4.     Samady H., Elefteriades J.A., Abbott B.G., et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation. 1999;100:1298- 304.

5.     Patel H.C., Ellis S.G.Role of revascularization to improveleft ventricular function. Heart Fail Clin. 2015 Apr; 11(2):203-14.

6.     Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary. J Am Coll Cardiol 2013;62:1495-539.

7.     McMurray J.J., Adamopoulos S., Anker S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787-847.

8.     Fonseca C., Morais H., Mota T., Matias F., Costa C., Gouveia-Oliveira A., Ceia F. EPICA Investigators. The diagnosis of heart failure in primary care: value of symptoms and signs. Eur J Heart Fail. 2004 Oct; 6(6):795-800, 821-2.

9.     Shabana A., El-Menyar A. Myocardial viability: what we knew and what is new. Cardiol Res Pract. 2012; 2012:607486.

10.   Ling L.F., Marwick T.H., Flores D.R., Jaber W.A.. Brunken R.C., Cerqueira M.D., Hachamovitch R.Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Circ Cardiovasc Imaging. 2013 May 1;6(3):363-72.

11.   Schinkel A.F., Poldermans D., Rizzello V., Vanoverschelde J.L., Elhendy A., Boersma E., Roelandt J.R., Bax J.J. Why do patients with ischemiccardiomyopathy and a substantialamount of viablemyocardium not always recover in function after revascularization? J Thorac Cardiovasc Surg. 2004 Feb;127(2):385-90.

12.   Mandegar M.H., Yousefnia M.A., Roshanali F., Rayatzadeh H., Alaeddini F. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium. J Thorac Cardiovasc Surg. 2008 Oct; 136(4):930-6.

13.   Beanlands R.S.B., Dawood F., Wen W.H. et al. Are the kinetics of technetium 99m-methoxy isobutyl isonitrile affected by cell metabolism and viability? Circulation. 1990; 82:1802-1814.

14.   Rizzello V., Schinkel A.F., Bax J.J., et al. «Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy: the scar-to-biphasic model» Am J Cardiol. 2003 Jun 15;91 (12): 1406-9.

15.   Chestuhin V.V., Mironkov A.B., Bljahman F.A., Ostroumov E.N., Kolchanova S.G., Shkljar T.F., Azoev Je.T., Sahovskij S.A. Vlijanie polnoty revaskuljarizacii serdca na funkcional'noe sostojanie miokarda pri ishemicheskoj kardiomiopatii [Influence of completeness of coronary revascularization on the functional state of the myocardium in ischemic cardiomyopathy.]. Vestnik transplantologii i iskusstvennyh organov. 2013: 14(4):55-63 [In Russ].

16.   Bax J.J., Visser F.C., Poldermans D., et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation. 2001; 104(Suppl 1):I314 -8.

 

Abstract:

Revascularization strategy definition in acute coronary syndrome in patients with multivessel coronary artery disease is a significant problem of modern interventional cardiology.

Aim: was to evaluate effectiveness of special PC programs «Sapphire 2015 - Right dominance» and «Sapphire 2015 - Left dominance» designed to the revascularization strategy definition ir acute coronary syndrome patients.

Materials and methods: revascularization strategy of 50 acute coronary syndrome patients was analyzed. In all cases the revascularization strategy was defined by the group of intervention cardiologists with the help of independent experts and special PC programs «Sapphire 2015 - Right dominance» and «Sapphire 2015 - Left dominance». Experts-, physicians-, and soft- based revascularization strategies were compared among themselves

Results: complete coincidence between expert-based and soft-based revascularization strategies was registered in 66% patients and the incomplete coincidence - in 32% patients. Complete mismatch between expert-based and soft-based revascularization strategies was registered in 2% patients. The complete coincidence between physicians-based and soft-based revascularization strategies was registered in 42% patients and the incomplete coincidence - ir 52% patients. Complete mismatch between physicians-based and soft-based revascularization strategies was registered in 6% patients.

Conclusion: as well as experts, special PC programs «Sapphire 2015 - Right dominance» and «Sapphire 2015 - Left dominance» provide success in the revascularization strategy definition 1г acute coronary syndrome patients with multivessel coronary artery disease.

 

References

1.     ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/ SAIP/ SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. Circulation. 2011; 124:54-130.

2.     Cohen D, Stolker J, Wang К, et al. Health-Related Quality of Life After Carotid Stenting Versus Carotid Endarterectomy. Results From CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). JACC Vol. 2011;15:58.

3.     Amirdjanova V.N., Goryachev D.V., Korshunov N.I., Rebrov A.P., Sorotskaya V.N. Populyatsionnie pokazateli kachestva zhizni po oprosniku SF-36 (rezultati mnogotsentrovogo issledovaniya kachestva zhizni) Mirazh. [Population' indicators of quality of life questionnaire SF-36 (results of a multicenter study of quality of life «MIRAGE»).]. Rheumatology Science and Practice. 2008;46(1):36-48. [In Russ].

4.     Stolker JM, Mahoney EM, Safley DM, et al. Health-related quality of life following carotid stenting versus endarterectomy: results from the SAPPHIRE (Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy) trial. J Am Coll Cardiol Intv. 2010;3: 515-23.

5.     PQcTte E, Slisers M, Miglane E et al. Health-Related Quality of Life Among Patients with Severe Carotid Artery Stenosis. The Journal of Latvian Academy of Sciences. 2015; 5:237-242.

6.     Kazmierski P, Kasielska A, Bogusiak K, Lysakowski M, Stela О gowski M. Influence of internal carotid endarterectomy on patients’ life quality. Pol Przegl Chir. 2012;84:17-22.

7.     Shan L. Saxena A .Quality of Life and Functional Status After Carotid Revascularisation: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2015;49: 634-645.

8.     Stolker JM, Mahoney EM, Safley DM, et al. Health-related quality of life following carotid stenting versus endarterectomy: results from the SAPPHIRE (Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy) trial. J Am Coll Cardiol Intv. 2010;3: 515-523.

9.     CaRESS Steering Committee. Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg. 2005;42:213-219.

 

 

Abstract:

The article is devoted to one of the most modern methods of treatment of benign prostatic hyperplasia (BPH) - endovascular prostatic artery embolization (PAE). This kind of intervention is performed, usually, with approach through the common femoral artery Transradial vascular approach has many advantages over the femoral approach, but its use in this type of intervention is currently limited.

Aim: was to conduct a comparative analysis of the use of transradial and transfemoral vascular approach when performing PAE.

Materials and methods: in a group of transradial approach included 24 patients, and in the femoral approach group - 23 patients

Results: success rate of the procedure and the frequency of complications of vascular approach were comparable between groups. The total duration of the procedure, the time spent on catheterization of internal iliac and prostatic arteries, radiation exposure dose were significantly lower in the group of transradial approach. Using the transradial approach is associated with a significant reduction in the incidence and severity of the discomfort associated with the procedure.

 

References

1.     Lee C., Kozlowski J.M., Grayhack J.T. Intrinsic and extrinsic factors controlling benigh prostatic growth. Prostate. 1997; 31(2):131-138.

2.     American Urological Association: Guideline on the Management of Benigh Prostatic Hyperplasia (BPH). Revised 2010.

3.     Appleton D.S., Sibley G.N., Doyle P.T. Internal iliac artery embolisation for the control of severe bladder and prostate haemorrhage. Br. J. Urol. 1988;61(1):45-47.

4.     Michel F., Dubruille T., Cercueil J.P. et al. Arterial embolization for massive hematuria following transurethral prostatectomy. J. Urol. 2002; 168(6):2550-2551.

5.     Rastinehad A.R., Caplin D.M., Ost M.C. et al. Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin. Urology. 2008;71(2):181- 184.

6.     DeMeritt J.S., Elmasri F.F., Esposito M.P. et al. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J. Vasc. Interv. Radiol. 2000;11(6):767-770.

7.     Carnevale F.C., Antunes A.A., da Motta Leal Filho J.M. et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc. Intervent. Radiol. 2010;33(2): 355-361.

8.     Worthington-Kirsch R.L., Andrews R.T., Siskin G.P. et al. Uterine fibroid embolization: technical aspects. Tech. Vasc. Interv. Radiol. 2002;5:17-34.

9.     Carnevale F.C., da Motta-Leal-Filho J.M., Antunes A.A. et al. Quality of life and symptoms relief support prostatic artery embolization for patients with acute urinary retention due to benign prostatic hyperplasia. J. Vasc. Interv. Radiol. 2012;24:535-542.

10.   Bilhim T., Pisco J., Rio Tinto H. et al. Unilateral versus bilateral prostatic arterial embolization for lower urinary tract symptoms in patients with prostate enlargement. Cardiovasc. Intervent. Radiol. 2013;36(2):403-411.

11.   Mclvor J., Rhymer J.C. 245 transaxillary arteriograms in arteriopathic patients: success rate and complications. Clin. Radiol. 1992;45(6):390-394.

12.   Jolly S.S., Yusuf S., Cairns J. et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011; 377(9775):1409-1420.

13.   Tavris D.R., Gallauresi B.A., Lin B. et al. Risk of local adverse events following cardiac catheterisation by hemostasis device use and gender. J. Invasive Cardiol. 2004; 16(9):459-464.

14.   Kanei Y, Kwan T., Nakra N.C. et al. Transradial cardiac catheterization: A review of access site complications. Catheter Cardiovasc. Interv. 2011;78(6):840-846.

15.   Caputo R.P, Tremmel J.A., Rao S. et al. Transradial arterial access for coronary and peripheral procedures: Executive summary by the transradial committee of the SCAI. Catheter Cardiovasc. Interv. 2011;78(6):823-839.

16.   Sherev D.A., Shaw R.E., Brent B.N. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc. Interv. 2005;65(2):196-202. 

authors: 

 

Abstract:

Good response to neoadjuvant chemotherapy is a favorable prognostic factor in patients with breast cancer. Early response evaluation might spare unnecessary chemotherapy in bad responders. Clinically mammography and ultrasound are used to evaluate response to treatment while being bac predictors of early response. MRI is getting wider acceptance but still lacks necessary accuracy to the absence of functional evaluation. Thus novel methods are being evaluated in early response prediction. Diffusion-weighted MRI, MR-spectroscopy, mammoscintigraphy PET as well as diffusion optic tomography are discussed in the review as potential ways to improve early prediction of response in breast cancer patients undergoing neoadjuvant chemotherapy.

 

References

1.     Davydov M.I., Aksel' E.M. Statistika zlokachestvennyh novoobrazovanij v Rossii i stranah SNG v 2012 g [Statistics of malignancies in Russian Federation and the CIS countries in 2012.]. Moskva, 2014;63-64 [In Russ].

2.     Montagna E., Bagnardi V., Rotmensz N. Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features. Breast Cancer Res Treat. 2010;124(3):689-99.

3.     Bonnefoi H., Litiere S., Piccart M. Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial. Ann Oncol. 2014 Jun;25(6):1128-36.

4.     Semiglazov V.F., Paltuev R.M., Semiglazova TJu. i dr. Klinicheskie rekomendacii po diagnostike i lecheniju raka molochnoj zhelezy [Clinical guidelines for the diagnosis and treatment of breast cancer.]. SPb.: ABS-press. 2013; 234 [In Russ].

5.     Schmitt E.L., Threatt B.A. Effective breast cancer detection with filmscreen mammography. Canad. Ass. Radiol. 1985;36(4):303-307.

6.     Mistry K.A., Thakur M.H., Kembhavi S.A. The effect of chemotherapy on the mammographic appearance of breast cancer and correlation with histopathology. Brit. J. Radiol. 2016; 89:1057-1063.

7.     Helvie M.A., Joynt L.K., Cody R.L. et al. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology. 1996;198:327-332.

8.    Komjahov A.V.. Ocenka jeffektivnosti neoad’juvantnoj sistemnoj terapii raka molochnoj zhelezy s pomoshhju magnitno-rezonansnoj tomografii i sonografii [Evaluation of the effectiveness of neoadjuvant systemic therapy for breast cancer using magnetic resonance imaging and sonography.]. Avtoreferat. Diss. kand. med. nauk SPb. 2016; 13-15 [In Russ].

9.    Gazhonova V.E., Efremova M.P., Dorohova E.A. Sovremennye metody neinvazivnoj luchevoj diagnostiki raka molochnoj zhelezy [Modern non-invasive methods of radiation diagnosis of breast cancer.]. RMZh. 2016;5:321-324 [In Russ].

10.  Meladze N.V., Ternovoj S.K., Abduraimov A.B. MR-spektroskopija v differencial'noj diagnostike uzlovyh obrazovanij molochnyh zhelez[MR spectroscopy in the differential diagnosis of nodular breast cancer.]. Bjulleten’ sibirskoj mediciny. 2012;5:78-79 [ In Russ].

11.   Semiglazov V.F., Semiglazov V.V., Krivorot'ko P.V. i dr. Rukovodstvo po lecheniju rannego raka molochnoj zhelezy [Guidelines for early breast cancer therapy.]. SPb. 2016; 12-13 [In Russ].

12.   Marinovich M.L., Macaskill P., Irwig L. et al. Metaanalysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy. Br. J. Cancer. 2013;109:1528-1536.

13.   Meladze N.V. Rol' Mr-spektroskopii v kompleksnoj diagnostiki raka molochnoj zhelezy [MR spectroscopy in the complex diagnosis of breast cancer]. Avtoreferat. Diss. kand. med. nauk. M. 2014;78-79 [In Russ].

14.   Danishad K.K., Sharma U., Sah R.G., et al. Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging. NMR Biomed. 2010;23(3):233-41.

15.   Jonathan K.P, Begley L., Thomas W. In vivo proton magnetic resonance spectroscopy of breast cancer: a review of the literature. Breast Cancer Research. 2012; 14:207.

16.   Bammer R. Basic principles of diffusion-weighted imaging. Eur Radiol. 2003;45:169-184.

17.   Kwee T., Takahara T., Ochiai R. et al. Whole-body diffusion weighted magnetic resonance imaging. Eur Radiol. 2009;70: 409-417.

18.   Smirnova N.A., Nazarov A.A., Del'gadil'o-Kuznecov L.Je. Radionuklidnye metody v diagnostike i lechenii raka molochnoj zhelezy [Radionuclide methods in the diagnosis and treatment of breast cancer.]. Vestnik RUDN. 2005;(29)1: 45-50 [In Russ].

19.  Brjanceva Zh.V. Avtoreferat. Diss. kand. med. nauk. Rolmammoscintigrafii v ocenke jeffektivnosti neoadjuvantnogo lechenija raka molochnoj zhelezy [Mammoscintigraphy role in assessing the effectiveness of neoadjuvant treatment of breast cancer.]. SPb. 2015;3-4 [In Russ].

20.   Qiufang Liu, Chen Wang, Panli Li. The Role of 18F- FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis. Biomed Res Int. 2016;2016:10.

21.   Tromberg B.J., Zhang Z., Leproux A. Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging. Сancer Research. 2016;5933.

22.   Baek H.M., Chen J.H, Nie K. Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative 1H MR Spectroscopy. Radiology. 2009 Jun; 251(3):653-662.

23.   Bufi E., Belli P, Matteo M. Hypervascularity Predicts Complete Pathologic Response to Chemotherapy and Late Outcomes in Breast Cancer. Clinical Breast Cancer. 2016; Jun 23. pii: S1526-8209(16)30162-8.

24.   Hylton N.M., Constantine A., Gatsonis M. Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL. Radiology. 2016; Apr; 279(1):44-55.

25.   Schaefgen B., Mati M., Sinn H. Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response? Annals of Surgical Oncology. 2016;23(3):789-795.

26.   Cho N., Im S.A., Kang K.W. Early prediction of response to neoadjuvant chemotherapy in breast cancer patients: comparison of single-voxel (1)H-magnetic resonance spectroscopy and (18)F-fluorodeoxyglucose positron emission tomography. Eur Radiol. 2016; 26(7):2279-90.

27.   Bufi E., Belli P., Costantini M. Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer. Clin Breast Cancer. 2015 0ct;15(5):370-80.

28.   Leong K.M., Lau P., Ramadan S. Utilisation of MR spectroscopy and diffusion weighted imaging in predicting and monitoring of breast cancer response to chemotherapy. J Med Imaging Radiat Oncol. 2015 Jun;59(3):268-77.

29.   Novikov S.N., Kanaev S.V., Petr K.V. Technetium-99m methoxyisobutylisonitrile scintimammography for monitoring and early prediction of breast cancer response to neoadjuvant chemotherapy. Nucl Med Commun. 2015 Aug; 36(8):795-801.

30.   Trehan R., Seam R.K., Gupta M.K. Role of scintimammography in assessing the response of neoadjuvant chemotherapy in locally advanced breast cancer. World J Nucl Med. 2014 Sep;13(3):163-9.

31.   Schaafsma B.E., van de Giessen M., Charehbili A. Optical mammography using diffuse optical spectroscopy for monitoring tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer. Clin Cancer Res. 2015 Feb; 21(3):5

 

Abstract:

Ventricular septal defect after myocardial infarction (post-MI VSD) is one of the most rare and lethal complication.

We present a case report of patient with recurrent VSD, 7 months after coronary artery bypass graft with cardiosurgical correction of post-MI VSD. Due to the high risk of re-operation, it was decided to perform endovascular closure of VSD.

Despite acceptable stability test, after delivery system disconnection - migration of occluder to left ventricular occurred. All efforts to retrieve device were not successful, due to strong fixation of the device in anterior leaflet chordal tendons of mitral valve (MV). The presence of 12 mm occluder didn't influence on existed MV insufficiency, so the decision to leave this device in place and to implant the bigger one to VSD was made. 14 mm occluder was successfully implanted, with immediate reduction of left-right shunt and normalization of pulmonary artery pressure. Follow-up period is 3 years - patient doesn't have any complaints. Ejection fraction 55%, mitral insufficiency 30% by volume, device is fully endothelialyzed.

Endovascular VSD occlusion can be effectively used in case of post-surgery re-occurence. In cases of migration of endovascular devices, thorough functional analysis should be performed for choosing the best strategy of further actions. In this clinical case the decision to leave the device in LV didn't cause any negative outcomes for the patient.

 

References

1.     Koh A.S., Loh YJ., Lim YP., Le Tan J. Ventricular septal rupture following acute myocardial infarction. Acta Cardiol. 2011;66(2):225-30.

2.     Crenshaw B.S., Granger C.B., Birnbaum Y et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction (GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators). Circulation. 2000;101:27-32.

3.     Serpytis P, Karvelyte N., Serpytis R. et al. Postinfarction ventricular septal defect: risk factors and early outcomes. Hellenic J Cardiol. 2015;56(1):66-71.

4.     Arnaoutakis G.J., Zhao Y, George T.J. et al. Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2012; 94:436-443.

5.     Assenza G.E., McElhinney D.B., Valente A.M. et al. Transcatheter closure of post-myocardial infarction ventricular septal rupture. Circ Cardiovasc Interv. 2013;6:59-67.

6.     Calvert PA., Cockburn J., Wynne D. et al. Percutaneous closure of postinfarction ventricular septal defect: in-hospital outcomes and long-term follow-up of UK experience. Circulation. 2014;129:2395-402.

7.     Deja M.A., Szostek J., Widenka K. et al. Post infarction ventricular septal defect - can we do better? Eur J Cardiothorac Surg. 2000;18:194-201.

8.     Takahashi H., Arif R., Almashhoor A., et al. Longterm results after surgical treatment of postinfarction ventricular septal rupture. Eur J Cardiothorac Surg. 2015;47(4):720-724.

9.     Holzer R., Balzer D., Lock Qi-Ling Cao K., Hijazi Z.M. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder. J Am Coll Cardiol. 2004;43:1257-1263.

 

 

 

 

Abstract:

Inflammatory breast cancer (BC) is a locally-spread unresectable primary diffuse form of tumor, occurring in 1- 6% of patients with breast cancer, and is one of the most malignant forms of cancer with a poor prognosis and a low survival rate.

The article describes the clinical case of successful experience in the application of repeated chemoembolization and one cycle of radical radiation therapy in patient with metastatic breast cancer (inflammatory form), resistant to conduct systemic chemotherapy (possibility to transfer tumor into operable condition).

Patient underwent three cycles of chemoembolization into right internal thoracic artery, followed by radical radiotherapy The combination of these techniques allowed to reach a complete response to treatment and subsequently perform a radical mastectomy. Postoperative follow-up period is 85 months of remission without specific therapy.

 

References

1.     Dawood S., Lei X., Dent R. et al. Survival of women inflammatory breast cancer: a lage population-based study. Ann. Oncol. 2014; 25(6): 1143-1151.

2.     Wilke D., Colwell B., Dewar R. Inflammatory breast carcinoma: comparison of survival of those diagnosed clinically, pathologically, or with both features. Am Surg. 1998; 64(5):428-431.

3.     Henderson M.A., Mc Bride C.M. Secondary inflammatory breast cancer: treatment options. South Med J. 1988; 81(12):1512-15177.

4.     Liauw S.L., Benda R.K., Morris C.G, et al, Inflammatory breast carcinoma: Outcomes with trimodality therapy for nonmetastatic disease. Cancer. 200; 100(5): 920-928.

5.     Masljukova E.A., Odincova S.V., Korytova L.I., Polikarpov A.A., Zhabina R.M. Vnutriarterial'naja himioterapija i luchevaja terapija v kombinirovannom lechenii bol'nyh rakom molochnoj zhelezy[Intra-arterial chemotherapy and radiation therapy in combined treatment of patients with breast cancer.]. Vestnik novyh medicinskih tehnologij. Jelektronnoe izdanie. 2015:4:2-10 [In Rus].

6.     Belka C. Biological Basis of Combined Radio and Chemotherapy. Multimodal Concepts for Integration of Cytotoxic Drugs. Ed. Brady L.W. et al., Springer, Heidelberg. 2006;3-17.

7.     Harada H. Combinations of Antimetabolites and Ionizing Radiation. Multimodal Concepts for Integration of Cytotoxic Drugs. Ed. Brady L.W. et al. Springer, Heidelberg. 2006;19-34.

8.     Perez C.A., Fields J.N., Fracasso PM., et. al, Management of locally advanced carcinoma of the breast. Inflammatory carcinoma. Cancer. 1994;74 (Supll 1): 466-76.

9.     Chhikvadze T.B. Mesto luchevogo, lekarstvennogo i hirurgicheskogo jetapov v kompleksnom lechenii otechnyh form raka molochnoj zhelezy [Role of beam, medicinal and surgical stages in complex treatment of inflammatory forms of breast cancer]: dis. kand. med. nauk: M., 2008; 82 [In Russ].

10.   Cristofanilli M., Valero V., Buzdar A.U. et al. Inflammatory breast cancer (IBC): patterns of recurrence and micrometastatic homing. Breast Cancer Res. Treat. 2006;100(Suppl 1):155.

11.   Fisher B, Brown A, Mamounas E. et. al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997; 15(7): 2483-2493.

12.  Granov A.M., Davydov M.I. Intervencionnaja radiologija v onkologii (puti razvitija i tehnologii) [Interventional radiology in oncology (path of development and technology)]. Izdanie vtoroe, dopolnennoe. Spb: Foliant, 2013;560 [In Russ].

 

Abstract:

Arteriovenous malformation (AVM) of kidney - is rarely seen vascular anomaly, with clinical polymorphism (hematuria, hypertension, left ventricular hypertrophy, heart failure, abdominal pain), and difficult diagnostic algorithms and is often a cause for radical organ-resecting operations (nephrectomy).

Article describes a case report of 37 years old patient with a diagnosis of «arteriovenous malformation of left renal artery», and the clinical picture of hematuria, post-hemorrhagic anemia. Patient underwent ultrasound of kidneys and bladder (no disease found) and multi-slice computed tomography (AVM of upper pole of left kidney, sized 5,4x5,0 cm).

Patient underwent endovascular embolization of AVM with 4 coils «Flipper». Patients was discharged on the 7th day without complications after the control ultrasound and MSCT The use of selective endovascular embolization of renal AVM reduces or removes clinical manifestations, and has lower operational risks, as well as allows you to save the function of the intact portion of renal parenchyma, which don't lead to patient's disability (in comparison with to organ-resecting surgery).

 

           References

1.     Varela M.E.: Aneurisma arteriovenoso de los vasos renales y asistolia consecutiva. Rev Med Latino-Am. 1928; 14: 32-44.

2.     Walsh PC., Retik A.B., Vaughan E.D. Anomalies of the upper urinary tract: Campbell's Urology. 2002; Amsterdam: Elsevier Science, 3422-3423.

3.     Sountoulides P, Zachos I. Massive hematuria due to a congenital renal arteriovenous malformation mimicking a renal pelvis tumor: a case report. J Med Case Reports. 2008;2:144

4.     Takaha M., Matsumoto A., Ochi K., Takeuchi M., Sonoda T. Intrarenal arteriovenous malformation. J Urol. 1980;124:315-318.

5.     Abdel-Gawad E.A., Housseini A.M., Cherry K.J., Bonatti H., Maged I.M., Norton PT., Hagspiel K.D. CT angiography of renal arteriovenous fistulae: a report of two cases. Vasc Endovascular Surg. 2009;43:416-420.

6.     Seitz M., Waggershauser T., Khoder W. Congenital intrarenal malformation presenting with gross hematuria after endoscopic intervention: a case report. J Med Case Reports. 2008;2:326.

7.     Donmez F.Y., Coskun M., Uyusur A., Hunca C., Tutar N.U., Ba§aran C., Cakir B. Noninvasive imaging findings of idiopathic renal arteriovenous fistula. Diagn Interv Radiol. 2008;14:103-105.

8.     Lacombe M. Renal arteriovenous fistula following nephrectomy. Urology. 1985;25:13-16.

9.     15. Bozgeyik Z., Ozdemir H., Orhan I., Cihangiroglu M., Cetinkaya Z. Pseudoaneurysm and renal arteriovenous fistula after nephrectomy: two cases treated by transcatheter coil embolization. Emerg Radiol. 2008;15:119-122.

10.   Oleaga J.A., Grossman R.A., McLean G.K., Rosen R.J., Freiman D.B., Ring E.J. Arteriovenous fistula of a segmental renal artery branch as a complication of a percutaneous angioplasty. AJR Am J Radiol. 1981;136:988-989.

11.   Cho K.J., Stanley J.C. Nonneoplastic congenital and acquired renal arteriovenous malformations and fistulas. Radiology. 1978;129:333-343.

12.   Lupattelli T., Garaci F.G., Manenti G., Belli A.M., Simonetti G. Giant high-flow renal arteriovenous fistula treated by percutaneous embolization. Urology. 2003; 61:837.

13.   Saliou C., Raynaud A., Blanc F., Azencot M., Fabiani J.N. Idiopathic renal arteriovenous fistula: treatment with embolization. Ann Vasc Surg. 1998;12:75-77.

14.   6. Campbell J.E., Davis C., Defade B.P., Tierney J.P., Stone P. A. Use of an Amplatzer Vascular Plug for transcatheter embolization of a renal arteriovenous fistula. Vascular. 2009;17:40-43.

15.   7. Trocciola S.M., Chaer R.A., Lin S.C., Dayal R., Scherer M., Garner M., Coll D., Kent K.C., Faries P.L. Embolization of renal artery aneurysm and arteriovenous fistula: a case report. Vasc Endovascular Surg.2005;39: 525-529.

16.   Somani B.K., Nabi G., Thorpe P., Hussey J., McClinton S. Therapeutic transarterial embolisation in the management of benign and malignant renal conditions. Surgeon. 2006;4:348-352.

17.   Carrafiello G., Lagana D. Gross hematuria caused by a congenital intrarenal arteriovenous malformation: a case report. Journal of Medical Case Reports. 2011; 5:510.

Abstract:

Aim: was to proceed comparative analysis of immediate and long-term results of chemoradiation treatment of unresectable local-spread oropharyngeal cancer with use of standart chemoradiatior therapy with intravenous chemoinjection and individual volume-controlled superselective intraarterial chemotherapy.

Materials and methods: 43 patients with unresectable oropharyngeal cancer were included in trial comparing intra-arterial (IA) and intravenous (IV) chemoradiation. IV chemoradiation (n=19 patients) comprised 3-4 times of 100 mg/m2 cisplatin infusion on days 1, 22, 43 combined 2Gy x 5 days fractions with total radiation dose 72Gy The IA chemoradiation group (n=24) comprised 3 or 4 x 90 mg/m2 cisplatin administered in the tumor-feeding artery by personified volume- controlled targeted perfusion. The induction IA chemotherapy was given one day before radiation. Then IA chemotherapy conducted regularly 22, 43, 64 days followed radiation.

Results: we made 86 IA procedures and had no IA-related death or procedure related complications. Five patients of IA group were excluded from long term analysis because of non-comleted protocol. The median follow-up was 21±2.3 months in IA group and 36 months in all patients in IV therapy group. In 19 patients received IA chemoradiotherapy protocol - 100% complete response (CR) and in IV chemoradiotherapy - only in 10 (53%) of 19 patients (ф = 6,820, р<0.05). CR was noted in 8 patients with N1 lymph-nodes and in 9 of 10 patients with N2 lymph nodes in IA therapy group. Initial lymph nodes regress more than 80-90% was observed and follow up improvement was confirmed by PET-CT. One-year overall survival (OS) rates were 95% and 79%, respectively in IA and IV groups (not significant OR = 4,8; ф = 1,51; р = 0,05), but two year OS rates were 90% and 58%, respectively (р<0,05). These data are encourage but further follow-up results need to be investigated. 

 

References

1.     Paches A.I. Opukholi golovy i shei [Head and neck cancer]. Moscow. 2013: 478 [In Russ].

2.     Korytova L.I., Sokurenko V.P., Maslennikova A.V. Sovremennye tendentsii v terapii mestnorasprostranennogo raka rotoglotki i polosti rta [Current trends in the treatment of locally advanced cancers of the oropharynx and oral cavity].Saint Petersburg. 2011; 112. [In Russ].

3.     Perevodchikova N.I., Gorbunova V.A. Rukovodstvo po khimioterapii opukholevykh zabolevaniy [Guidelines for chemotherapy of tumor diseases] .Moscow. 2015; 154-158 [In Russ].

4.     Alieva S.B., Tkachev S.I., Romanov I.S. et all. Varianty i rezultaty khimioluchevoy terapii bolnykh s mestnorasprostranennym ploskokletochnym rakom glotki [Modifications and results of chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the pharynx]. Meditsinskaya radiologiya i radiatsionnaya bezopasnost. 2012; 57 (3): 32-38 [In Russ].

5.     Pignon J. P, Bourhis J., Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analises of updated individual date. Lancet. 2000. 355(9208):949-55.

6.     Browman G.P, Hodson D.I., Mackenzie R.J. et al. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head Neck. 2001; 23(7):579-89.

7.     Granov A.M., Davydov M.I. Interventsionnaya radiologiya v onkologii [Interventional radiology in oncology]. Saint Petersburg. 2013; 560 [In Russ].

8.     Kovacs A.F. Intraarterial induction high-dose chemotherapy with cisplatin for oral and oropharyngeal cancer: Long-term result.Br. J. Cancer. 2004. 90(7): 1323-1328.

9.     Robbins K. T., Kumar P., Harris J. et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: Results of radiation therapy. Oncology Group trial 9615. J. Clin. 0ncol.2005;23(7):1447-54.

10.   Olshanskiy M.S., Znatkova N.A., Stikina S.A., Redkin A.N., Sukhochev E.N., Zdobnikov V.B., Konstantinova Yu.S. et all. Superselective himioinfuziya and intraarterial chemoembolization of tumor blood vessels with chemoradiation therapy for inoperable cancer of the oropharynx. Trudy XX Rossiyskogo onkologicheskogo kongressa «Zlokachestvennye opukholi» [Proc. XX Ros. Cancer congress «Malignant tumors»]. Moscow. 2016;4: 190-191 [In Russ].

11.   Rhode S., Paul M. C., Martens E. et al. Simulation of haemodynamic flow in head and neck cancer chemotherapy. Biomed. Enq. Online. 2011; 10.1186/1475-925X-10-104.

12.   Kumar P., Robbins K.T. Treatment of advanced head and neck cancer with intra-arterial cisplatin and concurrent radiation therapy: the “RADPLAT” protocol. Curr. Oncol. Rep. 2001;3(1):59-65.

13.   Robbins K.T., Kumar P., Regine W.F. et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: The Memphis experience. Int. J. Radiat. Oncol. Biol. Phys. 1997; 38(2):263-71.

14.   Robbins K.T., Kumar P., Wong FS, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck. 2000; 22(7):687-93.

15.   Yoshizaki T., Wakisaka N., Murono S. et al. Intraarterial chemotherapy less intensive than RADPLAT with concurrent radiotherapy for resectable advanced head and neck squamouse cell carcinoma: a prospective study. Ann. Otol. Rhinol. Laryngol. 2007;116(10):754-61.

 

Abstract:

Aim: was to estimate efficacy and safety of carotid stenting and carotid endarterectomy Г patients, admitted to center of cardiovascular surgery.

Material and methods: we investigated possibilities of treatment with randomization one-by-one, according to admittance to hospital and use of carotid endarterectomy or stenting. Final decision in each case was made by consilium. For the period 2011-2013, 269 patients were treated including 132 patients who underwent carotid endarterectomy and 137 patients who underwent carotid stenting. The majority of patients had an anamnesis of coronary heart disease or needed coronary revascularization. Symptomatic stenosis was an indication for 19,0 % revascularization in both groups (p = 0.994).

Results: there were no in-hospital deaths registered. Incidence of stroke after carotid endarterectomy was 6(4,5%) and 2(1,5%) after stenting. Transient ischemic attack occurred in 3(2,2 %) patients in the stenting and 1 patient (0,76 %) in endarterectomy groups. Major bleeding was observed in both groups with equal frequency (p = 0,584). Defeat of cranial nerves (7,6 %; p = 0,001) was only observed in the endarterectomy group. Finally both methods of carotid revascularization showed the same level of complications (p = 0,569) besides cranial nerve defeat.

Conclusion: carotid stenting and endarterectomy show similar results in the treatment of patients with atherosclerotic lesions of carotid arteries. Both methods can equally be used in clinics with adequate experience in surgical interventions on the heart and peripheral vessels. The complex assessment of the patient and the lesion by the vascular team is necessary.

 

References

1.     Casserly I.P, Sachar R., Yadav J.S. Practical peripheral vascular interventions. Second edition. Wolters Kluwer Health/Lippincott Williams & Wilkins. Philadelphia. 2011; 466 p.

2.     Cutlip D. E., Pinto D. S. Extracranial carotid disease revascularization. Circulation. 2012; 126(22): 2636-2644.

3.     Eller J. L., Dumont T. M., Sorkin G. C., Mokin M., Levy E. I., Kenneth V., L. Hopkins N., Siddiqui A. H. Endovascular advances for extracranial carotid stenosis. Neurosurgery. 2014; 74: 92-101.

4.     Al - Damluji M. S., Nagpal S., Stilp E., Remetz M., Mena C. Carotid revascularization: A systematic review of the evidence. J. Interv. Card. 2013; 26 (4): 399- 410.

5.     Tendera M., Aboyans V., Bartelink M-L., Baumgartner I., Clement D., Collet J-P, Cremonesi A., De Carlo M., Erbel R., Gerry F., Fowkes R., Heras M., Kownator S., Minar E., Ostergren J., Poldermans D., Riambau D., Roffi M., Rother J., Sievert H., van Sambeek M., Zeller T. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. European Heart Journal. 2011; 32: 2851 - 2906.

6.     White C. J., Ramee S. R., Collins T. J., Jenkins J. S., Reilly J. P, Patel R. A. G. Carotid artery stenting: patient, lesion, and procedural characteristics that increase procedural complications. Catheterization and Cardiovasc. Interv. 2013; 82: 715-726.

7.     Tas M. H., Simsek Z., Colak A., Koza Y, Demir P, Demir R., Kaya U., Tanboga I. H., Gundogdu F., Sevimli S. Comparison of carotid artery stenting and carotid endarterectomy in patients with symptomatic carotid artery stenosis: A single center study. Adv. Ther. 2013; 30: 845 853.

8.     Doig D., Brown M. M. Carotid stenting versus endarterectomy. Annu. Rev. Med. 2012; 63: 259-276.

9.     Ballotta E., Angelini A., Mazzalai F., Piatto G., Toniato A., Baracchini C. Carotid endarterectomy for symptomatic low-grade carotid stenosis. J. Vasc. Surg. 2014; 59(1): 25-31.

10.   Jashari F., Ibrahimi P., Nicoll R., Bajractari G., Wester P., Henein M. I. Coronary and carotid atherosclerosis: similarities and differences. Atherosclerosis. 2013; 227: 193-200.

11.   Schermerhorn M.L., Fokkema, M., Goodney P., Dillavou, E. D., Jim J., Kenwood C. T., Siami F. S., White R. A. The impact of Centers for Medicare and Medicaid Services high-risk criteria on outcome after carotid endarterectomy and carotid artery stenting in the SVS Vascular Registry. J. Vasc. Surg. 2013; 57: 1318 - 1324.

12.   Roffi M., Sievert H., Gray W. A., White C. J., Torsello G., Cao P., Reimers B., Mathias K., Setacci C., Schonholz C., Clair D. G., Schillinger M., Grunwald I., Bosiers M., Abou-Chebl A., Moussa I. D., Mudra H., Iyer S. S., Scheinert D., Yadav J. S., van Sambeek M. R., Holmes D. R., Cremonesi A. Carotid artery stenting versus surgery: adequate comparisons? Lancet. Neurol. 2010; 9: 339 - 341.

13.   Timaran C.H., Mantese V. A., Malas M., Brown O. W., Lal B. K., Moore W. S., Vocks J. H., Brott T. G. Differential outcomes of carotid stenting and endarterectomy performed exclusively by vascular surgeons in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). J. Vasc. Surg. 2013; 57: 303-308.

14.   Fokkema M., de Borst G. J., Nolan B. W., Indes J., Buck D. B., Lo R. C., Moll F. L., Schermerhorn M. L. Clinical relevance of cranial nerve injury following carotid endarterectomy. Eur. J. Vasc. and Endovasc. Surg. 2014; 47(1): 2-7.

15.   Thirumala P., Kumar H., Bertolet M., Habeych M., Crammond D., Balzer J. Risk factors for cranial nerve deficits during carotid endarterectomy: A retrospective study. Clinical Neurol. and Neurosurg. 2015; 130:150-154.

 

 

 

 

Abstract:

Diffuse liver lesion is one of the leading positions in the structure of hepatobiliary pathology Dispite the large number of available diagnostic methods biopsy followed by histological examination is a «gold standart» untill now. Bioimpedancemetry is a potential method of evaluation of morpho-functional analysys of the organ.

Aim: was to clarify dependence of indices of an electrical impedance of liver tissue on its morfo-functional status and to define general valuation principles of absolute and relative measures of an electrical impedance of an organ in case of liver diffusion pathology in an experiment.

Metarials and methods: the experimental study was carried out on 66 Wistar rats 180-230 g. The diffuse liver failure was modeled by using 0,02% solution of N-nitrozodiethylamin with water that animals were drinking during all the period of experiment (120 days). Bioimpedancemetry and morphological investigation as a next step were performed on 14, 30, 60, 90, 120 days in parallel with biochemical blood analysis, sonography of the liver and morphological analysis.

Results: biophysical parameters of liver's parenchyma in cases of toxic hepatitis were characterized by increasing of absolute bioimpedance indices more than 50% and increasing of impedance dispersion coefficient of 16%. But in cases of drrhosis of the liver biophysical paremeters were characterized by decreasing of absolute indices of electrical impedance and increasing of heterogeneity coefficient of the liver of 50 to 100% at different measurement frequencies.

Conclusion: obtained data confirm the diagnostic value of bioimpedancemetry and give prerequisites for further studying of parameters of an electric impedance of liver parenchyma in clinical practice.  

 

References

1.     Shirokikh I.N., Mavlitova L.A., Tuev A.V., Khlynova O.V Diagnostika fibroza pecheni: ideal'ny li metody? [Liver fibrosis diagnosis: are methods perfect?] Permskiy meditsinskiy zhurnal. 2013; 30(3): 93-102 [In Russ].

2.     Yuschuk N.D., Znoyko O.O., Dudina K.R., Belyy PA. Problema virusnogo gepatita C v Rossijskoj Federacii. [The problem of viral hepatitis C in the Russian Federation.] Terapevticheskiyarkhiv. 2014; 86 (10): 77-81 [In Russ].

3.     Fedeli U., Avossa F., Guzzinati S., Bovo E., Saugo M. Trends in mortality from chronic liver disease. Ann. Epidemiol. 2014; 24(7): 522-526.

4.     Morozov S.V., Isakov V.A., Kaganov B.S. Sovremennye metody neinvazivnoj ocenki vyrazhennosti fibroza pecheni. [Modern methods of non-invasive evaluation of the severity of hepatic fibrosis. ] Infektsionnye bolezni. 2009; 7(4): 44-49 [In Russ].

5.     Saba L., di Martino M., Bosco S., Del Monte M., de Cecco C.N., Lombardo V., Piga M., Catalano C. MDCT classification of steatotic liver: a multicentric analysis. Eur. J. Gastroenterol. Hepatol. 2015; 27 (3): 290-297.

6.     Toosi A.E. Liver Fibrosis: Causes and Methods of Assessment, A Review. Rom. J. Intern. Med. 2015; 53 (4): 304-314.

7.     Beloborodova E.V., Beloborodova E.I., Purlik I.L., Kalacheva T.P. State of the liver at chronic hepatites of various etiology (according to data of morphological study of liver biopsy specimens). Klinicheskie perspektivy gastroenterologii, gepatologii. 2014; 1: 31-36 [In Russ].

8.     Kobyliak N., Abenavoli L. The role of liver biopsy to assess non-alcoholic Fatty liver disease. Rev. Recent Clin. Trials. 2014; 9 (3): 159-169.

9.    Nikolaev D.V., Smirnov A.V., Bobrinskaya I.G., Rudnev S.G. Bioimpedansnyj analiz sostava tela cheloveka. [Bioelectric impedance analysis of human body composition.] Moscow: Nauka. 2009: 392 p. [In Russ].

10.  Rodin A.V., Pleshkov V.G., Leonov S.D. Opredelenie zhiznesposobnosti kishechnika pri ostroj kishechnoj neprohodimosti v ehksperimente. [Determination of the viability of the intestine during experimental acute intestinal obstruction.] Vestnik eksperimentalnoy i klinicheskoy khirurgii. 2011; 4(1): 145-147 [In Russ].

11.  Panchenkov D.N., Leonov S.D., Rodin A.V. Razrabotka algoritma bioimpedansnogo analiza novoobrazovanij na modeli perevivaemoj opuholi RS-1 v ehksperimente [Development of bioimpedance analysis algorithm of tumors on an experimental model with transplanted RS-1 tumor.] Vestnik eksperimentalnoy i klinichesk,oy khirurgii. 2013; 6 (3): 287-291 [In Russ].

12.  Panchenkov D.N., Leonov S.D., Rodin A.V. Bioimpedansnyj analiz v medicine. [Bioimpedance analysis in medicine.] Patologicheskaya fiziologiya i eksperimentalnaya terapiya. 2014; 2: 80-86 [In Russ].

13.   Tornuev Yu.V., Koldysheva E.V., Lapiy G.A., Molodykh O.P., Balakhnin S.M., Bushmanova G.M., Semenov D.E., Preobrazhenskaya V.K. Bioimpedancemetry in the diagnostics of inflammatory process in the mammary gland. Bulletin of Experimental Biology and Medicine. 2014; 156 (3): 381-383.

14.   Abdullaev N.A., Balahnin S.M., Bushmanova G.M., Karpova A. A., Koldysheva E.V., Krinicyna Ju.M., Lapij G.A., Mzhelskaja M.M., Majborodin I.I., Manvelidze R.A., Preobrazhenskaya V.K., Senchukova S.R., Tornuev Y.V., Shelkovnikova N.V., Sholenberg E.V., Yakovleva A.Y. Kriterii differencial'noj diagnostiki novoobrazovanij, gastritov i yazvennoj bolezni zheludka po pokazatelyam bioimpedansa. [Differential diagnostic criteria of tumors, gastritis and gastric ulcer by bioimpedance measuring]. Fundamentalnie issledovaniya. 2015; 1: 1775-1779 [In Russ].

15.   Antonienko S.G., Berdinskikh I.K., Mishnaevskaya E.G. Rol' nekotoryh komponentov sistemy ciklicheskih nukleotidov pri gepatokancerogeneze, inducirovannom N-nitrozdiehtilaminom u krys. [The role of some components of the cyclic nucleotide system in hepatocarcinogenesis induced by N- nitrozdietilaminom in rats.] Eksperimentalnaya onkologiya. 1990; 12 (5): 18-21 [In Russ].

16.   Portyanaya N.I., Osipenko B.G., Moskadynova G.A., Novokhatskiy N.K., Guschina A.A., Dobrolyubova B.A., Chernyak Yu.I., Sokolovskiy V.V. K biohimicheskomu mekhanizmu toksicheskogo dejstviya gidrazinov. [Biochemical mechanism of toxic action of hydrazines.] Materials of the 1 Congress of Toxicologists of Russia. М. 1998; 306 [In Russ].

17.   Bogdanov N.A. Patologiya, klinika i terapiya porazhenij zhidkimi raketnymi toplivami. [Pathology, clinic and therapy of damages with liquid rocket fuel. Leningrad:] VMA. 1970: 152 p [In Russ].

18.   Avakyan A.Kh. Novye molekulyarnye kriterii ocenki toksicheskogo dejstviya proizvodnyh gidrazina. Aktivnye formy kisloroda kak klyuchevye agenty v mekhanizme toksichnosti. [New molecular criteria for assessment the toxic effects of hydrazine derivatives. Reactive oxygen species as key agents in the mechanism of toxicity.] Farmakologiya i toksikologiya. 1990; 53 (1): 70-73 [In Russ].

19.   Obraztsov S.A., Leonov S.D., Troitskiy Yu.V., Fedorov G.N. Ustrojstvo dlya izmereniya impedansa biologicheskih tkanej. [Device to measure biological fabric impedance. ]Patent RF, no 2366360, 2009.

20.   Smorodinov A.V., Leonov S.D. Elektrod dlya provedeniya bioimpedansometrii. [Electrode for performing electric impedancemetry.] Patent RF, no 2318435, 2008.

 

 

authors: 

 

Abstract:

Ischemic stroke (AS) is one of the leading causes of death and disability of the working populatior around the world. According to modern recommendations, mechanical thrombectomy with use of stent-retrievers is the most effective method of treatment for stroke. with localization of thrombus in large cerebral arteries of the carotid basin.

The article presents a literature review devoted to various stent-retrievers, their technical characteristics, and their potential for application in the treatment of acute cerebrovascular accident, ischemic type. The analysis and comparative characteristics of existing modern stent-retrievers are presented, depending on the diameter and artery bend, thromb characteristics, stent characteristics. 

 

References

1.     Savello A.V., Voznjuk I.A., Svistov D.V. Vnutrisosudistoe lechenie ishemicheskogo insul'ta v ostrejshem periode (klinicheskie rekomendacii) [Intravascular treatment of ischemic stroke in acute period (clinical recommendations)]. Sankt-Peterburg. 2015.

2.     Powers W., Derdeyn C., Biller J., et al. Guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association //American Stroke Association Stroke. published online June 29, 2015.

3.     Abou-Chebl A., Bajzer C.T., Krieger D.W., et al. Multimodal therapy for the treatment of severe ischemic stroke combining GP IIb/IIIa antagonists and angioplasty after failure of thromboysis. Stroke. 2005. (36): 2286-2288.

4.     Levy E.I., Ecker R.D., Horowitz M.B., et al. Stent-assisted intracranial recanalization for acute stroke: early results. Neurosurgery. 2006 (58): 458-463.

5.     Gupta R., Vora N.A., Horowitz M.B., et al. Multimodal reperfusion therapy for acute ischemic stroke: factors predicting vessel recanalization. Stroke. 2006 (37): 986-990.

6.     Castano C., Dorado L., Guerrero C., et al. Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke. 2010 (41): 1836-1840.

7.     Kvan der Marel K., Chueh J.Y, Brooks O.W., et al. Quantitative assessment of device-clot interaction for stent retriever thrombectomy. JNeurointervSurg. 2016 (0): 1-6.

8.     Haussen D.,  Lima A., Nogueira R. The Trevo XP 3x20 mm retriever (‘Baby Trevo’) for the treatment of distal intracranial occlusions. J NeuroIntervent Surg. 2016 (8): 2951299.

9.     Kahles T., Garcia-Esperon C., Zeller S., et al. Mechanical thrombectomy using the new ERIC retrieval device is feasible, efficient, and safe in acute ischemic stroke: a swiss stroke center experience. Am. J. Neuroradiol. 2016 (37): 114 -119.

10.   Raoult H., Redjem H., Bourcier R., et al. Mechanical thrombectomy with the ERIC retrieval device: initial experience. J. NeuroIntervent. Surg. 2016 (0): 1-4.

11.   Machi P, Jourdan F., Ambard D., et. al. Experimental evaluation of stent retrievers mechanical properties and effectiveness J. NeuroIntervent. Surg. 2016 (0):1-7.

12.   Schwaiger B., Gersing A., Zimmer C., et al. The curved MCA: influence of vessel anatomy on recanalization results of mechanical thrombectomy after acute ischemic stroke. Am. J. Neuroradiol. 2015 (36): 971-976.

13.   Tetsuya Hashimoto, Mikito Hayakawa, Naoko Funatsu, et al., Histopathologic analysis of retrieved thrombi associated with successful reperfusion after acute stroke thrombectomy. Stroke. 2016 (47): 3035-3037.

14.   Mokin M., Morr S., Natarajan S., et al. Thrombus density predicts successful recanalization with Solitaire stent retriever thrombectomy in acute ischemic stroke. J. Neurointerv. Surg. 2015 (7): 104-107.

15.   Bourcier R., Volpi S., Guyomarch B., et al., Susceptibility vessel sign on MRI predicts favorable clinical outcome in patients with anterior circulation acute stroke treated with mechanical thrombectomy. Am. J. Neuroradi- -2353.

16.   Haussen D., Rebello L., Nogueira R. Optimizating clot retrieval in acute stroke: The push and fluff technique for closed-cell stentrievers. Stroke. 2015 (46): 2838-42.

 

 

  

Abstract:

Article presents the first successful experience of thrombolytic therapy in a patient with severe burns, complicated by pulmonary embolism. Article describes detailed analysis of tactics of treatment, with the help of foreign and domestic recommendtions. Analysis shows that in patient with burns in case of pulmonary embolism, thrombolytic therapy is a method of choice. 

 

References

1.     Trombojembolija legochnoj arterii. Kak lechit' i predotvrashhat' [Pulmonary embolism. How to treat and to prevent.] (Pod red. A.I. Kirienko, A.M. Chernjakovskogo, V.V. Andrijashkina). М.: MIA [MIA], 2015; 280 [In Russ].

2.     Konstantinides S.V., Torbicki A., Agnelli G. et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur. Heart J. 2014; 35(43): 3033-3069, 3069a-3069k.

3.     Kearon C., Akl E.A., Comerota A.J. et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest. 2012; 141 (2, Suppl): e419S- e494S.

4.     Rossijskie klinicheskie rekomendacii po diagnostike, lecheniju i profilaktike venoznyh trombojebolicheskih oslozhnenij. [Russian clinical recommendations on diagnostics, treatment and prophylaxis of venous thromboembolic complications.] Flebobgija. 2010; 1(2): 5-37 [In Russ].

5.     Bershtejn L.L. Trombojembolija legochnoj arterii: klinicheskie projavlenija i diagnostika v svete novyh rekomendacij Evropejskogo obshhestva kardiologov. [Pulmonary embolism: clinical presentation and diagnosis in the view of recommendations of the European Society of Cardiology] Kardiologija. 2015; 4: 111-119 [In Russ].

6.     Bershtejn L.L. Trombojembolija legochnoj arterii u pacienta so stabil'noj gemodinamikoj. [Pulmonary embolism in patients with stable hemodynamics]. Jeffektivnaja farmakoterapija. 2015; (24): 10-15 [In Russ].

7.     Charnaja M.A., Morozov Ju.A. Trombozy v klinicheskoj praktike. [Thrombosis in clinical practice]. М.: GJeOTAR-Media [GEOTAR Media], 2009; 224 [In Russ].

8.     Sibagatullin N.G., Zakirova I.A., Hatypov M.G. i dr. Ob jeffektivnosti tromboliticheskoj terapii pri lechenii trombojembolii legochnoj arterii v pozdnie sroki. [The effectiveness of thrombolytic therapy in the treatment of pulmonary embolism in later stages]. Kreativnaja onkologija i hirurgija. Jelektronnyj nauchno-prakticheskij zhurnal. 2013; 3: URL: http://eoncosurg.com/ob-effektivnosti-tromboliticheskojt [In Russ].

9.     Kurakina E.A. Sravnenie jeffektivnosti tromboliticheskoj i antikoaguljantnoj terapii geparinom pri trombojembolii legochnoj arterii promezhutochnogo riska. [Effectiveness of thrombolytic and anticoagulant therapy with in comparison with heparin in pulmonary embolism of intermediate risk]. Fundamental'nye issledovanija. 2012; 4(1): 69-731[In Russ].

10.   Kungurcev E.V., Mihajlov I.P., Kosolapov D.A. i dr. Sravnitel'nyj analiz lechenija bol'nyh s trombozami glubokih ven nizhnih konechnostej, oslozhnivshihsja TJeLA. Geparin ili trombolizis? [A comparative analysis of the treatment of patients with deep venous thrombosis of lower limbs, complicated by pulmonary embolism. Heparin or thrombolysis?]. Zhurnal im. N.V. Sklifosovskogo. Neotlozhnaja medicinskaja pomoshh'. 2012; 3: 25-28 [In Russ].

 

 

 

Abstract:

Endovascular treatment of thoracic aortic dissection type B is the method of choice in complicated cases. These interventions are obviously less traumatic, accompanied by less blood loss, shorten the length of stay in the intensive care unit, and there is a smaller number of complications. Successful treatment requires careful planning and determination of the existence of conditions for the implantation of endovascular prostheses. It is important to analyze the question of vascular approach, the availability of landing zone, the feasibility of switching aorta branches before implantation etc. However, you can have experience of not predicted of intraoperative complications. 

Article presents two clinical cases of implantation of stent-grafts in patients with challenging anatomy of the defeat of the thoracic aorta. In both cases, we used hybrid approach. In each case we used carotid-subclavian shunting before implantation of the stent-graft and in one case we usee «chimney» technique. Thoracic Endovascular Aortic Repair in these patients was accompanied by certain difficulties. Anatomical difficulties were overcome by using of not standart technique during operation.

 

References

1.     Rukovodstvo po kardiologii [Cardiology: guide-book]. V 4-h tomah. (Pod red. E.I. Chazova). M.: Praktika, 2014; 545-555 [ In Russ].

2.     Howard D.P, Banerjee A., Fairhead J.F. et al. Population-Based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study. Circulation 2013; 127:2031-2037.

3.  Hramcov, A.I., Hramcova G.F. Kliniko-morfologicheskoj harakteristike rasslaivajushhih anevrizm aorty. Mediko-social'nye problemy profilaktiki, diagnostiki i lechenija zabolevanij [Clinical and morphological charateristics of ruptured aortic aneurysms. Medical-social problems of prophylaxis, diagnostics and treatment of this disease]: Sbornik nauchnyh trudov. SPb., SPbGMA, 2000; 256 [In Russ].

4.     Borst H.G., Heinemann M.K., Stone C.D. Surgical treatment of aortic dissection. New York : Churchill Livingstone, 1996.

5.     Crawford M.H. Cardiology Clinics. - 1999;17(4): 609-854.

6.     Januzzi J.L., Eagle K.A., Cooper J.V. et al. Acute aortic dissection presenting with congestive heart failure: results from the International Registry of Acute Aortic Dissection. J. Am. Coll. Cardiol. 2005; 46:733-735.

7.     Burakovskij V.A., Bokerija L.A. Serdechno-sosudistaja hirurgija[Cardiovascular surgery] M. : Medicina; 1989 [In Russ].

8.     Moro H., Hayashi J., Sogawa M. Surgical management of the ruptured aortic arch. Ann. Thorac. Surg. 1999; 67: 593-594.

9.     Chiappini B., Schepens M., Tan E. et al. Early and late outcomes of acute type A aortic dissection: analysis of risk factors in 487 consecutive patients. Eur. Heart J. 2005; 26:180-186.

10.   Trimarchi S., Nienaber C.A., Rampoldi V. et al. Contemporary results of surgery in acute type A aortic dissection: The International Registry of Acute Aortic Dissection experience. J. Thorac. Cardiovasc. Surg. 2005; 129: 112-122.

11.   Perko M.J., Norgaard M., Herzog T. M. Et al. Unoperated aortic aneurysm: a survey of 170 patients. Ann. Thorac. Surg. 1995; 59:1204-1209.

12.   Grabenwoger M., Alfonso F., Bachet J. et al. Thoracic Endovascular Aortic Repair (TEVAR) for the treatment of aortic diseases: apposition statement from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 2012; 33: 1558-1563.

13.   Akchurin R.S., Imaev TJe., Komlev A.E. i dr. Varianty debranshinga dugi aorty pri gibridnyh hirurgicheskih vmeshatel'stvah [Debranching of aortic arch in hybrid surgical interventions]. Klinicheskaja fiziologija krovoobrashhenija. 2016; 13(2): 102-107 [In Russ].

14.   Bokerija L.A., Alekjan B.G. Rukovodstvo po rentgenjendovaskuljarnoj hirurgii serdca i sosudov [Guide-book on endovascular surgery of heart and vessels]. Tom 1 М: NCSSH  im A.N.Bakuleva RAMN, 2008 [in Russ]. 

15.  Akchurin R.S., Imaev TJe., Kolegaev A.S. i dr. Jendovaskuljarnoe lechenii spontannogo razryva aorty [Endovascular treatment of spontaneous aortic rupture]. Angiologija i sosudistaja hirurgija. 2015; 21(3): 168-172 [In Russ].

16.   Ishida M., Kato N., Hirano T. et al. Endovascular stent-graft treatment for thoracic aortic aneurysms: short-to-midterm results. J.Vasc.Interv.Radiol. 2004; 361-367.

 

 

 

Abstract:

Endovascular aortic repair (EVAR) proved to be safe and effective alternative to surgical treatment of abdominal aortic aneurism (AAA). Type II endoleaks development is the most frequent complication after EVAR that increases the rate of reinterventions and it is need to be treated in the case of aneurysm sac growth for rupture prevention. We present long-term results of the first case in our hospital of endovascular type II endoleak treatment. One month after EVAR of big AAA in high-risk patient type II endoleak on computer tomography (CT) was seen. 16 month after patient complained on lumbar and abdominal pain, expansion of endoleak size was seen on CT To prevent aneurysm sac rupture we performed endoleak' embolization with coil and micro-particles with good result during follow up period more than 3 years. Total follow-up period is more than 5 years, all elements of endograft are stable, aneurysm cavity decreased in diameter on 23 mm. Endovascular techniques for AAA treatment and for the treatment of it's possible life-threating complications are effective and safe during long-term follow-up period. 

 

References

1.     Chieba R., Melisano G., Setacci С. History of aortic surgery in the world. 2015; 2-10.

2.     Parodi J.C., Palmaz J.C., Barone H.D. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg. 1991;5:491-499.

3.     Malas M., Arhuidese I., Qazi U., et al. Perioperative mortality following repair of abdominal aortic aneurysms: application of a randomized clinical trial to real-world practice using a validated nationwide data set. JAMA Surg. 2014;149:1260-1265.

5.     Speicher P., Barbas A., Mureebe L.. Open versus endovascular repair of ruptured abdominal aortic aneurysms. Ann Vasc Surg. 2014;28:1239.

6.     Stather P.W., Sidloff D., Dattani N., Choke E., Bown M.J., Sayers R.D. Systematic review and meta-analysis of the early and late outcomes of open and endovascular repair of abdominal aortic aneurysm. Br J Surg. 2013;100(7):863-872.

7.     Lee K., Forbes T. Current understanding of the significance and treatment of type II endoleaks. Ital J Vasc Endovasc Surg. 2012;19:191-197.

8.     Jones J.E., Atkins M.D., Brewster D.C., et al. Persistent type 2 endoleak after endovascular repair of abdominal aortic aneurysm is associated with adverse late outcomes. J Vasc Surg. 2007;46:1-8.

9.     Sidloff D.A., Stather P.W., Choke E., Bown M.J., Sayers R.D. Type II endoleak after endovascular aneurysm repair. Br J Surg. 2013;100:1262-1270.

10.   El Batti S., Cochennec F., Roudot-Thoraval F., Becquemin J.P. Type II endoleaks after endovascular repair of abdominal aortic aneurysm are not always a benign condition. J Vasc Surg. 2013;57:1291-1297.

11.   Tolia A., Landis R., Lamparello P., et al. Type II endoleaks after endovascular repair of abdominal aortic aneurysms: natural history. Radiology. 2005;235:683-686.

12.   Fabre D., Fadel E., Brenot P., Hamdi S., Caro A.G., et al. Type II endoleak prevention with coil embolization during endovascular aneurysm repair in high-risk patients. J Vasc Surg. 2015;62:1-7.

13.   Van Marrewijk C.J., Fransen G., Laheij R.J., Harris P.L., Buth J., et al. Is a type II endoleak after EVAR a harbinger of risk? Causes and outcome of open conversion and aneurysm rupture during follow-up. Eur J Vasc Endovasc Surg. 2004;27:128-137.

14.   Funaki B., Birouti N., Zangan S.M., Van Ha T.G., Lorenz J.M., Navuluri R et al. Evaluation and treatment of suspected type II endoleaks in patients with enlarging abdominal aortic aneurysms. J Vasc Interv Radiol 2012; 23: 866-872.

15.   Malgor R.D., Oderich G.S., Vrtiska T.J., Kalra M., Duncan A.A., et al. A case-control study of intentional occlusion of accessory renal arteries during endovascular aortic aneurysm repair. J Vasc Surg. 2013;58:1467-1475.

16.   Alerci M., Giamboni A., Wyttenbach R., Porretta A.P., Antonucci F., et al. Endovascular abdominal aneurysm repair and impact of systematic preoperative embolization of collateral arteries: endoleak analysis and long-term follow-up. J Endovasc Ther. 2013;20:663-671.

17.   Jamieson R.W., Bachoo P., Tambyraja A.L. Evidence for Ethylene-Vinyl-Alcohol-Copolymer Liquid Embolic Agent as a Monotherapy in Treatment of Endoleaks. Eur J Vasc Endovasc Surg. 2016;51:810-814.

18.   Youssef M., Nurzai Z., Zerwes S., Jakob R., Dьnschede F., et al. Initial Experience in the Treatment of Extensive Iliac Artery Aneurysms With the Nellix Aneurysm Sealing System. J Endovasc Ther. 2016;23:290-296

authors: 

 

Abstract:

Aim: was to assess dynamics of strain (S) and strain rate (SR) of longitudinal, circular and radial fibers in patients with left ventricular (LV) aneurysm (LVA) before and in early stages after coronary artery bypass graft (CABG) using Velocity Vector Imaging.

Material and methods: in 270 segments LV in patients with LVA, S and SR of LV fibers was analyzed before and after CAB. Also analysis of S and SR was performed in patients with CABG and plastic of the LV (group 1, 144 segments) and in the group with CABG without plastic of the LV (group 2, 126 segments).

Results: a function of longitudinal, circular and radial fibers after CABG has improved in all patients. Only SR of radial fibers reached normal. In group 1 was received the positive dynamics from the longitudinal S and SR, and SR circular and radial fibers. In group 2 indicators of function of longitudinal and circular fibers remained without negative dynamics, but positive dynamics is observed only from the SR of the radial fibers. The SR of radial fibers in both groups was normalized.

Conclusion: improvement of LV function in all patients is due to the group I. It is important to study the LV function in patients with LVA depending on the type of surgery.

 

References

1.     Paramonova T.I., Basylev V.V., Vdovkin A.V., Palkova V.A., Karpuchin V.G. Vliyanie operacij rekonstrukcii levogo zheludochka na funkcional'nye i ob"emnye pokazateli u bol'nyh s postinfarktnoj anevrizmoj. [The impact of operations on the reconstruction of the left ventricle function and volume indices in patients with postinfarction aneurism.] Diagnostic radiology and radiotherapy. 2015; 1(6): 74-81 [In Russ].

2.     Dor V., Di Donato M., Civaya F. Postinfarktnoe remodelirovanie levogo zheludochka: magnitno-rezonansnaya tomografiya dlya ocenki patofiziologii posle rekonstrukcii levogo zheludochka. [Post myocardial infarct remodeling: role of magnetic resonance imaging for the assessment of its pathophysiology after left ventricular reconstruction.] Thoracic and Cardiovascular Surgery. 2014; 3: 14-27 [In Russ].

3.     Chernyavskii A.M., Kareva Yu. E., Denisova M.A.,Efendiev V.U. Problema predoperacionnogo modelirovaniya levogo zheludochka. [The problem of preoperative left ventricular modeling.] Cardiology and Cardiovascular Surgery. 2015; 2: 4-7 [In Russ].

4.     Carasso Sh., Biaggi P., Rakowski H. et al. Velocity Vector Imaging: Standart Tissue - Tracking Results Acquired in Normals - The VVI - Strain Study. Journal of the American Society of Echocardiography. 2012; 25(5): 543-552.

5.    Alekhin M.N. Ul'trazvukovye metody ocenki deformacii miokarda i ih klinicheskoe znachenie. [Ultrasound estimation techniques and their clinical significance.] M.: Vidar-M, 2012; 88 p [In Russ].

6.     Rostamzadeh A., Shojaeifard M., Rezaei Y, et al. Diagnostic accuracy of myocardial deformation indices for detecting high risk coronary artery disease in patient without regional wall motion abnormality. Int J Clin Exp Med. 2015; 8(6): 9412-9420.

7.    Pavlyukova E.N., Karpov R.S Deformaciya, rotaciya i povorot po osi levogo zheludochka u bol'nyh ishemicheskoj bolezn'yu serdca s tyazheloj levozheludochkovoj disfunkciej. [Deformation, rotation, and axial torsion of the left ventricle in coronary heart disease patients with its severe dysfunction. ] Terapevticeskij arhiv. 2012;9: 11-16 [In Russ].

8.     Lang R.M., Badano L.P, Mor-Avi V., et al. Recommendation for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. 2015; 16: 233-271.

9.     Helsinki declaration of VMA: Eticheskie principy medicinskih issledovanij s privlecheniem cheloveka, prinyataya 18-j General'noj Assambleej VMA (Hel'sinki, Finlyandiya, iyun’ 1964 п.) [Ethical principles of medical researches with involvement of the person, Accepted by the 18th General Assembly of VMA (Helsinki, Finland, June, 1964). ]http://www. psychiatr.ru/lib/helsinki_declaration.php. (date of the address: 25.05.2015 г.) [In Russ]

 

 

 

Abstract:

Aim: was to determine what dimensions of an end-diastolic volume (EDV) in patients with reducec left ventricular function (LV) higher chances to measure its value up to 50 ml with Echocardiography compared to MRI.

Materials and methods: the sample consisted of 134 patients with ischemic cardiomyopathy and ejection fraction (EF) less than 35%. A mathematical model that calculates what dimensions of the MLC are more likely to determine its size with an accuracy of up to 50 ml with Echocardiography compared to MRI. Produced logistic regression analysis and calculated odds ratios.

Results: аccording to Echocardiography the EDV was 250.5 ± 67.6 ml, EF was 29.4 ± 5.0 percent. According to MRI, the EDV was 249.3 ± 77.2 ml, EF was 29.9 ± 6.4 percent. Results of the logistic regression analysis showed that EDV to 150 ml have high chances of a consistent measure of EDV with Echocardiography and MRI (OR a 2,5). In groups with EDV more than 150 ml but less than 300 ml had low chances of an accurate measurement of the EDV at the Echocardiography (OR from 0,62 to 0,95). Since EDV is greater than 300 ml, a marked increase chances Echocardiography, to determine EDV up to 50 ml compared to MRI (OR from 2,3 to 4,2).

Conclusions: when EDV to 150 ml, and in dilatation of the left ventricle more than 300 ml MRI has no advantages compared to Echocardiography In these figures there is no need to duplicate echocardiographic study When the EDV of 150 to 300 ml, for determination of volumetric indices it is better to use MRI, because the computations do not depend on the geometric shape of the left ventricle.

 

References

1.     Brown M., Schaff N., Suri R. et al. Indexed Left Ventricular Dimensions Best Predict Survival After Aortic Valve Replacement in Patients With Aortic Valve Regurgitation. Ann Thorac Surg. 2009; 87: 1170-1176.

2.     Grayburn P, AppletonC., DeMaria A. et al. Echocardiographic Predictors of Morbidity and Mortality in Patients With Advanced Heart Failure. The Beta-blocker Evaluation of Survival Trial. J Am Coll Cardiol. 2005; 45: 1064-1071.

3.     Kleml., Shah D., White R. et al. Prognostic Value of Routine Cardiac Magnetic Resonance Assessment of Left Ventricular Ejection Fraction and Myocardial Damage. Circ Cardiovasc Imaging. 2011; 4: 610-619.

4.     Malm S., Frigstad S., Sagberg E.; et al. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography a comparison with magnetic resonance imaging. J Am Coll Cardiol. 2004; 44 (5): 1030-1035.

5.     Bogaert J., Dymarkowski S., Taylor A. M. et al. Clinical Cardiac MRI. Springer. 2012; 721.

6.     Kreitner, K-F, Sandstede J. Leitlinien for den Einsatz der MR-Tomographi in der Herzdiagnostik. Fortschr Roentgenstr. 2004; 176: 1185-1193.

7.     Bellenger N.G., Burgess M.I., Ray S.G. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionucleide ventriculography and cardiovascular magnetic resonance. Are they interchangeable? Eur Heart J. 2000; 21: 1387-1396.

8.     Bernard Y, Meneveau N., Boucher S. et al. Lack of agreement between left ventricular volumes and ejection fraction determined by two-dimensional echocardiography and contrast cineangiography in postinfarction patients. Echocardiography. 2001; 18: 113-122.

9.     De Haan S., de Boer K., Commandeur J. et al. Assessment of left ventricular ejection fraction in patients eligible for ICD therapy: Discrepancy between cardiac magnetic resonance imaging and 2D echocardiography. Neth Heart J. 2014; 22 (10): 449-455.

10.   Gardner B., Bingham S., Allen M. et al. Cardiac magnetic resonance versus transthoracic echocardiography for the assessment of cardiac volumes and regional function after myocardial infarction: an intrasubject comparison using simultaneous intrasubject recordings. The J of Cardiovasc ultrasound. 2009; 7: 38.

11.   Bellenger N.G., Francis J.M., Davies L.C. et al. Establishment and performance of a magnetic resonance cardiac function clinic. J Cardiovasc Magn Reson. 1999; 1 (4): 323-330.

12.   Darasz K.H., Underwood S.R., Bayliss J. et al. Measurement of left ventricular volume after anterior myocardial infarction: comparison of magnetic resonance imaging, echocardiography, and radionuclide ventriculography. The Int J of Cardiovasc Imaging. 2002; 18(2): 135-142.

13.   Li C., Lossnitzer D., Katus H.A. et al. Comparison of left ventricular volumes and ejection fraction by monoplane cineventriculography, unenhanced echocardiography and cardiac magnetic resonance imaging. Int J Cardiovasc Imaging. 2012; 28 (5): 1003-1010.

14.   Duncan A.I., Lowe B.S., Garcia M.J. et al. Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement. Ann Thorac Surg. 2008; 85 (6): 2030-2039.

15.   Lang R., Bierig M., Devereux R. et al. Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group. J Am Soc Echocardiogr. 2005; 18: 14401463.

16.   Belenkov Ju.N., Ternovoj S.K., Sinicyn V.E. Magnitno-rezonansnaja tomografija serdca i sosudov [Cardiac and vesssels MRI]. M.: Vidar. 1997; 144 [In Russ].

17.   Di Donato M., Sabatier M., Dor V. Akinetic versus dyskinetic postinfarction scar: relation to surgical outcome in patients undergoing endoventricular circular patch plasty repair. JACC. 1997; 29: 1569-1575.

18.   Hoffmann R., von Bardeleben S., ten Cate F., et al. Assessment of systolic left ventricular function: a multicentre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J. 2005; 26: 607-16.

19.   Jenkins C., Moir S., Chan J. et al. Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging. Eur Heart J. 2009; 30: 98-106.

20.   Lim T.K., Burden L., Janardhanan R., et al. Improved accuracy of low-power contrast echocardiography for the assessment of left ventricular remodeling compared with unenhanced harmonic echocardiography after acute myocardial infarction: comparison with cardiovascular magnetic resonance imaging. J Am Soc Echocardiogr. 2005; 18: 1203-1207.

21.   Thomson H.L., Basmadjian A., Rainbird A. et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: A prospective, randomly assigned, blinded study. J Am Coll Cardiol. 2001; 38: 867-875.

22.   Buziashvili Ju.I., Kljuchnikov I.V., Melkonjan A.M. i soavt. Ishemicheskoe remodelirovanie levogo zheludochka (opredelenie, patogenez, diagnostika, medikamentoznaja i hirurgicheskaja korrekcija) [Ischemic remodeling of left ventricle (determination, pathogenesis, diagnostics, drug and surgical correction]. Kardiologija. 2002; 42 (10): 88-94 [In Russ].

23.   Chernjavskij A.M., Kareva Ju.E., Denisova M.A. i soavt. Problema predoperacionnogo modelirovanija levogo zheludochka [Problem of post-operative remodeling of left ventricle]. Kardiologija i serdechno-sosudistaja hirurgija. 2015; 2: 4-7 [In Russ].

24.   Di Donato M., Castelvecchio S., Kukulski T. et al. Surgical Ventricular Restoration: Left Ventricular Shape Influence on Cardiac Function, Clinical Status, and Survival. Ann Thorac Surg. 2009; 87 (2): 455-461.

25.   Ahn H.S., Kim H.K., Park E.A. et al. Isolated, broad-based apical diverticulum: cardiac magnetic resonance is a «terminator» of cardiac imaging modality for the evaluation of cardiac apex. Korean Circ J. 2013; 43 (10): 702-704.

26.   Lloyd S.G., Buckberg G.D. Use of cardiac magnetic resonance imaging in surgical ventricular restoration. Eur J of Cardiothoracic Surg. 2006; 216-222.

 

 

Abstract:

Aim: was to increase diagnostic value of cardiac CTA (CCTA) by estimation of the CCTA informative value in CA (Coronary arteries) diseases and optimization of OOTA procedure for reducing of radiation dose (RD).

Materials and methods: CCTA informative value in CA diseases was assessed on the base of data of 200 patients (average age of patients was 60,4 (from 35 to 80 years), men/women ratio: 1.94:1(132/68). Parameters of coronary stenosis severities: its localization, extension, degree and characteristics of coronary stenosis. The study was performed with GE Optima 660 128-slice scanner and Missouri Ulrich injector with bolus injecting 60-100 ml of nonionic contrast media (350 mg/ml) at 4-6 ml/sec injector rate. For data processing used: «Auto Coronary Analysis» and «Auto Ejection Fraction» programs at - AW5 workstation.

Results: discovered various severity degrees of atherosclerotic lesions based stenosis intensity up to 50% (46 /23,5%), 50-60% (65/33%), 60-70% (35/17,9%), 70-80% (26/13,5%), 80% and more (23/11,8%). CCTA data coincided with conventional coronary angiography in 89% cases. RD decreasment was achieved by: pitch change depending on heart rate, scan area optimization (reduction), kV and mAc with radiation exposure decline in CCTA to 7,0-8,0 mSv In pitch value increasing to 1,48 - RD decreased to 45% (20 mSv). In prospective synchronization with ECG, RD decreased to 65% (7-12 mSv) as X-Ray tube radiates the highest RD at 70% cardiac cycle phase (120kV/180-200mAc), in other phases (80kV/100 mAc) RD values were lower.

Conclusion: CCTA is a valid non-invasive method in CA pathology diagnostics enabling accurate identification of stenosis location, extent, degree and characteristics. Scanning protocol individualization in CCTA enables significant reduce of RD.

 

References

1.     Kurbanov R.D., Urinov O. Profilaktika osnovnyh faktorov riska osnova snizheniya smertnosti ot serdechnososudistyh zabolevanij. [Prophylaxis of major risk factors-basis of reduction of mortality caused by cardiovascular diseases.] Zdravoohranenie Uzbekistana. 2011; 41, 1-2. [In Russ].

2.     Boguneckiy A.A. Vozmozhnosti magnitno-rezonansnoj tomografii serdca s kontrastnym usileniem v prognozirovanii posleoperacionnoj dinamiki u pacientov s ishemicheskoj bolezn'yu serdca. [Possibilities of cardiac MRI with contrast enhancement in prognosis of post-surgical dynamics in patients with ischemic cardiovascular disease.] Rossiyskiy elektronnyiy zhurnal luchevoy diagnostiki. 2012; 85-86. [In Russ].

3.     Multi-slice and Dual-source CT in Cardiac Imaging. Eds. Ohnesorge B.M., Flohr T.G., Becker C.R. Berlin: Springer. 2006; 359 p.

4.     Fedotenkov I.S., Veselova T.N., Ternovoy S.K., Sinitsyn V.E. Rol' mul'tispiral'noj komp'yuternoj tomografii v diagnostike kal'cinoza koronarnyh arterij. [The role of multispiral computed tomography in the diagnosis of coronary artery calcification.] Cardiologicheskiy vestnik. 2007; II (XIV): 45-48.

5.     Shevchenko I.I. Sravnenie dannyh registrov ostryh koronarnyh sindromov REKORD i REKORD-2: lechenie i ego iskhody v stacionarah, ne imeyushchih vozmozhnosti vypolneniya invazivnyh koronarnyh procedur. [Comparison of the RECORD and RECORD-2 registers data of the acute coronary syndrome: treatment and it’s result in hospitals without ability to carry out invasive manipulations.] Kardiologiya. 2013; 8: 4-10. [In Russ].

6.     Oganov R.G., Pozdnyakov Ju.M., Volkov B.C. Ishemicheskaya bolezn' serdca. [Ischemic heart disease.] M.: Izdatel'skiy Dom Sinergiya, 2002; 308 p. [In Russ].

7.     Ternovoy S.K., Nikonova M.E., Akchurin R.S. et al. Vozmozhnosti mul'tispiral'noj komp'yuternoj tomografii (MSKT) v ocenke koronarnogo rusla i ventrikulografii v sravnenii s intervencionnoj koronaroventrikulografiej. [Possibilities of multispiral computed tomography (MSCT) in assessing of coronary vessels and ventriculography in comparison with interventional coronaroventriculography.] Russian electronic journal of radiation diagnostics. 2013; 3(9): 28-36 [In Russ].

8.     Sinitsyn V.E., Ustjuzhanin D.V. Mul'tispiral'naya komp'yuternaya tomografiya: issledovanie koronarnyh arterij. [Multislice computer tomography: examination of coronary arteries.] Bolezni serdtsa i sosudov. 2006; 1: 20-24. [In Russ].

9.     Coronary Radiology, 2nd edition. Eds. Oudkerk M., Reiser M.F. Berlin: Springer. 2009; 349 p.

10.   Einstein A.J., Elliston C.D., Arai A.E., Chen M.Y. Mather R., Pearson G.D., Delapaz R.L., Nickoloff E., Dutta A., Brenner D.J. Radiation dose from single-heartbeat coronary CT angiography performed with a 320-detector row volume scanner. Radiology. 2010; 254: 698-706.

11.   Vardikov D.F., Yakovleva E.K., Maystrenko D.N. Analiz densitometricheskih pokazatelej koronarnogo rusla pri stenoziruyushchih porazheniyah koronarnyh arterij i posle procedury stentirovaniya metodom ob'emnoj MSKT- koronarografii. [Analysis of densitometric parameters of coronary artery stenosis and after the stenting procedure with the method of volume MDCT coronary angiography.] Luchevaya diagnostika i terapiya. 2015; 3: 53-56. [In Russ].


 

 

 

Abstract:

Anatomical variants of abdominal and retroperitoneal veins are characterized by a great diversity Mostly anomalies are asymptomatic, in some cases they may have clinical manifestations. Information about features of the venous anatomy is necessary when planning surgical operations and interventional procedures in the abdomen and retroperitoneum

Aim: was to increase efficacy of diagnostics of abdomen and retroperitoneal veins' anomalies by evaluating clinical significance of observed changes of veins and analysis of incidence of venous anomalies at MSCT of the abdomen.

Materials and methods: 440 patients with different diseases of the abdomen and retroperitoneum underwent MSCT Anomalies of the inferior vena cava (IVC) and its tributaries were classified by Huntington G.S. and C.F.W. McLure. As the normal anatomy of the portal vein (PV) was taken a «classic» variant of the division into two branches. Normal type of hepatic veins (HV) anatomy meant the presence of three venous trunks independently flowing into the IVC Results: venous malformations were detected in 67% cases, combined with each other in many cases. Most common were aberrations of renal veins (43%), followed by variants of HV (31%), PV (18%) and IVC (1,6%).

Conclusion: our results show the necessity of detailed assessment of venous anatomy during abdominal MSCT for selecting the optimal treatment strategy, planning and the success of surgery.

 

References

1.     Saylisoy S., Atasoy З., Ersoz S., et al. Multislice CT angiography in the evaluation of hepatic vascular anatomy in potential right lobe donors. Diagn IntervRadiol. 2005;11: 51-9.

2.     Muhtarulina S.V., Kaprin A.D., Astashov V.L., Aseeva I.A. Varianty stroenija nizhnej poloj veny i ee pritokov: klassifikacija, jembriogenez, kompjuternaja diagnostika i klinicheskoe znachenie pri paraaortal'noj limfodissekcii [Anatomical variants of inferior vena cava and its tributaries: classification, CT and clinical presentation in case of paraaortic lymph nodes dissection]. Onkourologija. 2013; 3: 10-16 [ In Russ].

3.     Nam J.K., Park S.W., Lee S.D., Chung M.K. The clinical significance of a retroaortic lef renal vein. Korean. J. Urol. 2010; 51(4):276-280.

4.     Huntington G.S., McLure C.F.W. The development of the veins in the domectic cat (felis domestica) with especial reference, 1) to the share taken by the supracardinal vein in the development of the postcava and azygous vein and 2) to the interpretation of the variant conditions of the postcava and its tributaries, as found in the adult. Anatomocal Record. 1920; 20:1-29.

5.     Koc Z., Oguzkurt L., Ulusan S.. Portal vein variations: clinical implications and frequencies in routine abdominal multidetector CT. Diagn Interv Radiol. 2007;13(2):75-80.

6.     Bergman R.A., Thompson S.A., Afifi A.K., Saadeh F.A. Compendium of human anatomic variation. Baltomore: Urban and Schwarzenberg. 1988; 593.

7.     Hassan A., Kammash T.E., Alam A. Multidetector computed tomography of renal vasculature. Anatomy and normal variants. Z.U.M.J. 2014; 20(4): 570-582.

8.     Bass JE, Redwine MD, Kramer LA, Huynh PT, Harris JH Jr. Spectrum of congenital anomalies of the inferior vena cava: cross-sectional imaging findings. Radiographics. 2000; 20(3):639-52.

9.     Yang C, Trad HS, Mendonзa SM, Trad CS. Congenital inferior vena cava anomalies: a review of findings at multidetector computed tomography and magnetic resonance imaging. Radiologia Brasileira. 2013;46(4):227-33.

10.   Rodrigues A., Cobenas R., Gallo J.C. et al. Incidental findings of vascular anatomic variants on computed tomography. RAR. 2013;77(1):1-7.doi: 10.7811/ rarv77n1a03.

11.   Toda R., Iguro Y, Moriyama Y, Hisashi Y, Masuda H., Sakata R. Double left renal vein associated with abdominal aortic aneurysm. Ann. Thorac. Cardiovasc. Surg. 2001;7(2):113-115.

12.   Jimenez R., Morant F. The impotence of venous and renal anomalies for surgical repair of abdominal aortic aneurysms. In: Grudmann R.T., editor. Diagnosis, Screening and Treatment of Abdominal, Thoracoabdominal and Thoracic Aortic Aneurysms. InTech; 2011: 269-275. doi:10.5772/19103.

13.   Nicolov D., Chervenkov V, Vachev E., Staneva M., Gorcheva D. Abdominal aortic repair and inferior vena cava interposition in a patient with ruptured aneurysm. European Jornal of the Vascular and Endovascular Surgery. 2012; 23:31-33.

14.   Polguj M., Szubert W., Topol M., Stefanczyk L. An unusual dublication of the inferior vena cava in patient with endovascular repair for abdominal aortic aneurism. Rom J MorpholEmbryol. 2015; 56(2):875-878.

15.   Cheng D., Zangan S.M. Duplication of the inferior vena cava in a patient presenting for IVC filter placement. J. Vasc. Access. 2010; 11(2):162-164.

16.   Leong S., Oisin F., Barry J.E., Maher M.M., Bogue C.O. Bilateral inferior vena cava filter insertion in a patient with duplication of the infrarenal vena cava. Ir. J. Med. Sci. 2012; 181(3): 389-391.

17.   Akiko Mano, Tetsuya Tatsumi, Hiromi Sakai, Yuko Imoto, Tetsuya Nomura, Susumu Nishkawa, Mitsuo Takeda, Miyuki Kobara, Takuji Yamagami, Hiroaki Matsubara. A case of deep venous thrombosis with a double inferior vena cava effectively treated by suprarenal filter implantation. Jpn Heart J. 2004; 45(6):1063-1069.

18.   Akgul E., Inal M., Soyupak S., et al. Portal venous variations. Prevalence with contrast-enhanced helical CT. Acta Radiol. 2002; 43(3): 315-319.

19.   Atasoy C, Ozybrek E. Prevalence and Types of Main and Right Portal Vein Branching Variations on MDCT. AJR. 2006;187(3):676-681.

20.   Zhuang Z.G., Qian L.J., Zhou Y, Chai W.M., Li Q.G., Xu J.R. Multidetector computed tomography angiography in the evaluation of potential living donors for liver transplantation: single-center experience in China. Transplantation Proceedings. 2008; 40:2466-2477.

21.   Seco M., Donato P., Costa J., Bernardes A., Caseiro-Alves F. Vascular liver anatomy and main variants: what the radiologist must to know. JBR-BTR. 2010. 93: 215-223.

22.   Galjan T.N., Hovrin V.V., Kim S.Ju., Kim Je.F., Semenkov A.V. Ocenka variantnoj sosudistoj anatomii u potencial'nyh zhivyh donorov fragmenta pecheni po dannym magnitno-rezonansnoj i mul'tispiral'noj komp'juternoj tomografii [Estimation of variants of vessel anatomy in potential alive donors of part of liver on the base of MR and CT imaging]. Medicinskaja vizualizacija. 2010; 5: 37-43 [In Russ].

23.   Sahani D., Mehta A., Blake M., Prasad S., Harris G., Saini S. Preoperative hepatic vascular evaluation with CT and MR angiography: implications for surgery. Radio Graphics. 2004; 24: 1367-1380.

24.   Efanov M.G., Vishnevskij V.A., Karmazanovskij G.G. i dr. Spiral'naja komp'juternaja tomografija: vozmozhnosti razlichnyh pokolenij tomografov v opredelenii normal'noj sosudistoj anatomii pecheniju Chast' 2. Anatomija jefferentnyh sosudov pecheni[ Spiral CT: possibilities of different generations of CT-scanners in estimation of normal vascular anatomy of liver]. Annaly hirurgicheskoj gepatologii. 2009;14(3):6-12 [In Russ].

25.   Galjan T.N. Angioarhitektonika i biliarnaja anatomija pecheni rodstvennogo donora po dannym mul'tispiral'noj komp'juternoj i magnitno-rezonansnoj tomografii. Avtoreferat. Diss. kand. med. nauk. Moskva[Vascular architectonics and bile duct anatomy of liver of related donor on the base of CT and MR imaging.]. 2011; 11-12 [In Russ].

26.   Xin Li, Xu Xuesong, Gong Jianping. Clinical Significance of Inferior Right Hepatic Vein. American Journal of Medical Case Reports. 2016; 4(1): 26-30.

27.   Broering D.C., Sterneck M., Rogiers X. Living donor liver transplantation. J Hepatol. 2003; 38(1):119-S135.

28.   Alonso-Torres A., Fernandez-Cuadrado J., Pinilla I. et al. Multidetector CT in the Evaluation of Potential Living Donors for Liver Transplantation. RadioGraphics. 2005; 25:1017-1030.

29.   Hennedige T., Anil G., Madhavan K. Expectations from imaging for pre-transplant evaluation of living donor liver transplantation. World J Radiol. 2014; 6(9): 693-707.

30.   Chen YS., Cheng YF., De Villa V.H. et al. Evaluation of living liver donors. Transplantation. 2003; 75(3 suppl): 16-19.

31.   Lee S.Y, Cherqui D., Kluger M.D. Extended right hepatectomy in a liver with a non-bifurcating portal vein: the hanging maneuver protects the portal system in the presence of anomalies. J Gastrointest Surg. 29 January 2013. DOI 10.1007/s11605-013-2161-1.

32.   Kawamoto S., Montgomery R.A., Lawler L.P., Horton K.M., Fishman E.K. Multidetector CT angiography for preoperative evaluation of living laparoscopic kidney donors. Am. J. Roentgenol. 2003; 180: 1633-1638.

33.   Srivastava A., Sigh K.J., Suri A., Vijjan V., Dubey D. Inferior vena cava in urology: Importance of developmental abnormalities in clinical practice. The Scientific World Jornal. 2005; 5: 558-563.

 

 

 

ANGIOLOGIA.ru (АНГИОЛОГИЯ.ру) - портал о диагностике и лечении заболеваний сосудистой системы